0	1	Inhibition	0	None
1	2	of	0	None
2	4	monoamine oxidase	2	GENE-N
4	5	type	0	None
5	6	A	0	None
6	7	,	0	None
7	8	but	0	None
8	9	not	0	None
9	10	type	0	None
10	11	B	0	None
11	12	,	0	None
12	13	is	0	None
13	14	an	0	None
14	15	effective	0	None
15	16	means	0	None
16	17	of	0	None
17	18	inducing	0	None
18	19	anticonvulsant	0	None
19	20	activity	0	None
20	21	in	0	None
21	22	the	0	None
22	23	kindling	0	None
23	24	model	0	None
24	25	of	0	None
25	26	epilepsy	0	None
26	27	.	0	None

28	29	The	0	None
29	30	anticonvulsant	0	None
30	31	activity	0	None
31	32	of	0	None
32	33	inhibitors	0	None
33	34	of	0	None
34	36	monoamine oxidase	2	GENE-N
36	37	(	0	None
37	38	MAO	2	GENE-N
38	39	)	0	None
39	40	was	0	None
40	41	reported	0	None
41	42	early	0	None
42	43	after	0	None
43	44	the	0	None
44	45	development	0	None
45	46	of	0	None
46	47	irreversible	0	None
47	48	MAO	2	GENE-N
48	49	inhibitors	0	None
49	50	such	0	None
50	51	as	0	None
51	52	tranylcypromine	3	CHEMICAL
52	53	,	0	None
53	54	but	0	None
54	55	was	0	None
55	56	never	0	None
56	57	clinically	0	None
57	58	used	0	None
58	59	because	0	None
59	60	of	0	None
60	61	the	0	None
61	62	adverse	0	None
62	63	effects	0	None
63	64	of	0	None
64	65	these	0	None
65	66	compounds	0	None
66	67	.	0	None

68	69	The	0	None
69	70	more	0	None
70	71	recently	0	None
71	72	developed	0	None
72	73	reversible	0	None
73	74	MAO	2	GENE-N
74	75	inhibitors	0	None
75	76	with	0	None
76	77	selectivity	0	None
77	78	for	0	None
78	79	either	0	None
79	80	the	0	None
80	81	MAO	2	GENE-N
81	82	-	0	None
82	83	A	0	None
83	84	or	0	None
84	85	MAO	2	GENE-N
85	86	-	0	None
86	87	B	0	None
87	88	isoenzyme	0	None
88	89	forms	0	None
89	90	have	0	None
90	91	not	0	None
91	92	been	0	None
92	93	studied	0	None
93	94	extensively	0	None
94	95	in	0	None
95	96	animal	0	None
96	97	models	0	None
97	98	of	0	None
98	99	epilepsy	0	None
99	100	,	0	None
100	101	so	0	None
101	102	it	0	None
102	103	is	0	None
103	104	not	0	None
104	105	known	0	None
105	106	which	0	None
106	107	type	0	None
107	108	of	0	None
108	109	MAO	2	GENE-N
109	110	inhibitor	0	None
110	111	is	0	None
111	112	particularly	0	None
112	113	effective	0	None
113	114	in	0	None
114	115	this	0	None
115	116	respect	0	None
116	117	.	0	None

118	119	We	0	None
119	120	compared	0	None
120	121	the	0	None
121	122	following	0	None
122	123	drugs	0	None
123	124	in	0	None
124	125	the	0	None
125	126	kindling	0	None
126	127	model	0	None
127	128	of	0	None
128	129	epilepsy	0	None
129	130	:	0	None
130	131	1	0	None
131	132	)	0	None
132	133	L	0	None
133	134	-	0	None
134	135	deprenyl	0	None
135	136	(	0	None
136	137	selegiline	0	None
137	138	)	0	None
138	139	,	0	None
139	140	i	0	None
140	141	.	0	None
141	142	e	0	None
142	143	.	0	None
143	144	,	0	None
144	145	an	0	None
145	146	irreversible	0	None
146	147	inhibitor	0	None
147	148	of	0	None
148	149	MAO	2	GENE-N
149	150	-	0	None
150	151	B	0	None
151	152	,	0	None
152	153	which	0	None
153	154	,	0	None
154	155	however	0	None
155	156	,	0	None
156	157	also	0	None
157	158	inhibits	0	None
158	159	MAO	2	GENE-N
159	160	-	0	None
160	161	A	0	None
161	162	at	0	None
162	163	higher	0	None
163	164	doses	0	None
164	165	,	0	None
165	166	2	0	None
166	167	)	0	None
167	168	the	0	None
168	169	novel	0	None
169	170	reversible	0	None
170	171	MAO	2	GENE-N
171	172	-	0	None
172	173	B	0	None
173	174	inhibitor	0	None
174	176	LU 53439	3	CHEMICAL
176	177	(	0	None
177	178	3	0	None
178	179	,	0	None
179	180	4	0	None
180	181	-	0	None
181	182	dimethyl	0	None
182	183	-	0	None
183	184	7	0	None
184	185	-	0	None
185	186	(	0	None
186	187	2	0	None
187	188	-	0	None
188	189	isopropyl	0	None
189	190	-	0	None
190	191	1	0	None
191	192	,	0	None
192	193	3	0	None
193	194	,	0	None
194	195	4	0	None
195	196	-	0	None
196	197	thiadiazol	0	None
197	198	-	0	None
198	199	5	0	None
199	200	-	0	None
200	201	yl	0	None
201	202	)	0	None
202	203	-	0	None
203	204	methoxy	3	CHEMICAL
204	205	-	0	None
205	206	coumarin	3	CHEMICAL
206	207	)	0	None
207	208	,	0	None
208	209	which	0	None
209	210	is	0	None
210	211	much	0	None
211	212	more	0	None
212	213	selective	0	None
213	214	for	0	None
214	215	MAO	2	GENE-N
215	216	-	0	None
216	217	B	0	None
217	218	than	0	None
218	219	L	0	None
219	220	-	0	None
220	221	deprenyl	0	None
221	222	,	0	None
222	223	3	0	None
223	224	)	0	None
224	225	the	0	None
225	226	novel	0	None
226	227	reversible	0	None
227	228	and	0	None
228	229	highly	0	None
229	230	selective	0	None
230	231	MAO	2	GENE-N
231	232	-	0	None
232	233	A	0	None
233	234	inhibitor	0	None
234	236	LU 43839	0	None
236	237	(	0	None
237	238	esuprone	3	CHEMICAL
238	239	;	0	None
239	240	7	0	None
240	241	-	0	None
241	242	hydroxy	3	CHEMICAL
242	243	-	0	None
243	244	3	0	None
244	245	,	0	None
245	246	4	0	None
246	247	-	0	None
247	248	dimethylcoumarin	0	None
248	249	ethanesulfonate	0	None
249	250	)	0	None
250	251	,	0	None
251	252	and	0	None
252	253	4	0	None
253	254	)	0	None
254	255	the	0	None
255	256	irreversible	0	None
256	257	nonselective	0	None
257	258	MAO	2	GENE-N
258	259	inhibitor	0	None
259	260	tranylcypromine	3	CHEMICAL
260	261	.	0	None

262	263	Esuprone	3	CHEMICAL
263	264	proved	0	None
264	265	to	0	None
265	266	be	0	None
266	267	an	0	None
267	268	effective	0	None
268	269	anticonvulsant	0	None
269	270	in	0	None
270	271	the	0	None
271	272	kindling	0	None
272	273	model	0	None
273	274	with	0	None
274	275	a	0	None
275	276	similar	0	None
276	277	potency	0	None
277	278	as	0	None
278	279	L	0	None
279	280	-	0	None
280	281	deprenyl	0	None
281	282	.	0	None

283	284	In	0	None
284	285	contrast	0	None
285	286	to	0	None
286	287	esuprone	3	CHEMICAL
287	288	and	0	None
288	289	L	0	None
289	290	-	0	None
290	291	deprenyl	0	None
291	292	,	0	None
292	293	the	0	None
293	294	selective	0	None
294	295	MAO	2	GENE-N
295	296	-	0	None
296	297	B	0	None
297	298	inhibitor	0	None
298	300	LU 53439	3	CHEMICAL
300	301	was	0	None
301	302	not	0	None
302	303	effective	0	None
303	304	in	0	None
304	305	the	0	None
305	306	kindling	0	None
306	307	model	0	None
307	308	;	0	None
308	309	this	0	None
309	310	substantiates	0	None
310	311	the	0	None
311	312	previous	0	None
312	313	notion	0	None
313	314	that	0	None
314	315	the	0	None
315	316	anticonvulsant	0	None
316	317	activity	0	None
317	318	of	0	None
318	319	L	0	None
319	320	-	0	None
320	321	deprenyl	0	None
321	322	is	0	None
322	323	not	0	None
323	324	related	0	None
324	325	to	0	None
325	326	MAO	2	GENE-N
326	327	-	0	None
327	328	B	0	None
328	329	inhibition	0	None
329	330	,	0	None
330	331	but	0	None
331	332	to	0	None
332	333	other	0	None
333	334	effects	0	None
334	335	of	0	None
335	336	this	0	None
336	337	drug	0	None
337	338	,	0	None
338	339	such	0	None
339	340	as	0	None
340	341	inhibition	0	None
341	342	of	0	None
342	343	MAO	2	GENE-N
343	344	-	0	None
344	345	A	0	None
345	346	.	0	None

347	348	Drugs	0	None
348	349	inhibiting	0	None
349	350	both	0	None
350	351	MAO	2	GENE-N
351	352	-	0	None
352	353	A	0	None
353	354	and	0	None
354	355	MAO	2	GENE-N
355	356	-	0	None
356	357	B	0	None
357	358	to	0	None
358	359	a	0	None
359	360	similar	0	None
360	361	extent	0	None
361	362	(	0	None
362	363	tranylcypromine	3	CHEMICAL
363	364	)	0	None
364	365	or	0	None
365	366	combinations	0	None
366	367	of	0	None
367	368	selective	0	None
368	369	MAO	2	GENE-N
369	370	-	0	None
370	371	A	0	None
371	372	and	0	None
372	373	MAO	2	GENE-N
373	374	-	0	None
374	375	B	0	None
375	376	inhibitors	0	None
376	377	(	0	None
377	378	esuprone	3	CHEMICAL
378	379	plus	0	None
379	381	LU 53439	3	CHEMICAL
381	382	)	0	None
382	383	had	0	None
383	384	no	0	None
384	385	advantage	0	None
385	386	over	0	None
386	387	MAO	2	GENE-N
387	388	-	0	None
388	389	A	0	None
389	390	inhibition	0	None
390	391	alone	0	None
391	392	,	0	None
392	393	but	0	None
393	394	were	0	None
394	395	less	0	None
395	396	well	0	None
396	397	tolerated	0	None
397	398	.	0	None

399	400	The	0	None
400	401	data	0	None
401	402	thus	0	None
402	403	suggest	0	None
403	404	that	0	None
404	405	selective	0	None
405	406	MAO	2	GENE-N
406	407	-	0	None
407	408	A	0	None
408	409	inhibitors	0	None
409	410	such	0	None
410	411	as	0	None
411	412	esuprone	3	CHEMICAL
412	413	may	0	None
413	414	be	0	None
414	415	an	0	None
415	416	interesting	0	None
416	417	new	0	None
417	418	approach	0	None
418	419	for	0	None
419	420	the	0	None
420	421	treatment	0	None
421	422	of	0	None
422	423	epilepsy	0	None
423	424	.	0	None

425	426	Effects	0	None
426	427	of	0	None
427	428	mCPP	0	None
428	429	on	0	None
429	430	the	0	None
430	431	extracellular	3	CHEMICAL
431	432	concentrations	0	None
432	433	of	0	None
433	434	serotonin	3	CHEMICAL
434	435	and	0	None
435	436	dopamine	3	CHEMICAL
436	437	in	0	None
437	438	rat	0	None
438	439	brain	0	None
439	440	.	0	None

441	442	Intravenous	0	None
442	443	administration	0	None
443	444	of	0	None
444	445	m	0	None
445	446	-	0	None
446	447	chloro	3	CHEMICAL
447	448	-	0	None
448	449	phenylpiperazine	0	None
449	450	(	0	None
450	451	mCPP	0	None
451	452	)	0	None
452	453	(	0	None
453	454	0	0	None
454	455	.	0	None
455	456	25	0	None
456	457	or	0	None
457	458	2	0	None
458	459	.	0	None
459	460	5	0	None
460	461	mg	0	None
461	462	/	0	None
462	463	kg	0	None
463	464	)	0	None
464	465	induced	0	None
465	466	a	0	None
466	467	marked	0	None
467	468	and	0	None
468	469	dose	0	None
469	470	-	0	None
470	471	related	0	None
471	472	increase	0	None
472	473	in	0	None
473	474	extracellular	3	CHEMICAL
474	475	concentrations	0	None
475	476	of	0	None
476	477	serotonin	3	CHEMICAL
477	478	in	0	None
478	479	hippocampus	0	None
479	480	(	0	None
480	481	300	0	None
481	482	-	0	None
482	483	1	0	None
483	484	,	0	None
484	485	400	0	None
485	486	%	0	None
486	487	of	0	None
487	488	baseline	0	None
488	489	)	0	None
489	490	as	0	None
490	491	measured	0	None
491	492	using	0	None
492	493	in	0	None
493	494	vivo	0	None
494	495	microdialysis	0	None
495	496	in	0	None
496	497	awake	0	None
497	498	male	0	None
498	499	Wistar	0	None
499	500	rats	0	None
500	501	of	0	None
501	502	the	0	None
502	503	spontaneously	0	None
503	504	hypertensive	0	None
504	505	(	0	None
505	506	SH	3	CHEMICAL
506	507	)	0	None
507	508	strain	0	None
508	509	.	0	None

510	511	Indicating	0	None
511	512	that	0	None
512	513	the	0	None
513	514	effect	0	None
514	515	of	0	None
515	516	mCPP	0	None
516	517	was	0	None
517	518	caused	0	None
518	519	by	0	None
519	520	a	0	None
520	521	reversal	0	None
521	522	of	0	None
522	523	the	0	None
523	525	serotonin transporter	1	GENE-Y
525	526	,	0	None
526	527	it	0	None
527	528	was	0	None
528	529	antagonized	0	None
529	530	by	0	None
530	531	pretreatment	0	None
531	532	with	0	None
532	533	the	0	None
533	534	serotonin	3	CHEMICAL
534	535	re	0	None
535	536	-	0	None
536	537	uptake	0	None
537	538	inhibitor	0	None
538	539	citalopram	3	CHEMICAL
539	540	(	0	None
540	541	10	0	None
541	542	mg	0	None
542	543	/	0	None
543	544	kg	0	None
544	545	)	0	None
545	546	but	0	None
546	547	was	0	None
547	548	unaffected	0	None
548	549	by	0	None
549	550	local	0	None
550	551	administration	0	None
551	552	of	0	None
552	553	the	0	None
553	555	sodium channel	2	GENE-N
555	556	blocker	0	None
556	557	tetrodotoxin	3	CHEMICAL
557	558	(	0	None
558	559	TTX	3	CHEMICAL
559	560	;	0	None
560	561	1	0	None
561	562	microns	0	None
562	563	)	0	None
563	564	.	0	None

565	566	mCPP	0	None
566	567	was	0	None
567	568	also	0	None
568	569	shown	0	None
569	570	to	0	None
570	571	induce	0	None
571	572	an	0	None
572	573	increase	0	None
573	574	in	0	None
574	575	extracellular	0	None
575	576	concentrations	0	None
576	577	of	0	None
577	578	dopamine	3	CHEMICAL
578	579	in	0	None
579	580	the	0	None
580	581	nucleus	0	None
581	582	accumbens	0	None
582	583	and	0	None
583	584	the	0	None
584	585	striatum	0	None
585	586	of	0	None
586	587	SH	3	CHEMICAL
587	588	rats	0	None
588	589	and	0	None
589	590	in	0	None
590	591	the	0	None
591	592	nucleus	0	None
592	593	accumbens	0	None
593	594	of	0	None
594	595	rats	0	None
595	596	of	0	None
596	597	the	0	None
597	598	Sprague	0	None
598	599	-	0	None
599	600	Dawley	0	None
600	601	(	0	None
601	602	SD	0	None
602	603	)	0	None
603	604	strain	0	None
604	605	;	0	None
605	606	this	0	None
606	607	effect	0	None
607	608	of	0	None
608	609	mCPP	0	None
609	610	was	0	None
610	611	,	0	None
611	612	however	0	None
612	613	,	0	None
613	614	much	0	None
614	615	weaker	0	None
615	616	(	0	None
616	617	125	0	None
617	618	-	0	None
618	619	170	0	None
619	620	%	0	None
620	621	of	0	None
621	622	baseline	0	None
622	623	)	0	None
623	624	than	0	None
624	625	the	0	None
625	626	effect	0	None
626	627	on	0	None
627	628	serotonin	3	CHEMICAL
628	629	;	0	None
629	630	moreover	0	None
630	631	,	0	None
631	632	it	0	None
632	633	seems	0	None
633	634	to	0	None
634	635	be	0	None
635	636	TTX	3	CHEMICAL
636	637	-	0	None
637	638	sensitive	0	None
638	639	.	0	None

640	641	In	0	None
641	642	anesthetized	0	None
642	643	SD	0	None
643	644	rats	0	None
644	645	,	0	None
645	646	mCPP	0	None
646	647	induced	0	None
647	648	a	0	None
648	649	moderate	0	None
649	650	reduction	0	None
650	651	of	0	None
651	652	nigral	0	None
652	653	dopamine	3	CHEMICAL
653	654	cell	0	None
654	655	firing	0	None
655	656	rate	0	None
656	657	;	0	None
657	658	supporting	0	None
658	659	the	0	None
659	660	assumption	0	None
660	661	that	0	None
661	662	this	0	None
662	663	effect	0	None
663	664	is	0	None
664	665	secondary	2	GENE-N
665	666	to	0	None
666	667	the	0	None
667	668	observed	0	None
668	669	increase	0	None
669	670	in	0	None
670	671	dopamine	3	CHEMICAL
671	672	release	0	None
672	673	,	0	None
673	674	it	0	None
674	675	was	0	None
675	676	blocked	0	None
676	677	by	0	None
677	678	pretreatment	0	None
678	679	either	0	None
679	680	with	0	None
680	681	the	0	None
681	682	dopamine	3	CHEMICAL
682	683	synthesis	0	None
683	684	inhibitor	0	None
684	685	alpha	0	None
685	686	-	0	None
686	687	methyl	3	CHEMICAL
687	688	-	0	None
688	689	para	0	None
689	690	-	0	None
690	691	tyrosine	3	CHEMICAL
691	692	or	0	None
692	693	with	0	None
693	694	the	0	None
694	697	dopamine D2 receptor	1	GENE-Y
697	698	antagonist	0	None
698	699	haloperidol	3	CHEMICAL
699	700	.	0	None

701	702	In	0	None
702	703	conclusion	0	None
703	704	,	0	None
704	705	the	0	None
705	706	results	0	None
706	707	suggest	0	None
707	708	that	0	None
708	709	mCPP	0	None
709	710	induces	0	None
710	711	a	0	None
711	712	marked	0	None
712	713	,	0	None
713	714	TTX	3	CHEMICAL
714	715	-	0	None
715	716	insensitive	0	None
716	717	increase	0	None
717	718	in	0	None
718	719	serotonin	3	CHEMICAL
719	720	release	0	None
720	721	in	0	None
721	722	rat	0	None
722	723	brain	0	None
723	724	,	0	None
724	725	but	0	None
725	726	only	0	None
726	727	a	0	None
727	728	modest	0	None
728	729	and	0	None
729	730	TTX	3	CHEMICAL
730	731	-	0	None
731	732	sensitive	0	None
732	733	increase	0	None
733	734	in	0	None
734	735	the	0	None
735	736	extracellular	3	CHEMICAL
736	737	levels	0	None
737	738	of	0	None
738	739	dopamine	3	CHEMICAL
739	740	.	0	None

741	742	The	0	None
742	743	human	0	None
743	744	NADH	3	CHEMICAL
744	745	:	0	None
745	746	ubiquinone	3	CHEMICAL
746	748	oxidoreductase NDUFS5	0	None
748	749	(	0	None
749	750	15	0	None
750	751	kDa	0	None
751	752	)	0	None
752	753	subunit	0	None
753	754	:	0	None
754	755	cDNA	0	None
755	756	cloning	0	None
756	757	,	0	None
757	758	chromosomal	0	None
758	759	localization	0	None
759	760	,	0	None
760	761	tissue	0	None
761	762	distribution	0	None
762	763	and	0	None
763	764	the	0	None
764	765	absence	0	None
765	766	of	0	None
766	767	mutations	0	None
767	768	in	0	None
768	769	isolated	0	None
769	770	complex	0	None
770	771	I	0	None
771	772	-	0	None
772	773	deficient	0	None
773	774	patients	0	None
774	775	.	0	None

776	777	We	0	None
777	778	have	0	None
778	779	cloned	0	None
779	780	the	0	None
780	781	cDNA	0	None
781	782	of	0	None
782	783	the	0	None
783	784	NDUFS5	0	None
784	785	subunit	0	None
785	786	(	0	None
786	787	15	0	None
787	788	kDa	0	None
788	789	)	0	None
789	790	of	0	None
790	791	the	0	None
791	792	human	0	None
792	797	mitochondrial respiratory chain complex NADH	3	CHEMICAL
797	798	:	0	None
798	800	ubiquinone oxidoreductase	1	GENE-Y
800	801	(	0	None
801	802	complex	0	None
802	803	I	0	None
803	804	)	0	None
804	805	.	0	None

806	807	The	0	None
807	810	open reading frame	2	GENE-N
810	811	consists	0	None
811	812	of	0	None
812	813	321	0	None
813	814	base	0	None
814	815	-	0	None
815	816	pairs	0	None
816	817	,	0	None
817	818	coding	0	None
818	819	for	0	None
819	820	106	0	None
820	822	amino acids	3	CHEMICAL
822	823	,	0	None
823	824	with	0	None
824	825	a	0	None
825	826	calculated	0	None
826	827	molecular	0	None
827	828	mass	0	None
828	829	of	0	None
829	830	12	0	None
830	831	.	0	None
831	832	5	0	None
832	833	kDa	0	None
833	834	.	0	None

835	836	There	0	None
836	837	is	0	None
837	838	an	0	None
838	839	81	0	None
839	840	.	0	None
840	841	0	0	None
841	842	%	0	None
842	843	identity	0	None
843	844	with	0	None
844	845	the	0	None
845	846	bovine	0	None
846	847	equivalent	0	None
847	848	on	0	None
848	849	cDNA	0	None
849	850	level	0	None
850	851	and	0	None
851	852	74	0	None
852	853	.	0	None
853	854	5	0	None
854	855	%	0	None
855	856	identity	0	None
856	857	on	0	None
857	859	amino acid	3	CHEMICAL
859	860	basis	0	None
860	861	.	0	None

862	863	PCR	0	None
863	864	analysis	0	None
864	865	of	0	None
865	866	rodent	0	None
866	867	-	0	None
867	868	human	0	None
868	869	somatic	0	None
869	870	cell	0	None
870	871	hybrids	0	None
871	872	revealed	0	None
872	873	that	0	None
873	874	the	0	None
874	876	human NDUFS5	1	GENE-Y
876	877	gene	0	None
877	878	maps	2	GENE-N
878	879	to	0	None
879	880	chromosome	0	None
880	881	1	0	None
881	882	.	0	None

883	884	The	0	None
884	885	NDUFS5	0	None
885	886	mRNA	0	None
886	887	is	0	None
887	888	expressed	0	None
888	889	ubiquitously	0	None
889	890	in	0	None
890	891	human	0	None
891	892	tissues	0	None
892	893	,	0	None
893	894	with	0	None
894	895	a	0	None
895	896	relative	0	None
896	897	higher	0	None
897	898	expression	0	None
898	899	in	0	None
899	900	human	0	None
900	901	heart	0	None
901	902	,	0	None
902	903	skeletal	0	None
903	904	muscle	0	None
904	905	,	0	None
905	906	liver	0	None
906	907	,	0	None
907	908	kidney	0	None
908	909	and	0	None
909	910	fetal	0	None
910	911	heart	0	None
911	912	.	0	None

913	914	A	0	None
914	915	mutation	0	None
915	916	detection	0	None
916	917	study	0	None
917	918	of	0	None
918	919	twenty	0	None
919	920	isolated	0	None
920	921	enzymatic	0	None
921	922	complex	0	None
922	923	I	0	None
923	924	-	0	None
924	925	deficient	0	None
925	926	patients	0	None
926	927	revealed	0	None
927	928	no	0	None
928	929	mutations	0	None
929	930	,	0	None
930	931	nor	0	None
931	932	polymorphisms	0	None
932	933	.	0	None

934	935	Participation	0	None
935	936	of	0	None
936	937	beta	0	None
937	938	-	0	None
938	939	adrenergic	0	None
939	940	receptors	0	None
940	941	on	0	None
941	942	macrophages	0	None
942	943	in	0	None
943	944	modulation	0	None
944	945	of	0	None
945	946	LPS	0	None
946	947	-	0	None
947	948	induced	0	None
948	949	cytokine	2	GENE-N
949	950	release	0	None
950	951	.	0	None

952	953	For	0	None
953	954	several	0	None
954	955	years	0	None
955	956	it	0	None
956	957	is	0	None
957	958	known	0	None
958	959	that	0	None
959	960	beta	0	None
960	961	-	0	None
961	962	adrenergic	0	None
962	963	receptor	1	GENE-Y
963	964	agonists	0	None
964	965	have	0	None
965	966	anti	0	None
966	967	-	0	None
967	968	inflammatory	0	None
968	969	effects	0	None
969	970	.	0	None

971	972	However	0	None
972	973	,	0	None
973	974	little	0	None
974	975	is	0	None
975	976	known	0	None
976	977	about	0	None
977	978	the	0	None
978	979	role	0	None
979	980	of	0	None
980	981	beta	0	None
981	982	-	0	None
982	984	adrenergic receptors	2	GENE-N
984	985	on	0	None
985	986	macrophages	0	None
986	987	in	0	None
987	988	the	0	None
988	989	modulation	0	None
989	990	of	0	None
990	991	cytokine	2	GENE-N
991	992	production	0	None
992	993	by	0	None
993	994	beta	0	None
994	995	-	0	None
995	996	agonists	0	None
996	997	during	0	None
997	998	inflammation	0	None
998	999	.	0	None

1000	1001	In	0	None
1001	1002	this	0	None
1002	1003	study	0	None
1003	1004	,	0	None
1004	1005	the	0	None
1005	1006	presence	0	None
1006	1007	of	0	None
1007	1008	beta	0	None
1008	1009	-	0	None
1009	1010	receptors	0	None
1010	1011	on	0	None
1011	1012	PMA	3	CHEMICAL
1012	1013	-	0	None
1013	1014	differentiated	0	None
1014	1015	U937	0	None
1015	1016	human	0	None
1016	1017	macrophages	0	None
1017	1018	,	0	None
1018	1019	and	0	None
1019	1020	the	0	None
1020	1021	participation	0	None
1021	1022	of	0	None
1022	1023	these	0	None
1023	1024	receptors	0	None
1024	1025	in	0	None
1025	1026	the	0	None
1026	1027	modulation	0	None
1027	1028	of	0	None
1028	1029	LPS	0	None
1029	1030	-	0	None
1030	1031	mediated	0	None
1031	1032	cytokine	2	GENE-N
1032	1033	production	0	None
1033	1034	by	0	None
1034	1035	beta	0	None
1035	1036	-	0	None
1036	1037	agonists	0	None
1037	1038	was	0	None
1038	1039	investigated	0	None
1039	1040	.	0	None

1041	1042	Total	0	None
1042	1043	beta	0	None
1043	1044	-	0	None
1044	1045	receptor	0	None
1045	1046	expression	0	None
1046	1047	on	0	None
1047	1048	undifferentiated	0	None
1048	1049	(	0	None
1049	1050	monocyte	0	None
1050	1051	)	0	None
1051	1052	and	0	None
1052	1053	PMA	3	CHEMICAL
1053	1054	-	0	None
1054	1055	differentiated	0	None
1055	1056	U937	0	None
1056	1057	cells	0	None
1057	1058	was	0	None
1058	1059	established	0	None
1059	1060	using	0	None
1060	1061	receptor	0	None
1061	1062	binding	0	None
1062	1063	studies	0	None
1063	1064	on	0	None
1064	1065	membrane	0	None
1065	1066	fractions	0	None
1066	1067	with	0	None
1067	1068	a	0	None
1068	1069	radio	0	None
1069	1070	ligand	0	None
1070	1071	.	0	None

1072	1073	The	0	None
1073	1074	expression	0	None
1074	1075	of	0	None
1075	1076	beta	0	None
1076	1077	-	0	None
1077	1078	receptors	0	None
1078	1079	proved	0	None
1079	1080	to	0	None
1080	1081	be	0	None
1081	1082	significantly	0	None
1082	1083	lower	0	None
1083	1084	on	0	None
1084	1085	monocytes	0	None
1085	1086	than	0	None
1086	1087	on	0	None
1087	1088	macrophages	0	None
1088	1089	,	0	None
1089	1090	additionally	0	None
1090	1091	a	0	None
1091	1092	predominant	0	None
1092	1093	expression	0	None
1093	1094	of	0	None
1094	1096	beta 2	1	GENE-Y
1096	1097	-	0	None
1097	1098	receptors	0	None
1098	1099	was	0	None
1099	1100	found	0	None
1100	1101	.	0	None

1102	1103	Production	0	None
1103	1104	of	0	None
1104	1105	the	0	None
1105	1106	cytokines	0	None
1106	1107	TNF	2	GENE-N
1107	1108	-	0	None
1108	1109	alpha	0	None
1109	1110	,	0	None
1110	1111	IL	0	None
1111	1112	-	0	None
1112	1113	6	0	None
1113	1114	,	0	None
1114	1115	and	0	None
1115	1116	IL	0	None
1116	1117	-	0	None
1117	1118	10	0	None
1118	1119	by	0	None
1119	1120	LPS	0	None
1120	1121	-	0	None
1121	1122	stimulated	0	None
1122	1123	differentiated	0	None
1123	1124	U937	0	None
1124	1125	cells	0	None
1125	1126	was	0	None
1126	1127	measured	0	None
1127	1128	in	0	None
1128	1129	time	0	None
1129	1130	.	0	None

1131	1132	Peak	0	None
1132	1133	concentrations	0	None
1133	1134	for	0	None
1134	1135	TNF	2	GENE-N
1135	1136	-	0	None
1136	1137	alpha	0	None
1137	1138	,	0	None
1138	1139	IL	0	None
1139	1140	-	0	None
1140	1141	6	0	None
1141	1142	and	0	None
1142	1143	IL	0	None
1143	1144	-	0	None
1144	1145	10	0	None
1145	1146	occurred	0	None
1146	1147	at	0	None
1147	1148	3	0	None
1148	1149	,	0	None
1149	1150	12	0	None
1150	1151	and	0	None
1151	1152	9	0	None
1152	1153	hrs	0	None
1153	1154	,	0	None
1154	1155	respectively	0	None
1155	1156	.	0	None

1157	1158	When	0	None
1158	1159	differentiated	0	None
1159	1160	U937	0	None
1160	1161	cells	0	None
1161	1162	were	0	None
1162	1163	incubated	0	None
1163	1164	with	0	None
1164	1165	both	0	None
1165	1166	LPS	0	None
1166	1167	and	0	None
1167	1168	the	0	None
1168	1169	beta	0	None
1169	1170	-	0	None
1170	1171	agonist	0	None
1171	1172	clenbuterol	3	CHEMICAL
1172	1173	the	0	None
1173	1174	production	0	None
1174	1175	of	0	None
1175	1176	TNF	2	GENE-N
1176	1177	-	0	None
1177	1178	alpha	0	None
1178	1179	and	0	None
1179	1180	IL	0	None
1180	1181	-	0	None
1181	1182	6	0	None
1182	1183	was	0	None
1183	1184	significantly	0	None
1184	1185	reduced	0	None
1185	1186	.	0	None

1187	1188	However	0	None
1188	1189	the	0	None
1189	1190	production	0	None
1190	1191	of	0	None
1191	1192	IL	0	None
1192	1193	-	0	None
1193	1194	10	0	None
1194	1195	was	0	None
1195	1196	increased	0	None
1196	1197	.	0	None

1198	1199	To	0	None
1199	1200	study	0	None
1200	1201	the	0	None
1201	1202	mechanism	0	None
1202	1203	of	0	None
1203	1204	modulation	0	None
1204	1205	of	0	None
1205	1206	cytokine	2	GENE-N
1206	1207	production	0	None
1207	1208	in	0	None
1208	1209	more	0	None
1209	1210	detail	0	None
1210	1211	,	0	None
1211	1212	U937	0	None
1212	1213	macrophages	0	None
1213	1214	were	0	None
1214	1215	incubated	0	None
1215	1216	with	0	None
1216	1217	LPS	0	None
1217	1218	/	0	None
1218	1219	clenbuterol	3	CHEMICAL
1219	1220	in	0	None
1220	1221	combination	0	None
1221	1222	with	0	None
1222	1223	selective	0	None
1223	1225	beta 1	1	GENE-Y
1225	1226	-	0	None
1226	1227	and	0	None
1227	1228	beta	0	None
1228	1229	2	0	None
1229	1230	-	0	None
1230	1231	antagonists	0	None
1231	1232	.	0	None

1233	1234	These	0	None
1234	1235	results	0	None
1235	1236	indicated	0	None
1236	1237	that	0	None
1237	1238	the	0	None
1238	1240	beta 2	1	GENE-Y
1240	1241	-	0	None
1241	1242	and	0	None
1242	1243	not	0	None
1243	1244	the	0	None
1244	1246	beta 1	1	GENE-Y
1246	1247	-	0	None
1247	1248	receptor	0	None
1248	1249	is	0	None
1249	1250	involved	0	None
1250	1251	in	0	None
1251	1252	the	0	None
1252	1253	anti	0	None
1253	1254	-	0	None
1254	1255	inflammatory	0	None
1255	1256	activity	0	None
1256	1257	of	0	None
1257	1258	clenbuterol	3	CHEMICAL
1258	1259	.	0	None

1260	1261	Androgen	0	None
1261	1262	antagonistic	0	None
1262	1263	effect	0	None
1263	1264	of	0	None
1264	1266	estramustine phosphate	3	CHEMICAL
1266	1267	(	0	None
1267	1268	EMP	0	None
1268	1269	)	0	None
1269	1270	metabolites	0	None
1270	1271	on	0	None
1271	1272	wild	0	None
1272	1273	-	0	None
1273	1274	type	0	None
1274	1275	and	0	None
1275	1276	mutated	0	None
1276	1278	androgen receptor	1	GENE-Y
1278	1279	.	0	None

1280	1282	Estramustine phosphate	3	CHEMICAL
1282	1283	is	0	None
1283	1284	used	0	None
1284	1285	frequently	0	None
1285	1286	,	0	None
1286	1287	alone	0	None
1287	1288	or	0	None
1288	1289	in	0	None
1289	1290	combination	0	None
1290	1291	with	0	None
1291	1292	other	0	None
1292	1293	antitumor	0	None
1293	1294	agents	0	None
1294	1295	,	0	None
1295	1296	for	0	None
1296	1297	the	0	None
1297	1298	treatment	0	None
1298	1299	of	0	None
1299	1300	hormone	0	None
1300	1301	-	0	None
1301	1302	refractory	0	None
1302	1303	prostate	0	None
1303	1304	cancer	0	None
1304	1305	.	0	None

1306	1308	Estramustine phosphate	3	CHEMICAL
1308	1309	is	0	None
1309	1310	metabolically	0	None
1310	1311	activated	0	None
1311	1312	in	0	None
1312	1313	vivo	0	None
1313	1314	,	0	None
1314	1315	and	0	None
1315	1316	its	0	None
1316	1317	metabolites	0	None
1317	1318	,	0	None
1318	1319	estramustine	3	CHEMICAL
1319	1320	,	0	None
1320	1321	estromustine	3	CHEMICAL
1321	1322	,	0	None
1322	1323	estrone	3	CHEMICAL
1323	1324	,	0	None
1324	1325	and	0	None
1325	1326	beta	0	None
1326	1327	-	0	None
1327	1328	estradiol	3	CHEMICAL
1328	1329	inhibit	0	None
1329	1330	the	0	None
1330	1331	assembly	0	None
1331	1332	of	0	None
1332	1333	microtubules	0	None
1333	1334	[	0	None
1334	1335	for	0	None
1335	1336	review	0	None
1336	1337	see	0	None
1337	1338	:	0	None
1338	1339	Kreis	0	None
1339	1340	W	0	None
1340	1341	,	0	None
1341	1342	In	0	None
1342	1343	:	0	None
1343	1344	Concepts	0	None
1344	1345	,	0	None
1345	1346	Mechanisms	0	None
1346	1347	,	0	None
1347	1348	and	0	None
1348	1349	New	0	None
1349	1350	Targets	0	None
1350	1351	for	0	None
1351	1352	Chemotherapy	0	None
1352	1353	(	0	None
1353	1354	Ed	0	None
1354	1355	.	0	None
1355	1356	Muggia	0	None
1356	1357	FM	0	None
1357	1358	)	0	None
1358	1359	,	0	None
1359	1360	pp	0	None
1360	1361	.	0	None
1361	1362	163	0	None
1362	1363	-	0	None
1363	1364	184	0	None
1364	1365	.	0	None
1365	1366	Kluwer	0	None
1366	1367	Academic	0	None
1367	1368	Publishers	0	None
1368	1369	,	0	None
1369	1370	Boston	0	None
1370	1371	,	0	None
1371	1372	1995	0	None
1372	1373	]	0	None
1373	1374	.	0	None

1375	1376	We	0	None
1376	1377	investigated	0	None
1377	1378	,	0	None
1378	1379	by	0	None
1379	1380	displacement	0	None
1380	1381	of	0	None
1381	1382	[	0	None
1382	1383	3H	0	None
1383	1384	]	0	None
1384	1385	methyltrienolone	3	CHEMICAL
1385	1386	in	0	None
1386	1387	the	0	None
1387	1388	presence	0	None
1388	1389	of	0	None
1389	1390	2	0	None
1390	1391	.	0	None
1391	1392	5	0	None
1392	1393	mM	0	None
1393	1394	of	0	None
1394	1396	triamcinolone acetonide	3	CHEMICAL
1396	1397	,	0	None
1397	1398	the	0	None
1398	1399	binding	0	None
1399	1400	of	0	None
1400	1402	estramustine phosphate	3	CHEMICAL
1402	1403	and	0	None
1403	1404	its	0	None
1404	1405	metabolites	0	None
1405	1406	,	0	None
1406	1407	estramustine	3	CHEMICAL
1407	1408	,	0	None
1408	1409	estromustine	3	CHEMICAL
1409	1410	,	0	None
1410	1411	estrone	3	CHEMICAL
1411	1412	,	0	None
1412	1413	and	0	None
1413	1414	beta	0	None
1414	1415	-	0	None
1415	1416	estradiol	3	CHEMICAL
1416	1417	,	0	None
1417	1418	as	0	None
1418	1419	well	0	None
1419	1420	as	0	None
1420	1421	other	0	None
1421	1422	antiandrogen	0	None
1422	1423	agents	0	None
1423	1424	including	0	None
1424	1425	alpha	0	None
1425	1426	-	0	None
1426	1427	estradiol	3	CHEMICAL
1427	1428	,	0	None
1428	1429	bicalutamide	3	CHEMICAL
1429	1430	,	0	None
1430	1431	and	0	None
1431	1432	hydroxyflutamide	0	None
1432	1433	,	0	None
1433	1434	to	0	None
1434	1435	the	0	None
1435	1436	mutated	0	None
1436	1438	androgen receptor	1	GENE-Y
1438	1439	(	0	None
1439	1440	m	0	None
1440	1441	-	0	None
1441	1442	AR	1	GENE-Y
1442	1443	)	0	None
1443	1444	in	0	None
1444	1445	LNCaP	0	None
1445	1446	cells	0	None
1446	1447	and	0	None
1447	1448	to	0	None
1448	1449	the	0	None
1449	1450	wild	0	None
1450	1451	-	0	None
1451	1452	type	0	None
1452	1454	androgen receptor	1	GENE-Y
1454	1455	in	0	None
1455	1456	wild	0	None
1456	1457	-	0	None
1457	1458	type	0	None
1458	1459	AR	1	GENE-Y
1459	1460	cDNA	0	None
1460	1461	expression	0	None
1461	1462	plasmid	0	None
1462	1463	(	0	None
1463	1464	w	0	None
1464	1465	-	0	None
1465	1466	pAR0	0	None
1466	1467	)	0	None
1467	1468	cDNA	0	None
1468	1469	-	0	None
1469	1470	transfected	0	None
1470	1471	HeLa	0	None
1471	1472	cells	0	None
1472	1473	.	0	None

1474	1475	Analogous	0	None
1475	1476	to	0	None
1476	1477	the	0	None
1477	1478	antiandrogens	0	None
1478	1479	,	0	None
1479	1480	bicalutamide	3	CHEMICAL
1480	1481	and	0	None
1481	1482	hydroxyflutamide	0	None
1482	1483	,	0	None
1483	1484	binding	0	None
1484	1485	of	0	None
1485	1487	estramustine phosphate	3	CHEMICAL
1487	1488	metabolites	0	None
1488	1489	to	0	None
1489	1490	the	0	None
1490	1492	androgen receptor	1	GENE-Y
1492	1493	was	0	None
1493	1494	observed	0	None
1494	1495	.	0	None

1496	1497	The	0	None
1497	1498	EC50	0	None
1498	1499	values	0	None
1499	1500	(	0	None
1500	1501	in	0	None
1501	1502	microM	0	None
1502	1503	)	0	None
1503	1504	were	0	None
1504	1505	:	0	None
1505	1507	estramustine phosphate	3	CHEMICAL
1507	1508	,	0	None
1508	1509	>	0	None
1509	1510	10	0	None
1510	1511	;	0	None
1511	1512	estramustine	3	CHEMICAL
1512	1513	,	0	None
1513	1514	3	0	None
1514	1515	.	0	None
1515	1516	129	0	None
1516	1517	+	0	None
1517	1518	/	0	None
1518	1519	-	0	None
1519	1520	0	0	None
1520	1521	.	0	None
1521	1522	312	0	None
1522	1523	;	0	None
1523	1524	estromustine	3	CHEMICAL
1524	1525	;	0	None
1525	1526	2	0	None
1526	1527	.	0	None
1527	1528	612	0	None
1528	1529	+	0	None
1529	1530	/	0	None
1530	1531	-	0	None
1531	1532	0	0	None
1532	1533	.	0	None
1533	1534	584	0	None
1534	1535	;	0	None
1535	1536	estrone	3	CHEMICAL
1536	1537	,	0	None
1537	1538	0	0	None
1538	1539	.	0	None
1539	1540	800	0	None
1540	1541	+	0	None
1541	1542	/	0	None
1542	1543	-	0	None
1543	1544	0	0	None
1544	1545	.	0	None
1545	1546	090	0	None
1546	1547	;	0	None
1547	1548	alpha	0	None
1548	1549	-	0	None
1549	1550	estradiol	3	CHEMICAL
1550	1551	,	0	None
1551	1552	1	0	None
1552	1553	.	0	None
1553	1554	051	0	None
1554	1555	+	0	None
1555	1556	/	0	None
1556	1557	-	0	None
1557	1558	0	0	None
1558	1559	.	0	None
1559	1560	096	0	None
1560	1561	;	0	None
1561	1562	beta	0	None
1562	1563	-	0	None
1563	1564	estradiol	3	CHEMICAL
1564	1565	,	0	None
1565	1566	0	0	None
1566	1567	.	0	None
1567	1568	523	0	None
1568	1569	+	0	None
1569	1570	/	0	None
1570	1571	-	0	None
1571	1572	0	0	None
1572	1573	.	0	None
1573	1574	028	0	None
1574	1575	;	0	None
1575	1576	bicalutamide	3	CHEMICAL
1576	1577	,	0	None
1577	1578	4	0	None
1578	1579	.	0	None
1579	1580	920	0	None
1580	1581	+	0	None
1581	1582	/	0	None
1582	1583	-	0	None
1583	1584	0	0	None
1584	1585	.	0	None
1585	1586	361	0	None
1586	1587	;	0	None
1587	1588	and	0	None
1588	1589	hydroxyflutamide	0	None
1589	1590	,	0	None
1590	1591	0	0	None
1591	1592	.	0	None
1592	1593	254	0	None
1593	1594	+	0	None
1594	1595	/	0	None
1595	1596	-	0	None
1596	1597	0	0	None
1597	1598	.	0	None
1598	1599	012	0	None
1599	1600	.	0	None

1601	1602	The	0	None
1602	1603	transactivation	0	None
1603	1604	assay	0	None
1604	1605	demonstrated	0	None
1605	1606	that	0	None
1606	1607	,	0	None
1607	1608	analogous	0	None
1608	1609	to	0	None
1609	1610	bicalutamide	3	CHEMICAL
1610	1611	,	0	None
1611	1612	estramustine	3	CHEMICAL
1612	1613	could	0	None
1613	1614	not	0	None
1614	1615	induce	0	None
1615	1616	luciferase	0	None
1616	1617	activity	0	None
1617	1618	in	0	None
1618	1619	either	0	None
1619	1620	w	0	None
1620	1621	-	0	None
1621	1622	pAR0	0	None
1622	1623	or	0	None
1623	1624	m	0	None
1624	1625	-	0	None
1625	1626	pARL	0	None
1626	1627	transfected	0	None
1627	1628	HeLa	0	None
1628	1629	cells	0	None
1629	1630	.	0	None

1631	1632	In	0	None
1632	1633	contrast	0	None
1633	1634	,	0	None
1634	1635	a	0	None
1635	1636	strong	0	None
1636	1637	induction	0	None
1637	1638	of	0	None
1638	1639	the	0	None
1639	1640	reporter	0	None
1640	1641	activity	0	None
1641	1642	by	0	None
1642	1643	dihydrotestosterone	3	CHEMICAL
1643	1644	was	0	None
1644	1645	observed	0	None
1645	1646	.	0	None

1647	1648	Down	0	None
1648	1649	-	0	None
1649	1650	regulation	0	None
1650	1651	of	0	None
1651	1652	prostate	0	None
1652	1653	-	0	None
1653	1654	specific	0	None
1654	1655	antigen	0	None
1655	1656	(	0	None
1656	1657	PSA	1	GENE-Y
1657	1658	)	0	None
1658	1659	expression	0	None
1659	1660	,	0	None
1660	1661	an	0	None
1661	1662	AR	1	GENE-Y
1662	1663	-	0	None
1663	1664	target	0	None
1664	1665	gene	0	None
1665	1666	,	0	None
1666	1667	by	0	None
1667	1668	estramustine	3	CHEMICAL
1668	1669	and	0	None
1669	1670	bicalutamide	3	CHEMICAL
1670	1671	was	0	None
1671	1672	accompanied	0	None
1672	1673	by	0	None
1673	1674	the	0	None
1674	1675	blockade	0	None
1675	1676	of	0	None
1676	1677	the	0	None
1677	1678	mutated	0	None
1678	1680	androgen receptor	1	GENE-Y
1680	1681	.	0	None

1682	1683	Exposure	0	None
1683	1684	of	0	None
1684	1685	LNCaP	0	None
1685	1686	cells	0	None
1686	1687	to	0	None
1687	1688	estramustine	3	CHEMICAL
1688	1689	for	0	None
1689	1690	24	0	None
1690	1691	hr	2	GENE-N
1691	1692	caused	0	None
1692	1693	transcriptional	0	None
1693	1694	inhibition	0	None
1694	1695	of	0	None
1695	1696	PSA	1	GENE-Y
1696	1697	in	0	None
1697	1698	a	0	None
1698	1699	concentration	0	None
1699	1700	-	0	None
1700	1701	dependent	0	None
1701	1702	manner	0	None
1702	1703	.	0	None

1704	1705	The	0	None
1705	1706	levels	0	None
1706	1707	of	0	None
1707	1708	PSA	1	GENE-Y
1708	1709	mRNA	0	None
1709	1710	decreased	0	None
1710	1711	56	0	None
1711	1712	and	0	None
1712	1713	90	0	None
1713	1714	%	0	None
1714	1715	when	0	None
1715	1716	LNCaP	0	None
1716	1717	cells	0	None
1717	1718	were	0	None
1718	1719	treated	0	None
1719	1720	with	0	None
1720	1721	5	0	None
1721	1722	and	0	None
1722	1723	10	0	None
1723	1724	microM	0	None
1724	1725	of	0	None
1725	1726	estramustine	3	CHEMICAL
1726	1727	,	0	None
1727	1728	respectively	0	None
1728	1729	(	0	None
1729	1730	IC50	0	None
1730	1731	=	0	None
1731	1732	10	0	None
1732	1733	.	0	None
1733	1734	97	0	None
1734	1735	+	0	None
1735	1736	/	0	None
1736	1737	-	0	None
1737	1738	1	0	None
1738	1739	.	0	None
1739	1740	68	0	None
1740	1741	microM	0	None
1741	1742	)	0	None
1742	1743	.	0	None

1744	1745	Binding	0	None
1745	1746	of	0	None
1746	1747	hydroxyflutamide	0	None
1747	1748	to	0	None
1748	1749	m	0	None
1749	1750	-	0	None
1750	1751	AR	1	GENE-Y
1751	1752	in	0	None
1752	1753	LNCaP	0	None
1753	1754	cells	0	None
1754	1755	resulted	0	None
1755	1756	in	0	None
1756	1757	a	0	None
1757	1758	concentration	0	None
1758	1759	-	0	None
1759	1760	dependent	0	None
1760	1761	stimulation	0	None
1761	1762	of	0	None
1762	1763	PSA	1	GENE-Y
1763	1764	expression	0	None
1764	1765	,	0	None
1765	1766	suggesting	0	None
1766	1767	that	0	None
1767	1768	hydroxyflutamide	0	None
1768	1769	acted	0	None
1769	1770	as	0	None
1770	1771	an	0	None
1771	1772	agonist	0	None
1772	1773	of	0	None
1773	1774	the	0	None
1774	1775	m	0	None
1775	1776	-	0	None
1776	1777	AR	1	GENE-Y
1777	1778	.	0	None

1779	1780	Our	0	None
1780	1781	data	0	None
1781	1782	indicate	0	None
1782	1783	that	0	None
1783	1785	estramustine phosphate	3	CHEMICAL
1785	1786	metabolites	0	None
1786	1787	perform	0	None
1787	1788	as	0	None
1788	1789	androgen	3	CHEMICAL
1789	1790	antagonists	0	None
1790	1791	of	0	None
1791	1792	AR	1	GENE-Y
1792	1793	,	0	None
1793	1794	an	0	None
1794	1795	additional	0	None
1795	1796	mechanism	0	None
1796	1797	involved	0	None
1797	1798	in	0	None
1798	1799	the	0	None
1799	1800	therapeutic	0	None
1800	1801	effect	0	None
1801	1802	of	0	None
1802	1804	estramustine phosphate	3	CHEMICAL
1804	1805	in	0	None
1805	1806	patients	0	None
1806	1807	with	0	None
1807	1808	prostate	0	None
1808	1809	cancer	0	None
1809	1810	.	0	None

1811	1812	Determinants	0	None
1812	1813	of	0	None
1813	1814	specificity	0	None
1814	1815	for	0	None
1815	1816	aflatoxin	3	CHEMICAL
1816	1817	B1	0	None
1817	1818	-	0	None
1818	1819	8	0	None
1819	1820	,	0	None
1820	1821	9	0	None
1821	1822	-	0	None
1822	1823	epoxide	3	CHEMICAL
1823	1824	in	0	None
1824	1825	alpha	0	None
1825	1826	-	0	None
1826	1827	class	0	None
1827	1829	glutathione S	3	CHEMICAL
1829	1830	-	0	None
1830	1831	transferases	2	GENE-N
1831	1832	.	0	None

1833	1834	We	0	None
1834	1835	have	0	None
1835	1836	used	0	None
1836	1837	homology	0	None
1837	1838	modelling	0	None
1838	1839	,	0	None
1839	1840	based	0	None
1840	1841	on	0	None
1841	1842	the	0	None
1842	1843	crystal	0	None
1843	1844	structure	0	None
1844	1845	of	0	None
1845	1846	the	0	None
1846	1849	human glutathione S	3	CHEMICAL
1849	1850	-	0	None
1850	1851	transferase	0	None
1851	1852	(	0	None
1852	1853	GST	0	None
1853	1854	)	0	None
1854	1855	A1	1	GENE-Y
1855	1856	-	0	None
1856	1857	1	0	None
1857	1858	,	0	None
1858	1859	to	0	None
1859	1860	obtain	0	None
1860	1861	the	0	None
1861	1862	three	0	None
1862	1863	-	0	None
1863	1864	dimensional	0	None
1864	1865	structures	0	None
1865	1866	of	0	None
1866	1868	rat GSTA3	1	GENE-Y
1868	1869	and	0	None
1869	1871	rat GSTA5	1	GENE-Y
1871	1872	subunits	0	None
1872	1873	bound	0	None
1873	1874	to	0	None
1874	1875	S	0	None
1875	1876	-	0	None
1876	1877	aflatoxinyl	0	None
1877	1878	-	0	None
1878	1879	glutathione	3	CHEMICAL
1879	1880	.	0	None

1881	1882	The	0	None
1882	1883	resulting	0	None
1883	1884	models	0	None
1884	1885	highlight	0	None
1885	1886	two	0	None
1886	1887	residues	0	None
1887	1888	,	0	None
1888	1889	at	0	None
1889	1890	positions	0	None
1890	1891	208	0	None
1891	1892	and	0	None
1892	1893	108	0	None
1893	1894	,	0	None
1894	1895	that	0	None
1895	1896	could	0	None
1896	1897	be	0	None
1897	1898	important	0	None
1898	1899	for	0	None
1899	1900	determining	0	None
1900	1901	,	0	None
1901	1902	either	0	None
1902	1903	directly	0	None
1903	1904	or	0	None
1904	1905	indirectly	0	None
1905	1906	,	0	None
1906	1907	substrate	0	None
1907	1908	specificity	0	None
1908	1909	for	0	None
1909	1910	aflatoxin	3	CHEMICAL
1910	1911	-	0	None
1911	1912	exo	0	None
1912	1913	-	0	None
1913	1914	8	0	None
1914	1915	,	0	None
1915	1916	9	0	None
1916	1917	-	0	None
1917	1918	epoxide	3	CHEMICAL
1918	1919	among	0	None
1919	1920	the	0	None
1920	1921	Alpha	0	None
1921	1922	-	0	None
1922	1923	class	0	None
1923	1924	GSTs	0	None
1924	1925	.	0	None

1926	1927	Residues	0	None
1927	1928	at	0	None
1928	1929	these	0	None
1929	1930	positions	0	None
1930	1931	were	0	None
1931	1932	mutated	0	None
1932	1933	in	0	None
1933	1934	human	0	None
1934	1935	GSTA1	0	None
1935	1936	-	0	None
1936	1937	1	0	None
1937	1938	(	0	None
1938	1939	Met	3	CHEMICAL
1939	1940	-	0	None
1940	1941	208	0	None
1941	1942	,	0	None
1942	1943	Leu	3	CHEMICAL
1943	1944	-	0	None
1944	1945	108	0	None
1945	1946	)	0	None
1946	1947	,	0	None
1947	1948	rat	0	None
1948	1949	GSTA3	1	GENE-Y
1949	1950	-	0	None
1950	1951	3	0	None
1951	1952	(	0	None
1952	1953	Glu	3	CHEMICAL
1953	1954	-	0	None
1954	1955	208	0	None
1955	1956	,	0	None
1956	1957	His	0	None
1957	1958	-	0	None
1958	1959	108	0	None
1959	1960	)	0	None
1960	1961	and	0	None
1961	1963	rat GSTA5	1	GENE-Y
1963	1964	-	0	None
1964	1965	5	0	None
1965	1966	(	0	None
1966	1967	Asp	3	CHEMICAL
1967	1968	-	0	None
1968	1969	208	0	None
1969	1970	,	0	None
1970	1971	Tyr	3	CHEMICAL
1971	1972	-	0	None
1972	1973	108	0	None
1973	1974	)	0	None
1974	1975	:	0	None
1975	1976	in	0	None
1976	1977	the	0	None
1977	1978	active	0	None
1978	1980	rat GSTA5	1	GENE-Y
1980	1981	-	0	None
1981	1982	5	0	None
1982	1983	to	0	None
1983	1984	those	0	None
1984	1985	in	0	None
1985	1986	the	0	None
1986	1987	inactive	0	None
1987	1988	GSTA1	0	None
1988	1989	-	0	None
1989	1990	1	0	None
1990	1991	;	0	None
1991	1992	and	0	None
1992	1993	in	0	None
1993	1994	the	0	None
1994	1995	inactive	0	None
1995	1996	human	0	None
1996	1997	GSTA1	0	None
1997	1998	-	0	None
1998	1999	1	0	None
1999	2000	and	0	None
2000	2002	rat GSTA3	1	GENE-Y
2002	2003	-	0	None
2003	2004	3	0	None
2004	2005	to	0	None
2005	2006	those	0	None
2006	2007	in	0	None
2007	2008	the	0	None
2008	2009	active	0	None
2009	2011	rat GSTA5	1	GENE-Y
2011	2012	-	0	None
2012	2013	5	0	None
2013	2014	.	0	None

2015	2016	These	0	None
2016	2017	studies	0	None
2017	2018	show	0	None
2018	2019	clearly	0	None
2019	2020	that	0	None
2020	2021	,	0	None
2021	2022	in	0	None
2022	2023	all	0	None
2023	2024	three	0	None
2024	2025	GSTs	1	GENE-Y
2025	2026	,	0	None
2026	2027	an	0	None
2027	2028	aspartate	3	CHEMICAL
2028	2029	residue	0	None
2029	2030	at	0	None
2030	2031	position	0	None
2031	2032	208	0	None
2032	2033	is	0	None
2033	2034	a	0	None
2034	2035	prerequisite	0	None
2035	2036	for	0	None
2036	2037	high	0	None
2037	2038	activity	0	None
2038	2039	in	0	None
2039	2040	aflatoxin	3	CHEMICAL
2040	2041	-	0	None
2041	2042	exo	0	None
2042	2043	-	0	None
2043	2044	8	0	None
2044	2045	,	0	None
2045	2046	9	0	None
2046	2047	-	0	None
2047	2048	epoxide	3	CHEMICAL
2048	2049	conjugation	0	None
2049	2050	,	0	None
2050	2051	although	0	None
2051	2052	this	0	None
2052	2053	alone	0	None
2053	2054	is	0	None
2054	2055	not	0	None
2055	2056	sufficient	0	None
2056	2057	;	0	None
2057	2058	other	0	None
2058	2059	residues	0	None
2059	2060	in	0	None
2060	2061	the	0	None
2061	2062	vicinity	0	None
2062	2063	,	0	None
2063	2064	particularly	0	None
2064	2065	residues	0	None
2065	2066	103	0	None
2066	2067	-	0	None
2067	2068	112	0	None
2068	2069	,	0	None
2069	2070	are	0	None
2070	2071	important	0	None
2071	2072	,	0	None
2072	2073	perhaps	0	None
2073	2074	for	0	None
2074	2075	the	0	None
2075	2076	optimal	0	None
2076	2077	orientation	0	None
2077	2078	of	0	None
2078	2079	the	0	None
2079	2080	aflatoxin	3	CHEMICAL
2080	2081	-	0	None
2081	2082	exo	0	None
2082	2083	-	0	None
2083	2084	8	0	None
2084	2085	,	0	None
2085	2086	9	0	None
2086	2087	-	0	None
2087	2088	epoxide	3	CHEMICAL
2088	2089	in	0	None
2089	2090	the	0	None
2090	2091	active	0	None
2091	2092	site	0	None
2092	2093	for	0	None
2093	2094	catalysis	0	None
2094	2095	to	0	None
2095	2096	occur	0	None
2096	2097	.	0	None

2098	2099	Static	0	None
2099	2100	Laue	0	None
2100	2101	diffraction	0	None
2101	2102	studies	0	None
2102	2103	on	0	None
2103	2104	acetylcholinesterase	1	GENE-Y
2104	2105	.	0	None

2106	2107	Acetylcholinesterase	0	None
2107	2108	(	0	None
2108	2109	AChE	1	GENE-Y
2109	2110	)	0	None
2110	2111	is	0	None
2111	2112	one	0	None
2112	2113	of	0	None
2113	2114	nature	0	None
2114	2115	'	0	None
2115	2116	s	0	None
2116	2117	fastest	0	None
2117	2118	enzymes	0	None
2118	2119	,	0	None
2119	2120	despite	0	None
2120	2121	the	0	None
2121	2122	fact	0	None
2122	2123	that	0	None
2123	2124	its	0	None
2124	2125	three	0	None
2125	2126	-	0	None
2126	2127	dimensional	0	None
2127	2128	structure	0	None
2128	2129	reveals	0	None
2129	2130	its	0	None
2130	2131	active	0	None
2131	2132	site	0	None
2132	2133	to	0	None
2133	2134	be	0	None
2134	2135	deeply	0	None
2135	2136	sequestered	0	None
2136	2137	within	0	None
2137	2138	the	0	None
2138	2139	molecule	0	None
2139	2140	.	0	None

2141	2142	This	0	None
2142	2143	raises	0	None
2143	2144	questions	0	None
2144	2145	with	0	None
2145	2146	respect	0	None
2146	2147	to	0	None
2147	2148	traffic	0	None
2148	2149	of	0	None
2149	2150	substrate	0	None
2150	2151	to	0	None
2151	2152	,	0	None
2152	2153	and	0	None
2153	2154	products	0	None
2154	2155	from	0	None
2155	2156	,	0	None
2156	2157	the	0	None
2157	2158	active	0	None
2158	2159	site	0	None
2159	2160	,	0	None
2160	2161	which	0	None
2161	2162	may	0	None
2162	2163	be	0	None
2163	2164	investigated	0	None
2164	2165	by	0	None
2165	2166	time	0	None
2166	2167	-	0	None
2167	2168	resolved	0	None
2168	2169	crystallography	0	None
2169	2170	.	0	None

2171	2172	In	0	None
2172	2173	order	0	None
2173	2174	to	0	None
2174	2175	address	0	None
2175	2176	one	0	None
2176	2177	aspect	0	None
2177	2178	of	0	None
2178	2179	the	0	None
2179	2180	feasibility	0	None
2180	2181	of	0	None
2181	2182	performing	0	None
2182	2183	time	0	None
2183	2184	-	0	None
2184	2185	resolved	0	None
2185	2186	studies	0	None
2186	2187	on	0	None
2187	2188	AChE	1	GENE-Y
2188	2189	,	0	None
2189	2190	a	0	None
2190	2191	data	0	None
2191	2192	set	0	None
2192	2193	has	0	None
2193	2194	been	0	None
2194	2195	collected	0	None
2195	2196	using	0	None
2196	2197	the	0	None
2197	2198	Laue	0	None
2198	2199	technique	0	None
2199	2200	on	0	None
2200	2201	a	0	None
2201	2202	trigonal	0	None
2202	2203	crystal	0	None
2203	2204	of	0	None
2204	2207	Torpedo californica AChE	1	GENE-Y
2207	2208	soaked	0	None
2208	2209	with	0	None
2209	2210	the	0	None
2210	2211	reversible	0	None
2211	2212	inhibitor	0	None
2212	2213	edrophonium	0	None
2213	2214	,	0	None
2214	2215	using	0	None
2215	2216	a	0	None
2216	2217	total	0	None
2217	2218	X	0	None
2218	2219	-	0	None
2219	2220	ray	0	None
2220	2221	exposure	0	None
2221	2222	time	0	None
2222	2223	of	0	None
2223	2224	24	0	None
2224	2225	ms	0	None
2225	2226	.	0	None

2227	2228	Electron	0	None
2228	2229	-	0	None
2229	2230	density	0	None
2230	2231	maps	2	GENE-N
2231	2232	obtained	0	None
2232	2233	from	0	None
2233	2234	the	0	None
2234	2235	Laue	0	None
2235	2236	data	0	None
2236	2237	,	0	None
2237	2238	which	0	None
2238	2239	are	0	None
2239	2240	of	0	None
2240	2241	surprisingly	0	None
2241	2242	good	0	None
2242	2243	quality	0	None
2243	2244	compared	0	None
2244	2245	with	0	None
2245	2246	similar	0	None
2246	2247	maps	2	GENE-N
2247	2248	from	0	None
2248	2249	monochromatic	0	None
2249	2250	data	0	None
2250	2251	,	0	None
2251	2252	show	0	None
2252	2253	essentially	0	None
2253	2254	the	0	None
2254	2255	same	0	None
2255	2256	features	0	None
2256	2257	.	0	None

2258	2259	They	0	None
2259	2260	clearly	0	None
2260	2261	reveal	0	None
2261	2262	the	0	None
2262	2263	bound	0	None
2263	2264	ligand	0	None
2264	2265	,	0	None
2265	2266	as	0	None
2266	2267	well	0	None
2267	2268	as	0	None
2268	2269	a	0	None
2269	2270	structural	0	None
2270	2271	change	0	None
2271	2272	in	0	None
2272	2273	the	0	None
2273	2274	conformation	0	None
2274	2275	of	0	None
2275	2276	the	0	None
2276	2277	active	0	None
2277	2278	-	0	None
2278	2279	site	0	None
2279	2280	Ser200	0	None
2280	2281	induced	0	None
2281	2282	upon	0	None
2282	2283	binding	0	None
2283	2284	.	0	None

2285	2286	YAP1	1	GENE-Y
2286	2287	confers	0	None
2287	2288	resistance	0	None
2288	2289	to	0	None
2289	2290	the	0	None
2290	2293	fatty acid synthase	1	GENE-Y
2293	2294	inhibitor	0	None
2294	2295	cerulenin	3	CHEMICAL
2295	2296	through	0	None
2296	2297	the	0	None
2297	2298	transporter	0	None
2298	2299	Flr1p	0	None
2299	2300	in	0	None
2300	2301	Saccharomyces	0	None
2301	2302	cerevisiae	0	None
2302	2303	.	0	None

2304	2305	In	0	None
2305	2306	this	0	None
2306	2307	study	0	None
2307	2308	,	0	None
2308	2309	we	0	None
2309	2310	utilized	0	None
2310	2311	a	0	None
2311	2312	genetic	0	None
2312	2313	approach	0	None
2313	2314	to	0	None
2314	2315	identify	0	None
2315	2316	genes	0	None
2316	2317	which	0	None
2317	2318	render	0	None
2318	2319	yeast	1	GENE-Y
2319	2320	cells	0	None
2320	2321	resistant	0	None
2321	2322	to	0	None
2322	2323	cerulenin	3	CHEMICAL
2323	2324	(	0	None
2324	2325	Cer	0	None
2325	2326	)	0	None
2326	2327	,	0	None
2327	2328	a	0	None
2328	2329	potent	0	None
2329	2330	and	0	None
2330	2331	noncompetitive	0	None
2331	2332	inhibitor	0	None
2332	2333	of	0	None
2333	2336	fatty acid synthase	1	GENE-Y
2336	2337	(	0	None
2337	2338	FAS	1	GENE-Y
2338	2339	)	0	None
2339	2340	.	0	None

2341	2342	Overexpression	0	None
2342	2343	of	0	None
2343	2344	the	0	None
2344	2348	yeast transcription factor Yap1p	2	GENE-N
2348	2349	was	0	None
2349	2350	found	0	None
2350	2351	to	0	None
2351	2352	confer	0	None
2352	2353	Cer	0	None
2353	2354	resistance	0	None
2354	2355	(	0	None
2355	2356	CerR	0	None
2356	2357	)	0	None
2357	2358	.	0	None

2359	2360	This	0	None
2360	2361	resistance	0	None
2361	2362	was	0	None
2362	2363	shown	0	None
2363	2364	to	0	None
2364	2365	be	0	None
2365	2366	less	0	None
2366	2367	pronounced	0	None
2367	2368	in	0	None
2368	2369	a	0	None
2369	2370	strain	0	None
2370	2371	deleted	0	None
2371	2372	for	0	None
2372	2373	YCF1	1	GENE-Y
2373	2374	,	0	None
2374	2375	a	0	None
2375	2376	multidrug	0	None
2376	2378	resistance ABC	2	GENE-N
2378	2379	transporter	0	None
2379	2380	,	0	None
2380	2381	supporting	0	None
2381	2382	previous	0	None
2382	2383	observations	0	None
2383	2384	that	0	None
2384	2385	implicated	0	None
2385	2386	YCF1	1	GENE-Y
2386	2387	in	0	None
2387	2388	mediating	0	None
2388	2389	CerR	0	None
2389	2390	.	0	None

2391	2392	However	0	None
2392	2393	,	0	None
2393	2394	isolation	0	None
2394	2395	of	0	None
2395	2396	YAP1	1	GENE-Y
2396	2397	as	0	None
2397	2398	a	0	None
2398	2399	high	0	None
2399	2400	-	0	None
2400	2401	copy	0	None
2401	2402	CerR	0	None
2402	2403	gene	0	None
2403	2404	in	0	None
2404	2405	a	0	None
2405	2406	ycf1delta	0	None
2406	2407	strain	0	None
2407	2408	suggested	0	None
2408	2409	that	0	None
2409	2410	YAP1	1	GENE-Y
2410	2411	-	0	None
2411	2412	induced	0	None
2412	2413	CerR	0	None
2413	2414	was	0	None
2414	2415	mediated	0	None
2415	2416	by	0	None
2416	2417	additional	0	None
2417	2418	downstream	0	None
2418	2419	effectors	0	None
2419	2420	.	0	None

2421	2422	Overexpression	0	None
2422	2423	of	0	None
2423	2424	neither	0	None
2424	2426	glutathione reductase	2	GENE-N
2426	2427	nor	0	None
2427	2428	a	0	None
2428	2429	predicted	0	None
2429	2432	aryl alcohol dehydrogenase	2	GENE-N
2432	2433	(	0	None
2433	2434	the	0	None
2434	2435	products	0	None
2435	2436	of	0	None
2436	2437	two	0	None
2437	2438	YAP1	1	GENE-Y
2438	2439	-	0	None
2439	2440	regulated	0	None
2440	2441	genes	0	None
2441	2442	involved	0	None
2442	2443	in	0	None
2443	2444	detoxification	0	None
2444	2445	)	0	None
2445	2446	conferred	0	None
2446	2447	CerR	0	None
2447	2448	.	0	None

2449	2450	Overexpression	0	None
2450	2451	of	0	None
2451	2452	ATR1	1	GENE-Y
2452	2453	,	0	None
2453	2454	another	0	None
2454	2455	YAP1	1	GENE-Y
2455	2456	-	0	None
2456	2457	regulated	0	None
2457	2458	gene	0	None
2458	2459	previously	0	None
2459	2460	implicated	0	None
2460	2461	in	0	None
2461	2462	conferring	0	None
2462	2463	resistance	0	None
2463	2464	to	0	None
2464	2465	a	0	None
2465	2466	number	0	None
2466	2467	of	0	None
2467	2468	cytotoxic	0	None
2468	2469	drugs	0	None
2469	2470	,	0	None
2470	2471	was	0	None
2471	2472	also	0	None
2472	2473	incapable	0	None
2473	2474	of	0	None
2474	2475	making	0	None
2475	2476	cells	0	None
2476	2477	resistant	0	None
2477	2478	to	0	None
2478	2479	Cer	0	None
2479	2480	.	0	None

2481	2482	In	0	None
2482	2483	contrast	0	None
2483	2484	,	0	None
2484	2485	overexpression	0	None
2485	2486	of	0	None
2486	2487	Flr1p	0	None
2487	2488	,	0	None
2488	2489	a	0	None
2489	2491	yeast transporter	1	GENE-Y
2491	2492	of	0	None
2492	2493	the	0	None
2493	2494	major	0	None
2494	2495	facilitator	0	None
2495	2496	superfamily	0	None
2496	2497	which	0	None
2497	2498	is	0	None
2498	2499	also	0	None
2499	2500	under	0	None
2500	2501	the	0	None
2501	2502	control	0	None
2502	2503	of	0	None
2503	2504	YAP1	1	GENE-Y
2504	2505	,	0	None
2505	2506	was	0	None
2506	2507	sufficient	0	None
2507	2508	to	0	None
2508	2509	confer	0	None
2509	2510	CerR	0	None
2510	2511	in	0	None
2511	2512	an	0	None
2512	2513	otherwise	0	None
2513	2514	wild	0	None
2514	2515	-	0	None
2515	2516	type	0	None
2516	2517	background	0	None
2517	2518	.	0	None

2519	2520	Moreover	0	None
2520	2521	,	0	None
2521	2522	CerR	0	None
2522	2523	was	0	None
2523	2524	markedly	0	None
2524	2525	diminished	0	None
2525	2526	in	0	None
2526	2527	a	0	None
2527	2528	strain	0	None
2528	2529	deleted	0	None
2529	2530	for	0	None
2530	2531	FLR1	1	GENE-Y
2531	2532	.	0	None

2533	2534	These	0	None
2534	2535	findings	0	None
2535	2536	implicate	0	None
2536	2537	members	0	None
2537	2538	of	0	None
2538	2539	both	0	None
2539	2540	of	0	None
2540	2541	the	0	None
2541	2542	transporter	0	None
2542	2543	superfamilies	0	None
2543	2544	involved	0	None
2544	2545	in	0	None
2545	2546	multiple	0	None
2546	2547	drug	0	None
2547	2548	resistance	0	None
2548	2549	(	0	None
2549	2550	MDR	0	None
2550	2551	)	0	None
2551	2552	in	0	None
2552	2553	the	0	None
2553	2554	acquisition	0	None
2554	2555	of	0	None
2555	2556	CerR	0	None
2556	2557	in	0	None
2557	2558	yeast	1	GENE-Y
2558	2559	.	0	None

2560	2561	Furthermore	0	None
2561	2562	,	0	None
2562	2563	our	0	None
2563	2564	studies	0	None
2564	2565	indicate	0	None
2565	2566	that	0	None
2566	2567	yeast	2	GENE-N
2567	2568	may	0	None
2568	2569	be	0	None
2569	2570	a	0	None
2570	2571	useful	0	None
2571	2572	model	0	None
2572	2573	system	0	None
2573	2574	in	0	None
2574	2575	which	0	None
2575	2576	to	0	None
2576	2577	investigate	0	None
2577	2578	the	0	None
2578	2579	role	0	None
2579	2580	of	0	None
2580	2581	FAS	1	GENE-Y
2581	2582	in	0	None
2582	2583	cancer	0	None
2583	2584	biology	0	None
2584	2585	and	0	None
2585	2586	the	0	None
2586	2587	effects	0	None
2587	2588	of	0	None
2588	2589	Cer	0	None
2589	2590	on	0	None
2590	2593	eukaryotic cell growth	1	GENE-Y
2593	2594	.	0	None

2595	2596	Mortality	0	None
2596	2597	risk	0	None
2597	2598	in	0	None
2598	2599	men	0	None
2599	2600	is	0	None
2600	2601	associated	0	None
2601	2602	with	0	None
2602	2603	a	0	None
2603	2604	common	0	None
2604	2605	mutation	0	None
2605	2606	in	0	None
2606	2607	the	0	None
2607	2608	methylene	3	CHEMICAL
2608	2609	-	0	None
2609	2610	tetrahydrofolate	3	CHEMICAL
2610	2611	reductase	2	GENE-N
2611	2612	gene	0	None
2612	2613	(	0	None
2613	2614	MTHFR	1	GENE-Y
2614	2615	)	0	None
2615	2616	.	0	None

2617	2618	An	0	None
2618	2619	elevated	0	None
2619	2620	level	0	None
2620	2621	of	0	None
2621	2622	homocysteine	0	None
2622	2623	in	0	None
2623	2624	plasma	0	None
2624	2625	is	0	None
2625	2626	associated	0	None
2626	2627	with	0	None
2627	2628	the	0	None
2628	2629	occurrence	0	None
2629	2630	of	0	None
2630	2631	cardiovascular	0	None
2631	2632	disease	0	None
2632	2633	.	0	None

2634	2635	A	0	None
2635	2636	common	0	None
2636	2637	ala	0	None
2637	2638	-	0	None
2638	2639	to	0	None
2639	2640	-	0	None
2640	2641	val	3	CHEMICAL
2641	2642	mutation	0	None
2642	2643	in	0	None
2643	2644	the	0	None
2644	2647	methylenetetrahydrofolate reductase gene	1	GENE-Y
2647	2648	(	0	None
2648	2649	MTHFR	1	GENE-Y
2649	2650	)	0	None
2650	2651	is	0	None
2651	2652	associated	0	None
2652	2653	with	0	None
2653	2654	an	0	None
2654	2655	elevated	0	None
2655	2656	level	0	None
2656	2657	of	0	None
2657	2658	plasma	0	None
2658	2659	homocysteine	0	None
2659	2660	.	0	None

2661	2662	We	0	None
2662	2663	studied	0	None
2663	2664	the	0	None
2664	2665	possible	0	None
2665	2666	detrimental	0	None
2666	2667	effects	0	None
2667	2668	of	0	None
2668	2669	the	0	None
2669	2670	MTHFR	1	GENE-Y
2670	2671	mutation	0	None
2671	2672	on	0	None
2672	2673	mortality	0	None
2673	2674	.	0	None

2675	2676	Within	0	None
2676	2677	a	0	None
2677	2678	population	0	None
2678	2679	-	0	None
2679	2680	based	0	None
2680	2681	study	0	None
2681	2682	in	0	None
2682	2683	the	0	None
2683	2684	city	0	None
2684	2685	of	0	None
2685	2686	Leiden	0	None
2686	2687	,	0	None
2687	2688	the	0	None
2688	2689	Netherlands	0	None
2689	2690	,	0	None
2690	2691	we	0	None
2691	2692	first	0	None
2692	2693	compared	0	None
2693	2694	the	0	None
2694	2695	MTHFR	1	GENE-Y
2695	2696	genotype	0	None
2696	2697	distribution	0	None
2697	2698	among	0	None
2698	2699	365	0	None
2699	2700	elderly	0	None
2700	2701	subjects	0	None
2701	2702	aged	0	None
2702	2703	85	0	None
2703	2704	years	0	None
2704	2705	and	0	None
2705	2706	over	0	None
2706	2707	born	0	None
2707	2708	in	0	None
2708	2709	Leiden	0	None
2709	2710	,	0	None
2710	2711	and	0	None
2711	2712	250	0	None
2712	2713	young	0	None
2713	2714	subjects	0	None
2714	2715	aged	0	None
2715	2716	18	0	None
2716	2717	to	0	None
2717	2718	40	0	None
2718	2719	years	0	None
2719	2720	whose	0	None
2720	2721	families	0	None
2721	2722	originated	0	None
2722	2723	from	0	None
2723	2724	the	0	None
2724	2725	same	0	None
2725	2726	geographical	0	None
2726	2727	region	0	None
2727	2728	.	0	None

2729	2730	Second	0	None
2730	2731	,	0	None
2731	2732	the	0	None
2732	2733	complete	0	None
2733	2734	cohort	0	None
2734	2735	of	0	None
2735	2736	666	0	None
2736	2737	subjects	0	None
2737	2738	aged	0	None
2738	2739	85	0	None
2739	2740	years	0	None
2740	2741	and	0	None
2741	2742	over	0	None
2742	2743	was	0	None
2743	2744	followed	0	None
2744	2745	over	0	None
2745	2746	a	0	None
2746	2747	period	0	None
2747	2748	of	0	None
2748	2749	10	0	None
2749	2750	years	0	None
2750	2751	for	0	None
2751	2752	all	0	None
2752	2753	-	0	None
2753	2754	cause	0	None
2754	2755	and	0	None
2755	2756	cause	0	None
2756	2757	-	0	None
2757	2758	specific	0	None
2758	2759	mortality	0	None
2759	2760	and	0	None
2760	2761	stratified	0	None
2761	2762	according	0	None
2762	2763	to	0	None
2763	2764	MTHFR	1	GENE-Y
2764	2765	genotype	0	None
2765	2766	.	0	None

2767	2768	The	0	None
2768	2769	frequency	0	None
2769	2770	of	0	None
2770	2771	the	0	None
2771	2772	MTHFR	1	GENE-Y
2772	2773	mutation	0	None
2773	2774	was	0	None
2774	2775	significantly	0	None
2775	2776	lower	0	None
2776	2777	in	0	None
2777	2778	the	0	None
2778	2779	elderly	0	None
2779	2780	than	0	None
2780	2781	in	0	None
2781	2782	the	0	None
2782	2783	young	0	None
2783	2784	(	0	None
2784	2785	0	0	None
2785	2786	.	0	None
2786	2787	30	0	None
2787	2788	and	0	None
2788	2789	0	0	None
2789	2790	.	0	None
2790	2791	36	0	None
2791	2792	,	0	None
2792	2793	respectively	0	None
2793	2794	;	0	None
2794	2795	P	0	None
2795	2796	=	0	None
2796	2797	0	0	None
2797	2798	.	0	None
2798	2799	03	0	None
2799	2800	)	0	None
2800	2801	.	0	None

2802	2803	The	0	None
2803	2804	difference	0	None
2804	2805	in	0	None
2805	2806	genotype	0	None
2806	2807	distribution	0	None
2807	2808	was	0	None
2808	2809	only	0	None
2809	2810	present	0	None
2810	2811	in	0	None
2811	2812	men	0	None
2812	2813	.	0	None

2814	2815	The	0	None
2815	2816	estimated	0	None
2816	2817	mortality	0	None
2817	2818	risk	0	None
2818	2819	up	0	None
2819	2820	to	0	None
2820	2821	85	0	None
2821	2822	years	0	None
2822	2823	in	0	None
2823	2824	men	0	None
2824	2825	carrying	0	None
2825	2826	the	0	None
2826	2827	vallval	0	None
2827	2828	genotype	0	None
2828	2829	was	0	None
2829	2830	3	0	None
2830	2831	.	0	None
2831	2832	7	0	None
2832	2833	(	0	None
2833	2834	95	0	None
2834	2835	%	0	None
2835	2836	confidence	0	None
2836	2837	interval	0	None
2837	2838	(	0	None
2838	2839	CI	0	None
2839	2840	)	0	None
2840	2841	,	0	None
2841	2842	1	0	None
2842	2843	.	0	None
2843	2844	3	0	None
2844	2845	-	0	None
2845	2846	10	0	None
2846	2847	.	0	None
2847	2848	9	0	None
2848	2849	)	0	None
2849	2850	.	0	None

2851	2852	Over	0	None
2852	2853	the	0	None
2853	2854	age	1	GENE-Y
2854	2855	of	0	None
2855	2856	85	0	None
2856	2857	,	0	None
2857	2858	mortality	0	None
2858	2859	in	0	None
2859	2860	men	0	None
2860	2861	with	0	None
2861	2862	the	0	None
2862	2863	vallval	0	None
2863	2864	genotype	0	None
2864	2865	was	0	None
2865	2866	increased	0	None
2866	2867	2	0	None
2867	2868	.	0	None
2868	2869	0	0	None
2869	2870	-	0	None
2870	2871	fold	0	None
2871	2872	(	0	None
2872	2873	95	0	None
2873	2874	%	0	None
2874	2875	CI	0	None
2875	2876	,	0	None
2876	2877	1	0	None
2877	2878	.	0	None
2878	2879	1	0	None
2879	2880	-	0	None
2880	2881	3	0	None
2881	2882	.	0	None
2882	2883	9	0	None
2883	2884	)	0	None
2884	2885	and	0	None
2885	2886	appeared	0	None
2886	2887	to	0	None
2887	2888	be	0	None
2888	2889	attributable	0	None
2889	2890	to	0	None
2890	2891	cancer	0	None
2891	2892	rather	0	None
2892	2893	than	0	None
2893	2894	cardiovascular	0	None
2894	2895	causes	0	None
2895	2896	of	0	None
2896	2897	death	0	None
2897	2898	.	0	None

2899	2900	Among	0	None
2900	2901	women	0	None
2901	2902	aged	0	None
2902	2903	85	0	None
2903	2904	years	0	None
2904	2905	and	0	None
2905	2906	over	0	None
2906	2907	,	0	None
2907	2908	no	0	None
2908	2909	deleterious	0	None
2909	2910	effect	0	None
2910	2911	of	0	None
2911	2912	the	0	None
2912	2913	MTHFR	1	GENE-Y
2913	2914	mutation	0	None
2914	2915	was	0	None
2915	2916	observed	0	None
2916	2917	.	0	None

2918	2919	In	0	None
2919	2920	conclusion	0	None
2920	2921	,	0	None
2921	2922	the	0	None
2922	2923	MTHFR	1	GENE-Y
2923	2924	mutation	0	None
2924	2925	is	0	None
2925	2926	associated	0	None
2926	2927	with	0	None
2927	2928	increased	0	None
2928	2929	mortality	0	None
2929	2930	in	0	None
2930	2931	men	0	None
2931	2932	in	0	None
2932	2933	middle	0	None
2933	2934	and	0	None
2934	2935	old	0	None
2935	2936	age	1	GENE-Y
2936	2937	,	0	None
2937	2938	but	0	None
2938	2939	not	0	None
2939	2940	in	0	None
2940	2941	women	0	None
2941	2942	.	0	None

2943	2944	The	0	None
2944	2945	NDUFA1	0	None
2945	2946	gene	0	None
2946	2947	product	0	None
2947	2948	(	0	None
2948	2949	MWFE	1	GENE-Y
2949	2950	protein	0	None
2950	2951	)	0	None
2951	2952	is	0	None
2952	2953	essential	0	None
2953	2954	for	0	None
2954	2955	activity	0	None
2955	2956	of	0	None
2956	2957	complex	0	None
2957	2958	I	0	None
2958	2959	in	0	None
2959	2960	mammalian	0	None
2960	2961	mitochondria	0	None
2961	2962	.	0	None

2963	2964	The	0	None
2964	2965	MWFE	1	GENE-Y
2965	2966	polypeptide	0	None
2966	2967	of	0	None
2967	2970	mammalian complex I	1	GENE-Y
2970	2971	(	0	None
2971	2972	the	0	None
2972	2973	proton	0	None
2973	2974	-	0	None
2974	2975	translocating	0	None
2975	2976	NADH	3	CHEMICAL
2976	2977	-	0	None
2977	2979	quinone oxidoreductase	1	GENE-Y
2979	2980	)	0	None
2980	2981	is	0	None
2981	2982	70	0	None
2982	2984	amino acids	3	CHEMICAL
2984	2985	long	0	None
2985	2986	,	0	None
2986	2987	and	0	None
2987	2988	it	0	None
2988	2989	is	0	None
2989	2990	predicted	0	None
2990	2991	to	0	None
2991	2992	be	0	None
2992	2993	a	0	None
2993	2994	membrane	0	None
2994	2995	protein	0	None
2995	2996	.	0	None

2997	2998	The	0	None
2998	2999	NDUFA1	0	None
2999	3000	gene	0	None
3000	3001	encoding	0	None
3001	3002	the	0	None
3002	3003	MWFE	1	GENE-Y
3003	3004	polypeptide	0	None
3004	3005	is	0	None
3005	3006	located	0	None
3006	3007	on	0	None
3007	3008	the	0	None
3008	3009	X	0	None
3009	3010	chromosome	0	None
3010	3011	.	0	None

3012	3013	This	0	None
3013	3014	polypeptide	0	None
3014	3015	is	0	None
3015	3016	1	0	None
3016	3017	of	0	None
3017	3018	approximately	0	None
3018	3019	28	0	None
3019	3020	"	0	None
3020	3021	accessory	0	None
3021	3022	proteins	0	None
3022	3023	"	0	None
3023	3024	identified	0	None
3024	3025	in	0	None
3025	3026	complex	0	None
3026	3027	I	0	None
3027	3028	,	0	None
3028	3029	which	0	None
3029	3030	is	0	None
3030	3031	composed	0	None
3031	3032	of	0	None
3032	3033	42	0	None
3033	3034	unlike	0	None
3034	3035	subunits	0	None
3035	3036	.	0	None

3037	3038	It	0	None
3038	3039	was	0	None
3039	3040	considered	0	None
3040	3041	accessory	0	None
3041	3042	,	0	None
3042	3043	because	0	None
3043	3044	it	0	None
3044	3045	is	0	None
3045	3046	not	0	None
3046	3047	one	0	None
3047	3048	of	0	None
3048	3049	the	0	None
3049	3050	14	0	None
3050	3051	polypeptides	0	None
3051	3052	making	0	None
3052	3053	up	0	None
3053	3054	the	0	None
3054	3055	core	0	None
3055	3056	complex	0	None
3056	3057	I	0	None
3057	3058	;	0	None
3058	3059	a	0	None
3059	3060	homologous	0	None
3060	3061	set	0	None
3061	3062	of	0	None
3062	3063	14	0	None
3063	3064	polypeptides	0	None
3064	3065	can	0	None
3065	3066	make	0	None
3066	3067	a	0	None
3067	3068	fully	0	None
3068	3069	functional	0	None
3069	3070	proton	0	None
3070	3071	-	0	None
3071	3072	translocating	0	None
3072	3073	NADH	3	CHEMICAL
3073	3074	-	0	None
3074	3076	quinone oxidoreductase	1	GENE-Y
3076	3077	in	0	None
3077	3078	prokaryotes	0	None
3078	3079	.	0	None

3080	3081	One	0	None
3081	3082	MWFE	1	GENE-Y
3082	3083	mutant	0	None
3083	3084	has	0	None
3084	3085	been	0	None
3085	3086	identified	0	None
3086	3087	and	0	None
3087	3088	isolated	0	None
3088	3089	from	0	None
3089	3090	a	0	None
3090	3091	collection	0	None
3091	3092	of	0	None
3092	3093	respiration	0	None
3093	3094	-	0	None
3094	3095	deficient	0	None
3095	3096	Chinese	0	None
3096	3097	hamster	0	None
3097	3098	cell	0	None
3098	3099	mutants	0	None
3099	3100	.	0	None

3101	3102	The	0	None
3102	3103	CCL16	0	None
3103	3104	-	0	None
3104	3105	B2	0	None
3105	3106	mutant	0	None
3106	3107	has	0	None
3107	3108	suffered	0	None
3108	3109	a	0	None
3109	3110	deletion	0	None
3110	3111	that	0	None
3111	3112	would	0	None
3112	3113	produce	0	None
3113	3114	a	0	None
3114	3115	truncated	0	None
3115	3116	and	0	None
3116	3117	abnormal	0	None
3117	3118	MWFE	1	GENE-Y
3118	3119	protein	0	None
3119	3120	.	0	None

3121	3122	In	0	None
3122	3123	these	0	None
3123	3124	mutant	0	None
3124	3125	cells	0	None
3125	3126	,	0	None
3126	3127	complex	0	None
3127	3128	I	0	None
3128	3129	activity	0	None
3129	3130	is	0	None
3130	3131	reduced	0	None
3131	3132	severely	0	None
3132	3133	(	0	None
3133	3134	<	0	None
3134	3135	10	0	None
3135	3136	%	0	None
3136	3137	)	0	None
3137	3138	.	0	None

3139	3140	Complementation	0	None
3140	3141	with	0	None
3141	3142	hamster	0	None
3142	3143	NDUFA1	0	None
3143	3144	cDNA	0	None
3144	3145	restored	0	None
3145	3146	the	0	None
3146	3147	rotenone	3	CHEMICAL
3147	3148	-	0	None
3148	3149	sensitive	0	None
3149	3150	complex	0	None
3150	3151	I	0	None
3151	3152	activity	0	None
3152	3153	of	0	None
3153	3154	these	0	None
3154	3155	mutant	0	None
3155	3156	cells	0	None
3156	3157	to	0	None
3157	3158	approximately	0	None
3158	3159	100	0	None
3159	3160	%	0	None
3160	3161	of	0	None
3161	3162	the	0	None
3162	3163	parent	0	None
3163	3164	cell	0	None
3164	3165	activity	0	None
3165	3166	.	0	None

3167	3168	Thus	0	None
3168	3169	,	0	None
3169	3170	it	0	None
3170	3171	is	0	None
3171	3172	established	0	None
3172	3173	that	0	None
3173	3174	the	0	None
3174	3175	MWFE	1	GENE-Y
3175	3176	polypeptide	0	None
3176	3177	is	0	None
3177	3178	absolutely	0	None
3178	3179	essential	0	None
3179	3180	for	0	None
3180	3181	an	0	None
3181	3182	active	0	None
3182	3183	complex	0	None
3183	3184	I	0	None
3184	3185	in	0	None
3185	3186	mammals	0	None
3186	3187	.	0	None

3188	3189	Synthesis	0	None
3189	3190	of	0	None
3190	3191	thrombin	2	GENE-N
3191	3192	-	0	None
3192	3193	inhibiting	0	None
3193	3194	heparin	0	None
3194	3195	mimetics	0	None
3195	3196	without	0	None
3196	3197	side	0	None
3197	3198	effects	0	None
3198	3199	.	0	None

3200	3201	Unwanted	0	None
3201	3202	side	0	None
3202	3203	effects	0	None
3203	3204	of	0	None
3204	3205	pharmacologically	0	None
3205	3206	active	0	None
3206	3207	compounds	0	None
3207	3208	can	0	None
3208	3209	usually	0	None
3209	3210	be	0	None
3210	3211	eliminated	0	None
3211	3212	by	0	None
3212	3213	structural	0	None
3213	3214	modifications	0	None
3214	3215	.	0	None

3216	3217	But	0	None
3217	3218	the	0	None
3218	3219	complex	0	None
3219	3220	heterogeneous	0	None
3220	3221	structure	0	None
3221	3222	of	0	None
3222	3223	the	0	None
3223	3224	polysaccharide	0	None
3224	3225	heparin	0	None
3225	3226	has	0	None
3226	3227	limited	0	None
3227	3228	this	0	None
3228	3229	approach	0	None
3229	3230	to	0	None
3230	3231	fragmentation	0	None
3231	3232	,	0	None
3232	3233	leading	0	None
3233	3234	to	0	None
3234	3235	slightly	0	None
3235	3236	better	0	None
3236	3237	-	0	None
3237	3238	tolerated	0	None
3238	3239	heparin	0	None
3239	3240	preparations	0	None
3240	3241	of	0	None
3241	3242	low	0	None
3242	3243	molecular	0	None
3243	3244	mass	0	None
3244	3245	.	0	None

3246	3247	Despite	0	None
3247	3248	this	0	None
3248	3249	improvement	0	None
3249	3250	,	0	None
3250	3251	heparin	0	None
3251	3252	-	0	None
3252	3253	induced	0	None
3253	3254	thrombocytopaenia	0	None
3254	3255	(	0	None
3255	3256	HIT	1	GENE-Y
3256	3257	)	0	None
3257	3258	,	0	None
3258	3259	related	0	None
3259	3260	to	0	None
3260	3261	an	0	None
3261	3262	interaction	0	None
3262	3263	with	0	None
3263	3265	platelet factor	0	None
3265	3266	4	0	None
3266	3267	(	0	None
3267	3268	PF4	0	None
3268	3269	)	0	None
3269	3270	and	0	None
3270	3271	,	0	None
3271	3272	to	0	None
3272	3273	a	0	None
3273	3274	lesser	0	None
3274	3275	extent	0	None
3275	3276	,	0	None
3276	3277	haemorrhages	0	None
3277	3278	,	0	None
3278	3279	remain	0	None
3279	3280	significant	0	None
3280	3281	side	0	None
3281	3282	effects	0	None
3282	3283	of	0	None
3283	3284	heparinotherapy	0	None
3284	3285	.	0	None

3286	3287	Breakthroughs	0	None
3287	3288	in	0	None
3288	3289	oligosaccharide	0	None
3289	3290	chemistry	0	None
3290	3291	made	0	None
3291	3292	possible	0	None
3292	3293	the	0	None
3293	3294	total	0	None
3294	3295	synthesis	0	None
3295	3296	of	0	None
3296	3297	the	0	None
3297	3299	pentasaccharide antithrombin	1	GENE-Y
3299	3300	-	0	None
3300	3301	binding	0	None
3301	3302	site	0	None
3302	3303	of	0	None
3303	3304	heparin	0	None
3304	3305	.	0	None

3306	3307	This	0	None
3307	3308	pentasaccharide	0	None
3308	3309	represents	0	None
3309	3310	a	0	None
3310	3311	new	0	None
3311	3312	family	0	None
3312	3313	of	0	None
3313	3314	potential	0	None
3314	3315	antithrombotic	0	None
3315	3316	drugs	0	None
3316	3317	,	0	None
3317	3318	devoid	0	None
3318	3319	of	0	None
3319	3320	thrombin	1	GENE-Y
3320	3321	inhibitory	0	None
3321	3322	properties	0	None
3322	3323	,	0	None
3323	3324	and	0	None
3324	3325	free	0	None
3325	3326	of	0	None
3326	3327	undesired	0	None
3327	3328	interactions	0	None
3328	3329	with	0	None
3329	3330	blood	0	None
3330	3331	and	0	None
3331	3332	vessel	0	None
3332	3333	components	0	None
3333	3334	.	0	None

3335	3336	To	0	None
3336	3337	obtain	0	None
3337	3338	more	0	None
3338	3339	potent	0	None
3339	3340	and	0	None
3340	3341	well	0	None
3341	3342	-	0	None
3342	3343	tolerated	0	None
3343	3344	antithrombotic	0	None
3344	3345	drugs	0	None
3345	3346	,	0	None
3346	3347	we	0	None
3347	3348	wished	0	None
3348	3349	to	0	None
3349	3350	synthesize	0	None
3350	3351	heparin	0	None
3351	3352	mimetics	0	None
3352	3353	able	0	None
3353	3354	to	0	None
3354	3355	inhibit	0	None
3355	3356	thrombin	1	GENE-Y
3356	3357	,	0	None
3357	3358	that	0	None
3358	3359	is	0	None
3359	3360	,	0	None
3360	3361	longer	0	None
3361	3362	oligosaccharides	0	None
3362	3363	.	0	None

3364	3365	Like	0	None
3365	3366	thrombin	2	GENE-N
3366	3367	inhibition	0	None
3367	3368	,	0	None
3368	3369	undesired	0	None
3369	3370	interactions	0	None
3370	3371	are	0	None
3371	3372	directly	0	None
3372	3373	correlated	0	None
3373	3374	to	0	None
3374	3375	the	0	None
3375	3376	charge	0	None
3376	3377	and	0	None
3377	3378	the	0	None
3378	3379	size	0	None
3379	3380	of	0	None
3380	3381	the	0	None
3381	3382	molecules	0	None
3382	3383	,	0	None
3383	3384	so	0	None
3384	3385	we	0	None
3385	3386	had	0	None
3386	3387	to	0	None
3387	3388	design	0	None
3388	3389	structures	0	None
3389	3390	that	0	None
3390	3391	were	0	None
3391	3392	able	0	None
3392	3393	to	0	None
3393	3394	discriminate	0	None
3394	3395	between	0	None
3395	3396	thrombin	1	GENE-Y
3396	3397	and	0	None
3397	3398	other	0	None
3398	3399	proteins	0	None
3399	3400	,	0	None
3400	3401	particularly	0	None
3401	3402	PF4	0	None
3402	3403	.	0	None

3404	3405	Here	0	None
3405	3406	we	0	None
3406	3407	describe	0	None
3407	3408	the	0	None
3408	3409	use	0	None
3409	3410	of	0	None
3410	3411	multistep	0	None
3411	3412	converging	0	None
3412	3413	synthesis	0	None
3413	3414	to	0	None
3414	3415	obtain	0	None
3415	3416	sulphated	0	None
3416	3417	oligosaccharides	0	None
3417	3418	that	0	None
3418	3419	meet	0	None
3419	3420	these	0	None
3420	3421	requirements	0	None
3421	3422	.	0	None

3423	3424	Effects	0	None
3424	3425	of	0	None
3425	3426	candesartan	3	CHEMICAL
3426	3427	and	0	None
3427	3428	cilazapril	3	CHEMICAL
3428	3429	on	0	None
3429	3430	rats	0	None
3430	3431	with	0	None
3431	3432	myocardial	0	None
3432	3433	infarction	0	None
3433	3434	assessed	0	None
3434	3435	by	0	None
3435	3436	echocardiography	0	None
3436	3437	.	0	None

3438	3439	The	0	None
3439	3440	purpose	0	None
3440	3441	of	0	None
3441	3442	this	0	None
3442	3443	study	0	None
3443	3444	was	0	None
3444	3445	to	0	None
3445	3446	compare	0	None
3446	3447	the	0	None
3447	3451	angiotensin II type 1	1	GENE-Y
3451	3452	receptor	0	None
3452	3453	antagonist	0	None
3453	3455	candesartan cilexitil	3	CHEMICAL
3455	3456	(	0	None
3456	3457	candesartan	3	CHEMICAL
3457	3458	)	0	None
3458	3459	and	0	None
3459	3460	the	0	None
3460	3461	angiotensin	3	CHEMICAL
3461	3462	-	0	None
3462	3463	converting	0	None
3463	3464	enzyme	1	GENE-Y
3464	3465	inhibitor	0	None
3465	3466	cilazapril	3	CHEMICAL
3466	3467	on	0	None
3467	3468	cardiac	0	None
3468	3469	function	0	None
3469	3470	,	0	None
3470	3471	assessed	0	None
3471	3472	by	0	None
3472	3473	Doppler	0	None
3473	3474	echocardiography	0	None
3474	3475	and	0	None
3475	3476	cardiac	0	None
3476	3477	gene	0	None
3477	3478	expression	0	None
3478	3479	associated	0	None
3479	3480	with	0	None
3480	3481	cardiac	0	None
3481	3482	remodeling	0	None
3482	3483	,	0	None
3483	3484	in	0	None
3484	3485	rats	0	None
3485	3486	with	0	None
3486	3487	myocardial	0	None
3487	3488	infarction	0	None
3488	3489	.	0	None

3490	3491	Candesartan	0	None
3491	3492	or	0	None
3492	3493	cilazapril	3	CHEMICAL
3493	3494	was	0	None
3494	3495	administered	0	None
3495	3496	after	0	None
3496	3497	myocardial	0	None
3497	3498	infarction	0	None
3498	3499	.	0	None

3500	3501	At	0	None
3501	3502	1	0	None
3502	3503	and	0	None
3503	3504	4	0	None
3504	3505	weeks	0	None
3505	3506	after	0	None
3506	3507	myocardial	0	None
3507	3508	infarction	0	None
3508	3509	,	0	None
3509	3510	cardiac	0	None
3510	3511	function	0	None
3511	3512	and	0	None
3512	3513	mRNA	0	None
3513	3514	expression	0	None
3514	3515	in	0	None
3515	3516	noninfarcted	0	None
3516	3517	myocardium	0	None
3517	3518	were	0	None
3518	3519	analyzed	0	None
3519	3520	.	0	None

3521	3522	Candesartan	0	None
3522	3523	and	0	None
3523	3524	cilazapril	3	CHEMICAL
3524	3525	equally	0	None
3525	3526	prevented	0	None
3526	3527	increases	0	None
3527	3528	in	0	None
3528	3529	hypertrophy	0	None
3529	3530	in	0	None
3530	3531	noninfarcted	0	None
3531	3532	myocardium	0	None
3532	3533	,	0	None
3533	3534	left	0	None
3534	3535	ventricular	0	None
3535	3536	dilatation	0	None
3536	3537	,	0	None
3537	3538	and	0	None
3538	3539	ejection	0	None
3539	3540	fraction	0	None
3540	3541	at	0	None
3541	3542	4	0	None
3542	3543	weeks	0	None
3543	3544	.	0	None

3545	3546	The	0	None
3546	3547	E	0	None
3547	3548	-	0	None
3548	3549	wave	0	None
3549	3550	/	0	None
3550	3551	A	0	None
3551	3552	-	0	None
3552	3553	wave	0	None
3553	3554	velocity	0	None
3554	3555	ratio	0	None
3555	3556	and	0	None
3556	3557	the	0	None
3557	3558	rate	0	None
3558	3559	of	0	None
3559	3560	E	0	None
3560	3561	-	0	None
3561	3562	wave	0	None
3562	3563	deceleration	0	None
3563	3564	,	0	None
3564	3565	measures	0	None
3565	3566	of	0	None
3566	3567	diastolic	0	None
3567	3568	function	0	None
3568	3569	,	0	None
3569	3570	increased	0	None
3570	3571	to	0	None
3571	3572	9	0	None
3572	3573	.	0	None
3573	3574	2	0	None
3574	3575	+	0	None
3575	3576	/	0	None
3576	3577	-	0	None
3577	3578	0	0	None
3578	3579	.	0	None
3579	3580	6	0	None
3580	3581	and	0	None
3581	3582	26	0	None
3582	3583	.	0	None
3583	3584	3	0	None
3584	3585	+	0	None
3585	3586	/	0	None
3586	3587	-	0	None
3587	3588	2	0	None
3588	3589	.	0	None

3590	3591	6	0	None
3591	3592	m	0	None
3592	3593	/	0	None
3593	3594	s2	0	None
3594	3595	at	0	None
3595	3596	1	0	None
3596	3597	week	0	None
3597	3598	after	0	None
3598	3599	myocardial	0	None
3599	3600	infarction	0	None
3600	3601	.	0	None

3602	3603	Candesartan	0	None
3603	3604	and	0	None
3604	3605	cilazapril	3	CHEMICAL
3605	3606	,	0	None
3606	3607	administered	0	None
3607	3608	at	0	None
3608	3609	a	0	None
3609	3610	dose	0	None
3610	3611	of	0	None
3611	3612	1	0	None
3612	3613	mg	0	None
3613	3614	/	0	None
3614	3615	kg	0	None
3615	3616	per	0	None
3616	3617	day	0	None
3617	3618	,	0	None
3618	3619	prevented	0	None
3619	3620	increases	0	None
3620	3621	in	0	None
3621	3622	E	0	None
3622	3623	-	0	None
3623	3624	wave	0	None
3624	3625	/	0	None
3625	3626	A	0	None
3626	3627	-	0	None
3627	3628	wave	0	None
3628	3629	velocity	0	None
3629	3630	ratio	0	None
3630	3631	and	0	None
3631	3632	E	0	None
3632	3633	-	0	None
3633	3634	wave	0	None
3634	3635	deceleration	0	None
3635	3636	at	0	None
3636	3637	1	0	None
3637	3638	and	0	None
3638	3639	4	0	None
3639	3640	weeks	0	None
3640	3641	.	0	None

3642	3643	Candesartan	0	None
3643	3644	and	0	None
3644	3645	cilazapril	3	CHEMICAL
3645	3646	significantly	0	None
3646	3647	suppressed	0	None
3647	3648	increased	0	None
3648	3649	mRNA	0	None
3649	3650	expression	0	None
3650	3651	of	0	None
3651	3652	beta	0	None
3652	3653	-	0	None
3653	3654	myosin	0	None
3654	3655	heavy	0	None
3655	3656	chain	0	None
3656	3657	,	0	None
3657	3658	alpha	0	None
3658	3659	-	0	None
3659	3660	skeletal	0	None
3660	3661	actin	0	None
3661	3662	,	0	None
3662	3663	and	0	None
3663	3666	atrial natriuretic peptide	1	GENE-Y
3666	3667	in	0	None
3667	3668	noninfarcted	0	None
3668	3669	ventricle	0	None
3669	3670	at	0	None
3670	3671	1	0	None
3671	3672	and	0	None
3672	3673	4	0	None
3673	3674	weeks	0	None
3674	3675	and	0	None
3675	3676	expression	0	None
3676	3677	of	0	None
3677	3681	collagen I and III	1	GENE-Y
3681	3682	at	0	None
3682	3683	4	0	None
3683	3684	weeks	0	None
3684	3685	to	0	None
3685	3686	a	0	None
3686	3687	similar	0	None
3687	3688	extent	0	None
3688	3689	.	0	None

3690	3691	When	0	None
3691	3692	given	0	None
3692	3693	at	0	None
3693	3694	a	0	None
3694	3695	dose	0	None
3695	3696	of	0	None
3696	3697	10	0	None
3697	3698	mg	0	None
3698	3699	/	0	None
3699	3700	kg	0	None
3700	3701	per	0	None
3701	3702	day	0	None
3702	3703	,	0	None
3703	3704	both	0	None
3704	3705	candesartan	3	CHEMICAL
3705	3706	and	0	None
3706	3707	cilazapril	3	CHEMICAL
3707	3708	prevented	0	None
3708	3709	cardiac	0	None
3709	3710	dysfunction	0	None
3710	3711	and	0	None
3711	3712	gene	0	None
3712	3713	expression	0	None
3713	3714	to	0	None
3714	3715	the	0	None
3715	3716	same	0	None
3716	3717	extent	0	None
3717	3718	as	0	None
3718	3719	when	0	None
3719	3720	given	0	None
3720	3721	at	0	None
3721	3722	1	0	None
3722	3723	mg	0	None
3723	3724	/	0	None
3724	3725	kg	0	None
3725	3726	per	0	None
3726	3727	day	0	None
3727	3728	.	0	None

3729	3730	In	0	None
3730	3731	conclusion	0	None
3731	3732	,	0	None
3732	3733	Doppler	0	None
3733	3734	echocardiography	0	None
3734	3735	showed	0	None
3735	3736	that	0	None
3736	3737	candesartan	3	CHEMICAL
3737	3738	and	0	None
3738	3739	cilazapril	3	CHEMICAL
3739	3740	equally	0	None
3740	3741	improved	0	None
3741	3742	systolic	0	None
3742	3743	and	0	None
3743	3744	diastolic	0	None
3744	3745	function	0	None
3745	3746	and	0	None
3746	3747	that	0	None
3747	3748	ventricular	0	None
3748	3749	remodeling	0	None
3749	3750	accompanied	0	None
3750	3751	modulation	0	None
3751	3752	of	0	None
3752	3753	cardiac	0	None
3753	3754	gene	0	None
3754	3755	expression	0	None
3755	3756	.	0	None

3757	3758	Genetic	0	None
3758	3759	causes	0	None
3759	3760	of	0	None
3760	3761	mild	0	None
3761	3762	hyperhomocysteinemia	0	None
3762	3763	in	0	None
3763	3764	patients	0	None
3764	3765	with	0	None
3765	3766	premature	0	None
3766	3767	occlusive	0	None
3767	3768	coronary	0	None
3768	3769	artery	0	None
3769	3770	diseases	0	None
3770	3771	.	0	None

3772	3773	Elevated	0	None
3773	3774	plasma	0	None
3774	3775	homocysteine	3	CHEMICAL
3775	3776	is	0	None
3776	3777	increasingly	0	None
3777	3778	being	0	None
3778	3779	recognized	0	None
3779	3780	as	0	None
3780	3781	a	0	None
3781	3782	risk	0	None
3782	3783	factor	0	None
3783	3784	for	0	None
3784	3785	coronary	0	None
3785	3786	artery	0	None
3786	3787	disease	0	None
3787	3788	(	0	None
3788	3789	CAD	0	None
3789	3790	)	0	None
3790	3791	.	0	None

3792	3793	Although	0	None
3793	3794	there	0	None
3794	3795	is	0	None
3795	3796	general	0	None
3796	3797	agreement	0	None
3797	3798	on	0	None
3798	3799	the	0	None
3799	3800	importance	0	None
3800	3801	of	0	None
3801	3802	micronutrients	0	None
3802	3803	and	0	None
3803	3804	genetic	0	None
3804	3805	predisposition	0	None
3805	3806	to	0	None
3806	3807	elevated	0	None
3807	3808	plasma	0	None
3808	3809	homocysteine	3	CHEMICAL
3809	3810	,	0	None
3810	3811	the	0	None
3811	3812	exact	0	None
3812	3813	influence	0	None
3813	3814	of	0	None
3814	3815	the	0	None
3815	3816	known	0	None
3816	3817	prevalent	0	None
3817	3818	mutations	0	None
3818	3819	in	0	None
3819	3820	genes	0	None
3820	3821	which	0	None
3821	3822	regulate	0	None
3822	3823	homocysteine	0	None
3823	3824	metabolism	0	None
3824	3825	is	0	None
3825	3826	not	0	None
3826	3827	clear	0	None
3827	3828	.	0	None

3829	3830	We	0	None
3830	3831	studied	0	None
3831	3832	376	0	None
3832	3833	cases	0	None
3833	3834	of	0	None
3834	3835	individuals	0	None
3835	3836	with	0	None
3836	3837	premature	0	None
3837	3838	CAD	0	None
3838	3839	with	0	None
3839	3840	respect	0	None
3840	3841	to	0	None
3841	3842	their	0	None
3842	3843	fasting	0	None
3843	3844	and	0	None
3844	3845	post	0	None
3845	3846	-	0	None
3846	3847	methionine	3	CHEMICAL
3847	3848	load	0	None
3848	3849	(	0	None
3849	3850	PML	1	GENE-Y
3850	3851	)	0	None
3851	3852	total	0	None
3852	3853	homocysteine	0	None
3853	3854	(	0	None
3854	3855	tHcy	0	None
3855	3856	)	0	None
3856	3857	concentrations	0	None
3857	3858	.	0	None

3859	3860	We	0	None
3860	3861	also	0	None
3861	3862	determined	0	None
3862	3863	the	0	None
3863	3864	presence	0	None
3864	3865	or	0	None
3865	3866	absence	0	None
3866	3867	of	0	None
3867	3868	the	0	None
3868	3869	T833C	2	GENE-N
3869	3870	and	0	None
3870	3871	G919A	0	None
3871	3872	mutations	0	None
3872	3873	of	0	None
3873	3874	the	0	None
3874	3875	cystathionine	3	CHEMICAL
3875	3876	-	0	None
3876	3877	beta	0	None
3877	3878	-	0	None
3878	3879	synthase	0	None
3879	3880	(	0	None
3880	3881	CBS	0	None
3881	3882	)	0	None
3882	3883	gene	0	None
3883	3884	,	0	None
3884	3885	the	0	None
3885	3886	C677T	2	GENE-N
3886	3887	mutation	0	None
3887	3888	of	0	None
3888	3889	the	0	None
3889	3890	methylene	3	CHEMICAL
3890	3892	tetrahydrofolate reductase	2	GENE-N
3892	3893	(	0	None
3893	3894	MTHFR	1	GENE-Y
3894	3895	)	0	None
3895	3896	gene	0	None
3896	3897	,	0	None
3897	3898	and	0	None
3898	3899	the	0	None
3899	3900	A2756G	0	None
3900	3901	transition	0	None
3901	3902	of	0	None
3902	3903	the	0	None
3903	3904	B12	0	None
3904	3905	dependent	0	None
3905	3907	methionine synthase	1	GENE-Y
3907	3908	(	0	None
3908	3909	MS	0	None
3909	3910	)	0	None
3910	3911	gene	0	None
3911	3912	.	0	None

3913	3914	Our	0	None
3914	3915	objectives	0	None
3915	3916	were	0	None
3916	3917	therefore	0	None
3917	3918	both	0	None
3918	3919	to	0	None
3919	3920	confirm	0	None
3920	3921	the	0	None
3921	3922	relationship	0	None
3922	3923	of	0	None
3923	3924	plasma	0	None
3924	3925	homocysteine	3	CHEMICAL
3925	3926	with	0	None
3926	3927	premature	0	None
3927	3928	CAD	0	None
3928	3929	and	0	None
3929	3930	to	0	None
3930	3931	examine	0	None
3931	3932	the	0	None
3932	3933	importance	0	None
3933	3934	of	0	None
3934	3935	genetic	0	None
3935	3936	influence	0	None
3936	3937	on	0	None
3937	3938	both	0	None
3938	3939	fasting	0	None
3939	3940	and	0	None
3940	3941	PML	1	GENE-Y
3941	3942	homocysteine	3	CHEMICAL
3942	3943	.	0	None

3944	3945	Approximately	0	None
3945	3946	32	0	None
3946	3947	%	0	None
3947	3948	of	0	None
3948	3949	the	0	None
3949	3950	CAD	0	None
3950	3951	patients	0	None
3951	3952	had	0	None
3952	3953	fasting	0	None
3953	3954	hyperhomocysteinemia	0	None
3954	3955	and	0	None
3955	3956	16	0	None
3956	3957	%	0	None
3957	3958	had	0	None
3958	3959	PML	1	GENE-Y
3959	3960	hyperhomocysteinemia	0	None
3960	3961	.	0	None

3962	3963	Of	0	None
3963	3964	these	0	None
3964	3965	,	0	None
3965	3966	8	0	None
3966	3967	.	0	None
3967	3968	5	0	None
3968	3969	%	0	None
3969	3970	had	0	None
3970	3971	both	0	None
3971	3972	forms	0	None
3972	3973	of	0	None
3973	3974	hyperhomocysteinemia	0	None
3974	3975	(	0	None
3975	3976	combined	0	None
3976	3977	hyperhomocysteinemia	0	None
3977	3978	)	0	None
3978	3979	.	0	None

3980	3981	The	0	None
3981	3982	T133C	0	None
3982	3983	mutation	0	None
3983	3984	in	0	None
3984	3985	the	0	None
3985	3986	CBS	0	None
3986	3987	gene	0	None
3987	3988	and	0	None
3988	3989	the	0	None
3989	3990	thermolabile	0	None
3990	3991	C677T	2	GENE-N
3991	3992	mutation	0	None
3992	3993	in	0	None
3993	3994	the	0	None
3994	3995	MTHFR	1	GENE-Y
3995	3996	gene	0	None
3996	3997	seem	0	None
3997	3998	to	0	None
3998	3999	play	0	None
3999	4000	an	0	None
4000	4001	important	0	None
4001	4002	role	0	None
4002	4003	in	0	None
4003	4004	the	0	None
4004	4005	subset	0	None
4005	4006	of	0	None
4006	4007	individuals	0	None
4007	4008	with	0	None
4008	4009	combined	0	None
4009	4010	hyperhomocysteinemia	0	None
4010	4011	.	0	None

4012	4013	The	0	None
4013	4014	A2756G	0	None
4014	4015	transition	0	None
4015	4016	in	0	None
4016	4017	the	0	None
4017	4018	MS	0	None
4018	4019	gene	0	None
4019	4020	is	0	None
4020	4021	not	0	None
4021	4022	associated	0	None
4022	4023	with	0	None
4023	4024	elevated	0	None
4024	4025	plasma	0	None
4025	4026	tHcy	0	None
4026	4027	.	0	None

4028	4029	Many	0	None
4029	4030	cases	0	None
4030	4031	(	0	None
4031	4032	47	0	None
4032	4033	%	0	None
4033	4034	)	0	None
4034	4035	of	0	None
4035	4036	hyperhomocysteinemia	0	None
4036	4037	are	0	None
4037	4038	not	0	None
4038	4039	associated	0	None
4039	4040	with	0	None
4040	4041	micronutrient	0	None
4041	4042	deficiencies	0	None
4042	4043	,	0	None
4043	4044	impaired	0	None
4044	4045	renal	0	None
4045	4046	function	0	None
4046	4047	,	0	None
4047	4048	and	0	None
4048	4049	/	0	None
4049	4050	or	0	None
4050	4051	currently	0	None
4051	4052	known	0	None
4052	4053	genetic	0	None
4053	4054	mutations	0	None
4054	4055	.	0	None

4056	4057	Further	0	None
4057	4058	work	0	None
4058	4059	is	0	None
4059	4060	needed	0	None
4060	4061	to	0	None
4061	4062	study	0	None
4062	4063	whether	0	None
4063	4064	unknown	0	None
4064	4065	mutations	0	None
4065	4066	,	0	None
4066	4067	particularly	0	None
4067	4068	those	0	None
4068	4069	residing	0	None
4069	4070	in	0	None
4070	4071	the	0	None
4071	4072	intronic	0	None
4072	4073	sequences	0	None
4073	4074	of	0	None
4074	4075	the	0	None
4075	4076	genes	0	None
4076	4077	involved	0	None
4077	4078	in	0	None
4078	4079	homocysteine	0	None
4079	4080	metabolism	0	None
4080	4081	,	0	None
4081	4082	other	0	None
4082	4083	environmental	0	None
4083	4084	factors	0	None
4084	4085	,	0	None
4085	4086	or	0	None
4086	4087	interaction	0	None
4087	4088	of	0	None
4088	4089	gene	0	None
4089	4090	,	0	None
4090	4091	nutrient	0	None
4091	4092	,	0	None
4092	4093	and	0	None
4093	4094	environmental	0	None
4094	4095	factors	0	None
4095	4096	may	0	None
4096	4097	be	0	None
4097	4098	the	0	None
4098	4099	cause	0	None
4099	4100	of	0	None
4100	4101	currently	0	None
4101	4102	unexplained	0	None
4102	4103	cases	0	None
4103	4104	of	0	None
4104	4105	mild	0	None
4105	4106	hyperhomocysteinemia	0	None
4106	4107	.	0	None

4108	4109	Effects	0	None
4109	4110	of	0	None
4110	4111	bis	0	None
4111	4112	(	0	None
4112	4113	7	0	None
4113	4114	)	0	None
4114	4115	-	0	None
4115	4116	tacrine	3	CHEMICAL
4116	4117	,	0	None
4117	4118	a	0	None
4118	4119	novel	0	None
4119	4120	anti	0	None
4120	4121	-	0	None
4121	4122	Alzheimer	0	None
4122	4123	'	0	None
4123	4124	s	0	None
4124	4125	agent	0	None
4125	4126	,	0	None
4126	4127	on	0	None
4127	4130	rat brain AChE	1	GENE-Y
4130	4131	.	0	None

4132	4133	The	0	None
4133	4134	anticholinesterase	1	GENE-Y
4134	4135	effects	0	None
4135	4136	of	0	None
4136	4137	bis	0	None
4137	4138	(	0	None
4138	4139	7	0	None
4139	4140	)	0	None
4140	4141	-	0	None
4141	4142	tacrine	3	CHEMICAL
4142	4143	were	0	None
4143	4144	compared	0	None
4144	4145	with	0	None
4145	4146	tacrine	3	CHEMICAL
4146	4147	in	0	None
4147	4148	vitro	0	None
4148	4149	and	0	None
4149	4150	in	0	None
4150	4151	vivo	0	None
4151	4152	.	0	None

4153	4154	Based	0	None
4154	4155	on	0	None
4155	4156	IC50	0	None
4156	4157	ratios	0	None
4157	4158	,	0	None
4158	4159	the	0	None
4159	4160	dimeric	0	None
4160	4161	analog	0	None
4161	4162	bis	3	CHEMICAL
4162	4163	(	0	None
4163	4164	7	0	None
4164	4165	)	0	None
4165	4166	-	0	None
4166	4167	tacrine	3	CHEMICAL
4167	4168	was	0	None
4168	4169	,	0	None
4169	4170	in	0	None
4170	4171	a	0	None
4171	4172	reversible	0	None
4172	4173	manner	0	None
4173	4174	,	0	None
4174	4175	up	0	None
4175	4176	to	0	None
4176	4177	150	0	None
4177	4178	-	0	None
4178	4179	fold	0	None
4179	4180	more	0	None
4180	4181	potent	0	None
4181	4182	and	0	None
4182	4183	250	0	None
4183	4184	-	0	None
4184	4185	fold	0	None
4185	4186	more	0	None
4186	4187	selective	0	None
4187	4188	than	0	None
4188	4189	tacrine	3	CHEMICAL
4189	4190	for	0	None
4190	4191	acetylcholinesterase	1	GENE-Y
4191	4192	(	0	None
4192	4193	AChE	1	GENE-Y
4193	4194	)	0	None
4194	4195	over	0	None
4195	4196	butyrylcholinesterase	1	GENE-Y
4196	4197	(	0	None
4197	4198	BChE	1	GENE-Y
4198	4199	)	0	None
4199	4200	.	0	None

4201	4202	Following	0	None
4202	4203	a	0	None
4203	4204	single	0	None
4204	4205	oral	0	None
4205	4206	administration	0	None
4206	4207	,	0	None
4207	4208	both	0	None
4208	4209	bis	3	CHEMICAL
4209	4210	(	0	None
4210	4211	7	0	None
4211	4212	)	0	None
4212	4213	-	0	None
4213	4214	tacrine	3	CHEMICAL
4214	4215	and	0	None
4215	4216	tacrine	3	CHEMICAL
4216	4217	produced	0	None
4217	4218	dose	0	None
4218	4219	-	0	None
4219	4220	dependent	0	None
4220	4221	inhibitions	0	None
4221	4222	of	0	None
4222	4223	AChE	1	GENE-Y
4223	4224	in	0	None
4224	4225	rat	0	None
4225	4226	brain	0	None
4226	4227	,	0	None
4227	4228	but	0	None
4228	4229	bis	0	None
4229	4230	(	0	None
4230	4231	7	0	None
4231	4232	)	0	None
4232	4233	-	0	None
4233	4234	tacrine	3	CHEMICAL
4234	4235	exhibited	0	None
4235	4236	higher	0	None
4236	4237	efficacy	0	None
4237	4238	and	0	None
4238	4239	AChE	1	GENE-Y
4239	4240	/	0	None
4240	4241	BChE	1	GENE-Y
4241	4242	selectivity	0	None
4242	4243	than	0	None
4243	4244	tacrine	3	CHEMICAL
4244	4245	.	0	None

4246	4247	The	0	None
4247	4248	anti	0	None
4248	4249	-	0	None
4249	4250	AChE	1	GENE-Y
4250	4251	efficacy	0	None
4251	4252	of	0	None
4252	4253	bis	0	None
4253	4254	(	0	None
4254	4255	7	0	None
4255	4256	)	0	None
4256	4257	-	0	None
4257	4258	tacrine	3	CHEMICAL
4258	4259	was	0	None
4259	4260	quite	0	None
4260	4261	similar	0	None
4261	4262	following	0	None
4262	4263	an	0	None
4263	4264	oral	0	None
4264	4265	or	0	None
4265	4266	i	0	None
4266	4267	.	0	None
4267	4268	p	0	None
4268	4269	.	0	None
4269	4270	administration	0	None
4270	4271	,	0	None
4271	4272	but	0	None
4272	4273	tacrine	3	CHEMICAL
4273	4274	showed	0	None
4274	4275	much	0	None
4275	4276	lower	0	None
4276	4277	efficacy	0	None
4277	4278	when	0	None
4278	4279	administered	0	None
4279	4280	orally	0	None
4280	4281	than	0	None
4281	4282	when	0	None
4282	4283	given	0	None
4283	4284	i	0	None
4284	4285	.	0	None
4285	4286	p	0	None
4286	4287	.	0	None

4288	4289	These	0	None
4289	4290	findings	0	None
4290	4291	suggest	0	None
4291	4292	bis	3	CHEMICAL
4292	4293	(	0	None
4293	4294	7	0	None
4294	4295	)	0	None
4295	4296	-	0	None
4296	4297	tacrine	3	CHEMICAL
4297	4298	,	0	None
4298	4299	a	0	None
4299	4300	highly	0	None
4300	4301	potent	0	None
4301	4302	and	0	None
4302	4303	selective	0	None
4303	4304	inhibitor	0	None
4304	4305	of	0	None
4305	4306	AChE	1	GENE-Y
4306	4307	,	0	None
4307	4308	can	0	None
4308	4309	probably	0	None
4309	4310	be	0	None
4310	4311	used	0	None
4311	4312	as	0	None
4312	4313	an	0	None
4313	4314	improved	0	None
4314	4315	drug	0	None
4315	4316	in	0	None
4316	4317	the	0	None
4317	4318	palliative	0	None
4318	4319	treatment	0	None
4319	4320	of	0	None
4320	4321	AD	0	None
4321	4322	.	0	None

4323	4324	Fibroblast	0	None
4324	4325	growth	0	None
4325	4326	factor	0	None
4326	4327	-	0	None
4327	4328	10	0	None
4328	4329	.	0	None

4330	4331	A	0	None
4331	4332	second	0	None
4332	4333	candidate	0	None
4333	4334	stromal	0	None
4334	4335	to	0	None
4335	4336	epithelial	0	None
4336	4337	cell	0	None
4337	4338	andromedin	0	None
4338	4339	in	0	None
4339	4340	prostate	0	None
4340	4341	.	0	None

4342	4343	Fibroblast	0	None
4343	4344	growth	0	None
4344	4345	factor	0	None
4345	4346	(	0	None
4346	4347	FGF	2	GENE-N
4347	4348	)	0	None
4348	4349	-	0	None
4349	4350	10	0	None
4350	4351	,	0	None
4351	4352	a	0	None
4352	4353	homologue	0	None
4353	4354	of	0	None
4354	4355	FGF	2	GENE-N
4355	4356	-	0	None
4356	4357	7	0	None
4357	4358	,	0	None
4358	4359	is	0	None
4359	4360	expressed	0	None
4360	4361	significantly	0	None
4361	4362	in	0	None
4362	4363	normal	0	None
4363	4364	rat	0	None
4364	4365	prostate	0	None
4365	4366	tissue	0	None
4366	4367	,	0	None
4367	4368	well	0	None
4368	4369	differentiated	0	None
4369	4370	rat	0	None
4370	4371	prostate	0	None
4371	4372	tumors	0	None
4372	4373	with	0	None
4373	4374	an	0	None
4374	4375	epithelial	0	None
4375	4376	and	0	None
4376	4377	stromal	0	None
4377	4378	compartment	0	None
4378	4379	and	0	None
4379	4380	only	0	None
4380	4381	in	0	None
4381	4382	derived	0	None
4382	4383	prostate	0	None
4383	4384	stromal	0	None
4384	4385	cells	0	None
4385	4386	in	0	None
4386	4387	culture	0	None
4387	4388	.	0	None

4389	4390	Similar	0	None
4390	4391	to	0	None
4391	4392	FGF	2	GENE-N
4392	4393	-	0	None
4393	4394	7	0	None
4394	4395	,	0	None
4395	4398	recombinant rat FGF	2	GENE-N
4398	4399	-	0	None
4399	4400	10	0	None
4400	4401	was	0	None
4401	4402	a	0	None
4402	4403	specific	0	None
4403	4404	mitogen	0	None
4404	4405	for	0	None
4405	4406	prostate	0	None
4406	4407	epithelial	0	None
4407	4408	cells	0	None
4408	4409	.	0	None

4410	4411	In	0	None
4411	4412	contrast	0	None
4412	4413	to	0	None
4413	4414	FGF	2	GENE-N
4414	4415	-	0	None
4415	4416	7	0	None
4416	4417	which	0	None
4417	4418	is	0	None
4418	4419	widely	0	None
4419	4420	expressed	0	None
4420	4421	among	0	None
4421	4422	stromal	0	None
4422	4423	cells	0	None
4423	4424	in	0	None
4424	4425	tissues	0	None
4425	4426	,	0	None
4426	4427	the	0	None
4427	4428	expression	0	None
4428	4429	of	0	None
4429	4430	FGF	2	GENE-N
4430	4431	-	0	None
4431	4432	10	0	None
4432	4433	correlated	0	None
4433	4434	with	0	None
4434	4435	the	0	None
4435	4436	presence	0	None
4436	4437	of	0	None
4437	4438	stromal	0	None
4438	4439	cells	0	None
4439	4440	of	0	None
4440	4441	muscle	0	None
4441	4442	origin	0	None
4442	4443	.	0	None

4444	4445	Radioreceptor	0	None
4445	4446	binding	0	None
4446	4447	assays	0	None
4447	4448	and	0	None
4448	4449	covalent	0	None
4449	4450	cross	0	None
4450	4451	-	0	None
4451	4452	linking	0	None
4452	4453	analysis	0	None
4453	4454	revealed	0	None
4454	4455	that	0	None
4455	4456	FGF	2	GENE-N
4456	4457	-	0	None
4457	4458	10	0	None
4458	4459	binds	0	None
4459	4460	with	0	None
4460	4461	an	0	None
4461	4462	affinity	0	None
4462	4463	equal	0	None
4463	4464	to	0	None
4464	4465	FGF	2	GENE-N
4465	4466	-	0	None
4466	4467	7	0	None
4467	4468	to	0	None
4468	4469	resident	0	None
4469	4472	epithelial cell receptor	2	GENE-N
4472	4473	,	0	None
4473	4474	FGFR2IIIb	0	None
4474	4475	,	0	None
4475	4476	but	0	None
4476	4477	unlike	0	None
4477	4478	FGF	2	GENE-N
4478	4479	-	0	None
4479	4480	7	0	None
4480	4481	also	0	None
4481	4482	binds	0	None
4482	4483	the	0	None
4483	4484	IIIb	0	None
4484	4485	splice	0	None
4485	4486	variant	0	None
4486	4487	of	0	None
4487	4488	FGFR1	1	GENE-Y
4488	4489	.	0	None

4490	4491	Analysis	0	None
4491	4492	of	0	None
4492	4493	mRNA	0	None
4493	4494	expression	0	None
4494	4495	by	0	None
4495	4496	RNase	0	None
4496	4497	protection	0	None
4497	4498	revealed	0	None
4498	4499	that	0	None
4499	4500	,	0	None
4500	4501	similar	0	None
4501	4502	to	0	None
4502	4503	FGF	2	GENE-N
4503	4504	-	0	None
4504	4505	7	0	None
4505	4506	,	0	None
4506	4507	the	0	None
4507	4508	expression	0	None
4508	4509	of	0	None
4509	4510	FGF	2	GENE-N
4510	4511	-	0	None
4511	4512	10	0	None
4512	4513	was	0	None
4513	4514	responsive	0	None
4514	4515	to	0	None
4515	4516	androgen	3	CHEMICAL
4516	4517	in	0	None
4517	4518	stromal	0	None
4518	4519	cells	0	None
4519	4520	from	0	None
4520	4521	normal	0	None
4521	4522	prostate	0	None
4522	4523	and	0	None
4523	4524	non	0	None
4524	4525	-	0	None
4525	4526	malignant	0	None
4526	4527	differentiated	0	None
4527	4528	tumors	0	None
4528	4529	.	0	None

4530	4531	Although	0	None
4531	4532	FGF	2	GENE-N
4532	4533	-	0	None
4533	4534	10	0	None
4534	4535	cDNA	0	None
4535	4536	exhibits	0	None
4536	4537	a	0	None
4537	4538	signal	0	None
4538	4539	sequence	0	None
4539	4540	for	0	None
4540	4541	secretion	0	None
4541	4542	,	0	None
4542	4543	cultured	0	None
4543	4544	stromal	0	None
4544	4545	cells	0	None
4545	4546	exhibit	0	None
4546	4547	strictly	0	None
4547	4548	a	0	None
4548	4549	cell	0	None
4549	4550	-	0	None
4550	4551	associated	0	None
4551	4552	FGF	2	GENE-N
4552	4553	-	0	None
4553	4554	10	0	None
4554	4555	antigen	0	None
4555	4556	that	0	None
4556	4557	correlates	0	None
4557	4558	with	0	None
4558	4559	an	0	None
4559	4560	alternately	0	None
4560	4561	translated	0	None
4561	4562	intracellular	0	None
4562	4563	isoform	0	None
4563	4564	.	0	None

4565	4566	FGF	2	GENE-N
4566	4567	-	0	None
4567	4568	10	0	None
4568	4569	requires	0	None
4569	4570	1	0	None
4570	4571	.	0	None
4571	4572	4	0	None
4572	4573	times	0	None
4573	4574	higher	0	None
4574	4575	NaCl	3	CHEMICAL
4575	4576	for	0	None
4576	4577	elution	0	None
4577	4578	from	0	None
4578	4579	immobilized	0	None
4579	4580	heparin	0	None
4580	4581	than	0	None
4581	4582	does	0	None
4582	4583	FGF	2	GENE-N
4583	4584	-	0	None
4584	4585	7	0	None
4585	4586	and	0	None
4586	4587	binds	0	None
4587	4588	to	0	None
4588	4589	four	0	None
4589	4590	times	0	None
4590	4591	the	0	None
4591	4592	number	0	None
4592	4593	of	0	None
4593	4594	sites	0	None
4594	4595	on	0	None
4595	4596	the	0	None
4596	4597	pericellular	0	None
4597	4598	matrix	0	None
4598	4599	of	0	None
4599	4600	epithelial	0	None
4600	4601	cells	0	None
4601	4602	.	0	None

4603	4604	The	0	None
4604	4605	results	0	None
4605	4606	show	0	None
4606	4607	that	0	None
4607	4608	prostate	0	None
4608	4609	stromal	0	None
4609	4610	cell	0	None
4610	4611	-	0	None
4611	4612	derived	0	None
4612	4613	FGF	2	GENE-N
4613	4614	-	0	None
4614	4615	10	0	None
4615	4616	,	0	None
4616	4617	like	0	None
4617	4618	FGF	2	GENE-N
4618	4619	-	0	None
4619	4620	7	0	None
4620	4621	,	0	None
4621	4622	exhibits	0	None
4622	4623	the	0	None
4623	4624	properties	0	None
4624	4625	of	0	None
4625	4626	an	0	None
4626	4627	andromedin	0	None
4627	4628	which	0	None
4628	4629	may	0	None
4629	4630	indirectly	0	None
4630	4631	mediate	0	None
4631	4632	control	0	None
4632	4633	of	0	None
4633	4634	epithelial	0	None
4634	4635	cell	0	None
4635	4636	growth	0	None
4636	4637	and	0	None
4637	4638	function	0	None
4638	4639	by	0	None
4639	4640	androgen	3	CHEMICAL
4640	4641	.	0	None

4642	4643	Although	0	None
4643	4644	FGF	2	GENE-N
4644	4645	-	0	None
4645	4646	10	0	None
4646	4647	and	0	None
4647	4648	FGF	2	GENE-N
4648	4649	-	0	None
4649	4650	7	0	None
4650	4651	bind	0	None
4651	4652	and	0	None
4652	4653	activate	0	None
4653	4654	the	0	None
4654	4655	same	0	None
4655	4656	resident	0	None
4656	4659	epithelial cell receptor	2	GENE-N
4659	4660	(	0	None
4660	4661	FGFR2IIIb	0	None
4661	4662	)	0	None
4662	4663	,	0	None
4663	4664	differences	0	None
4664	4665	in	0	None
4665	4666	cell	0	None
4666	4667	type	0	None
4667	4668	of	0	None
4668	4669	origin	0	None
4669	4670	,	0	None
4670	4671	compartmentation	0	None
4671	4672	by	0	None
4672	4673	alternate	0	None
4673	4674	translation	0	None
4674	4675	,	0	None
4675	4676	the	0	None
4676	4677	affinity	0	None
4677	4678	for	0	None
4678	4679	FGFR1IIIb	0	None
4679	4680	,	0	None
4680	4681	and	0	None
4681	4682	access	0	None
4682	4683	to	0	None
4683	4684	FGFR	2	GENE-N
4684	4685	by	0	None
4685	4686	differential	0	None
4686	4687	interaction	0	None
4687	4688	with	0	None
4688	4689	pericellular	0	None
4689	4690	matrix	0	None
4690	4692	heparan sulfate	3	CHEMICAL
4692	4693	suggest	0	None
4693	4694	they	0	None
4694	4695	may	0	None
4695	4696	play	0	None
4696	4697	both	0	None
4697	4698	independent	0	None
4698	4699	and	0	None
4699	4700	compensatory	0	None
4700	4701	roles	0	None
4701	4702	in	0	None
4702	4703	prostate	0	None
4703	4704	homeostasis	0	None
4704	4705	.	0	None

4706	4707	Pre	0	None
4707	4708	-	0	None
4708	4709	or	0	None
4709	4710	post	0	None
4710	4711	-	0	None
4711	4712	training	0	None
4712	4713	injection	0	None
4713	4714	of	0	None
4714	4715	buspirone	3	CHEMICAL
4715	4716	impaired	0	None
4716	4717	retention	0	None
4717	4718	in	0	None
4718	4719	the	0	None
4719	4720	inhibitory	0	None
4720	4721	avoidance	0	None
4721	4722	task	0	None
4722	4723	:	0	None
4723	4724	involvement	0	None
4724	4725	of	0	None
4725	4726	amygdala	0	None
4726	4727	5	0	None
4727	4728	-	0	None
4728	4729	HT1A	0	None
4729	4730	receptors	0	None
4730	4731	.	0	None

4732	4733	The	0	None
4733	4734	present	0	None
4734	4735	study	0	None
4735	4736	investigated	0	None
4736	4737	the	0	None
4737	4738	effect	0	None
4738	4739	of	0	None
4739	4740	buspirone	3	CHEMICAL
4740	4741	on	0	None
4741	4742	memory	0	None
4742	4743	formation	0	None
4743	4744	in	0	None
4744	4745	an	0	None
4745	4746	aversive	0	None
4746	4747	learning	0	None
4747	4748	task	0	None
4748	4749	.	0	None

4750	4751	Male	0	None
4751	4752	Wistar	0	None
4752	4753	rats	0	None
4753	4754	were	0	None
4754	4755	trained	0	None
4755	4756	on	0	None
4756	4757	the	0	None
4757	4758	inhibitory	0	None
4758	4759	avoidance	0	None
4759	4760	task	0	None
4760	4761	and	0	None
4761	4762	tested	0	None
4762	4763	for	0	None
4763	4764	retention	0	None
4764	4765	1	0	None
4765	4766	day	0	None
4766	4767	after	0	None
4767	4768	training	0	None
4768	4769	.	0	None

4770	4771	They	0	None
4771	4772	received	0	None
4772	4773	peripheral	0	None
4773	4774	or	0	None
4774	4775	intra	0	None
4775	4776	-	0	None
4776	4777	amygdala	0	None
4777	4778	administration	0	None
4778	4779	of	0	None
4779	4780	buspirone	3	CHEMICAL
4780	4781	or	0	None
4781	4782	other	0	None
4782	4783	5	0	None
4783	4784	-	0	None
4784	4785	HT1A	0	None
4785	4786	drugs	0	None
4786	4787	either	0	None
4787	4788	before	0	None
4788	4789	or	0	None
4789	4790	after	0	None
4790	4791	training	0	None
4791	4792	.	0	None

4793	4794	Results	0	None
4794	4795	indicated	0	None
4795	4796	that	0	None
4796	4797	pretraining	0	None
4797	4798	systemic	0	None
4798	4799	injections	0	None
4799	4800	of	0	None
4800	4801	buspirone	3	CHEMICAL
4801	4802	caused	0	None
4802	4803	a	0	None
4803	4804	dose	0	None
4804	4805	-	0	None
4805	4806	dependent	0	None
4806	4807	retention	0	None
4807	4808	deficit	0	None
4808	4809	;	0	None
4809	4810	5	0	None
4810	4811	.	0	None

4812	4813	0	0	None
4813	4814	mg	0	None
4814	4815	/	0	None
4815	4816	kg	0	None
4816	4817	had	0	None
4817	4818	a	0	None
4818	4819	marked	0	None
4819	4820	effect	0	None
4820	4821	and	0	None
4821	4822	1	0	None
4822	4823	.	0	None
4823	4824	0	0	None
4824	4825	mg	0	None
4825	4826	/	0	None
4826	4827	kg	0	None
4827	4828	had	0	None
4828	4829	no	0	None
4829	4830	effect	0	None
4830	4831	.	0	None

4832	4833	Post	0	None
4833	4834	-	0	None
4834	4835	training	0	None
4835	4836	injections	0	None
4836	4837	of	0	None
4837	4838	the	0	None
4838	4839	drug	0	None
4839	4840	caused	0	None
4840	4841	a	0	None
4841	4842	time	0	None
4842	4843	-	0	None
4843	4844	dependent	0	None
4844	4845	retention	0	None
4845	4846	deficit	0	None
4846	4847	,	0	None
4847	4848	which	0	None
4848	4849	was	0	None
4849	4850	not	0	None
4850	4851	due	0	None
4851	4852	to	0	None
4852	4853	a	0	None
4853	4854	state	0	None
4854	4855	-	0	None
4855	4856	dependent	0	None
4856	4857	effect	0	None
4857	4858	on	0	None
4858	4859	retrieval	0	None
4859	4860	.	0	None

4861	4862	When	0	None
4862	4863	training	0	None
4863	4864	in	0	None
4864	4865	the	0	None
4865	4866	inhibitory	0	None
4866	4867	avoidance	0	None
4867	4868	task	0	None
4868	4869	was	0	None
4869	4870	divided	0	None
4870	4871	into	0	None
4871	4872	a	0	None
4872	4873	context	0	None
4873	4874	-	0	None
4874	4875	training	0	None
4875	4876	phase	0	None
4876	4877	and	0	None
4877	4878	a	0	None
4878	4879	shock	0	None
4879	4880	-	0	None
4880	4881	training	0	None
4881	4882	phase	0	None
4882	4883	,	0	None
4883	4884	buspirone	3	CHEMICAL
4884	4885	impaired	0	None
4885	4886	retention	0	None
4886	4887	only	0	None
4887	4888	when	0	None
4888	4889	administered	0	None
4889	4890	in	0	None
4890	4891	the	0	None
4891	4892	shock	0	None
4892	4893	-	0	None
4893	4894	training	0	None
4894	4895	phase	0	None
4895	4896	,	0	None
4896	4897	suggesting	0	None
4897	4898	that	0	None
4898	4899	the	0	None
4899	4900	drug	0	None
4900	4901	influenced	0	None
4901	4902	memory	0	None
4902	4903	processing	0	None
4903	4904	of	0	None
4904	4905	affective	0	None
4905	4906	events	0	None
4906	4907	.	0	None

4908	4909	Further	0	None
4909	4910	results	0	None
4910	4911	indicated	0	None
4911	4912	that	0	None
4912	4913	post	0	None
4913	4914	-	0	None
4914	4915	training	0	None
4915	4916	intra	0	None
4916	4917	-	0	None
4917	4918	amygdala	0	None
4918	4919	infusion	0	None
4919	4920	of	0	None
4920	4921	buspirone	3	CHEMICAL
4921	4922	or	0	None
4922	4923	the	0	None
4923	4924	5	0	None
4924	4925	-	0	None
4925	4926	HT1A	0	None
4926	4927	agonist	0	None
4927	4928	8	0	None
4928	4929	-	0	None
4929	4930	hydroxy	3	CHEMICAL
4930	4931	-	0	None
4931	4932	di	3	CHEMICAL
4932	4933	-	0	None
4933	4934	n	0	None
4934	4935	-	0	None
4935	4936	propylaminotetralin	0	None
4936	4937	(	0	None
4937	4938	8	0	None
4938	4939	-	0	None
4939	4940	OH	0	None
4940	4941	-	0	None
4941	4942	DPAT	0	None
4942	4943	)	0	None
4943	4944	caused	0	None
4944	4945	a	0	None
4945	4946	time	0	None
4946	4947	-	0	None
4947	4948	dependent	0	None
4948	4949	and	0	None
4949	4950	dose	0	None
4950	4951	-	0	None
4951	4952	dependent	0	None
4952	4953	retention	0	None
4953	4954	deficit	0	None
4954	4955	.	0	None

4956	4957	Post	0	None
4957	4958	-	0	None
4958	4959	training	0	None
4959	4960	intra	0	None
4960	4961	-	0	None
4961	4962	amygdala	0	None
4962	4963	infusion	0	None
4963	4964	of	0	None
4964	4965	the	0	None
4965	4966	5	0	None
4966	4967	-	0	None
4967	4968	HT1A	0	None
4968	4969	antagonist	0	None
4969	4970	WAY100635	3	CHEMICAL
4970	4971	(	0	None
4971	4972	N	0	None
4972	4973	-	0	None
4973	4974	(	0	None
4974	4975	2	0	None
4975	4976	-	0	None
4976	4977	(	0	None
4977	4978	4	0	None
4978	4979	-	0	None
4979	4980	(	0	None
4980	4981	2	0	None
4981	4982	-	0	None
4982	4983	methoxyphenyl	3	CHEMICAL
4983	4984	)	0	None
4984	4985	-	0	None
4985	4986	1	0	None
4986	4987	-	0	None
4987	4988	piperazinyl	0	None
4988	4989	)	0	None
4989	4990	-	0	None
4990	4991	N	0	None
4991	4992	-	0	None
4992	4993	(	0	None
4993	4994	2	0	None
4994	4995	-	0	None
4995	4996	pyridyl	3	CHEMICAL
4996	4997	)	0	None
4997	4998	cyclohexane	0	None
4998	4999	carboxamine	0	None
4999	5000	maleate	0	None
5000	5001	)	0	None
5001	5002	attenuated	0	None
5002	5003	the	0	None
5003	5004	memory	0	None
5004	5005	-	0	None
5005	5006	impairing	0	None
5006	5007	effects	0	None
5007	5008	of	0	None
5008	5009	buspirone	3	CHEMICAL
5009	5010	.	0	None

5011	5012	These	0	None
5012	5013	findings	0	None
5013	5014	suggest	0	None
5014	5015	that	0	None
5015	5016	buspirone	3	CHEMICAL
5016	5017	may	0	None
5017	5018	modulate	0	None
5018	5019	memory	0	None
5019	5020	storage	0	None
5020	5021	processes	0	None
5021	5022	in	0	None
5022	5023	the	0	None
5023	5024	inhibitory	0	None
5024	5025	avoidance	0	None
5025	5026	task	0	None
5026	5027	through	0	None
5027	5028	an	0	None
5028	5029	action	0	None
5029	5030	on	0	None
5030	5031	amygdaloid	0	None
5031	5032	5	0	None
5032	5033	-	0	None
5033	5034	HT1A	0	None
5034	5035	receptors	0	None
5035	5036	.	0	None

5037	5038	Selective	0	None
5038	5039	inhibition	0	None
5039	5040	of	0	None
5040	5041	cyclooxygenase	2	GENE-N
5041	5042	2	0	None
5042	5043	spares	0	None
5043	5044	renal	0	None
5044	5045	function	0	None
5045	5046	and	0	None
5046	5047	prostaglandin	3	CHEMICAL
5047	5048	synthesis	0	None
5048	5049	in	0	None
5049	5050	cirrhotic	0	None
5050	5051	rats	0	None
5051	5052	with	0	None
5052	5053	ascites	0	None
5053	5054	.	0	None

5055	5056	BACKGROUND	0	None
5056	5057	&	0	None
5057	5058	AIMS	0	None
5058	5059	:	0	None
5059	5060	The	0	None
5060	5061	critical	0	None
5061	5062	role	0	None
5062	5063	of	0	None
5063	5064	cyclooxygenase	2	GENE-N
5064	5065	(	0	None
5065	5066	COX	2	GENE-N
5066	5067	)	0	None
5067	5068	products	0	None
5068	5069	in	0	None
5069	5070	maintenance	0	None
5070	5071	of	0	None
5071	5072	renal	0	None
5072	5073	function	0	None
5073	5074	in	0	None
5074	5075	cirrhosis	0	None
5075	5076	with	0	None
5076	5077	ascites	0	None
5077	5078	discourages	0	None
5078	5079	the	0	None
5079	5080	use	0	None
5080	5081	of	0	None
5081	5082	nonsteroidal	0	None
5082	5083	anti	0	None
5083	5084	-	0	None
5084	5085	inflammatory	0	None
5085	5086	drugs	0	None
5086	5087	in	0	None
5087	5088	this	0	None
5088	5089	disease	0	None
5089	5090	.	0	None

5091	5092	The	0	None
5092	5093	recent	0	None
5093	5094	development	0	None
5094	5095	of	0	None
5095	5096	selective	0	None
5096	5097	COX	2	GENE-N
5097	5098	-	0	None
5098	5099	2	0	None
5099	5100	inhibitors	0	None
5100	5101	opens	0	None
5101	5102	new	0	None
5102	5103	avenues	0	None
5103	5104	for	0	None
5104	5105	the	0	None
5105	5106	use	0	None
5106	5107	of	0	None
5107	5108	these	0	None
5108	5109	compounds	0	None
5109	5110	in	0	None
5110	5111	decompensated	0	None
5111	5112	cirrhosis	0	None
5112	5113	.	0	None

5114	5115	The	0	None
5115	5116	current	0	None
5116	5117	study	0	None
5117	5118	evaluates	0	None
5118	5119	the	0	None
5119	5120	effects	0	None
5120	5121	of	0	None
5121	5122	a	0	None
5122	5123	selective	0	None
5123	5124	COX	2	GENE-N
5124	5125	-	0	None
5125	5126	2	0	None
5126	5127	inhibitor	0	None
5127	5128	(	0	None
5128	5129	SC	0	None
5129	5130	-	0	None
5130	5131	236	0	None
5131	5132	)	0	None
5132	5133	on	0	None
5133	5134	renal	0	None
5134	5135	function	0	None
5135	5136	in	0	None
5136	5137	cirrhotic	0	None
5137	5138	rats	0	None
5138	5139	with	0	None
5139	5140	ascites	0	None
5140	5141	.	0	None

5142	5143	METHODS	0	None
5143	5144	:	0	None
5144	5145	In	0	None
5145	5146	protocol	0	None
5146	5147	1	0	None
5147	5148	,	0	None
5148	5149	urine	0	None
5149	5150	volume	0	None
5150	5151	,	0	None
5151	5152	urinary	0	None
5152	5153	excretion	0	None
5153	5154	of	0	None
5154	5155	sodium	3	CHEMICAL
5155	5156	and	0	None
5156	5157	prostaglandins	3	CHEMICAL
5157	5158	,	0	None
5158	5159	glomerular	0	None
5159	5160	filtration	0	None
5160	5161	rate	0	None
5161	5162	,	0	None
5162	5163	and	0	None
5163	5164	renal	0	None
5164	5165	plasma	0	None
5165	5166	flow	0	None
5166	5167	were	0	None
5167	5168	measured	0	None
5168	5169	before	0	None
5169	5170	and	0	None
5170	5171	after	0	None
5171	5172	administration	0	None
5172	5173	of	0	None
5173	5174	SC	0	None
5174	5175	-	0	None
5175	5176	236	0	None
5176	5177	(	0	None
5177	5178	n	0	None
5178	5179	=	0	None
5179	5180	12	0	None
5180	5181	)	0	None
5181	5182	or	0	None
5182	5183	ketorolac	3	CHEMICAL
5183	5184	(	0	None
5184	5185	n	0	None
5185	5186	=	0	None
5186	5187	10	0	None
5187	5188	)	0	None
5188	5189	to	0	None
5189	5190	rats	0	None
5190	5191	with	0	None
5191	5192	cirrhosis	0	None
5192	5193	.	0	None

5194	5195	Protocol	0	None
5195	5196	2	0	None
5196	5197	was	0	None
5197	5198	aimed	0	None
5198	5199	at	0	None
5199	5200	assessing	0	None
5200	5201	the	0	None
5201	5202	effects	0	None
5202	5203	of	0	None
5203	5204	COX	2	GENE-N
5204	5205	inhibitors	0	None
5205	5206	on	0	None
5206	5207	renal	0	None
5207	5208	water	0	None
5208	5209	metabolism	0	None
5209	5210	in	0	None
5210	5211	28	0	None
5211	5212	cirrhotic	0	None
5212	5213	rats	0	None
5213	5214	.	0	None

5215	5216	RESULTS	0	None
5216	5217	:	0	None
5217	5218	Administration	0	None
5218	5219	of	0	None
5219	5220	SC	0	None
5220	5221	-	0	None
5221	5222	236	0	None
5222	5223	to	0	None
5223	5224	cirrhotic	0	None
5224	5225	animals	0	None
5225	5226	did	0	None
5226	5227	not	0	None
5227	5228	produce	0	None
5228	5229	significant	0	None
5229	5230	renal	0	None
5230	5231	effects	0	None
5231	5232	,	0	None
5232	5233	whereas	0	None
5233	5234	administration	0	None
5234	5235	of	0	None
5235	5236	the	0	None
5236	5237	nonselective	0	None
5237	5238	COX	2	GENE-N
5238	5239	-	0	None
5239	5240	1	0	None
5240	5241	/	0	None
5241	5242	COX	2	GENE-N
5242	5243	-	0	None
5243	5244	2	0	None
5244	5245	inhibitor	0	None
5245	5246	,	0	None
5246	5247	ketorolac	3	CHEMICAL
5247	5248	,	0	None
5248	5249	resulted	0	None
5249	5250	in	0	None
5250	5251	a	0	None
5251	5252	marked	0	None
5252	5253	reduction	0	None
5253	5254	in	0	None
5254	5255	urine	0	None
5255	5256	volume	0	None
5256	5257	,	0	None
5257	5258	urinary	0	None
5258	5259	excretion	0	None
5259	5260	of	0	None
5260	5261	prostaglandins	3	CHEMICAL
5261	5262	,	0	None
5262	5263	and	0	None
5263	5264	glomerular	0	None
5264	5265	filtration	0	None
5265	5266	rate	0	None
5266	5267	and	0	None
5267	5268	in	0	None
5268	5269	a	0	None
5269	5270	significant	0	None
5270	5271	impairment	0	None
5271	5272	in	0	None
5272	5273	renal	0	None
5273	5274	water	0	None
5274	5275	metabolism	0	None
5275	5276	.	0	None

5277	5278	CONCLUSIONS	0	None
5278	5279	:	0	None
5279	5280	These	0	None
5280	5281	findings	0	None
5281	5282	indicate	0	None
5282	5283	that	0	None
5283	5284	SC	0	None
5284	5285	-	0	None
5285	5286	236	0	None
5286	5287	does	0	None
5287	5288	not	0	None
5288	5289	significantly	0	None
5289	5290	impair	0	None
5290	5291	renal	0	None
5291	5292	function	0	None
5292	5293	in	0	None
5293	5294	rats	0	None
5294	5295	with	0	None
5295	5296	cirrhosis	0	None
5296	5297	.	0	None

5298	5299	[	0	None
5299	5300	Pharmacodynamic	0	None
5300	5301	and	0	None
5301	5302	pharmacokinetic	0	None
5302	5303	aspects	0	None
5303	5304	of	0	None
5304	5305	the	0	None
5305	5306	non	0	None
5306	5307	-	0	None
5307	5308	inflammatory	0	None
5308	5309	non	0	None
5309	5310	-	0	None
5310	5311	steroidal	0	None
5311	5312	agent	0	None
5312	5313	meloxicam	3	CHEMICAL
5313	5314	in	0	None
5314	5315	dogs	0	None
5315	5316	]	0	None
5316	5317	.	0	None

5318	5319	The	0	None
5319	5320	pharmacodynamics	0	None
5320	5321	of	0	None
5321	5322	non	0	None
5322	5323	-	0	None
5323	5324	steroidal	0	None
5324	5325	anti	0	None
5325	5326	-	0	None
5326	5327	inflammatory	0	None
5327	5328	drugs	0	None
5328	5329	(	0	None
5329	5330	NSAIDs	0	None
5330	5331	)	0	None
5331	5332	are	0	None
5332	5333	for	0	None
5333	5334	the	0	None
5334	5335	most	0	None
5335	5336	part	0	None
5336	5337	well	0	None
5337	5338	-	0	None
5338	5339	understood	0	None
5339	5340	.	0	None

5341	5342	All	0	None
5342	5343	NSAIDs	0	None
5343	5344	inhibit	0	None
5344	5345	the	0	None
5345	5346	enzyme	0	None
5346	5347	cyclooxygenase	2	GENE-N
5347	5348	(	0	None
5348	5349	COX	2	GENE-N
5349	5350	)	0	None
5350	5351	,	0	None
5351	5352	and	0	None
5352	5353	for	0	None
5353	5354	this	0	None
5354	5355	reason	0	None
5355	5356	prostaglandin	3	CHEMICAL
5356	5357	synthesis	0	None
5357	5358	.	0	None

5359	5360	Two	0	None
5360	5361	isoforms	0	None
5361	5362	of	0	None
5362	5363	COX	2	GENE-N
5363	5364	could	0	None
5364	5365	be	0	None
5365	5366	isolated	0	None
5366	5367	.	0	None

5368	5369	COX	2	GENE-N
5369	5370	-	0	None
5370	5371	1	0	None
5371	5372	is	0	None
5372	5373	detectable	0	None
5373	5374	in	0	None
5374	5375	most	0	None
5375	5376	tissues	0	None
5376	5377	on	0	None
5377	5378	a	0	None
5378	5379	constant	0	None
5379	5380	level	0	None
5380	5381	and	0	None
5381	5382	is	0	None
5382	5383	responsible	0	None
5383	5384	for	0	None
5384	5385	the	0	None
5385	5386	synthesis	0	None
5386	5387	of	0	None
5387	5388	prostaglandins	3	CHEMICAL
5388	5389	with	0	None
5389	5390	cytoprotective	0	None
5390	5391	effects	0	None
5391	5392	.	0	None

5393	5394	COX	2	GENE-N
5394	5395	-	0	None
5395	5396	2	0	None
5396	5397	is	0	None
5397	5398	induced	0	None
5398	5399	through	0	None
5399	5400	inflammation	0	None
5400	5401	and	0	None
5401	5402	supports	0	None
5402	5403	the	0	None
5403	5404	inflammatory	0	None
5404	5405	process	0	None
5405	5406	by	0	None
5406	5407	producing	0	None
5407	5408	pro	0	None
5408	5409	-	0	None
5409	5410	inflammatory	0	None
5410	5411	prostaglandins	3	CHEMICAL
5411	5412	.	0	None

5413	5414	The	0	None
5414	5415	desired	0	None
5415	5416	effects	0	None
5416	5417	of	0	None
5417	5418	NSAIDs	0	None
5418	5419	are	0	None
5419	5420	related	0	None
5420	5421	to	0	None
5421	5422	inhibition	0	None
5422	5423	of	0	None
5423	5424	COX	2	GENE-N
5424	5425	-	0	None
5425	5426	2	0	None
5426	5427	,	0	None
5427	5428	whereas	0	None
5428	5429	inhibition	0	None
5429	5430	of	0	None
5430	5431	COX	2	GENE-N
5431	5432	-	0	None
5432	5433	1	0	None
5433	5434	has	0	None
5434	5435	been	0	None
5435	5436	linked	0	None
5436	5437	to	0	None
5437	5438	the	0	None
5438	5439	typical	0	None
5439	5440	side	0	None
5440	5441	-	0	None
5441	5442	effects	0	None
5442	5443	of	0	None
5443	5444	NSAIDs	0	None
5444	5445	,	0	None
5445	5446	especially	0	None
5446	5447	in	0	None
5447	5448	the	0	None
5448	5449	stomach	0	None
5449	5450	and	0	None
5450	5451	kidney	0	None
5451	5452	.	0	None

5453	5454	The	0	None
5454	5455	great	0	None
5455	5456	differences	0	None
5456	5457	between	0	None
5457	5458	effects	0	None
5458	5459	and	0	None
5459	5460	side	0	None
5460	5461	-	0	None
5461	5462	effects	0	None
5462	5463	in	0	None
5463	5464	the	0	None
5464	5465	numerous	0	None
5465	5466	substances	0	None
5466	5467	can	0	None
5467	5468	be	0	None
5468	5469	explained	0	None
5469	5470	because	0	None
5470	5471	of	0	None
5471	5472	different	0	None
5472	5473	interactions	0	None
5473	5474	of	0	None
5474	5475	the	0	None
5475	5476	NSAIDs	0	None
5476	5477	on	0	None
5477	5478	COX	2	GENE-N
5478	5479	-	0	None
5479	5480	1	0	None
5480	5481	and	0	None
5481	5482	COX	2	GENE-N
5482	5483	-	0	None
5483	5484	2	0	None
5484	5485	.	0	None

5486	5487	In	0	None
5487	5488	various	0	None
5488	5489	test	3	CHEMICAL
5489	5490	systems	0	None
5490	5491	meloxicam	3	CHEMICAL
5491	5492	has	0	None
5492	5493	been	0	None
5493	5494	shown	0	None
5494	5495	to	0	None
5495	5496	be	0	None
5496	5497	a	0	None
5497	5498	preferential	0	None
5498	5499	inhibitor	0	None
5499	5500	of	0	None
5500	5501	COX	2	GENE-N
5501	5502	-	0	None
5502	5503	2	0	None
5503	5504	.	0	None

5505	5506	There	0	None
5506	5507	are	0	None
5507	5508	also	0	None
5508	5509	large	0	None
5509	5510	differences	0	None
5510	5511	between	0	None
5511	5512	the	0	None
5512	5513	individual	0	None
5513	5514	NSAIDs	0	None
5514	5515	with	0	None
5515	5516	regard	0	None
5516	5517	to	0	None
5517	5518	pharmacokinetics	0	None
5518	5519	.	0	None

5520	5521	Meloxicam	0	None
5521	5522	is	0	None
5522	5523	completely	0	None
5523	5524	absorbed	0	None
5524	5525	from	0	None
5525	5526	the	0	None
5526	5527	gastrointestinal	0	None
5527	5528	tract	0	None
5528	5529	and	0	None
5529	5530	has	0	None
5530	5531	an	0	None
5531	5532	elimination	0	None
5532	5533	half	0	None
5533	5534	-	0	None
5534	5535	life	0	None
5535	5536	of	0	None
5536	5537	24	0	None
5537	5538	hours	0	None
5538	5539	in	0	None
5539	5540	the	0	None
5540	5541	dog	0	None
5541	5542	.	0	None

5543	5544	It	0	None
5544	5545	is	0	None
5545	5546	excreted	0	None
5546	5547	in	0	None
5547	5548	faeces	0	None
5548	5549	and	0	None
5549	5550	urine	0	None
5550	5551	.	0	None

5552	5553	The	0	None
5553	5554	metabolites	0	None
5554	5555	,	0	None
5555	5556	detectable	0	None
5556	5557	in	0	None
5557	5558	urine	0	None
5558	5559	are	0	None
5559	5560	biologically	0	None
5560	5561	inactive	0	None
5561	5562	and	0	None
5562	5563	do	0	None
5563	5564	not	0	None
5564	5565	influence	0	None
5565	5566	the	0	None
5566	5567	prostaglandin	3	CHEMICAL
5567	5568	synthesis	0	None
5568	5569	in	0	None
5569	5570	the	0	None
5570	5571	kidney	0	None
5571	5572	.	0	None

5573	5574	In	0	None
5574	5575	the	0	None
5575	5576	underlying	0	None
5576	5577	study	0	None
5577	5578	,	0	None
5578	5579	plasma	0	None
5579	5580	concentration	0	None
5580	5581	of	0	None
5581	5582	meloxicam	3	CHEMICAL
5582	5583	was	0	None
5583	5584	determined	0	None
5584	5585	after	0	None
5585	5586	a	0	None
5586	5587	subcutaneous	0	None
5587	5588	injection	0	None
5588	5589	of	0	None
5589	5590	0	0	None
5590	5591	.	0	None
5591	5592	2	0	None
5592	5593	mg	0	None
5593	5594	/	0	None
5594	5595	kg	0	None
5595	5596	b	0	None
5596	5597	.	0	None

5598	5599	w	0	None
5599	5600	.	0	None

5601	5602	(	0	None
5602	5603	day	0	None
5603	5604	1	0	None
5604	5605	)	0	None
5605	5606	followed	0	None
5606	5607	by	0	None
5607	5608	oral	0	None
5608	5609	treatment	0	None
5609	5610	of	0	None
5610	5611	0	0	None
5611	5612	.	0	None
5612	5613	1	0	None
5613	5614	mg	0	None
5614	5615	/	0	None
5615	5616	kg	0	None
5616	5617	b	0	None
5617	5618	.	0	None

5619	5620	w	0	None
5620	5621	.	0	None

5622	5623	(	0	None
5623	5624	days	0	None
5624	5625	2	0	None
5625	5626	-	0	None
5626	5627	14	0	None
5627	5628	)	0	None
5628	5629	.	0	None

5630	5631	The	0	None
5631	5632	results	0	None
5632	5633	confirm	0	None
5633	5634	the	0	None
5634	5635	recommended	0	None
5635	5636	dosage	0	None
5636	5637	regime	0	None
5637	5638	of	0	None
5638	5639	meloxicam	3	CHEMICAL
5639	5640	with	0	None
5640	5641	its	0	None
5641	5642	initial	0	None
5642	5643	loading	0	None
5643	5644	dose	0	None
5644	5645	and	0	None
5645	5646	the	0	None
5646	5647	subsequent	0	None
5647	5648	maintenance	0	None
5648	5649	dose	0	None
5649	5650	.	0	None

5651	5652	This	0	None
5652	5653	dosing	0	None
5653	5654	regime	0	None
5654	5655	results	0	None
5655	5656	in	0	None
5656	5657	a	0	None
5657	5658	very	0	None
5658	5659	favourable	0	None
5659	5660	curve	0	None
5660	5661	of	0	None
5661	5662	concentrations	0	None
5662	5663	with	0	None
5663	5664	a	0	None
5664	5665	very	0	None
5665	5666	rapidly	0	None
5666	5667	attained	0	None
5667	5668	steady	0	None
5668	5669	state	0	None
5669	5670	after	0	None
5670	5671	roughly	0	None
5671	5672	two	0	None
5672	5673	days	0	None
5673	5674	,	0	None
5674	5675	without	0	None
5675	5676	accumulation	0	None
5676	5677	even	0	None
5677	5678	in	0	None
5678	5679	long	0	None
5679	5680	-	0	None
5680	5681	term	0	None
5681	5682	treatment	0	None
5682	5683	.	0	None

5684	5685	In	0	None
5685	5686	vitro	0	None
5686	5687	activities	0	None
5687	5688	of	0	None
5688	5689	the	0	None
5689	5690	potent	0	None
5690	5691	,	0	None
5691	5692	broad	0	None
5692	5693	-	0	None
5693	5694	spectrum	0	None
5694	5695	carbapenem	0	None
5695	5696	MK	1	GENE-Y
5696	5697	-	0	None
5697	5698	0826	0	None
5698	5699	(	0	None
5699	5700	L	0	None
5700	5701	-	0	None
5701	5702	749	0	None
5702	5703	,	0	None
5703	5704	345	0	None
5704	5705	)	0	None
5705	5706	against	0	None
5706	5707	broad	0	None
5707	5708	-	0	None
5708	5709	spectrum	0	None
5709	5710	beta	0	None
5710	5711	-	0	None
5711	5712	lactamase	0	None
5712	5713	-	0	None
5713	5714	and	0	None
5714	5715	extended	0	None
5715	5716	-	0	None
5716	5717	spectrum	0	None
5717	5718	beta	0	None
5718	5719	-	0	None
5719	5720	lactamase	0	None
5720	5721	-	0	None
5721	5722	producing	0	None
5722	5723	Klebsiella	0	None
5723	5724	pneumoniae	0	None
5724	5725	and	0	None
5725	5726	Escherichia	0	None
5726	5727	coli	0	None
5727	5728	clinical	0	None
5728	5729	isolates	0	None
5729	5730	.	0	None

5731	5732	An	0	None
5732	5733	important	0	None
5733	5734	mechanism	0	None
5734	5735	of	0	None
5735	5736	bacterial	0	None
5736	5737	resistance	0	None
5737	5738	to	0	None
5738	5739	beta	0	None
5739	5740	-	0	None
5740	5741	lactam	3	CHEMICAL
5741	5742	antibiotics	0	None
5742	5743	is	0	None
5743	5744	inactivation	0	None
5744	5745	by	0	None
5745	5746	beta	0	None
5746	5747	-	0	None
5747	5748	lactam	3	CHEMICAL
5748	5749	-	0	None
5749	5750	hydrolyzing	0	None
5750	5751	enzymes	0	None
5751	5752	(	0	None
5752	5753	beta	0	None
5753	5754	-	0	None
5754	5755	lactamases	0	None
5755	5756	)	0	None
5756	5757	.	0	None

5758	5759	The	0	None
5759	5760	evolution	0	None
5760	5761	of	0	None
5761	5762	the	0	None
5762	5763	extended	0	None
5763	5764	-	0	None
5764	5765	spectrum	0	None
5765	5766	beta	0	None
5766	5767	-	0	None
5767	5768	lactamases	0	None
5768	5769	(	0	None
5769	5770	ESBLs	0	None
5770	5771	)	0	None
5771	5772	is	0	None
5772	5773	associated	0	None
5773	5774	with	0	None
5774	5775	extensive	0	None
5775	5776	use	0	None
5776	5777	of	0	None
5777	5778	beta	0	None
5778	5779	-	0	None
5779	5780	lactam	3	CHEMICAL
5780	5781	antibiotics	0	None
5781	5782	,	0	None
5782	5783	particularly	0	None
5783	5784	cephalosporins	3	CHEMICAL
5784	5785	,	0	None
5785	5786	and	0	None
5786	5787	is	0	None
5787	5788	a	0	None
5788	5789	serious	0	None
5789	5790	threat	0	None
5790	5791	to	0	None
5791	5792	therapeutic	0	None
5792	5793	efficacy	0	None
5793	5794	.	0	None

5795	5796	ESBLs	0	None
5796	5797	and	0	None
5797	5798	broad	0	None
5798	5799	-	0	None
5799	5800	spectrum	0	None
5800	5801	beta	0	None
5801	5802	-	0	None
5802	5803	lactamases	0	None
5803	5804	(	0	None
5804	5805	BDSBLs	0	None
5805	5806	)	0	None
5806	5807	are	0	None
5807	5808	plasmid	0	None
5808	5809	-	0	None
5809	5810	mediated	0	None
5810	5811	class	0	None
5811	5812	A	0	None
5812	5813	enzymes	0	None
5813	5814	produced	0	None
5814	5815	by	0	None
5815	5816	gram	0	None
5816	5817	-	0	None
5817	5818	negative	0	None
5818	5819	pathogens	0	None
5819	5820	,	0	None
5820	5821	principally	0	None
5821	5822	Escherichia	0	None
5822	5823	coli	0	None
5823	5824	and	0	None
5824	5825	Klebsiella	0	None
5825	5826	pneumoniae	0	None
5826	5827	.	0	None

5828	5829	MK	1	GENE-Y
5829	5830	-	0	None
5830	5831	0826	0	None
5831	5832	was	0	None
5832	5833	highly	0	None
5833	5834	potent	0	None
5834	5835	against	0	None
5835	5836	all	0	None
5836	5837	ESBL	0	None
5837	5838	-	0	None
5838	5839	and	0	None
5839	5840	BDSBL	0	None
5840	5841	-	0	None
5841	5842	producing	0	None
5842	5843	K	0	None
5843	5844	.	0	None
5844	5845	pneumoniae	0	None
5845	5846	and	0	None
5846	5847	E	0	None
5847	5848	.	0	None
5848	5849	coli	0	None
5849	5850	clinical	0	None
5850	5851	isolates	0	None
5851	5852	tested	0	None
5852	5853	(	0	None
5853	5854	MIC	0	None
5854	5855	range	0	None
5855	5856	,	0	None
5856	5857	0	0	None
5857	5858	.	0	None
5858	5859	008	0	None
5859	5860	to	0	None
5860	5861	0	0	None
5861	5862	.	0	None
5862	5863	12	0	None
5863	5864	microgram	0	None
5864	5865	/	0	None
5865	5866	ml	0	None
5866	5867	)	0	None
5867	5868	.	0	None

5869	5870	In	0	None
5870	5871	E	0	None
5871	5872	.	0	None
5872	5873	coli	0	None
5873	5874	,	0	None
5874	5875	this	0	None
5875	5876	activity	0	None
5876	5877	was	0	None
5877	5878	associated	0	None
5878	5879	with	0	None
5879	5880	high	0	None
5880	5881	-	0	None
5881	5882	affinity	0	None
5882	5883	binding	0	None
5883	5884	to	0	None
5884	5885	penicillin	3	CHEMICAL
5885	5886	-	0	None
5886	5887	binding	0	None
5887	5888	proteins	0	None
5888	5889	2	0	None
5889	5890	and	0	None
5890	5891	3	0	None
5891	5892	.	0	None

5893	5894	When	0	None
5894	5895	the	0	None
5895	5896	inoculum	0	None
5896	5897	level	0	None
5897	5898	was	0	None
5898	5899	increased	0	None
5899	5900	10	0	None
5900	5901	-	0	None
5901	5902	fold	0	None
5902	5903	,	0	None
5903	5904	increasing	0	None
5904	5905	the	0	None
5905	5906	amount	0	None
5906	5907	of	0	None
5907	5908	beta	0	None
5908	5909	-	0	None
5909	5910	lactamase	0	None
5910	5911	present	0	None
5911	5912	,	0	None
5912	5913	the	0	None
5913	5914	MK	1	GENE-Y
5914	5915	-	0	None
5915	5916	0826	0	None
5916	5917	MIC	0	None
5917	5918	range	0	None
5918	5919	increased	0	None
5919	5920	to	0	None
5920	5921	0	0	None
5921	5922	.	0	None
5922	5923	008	0	None
5923	5924	to	0	None
5924	5925	1	0	None
5925	5926	microgram	0	None
5926	5927	/	0	None
5927	5928	ml	0	None
5928	5929	.	0	None

5930	5931	By	0	None
5931	5932	comparison	0	None
5932	5933	,	0	None
5933	5934	similar	0	None
5934	5935	observations	0	None
5935	5936	were	0	None
5936	5937	made	0	None
5937	5938	with	0	None
5938	5939	meropenem	3	CHEMICAL
5939	5940	while	0	None
5940	5941	imipenem	3	CHEMICAL
5941	5942	MICs	0	None
5942	5943	were	0	None
5943	5944	usually	0	None
5944	5945	less	0	None
5945	5946	affected	0	None
5946	5947	.	0	None

5948	5949	Not	0	None
5949	5950	surprisingly	0	None
5950	5951	,	0	None
5951	5952	MIC	0	None
5952	5953	increases	0	None
5953	5954	with	0	None
5954	5955	noncarbapenem	0	None
5955	5956	beta	0	None
5956	5957	-	0	None
5957	5958	lactams	0	None
5958	5959	were	0	None
5959	5960	generally	0	None
5960	5961	substantially	0	None
5961	5962	greater	0	None
5962	5963	,	0	None
5963	5964	resulting	0	None
5964	5965	in	0	None
5965	5966	resistance	0	None
5966	5967	in	0	None
5967	5968	many	0	None
5968	5969	cases	0	None
5969	5970	.	0	None

5971	5972	E	0	None
5972	5973	.	0	None
5973	5974	coli	0	None
5974	5975	strains	0	None
5975	5976	that	0	None
5976	5977	produce	0	None
5977	5978	chromosomal	0	None
5978	5979	(	0	None
5979	5980	Bush	0	None
5980	5981	group	0	None
5981	5982	1	0	None
5982	5983	)	0	None
5983	5984	beta	0	None
5984	5985	-	0	None
5985	5986	lactamase	0	None
5986	5987	served	0	None
5987	5988	as	0	None
5988	5989	controls	0	None
5989	5990	.	0	None

5991	5992	All	0	None
5992	5993	three	0	None
5993	5994	carbapenems	3	CHEMICAL
5994	5995	were	0	None
5995	5996	subject	0	None
5996	5997	to	0	None
5997	5998	an	0	None
5998	5999	inoculum	0	None
5999	6000	effect	0	None
6000	6001	with	0	None
6001	6002	the	0	None
6002	6003	majority	0	None
6003	6004	of	0	None
6004	6005	the	0	None
6005	6006	BDSBL	0	None
6006	6007	-	0	None
6007	6008	and	0	None
6008	6009	ESBL	0	None
6009	6010	-	0	None
6010	6011	producers	0	None
6011	6012	but	0	None
6012	6013	not	0	None
6013	6014	the	0	None
6014	6015	Bush	0	None
6015	6016	group	0	None
6016	6017	1	0	None
6017	6018	strains	0	None
6018	6019	,	0	None
6019	6020	implying	0	None
6020	6021	some	0	None
6021	6022	effect	0	None
6022	6023	of	0	None
6023	6024	the	0	None
6024	6025	plasmid	0	None
6025	6026	-	0	None
6026	6027	borne	0	None
6027	6028	enzymes	0	None
6028	6029	on	0	None
6029	6030	potency	0	None
6030	6031	.	0	None

6032	6033	Importantly	0	None
6033	6034	,	0	None
6034	6035	MK	1	GENE-Y
6035	6036	-	0	None
6036	6037	0826	0	None
6037	6038	MICs	0	None
6038	6039	remained	0	None
6039	6040	at	0	None
6040	6041	or	0	None
6041	6042	below	0	None
6042	6043	1	0	None
6043	6044	microgram	0	None
6044	6045	/	0	None
6045	6046	ml	0	None
6046	6047	under	0	None
6047	6048	all	0	None
6048	6049	test	3	CHEMICAL
6049	6050	conditions	0	None
6050	6051	.	0	None

6052	6053	Molecular	0	None
6053	6054	cloning	0	None
6054	6055	and	0	None
6055	6056	characterization	0	None
6056	6057	of	0	None
6057	6058	a	0	None
6058	6059	new	0	None
6059	6060	multispecific	0	None
6060	6063	organic anion transporter	2	GENE-N
6063	6064	from	0	None
6064	6065	rat	0	None
6065	6066	brain	0	None
6066	6067	.	0	None

6068	6069	A	0	None
6069	6070	cDNA	0	None
6070	6071	encoding	0	None
6071	6072	the	0	None
6072	6073	new	0	None
6073	6074	member	0	None
6074	6075	of	0	None
6075	6076	the	0	None
6076	6077	multispecific	0	None
6077	6081	organic anion transporter family	2	GENE-N
6081	6082	,	0	None
6082	6083	OAT3	1	GENE-Y
6083	6084	,	0	None
6084	6085	was	0	None
6085	6086	isolated	0	None
6086	6087	by	0	None
6087	6088	the	0	None
6088	6090	reverse transcription	1	GENE-Y
6090	6091	-	0	None
6091	6092	polymerase	2	GENE-N
6092	6093	chain	0	None
6093	6094	reaction	0	None
6094	6095	cloning	0	None
6095	6096	method	0	None
6096	6097	.	0	None

6098	6099	Degenerate	0	None
6099	6100	primers	0	None
6100	6101	were	0	None
6101	6102	designed	0	None
6102	6103	based	0	None
6103	6104	on	0	None
6104	6105	the	0	None
6105	6106	sequences	0	None
6106	6107	conserved	0	None
6107	6108	among	0	None
6108	6109	OAT1	1	GENE-Y
6109	6110	,	0	None
6110	6111	OAT2	1	GENE-Y
6111	6112	,	0	None
6112	6113	and	0	None
6113	6117	organic cation transporter 1	2	GENE-N
6117	6118	(	0	None
6118	6119	OCT1	0	None
6119	6120	)	0	None
6120	6121	,	0	None
6121	6122	and	0	None
6122	6124	reverse transcription	2	GENE-N
6124	6125	-	0	None
6125	6126	polymerase	2	GENE-N
6126	6127	chain	0	None
6127	6128	reaction	0	None
6128	6129	was	0	None
6129	6130	performed	0	None
6130	6131	using	0	None
6131	6132	rat	0	None
6132	6134	brain poly	3	CHEMICAL
6134	6135	(	0	None
6135	6136	A	0	None
6136	6137	)	0	None
6137	6138	+	0	None
6138	6139	RNA	0	None
6139	6140	.	0	None

6141	6142	The	0	None
6142	6143	536	0	None
6143	6144	-	0	None
6144	6147	amino acid protein	2	GENE-N
6147	6148	sequence	0	None
6148	6149	encoded	0	None
6149	6150	by	0	None
6150	6151	OAT3	1	GENE-Y
6151	6152	showed	0	None
6152	6153	49	0	None
6153	6154	,	0	None
6154	6155	39	0	None
6155	6156	,	0	None
6156	6157	and	0	None
6157	6158	36	0	None
6158	6159	%	0	None
6159	6160	identity	0	None
6160	6161	to	0	None
6161	6162	those	0	None
6162	6163	of	0	None
6163	6164	OAT1	1	GENE-Y
6164	6165	,	0	None
6165	6166	OAT2	1	GENE-Y
6166	6167	,	0	None
6167	6168	and	0	None
6168	6169	OCT1	0	None
6169	6170	,	0	None
6170	6171	respectively	0	None
6171	6172	.	0	None

6173	6174	Northern	0	None
6174	6175	blot	0	None
6175	6176	analysis	0	None
6176	6177	revealed	0	None
6177	6178	that	0	None
6178	6180	rat OAT3	1	GENE-Y
6180	6181	mRNA	0	None
6181	6182	is	0	None
6182	6183	expressed	0	None
6183	6184	in	0	None
6184	6185	the	0	None
6185	6186	liver	0	None
6186	6187	,	0	None
6187	6188	brain	0	None
6188	6189	,	0	None
6189	6190	kidney	0	None
6190	6191	,	0	None
6191	6192	and	0	None
6192	6193	eye	0	None
6193	6194	.	0	None

6195	6196	When	0	None
6196	6197	expressed	0	None
6197	6198	in	0	None
6198	6199	Xenopus	0	None
6199	6200	laevis	0	None
6200	6201	oocytes	0	None
6201	6202	,	0	None
6202	6203	OAT3	1	GENE-Y
6203	6204	mediated	0	None
6204	6205	the	0	None
6205	6206	uptake	0	None
6206	6207	of	0	None
6207	6208	organic	3	CHEMICAL
6208	6209	anions	0	None
6209	6210	,	0	None
6210	6211	such	0	None
6211	6212	as	0	None
6212	6213	p	0	None
6213	6214	-	0	None
6214	6215	aminohippurate	0	None
6215	6216	(	0	None
6216	6217	Km	0	None
6217	6218	=	0	None
6218	6219	65	0	None
6219	6220	microM	0	None
6220	6221	)	0	None
6221	6222	,	0	None
6222	6224	ochratoxin A	3	CHEMICAL
6224	6225	(	0	None
6225	6226	Km	0	None
6226	6227	=	0	None
6227	6228	0	0	None
6228	6229	.	0	None
6229	6230	74	0	None
6230	6231	microM	0	None
6231	6232	)	0	None
6232	6233	,	0	None
6233	6234	and	0	None
6234	6236	estrone sulfate	3	CHEMICAL
6236	6237	(	0	None
6237	6238	Km	0	None
6238	6239	=	0	None
6239	6240	2	0	None
6240	6241	.	0	None
6241	6242	3	0	None
6242	6243	microM	0	None
6243	6244	)	0	None
6244	6245	and	0	None
6245	6246	a	0	None
6246	6247	cationic	0	None
6247	6248	compound	0	None
6248	6249	,	0	None
6249	6250	cimetidine	3	CHEMICAL
6250	6251	.	0	None

6252	6253	OAT3	1	GENE-Y
6253	6254	-	0	None
6254	6255	mediated	0	None
6255	6256	uptake	0	None
6256	6257	of	0	None
6257	6258	[	0	None
6258	6259	3H	0	None
6259	6260	]	0	None
6260	6262	estrone sulfate	3	CHEMICAL
6262	6263	was	0	None
6263	6264	sodium	3	CHEMICAL
6264	6265	-	0	None
6265	6266	independent	0	None
6266	6267	.	0	None

6268	6269	para	0	None
6269	6270	-	0	None
6270	6271	Aminohippuric	0	None
6271	6272	acid	0	None
6272	6273	,	0	None
6273	6275	estrone sulfate	3	CHEMICAL
6275	6276	or	0	None
6276	6278	ochratoxin A	3	CHEMICAL
6278	6279	did	0	None
6279	6280	not	0	None
6280	6281	show	0	None
6281	6282	any	0	None
6282	6283	trans	0	None
6283	6284	-	0	None
6284	6285	stimulatory	0	None
6285	6286	effect	0	None
6286	6287	on	0	None
6287	6288	either	0	None
6288	6289	influx	0	None
6289	6290	or	0	None
6290	6291	efflux	0	None
6291	6292	of	0	None
6292	6293	[	0	None
6293	6294	3H	0	None
6294	6295	]	0	None
6295	6297	estrone sulfate	3	CHEMICAL
6297	6298	via	0	None
6298	6299	OAT3	1	GENE-Y
6299	6300	.	0	None

6301	6302	Organic	0	None
6302	6303	anions	0	None
6303	6304	such	0	None
6304	6305	as	0	None
6305	6306	sulfobromophthalein	0	None
6306	6307	,	0	None
6307	6308	probenecid	3	CHEMICAL
6308	6309	,	0	None
6309	6310	indocyanine	0	None
6310	6311	green	0	None
6311	6312	,	0	None
6312	6313	bumetanide	3	CHEMICAL
6313	6314	,	0	None
6314	6315	piroxicam	3	CHEMICAL
6315	6316	,	0	None
6316	6317	furosemide	3	CHEMICAL
6317	6318	,	0	None
6318	6319	azidodeoxythymidine	0	None
6319	6320	,	0	None
6320	6321	4	0	None
6321	6322	,	0	None
6322	6323	4	0	None
6323	6324	'	0	None
6324	6325	-	0	None
6325	6326	diisothiocyanostilbene	0	None
6326	6327	-	0	None
6327	6328	3	0	None
6328	6329	,	0	None
6329	6330	3	0	None
6330	6331	'	0	None
6331	6332	-	0	None
6332	6333	disulfonic	0	None
6333	6334	acid	0	None
6334	6335	,	0	None
6335	6336	and	0	None
6336	6337	benzylpenicillin	3	CHEMICAL
6337	6338	inhibited	0	None
6338	6339	OAT3	1	GENE-Y
6339	6340	-	0	None
6340	6341	mediated	0	None
6341	6343	estrone sulfate	3	CHEMICAL
6343	6344	uptake	0	None
6344	6345	,	0	None
6345	6346	while	0	None
6346	6347	ouabain	3	CHEMICAL
6347	6348	and	0	None
6348	6349	digoxin	0	None
6349	6350	did	0	None
6350	6351	not	0	None
6351	6352	.	0	None

6353	6354	Organic	0	None
6354	6355	cations	0	None
6355	6356	such	0	None
6356	6357	as	0	None
6357	6358	tetraethylammonium	3	CHEMICAL
6358	6359	,	0	None
6359	6360	guanidine	0	None
6360	6361	,	0	None
6361	6362	verapamil	3	CHEMICAL
6362	6363	,	0	None
6363	6364	and	0	None
6364	6365	quinidine	3	CHEMICAL
6365	6366	did	0	None
6366	6367	not	0	None
6367	6368	interact	0	None
6368	6369	with	0	None
6369	6370	OAT3	1	GENE-Y
6370	6371	.	0	None

6372	6373	Acidic	0	None
6373	6374	metabolites	0	None
6374	6375	of	0	None
6375	6376	neurotransmitters	0	None
6376	6377	derived	0	None
6377	6378	from	0	None
6378	6379	dopamine	3	CHEMICAL
6379	6380	,	0	None
6380	6381	epinephrine	0	None
6381	6382	,	0	None
6382	6383	norepinephrine	3	CHEMICAL
6383	6384	,	0	None
6384	6385	and	0	None
6385	6386	serotonin	3	CHEMICAL
6386	6387	inhibited	0	None
6387	6388	the	0	None
6388	6389	uptake	0	None
6389	6390	of	0	None
6390	6392	estrone sulfate	3	CHEMICAL
6392	6393	via	0	None
6393	6394	OAT3	1	GENE-Y
6394	6395	.	0	None

6396	6397	These	0	None
6397	6398	results	0	None
6398	6399	suggest	0	None
6399	6400	an	0	None
6400	6401	important	0	None
6401	6402	role	0	None
6402	6403	of	0	None
6403	6404	OAT3	1	GENE-Y
6404	6405	in	0	None
6405	6406	the	0	None
6406	6407	excretion	0	None
6407	6408	/	0	None
6408	6409	detoxification	0	None
6409	6410	of	0	None
6410	6411	endogenous	0	None
6411	6412	and	0	None
6412	6413	exogenous	0	None
6413	6414	organic	3	CHEMICAL
6414	6415	anions	0	None
6415	6416	,	0	None
6416	6417	especially	0	None
6417	6418	from	0	None
6418	6419	the	0	None
6419	6420	brain	0	None
6420	6421	.	0	None

6422	6423	Influence	0	None
6423	6424	of	0	None
6424	6425	halothane	3	CHEMICAL
6425	6426	on	0	None
6426	6428	phospholipase A2	1	GENE-Y
6428	6429	and	0	None
6429	6430	enzymatic	0	None
6430	6431	methylations	0	None
6431	6432	in	0	None
6432	6433	the	0	None
6433	6434	rat	0	None
6434	6435	retinal	3	CHEMICAL
6435	6436	membranes	0	None
6436	6437	.	0	None

6438	6439	Phospholipase	0	None
6439	6440	A2	0	None
6440	6441	(	0	None
6441	6442	PLA2	0	None
6442	6443	)	0	None
6443	6444	and	0	None
6444	6445	phospholipid	3	CHEMICAL
6445	6446	methylases	0	None
6446	6447	(	0	None
6447	6448	PLM	0	None
6448	6449	)	0	None
6449	6450	play	0	None
6450	6451	significant	0	None
6451	6452	roles	0	None
6452	6453	in	0	None
6453	6454	transmitter	0	None
6454	6455	release	0	None
6455	6456	and	0	None
6456	6457	membrane	0	None
6457	6458	signal	0	None
6458	6459	transduction	0	None
6459	6460	,	0	None
6460	6461	respectively	0	None
6461	6462	.	0	None

6463	6464	Previous	0	None
6464	6465	studies	0	None
6465	6466	have	0	None
6466	6467	indicated	0	None
6467	6468	that	0	None
6468	6469	PLMs	0	None
6469	6470	occur	0	None
6470	6471	in	0	None
6471	6472	the	0	None
6472	6473	rat	0	None
6473	6474	brain	0	None
6474	6475	synaptosomal	0	None
6475	6476	and	0	None
6476	6477	retinal	3	CHEMICAL
6477	6478	membranes	0	None
6478	6479	,	0	None
6479	6480	and	0	None
6480	6481	they	0	None
6481	6482	are	0	None
6482	6483	activated	0	None
6483	6484	under	0	None
6484	6485	halothane	3	CHEMICAL
6485	6486	anesthesia	0	None
6486	6487	.	0	None

6488	6489	The	0	None
6489	6490	influence	0	None
6490	6491	of	0	None
6491	6492	halothane	3	CHEMICAL
6492	6493	on	0	None
6493	6494	PLA2	0	None
6494	6495	is	0	None
6495	6496	not	0	None
6496	6497	known	0	None
6497	6498	.	0	None

6499	6500	Therefore	0	None
6500	6501	,	0	None
6501	6502	we	0	None
6502	6503	have	0	None
6503	6504	investigated	0	None
6504	6505	the	0	None
6505	6506	effect	0	None
6506	6507	of	0	None
6507	6508	halothane	3	CHEMICAL
6508	6509	on	0	None
6509	6510	retinal	3	CHEMICAL
6510	6511	PLA2	0	None
6511	6512	activity	0	None
6512	6513	.	0	None

6514	6515	Rat	0	None
6515	6516	retinal	3	CHEMICAL
6516	6517	sonicates	0	None
6517	6518	were	0	None
6518	6519	assayed	0	None
6519	6520	for	0	None
6520	6521	PLA2	0	None
6521	6522	activity	0	None
6522	6523	using	0	None
6523	6524	1	0	None
6524	6525	-	0	None
6525	6526	palmitoyl	3	CHEMICAL
6526	6527	-	0	None
6527	6528	2	0	None
6528	6529	[	0	None
6529	6530	1	0	None
6530	6531	-	0	None
6531	6532	14C	3	CHEMICAL
6532	6533	]	0	None
6533	6534	arachidonyl	0	None
6534	6535	-	0	None
6535	6536	phosphatidylethanolamine	3	CHEMICAL
6536	6537	(	0	None
6537	6538	PE	3	CHEMICAL
6538	6539	,	0	None
6539	6540	2	0	None
6540	6541	.	0	None
6541	6542	2	0	None
6542	6543	nmol	0	None
6543	6544	)	0	None
6544	6545	in	0	None
6545	6546	Tris	0	None
6546	6547	buffer	0	None
6547	6548	(	0	None
6548	6549	10	0	None
6549	6550	mM	0	None
6550	6551	,	0	None
6551	6552	pH	0	None
6552	6553	7	0	None
6553	6554	.	0	None
6554	6555	4	0	None
6555	6556	)	0	None
6556	6557	at	0	None
6557	6558	37	0	None
6558	6559	degrees	0	None
6559	6560	C	0	None
6560	6561	with	0	None
6561	6562	and	0	None
6562	6563	without	0	None
6563	6564	halothane	3	CHEMICAL
6564	6565	(	0	None
6565	6566	0	0	None
6566	6567	.	0	None
6567	6568	25	0	None
6568	6569	-	0	None
6569	6570	2	0	None
6570	6571	.	0	None
6571	6572	0	0	None
6572	6573	mM	0	None
6573	6574	)	0	None
6574	6575	in	0	None
6575	6576	the	0	None
6576	6577	assay	0	None
6577	6578	medium	0	None
6578	6579	.	0	None

6580	6581	These	0	None
6581	6582	studies	0	None
6582	6583	gave	0	None
6583	6584	the	0	None
6584	6585	following	0	None
6585	6586	results	0	None
6586	6587	:	0	None
6587	6588	(	0	None
6588	6589	1	0	None
6589	6590	)	0	None
6590	6591	Rat	0	None
6591	6592	retinal	3	CHEMICAL
6592	6593	sonicates	0	None
6593	6594	contained	0	None
6594	6595	PLA2	0	None
6595	6596	activity	0	None
6596	6597	of	0	None
6597	6598	4	0	None
6598	6599	.	0	None
6599	6600	2	0	None
6600	6601	+	0	None
6601	6602	/	0	None
6602	6603	-	0	None
6603	6604	0	0	None
6604	6605	.	0	None
6605	6606	8	0	None
6606	6607	pmol	0	None
6607	6608	PE	3	CHEMICAL
6608	6609	hydrolyzed	0	None
6609	6610	/	0	None
6610	6611	100	0	None
6611	6612	ng	0	None
6612	6613	protein	0	None
6613	6614	/	0	None
6614	6615	hr	2	GENE-N
6615	6616	;	0	None
6616	6617	(	0	None
6617	6618	2	0	None
6618	6619	)	0	None
6619	6620	Halothane	0	None
6620	6621	(	0	None
6621	6622	0	0	None
6622	6623	.	0	None
6623	6624	25	0	None
6624	6625	-	0	None
6625	6626	2	0	None
6626	6627	.	0	None
6627	6628	0	0	None
6628	6629	mM	0	None
6629	6630	)	0	None
6630	6631	increased	0	None
6631	6632	PLA2	0	None
6632	6633	activity	0	None
6633	6634	by	0	None
6634	6635	20	0	None
6635	6636	to	0	None
6636	6637	150	0	None
6637	6638	%	0	None
6638	6639	depending	0	None
6639	6640	upon	0	None
6640	6641	concentration	0	None
6641	6642	;	0	None
6642	6643	(	0	None
6643	6644	3	0	None
6644	6645	)	0	None
6645	6646	The	0	None
6646	6647	lower	0	None
6647	6648	concentration	0	None
6648	6649	of	0	None
6649	6650	halothane	3	CHEMICAL
6650	6651	(	0	None
6651	6652	0	0	None
6652	6653	.	0	None
6653	6654	25	0	None
6654	6655	mM	0	None
6655	6656	)	0	None
6656	6657	exhibited	0	None
6657	6658	high	0	None
6658	6659	activation	0	None
6659	6660	of	0	None
6660	6661	PLA2	0	None
6661	6662	(	0	None
6662	6663	150	0	None
6663	6664	%	0	None
6664	6665	)	0	None
6665	6666	;	0	None
6666	6667	(	0	None
6667	6668	4	0	None
6668	6669	)	0	None
6669	6670	High	0	None
6670	6671	concentrations	0	None
6671	6672	of	0	None
6672	6673	halothane	3	CHEMICAL
6673	6674	(	0	None
6674	6675	1	0	None
6675	6676	.	0	None
6676	6677	0	0	None
6677	6678	-	0	None
6678	6679	2	0	None
6679	6680	.	0	None
6680	6681	0	0	None
6681	6682	mM	0	None
6682	6683	)	0	None
6683	6684	caused	0	None
6684	6685	a	0	None
6685	6686	low	0	None
6686	6687	degree	0	None
6687	6688	of	0	None
6688	6689	activation	0	None
6689	6690	of	0	None
6690	6691	PLA2	0	None
6691	6692	(	0	None
6692	6693	20	0	None
6693	6694	%	0	None
6694	6695	)	0	None
6695	6696	;	0	None
6696	6697	and	0	None
6697	6698	(	0	None
6698	6699	5	0	None
6699	6700	)	0	None
6700	6701	During	0	None
6701	6702	phospholipid	3	CHEMICAL
6702	6703	methylation	0	None
6703	6704	of	0	None
6704	6705	retinal	3	CHEMICAL
6705	6706	membranes	0	None
6706	6707	with	0	None
6707	6708	S	0	None
6708	6709	-	0	None
6709	6710	adenosyl	3	CHEMICAL
6710	6711	-	0	None
6711	6712	L	0	None
6712	6713	-	0	None
6713	6714	methionine	3	CHEMICAL
6714	6715	in	0	None
6715	6716	the	0	None
6716	6717	presence	0	None
6717	6718	of	0	None
6718	6719	halothane	3	CHEMICAL
6719	6720	,	0	None
6720	6721	increased	0	None
6721	6722	amounts	0	None
6722	6723	of	0	None
6723	6727	fatty acid methyl esters	3	CHEMICAL
6727	6728	(	0	None
6728	6729	FAME	0	None
6729	6730	)	0	None
6730	6731	were	0	None
6731	6732	formed	0	None
6732	6733	.	0	None

6734	6735	This	0	None
6735	6736	increase	0	None
6736	6737	in	0	None
6737	6738	FAME	0	None
6738	6739	(	0	None
6739	6740	45	0	None
6740	6741	%	0	None
6741	6742	)	0	None
6742	6743	was	0	None
6743	6744	possibly	0	None
6744	6745	due	0	None
6745	6746	to	0	None
6746	6747	the	0	None
6747	6748	hydrolysis	0	None
6748	6749	of	0	None
6749	6750	phospholipids	0	None
6750	6751	by	0	None
6751	6752	activated	0	None
6752	6753	PLA2	0	None
6753	6754	,	0	None
6754	6755	liberating	0	None
6755	6757	fatty acids	3	CHEMICAL
6757	6758	which	0	None
6758	6759	were	0	None
6759	6760	methylated	0	None
6760	6761	.	0	None

6762	6763	This	0	None
6763	6764	increase	0	None
6764	6765	in	0	None
6765	6766	FAME	0	None
6766	6767	(	0	None
6767	6768	45	0	None
6768	6769	%	0	None
6769	6770	)	0	None
6770	6771	was	0	None
6771	6772	inhibited	0	None
6772	6773	by	0	None
6773	6774	mepacrine	3	CHEMICAL
6774	6775	(	0	None
6775	6776	quinacrine	3	CHEMICAL
6776	6777	)	0	None
6777	6778	(	0	None
6778	6779	10	0	None
6779	6780	microM	0	None
6780	6781	)	0	None
6781	6782	,	0	None
6782	6783	an	0	None
6783	6784	inhibitor	0	None
6784	6785	of	0	None
6785	6786	PLA2	0	None
6786	6787	.	0	None

6788	6789	These	0	None
6789	6790	observations	0	None
6790	6791	suggest	0	None
6791	6792	that	0	None
6792	6793	the	0	None
6793	6794	release	0	None
6794	6795	of	0	None
6795	6796	retinal	3	CHEMICAL
6796	6797	transmitters	0	None
6797	6798	(	0	None
6798	6799	dopamine	3	CHEMICAL
6799	6800	,	0	None
6800	6801	acetylcholine	3	CHEMICAL
6801	6802	and	0	None
6802	6803	others	0	None
6803	6804	)	0	None
6804	6805	is	0	None
6805	6806	affected	0	None
6806	6807	during	0	None
6807	6808	halothane	3	CHEMICAL
6808	6809	anesthesia	0	None
6809	6810	,	0	None
6810	6811	due	0	None
6811	6812	to	0	None
6812	6813	activation	0	None
6813	6814	of	0	None
6814	6815	PLA2	0	None
6815	6816	and	0	None
6816	6817	enhanced	0	None
6817	6818	fusogenic	0	None
6818	6819	activity	0	None
6819	6820	of	0	None
6820	6821	vesicular	0	None
6821	6822	membranes	0	None
6822	6823	with	0	None
6823	6824	plasma	0	None
6824	6825	membrane	0	None
6825	6826	and	0	None
6826	6827	depletion	0	None
6827	6828	of	0	None
6828	6829	vesicles	0	None
6829	6830	.	0	None

6831	6832	Atypical	0	None
6832	6833	teratoid	0	None
6833	6834	/	0	None
6834	6835	rhabdoid	0	None
6835	6836	tumor	0	None
6836	6837	of	0	None
6837	6838	the	0	None
6838	6839	CNS	0	None
6839	6840	:	0	None
6840	6841	cytopathology	0	None
6841	6842	and	0	None
6842	6843	immunohistochemistry	0	None
6843	6844	of	0	None
6844	6845	insulin	0	None
6845	6846	-	0	None
6846	6847	like	0	None
6847	6848	growth	0	None
6848	6849	factor	0	None
6849	6850	-	0	None
6850	6851	II	0	None
6851	6852	,	0	None
6852	6853	insulin	0	None
6853	6854	-	0	None
6854	6855	like	0	None
6855	6860	growth factor receptor type 1	1	GENE-Y
6860	6861	,	0	None
6861	6863	cathepsin D	1	GENE-Y
6863	6864	,	0	None
6864	6865	and	0	None
6865	6866	Ki	0	None
6866	6867	-	0	None
6867	6868	67	0	None
6868	6869	.	0	None

6870	6871	Insulin	0	None
6871	6872	-	0	None
6872	6873	like	0	None
6873	6875	growth factor	0	None
6875	6876	(	0	None
6876	6877	IGF	1	GENE-Y
6877	6878	)	0	None
6878	6879	-	0	None
6879	6880	II	0	None
6880	6881	is	0	None
6881	6882	a	0	None
6882	6883	potent	0	None
6883	6885	growth factor	1	GENE-Y
6885	6886	,	0	None
6886	6887	normally	0	None
6887	6888	controlled	0	None
6888	6889	by	0	None
6889	6890	a	0	None
6890	6891	number	0	None
6891	6892	of	0	None
6892	6893	other	0	None
6893	6894	factors	0	None
6894	6895	,	0	None
6895	6896	including	0	None
6896	6899	IGF binding proteins	2	GENE-N
6899	6900	and	0	None
6900	6904	IGF binding protein proteases	2	GENE-N
6904	6905	.	0	None

6906	6907	In	0	None
6907	6908	general	0	None
6908	6909	,	0	None
6909	6910	the	0	None
6910	6911	latter	0	None
6911	6912	increase	0	None
6912	6913	the	0	None
6913	6914	bioavailability	0	None
6914	6915	of	0	None
6915	6916	IGF	1	GENE-Y
6916	6917	by	0	None
6917	6918	cleaving	0	None
6918	6919	IGF	1	GENE-Y
6919	6920	binding	0	None
6920	6921	proteins	0	None
6921	6922	.	0	None

6923	6925	Cathepsin D	1	GENE-Y
6925	6926	(	0	None
6926	6927	an	0	None
6927	6931	IGF binding protein protease	2	GENE-N
6931	6932	)	0	None
6932	6933	was	0	None
6933	6934	also	0	None
6934	6935	implicated	0	None
6935	6936	in	0	None
6936	6937	tumor	0	None
6937	6938	invasion	0	None
6938	6939	.	0	None

6940	6941	Although	0	None
6941	6942	IGF	1	GENE-Y
6942	6943	-	0	None
6943	6944	II	0	None
6944	6945	was	0	None
6945	6946	implicated	0	None
6946	6947	in	0	None
6947	6948	the	0	None
6948	6949	pathogeneses	0	None
6949	6950	of	0	None
6950	6951	various	0	None
6951	6952	childhood	0	None
6952	6953	neoplasms	0	None
6953	6954	,	0	None
6954	6955	its	0	None
6955	6956	significance	0	None
6956	6957	in	0	None
6957	6958	the	0	None
6958	6959	pathogenesis	0	None
6959	6960	of	0	None
6960	6961	atypical	0	None
6961	6962	teratoid	0	None
6962	6963	/	0	None
6963	6964	rhabdoid	0	None
6964	6965	tumor	0	None
6965	6966	of	0	None
6966	6967	the	0	None
6967	6968	central	0	None
6968	6969	nervous	0	None
6969	6970	system	0	None
6970	6971	(	0	None
6971	6972	ATRT	0	None
6972	6973	-	0	None
6973	6974	CNS	0	None
6974	6975	)	0	None
6975	6976	was	0	None
6976	6977	not	0	None
6977	6978	studied	0	None
6978	6979	to	0	None
6979	6980	date	0	None
6980	6981	.	0	None

6982	6983	We	0	None
6983	6984	present	0	None
6984	6985	clinicopathologic	0	None
6985	6986	features	0	None
6986	6987	of	0	None
6987	6988	two	0	None
6988	6989	cases	0	None
6989	6990	of	0	None
6990	6991	ATRT	0	None
6991	6992	-	0	None
6992	6993	CNS	0	None
6993	6994	.	0	None

6995	6996	In	0	None
6996	6997	addition	0	None
6997	6998	,	0	None
6998	6999	formalin	3	CHEMICAL
6999	7000	-	0	None
7000	7001	fixed	0	None
7001	7002	,	0	None
7002	7003	paraffin	0	None
7003	7004	-	0	None
7004	7005	embedded	0	None
7005	7006	tissue	0	None
7006	7007	sections	0	None
7007	7008	were	0	None
7008	7009	stained	0	None
7009	7010	immunohistochemically	0	None
7010	7011	for	0	None
7011	7012	IGF	1	GENE-Y
7012	7013	-	0	None
7013	7014	II	0	None
7014	7015	,	0	None
7015	7017	IGF receptor	2	GENE-N
7017	7018	type	0	None
7018	7019	1	0	None
7019	7020	,	0	None
7020	7022	cathepsin D	1	GENE-Y
7022	7023	,	0	None
7023	7024	and	0	None
7024	7025	Ki	0	None
7025	7026	-	0	None
7026	7027	67	0	None
7027	7028	.	0	None

7029	7030	Both	0	None
7030	7031	tumors	0	None
7031	7032	demonstrated	0	None
7032	7033	diffuse	0	None
7033	7034	strong	0	None
7034	7035	cytoplasmic	0	None
7035	7036	positivity	0	None
7036	7037	for	0	None
7037	7038	IGF	1	GENE-Y
7038	7039	-	0	None
7039	7040	II	0	None
7040	7041	,	0	None
7041	7042	diffuse	0	None
7042	7043	cytoplasmic	0	None
7043	7044	and	0	None
7044	7045	focal	0	None
7045	7046	membranous	0	None
7046	7047	positivity	0	None
7047	7048	for	0	None
7048	7052	IGF receptor type I	1	GENE-Y
7052	7053	,	0	None
7053	7054	and	0	None
7054	7055	diffuse	0	None
7055	7056	cytoplasmic	0	None
7056	7057	positivity	0	None
7057	7058	for	0	None
7058	7060	cathepsin D	1	GENE-Y
7060	7061	.	0	None

7062	7063	The	0	None
7063	7064	Ki	0	None
7064	7065	-	0	None
7065	7066	67	0	None
7066	7067	labeling	0	None
7067	7068	indices	0	None
7068	7069	were	0	None
7069	7070	10	0	None
7070	7071	.	0	None
7071	7072	0	0	None
7072	7073	%	0	None
7073	7074	and	0	None
7074	7075	1	0	None
7075	7076	.	0	None
7076	7077	4	0	None
7077	7078	%	0	None
7078	7079	.	0	None

7080	7081	We	0	None
7081	7082	conclude	0	None
7082	7083	that	0	None
7083	7084	ATRT	0	None
7084	7085	-	0	None
7085	7086	CNS	0	None
7086	7087	cells	0	None
7087	7088	express	0	None
7088	7089	both	0	None
7089	7090	IGF	1	GENE-Y
7090	7091	-	0	None
7091	7092	II	0	None
7092	7093	and	0	None
7093	7095	IGF receptor	2	GENE-N
7095	7096	type	0	None
7096	7097	1	0	None
7097	7098	,	0	None
7098	7099	supporting	0	None
7099	7100	the	0	None
7100	7101	hypothesis	0	None
7101	7102	that	0	None
7102	7103	autocrine	0	None
7103	7104	/	0	None
7104	7105	paracrine	0	None
7105	7106	stimulation	0	None
7106	7107	of	0	None
7107	7108	cell	0	None
7108	7109	growth	0	None
7109	7110	by	0	None
7110	7111	IGF	1	GENE-Y
7111	7112	-	0	None
7112	7113	II	0	None
7113	7114	might	0	None
7114	7115	be	0	None
7115	7116	one	0	None
7116	7117	mechanism	0	None
7117	7118	involved	0	None
7118	7119	in	0	None
7119	7120	ATRT	0	None
7120	7121	-	0	None
7121	7122	CNS	0	None
7122	7123	tumorigenesis	0	None
7123	7124	.	0	None

7125	7127	Cathepsin D	2	GENE-N
7127	7128	expressed	0	None
7128	7129	by	0	None
7129	7130	the	0	None
7130	7131	tumor	0	None
7131	7132	cells	0	None
7132	7133	might	0	None
7133	7134	also	0	None
7134	7135	be	0	None
7135	7136	involved	0	None
7136	7137	in	0	None
7137	7138	both	0	None
7138	7139	tumor	0	None
7139	7140	cell	0	None
7140	7141	invasion	0	None
7141	7142	and	0	None
7142	7143	growth	0	None
7143	7144	.	0	None

7145	7146	The	0	None
7146	7147	exact	0	None
7147	7148	pathogenesis	0	None
7148	7149	of	0	None
7149	7150	ATRT	0	None
7150	7151	-	0	None
7151	7152	CNS	0	None
7152	7153	remains	0	None
7153	7154	to	0	None
7154	7155	be	0	None
7155	7156	elucidated	0	None
7156	7157	.	0	None

7158	7159	Is	0	None
7159	7160	phentermine	3	CHEMICAL
7160	7161	an	0	None
7161	7162	inhibitor	0	None
7162	7163	of	0	None
7163	7165	monoamine oxidase	2	GENE-N
7165	7166	?	0	None

7167	7168	A	0	None
7168	7169	critical	0	None
7169	7170	appraisal	0	None
7170	7171	.	0	None

7172	7173	Phentermine	0	None
7173	7174	produces	0	None
7174	7175	a	0	None
7175	7176	spectrum	0	None
7176	7177	of	0	None
7177	7178	concentration	0	None
7178	7179	-	0	None
7179	7180	dependent	0	None
7180	7181	biochemical	0	None
7181	7182	effects	0	None
7182	7183	.	0	None

7184	7185	It	0	None
7185	7186	interacts	0	None
7186	7187	with	0	None
7187	7189	NE transporters	2	GENE-N
7189	7190	at	0	None
7190	7191	0	0	None
7191	7192	.	0	None
7192	7193	1	0	None
7193	7194	microM	0	None
7194	7195	,	0	None
7195	7197	DA transporters	2	GENE-N
7197	7198	at	0	None
7198	7199	about	0	None
7199	7200	1	0	None
7200	7201	microM	0	None
7201	7202	,	0	None
7202	7203	5	0	None
7203	7204	-	0	None
7204	7205	HT	3	CHEMICAL
7205	7206	transporters	0	None
7206	7207	at	0	None
7207	7208	15	0	None
7208	7209	microM	0	None
7209	7210	and	0	None
7210	7211	MAO	2	GENE-N
7211	7212	-	0	None
7212	7213	A	0	None
7213	7214	at	0	None
7214	7215	about	0	None
7215	7216	100	0	None
7216	7217	microM	0	None
7217	7218	.	0	None

7219	7220	When	0	None
7220	7221	administered	0	None
7221	7222	at	0	None
7222	7223	typical	0	None
7223	7224	anorectic	0	None
7224	7225	doses	0	None
7225	7226	,	0	None
7226	7227	phentermine	3	CHEMICAL
7227	7228	primarily	0	None
7228	7229	interacts	0	None
7229	7230	with	0	None
7230	7234	DA and NE transporters	2	GENE-N
7234	7235	and	0	None
7235	7236	does	0	None
7236	7237	not	0	None
7237	7238	produce	0	None
7238	7239	biochemical	0	None
7239	7240	or	0	None
7240	7241	neurochemical	0	None
7241	7242	effects	0	None
7242	7243	which	0	None
7243	7244	would	0	None
7244	7245	occur	0	None
7245	7246	if	0	None
7246	7247	it	0	None
7247	7248	were	0	None
7248	7249	inhibiting	0	None
7249	7250	MAO	2	GENE-N
7250	7251	-	0	None
7251	7252	A	0	None
7252	7253	.	0	None

7254	7255	Some	0	None
7255	7256	other	0	None
7256	7257	explanation	0	None
7257	7258	other	0	None
7258	7259	than	0	None
7259	7260	MAO	2	GENE-N
7260	7261	inhibition	0	None
7261	7262	must	0	None
7262	7263	be	0	None
7263	7264	sought	0	None
7264	7265	to	0	None
7265	7266	explain	0	None
7266	7267	how	0	None
7267	7268	oral	0	None
7268	7269	phentermine	3	CHEMICAL
7269	7270	increases	0	None
7270	7271	platelet	0	None
7271	7272	5	0	None
7272	7273	-	0	None
7273	7274	HT	3	CHEMICAL
7274	7275	,	0	None
7275	7276	since	0	None
7276	7277	platelet	0	None
7277	7278	MAO	2	GENE-N
7278	7279	-	0	None
7279	7280	B	0	None
7280	7281	does	0	None
7281	7282	not	0	None
7282	7283	metabolize	0	None
7283	7284	platelet	0	None
7284	7285	5	0	None
7285	7286	-	0	None
7286	7287	HT	3	CHEMICAL
7287	7288	,	0	None
7288	7289	and	0	None
7289	7290	since	0	None
7290	7291	amphetamine	3	CHEMICAL
7291	7292	-	0	None
7292	7293	type	0	None
7293	7294	drugs	0	None
7294	7295	are	0	None
7295	7296	even	0	None
7296	7297	weaker	0	None
7297	7298	inhibitors	0	None
7298	7299	of	0	None
7299	7300	MAO	2	GENE-N
7300	7301	-	0	None
7301	7302	B	0	None
7302	7303	than	0	None
7303	7304	MAO	2	GENE-N
7304	7305	-	0	None
7305	7306	A	0	None
7306	7307	.	0	None

7308	7309	Clinical	0	None
7309	7310	studies	0	None
7310	7311	in	0	None
7311	7312	humans	0	None
7312	7313	have	0	None
7313	7314	shown	0	None
7314	7315	that	0	None
7315	7316	amphetamine	3	CHEMICAL
7316	7317	,	0	None
7317	7318	which	0	None
7318	7319	is	0	None
7319	7320	a	0	None
7320	7321	more	0	None
7321	7322	potent	0	None
7322	7323	inhibitor	0	None
7323	7324	of	0	None
7324	7325	MAO	2	GENE-N
7325	7326	-	0	None
7326	7327	A	0	None
7327	7328	than	0	None
7328	7329	phentermine	3	CHEMICAL
7329	7330	,	0	None
7330	7331	does	0	None
7331	7332	not	0	None
7332	7333	inhibit	0	None
7333	7334	MAO	2	GENE-N
7334	7335	-	0	None
7335	7336	A	0	None
7336	7337	at	0	None
7337	7338	therapeutic	0	None
7338	7339	doses	0	None
7339	7340	.	0	None

7341	7342	Neither	0	None
7342	7343	phentermine	3	CHEMICAL
7343	7344	alone	0	None
7344	7345	,	0	None
7345	7346	fluoxetine	3	CHEMICAL
7346	7347	alone	0	None
7347	7348	or	0	None
7348	7349	their	0	None
7349	7350	combined	0	None
7350	7351	use	0	None
7351	7352	have	0	None
7352	7353	been	0	None
7353	7354	associated	0	None
7354	7355	with	0	None
7355	7356	cardiac	0	None
7356	7357	valvulopathy	0	None
7357	7358	,	0	None
7358	7359	and	0	None
7359	7360	clinical	0	None
7360	7361	experience	0	None
7361	7362	has	0	None
7362	7363	shown	0	None
7363	7364	their	0	None
7364	7365	combined	0	None
7365	7366	use	0	None
7366	7367	to	0	None
7367	7368	be	0	None
7368	7369	free	0	None
7369	7370	of	0	None
7370	7371	significant	0	None
7371	7372	adverse	0	None
7372	7373	effects	0	None
7373	7374	.	0	None

7375	7376	Viewed	0	None
7376	7377	collectively	0	None
7377	7378	,	0	None
7378	7379	there	0	None
7379	7380	appears	0	None
7380	7381	to	0	None
7381	7382	be	0	None
7382	7383	no	0	None
7383	7384	data	0	None
7384	7385	to	0	None
7385	7386	support	0	None
7386	7387	the	0	None
7387	7388	hypothesis	0	None
7388	7389	that	0	None
7389	7390	phentermine	3	CHEMICAL
7390	7391	inhibits	0	None
7391	7392	MAO	2	GENE-N
7392	7393	at	0	None
7393	7394	typical	0	None
7394	7395	therapeutic	0	None
7395	7396	doses	0	None
7396	7397	.	0	None

7398	7399	Identification	0	None
7399	7400	of	0	None
7400	7401	a	0	None
7401	7403	nuclear receptor	2	GENE-N
7403	7404	for	0	None
7404	7406	bile acids	3	CHEMICAL
7406	7407	.	0	None

7408	7409	Bile	0	None
7409	7410	acids	0	None
7410	7411	are	0	None
7411	7412	essential	0	None
7412	7413	for	0	None
7413	7414	the	0	None
7414	7415	solubilization	0	None
7415	7416	and	0	None
7416	7417	transport	0	None
7417	7418	of	0	None
7418	7419	dietary	0	None
7419	7420	lipids	0	None
7420	7421	and	0	None
7421	7422	are	0	None
7422	7423	the	0	None
7423	7424	major	0	None
7424	7425	products	0	None
7425	7426	of	0	None
7426	7427	cholesterol	0	None
7427	7428	catabolism	0	None
7428	7429	.	0	None

7430	7431	Results	0	None
7431	7432	presented	0	None
7432	7433	here	0	None
7433	7434	show	0	None
7434	7435	that	0	None
7435	7437	bile acids	3	CHEMICAL
7437	7438	are	0	None
7438	7439	physiological	0	None
7439	7440	ligands	0	None
7440	7441	for	0	None
7441	7442	the	0	None
7442	7443	farnesoid	0	None
7443	7444	X	0	None
7444	7445	receptor	0	None
7445	7446	(	0	None
7446	7447	FXR	0	None
7447	7448	)	0	None
7448	7449	,	0	None
7449	7450	an	0	None
7450	7453	orphan nuclear receptor	2	GENE-N
7453	7454	.	0	None

7455	7456	When	0	None
7456	7457	bound	0	None
7457	7458	to	0	None
7458	7460	bile acids	3	CHEMICAL
7460	7461	,	0	None
7461	7462	FXR	0	None
7462	7463	repressed	0	None
7463	7464	transcription	0	None
7464	7465	of	0	None
7465	7466	the	0	None
7466	7467	gene	0	None
7467	7468	encoding	0	None
7468	7470	cholesterol 7alpha	3	CHEMICAL
7470	7471	-	0	None
7471	7472	hydroxylase	0	None
7472	7473	,	0	None
7473	7474	which	0	None
7474	7475	is	0	None
7475	7476	the	0	None
7476	7477	rate	0	None
7477	7478	-	0	None
7478	7479	limiting	0	None
7479	7480	enzyme	0	None
7480	7481	in	0	None
7481	7483	bile acid	3	CHEMICAL
7483	7484	synthesis	0	None
7484	7485	,	0	None
7485	7486	and	0	None
7486	7487	activated	0	None
7487	7488	the	0	None
7488	7489	gene	0	None
7489	7490	encoding	0	None
7490	7493	intestinal bile acid	3	CHEMICAL
7493	7494	-	0	None
7494	7495	binding	0	None
7495	7496	protein	0	None
7496	7497	,	0	None
7497	7498	which	0	None
7498	7499	is	0	None
7499	7500	a	0	None
7500	7501	candidate	0	None
7501	7504	bile acid transporter	2	GENE-N
7504	7505	.	0	None

7506	7507	These	0	None
7507	7508	results	0	None
7508	7509	demonstrate	0	None
7509	7510	a	0	None
7510	7511	mechanism	0	None
7511	7512	by	0	None
7512	7513	which	0	None
7513	7515	bile acids	3	CHEMICAL
7515	7516	transcriptionally	0	None
7516	7517	regulate	0	None
7517	7518	their	0	None
7518	7519	biosynthesis	0	None
7519	7520	and	0	None
7520	7521	enterohepatic	0	None
7521	7522	transport	0	None
7522	7523	.	0	None

7524	7525	Inhibition	0	None
7525	7526	of	0	None
7526	7527	cPLA2	1	GENE-Y
7527	7528	translocation	0	None
7528	7529	and	0	None
7529	7531	leukotriene C4	3	CHEMICAL
7531	7532	secretion	0	None
7532	7533	by	0	None
7533	7535	fluticasone propionate	3	CHEMICAL
7535	7536	in	0	None
7536	7537	exogenously	0	None
7537	7538	activated	0	None
7538	7539	human	0	None
7539	7540	eosinophils	0	None
7540	7541	.	0	None

7542	7543	We	0	None
7543	7544	examined	0	None
7544	7545	the	0	None
7545	7546	effect	0	None
7546	7547	of	0	None
7547	7548	the	0	None
7548	7549	highly	0	None
7549	7550	lipophilic	0	None
7550	7551	corticosteroid	3	CHEMICAL
7551	7552	,	0	None
7552	7554	fluticasone propionate	3	CHEMICAL
7554	7555	(	0	None
7555	7556	FP	3	CHEMICAL
7556	7557	)	0	None
7557	7558	,	0	None
7558	7559	in	0	None
7559	7560	causing	0	None
7560	7561	(	0	None
7561	7562	1	0	None
7562	7563	)	0	None
7563	7564	inhibition	0	None
7564	7565	of	0	None
7565	7566	nuclear	0	None
7566	7567	translocation	0	None
7567	7568	of	0	None
7568	7569	cytosolic	0	None
7569	7571	phospholipase A2	2	GENE-N
7571	7572	(	0	None
7572	7573	cPLA2	1	GENE-Y
7573	7574	)	0	None
7574	7575	,	0	None
7575	7576	and	0	None
7576	7577	(	0	None
7577	7578	2	0	None
7578	7579	)	0	None
7579	7580	blockade	0	None
7580	7581	of	0	None
7581	7583	leukotriene C4	3	CHEMICAL
7583	7584	(	0	None
7584	7585	LTC4	0	None
7585	7586	)	0	None
7586	7587	synthesis	0	None
7587	7588	in	0	None
7588	7589	isolated	0	None
7589	7590	human	0	None
7590	7591	eosinophils	0	None
7591	7592	in	0	None
7592	7593	vitro	0	None
7593	7594	.	0	None

7595	7596	Eosinophils	0	None
7596	7597	were	0	None
7597	7598	isolated	0	None
7598	7599	from	0	None
7599	7600	peripheral	0	None
7600	7601	blood	0	None
7601	7602	,	0	None
7602	7603	treated	0	None
7603	7604	with	0	None
7604	7605	either	0	None
7605	7606	buffer	0	None
7606	7607	or	0	None
7607	7608	10	0	None
7608	7609	(	0	None
7609	7610	-	0	None
7610	7611	)	0	None
7611	7612	10	0	None
7612	7613	M	0	None
7613	7614	to	0	None
7614	7615	10	0	None
7615	7616	(	0	None
7616	7617	-	0	None
7617	7618	)	0	None
7618	7619	6	0	None
7619	7620	M	0	None
7620	7621	FP	3	CHEMICAL
7621	7622	in	0	None
7622	7623	the	0	None
7623	7624	presence	0	None
7624	7625	of	0	None
7625	7626	10	0	None
7626	7627	pg	3	CHEMICAL
7627	7628	/	0	None
7628	7629	ml	0	None
7629	7632	human recombinant interleukin	1	GENE-Y
7632	7633	-	0	None
7633	7634	5	0	None
7634	7635	(	0	None
7635	7636	rhIL	0	None
7636	7637	-	0	None
7637	7638	5	0	None
7638	7639	)	0	None
7639	7640	and	0	None
7640	7641	activated	0	None
7641	7642	with	0	None
7642	7643	formyl	3	CHEMICAL
7643	7644	-	0	None
7644	7645	met	3	CHEMICAL
7645	7646	-	0	None
7646	7647	leu	3	CHEMICAL
7647	7648	-	0	None
7648	7649	phe	0	None
7649	7650	(	0	None
7650	7651	FMLP	0	None
7651	7652	)	0	None
7652	7653	+	0	None
7653	7654	cytochalasin	0	None
7654	7655	B	0	None
7655	7656	(	0	None
7656	7657	CB	3	CHEMICAL
7657	7658	)	0	None
7658	7659	.	0	None

7660	7661	At	0	None
7661	7662	24	0	None
7662	7663	h	0	None
7663	7664	,	0	None
7664	7665	stimulated	0	None
7665	7666	LTC4	0	None
7666	7667	secretion	0	None
7667	7668	from	0	None
7668	7669	eosinophils	0	None
7669	7670	was	0	None
7670	7671	unchanged	0	None
7671	7672	;	0	None
7672	7673	however	0	None
7673	7674	,	0	None
7674	7675	when	0	None
7675	7676	corrected	0	None
7676	7677	for	0	None
7677	7678	cell	0	None
7678	7679	viability	0	None
7679	7680	,	0	None
7680	7681	LTC4	0	None
7681	7682	secretion	0	None
7682	7683	decreased	0	None
7683	7684	from	0	None
7684	7685	1	0	None
7685	7686	,	0	None
7686	7687	429	0	None
7687	7688	+	0	None
7688	7689	/	0	None
7689	7690	-	0	None
7690	7691	327	0	None
7691	7692	pg	3	CHEMICAL
7692	7693	/	0	None
7693	7694	10	0	None
7694	7695	(	0	None
7695	7696	6	0	None
7696	7697	)	0	None
7697	7698	cells	0	None
7698	7699	to	0	None
7699	7700	762	0	None
7700	7701	+	0	None
7701	7702	/	0	None
7702	7703	-	0	None
7703	7704	113	0	None
7704	7705	pg	3	CHEMICAL
7705	7706	/	0	None
7706	7707	10	0	None
7707	7708	(	0	None
7708	7709	6	0	None
7709	7710	)	0	None
7710	7711	cells	0	None
7711	7712	for	0	None
7712	7713	eosinophils	0	None
7713	7714	treated	0	None
7714	7715	for	0	None
7715	7716	48	0	None
7716	7717	h	0	None
7717	7718	with	0	None
7718	7719	>	0	None
7719	7720	/	0	None
7720	7721	=	0	None
7721	7722	10	0	None
7722	7723	(	0	None
7723	7724	-	0	None
7724	7725	)	0	None
7725	7726	8	0	None
7726	7727	M	0	None
7727	7728	FP	3	CHEMICAL
7728	7729	(	0	None
7729	7730	p	0	None
7730	7731	<	0	None
7731	7732	0	0	None
7732	7733	.	0	None
7733	7734	003	0	None
7734	7735	)	0	None
7735	7736	.	0	None

7737	7738	FMLP	0	None
7738	7739	/	0	None
7739	7740	CB	3	CHEMICAL
7740	7741	-	0	None
7741	7742	stimulated	0	None
7742	7743	translocation	0	None
7743	7744	of	0	None
7744	7745	cPLA2	1	GENE-Y
7745	7746	to	0	None
7746	7747	the	0	None
7747	7748	nuclear	0	None
7748	7749	envelope	0	None
7749	7750	assessed	0	None
7750	7751	by	0	None
7751	7752	specific	0	None
7752	7753	immunohistochemical	0	None
7753	7754	staining	0	None
7754	7755	also	0	None
7755	7756	was	0	None
7756	7757	blocked	0	None
7757	7758	by	0	None
7758	7759	FP	3	CHEMICAL
7759	7760	.	0	None

7761	7762	By	0	None
7762	7763	contrast	0	None
7763	7764	,	0	None
7764	7765	membrane	0	None
7765	7766	expression	0	None
7766	7767	of	0	None
7767	7768	annexin	0	None
7768	7769	-	0	None
7769	7770	1	0	None
7770	7771	,	0	None
7771	7772	which	0	None
7772	7773	was	0	None
7773	7774	not	0	None
7774	7775	minimal	0	None
7775	7776	at	0	None
7776	7777	30	0	None
7777	7778	min	0	None
7778	7779	,	0	None
7779	7780	was	0	None
7780	7781	substantial	0	None
7781	7782	at	0	None
7782	7783	48	0	None
7783	7784	h	0	None
7784	7785	for	0	None
7785	7786	eosinophils	0	None
7786	7787	treated	0	None
7787	7788	with	0	None
7788	7789	>	0	None
7789	7790	10	0	None
7790	7791	(	0	None
7791	7792	-	0	None
7792	7793	)	0	None
7793	7794	10	0	None
7794	7795	M	0	None
7795	7796	FP	3	CHEMICAL
7796	7797	,	0	None
7797	7798	and	0	None
7798	7799	inhibition	0	None
7799	7800	of	0	None
7800	7801	LTC4	0	None
7801	7802	synthesis	0	None
7802	7803	was	0	None
7803	7804	reversed	0	None
7804	7805	by	0	None
7805	7806	exogenous	0	None
7806	7808	arachidonic acid	3	CHEMICAL
7808	7809	(	0	None
7809	7810	AA	3	CHEMICAL
7810	7811	)	0	None
7811	7812	.	0	None

7813	7814	We	0	None
7814	7815	find	0	None
7815	7816	that	0	None
7816	7817	FP	3	CHEMICAL
7817	7818	causes	0	None
7818	7819	a	0	None
7819	7820	decrease	0	None
7820	7821	in	0	None
7821	7822	stimulated	0	None
7822	7823	eosinophil	0	None
7823	7824	secretion	0	None
7824	7825	of	0	None
7825	7826	LTC4	0	None
7826	7827	that	0	None
7827	7828	is	0	None
7828	7829	regulated	0	None
7829	7830	by	0	None
7830	7832	phospholipase A2	2	GENE-N
7832	7833	(	0	None
7833	7834	PLA2	0	None
7834	7835	)	0	None
7835	7836	.	0	None

7837	7838	Inhibition	0	None
7838	7839	of	0	None
7839	7840	LTC4	0	None
7840	7841	synthesis	0	None
7841	7842	precedes	0	None
7842	7843	the	0	None
7843	7844	global	0	None
7844	7845	cytotoxic	0	None
7845	7846	effects	0	None
7846	7847	of	0	None
7847	7848	FP	3	CHEMICAL
7848	7849	as	0	None
7849	7850	indicated	0	None
7850	7851	by	0	None
7851	7852	the	0	None
7852	7853	simultaneous	0	None
7853	7854	upregulation	0	None
7854	7855	of	0	None
7855	7856	annexin	0	None
7856	7857	-	0	None
7857	7858	1	0	None
7858	7859	expression	0	None
7859	7860	.	0	None

7861	7862	Inhibited	0	None
7862	7863	stimulated	0	None
7863	7864	secretion	0	None
7864	7865	corresponds	0	None
7865	7866	to	0	None
7866	7867	inhibited	0	None
7867	7868	translocation	0	None
7868	7869	of	0	None
7869	7870	cPLA2	1	GENE-Y
7870	7871	to	0	None
7871	7872	the	0	None
7872	7873	nuclear	0	None
7873	7874	envelope	0	None
7874	7875	during	0	None
7875	7876	cellular	0	None
7876	7877	activation	0	None
7877	7878	.	0	None

7879	7880	Hyperammonemia	0	None
7880	7881	:	0	None
7881	7882	regulation	0	None
7882	7883	of	0	None
7883	7885	argininosuccinate synthetase	1	GENE-Y
7885	7886	and	0	None
7886	7887	argininosuccinate	0	None
7887	7888	lyase	0	None
7888	7889	genes	0	None
7889	7890	in	0	None
7890	7891	aggregating	0	None
7891	7892	cell	0	None
7892	7893	cultures	0	None
7893	7894	of	0	None
7894	7895	fetal	0	None
7895	7896	rat	0	None
7896	7897	brain	0	None
7897	7898	.	0	None

7899	7900	Hyperammonemia	0	None
7900	7901	in	0	None
7901	7902	the	0	None
7902	7903	brain	0	None
7903	7904	leads	0	None
7904	7905	to	0	None
7905	7906	poorly	0	None
7906	7907	understood	0	None
7907	7908	alterations	0	None
7908	7909	of	0	None
7909	7911	nitric oxide	3	CHEMICAL
7911	7912	(	0	None
7912	7913	NO	0	None
7913	7914	)	0	None
7914	7915	synthesis	0	None
7915	7916	.	0	None

7917	7918	Arginine	0	None
7918	7919	,	0	None
7919	7920	the	0	None
7920	7921	substrate	0	None
7921	7922	of	0	None
7922	7925	nitric oxide synthases	2	GENE-N
7925	7926	,	0	None
7926	7927	might	0	None
7927	7928	be	0	None
7928	7929	recycled	0	None
7929	7930	from	0	None
7930	7931	the	0	None
7931	7932	citrulline	0	None
7932	7933	produced	0	None
7933	7934	with	0	None
7934	7935	NO	0	None
7935	7936	by	0	None
7936	7938	argininosuccinate synthetase	1	GENE-Y
7938	7939	(	0	None
7939	7940	AS	0	None
7940	7941	)	0	None
7941	7942	and	0	None
7942	7943	argininosuccinate	0	None
7943	7944	lyase	0	None
7944	7945	(	0	None
7945	7946	AL	1	GENE-Y
7946	7947	)	0	None
7947	7948	.	0	None

7949	7950	The	0	None
7950	7951	regulation	0	None
7951	7952	of	0	None
7952	7953	AS	0	None
7953	7954	and	0	None
7954	7955	AL	2	GENE-N
7955	7956	genes	0	None
7956	7957	during	0	None
7957	7958	hyperammonemia	0	None
7958	7959	is	0	None
7959	7960	unknown	0	None
7960	7961	in	0	None
7961	7962	the	0	None
7962	7963	brain	0	None
7963	7964	.	0	None

7965	7966	We	0	None
7966	7967	used	0	None
7967	7968	brain	0	None
7968	7969	cell	0	None
7969	7970	aggregates	0	None
7970	7971	cultured	0	None
7971	7972	from	0	None
7972	7973	dissociated	0	None
7973	7974	telencephalic	0	None
7974	7975	cortex	0	None
7975	7976	of	0	None
7976	7977	rat	0	None
7977	7978	embryos	0	None
7978	7979	to	0	None
7979	7980	analyze	0	None
7980	7981	the	0	None
7981	7982	regulation	0	None
7982	7983	of	0	None
7983	7984	AS	0	None
7984	7985	and	0	None
7985	7986	AL	1	GENE-Y
7986	7987	genes	0	None
7987	7988	in	0	None
7988	7989	hyperammonemia	0	None
7989	7990	.	0	None

7991	7992	Using	0	None
7992	7993	RNase	0	None
7993	7994	protection	0	None
7994	7995	assay	0	None
7995	7996	and	0	None
7996	7997	non	0	None
7997	7998	-	0	None
7998	7999	radioactive	0	None
7999	8000	in	0	None
8000	8001	situ	0	None
8001	8002	hybridization	0	None
8002	8003	on	0	None
8003	8004	aggregate	0	None
8004	8005	cryosections	0	None
8005	8006	,	0	None
8006	8007	we	0	None
8007	8008	show	0	None
8008	8009	that	0	None
8009	8010	both	0	None
8010	8011	AS	0	None
8011	8012	and	0	None
8012	8013	AL	2	GENE-N
8013	8014	genes	0	None
8014	8015	are	0	None
8015	8016	induced	0	None
8016	8017	in	0	None
8017	8018	astrocytes	0	None
8018	8019	but	0	None
8019	8020	not	0	None
8020	8021	in	0	None
8021	8022	neurons	0	None
8022	8023	of	0	None
8023	8024	aggregates	0	None
8024	8025	exposed	0	None
8025	8026	to	0	None
8026	8027	5	0	None
8027	8028	mM	0	None
8028	8029	NH4Cl	0	None
8029	8030	.	0	None

8031	8032	Our	0	None
8032	8033	work	0	None
8033	8034	suggests	0	None
8034	8035	that	0	None
8035	8036	the	0	None
8036	8037	hyperammonemic	0	None
8037	8038	brain	0	None
8038	8039	might	0	None
8039	8040	increase	0	None
8040	8041	its	0	None
8041	8042	recycling	0	None
8042	8043	of	0	None
8043	8044	citrulline	0	None
8044	8045	to	0	None
8045	8046	arginine	3	CHEMICAL
8046	8047	.	0	None

8048	8049	Reduced	0	None
8049	8050	satiating	0	None
8050	8051	effect	0	None
8051	8052	of	0	None
8052	8053	d	0	None
8053	8054	-	0	None
8054	8055	fenfluramine	3	CHEMICAL
8055	8056	in	0	None
8056	8057	serotonin	3	CHEMICAL
8057	8058	5	0	None
8058	8059	-	0	None
8059	8060	HT	3	CHEMICAL
8060	8061	(	0	None
8061	8062	2C	0	None
8062	8063	)	0	None
8063	8064	receptor	0	None
8064	8065	mutant	0	None
8065	8066	mice	0	None
8066	8067	.	0	None

8068	8069	RATIONALE	0	None
8069	8070	:	0	None
8070	8071	d	0	None
8071	8072	-	0	None
8072	8073	Fenfluramine	0	None
8073	8074	stimulates	0	None
8074	8075	the	0	None
8075	8076	release	0	None
8076	8077	of	0	None
8077	8078	serotonin	3	CHEMICAL
8078	8079	(	0	None
8079	8080	5	0	None
8080	8081	-	0	None
8081	8082	HT	3	CHEMICAL
8082	8083	)	0	None
8083	8084	and	0	None
8084	8085	is	0	None
8085	8086	a	0	None
8086	8087	potent	0	None
8087	8088	inhibitor	0	None
8088	8089	of	0	None
8089	8090	the	0	None
8090	8091	re	0	None
8091	8092	-	0	None
8092	8093	uptake	0	None
8093	8094	of	0	None
8094	8095	5	0	None
8095	8096	-	0	None
8096	8097	HT	3	CHEMICAL
8097	8098	into	0	None
8098	8099	nerve	0	None
8099	8100	terminals	0	None
8100	8101	.	0	None

8102	8103	Administration	0	None
8103	8104	of	0	None
8104	8105	d	0	None
8105	8106	-	0	None
8106	8107	fenfluramine	3	CHEMICAL
8107	8108	suppresses	0	None
8108	8109	food	0	None
8109	8110	intake	0	None
8110	8111	in	0	None
8111	8112	both	0	None
8112	8113	animals	0	None
8113	8114	and	0	None
8114	8115	humans	0	None
8115	8116	.	0	None

8117	8118	OBJECTIVE	0	None
8118	8119	:	0	None
8119	8120	We	0	None
8120	8121	have	0	None
8121	8122	investigated	0	None
8122	8123	the	0	None
8123	8124	role	0	None
8124	8125	of	0	None
8125	8126	the	0	None
8126	8127	5	0	None
8127	8128	-	0	None
8128	8129	HT2C	0	None
8129	8130	receptor	0	None
8130	8131	in	0	None
8131	8132	mediating	0	None
8132	8133	the	0	None
8133	8134	effect	0	None
8134	8135	of	0	None
8135	8136	d	0	None
8136	8137	-	0	None
8137	8138	fenfluramine	3	CHEMICAL
8138	8139	on	0	None
8139	8140	mouse	0	None
8140	8141	food	0	None
8141	8142	intake	0	None
8142	8143	and	0	None
8143	8144	the	0	None
8144	8145	behavioural	0	None
8145	8146	satiety	0	None
8146	8147	sequence	0	None
8147	8148	.	0	None

8149	8150	METHODS	0	None
8150	8151	:	0	None
8151	8152	Mutant	0	None
8152	8153	mice	0	None
8153	8154	lacking	0	None
8154	8155	serotonin	3	CHEMICAL
8155	8156	5	0	None
8156	8157	-	0	None
8157	8158	HT2C	0	None
8158	8159	receptors	0	None
8159	8160	and	0	None
8160	8161	wild	0	None
8161	8162	-	0	None
8162	8163	type	0	None
8163	8164	animals	0	None
8164	8165	were	0	None
8165	8166	habituated	0	None
8166	8167	to	0	None
8167	8168	a	0	None
8168	8169	daily	0	None
8169	8170	presentation	0	None
8170	8171	of	0	None
8171	8172	wet	0	None
8172	8173	mash	0	None
8173	8174	.	0	None

8175	8176	Animals	0	None
8176	8177	were	0	None
8177	8178	non	0	None
8178	8179	-	0	None
8179	8180	deprived	0	None
8180	8181	and	0	None
8181	8182	received	0	None
8182	8183	d	0	None
8183	8184	-	0	None
8184	8185	fenfluramine	3	CHEMICAL
8185	8186	(	0	None
8186	8187	3	0	None
8187	8188	-	0	None
8188	8189	30	0	None
8189	8190	mg	0	None
8190	8191	/	0	None
8191	8192	kg	0	None
8192	8193	)	0	None
8193	8194	30	0	None
8194	8195	min	0	None
8195	8196	prior	0	None
8196	8197	to	0	None
8197	8198	being	0	None
8198	8199	assessed	0	None
8199	8200	for	0	None
8200	8201	the	0	None
8201	8202	presence	0	None
8202	8203	of	0	None
8203	8204	stereotypy	0	None
8204	8205	and	0	None
8205	8206	presented	0	None
8206	8207	with	0	None
8207	8208	wet	0	None
8208	8209	mash	0	None
8209	8210	.	0	None

8211	8212	The	0	None
8212	8213	behaviour	0	None
8213	8214	of	0	None
8214	8215	animals	0	None
8215	8216	was	0	None
8216	8217	observed	0	None
8217	8218	for	0	None
8218	8219	the	0	None
8219	8220	subsequent	0	None
8220	8221	40	0	None
8221	8222	min	0	None
8222	8223	and	0	None
8223	8224	food	0	None
8224	8225	intake	0	None
8225	8226	was	0	None
8226	8227	recorded	0	None
8227	8228	.	0	None

8229	8230	RESULTS	0	None
8230	8231	:	0	None
8231	8232	d	0	None
8232	8233	-	0	None
8233	8234	Fenfluramine	0	None
8234	8235	dose	0	None
8235	8236	-	0	None
8236	8237	dependently	0	None
8237	8238	inhibited	0	None
8238	8239	the	0	None
8239	8240	consumption	0	None
8240	8241	of	0	None
8241	8242	a	0	None
8242	8243	palatable	0	None
8243	8244	wet	0	None
8244	8245	mash	0	None
8245	8246	by	0	None
8246	8247	the	0	None
8247	8248	mice	0	None
8248	8249	.	0	None

8250	8251	d	0	None
8251	8252	-	0	None
8252	8253	Fenfluramine	0	None
8253	8254	(	0	None
8254	8255	3	0	None
8255	8256	mg	0	None
8256	8257	/	0	None
8257	8258	kg	0	None
8258	8259	)	0	None
8259	8260	significantly	0	None
8260	8261	reduced	0	None
8261	8262	the	0	None
8262	8263	amount	0	None
8263	8264	of	0	None
8264	8265	wet	0	None
8265	8266	mash	0	None
8266	8267	consumed	0	None
8267	8268	by	0	None
8268	8269	wild	0	None
8269	8270	-	0	None
8270	8271	type	0	None
8271	8272	mice	0	None
8272	8273	and	0	None
8273	8274	induced	0	None
8274	8275	a	0	None
8275	8276	temporal	0	None
8276	8277	advance	0	None
8277	8278	in	0	None
8278	8279	the	0	None
8279	8280	behavioural	0	None
8280	8281	satiety	0	None
8281	8282	sequence	0	None
8282	8283	consistent	0	None
8283	8284	with	0	None
8284	8285	an	0	None
8285	8286	enhancement	0	None
8286	8287	of	0	None
8287	8288	satiety	0	None
8288	8289	.	0	None

8290	8291	Mutant	0	None
8291	8292	mice	0	None
8292	8293	were	0	None
8293	8294	less	0	None
8294	8295	sensitive	0	None
8295	8296	to	0	None
8296	8297	the	0	None
8297	8298	satiating	0	None
8298	8299	effects	0	None
8299	8300	of	0	None
8300	8301	3	0	None
8301	8302	mg	0	None
8302	8303	/	0	None
8303	8304	kg	0	None
8304	8305	d	0	None
8305	8306	-	0	None
8306	8307	fenfluramine	3	CHEMICAL
8307	8308	.	0	None

8309	8310	Hence	0	None
8310	8311	,	0	None
8311	8312	this	0	None
8312	8313	dose	0	None
8313	8314	of	0	None
8314	8315	d	0	None
8315	8316	-	0	None
8316	8317	fenfluramine	3	CHEMICAL
8317	8318	had	0	None
8318	8319	a	0	None
8319	8320	reduced	0	None
8320	8321	effect	0	None
8321	8322	on	0	None
8322	8323	both	0	None
8323	8324	food	0	None
8324	8325	consumption	0	None
8325	8326	and	0	None
8326	8327	the	0	None
8327	8328	behavioural	0	None
8328	8329	satiety	0	None
8329	8330	sequence	0	None
8330	8331	in	0	None
8331	8332	the	0	None
8332	8333	5	0	None
8333	8334	-	0	None
8334	8335	HT2C	0	None
8335	8336	mutant	0	None
8336	8337	mice	0	None
8337	8338	.	0	None

8339	8340	In	0	None
8340	8341	contrast	0	None
8341	8342	,	0	None
8342	8343	mutant	0	None
8343	8344	mice	0	None
8344	8345	showed	0	None
8345	8346	an	0	None
8346	8347	increased	0	None
8347	8348	sensitivity	0	None
8348	8349	to	0	None
8349	8350	the	0	None
8350	8351	stereotypy	0	None
8351	8352	induced	0	None
8352	8353	by	0	None
8353	8354	high	0	None
8354	8355	doses	0	None
8355	8356	of	0	None
8356	8357	d	0	None
8357	8358	-	0	None
8358	8359	fenfluramine	3	CHEMICAL
8359	8360	(	0	None
8360	8361	10	0	None
8361	8362	,	0	None
8362	8363	30	0	None
8363	8364	mg	0	None
8364	8365	/	0	None
8365	8366	kg	0	None
8366	8367	)	0	None
8367	8368	compared	0	None
8368	8369	to	0	None
8369	8370	that	0	None
8370	8371	of	0	None
8371	8372	wild	0	None
8372	8373	-	0	None
8373	8374	type	0	None
8374	8375	littermates	0	None
8375	8376	.	0	None

8377	8378	CONCLUSION	0	None
8378	8379	:	0	None
8379	8380	These	0	None
8380	8381	data	0	None
8381	8382	demonstrate	0	None
8382	8383	a	0	None
8383	8384	role	0	None
8384	8385	for	0	None
8385	8386	the	0	None
8386	8387	5	0	None
8387	8388	-	0	None
8388	8389	HT2C	0	None
8389	8390	receptor	0	None
8390	8391	in	0	None
8391	8392	mediating	0	None
8392	8393	d	0	None
8393	8394	-	0	None
8394	8395	fenfluramine	3	CHEMICAL
8395	8396	-	0	None
8396	8397	induced	0	None
8397	8398	satiety	0	None
8398	8399	.	0	None

8400	8401	Role	0	None
8401	8402	of	0	None
8402	8403	acetylcholinesterase	1	GENE-Y
8403	8404	(	0	None
8404	8405	AChE	1	GENE-Y
8405	8406	)	0	None
8406	8407	secreted	0	None
8407	8408	by	0	None
8408	8409	parasitic	0	None
8409	8410	nematodes	0	None
8410	8411	on	0	None
8411	8412	the	0	None
8412	8413	growth	0	None
8413	8414	of	0	None
8414	8415	the	0	None
8415	8416	cell	0	None
8416	8417	line	0	None
8417	8418	from	0	None
8418	8419	epithelial	0	None
8419	8420	origin	0	None
8420	8421	HT29	0	None
8421	8422	-	0	None
8422	8423	D4	0	None
8423	8424	.	0	None

8425	8426	The	0	None
8426	8427	excretory	0	None
8427	8428	-	0	None
8428	8429	secretory	0	None
8429	8430	(	0	None
8430	8431	E	0	None
8431	8432	-	0	None
8432	8433	S	0	None
8433	8434	)	0	None
8434	8435	products	0	None
8435	8436	of	0	None
8436	8437	the	0	None
8437	8438	parasitic	0	None
8438	8439	nematodes	0	None
8439	8440	Trichostrongylus	0	None
8440	8441	colubriformis	0	None
8441	8442	and	0	None
8442	8443	Nematodirus	0	None
8443	8444	battus	0	None
8444	8445	were	0	None
8445	8446	found	0	None
8446	8447	to	0	None
8447	8448	modify	0	None
8448	8449	the	0	None
8449	8450	in	0	None
8450	8451	vitro	0	None
8451	8452	proliferation	0	None
8452	8453	of	0	None
8453	8454	the	0	None
8454	8455	tumorous	0	None
8455	8456	colic	0	None
8456	8457	HT29	0	None
8457	8458	-	0	None
8458	8459	D4	0	None
8459	8460	cell	0	None
8460	8461	line	0	None
8461	8462	of	0	None
8462	8463	epithelial	0	None
8463	8464	origin	0	None
8464	8465	.	0	None

8466	8467	A	0	None
8467	8468	characteristic	0	None
8468	8469	feature	0	None
8469	8470	of	0	None
8470	8471	these	0	None
8471	8472	E	0	None
8472	8473	-	0	None
8473	8474	S	0	None
8474	8475	products	0	None
8475	8476	is	0	None
8476	8477	the	0	None
8477	8478	presence	0	None
8478	8479	of	0	None
8479	8480	a	0	None
8480	8481	high	0	None
8481	8482	level	0	None
8482	8483	of	0	None
8483	8484	acetylcholinesterase	1	GENE-Y
8484	8485	(	0	None
8485	8486	AChE	1	GENE-Y
8486	8487	)	0	None
8487	8488	activity	0	None
8488	8489	,	0	None
8489	8490	the	0	None
8490	8491	biological	0	None
8491	8492	significance	0	None
8492	8493	of	0	None
8493	8494	which	0	None
8494	8495	remains	0	None
8495	8496	unclear	0	None
8496	8497	.	0	None

8498	8499	To	0	None
8499	8500	determine	0	None
8500	8501	a	0	None
8501	8502	possible	0	None
8502	8503	role	0	None
8503	8504	of	0	None
8504	8505	AChE	1	GENE-Y
8505	8506	on	0	None
8506	8507	cell	0	None
8507	8508	growth	0	None
8508	8509	,	0	None
8509	8510	the	0	None
8510	8511	enzyme	0	None
8511	8512	was	0	None
8512	8513	purified	0	None
8513	8514	from	0	None
8514	8515	E	0	None
8515	8516	-	0	None
8516	8517	S	0	None
8517	8518	products	0	None
8518	8519	using	0	None
8519	8521	edrophonium chloride	3	CHEMICAL
8521	8522	.	0	None

8523	8524	Purity	0	None
8524	8525	was	0	None
8525	8526	confirmed	0	None
8526	8527	by	0	None
8527	8528	polyacrylamide	3	CHEMICAL
8528	8529	gel	0	None
8529	8530	electrophoresis	0	None
8530	8531	,	0	None
8531	8532	using	0	None
8532	8533	silver	0	None
8533	8534	and	0	None
8534	8535	Karnovsky	0	None
8535	8536	stains	0	None
8536	8537	,	0	None
8537	8538	before	0	None
8538	8539	assessing	0	None
8539	8540	its	0	None
8540	8541	effects	0	None
8541	8542	on	0	None
8542	8543	cell	0	None
8543	8544	proliferation	0	None
8544	8545	.	0	None

8546	8547	The	0	None
8547	8548	purified	0	None
8548	8549	AChE	1	GENE-Y
8549	8550	was	0	None
8550	8551	incorporated	0	None
8551	8552	at	0	None
8552	8553	different	0	None
8553	8554	concentrations	0	None
8554	8555	in	0	None
8555	8556	a	0	None
8556	8557	culture	0	None
8557	8558	medium	0	None
8558	8559	of	0	None
8559	8560	HT29	0	None
8560	8561	-	0	None
8561	8562	D4	0	None
8562	8563	cells	0	None
8563	8564	.	0	None

8565	8566	A	0	None
8566	8567	mitogenic	0	None
8567	8568	effect	0	None
8568	8569	was	0	None
8569	8570	shown	0	None
8570	8571	for	0	None
8571	8572	low	0	None
8572	8573	concentrations	0	None
8573	8574	(	0	None
8574	8575	0	0	None
8575	8576	.	0	None
8576	8577	1	0	None
8577	8578	-	0	None
8578	8579	14	0	None
8579	8580	units	0	None
8580	8581	)	0	None
8581	8582	.	0	None

8583	8584	By	0	None
8584	8585	contrast	0	None
8585	8586	,	0	None
8586	8587	an	0	None
8587	8588	inhibitory	0	None
8588	8589	effect	0	None
8589	8590	was	0	None
8590	8591	noted	0	None
8591	8592	at	0	None
8592	8593	high	0	None
8593	8594	concentrations	0	None
8594	8595	(	0	None
8595	8596	35	0	None
8596	8597	-	0	None
8597	8598	1400	0	None
8598	8599	units	0	None
8599	8600	)	0	None
8600	8601	.	0	None

8602	8603	Furthermore	0	None
8603	8604	,	0	None
8604	8605	polyclonal	0	None
8605	8606	antibodies	0	None
8606	8607	were	0	None
8607	8608	prepared	0	None
8608	8609	and	0	None
8609	8610	depletion	0	None
8610	8611	of	0	None
8611	8612	AChE	1	GENE-Y
8612	8613	in	0	None
8613	8614	E	0	None
8614	8615	-	0	None
8615	8616	S	0	None
8616	8617	products	0	None
8617	8618	by	0	None
8618	8619	immunoprecipitation	0	None
8619	8620	or	0	None
8620	8621	affinity	0	None
8621	8622	chromatography	0	None
8622	8623	resulted	0	None
8623	8624	in	0	None
8624	8625	a	0	None
8625	8626	partial	0	None
8626	8627	or	0	None
8627	8628	total	0	None
8628	8629	disappearance	0	None
8629	8630	of	0	None
8630	8631	the	0	None
8631	8632	stimulatory	0	None
8632	8633	effect	0	None
8633	8634	of	0	None
8634	8635	cell	0	None
8635	8636	growth	0	None
8636	8637	.	0	None

8638	8639	Thus	0	None
8639	8640	,	0	None
8640	8641	the	0	None
8641	8642	results	0	None
8642	8643	form	0	None
8643	8644	this	0	None
8644	8645	in	0	None
8645	8646	vitro	0	None
8646	8647	study	0	None
8647	8648	suggest	0	None
8648	8649	a	0	None
8649	8650	modulatory	0	None
8650	8651	role	0	None
8651	8652	for	0	None
8652	8653	AChE	1	GENE-Y
8653	8654	secreted	0	None
8654	8655	by	0	None
8655	8656	nematode	0	None
8656	8657	parasites	0	None
8657	8658	on	0	None
8658	8659	the	0	None
8659	8660	proliferation	0	None
8660	8661	of	0	None
8661	8662	epithelial	0	None
8662	8663	cells	0	None
8663	8664	of	0	None
8664	8665	the	0	None
8665	8666	host	0	None
8666	8667	.	0	None

8668	8669	Methimazole	0	None
8669	8670	and	0	None
8670	8671	propylthiouracil	3	CHEMICAL
8671	8672	increase	0	None
8672	8673	cellular	0	None
8673	8675	thyroid peroxidase	2	GENE-N
8675	8676	activity	0	None
8676	8677	and	0	None
8677	8679	thyroid peroxidase	2	GENE-N
8679	8680	mRNA	0	None
8680	8681	in	0	None
8681	8682	cultured	0	None
8682	8683	porcine	0	None
8683	8684	thyroid	0	None
8684	8685	follicles	0	None
8685	8686	.	0	None

8687	8688	Methimazole	0	None
8688	8689	(	0	None
8689	8690	MMI	3	CHEMICAL
8690	8691	)	0	None
8691	8692	and	0	None
8692	8693	propylthiouracil	3	CHEMICAL
8693	8694	(	0	None
8694	8695	PTU	3	CHEMICAL
8695	8696	)	0	None
8696	8697	are	0	None
8697	8698	common	0	None
8698	8699	antithyroid	0	None
8699	8700	drugs	0	None
8700	8701	for	0	None
8701	8702	treating	0	None
8702	8703	hyperthyroidism	0	None
8703	8704	because	0	None
8704	8705	the	0	None
8705	8706	2	0	None
8706	8707	drugs	0	None
8707	8708	inhibit	0	None
8708	8710	thyroid peroxidase	2	GENE-N
8710	8711	(	0	None
8711	8712	TPO	0	None
8712	8713	)	0	None
8713	8714	-	0	None
8714	8715	catalyzed	0	None
8715	8717	thyroid hormone	1	GENE-Y
8717	8718	formation	0	None
8718	8719	.	0	None

8720	8721	We	0	None
8721	8722	studied	0	None
8722	8723	whether	0	None
8723	8724	the	0	None
8724	8725	2	0	None
8725	8726	drugs	0	None
8726	8727	actually	0	None
8727	8728	inhibit	0	None
8728	8729	cellular	0	None
8729	8730	TPO	0	None
8730	8731	activity	0	None
8731	8732	in	0	None
8732	8733	cultured	0	None
8733	8734	porcine	0	None
8734	8735	follicles	0	None
8735	8736	.	0	None

8737	8738	Porcine	0	None
8738	8739	follicles	0	None
8739	8740	were	0	None
8740	8741	cultured	0	None
8741	8742	in	0	None
8742	8743	the	0	None
8743	8744	presence	0	None
8744	8745	of	0	None
8745	8746	1	0	None
8746	8747	mU	0	None
8747	8748	/	0	None
8748	8749	mL	0	None
8749	8750	thyrotropin	3	CHEMICAL
8750	8751	(	0	None
8751	8752	TSH	0	None
8752	8753	)	0	None
8753	8754	for	0	None
8754	8755	7	0	None
8755	8756	days	0	None
8756	8757	.	0	None

8758	8759	Then	0	None
8759	8760	follicles	0	None
8760	8761	were	0	None
8761	8762	exposed	0	None
8762	8763	to	0	None
8763	8764	MMI	3	CHEMICAL
8764	8765	or	0	None
8765	8766	PTU	3	CHEMICAL
8766	8767	in	0	None
8767	8768	the	0	None
8768	8769	presence	0	None
8769	8770	of	0	None
8770	8771	0	0	None
8771	8772	.	0	None
8772	8773	1	0	None
8773	8774	microM	0	None
8774	8775	Kl	0	None
8775	8776	for	0	None
8776	8777	2	0	None
8777	8778	days	0	None
8778	8779	.	0	None

8780	8781	TPO	0	None
8781	8782	activity	0	None
8782	8783	was	0	None
8783	8784	measured	0	None
8784	8785	in	0	None
8785	8786	the	0	None
8786	8787	100	0	None
8787	8788	,	0	None
8788	8789	000	0	None
8789	8790	x	0	None
8790	8791	g	0	None
8791	8792	-	0	None
8792	8793	pellet	0	None
8793	8794	of	0	None
8794	8795	the	0	None
8795	8796	thyroid	0	None
8796	8797	sonicate	0	None
8797	8798	by	0	None
8798	8799	the	0	None
8799	8800	guaiacol	3	CHEMICAL
8800	8801	oxidation	0	None
8801	8802	method	0	None
8802	8803	.	0	None

8804	8805	Exposure	0	None
8805	8806	to	0	None
8806	8807	MMI	3	CHEMICAL
8807	8808	(	0	None
8808	8809	1	0	None
8809	8810	microM	0	None
8810	8811	and	0	None
8811	8812	10	0	None
8812	8813	microM	0	None
8813	8814	)	0	None
8814	8815	or	0	None
8815	8816	PTU	3	CHEMICAL
8816	8817	(	0	None
8817	8818	10	0	None
8818	8819	microM	0	None
8819	8820	and	0	None
8820	8821	100	0	None
8821	8822	microM	0	None
8822	8823	)	0	None
8823	8824	for	0	None
8824	8825	2	0	None
8825	8826	days	0	None
8826	8827	caused	0	None
8827	8828	a	0	None
8828	8829	significant	0	None
8829	8830	increase	0	None
8830	8831	in	0	None
8831	8832	cellular	0	None
8832	8833	TPO	0	None
8833	8834	activity	0	None
8834	8835	;	0	None
8835	8836	100	0	None
8836	8837	microM	0	None
8837	8838	MMI	3	CHEMICAL
8838	8839	inhibited	0	None
8839	8840	cellular	0	None
8840	8841	TPO	0	None
8841	8842	activity	0	None
8842	8843	.	0	None

8844	8845	The	0	None
8845	8846	presence	0	None
8846	8847	of	0	None
8847	8850	cyclic adenosine monophosphate	3	CHEMICAL
8850	8851	(	0	None
8851	8852	cAMP	0	None
8852	8853	)	0	None
8853	8854	-	0	None
8854	8855	generating	0	None
8855	8856	system	0	None
8856	8857	(	0	None
8857	8858	forskolin	3	CHEMICAL
8858	8859	)	0	None
8859	8860	in	0	None
8860	8861	TSH	0	None
8861	8862	-	0	None
8862	8863	free	0	None
8863	8864	medium	0	None
8864	8865	increased	0	None
8865	8866	MMI	3	CHEMICAL
8866	8867	-	0	None
8867	8868	mediated	0	None
8868	8869	TPO	0	None
8869	8870	activity	0	None
8870	8871	.	0	None

8872	8873	Cyclohexamide	3	CHEMICAL
8873	8874	inhibited	0	None
8874	8875	MMI	3	CHEMICAL
8875	8876	-	0	None
8876	8877	mediated	0	None
8877	8878	TPO	0	None
8878	8879	activation	0	None
8879	8880	,	0	None
8880	8881	indicating	0	None
8881	8882	that	0	None
8882	8883	new	0	None
8883	8884	protein	0	None
8884	8885	synthesis	0	None
8885	8886	is	0	None
8886	8887	required	0	None
8887	8888	for	0	None
8888	8889	increased	0	None
8889	8890	TPO	0	None
8890	8891	activity	0	None
8891	8892	.	0	None

8893	8894	Reverse	0	None
8894	8895	transcriptase	0	None
8895	8896	-	0	None
8896	8897	polymerase	2	GENE-N
8897	8898	chain	0	None
8898	8899	reaction	0	None
8899	8900	(	0	None
8900	8901	RT	0	None
8901	8902	-	0	None
8902	8903	PCR	0	None
8903	8904	)	0	None
8904	8905	showed	0	None
8905	8906	an	0	None
8906	8907	increase	0	None
8907	8908	in	0	None
8908	8909	TPO	0	None
8909	8910	mRNA	0	None
8910	8911	by	0	None
8911	8912	PTU	3	CHEMICAL
8912	8913	or	0	None
8913	8914	MMI	3	CHEMICAL
8914	8915	.	0	None

8916	8917	In	0	None
8917	8918	conclusion	0	None
8918	8919	,	0	None
8919	8920	MMI	3	CHEMICAL
8920	8921	and	0	None
8921	8922	PTU	3	CHEMICAL
8922	8923	at	0	None
8923	8924	therapeutic	0	None
8924	8925	concentrations	0	None
8925	8926	can	0	None
8926	8927	increase	0	None
8927	8928	TPO	0	None
8928	8929	mRNA	0	None
8929	8930	and	0	None
8930	8931	cellular	0	None
8931	8932	TPO	0	None
8932	8933	activity	0	None
8933	8934	,	0	None
8934	8935	although	0	None
8935	8936	the	0	None
8936	8937	2	0	None
8937	8938	drugs	0	None
8938	8939	inhibit	0	None
8939	8940	the	0	None
8940	8941	TPO	0	None
8941	8942	-	0	None
8942	8943	H2O2	3	CHEMICAL
8943	8944	-	0	None
8944	8945	mediated	0	None
8945	8946	catalytic	0	None
8946	8947	reaction	0	None
8947	8948	.	0	None

8949	8950	Structure	0	None
8950	8951	of	0	None
8951	8952	acetylcholinesterase	1	GENE-Y
8952	8953	complexed	0	None
8953	8954	with	0	None
8954	8955	E2020	0	None
8955	8956	(	0	None
8956	8957	Aricept	0	None
8957	8958	)	0	None
8958	8959	:	0	None
8959	8960	implications	0	None
8960	8961	for	0	None
8961	8962	the	0	None
8962	8963	design	0	None
8963	8964	of	0	None
8964	8965	new	0	None
8965	8966	anti	0	None
8966	8967	-	0	None
8967	8968	Alzheimer	0	None
8968	8969	drugs	0	None
8969	8970	.	0	None

8971	8972	BACKGROUND	0	None
8972	8973	:	0	None
8973	8974	Several	0	None
8974	8975	cholinesterase	1	GENE-Y
8975	8976	inhibitors	0	None
8976	8977	are	0	None
8977	8978	either	0	None
8978	8979	being	0	None
8979	8980	utilized	0	None
8980	8981	for	0	None
8981	8982	symptomatic	0	None
8982	8983	treatment	0	None
8983	8984	of	0	None
8984	8985	Alzheimer	0	None
8985	8986	'	0	None
8986	8987	s	0	None
8987	8988	disease	0	None
8988	8989	or	0	None
8989	8990	are	0	None
8990	8991	in	0	None
8991	8992	advanced	0	None
8992	8993	clinical	0	None
8993	8994	trials	0	None
8994	8995	.	0	None

8996	8997	E2020	0	None
8997	8998	,	0	None
8998	8999	marketed	0	None
8999	9000	as	0	None
9000	9001	Aricept	0	None
9001	9002	,	0	None
9002	9003	is	0	None
9003	9004	a	0	None
9004	9005	member	0	None
9005	9006	of	0	None
9006	9007	a	0	None
9007	9008	large	0	None
9008	9009	family	0	None
9009	9010	of	0	None
9010	9011	N	0	None
9011	9012	-	0	None
9012	9013	benzylpiperidine	0	None
9013	9014	-	0	None
9014	9015	based	0	None
9015	9016	acetylcholinesterase	1	GENE-Y
9016	9017	(	0	None
9017	9018	AChE	1	GENE-Y
9018	9019	)	0	None
9019	9020	inhibitors	0	None
9020	9021	developed	0	None
9021	9022	,	0	None
9022	9023	synthesized	0	None
9023	9024	and	0	None
9024	9025	evaluated	0	None
9025	9026	by	0	None
9026	9027	the	0	None
9027	9028	Eisai	0	None
9028	9029	Company	0	None
9029	9030	in	0	None
9030	9031	Japan	0	None
9031	9032	.	0	None

9033	9034	These	0	None
9034	9035	inhibitors	0	None
9035	9036	were	0	None
9036	9037	designed	0	None
9037	9038	on	0	None
9038	9039	the	0	None
9039	9040	basis	0	None
9040	9041	of	0	None
9041	9042	QSAR	0	None
9042	9043	studies	0	None
9043	9044	,	0	None
9044	9045	prior	0	None
9045	9046	to	0	None
9046	9047	elucidation	0	None
9047	9048	of	0	None
9048	9049	the	0	None
9049	9050	three	0	None
9050	9051	-	0	None
9051	9052	dimensional	0	None
9052	9053	structure	0	None
9053	9054	of	0	None
9054	9057	Torpedo californica AChE	1	GENE-Y
9057	9058	(	0	None
9058	9059	TcAChE	1	GENE-Y
9059	9060	)	0	None
9060	9061	.	0	None

9062	9063	It	0	None
9063	9064	significantly	0	None
9064	9065	enhances	0	None
9065	9066	performance	0	None
9066	9067	in	0	None
9067	9068	animal	0	None
9068	9069	models	0	None
9069	9070	of	0	None
9070	9071	cholinergic	0	None
9071	9072	hypofunction	0	None
9072	9073	and	0	None
9073	9074	has	0	None
9074	9075	a	0	None
9075	9076	high	0	None
9076	9077	affinity	0	None
9077	9078	for	0	None
9078	9079	AChE	1	GENE-Y
9079	9080	,	0	None
9080	9081	binding	0	None
9081	9082	to	0	None
9082	9083	both	0	None
9083	9085	electric eel	1	GENE-Y
9085	9086	and	0	None
9086	9087	mouse	0	None
9087	9088	AChE	1	GENE-Y
9088	9089	in	0	None
9089	9090	the	0	None
9090	9091	nanomolar	0	None
9091	9092	range	0	None
9092	9093	.	0	None

9094	9095	RESULTS	0	None
9095	9096	:	0	None
9096	9097	Our	0	None
9097	9098	experimental	0	None
9098	9099	structure	0	None
9099	9100	of	0	None
9100	9101	the	0	None
9101	9102	E2020	0	None
9102	9103	-	0	None
9103	9104	TcAChE	1	GENE-Y
9104	9105	complex	0	None
9105	9106	pinpoints	0	None
9106	9107	specific	0	None
9107	9108	interactions	0	None
9108	9109	responsible	0	None
9109	9110	for	0	None
9110	9111	the	0	None
9111	9112	high	0	None
9112	9113	affinity	0	None
9113	9114	and	0	None
9114	9115	selectivity	0	None
9115	9116	demonstrated	0	None
9116	9117	previously	0	None
9117	9118	.	0	None

9119	9120	It	0	None
9120	9121	shows	0	None
9121	9122	that	0	None
9122	9123	E2020	0	None
9123	9124	has	0	None
9124	9125	a	0	None
9125	9126	unique	0	None
9126	9127	orientation	0	None
9127	9128	along	0	None
9128	9129	the	0	None
9129	9130	active	0	None
9130	9131	-	0	None
9131	9132	site	0	None
9132	9133	gorge	0	None
9133	9134	,	0	None
9134	9135	extending	0	None
9135	9136	from	0	None
9136	9137	the	0	None
9137	9138	anionic	0	None
9138	9139	subsite	0	None
9139	9140	of	0	None
9140	9141	the	0	None
9141	9142	active	0	None
9142	9143	site	0	None
9143	9144	,	0	None
9144	9145	at	0	None
9145	9146	the	0	None
9146	9147	bottom	0	None
9147	9148	,	0	None
9148	9149	to	0	None
9149	9150	the	0	None
9150	9151	peripheral	0	None
9151	9152	anionic	0	None
9152	9153	site	0	None
9153	9154	,	0	None
9154	9155	at	0	None
9155	9156	the	0	None
9156	9157	top	0	None
9157	9158	,	0	None
9158	9159	via	0	None
9159	9160	aromatic	3	CHEMICAL
9160	9161	stacking	0	None
9161	9162	interactions	0	None
9162	9163	with	0	None
9163	9164	conserved	0	None
9164	9166	aromatic acid	3	CHEMICAL
9166	9167	residues	0	None
9167	9168	.	0	None

9169	9170	E2020	0	None
9170	9171	does	0	None
9171	9172	not	0	None
9172	9173	,	0	None
9173	9174	however	0	None
9174	9175	,	0	None
9175	9176	interact	0	None
9176	9177	directly	0	None
9177	9178	with	0	None
9178	9179	either	0	None
9179	9180	the	0	None
9180	9181	catalytic	0	None
9181	9182	triad	0	None
9182	9183	or	0	None
9183	9184	the	0	None
9184	9185	'	0	None
9185	9186	oxyanion	0	None
9186	9187	hole	0	None
9187	9188	'	0	None
9188	9189	,	0	None
9189	9190	but	0	None
9190	9191	only	0	None
9191	9192	indirectly	0	None
9192	9193	via	0	None
9193	9194	solvent	0	None
9194	9195	molecules	0	None
9195	9196	.	0	None

9197	9198	CONCLUSIONS	0	None
9198	9199	:	0	None
9199	9200	Our	0	None
9200	9201	study	0	None
9201	9202	shows	0	None
9202	9203	,	0	None
9203	9204	a	0	None
9204	9205	posteriori	0	None
9205	9206	,	0	None
9206	9207	that	0	None
9207	9208	the	0	None
9208	9209	design	0	None
9209	9210	of	0	None
9210	9211	E2020	0	None
9211	9212	took	0	None
9212	9213	advantage	0	None
9213	9214	of	0	None
9214	9215	several	0	None
9215	9216	important	0	None
9216	9217	features	0	None
9217	9218	of	0	None
9218	9219	the	0	None
9219	9220	active	0	None
9220	9221	-	0	None
9221	9222	site	0	None
9222	9223	gorge	0	None
9223	9224	of	0	None
9224	9225	AChE	1	GENE-Y
9225	9226	to	0	None
9226	9227	produce	0	None
9227	9228	a	0	None
9228	9229	drug	0	None
9229	9230	with	0	None
9230	9231	both	0	None
9231	9232	high	0	None
9232	9233	affinity	0	None
9233	9234	for	0	None
9234	9235	AChE	1	GENE-Y
9235	9236	and	0	None
9236	9237	a	0	None
9237	9238	high	0	None
9238	9239	degree	0	None
9239	9240	of	0	None
9240	9241	selectivity	0	None
9241	9242	for	0	None
9242	9243	AChE	1	GENE-Y
9243	9244	versus	0	None
9244	9245	butyrylcholinesterase	1	GENE-Y
9245	9246	(	0	None
9246	9247	BChE	1	GENE-Y
9247	9248	)	0	None
9248	9249	.	0	None

9250	9251	It	0	None
9251	9252	also	0	None
9252	9253	delineates	0	None
9253	9254	voids	0	None
9254	9255	within	0	None
9255	9256	the	0	None
9256	9257	gorge	0	None
9257	9258	that	0	None
9258	9259	are	0	None
9259	9260	not	0	None
9260	9261	occupied	0	None
9261	9262	by	0	None
9262	9263	E2020	0	None
9263	9264	and	0	None
9264	9265	could	0	None
9265	9266	provide	0	None
9266	9267	sites	0	None
9267	9268	for	0	None
9268	9269	potential	0	None
9269	9270	modification	0	None
9270	9271	of	0	None
9271	9272	E2020	0	None
9272	9273	to	0	None
9273	9274	produce	0	None
9274	9275	drugs	0	None
9275	9276	with	0	None
9276	9277	improved	0	None
9277	9278	pharmacological	0	None
9278	9279	profiles	0	None
9279	9280	.	0	None

9281	9282	Maturation	0	None
9282	9283	of	0	None
9283	9284	neuromuscular	0	None
9284	9285	transmission	0	None
9285	9286	during	0	None
9286	9287	early	0	None
9287	9288	development	0	None
9288	9289	in	0	None
9289	9290	zebrafish	0	None
9290	9291	.	0	None

9292	9293	We	0	None
9293	9294	have	0	None
9294	9295	examined	0	None
9295	9296	the	0	None
9296	9297	rapid	0	None
9297	9298	development	0	None
9298	9299	of	0	None
9299	9300	synaptic	0	None
9300	9301	transmission	0	None
9301	9302	at	0	None
9302	9303	the	0	None
9303	9304	neuromuscular	0	None
9304	9305	junction	0	None
9305	9306	(	0	None
9306	9307	NMJ	0	None
9307	9308	)	0	None
9308	9309	in	0	None
9309	9310	zebrafish	0	None
9310	9311	embryos	0	None
9311	9312	and	0	None
9312	9313	larvae	0	None
9313	9314	by	0	None
9314	9315	patch	0	None
9315	9316	-	0	None
9316	9317	clamp	0	None
9317	9318	recording	0	None
9318	9319	of	0	None
9319	9320	spontaneous	0	None
9320	9321	miniature	0	None
9321	9322	endplate	0	None
9322	9323	currents	0	None
9323	9324	(	0	None
9324	9325	mEPCs	0	None
9325	9326	)	0	None
9326	9327	and	0	None
9327	9328	single	0	None
9328	9330	acetylcholine receptor	2	GENE-N
9330	9331	(	0	None
9331	9332	AChR	2	GENE-N
9332	9333	)	0	None
9333	9334	channels	0	None
9334	9335	.	0	None

9336	9337	Embryonic	0	None
9337	9338	(	0	None
9338	9339	24	0	None
9339	9340	-	0	None
9340	9341	36	0	None
9341	9342	h	0	None
9342	9343	)	0	None
9343	9344	mEPCs	0	None
9344	9345	recorded	0	None
9345	9346	in	0	None
9346	9347	vivo	0	None
9347	9348	were	0	None
9348	9349	small	0	None
9349	9350	in	0	None
9350	9351	amplitude	0	None
9351	9352	(	0	None
9352	9353	<	0	None
9353	9354	50	0	None
9354	9355	pA	0	None
9355	9356	)	0	None
9356	9357	.	0	None

9358	9359	The	0	None
9359	9360	rate	0	None
9360	9361	of	0	None
9361	9362	mEPCs	0	None
9362	9363	increased	0	None
9363	9364	in	0	None
9364	9365	larvae	0	None
9365	9366	(	0	None
9366	9367	3	0	None
9367	9368	.	0	None
9368	9369	5	0	None
9369	9370	-	0	None
9370	9371	fold	0	None
9371	9372	increase	0	None
9372	9373	measured	0	None
9373	9374	by	0	None
9374	9375	6	0	None
9375	9376	days	0	None
9376	9377	)	0	None
9377	9378	,	0	None
9378	9379	and	0	None
9379	9380	these	0	None
9380	9381	mEPCs	0	None
9381	9382	were	0	None
9382	9383	mostly	0	None
9383	9384	of	0	None
9384	9385	larger	0	None
9385	9386	amplitude	0	None
9386	9387	(	0	None
9387	9388	10	0	None
9388	9389	-	0	None
9389	9390	fold	0	None
9390	9391	on	0	None
9391	9392	average	0	None
9392	9393	)	0	None
9393	9394	with	0	None
9394	9395	(	0	None
9395	9396	<	0	None
9396	9397	/	0	None
9397	9398	=	0	None
9398	9399	5	0	None
9399	9400	-	0	None
9400	9401	fold	0	None
9401	9402	)	0	None
9402	9403	faster	0	None
9403	9404	kinetics	0	None
9404	9405	.	0	None

9406	9407	Intracellular	0	None
9407	9408	labeling	0	None
9408	9409	with	0	None
9409	9410	Lucifer	0	None
9410	9411	yellow	0	None
9411	9412	indicated	0	None
9412	9413	extensive	0	None
9413	9414	coupling	0	None
9414	9415	between	0	None
9415	9416	muscle	0	None
9416	9417	cells	0	None
9417	9418	in	0	None
9418	9419	both	0	None
9419	9420	embryos	0	None
9420	9421	and	0	None
9421	9422	larvae	0	None
9422	9423	(	0	None
9423	9424	<	0	None
9424	9425	/	0	None
9425	9426	=	0	None
9426	9427	10	0	None
9427	9428	days	0	None
9428	9429	)	0	None
9429	9430	.	0	None

9431	9432	Blocking	0	None
9432	9433	acetylcholinesterase	1	GENE-Y
9433	9434	(	0	None
9434	9435	AChE	1	GENE-Y
9435	9436	)	0	None
9436	9437	with	0	None
9437	9438	eserine	0	None
9438	9439	had	0	None
9439	9440	no	0	None
9440	9441	effect	0	None
9441	9442	on	0	None
9442	9443	mEPC	0	None
9443	9444	kinetics	0	None
9444	9445	in	0	None
9445	9446	embryos	0	None
9446	9447	at	0	None
9447	9448	1	0	None
9448	9449	day	0	None
9449	9450	and	0	None
9450	9451	only	0	None
9451	9452	partially	0	None
9452	9453	slowed	0	None
9453	9454	(	0	None
9454	9455	by	0	None
9455	9456	approximately	0	None
9456	9457	1	0	None
9457	9458	/	0	None
9458	9459	2	0	None
9459	9460	)	0	None
9460	9461	the	0	None
9461	9462	decay	0	None
9462	9463	rate	0	None
9463	9464	in	0	None
9464	9465	larvae	0	None
9465	9466	at	0	None
9466	9467	6	0	None
9467	9468	days	0	None
9468	9469	.	0	None

9470	9471	In	0	None
9471	9472	acutely	0	None
9472	9473	dissociated	0	None
9473	9474	muscle	0	None
9474	9475	cells	0	None
9475	9476	,	0	None
9476	9477	we	0	None
9477	9478	observed	0	None
9478	9479	the	0	None
9479	9480	same	0	None
9480	9481	two	0	None
9481	9482	types	0	None
9482	9483	of	0	None
9483	9484	AChR	2	GENE-N
9484	9485	with	0	None
9485	9486	conductances	0	None
9486	9487	of	0	None
9487	9488	45	0	None
9488	9489	and	0	None
9489	9490	60	0	None
9490	9491	pS	0	None
9491	9492	and	0	None
9492	9493	with	0	None
9493	9494	similar	0	None
9494	9495	,	0	None
9495	9496	brief	0	None
9496	9497	(	0	None
9497	9498	<	0	None
9498	9499	0	0	None
9499	9500	.	0	None
9500	9501	5	0	None
9501	9502	ms	0	None
9502	9503	)	0	None
9503	9504	mean	0	None
9504	9505	open	0	None
9505	9506	times	0	None
9506	9507	in	0	None
9507	9508	both	0	None
9508	9509	embryos	0	None
9509	9510	and	0	None
9510	9511	larvae	0	None
9511	9512	.	0	None

9513	9514	We	0	None
9514	9515	conclude	0	None
9515	9516	that	0	None
9516	9517	AChR	2	GENE-N
9517	9518	properties	0	None
9518	9519	are	0	None
9519	9520	set	0	None
9520	9521	early	0	None
9521	9522	during	0	None
9522	9523	development	0	None
9523	9524	at	0	None
9524	9525	these	0	None
9525	9526	early	0	None
9526	9527	stages	0	None
9527	9528	;	0	None
9528	9529	functional	0	None
9529	9530	maturation	0	None
9530	9531	of	0	None
9531	9532	the	0	None
9532	9533	NMJ	0	None
9533	9534	is	0	None
9534	9535	only	0	None
9535	9536	partly	0	None
9536	9537	shaped	0	None
9537	9538	by	0	None
9538	9539	expression	0	None
9539	9540	of	0	None
9540	9541	AChE	1	GENE-Y
9541	9542	and	0	None
9542	9543	may	0	None
9543	9544	also	0	None
9544	9545	depend	0	None
9545	9546	on	0	None
9546	9547	postsynaptic	0	None
9547	9548	AChR	2	GENE-N
9548	9549	clustering	0	None
9549	9550	and	0	None
9550	9551	presynaptic	0	None
9551	9552	maturation	0	None
9552	9553	.	0	None

9554	9555	Multiple	0	None
9555	9556	mechanisms	0	None
9556	9557	of	0	None
9557	9558	action	0	None
9558	9559	:	0	None
9559	9560	the	0	None
9560	9561	pharmacological	0	None
9561	9562	profile	0	None
9562	9563	of	0	None
9563	9564	budipine	0	None
9564	9565	.	0	None

9566	9567	Four	0	None
9567	9568	major	0	None
9568	9569	components	0	None
9569	9570	of	0	None
9570	9571	the	0	None
9571	9572	mechanism	0	None
9572	9573	of	0	None
9573	9574	action	0	None
9574	9575	have	0	None
9575	9576	been	0	None
9576	9577	identified	0	None
9577	9578	for	0	None
9578	9579	the	0	None
9579	9580	antiparkinsonian	0	None
9580	9581	drug	0	None
9581	9582	budipine	0	None
9582	9583	up	0	None
9583	9584	to	0	None
9584	9585	now	0	None
9585	9586	.	0	None

9587	9588	1	0	None
9588	9589	)	0	None
9589	9590	The	0	None
9590	9591	primary	0	None
9591	9592	action	0	None
9592	9593	of	0	None
9593	9594	budipine	0	None
9594	9595	is	0	None
9595	9596	an	0	None
9596	9597	indirect	0	None
9597	9598	dopaminergic	0	None
9598	9599	effect	0	None
9599	9600	as	0	None
9600	9601	shown	0	None
9601	9602	by	0	None
9602	9603	facilitation	0	None
9603	9604	of	0	None
9604	9605	dopamine	3	CHEMICAL
9605	9606	(	0	None
9606	9607	DA	3	CHEMICAL
9607	9608	)	0	None
9608	9609	release	0	None
9609	9610	,	0	None
9610	9611	inhibition	0	None
9611	9612	of	0	None
9612	9614	monoamine oxidase	2	GENE-N
9614	9615	type	0	None
9615	9616	B	0	None
9616	9617	(	0	None
9617	9618	MAO	2	GENE-N
9618	9619	-	0	None
9619	9620	B	0	None
9620	9621	)	0	None
9621	9622	and	0	None
9622	9623	of	0	None
9623	9624	DA	3	CHEMICAL
9624	9625	(	0	None
9625	9626	re	0	None
9626	9627	)	0	None
9627	9628	up	0	None
9628	9629	-	0	None
9629	9630	take	0	None
9630	9631	and	0	None
9631	9632	stimulation	0	None
9632	9633	of	0	None
9633	9634	aromatic	3	CHEMICAL
9634	9635	L	0	None
9635	9636	-	0	None
9636	9639	amino acid decarboxylase	2	GENE-N
9639	9640	(	0	None
9640	9641	AADC	0	None
9641	9642	)	0	None
9642	9643	,	0	None
9643	9644	which	0	None
9644	9645	in	0	None
9645	9646	sum	0	None
9646	9647	might	0	None
9647	9648	be	0	None
9648	9649	responsible	0	None
9649	9650	for	0	None
9650	9651	enhancing	0	None
9651	9652	the	0	None
9652	9653	endogenous	0	None
9653	9654	dopaminergic	0	None
9654	9655	activity	0	None
9655	9656	.	0	None

9657	9658	2	0	None
9658	9659	)	0	None
9659	9660	Radioligand	0	None
9660	9661	and	0	None
9661	9662	functional	0	None
9662	9663	studies	0	None
9663	9664	at	0	None
9664	9665	the	0	None
9665	9666	N	0	None
9666	9667	-	0	None
9667	9668	methyl	3	CHEMICAL
9668	9669	-	0	None
9669	9670	D	0	None
9670	9671	-	0	None
9671	9672	aspartate	3	CHEMICAL
9672	9673	(	0	None
9673	9674	NMDA	3	CHEMICAL
9674	9675	)	0	None
9675	9676	type	0	None
9676	9677	glutamate	3	CHEMICAL
9677	9678	receptor	0	None
9678	9679	characterize	0	None
9679	9680	budipine	0	None
9680	9681	as	0	None
9681	9682	a	0	None
9682	9683	low	0	None
9683	9684	-	0	None
9684	9685	affinity	0	None
9685	9686	,	0	None
9686	9687	uncompetitive	0	None
9687	9688	antagonist	0	None
9688	9689	with	0	None
9689	9690	fast	0	None
9690	9691	kinetics	0	None
9691	9692	and	0	None
9692	9693	moderate	0	None
9693	9694	voltage	0	None
9694	9695	-	0	None
9695	9696	dependency	0	None
9696	9697	at	0	None
9697	9698	the	0	None
9698	9699	phencyclidine	0	None
9699	9700	(	0	None
9700	9701	PCP	3	CHEMICAL
9701	9702	)	0	None
9702	9703	binding	0	None
9703	9704	site	0	None
9704	9705	,	0	None
9705	9706	comparable	0	None
9706	9707	to	0	None
9707	9708	that	0	None
9708	9709	observed	0	None
9709	9710	with	0	None
9710	9711	amantadine	0	None
9711	9712	,	0	None
9712	9713	thereby	0	None
9713	9714	counteracting	0	None
9714	9715	an	0	None
9715	9716	increased	0	None
9716	9717	excitatory	0	None
9717	9718	glutamatergic	3	CHEMICAL
9718	9719	activity	0	None
9719	9720	.	0	None

9721	9722	3	0	None
9722	9723	)	0	None
9723	9724	The	0	None
9724	9725	antimuscarinic	0	None
9725	9726	action	0	None
9726	9727	of	0	None
9727	9728	budipine	0	None
9728	9729	,	0	None
9729	9730	verified	0	None
9730	9731	by	0	None
9731	9732	functional	0	None
9732	9733	and	0	None
9733	9734	binding	0	None
9734	9735	studies	0	None
9735	9736	at	0	None
9736	9737	native	0	None
9737	9739	muscarinic M1	1	GENE-Y
9739	9740	-	0	None
9740	9741	M3	0	None
9741	9742	and	0	None
9742	9745	human recombinant m1	1	GENE-Y
9745	9746	-	0	None
9746	9747	m5	0	None
9747	9748	receptor	0	None
9748	9749	subtypes	0	None
9749	9750	in	0	None
9750	9751	vitro	0	None
9751	9752	,	0	None
9752	9753	is	0	None
9753	9754	up	0	None
9754	9755	to	0	None
9755	9756	125	0	None
9756	9757	-	0	None
9757	9758	fold	0	None
9758	9759	weaker	0	None
9759	9760	than	0	None
9760	9761	that	0	None
9761	9762	of	0	None
9762	9763	biperiden	0	None
9763	9764	and	0	None
9764	9765	corresponds	0	None
9765	9766	to	0	None
9766	9767	its	0	None
9767	9768	approximately	0	None
9768	9769	100	0	None
9769	9770	-	0	None
9770	9771	fold	0	None
9771	9772	lower	0	None
9772	9773	potency	0	None
9773	9774	to	0	None
9774	9775	cause	0	None
9775	9776	experimentally	0	None
9776	9777	-	0	None
9777	9778	induced	0	None
9778	9779	peripheral	0	None
9779	9780	antimuscarinic	0	None
9780	9781	effects	0	None
9781	9782	and	0	None
9782	9783	explains	0	None
9783	9784	only	0	None
9784	9785	part	0	None
9785	9786	of	0	None
9786	9787	its	0	None
9787	9788	high	0	None
9788	9789	potency	0	None
9789	9790	,	0	None
9790	9791	which	0	None
9791	9792	equals	0	None
9792	9793	biperiden	0	None
9793	9794	,	0	None
9794	9795	to	0	None
9795	9796	suppress	0	None
9796	9797	cholinergically	0	None
9797	9798	evoked	0	None
9798	9799	tremor	0	None
9799	9800	.	0	None

9801	9802	4	0	None
9802	9803	)	0	None
9803	9804	An	0	None
9804	9805	additional	0	None
9805	9806	inhibition	0	None
9806	9807	of	0	None
9807	9808	striatal	0	None
9808	9809	gamma	0	None
9809	9810	-	0	None
9810	9812	aminobutyric acid	3	CHEMICAL
9812	9813	(	0	None
9813	9814	GABA	3	CHEMICAL
9814	9815	)	0	None
9815	9816	release	0	None
9816	9817	by	0	None
9817	9818	budipine	0	None
9818	9819	may	0	None
9819	9820	be	0	None
9820	9821	beneficial	0	None
9821	9822	to	0	None
9822	9823	suppress	0	None
9823	9824	an	0	None
9824	9825	increased	0	None
9825	9826	striatal	0	None
9826	9827	GABAergic	0	None
9827	9828	output	0	None
9828	9829	activity	0	None
9829	9830	.	0	None

9831	9832	The	0	None
9832	9833	contribution	0	None
9833	9834	of	0	None
9834	9835	other	0	None
9835	9836	observed	0	None
9836	9837	effects	0	None
9837	9838	to	0	None
9838	9839	the	0	None
9839	9840	therapeutic	0	None
9840	9841	action	0	None
9841	9842	of	0	None
9842	9843	budipine	0	None
9843	9844	,	0	None
9844	9845	i	0	None
9845	9846	.	0	None
9846	9847	e	0	None
9847	9848	.	0	None
9848	9849	weak	0	None
9849	9850	stimulation	0	None
9850	9851	of	0	None
9851	9852	noradrenaline	3	CHEMICAL
9852	9853	and	0	None
9853	9854	serotonin	3	CHEMICAL
9854	9855	release	0	None
9855	9856	,	0	None
9856	9857	binding	0	None
9857	9858	to	0	None
9858	9861	brain sigma1 receptors	2	GENE-N
9861	9862	and	0	None
9862	9863	blockade	0	None
9863	9864	of	0	None
9864	9867	histamine H1 receptors	1	GENE-Y
9867	9868	,	0	None
9868	9869	is	0	None
9869	9870	not	0	None
9870	9871	yet	0	None
9871	9872	clear	0	None
9872	9873	.	0	None

9874	9875	By	0	None
9875	9876	means	0	None
9876	9877	of	0	None
9877	9878	these	0	None
9878	9879	multiple	0	None
9879	9880	mechanisms	0	None
9880	9881	,	0	None
9881	9882	budipine	0	None
9882	9883	might	0	None
9883	9884	correct	0	None
9884	9885	the	0	None
9885	9886	imbalance	0	None
9886	9887	of	0	None
9887	9888	striatal	0	None
9888	9889	output	0	None
9889	9890	pathways	0	None
9890	9891	by	0	None
9891	9892	restoring	0	None
9892	9893	DA	3	CHEMICAL
9893	9894	levels	0	None
9894	9895	in	0	None
9895	9896	the	0	None
9896	9897	striatum	0	None
9897	9898	,	0	None
9898	9899	and	0	None
9899	9900	positively	0	None
9900	9901	influence	0	None
9901	9902	the	0	None
9902	9903	secondary	2	GENE-N
9903	9904	changes	0	None
9904	9905	in	0	None
9905	9906	other	0	None
9906	9907	transmitter	0	None
9907	9908	systems	0	None
9908	9909	(	0	None
9909	9910	glutamate	3	CHEMICAL
9910	9911	,	0	None
9911	9912	acetylcholine	3	CHEMICAL
9912	9913	,	0	None
9913	9914	GABA	3	CHEMICAL
9914	9915	)	0	None
9915	9916	observed	0	None
9916	9917	in	0	None
9917	9918	Parkinson	0	None
9918	9919	'	0	None
9919	9920	s	0	None
9920	9921	disease	0	None
9921	9922	.	0	None

9923	9924	Disparate	0	None
9924	9925	actions	0	None
9925	9926	of	0	None
9926	9927	mifepristone	0	None
9927	9928	(	0	None
9928	9929	RU	0	None
9929	9930	486	0	None
9930	9931	)	0	None
9931	9932	on	0	None
9932	9933	glands	0	None
9933	9934	and	0	None
9934	9935	stroma	0	None
9935	9936	in	0	None
9936	9937	the	0	None
9937	9938	primate	0	None
9938	9939	endometrium	0	None
9939	9940	.	0	None

9941	9942	Besides	0	None
9942	9943	being	0	None
9943	9944	an	0	None
9944	9945	antiprogestin	0	None
9945	9946	,	0	None
9946	9947	mifepristone	0	None
9947	9948	(	0	None
9948	9949	RU	0	None
9949	9950	486	0	None
9950	9951	)	0	None
9951	9952	was	0	None
9952	9953	recently	0	None
9953	9954	shown	0	None
9954	9955	to	0	None
9955	9956	antagonize	0	None
9956	9957	oestrogen	3	CHEMICAL
9957	9958	-	0	None
9958	9959	dependent	0	None
9959	9960	growth	0	None
9960	9961	in	0	None
9961	9962	the	0	None
9962	9963	endometrium	0	None
9963	9964	.	0	None

9965	9966	To	0	None
9966	9967	explore	0	None
9967	9968	the	0	None
9968	9969	molecular	0	None
9969	9970	mechanisms	0	None
9970	9971	for	0	None
9971	9972	this	0	None
9972	9973	phenomenon	0	None
9973	9974	,	0	None
9974	9975	we	0	None
9975	9976	investigated	0	None
9976	9977	whether	0	None
9977	9978	or	0	None
9978	9979	not	0	None
9979	9980	the	0	None
9980	9981	morphological	0	None
9981	9982	effects	0	None
9982	9983	of	0	None
9983	9984	mifepristone	0	None
9984	9985	are	0	None
9985	9986	mediated	0	None
9986	9987	by	0	None
9987	9988	the	0	None
9988	9990	progesterone receptor	2	GENE-N
9990	9991	(	0	None
9991	9992	PR	2	GENE-N
9992	9993	)	0	None
9993	9994	and	0	None
9994	9995	whether	0	None
9995	9996	mifepristone	0	None
9996	9997	has	0	None
9997	9998	disparate	0	None
9998	9999	effects	0	None
9999	10000	on	0	None
10000	10001	the	0	None
10001	10002	glandular	0	None
10002	10003	epithelium	0	None
10003	10004	and	0	None
10004	10005	stroma	0	None
10005	10006	.	0	None

10007	10008	Six	0	None
10008	10009	groups	0	None
10009	10010	of	0	None
10010	10011	hypogonadal	0	None
10011	10012	,	0	None
10012	10013	oestrogen	3	CHEMICAL
10013	10014	-	0	None
10014	10015	primed	0	None
10015	10016	cynomolgus	0	None
10016	10017	monkeys	0	None
10017	10018	were	0	None
10018	10019	treated	0	None
10019	10020	for	0	None
10020	10021	2	0	None
10021	10022	weeks	0	None
10022	10023	with	0	None
10023	10024	:	0	None
10024	10025	vehicle	0	None
10025	10026	only	0	None
10026	10027	(	0	None
10027	10028	group	0	None
10028	10029	I	0	None
10029	10030	)	0	None
10030	10031	;	0	None
10031	10032	mifepristone	0	None
10032	10033	(	0	None
10033	10034	group	0	None
10034	10035	II	0	None
10035	10036	)	0	None
10036	10037	;	0	None
10037	10038	mifepristone	0	None
10038	10039	plus	0	None
10039	10040	progesterone	3	CHEMICAL
10040	10041	at	0	None
10041	10042	0	0	None
10042	10043	.	0	None
10043	10044	2	0	None
10044	10045	mg	0	None
10045	10046	/	0	None
10046	10047	kg	0	None
10047	10048	(	0	None
10048	10049	group	0	None
10049	10050	III	1	GENE-Y
10050	10051	)	0	None
10051	10052	,	0	None
10052	10053	1	0	None
10053	10054	.	0	None
10054	10055	0	0	None
10055	10056	mg	0	None
10056	10057	/	0	None
10057	10058	kg	0	None
10058	10059	(	0	None
10059	10060	group	0	None
10060	10061	IV	0	None
10061	10062	)	0	None
10062	10063	or	0	None
10063	10064	5	0	None
10064	10065	.	0	None
10065	10066	0	0	None
10066	10067	mg	0	None
10067	10068	/	0	None
10068	10069	kg	0	None
10069	10070	(	0	None
10070	10071	group	0	None
10071	10072	V	0	None
10072	10073	)	0	None
10073	10074	;	0	None
10074	10075	and	0	None
10075	10076	progesterone	3	CHEMICAL
10076	10077	only	0	None
10077	10078	(	0	None
10078	10079	5	0	None
10079	10080	.	0	None
10080	10081	0	0	None
10081	10082	mg	0	None
10082	10083	/	0	None
10083	10084	kg	0	None
10084	10085	)	0	None
10085	10086	(	0	None
10086	10087	group	0	None
10087	10088	VI	0	None
10088	10089	)	0	None
10089	10090	.	0	None

10091	10092	Histomorphological	0	None
10092	10093	evaluation	0	None
10093	10094	showed	0	None
10094	10095	strikingly	0	None
10095	10096	compacted	0	None
10096	10097	stroma	0	None
10097	10098	in	0	None
10098	10099	the	0	None
10099	10100	mifepristone	0	None
10100	10101	-	0	None
10101	10102	exposed	0	None
10102	10103	endometria	0	None
10103	10104	(	0	None
10104	10105	group	0	None
10105	10106	II	0	None
10106	10107	)	0	None
10107	10108	,	0	None
10108	10109	which	0	None
10109	10110	was	0	None
10110	10111	partially	0	None
10111	10112	reversible	0	None
10112	10113	by	0	None
10113	10114	additional	0	None
10114	10115	progesterone	3	CHEMICAL
10115	10116	treatment	0	None
10116	10117	(	0	None
10117	10118	groups	0	None
10118	10119	III	0	None
10119	10120	-	0	None
10120	10121	V	0	None
10121	10122	)	0	None
10122	10123	.	0	None

10124	10125	Glandular	0	None
10125	10126	proliferation	0	None
10126	10127	(	0	None
10127	10128	pseudostratification	0	None
10128	10129	,	0	None
10129	10130	glandular	0	None
10130	10131	mitoses	0	None
10131	10132	)	0	None
10132	10133	in	0	None
10133	10134	mifepristone	0	None
10134	10135	-	0	None
10135	10136	treated	0	None
10136	10137	monkeys	0	None
10137	10138	was	0	None
10138	10139	not	0	None
10139	10140	significantly	0	None
10140	10141	different	0	None
10141	10142	from	0	None
10142	10143	that	0	None
10143	10144	in	0	None
10144	10145	vehicle	0	None
10145	10146	(	0	None
10146	10147	oestradiol	3	CHEMICAL
10147	10148	)	0	None
10148	10149	-	0	None
10149	10150	treated	0	None
10150	10151	monkeys	0	None
10151	10152	,	0	None
10152	10153	but	0	None
10153	10154	was	0	None
10154	10155	inhibited	0	None
10155	10156	by	0	None
10156	10157	progesterone	3	CHEMICAL
10157	10158	-	0	None
10158	10159	only	0	None
10159	10160	treatment	0	None
10160	10161	.	0	None

10162	10163	Cells	0	None
10163	10164	containing	0	None
10164	10165	vacuoles	0	None
10165	10166	were	0	None
10166	10167	scarce	0	None
10167	10168	in	0	None
10168	10169	the	0	None
10169	10170	mifepristone	0	None
10170	10171	-	0	None
10171	10172	exposed	0	None
10172	10173	endometrium	0	None
10173	10174	,	0	None
10174	10175	but	0	None
10175	10176	detected	0	None
10176	10177	frequently	0	None
10177	10178	in	0	None
10178	10179	progesterone	3	CHEMICAL
10179	10180	-	0	None
10180	10181	exposed	0	None
10181	10182	endometria	0	None
10182	10183	,	0	None
10183	10184	indicating	0	None
10184	10185	the	0	None
10185	10186	strong	0	None
10186	10187	antisecretory	0	None
10187	10188	effect	0	None
10188	10189	of	0	None
10189	10190	mifepristone	0	None
10190	10191	on	0	None
10191	10192	glands	0	None
10192	10193	.	0	None

10194	10195	We	0	None
10195	10196	conclude	0	None
10196	10197	that	0	None
10197	10198	oestrogen	3	CHEMICAL
10198	10199	-	0	None
10199	10200	dependent	0	None
10200	10201	oedema	0	None
10201	10202	in	0	None
10202	10203	the	0	None
10203	10204	stroma	0	None
10204	10205	is	0	None
10205	10206	antagonized	0	None
10206	10207	by	0	None
10207	10208	mifepristone	0	None
10208	10209	.	0	None

10210	10211	The	0	None
10211	10212	reversal	0	None
10212	10213	of	0	None
10213	10214	this	0	None
10214	10215	effect	0	None
10215	10216	by	0	None
10216	10217	progesterone	3	CHEMICAL
10217	10218	suggests	0	None
10218	10219	a	0	None
10219	10220	PR	2	GENE-N
10220	10221	-	0	None
10221	10222	mediated	0	None
10222	10223	mechanism	0	None
10223	10224	.	0	None

10225	10226	In	0	None
10226	10227	glands	0	None
10227	10228	,	0	None
10228	10229	mifepristone	0	None
10229	10230	is	0	None
10230	10231	antiprogestogenic	0	None
10231	10232	,	0	None
10232	10233	but	0	None
10233	10234	not	0	None
10234	10235	antioestrogenic	0	None
10235	10236	.	0	None

10237	10238	Thus	0	None
10238	10239	,	0	None
10239	10240	stromal	0	None
10240	10241	cells	0	None
10241	10242	may	0	None
10242	10243	be	0	None
10243	10244	the	0	None
10244	10245	target	0	None
10245	10246	of	0	None
10246	10247	antiprogestin	0	None
10247	10248	-	0	None
10248	10249	induced	0	None
10249	10250	inhibition	0	None
10250	10251	of	0	None
10251	10252	oedema	0	None
10252	10253	and	0	None
10253	10254	endometrial	0	None
10254	10255	growth	0	None
10255	10256	.	0	None

10257	10258	An	0	None
10258	10259	Arg	3	CHEMICAL
10259	10260	/	0	None
10260	10261	Ser	0	None
10261	10262	substitution	0	None
10262	10263	in	0	None
10263	10264	the	0	None
10264	10265	second	0	None
10265	10268	epidermal growth factor	1	GENE-Y
10268	10269	-	0	None
10269	10270	like	0	None
10270	10271	module	0	None
10271	10272	of	0	None
10272	10273	factor	0	None
10273	10274	IX	0	None
10274	10275	introduces	0	None
10275	10276	an	0	None
10276	10277	O	0	None
10277	10278	-	0	None
10278	10279	linked	0	None
10279	10280	carbohydrate	3	CHEMICAL
10280	10281	and	0	None
10281	10282	markedly	0	None
10282	10283	impairs	0	None
10283	10284	activation	0	None
10284	10285	by	0	None
10285	10287	factor XIa	1	GENE-Y
10287	10288	and	0	None
10288	10290	factor VIIa	1	GENE-Y
10290	10291	/	0	None
10291	10292	Tissue	0	None
10292	10293	factor	0	None
10293	10294	and	0	None
10294	10295	catalytic	0	None
10295	10296	efficiency	0	None
10296	10297	of	0	None
10297	10299	factor IXa	1	GENE-Y
10299	10300	.	0	None

10301	10302	Factor	0	None
10302	10303	IXR94S	0	None
10303	10304	is	0	None
10304	10305	a	0	None
10305	10306	naturally	0	None
10306	10307	occurring	0	None
10307	10308	hemophilia	0	None
10308	10309	B	0	None
10309	10310	defect	0	None
10310	10311	,	0	None
10311	10312	which	0	None
10312	10313	results	0	None
10313	10314	from	0	None
10314	10315	an	0	None
10315	10319	Arg 94 to Ser	2	GENE-N
10319	10320	mutation	0	None
10320	10321	in	0	None
10321	10322	the	0	None
10322	10323	second	0	None
10323	10326	epidermal growth factor	1	GENE-Y
10326	10327	(	0	None
10327	10328	EGF	1	GENE-Y
10328	10329	)	0	None
10329	10330	-	0	None
10330	10331	like	0	None
10331	10332	module	0	None
10332	10333	of	0	None
10333	10334	factor	0	None
10334	10335	IX	0	None
10335	10336	.	0	None

10337	10338	Recombinant	0	None
10338	10340	factor IXR94S	1	GENE-Y
10340	10341	was	0	None
10341	10342	activated	0	None
10342	10343	by	0	None
10343	10345	factor XIa	1	GENE-Y
10345	10346	/	0	None
10346	10347	calcium	0	None
10347	10348	with	0	None
10348	10349	an	0	None
10349	10350	approximately	0	None
10350	10351	50	0	None
10351	10352	-	0	None
10352	10353	fold	0	None
10353	10354	reduced	0	None
10354	10355	rate	0	None
10355	10356	and	0	None
10356	10357	by	0	None
10357	10359	factor VIIa	1	GENE-Y
10359	10360	/	0	None
10360	10361	tissue	0	None
10361	10362	factor	0	None
10362	10363	/	0	None
10363	10364	phospholipid	3	CHEMICAL
10364	10365	/	0	None
10365	10366	calcium	0	None
10366	10367	with	0	None
10367	10368	an	0	None
10368	10369	approximately	0	None
10369	10370	20	0	None
10370	10371	-	0	None
10371	10372	fold	0	None
10372	10373	reduced	0	None
10373	10374	rate	0	None
10374	10375	compared	0	None
10375	10376	with	0	None
10376	10377	wild	0	None
10377	10378	-	0	None
10378	10379	type	0	None
10379	10380	factor	0	None
10380	10381	IX	0	None
10381	10382	.	0	None

10383	10384	The	0	None
10384	10385	apparent	0	None
10385	10386	molecular	0	None
10386	10387	mass	0	None
10387	10388	of	0	None
10388	10389	the	0	None
10389	10394	light chain of factor IXaR94S	2	GENE-N
10394	10395	was	0	None
10395	10396	approximately	0	None
10396	10397	6	0	None
10397	10398	kD	0	None
10398	10399	higher	0	None
10399	10400	than	0	None
10400	10401	that	0	None
10401	10402	of	0	None
10402	10403	plasma	0	None
10403	10404	or	0	None
10404	10405	wild	0	None
10405	10406	-	0	None
10406	10407	type	0	None
10407	10408	factor	0	None
10408	10409	IX	0	None
10409	10410	,	0	None
10410	10411	which	0	None
10411	10412	was	0	None
10412	10413	not	0	None
10413	10414	corrected	0	None
10414	10415	by	0	None
10415	10416	N	0	None
10416	10417	-	0	None
10417	10418	glycosidase	0	None
10418	10419	F	0	None
10419	10420	digestion	0	None
10420	10421	.	0	None

10422	10423	This	0	None
10423	10424	result	0	None
10424	10425	indicated	0	None
10425	10426	the	0	None
10426	10427	presence	0	None
10427	10428	of	0	None
10428	10429	additional	0	None
10429	10430	O	0	None
10430	10431	-	0	None
10431	10432	linked	0	None
10432	10433	carbohydrate	3	CHEMICAL
10433	10434	in	0	None
10434	10435	the	0	None
10435	10436	mutant	0	None
10436	10437	light	0	None
10437	10438	chain	0	None
10438	10439	,	0	None
10439	10440	probably	0	None
10440	10441	at	0	None
10441	10442	new	0	None
10442	10443	Ser	0	None
10443	10444	94	0	None
10444	10445	.	0	None

10446	10447	The	0	None
10447	10448	initial	0	None
10448	10449	rate	0	None
10449	10450	of	0	None
10450	10451	activation	0	None
10451	10452	of	0	None
10452	10453	factor	0	None
10453	10454	X	0	None
10454	10455	by	0	None
10455	10457	factor IXaR94S	1	GENE-Y
10457	10458	in	0	None
10458	10459	the	0	None
10459	10460	presence	0	None
10460	10461	of	0	None
10461	10462	polylysine	0	None
10462	10463	was	0	None
10463	10464	7	0	None
10464	10465	%	0	None
10465	10466	+	0	None
10466	10467	/	0	None
10467	10468	-	0	None
10468	10469	1	0	None
10469	10470	%	0	None
10470	10471	of	0	None
10471	10472	the	0	None
10472	10473	initial	0	None
10473	10474	rate	0	None
10474	10475	of	0	None
10475	10476	activation	0	None
10476	10477	of	0	None
10477	10478	factor	0	None
10478	10479	X	0	None
10479	10480	by	0	None
10480	10481	plasma	0	None
10481	10483	factor IXa	1	GENE-Y
10483	10484	,	0	None
10484	10485	and	0	None
10485	10486	the	0	None
10486	10487	kc	1	GENE-Y
10487	10488	/	0	None
10488	10489	Km	0	None
10489	10490	for	0	None
10490	10491	activation	0	None
10491	10492	of	0	None
10492	10493	factor	0	None
10493	10494	X	0	None
10494	10495	by	0	None
10495	10497	factor IXaR94S	1	GENE-Y
10497	10498	/	0	None
10498	10500	factor VIIIa	1	GENE-Y
10500	10501	/	0	None
10501	10502	phospholipid	3	CHEMICAL
10502	10503	/	0	None
10503	10504	calcium	0	None
10504	10505	was	0	None
10505	10506	4	0	None
10506	10507	%	0	None
10507	10508	+	0	None
10508	10509	/	0	None
10509	10510	-	0	None
10510	10511	1	0	None
10511	10512	%	0	None
10512	10513	of	0	None
10513	10514	the	0	None
10514	10515	kc	1	GENE-Y
10515	10516	/	0	None
10516	10517	Km	0	None
10517	10518	for	0	None
10518	10519	activation	0	None
10519	10520	of	0	None
10520	10521	factor	0	None
10521	10522	X	0	None
10522	10523	by	0	None
10523	10524	plasma	0	None
10524	10526	factor IXa	1	GENE-Y
10526	10527	/	0	None
10527	10529	factor VIIIa	1	GENE-Y
10529	10530	/	0	None
10530	10531	phospholipid	3	CHEMICAL
10531	10532	/	0	None
10532	10533	calcium	0	None
10533	10534	.	0	None

10535	10536	The	0	None
10536	10537	reduced	0	None
10537	10538	efficiency	0	None
10538	10539	of	0	None
10539	10540	activation	0	None
10540	10541	of	0	None
10541	10542	factor	0	None
10542	10543	X	0	None
10543	10544	by	0	None
10544	10546	factor IXaR94S	1	GENE-Y
10546	10547	in	0	None
10547	10548	the	0	None
10548	10551	tenase enzyme complex	2	GENE-N
10551	10552	was	0	None
10552	10553	due	0	None
10553	10554	to	0	None
10554	10555	a	0	None
10555	10556	58	0	None
10556	10557	-	0	None
10557	10558	fold	0	None
10558	10559	+	0	None
10559	10560	/	0	None
10560	10561	-	0	None
10561	10562	12	0	None
10562	10563	-	0	None
10563	10564	fold	0	None
10564	10565	decrease	0	None
10565	10566	in	0	None
10566	10567	kcat	0	None
10567	10568	with	0	None
10568	10569	little	0	None
10569	10570	effect	0	None
10570	10571	on	0	None
10571	10572	Km	0	None
10572	10573	.	0	None

10574	10575	In	0	None
10575	10576	conclusion	0	None
10576	10577	,	0	None
10577	10578	the	0	None
10578	10579	R94S	1	GENE-Y
10579	10580	mutation	0	None
10580	10581	had	0	None
10581	10582	introduced	0	None
10582	10583	an	0	None
10583	10584	O	0	None
10584	10585	-	0	None
10585	10586	linked	0	None
10586	10587	carbohydrate	3	CHEMICAL
10587	10588	,	0	None
10588	10589	which	0	None
10589	10590	markedly	0	None
10590	10591	impaired	0	None
10591	10592	both	0	None
10592	10593	activation	0	None
10593	10594	by	0	None
10594	10596	factor XIa	1	GENE-Y
10596	10597	and	0	None
10597	10598	turnover	0	None
10598	10599	of	0	None
10599	10600	factor	0	None
10600	10601	X	0	None
10601	10602	in	0	None
10602	10603	the	0	None
10603	10606	tenase enzyme complex	2	GENE-N
10606	10607	.	0	None

10608	10609	Expression	0	None
10609	10610	of	0	None
10610	10611	multiple	0	None
10611	10612	alpha1	2	GENE-N
10612	10613	-	0	None
10613	10614	adrenoceptors	2	GENE-N
10614	10615	on	0	None
10615	10616	vascular	0	None
10616	10617	smooth	0	None
10617	10618	muscle	0	None
10618	10619	:	0	None
10619	10620	correlation	0	None
10620	10621	with	0	None
10621	10622	the	0	None
10622	10623	regulation	0	None
10623	10624	of	0	None
10624	10625	contraction	0	None
10625	10626	.	0	None

10627	10628	Previous	0	None
10628	10629	work	0	None
10629	10630	has	0	None
10630	10631	shown	0	None
10631	10632	that	0	None
10632	10633	the	0	None
10633	10634	genes	0	None
10634	10635	encoding	0	None
10635	10636	each	0	None
10636	10637	alpha1	2	GENE-N
10637	10638	-	0	None
10638	10639	adrenoceptor	0	None
10639	10640	subtype	0	None
10640	10641	are	0	None
10641	10642	coexpressed	0	None
10642	10643	throughout	0	None
10643	10644	the	0	None
10644	10645	peripheral	0	None
10645	10646	vascular	0	None
10646	10647	system	0	None
10647	10648	.	0	None

10649	10650	We	0	None
10650	10651	have	0	None
10651	10652	evaluated	0	None
10652	10653	subtype	0	None
10653	10654	-	0	None
10654	10655	selective	0	None
10655	10656	antibodies	0	None
10656	10657	as	0	None
10657	10658	tools	0	None
10658	10659	to	0	None
10659	10660	determine	0	None
10660	10661	the	0	None
10661	10662	extent	0	None
10662	10663	of	0	None
10663	10664	protein	0	None
10664	10665	expression	0	None
10665	10666	in	0	None
10666	10667	arteries	0	None
10667	10668	.	0	None

10669	10670	The	0	None
10670	10671	alpha1A	0	None
10671	10672	-	0	None
10672	10673	,	0	None
10673	10674	alpha1B	0	None
10674	10675	-	0	None
10675	10676	,	0	None
10676	10677	and	0	None
10677	10678	alpha1D	0	None
10678	10679	-	0	None
10679	10680	adrenoceptors	2	GENE-N
10680	10681	were	0	None
10681	10682	detected	0	None
10682	10683	in	0	None
10683	10684	the	0	None
10684	10685	medial	0	None
10685	10686	layer	0	None
10686	10687	of	0	None
10687	10688	the	0	None
10688	10689	aorta	0	None
10689	10690	,	0	None
10690	10691	caudal	0	None
10691	10692	,	0	None
10692	10693	femoral	0	None
10693	10694	,	0	None
10694	10695	iliac	0	None
10695	10696	,	0	None
10696	10697	renal	0	None
10697	10698	,	0	None
10698	10699	superior	0	None
10699	10700	mesenteric	0	None
10700	10701	,	0	None
10701	10702	and	0	None
10702	10703	mesenteric	0	None
10703	10704	resistance	0	None
10704	10705	arteries	0	None
10705	10706	.	0	None

10707	10708	In	0	None
10708	10709	Rat1	0	None
10709	10710	fibroblasts	0	None
10710	10711	expressing	0	None
10711	10712	each	0	None
10712	10713	subtype	0	None
10713	10714	,	0	None
10714	10715	immunoreactivity	0	None
10715	10716	was	0	None
10716	10717	noted	0	None
10717	10718	both	0	None
10718	10719	on	0	None
10719	10720	the	0	None
10720	10721	cell	0	None
10721	10722	surface	0	None
10722	10723	and	0	None
10723	10724	in	0	None
10724	10725	a	0	None
10725	10726	perinuclear	0	None
10726	10727	orientation	0	None
10727	10728	.	0	None

10729	10730	Intense	0	None
10730	10731	alpha1B	0	None
10731	10732	-	0	None
10732	10733	adrenoceptor	0	None
10733	10734	immunostaining	0	None
10734	10735	was	0	None
10735	10736	similarly	0	None
10736	10737	localized	0	None
10737	10738	in	0	None
10738	10739	cultured	0	None
10739	10740	femoral	0	None
10740	10741	and	0	None
10741	10742	renal	0	None
10742	10743	vascular	0	None
10743	10744	smooth	0	None
10744	10745	muscle	0	None
10745	10746	cells	0	None
10746	10747	.	0	None

10748	10749	Although	0	None
10749	10750	the	0	None
10750	10751	cellular	0	None
10751	10752	localization	0	None
10752	10753	appeared	0	None
10753	10754	to	0	None
10754	10755	be	0	None
10755	10756	the	0	None
10756	10757	same	0	None
10757	10758	,	0	None
10758	10759	immunoreactivity	0	None
10759	10760	obtained	0	None
10760	10761	with	0	None
10761	10762	alpha1A	0	None
10762	10763	-	0	None
10763	10764	and	0	None
10764	10765	alpha1D	0	None
10765	10766	-	0	None
10766	10767	adrenoceptors	2	GENE-N
10767	10768	was	0	None
10768	10769	much	0	None
10769	10770	less	0	None
10770	10771	intense	0	None
10771	10772	than	0	None
10772	10773	that	0	None
10773	10774	with	0	None
10774	10775	the	0	None
10775	10776	alpha1B	0	None
10776	10777	-	0	None
10777	10778	adrenoceptor	0	None
10778	10779	.	0	None

10780	10781	The	0	None
10781	10782	alpha1A	0	None
10782	10783	-	0	None
10783	10784	adrenoceptor	0	None
10784	10785	selective	0	None
10785	10786	agonist	0	None
10786	10787	A	0	None
10787	10788	-	0	None
10788	10789	61603	0	None
10789	10790	was	0	None
10790	10791	22	0	None
10791	10792	-	0	None
10792	10793	fold	0	None
10793	10794	more	0	None
10794	10795	potent	0	None
10795	10796	in	0	None
10796	10797	activating	0	None
10797	10798	renal	0	None
10798	10799	artery	0	None
10799	10800	contraction	0	None
10800	10801	when	0	None
10801	10802	compared	0	None
10802	10803	with	0	None
10803	10804	the	0	None
10804	10805	femoral	0	None
10805	10806	artery	0	None
10806	10807	.	0	None

10808	10809	The	0	None
10809	10810	expression	0	None
10810	10811	of	0	None
10811	10812	each	0	None
10812	10813	alpha1	2	GENE-N
10813	10814	-	0	None
10814	10815	adrenoceptor	0	None
10815	10816	was	0	None
10816	10817	significantly	0	None
10817	10818	decreased	0	None
10818	10819	by	0	None
10819	10820	in	0	None
10820	10821	vivo	0	None
10821	10822	application	0	None
10822	10823	of	0	None
10823	10824	antisense	0	None
10824	10825	oligonucleotides	0	None
10825	10826	targeted	0	None
10826	10827	against	0	None
10827	10828	each	0	None
10828	10829	subtype	0	None
10829	10830	.	0	None

10831	10832	Inhibition	0	None
10832	10833	of	0	None
10833	10834	the	0	None
10834	10835	expression	0	None
10835	10836	of	0	None
10836	10837	only	0	None
10837	10838	one	0	None
10838	10839	,	0	None
10839	10840	the	0	None
10840	10841	alpha1A	0	None
10841	10842	in	0	None
10842	10843	renal	0	None
10843	10844	and	0	None
10844	10845	the	0	None
10845	10846	alpha1D	0	None
10846	10847	in	0	None
10847	10848	femoral	0	None
10848	10849	arteries	0	None
10849	10850	,	0	None
10850	10851	reduced	0	None
10851	10852	the	0	None
10852	10853	contractile	0	None
10853	10854	response	0	None
10854	10855	to	0	None
10855	10856	naphazoline	3	CHEMICAL
10856	10857	.	0	None

10858	10859	The	0	None
10859	10860	results	0	None
10860	10861	show	0	None
10861	10862	:	0	None
10862	10863	1	0	None
10863	10864	)	0	None
10864	10865	subtype	0	None
10865	10866	-	0	None
10866	10867	selective	0	None
10867	10868	antibodies	0	None
10868	10869	can	0	None
10869	10870	be	0	None
10870	10871	used	0	None
10871	10872	in	0	None
10872	10873	tissues	0	None
10873	10874	and	0	None
10874	10875	cell	0	None
10875	10876	culture	0	None
10876	10877	to	0	None
10877	10878	localize	0	None
10878	10879	the	0	None
10879	10880	alpha1	2	GENE-N
10880	10881	-	0	None
10881	10882	adrenoceptor	0	None
10882	10883	subtypes	0	None
10883	10884	,	0	None
10884	10885	2	0	None
10885	10886	)	0	None
10886	10887	in	0	None
10887	10888	addition	0	None
10888	10889	to	0	None
10889	10890	expression	0	None
10890	10891	on	0	None
10891	10892	the	0	None
10892	10893	cell	0	None
10893	10894	surface	0	None
10894	10895	,	0	None
10895	10896	the	0	None
10896	10897	alpha1	2	GENE-N
10897	10898	-	0	None
10898	10899	adrenoceptors	2	GENE-N
10899	10900	are	0	None
10900	10901	expressed	0	None
10901	10902	intracellularly	0	None
10902	10903	,	0	None
10903	10904	and	0	None
10904	10905	3	0	None
10905	10906	)	0	None
10906	10907	despite	0	None
10907	10908	expression	0	None
10908	10909	of	0	None
10909	10910	all	0	None
10910	10911	adrenoceptors	2	GENE-N
10911	10912	,	0	None
10912	10913	a	0	None
10913	10914	single	0	None
10914	10915	subtype	0	None
10915	10916	mediates	0	None
10916	10917	the	0	None
10917	10918	contractile	0	None
10918	10919	response	0	None
10919	10920	in	0	None
10920	10921	the	0	None
10921	10922	femoral	0	None
10922	10923	and	0	None
10923	10924	renal	0	None
10924	10925	arteries	0	None
10925	10926	.	0	None

10927	10928	Probing	0	None
10928	10929	the	0	None
10929	10930	structural	0	None
10930	10931	changes	0	None
10931	10932	in	0	None
10932	10933	the	0	None
10933	10940	light chain of human coagulation factor VIIa	1	GENE-Y
10940	10941	due	0	None
10941	10942	to	0	None
10942	10943	tissue	0	None
10943	10944	factor	0	None
10944	10945	association	0	None
10945	10946	.	0	None

10947	10948	The	0	None
10948	10949	crystallographic	3	CHEMICAL
10949	10950	structure	0	None
10950	10951	of	0	None
10951	10955	human coagulation factor VIIa	1	GENE-Y
10955	10956	/	0	None
10956	10959	tissue factor complex	2	GENE-N
10959	10960	bound	0	None
10960	10961	with	0	None
10961	10962	calcium	0	None
10962	10963	ions	0	None
10963	10964	was	0	None
10964	10965	used	0	None
10965	10966	to	0	None
10966	10967	model	0	None
10967	10968	the	0	None
10968	10969	solution	0	None
10969	10970	structure	0	None
10970	10971	of	0	None
10971	10972	the	0	None
10972	10977	light chain of factor VIIa	1	GENE-Y
10977	10978	(	0	None
10978	10979	residues	0	None
10979	10980	1	0	None
10980	10981	-	0	None
10981	10982	142	0	None
10982	10983	)	0	None
10983	10984	in	0	None
10984	10985	the	0	None
10985	10986	absence	0	None
10986	10987	of	0	None
10987	10988	tissue	0	None
10988	10989	factor	0	None
10989	10990	.	0	None

10991	10992	The	0	None
10992	10993	Amber	0	None
10993	10994	force	0	None
10994	10995	field	0	None
10995	10996	in	0	None
10996	10997	conjunction	0	None
10997	10998	with	0	None
10998	10999	the	0	None
10999	11000	particle	0	None
11000	11001	mesh	0	None
11001	11002	Ewald	0	None
11002	11003	summation	0	None
11003	11004	method	0	None
11004	11005	to	0	None
11005	11006	accommodate	0	None
11006	11007	long	0	None
11007	11008	-	0	None
11008	11009	range	0	None
11009	11010	electrostatic	0	None
11010	11011	interactions	0	None
11011	11012	was	0	None
11012	11013	used	0	None
11013	11014	in	0	None
11014	11015	the	0	None
11015	11016	trajectory	0	None
11016	11017	calculations	0	None
11017	11018	.	0	None

11019	11020	The	0	None
11020	11021	estimated	0	None
11021	11022	TF	1	GENE-Y
11022	11023	-	0	None
11023	11024	free	0	None
11024	11025	solution	0	None
11025	11026	structure	0	None
11026	11027	was	0	None
11027	11028	then	0	None
11028	11029	compared	0	None
11029	11030	with	0	None
11030	11031	the	0	None
11031	11032	crystal	0	None
11032	11033	structure	0	None
11033	11034	of	0	None
11034	11036	factor VIIa	1	GENE-Y
11036	11037	/	0	None
11037	11040	tissue factor complex	2	GENE-N
11040	11041	to	0	None
11041	11042	estimate	0	None
11042	11043	the	0	None
11043	11044	restructuring	0	None
11044	11045	of	0	None
11045	11047	factor VIIa	1	GENE-Y
11047	11048	due	0	None
11048	11049	to	0	None
11049	11050	tissue	0	None
11050	11051	factor	0	None
11051	11052	binding	0	None
11052	11053	.	0	None

11054	11055	The	0	None
11055	11056	solution	0	None
11056	11057	structure	0	None
11057	11058	of	0	None
11058	11059	the	0	None
11059	11064	light chain of factor VIIa	1	GENE-Y
11064	11065	in	0	None
11065	11066	the	0	None
11066	11067	absence	0	None
11067	11068	of	0	None
11068	11069	tissue	0	None
11069	11070	factor	0	None
11070	11071	is	0	None
11071	11072	predicted	0	None
11072	11073	to	0	None
11073	11074	be	0	None
11074	11075	an	0	None
11075	11076	extended	0	None
11076	11077	domain	0	None
11077	11078	structure	0	None
11078	11079	similar	0	None
11079	11080	to	0	None
11080	11081	that	0	None
11081	11082	of	0	None
11082	11083	the	0	None
11083	11084	tissue	0	None
11084	11085	factor	0	None
11085	11086	-	0	None
11086	11087	bound	0	None
11087	11088	crystal	0	None
11088	11089	.	0	None

11090	11091	Removal	0	None
11091	11092	of	0	None
11092	11093	the	0	None
11093	11094	EGF1	0	None
11094	11095	-	0	None
11095	11096	bound	0	None
11096	11097	calcium	0	None
11097	11098	ion	3	CHEMICAL
11098	11099	is	0	None
11099	11100	shown	0	None
11100	11101	by	0	None
11101	11102	simulation	0	None
11102	11103	to	0	None
11103	11104	lead	0	None
11104	11105	to	0	None
11105	11106	minor	0	None
11106	11107	structural	0	None
11107	11108	changes	0	None
11108	11109	within	0	None
11109	11110	the	0	None
11110	11112	EGF1 domain	2	GENE-N
11112	11113	,	0	None
11113	11114	but	0	None
11114	11115	also	0	None
11115	11116	leads	0	None
11116	11117	to	0	None
11117	11118	substantial	0	None
11118	11119	relative	0	None
11119	11120	reorientation	0	None
11120	11121	of	0	None
11121	11122	the	0	None
11122	11126	Gla and EGF1 domains	2	GENE-N
11126	11127	.	0	None

11128	11129	A	0	None
11129	11130	noncatalytic	0	None
11130	11131	tetrahydrofolate	3	CHEMICAL
11131	11132	tight	0	None
11132	11133	binding	0	None
11133	11134	site	0	None
11134	11135	is	0	None
11135	11136	on	0	None
11136	11137	the	0	None
11137	11138	small	0	None
11138	11139	domain	0	None
11139	11140	of	0	None
11140	11141	10	0	None
11141	11142	-	0	None
11142	11143	formyltetrahydrofolate	0	None
11143	11144	dehydrogenase	0	None
11144	11145	.	0	None

11146	11147	10	0	None
11147	11148	-	0	None
11148	11149	Formyltetrahydrofolate	0	None
11149	11150	dehydrogenase	0	None
11150	11151	has	0	None
11151	11152	previously	0	None
11152	11153	been	0	None
11153	11154	identified	0	None
11154	11155	as	0	None
11155	11156	a	0	None
11156	11157	tight	0	None
11157	11159	binding protein	2	GENE-N
11159	11160	of	0	None
11160	11161	the	0	None
11161	11162	polyglutamate	3	CHEMICAL
11162	11163	forms	0	None
11163	11164	of	0	None
11164	11165	tetrahydrofolate	3	CHEMICAL
11165	11166	(	0	None
11166	11167	R	0	None
11167	11168	.	0	None
11168	11169	J	0	None
11169	11170	.	0	None
11170	11171	Cook	0	None
11171	11172	and	0	None
11172	11173	C	0	None
11173	11174	.	0	None
11174	11175	Wagner	0	None
11175	11176	,	0	None
11176	11177	Biochemistry	0	None
11177	11178	21	0	None
11178	11179	,	0	None
11179	11180	4427	0	None
11180	11181	-	0	None
11181	11182	4434	0	None
11182	11183	,	0	None
11183	11184	1982	0	None
11184	11185	)	0	None
11185	11186	.	0	None

11187	11188	Each	0	None
11188	11189	subunit	0	None
11189	11190	contains	0	None
11190	11191	two	0	None
11191	11192	independently	0	None
11192	11193	folded	0	None
11193	11194	domains	0	None
11194	11195	connected	0	None
11195	11196	by	0	None
11196	11197	a	0	None
11197	11198	linking	0	None
11198	11199	peptide	0	None
11199	11200	.	0	None

11201	11202	By	0	None
11202	11203	using	0	None
11203	11204	the	0	None
11204	11205	stable	0	None
11205	11206	substrate	0	None
11206	11207	and	0	None
11207	11208	product	0	None
11208	11209	analogs	0	None
11209	11210	10	0	None
11210	11211	-	0	None
11211	11212	formyl	3	CHEMICAL
11212	11213	5	0	None
11213	11214	,	0	None
11214	11215	8	0	None
11215	11216	-	0	None
11216	11217	dideazafolate	0	None
11217	11218	and	0	None
11218	11219	5	0	None
11219	11220	,	0	None
11220	11221	8	0	None
11221	11222	-	0	None
11222	11223	dideazafolate	0	None
11223	11224	,	0	None
11224	11225	respectively	0	None
11225	11226	,	0	None
11226	11227	we	0	None
11227	11228	have	0	None
11228	11229	determined	0	None
11229	11230	that	0	None
11230	11231	the	0	None
11231	11232	tight	0	None
11232	11233	binding	0	None
11233	11234	folate	0	None
11234	11235	site	0	None
11235	11236	is	0	None
11236	11237	separate	0	None
11237	11238	from	0	None
11238	11239	the	0	None
11239	11240	catalytic	0	None
11240	11241	site	0	None
11241	11242	and	0	None
11242	11243	that	0	None
11243	11244	it	0	None
11244	11245	is	0	None
11245	11246	located	0	None
11246	11247	on	0	None
11247	11248	the	0	None
11248	11249	N	0	None
11249	11250	-	0	None
11250	11251	terminal	0	None
11251	11252	domain	0	None
11252	11253	of	0	None
11253	11254	the	0	None
11254	11255	protein	0	None
11255	11256	.	0	None

11257	11258	This	0	None
11258	11259	was	0	None
11259	11260	achieved	0	None
11260	11261	by	0	None
11261	11262	cross	0	None
11262	11263	-	0	None
11263	11264	linking	0	None
11264	11265	10	0	None
11265	11266	-	0	None
11266	11267	formyl	3	CHEMICAL
11267	11268	5	0	None
11268	11269	,	0	None
11269	11270	8	0	None
11270	11271	-	0	None
11271	11272	dideazafolate	0	None
11272	11273	to	0	None
11273	11274	the	0	None
11274	11275	dehydrogenase	0	None
11275	11276	through	0	None
11276	11277	the	0	None
11277	11278	carboxyl	0	None
11278	11279	group	0	None
11279	11280	of	0	None
11280	11281	the	0	None
11281	11282	substrate	0	None
11282	11283	analog	0	None
11283	11284	.	0	None

11285	11286	The	0	None
11286	11287	cross	0	None
11287	11288	-	0	None
11288	11289	linked	0	None
11289	11290	substrate	0	None
11290	11291	analog	0	None
11291	11292	was	0	None
11292	11293	converted	0	None
11293	11294	to	0	None
11294	11295	the	0	None
11295	11296	cross	0	None
11296	11297	-	0	None
11297	11298	linked	0	None
11298	11299	product	0	None
11299	11300	complex	0	None
11300	11301	by	0	None
11301	11302	adding	0	None
11302	11303	either	0	None
11303	11304	NADP	3	CHEMICAL
11304	11305	+	0	None
11305	11306	or	0	None
11306	11307	2	0	None
11307	11308	-	0	None
11308	11309	mercaptoethanol	0	None
11309	11310	,	0	None
11310	11311	proving	0	None
11311	11312	that	0	None
11312	11313	the	0	None
11313	11314	10	0	None
11314	11315	-	0	None
11315	11316	formyl	3	CHEMICAL
11316	11317	5	0	None
11317	11318	,	0	None
11318	11319	8	0	None
11319	11320	-	0	None
11320	11321	dideazafolate	0	None
11321	11322	was	0	None
11322	11323	bound	0	None
11323	11324	at	0	None
11324	11325	the	0	None
11325	11326	active	0	None
11326	11327	site	0	None
11327	11328	.	0	None

11329	11330	With	0	None
11330	11331	the	0	None
11331	11332	active	0	None
11332	11333	site	0	None
11333	11334	cross	0	None
11334	11335	-	0	None
11335	11336	linked	0	None
11336	11337	to	0	None
11337	11338	5	0	None
11338	11339	,	0	None
11339	11340	8	0	None
11340	11341	-	0	None
11341	11342	dideazafolate	0	None
11342	11343	and	0	None
11343	11344	not	0	None
11344	11345	available	0	None
11345	11346	for	0	None
11346	11347	binding	0	None
11347	11348	,	0	None
11348	11349	the	0	None
11349	11350	enzyme	0	None
11350	11351	still	0	None
11351	11352	bound	0	None
11352	11353	5	0	None
11353	11354	,	0	None
11354	11355	8	0	None
11355	11356	-	0	None
11356	11357	dideazafolate	0	None
11357	11358	-	0	None
11358	11359	[	0	None
11359	11360	3H	0	None
11360	11361	]	0	None
11361	11362	tetraglutamate	0	None
11362	11363	tightly	0	None
11363	11364	but	0	None
11364	11365	noncovalently	0	None
11365	11366	.	0	None

11367	11368	Separation	0	None
11368	11369	of	0	None
11369	11370	the	0	None
11370	11371	large	0	None
11371	11372	and	0	None
11372	11373	small	0	None
11373	11374	domains	0	None
11374	11375	by	0	None
11375	11376	limited	0	None
11376	11377	proteolysis	0	None
11377	11378	showed	0	None
11378	11379	that	0	None
11379	11380	the	0	None
11380	11381	tightly	0	None
11381	11382	bound	0	None
11382	11383	5	0	None
11383	11384	,	0	None
11384	11385	8	0	None
11385	11386	-	0	None
11386	11387	dideazafolate	0	None
11387	11388	-	0	None
11388	11389	[	0	None
11389	11390	3H	0	None
11390	11391	]	0	None
11391	11392	tetraglutamate	0	None
11392	11393	was	0	None
11393	11394	located	0	None
11394	11395	on	0	None
11395	11396	the	0	None
11396	11397	small	0	None
11397	11398	domain	0	None
11398	11399	.	0	None

11400	11401	The	0	None
11401	11402	location	0	None
11402	11403	of	0	None
11403	11404	the	0	None
11404	11405	cross	0	None
11405	11406	-	0	None
11406	11407	linked	0	None
11407	11408	10	0	None
11408	11409	-	0	None
11409	11410	formyl	3	CHEMICAL
11410	11411	5	0	None
11411	11412	,	0	None
11412	11413	8	0	None
11413	11414	-	0	None
11414	11415	dideazafolate	0	None
11415	11416	at	0	None
11416	11417	the	0	None
11417	11418	active	0	None
11418	11419	site	0	None
11419	11420	was	0	None
11420	11421	determined	0	None
11421	11422	by	0	None
11422	11424	amino acid	3	CHEMICAL
11424	11425	sequencing	0	None
11425	11426	of	0	None
11426	11427	an	0	None
11427	11428	isolated	0	None
11428	11429	tryptic	0	None
11429	11430	peptide	0	None
11430	11431	.	0	None

11432	11433	Inhibition	0	None
11433	11434	of	0	None
11434	11438	tumor necrosis factor alpha	1	GENE-Y
11438	11439	-	0	None
11439	11440	stimulated	0	None
11440	11441	aromatase	1	GENE-Y
11441	11442	activity	0	None
11442	11443	by	0	None
11443	11444	microtubule	2	GENE-N
11444	11445	-	0	None
11445	11446	stabilizing	0	None
11446	11447	agents	0	None
11447	11448	,	0	None
11448	11449	paclitaxel	3	CHEMICAL
11449	11450	and	0	None
11450	11451	2	0	None
11451	11452	-	0	None
11452	11453	methoxyestradiol	0	None
11453	11454	.	0	None

11455	11456	The	0	None
11456	11457	aromatase	1	GENE-Y
11457	11458	enzyme	0	None
11458	11459	,	0	None
11459	11460	which	0	None
11460	11461	converts	0	None
11461	11462	androstenedione	0	None
11462	11463	to	0	None
11463	11464	oestrone	3	CHEMICAL
11464	11465	,	0	None
11465	11466	regulates	0	None
11466	11467	the	0	None
11467	11468	availability	0	None
11468	11469	of	0	None
11469	11470	oestrogen	2	GENE-N
11470	11471	to	0	None
11471	11472	support	0	None
11472	11473	the	0	None
11473	11474	growth	0	None
11474	11475	of	0	None
11475	11476	hormone	0	None
11476	11477	-	0	None
11477	11478	dependent	0	None
11478	11479	breast	0	None
11479	11480	tumours	0	None
11480	11481	.	0	None

11482	11483	Cytokines	0	None
11483	11484	,	0	None
11484	11485	such	0	None
11485	11486	as	0	None
11486	11488	interleukin 6	1	GENE-Y
11488	11489	(	0	None
11489	11490	IL	0	None
11490	11491	-	0	None
11491	11492	6	0	None
11492	11493	)	0	None
11493	11494	and	0	None
11494	11498	tumour necrosis factor alpha	1	GENE-Y
11498	11499	(	0	None
11499	11500	TNFalpha	1	GENE-Y
11500	11501	)	0	None
11501	11502	or	0	None
11502	11504	prostaglandin E	3	CHEMICAL
11504	11505	(	0	None
11505	11506	2	0	None
11506	11507	)	0	None
11507	11508	(	0	None
11508	11509	PGE	3	CHEMICAL
11509	11510	(	0	None
11510	11511	2	0	None
11511	11512	)	0	None
11512	11513	)	0	None
11513	11514	,	0	None
11514	11515	can	0	None
11515	11516	stimulate	0	None
11516	11517	aromatase	1	GENE-Y
11517	11518	activity	0	None
11518	11519	.	0	None

11520	11521	These	0	None
11521	11522	factors	0	None
11522	11523	may	0	None
11523	11524	originate	0	None
11524	11525	from	0	None
11525	11526	cells	0	None
11526	11527	of	0	None
11527	11528	the	0	None
11528	11529	immune	0	None
11529	11530	system	0	None
11530	11531	that	0	None
11531	11532	infiltrate	0	None
11532	11533	breast	0	None
11533	11534	tumours	0	None
11534	11535	.	0	None

11536	11537	Paclitaxel	0	None
11537	11538	,	0	None
11538	11539	which	0	None
11539	11540	is	0	None
11540	11541	used	0	None
11541	11542	in	0	None
11542	11543	the	0	None
11543	11544	treatment	0	None
11544	11545	of	0	None
11545	11546	breast	0	None
11546	11547	cancer	0	None
11547	11548	,	0	None
11548	11549	stabilizes	0	None
11549	11550	microtubules	0	None
11550	11551	and	0	None
11551	11552	has	0	None
11552	11553	previously	0	None
11553	11554	been	0	None
11554	11555	shown	0	None
11555	11556	to	0	None
11556	11557	rapidly	0	None
11557	11558	down	0	None
11558	11559	-	0	None
11559	11560	regulate	0	None
11560	11561	TNF	2	GENE-N
11561	11562	-	0	None
11562	11563	receptors	0	None
11563	11564	on	0	None
11564	11565	human	0	None
11565	11566	macrophages	0	None
11566	11567	.	0	None

11568	11569	The	0	None
11569	11570	endogenous	0	None
11570	11571	oestrogen	3	CHEMICAL
11571	11572	metabolite	0	None
11572	11573	,	0	None
11573	11574	2	0	None
11574	11575	-	0	None
11575	11576	methoxyestradiol	0	None
11576	11577	(	0	None
11577	11578	2	0	None
11578	11579	-	0	None
11579	11580	meOE2	0	None
11580	11581	)	0	None
11581	11582	,	0	None
11582	11583	also	0	None
11583	11584	acts	0	None
11584	11585	to	0	None
11585	11586	stabilize	0	None
11586	11587	microtubules	0	None
11587	11588	.	0	None

11589	11590	In	0	None
11590	11591	this	0	None
11591	11592	study	0	None
11592	11593	,	0	None
11593	11594	we	0	None
11594	11595	have	0	None
11595	11596	examined	0	None
11596	11597	the	0	None
11597	11598	ability	0	None
11598	11599	of	0	None
11599	11600	paclitaxel	3	CHEMICAL
11600	11601	or	0	None
11601	11602	2	0	None
11602	11603	-	0	None
11603	11604	meOE2	0	None
11604	11605	to	0	None
11605	11606	antagonise	0	None
11606	11607	TNFalpha	1	GENE-Y
11607	11608	-	0	None
11608	11609	stimulated	0	None
11609	11610	aromatase	1	GENE-Y
11610	11611	activity	0	None
11611	11612	in	0	None
11612	11613	stromal	0	None
11613	11614	fibroblasts	0	None
11614	11615	derived	0	None
11615	11616	from	0	None
11616	11617	normal	0	None
11617	11618	or	0	None
11618	11619	malignant	0	None
11619	11620	breast	0	None
11620	11621	tissues	0	None
11621	11622	.	0	None

11623	11624	Paclitaxel	0	None
11624	11625	inhibited	0	None
11625	11626	basal	0	None
11626	11627	and	0	None
11627	11628	TNFalpha	1	GENE-Y
11628	11629	-	0	None
11629	11630	stimulated	0	None
11630	11631	aromatase	1	GENE-Y
11631	11632	activities	0	None
11632	11633	by	0	None
11633	11634	88	0	None
11634	11635	%	0	None
11635	11636	and	0	None
11636	11637	91	0	None
11637	11638	%	0	None
11638	11639	respectively	0	None
11639	11640	.	0	None

11641	11642	2	0	None
11642	11643	-	0	None
11643	11644	MeOE2	0	None
11644	11645	also	0	None
11645	11646	reduced	0	None
11646	11647	basal	0	None
11647	11648	and	0	None
11648	11649	TNFalpha	1	GENE-Y
11649	11650	-	0	None
11650	11651	stimulated	0	None
11651	11652	aromatase	1	GENE-Y
11652	11653	activities	0	None
11653	11654	by	0	None
11654	11655	46	0	None
11655	11656	%	0	None
11656	11657	and	0	None
11657	11658	56	0	None
11658	11659	%	0	None
11659	11660	respectively	0	None
11660	11661	.	0	None

11662	11663	Both	0	None
11663	11664	paclitaxel	3	CHEMICAL
11664	11665	and	0	None
11665	11666	2	0	None
11666	11667	-	0	None
11667	11668	meOE2	0	None
11668	11669	also	0	None
11669	11670	inhibited	0	None
11670	11671	stimulation	0	None
11671	11672	of	0	None
11672	11673	aromatase	1	GENE-Y
11673	11674	activity	0	None
11674	11675	by	0	None
11675	11676	IL	0	None
11676	11677	-	0	None
11677	11678	6	0	None
11678	11679	plus	0	None
11679	11680	its	0	None
11680	11681	soluble	0	None
11681	11682	receptor	0	None
11682	11683	and	0	None
11683	11684	PGE	3	CHEMICAL
11684	11685	(	0	None
11685	11686	2	0	None
11686	11687	)	0	None
11687	11688	.	0	None

11689	11690	The	0	None
11690	11691	16alpha	0	None
11691	11692	-	0	None
11692	11693	hydroxylated	0	None
11693	11694	derivative	0	None
11694	11695	of	0	None
11695	11696	2	0	None
11696	11697	-	0	None
11697	11698	meoE2	0	None
11698	11699	and	0	None
11699	11700	2	0	None
11700	11701	-	0	None
11701	11702	meOE3	0	None
11702	11703	,	0	None
11703	11704	which	0	None
11704	11705	does	0	None
11705	11706	not	0	None
11706	11707	bind	0	None
11707	11708	to	0	None
11708	11709	microtubules	0	None
11709	11710	,	0	None
11710	11711	was	0	None
11711	11712	less	0	None
11712	11713	effective	0	None
11713	11714	at	0	None
11714	11715	inhibiting	0	None
11715	11716	TNFalpha	1	GENE-Y
11716	11717	-	0	None
11717	11718	stimulated	0	None
11718	11719	aromatase	1	GENE-Y
11719	11720	activity	0	None
11720	11721	.	0	None

11722	11723	Increased	0	None
11723	11724	2	0	None
11724	11725	-	0	None
11725	11726	hydroxylation	0	None
11726	11727	of	0	None
11727	11728	oestrogens	0	None
11728	11729	,	0	None
11729	11730	and	0	None
11730	11731	subsequent	0	None
11731	11732	formation	0	None
11732	11733	of	0	None
11733	11734	their	0	None
11734	11735	2	0	None
11735	11736	-	0	None
11736	11737	methoxy	3	CHEMICAL
11737	11738	derivatives	0	None
11738	11739	,	0	None
11739	11740	may	0	None
11740	11741	be	0	None
11741	11742	associated	0	None
11742	11743	with	0	None
11743	11744	a	0	None
11744	11745	reduced	0	None
11745	11746	risk	0	None
11746	11747	of	0	None
11747	11748	breast	0	None
11748	11749	cancer	0	None
11749	11750	.	0	None

11751	11752	It	0	None
11752	11753	is	0	None
11753	11754	possible	0	None
11754	11755	that	0	None
11755	11756	the	0	None
11756	11757	pathway	0	None
11757	11758	of	0	None
11758	11759	oestrogen	3	CHEMICAL
11759	11760	metabolism	0	None
11760	11761	may	0	None
11761	11762	influence	0	None
11762	11763	the	0	None
11763	11764	ability	0	None
11764	11765	of	0	None
11765	11766	stromal	0	None
11766	11767	cells	0	None
11767	11768	to	0	None
11768	11769	respond	0	None
11769	11770	to	0	None
11770	11771	cytokine	2	GENE-N
11771	11772	stimulation	0	None
11772	11773	.	0	None

11774	11775	Insulin	0	None
11775	11776	resistance	0	None
11776	11777	and	0	None
11777	11778	thrombosis	0	None
11778	11779	:	0	None
11779	11780	a	0	None
11780	11781	cardiologist	0	None
11781	11782	'	0	None
11782	11783	s	0	None
11783	11784	view	0	None
11784	11785	.	0	None

11786	11787	Atherogenesis	0	None
11787	11788	in	0	None
11788	11789	the	0	None
11789	11790	vasculature	0	None
11790	11791	is	0	None
11791	11792	accelerated	0	None
11792	11793	by	0	None
11793	11794	changes	0	None
11794	11795	in	0	None
11795	11796	the	0	None
11796	11797	dynamic	0	None
11797	11798	equilibrium	0	None
11798	11799	between	0	None
11799	11800	endogenous	0	None
11800	11801	tissue	0	None
11801	11807	plasminogen activator and plasminogen activator inhibitor	2	GENE-N
11807	11808	-	0	None
11808	11809	1	0	None
11809	11810	(	0	None
11810	11811	PAI	2	GENE-N
11811	11812	-	0	None
11812	11813	1	0	None
11813	11814	)	0	None
11814	11815	.	0	None

11816	11817	Increased	0	None
11817	11818	expression	0	None
11818	11819	of	0	None
11819	11820	PAI	2	GENE-N
11820	11821	-	0	None
11821	11822	1	0	None
11822	11823	,	0	None
11823	11824	decreased	0	None
11824	11825	expression	0	None
11825	11826	of	0	None
11826	11829	tissue plasminogen activator	1	GENE-Y
11829	11830	,	0	None
11830	11831	or	0	None
11831	11832	both	0	None
11832	11833	can	0	None
11833	11834	lead	0	None
11834	11835	to	0	None
11835	11836	decreased	0	None
11836	11837	fibrinolytic	0	None
11837	11838	activity	0	None
11838	11839	and	0	None
11839	11840	predispose	0	None
11840	11841	to	0	None
11841	11842	thrombosis	0	None
11842	11843	.	0	None

11844	11845	Increased	0	None
11845	11846	concentrations	0	None
11846	11847	of	0	None
11847	11848	insulin	0	None
11848	11849	(	0	None
11849	11850	and	0	None
11850	11851	proinsulin	0	None
11851	11852	)	0	None
11852	11853	in	0	None
11853	11854	the	0	None
11854	11855	plasma	0	None
11855	11856	increase	0	None
11856	11857	plasma	0	None
11857	11858	PAI	2	GENE-N
11858	11859	-	0	None
11859	11860	1	0	None
11860	11861	,	0	None
11861	11862	although	0	None
11862	11863	the	0	None
11863	11864	mechanisms	0	None
11864	11865	of	0	None
11865	11866	this	0	None
11866	11867	effect	0	None
11867	11868	are	0	None
11868	11869	not	0	None
11869	11870	known	0	None
11870	11871	.	0	None

11872	11873	In	0	None
11873	11874	addition	0	None
11874	11875	,	0	None
11875	11876	it	0	None
11876	11877	has	0	None
11877	11878	been	0	None
11878	11879	observed	0	None
11879	11880	that	0	None
11880	11881	basal	0	None
11881	11882	fibrinolytic	0	None
11882	11883	activity	0	None
11883	11884	is	0	None
11884	11885	decreased	0	None
11885	11886	in	0	None
11886	11887	patients	0	None
11887	11888	with	0	None
11888	11889	type	0	None
11889	11890	2	0	None
11890	11891	diabetes	0	None
11891	11892	;	0	None
11892	11893	this	0	None
11893	11894	may	0	None
11894	11895	accelerate	0	None
11895	11896	atherosclerosis	0	None
11896	11897	by	0	None
11897	11898	exposing	0	None
11898	11899	vascular	0	None
11899	11900	luminal	0	None
11900	11901	wall	0	None
11901	11902	surfaces	0	None
11902	11903	to	0	None
11903	11904	persistent	0	None
11904	11905	and	0	None
11905	11906	recurrent	0	None
11906	11907	thrombi	0	None
11907	11908	.	0	None

11909	11910	Abnormalities	0	None
11910	11911	in	0	None
11911	11912	the	0	None
11912	11913	vessel	0	None
11913	11914	wall	0	None
11914	11915	appear	0	None
11915	11916	to	0	None
11916	11917	contribute	0	None
11917	11918	to	0	None
11918	11919	the	0	None
11919	11920	increased	0	None
11920	11921	risk	0	None
11921	11922	.	0	None

11923	11924	There	0	None
11924	11925	is	0	None
11925	11926	also	0	None
11926	11927	evidence	0	None
11927	11928	that	0	None
11928	11929	PAI	2	GENE-N
11929	11930	-	0	None
11930	11931	1	0	None
11931	11932	content	0	None
11932	11933	is	0	None
11933	11934	increased	0	None
11934	11935	in	0	None
11935	11936	atherosclerotic	0	None
11936	11937	lesions	0	None
11937	11938	of	0	None
11938	11939	patients	0	None
11939	11940	with	0	None
11940	11941	type	0	None
11941	11942	2	0	None
11942	11943	diabetes	0	None
11943	11944	,	0	None
11944	11945	suggesting	0	None
11945	11946	that	0	None
11946	11947	interventions	0	None
11947	11948	to	0	None
11948	11949	reduce	0	None
11949	11950	insulin	0	None
11950	11951	resistance	0	None
11951	11952	and	0	None
11952	11953	improve	0	None
11953	11954	glycemic	0	None
11954	11955	control	0	None
11955	11956	may	0	None
11956	11957	improve	0	None
11957	11958	the	0	None
11958	11959	fibrinolytic	0	None
11959	11960	response	0	None
11960	11961	.	0	None

11962	11963	Clinical	0	None
11963	11964	studies	0	None
11964	11965	in	0	None
11965	11966	patients	0	None
11966	11967	with	0	None
11967	11968	polycystic	0	None
11968	11969	ovary	0	None
11969	11970	syndrome	0	None
11970	11971	(	0	None
11971	11972	characterized	0	None
11972	11973	by	0	None
11973	11974	insulin	0	None
11974	11975	resistance	0	None
11975	11976	,	0	None
11976	11977	hyperinsulinemia	0	None
11977	11978	,	0	None
11978	11979	ovarian	0	None
11979	11980	androgen	3	CHEMICAL
11980	11981	overproduction	0	None
11981	11982	,	0	None
11982	11983	and	0	None
11983	11984	impaired	0	None
11984	11985	fibrinolytic	0	None
11985	11986	capacity	0	None
11986	11987	)	0	None
11987	11988	demonstrated	0	None
11988	11989	that	0	None
11989	11990	treatment	0	None
11990	11991	with	0	None
11991	11992	troglitazone	3	CHEMICAL
11992	11993	,	0	None
11993	11994	an	0	None
11994	11995	insulin	0	None
11995	11996	-	0	None
11996	11997	sensitizing	0	None
11997	11998	agent	0	None
11998	11999	,	0	None
11999	12000	can	0	None
12000	12001	markedly	0	None
12001	12002	reduce	0	None
12002	12003	blood	0	None
12003	12004	levels	0	None
12004	12005	of	0	None
12005	12006	PAI	2	GENE-N
12006	12007	-	0	None
12007	12008	1	0	None
12008	12009	.	0	None

12010	12011	There	0	None
12011	12012	is	0	None
12012	12013	also	0	None
12013	12014	clinical	0	None
12014	12015	evidence	0	None
12015	12016	that	0	None
12016	12017	these	0	None
12017	12018	agents	0	None
12018	12019	may	0	None
12019	12020	contribute	0	None
12020	12021	to	0	None
12021	12022	regression	0	None
12022	12023	of	0	None
12023	12024	intimal	0	None
12024	12025	medial	0	None
12025	12026	thickness	0	None
12026	12027	in	0	None
12027	12028	patients	0	None
12028	12029	with	0	None
12029	12030	type	0	None
12030	12031	2	0	None
12031	12032	diabetes	0	None
12032	12033	,	0	None
12033	12034	providing	0	None
12034	12035	further	0	None
12035	12036	indication	0	None
12036	12037	that	0	None
12037	12038	antidiabetic	0	None
12038	12039	interventions	0	None
12039	12040	may	0	None
12040	12041	help	0	None
12041	12042	inhibit	0	None
12042	12043	the	0	None
12043	12044	progression	0	None
12044	12045	of	0	None
12045	12046	early	0	None
12046	12047	atherosclerotic	0	None
12047	12048	lesions	0	None
12048	12049	.	0	None

12050	12051	An	0	None
12051	12053	estrogen receptor	1	GENE-Y
12053	12054	basis	0	None
12054	12055	for	0	None
12055	12056	raloxifene	3	CHEMICAL
12056	12057	action	0	None
12057	12058	in	0	None
12058	12059	bone	0	None
12059	12060	.	0	None

12061	12062	Although	0	None
12062	12063	controversy	0	None
12063	12064	remains	0	None
12064	12065	regarding	0	None
12065	12066	direct	0	None
12066	12067	effects	0	None
12067	12068	of	0	None
12068	12069	estrogen	3	CHEMICAL
12069	12070	on	0	None
12070	12071	bone	0	None
12071	12072	,	0	None
12072	12073	in	0	None
12073	12074	vivo	0	None
12074	12075	data	0	None
12075	12076	clearly	0	None
12076	12077	show	0	None
12077	12078	that	0	None
12078	12079	estrogens	3	CHEMICAL
12079	12080	suppress	0	None
12080	12081	bone	0	None
12081	12082	turnover	0	None
12082	12083	,	0	None
12083	12084	resulting	0	None
12084	12085	in	0	None
12085	12086	decreased	0	None
12086	12087	bone	0	None
12087	12088	resorption	0	None
12088	12089	and	0	None
12089	12090	formation	0	None
12090	12091	activity	0	None
12091	12092	.	0	None

12093	12094	Selective	0	None
12094	12096	estrogen receptor	1	GENE-Y
12096	12097	modulators	0	None
12097	12098	(	0	None
12098	12099	SERMs	0	None
12099	12100	)	0	None
12100	12101	,	0	None
12101	12102	such	0	None
12102	12103	as	0	None
12103	12104	raloxifene	3	CHEMICAL
12104	12105	,	0	None
12105	12106	produce	0	None
12106	12107	effects	0	None
12107	12108	on	0	None
12108	12109	bone	0	None
12109	12110	which	0	None
12110	12111	are	0	None
12111	12112	very	0	None
12112	12113	similar	0	None
12113	12114	to	0	None
12114	12115	those	0	None
12115	12116	of	0	None
12116	12117	estrogen	3	CHEMICAL
12117	12118	.	0	None

12119	12120	In	0	None
12120	12121	vitro	0	None
12121	12122	,	0	None
12122	12123	both	0	None
12123	12124	raloxifene	3	CHEMICAL
12124	12125	and	0	None
12125	12126	estrogen	3	CHEMICAL
12126	12127	inhibit	0	None
12127	12128	mammalian	0	None
12128	12129	osteoclast	0	None
12129	12130	differentiation	0	None
12130	12131	and	0	None
12131	12132	bone	0	None
12132	12133	resorption	0	None
12133	12134	activity	0	None
12134	12135	,	0	None
12135	12136	but	0	None
12136	12137	only	0	None
12137	12138	in	0	None
12138	12139	the	0	None
12139	12140	presence	0	None
12140	12141	of	0	None
12141	12142	IL	0	None
12142	12143	-	0	None
12143	12144	6	0	None
12144	12145	.	0	None

12146	12147	Data	0	None
12147	12148	from	0	None
12148	12149	a	0	None
12149	12150	number	0	None
12150	12151	of	0	None
12151	12152	ovariectomized	0	None
12152	12153	rat	0	None
12153	12154	model	0	None
12154	12155	manipulations	0	None
12155	12156	(	0	None
12156	12157	i	0	None
12157	12158	.	0	None
12158	12159	e	0	None
12159	12160	.	0	None
12160	12161	hypophysectomy	0	None
12161	12162	,	0	None
12162	12163	low	0	None
12163	12164	calcium	0	None
12164	12165	diet	0	None
12165	12166	and	0	None
12166	12167	drug	0	None
12167	12168	combinations	0	None
12168	12169	)	0	None
12169	12170	demonstrate	0	None
12170	12171	a	0	None
12171	12172	strong	0	None
12172	12173	parallel	0	None
12173	12174	between	0	None
12174	12175	the	0	None
12175	12176	antiosteopenic	0	None
12176	12177	effects	0	None
12177	12178	of	0	None
12178	12179	raloxifene	3	CHEMICAL
12179	12180	and	0	None
12180	12181	estrogen	3	CHEMICAL
12181	12182	.	0	None

12183	12184	A	0	None
12184	12185	characteristic	0	None
12185	12186	action	0	None
12186	12187	of	0	None
12187	12188	estrogens	3	CHEMICAL
12188	12189	on	0	None
12189	12190	the	0	None
12190	12191	skeleton	0	None
12191	12192	is	0	None
12192	12193	inhibition	0	None
12193	12194	of	0	None
12194	12195	longitudinal	0	None
12195	12196	bone	0	None
12196	12197	growth	0	None
12197	12198	,	0	None
12198	12199	an	0	None
12199	12200	effect	0	None
12200	12201	which	0	None
12201	12202	is	0	None
12202	12203	not	0	None
12203	12204	observed	0	None
12204	12205	with	0	None
12205	12206	other	0	None
12206	12207	resorption	0	None
12207	12208	inhibitors	0	None
12208	12209	,	0	None
12209	12210	including	0	None
12210	12211	calcitonin	1	GENE-Y
12211	12212	and	0	None
12212	12213	bisphosphonates	3	CHEMICAL
12213	12214	.	0	None

12215	12216	Consistent	0	None
12216	12217	with	0	None
12217	12218	an	0	None
12218	12219	estrogen	3	CHEMICAL
12219	12220	-	0	None
12220	12221	like	0	None
12221	12222	mechanism	0	None
12222	12223	on	0	None
12223	12224	bone	0	None
12224	12225	,	0	None
12225	12226	raloxifene	3	CHEMICAL
12226	12227	inhibits	0	None
12227	12228	longitudinal	0	None
12228	12229	bone	0	None
12229	12230	growth	0	None
12230	12231	in	0	None
12231	12232	growing	0	None
12232	12233	rats	0	None
12233	12234	.	0	None

12235	12236	In	0	None
12236	12237	addition	0	None
12237	12238	to	0	None
12238	12239	the	0	None
12239	12240	overall	0	None
12240	12241	similarity	0	None
12241	12242	of	0	None
12242	12243	the	0	None
12243	12244	bone	0	None
12244	12245	activity	0	None
12245	12246	profile	0	None
12246	12247	in	0	None
12247	12248	animals	0	None
12248	12249	,	0	None
12249	12250	estrogen	3	CHEMICAL
12250	12251	and	0	None
12251	12252	raloxifene	3	CHEMICAL
12252	12253	also	0	None
12253	12254	produce	0	None
12254	12255	similar	0	None
12255	12256	effects	0	None
12256	12257	on	0	None
12257	12258	various	0	None
12258	12259	signaling	0	None
12259	12260	pathways	0	None
12260	12261	relative	0	None
12261	12262	to	0	None
12262	12263	the	0	None
12263	12264	antiosteopenic	0	None
12264	12265	effect	0	None
12265	12266	of	0	None
12266	12267	these	0	None
12267	12268	two	0	None
12268	12269	agents	0	None
12269	12270	.	0	None

12271	12272	For	0	None
12272	12273	example	0	None
12273	12274	,	0	None
12274	12275	IL	0	None
12275	12276	-	0	None
12276	12277	6	0	None
12277	12278	,	0	None
12278	12279	a	0	None
12279	12280	cytokine	2	GENE-N
12280	12281	involved	0	None
12281	12282	in	0	None
12282	12283	high	0	None
12283	12284	turnover	0	None
12284	12285	bone	0	None
12285	12286	resorption	0	None
12286	12287	following	0	None
12287	12288	estrogen	3	CHEMICAL
12288	12289	deficiency	0	None
12289	12290	in	0	None
12290	12291	rats	0	None
12291	12292	,	0	None
12292	12293	is	0	None
12293	12294	suppressed	0	None
12294	12295	by	0	None
12295	12296	both	0	None
12296	12297	raloxifene	3	CHEMICAL
12297	12298	and	0	None
12298	12299	estrogen	3	CHEMICAL
12299	12300	.	0	None

12301	12302	Raloxifene	0	None
12302	12303	and	0	None
12303	12304	estrogen	3	CHEMICAL
12304	12305	also	0	None
12305	12306	produce	0	None
12306	12307	a	0	None
12307	12308	similar	0	None
12308	12309	activation	0	None
12309	12310	of	0	None
12310	12311	TGF	0	None
12311	12312	-	0	None
12312	12313	beta3	0	None
12313	12314	(	0	None
12314	12315	a	0	None
12315	12316	cytokine	2	GENE-N
12316	12317	associated	0	None
12317	12318	with	0	None
12318	12319	inhibition	0	None
12319	12320	of	0	None
12320	12321	osteoclast	0	None
12321	12322	differentiation	0	None
12322	12323	and	0	None
12323	12324	activity	0	None
12324	12325	)	0	None
12325	12326	in	0	None
12326	12327	ovariectomized	0	None
12327	12328	rats	0	None
12328	12329	.	0	None

12330	12331	Like	0	None
12331	12332	17beta	0	None
12332	12333	-	0	None
12333	12334	estradiol	3	CHEMICAL
12334	12335	,	0	None
12335	12336	raloxifene	3	CHEMICAL
12336	12337	binds	0	None
12337	12338	with	0	None
12338	12339	high	0	None
12339	12340	affinity	0	None
12340	12341	to	0	None
12341	12342	both	0	None
12342	12344	estrogen receptor	1	GENE-Y
12344	12345	-	0	None
12345	12346	alpha	0	None
12346	12347	(	0	None
12347	12348	ER	1	GENE-Y
12348	12349	alpha	0	None
12349	12350	)	0	None
12350	12351	and	0	None
12351	12353	estrogen receptor	1	GENE-Y
12353	12354	-	0	None
12354	12355	beta	0	None
12355	12356	(	0	None
12356	12357	ER	1	GENE-Y
12357	12358	beta	0	None
12358	12359	)	0	None
12359	12360	.	0	None

12361	12362	Crystal	0	None
12362	12363	structure	0	None
12363	12364	analyses	0	None
12364	12365	have	0	None
12365	12366	shown	0	None
12366	12367	that	0	None
12367	12368	17beta	0	None
12368	12369	-	0	None
12369	12370	estradiol	3	CHEMICAL
12370	12371	and	0	None
12371	12372	raloxifene	3	CHEMICAL
12372	12373	bind	0	None
12373	12374	to	0	None
12374	12375	ER	1	GENE-Y
12375	12376	alpha	0	None
12376	12377	with	0	None
12377	12378	small	0	None
12378	12379	,	0	None
12379	12380	but	0	None
12380	12381	important	0	None
12381	12382	,	0	None
12382	12383	differences	0	None
12383	12384	in	0	None
12384	12385	three	0	None
12385	12386	dimensional	0	None
12386	12387	structure	0	None
12387	12388	.	0	None

12389	12390	These	0	None
12390	12391	subtle	0	None
12391	12392	differences	0	None
12392	12393	in	0	None
12393	12394	the	0	None
12394	12395	conformation	0	None
12395	12396	of	0	None
12396	12397	the	0	None
12397	12398	ligand	0	None
12398	12399	:	0	None
12399	12400	receptor	0	None
12400	12401	complex	0	None
12401	12402	are	0	None
12402	12403	likely	0	None
12403	12404	the	0	None
12404	12405	basis	0	None
12405	12406	for	0	None
12406	12407	the	0	None
12407	12408	key	0	None
12408	12409	pharmacological	0	None
12409	12410	differences	0	None
12410	12411	between	0	None
12411	12412	estrogens	3	CHEMICAL
12412	12413	and	0	None
12413	12414	the	0	None
12414	12415	various	0	None
12415	12416	SERMs	0	None
12416	12417	(	0	None
12417	12418	i	0	None
12418	12419	.	0	None
12419	12420	e	0	None
12420	12421	.	0	None
12421	12422	raloxifene	3	CHEMICAL
12422	12423	vs	0	None
12423	12424	tamoxifen	3	CHEMICAL
12424	12425	)	0	None
12425	12426	.	0	None

12427	12428	Raloxifene	0	None
12428	12429	also	0	None
12429	12430	produces	0	None
12430	12431	estrogen	3	CHEMICAL
12431	12432	-	0	None
12432	12433	like	0	None
12433	12434	effects	0	None
12434	12435	on	0	None
12435	12436	serum	0	None
12436	12437	cholesterol	3	CHEMICAL
12437	12438	metabolism	0	None
12438	12439	and	0	None
12439	12440	the	0	None
12440	12441	vasculature	0	None
12441	12442	.	0	None

12443	12444	Thus	0	None
12444	12445	,	0	None
12445	12446	while	0	None
12446	12447	raloxifene	3	CHEMICAL
12447	12448	exhibits	0	None
12448	12449	a	0	None
12449	12450	complete	0	None
12450	12451	estrogen	3	CHEMICAL
12451	12452	antagonist	0	None
12452	12453	in	0	None
12453	12454	mammary	0	None
12454	12455	tissue	0	None
12455	12456	and	0	None
12456	12457	the	0	None
12457	12458	uterus	0	None
12458	12459	,	0	None
12459	12460	it	0	None
12460	12461	produces	0	None
12461	12462	beneficial	0	None
12462	12463	effects	0	None
12463	12464	on	0	None
12464	12465	the	0	None
12465	12466	cardiovascular	0	None
12466	12467	system	0	None
12467	12468	and	0	None
12468	12469	prevents	0	None
12469	12470	bone	0	None
12470	12471	loss	0	None
12471	12472	via	0	None
12472	12473	an	0	None
12473	12475	estrogen receptor	1	GENE-Y
12475	12476	mediated	0	None
12476	12477	mechanism	0	None
12477	12478	.	0	None

12479	12480	Discovery	0	None
12480	12481	of	0	None
12481	12482	novel	0	None
12482	12483	peptidic	0	None
12483	12485	dopamine transporter	1	GENE-Y
12485	12486	ligands	0	None
12486	12487	by	0	None
12487	12488	screening	0	None
12488	12489	a	0	None
12489	12490	positional	0	None
12490	12491	scanning	0	None
12491	12492	combinatorial	0	None
12492	12493	hexapeptide	0	None
12493	12494	library	0	None
12494	12495	.	0	None

12496	12497	The	0	None
12497	12498	acute	0	None
12498	12499	reinforcing	0	None
12499	12500	effects	0	None
12500	12501	of	0	None
12501	12502	cocaine	0	None
12502	12503	are	0	None
12503	12504	thought	0	None
12504	12505	by	0	None
12505	12506	some	0	None
12506	12507	to	0	None
12507	12508	result	0	None
12508	12509	from	0	None
12509	12510	cocaine	0	None
12510	12511	binding	0	None
12511	12512	to	0	None
12512	12513	the	0	None
12513	12514	dopamine	3	CHEMICAL
12514	12515	(	0	None
12515	12516	DA	3	CHEMICAL
12516	12517	)	0	None
12517	12518	transporter	0	None
12518	12519	,	0	None
12519	12520	which	0	None
12520	12521	inhibits	0	None
12521	12522	DA	3	CHEMICAL
12522	12523	uptake	0	None
12523	12524	and	0	None
12524	12525	increases	0	None
12525	12526	synaptic	0	None
12526	12527	DA	3	CHEMICAL
12527	12528	levels	0	None
12528	12529	in	0	None
12529	12530	the	0	None
12530	12531	mesolimbic	0	None
12531	12532	system	0	None
12532	12533	.	0	None

12534	12535	Other	0	None
12535	12536	data	0	None
12536	12537	suggest	0	None
12537	12538	that	0	None
12538	12539	neurotransmitters	0	None
12539	12540	other	0	None
12540	12541	than	0	None
12541	12542	DA	3	CHEMICAL
12542	12543	contribute	0	None
12543	12544	to	0	None
12544	12545	cocaine	0	None
12545	12546	reinforcement	0	None
12546	12547	and	0	None
12547	12548	addiction	0	None
12548	12549	.	0	None

12550	12551	These	0	None
12551	12552	considerations	0	None
12552	12553	illustrate	0	None
12553	12554	the	0	None
12554	12555	need	0	None
12555	12556	to	0	None
12556	12557	have	0	None
12557	12558	additional	0	None
12558	12559	research	0	None
12559	12560	tools	0	None
12560	12561	with	0	None
12561	12562	which	0	None
12562	12563	to	0	None
12563	12564	test	3	CHEMICAL
12564	12565	the	0	None
12565	12566	"	0	None
12566	12567	DA	3	CHEMICAL
12567	12568	hypothesis	0	None
12568	12569	.	0	None
12569	12570	"	0	None
12570	12571	One	0	None
12571	12572	strategy	0	None
12572	12573	is	0	None
12573	12574	to	0	None
12574	12575	identify	0	None
12575	12576	drugs	0	None
12576	12577	which	0	None
12577	12578	bind	0	None
12578	12579	to	0	None
12579	12580	the	0	None
12580	12582	DA transporter	1	GENE-Y
12582	12583	(	0	None
12583	12584	DAT	1	GENE-Y
12584	12585	ligands	0	None
12585	12586	)	0	None
12586	12587	but	0	None
12587	12588	which	0	None
12588	12589	do	0	None
12589	12590	not	0	None
12590	12591	inhibit	0	None
12591	12592	DA	3	CHEMICAL
12592	12593	uptake	0	None
12593	12594	as	0	None
12594	12595	effectively	0	None
12595	12596	as	0	None
12596	12597	cocaine	0	None
12597	12598	.	0	None

12599	12600	The	0	None
12600	12601	purpose	0	None
12601	12602	of	0	None
12602	12603	the	0	None
12603	12604	present	0	None
12604	12605	study	0	None
12605	12606	was	0	None
12606	12607	to	0	None
12607	12608	identify	0	None
12608	12609	members	0	None
12609	12610	of	0	None
12610	12611	a	0	None
12611	12612	novel	0	None
12612	12613	structural	0	None
12613	12614	class	0	None
12614	12615	of	0	None
12615	12616	DAT	1	GENE-Y
12616	12617	ligands	0	None
12617	12618	and	0	None
12618	12619	to	0	None
12619	12620	characterize	0	None
12620	12621	their	0	None
12621	12622	interactions	0	None
12622	12623	at	0	None
12623	12624	the	0	None
12624	12626	DA transporter	1	GENE-Y
12626	12627	.	0	None

12628	12629	A	0	None
12629	12630	positional	0	None
12630	12631	scanning	0	None
12631	12632	hexapeptide	0	None
12632	12633	D	0	None
12633	12634	-	0	None
12634	12636	amino acid	3	CHEMICAL
12636	12637	library	0	None
12637	12638	was	0	None
12638	12639	screened	0	None
12639	12640	for	0	None
12640	12641	inhibition	0	None
12641	12642	of	0	None
12642	12643	[	0	None
12643	12644	(	0	None
12644	12645	125	0	None
12645	12646	)	0	None
12646	12647	I	0	None
12647	12648	]	0	None
12648	12649	RTI	0	None
12649	12650	-	0	None
12650	12651	55	0	None
12651	12652	binding	0	None
12652	12653	to	0	None
12653	12657	rat caudate DA transporters	2	GENE-N
12657	12658	.	0	None

12659	12660	Based	0	None
12660	12661	on	0	None
12661	12662	the	0	None
12662	12663	results	0	None
12663	12664	,	0	None
12664	12665	12	0	None
12665	12666	peptides	0	None
12666	12667	were	0	None
12667	12668	synthesized	0	None
12668	12669	.	0	None

12670	12671	All	0	None
12671	12672	12	0	None
12672	12673	peptides	0	None
12673	12674	inhibited	0	None
12674	12675	[	0	None
12675	12676	(	0	None
12676	12677	125	0	None
12677	12678	)	0	None
12678	12679	I	0	None
12679	12680	]	0	None
12680	12681	RTI	0	None
12681	12682	-	0	None
12682	12683	55	0	None
12683	12684	binding	0	None
12684	12685	to	0	None
12685	12687	DA transporters	2	GENE-N
12687	12688	with	0	None
12688	12689	IC	0	None
12689	12690	(	0	None
12690	12691	50	0	None
12691	12692	)	0	None
12692	12693	values	0	None
12693	12694	,	0	None
12694	12695	which	0	None
12695	12696	ranged	0	None
12696	12697	from	0	None
12697	12698	1	0	None
12698	12699	.	0	None
12699	12700	8	0	None
12700	12701	microM	0	None
12701	12702	to	0	None
12702	12703	12	0	None
12703	12704	microM	0	None
12704	12705	.	0	None

12706	12707	The	0	None
12707	12708	two	0	None
12708	12709	most	0	None
12709	12710	potent	0	None
12710	12711	peptides	0	None
12711	12712	(	0	None
12712	12713	TPI	3	CHEMICAL
12713	12714	-	0	None
12714	12715	669	0	None
12715	12716	-	0	None
12716	12717	1	0	None
12717	12718	and	0	None
12718	12719	TPI	3	CHEMICAL
12719	12720	-	0	None
12720	12721	669	0	None
12721	12722	-	0	None
12722	12723	4	0	None
12723	12724	)	0	None
12724	12725	were	0	None
12725	12726	prepared	0	None
12726	12727	in	0	None
12727	12728	larger	0	None
12728	12729	quantities	0	None
12729	12730	and	0	None
12730	12731	were	0	None
12731	12732	characterized	0	None
12732	12733	further	0	None
12733	12734	for	0	None
12734	12735	activity	0	None
12735	12736	at	0	None
12736	12737	the	0	None
12737	12738	DAT	1	GENE-Y
12738	12739	and	0	None
12739	12740	5	0	None
12740	12741	-	0	None
12741	12742	HT	3	CHEMICAL
12742	12743	transporter	0	None
12743	12744	.	0	None

12745	12746	Both	0	None
12746	12747	peptides	0	None
12747	12748	inhibited	0	None
12748	12749	DA	3	CHEMICAL
12749	12750	and	0	None
12750	12751	5	0	None
12751	12752	-	0	None
12752	12753	HT	3	CHEMICAL
12753	12754	uptake	0	None
12754	12755	and	0	None
12755	12756	transporter	0	None
12756	12757	binding	0	None
12757	12758	with	0	None
12758	12759	IC	0	None
12759	12760	(	0	None
12760	12761	50	0	None
12761	12762	)	0	None
12762	12763	/	0	None
12763	12764	K	0	None
12764	12765	(	0	None
12765	12766	i	0	None
12766	12767	)	0	None
12767	12768	values	0	None
12768	12769	in	0	None
12769	12770	the	0	None
12770	12771	low	0	None
12771	12772	micromolar	0	None
12772	12773	range	0	None
12773	12774	.	0	None

12775	12776	In	0	None
12776	12777	vivo	0	None
12777	12778	microdialysis	0	None
12778	12779	studies	0	None
12779	12780	demonstrated	0	None
12780	12781	that	0	None
12781	12782	both	0	None
12782	12783	peptides	0	None
12783	12784	increase	0	None
12784	12786	extracellular DA	3	CHEMICAL
12786	12787	and	0	None
12787	12788	5	0	None
12788	12789	-	0	None
12789	12790	HT	3	CHEMICAL
12790	12791	in	0	None
12791	12792	the	0	None
12792	12793	nucleus	0	None
12793	12794	accumbens	0	None
12794	12795	of	0	None
12795	12796	rats	0	None
12796	12797	.	0	None

12798	12799	These	0	None
12799	12800	data	0	None
12800	12801	demonstrate	0	None
12801	12802	that	0	None
12802	12803	peptides	0	None
12803	12804	can	0	None
12804	12805	function	0	None
12805	12806	as	0	None
12806	12807	inhibitors	0	None
12807	12808	of	0	None
12808	12809	biogenic	0	None
12809	12810	amine	3	CHEMICAL
12810	12811	transport	0	None
12811	12812	.	0	None

12813	12814	Future	0	None
12814	12815	work	0	None
12815	12816	will	0	None
12816	12817	focus	0	None
12817	12818	on	0	None
12818	12819	developing	0	None
12819	12820	more	0	None
12820	12821	potent	0	None
12821	12822	and	0	None
12822	12823	selective	0	None
12823	12824	peptides	0	None
12824	12825	.	0	None

12826	12827	Published	0	None
12827	12828	1999	0	None
12828	12829	Wiley	0	None
12829	12830	-	0	None
12830	12831	Liss	0	None
12831	12832	,	0	None
12832	12833	Inc	0	None
12833	12834	.	0	None

12835	12836	Role	0	None
12836	12837	of	0	None
12837	12838	edrophonium	0	None
12838	12839	in	0	None
12839	12840	prevention	0	None
12840	12841	of	0	None
12841	12842	the	0	None
12842	12843	re	0	None
12843	12844	-	0	None
12844	12845	inhibition	0	None
12845	12846	of	0	None
12846	12847	acetylcholinesterase	1	GENE-Y
12847	12848	by	0	None
12848	12849	phosphorylated	0	None
12849	12850	oxime	0	None
12850	12851	.	0	None

12852	12853	We	0	None
12853	12854	examined	0	None
12854	12855	the	0	None
12855	12856	role	0	None
12856	12857	of	0	None
12857	12858	edrophonium	0	None
12858	12859	in	0	None
12859	12860	the	0	None
12860	12861	acceleration	0	None
12861	12862	phenomenon	0	None
12862	12863	using	0	None
12863	12864	mouse	0	None
12864	12865	wild	0	None
12865	12866	-	0	None
12866	12867	type	0	None
12867	12868	and	0	None
12868	12869	mutant	0	None
12869	12870	D74N	2	GENE-N
12870	12871	AChE	1	GENE-Y
12871	12872	inhibited	0	None
12872	12873	with	0	None
12873	12874	7	0	None
12874	12875	-	0	None
12875	12876	(	0	None
12876	12877	O	0	None
12877	12878	,	0	None
12878	12879	O	0	None
12879	12880	-	0	None
12880	12881	diethyl	0	None
12881	12882	-	0	None
12882	12883	phosphinyloxy	0	None
12883	12884	)	0	None
12884	12885	-	0	None
12885	12886	1	0	None
12886	12887	-	0	None
12887	12888	methylquinolinium	0	None
12888	12889	methylsulfate	0	None
12889	12890	(	0	None
12890	12891	DEPQ	3	CHEMICAL
12891	12892	)	0	None
12892	12893	.	0	None

12894	12895	With	0	None
12895	12896	DEPQ	3	CHEMICAL
12896	12897	-	0	None
12897	12898	inhibited	0	None
12898	12899	wild	0	None
12899	12900	-	0	None
12900	12901	type	0	None
12901	12902	mouse	0	None
12902	12903	acetylcholinesterase	1	GENE-Y
12903	12904	(	0	None
12904	12905	AChE	1	GENE-Y
12905	12906	)	0	None
12906	12907	,	0	None
12907	12908	the	0	None
12908	12909	reactivation	0	None
12909	12910	kinetic	0	None
12910	12911	profile	0	None
12911	12912	demonstrated	0	None
12912	12913	one	0	None
12913	12914	-	0	None
12914	12915	phase	0	None
12915	12916	exponential	0	None
12916	12917	association	0	None
12917	12918	only	0	None
12918	12919	when	0	None
12919	12920	2	0	None
12920	12921	-	0	None
12921	12922	[	0	None
12922	12923	hydroxyimino	0	None
12923	12924	methyl	3	CHEMICAL
12924	12925	]	0	None
12925	12926	-	0	None
12926	12927	1	0	None
12927	12928	-	0	None
12928	12929	methylpyridinium	0	None
12929	12930	chloride	3	CHEMICAL
12930	12931	(	0	None
12931	12932	2	0	None
12932	12933	-	0	None
12933	12934	PAM	0	None
12934	12935	)	0	None
12935	12936	and	0	None
12936	12937	1	0	None
12937	12938	-	0	None
12938	12939	(	0	None
12939	12940	2	0	None
12940	12941	-	0	None
12941	12942	hydroxy	3	CHEMICAL
12942	12943	-	0	None
12943	12944	iminomethyl	0	None
12944	12945	-	0	None
12945	12946	1	0	None
12946	12947	-	0	None
12947	12948	pyridinium	0	None
12948	12949	)	0	None
12949	12950	-	0	None
12950	12951	1	0	None
12951	12952	-	0	None
12952	12953	(	0	None
12953	12954	4	0	None
12954	12955	-	0	None
12955	12956	carboxy	3	CHEMICAL
12956	12957	-	0	None
12957	12958	aminopyridi	0	None
12958	12959	nium	0	None
12959	12960	)	0	None
12960	12961	-	0	None
12961	12962	dimethyl	0	None
12962	12963	ether	0	None
12963	12964	hydrochloride	0	None
12964	12965	(	0	None
12965	12966	HI	0	None
12966	12967	-	0	None
12967	12968	6	0	None
12968	12969	)	0	None
12969	12970	were	0	None
12970	12971	used	0	None
12971	12972	as	0	None
12972	12973	reactivators	0	None
12973	12974	.	0	None

12975	12976	When	0	None
12976	12977	1	0	None
12977	12978	,	0	None
12978	12979	1	0	None
12979	12980	[	0	None
12980	12981	oxybis	0	None
12981	12982	-	0	None
12982	12983	methylene	3	CHEMICAL
12983	12984	)	0	None
12984	12985	bis	0	None
12985	12986	[	0	None
12986	12987	4	0	None
12987	12988	-	0	None
12988	12989	(	0	None
12989	12990	hydroxyimino	0	None
12990	12991	)	0	None
12991	12992	methyl	3	CHEMICAL
12992	12993	]	0	None
12993	12994	pyridinium	0	None
12994	12995	dichloride	0	None
12995	12996	(	0	None
12996	12997	LuH6	3	CHEMICAL
12997	12998	)	0	None
12998	12999	and	0	None
12999	13000	1	0	None
13000	13001	,	0	None
13001	13002	1	0	None
13002	13003	-	0	None
13003	13004	trimethylene	0	None
13004	13005	bis	0	None
13005	13006	(	0	None
13006	13007	4	0	None
13007	13008	-	0	None
13008	13009	hydroxyimino	0	None
13009	13010	methyl	3	CHEMICAL
13010	13011	)	0	None
13011	13012	pyridinium	0	None
13012	13013	dichloride	0	None
13013	13014	(	0	None
13014	13015	TMB4	3	CHEMICAL
13015	13016	)	0	None
13016	13017	were	0	None
13017	13018	used	0	None
13018	13019	,	0	None
13019	13020	the	0	None
13020	13021	reactivation	0	None
13021	13022	kinetic	0	None
13022	13023	profile	0	None
13023	13024	was	0	None
13024	13025	biphasic	0	None
13025	13026	in	0	None
13026	13027	nature	0	None
13027	13028	.	0	None

13029	13030	Edrophonium	0	None
13030	13031	had	0	None
13031	13032	no	0	None
13032	13033	effect	0	None
13033	13034	on	0	None
13034	13035	reactivation	0	None
13035	13036	by	0	None
13036	13037	2	0	None
13037	13038	-	0	None
13038	13039	PAM	0	None
13039	13040	and	0	None
13040	13041	HI	0	None
13041	13042	-	0	None
13042	13043	6	0	None
13043	13044	,	0	None
13044	13045	but	0	None
13045	13046	significantly	0	None
13046	13047	accelerated	0	None
13047	13048	LuH6	3	CHEMICAL
13048	13049	-	0	None
13049	13050	and	0	None
13050	13051	TMB4	3	CHEMICAL
13051	13052	-	0	None
13052	13053	induced	0	None
13053	13054	reactivation	0	None
13054	13055	of	0	None
13055	13056	DEPQ	3	CHEMICAL
13056	13057	-	0	None
13057	13058	inhibited	0	None
13058	13059	wild	0	None
13059	13060	-	0	None
13060	13061	type	0	None
13061	13062	mouse	0	None
13062	13063	AChE	1	GENE-Y
13063	13064	.	0	None

13065	13066	Comparison	0	None
13066	13067	of	0	None
13067	13068	the	0	None
13068	13069	initial	0	None
13069	13070	and	0	None
13070	13071	overall	0	None
13071	13072	reactivation	0	None
13072	13073	rate	0	None
13073	13074	constants	0	None
13074	13075	with	0	None
13075	13076	five	0	None
13076	13077	oximes	3	CHEMICAL
13077	13078	indicated	0	None
13078	13079	that	0	None
13079	13080	acceleration	0	None
13080	13081	by	0	None
13081	13082	edrophonium	0	None
13082	13083	may	0	None
13083	13084	be	0	None
13084	13085	due	0	None
13085	13086	to	0	None
13086	13087	the	0	None
13087	13088	prevention	0	None
13088	13089	of	0	None
13089	13090	re	0	None
13090	13091	-	0	None
13091	13092	inhibition	0	None
13092	13093	of	0	None
13093	13094	the	0	None
13094	13095	reactivated	0	None
13095	13096	enzyme	0	None
13096	13097	by	0	None
13097	13098	the	0	None
13098	13099	phosphorylated	0	None
13099	13100	oxime	0	None
13100	13101	(	0	None
13101	13102	POX	1	GENE-Y
13102	13103	)	0	None
13103	13104	produced	0	None
13104	13105	during	0	None
13105	13106	the	0	None
13106	13107	reactivation	0	None
13107	13108	.	0	None

13109	13110	With	0	None
13110	13111	LuH6	3	CHEMICAL
13111	13112	and	0	None
13112	13113	TMB4	3	CHEMICAL
13113	13114	,	0	None
13114	13115	about	0	None
13115	13116	2	0	None
13116	13117	.	0	None
13117	13118	5	0	None
13118	13119	-	0	None
13119	13120	fold	0	None
13120	13121	increase	0	None
13121	13122	in	0	None
13122	13123	the	0	None
13123	13124	reactivation	0	None
13124	13125	rate	0	None
13125	13126	constants	0	None
13126	13127	was	0	None
13127	13128	observed	0	None
13128	13129	in	0	None
13129	13130	the	0	None
13130	13131	presence	0	None
13131	13132	of	0	None
13132	13133	edrophonium	0	None
13133	13134	,	0	None
13134	13135	but	0	None
13135	13136	little	0	None
13136	13137	or	0	None
13137	13138	no	0	None
13138	13139	effect	0	None
13139	13140	was	0	None
13140	13141	observed	0	None
13141	13142	with	0	None
13142	13143	the	0	None
13143	13144	other	0	None
13144	13145	three	0	None
13145	13146	oximes	3	CHEMICAL
13146	13147	.	0	None

13148	13149	The	0	None
13149	13150	initial	0	None
13150	13151	reactivation	0	None
13151	13152	rate	0	None
13152	13153	constants	0	None
13153	13154	were	0	None
13154	13155	5	0	None
13155	13156	.	0	None
13156	13157	4	0	None
13157	13158	-	0	None
13158	13159	and	0	None
13159	13160	4	0	None
13160	13161	.	0	None
13161	13162	2	0	None
13162	13163	-	0	None
13163	13164	fold	0	None
13164	13165	of	0	None
13165	13166	the	0	None
13166	13167	overall	0	None
13167	13168	rate	0	None
13168	13169	constants	0	None
13169	13170	with	0	None
13170	13171	LuH6	3	CHEMICAL
13171	13172	and	0	None
13172	13173	TMB4	3	CHEMICAL
13173	13174	as	0	None
13174	13175	reactivators	0	None
13175	13176	respectively	0	None
13176	13177	,	0	None
13177	13178	however	0	None
13178	13179	,	0	None
13179	13180	very	0	None
13180	13181	little	0	None
13181	13182	change	0	None
13182	13183	was	0	None
13183	13184	found	0	None
13184	13185	between	0	None
13185	13186	the	0	None
13186	13187	initial	0	None
13187	13188	and	0	None
13188	13189	overall	0	None
13189	13190	rate	0	None
13190	13191	constants	0	None
13191	13192	with	0	None
13192	13193	the	0	None
13193	13194	other	0	None
13194	13195	three	0	None
13195	13196	oximes	3	CHEMICAL
13196	13197	.	0	None

13198	13199	In	0	None
13199	13200	experiments	0	None
13200	13201	with	0	None
13201	13202	D74N	2	GENE-N
13202	13203	AChE	1	GENE-Y
13203	13204	,	0	None
13204	13205	for	0	None
13205	13206	which	0	None
13206	13207	the	0	None
13207	13208	inhibition	0	None
13208	13209	potency	0	None
13209	13210	of	0	None
13210	13211	charged	0	None
13211	13212	organophosphate	3	CHEMICAL
13212	13213	(	0	None
13213	13214	OP	0	None
13214	13215	)	0	None
13215	13216	was	0	None
13216	13217	two	0	None
13217	13218	to	0	None
13218	13219	three	0	None
13219	13220	orders	0	None
13220	13221	less	0	None
13221	13222	than	0	None
13222	13223	wild	0	None
13223	13224	-	0	None
13224	13225	type	0	None
13225	13226	enzyme	0	None
13226	13227	,	0	None
13227	13228	edrophonium	0	None
13228	13229	had	0	None
13229	13230	no	0	None
13230	13231	effect	0	None
13231	13232	on	0	None
13232	13233	the	0	None
13233	13234	reactivation	0	None
13234	13235	by	0	None
13235	13236	LuH6	3	CHEMICAL
13236	13237	and	0	None
13237	13238	TMB4	3	CHEMICAL
13238	13239	and	0	None
13239	13240	the	0	None
13240	13241	time	0	None
13241	13242	courses	0	None
13242	13243	of	0	None
13243	13244	reactivation	0	None
13244	13245	were	0	None
13245	13246	monophasic	0	None
13246	13247	.	0	None

13248	13249	The	0	None
13249	13250	data	0	None
13250	13251	from	0	None
13251	13252	mutant	0	None
13252	13253	enzyme	0	None
13253	13254	substantiate	0	None
13254	13255	the	0	None
13255	13256	involvement	0	None
13256	13257	of	0	None
13257	13258	edrophonium	0	None
13258	13259	in	0	None
13259	13260	protecting	0	None
13260	13261	POX	1	GENE-Y
13261	13262	re	0	None
13262	13263	-	0	None
13263	13264	inhibition	0	None
13264	13265	of	0	None
13265	13266	reactivated	0	None
13266	13267	enzyme	0	None
13267	13268	formed	0	None
13268	13269	during	0	None
13269	13270	the	0	None
13270	13271	reactivation	0	None
13271	13272	of	0	None
13272	13273	OP	0	None
13273	13274	-	0	None
13274	13275	inhibited	0	None
13275	13276	AChE	1	GENE-Y
13276	13277	.	0	None

13278	13279	Synergistic	0	None
13279	13280	antiallodynic	0	None
13280	13281	effects	0	None
13281	13282	of	0	None
13282	13283	spinal	0	None
13283	13284	morphine	3	CHEMICAL
13284	13285	with	0	None
13285	13286	ketorolac	3	CHEMICAL
13286	13287	and	0	None
13287	13288	selective	0	None
13288	13289	COX1	1	GENE-Y
13289	13290	-	0	None
13290	13291	and	0	None
13291	13292	COX2	1	GENE-Y
13292	13293	-	0	None
13293	13294	inhibitors	0	None
13294	13295	in	0	None
13295	13296	nerve	0	None
13296	13297	-	0	None
13297	13298	injured	0	None
13298	13299	rats	0	None
13299	13300	.	0	None

13301	13302	The	0	None
13302	13303	possible	0	None
13303	13304	role	0	None
13304	13305	of	0	None
13305	13306	spinal	0	None
13306	13307	prostanoids	3	CHEMICAL
13307	13308	in	0	None
13308	13309	the	0	None
13309	13310	tactile	0	None
13310	13311	allodynia	0	None
13311	13312	and	0	None
13312	13313	thermal	0	None
13313	13314	hyperalgesia	0	None
13314	13315	associated	0	None
13315	13316	with	0	None
13316	13317	an	0	None
13317	13318	experimental	0	None
13318	13319	model	0	None
13319	13320	of	0	None
13320	13321	neuropathic	0	None
13321	13322	pain	0	None
13322	13323	was	0	None
13323	13324	investigated	0	None
13324	13325	.	0	None

13326	13327	Neuropathic	0	None
13327	13328	pain	0	None
13328	13329	was	0	None
13329	13330	induced	0	None
13330	13331	by	0	None
13331	13332	tight	0	None
13332	13333	ligation	0	None
13333	13334	of	0	None
13334	13335	the	0	None
13335	13336	L5	0	None
13336	13337	and	0	None
13337	13338	L6	0	None
13338	13339	spinal	0	None
13339	13340	nerves	0	None
13340	13341	.	0	None

13342	13343	Tactile	0	None
13343	13344	allodynia	0	None
13344	13345	was	0	None
13345	13346	assessed	0	None
13346	13347	7	0	None
13347	13348	days	0	None
13348	13349	after	0	None
13349	13350	the	0	None
13350	13351	surgery	0	None
13351	13352	by	0	None
13352	13353	measuring	0	None
13353	13354	hindpaw	0	None
13354	13355	withdrawal	0	None
13355	13356	threshold	0	None
13356	13357	to	0	None
13357	13358	probing	0	None
13358	13359	with	0	None
13359	13360	von	0	None
13360	13361	Frey	0	None
13361	13362	filaments	0	None
13362	13363	.	0	None

13364	13365	Thermal	0	None
13365	13366	hyperalgesia	0	None
13366	13367	and	0	None
13367	13368	nociception	0	None
13368	13369	were	0	None
13369	13370	determined	0	None
13370	13371	by	0	None
13371	13372	the	0	None
13372	13373	52	0	None
13373	13374	degrees	0	None
13374	13375	C	0	None
13375	13376	warm	0	None
13376	13377	-	0	None
13377	13378	water	0	None
13378	13379	tail	0	None
13379	13380	-	0	None
13380	13381	flick	0	None
13381	13382	test	3	CHEMICAL
13382	13383	and	0	None
13383	13384	by	0	None
13384	13385	applying	0	None
13385	13386	radiant	0	None
13386	13387	heat	1	GENE-Y
13387	13388	to	0	None
13388	13389	the	0	None
13389	13390	plantar	0	None
13390	13391	aspect	0	None
13391	13392	of	0	None
13392	13393	the	0	None
13393	13394	hindpaw	0	None
13394	13395	ipsilateral	0	None
13395	13396	to	0	None
13396	13397	the	0	None
13397	13398	ligation	0	None
13398	13399	.	0	None

13400	13401	Minimal	0	None
13401	13402	antiallodynic	0	None
13402	13403	effect	0	None
13403	13404	was	0	None
13404	13405	produced	0	None
13405	13406	by	0	None
13406	13407	intrathecal	0	None
13407	13408	(	0	None
13408	13409	i	0	None
13409	13410	.	0	None
13410	13411	th	0	None
13411	13412	.	0	None
13412	13413	)	0	None
13413	13414	administration	0	None
13414	13415	of	0	None
13415	13416	ketorolac	3	CHEMICAL
13416	13417	or	0	None
13417	13418	morphine	3	CHEMICAL
13418	13419	up	0	None
13419	13420	to	0	None
13420	13421	the	0	None
13421	13422	highest	0	None
13422	13423	testable	0	None
13423	13424	dose	0	None
13424	13425	(	0	None
13425	13426	100	0	None
13426	13427	microg	0	None
13427	13428	)	0	None
13428	13429	or	0	None
13429	13430	by	0	None
13430	13431	the	0	None
13431	13432	(	0	None
13432	13433	R	0	None
13433	13434	)	0	None
13434	13435	-	0	None
13435	13436	or	0	None
13436	13437	(	0	None
13437	13438	S	0	None
13438	13439	)	0	None
13439	13440	-	0	None
13440	13441	enantiomers	0	None
13441	13442	of	0	None
13442	13443	ketorolac	3	CHEMICAL
13443	13444	(	0	None
13444	13445	up	0	None
13445	13446	to	0	None
13446	13447	6	0	None
13447	13448	microg	0	None
13448	13449	)	0	None
13449	13450	when	0	None
13450	13451	administered	0	None
13451	13452	alone	0	None
13452	13453	.	0	None

13454	13455	However	0	None
13455	13456	,	0	None
13456	13457	i	0	None
13457	13458	.	0	None
13458	13459	th	0	None
13459	13460	.	0	None
13460	13461	administration	0	None
13461	13462	of	0	None
13462	13463	a	0	None
13463	13464	fixed	0	None
13464	13465	ratio	0	None
13465	13466	(	0	None
13466	13467	1	0	None
13467	13468	:	0	None
13468	13469	1	0	None
13469	13470	)	0	None
13470	13471	of	0	None
13471	13472	morphine	3	CHEMICAL
13472	13473	plus	0	None
13473	13474	racemic	0	None
13474	13475	ketorolac	3	CHEMICAL
13475	13476	or	0	None
13476	13477	of	0	None
13477	13478	morphine	3	CHEMICAL
13478	13479	plus	0	None
13479	13480	the	0	None
13480	13481	(	0	None
13481	13482	S	0	None
13482	13483	)	0	None
13483	13484	-	0	None
13484	13485	enantiomer	0	None
13485	13486	of	0	None
13486	13487	ketorolac	3	CHEMICAL
13487	13488	(	0	None
13488	13489	S	0	None
13489	13490	-	0	None
13490	13491	ketorolac	3	CHEMICAL
13491	13492	)	0	None
13492	13493	produced	0	None
13493	13494	a	0	None
13494	13495	dose	0	None
13495	13496	-	0	None
13496	13497	and	0	None
13497	13498	time	0	None
13498	13499	-	0	None
13499	13500	related	0	None
13500	13501	antiallodynic	0	None
13501	13502	effect	0	None
13502	13503	:	0	None
13503	13504	ED50	0	None
13504	13505	114	0	None
13505	13506	+	0	None
13506	13507	/	0	None
13507	13508	-	0	None
13508	13509	35	0	None
13509	13510	.	0	None
13510	13511	9	0	None
13511	13512	microg	0	None
13512	13513	(	0	None
13513	13514	total	0	None
13514	13515	dose	0	None
13515	13516	)	0	None
13516	13517	for	0	None
13517	13518	morphine	3	CHEMICAL
13518	13519	plus	0	None
13519	13520	ketorolac	3	CHEMICAL
13520	13521	and	0	None
13521	13522	70	0	None
13522	13523	.	0	None
13523	13524	5	0	None
13524	13525	+	0	None
13525	13526	/	0	None
13526	13527	-	0	None
13527	13528	21	0	None
13528	13529	.	0	None
13529	13530	0	0	None
13530	13531	microg	0	None
13531	13532	(	0	None
13532	13533	total	0	None
13533	13534	dose	0	None
13534	13535	)	0	None
13535	13536	for	0	None
13536	13537	morphine	3	CHEMICAL
13537	13538	plus	0	None
13538	13539	S	0	None
13539	13540	-	0	None
13540	13541	ketorolac	3	CHEMICAL
13541	13542	.	0	None

13543	13544	The	0	None
13544	13545	combination	0	None
13545	13546	of	0	None
13546	13547	i	0	None
13547	13548	.	0	None
13548	13549	th	0	None
13549	13550	.	0	None
13550	13551	morphine	3	CHEMICAL
13551	13552	plus	0	None
13552	13553	the	0	None
13553	13554	(	0	None
13554	13555	R	0	None
13555	13556	)	0	None
13556	13557	-	0	None
13557	13558	enantiomer	0	None
13558	13559	of	0	None
13559	13560	ketorolac	3	CHEMICAL
13560	13561	(	0	None
13561	13562	R	0	None
13562	13563	-	0	None
13563	13564	ketorolac	3	CHEMICAL
13564	13565	)	0	None
13565	13566	(	0	None
13566	13567	up	0	None
13567	13568	to	0	None
13568	13569	200	0	None
13569	13570	microg	0	None
13570	13571	total	0	None
13571	13572	dose	0	None
13572	13573	)	0	None
13573	13574	was	0	None
13574	13575	without	0	None
13575	13576	effect	0	None
13576	13577	.	0	None

13578	13579	Similar	0	None
13579	13580	antiallodynic	0	None
13580	13581	activity	0	None
13581	13582	was	0	None
13582	13583	obtained	0	None
13583	13584	for	0	None
13584	13585	the	0	None
13585	13586	co	0	None
13586	13587	-	0	None
13587	13588	administration	0	None
13588	13589	of	0	None
13589	13590	i	0	None
13590	13591	.	0	None
13591	13592	th	0	None
13592	13593	.	0	None
13593	13594	morphine	3	CHEMICAL
13594	13595	and	0	None
13595	13596	intravenous	0	None
13596	13597	(	0	None
13597	13598	i	0	None
13598	13599	.	0	None
13599	13600	v	0	None
13600	13601	.	0	None
13601	13602	)	0	None
13602	13603	racemic	0	None
13603	13604	ketorolac	3	CHEMICAL
13604	13605	.	0	None

13606	13607	In	0	None
13607	13608	order	0	None
13608	13609	to	0	None
13609	13610	investigate	0	None
13610	13611	the	0	None
13611	13612	role	0	None
13612	13613	of	0	None
13613	13614	cyclooxygenase	2	GENE-N
13614	13615	(	0	None
13615	13616	COX	2	GENE-N
13616	13617	)	0	None
13617	13618	isozymes	0	None
13618	13619	,	0	None
13619	13620	relatively	0	None
13620	13621	selective	0	None
13621	13622	COX1	1	GENE-Y
13622	13623	(	0	None
13623	13624	piroxicam	3	CHEMICAL
13624	13625	)	0	None
13625	13626	and	0	None
13626	13627	COX2	1	GENE-Y
13627	13628	N	0	None
13628	13629	-	0	None
13629	13630	[	0	None
13630	13631	2	0	None
13631	13632	-	0	None
13632	13633	cyclohexyloxy	0	None
13633	13634	-	0	None
13634	13635	4	0	None
13635	13636	-	0	None
13636	13637	nitrophenyl	0	None
13637	13638	]	0	None
13638	13639	metanesulfonamide	0	None
13639	13640	(	0	None
13640	13641	NS	0	None
13641	13642	-	0	None
13642	13643	398	0	None
13643	13644	)	0	None
13644	13645	inhibitors	0	None
13645	13646	were	0	None
13646	13647	administered	0	None
13647	13648	i	0	None
13648	13649	.	0	None
13649	13650	th	0	None
13650	13651	.	0	None

13652	13653	(	0	None
13653	13654	60	0	None
13654	13655	microg	0	None
13655	13656	)	0	None
13656	13657	alone	0	None
13657	13658	or	0	None
13658	13659	together	0	None
13659	13660	with	0	None
13660	13661	i	0	None
13661	13662	.	0	None
13662	13663	th	0	None
13663	13664	.	0	None
13664	13665	morphine	3	CHEMICAL
13665	13666	.	0	None

13667	13668	Piroxicam	0	None
13668	13669	,	0	None
13669	13670	NS	0	None
13670	13671	-	0	None
13671	13672	398	0	None
13672	13673	,	0	None
13673	13674	morphine	3	CHEMICAL
13674	13675	and	0	None
13675	13676	vehicle	0	None
13676	13677	(	0	None
13677	13678	90	0	None
13678	13679	%	0	None
13679	13680	DMSO	0	None
13680	13681	)	0	None
13681	13682	were	0	None
13682	13683	without	0	None
13683	13684	significant	0	None
13684	13685	antiallodynic	0	None
13685	13686	effect	0	None
13686	13687	when	0	None
13687	13688	administered	0	None
13688	13689	alone	0	None
13689	13690	,	0	None
13690	13691	but	0	None
13691	13692	moderate	0	None
13692	13693	antiallodynic	0	None
13693	13694	effects	0	None
13694	13695	were	0	None
13695	13696	produced	0	None
13696	13697	by	0	None
13697	13698	i	0	None
13698	13699	.	0	None
13699	13700	th	0	None
13700	13701	.	0	None
13701	13702	administration	0	None
13702	13703	of	0	None
13703	13704	fixed	0	None
13704	13705	ratio	0	None
13705	13706	(	0	None
13706	13707	1	0	None
13707	13708	:	0	None
13708	13709	1	0	None
13709	13710	)	0	None
13710	13711	combinations	0	None
13711	13712	of	0	None
13712	13713	morphine	3	CHEMICAL
13713	13714	with	0	None
13714	13715	60	0	None
13715	13716	microg	0	None
13716	13717	each	0	None
13717	13718	(	0	None
13718	13719	highest	0	None
13719	13720	soluble	0	None
13720	13721	dose	0	None
13721	13722	)	0	None
13722	13723	of	0	None
13723	13724	piroxicam	3	CHEMICAL
13724	13725	(	0	None
13725	13726	%	0	None
13726	13727	MPE	0	None
13727	13728	=	0	None
13728	13729	40	0	None
13729	13730	.	0	None
13730	13731	8	0	None
13731	13732	+	0	None
13732	13733	/	0	None
13733	13734	-	0	None
13734	13735	10	0	None
13735	13736	.	0	None
13736	13737	2	0	None
13737	13738	)	0	None
13738	13739	or	0	None
13739	13740	NS	0	None
13740	13741	-	0	None
13741	13742	398	0	None
13742	13743	(	0	None
13743	13744	%	0	None
13744	13745	MPE	0	None
13745	13746	=	0	None
13746	13747	32	0	None
13747	13748	.	0	None
13748	13749	4	0	None
13749	13750	+	0	None
13750	13751	/	0	None
13751	13752	-	0	None
13752	13753	9	0	None
13753	13754	.	0	None
13754	13755	5	0	None
13755	13756	)	0	None
13756	13757	.	0	None

13758	13759	Further	0	None
13759	13760	,	0	None
13760	13761	the	0	None
13761	13762	combined	0	None
13762	13763	i	0	None
13763	13764	.	0	None
13764	13765	th	0	None
13765	13766	.	0	None
13766	13767	administration	0	None
13767	13768	of	0	None
13768	13769	morphine	3	CHEMICAL
13769	13770	,	0	None
13770	13771	piroxicam	3	CHEMICAL
13771	13772	and	0	None
13772	13773	NS	0	None
13773	13774	-	0	None
13774	13775	398	0	None
13775	13776	in	0	None
13776	13777	fixed	0	None
13777	13778	1	0	None
13778	13779	:	0	None
13779	13780	1	0	None
13780	13781	:	0	None
13781	13782	1	0	None
13782	13783	ratio	0	None
13783	13784	(	0	None
13784	13785	60	0	None
13785	13786	microg	0	None
13786	13787	each	0	None
13787	13788	)	0	None
13788	13789	resulted	0	None
13789	13790	in	0	None
13790	13791	a	0	None
13791	13792	supraadditive	0	None
13792	13793	antiallodynic	0	None
13793	13794	effect	0	None
13794	13795	(	0	None
13795	13796	%	0	None
13796	13797	MPE	0	None
13797	13798	=	0	None
13798	13799	70	0	None
13799	13800	.	0	None
13800	13801	4	0	None
13801	13802	+	0	None
13802	13803	/	0	None
13803	13804	-	0	None
13804	13805	10	0	None
13805	13806	.	0	None
13806	13807	8	0	None
13807	13808	)	0	None
13808	13809	.	0	None

13810	13811	Finally	0	None
13811	13812	,	0	None
13812	13813	morphine	3	CHEMICAL
13813	13814	,	0	None
13814	13815	but	0	None
13815	13816	not	0	None
13816	13817	ketorolac	3	CHEMICAL
13817	13818	,	0	None
13818	13819	given	0	None
13819	13820	i	0	None
13820	13821	.	0	None
13821	13822	th	0	None
13822	13823	.	0	None
13823	13824	produced	0	None
13824	13825	dose	0	None
13825	13826	-	0	None
13826	13827	dependent	0	None
13827	13828	anti	0	None
13828	13829	nociception	0	None
13829	13830	in	0	None
13830	13831	either	0	None
13831	13832	the	0	None
13832	13833	tail	0	None
13833	13834	-	0	None
13834	13835	flick	0	None
13835	13836	or	0	None
13836	13837	the	0	None
13837	13838	paw	0	None
13838	13839	-	0	None
13839	13840	flick	0	None
13840	13841	tests	0	None
13841	13842	.	0	None

13843	13844	However	0	None
13844	13845	,	0	None
13845	13846	there	0	None
13846	13847	was	0	None
13847	13848	no	0	None
13848	13849	synergy	0	None
13849	13850	between	0	None
13850	13851	morphine	3	CHEMICAL
13851	13852	and	0	None
13852	13853	ketorolac	3	CHEMICAL
13853	13854	against	0	None
13854	13855	thermal	0	None
13855	13856	nociception	0	None
13856	13857	in	0	None
13857	13858	either	0	None
13858	13859	of	0	None
13859	13860	the	0	None
13860	13861	tests	0	None
13861	13862	.	0	None

13863	13864	These	0	None
13864	13865	findings	0	None
13865	13866	suggest	0	None
13866	13867	that	0	None
13867	13868	spinal	0	None
13868	13869	prostanoids	3	CHEMICAL
13869	13870	produced	0	None
13870	13871	via	0	None
13871	13872	both	0	None
13872	13873	COX1	1	GENE-Y
13873	13874	and	0	None
13874	13875	COX2	1	GENE-Y
13875	13876	pathways	0	None
13876	13877	may	0	None
13877	13878	play	0	None
13878	13879	a	0	None
13879	13880	role	0	None
13880	13881	in	0	None
13881	13882	neuropathic	0	None
13882	13883	pain	0	None
13883	13884	states	0	None
13884	13885	and	0	None
13885	13886	suggest	0	None
13886	13887	the	0	None
13887	13888	clinical	0	None
13888	13889	utility	0	None
13889	13890	of	0	None
13890	13891	opioid	0	None
13891	13892	plus	0	None
13892	13893	COX	2	GENE-N
13893	13894	-	0	None
13894	13895	inhibitor	0	None
13895	13896	combination	0	None
13896	13897	therapy	0	None
13897	13898	.	0	None

13899	13900	Desipramine	0	None
13900	13901	treatment	0	None
13901	13902	decreases	0	None
13902	13903	3H	0	None
13903	13904	-	0	None
13904	13905	nisoxetine	0	None
13905	13906	binding	0	None
13906	13907	and	0	None
13907	13909	norepinephrine transporter	1	GENE-Y
13909	13910	mRNA	0	None
13910	13911	in	0	None
13911	13912	SK	2	GENE-N
13912	13913	-	0	None
13913	13914	N	0	None
13914	13915	-	0	None
13915	13916	SHSY5Y	0	None
13916	13917	cells	0	None
13917	13918	.	0	None

13919	13920	The	0	None
13920	13921	antidepressant	0	None
13921	13922	desipramine	3	CHEMICAL
13922	13923	has	0	None
13923	13924	been	0	None
13924	13925	shown	0	None
13925	13926	to	0	None
13926	13927	decrease	0	None
13927	13928	synaptic	0	None
13928	13929	membrane	0	None
13929	13930	concentrations	0	None
13930	13931	of	0	None
13931	13932	the	0	None
13932	13933	norepinephrine	3	CHEMICAL
13933	13934	re	0	None
13934	13935	-	0	None
13935	13936	uptake	0	None
13936	13937	transporter	0	None
13937	13938	(	0	None
13938	13939	NET	1	GENE-Y
13939	13940	)	0	None
13940	13941	in	0	None
13941	13942	vivo	0	None
13942	13943	and	0	None
13943	13944	in	0	None
13944	13945	vitro	0	None
13945	13946	,	0	None
13946	13947	on	0	None
13947	13948	both	0	None
13948	13949	an	0	None
13949	13950	acute	0	None
13950	13951	and	0	None
13951	13952	a	0	None
13952	13953	chronic	0	None
13953	13954	basis	0	None
13954	13955	.	0	None

13956	13957	The	0	None
13957	13958	possible	0	None
13958	13959	contribution	0	None
13959	13960	of	0	None
13960	13961	decreased	0	None
13961	13962	NET	1	GENE-Y
13962	13963	synthesis	0	None
13963	13964	to	0	None
13964	13965	the	0	None
13965	13966	chronic	0	None
13966	13967	downregulation	0	None
13967	13968	of	0	None
13968	13969	the	0	None
13969	13970	NETs	0	None
13970	13971	has	0	None
13971	13972	not	0	None
13972	13973	been	0	None
13973	13974	definitively	0	None
13974	13975	established	0	None
13975	13976	.	0	None

13977	13978	In	0	None
13978	13979	this	0	None
13979	13980	study	0	None
13980	13981	,	0	None
13981	13982	we	0	None
13982	13983	treated	0	None
13983	13984	SK	2	GENE-N
13984	13985	-	0	None
13985	13986	N	0	None
13986	13987	-	0	None
13987	13988	SHSY5Y	0	None
13988	13989	cells	0	None
13989	13990	with	0	None
13990	13991	100	0	None
13991	13992	nM	0	None
13992	13993	desipramine	3	CHEMICAL
13993	13994	for	0	None
13994	13995	24	0	None
13995	13996	or	0	None
13996	13997	72	0	None
13997	13998	h	0	None
13998	13999	,	0	None
13999	14000	and	0	None
14000	14001	measured	0	None
14001	14002	3H	0	None
14002	14003	-	0	None
14003	14004	nisoxetine	0	None
14004	14005	binding	0	None
14005	14006	(	0	None
14006	14007	as	0	None
14007	14008	an	0	None
14008	14009	estimate	0	None
14009	14010	of	0	None
14010	14011	NETs	0	None
14011	14012	)	0	None
14012	14013	and	0	None
14013	14014	NET	1	GENE-Y
14014	14015	mRNA	0	None
14015	14016	by	0	None
14016	14017	quantitative	0	None
14017	14020	reverse transcription polymerase	2	GENE-N
14020	14021	chain	0	None
14021	14022	reaction	0	None
14022	14023	.	0	None

14024	14025	Similar	0	None
14025	14026	to	0	None
14026	14027	what	0	None
14027	14028	has	0	None
14028	14029	been	0	None
14029	14030	reported	0	None
14030	14031	previously	0	None
14031	14032	,	0	None
14032	14033	membrane	0	None
14033	14034	3H	0	None
14034	14035	-	0	None
14035	14036	nisoxetine	0	None
14036	14037	binding	0	None
14037	14038	was	0	None
14038	14039	significantly	0	None
14039	14040	decreased	0	None
14040	14041	at	0	None
14041	14042	both	0	None
14042	14043	24	0	None
14043	14044	and	0	None
14044	14045	72	0	None
14045	14046	h	0	None
14046	14047	(	0	None
14047	14048	approximately	0	None
14048	14049	50	0	None
14049	14050	%	0	None
14050	14051	at	0	None
14051	14052	both	0	None
14052	14053	time	0	None
14053	14054	points	0	None
14054	14055	)	0	None
14055	14056	.	0	None

14057	14058	However	0	None
14058	14059	,	0	None
14059	14060	a	0	None
14060	14061	significant	0	None
14061	14062	decrease	0	None
14062	14063	(	0	None
14063	14064	64	0	None
14064	14065	+	0	None
14065	14066	/	0	None
14066	14067	-	0	None
14067	14068	8	0	None
14068	14069	%	0	None
14069	14070	of	0	None
14070	14071	paired	0	None
14071	14072	control	0	None
14072	14073	)	0	None
14073	14074	of	0	None
14074	14075	NET	1	GENE-Y
14075	14076	mRNA	0	None
14076	14077	was	0	None
14077	14078	observed	0	None
14078	14079	only	0	None
14079	14080	at	0	None
14080	14081	the	0	None
14081	14082	72	0	None
14082	14083	-	0	None
14083	14084	h	0	None
14084	14085	time	0	None
14085	14086	point	0	None
14086	14087	.	0	None

14088	14089	We	0	None
14089	14090	conclude	0	None
14090	14091	that	0	None
14091	14092	decreased	0	None
14092	14093	NET	1	GENE-Y
14093	14094	synthesis	0	None
14094	14095	may	0	None
14095	14096	contribute	0	None
14096	14097	to	0	None
14097	14098	the	0	None
14098	14099	chronic	0	None
14099	14100	,	0	None
14100	14101	but	0	None
14101	14102	not	0	None
14102	14103	acute	0	None
14103	14104	,	0	None
14104	14105	effect	0	None
14105	14106	of	0	None
14106	14107	desipramine	3	CHEMICAL
14107	14108	to	0	None
14108	14109	downregulate	0	None
14109	14110	the	0	None
14110	14111	NET	1	GENE-Y
14111	14112	.	0	None

14113	14114	Antitumor	0	None
14114	14115	activity	0	None
14115	14116	of	0	None
14116	14117	ZD1694	0	None
14117	14118	(	0	None
14118	14119	tomudex	0	None
14119	14120	)	0	None
14120	14121	against	0	None
14121	14122	human	0	None
14122	14123	head	0	None
14123	14124	and	0	None
14124	14125	neck	0	None
14125	14126	cancer	0	None
14126	14127	in	0	None
14127	14128	nude	0	None
14128	14129	mouse	0	None
14129	14130	models	0	None
14130	14131	:	0	None
14131	14132	role	0	None
14132	14133	of	0	None
14133	14134	dosing	0	None
14134	14135	schedule	0	None
14135	14136	and	0	None
14136	14137	plasma	0	None
14137	14138	thymidine	3	CHEMICAL
14138	14139	.	0	None

14140	14141	We	0	None
14141	14142	studied	0	None
14142	14143	the	0	None
14143	14144	antitumor	0	None
14144	14145	activity	0	None
14145	14146	and	0	None
14146	14147	toxicity	0	None
14147	14148	of	0	None
14148	14149	ZD1694	0	None
14149	14150	(	0	None
14150	14151	tomudex	0	None
14151	14152	)	0	None
14152	14153	,	0	None
14153	14154	a	0	None
14154	14155	specific	0	None
14155	14156	inhibitor	0	None
14156	14157	of	0	None
14157	14159	thymidylate synthase	1	GENE-Y
14159	14160	(	0	None
14160	14161	TS	0	None
14161	14162	)	0	None
14162	14163	,	0	None
14163	14164	in	0	None
14164	14165	nude	0	None
14165	14166	mice	0	None
14166	14167	bearing	0	None
14167	14168	human	0	None
14168	14169	head	0	None
14169	14170	and	0	None
14170	14171	neck	0	None
14171	14172	squamous	0	None
14172	14173	cell	0	None
14173	14174	carcinoma	0	None
14174	14175	A253	0	None
14175	14176	and	0	None
14176	14177	FaDu	0	None
14177	14178	xenografts	0	None
14178	14179	.	0	None

14180	14181	Mice	0	None
14181	14182	were	0	None
14182	14183	treated	0	None
14183	14184	by	0	None
14184	14185	single	0	None
14185	14186	i	0	None
14186	14187	.	0	None
14187	14188	v	0	None
14188	14189	.	0	None
14189	14190	push	0	None
14190	14191	(	0	None
14191	14192	i	0	None
14192	14193	.	0	None
14193	14194	v	0	None
14194	14195	.	0	None
14195	14196	x	0	None
14196	14197	1	0	None
14197	14198	)	0	None
14198	14199	,	0	None
14199	14200	i	0	None
14200	14201	.	0	None
14201	14202	v	0	None
14202	14203	.	0	None
14203	14204	push	0	None
14204	14205	once	0	None
14205	14206	a	0	None
14206	14207	week	0	None
14207	14208	for	0	None
14208	14209	3	0	None
14209	14210	weeks	0	None
14210	14211	(	0	None
14211	14212	weekly	0	None
14212	14213	x	0	None
14213	14214	3	0	None
14214	14215	)	0	None
14215	14216	,	0	None
14216	14217	and	0	None
14217	14218	i	0	None
14218	14219	.	0	None
14219	14220	v	0	None
14220	14221	.	0	None
14221	14222	push	0	None
14222	14223	once	0	None
14223	14224	a	0	None
14224	14225	day	0	None
14225	14226	for	0	None
14226	14227	5	0	None
14227	14228	days	0	None
14228	14229	(	0	None
14229	14230	daily	0	None
14230	14231	x	0	None
14231	14232	5	0	None
14232	14233	)	0	None
14233	14234	,	0	None
14234	14235	and	0	None
14235	14236	the	0	None
14236	14237	maximum	0	None
14237	14238	tolerated	0	None
14238	14239	doses	0	None
14239	14240	(	0	None
14240	14241	MTDs	0	None
14241	14242	)	0	None
14242	14243	of	0	None
14243	14244	ZD1694	0	None
14244	14245	were	0	None
14245	14246	300	0	None
14246	14247	mg	0	None
14247	14248	/	0	None
14248	14249	kg	0	None
14249	14250	,	0	None
14250	14251	60	0	None
14251	14252	mg	0	None
14252	14253	/	0	None
14253	14254	kg	0	None
14254	14255	/	0	None
14255	14256	week	0	None
14256	14257	,	0	None
14257	14258	and	0	None
14258	14259	30	0	None
14259	14260	mg	0	None
14260	14261	/	0	None
14261	14262	kg	0	None
14262	14263	/	0	None
14263	14264	day	0	None
14264	14265	,	0	None
14265	14266	respectively	0	None
14266	14267	.	0	None

14268	14269	ZD1694	0	None
14269	14270	was	0	None
14270	14271	moderately	0	None
14271	14272	active	0	None
14272	14273	against	0	None
14273	14274	both	0	None
14274	14275	A253	0	None
14275	14276	and	0	None
14276	14277	FaDu	0	None
14277	14278	xenografts	0	None
14278	14279	.	0	None

14280	14281	Antitumor	0	None
14281	14282	activity	0	None
14282	14283	was	0	None
14283	14284	schedule	0	None
14284	14285	-	0	None
14285	14286	dependent	0	None
14286	14287	in	0	None
14287	14288	both	0	None
14288	14289	tumors	0	None
14289	14290	:	0	None
14290	14291	weekly	0	None
14291	14292	x	0	None
14292	14293	3	0	None
14293	14294	>	0	None
14294	14295	or	0	None
14295	14296	=	0	None
14296	14297	i	0	None
14297	14298	.	0	None
14298	14299	v	0	None
14299	14300	.	0	None
14300	14301	x	0	None
14301	14302	1	0	None
14302	14303	>	0	None
14303	14304	>	0	None
14304	14305	daily	0	None
14305	14306	x	0	None
14306	14307	5	0	None
14307	14308	.	0	None

14309	14310	In	0	None
14310	14311	contrast	0	None
14311	14312	,	0	None
14312	14313	the	0	None
14313	14314	rank	2	GENE-N
14314	14315	order	0	None
14315	14316	of	0	None
14316	14317	toxicity	0	None
14317	14318	was	0	None
14318	14319	daily	0	None
14319	14320	x	0	None
14320	14321	5	0	None
14321	14322	>	0	None
14322	14323	>	0	None
14323	14324	weekly	0	None
14324	14325	x	0	None
14325	14326	3	0	None
14326	14327	>	0	None
14327	14328	or	0	None
14328	14329	=	0	None
14329	14330	i	0	None
14330	14331	.	0	None
14331	14332	v	0	None
14332	14333	.	0	None
14333	14334	x	0	None
14334	14335	1	0	None
14335	14336	.	0	None

14337	14338	ZD1694	0	None
14338	14339	at	0	None
14339	14340	the	0	None
14340	14341	MTD	0	None
14341	14342	produced	0	None
14342	14343	20	0	None
14343	14344	%	0	None
14344	14345	complete	0	None
14345	14346	tumor	0	None
14346	14347	regression	0	None
14347	14348	and	0	None
14348	14349	20	0	None
14349	14350	%	0	None
14350	14351	partial	0	None
14351	14352	tumor	0	None
14352	14353	regression	0	None
14353	14354	(	0	None
14354	14355	PR	2	GENE-N
14355	14356	)	0	None
14356	14357	with	0	None
14357	14358	i	0	None
14358	14359	.	0	None
14359	14360	v	0	None
14360	14361	.	0	None
14361	14362	x	0	None
14362	14363	1	0	None
14363	14364	and	0	None
14364	14365	weekly	0	None
14365	14366	x	0	None
14366	14367	3	0	None
14367	14368	schedules	0	None
14368	14369	and	0	None
14369	14370	12	0	None
14370	14371	-	0	None
14371	14372	day	0	None
14372	14373	tumor	0	None
14373	14374	growth	0	None
14374	14375	delay	0	None
14375	14376	with	0	None
14376	14377	daily	0	None
14377	14378	x	0	None
14378	14379	5	0	None
14379	14380	schedule	0	None
14380	14381	against	0	None
14381	14382	FaDu	0	None
14382	14383	xenografts	0	None
14383	14384	.	0	None

14385	14386	No	0	None
14386	14387	complete	0	None
14387	14388	tumor	0	None
14388	14389	regression	0	None
14389	14390	was	0	None
14390	14391	achieved	0	None
14391	14392	with	0	None
14392	14393	ZD1694	0	None
14393	14394	with	0	None
14394	14395	any	0	None
14395	14396	schedule	0	None
14396	14397	against	0	None
14397	14398	A253	0	None
14398	14399	;	0	None
14399	14400	a	0	None
14400	14401	20	0	None
14401	14402	%	0	None
14402	14403	PR	2	GENE-N
14403	14404	,	0	None
14404	14405	40	0	None
14405	14406	%	0	None
14406	14407	PR	2	GENE-N
14407	14408	,	0	None
14408	14409	and	0	None
14409	14410	10	0	None
14410	14411	-	0	None
14411	14412	day	0	None
14412	14413	tumor	0	None
14413	14414	growth	0	None
14414	14415	delay	0	None
14415	14416	were	0	None
14416	14417	observed	0	None
14417	14418	with	0	None
14418	14419	i	0	None
14419	14420	.	0	None
14420	14421	v	0	None
14421	14422	.	0	None
14422	14423	x	0	None
14423	14424	1	0	None
14424	14425	,	0	None
14425	14426	weekly	0	None
14426	14427	x	0	None
14427	14428	3	0	None
14428	14429	,	0	None
14429	14430	and	0	None
14430	14431	daily	0	None
14431	14432	x	0	None
14432	14433	5	0	None
14433	14434	schedules	0	None
14434	14435	,	0	None
14435	14436	respectively	0	None
14436	14437	.	0	None

14438	14439	The	0	None
14439	14440	data	0	None
14440	14441	indicate	0	None
14441	14442	that	0	None
14442	14443	ZD1694	0	None
14443	14444	was	0	None
14444	14445	slightly	0	None
14445	14446	more	0	None
14446	14447	effective	0	None
14447	14448	against	0	None
14448	14449	FaDu	0	None
14449	14450	than	0	None
14450	14451	against	0	None
14451	14452	A253	0	None
14452	14453	.	0	None

14454	14455	Of	0	None
14455	14456	interest	0	None
14456	14457	and	0	None
14457	14458	potential	0	None
14458	14459	clinical	0	None
14459	14460	importance	0	None
14460	14461	was	0	None
14461	14462	the	0	None
14462	14463	observation	0	None
14463	14464	that	0	None
14464	14465	ZD1694	0	None
14465	14466	was	0	None
14466	14467	still	0	None
14467	14468	active	0	None
14468	14469	at	0	None
14469	14470	doses	0	None
14470	14471	lower	0	None
14471	14472	than	0	None
14472	14473	the	0	None
14473	14474	MTD	0	None
14474	14475	(	0	None
14475	14476	>	0	None
14476	14477	or	0	None
14477	14478	=	0	None
14478	14479	1	0	None
14479	14480	/	0	None
14480	14481	3	0	None
14481	14482	MTD	0	None
14482	14483	)	0	None
14483	14484	,	0	None
14484	14485	which	0	None
14485	14486	showed	0	None
14486	14487	a	0	None
14487	14488	high	0	None
14488	14489	therapeutic	0	None
14489	14490	index	0	None
14490	14491	and	0	None
14491	14492	wide	0	None
14492	14493	safety	0	None
14493	14494	margin	0	None
14494	14495	.	0	None

14496	14497	Study	0	None
14497	14498	of	0	None
14498	14499	ZD1694	0	None
14499	14500	compared	0	None
14500	14501	with	0	None
14501	14502	5	0	None
14502	14503	-	0	None
14503	14504	fluorouracil	3	CHEMICAL
14504	14505	and	0	None
14505	14506	5	0	None
14506	14507	-	0	None
14507	14508	fluoro	0	None
14508	14509	-	0	None
14509	14510	2	0	None
14510	14511	'	0	None
14511	14512	-	0	None
14512	14513	deoxyuridine	0	None
14513	14514	at	0	None
14514	14515	the	0	None
14515	14516	MTD	0	None
14516	14517	revealed	0	None
14517	14518	that	0	None
14518	14519	the	0	None
14519	14520	antitumor	0	None
14520	14521	activity	0	None
14521	14522	of	0	None
14522	14523	ZD1694	0	None
14523	14524	was	0	None
14524	14525	comparable	0	None
14525	14526	with	0	None
14526	14527	or	0	None
14527	14528	superior	0	None
14528	14529	to	0	None
14529	14530	5	0	None
14530	14531	-	0	None
14531	14532	fluorouracil	3	CHEMICAL
14532	14533	and	0	None
14533	14534	5	0	None
14534	14535	-	0	None
14535	14536	fluoro	0	None
14536	14537	-	0	None
14537	14538	2	0	None
14538	14539	'	0	None
14539	14540	-	0	None
14540	14541	deoxyuridine	0	None
14541	14542	against	0	None
14542	14543	both	0	None
14543	14544	A253	0	None
14544	14545	and	0	None
14545	14546	FaDu	0	None
14546	14547	xenografts	0	None
14547	14548	,	0	None
14548	14549	with	0	None
14549	14550	less	0	None
14550	14551	toxicity	0	None
14551	14552	.	0	None

14553	14554	High	0	None
14554	14555	plasma	0	None
14555	14556	thymidine	3	CHEMICAL
14556	14557	in	0	None
14557	14558	mouse	0	None
14558	14559	relative	0	None
14559	14560	to	0	None
14560	14561	human	0	None
14561	14562	(	0	None
14562	14563	approximately	0	None
14563	14564	1	0	None
14564	14565	.	0	None
14565	14566	3	0	None
14566	14567	microM	0	None
14567	14568	and	0	None
14568	14569	<	0	None
14569	14570	0	0	None
14570	14571	.	0	None
14571	14572	1	0	None
14572	14573	microM	0	None
14573	14574	,	0	None
14574	14575	respectively	0	None
14575	14576	)	0	None
14576	14577	may	0	None
14577	14578	complicate	0	None
14578	14579	the	0	None
14579	14580	study	0	None
14580	14581	of	0	None
14581	14582	antitumor	0	None
14582	14583	activity	0	None
14583	14584	and	0	None
14584	14585	toxicity	0	None
14585	14586	of	0	None
14586	14587	TS	0	None
14587	14588	inhibitors	0	None
14588	14589	with	0	None
14589	14590	human	0	None
14590	14591	tumor	0	None
14591	14592	xenografts	0	None
14592	14593	grown	0	None
14593	14594	in	0	None
14594	14595	the	0	None
14595	14596	mouse	0	None
14596	14597	.	0	None

14598	14599	To	0	None
14599	14600	test	3	CHEMICAL
14600	14601	this	0	None
14601	14602	hypothesis	0	None
14602	14603	,	0	None
14603	14604	we	0	None
14604	14605	preadministered	0	None
14605	14606	methoxypolyethyleneglycol	0	None
14606	14607	-	0	None
14607	14608	conjugated	0	None
14608	14610	thymidine phosphorylase	1	GENE-Y
14610	14611	(	0	None
14611	14612	MPEG	3	CHEMICAL
14612	14613	-	0	None
14613	14614	TPase	0	None
14614	14615	;	0	None
14615	14616	2500	0	None
14616	14617	units	0	None
14617	14618	/	0	None
14618	14619	kg	0	None
14619	14620	/	0	None
14620	14621	dose	0	None
14621	14622	)	0	None
14622	14623	to	0	None
14623	14624	reduce	0	None
14624	14625	mouse	0	None
14625	14626	plasma	0	None
14626	14627	thymidine	3	CHEMICAL
14627	14628	,	0	None
14628	14629	then	0	None
14629	14630	treated	0	None
14630	14631	with	0	None
14631	14632	various	0	None
14632	14633	doses	0	None
14633	14634	of	0	None
14634	14635	ZD1694	0	None
14635	14636	using	0	None
14636	14637	the	0	None
14637	14638	daily	0	None
14638	14639	x	0	None
14639	14640	5	0	None
14640	14641	or	0	None
14641	14642	i	0	None
14642	14643	.	0	None
14643	14644	v	0	None
14644	14645	.	0	None
14645	14646	x	0	None
14646	14647	1	0	None
14647	14648	schedules	0	None
14648	14649	in	0	None
14649	14650	the	0	None
14650	14651	A253	0	None
14651	14652	tumor	0	None
14652	14653	model	0	None
14653	14654	.	0	None

14655	14656	MPEG	3	CHEMICAL
14656	14657	-	0	None
14657	14658	TPase	0	None
14658	14659	significantly	0	None
14659	14660	increased	0	None
14660	14661	the	0	None
14661	14662	toxicity	0	None
14662	14663	of	0	None
14663	14664	ZD1694	0	None
14664	14665	;	0	None
14665	14666	the	0	None
14666	14667	MTD	0	None
14667	14668	of	0	None
14668	14669	ZD1694	0	None
14669	14670	plus	0	None
14670	14671	MPEG	3	CHEMICAL
14671	14672	-	0	None
14672	14673	TPase	0	None
14673	14674	was	0	None
14674	14675	reduced	0	None
14675	14676	3	0	None
14676	14677	-	0	None
14677	14678	and	0	None
14678	14679	10	0	None
14679	14680	-	0	None
14680	14681	fold	0	None
14681	14682	compared	0	None
14682	14683	with	0	None
14683	14684	ZD1694	0	None
14684	14685	alone	0	None
14685	14686	for	0	None
14686	14687	i	0	None
14687	14688	.	0	None
14688	14689	v	0	None
14689	14690	x	0	None
14690	14691	1	0	None
14691	14692	and	0	None
14692	14693	daily	0	None
14693	14694	x	0	None
14694	14695	5	0	None
14695	14696	schedules	0	None
14696	14697	,	0	None
14697	14698	respectively	0	None
14698	14699	.	0	None

14700	14701	However	0	None
14701	14702	,	0	None
14702	14703	preadministration	0	None
14703	14704	of	0	None
14704	14705	MPEG	3	CHEMICAL
14705	14706	-	0	None
14706	14707	TPase	0	None
14707	14708	did	0	None
14708	14709	not	0	None
14709	14710	potentiate	0	None
14710	14711	the	0	None
14711	14712	antitumor	0	None
14712	14713	activity	0	None
14713	14714	of	0	None
14714	14715	ZD1694	0	None
14715	14716	with	0	None
14716	14717	either	0	None
14717	14718	schedule	0	None
14718	14719	.	0	None

14720	14721	The	0	None
14721	14722	data	0	None
14722	14723	indicate	0	None
14723	14724	that	0	None
14724	14725	the	0	None
14725	14726	study	0	None
14726	14727	of	0	None
14727	14728	TS	0	None
14728	14729	inhibitors	0	None
14729	14730	in	0	None
14730	14731	rodent	0	None
14731	14732	models	0	None
14732	14733	may	0	None
14733	14734	not	0	None
14734	14735	be	0	None
14735	14736	suitable	0	None
14736	14737	for	0	None
14737	14738	predicting	0	None
14738	14739	a	0	None
14739	14740	safe	0	None
14740	14741	dose	0	None
14741	14742	for	0	None
14742	14743	clinical	0	None
14743	14744	study	0	None
14744	14745	.	0	None

14746	14747	However	0	None
14747	14748	,	0	None
14748	14749	rodent	0	None
14749	14750	models	0	None
14750	14751	,	0	None
14751	14752	particularly	0	None
14752	14753	human	0	None
14753	14754	tumor	0	None
14754	14755	xenografts	0	None
14755	14756	,	0	None
14756	14757	are	0	None
14757	14758	still	0	None
14758	14759	useful	0	None
14759	14760	models	0	None
14760	14761	for	0	None
14761	14762	evaluation	0	None
14762	14763	of	0	None
14763	14764	antitumor	0	None
14764	14765	activity	0	None
14765	14766	and	0	None
14766	14767	schedule	0	None
14767	14768	selection	0	None
14768	14769	for	0	None
14769	14770	TS	0	None
14770	14771	inhibitors	0	None
14771	14772	.	0	None

14773	14774	Crystal	0	None
14774	14775	structure	0	None
14775	14776	of	0	None
14776	14781	human quinone reductase type 2	1	GENE-Y
14781	14782	,	0	None
14782	14783	a	0	None
14783	14784	metalloflavoprotein	0	None
14784	14785	.	0	None

14786	14787	In	0	None
14787	14788	mammals	0	None
14788	14789	,	0	None
14789	14790	two	0	None
14790	14791	separate	0	None
14791	14792	but	0	None
14792	14793	homologous	0	None
14793	14794	cytosolic	0	None
14794	14796	quinone reductases	2	GENE-N
14796	14797	have	0	None
14797	14798	been	0	None
14798	14799	identified	0	None
14799	14800	:	0	None
14800	14801	NAD	3	CHEMICAL
14801	14802	(	0	None
14802	14803	P	0	None
14803	14804	)	0	None
14804	14805	H	0	None
14805	14806	:	0	None
14806	14810	quinone oxidoreductase type 1	1	GENE-Y
14810	14811	(	0	None
14811	14812	QR1	1	GENE-Y
14812	14813	)	0	None
14813	14814	(	0	None
14814	14815	EC	0	None
14815	14816	1	0	None
14816	14817	.	0	None
14817	14818	6	0	None
14818	14819	.	0	None
14819	14820	99	0	None
14820	14821	.	0	None
14821	14822	2	0	None
14822	14823	)	0	None
14823	14824	and	0	None
14824	14828	quinone reductase type 2	1	GENE-Y
14828	14829	(	0	None
14829	14830	QR2	0	None
14830	14831	)	0	None
14831	14832	.	0	None

14833	14834	Although	0	None
14834	14835	QR1	1	GENE-Y
14835	14836	and	0	None
14836	14837	QR2	0	None
14837	14838	are	0	None
14838	14839	nearly	0	None
14839	14840	50	0	None
14840	14841	%	0	None
14841	14842	identical	0	None
14842	14843	in	0	None
14843	14844	protein	0	None
14844	14845	sequence	0	None
14845	14846	,	0	None
14846	14847	they	0	None
14847	14848	display	0	None
14848	14849	markedly	0	None
14849	14850	different	0	None
14850	14851	catalytic	0	None
14851	14852	properties	0	None
14852	14853	and	0	None
14853	14854	substrate	0	None
14854	14855	specificities	0	None
14855	14856	.	0	None

14857	14858	We	0	None
14858	14859	report	0	None
14859	14860	here	0	None
14860	14861	two	0	None
14861	14862	crystal	0	None
14862	14863	structures	0	None
14863	14864	of	0	None
14864	14865	QR2	0	None
14865	14866	:	0	None
14866	14867	in	0	None
14867	14868	its	0	None
14868	14869	native	0	None
14869	14870	form	0	None
14870	14871	and	0	None
14871	14872	bound	0	None
14872	14873	to	0	None
14873	14874	menadione	0	None
14874	14875	(	0	None
14875	14877	vitamin K	3	CHEMICAL
14877	14878	(	0	None
14878	14879	3	0	None
14879	14880	)	0	None
14880	14881	)	0	None
14881	14882	,	0	None
14882	14883	a	0	None
14883	14884	physiological	0	None
14884	14885	substrate	0	None
14885	14886	.	0	None

14887	14888	Phases	0	None
14888	14889	were	0	None
14889	14890	obtained	0	None
14890	14891	by	0	None
14891	14892	molecular	0	None
14892	14893	replacement	0	None
14893	14894	,	0	None
14894	14895	using	0	None
14895	14896	our	0	None
14896	14897	previously	0	None
14897	14898	determined	0	None
14898	14900	rat QR1	1	GENE-Y
14900	14901	structure	0	None
14901	14902	as	0	None
14902	14903	the	0	None
14903	14904	search	0	None
14904	14905	model	0	None
14905	14906	.	0	None

14907	14908	QR2	0	None
14908	14909	shares	0	None
14909	14910	the	0	None
14910	14911	overall	0	None
14911	14912	fold	0	None
14912	14913	of	0	None
14913	14914	the	0	None
14914	14915	major	0	None
14915	14916	catalytic	0	None
14916	14917	domain	0	None
14917	14918	of	0	None
14918	14919	QR1	1	GENE-Y
14919	14920	,	0	None
14920	14921	but	0	None
14921	14922	lacks	0	None
14922	14923	the	0	None
14923	14924	smaller	0	None
14924	14925	C	0	None
14925	14926	-	0	None
14926	14927	terminal	0	None
14927	14928	domain	0	None
14928	14929	.	0	None

14930	14931	The	0	None
14931	14934	FAD binding sites	2	GENE-N
14934	14935	of	0	None
14935	14936	QR1	1	GENE-Y
14936	14937	and	0	None
14937	14938	QR2	0	None
14938	14939	are	0	None
14939	14940	very	0	None
14940	14941	similar	0	None
14941	14942	,	0	None
14942	14943	but	0	None
14943	14944	their	0	None
14944	14945	hydride	0	None
14945	14946	donor	0	None
14946	14947	binding	0	None
14947	14948	sites	0	None
14948	14949	are	0	None
14949	14950	considerably	0	None
14950	14951	different	0	None
14951	14952	.	0	None

14953	14954	Unexpectedly	0	None
14954	14955	,	0	None
14955	14956	we	0	None
14956	14957	found	0	None
14957	14958	that	0	None
14958	14959	QR2	0	None
14959	14960	contains	0	None
14960	14961	a	0	None
14961	14962	specific	0	None
14962	14963	metal	0	None
14963	14964	binding	0	None
14964	14965	site	0	None
14965	14966	,	0	None
14966	14967	which	0	None
14967	14968	is	0	None
14968	14969	not	0	None
14969	14970	present	0	None
14970	14971	in	0	None
14971	14972	QR1	1	GENE-Y
14972	14973	.	0	None

14974	14975	Two	0	None
14975	14976	histidine	3	CHEMICAL
14976	14977	nitrogens	0	None
14977	14978	,	0	None
14978	14979	one	0	None
14979	14980	cysteine	3	CHEMICAL
14980	14981	thiol	3	CHEMICAL
14981	14982	,	0	None
14982	14983	and	0	None
14983	14984	a	0	None
14984	14985	main	0	None
14985	14986	chain	0	None
14986	14987	carbonyl	3	CHEMICAL
14987	14988	group	0	None
14988	14989	are	0	None
14989	14990	involved	0	None
14990	14991	in	0	None
14991	14992	metal	0	None
14992	14993	coordination	0	None
14993	14994	.	0	None

14995	14996	The	0	None
14996	14997	metal	0	None
14997	14998	binding	0	None
14998	14999	site	0	None
14999	15000	is	0	None
15000	15001	solvent	0	None
15001	15002	-	0	None
15002	15003	accessible	0	None
15003	15004	,	0	None
15004	15005	and	0	None
15005	15006	is	0	None
15006	15007	separated	0	None
15007	15008	from	0	None
15008	15009	the	0	None
15009	15010	FAD	3	CHEMICAL
15010	15011	cofactor	0	None
15011	15012	by	0	None
15012	15013	a	0	None
15013	15014	distance	0	None
15014	15015	of	0	None
15015	15016	about	0	None
15016	15017	13	0	None
15017	15018	A	0	None
15018	15019	.	0	None

15020	15021	Direct	0	None
15021	15022	effects	0	None
15022	15023	of	0	None
15023	15024	ephedrine	3	CHEMICAL
15024	15025	isomers	0	None
15025	15026	on	0	None
15026	15027	human	0	None
15027	15028	beta	0	None
15028	15029	-	0	None
15029	15030	adrenergic	0	None
15030	15031	receptor	1	GENE-Y
15031	15032	subtypes	0	None
15032	15033	.	0	None

15034	15035	Ephedrine	0	None
15035	15036	and	0	None
15036	15037	its	0	None
15037	15038	alkaloids	0	None
15038	15039	are	0	None
15039	15040	used	0	None
15040	15041	for	0	None
15041	15042	the	0	None
15042	15043	treatment	0	None
15043	15044	of	0	None
15044	15045	asthma	0	None
15045	15046	,	0	None
15046	15047	nasal	0	None
15047	15048	congestion	0	None
15048	15049	,	0	None
15049	15050	and	0	None
15050	15051	obesity	0	None
15051	15052	.	0	None

15053	15054	Ephedrine	0	None
15054	15055	,	0	None
15055	15056	with	0	None
15056	15057	two	0	None
15057	15058	chiral	0	None
15058	15059	centers	0	None
15059	15060	,	0	None
15060	15061	exists	0	None
15061	15062	as	0	None
15062	15063	four	0	None
15063	15064	isomers	0	None
15064	15065	that	0	None
15065	15066	exhibit	0	None
15066	15067	direct	0	None
15067	15068	and	0	None
15068	15069	indirect	0	None
15069	15070	effects	0	None
15070	15071	on	0	None
15071	15072	both	0	None
15072	15073	alpha	0	None
15073	15074	-	0	None
15074	15075	and	0	None
15075	15076	beta	0	None
15076	15077	-	0	None
15077	15079	adrenergic receptors	2	GENE-N
15079	15080	(	0	None
15080	15081	AR	1	GENE-Y
15081	15082	)	0	None
15082	15083	.	0	None

15084	15085	Our	0	None
15085	15086	main	0	None
15086	15087	goal	0	None
15087	15088	was	0	None
15088	15089	to	0	None
15089	15090	study	0	None
15090	15091	the	0	None
15091	15092	direct	0	None
15092	15093	effects	0	None
15093	15094	of	0	None
15094	15095	the	0	None
15095	15096	ephedrine	3	CHEMICAL
15096	15097	isomers	0	None
15097	15098	on	0	None
15098	15099	human	0	None
15099	15100	beta1	1	GENE-Y
15100	15101	-	0	None
15101	15102	,	0	None
15102	15103	beta2	0	None
15103	15104	-	0	None
15104	15105	,	0	None
15105	15106	and	0	None
15106	15107	beta3	0	None
15107	15108	-	0	None
15108	15109	AR	1	GENE-Y
15109	15110	expressed	0	None
15110	15111	in	0	None
15111	15112	Chinese	0	None
15112	15113	hamster	0	None
15113	15114	ovary	0	None
15114	15115	cells	0	None
15115	15116	.	0	None

15117	15118	Previous	0	None
15118	15119	work	0	None
15119	15120	indicated	0	None
15120	15121	that	0	None
15121	15122	the	0	None
15122	15123	ephedrine	3	CHEMICAL
15123	15124	isomers	0	None
15124	15125	are	0	None
15125	15126	inactive	0	None
15126	15127	as	0	None
15127	15128	agonists	0	None
15128	15129	and	0	None
15129	15130	that	0	None
15130	15131	1R	0	None
15131	15132	,	0	None
15132	15133	2S	0	None
15133	15134	-	0	None
15134	15135	ephedrine	3	CHEMICAL
15135	15136	is	0	None
15136	15137	more	0	None
15137	15138	potent	0	None
15138	15139	than	0	None
15139	15140	the	0	None
15140	15141	1S	0	None
15141	15142	,	0	None
15142	15143	2R	0	None
15143	15144	-	0	None
15144	15145	isomer	0	None
15145	15146	as	0	None
15146	15147	an	0	None
15147	15148	antagonist	0	None
15148	15149	of	0	None
15149	15150	catecholamine	3	CHEMICAL
15150	15151	-	0	None
15151	15152	induced	0	None
15152	15153	lipolysis	0	None
15153	15154	in	0	None
15154	15155	rat	0	None
15155	15156	adipose	0	None
15156	15157	tissue	0	None
15157	15158	(	0	None
15158	15159	Lee	0	None
15159	15160	et	0	None
15160	15161	al	0	None
15161	15162	.	0	None
15162	15163	,	0	None
15163	15164	J	0	None
15164	15165	Pharmacol	0	None
15165	15166	Exp	0	None
15166	15167	Ther	0	None
15167	15168	190	0	None
15168	15169	:	0	None
15169	15170	249	0	None
15170	15171	-	0	None
15171	15172	259	0	None
15172	15173	,	0	None
15173	15174	1974	0	None
15174	15175	)	0	None
15175	15176	.	0	None

15177	15178	Stimulation	0	None
15178	15179	of	0	None
15179	15181	adenylyl cyclase	2	GENE-N
15181	15182	,	0	None
15182	15183	associated	0	None
15183	15184	with	0	None
15184	15186	cyclic AMP	3	CHEMICAL
15186	15187	accumulations	0	None
15187	15188	,	0	None
15188	15189	was	0	None
15189	15190	measured	0	None
15190	15191	by	0	None
15191	15192	a	0	None
15192	15193	luciferase	0	None
15193	15194	reporter	0	None
15194	15195	gene	0	None
15195	15196	assay	0	None
15196	15197	.	0	None

15198	15199	On	0	None
15199	15200	human	0	None
15200	15201	beta1	1	GENE-Y
15201	15202	-	0	None
15202	15203	AR	1	GENE-Y
15203	15204	,	0	None
15204	15205	the	0	None
15205	15206	rank	1	GENE-Y
15206	15207	order	0	None
15207	15208	of	0	None
15208	15209	potency	0	None
15209	15210	(	0	None
15210	15211	EC50	0	None
15211	15212	values	0	None
15212	15213	,	0	None
15213	15214	maximal	0	None
15214	15215	response	0	None
15215	15216	relative	0	None
15216	15217	to	0	None
15217	15218	isoproterenol	3	CHEMICAL
15218	15219	=	0	None
15219	15220	100	0	None
15220	15221	%	0	None
15221	15222	)	0	None
15222	15223	was	0	None
15223	15224	1R	0	None
15224	15225	,	0	None
15225	15226	2S	0	None
15226	15227	-	0	None
15227	15228	ephedrine	3	CHEMICAL
15228	15229	(	0	None
15229	15230	0	0	None
15230	15231	.	0	None
15231	15232	5	0	None
15232	15233	microM	0	None
15233	15234	,	0	None
15234	15235	68	0	None
15235	15236	%	0	None
15236	15237	)	0	None
15237	15238	>	0	None
15238	15239	1S	0	None
15239	15240	,	0	None
15240	15241	2R	0	None
15241	15242	-	0	None
15242	15243	ephedrine	3	CHEMICAL
15243	15244	(	0	None
15244	15245	72	0	None
15245	15246	microM	0	None
15246	15247	,	0	None
15247	15248	66	0	None
15248	15249	%	0	None
15249	15250	)	0	None
15250	15251	>	0	None
15251	15252	1S	0	None
15252	15253	,	0	None
15253	15254	2S	0	None
15254	15255	-	0	None
15255	15256	pseudoephedrine	0	None
15256	15257	(	0	None
15257	15258	309	0	None
15258	15259	microM	0	None
15259	15260	,	0	None
15260	15261	53	0	None
15261	15262	%	0	None
15262	15263	)	0	None
15263	15264	=	0	None
15264	15265	1R	0	None
15265	15266	,	0	None
15266	15267	2R	0	None
15267	15268	-	0	None
15268	15269	pseudoephedrine	0	None
15269	15270	(	0	None
15270	15271	1122	0	None
15271	15272	microM	0	None
15272	15273	,	0	None
15273	15274	53	0	None
15274	15275	%	0	None
15275	15276	)	0	None
15276	15277	.	0	None

15278	15279	On	0	None
15279	15280	human	0	None
15280	15281	beta2	0	None
15281	15282	-	0	None
15282	15283	AR	1	GENE-Y
15283	15284	,	0	None
15284	15285	the	0	None
15285	15286	rank	2	GENE-N
15286	15287	order	0	None
15287	15288	of	0	None
15288	15289	potency	0	None
15289	15290	was	0	None
15290	15291	1R	0	None
15291	15292	,	0	None
15292	15293	2S	0	None
15293	15294	-	0	None
15294	15295	ephedrine	3	CHEMICAL
15295	15296	(	0	None
15296	15297	0	0	None
15297	15298	.	0	None
15298	15299	36	0	None
15299	15300	microM	0	None
15300	15301	,	0	None
15301	15302	78	0	None
15302	15303	%	0	None
15303	15304	)	0	None
15304	15305	>	0	None
15305	15306	1R	0	None
15306	15307	,	0	None
15307	15308	2R	0	None
15308	15309	-	0	None
15309	15310	pseudoephedrine	0	None
15310	15311	(	0	None
15311	15312	7	0	None
15312	15313	microM	0	None
15313	15314	,	0	None
15314	15315	50	0	None
15315	15316	%	0	None
15316	15317	)	0	None
15317	15318	>	0	None
15318	15319	or	0	None
15319	15320	=	0	None
15320	15321	1S	0	None
15321	15322	,	0	None
15322	15323	2S	0	None
15323	15324	-	0	None
15324	15325	pseudoephedrine	0	None
15325	15326	(	0	None
15326	15327	10	0	None
15327	15328	microM	0	None
15328	15329	,	0	None
15329	15330	47	0	None
15330	15331	%	0	None
15331	15332	)	0	None
15332	15333	>	0	None
15333	15334	1S	0	None
15334	15335	,	0	None
15335	15336	2R	0	None
15336	15337	-	0	None
15337	15338	ephedrine	3	CHEMICAL
15338	15339	(	0	None
15339	15340	106	0	None
15340	15341	microM	0	None
15341	15342	,	0	None
15342	15343	22	0	None
15343	15344	%	0	None
15344	15345	)	0	None
15345	15346	.	0	None

15347	15348	Only	0	None
15348	15349	1R	0	None
15349	15350	,	0	None
15350	15351	2S	0	None
15351	15352	-	0	None
15352	15353	ephedrine	3	CHEMICAL
15353	15354	showed	0	None
15354	15355	significant	0	None
15355	15356	agonist	0	None
15356	15357	activity	0	None
15357	15358	on	0	None
15358	15359	human	0	None
15359	15360	beta3	0	None
15360	15361	-	0	None
15361	15362	AR	1	GENE-Y
15362	15363	with	0	None
15363	15364	an	0	None
15364	15365	EC50	0	None
15365	15366	=	0	None
15366	15367	45	0	None
15367	15368	betaM	0	None
15368	15369	and	0	None
15369	15370	a	0	None
15370	15371	maximal	0	None
15371	15372	response	0	None
15372	15373	of	0	None
15373	15374	31	0	None
15374	15375	%	0	None
15375	15376	.	0	None

15377	15378	Our	0	None
15378	15379	studies	0	None
15379	15380	demonstrated	0	None
15380	15381	that	0	None
15381	15382	(	0	None
15382	15383	a	0	None
15383	15384	)	0	None
15384	15385	stereoselective	0	None
15385	15386	and	0	None
15386	15387	rank	2	GENE-N
15387	15388	order	0	None
15388	15389	differences	0	None
15389	15390	exist	0	None
15390	15391	among	0	None
15391	15392	the	0	None
15392	15393	direct	0	None
15393	15394	effects	0	None
15394	15395	of	0	None
15395	15396	ephedrine	3	CHEMICAL
15396	15397	isomers	0	None
15397	15398	;	0	None
15398	15399	(	0	None
15399	15400	b	0	None
15400	15401	)	0	None
15401	15402	1R	0	None
15402	15403	,	0	None
15403	15404	2S	0	None
15404	15405	-	0	None
15405	15406	ephedrine	3	CHEMICAL
15406	15407	is	0	None
15407	15408	the	0	None
15408	15409	most	0	None
15409	15410	potent	0	None
15410	15411	of	0	None
15411	15412	the	0	None
15412	15413	four	0	None
15413	15414	ephedrine	3	CHEMICAL
15414	15415	isomers	0	None
15415	15416	on	0	None
15416	15417	all	0	None
15417	15418	three	0	None
15418	15420	human beta	1	GENE-Y
15420	15421	-	0	None
15421	15422	AR	1	GENE-Y
15422	15423	;	0	None
15423	15424	and	0	None
15424	15425	(	0	None
15425	15426	c	0	None
15426	15427	)	0	None
15427	15428	1R	0	None
15428	15429	,	0	None
15429	15430	2S	0	None
15430	15431	-	0	None
15431	15432	ephedrine	3	CHEMICAL
15432	15433	was	0	None
15433	15434	nearly	0	None
15434	15435	equipotent	0	None
15435	15436	as	0	None
15436	15437	a	0	None
15437	15438	beta1	0	None
15438	15439	-	0	None
15439	15440	/	0	None
15440	15441	beta2	0	None
15441	15442	-	0	None
15442	15443	AR	1	GENE-Y
15443	15444	agonist	0	None
15444	15445	and	0	None
15445	15446	the	0	None
15446	15447	only	0	None
15447	15448	isomer	0	None
15448	15449	possessing	0	None
15449	15450	weak	0	None
15450	15451	partial	0	None
15451	15452	agonist	0	None
15452	15453	activity	0	None
15453	15454	on	0	None
15454	15455	beta3	0	None
15455	15456	-	0	None
15456	15457	AR	1	GENE-Y
15457	15458	.	0	None

15459	15460	Marimastat	0	None
15460	15461	inhibits	0	None
15461	15462	elastin	1	GENE-Y
15462	15463	degradation	0	None
15463	15464	and	0	None
15464	15467	matrix metalloproteinase 2	2	GENE-N
15467	15468	activity	0	None
15468	15469	in	0	None
15469	15470	a	0	None
15470	15471	model	0	None
15471	15472	of	0	None
15472	15473	aneurysm	0	None
15473	15474	disease	0	None
15474	15475	.	0	None

15476	15477	BACKGROUND	0	None
15477	15478	:	0	None
15478	15479	Abdominal	0	None
15479	15480	aortic	0	None
15480	15481	aneurysms	0	None
15481	15482	are	0	None
15482	15483	characterized	0	None
15483	15484	by	0	None
15484	15485	degradation	0	None
15485	15486	of	0	None
15486	15487	the	0	None
15487	15489	extracellular matrix	3	CHEMICAL
15489	15490	,	0	None
15490	15491	with	0	None
15491	15492	a	0	None
15492	15493	reduction	0	None
15493	15494	in	0	None
15494	15495	the	0	None
15495	15496	elastin	1	GENE-Y
15496	15497	concentration	0	None
15497	15498	of	0	None
15498	15499	the	0	None
15499	15500	arterial	0	None
15500	15501	media	0	None
15501	15502	.	0	None

15503	15504	These	0	None
15504	15505	changes	0	None
15505	15506	have	0	None
15506	15507	been	0	None
15507	15508	linked	0	None
15508	15509	to	0	None
15509	15510	increased	0	None
15510	15511	levels	0	None
15511	15512	of	0	None
15512	15513	endogenous	0	None
15513	15514	metalloproteinases	2	GENE-N
15514	15515	(	0	None
15515	15516	MMPs	2	GENE-N
15516	15517	)	0	None
15517	15518	within	0	None
15518	15519	the	0	None
15519	15520	aorta	0	None
15520	15521	,	0	None
15521	15522	particularly	0	None
15522	15523	MMP	1	GENE-Y
15523	15524	-	0	None
15524	15525	2	0	None
15525	15526	and	0	None
15526	15527	MMP	1	GENE-Y
15527	15528	-	0	None
15528	15529	9	0	None
15529	15530	.	0	None

15531	15532	This	0	None
15532	15533	provides	0	None
15533	15534	a	0	None
15534	15535	potential	0	None
15535	15536	therapeutic	0	None
15536	15537	target	0	None
15537	15538	for	0	None
15538	15539	pharmacological	0	None
15539	15540	agents	0	None
15540	15541	aimed	0	None
15541	15542	at	0	None
15542	15543	reducing	0	None
15543	15544	the	0	None
15544	15545	growth	0	None
15545	15546	rate	0	None
15546	15547	of	0	None
15547	15548	small	0	None
15548	15549	aneurysms	0	None
15549	15550	.	0	None

15551	15552	In	0	None
15552	15553	this	0	None
15553	15554	study	0	None
15554	15555	,	0	None
15555	15556	the	0	None
15556	15557	ability	0	None
15557	15558	of	0	None
15558	15559	marimastat	3	CHEMICAL
15559	15560	(	0	None
15560	15561	an	0	None
15561	15562	MMP	1	GENE-Y
15562	15563	inhibitor	0	None
15563	15564	)	0	None
15564	15565	to	0	None
15565	15566	reduce	0	None
15566	15567	matrix	0	None
15567	15568	degradation	0	None
15568	15569	was	0	None
15569	15570	assessed	0	None
15570	15571	in	0	None
15571	15572	a	0	None
15572	15573	previously	0	None
15573	15574	described	0	None
15574	15575	model	0	None
15575	15576	of	0	None
15576	15577	aneurysm	0	None
15577	15578	disease	0	None
15578	15579	.	0	None

15580	15581	METHODS	0	None
15581	15582	:	0	None
15582	15583	Porcine	0	None
15583	15584	aortic	0	None
15584	15585	segments	0	None
15585	15586	(	0	None
15586	15587	n	0	None
15587	15588	=	0	None
15588	15589	12	0	None
15589	15590	)	0	None
15590	15591	were	0	None
15591	15592	preincubated	0	None
15592	15593	in	0	None
15593	15594	exogenous	0	None
15594	15595	pancreatic	0	None
15595	15596	elastase	2	GENE-N
15596	15597	for	0	None
15597	15598	24	0	None
15598	15599	h	0	None
15599	15600	before	0	None
15600	15601	culture	0	None
15601	15602	in	0	None
15602	15603	standard	0	None
15603	15604	conditions	0	None
15604	15605	for	0	None
15605	15606	13	0	None
15606	15607	days	0	None
15607	15608	with	0	None
15608	15609	marimastat	3	CHEMICAL
15609	15610	10	0	None
15610	15611	(	0	None
15611	15612	-	0	None
15612	15613	5	0	None
15613	15614	)	0	None
15614	15615	,	0	None
15615	15616	10	0	None
15616	15617	(	0	None
15617	15618	-	0	None
15618	15619	6	0	None
15619	15620	)	0	None
15620	15621	and	0	None
15621	15622	10	0	None
15622	15623	(	0	None
15623	15624	-	0	None
15624	15625	7	0	None
15625	15626	)	0	None
15626	15627	mol	0	None
15627	15628	/	0	None
15628	15629	l	0	None
15629	15630	.	0	None

15631	15632	Control	0	None
15632	15633	segments	0	None
15633	15634	were	0	None
15634	15635	cultured	0	None
15635	15636	both	0	None
15636	15637	without	0	None
15637	15638	marimastat	3	CHEMICAL
15638	15639	and	0	None
15639	15640	without	0	None
15640	15641	elastase	2	GENE-N
15641	15642	.	0	None

15643	15644	At	0	None
15644	15645	the	0	None
15645	15646	termination	0	None
15646	15647	of	0	None
15647	15648	culture	0	None
15648	15649	,	0	None
15649	15650	MMPs	2	GENE-N
15650	15651	were	0	None
15651	15652	extracted	0	None
15652	15653	from	0	None
15653	15654	the	0	None
15654	15655	tissue	0	None
15655	15656	and	0	None
15656	15657	quantified	0	None
15657	15658	by	0	None
15658	15659	substrate	0	None
15659	15660	gel	0	None
15660	15661	enzymography	0	None
15661	15662	.	0	None

15663	15664	The	0	None
15664	15665	volume	0	None
15665	15666	fractions	0	None
15666	15667	of	0	None
15667	15668	elastin	1	GENE-Y
15668	15669	and	0	None
15669	15670	collagen	0	None
15670	15671	were	0	None
15671	15672	determined	0	None
15672	15673	by	0	None
15673	15674	stereological	0	None
15674	15675	analysis	0	None
15675	15676	of	0	None
15676	15677	sections	0	None
15677	15678	stained	0	None
15678	15679	with	0	None
15679	15680	Miller	0	None
15680	15681	'	0	None
15681	15682	s	0	None
15682	15683	elastin	1	GENE-Y
15683	15684	and	0	None
15684	15685	van	0	None
15685	15686	Gieson	0	None
15686	15687	'	0	None
15687	15688	s	0	None
15688	15689	stain	0	None
15689	15690	.	0	None

15691	15692	RESULTS	0	None
15692	15693	:	0	None
15693	15694	Stereological	0	None
15694	15695	analysis	0	None
15695	15696	demonstrated	0	None
15696	15697	preservation	0	None
15697	15698	of	0	None
15698	15699	elastin	1	GENE-Y
15699	15700	in	0	None
15700	15701	aorta	0	None
15701	15702	treated	0	None
15702	15703	with	0	None
15703	15704	marimastat	3	CHEMICAL
15704	15705	at	0	None
15705	15706	10	0	None
15706	15707	(	0	None
15707	15708	-	0	None
15708	15709	6	0	None
15709	15710	)	0	None
15710	15711	and	0	None
15711	15712	10	0	None
15712	15713	(	0	None
15713	15714	-	0	None
15714	15715	5	0	None
15715	15716	)	0	None
15716	15717	mol	0	None
15717	15718	/	0	None
15718	15719	l	0	None
15719	15720	;	0	None
15720	15721	this	0	None
15721	15722	was	0	None
15722	15723	significant	0	None
15723	15724	at	0	None
15724	15725	the	0	None
15725	15726	latter	0	None
15726	15727	concentration	0	None
15727	15728	(	0	None
15728	15729	P	0	None
15729	15730	=	0	None
15730	15731	0	0	None
15731	15732	.	0	None
15732	15733	007	0	None
15733	15734	)	0	None
15734	15735	.	0	None

15736	15737	This	0	None
15737	15738	was	0	None
15738	15739	accompanied	0	None
15739	15740	by	0	None
15740	15741	a	0	None
15741	15742	significant	0	None
15742	15743	reduction	0	None
15743	15744	in	0	None
15744	15745	active	0	None
15745	15746	MMP	1	GENE-Y
15746	15747	-	0	None
15747	15748	2	0	None
15748	15749	activity	0	None
15749	15750	in	0	None
15750	15751	the	0	None
15751	15752	samples	0	None
15752	15753	treated	0	None
15753	15754	with	0	None
15754	15755	marimastat	3	CHEMICAL
15755	15756	10	0	None
15756	15757	(	0	None
15757	15758	-	0	None
15758	15759	5	0	None
15759	15760	)	0	None
15760	15761	mol	0	None
15761	15762	/	0	None
15762	15763	l	0	None
15763	15764	(	0	None
15764	15765	P	0	None
15765	15766	<	0	None
15766	15767	0	0	None
15767	15768	.	0	None
15768	15769	01	0	None
15769	15770	)	0	None
15770	15771	.	0	None

15772	15773	CONCLUSION	0	None
15773	15774	:	0	None
15774	15775	Marimastat	0	None
15775	15776	significantly	0	None
15776	15777	inhibited	0	None
15777	15778	elastin	1	GENE-Y
15778	15779	degradation	0	None
15779	15780	and	0	None
15780	15781	active	0	None
15781	15782	MMP	1	GENE-Y
15782	15783	-	0	None
15783	15784	2	0	None
15784	15785	production	0	None
15785	15786	within	0	None
15786	15787	aortic	0	None
15787	15788	organ	0	None
15788	15789	cultures	0	None
15789	15790	.	0	None

15791	15792	[	0	None
15792	15793	The	0	None
15793	15794	relation	0	None
15794	15795	between	0	None
15795	15796	metabolism	0	None
15796	15797	of	0	None
15797	15798	biopterin	0	None
15798	15799	and	0	None
15799	15800	dystonia	0	None
15800	15801	-	0	None
15801	15802	parkinsonism	0	None
15802	15803	]	0	None
15803	15804	.	0	None

15805	15806	Tetrahydrobiopterin	3	CHEMICAL
15806	15807	(	0	None
15807	15808	BH4	3	CHEMICAL
15808	15809	)	0	None
15809	15810	is	0	None
15810	15811	an	0	None
15811	15812	essential	0	None
15812	15813	cofactor	0	None
15813	15814	for	0	None
15814	15816	tyrosine hydroxylase	1	GENE-Y
15816	15817	.	0	None

15818	15819	BH4	3	CHEMICAL
15819	15820	can	0	None
15820	15821	be	0	None
15821	15822	synthesized	0	None
15822	15823	from	0	None
15823	15824	GTP	3	CHEMICAL
15824	15825	through	0	None
15825	15826	three	0	None
15826	15827	enzymatic	0	None
15827	15828	reactions	0	None
15828	15829	.	0	None

15830	15831	The	0	None
15831	15832	rate	0	None
15832	15833	-	0	None
15833	15834	limiting	0	None
15834	15835	step	0	None
15835	15836	of	0	None
15836	15837	the	0	None
15837	15838	BH4	3	CHEMICAL
15838	15839	synthesis	0	None
15839	15840	is	0	None
15840	15841	catalyzed	0	None
15841	15842	by	0	None
15842	15845	GTP cyclohydrolase I	1	GENE-Y
15845	15846	(	0	None
15846	15847	GCH	1	GENE-Y
15847	15848	)	0	None
15848	15849	.	0	None

15850	15851	Recently	0	None
15851	15852	,	0	None
15852	15853	we	0	None
15853	15854	found	0	None
15854	15855	that	0	None
15855	15856	GCH	1	GENE-Y
15856	15857	is	0	None
15857	15858	a	0	None
15858	15859	causative	0	None
15859	15860	gene	0	None
15860	15861	for	0	None
15861	15862	hereditary	0	None
15862	15863	progressive	0	None
15863	15864	dystonia	0	None
15864	15865	/	0	None
15865	15866	dopa	0	None
15866	15867	-	0	None
15867	15868	responsive	0	None
15868	15869	dystonia	0	None
15869	15870	(	0	None
15870	15871	HPD	0	None
15871	15872	/	0	None
15872	15873	DRD	0	None
15873	15874	)	0	None
15874	15875	.	0	None

15876	15877	However	0	None
15877	15878	,	0	None
15878	15879	several	0	None
15879	15880	problems	0	None
15880	15881	still	0	None
15881	15882	remain	0	None
15882	15883	to	0	None
15883	15884	be	0	None
15884	15885	solved	0	None
15885	15886	.	0	None

15887	15888	The	0	None
15888	15889	first	0	None
15889	15890	concern	0	None
15890	15891	is	0	None
15891	15892	the	0	None
15892	15893	presence	0	None
15893	15894	of	0	None
15894	15895	asymptomatic	0	None
15895	15896	carriers	0	None
15896	15897	in	0	None
15897	15898	the	0	None
15898	15899	disease	0	None
15899	15900	.	0	None

15901	15902	The	0	None
15902	15903	difference	0	None
15903	15904	between	0	None
15904	15905	symptomatic	0	None
15905	15906	and	0	None
15906	15907	asymptomatic	0	None
15907	15908	carriers	0	None
15908	15909	is	0	None
15909	15910	unknown	0	None
15910	15911	.	0	None

15912	15913	Second	0	None
15913	15914	,	0	None
15914	15915	we	0	None
15915	15916	cannot	0	None
15916	15917	find	0	None
15917	15918	any	0	None
15918	15919	mutation	0	None
15919	15920	in	0	None
15920	15921	the	0	None
15921	15922	coding	0	None
15922	15923	region	0	None
15923	15924	of	0	None
15924	15925	the	0	None
15925	15926	GCH	1	GENE-Y
15926	15927	gene	0	None
15927	15928	in	0	None
15928	15929	about	0	None
15929	15930	40	0	None
15930	15931	%	0	None
15931	15932	of	0	None
15932	15933	the	0	None
15933	15934	patients	0	None
15934	15935	.	0	None

15936	15937	What	0	None
15937	15938	kind	0	None
15938	15939	of	0	None
15939	15940	mutation	0	None
15940	15941	would	0	None
15941	15942	be	0	None
15942	15943	present	0	None
15943	15944	in	0	None
15944	15945	these	0	None
15945	15946	patients	0	None
15946	15947	.	0	None

15948	15949	The	0	None
15949	15950	last	0	None
15950	15951	concern	0	None
15951	15952	is	0	None
15952	15953	the	0	None
15953	15954	molecular	0	None
15954	15955	mechanism	0	None
15955	15956	how	0	None
15956	15957	the	0	None
15957	15958	enzymatic	0	None
15958	15959	activity	0	None
15959	15960	is	0	None
15960	15961	decreased	0	None
15961	15962	to	0	None
15962	15963	less	0	None
15963	15964	than	0	None
15964	15965	20	0	None
15965	15966	%	0	None
15966	15967	of	0	None
15967	15968	normal	0	None
15968	15969	values	0	None
15969	15970	.	0	None

15971	15972	Further	0	None
15972	15973	studies	0	None
15973	15974	are	0	None
15974	15975	required	0	None
15975	15976	to	0	None
15976	15977	solve	0	None
15977	15978	the	0	None
15978	15979	questions	0	None
15979	15980	.	0	None

15981	15982	Use	0	None
15982	15983	of	0	None
15983	15984	a	0	None
15984	15985	PPAR	1	GENE-Y
15985	15986	gamma	0	None
15986	15987	-	0	None
15987	15988	specific	0	None
15988	15990	monoclonal antibody	2	GENE-N
15990	15991	to	0	None
15991	15992	demonstrate	0	None
15992	15993	thiazolidinediones	3	CHEMICAL
15993	15994	induce	0	None
15994	15995	PPAR	0	None
15995	15997	gamma receptor	1	GENE-Y
15997	15998	expression	0	None
15998	15999	in	0	None
15999	16000	vitro	0	None
16000	16001	.	0	None

16002	16003	Troglitazone	0	None
16003	16004	and	0	None
16004	16005	rosiglitazone	3	CHEMICAL
16005	16006	(	0	None
16006	16007	BRL49653	3	CHEMICAL
16007	16008	)	0	None
16008	16009	,	0	None
16009	16010	members	0	None
16010	16011	of	0	None
16011	16012	the	0	None
16012	16013	thiazolidinedione	3	CHEMICAL
16013	16014	(	0	None
16014	16015	TZD	3	CHEMICAL
16015	16016	)	0	None
16016	16017	class	0	None
16017	16018	of	0	None
16018	16019	antidiabetic	0	None
16019	16020	drugs	0	None
16020	16021	,	0	None
16021	16022	are	0	None
16022	16023	peroxisome	0	None
16023	16024	proliferator	0	None
16024	16025	-	0	None
16025	16026	activated	0	None
16026	16027	receptor	0	None
16027	16028	gamma	0	None
16028	16029	(	0	None
16029	16030	PPARgamma	1	GENE-Y
16030	16031	)	0	None
16031	16032	ligands	0	None
16032	16033	that	0	None
16033	16034	induce	0	None
16034	16035	adipocyte	0	None
16035	16036	differentiation	0	None
16036	16037	and	0	None
16037	16038	increase	0	None
16038	16039	the	0	None
16039	16040	expression	0	None
16040	16041	of	0	None
16041	16042	PPARgamma	1	GENE-Y
16042	16043	protein	0	None
16043	16044	.	0	None

16045	16046	Here	0	None
16046	16047	,	0	None
16047	16048	we	0	None
16048	16049	report	0	None
16049	16050	the	0	None
16050	16051	characterization	0	None
16051	16052	of	0	None
16052	16053	a	0	None
16053	16054	PPARgamma	1	GENE-Y
16054	16055	specific	0	None
16055	16057	monoclonal antibody	2	GENE-N
16057	16058	(	0	None
16058	16059	MAb	0	None
16059	16060	)	0	None
16060	16061	,	0	None
16061	16062	PgammaA53	0	None
16062	16063	.	0	None
16063	16064	25	0	None
16064	16065	,	0	None
16065	16066	and	0	None
16066	16067	its	0	None
16067	16068	use	0	None
16068	16069	to	0	None
16069	16070	monitor	0	None
16070	16071	PPARgamma	1	GENE-Y
16071	16072	expression	0	None
16072	16073	in	0	None
16073	16074	the	0	None
16074	16075	noncommitted	0	None
16075	16076	pluripotent	0	None
16076	16077	murine	0	None
16077	16078	mesenchymal	0	None
16078	16079	stem	0	None
16079	16080	cell	0	None
16080	16081	line	0	None
16081	16082	,	0	None
16082	16083	C3H10T1	0	None
16083	16084	/	0	None
16084	16085	2	0	None
16085	16086	,	0	None
16086	16087	treated	0	None
16087	16088	with	0	None
16088	16089	TZDs	3	CHEMICAL
16089	16090	.	0	None

16091	16092	MAb	0	None
16092	16093	PgammaA53	0	None
16093	16094	.	0	None
16094	16095	25	0	None
16095	16096	was	0	None
16096	16097	raised	0	None
16097	16098	against	0	None
16098	16099	a	0	None
16099	16100	region	0	None
16100	16101	in	0	None
16101	16102	the	0	None
16102	16103	N	0	None
16103	16104	-	0	None
16104	16105	terminal	0	None
16105	16106	domain	0	None
16106	16107	of	0	None
16107	16109	human PPARgamma	1	GENE-Y
16109	16110	shared	0	None
16110	16111	by	0	None
16111	16112	splice	0	None
16112	16113	variants	0	None
16113	16114	PPARgamma1	0	None
16114	16115	and	0	None
16115	16116	PPARgamma2	1	GENE-Y
16116	16117	.	0	None

16118	16119	It	0	None
16119	16120	recognizes	0	None
16120	16121	immunizing	0	None
16121	16122	antigen	0	None
16122	16123	in	0	None
16123	16124	enzyme	0	None
16124	16125	-	0	None
16125	16126	linked	0	None
16126	16127	immunoadsorbent	0	None
16127	16128	assay	0	None
16128	16129	(	0	None
16129	16130	ELISA	0	None
16130	16131	)	0	None
16131	16132	,	0	None
16132	16133	and	0	None
16133	16134	does	0	None
16134	16135	not	0	None
16135	16136	cross	0	None
16136	16137	-	0	None
16137	16138	react	0	None
16138	16139	with	0	None
16139	16140	the	0	None
16140	16141	N	0	None
16141	16142	-	0	None
16142	16143	terminal	0	None
16143	16144	domains	0	None
16144	16145	of	0	None
16145	16146	PPARalpha	1	GENE-Y
16146	16147	or	0	None
16147	16148	PPARdelta	0	None
16148	16149	.	0	None

16150	16151	In	0	None
16151	16152	Western	0	None
16152	16153	blotting	0	None
16153	16154	,	0	None
16154	16155	PgammaA53	0	None
16155	16156	.	0	None
16156	16157	25	0	None
16157	16158	reacts	0	None
16158	16159	with	0	None
16159	16160	the	0	None
16160	16161	immunizing	0	None
16161	16162	antigen	0	None
16162	16163	as	0	None
16163	16164	well	0	None
16164	16165	as	0	None
16165	16166	distinct	0	None
16166	16167	protein	0	None
16167	16168	bands	0	None
16168	16169	corresponding	0	None
16169	16170	to	0	None
16170	16171	the	0	None
16171	16172	molecular	0	None
16172	16173	weight	0	None
16173	16174	of	0	None
16174	16175	full	0	None
16175	16176	length	0	None
16176	16177	PPARgamma	1	GENE-Y
16177	16178	from	0	None
16178	16179	C3H10T1	0	None
16179	16180	/	0	None
16180	16181	2	0	None
16181	16182	cells	0	None
16182	16183	and	0	None
16183	16184	rat	0	None
16184	16185	tissue	0	None
16185	16186	lysates	0	None
16186	16187	.	0	None

16188	16189	In	0	None
16189	16190	fluorescent	0	None
16190	16191	microscopy	0	None
16191	16192	,	0	None
16192	16193	PgammaA53	0	None
16193	16194	.	0	None
16194	16195	25	0	None
16195	16196	immunostains	0	None
16196	16197	nuclei	0	None
16197	16198	of	0	None
16198	16199	C3H10T1	0	None
16199	16200	/	0	None
16200	16201	2	0	None
16201	16202	cells	0	None
16202	16203	treated	0	None
16203	16204	with	0	None
16204	16205	PPARgamma	1	GENE-Y
16205	16206	ligands	0	None
16206	16207	.	0	None

16208	16209	The	0	None
16209	16210	fluorescence	0	None
16210	16211	intensity	0	None
16211	16212	of	0	None
16212	16213	the	0	None
16213	16214	treated	0	None
16214	16215	cells	0	None
16215	16216	is	0	None
16216	16217	TZD	3	CHEMICAL
16217	16218	dose	0	None
16218	16219	-	0	None
16219	16220	dependent	0	None
16220	16221	,	0	None
16221	16222	and	0	None
16222	16223	correlates	0	None
16223	16224	with	0	None
16224	16225	lipid	0	None
16225	16226	accumulation	0	None
16226	16227	consistent	0	None
16227	16228	with	0	None
16228	16229	adipogenesis	0	None
16229	16230	.	0	None

16231	16232	Based	0	None
16232	16233	on	0	None
16233	16234	these	0	None
16234	16235	results	0	None
16235	16236	,	0	None
16236	16237	we	0	None
16237	16238	propose	0	None
16238	16239	that	0	None
16239	16240	MAb	0	None
16240	16241	PgammaA53	0	None
16241	16242	.	0	None
16242	16243	25	0	None
16243	16244	will	0	None
16244	16245	be	0	None
16245	16246	a	0	None
16246	16247	useful	0	None
16247	16248	tool	0	None
16248	16249	for	0	None
16249	16250	elucidating	0	None
16250	16251	the	0	None
16251	16252	role	0	None
16252	16253	of	0	None
16253	16254	PPARgamma	1	GENE-Y
16254	16255	in	0	None
16255	16257	fatty acid	3	CHEMICAL
16257	16258	metabolism	0	None
16258	16259	and	0	None
16259	16260	adipocyte	0	None
16260	16261	differentiation	0	None
16261	16262	.	0	None

16263	16264	Increased	0	None
16264	16265	cyclooxygenase	2	GENE-N
16265	16266	-	0	None
16266	16267	2	0	None
16267	16268	expression	0	None
16268	16269	in	0	None
16269	16270	human	0	None
16270	16271	pancreatic	0	None
16271	16272	carcinomas	0	None
16272	16273	and	0	None
16273	16274	cell	0	None
16274	16275	lines	0	None
16275	16276	:	0	None
16276	16277	growth	0	None
16277	16278	inhibition	0	None
16278	16279	by	0	None
16279	16280	nonsteroidal	0	None
16280	16281	anti	0	None
16281	16282	-	0	None
16282	16283	inflammatory	0	None
16283	16284	drugs	0	None
16284	16285	.	0	None

16286	16287	Cyclooxygenase	0	None
16287	16288	(	0	None
16288	16289	COX	2	GENE-N
16289	16290	)	0	None
16290	16291	-	0	None
16291	16292	2	0	None
16292	16293	mRNA	0	None
16293	16294	and	0	None
16294	16295	protein	0	None
16295	16296	expression	0	None
16296	16297	were	0	None
16297	16298	found	0	None
16298	16299	to	0	None
16299	16300	be	0	None
16300	16301	frequently	0	None
16301	16302	elevated	0	None
16302	16303	in	0	None
16303	16304	human	0	None
16304	16305	pancreatic	0	None
16305	16306	adenocarcinomas	0	None
16306	16307	and	0	None
16307	16308	cell	0	None
16308	16309	lines	0	None
16309	16310	derived	0	None
16310	16311	from	0	None
16311	16312	such	0	None
16312	16313	tumors	0	None
16313	16314	.	0	None

16315	16316	Immunohistochemistry	0	None
16316	16317	demonstrated	0	None
16317	16318	cytoplasmic	0	None
16318	16319	COX	2	GENE-N
16319	16320	-	0	None
16320	16321	2	0	None
16321	16322	expression	0	None
16322	16323	in	0	None
16323	16324	14	0	None
16324	16325	of	0	None
16325	16326	21	0	None
16326	16327	(	0	None
16327	16328	67	0	None
16328	16329	%	0	None
16329	16330	)	0	None
16330	16331	pancreatic	0	None
16331	16332	carcinomas	0	None
16332	16333	.	0	None

16334	16335	The	0	None
16335	16336	level	0	None
16336	16337	of	0	None
16337	16338	COX	2	GENE-N
16338	16339	-	0	None
16339	16340	2	0	None
16340	16341	mRNA	0	None
16341	16342	was	0	None
16342	16343	found	0	None
16343	16344	to	0	None
16344	16345	be	0	None
16345	16346	elevated	0	None
16346	16347	in	0	None
16347	16348	carcinomas	0	None
16348	16349	,	0	None
16349	16350	relative	0	None
16350	16351	to	0	None
16351	16352	histologically	0	None
16352	16353	normal	0	None
16353	16354	pancreas	0	None
16354	16355	from	0	None
16355	16356	a	0	None
16356	16357	healthy	0	None
16357	16358	individual	0	None
16358	16359	,	0	None
16359	16360	as	0	None
16360	16361	assessed	0	None
16361	16362	by	0	None
16362	16364	reverse transcription	1	GENE-Y
16364	16365	-	0	None
16365	16366	PCR	0	None
16366	16367	.	0	None

16368	16369	COX	2	GENE-N
16369	16370	-	0	None
16370	16371	2	0	None
16371	16372	protein	0	None
16372	16373	expression	0	None
16373	16374	was	0	None
16374	16375	detected	0	None
16375	16376	by	0	None
16376	16377	the	0	None
16377	16378	Western	0	None
16378	16379	blot	0	None
16379	16380	assay	0	None
16380	16381	in	0	None
16381	16382	three	0	None
16382	16383	of	0	None
16383	16384	five	0	None
16384	16385	pancreatic	0	None
16385	16386	carcinoma	0	None
16386	16387	cell	0	None
16387	16388	lines	0	None
16388	16389	(	0	None
16389	16390	BxPC	0	None
16390	16391	-	0	None
16391	16392	3	0	None
16392	16393	,	0	None
16393	16394	Capan	0	None
16394	16395	-	0	None
16395	16396	1	0	None
16396	16397	,	0	None
16397	16398	and	0	None
16398	16399	MDAPanc	0	None
16399	16400	-	0	None
16400	16401	3	0	None
16401	16402	)	0	None
16402	16403	,	0	None
16403	16404	whereas	0	None
16404	16405	COX	2	GENE-N
16405	16406	-	0	None
16406	16407	1	0	None
16407	16408	protein	0	None
16408	16409	was	0	None
16409	16410	detected	0	None
16410	16411	in	0	None
16411	16412	two	0	None
16412	16413	of	0	None
16413	16414	the	0	None
16414	16415	five	0	None
16415	16416	cell	0	None
16416	16417	lines	0	None
16417	16418	(	0	None
16418	16419	BxPC	0	None
16419	16420	-	0	None
16420	16421	3	0	None
16421	16422	and	0	None
16422	16423	Capan	0	None
16423	16424	-	0	None
16424	16425	1	0	None
16425	16426	)	0	None
16426	16427	.	0	None

16428	16429	Increased	0	None
16429	16430	levels	0	None
16430	16431	of	0	None
16431	16432	COX	2	GENE-N
16432	16433	-	0	None
16433	16434	2	0	None
16434	16435	mRNA	0	None
16435	16436	were	0	None
16436	16437	found	0	None
16437	16438	in	0	None
16438	16439	four	0	None
16439	16440	of	0	None
16440	16441	five	0	None
16441	16442	cell	0	None
16442	16443	lines	0	None
16443	16444	,	0	None
16444	16445	and	0	None
16445	16446	only	0	None
16446	16447	in	0	None
16447	16448	PANC	0	None
16448	16449	-	0	None
16449	16450	1	0	None
16450	16451	cells	0	None
16451	16452	was	0	None
16452	16453	the	0	None
16453	16454	low	0	None
16454	16455	level	0	None
16455	16456	of	0	None
16456	16457	transcript	0	None
16457	16458	comparable	0	None
16458	16459	to	0	None
16459	16460	that	0	None
16460	16461	in	0	None
16461	16462	the	0	None
16462	16463	normal	0	None
16463	16464	pancreas	0	None
16464	16465	.	0	None

16466	16467	The	0	None
16467	16468	level	0	None
16468	16469	of	0	None
16469	16470	COX	2	GENE-N
16470	16471	-	0	None
16471	16472	2	0	None
16472	16473	mRNA	0	None
16473	16474	was	0	None
16474	16475	positively	0	None
16475	16476	correlated	0	None
16476	16477	with	0	None
16477	16478	the	0	None
16478	16479	differentiation	0	None
16479	16480	status	0	None
16480	16481	of	0	None
16481	16482	the	0	None
16482	16483	tumor	0	None
16483	16484	of	0	None
16484	16485	origin	0	None
16485	16486	for	0	None
16486	16487	each	0	None
16487	16488	cell	0	None
16488	16489	line	0	None
16489	16490	,	0	None
16490	16491	COX	2	GENE-N
16491	16492	-	0	None
16492	16493	2	0	None
16493	16494	protein	0	None
16494	16495	expression	0	None
16495	16496	was	0	None
16496	16497	up	0	None
16497	16498	-	0	None
16498	16499	regulated	0	None
16499	16500	by	0	None
16500	16503	epidermal growth factor	1	GENE-Y
16503	16504	when	0	None
16504	16505	the	0	None
16505	16506	cells	0	None
16506	16507	were	0	None
16507	16508	grown	0	None
16508	16509	in	0	None
16509	16510	absence	0	None
16510	16511	of	0	None
16511	16512	serum	0	None
16512	16513	.	0	None

16514	16515	Finally	0	None
16515	16516	,	0	None
16516	16517	two	0	None
16517	16518	nonsteroidal	0	None
16518	16519	anti	0	None
16519	16520	-	0	None
16520	16521	inflammatory	0	None
16521	16522	drugs	0	None
16522	16523	,	0	None
16523	16525	sulindac sulfide	3	CHEMICAL
16525	16526	and	0	None
16526	16527	NS398	3	CHEMICAL
16527	16528	,	0	None
16528	16529	produced	0	None
16529	16530	a	0	None
16530	16531	dose	0	None
16531	16532	-	0	None
16532	16533	dependent	0	None
16533	16534	inhibition	0	None
16534	16535	of	0	None
16535	16536	cell	0	None
16536	16537	proliferation	0	None
16537	16538	in	0	None
16538	16539	all	0	None
16539	16540	pancreatic	0	None
16540	16541	cell	0	None
16541	16542	lines	0	None
16542	16543	tested	0	None
16543	16544	.	0	None

16545	16546	No	0	None
16546	16547	correlation	0	None
16547	16548	was	0	None
16548	16549	found	0	None
16549	16550	between	0	None
16550	16551	the	0	None
16551	16552	level	0	None
16552	16553	of	0	None
16553	16554	COX	2	GENE-N
16554	16555	-	0	None
16555	16556	2	0	None
16556	16557	or	0	None
16557	16558	COX	2	GENE-N
16558	16559	-	0	None
16559	16560	1	0	None
16560	16561	expression	0	None
16561	16562	and	0	None
16562	16563	the	0	None
16563	16564	extent	0	None
16564	16565	of	0	None
16565	16566	growth	0	None
16566	16567	inhibition	0	None
16567	16568	.	0	None

16569	16570	Treatment	0	None
16570	16571	of	0	None
16571	16572	BxPC	0	None
16572	16573	-	0	None
16573	16574	3	0	None
16574	16575	cells	0	None
16575	16576	with	0	None
16576	16578	sulindac sulfide	3	CHEMICAL
16578	16579	and	0	None
16579	16580	NS398	3	CHEMICAL
16580	16581	resulted	0	None
16581	16582	in	0	None
16582	16583	an	0	None
16583	16584	induction	0	None
16584	16585	of	0	None
16585	16586	COX	2	GENE-N
16586	16587	-	0	None
16587	16588	2	0	None
16588	16589	expression	0	None
16589	16590	.	0	None

16591	16592	Our	0	None
16592	16593	findings	0	None
16593	16594	indicate	0	None
16594	16595	that	0	None
16595	16596	COX	2	GENE-N
16596	16597	-	0	None
16597	16598	2	0	None
16598	16599	up	0	None
16599	16600	-	0	None
16600	16601	regulation	0	None
16601	16602	is	0	None
16602	16603	a	0	None
16603	16604	frequent	0	None
16604	16605	event	0	None
16605	16606	in	0	None
16606	16607	pancreatic	0	None
16607	16608	cancers	0	None
16608	16609	and	0	None
16609	16610	suggest	0	None
16610	16611	that	0	None
16611	16612	nonsteroidal	0	None
16612	16613	anti	0	None
16613	16614	-	0	None
16614	16615	inflammatory	0	None
16615	16616	drugs	0	None
16616	16617	may	0	None
16617	16618	be	0	None
16618	16619	useful	0	None
16619	16620	in	0	None
16620	16621	the	0	None
16621	16622	chemoprevention	0	None
16622	16623	and	0	None
16623	16624	therapy	0	None
16624	16625	of	0	None
16625	16626	pancreatic	0	None
16626	16627	carcinoma	0	None
16627	16628	.	0	None

16629	16630	Inhibition	0	None
16630	16631	of	0	None
16631	16632	ATM	1	GENE-Y
16632	16633	and	0	None
16633	16634	ATR	1	GENE-Y
16634	16635	kinase	2	GENE-N
16635	16636	activities	0	None
16636	16637	by	0	None
16637	16638	the	0	None
16638	16639	radiosensitizing	0	None
16639	16640	agent	0	None
16640	16641	,	0	None
16641	16642	caffeine	3	CHEMICAL
16642	16643	.	0	None

16644	16645	Caffeine	0	None
16645	16646	exposure	0	None
16646	16647	sensitizes	0	None
16647	16648	tumor	0	None
16648	16649	cells	0	None
16649	16650	to	0	None
16650	16651	ionizing	0	None
16651	16652	radiation	0	None
16652	16653	and	0	None
16653	16654	other	0	None
16654	16655	genotoxic	0	None
16655	16656	agents	0	None
16656	16657	.	0	None

16658	16659	The	0	None
16659	16660	radiosensitizing	0	None
16660	16661	effects	0	None
16661	16662	of	0	None
16662	16663	caffeine	3	CHEMICAL
16663	16664	are	0	None
16664	16665	associated	0	None
16665	16666	with	0	None
16666	16667	the	0	None
16667	16668	disruption	0	None
16668	16669	of	0	None
16669	16670	multiple	0	None
16670	16671	DNA	3	CHEMICAL
16671	16672	damage	0	None
16672	16673	-	0	None
16673	16674	responsive	0	None
16674	16675	cell	0	None
16675	16676	cycle	0	None
16676	16677	checkpoints	0	None
16677	16678	.	0	None

16679	16680	The	0	None
16680	16681	similarity	0	None
16681	16682	of	0	None
16682	16683	these	0	None
16683	16684	checkpoint	0	None
16684	16685	defects	0	None
16685	16686	to	0	None
16686	16687	those	0	None
16687	16688	seen	0	None
16688	16689	in	0	None
16689	16690	ataxia	0	None
16690	16691	-	0	None
16691	16692	telangiectasia	0	None
16692	16693	(	0	None
16693	16694	A	0	None
16694	16695	-	0	None
16695	16696	T	0	None
16696	16697	)	0	None
16697	16698	suggested	0	None
16698	16699	that	0	None
16699	16700	caffeine	3	CHEMICAL
16700	16701	might	0	None
16701	16702	inhibit	0	None
16702	16703	one	0	None
16703	16704	or	0	None
16704	16705	more	0	None
16705	16706	components	0	None
16706	16707	in	0	None
16707	16708	an	0	None
16708	16709	A	0	None
16709	16710	-	0	None
16710	16711	T	0	None
16711	16712	mutated	0	None
16712	16713	(	0	None
16713	16714	ATM	1	GENE-Y
16714	16715	)	0	None
16715	16716	-	0	None
16716	16717	dependent	0	None
16717	16718	checkpoint	0	None
16718	16719	pathway	0	None
16719	16720	in	0	None
16720	16721	DNA	3	CHEMICAL
16721	16722	-	0	None
16722	16723	damaged	0	None
16723	16724	cells	0	None
16724	16725	.	0	None

16726	16727	We	0	None
16727	16728	now	0	None
16728	16729	show	0	None
16729	16730	that	0	None
16730	16731	caffeine	3	CHEMICAL
16731	16732	inhibits	0	None
16732	16733	the	0	None
16733	16734	catalytic	0	None
16734	16735	activity	0	None
16735	16736	of	0	None
16736	16737	both	0	None
16737	16738	ATM	1	GENE-Y
16738	16739	and	0	None
16739	16740	the	0	None
16740	16741	related	0	None
16741	16742	kinase	2	GENE-N
16742	16743	,	0	None
16743	16744	ATM	1	GENE-Y
16744	16745	and	0	None
16745	16746	Rad3	0	None
16746	16747	-	0	None
16747	16748	related	0	None
16748	16749	(	0	None
16749	16750	ATR	1	GENE-Y
16750	16751	)	0	None
16751	16752	,	0	None
16752	16753	at	0	None
16753	16754	drug	0	None
16754	16755	concentrations	0	None
16755	16756	similar	0	None
16756	16757	to	0	None
16757	16758	those	0	None
16758	16759	that	0	None
16759	16760	induce	0	None
16760	16761	radiosensitization	0	None
16761	16762	.	0	None

16763	16764	Moreover	0	None
16764	16765	,	0	None
16765	16766	like	0	None
16766	16767	ATM	1	GENE-Y
16767	16768	-	0	None
16768	16769	deficient	0	None
16769	16770	cells	0	None
16770	16771	,	0	None
16771	16772	caffeine	3	CHEMICAL
16772	16773	-	0	None
16773	16774	treated	0	None
16774	16775	A549	0	None
16775	16776	lung	0	None
16776	16777	carcinoma	0	None
16777	16778	cells	0	None
16778	16779	irradiated	0	None
16779	16780	in	0	None
16780	16781	G2	0	None
16781	16782	fail	0	None
16782	16783	to	0	None
16783	16784	arrest	0	None
16784	16785	progression	0	None
16785	16786	into	0	None
16786	16787	mitosis	0	None
16787	16788	,	0	None
16788	16789	and	0	None
16789	16790	S	0	None
16790	16791	-	0	None
16791	16792	phase	0	None
16792	16793	-	0	None
16793	16794	irradiated	0	None
16794	16795	cells	0	None
16795	16796	exhibit	0	None
16796	16797	radioresistant	0	None
16797	16798	DNA	3	CHEMICAL
16798	16799	synthesis	0	None
16799	16800	.	0	None

16801	16802	Similar	0	None
16802	16803	concentrations	0	None
16803	16804	of	0	None
16804	16805	caffeine	3	CHEMICAL
16805	16806	also	0	None
16806	16807	inhibit	0	None
16807	16808	gamma	0	None
16808	16809	-	0	None
16809	16810	and	0	None
16810	16811	UV	0	None
16811	16812	radiation	0	None
16812	16813	-	0	None
16813	16814	induced	0	None
16814	16815	phosphorylation	0	None
16815	16816	of	0	None
16816	16817	p53	0	None
16817	16818	on	0	None
16818	16819	Ser15	1	GENE-Y
16819	16820	,	0	None
16820	16821	a	0	None
16821	16822	modification	0	None
16822	16823	that	0	None
16823	16824	may	0	None
16824	16825	be	0	None
16825	16826	directly	0	None
16826	16827	mediated	0	None
16827	16828	by	0	None
16828	16829	the	0	None
16829	16830	ATM	1	GENE-Y
16830	16831	and	0	None
16831	16832	ATR	1	GENE-Y
16832	16833	kinases	2	GENE-N
16833	16834	.	0	None

16835	16836	DNA	3	CHEMICAL
16836	16837	-	0	None
16837	16838	dependent	0	None
16838	16840	protein kinase	2	GENE-N
16840	16841	,	0	None
16841	16842	another	0	None
16842	16843	ATM	1	GENE-Y
16843	16844	-	0	None
16844	16845	related	0	None
16845	16846	protein	0	None
16846	16847	involved	0	None
16847	16848	in	0	None
16848	16849	DNA	3	CHEMICAL
16849	16850	damage	0	None
16850	16851	repair	0	None
16851	16852	,	0	None
16852	16853	was	0	None
16853	16854	resistant	0	None
16854	16855	to	0	None
16855	16856	the	0	None
16856	16857	inhibitory	0	None
16857	16858	effects	0	None
16858	16859	of	0	None
16859	16860	caffeine	3	CHEMICAL
16860	16861	.	0	None

16862	16863	Likewise	0	None
16863	16864	,	0	None
16864	16865	the	0	None
16865	16866	catalytic	0	None
16866	16867	activity	0	None
16867	16868	of	0	None
16868	16869	the	0	None
16869	16870	G2	0	None
16870	16872	checkpoint kinase	2	GENE-N
16872	16873	,	0	None
16873	16874	hChk1	1	GENE-Y
16874	16875	,	0	None
16875	16876	was	0	None
16876	16877	only	0	None
16877	16878	marginally	0	None
16878	16879	suppressed	0	None
16879	16880	by	0	None
16880	16881	caffeine	3	CHEMICAL
16881	16882	but	0	None
16882	16883	was	0	None
16883	16884	inhibited	0	None
16884	16885	potently	0	None
16885	16886	by	0	None
16886	16887	the	0	None
16887	16888	structurally	0	None
16888	16889	distinct	0	None
16889	16890	radiosensitizer	0	None
16890	16891	,	0	None
16891	16892	UCN	0	None
16892	16893	-	0	None
16893	16894	01	0	None
16894	16895	.	0	None

16896	16897	These	0	None
16897	16898	data	0	None
16898	16899	suggest	0	None
16899	16900	that	0	None
16900	16901	the	0	None
16901	16902	radiosensitizing	0	None
16902	16903	effects	0	None
16903	16904	of	0	None
16904	16905	caffeine	3	CHEMICAL
16905	16906	are	0	None
16906	16907	related	0	None
16907	16908	to	0	None
16908	16909	inhibition	0	None
16909	16910	of	0	None
16910	16911	the	0	None
16911	16913	protein kinase	2	GENE-N
16913	16914	activities	0	None
16914	16915	of	0	None
16915	16916	ATM	1	GENE-Y
16916	16917	and	0	None
16917	16918	ATR	1	GENE-Y
16918	16919	and	0	None
16919	16920	that	0	None
16920	16921	both	0	None
16921	16922	proteins	0	None
16922	16923	are	0	None
16923	16924	relevant	0	None
16924	16925	targets	0	None
16925	16926	for	0	None
16926	16927	the	0	None
16927	16928	development	0	None
16928	16929	of	0	None
16929	16930	novel	0	None
16930	16931	anticancer	0	None
16931	16932	agents	0	None
16932	16933	.	0	None

16934	16935	Stimulation	0	None
16935	16936	by	0	None
16936	16939	transforming growth factor	1	GENE-Y
16939	16940	-	0	None
16940	16941	alpha	0	None
16941	16942	of	0	None
16942	16943	DNA	3	CHEMICAL
16943	16944	synthesis	0	None
16944	16945	and	0	None
16945	16946	proliferation	0	None
16946	16947	of	0	None
16947	16948	adult	0	None
16948	16949	rat	0	None
16949	16950	hepatocytes	0	None
16950	16951	in	0	None
16951	16952	primary	0	None
16952	16953	cultures	0	None
16953	16954	:	0	None
16954	16955	modulation	0	None
16955	16956	by	0	None
16956	16957	alpha	0	None
16957	16958	-	0	None
16958	16959	and	0	None
16959	16960	beta	0	None
16960	16961	-	0	None
16961	16962	adrenoceptor	0	None
16962	16963	agonists	0	None
16963	16964	.	0	None

16965	16966	We	0	None
16966	16967	investigated	0	None
16967	16968	the	0	None
16968	16969	effects	0	None
16969	16970	of	0	None
16970	16974	transforming growth factor alpha	1	GENE-Y
16974	16975	(	0	None
16975	16976	TGF	0	None
16976	16977	-	0	None
16977	16978	alpha	0	None
16978	16979	)	0	None
16979	16980	on	0	None
16980	16981	DNA	3	CHEMICAL
16981	16982	synthesis	0	None
16982	16983	and	0	None
16983	16984	proliferation	0	None
16984	16985	in	0	None
16985	16986	primary	0	None
16986	16987	cultures	0	None
16987	16988	of	0	None
16988	16989	adult	0	None
16989	16990	rat	0	None
16990	16991	hepatocytes	0	None
16991	16992	and	0	None
16992	16993	examined	0	None
16993	16994	the	0	None
16994	16995	influence	0	None
16995	16996	of	0	None
16996	17000	alpha and beta adrenoceptor	2	GENE-N
17000	17001	agonists	0	None
17001	17002	on	0	None
17002	17003	the	0	None
17003	17004	TGF	0	None
17004	17005	-	0	None
17005	17006	alpha	0	None
17006	17007	-	0	None
17007	17008	induced	0	None
17008	17009	responses	0	None
17009	17010	.	0	None

17011	17012	TGF	0	None
17012	17013	-	0	None
17013	17014	alpha	0	None
17014	17015	(	0	None
17015	17016	1	0	None
17016	17017	.	0	None
17017	17018	0	0	None
17018	17019	ng	0	None
17019	17020	/	0	None
17020	17021	ml	0	None
17021	17022	)	0	None
17022	17023	produced	0	None
17023	17024	a	0	None
17024	17025	4	0	None
17025	17026	.	0	None
17026	17027	1	0	None
17027	17028	-	0	None
17028	17029	fold	0	None
17029	17030	elevation	0	None
17030	17031	of	0	None
17031	17032	DNA	3	CHEMICAL
17032	17033	synthesis	0	None
17033	17034	during	0	None
17034	17035	3	0	None
17035	17036	h	0	None
17036	17037	of	0	None
17037	17038	culture	0	None
17038	17039	and	0	None
17039	17040	a	0	None
17040	17041	1	0	None
17041	17042	.	0	None
17042	17043	2	0	None
17043	17044	-	0	None
17044	17045	fold	0	None
17045	17046	increase	0	None
17046	17047	in	0	None
17047	17048	the	0	None
17048	17049	nucleus	0	None
17049	17050	number	0	None
17050	17051	(	0	None
17051	17052	proliferation	0	None
17052	17053	)	0	None
17053	17054	during	0	None
17054	17055	4	0	None
17055	17056	h	0	None
17056	17057	of	0	None
17057	17058	culture	0	None
17058	17059	at	0	None
17059	17060	a	0	None
17060	17061	cell	0	None
17061	17062	density	0	None
17062	17063	of	0	None
17063	17064	3	0	None
17064	17065	.	0	None
17065	17066	3	0	None
17066	17067	x	0	None
17067	17068	10	0	None
17068	17069	(	0	None
17069	17070	4	0	None
17070	17071	)	0	None
17071	17072	cells	0	None
17072	17073	/	0	None
17073	17074	cm	0	None
17074	17075	(	0	None
17075	17076	2	0	None
17076	17077	)	0	None
17077	17078	.	0	None

17079	17080	The	0	None
17080	17081	TGF	0	None
17081	17082	-	0	None
17082	17083	alpha	0	None
17083	17084	-	0	None
17084	17085	induced	0	None
17085	17086	hepatocyte	0	None
17086	17087	DNA	3	CHEMICAL
17087	17088	synthesis	0	None
17088	17089	and	0	None
17089	17090	proliferation	0	None
17090	17091	were	0	None
17091	17092	dose	0	None
17092	17093	-	0	None
17093	17094	dependent	0	None
17094	17095	at	0	None
17095	17096	EC	0	None
17096	17097	(	0	None
17097	17098	50	0	None
17098	17099	)	0	None
17099	17100	values	0	None
17100	17101	of	0	None
17101	17102	0	0	None
17102	17103	.	0	None
17103	17104	36	0	None
17104	17105	ng	0	None
17105	17106	/	0	None
17106	17107	ml	0	None
17107	17108	and	0	None
17108	17109	0	0	None
17109	17110	.	0	None
17110	17111	45	0	None
17111	17112	ng	0	None
17112	17113	/	0	None
17113	17114	ml	0	None
17114	17115	,	0	None
17115	17116	respectively	0	None
17116	17117	.	0	None

17118	17119	Hepatocyte	0	None
17119	17120	DNA	0	None
17120	17121	synthesis	0	None
17121	17122	and	0	None
17122	17123	proliferation	0	None
17123	17124	induced	0	None
17124	17125	by	0	None
17125	17126	1	0	None
17126	17127	.	0	None
17127	17128	0	0	None
17128	17129	ng	0	None
17129	17130	/	0	None
17130	17131	ml	0	None
17131	17132	TGF	0	None
17132	17133	-	0	None
17133	17134	alpha	0	None
17134	17135	did	0	None
17135	17136	not	0	None
17136	17137	reduce	0	None
17137	17138	even	0	None
17138	17139	at	0	None
17139	17140	higher	0	None
17140	17141	initial	0	None
17141	17142	plating	0	None
17142	17143	densities	0	None
17143	17144	(	0	None
17144	17145	5	0	None
17145	17146	.	0	None
17146	17147	0	0	None
17147	17148	x	0	None
17148	17149	10	0	None
17149	17150	(	0	None
17150	17151	4	0	None
17151	17152	)	0	None
17152	17153	and	0	None
17153	17154	1	0	None
17154	17155	.	0	None
17155	17156	0	0	None
17156	17157	x	0	None
17157	17158	10	0	None
17158	17159	(	0	None
17159	17160	5	0	None
17160	17161	)	0	None
17161	17162	cells	0	None
17162	17163	/	0	None
17163	17164	cm	0	None
17164	17165	(	0	None
17165	17166	2	0	None
17166	17167	)	0	None
17167	17168	)	0	None
17168	17169	.	0	None

17170	17171	Increasing	0	None
17171	17172	concentrations	0	None
17172	17173	of	0	None
17173	17174	the	0	None
17174	17175	beta	0	None
17175	17176	(	0	None
17176	17177	2	0	None
17177	17178	)	0	None
17178	17179	adrenoceptor	0	None
17179	17180	agonist	0	None
17180	17181	metaproterenol	3	CHEMICAL
17181	17182	(	0	None
17182	17183	10	0	None
17183	17184	(	0	None
17184	17185	-	0	None
17185	17186	7	0	None
17186	17187	)	0	None
17187	17188	-	0	None
17188	17189	10	0	None
17189	17190	(	0	None
17190	17191	-	0	None
17191	17192	6	0	None
17192	17193	)	0	None
17193	17194	M	0	None
17194	17195	)	0	None
17195	17196	markedly	0	None
17196	17197	reduced	0	None
17197	17198	the	0	None
17198	17199	proliferative	0	None
17199	17200	effects	0	None
17200	17201	of	0	None
17201	17202	TGF	0	None
17202	17203	-	0	None
17203	17204	alpha	0	None
17204	17205	,	0	None
17205	17206	whereas	0	None
17206	17207	those	0	None
17207	17208	of	0	None
17208	17209	the	0	None
17209	17210	alpha	0	None
17210	17211	(	0	None
17211	17212	2	0	None
17212	17213	)	0	None
17213	17214	adrenoceptor	0	None
17214	17215	agonist	0	None
17215	17216	5	0	None
17216	17217	-	0	None
17217	17218	bromo	0	None
17218	17219	-	0	None
17219	17220	6	0	None
17220	17221	-	0	None
17221	17222	[	0	None
17222	17223	2	0	None
17223	17224	-	0	None
17224	17225	imidazolin	0	None
17225	17226	-	0	None
17226	17227	2	0	None
17227	17228	-	0	None
17228	17229	yl	0	None
17229	17230	-	0	None
17230	17231	amino	3	CHEMICAL
17231	17232	]	0	None
17232	17233	-	0	None
17233	17234	quinoxaline	0	None
17234	17235	(	0	None
17235	17236	UK	0	None
17236	17237	-	0	None
17237	17238	14304	0	None
17238	17239	;	0	None
17239	17240	10	0	None
17240	17241	(	0	None
17241	17242	-	0	None
17242	17243	6	0	None
17243	17244	)	0	None
17244	17245	-	0	None
17245	17246	10	0	None
17246	17247	(	0	None
17247	17248	-	0	None
17248	17249	5	0	None
17249	17250	)	0	None
17250	17251	M	0	None
17251	17252	)	0	None
17252	17253	and	0	None
17253	17254	the	0	None
17254	17255	alpha	0	None
17255	17256	(	0	None
17256	17257	1	0	None
17257	17258	)	0	None
17258	17259	adrenoceptor	0	None
17259	17260	agonist	0	None
17260	17261	phenylephrine	3	CHEMICAL
17261	17262	(	0	None
17262	17263	10	0	None
17263	17264	(	0	None
17264	17265	-	0	None
17265	17266	7	0	None
17266	17267	)	0	None
17267	17268	-	0	None
17268	17269	10	0	None
17269	17270	(	0	None
17270	17271	-	0	None
17271	17272	6	0	None
17272	17273	)	0	None
17273	17274	M	0	None
17274	17275	)	0	None
17275	17276	significantly	0	None
17276	17277	potentiated	0	None
17277	17278	the	0	None
17278	17279	TGF	0	None
17279	17280	-	0	None
17280	17281	alpha	0	None
17281	17282	action	0	None
17282	17283	.	0	None

17284	17285	The	0	None
17285	17286	proliferative	0	None
17286	17287	effects	0	None
17287	17288	of	0	None
17288	17289	TGF	0	None
17289	17290	-	0	None
17290	17291	alpha	0	None
17291	17292	(	0	None
17292	17293	1	0	None
17293	17294	.	0	None
17294	17295	0	0	None
17295	17296	ng	0	None
17296	17297	/	0	None
17297	17298	ml	0	None
17298	17299	)	0	None
17299	17300	were	0	None
17300	17301	not	0	None
17301	17302	affected	0	None
17302	17303	significantly	0	None
17303	17304	by	0	None
17304	17305	a	0	None
17305	17307	monoclonal antiepidermal	0	None
17307	17310	growth factor receptor	2	GENE-N
17310	17311	antibody	0	None
17311	17312	(	0	None
17312	17313	1	0	None
17313	17314	-	0	None
17314	17315	100	0	None
17315	17316	ng	0	None
17316	17317	/	0	None
17317	17318	ml	0	None
17318	17319	)	0	None
17319	17320	and	0	None
17320	17321	were	0	None
17321	17322	almost	0	None
17322	17323	completely	0	None
17323	17324	blocked	0	None
17324	17325	by	0	None
17325	17326	specific	0	None
17326	17327	inhibitors	0	None
17327	17328	of	0	None
17328	17329	signal	0	None
17329	17330	transducers	0	None
17330	17331	such	0	None
17331	17332	as	0	None
17332	17333	genistein	3	CHEMICAL
17333	17334	(	0	None
17334	17335	10	0	None
17335	17336	(	0	None
17336	17337	-	0	None
17337	17338	5	0	None
17338	17339	)	0	None
17339	17340	M	0	None
17340	17341	)	0	None
17341	17342	,	0	None
17342	17343	1	0	None
17343	17344	-	0	None
17344	17345	6	0	None
17345	17346	[	0	None
17346	17347	[	0	None
17347	17348	17beta	0	None
17348	17349	-	0	None
17349	17350	3methoxyestra	0	None
17350	17351	-	0	None
17351	17352	1	0	None
17352	17353	,	0	None
17353	17354	3	0	None
17354	17355	,	0	None
17355	17356	5	0	None
17356	17357	(	0	None
17357	17358	10	0	None
17358	17359	)	0	None
17359	17360	-	0	None
17360	17361	trien	0	None
17361	17362	-	0	None
17362	17363	17	0	None
17363	17364	-	0	None
17364	17365	yl	0	None
17365	17366	]	0	None
17366	17367	amino	3	CHEMICAL
17367	17368	]	0	None
17368	17369	hexyl	0	None
17369	17370	]	0	None
17370	17371	-	0	None
17371	17372	1H	3	CHEMICAL
17372	17373	-	0	None
17373	17374	pyrrol2	0	None
17374	17375	,	0	None
17375	17376	5	0	None
17376	17377	-	0	None
17377	17378	dione	0	None
17378	17379	(	0	None
17379	17380	U	0	None
17380	17381	-	0	None
17381	17382	73122	0	None
17382	17383	;	0	None
17383	17384	0	0	None
17384	17385	(	0	None
17385	17386	-	0	None
17386	17387	5	0	None
17387	17388	)	0	None
17388	17389	M	0	None
17389	17390	)	0	None
17390	17391	,	0	None
17391	17392	wortmannin	3	CHEMICAL
17392	17393	(	0	None
17393	17394	5	0	None
17394	17395	x	0	None
17395	17396	10	0	None
17396	17397	(	0	None
17397	17398	-	0	None
17398	17399	7	0	None
17399	17400	)	0	None
17400	17401	M	0	None
17401	17402	)	0	None
17402	17403	,	0	None
17403	17404	sphingosine	3	CHEMICAL
17404	17405	(	0	None
17405	17406	5	0	None
17406	17407	x	0	None
17407	17408	10	0	None
17408	17409	(	0	None
17409	17410	-	0	None
17410	17411	6	0	None
17411	17412	)	0	None
17412	17413	M	0	None
17413	17414	)	0	None
17414	17415	,	0	None
17415	17416	2	0	None
17416	17417	'	0	None
17417	17418	-	0	None
17418	17419	amino	3	CHEMICAL
17419	17420	-	0	None
17420	17421	3	0	None
17421	17422	'	0	None
17422	17423	-	0	None
17423	17424	methoxyflavone	0	None
17424	17425	(	0	None
17425	17426	PD98059	0	None
17426	17427	;	0	None
17427	17428	5	0	None
17428	17429	x	0	None
17429	17430	10	0	None
17430	17431	(	0	None
17431	17432	-	0	None
17432	17433	5	0	None
17433	17434	)	0	None
17434	17435	M	0	None
17435	17436	)	0	None
17436	17437	,	0	None
17437	17438	and	0	None
17438	17439	rapamycin	1	GENE-Y
17439	17440	(	0	None
17440	17441	10	0	None
17441	17442	ng	0	None
17442	17443	/	0	None
17443	17444	ml	0	None
17444	17445	)	0	None
17445	17446	.	0	None

17447	17448	These	0	None
17448	17449	results	0	None
17449	17450	suggest	0	None
17450	17451	that	0	None
17451	17452	among	0	None
17452	17453	the	0	None
17453	17454	elements	0	None
17454	17455	that	0	None
17455	17456	link	0	None
17456	17457	signals	0	None
17457	17458	of	0	None
17458	17461	cell surface receptor	2	GENE-N
17461	17462	to	0	None
17462	17463	the	0	None
17463	17464	nucleus	0	None
17464	17465	,	0	None
17465	17466	the	0	None
17466	17467	proliferative	0	None
17467	17468	action	0	None
17468	17469	of	0	None
17469	17470	TGF	0	None
17470	17471	-	0	None
17471	17472	alpha	0	None
17472	17473	is	0	None
17473	17474	mediated	0	None
17474	17475	,	0	None
17475	17476	at	0	None
17476	17477	least	0	None
17477	17478	,	0	None
17478	17479	by	0	None
17479	17481	tyrosine kinase	2	GENE-N
17481	17482	,	0	None
17482	17484	phospholipase C	0	None
17484	17485	,	0	None
17485	17486	phosphatidylinositol	3	CHEMICAL
17486	17487	3	0	None
17487	17488	-	0	None
17488	17489	kinase	2	GENE-N
17489	17490	,	0	None
17490	17493	protein kinase C	1	GENE-Y
17493	17494	,	0	None
17494	17495	mitogen	0	None
17495	17496	-	0	None
17496	17497	activated	0	None
17497	17500	protein kinase kinase	2	GENE-N
17500	17501	,	0	None
17501	17502	and	0	None
17502	17506	ribosomal protein p70 S6	2	GENE-N
17506	17507	kinase	2	GENE-N
17507	17508	.	0	None

17509	17510	Cell	0	None
17510	17511	culture	0	None
17511	17512	conditions	0	None
17512	17513	determine	0	None
17513	17515	apolipoprotein CIII	1	GENE-Y
17515	17516	secretion	0	None
17516	17517	and	0	None
17517	17518	regulation	0	None
17518	17519	by	0	None
17519	17520	fibrates	3	CHEMICAL
17520	17521	in	0	None
17521	17522	human	0	None
17522	17523	hepatoma	0	None
17523	17524	HepG2	0	None
17524	17525	cells	0	None
17525	17526	.	0	None

17527	17528	Fibrates	0	None
17528	17529	are	0	None
17529	17530	widely	0	None
17530	17531	used	0	None
17531	17532	drugs	0	None
17532	17533	which	0	None
17533	17534	lower	0	None
17534	17535	triglycerides	0	None
17535	17536	and	0	None
17536	17537	increase	0	None
17537	17538	HDL	2	GENE-N
17538	17539	concentrations	0	None
17539	17540	in	0	None
17540	17541	serum	0	None
17541	17542	.	0	None

17543	17544	Recent	0	None
17544	17545	findings	0	None
17545	17546	from	0	None
17546	17547	our	0	None
17547	17548	laboratory	0	None
17548	17549	have	0	None
17549	17550	shown	0	None
17550	17551	that	0	None
17551	17552	fibrates	3	CHEMICAL
17552	17553	repress	0	None
17553	17554	apolipoprotein	2	GENE-N
17554	17555	(	0	None
17555	17556	apo	2	GENE-N
17556	17557	)	0	None
17557	17558	CIII	0	None
17558	17559	gene	0	None
17559	17560	expression	0	None
17560	17561	,	0	None
17561	17562	an	0	None
17562	17563	effect	0	None
17563	17564	that	0	None
17564	17565	explains	0	None
17565	17566	partially	0	None
17566	17567	the	0	None
17567	17568	triglyceride	3	CHEMICAL
17568	17569	-	0	None
17569	17570	lowering	0	None
17570	17571	activity	0	None
17571	17572	of	0	None
17572	17573	these	0	None
17573	17574	drugs	0	None
17574	17575	.	0	None

17576	17577	The	0	None
17577	17578	goal	0	None
17578	17579	of	0	None
17579	17580	the	0	None
17580	17581	present	0	None
17581	17582	study	0	None
17582	17583	was	0	None
17583	17584	to	0	None
17584	17585	compare	0	None
17585	17586	the	0	None
17586	17587	effect	0	None
17587	17588	of	0	None
17588	17589	various	0	None
17589	17590	fibrates	3	CHEMICAL
17590	17591	on	0	None
17591	17592	apo	2	GENE-N
17592	17593	CIII	0	None
17593	17594	gene	0	None
17594	17595	expression	0	None
17595	17596	in	0	None
17596	17597	the	0	None
17597	17598	human	0	None
17598	17599	hepatoblastoma	0	None
17599	17600	cell	0	None
17600	17601	line	0	None
17601	17602	HepG2	0	None
17602	17603	.	0	None

17604	17605	First	0	None
17605	17606	,	0	None
17606	17607	we	0	None
17607	17608	demonstrate	0	None
17608	17609	that	0	None
17609	17610	the	0	None
17610	17611	level	0	None
17611	17612	of	0	None
17612	17613	apo	2	GENE-N
17613	17614	CIII	0	None
17614	17615	secretion	0	None
17615	17616	by	0	None
17616	17617	HepG2	0	None
17617	17618	cells	0	None
17618	17619	is	0	None
17619	17620	controlled	0	None
17620	17621	by	0	None
17621	17622	serum	0	None
17622	17623	factors	0	None
17623	17624	whereas	0	None
17624	17625	apo	2	GENE-N
17625	17626	CIII	0	None
17626	17627	mRNA	0	None
17627	17628	levels	0	None
17628	17629	are	0	None
17629	17630	not	0	None
17630	17631	and	0	None
17631	17632	even	0	None
17632	17633	increase	0	None
17633	17634	under	0	None
17634	17635	conditions	0	None
17635	17636	when	0	None
17636	17637	apo	2	GENE-N
17637	17638	CIII	0	None
17638	17639	secretion	0	None
17639	17640	dramatically	0	None
17640	17641	decreases	0	None
17641	17642	.	0	None

17643	17644	Twelve	0	None
17644	17645	different	0	None
17645	17646	fetal	0	None
17646	17647	calf	0	None
17647	17648	serum	0	None
17648	17649	batches	0	None
17649	17650	were	0	None
17650	17651	tested	0	None
17651	17652	during	0	None
17652	17653	this	0	None
17653	17654	study	0	None
17654	17655	and	0	None
17655	17656	apo	2	GENE-N
17656	17657	CIII	0	None
17657	17658	secretion	0	None
17658	17659	in	0	None
17659	17660	cell	0	None
17660	17661	medium	0	None
17661	17662	could	0	None
17662	17663	only	0	None
17663	17664	be	0	None
17664	17665	detected	0	None
17665	17666	with	0	None
17666	17667	three	0	None
17667	17668	of	0	None
17668	17669	them	0	None
17669	17670	.	0	None

17671	17672	The	0	None
17672	17673	effect	0	None
17673	17674	of	0	None
17674	17675	serum	0	None
17675	17676	on	0	None
17676	17677	apolipoprotein	2	GENE-N
17677	17678	secretion	0	None
17678	17679	was	0	None
17679	17680	more	0	None
17680	17681	pronounced	0	None
17681	17682	for	0	None
17682	17683	apo	2	GENE-N
17683	17684	CIII	0	None
17684	17685	whereas	0	None
17685	17686	other	0	None
17686	17687	apolipoproteins	0	None
17687	17688	(	0	None
17688	17690	apo E	2	GENE-N
17690	17691	,	0	None
17691	17693	apo B	2	GENE-N
17693	17694	,	0	None
17694	17696	apo AII	1	GENE-Y
17696	17697	and	0	None
17697	17699	apo AI	2	GENE-N
17699	17700	)	0	None
17700	17701	were	0	None
17701	17702	affected	0	None
17702	17703	to	0	None
17703	17704	a	0	None
17704	17705	lesser	0	None
17705	17706	extent	0	None
17706	17707	.	0	None

17708	17709	Under	0	None
17709	17710	serum	0	None
17710	17711	conditions	0	None
17711	17712	allowing	0	None
17712	17713	apo	2	GENE-N
17713	17714	CIII	0	None
17714	17715	secretion	0	None
17715	17716	,	0	None
17716	17717	treatment	0	None
17717	17718	with	0	None
17718	17719	the	0	None
17719	17720	peroxisome	0	None
17720	17721	-	0	None
17721	17722	proliferator	0	None
17722	17723	activated	0	None
17723	17724	receptor	0	None
17724	17725	(	0	None
17725	17726	PPAR	1	GENE-Y
17726	17727	)	0	None
17727	17728	alpha	0	None
17728	17729	activators	0	None
17729	17730	fenofibrate	3	CHEMICAL
17730	17731	,	0	None
17731	17732	gemfibrozil	3	CHEMICAL
17732	17733	and	0	None
17733	17734	Wy	0	None
17734	17735	-	0	None
17735	17736	14643	0	None
17736	17737	result	0	None
17737	17738	in	0	None
17738	17739	a	0	None
17739	17740	marked	0	None
17740	17741	lowering	0	None
17741	17742	of	0	None
17742	17743	apo	2	GENE-N
17743	17744	CIII	0	None
17744	17745	secretion	0	None
17745	17746	and	0	None
17746	17747	gene	0	None
17747	17748	expression	0	None
17748	17749	,	0	None
17749	17750	this	0	None
17750	17751	effect	0	None
17751	17752	being	0	None
17752	17753	most	0	None
17753	17754	pronounced	0	None
17754	17755	with	0	None
17755	17756	Wy	0	None
17756	17757	-	0	None
17757	17758	14643	0	None
17758	17759	.	0	None

17760	17761	Comparison	0	None
17761	17762	of	0	None
17762	17763	the	0	None
17763	17764	activity	0	None
17764	17765	of	0	None
17765	17766	a	0	None
17766	17767	PPARgamma	1	GENE-Y
17767	17768	-	0	None
17768	17769	specific	0	None
17769	17770	ligand	0	None
17770	17771	,	0	None
17771	17772	the	0	None
17772	17773	antidiabetic	0	None
17773	17774	thiazolidinedione	3	CHEMICAL
17774	17775	,	0	None
17775	17776	BRL	0	None
17776	17777	-	0	None
17777	17778	49653	0	None
17778	17779	and	0	None
17779	17780	a	0	None
17780	17781	PPARalpha	1	GENE-Y
17781	17782	ligand	0	None
17782	17783	Wy	0	None
17783	17784	-	0	None
17784	17785	14643	0	None
17785	17786	showed	0	None
17786	17787	a	0	None
17787	17788	marked	0	None
17788	17789	decrease	0	None
17789	17790	of	0	None
17790	17791	apo	2	GENE-N
17791	17792	CIII	0	None
17792	17793	secretion	0	None
17793	17794	and	0	None
17794	17795	gene	0	None
17795	17796	expression	0	None
17796	17797	after	0	None
17797	17798	activation	0	None
17798	17799	of	0	None
17799	17800	PPARalpha	1	GENE-Y
17800	17801	but	0	None
17801	17802	not	0	None
17802	17803	PPARgamma	1	GENE-Y
17803	17804	.	0	None

17805	17806	In	0	None
17806	17807	conclusion	0	None
17807	17808	,	0	None
17808	17809	fibrates	3	CHEMICAL
17809	17810	down	0	None
17810	17811	-	0	None
17811	17812	regulate	0	None
17812	17813	apo	2	GENE-N
17813	17814	CIII	0	None
17814	17815	gene	0	None
17815	17816	expression	0	None
17816	17817	in	0	None
17817	17818	human	0	None
17818	17819	HepG2	0	None
17819	17820	cells	0	None
17820	17821	,	0	None
17821	17822	most	0	None
17822	17823	likely	0	None
17823	17824	via	0	None
17824	17825	PPARalpha	1	GENE-Y
17825	17826	but	0	None
17826	17827	not	0	None
17827	17828	via	0	None
17828	17829	PPARgamma	1	GENE-Y
17829	17830	.	0	None

17831	17832	However	0	None
17832	17833	,	0	None
17833	17834	these	0	None
17834	17835	effects	0	None
17835	17836	are	0	None
17836	17837	only	0	None
17837	17838	observed	0	None
17838	17839	in	0	None
17839	17840	HepG2	0	None
17840	17841	cells	0	None
17841	17842	cultured	0	None
17842	17843	under	0	None
17843	17844	appropriate	0	None
17844	17845	conditions	0	None
17845	17846	.	0	None

17847	17848	Variations	0	None
17848	17849	of	0	None
17849	17851	progesterone receptor	2	GENE-N
17851	17852	and	0	None
17852	17853	c	0	None
17853	17854	-	0	None
17854	17855	fos	1	GENE-Y
17855	17856	gene	0	None
17856	17857	expression	0	None
17857	17858	in	0	None
17858	17859	the	0	None
17859	17860	rat	0	None
17860	17861	uterus	0	None
17861	17862	after	0	None
17862	17863	treatment	0	None
17863	17864	with	0	None
17864	17865	norethisterone	0	None
17865	17866	and	0	None
17866	17867	its	0	None
17867	17868	A	0	None
17868	17869	-	0	None
17869	17870	ring	2	GENE-N
17870	17871	reduced	0	None
17871	17872	metabolites	0	None
17872	17873	.	0	None

17874	17875	It	0	None
17875	17876	has	0	None
17876	17877	been	0	None
17877	17878	suggested	0	None
17878	17879	that	0	None
17879	17880	some	0	None
17880	17881	contraceptive	0	None
17881	17882	derivatives	0	None
17882	17883	of	0	None
17883	17884	19	0	None
17884	17885	-	0	None
17885	17886	nor	0	None
17886	17887	-	0	None
17887	17888	testosterone	3	CHEMICAL
17888	17889	possess	0	None
17889	17890	estrogenic	0	None
17890	17891	activity	0	None
17891	17892	that	0	None
17892	17893	may	0	None
17893	17894	facilitate	0	None
17894	17895	the	0	None
17895	17896	development	0	None
17896	17897	of	0	None
17897	17898	breast	0	None
17898	17899	cancer	0	None
17899	17900	.	0	None

17901	17902	The	0	None
17902	17903	aim	0	None
17903	17904	of	0	None
17904	17905	this	0	None
17905	17906	work	0	None
17906	17907	was	0	None
17907	17908	to	0	None
17908	17909	investigate	0	None
17909	17910	the	0	None
17910	17911	estrogenic	0	None
17911	17912	properties	0	None
17912	17913	of	0	None
17913	17914	norethisterone	0	None
17914	17915	(	0	None
17915	17916	NET	1	GENE-Y
17916	17917	)	0	None
17917	17918	and	0	None
17918	17919	its	0	None
17919	17920	A	0	None
17920	17921	-	0	None
17921	17922	ring	2	GENE-N
17922	17923	-	0	None
17923	17924	reduced	0	None
17924	17925	derivatives	0	None
17925	17926	by	0	None
17926	17927	determining	0	None
17927	17929	progesterone receptor	2	GENE-N
17929	17930	(	0	None
17930	17931	PR	2	GENE-N
17931	17932	)	0	None
17932	17933	and	0	None
17933	17934	c	0	None
17934	17935	-	0	None
17935	17936	fos	1	GENE-Y
17936	17937	mRNA	0	None
17937	17938	content	0	None
17938	17939	of	0	None
17939	17940	two	0	None
17940	17941	estrogen	3	CHEMICAL
17941	17942	-	0	None
17942	17943	regulated	0	None
17943	17944	genes	0	None
17944	17945	in	0	None
17945	17946	the	0	None
17946	17947	uterus	0	None
17947	17948	of	0	None
17948	17949	ovariectomized	0	None
17949	17950	rats	0	None
17950	17951	.	0	None

17952	17953	mRNA	0	None
17953	17954	content	0	None
17954	17955	was	0	None
17955	17956	evaluated	0	None
17956	17957	by	0	None
17957	17958	Northern	0	None
17958	17959	blot	0	None
17959	17960	1	0	None
17960	17961	-	0	None
17961	17962	6	0	None
17962	17963	h	0	None
17963	17964	after	0	None
17964	17965	17	0	None
17965	17966	beta	0	None
17966	17967	-	0	None
17967	17968	estradiol	3	CHEMICAL
17968	17969	administration	0	None
17969	17970	.	0	None

17971	17972	The	0	None
17972	17973	highest	0	None
17973	17974	PR	2	GENE-N
17974	17975	and	0	None
17975	17976	c	0	None
17976	17977	-	0	None
17977	17978	fos	1	GENE-Y
17978	17979	mRNA	0	None
17979	17980	content	0	None
17980	17981	was	0	None
17981	17982	observed	0	None
17982	17983	3	0	None
17983	17984	h	0	None
17984	17985	and	0	None
17985	17986	2	0	None
17986	17987	h	0	None
17987	17988	after	0	None
17988	17989	17	0	None
17989	17990	beta	0	None
17990	17991	-	0	None
17991	17992	estradiol	3	CHEMICAL
17992	17993	administration	0	None
17993	17994	,	0	None
17994	17995	respectively	0	None
17995	17996	.	0	None

17997	17998	NET	1	GENE-Y
17998	17999	did	0	None
17999	18000	not	0	None
18000	18001	modify	0	None
18001	18002	either	0	None
18002	18003	PR	2	GENE-N
18003	18004	or	0	None
18004	18005	c	0	None
18005	18006	-	0	None
18006	18007	fos	1	GENE-Y
18007	18008	mRNA	0	None
18008	18009	content	0	None
18009	18010	.	0	None

18011	18012	In	0	None
18012	18013	contrast	0	None
18013	18014	,	0	None
18014	18015	5	0	None
18015	18016	alpha	0	None
18016	18017	-	0	None
18017	18018	and	0	None
18018	18019	3	0	None
18019	18020	beta	0	None
18020	18021	,	0	None
18021	18022	5	0	None
18022	18023	alpha	0	None
18023	18024	-	0	None
18024	18025	NET	1	GENE-Y
18025	18026	significantly	0	None
18026	18027	increased	0	None
18027	18028	mRNA	0	None
18028	18029	content	0	None
18029	18030	of	0	None
18030	18031	both	0	None
18031	18032	genes	0	None
18032	18033	.	0	None

18034	18035	The	0	None
18035	18036	increase	0	None
18036	18037	in	0	None
18037	18038	c	0	None
18038	18039	-	0	None
18039	18040	fos	1	GENE-Y
18040	18041	mRNA	0	None
18041	18042	content	0	None
18042	18043	induced	0	None
18043	18044	by	0	None
18044	18045	these	0	None
18045	18046	reduced	0	None
18046	18047	compounds	0	None
18047	18048	was	0	None
18048	18049	lower	0	None
18049	18050	than	0	None
18050	18051	that	0	None
18051	18052	found	0	None
18052	18053	with	0	None
18053	18054	estradiol	3	CHEMICAL
18054	18055	treatment	0	None
18055	18056	.	0	None

18057	18058	The	0	None
18058	18059	overall	0	None
18059	18060	results	0	None
18060	18061	indicate	0	None
18061	18062	that	0	None
18062	18063	NET	1	GENE-Y
18063	18064	administration	0	None
18064	18065	can	0	None
18065	18066	indirectly	0	None
18066	18067	induce	0	None
18067	18068	estrogenic	0	None
18068	18069	effects	0	None
18069	18070	through	0	None
18070	18071	the	0	None
18071	18072	action	0	None
18072	18073	of	0	None
18073	18074	its	0	None
18074	18075	5	0	None
18075	18076	alpha	0	None
18076	18077	-	0	None
18077	18078	dihydro	0	None
18078	18079	and	0	None
18079	18080	3	0	None
18080	18081	beta	0	None
18081	18082	,	0	None
18082	18083	5	0	None
18083	18084	alpha	0	None
18084	18085	-	0	None
18085	18086	tetrahydro	0	None
18086	18087	derivatives	0	None
18087	18088	.	0	None

18089	18090	Involvement	0	None
18090	18091	of	0	None
18091	18092	bcl	0	None
18092	18093	-	0	None
18093	18094	2	0	None
18094	18095	and	0	None
18095	18096	p21waf1	0	None
18096	18097	proteins	0	None
18097	18098	in	0	None
18098	18099	response	0	None
18099	18100	of	0	None
18100	18101	human	0	None
18101	18102	breast	0	None
18102	18103	cancer	0	None
18103	18104	cell	0	None
18104	18105	clones	0	None
18105	18106	to	0	None
18106	18107	Tomudex	0	None
18107	18108	.	0	None

18109	18110	Mechanisms	0	None
18110	18111	of	0	None
18111	18112	resistance	0	None
18112	18113	to	0	None
18113	18114	Tomudex	0	None
18114	18115	include	0	None
18115	18116	increased	0	None
18116	18118	thymidylate synthase	1	GENE-Y
18118	18119	activity	0	None
18119	18120	,	0	None
18120	18121	as	0	None
18121	18122	well	0	None
18122	18123	as	0	None
18123	18124	reduced	0	None
18124	18125	intracellular	0	None
18125	18126	drug	0	None
18126	18127	uptake	0	None
18127	18128	and	0	None
18128	18129	polyglutamation	0	None
18129	18130	.	0	None

18131	18132	However	0	None
18132	18133	,	0	None
18133	18134	little	0	None
18134	18135	is	0	None
18135	18136	known	0	None
18136	18137	about	0	None
18137	18138	other	0	None
18138	18139	mechanisms	0	None
18139	18140	of	0	None
18140	18141	resistance	0	None
18141	18142	,	0	None
18142	18143	such	0	None
18143	18144	as	0	None
18144	18145	a	0	None
18145	18146	possible	0	None
18146	18147	protection	0	None
18147	18148	against	0	None
18148	18149	Tomudex	0	None
18149	18150	-	0	None
18150	18151	induced	0	None
18151	18152	apoptosis	0	None
18152	18153	mediated	0	None
18153	18154	by	0	None
18154	18155	bcl	0	None
18155	18156	-	0	None
18156	18157	2	0	None
18157	18158	.	0	None

18159	18160	We	0	None
18160	18161	transfected	0	None
18161	18162	the	0	None
18162	18163	MDA	2	GENE-N
18163	18164	-	0	None
18164	18165	MB	1	GENE-Y
18165	18166	-	0	None
18166	18167	435	0	None
18167	18168	human	0	None
18168	18169	breast	0	None
18169	18170	cancer	0	None
18170	18171	cell	0	None
18171	18172	line	0	None
18172	18173	,	0	None
18173	18174	which	0	None
18174	18175	is	0	None
18175	18176	characterized	0	None
18176	18177	by	0	None
18177	18178	a	0	None
18178	18179	mutated	0	None
18179	18180	p53	0	None
18180	18181	gene	0	None
18181	18182	,	0	None
18182	18183	with	0	None
18183	18184	cDNA	0	None
18184	18185	of	0	None
18185	18186	the	0	None
18186	18187	bcl	0	None
18187	18188	-	0	None
18188	18189	2	0	None
18189	18190	gene	0	None
18190	18191	and	0	None
18191	18192	generated	0	None
18192	18193	two	0	None
18193	18194	clones	0	None
18194	18195	(	0	None
18195	18196	MDA	2	GENE-N
18196	18197	-	0	None
18197	18198	bcl4	0	None
18198	18199	and	0	None
18199	18200	MDA	2	GENE-N
18200	18201	-	0	None
18201	18202	bcl7	0	None
18202	18203	)	0	None
18203	18204	characterized	0	None
18204	18205	by	0	None
18205	18206	bcl	0	None
18206	18207	-	0	None
18207	18208	2	0	None
18208	18209	expression	0	None
18209	18210	twofold	0	None
18210	18211	and	0	None
18211	18212	fourfold	0	None
18212	18213	that	0	None
18213	18214	observed	0	None
18214	18215	in	0	None
18215	18216	the	0	None
18216	18217	control	0	None
18217	18218	cell	0	None
18218	18219	clone	0	None
18219	18220	(	0	None
18220	18221	MDAneo	0	None
18221	18222	)	0	None
18222	18223	.	0	None

18224	18225	A	0	None
18225	18226	concomitant	0	None
18226	18227	overexpression	0	None
18227	18228	of	0	None
18228	18229	p21wafl	1	GENE-Y
18229	18230	was	0	None
18230	18231	also	0	None
18231	18232	detected	0	None
18232	18233	in	0	None
18233	18234	the	0	None
18234	18235	MDA	2	GENE-N
18235	18236	-	0	None
18236	18237	bcl7	0	None
18237	18238	clone	0	None
18238	18239	.	0	None

18240	18241	The	0	None
18241	18242	MDA	2	GENE-N
18242	18243	-	0	None
18243	18244	bcl4	0	None
18244	18245	clone	0	None
18245	18246	was	0	None
18246	18247	three	0	None
18247	18248	times	0	None
18248	18249	more	0	None
18249	18250	resistant	0	None
18250	18251	to	0	None
18251	18252	a	0	None
18252	18253	24	0	None
18253	18254	-	0	None
18254	18255	h	0	None
18255	18256	Tomudex	0	None
18256	18257	exposure	0	None
18257	18258	than	0	None
18258	18259	the	0	None
18259	18260	MDAneo	0	None
18260	18261	clone	0	None
18261	18262	,	0	None
18262	18263	whereas	0	None
18263	18264	the	0	None
18264	18265	MDA	2	GENE-N
18265	18266	-	0	None
18266	18267	bcl7	0	None
18267	18268	clone	0	None
18268	18269	was	0	None
18269	18270	as	0	None
18270	18271	sensitive	0	None
18271	18272	to	0	None
18272	18273	Tomudex	0	None
18273	18274	as	0	None
18274	18275	the	0	None
18275	18276	control	0	None
18276	18277	cell	0	None
18277	18278	clone	0	None
18278	18279	.	0	None

18280	18281	A	0	None
18281	18282	lower	0	None
18282	18283	sensitivity	0	None
18283	18284	of	0	None
18284	18285	the	0	None
18285	18286	MDA	2	GENE-N
18286	18287	-	0	None
18287	18288	bcl4	0	None
18288	18289	clone	0	None
18289	18290	than	0	None
18290	18291	MDAneo	0	None
18291	18292	and	0	None
18292	18293	MDA	2	GENE-N
18293	18294	-	0	None
18294	18295	bcl7	0	None
18295	18296	clones	0	None
18296	18297	to	0	None
18297	18298	5	0	None
18298	18299	-	0	None
18299	18300	fluorouracil	3	CHEMICAL
18300	18301	and	0	None
18301	18302	gemcitabine	3	CHEMICAL
18302	18303	was	0	None
18303	18304	also	0	None
18304	18305	observed	0	None
18305	18306	.	0	None

18307	18308	No	0	None
18308	18309	significant	0	None
18309	18310	difference	0	None
18310	18311	was	0	None
18311	18312	noted	0	None
18312	18313	in	0	None
18313	18314	the	0	None
18314	18315	susceptibility	0	None
18315	18316	of	0	None
18316	18317	clones	0	None
18317	18318	to	0	None
18318	18319	fludarabine	0	None
18319	18320	and	0	None
18320	18321	methothrexate	0	None
18321	18322	.	0	None

18323	18324	Basal	0	None
18324	18325	levels	0	None
18325	18326	of	0	None
18326	18328	thymidylate synthase	1	GENE-Y
18328	18329	activity	0	None
18329	18330	were	0	None
18330	18331	superimposable	0	None
18331	18332	in	0	None
18332	18333	the	0	None
18333	18334	three	0	None
18334	18335	clones	0	None
18335	18336	.	0	None

18337	18338	Tomudex	0	None
18338	18339	induced	0	None
18339	18340	a	0	None
18340	18341	marked	0	None
18341	18342	accumulation	0	None
18342	18343	of	0	None
18343	18344	cells	0	None
18344	18345	in	0	None
18345	18346	the	0	None
18346	18347	S	0	None
18347	18348	phase	0	None
18348	18349	in	0	None
18349	18350	all	0	None
18350	18351	the	0	None
18351	18352	clones	0	None
18352	18353	.	0	None

18354	18355	However	0	None
18355	18356	,	0	None
18356	18357	an	0	None
18357	18358	apoptotic	0	None
18358	18359	hypodiploid	0	None
18359	18360	DNA	3	CHEMICAL
18360	18361	peak	0	None
18361	18362	and	0	None
18362	18363	the	0	None
18363	18364	characteristic	0	None
18364	18365	nuclear	0	None
18365	18366	morphology	0	None
18366	18367	of	0	None
18367	18368	apoptosis	0	None
18368	18369	were	0	None
18369	18370	observed	0	None
18370	18371	only	0	None
18371	18372	in	0	None
18372	18373	the	0	None
18373	18374	MDA	2	GENE-N
18374	18375	-	0	None
18375	18376	bcl7	0	None
18376	18377	clone	0	None
18377	18378	after	0	None
18378	18379	exposure	0	None
18379	18380	to	0	None
18380	18381	Tomudex	0	None
18381	18382	.	0	None

18383	18384	No	0	None
18384	18385	difference	0	None
18385	18386	in	0	None
18386	18387	the	0	None
18387	18388	treatment	0	None
18388	18389	-	0	None
18389	18390	induced	0	None
18390	18391	modulation	0	None
18391	18392	of	0	None
18392	18393	proteins	0	None
18393	18394	involved	0	None
18394	18395	in	0	None
18395	18396	cell	0	None
18396	18397	cycle	0	None
18397	18398	progression	0	None
18398	18399	(	0	None
18399	18400	cyclin	2	GENE-N
18400	18401	A	0	None
18401	18402	,	0	None
18402	18403	cdk2	1	GENE-Y
18403	18404	,	0	None
18404	18405	pRB	1	GENE-Y
18405	18406	,	0	None
18406	18407	E2F	0	None
18407	18408	-	0	None
18408	18409	1	0	None
18409	18410	)	0	None
18410	18411	and	0	None
18411	18412	apoptosis	0	None
18412	18413	(	0	None
18413	18414	bcl	0	None
18414	18415	-	0	None
18415	18416	2	0	None
18416	18417	,	0	None
18417	18418	bax	0	None
18418	18419	)	0	None
18419	18420	was	0	None
18420	18421	observed	0	None
18421	18422	in	0	None
18422	18423	the	0	None
18423	18424	three	0	None
18424	18425	clones	0	None
18425	18426	.	0	None

18427	18428	The	0	None
18428	18429	only	0	None
18429	18430	exception	0	None
18430	18431	was	0	None
18431	18432	that	0	None
18432	18433	the	0	None
18433	18434	expression	0	None
18434	18435	of	0	None
18435	18436	p21wafl	1	GENE-Y
18436	18437	in	0	None
18437	18438	the	0	None
18438	18439	MDA	2	GENE-N
18439	18440	-	0	None
18440	18441	bcl4	0	None
18441	18442	clone	0	None
18442	18443	was	0	None
18443	18444	inducible	0	None
18444	18445	at	0	None
18445	18446	a	0	None
18446	18447	Tomudex	0	None
18447	18448	concentration	0	None
18448	18449	much	0	None
18449	18450	higher	0	None
18450	18451	than	0	None
18451	18452	that	0	None
18452	18453	required	0	None
18453	18454	to	0	None
18454	18455	induce	0	None
18455	18456	the	0	None
18456	18457	protein	0	None
18457	18458	in	0	None
18458	18459	the	0	None
18459	18460	other	0	None
18460	18461	clones	0	None
18461	18462	.	0	None

18463	18464	Overall	0	None
18464	18465	,	0	None
18465	18466	the	0	None
18466	18467	results	0	None
18467	18468	indicate	0	None
18468	18469	that	0	None
18469	18470	bcl	0	None
18470	18471	-	0	None
18471	18472	2	0	None
18472	18473	and	0	None
18473	18474	p21wafl	1	GENE-Y
18474	18475	proteins	0	None
18475	18476	concur	0	None
18476	18477	in	0	None
18477	18478	determining	0	None
18478	18479	the	0	None
18479	18480	cellular	0	None
18480	18481	profile	0	None
18481	18482	of	0	None
18482	18483	sensitivity	0	None
18483	18484	/	0	None
18484	18485	resistance	0	None
18485	18486	to	0	None
18486	18487	Tomudex	0	None
18487	18488	.	0	None

18489	18490	Suppression	0	None
18490	18491	of	0	None
18491	18492	Delta	0	None
18492	18493	(	0	None
18493	18494	5	0	None
18494	18495	)	0	None
18495	18496	-	0	None
18496	18497	androstenediol	0	None
18497	18498	-	0	None
18498	18499	induced	0	None
18499	18500	androgen	3	CHEMICAL
18500	18501	receptor	0	None
18501	18502	transactivation	0	None
18502	18503	by	0	None
18503	18504	selective	0	None
18504	18505	steroids	3	CHEMICAL
18505	18506	in	0	None
18506	18507	human	0	None
18507	18508	prostate	0	None
18508	18509	cancer	0	None
18509	18510	cells	0	None
18510	18511	.	0	None

18512	18513	Our	0	None
18513	18514	earlier	0	None
18514	18515	report	0	None
18515	18516	suggested	0	None
18516	18517	that	0	None
18517	18518	androst	0	None
18518	18519	-	0	None
18519	18520	5	0	None
18520	18521	-	0	None
18521	18522	ene	0	None
18522	18523	-	0	None
18523	18524	3beta	0	None
18524	18525	,	0	None
18525	18526	7beta	0	None
18526	18527	-	0	None
18527	18528	diol	3	CHEMICAL
18528	18529	(	0	None
18529	18530	Delta	0	None
18530	18531	(	0	None
18531	18532	5	0	None
18532	18533	)	0	None
18533	18534	-	0	None
18534	18535	androstenediol	0	None
18535	18536	or	0	None
18536	18537	Adiol	0	None
18537	18538	)	0	None
18538	18539	is	0	None
18539	18540	a	0	None
18540	18541	natural	0	None
18541	18542	hormone	0	None
18542	18543	with	0	None
18543	18544	androgenic	0	None
18544	18545	activity	0	None
18545	18546	and	0	None
18546	18547	that	0	None
18547	18548	two	0	None
18548	18549	potent	0	None
18549	18550	antiandrogens	0	None
18550	18551	,	0	None
18551	18552	hydroxyflutamide	0	None
18552	18553	(	0	None
18553	18554	Eulexin	0	None
18554	18555	)	0	None
18555	18556	and	0	None
18556	18557	bicalutamide	3	CHEMICAL
18557	18558	(	0	None
18558	18559	Casodex	3	CHEMICAL
18559	18560	)	0	None
18560	18561	,	0	None
18561	18562	fail	0	None
18562	18563	to	0	None
18563	18564	block	0	None
18564	18565	completely	0	None
18565	18566	the	0	None
18566	18567	Adiol	0	None
18567	18568	-	0	None
18568	18569	induced	0	None
18569	18571	androgen receptor	1	GENE-Y
18571	18572	(	0	None
18572	18573	AR	1	GENE-Y
18573	18574	)	0	None
18574	18575	transactivation	0	None
18575	18576	in	0	None
18576	18577	prostate	0	None
18577	18578	cancer	0	None
18578	18579	cells	0	None
18579	18580	.	0	None

18581	18582	Here	0	None
18582	18583	,	0	None
18583	18584	we	0	None
18584	18585	report	0	None
18585	18586	the	0	None
18586	18587	development	0	None
18587	18588	of	0	None
18588	18589	a	0	None
18589	18590	reporter	0	None
18590	18591	assay	0	None
18591	18592	to	0	None
18592	18593	screen	0	None
18593	18594	several	0	None
18594	18595	selective	0	None
18595	18596	steroids	3	CHEMICAL
18596	18597	with	0	None
18597	18598	anti	0	None
18598	18599	-	0	None
18599	18600	Adiol	0	None
18600	18601	activity	0	None
18601	18602	.	0	None

18603	18604	Among	0	None
18604	18605	22	0	None
18605	18606	derivatives	0	None
18606	18607	/	0	None
18607	18608	metabolites	0	None
18608	18609	of	0	None
18609	18610	dehydroepiandrosterone	3	CHEMICAL
18610	18611	,	0	None
18611	18612	we	0	None
18612	18613	found	0	None
18613	18614	4	0	None
18614	18615	steroids	3	CHEMICAL
18615	18616	[	0	None
18616	18617	no	0	None
18617	18618	.	0	None
18618	18619	4	0	None
18619	18620	,	0	None
18620	18621	1	0	None
18621	18622	,	0	None
18622	18623	3	0	None
18623	18624	,	0	None
18624	18625	5	0	None
18625	18626	(	0	None
18626	18627	10	0	None
18627	18628	)	0	None
18628	18629	-	0	None
18629	18630	estratriene	0	None
18630	18631	-	0	None
18631	18632	17alpha	0	None
18632	18633	-	0	None
18633	18634	ethynyl	3	CHEMICAL
18634	18635	-	0	None
18635	18636	3	0	None
18636	18637	,	0	None
18637	18638	17beta	0	None
18638	18639	-	0	None
18639	18640	diol	3	CHEMICAL
18640	18641	;	0	None
18641	18642	no	0	None
18642	18643	.	0	None
18643	18644	6	0	None
18644	18645	,	0	None
18645	18646	17alpha	0	None
18646	18647	-	0	None
18647	18648	ethynyl	3	CHEMICAL
18648	18649	-	0	None
18649	18650	androstene	3	CHEMICAL
18650	18651	-	0	None
18651	18652	diol	3	CHEMICAL
18652	18653	;	0	None
18653	18654	no	0	None
18654	18655	.	0	None
18655	18656	8	0	None
18656	18657	,	0	None
18657	18658	3beta	0	None
18658	18659	,	0	None
18659	18660	17beta	0	None
18660	18661	-	0	None
18661	18662	dihydroxy	3	CHEMICAL
18662	18663	-	0	None
18663	18664	androst	0	None
18664	18665	-	0	None
18665	18666	5	0	None
18666	18667	-	0	None
18667	18668	ene	0	None
18668	18669	-	0	None
18669	18670	16	0	None
18670	18671	-	0	None
18671	18672	one	0	None
18672	18673	;	0	None
18673	18674	and	0	None
18674	18675	no	0	None
18675	18676	.	0	None
18676	18677	10	0	None
18677	18678	,	0	None
18678	18679	3beta	0	None
18679	18680	-	0	None
18680	18681	methylcarbonate	0	None
18681	18682	-	0	None
18682	18683	androst	0	None
18683	18684	-	0	None
18684	18685	5	0	None
18685	18686	-	0	None
18686	18687	ene	0	None
18687	18688	-	0	None
18688	18689	7	0	None
18689	18690	,	0	None
18690	18691	17	0	None
18691	18692	-	0	None
18692	18693	dione	0	None
18693	18694	]	0	None
18694	18695	that	0	None
18695	18696	have	0	None
18696	18697	no	0	None
18697	18698	androgenic	0	None
18698	18699	activity	0	None
18699	18700	and	0	None
18700	18701	could	0	None
18701	18702	also	0	None
18702	18703	block	0	None
18703	18704	the	0	None
18704	18705	Adiol	0	None
18705	18706	-	0	None
18706	18707	induced	0	None
18707	18708	AR	1	GENE-Y
18708	18709	transactivation	0	None
18709	18710	in	0	None
18710	18711	prostate	0	None
18711	18713	cancer PC	1	GENE-Y
18713	18714	-	0	None
18714	18715	3	0	None
18715	18716	cells	0	None
18716	18717	.	0	None

18718	18719	Interestingly	0	None
18719	18720	,	0	None
18720	18721	these	0	None
18721	18722	compounds	0	None
18722	18723	,	0	None
18723	18724	in	0	None
18724	18725	combination	0	None
18725	18726	with	0	None
18726	18727	hydroxyflutamide	0	None
18727	18728	,	0	None
18728	18729	further	0	None
18729	18730	suppressed	0	None
18730	18731	the	0	None
18731	18732	Adiol	0	None
18732	18733	-	0	None
18733	18734	induced	0	None
18734	18735	AR	1	GENE-Y
18735	18736	transactivation	0	None
18736	18737	.	0	None

18738	18739	Reporter	0	None
18739	18740	assays	0	None
18740	18741	further	0	None
18741	18742	showed	0	None
18742	18743	that	0	None
18743	18744	these	0	None
18744	18745	four	0	None
18745	18746	anti	0	None
18746	18747	-	0	None
18747	18748	Adiol	0	None
18748	18749	steroids	3	CHEMICAL
18749	18750	have	0	None
18750	18751	relatively	0	None
18751	18752	lower	0	None
18752	18753	glucocorticoid	1	GENE-Y
18753	18754	,	0	None
18754	18755	progesterone	3	CHEMICAL
18755	18756	,	0	None
18756	18757	and	0	None
18757	18758	estrogenic	0	None
18758	18759	activity	0	None
18759	18760	.	0	None

18761	18762	Together	0	None
18762	18763	,	0	None
18763	18764	these	0	None
18764	18765	data	0	None
18765	18766	suggest	0	None
18766	18767	some	0	None
18767	18768	selective	0	None
18768	18769	steroids	3	CHEMICAL
18769	18770	might	0	None
18770	18771	have	0	None
18771	18772	anti	0	None
18772	18773	-	0	None
18773	18774	Adiol	0	None
18774	18775	activity	0	None
18775	18776	,	0	None
18776	18777	which	0	None
18777	18778	may	0	None
18778	18779	have	0	None
18779	18780	potential	0	None
18780	18781	clinical	0	None
18781	18782	application	0	None
18782	18783	in	0	None
18783	18784	the	0	None
18784	18785	battle	0	None
18785	18786	against	0	None
18786	18787	the	0	None
18787	18788	androgen	3	CHEMICAL
18788	18789	-	0	None
18789	18790	dependent	0	None
18790	18791	prostate	0	None
18791	18792	cancer	0	None
18792	18793	growth	0	None
18793	18794	.	0	None

18795	18796	EPR	0	None
18796	18797	studies	0	None
18797	18798	on	0	None
18798	18799	the	0	None
18799	18800	photo	0	None
18800	18801	-	0	None
18801	18802	induced	0	None
18802	18803	intermediates	0	None
18803	18804	of	0	None
18804	18806	ferric NO	3	CHEMICAL
18806	18807	complexes	0	None
18807	18808	of	0	None
18808	18813	rat neuronal nitric oxide synthase	1	GENE-Y
18813	18814	trapped	0	None
18814	18815	at	0	None
18815	18816	low	0	None
18816	18817	temperature	0	None
18817	18818	.	0	None

18819	18820	Rat	0	None
18820	18824	neuronal nitric oxide synthase	1	GENE-Y
18824	18825	(	0	None
18825	18826	nNOS	0	None
18826	18827	)	0	None
18827	18828	was	0	None
18828	18829	expressed	0	None
18829	18830	in	0	None
18830	18831	Escherichia	0	None
18831	18832	coli	0	None
18832	18833	and	0	None
18833	18834	purified	0	None
18834	18835	.	0	None

18836	18837	Although	0	None
18837	18838	the	0	None
18838	18840	nitric oxide	3	CHEMICAL
18840	18841	(	0	None
18841	18842	NO	0	None
18842	18843	)	0	None
18843	18844	complex	0	None
18844	18845	of	0	None
18845	18846	the	0	None
18846	18848	ferric heme	3	CHEMICAL
18848	18849	was	0	None
18849	18850	EPR	0	None
18850	18851	-	0	None
18851	18852	silent	0	None
18852	18853	,	0	None
18853	18854	photo	0	None
18854	18855	-	0	None
18855	18856	illumination	0	None
18856	18857	at	0	None
18857	18858	5	0	None
18858	18859	K	0	None
18859	18860	to	0	None
18860	18861	the	0	None
18861	18862	NO	0	None
18862	18863	complex	0	None
18863	18864	of	0	None
18864	18865	the	0	None
18865	18867	ferric nNOS	1	GENE-Y
18867	18868	in	0	None
18868	18869	the	0	None
18869	18870	substrate	0	None
18870	18871	-	0	None
18871	18872	free	0	None
18872	18873	form	0	None
18873	18874	produced	0	None
18874	18875	a	0	None
18875	18876	new	0	None
18876	18877	high	0	None
18877	18878	spin	0	None
18878	18879	EPR	0	None
18879	18880	signal	0	None
18880	18881	similar	0	None
18881	18882	to	0	None
18882	18883	that	0	None
18883	18884	of	0	None
18884	18885	the	0	None
18885	18887	ferric heme	3	CHEMICAL
18887	18888	of	0	None
18888	18889	N	0	None
18889	18890	(	0	None
18890	18891	omega	0	None
18891	18892	)	0	None
18892	18893	-	0	None
18893	18894	nitro	3	CHEMICAL
18894	18895	-	0	None
18895	18896	L	0	None
18896	18897	-	0	None
18897	18898	arginine	3	CHEMICAL
18898	18899	-	0	None
18899	18900	bound	0	None
18900	18901	nNOS	0	None
18901	18902	,	0	None
18902	18903	suggesting	0	None
18903	18904	that	0	None
18904	18905	the	0	None
18905	18906	photo	0	None
18906	18907	-	0	None
18907	18908	dissociated	0	None
18908	18909	NO	0	None
18909	18910	might	0	None
18910	18911	move	0	None
18911	18912	away	0	None
18912	18913	from	0	None
18913	18914	the	0	None
18914	18915	heme	3	CHEMICAL
18915	18916	.	0	None

18917	18918	Low	0	None
18918	18919	photo	0	None
18919	18920	-	0	None
18920	18921	dissociability	0	None
18921	18922	of	0	None
18922	18923	NO	0	None
18923	18924	in	0	None
18924	18925	this	0	None
18925	18926	complex	0	None
18926	18927	indicated	0	None
18927	18928	less	0	None
18928	18929	restricted	0	None
18929	18930	movement	0	None
18930	18931	of	0	None
18931	18932	the	0	None
18932	18933	dissociated	0	None
18933	18934	NO	0	None
18934	18935	in	0	None
18935	18936	the	0	None
18936	18937	distal	0	None
18937	18938	region	0	None
18938	18939	of	0	None
18939	18940	the	0	None
18940	18941	heme	3	CHEMICAL
18941	18942	,	0	None
18942	18943	which	0	None
18943	18944	might	0	None
18944	18945	result	0	None
18945	18946	in	0	None
18946	18947	the	0	None
18947	18948	rapid	0	None
18948	18949	rebinding	0	None
18949	18950	of	0	None
18950	18951	the	0	None
18951	18952	NO	0	None
18952	18953	to	0	None
18953	18954	the	0	None
18954	18956	ferric heme	3	CHEMICAL
18956	18957	at	0	None
18957	18958	5	0	None
18958	18959	K	0	None
18959	18960	.	0	None

18961	18962	In	0	None
18962	18963	the	0	None
18963	18964	presence	0	None
18964	18965	of	0	None
18965	18966	substrate	0	None
18966	18967	L	0	None
18967	18968	-	0	None
18968	18969	arginine	3	CHEMICAL
18969	18970	,	0	None
18970	18971	derivatives	0	None
18971	18972	,	0	None
18972	18973	or	0	None
18973	18974	product	0	None
18974	18975	L	0	None
18975	18976	-	0	None
18976	18977	citrulline	0	None
18977	18978	,	0	None
18978	18979	the	0	None
18979	18980	photo	0	None
18980	18981	-	0	None
18981	18982	products	0	None
18982	18983	from	0	None
18983	18984	the	0	None
18984	18986	ferric NO	3	CHEMICAL
18986	18987	complexes	0	None
18987	18988	exhibited	0	None
18988	18989	large	0	None
18989	18990	novel	0	None
18990	18991	EPR	0	None
18991	18992	signals	0	None
18992	18993	with	0	None
18993	18994	a	0	None
18994	18995	spin	0	None
18995	18996	-	0	None
18996	18997	coupled	0	None
18997	18998	interaction	0	None
18998	18999	between	0	None
18999	19000	the	0	None
19000	19002	ferric heme	3	CHEMICAL
19002	19003	(	0	None
19003	19004	S	0	None
19004	19005	=	0	None
19005	19006	5	0	None
19006	19007	/	0	None
19007	19008	2	0	None
19008	19009	)	0	None
19009	19010	and	0	None
19010	19011	the	0	None
19011	19012	photolyzed	0	None
19012	19013	NO	0	None
19013	19014	(	0	None
19014	19015	S	0	None
19015	19016	=	0	None
19016	19017	1	0	None
19017	19018	/	0	None
19018	19019	2	0	None
19019	19020	)	0	None
19020	19021	,	0	None
19021	19022	suggesting	0	None
19022	19023	a	0	None
19023	19024	stereochemically	0	None
19024	19025	restricted	0	None
19025	19026	interaction	0	None
19026	19027	between	0	None
19027	19028	the	0	None
19028	19029	photo	0	None
19029	19030	-	0	None
19030	19031	dissociated	0	None
19031	19032	NO	0	None
19032	19033	and	0	None
19033	19034	the	0	None
19034	19035	guanidino	3	CHEMICAL
19035	19036	-	0	None
19036	19037	or	0	None
19037	19038	the	0	None
19038	19039	ureido	3	CHEMICAL
19039	19040	-	0	None
19040	19041	group	0	None
19041	19042	of	0	None
19042	19043	the	0	None
19043	19044	substrate	0	None
19044	19045	analogues	0	None
19045	19046	at	0	None
19046	19047	the	0	None
19047	19048	distal	0	None
19048	19049	heme	3	CHEMICAL
19049	19050	region	0	None
19050	19051	of	0	None
19051	19052	nNOS	0	None
19052	19053	.	0	None

19054	19055	The	0	None
19055	19056	photo	0	None
19056	19057	-	0	None
19057	19058	product	0	None
19058	19059	from	0	None
19059	19060	the	0	None
19060	19061	NO	0	None
19061	19062	complex	0	None
19062	19063	produced	0	None
19063	19064	from	0	None
19064	19065	citrulline	0	None
19065	19066	-	0	None
19066	19067	bound	0	None
19067	19068	nNOS	0	None
19068	19069	might	0	None
19069	19070	be	0	None
19070	19071	the	0	None
19071	19072	same	0	None
19072	19073	intermediate	0	None
19073	19074	species	0	None
19074	19075	as	0	None
19075	19076	that	0	None
19076	19077	formed	0	None
19077	19078	in	0	None
19078	19079	the	0	None
19079	19080	last	0	None
19080	19081	step	0	None
19081	19082	of	0	None
19082	19083	the	0	None
19083	19084	catalytic	0	None
19084	19085	cycle	0	None
19085	19086	.	0	None

19087	19088	Raloxifene	0	None
19088	19089	:	0	None
19089	19090	a	0	None
19090	19091	selective	0	None
19091	19093	estrogen receptor	1	GENE-Y
19093	19094	modulator	0	None
19094	19095	.	0	None

19096	19097	Raloxifene	0	None
19097	19098	is	0	None
19098	19099	a	0	None
19099	19100	selective	0	None
19100	19102	estrogen receptor	1	GENE-Y
19102	19103	modulator	0	None
19103	19104	that	0	None
19104	19105	produces	0	None
19105	19106	both	0	None
19106	19107	estrogen	3	CHEMICAL
19107	19108	-	0	None
19108	19109	agonistic	0	None
19109	19110	effects	0	None
19110	19111	on	0	None
19111	19112	bone	0	None
19112	19113	and	0	None
19113	19114	lipid	0	None
19114	19115	metabolism	0	None
19115	19116	and	0	None
19116	19117	estrogen	3	CHEMICAL
19117	19118	-	0	None
19118	19119	antagonistic	0	None
19119	19120	effects	0	None
19120	19121	on	0	None
19121	19122	uterine	0	None
19122	19123	endometrium	0	None
19123	19124	and	0	None
19124	19125	breast	0	None
19125	19126	tissue	0	None
19126	19127	.	0	None

19128	19129	Because	0	None
19129	19130	of	0	None
19130	19131	its	0	None
19131	19132	tissue	0	None
19132	19133	selectivity	0	None
19133	19134	,	0	None
19134	19135	raloxifene	3	CHEMICAL
19135	19136	may	0	None
19136	19137	have	0	None
19137	19138	fewer	0	None
19138	19139	side	0	None
19139	19140	effects	0	None
19140	19141	than	0	None
19141	19142	are	0	None
19142	19143	typically	0	None
19143	19144	observed	0	None
19144	19145	with	0	None
19145	19146	estrogen	3	CHEMICAL
19146	19147	therapy	0	None
19147	19148	.	0	None

19149	19150	The	0	None
19150	19151	most	0	None
19151	19152	common	0	None
19152	19153	adverse	0	None
19153	19154	effects	0	None
19154	19155	of	0	None
19155	19156	raloxifene	3	CHEMICAL
19156	19157	are	0	None
19157	19158	hot	0	None
19158	19159	flushes	0	None
19159	19160	and	0	None
19160	19161	leg	0	None
19161	19162	cramps	0	None
19162	19163	.	0	None

19164	19165	The	0	None
19165	19166	drug	0	None
19166	19167	is	0	None
19167	19168	also	0	None
19168	19169	associated	0	None
19169	19170	with	0	None
19170	19171	an	0	None
19171	19172	increased	0	None
19172	19173	risk	0	None
19173	19174	of	0	None
19174	19175	thromboembolic	0	None
19175	19176	events	0	None
19176	19177	.	0	None

19178	19179	The	0	None
19179	19180	beneficial	0	None
19180	19181	estrogenic	0	None
19181	19182	activities	0	None
19182	19183	of	0	None
19183	19184	raloxifene	3	CHEMICAL
19184	19185	include	0	None
19185	19186	a	0	None
19186	19187	lowering	0	None
19187	19188	of	0	None
19188	19189	total	0	None
19189	19190	and	0	None
19190	19191	low	0	None
19191	19192	-	0	None
19192	19193	density	0	None
19193	19194	lipoprotein	2	GENE-N
19194	19195	cholesterol	0	None
19195	19196	levels	0	None
19196	19197	and	0	None
19197	19198	an	0	None
19198	19199	augmentation	0	None
19199	19200	of	0	None
19200	19201	bone	0	None
19201	19202	mineral	3	CHEMICAL
19202	19203	density	0	None
19203	19204	.	0	None

19205	19206	Raloxifene	0	None
19206	19207	has	0	None
19207	19208	been	0	None
19208	19209	labeled	0	None
19209	19210	by	0	None
19210	19211	the	0	None
19211	19212	U	0	None
19212	19213	.	0	None
19213	19214	S	0	None
19214	19215	.	0	None

19216	19217	Food	0	None
19217	19218	and	0	None
19218	19219	Drug	0	None
19219	19220	Administration	0	None
19220	19221	for	0	None
19221	19222	the	0	None
19222	19223	prevention	0	None
19223	19224	of	0	None
19224	19225	osteoporosis	0	None
19225	19226	.	0	None

19227	19228	However	0	None
19228	19229	,	0	None
19229	19230	its	0	None
19230	19231	effects	0	None
19231	19232	on	0	None
19232	19233	fracture	0	None
19233	19234	risk	0	None
19234	19235	and	0	None
19235	19236	its	0	None
19236	19237	ability	0	None
19237	19238	to	0	None
19238	19239	protect	0	None
19239	19240	against	0	None
19240	19241	cardiovascular	0	None
19241	19242	disease	0	None
19242	19243	have	0	None
19243	19244	yet	0	None
19244	19245	to	0	None
19245	19246	be	0	None
19246	19247	determined	0	None
19247	19248	.	0	None

19249	19250	Studies	0	None
19250	19251	are	0	None
19251	19252	also	0	None
19252	19253	being	0	None
19253	19254	conducted	0	None
19254	19255	to	0	None
19255	19256	determine	0	None
19256	19257	its	0	None
19257	19258	impact	0	None
19258	19259	on	0	None
19259	19260	breast	0	None
19260	19261	and	0	None
19261	19262	endometrial	0	None
19262	19263	cancer	0	None
19263	19264	reduction	0	None
19264	19265	.	0	None

19266	19267	Inhibition	0	None
19267	19268	of	0	None
19268	19269	the	0	None
19269	19270	human	0	None
19270	19271	ether	3	CHEMICAL
19271	19272	-	0	None
19272	19273	a	0	None
19273	19274	-	0	None
19274	19275	go	0	None
19275	19276	-	0	None
19276	19277	go	0	None
19277	19278	-	0	None
19278	19279	related	0	None
19279	19280	gene	0	None
19280	19281	(	0	None
19281	19282	HERG	0	None
19282	19283	)	0	None
19283	19285	potassium channel	2	GENE-N
19285	19286	by	0	None
19286	19287	cisapride	3	CHEMICAL
19287	19288	:	0	None
19288	19289	affinity	0	None
19289	19290	for	0	None
19290	19291	open	0	None
19291	19292	and	0	None
19292	19293	inactivated	0	None
19293	19294	states	0	None
19294	19295	.	0	None

19296	19297	1	0	None
19297	19298	Cisapride	0	None
19298	19299	is	0	None
19299	19300	a	0	None
19300	19301	prokinetic	0	None
19301	19302	agent	0	None
19302	19303	which	0	None
19303	19304	has	0	None
19304	19305	been	0	None
19305	19306	associated	0	None
19306	19307	with	0	None
19307	19308	QT	0	None
19308	19309	prolongation	0	None
19309	19310	,	0	None
19310	19311	torsades	0	None
19311	19312	de	0	None
19312	19313	pointes	0	None
19313	19314	and	0	None
19314	19315	cardiac	0	None
19315	19316	arrest	0	None
19316	19317	.	0	None

19318	19319	The	0	None
19319	19320	cellular	0	None
19320	19321	mechanism	0	None
19321	19322	for	0	None
19322	19323	these	0	None
19323	19324	observations	0	None
19324	19325	is	0	None
19325	19326	high	0	None
19326	19327	affinity	0	None
19327	19328	blockade	0	None
19328	19329	of	0	None
19329	19330	IKr	2	GENE-N
19330	19331	(	0	None
19331	19332	encoded	0	None
19332	19333	by	0	None
19333	19334	HERG	0	None
19334	19335	)	0	None
19335	19336	.	0	None

19337	19338	2	0	None
19338	19339	In	0	None
19339	19340	a	0	None
19340	19341	chronic	0	None
19341	19342	transfection	0	None
19342	19343	model	0	None
19343	19344	using	0	None
19344	19345	CHO	3	CHEMICAL
19345	19346	-	0	None
19346	19347	K1	0	None
19347	19348	cells	0	None
19348	19349	,	0	None
19349	19350	cisapride	3	CHEMICAL
19350	19351	inhibited	0	None
19351	19352	HERG	1	GENE-Y
19352	19353	tail	0	None
19353	19354	currents	0	None
19354	19355	after	0	None
19355	19356	a	0	None
19356	19357	step	0	None
19357	19358	to	0	None
19358	19359	+	0	None
19359	19360	25	0	None
19360	19361	mV	0	None
19361	19362	with	0	None
19362	19363	similar	0	None
19363	19364	potency	0	None
19364	19365	at	0	None
19365	19366	room	0	None
19366	19367	and	0	None
19367	19368	physiological	0	None
19368	19369	temperatures	0	None
19369	19370	(	0	None
19370	19371	IC50	0	None
19371	19372	16	0	None
19372	19373	.	0	None
19373	19374	4	0	None
19374	19375	nM	0	None
19375	19376	at	0	None
19376	19377	20	0	None
19377	19378	-	0	None
19378	19379	22	0	None
19379	19380	degrees	0	None
19380	19381	C	0	None
19381	19382	and	0	None
19382	19383	23	0	None
19383	19384	.	0	None
19384	19385	6	0	None
19385	19386	nM	0	None
19386	19387	at	0	None
19387	19388	37	0	None
19388	19389	degrees	0	None
19389	19390	C	0	None
19390	19391	)	0	None
19391	19392	.	0	None

19393	19394	3	0	None
19394	19395	Channel	0	None
19395	19396	inhibition	0	None
19396	19397	exhibited	0	None
19397	19398	time	0	None
19398	19399	-	0	None
19399	19400	,	0	None
19400	19401	voltage	0	None
19401	19402	-	0	None
19402	19403	and	0	None
19403	19404	frequency	0	None
19404	19405	-	0	None
19405	19406	dependence	0	None
19406	19407	.	0	None

19408	19409	In	0	None
19409	19410	an	0	None
19410	19411	envelope	0	None
19411	19412	of	0	None
19412	19413	tails	0	None
19413	19414	test	3	CHEMICAL
19414	19415	,	0	None
19415	19416	channel	0	None
19416	19417	blockade	0	None
19417	19418	increased	0	None
19418	19419	from	0	None
19419	19420	27	0	None
19420	19421	+	0	None
19421	19422	/	0	None
19422	19423	-	0	None
19423	19424	8	0	None
19424	19425	%	0	None
19425	19426	after	0	None
19426	19427	a	0	None
19427	19428	120	0	None
19428	19429	ms	0	None
19429	19430	depolarizing	0	None
19430	19431	step	0	None
19431	19432	to	0	None
19432	19433	50	0	None
19433	19434	+	0	None
19434	19435	/	0	None
19435	19436	-	0	None
19436	19437	4	0	None
19437	19438	%	0	None
19438	19439	after	0	None
19439	19440	a	0	None
19440	19441	1	0	None
19441	19442	.	0	None
19442	19443	0	0	None
19443	19444	s	0	None
19444	19445	step	0	None
19445	19446	.	0	None

19447	19448	These	0	None
19448	19449	findings	0	None
19449	19450	suggested	0	None
19450	19451	affinity	0	None
19451	19452	for	0	None
19452	19453	open	0	None
19453	19454	and	0	None
19454	19455	/	0	None
19455	19456	or	0	None
19456	19457	inactivated	0	None
19457	19458	channel	0	None
19458	19459	states	0	None
19459	19460	.	0	None

19461	19462	4	0	None
19462	19463	Inactivation	0	None
19463	19464	was	0	None
19464	19465	significantly	0	None
19465	19466	accelerated	0	None
19466	19467	by	0	None
19467	19468	cisapride	3	CHEMICAL
19468	19469	in	0	None
19469	19470	a	0	None
19470	19471	concentration	0	None
19471	19472	-	0	None
19472	19473	dependent	0	None
19473	19474	manner	0	None
19474	19475	and	0	None
19475	19476	there	0	None
19476	19477	was	0	None
19477	19478	a	0	None
19478	19479	small	0	None
19479	19480	(	0	None
19480	19481	-	0	None
19481	19482	7	0	None
19482	19483	mV	0	None
19483	19484	)	0	None
19484	19485	shift	0	None
19485	19486	in	0	None
19486	19487	the	0	None
19487	19488	voltage	0	None
19488	19489	dependence	0	None
19489	19490	of	0	None
19490	19491	steady	0	None
19491	19492	state	0	None
19492	19493	inactivation	0	None
19493	19494	.	0	None

19495	19496	5	0	None
19496	19497	Channel	0	None
19497	19498	blockade	0	None
19498	19499	by	0	None
19499	19500	cisapride	3	CHEMICAL
19500	19501	was	0	None
19501	19502	modulated	0	None
19502	19503	by	0	None
19503	19504	[	0	None
19504	19505	K	0	None
19505	19506	+	0	None
19506	19507	]	0	None
19507	19508	o	0	None
19508	19509	,	0	None
19509	19510	with	0	None
19510	19511	a	0	None
19511	19512	26	0	None
19512	19513	%	0	None
19513	19514	reduction	0	None
19514	19515	in	0	None
19515	19516	the	0	None
19516	19517	potency	0	None
19517	19518	of	0	None
19518	19519	channel	0	None
19519	19520	blockade	0	None
19520	19521	when	0	None
19521	19522	[	0	None
19522	19523	K	0	None
19523	19524	+	0	None
19524	19525	]	0	None
19525	19526	o	0	None
19526	19527	was	0	None
19527	19528	increased	0	None
19528	19529	from	0	None
19529	19530	1	0	None
19530	19531	to	0	None
19531	19532	10	0	None
19532	19533	mM	0	None
19533	19534	.	0	None

19535	19536	6	0	None
19536	19537	In	0	None
19537	19538	conclusion	0	None
19538	19539	,	0	None
19539	19540	HERG	1	GENE-Y
19540	19541	channel	0	None
19541	19542	inhibition	0	None
19542	19543	by	0	None
19543	19544	cisapride	3	CHEMICAL
19544	19545	exhibits	0	None
19545	19546	features	0	None
19546	19547	consistent	0	None
19547	19548	with	0	None
19548	19549	open	0	None
19549	19550	and	0	None
19550	19551	inactivated	0	None
19551	19552	state	0	None
19552	19553	binding	0	None
19553	19554	and	0	None
19554	19555	is	0	None
19555	19556	sensitive	0	None
19556	19557	to	0	None
19557	19559	external potassium	3	CHEMICAL
19559	19560	concentration	0	None
19560	19561	.	0	None

19562	19563	These	0	None
19563	19564	features	0	None
19564	19565	may	0	None
19565	19566	have	0	None
19566	19567	significant	0	None
19567	19568	clinical	0	None
19568	19569	implications	0	None
19569	19570	with	0	None
19570	19571	regard	0	None
19571	19572	to	0	None
19572	19573	the	0	None
19573	19574	mechanism	0	None
19574	19575	and	0	None
19575	19576	treatment	0	None
19576	19577	of	0	None
19577	19578	cisapride	3	CHEMICAL
19578	19579	-	0	None
19579	19580	induced	0	None
19580	19581	proarrhythmia	0	None
19581	19582	.	0	None

19583	19584	Modification	0	None
19584	19585	of	0	None
19585	19588	dopamine D2 receptor	1	GENE-Y
19588	19589	activity	0	None
19589	19590	by	0	None
19590	19591	pergolide	3	CHEMICAL
19591	19592	in	0	None
19592	19593	Parkinson	0	None
19593	19594	'	0	None
19594	19595	s	0	None
19595	19596	disease	0	None
19596	19597	:	0	None
19597	19598	an	0	None
19598	19599	in	0	None
19599	19600	vivo	0	None
19600	19601	study	0	None
19601	19602	by	0	None
19602	19603	PET	3	CHEMICAL
19603	19604	.	0	None

19605	19606	It	0	None
19606	19607	is	0	None
19607	19608	well	0	None
19608	19609	known	0	None
19609	19610	that	0	None
19610	19611	chronic	0	None
19611	19612	administration	0	None
19612	19613	of	0	None
19613	19614	pergolide	3	CHEMICAL
19614	19615	and	0	None
19615	19616	other	0	None
19616	19617	dopamine	3	CHEMICAL
19617	19618	agonists	0	None
19618	19619	may	0	None
19619	19620	induce	0	None
19620	19621	a	0	None
19621	19622	downregulation	0	None
19622	19623	of	0	None
19623	19626	dopamine D2 receptors	1	GENE-Y
19626	19627	in	0	None
19627	19628	the	0	None
19628	19629	rat	0	None
19629	19630	model	0	None
19630	19631	of	0	None
19631	19632	Parkinson	0	None
19632	19633	'	0	None
19633	19634	s	0	None
19634	19635	disease	0	None
19635	19636	(	0	None
19636	19637	PD	0	None
19637	19638	)	0	None
19638	19639	.	0	None

19640	19641	To	0	None
19641	19642	our	0	None
19642	19643	knowledge	0	None
19643	19644	,	0	None
19644	19645	this	0	None
19645	19646	effect	0	None
19646	19647	has	0	None
19647	19648	not	0	None
19648	19649	been	0	None
19649	19650	demonstrated	0	None
19650	19651	in	0	None
19651	19652	vivo	0	None
19652	19653	in	0	None
19653	19654	patients	0	None
19654	19655	with	0	None
19655	19656	PD	0	None
19656	19657	.	0	None

19658	19659	At	0	None
19659	19660	present	0	None
19660	19661	,	0	None
19661	19662	the	0	None
19662	19663	status	0	None
19663	19664	of	0	None
19664	19668	striatal dopamine D2 receptors	1	GENE-Y
19668	19669	can	0	None
19669	19670	be	0	None
19670	19671	studied	0	None
19671	19672	with	0	None
19672	19673	use	0	None
19673	19674	of	0	None
19674	19675	positron	0	None
19675	19676	emission	0	None
19676	19677	tomographic	0	None
19677	19678	(	0	None
19678	19679	PET	0	None
19679	19680	)	0	None
19680	19681	technology	0	None
19681	19682	.	0	None

19683	19684	Five	0	None
19684	19685	patients	0	None
19685	19686	with	0	None
19686	19687	PD	0	None
19687	19688	chronically	0	None
19688	19689	treated	0	None
19689	19690	with	0	None
19690	19691	levodopa	3	CHEMICAL
19691	19692	were	0	None
19692	19693	studied	0	None
19693	19694	with	0	None
19694	19695	use	0	None
19695	19696	of	0	None
19696	19697	PET	3	CHEMICAL
19697	19698	and	0	None
19698	19699	[	0	None
19699	19700	11C	3	CHEMICAL
19700	19701	]	0	None
19701	19702	-	0	None
19702	19703	raclopride	3	CHEMICAL
19703	19704	before	0	None
19704	19705	and	0	None
19705	19706	after	0	None
19706	19707	6	0	None
19707	19708	months	0	None
19708	19709	of	0	None
19709	19710	pergolide	3	CHEMICAL
19710	19711	treatment	0	None
19711	19712	(	0	None
19712	19713	dose	0	None
19713	19714	range	0	None
19714	19715	=	0	None
19715	19716	4	0	None
19716	19717	.	0	None
19717	19718	5	0	None
19718	19719	-	0	None
19719	19720	7	0	None
19720	19721	.	0	None
19721	19722	5	0	None
19722	19723	mg	0	None
19723	19724	/	0	None
19724	19725	d	0	None
19725	19726	)	0	None
19726	19727	.	0	None

19728	19729	We	0	None
19729	19730	found	0	None
19730	19731	a	0	None
19731	19732	slight	0	None
19732	19733	reduction	0	None
19733	19734	in	0	None
19734	19735	the	0	None
19735	19736	specific	0	None
19736	19737	striatal	0	None
19737	19738	[	0	None
19738	19739	11C	3	CHEMICAL
19739	19740	]	0	None
19740	19741	-	0	None
19741	19742	raclopride	3	CHEMICAL
19742	19743	uptake	0	None
19743	19744	index	0	None
19744	19745	(	0	None
19745	19746	mean	0	None
19746	19747	reduction	0	None
19747	19748	14	0	None
19748	19749	%	0	None
19749	19750	in	0	None
19750	19751	putamen	0	None
19751	19752	and	0	None
19752	19753	9	0	None
19753	19754	%	0	None
19754	19755	in	0	None
19755	19756	caudate	0	None
19756	19757	)	0	None
19757	19758	after	0	None
19758	19759	pergolide	3	CHEMICAL
19759	19760	treatment	0	None
19760	19761	.	0	None

19762	19763	This	0	None
19763	19764	reduction	0	None
19764	19765	appears	0	None
19765	19766	to	0	None
19766	19767	be	0	None
19767	19768	related	0	None
19768	19769	to	0	None
19769	19770	downregulation	0	None
19770	19771	of	0	None
19771	19772	the	0	None
19772	19773	receptor	0	None
19773	19774	,	0	None
19774	19775	although	0	None
19775	19776	competitive	0	None
19776	19777	binding	0	None
19777	19778	of	0	None
19778	19779	pergolide	3	CHEMICAL
19779	19780	at	0	None
19780	19781	the	0	None
19781	19783	D2 receptor	1	GENE-Y
19783	19784	cannot	0	None
19784	19785	be	0	None
19785	19786	excluded	0	None
19786	19787	.	0	None

19788	19789	Comparison	0	None
19789	19790	of	0	None
19790	19791	the	0	None
19791	19792	novel	0	None
19792	19793	antipsychotic	0	None
19793	19794	ziprasidone	3	CHEMICAL
19794	19795	with	0	None
19795	19796	clozapine	3	CHEMICAL
19796	19797	and	0	None
19797	19798	olanzapine	3	CHEMICAL
19798	19799	:	0	None
19799	19800	inhibition	0	None
19800	19801	of	0	None
19801	19802	dorsal	0	None
19802	19803	raphe	0	None
19803	19804	cell	0	None
19804	19805	firing	0	None
19805	19806	and	0	None
19806	19807	the	0	None
19807	19808	role	0	None
19808	19809	of	0	None
19809	19810	5	0	None
19810	19811	-	0	None
19811	19812	HT1A	0	None
19812	19813	receptor	0	None
19813	19814	activation	0	None
19814	19815	.	0	None

19816	19817	Ziprasidone	0	None
19817	19818	is	0	None
19818	19819	a	0	None
19819	19820	novel	0	None
19820	19821	antipsychotic	0	None
19821	19822	agent	0	None
19822	19823	which	0	None
19823	19824	binds	0	None
19824	19825	with	0	None
19825	19826	high	0	None
19826	19827	affinity	0	None
19827	19828	to	0	None
19828	19829	5	0	None
19829	19830	-	0	None
19830	19831	HT1A	0	None
19831	19832	receptors	0	None
19832	19833	(	0	None
19833	19834	Ki	0	None
19834	19835	=	0	None
19835	19836	3	0	None
19836	19837	.	0	None
19837	19838	4	0	None
19838	19839	nM	0	None
19839	19840	)	0	None
19840	19841	,	0	None
19841	19842	in	0	None
19842	19843	addition	0	None
19843	19844	to	0	None
19844	19845	5	0	None
19845	19846	-	0	None
19846	19847	HT1D	0	None
19847	19848	,	0	None
19848	19849	5	0	None
19849	19850	-	0	None
19850	19851	HT2	0	None
19851	19852	,	0	None
19852	19853	and	0	None
19853	19854	D2	1	GENE-Y
19854	19855	sites	0	None
19855	19856	.	0	None

19857	19858	While	0	None
19858	19859	it	0	None
19859	19860	is	0	None
19860	19861	an	0	None
19861	19862	antagonist	0	None
19862	19863	at	0	None
19863	19864	these	0	None
19864	19865	latter	0	None
19865	19866	receptors	0	None
19866	19867	,	0	None
19867	19868	ziprasidone	3	CHEMICAL
19868	19869	behaves	0	None
19869	19870	as	0	None
19870	19871	a	0	None
19871	19872	5	0	None
19872	19873	-	0	None
19873	19874	HT1A	0	None
19874	19875	agonist	0	None
19875	19876	in	0	None
19876	19877	vitro	0	None
19877	19878	in	0	None
19878	19879	adenylate	0	None
19879	19880	cyclase	1	GENE-Y
19880	19881	measurements	0	None
19881	19882	.	0	None

19883	19884	The	0	None
19884	19885	goal	0	None
19885	19886	of	0	None
19886	19887	the	0	None
19887	19888	present	0	None
19888	19889	study	0	None
19889	19890	was	0	None
19890	19891	to	0	None
19891	19892	examine	0	None
19892	19893	the	0	None
19893	19894	5	0	None
19894	19895	-	0	None
19895	19896	HT1A	0	None
19896	19897	properties	0	None
19897	19898	of	0	None
19898	19899	ziprasidone	3	CHEMICAL
19899	19900	in	0	None
19900	19901	vivo	0	None
19901	19902	using	0	None
19902	19903	as	0	None
19903	19904	a	0	None
19904	19905	marker	0	None
19905	19906	of	0	None
19906	19907	central	0	None
19907	19908	5	0	None
19908	19909	-	0	None
19909	19910	HT1A	0	None
19910	19911	activity	0	None
19911	19912	the	0	None
19912	19913	inhibition	0	None
19913	19914	of	0	None
19914	19915	firing	0	None
19915	19916	of	0	None
19916	19917	serotonin	3	CHEMICAL
19917	19918	-	0	None
19918	19919	containing	0	None
19919	19920	neurons	0	None
19920	19921	in	0	None
19921	19922	the	0	None
19922	19923	dorsal	0	None
19923	19924	raphe	0	None
19924	19925	nucleus	0	None
19925	19926	.	0	None

19927	19928	In	0	None
19928	19929	anesthetized	0	None
19929	19930	rats	0	None
19930	19931	,	0	None
19931	19932	ziprasidone	3	CHEMICAL
19932	19933	dose	0	None
19933	19934	-	0	None
19934	19935	dependently	0	None
19935	19936	slowed	0	None
19936	19937	raphe	0	None
19937	19938	unit	0	None
19938	19939	activity	0	None
19939	19940	(	0	None
19940	19941	ED50	0	None
19941	19942	=	0	None
19942	19943	300	0	None
19943	19944	micrograms	0	None
19944	19945	/	0	None
19945	19946	kg	0	None
19946	19947	i	0	None
19947	19948	.	0	None
19948	19949	v	0	None
19949	19950	.	0	None
19950	19951	)	0	None
19951	19952	as	0	None
19952	19953	did	0	None
19953	19954	the	0	None
19954	19955	atypical	0	None
19955	19956	antipsychotics	0	None
19956	19957	clozapine	3	CHEMICAL
19957	19958	(	0	None
19958	19959	ED50	0	None
19959	19960	=	0	None
19960	19961	250	0	None
19961	19962	micrograms	0	None
19962	19963	/	0	None
19963	19964	kg	0	None
19964	19965	i	0	None
19965	19966	.	0	None
19966	19967	v	0	None
19967	19968	.	0	None
19968	19969	)	0	None
19969	19970	and	0	None
19970	19971	olanzapine	3	CHEMICAL
19971	19972	(	0	None
19972	19973	ED50	0	None
19973	19974	=	0	None
19974	19975	1000	0	None
19975	19976	micrograms	0	None
19976	19977	/	0	None
19977	19978	kg	0	None
19978	19979	i	0	None
19979	19980	.	0	None
19980	19981	v	0	None
19981	19982	.	0	None
19982	19983	)	0	None
19983	19984	.	0	None

19985	19986	Pretreatment	0	None
19986	19987	with	0	None
19987	19988	the	0	None
19988	19989	5	0	None
19989	19990	-	0	None
19990	19991	HT1A	0	None
19991	19992	antagonist	0	None
19992	19993	WAY	0	None
19993	19994	-	0	None
19994	19995	100	0	None
19995	19996	,	0	None
19996	19997	635	0	None
19997	19998	(	0	None
19998	19999	10	0	None
19999	20000	micrograms	0	None
20000	20001	/	0	None
20001	20002	kg	0	None
20002	20003	i	0	None
20003	20004	.	0	None
20004	20005	v	0	None
20005	20006	.	0	None
20006	20007	)	0	None
20007	20008	prevented	0	None
20008	20009	the	0	None
20009	20010	ziprasidone	3	CHEMICAL
20010	20011	-	0	None
20011	20012	induced	0	None
20012	20013	inhibition	0	None
20013	20014	;	0	None
20014	20015	the	0	None
20015	20016	same	0	None
20016	20017	dose	0	None
20017	20018	of	0	None
20018	20019	WAY	0	None
20019	20020	-	0	None
20020	20021	100	0	None
20021	20022	,	0	None
20022	20023	635	0	None
20023	20024	had	0	None
20024	20025	little	0	None
20025	20026	effect	0	None
20026	20027	on	0	None
20027	20028	the	0	None
20028	20029	inhibition	0	None
20029	20030	produced	0	None
20030	20031	by	0	None
20031	20032	clozapine	3	CHEMICAL
20032	20033	and	0	None
20033	20034	olanzapine	3	CHEMICAL
20034	20035	.	0	None

20036	20037	Because	0	None
20037	20038	all	0	None
20038	20039	three	0	None
20039	20040	agents	0	None
20040	20041	also	0	None
20041	20042	bind	0	None
20042	20043	to	0	None
20043	20046	alpha 1 receptors	2	GENE-N
20046	20047	,	0	None
20047	20048	antagonists	0	None
20048	20049	of	0	None
20049	20050	which	0	None
20050	20051	inhibit	0	None
20051	20052	serotonin	3	CHEMICAL
20052	20053	neuronal	2	GENE-N
20053	20054	firing	0	None
20054	20055	,	0	None
20055	20056	this	0	None
20056	20057	aspect	0	None
20057	20058	of	0	None
20058	20059	their	0	None
20059	20060	pharmacology	0	None
20060	20061	was	0	None
20061	20062	assessed	0	None
20062	20063	with	0	None
20063	20064	desipramine	3	CHEMICAL
20064	20065	(	0	None
20065	20066	DMI	3	CHEMICAL
20066	20067	)	0	None
20067	20068	,	0	None
20068	20069	a	0	None
20069	20070	NE	3	CHEMICAL
20070	20071	re	0	None
20071	20072	-	0	None
20072	20073	uptake	0	None
20073	20074	blocker	0	None
20074	20075	previously	0	None
20075	20076	shown	0	None
20076	20077	to	0	None
20077	20078	reverse	0	None
20078	20079	the	0	None
20079	20080	effects	0	None
20080	20081	of	0	None
20081	20082	alpha	0	None
20082	20083	1	0	None
20083	20084	antagonists	0	None
20084	20085	on	0	None
20085	20086	raphe	0	None
20086	20087	unit	0	None
20087	20088	activity	0	None
20088	20089	.	0	None

20090	20091	DMI	3	CHEMICAL
20091	20092	(	0	None
20092	20093	5	0	None
20093	20094	mg	0	None
20094	20095	/	0	None
20095	20096	kg	0	None
20096	20097	i	0	None
20097	20098	.	0	None
20098	20099	v	0	None
20099	20100	.	0	None
20100	20101	)	0	None
20101	20102	failed	0	None
20102	20103	to	0	None
20103	20104	reverse	0	None
20104	20105	the	0	None
20105	20106	inhibitory	0	None
20106	20107	effect	0	None
20107	20108	of	0	None
20108	20109	ziprasidone	3	CHEMICAL
20109	20110	but	0	None
20110	20111	produced	0	None
20111	20112	nearly	0	None
20112	20113	complete	0	None
20113	20114	reversal	0	None
20114	20115	of	0	None
20115	20116	that	0	None
20116	20117	of	0	None
20117	20118	clozapine	3	CHEMICAL
20118	20119	and	0	None
20119	20120	olanzapine	3	CHEMICAL
20120	20121	.	0	None

20122	20123	These	0	None
20123	20124	profiles	0	None
20124	20125	suggest	0	None
20125	20126	a	0	None
20126	20127	mechanism	0	None
20127	20128	of	0	None
20128	20129	action	0	None
20129	20130	for	0	None
20130	20131	each	0	None
20131	20132	agent	0	None
20132	20133	,	0	None
20133	20134	5	0	None
20134	20135	-	0	None
20135	20136	HT1A	0	None
20136	20137	agonism	0	None
20137	20138	for	0	None
20138	20139	ziprasidone	3	CHEMICAL
20139	20140	and	0	None
20140	20141	alpha	0	None
20141	20142	1	0	None
20142	20143	antagonism	0	None
20143	20144	for	0	None
20144	20145	clozapine	3	CHEMICAL
20145	20146	and	0	None
20146	20147	olanzapine	3	CHEMICAL
20147	20148	.	0	None

20149	20150	The	0	None
20150	20151	5	0	None
20151	20152	-	0	None
20152	20153	HT1A	0	None
20153	20154	agonist	0	None
20154	20155	activity	0	None
20155	20156	reported	0	None
20156	20157	here	0	None
20157	20158	clearly	0	None
20158	20159	distinguishes	0	None
20159	20160	ziprasidone	3	CHEMICAL
20160	20161	from	0	None
20161	20162	currently	0	None
20162	20163	available	0	None
20163	20164	antipsychotic	0	None
20164	20165	agents	0	None
20165	20166	and	0	None
20166	20167	suggests	0	None
20167	20168	that	0	None
20168	20169	this	0	None
20169	20170	property	0	None
20170	20171	may	0	None
20171	20172	play	0	None
20172	20173	a	0	None
20173	20174	significant	0	None
20174	20175	role	0	None
20175	20176	in	0	None
20176	20177	its	0	None
20177	20178	pharmacologic	0	None
20178	20179	actions	0	None
20179	20180	.	0	None

20181	20182	CCK	1	GENE-Y
20182	20183	-	0	None
20183	20184	mediated	0	None
20184	20185	response	0	None
20185	20186	in	0	None
20186	20187	the	0	None
20187	20188	activation	0	None
20188	20189	of	0	None
20189	20190	5	0	None
20190	20191	-	0	None
20191	20192	HT	3	CHEMICAL
20192	20193	receptor	0	None
20193	20194	types	0	None
20194	20195	in	0	None
20195	20196	the	0	None
20196	20197	guinea	0	None
20197	20198	-	0	None
20198	20199	pig	0	None
20199	20200	ileum	0	None
20200	20201	.	0	None

20202	20203	The	0	None
20203	20204	possible	0	None
20204	20205	interaction	0	None
20205	20206	between	0	None
20206	20207	cholecystokinin	2	GENE-N
20207	20208	(	0	None
20208	20209	CCK	1	GENE-Y
20209	20210	)	0	None
20210	20211	and	0	None
20211	20212	5	0	None
20212	20213	-	0	None
20213	20214	hydroxytryptamine	0	None
20214	20215	(	0	None
20215	20216	5	0	None
20216	20217	-	0	None
20217	20218	HT	3	CHEMICAL
20218	20219	)	0	None
20219	20220	was	0	None
20220	20221	evaluated	0	None
20221	20222	in	0	None
20222	20223	vitro	0	None
20223	20224	in	0	None
20224	20225	the	0	None
20225	20226	longitudinal	0	None
20226	20227	muscle	0	None
20227	20228	-	0	None
20228	20229	myenteric	0	None
20229	20230	plexus	0	None
20230	20231	of	0	None
20231	20232	the	0	None
20232	20233	guinea	0	None
20233	20234	-	0	None
20234	20235	pig	0	None
20235	20236	ileum	0	None
20236	20237	.	0	None

20238	20239	Devazepide	0	None
20239	20240	and	0	None
20240	20241	L	0	None
20241	20242	-	0	None
20242	20243	365	0	None
20243	20244	,	0	None
20244	20245	260	0	None
20245	20246	were	0	None
20246	20247	used	0	None
20247	20248	to	0	None
20248	20249	block	0	None
20249	20250	CCKA	0	None
20250	20251	and	0	None
20251	20252	CCK	1	GENE-Y
20252	20253	(	0	None
20253	20254	B	0	None
20254	20255	)	0	None
20255	20256	receptors	0	None
20256	20257	and	0	None
20257	20258	ondansetron	0	None
20258	20259	and	0	None
20259	20260	tropisetron	0	None
20260	20261	to	0	None
20261	20262	block	0	None
20262	20263	5	0	None
20263	20264	-	0	None
20264	20265	HT3	0	None
20265	20266	and	0	None
20266	20267	5	0	None
20267	20268	-	0	None
20268	20269	HT4	0	None
20269	20270	receptors	0	None
20270	20271	,	0	None
20271	20272	respectively	0	None
20272	20273	.	0	None

20274	20275	The	0	None
20275	20276	CCK	1	GENE-Y
20276	20277	receptor	0	None
20277	20278	antagonists	0	None
20278	20279	blocked	0	None
20279	20280	,	0	None
20280	20281	in	0	None
20281	20282	a	0	None
20282	20283	dose	0	None
20283	20284	-	0	None
20284	20285	dependent	0	None
20285	20286	manner	0	None
20286	20287	,	0	None
20287	20288	the	0	None
20288	20289	response	0	None
20289	20290	to	0	None
20290	20291	5	0	None
20291	20292	-	0	None
20292	20293	HT	3	CHEMICAL
20293	20294	and	0	None
20294	20295	to	0	None
20295	20296	the	0	None
20296	20297	selective	0	None
20297	20298	agonists	0	None
20298	20299	at	0	None
20299	20300	5	0	None
20300	20301	-	0	None
20301	20302	HT3	0	None
20302	20303	and	0	None
20303	20304	5	0	None
20304	20305	-	0	None
20305	20306	HT4	0	None
20306	20307	receptors	0	None
20307	20308	,	0	None
20308	20309	2	0	None
20309	20310	-	0	None
20310	20311	methyl	3	CHEMICAL
20311	20312	-	0	None
20312	20313	5	0	None
20313	20314	-	0	None
20314	20315	hydroxytryptamine	0	None
20315	20316	(	0	None
20316	20317	2	0	None
20317	20318	-	0	None
20318	20319	Me	0	None
20319	20320	-	0	None
20320	20321	5	0	None
20321	20322	-	0	None
20322	20323	HT	3	CHEMICAL
20323	20324	)	0	None
20324	20325	and	0	None
20325	20326	5	0	None
20326	20327	-	0	None
20327	20328	methoxytryptamine	0	None
20328	20329	(	0	None
20329	20330	5	0	None
20330	20331	-	0	None
20331	20332	MeOT	0	None
20332	20333	)	0	None
20333	20334	,	0	None
20334	20335	respectively	0	None
20335	20336	.	0	None

20337	20338	The	0	None
20338	20339	blockade	0	None
20339	20340	was	0	None
20340	20341	almost	0	None
20341	20342	complete	0	None
20342	20343	on	0	None
20343	20344	the	0	None
20344	20345	first	0	None
20345	20346	phase	0	None
20346	20347	of	0	None
20347	20348	the	0	None
20348	20349	concentration	0	None
20349	20350	response	0	None
20350	20351	curve	0	None
20351	20352	to	0	None
20352	20353	5	0	None
20353	20354	-	0	None
20354	20355	HT	3	CHEMICAL
20355	20356	and	0	None
20356	20357	for	0	None
20357	20358	all	0	None
20358	20359	the	0	None
20359	20360	concentrations	0	None
20360	20361	of	0	None
20361	20362	5	0	None
20362	20363	-	0	None
20363	20364	MeOT	0	None
20364	20365	tested	0	None
20365	20366	.	0	None

20367	20368	In	0	None
20368	20369	the	0	None
20369	20370	2	0	None
20370	20371	-	0	None
20371	20372	Me	0	None
20372	20373	-	0	None
20373	20374	5	0	None
20374	20375	-	0	None
20375	20376	HT	3	CHEMICAL
20376	20377	-	0	None
20377	20378	induced	0	None
20378	20379	contractile	0	None
20379	20380	response	0	None
20380	20381	there	0	None
20381	20382	was	0	None
20382	20383	a	0	None
20383	20384	component	0	None
20384	20385	with	0	None
20385	20386	the	0	None
20386	20387	same	0	None
20387	20388	sensitivity	0	None
20388	20389	to	0	None
20389	20390	devazepide	3	CHEMICAL
20390	20391	and	0	None
20391	20392	to	0	None
20392	20393	the	0	None
20393	20394	selective	0	None
20394	20395	NK1	1	GENE-Y
20395	20396	receptor	0	None
20396	20397	antagonist	0	None
20397	20398	,	0	None
20398	20400	GR 82334	2	GENE-N
20400	20401	,	0	None
20401	20402	and	0	None
20402	20403	another	0	None
20403	20404	resistant	0	None
20404	20405	component	0	None
20405	20406	that	0	None
20406	20407	was	0	None
20407	20408	abolished	0	None
20408	20409	by	0	None
20409	20410	atropine	3	CHEMICAL
20410	20411	.	0	None

20412	20413	However	0	None
20413	20414	,	0	None
20414	20415	the	0	None
20415	20416	blockade	0	None
20416	20417	of	0	None
20417	20418	the	0	None
20418	20420	NK1 receptor	1	GENE-Y
20420	20421	did	0	None
20421	20422	not	0	None
20422	20423	produce	0	None
20423	20424	a	0	None
20424	20425	significant	0	None
20425	20426	increase	0	None
20426	20427	in	0	None
20427	20428	the	0	None
20428	20429	inhibition	0	None
20429	20430	obtained	0	None
20430	20431	when	0	None
20431	20432	atropine	3	CHEMICAL
20432	20433	or	0	None
20433	20434	devazepide	3	CHEMICAL
20434	20435	were	0	None
20435	20436	separately	0	None
20436	20437	tested	0	None
20437	20438	on	0	None
20438	20439	the	0	None
20439	20440	5	0	None
20440	20441	-	0	None
20441	20442	MeOT	0	None
20442	20443	-	0	None
20443	20444	induced	0	None
20444	20445	response	0	None
20445	20446	.	0	None

20447	20448	These	0	None
20448	20449	results	0	None
20449	20450	suggest	0	None
20450	20451	that	0	None
20451	20452	CCK	1	GENE-Y
20452	20453	is	0	None
20453	20454	involved	0	None
20454	20455	in	0	None
20455	20456	the	0	None
20456	20457	5	0	None
20457	20458	-	0	None
20458	20459	HT	3	CHEMICAL
20459	20460	-	0	None
20460	20461	induced	0	None
20461	20462	contractile	0	None
20462	20463	response	0	None
20463	20464	,	0	None
20464	20465	particularly	0	None
20465	20466	in	0	None
20466	20467	the	0	None
20467	20468	response	0	None
20468	20469	induced	0	None
20469	20470	by	0	None
20470	20471	5	0	None
20471	20472	-	0	None
20472	20473	HT4	0	None
20473	20474	receptor	0	None
20474	20475	stimulation	0	None
20475	20476	.	0	None

20477	20478	Pharmacological	0	None
20478	20479	plasticity	0	None
20479	20480	of	0	None
20480	20481	cardiac	0	None
20481	20482	ATP	3	CHEMICAL
20482	20483	-	0	None
20483	20484	sensitive	0	None
20484	20486	potassium channels	2	GENE-N
20486	20487	toward	0	None
20487	20488	diazoxide	3	CHEMICAL
20488	20489	revealed	0	None
20489	20490	by	0	None
20490	20491	ADP	3	CHEMICAL
20491	20492	.	0	None

20493	20494	The	0	None
20494	20495	pharmacological	0	None
20495	20496	phenotype	0	None
20496	20497	of	0	None
20497	20498	ATP	3	CHEMICAL
20498	20499	-	0	None
20499	20500	sensitive	0	None
20500	20501	potassium	3	CHEMICAL
20501	20502	(	0	None
20502	20503	K	0	None
20503	20504	(	0	None
20504	20505	ATP	3	CHEMICAL
20505	20506	)	0	None
20506	20507	)	0	None
20507	20508	channels	0	None
20508	20509	is	0	None
20509	20510	defined	0	None
20510	20511	by	0	None
20511	20512	their	0	None
20512	20513	tissue	0	None
20513	20514	-	0	None
20514	20515	specific	0	None
20515	20516	regulatory	0	None
20516	20517	subunit	0	None
20517	20518	,	0	None
20518	20519	the	0	None
20519	20521	sulfonylurea receptor	2	GENE-N
20521	20522	(	0	None
20522	20523	SUR	0	None
20523	20524	)	0	None
20524	20525	,	0	None
20525	20526	which	0	None
20526	20527	associates	0	None
20527	20528	with	0	None
20528	20529	the	0	None
20529	20530	pore	0	None
20530	20531	-	0	None
20531	20532	forming	0	None
20532	20533	channel	0	None
20533	20534	core	0	None
20534	20535	,	0	None
20535	20536	Kir6	0	None
20536	20537	.	0	None
20537	20538	2	0	None
20538	20539	.	0	None

20540	20541	The	0	None
20541	20543	potassium channel	2	GENE-N
20543	20544	opener	0	None
20544	20545	diazoxide	3	CHEMICAL
20545	20546	has	0	None
20546	20547	hyperglycemic	0	None
20547	20548	and	0	None
20548	20549	hypotensive	0	None
20549	20550	properties	0	None
20550	20551	that	0	None
20551	20552	stem	0	None
20552	20553	from	0	None
20553	20554	its	0	None
20554	20555	ability	0	None
20555	20556	to	0	None
20556	20557	open	0	None
20557	20558	K	0	None
20558	20559	(	0	None
20559	20560	ATP	3	CHEMICAL
20560	20561	)	0	None
20561	20562	channels	0	None
20562	20563	in	0	None
20563	20564	pancreas	0	None
20564	20565	and	0	None
20565	20566	smooth	0	None
20566	20567	muscle	0	None
20567	20568	.	0	None

20569	20570	Diazoxide	0	None
20570	20571	is	0	None
20571	20572	believed	0	None
20572	20573	not	0	None
20573	20574	to	0	None
20574	20575	have	0	None
20575	20576	any	0	None
20576	20577	significant	0	None
20577	20578	action	0	None
20578	20579	on	0	None
20579	20580	cardiac	0	None
20580	20581	sarcolemmal	0	None
20581	20582	K	0	None
20582	20583	(	0	None
20583	20584	ATP	3	CHEMICAL
20584	20585	)	0	None
20585	20586	channels	0	None
20586	20587	.	0	None

20588	20589	Yet	0	None
20589	20590	,	0	None
20590	20591	diazoxide	3	CHEMICAL
20591	20592	can	0	None
20592	20593	be	0	None
20593	20594	cardioprotective	0	None
20594	20595	in	0	None
20595	20596	ischemia	0	None
20596	20597	and	0	None
20597	20598	has	0	None
20598	20599	been	0	None
20599	20600	found	0	None
20600	20601	to	0	None
20601	20602	bind	0	None
20602	20603	to	0	None
20603	20604	the	0	None
20604	20605	presumed	0	None
20605	20606	cardiac	0	None
20606	20607	sarcolemmal	0	None
20607	20608	K	0	None
20608	20609	(	0	None
20609	20610	ATP	3	CHEMICAL
20610	20611	)	0	None
20611	20612	channel	0	None
20612	20613	-	0	None
20613	20614	regulatory	0	None
20614	20615	subunit	0	None
20615	20616	,	0	None
20616	20617	SUR2A	0	None
20617	20618	.	0	None

20619	20620	Here	0	None
20620	20621	,	0	None
20621	20622	in	0	None
20622	20623	excised	0	None
20623	20624	patches	0	None
20624	20625	,	0	None
20625	20626	diazoxide	3	CHEMICAL
20626	20627	(	0	None
20627	20628	300	0	None
20628	20629	microM	0	None
20629	20630	)	0	None
20630	20631	activated	0	None
20631	20633	pancreatic SUR1	1	GENE-Y
20633	20634	/	0	None
20634	20635	Kir6	0	None
20635	20636	.	0	None
20636	20637	2	0	None
20637	20638	currents	0	None
20638	20639	and	0	None
20639	20640	had	0	None
20640	20641	little	0	None
20641	20642	effect	0	None
20642	20643	on	0	None
20643	20644	native	0	None
20644	20645	or	0	None
20645	20648	recombinant cardiac SUR2A	1	GENE-Y
20648	20649	/	0	None
20649	20650	Kir6	0	None
20650	20651	.	0	None
20651	20652	2	0	None
20652	20653	currents	0	None
20653	20654	.	0	None

20655	20656	However	0	None
20656	20657	,	0	None
20657	20658	in	0	None
20658	20659	the	0	None
20659	20660	presence	0	None
20660	20661	of	0	None
20661	20662	cytoplasmic	0	None
20662	20663	ADP	3	CHEMICAL
20663	20664	(	0	None
20664	20665	100	0	None
20665	20666	microM	0	None
20666	20667	)	0	None
20667	20668	,	0	None
20668	20669	SUR2A	0	None
20669	20670	/	0	None
20670	20671	Kir6	0	None
20671	20672	.	0	None
20672	20673	2	0	None
20673	20674	channels	0	None
20674	20675	became	0	None
20675	20676	as	0	None
20676	20677	sensitive	0	None
20677	20678	to	0	None
20678	20679	diazoxide	3	CHEMICAL
20679	20680	as	0	None
20680	20681	SUR1	1	GENE-Y
20681	20682	/	0	None
20682	20683	Kir6	0	None
20683	20684	.	0	None
20684	20685	2	0	None
20685	20686	channels	0	None
20686	20687	.	0	None

20688	20689	This	0	None
20689	20690	effect	0	None
20690	20691	involved	0	None
20691	20692	specific	0	None
20692	20693	interactions	0	None
20693	20694	between	0	None
20694	20695	MgADP	3	CHEMICAL
20695	20696	and	0	None
20696	20697	SUR	0	None
20697	20698	,	0	None
20698	20699	as	0	None
20699	20700	it	0	None
20700	20701	required	0	None
20701	20702	Mg	0	None
20702	20703	(	0	None
20703	20704	2	0	None
20704	20705	+	0	None
20705	20706	)	0	None
20706	20707	,	0	None
20707	20708	but	0	None
20708	20709	not	0	None
20709	20710	ATP	3	CHEMICAL
20710	20711	,	0	None
20711	20712	and	0	None
20712	20713	was	0	None
20713	20714	abolished	0	None
20714	20715	by	0	None
20715	20716	point	0	None
20716	20717	mutations	0	None
20717	20718	in	0	None
20718	20719	the	0	None
20719	20720	second	0	None
20720	20721	nucleotide	0	None
20721	20722	-	0	None
20722	20723	binding	0	None
20723	20724	domain	0	None
20724	20725	of	0	None
20725	20726	SUR	0	None
20726	20727	,	0	None
20727	20728	which	0	None
20728	20729	impaired	0	None
20729	20730	channel	0	None
20730	20731	activation	0	None
20731	20732	by	0	None
20732	20733	MgADP	3	CHEMICAL
20733	20734	.	0	None

20735	20736	At	0	None
20736	20737	the	0	None
20737	20738	whole	0	None
20738	20739	-	0	None
20739	20740	cell	0	None
20740	20741	level	0	None
20741	20742	,	0	None
20742	20743	in	0	None
20743	20744	cardiomyocytes	0	None
20744	20745	treated	0	None
20745	20746	with	0	None
20746	20747	oligomycin	0	None
20747	20748	to	0	None
20748	20749	block	0	None
20749	20750	mitochondrial	0	None
20750	20751	function	0	None
20751	20752	,	0	None
20752	20753	diazoxide	3	CHEMICAL
20753	20754	could	0	None
20754	20755	also	0	None
20755	20756	activate	0	None
20756	20757	K	0	None
20757	20758	(	0	None
20758	20759	ATP	3	CHEMICAL
20759	20760	)	0	None
20760	20761	currents	0	None
20761	20762	only	0	None
20762	20763	after	0	None
20763	20764	cytosolic	0	None
20764	20765	ADP	3	CHEMICAL
20765	20766	had	0	None
20766	20767	been	0	None
20767	20768	raised	0	None
20768	20769	by	0	None
20769	20770	a	0	None
20770	20772	creatine kinase	2	GENE-N
20772	20773	inhibitor	0	None
20773	20774	.	0	None

20775	20776	Thus	0	None
20776	20777	,	0	None
20777	20778	ADP	3	CHEMICAL
20778	20779	serves	0	None
20779	20780	as	0	None
20780	20781	a	0	None
20781	20782	cofactor	0	None
20782	20783	to	0	None
20783	20784	define	0	None
20784	20785	the	0	None
20785	20786	responsiveness	0	None
20786	20787	of	0	None
20787	20788	cardiac	0	None
20788	20789	K	0	None
20789	20790	(	0	None
20790	20791	ATP	3	CHEMICAL
20791	20792	)	0	None
20792	20793	channels	0	None
20793	20794	toward	0	None
20794	20795	diazoxide	3	CHEMICAL
20795	20796	.	0	None

20797	20798	The	0	None
20798	20799	present	0	None
20799	20800	demonstration	0	None
20800	20801	of	0	None
20801	20802	a	0	None
20802	20803	pharmacological	0	None
20803	20804	plasticity	0	None
20804	20805	of	0	None
20805	20806	K	0	None
20806	20807	(	0	None
20807	20808	ATP	3	CHEMICAL
20808	20809	)	0	None
20809	20810	channels	0	None
20810	20811	identifies	0	None
20811	20812	a	0	None
20812	20813	mechanism	0	None
20813	20814	for	0	None
20814	20815	the	0	None
20815	20816	control	0	None
20816	20817	of	0	None
20817	20818	channel	0	None
20818	20819	activity	0	None
20819	20820	in	0	None
20820	20821	cardiac	0	None
20821	20822	cells	0	None
20822	20823	depending	0	None
20823	20824	on	0	None
20824	20825	the	0	None
20825	20826	cellular	0	None
20826	20827	ADP	3	CHEMICAL
20827	20828	levels	0	None
20828	20829	,	0	None
20829	20830	which	0	None
20830	20831	are	0	None
20831	20832	elevated	0	None
20832	20833	under	0	None
20833	20834	ischemia	0	None
20834	20835	.	0	None

20836	20837	A	0	None
20837	20838	review	0	None
20838	20839	of	0	None
20839	20840	the	0	None
20840	20841	preclinical	0	None
20841	20842	and	0	None
20842	20843	clinical	0	None
20843	20844	data	0	None
20844	20845	of	0	None
20845	20846	newer	0	None
20846	20847	intranasal	0	None
20847	20848	steroids	3	CHEMICAL
20848	20849	used	0	None
20849	20850	in	0	None
20850	20851	the	0	None
20851	20852	treatment	0	None
20852	20853	of	0	None
20853	20854	allergic	0	None
20854	20855	rhinitis	0	None
20855	20856	.	0	None

20857	20858	The	0	None
20858	20859	anti	0	None
20859	20860	-	0	None
20860	20861	inflammatory	0	None
20861	20862	activity	0	None
20862	20863	of	0	None
20863	20864	corticosteroids	3	CHEMICAL
20864	20865	has	0	None
20865	20866	prompted	0	None
20866	20867	the	0	None
20867	20868	exploration	0	None
20868	20869	of	0	None
20869	20870	their	0	None
20870	20871	use	0	None
20871	20872	in	0	None
20872	20873	the	0	None
20873	20874	treatment	0	None
20874	20875	of	0	None
20875	20876	allergic	0	None
20876	20877	rhinitis	0	None
20877	20878	.	0	None

20879	20880	The	0	None
20880	20881	development	0	None
20881	20882	of	0	None
20882	20883	intranasal	0	None
20883	20884	steroids	3	CHEMICAL
20884	20885	has	0	None
20885	20886	resulted	0	None
20886	20887	in	0	None
20887	20888	several	0	None
20888	20889	agents	0	None
20889	20890	with	0	None
20890	20891	quick	0	None
20891	20892	actions	0	None
20892	20893	,	0	None
20893	20894	localized	0	None
20894	20895	effects	0	None
20895	20896	,	0	None
20896	20897	and	0	None
20897	20898	great	0	None
20898	20899	efficacy	0	None
20899	20900	in	0	None
20900	20901	the	0	None
20901	20902	treatment	0	None
20902	20903	of	0	None
20903	20904	seasonal	0	None
20904	20905	allergic	0	None
20905	20906	rhinitis	0	None
20906	20907	and	0	None
20907	20908	the	0	None
20908	20909	prophylactic	0	None
20909	20910	management	0	None
20910	20911	of	0	None
20911	20912	perennial	0	None
20912	20913	rhinitis	0	None
20913	20914	.	0	None

20915	20916	This	0	None
20916	20917	article	0	None
20917	20918	presents	0	None
20918	20919	a	0	None
20919	20920	concise	0	None
20920	20921	review	0	None
20921	20922	of	0	None
20922	20923	the	0	None
20923	20924	preclinical	0	None
20924	20925	and	0	None
20925	20926	clinical	0	None
20926	20927	evidence	0	None
20927	20928	with	0	None
20928	20929	these	0	None
20929	20930	new	0	None
20930	20931	agents	0	None
20931	20932	and	0	None
20932	20933	provides	0	None
20933	20934	data	0	None
20934	20935	-	0	None
20935	20936	based	0	None
20936	20937	guidance	0	None
20937	20938	for	0	None
20938	20939	the	0	None
20939	20940	selection	0	None
20940	20941	of	0	None
20941	20942	optimal	0	None
20942	20943	agents	0	None
20943	20944	.	0	None

20945	20946	The	0	None
20946	20947	survey	0	None
20947	20948	reveals	0	None
20948	20949	that	0	None
20949	20950	mometasone	0	None
20950	20951	furoate	0	None
20951	20952	,	0	None
20952	20953	a	0	None
20953	20954	new	0	None
20954	20956	inhaled steroid	3	CHEMICAL
20956	20957	with	0	None
20957	20958	topical	0	None
20958	20959	activity	0	None
20959	20960	,	0	None
20960	20961	has	0	None
20961	20962	the	0	None
20962	20963	greatest	0	None
20963	20964	binding	0	None
20964	20965	affinity	0	None
20965	20966	for	0	None
20966	20967	the	0	None
20967	20969	glucocorticoid receptor	1	GENE-Y
20969	20970	,	0	None
20970	20971	followed	0	None
20971	20972	by	0	None
20972	20974	fluticasone propionate	3	CHEMICAL
20974	20975	,	0	None
20975	20976	budesonide	0	None
20976	20977	,	0	None
20977	20979	triamcinolone acetonide	3	CHEMICAL
20979	20980	,	0	None
20980	20981	and	0	None
20981	20982	dexamethasone	3	CHEMICAL
20982	20983	.	0	None

20984	20985	Mometasone	0	None
20985	20986	furoate	0	None
20986	20987	also	0	None
20987	20988	has	0	None
20988	20989	strong	0	None
20989	20990	anti	0	None
20990	20991	-	0	None
20991	20992	inflammatory	0	None
20992	20993	activity	0	None
20993	20994	,	0	None
20994	20995	with	0	None
20995	20996	IL	0	None
20996	20997	-	0	None
20997	20998	4	0	None
20998	20999	and	0	None
20999	21000	IL	0	None
21000	21001	-	0	None
21001	21002	5	0	None
21002	21003	inhibition	0	None
21003	21004	activities	0	None
21004	21005	equivalent	0	None
21005	21006	to	0	None
21006	21007	those	0	None
21007	21008	of	0	None
21008	21010	fluticasone propionate	3	CHEMICAL
21010	21011	.	0	None

21012	21013	Clinically	0	None
21013	21014	,	0	None
21014	21015	both	0	None
21015	21016	mometasone	0	None
21016	21017	furoate	0	None
21017	21018	and	0	None
21018	21020	fluticasone propionate	3	CHEMICAL
21020	21021	appear	0	None
21021	21022	to	0	None
21022	21023	be	0	None
21023	21024	well	0	None
21024	21025	tolerated	0	None
21025	21026	,	0	None
21026	21027	to	0	None
21027	21028	have	0	None
21028	21029	quick	0	None
21029	21030	onsets	0	None
21030	21031	of	0	None
21031	21032	action	0	None
21032	21033	,	0	None
21033	21034	and	0	None
21034	21035	to	0	None
21035	21036	be	0	None
21036	21037	equivalent	0	None
21037	21038	in	0	None
21038	21039	efficacy	0	None
21039	21040	in	0	None
21040	21041	the	0	None
21041	21042	treatment	0	None
21042	21043	of	0	None
21043	21044	seasonal	0	None
21044	21045	allergic	0	None
21045	21046	and	0	None
21046	21047	perennial	0	None
21047	21048	rhinitis	0	None
21048	21049	.	0	None

21050	21051	Of	0	None
21051	21052	the	0	None
21052	21053	intranasal	0	None
21053	21054	steroids	3	CHEMICAL
21054	21055	currently	0	None
21055	21056	available	0	None
21056	21057	,	0	None
21057	21058	mometasone	0	None
21058	21059	furoate	0	None
21059	21060	has	0	None
21060	21061	been	0	None
21061	21062	shown	0	None
21062	21063	to	0	None
21063	21064	have	0	None
21064	21065	the	0	None
21065	21066	least	0	None
21066	21067	systemic	0	None
21067	21068	availability	0	None
21068	21069	and	0	None
21069	21070	,	0	None
21070	21071	consequently	0	None
21071	21072	,	0	None
21072	21073	is	0	None
21073	21074	expected	0	None
21074	21075	to	0	None
21075	21076	have	0	None
21076	21077	the	0	None
21077	21078	fewest	0	None
21078	21079	systemic	0	None
21079	21080	side	0	None
21080	21081	effects	0	None
21081	21082	.	0	None

21083	21084	Some	0	None
21084	21085	suppression	0	None
21085	21086	of	0	None
21086	21087	overnight	0	None
21087	21088	cortisol	3	CHEMICAL
21088	21089	levels	0	None
21089	21090	has	0	None
21090	21091	been	0	None
21091	21092	reported	0	None
21092	21093	with	0	None
21093	21095	fluticasone propionate	3	CHEMICAL
21095	21096	(	0	None
21096	21097	indicative	0	None
21097	21098	of	0	None
21098	21099	hypothalamic	0	None
21099	21100	-	0	None
21100	21101	pituitary	0	None
21101	21102	-	0	None
21102	21103	adrenal	0	None
21103	21104	axis	0	None
21104	21105	suppression	0	None
21105	21106	)	0	None
21106	21107	.	0	None

21108	21109	A	0	None
21109	21110	novel	0	None
21110	21111	mutation	0	None
21111	21112	of	0	None
21112	21113	delta	0	None
21113	21114	-	0	None
21114	21115	aminolaevulinate	0	None
21115	21116	dehydratase	2	GENE-N
21116	21117	in	0	None
21117	21118	a	0	None
21118	21119	healthy	0	None
21119	21120	child	0	None
21120	21121	with	0	None
21121	21122	12	0	None
21122	21123	%	0	None
21123	21124	erythrocyte	0	None
21124	21125	enzyme	0	None
21125	21126	activity	0	None
21126	21127	.	0	None

21128	21129	Cloning	0	None
21129	21130	,	0	None
21130	21131	expression	0	None
21131	21132	and	0	None
21132	21133	phenotype	0	None
21133	21134	studies	0	None
21134	21135	of	0	None
21135	21136	the	0	None
21136	21137	defective	0	None
21137	21138	gene	0	None
21138	21139	for	0	None
21139	21140	delta	0	None
21140	21141	-	0	None
21141	21142	aminolaevulinate	0	None
21142	21143	dehydratase	2	GENE-N
21143	21144	(	0	None
21144	21145	ALAD	1	GENE-Y
21145	21146	)	0	None
21146	21147	in	0	None
21147	21148	a	0	None
21148	21149	family	0	None
21149	21150	with	0	None
21150	21151	an	0	None
21151	21152	asymptomatic	0	None
21152	21153	girl	0	None
21153	21154	who	0	None
21154	21155	had	0	None
21155	21156	ALAD	1	GENE-Y
21156	21157	deficiency	0	None
21157	21158	were	0	None
21158	21159	carried	0	None
21159	21160	out	0	None
21160	21161	.	0	None

21162	21163	The	0	None
21163	21164	proband	0	None
21164	21165	was	0	None
21165	21166	identified	0	None
21166	21167	by	0	None
21167	21168	neonatal	0	None
21168	21169	ALAD	1	GENE-Y
21169	21170	screening	0	None
21170	21171	,	0	None
21171	21172	and	0	None
21172	21173	had	0	None
21173	21174	erythrocyte	0	None
21174	21175	ALAD	1	GENE-Y
21175	21176	activity	0	None
21176	21177	at	0	None
21177	21178	12	0	None
21178	21179	%	0	None
21179	21180	of	0	None
21180	21181	the	0	None
21181	21182	normal	0	None
21182	21183	control	0	None
21183	21184	.	0	None

21185	21186	She	0	None
21186	21187	was	0	None
21187	21188	heterozygous	0	None
21188	21189	for	0	None
21189	21190	ALAD	1	GENE-Y
21190	21191	deficiency	0	None
21191	21192	,	0	None
21192	21193	which	0	None
21193	21194	was	0	None
21194	21195	inherited	0	None
21195	21196	from	0	None
21196	21197	her	0	None
21197	21198	father	0	None
21198	21199	.	0	None

21200	21201	Nucleotide	0	None
21201	21202	sequence	0	None
21202	21203	analysis	0	None
21203	21204	of	0	None
21204	21205	the	0	None
21205	21206	cloned	0	None
21206	21207	ALAD	1	GENE-Y
21207	21208	cDNA	0	None
21208	21209	revealed	0	None
21209	21214	C36 to G and T168	2	GENE-N
21214	21215	to	0	None
21215	21216	C	0	None
21216	21217	mutations	0	None
21217	21218	on	0	None
21218	21219	the	0	None
21219	21220	same	0	None
21220	21221	allele	0	None
21221	21222	.	0	None

21223	21224	The	0	None
21224	21225	former	0	None
21225	21226	mutation	0	None
21226	21227	resulted	0	None
21227	21228	in	0	None
21228	21229	F12L	2	GENE-N
21229	21230	substitution	0	None
21230	21231	,	0	None
21231	21232	whereas	0	None
21232	21233	the	0	None
21233	21234	latter	0	None
21234	21235	was	0	None
21235	21236	a	0	None
21236	21237	silent	0	None
21237	21238	mutation	0	None
21238	21239	.	0	None

21240	21241	All	0	None
21241	21242	family	0	None
21242	21243	members	0	None
21243	21244	who	0	None
21244	21245	had	0	None
21245	21246	decreased	0	None
21246	21247	ALAD	1	GENE-Y
21247	21248	activity	0	None
21248	21249	had	0	None
21249	21250	the	0	None
21250	21251	same	0	None
21251	21252	mutation	0	None
21252	21253	.	0	None

21254	21255	Expression	0	None
21255	21256	of	0	None
21256	21257	the	0	None
21257	21258	mutant	0	None
21258	21259	ALAD	1	GENE-Y
21259	21260	cDNA	0	None
21260	21261	in	0	None
21261	21262	Chinese	0	None
21262	21263	hamster	0	None
21263	21264	ovary	0	None
21264	21265	cells	0	None
21265	21266	produced	0	None
21266	21267	an	0	None
21267	21268	ALAD	1	GENE-Y
21268	21269	protein	0	None
21269	21270	without	0	None
21270	21271	significant	0	None
21271	21272	enzyme	0	None
21272	21273	activity	0	None
21273	21274	.	0	None

21275	21276	Additionally	0	None
21276	21277	,	0	None
21277	21278	the	0	None
21278	21279	mutant	0	None
21279	21280	ALAD	1	GENE-Y
21280	21281	cDNA	0	None
21281	21282	which	0	None
21282	21283	encodes	0	None
21283	21284	F12L	2	GENE-N
21284	21285	substitution	0	None
21285	21286	produced	0	None
21286	21287	an	0	None
21287	21288	aberrant	0	None
21288	21289	migration	0	None
21289	21290	pattern	0	None
21290	21291	in	0	None
21291	21292	polyacrylamide	3	CHEMICAL
21292	21293	gel	0	None
21293	21294	electrophoresis	0	None
21294	21295	under	0	None
21295	21296	denaturing	0	None
21296	21297	conditions	0	None
21297	21298	.	0	None

21299	21300	This	0	None
21300	21301	finding	0	None
21301	21302	probably	0	None
21302	21303	reflects	0	None
21303	21304	an	0	None
21304	21305	abnormal	0	None
21305	21306	folding	0	None
21306	21307	of	0	None
21307	21308	the	0	None
21308	21309	F12L	2	GENE-N
21309	21310	protein	0	None
21310	21311	,	0	None
21311	21312	since	0	None
21312	21313	the	0	None
21313	21314	mutation	0	None
21314	21315	occurred	0	None
21315	21316	in	0	None
21316	21317	the	0	None
21317	21318	alpha1	2	GENE-N
21318	21319	helix	0	None
21319	21320	of	0	None
21320	21321	the	0	None
21321	21322	N	0	None
21322	21323	-	0	None
21323	21324	terminal	0	None
21324	21325	arm	0	None
21325	21326	of	0	None
21326	21327	the	0	None
21327	21328	enzyme	0	None
21328	21329	,	0	None
21329	21330	which	0	None
21330	21331	is	0	None
21331	21332	involved	0	None
21332	21333	in	0	None
21333	21334	the	0	None
21334	21335	extensive	0	None
21335	21336	quaternary	0	None
21336	21337	interactions	0	None
21337	21338	among	0	None
21338	21339	the	0	None
21339	21340	subunits	0	None
21340	21341	.	0	None

21342	21343	This	0	None
21343	21344	is	0	None
21344	21345	also	0	None
21345	21346	the	0	None
21346	21347	first	0	None
21347	21348	report	0	None
21348	21349	of	0	None
21349	21350	ALAD	1	GENE-Y
21350	21351	gene	0	None
21351	21352	mutation	0	None
21352	21353	in	0	None
21353	21354	an	0	None
21354	21355	asymptomatic	0	None
21355	21356	subject	0	None
21356	21357	.	0	None

21358	21359	Tamsulosin	0	None
21359	21360	:	0	None
21360	21361	assessment	0	None
21361	21362	of	0	None
21362	21363	affinityof	0	None
21363	21364	(	0	None
21364	21365	3	0	None
21365	21366	)	0	None
21366	21367	H	0	None
21367	21368	-	0	None
21368	21369	P	0	None
21369	21370	razosin	0	None
21370	21371	binding	0	None
21371	21372	to	0	None
21372	21373	two	0	None
21373	21374	alpha	0	None
21374	21375	-	0	None
21375	21376	1	0	None
21376	21377	-	0	None
21377	21378	adrenoceptor	0	None
21378	21379	subtypes	0	None
21379	21380	in	0	None
21380	21381	the	0	None
21381	21382	canine	0	None
21382	21383	aorta	0	None
21383	21384	.	0	None

21385	21386	This	0	None
21386	21387	study	0	None
21387	21388	was	0	None
21388	21389	performed	0	None
21389	21390	to	0	None
21390	21391	assess	0	None
21391	21392	the	0	None
21392	21393	affinity	0	None
21393	21394	of	0	None
21394	21395	tamsulosin	3	CHEMICAL
21395	21396	to	0	None
21396	21397	the	0	None
21397	21398	alpha	0	None
21398	21399	(	0	None
21399	21400	1L	0	None
21400	21401	)	0	None
21401	21402	-	0	None
21402	21403	in	0	None
21403	21404	addition	0	None
21404	21405	to	0	None
21405	21406	alpha	0	None
21406	21407	(	0	None
21407	21408	1B	0	None
21408	21409	)	0	None
21409	21410	-	0	None
21410	21411	adrenoceptor	0	None
21411	21412	(	0	None
21412	21413	alpha	0	None
21413	21414	(	0	None
21414	21415	1	0	None
21415	21416	)	0	None
21416	21417	-	0	None
21417	21418	AR	1	GENE-Y
21418	21419	)	0	None
21419	21420	subtypes	0	None
21420	21421	coexisting	0	None
21421	21422	in	0	None
21422	21423	the	0	None
21423	21424	canine	0	None
21424	21425	aorta	0	None
21425	21426	using	0	None
21426	21427	the	0	None
21427	21428	radioligand	0	None
21428	21429	binding	0	None
21429	21430	assay	0	None
21430	21431	.	0	None

21432	21433	The	0	None
21433	21434	antagonistic	0	None
21434	21435	effects	0	None
21435	21436	of	0	None
21436	21437	this	0	None
21437	21438	drug	0	None
21438	21439	on	0	None
21439	21440	contraction	0	None
21440	21441	of	0	None
21441	21442	the	0	None
21442	21443	rat	0	None
21443	21444	aorta	0	None
21444	21445	were	0	None
21445	21446	also	0	None
21446	21447	assessed	0	None
21447	21448	,	0	None
21448	21449	and	0	None
21449	21450	the	0	None
21450	21451	results	0	None
21451	21452	were	0	None
21452	21453	compared	0	None
21453	21454	with	0	None
21454	21455	those	0	None
21455	21456	obtained	0	None
21456	21457	with	0	None
21457	21458	prazosin	3	CHEMICAL
21458	21459	,	0	None
21459	21460	amosulalol	0	None
21460	21461	,	0	None
21461	21462	labetalol	3	CHEMICAL
21462	21463	,	0	None
21463	21464	ketanserin	3	CHEMICAL
21464	21465	,	0	None
21465	21466	clonidine	3	CHEMICAL
21466	21467	and	0	None
21467	21468	propranolol	3	CHEMICAL
21468	21469	.	0	None

21470	21471	The	0	None
21471	21472	pKi	0	None
21472	21473	value	0	None
21473	21474	of	0	None
21474	21475	tamsulosin	3	CHEMICAL
21475	21476	to	0	None
21476	21477	the	0	None
21477	21478	alpha	0	None
21478	21479	(	0	None
21479	21480	1L	0	None
21480	21481	)	0	None
21481	21482	-	0	None
21482	21483	subtype	0	None
21483	21484	was	0	None
21484	21485	lower	0	None
21485	21486	than	0	None
21486	21487	those	0	None
21487	21488	of	0	None
21488	21489	prazosin	3	CHEMICAL
21489	21490	and	0	None
21490	21491	HV	0	None
21491	21492	-	0	None
21492	21493	723	0	None
21493	21494	,	0	None
21494	21495	but	0	None
21495	21496	higher	0	None
21496	21497	than	0	None
21497	21498	those	0	None
21498	21499	of	0	None
21499	21500	amosulalol	0	None
21500	21501	,	0	None
21501	21502	ketanserin	3	CHEMICAL
21502	21503	and	0	None
21503	21504	labetalol	3	CHEMICAL
21504	21505	.	0	None

21506	21507	The	0	None
21507	21508	pKi	0	None
21508	21509	value	0	None
21509	21510	of	0	None
21510	21511	tamsulosin	3	CHEMICAL
21511	21512	for	0	None
21512	21513	the	0	None
21513	21514	alpha	0	None
21514	21515	(	0	None
21515	21516	1B	0	None
21516	21517	)	0	None
21517	21518	-	0	None
21518	21519	subtype	0	None
21519	21520	in	0	None
21520	21521	the	0	None
21521	21522	canine	0	None
21522	21523	aorta	0	None
21523	21524	was	0	None
21524	21525	similar	0	None
21525	21526	to	0	None
21526	21527	that	0	None
21527	21528	of	0	None
21528	21529	prazosin	3	CHEMICAL
21529	21530	.	0	None

21531	21532	However	0	None
21532	21533	,	0	None
21533	21534	this	0	None
21534	21535	drug	0	None
21535	21536	showed	0	None
21536	21537	a	0	None
21537	21538	higher	0	None
21538	21539	pKi	0	None
21539	21540	value	0	None
21540	21541	than	0	None
21541	21542	amosulalol	0	None
21542	21543	,	0	None
21543	21544	HV	0	None
21544	21545	-	0	None
21545	21546	723	0	None
21546	21547	,	0	None
21547	21548	labetalol	3	CHEMICAL
21548	21549	and	0	None
21549	21550	ketanserin	3	CHEMICAL
21550	21551	.	0	None

21552	21553	On	0	None
21553	21554	the	0	None
21554	21555	other	0	None
21555	21556	hand	0	None
21556	21557	,	0	None
21557	21558	the	0	None
21558	21559	order	0	None
21559	21560	of	0	None
21560	21561	inhibition	0	None
21561	21562	potencies	0	None
21562	21563	for	0	None
21563	21564	contraction	0	None
21564	21565	of	0	None
21565	21566	the	0	None
21566	21567	rat	0	None
21567	21568	aorta	0	None
21568	21569	by	0	None
21569	21570	phenylephrine	3	CHEMICAL
21570	21571	was	0	None
21571	21572	as	0	None
21572	21573	follows	0	None
21573	21574	:	0	None
21574	21575	prazosin	3	CHEMICAL
21575	21576	>	0	None
21576	21577	tamsulosin	3	CHEMICAL
21577	21578	>	0	None
21578	21579	amosulalol	0	None
21579	21580	>	0	None
21580	21581	HV	0	None
21581	21582	-	0	None
21582	21583	723	0	None
21583	21584	>	0	None
21584	21585	labetalol	3	CHEMICAL
21585	21586	>	0	None
21586	21587	ketanserin	3	CHEMICAL
21587	21588	>	0	None
21588	21589	clonidine	3	CHEMICAL
21589	21590	>	0	None
21590	21591	propranolol	3	CHEMICAL
21591	21592	.	0	None

21593	21594	Thus	0	None
21594	21595	,	0	None
21595	21596	although	0	None
21596	21597	the	0	None
21597	21598	affinity	0	None
21598	21599	of	0	None
21599	21600	tamsulosin	3	CHEMICAL
21600	21601	to	0	None
21601	21602	the	0	None
21602	21603	alpha	0	None
21603	21604	(	0	None
21604	21605	1B	0	None
21605	21606	)	0	None
21606	21607	-	0	None
21607	21608	AR	1	GENE-Y
21608	21609	subtype	0	None
21609	21610	in	0	None
21610	21611	the	0	None
21611	21612	canine	0	None
21612	21613	aorta	0	None
21613	21614	was	0	None
21614	21615	as	0	None
21615	21616	high	0	None
21616	21617	as	0	None
21617	21618	that	0	None
21618	21619	in	0	None
21619	21620	the	0	None
21620	21621	bovine	0	None
21621	21622	prostate	0	None
21622	21623	reported	0	None
21623	21624	in	0	None
21624	21625	our	0	None
21625	21626	previous	0	None
21626	21627	study	0	None
21627	21628	,	0	None
21628	21629	the	0	None
21629	21630	affinity	0	None
21630	21631	(	0	None
21631	21632	pKi	0	None
21632	21633	7	0	None
21633	21634	.	0	None
21634	21635	87	0	None
21635	21636	)	0	None
21636	21637	of	0	None
21637	21638	this	0	None
21638	21639	drug	0	None
21639	21640	to	0	None
21640	21641	alpha	0	None
21641	21642	(	0	None
21642	21643	1L	0	None
21643	21644	)	0	None
21644	21645	-	0	None
21645	21646	AR	1	GENE-Y
21646	21647	in	0	None
21647	21648	the	0	None
21648	21649	canine	0	None
21649	21650	aorta	0	None
21650	21651	was	0	None
21651	21652	lower	0	None
21652	21653	than	0	None
21653	21654	that	0	None
21654	21655	(	0	None
21655	21656	pKi	0	None
21656	21657	8	0	None
21657	21658	.	0	None
21658	21659	99	0	None
21659	21660	)	0	None
21660	21661	in	0	None
21661	21662	the	0	None
21662	21663	bovine	0	None
21663	21664	prostate	0	None
21664	21665	.	0	None

21666	21667	These	0	None
21667	21668	observations	0	None
21668	21669	suggested	0	None
21669	21670	that	0	None
21670	21671	the	0	None
21671	21672	pharmacological	0	None
21672	21673	potencies	0	None
21673	21674	of	0	None
21674	21675	tamsulosin	3	CHEMICAL
21675	21676	in	0	None
21676	21677	the	0	None
21677	21678	aorta	0	None
21678	21679	and	0	None
21679	21680	prostate	0	None
21680	21681	may	0	None
21681	21682	be	0	None
21682	21683	different	0	None
21683	21684	.	0	None

21685	21686	In	0	None
21686	21687	vitro	0	None
21687	21688	characterization	0	None
21688	21689	of	0	None
21689	21690	the	0	None
21690	21691	erythrocyte	0	None
21691	21692	distribution	0	None
21692	21693	of	0	None
21693	21694	methazolamide	3	CHEMICAL
21694	21695	:	0	None
21695	21696	a	0	None
21696	21697	model	0	None
21697	21698	of	0	None
21698	21699	erythrocyte	0	None
21699	21700	transport	0	None
21700	21701	and	0	None
21701	21702	binding	0	None
21702	21703	kinetics	0	None
21703	21704	.	0	None

21705	21706	The	0	None
21706	21707	rate	0	None
21707	21708	and	0	None
21708	21709	extent	0	None
21709	21710	of	0	None
21710	21711	binding	0	None
21711	21712	of	0	None
21712	21713	methazolamide	3	CHEMICAL
21713	21714	to	0	None
21714	21715	human	0	None
21715	21716	erythrocytes	0	None
21716	21717	was	0	None
21717	21718	studied	0	None
21718	21719	in	0	None
21719	21720	vitro	0	None
21720	21721	.	0	None

21722	21723	All	0	None
21723	21724	experiments	0	None
21724	21725	were	0	None
21725	21726	carried	0	None
21726	21727	out	0	None
21727	21728	at	0	None
21728	21729	physiological	0	None
21729	21730	temperature	0	None
21730	21731	(	0	None
21731	21732	37	0	None
21732	21733	C	0	None
21733	21734	)	0	None
21734	21735	and	0	None
21735	21736	pH	0	None
21736	21737	(	0	None
21737	21738	7	0	None
21738	21739	.	0	None
21739	21740	4	0	None
21740	21741	)	0	None
21741	21742	.	0	None

21743	21744	Methazolamide	0	None
21744	21745	(	0	None
21745	21746	MTZ	0	None
21746	21747	)	0	None
21747	21748	buffer	0	None
21748	21749	concentrations	0	None
21749	21750	were	0	None
21750	21751	analyzed	0	None
21751	21752	by	0	None
21752	21753	HPLC	0	None
21753	21754	.	0	None

21755	21756	Distributional	0	None
21756	21757	equilibrium	0	None
21757	21758	between	0	None
21758	21759	buffer	0	None
21759	21760	and	0	None
21760	21761	washed	0	None
21761	21762	red	0	None
21762	21763	blood	0	None
21763	21764	cells	0	None
21764	21765	was	0	None
21765	21766	achieved	0	None
21766	21767	after	0	None
21767	21768	1	0	None
21768	21769	hr	2	GENE-N
21769	21770	.	0	None

21771	21772	Results	0	None
21772	21773	of	0	None
21773	21774	equilibrium	0	None
21774	21775	studies	0	None
21775	21776	were	0	None
21776	21777	consistent	0	None
21777	21778	with	0	None
21778	21779	two	0	None
21779	21780	classes	0	None
21780	21781	of	0	None
21781	21782	binding	0	None
21782	21783	sites	0	None
21783	21784	for	0	None
21784	21785	MTZ	0	None
21785	21786	within	0	None
21786	21787	the	0	None
21787	21788	erythrocyte	0	None
21788	21789	:	0	None
21789	21790	a	0	None
21790	21791	low	0	None
21791	21792	affinity	0	None
21792	21793	,	0	None
21793	21794	high	0	None
21794	21795	capacity	0	None
21795	21796	site	0	None
21796	21797	(	0	None
21797	21798	CA	2	GENE-N
21798	21799	-	0	None
21799	21800	I	0	None
21800	21801	)	0	None
21801	21802	and	0	None
21802	21803	a	0	None
21803	21804	high	0	None
21804	21805	affinity	0	None
21805	21806	,	0	None
21806	21807	low	0	None
21807	21808	capacity	0	None
21808	21809	site	0	None
21809	21810	(	0	None
21810	21811	CA	2	GENE-N
21811	21812	-	0	None
21812	21813	II	0	None
21813	21814	)	0	None
21814	21815	.	0	None

21816	21817	A	0	None
21817	21818	two	0	None
21818	21819	-	0	None
21819	21820	binding	0	None
21820	21821	site	0	None
21821	21822	model	0	None
21822	21823	was	0	None
21823	21824	fitted	0	None
21824	21825	to	0	None
21825	21826	experimental	0	None
21826	21827	data	0	None
21827	21828	generating	0	None
21828	21829	estimates	0	None
21829	21830	for	0	None
21830	21831	binding	0	None
21831	21832	parameters	0	None
21832	21833	Ka1	0	None
21833	21834	(	0	None
21834	21835	0	0	None
21835	21836	.	0	None
21836	21837	0017	0	None
21837	21838	+	0	None
21838	21839	/	0	None
21839	21840	-	0	None
21840	21841	0	0	None
21841	21842	.	0	None
21842	21843	00022	0	None
21843	21844	microM	0	None
21844	21845	-	0	None
21845	21846	1	0	None
21846	21847	)	0	None
21847	21848	nM1	0	None
21848	21849	(	0	None
21849	21850	636	0	None
21850	21851	+	0	None
21851	21852	/	0	None
21852	21853	-	0	None
21853	21854	5	0	None
21854	21855	.	0	None
21855	21856	23	0	None
21856	21857	microM	0	None
21857	21858	)	0	None
21858	21859	,	0	None
21859	21860	Ka2	0	None
21860	21861	(	0	None
21861	21862	0	0	None
21862	21863	.	0	None
21863	21864	46	0	None
21864	21865	+	0	None
21865	21866	/	0	None
21866	21867	-	0	None
21867	21868	0	0	None
21868	21869	.	0	None
21869	21870	0083	0	None
21870	21871	microM	0	None
21871	21872	-	0	None
21872	21873	1	0	None
21873	21874	)	0	None
21874	21875	,	0	None
21875	21876	and	0	None
21876	21877	nM2	0	None
21877	21878	(	0	None
21878	21879	80	0	None
21879	21880	.	0	None
21880	21881	9	0	None
21881	21882	+	0	None
21882	21883	/	0	None
21883	21884	-	0	None
21884	21885	0	0	None
21885	21886	.	0	None
21886	21887	389	0	None
21887	21888	microM	0	None
21888	21889	)	0	None
21889	21890	.	0	None

21891	21892	Based	0	None
21892	21893	upon	0	None
21893	21894	these	0	None
21894	21895	findings	0	None
21895	21896	,	0	None
21896	21897	kinetic	0	None
21897	21898	studies	0	None
21898	21899	were	0	None
21899	21900	performed	0	None
21900	21901	in	0	None
21901	21902	order	0	None
21902	21903	to	0	None
21903	21904	characterize	0	None
21904	21905	the	0	None
21905	21906	rate	0	None
21906	21907	of	0	None
21907	21908	drug	0	None
21908	21909	distribution	0	None
21909	21910	.	0	None

21911	21912	The	0	None
21912	21913	rate	0	None
21913	21914	of	0	None
21914	21915	erythrocyte	0	None
21915	21916	uptake	0	None
21916	21917	of	0	None
21917	21918	MTZ	0	None
21918	21919	was	0	None
21919	21920	mathematically	0	None
21920	21921	modeled	0	None
21921	21922	using	0	None
21922	21923	a	0	None
21923	21924	series	0	None
21924	21925	of	0	None
21925	21926	differential	0	None
21926	21927	equations	0	None
21927	21928	describing	0	None
21928	21929	drug	0	None
21929	21930	diffusion	0	None
21930	21931	across	0	None
21931	21932	the	0	None
21932	21933	red	0	None
21933	21934	blood	0	None
21934	21935	cell	0	None
21935	21936	membrane	0	None
21936	21937	and	0	None
21937	21938	subsequent	0	None
21938	21939	complexation	0	None
21939	21940	with	0	None
21940	21941	intracellular	0	None
21941	21942	binding	0	None
21942	21943	sites	0	None
21943	21944	.	0	None

21945	21946	The	0	None
21946	21947	model	0	None
21947	21948	assumed	0	None
21948	21949	that	0	None
21949	21950	penetration	0	None
21950	21951	of	0	None
21951	21952	MTZ	0	None
21952	21953	into	0	None
21953	21954	the	0	None
21954	21955	red	0	None
21955	21956	blood	0	None
21956	21957	cells	0	None
21957	21958	was	0	None
21958	21959	passive	0	None
21959	21960	but	0	None
21960	21961	drug	0	None
21961	21962	binding	0	None
21962	21963	to	0	None
21963	21964	the	0	None
21964	21966	carbonic anhydrase	2	GENE-N
21966	21967	isozymes	0	None
21967	21968	was	0	None
21968	21969	not	0	None
21969	21970	instantaneous	0	None
21970	21971	.	0	None

21972	21973	Using	0	None
21973	21974	a	0	None
21974	21975	novel	0	None
21975	21976	curve	0	None
21976	21977	fitting	0	None
21977	21978	technique	0	None
21978	21979	,	0	None
21979	21980	parameter	0	None
21980	21981	estimates	0	None
21981	21982	of	0	None
21982	21983	RBC	0	None
21983	21984	membrane	0	None
21984	21985	permeability	0	None
21985	21986	(	0	None
21986	21987	0	0	None
21987	21988	.	0	None
21988	21989	0102	0	None
21989	21990	+	0	None
21990	21991	/	0	None
21991	21992	-	0	None
21992	21993	0	0	None
21993	21994	.	0	None
21994	21995	000618	0	None
21995	21996	cm	0	None
21996	21997	/	0	None
21997	21998	min	0	None
21998	21999	)	0	None
21999	22000	,	0	None
22000	22001	and	0	None
22001	22002	binding	0	None
22002	22003	rate	0	None
22003	22004	constants	0	None
22004	22005	k	0	None
22005	22006	-	0	None
22006	22007	1	0	None
22007	22008	(	0	None
22008	22009	0	0	None
22009	22010	.	0	None
22010	22011	254	0	None
22011	22012	+	0	None
22012	22013	/	0	None
22013	22014	-	0	None
22014	22015	0	0	None
22015	22016	.	0	None
22016	22017	0213	0	None
22017	22018	min	0	None
22018	22019	-	0	None
22019	22020	1	0	None
22020	22021	)	0	None
22021	22022	,	0	None
22022	22023	k1	0	None
22023	22024	(	0	None
22024	22025	0	0	None
22025	22026	.	0	None
22026	22027	0022	0	None
22027	22028	+	0	None
22028	22029	/	0	None
22029	22030	-	0	None
22030	22031	0	0	None
22031	22032	.	0	None
22032	22033	00020	0	None
22033	22034	ml	0	None
22034	22035	/	0	None
22035	22036	microgram	0	None
22036	22037	-	0	None
22037	22038	min	0	None
22038	22039	)	0	None
22039	22040	,	0	None
22040	22041	k	0	None
22041	22042	-	0	None
22042	22043	2	0	None
22043	22044	(	0	None
22044	22045	1	0	None
22045	22046	.	0	None
22046	22047	59	0	None
22047	22048	+	0	None
22048	22049	/	0	None
22049	22050	-	0	None
22050	22051	0	0	None
22051	22052	.	0	None
22052	22053	0358	0	None
22053	22054	min	0	None
22054	22055	-	0	None
22055	22056	1	0	None
22056	22057	)	0	None
22057	22058	,	0	None
22058	22059	and	0	None
22059	22060	k2	0	None
22060	22061	(	0	None
22061	22062	3	0	None
22062	22063	.	0	None
22063	22064	1	0	None
22064	22065	+	0	None
22065	22066	/	0	None
22066	22067	-	0	None
22067	22068	0	0	None
22068	22069	.	0	None
22069	22070	035	0	None
22070	22071	ml	0	None
22071	22072	/	0	None
22072	22073	microgram	0	None
22073	22074	-	0	None
22074	22075	min	0	None
22075	22076	)	0	None
22076	22077	were	0	None
22077	22078	obtained	0	None
22078	22079	.	0	None

22080	22081	The	0	None
22081	22082	model	0	None
22082	22083	characterized	0	None
22083	22084	the	0	None
22084	22085	observed	0	None
22085	22086	biphasic	0	None
22086	22087	decline	0	None
22087	22088	of	0	None
22088	22089	MTZ	0	None
22089	22090	buffer	0	None
22090	22091	concentrations	0	None
22091	22092	over	0	None
22092	22093	time	0	None
22093	22094	and	0	None
22094	22095	may	0	None
22095	22096	help	0	None
22096	22097	explain	0	None
22097	22098	the	0	None
22098	22099	prolonged	0	None
22099	22100	residence	0	None
22100	22101	of	0	None
22101	22102	MTZ	0	None
22102	22103	in	0	None
22103	22104	vivo	0	None
22104	22105	.	0	None

22106	22107	Radioimmunotherapy	0	None
22107	22108	of	0	None
22108	22109	relapsed	0	None
22109	22110	non	0	None
22110	22111	-	0	None
22111	22112	Hodgkin	0	None
22112	22113	'	0	None
22113	22114	s	0	None
22114	22115	lymphoma	0	None
22115	22116	with	0	None
22116	22117	zevalin	0	None
22117	22118	,	0	None
22118	22119	a	0	None
22119	22120	90Y	3	CHEMICAL
22120	22121	-	0	None
22121	22122	labeled	0	None
22122	22123	anti	0	None
22123	22124	-	0	None
22124	22125	CD20	0	None
22125	22127	monoclonal antibody	2	GENE-N
22127	22128	.	0	None

22129	22130	Approximately	0	None
22130	22131	55	0	None
22131	22132	,	0	None
22132	22133	400	0	None
22133	22134	new	0	None
22134	22135	cases	0	None
22135	22136	of	0	None
22136	22137	non	0	None
22137	22138	-	0	None
22138	22139	Hodgkin	0	None
22139	22140	'	0	None
22140	22141	s	0	None
22141	22142	lymphoma	0	None
22142	22143	(	0	None
22143	22144	NHL	0	None
22144	22145	)	0	None
22145	22146	are	0	None
22146	22147	diagnosed	0	None
22147	22148	each	0	None
22148	22149	year	0	None
22149	22150	,	0	None
22150	22151	with	0	None
22151	22152	the	0	None
22152	22153	overall	0	None
22153	22154	prevalence	0	None
22154	22155	of	0	None
22155	22156	the	0	None
22156	22157	disease	0	None
22157	22158	now	0	None
22158	22159	estimated	0	None
22159	22160	to	0	None
22160	22161	be	0	None
22161	22162	243	0	None
22162	22163	,	0	None
22163	22164	000	0	None
22164	22165	.	0	None

22166	22167	Until	0	None
22167	22168	recently	0	None
22168	22169	,	0	None
22169	22170	treatment	0	None
22170	22171	alternatives	0	None
22171	22172	for	0	None
22172	22173	advanced	0	None
22173	22174	disease	0	None
22174	22175	included	0	None
22175	22176	chemotherapy	0	None
22176	22177	with	0	None
22177	22178	or	0	None
22178	22179	without	0	None
22179	22180	external	0	None
22180	22181	beam	0	None
22181	22182	radiation	0	None
22182	22183	.	0	None

22184	22185	Based	0	None
22185	22186	on	0	None
22186	22187	the	0	None
22187	22188	results	0	None
22188	22189	of	0	None
22189	22190	several	0	None
22190	22191	clinical	0	None
22191	22192	trials	0	None
22192	22193	,	0	None
22193	22194	the	0	None
22194	22195	chimeric	0	None
22195	22197	monoclonal antibody	2	GENE-N
22197	22198	Rituximab	0	None
22198	22199	has	0	None
22199	22200	now	0	None
22200	22201	been	0	None
22201	22202	approved	0	None
22202	22203	by	0	None
22203	22204	the	0	None
22204	22205	United	0	None
22205	22206	States	0	None
22206	22207	Food	0	None
22207	22208	and	0	None
22208	22209	Drug	0	None
22209	22210	Administration	0	None
22210	22211	as	0	None
22211	22212	a	0	None
22212	22213	treatment	0	None
22213	22214	for	0	None
22214	22215	patients	0	None
22215	22216	with	0	None
22216	22217	relapsed	0	None
22217	22218	or	0	None
22218	22219	refractory	0	None
22219	22220	,	0	None
22220	22221	low	0	None
22221	22222	-	0	None
22222	22223	grade	0	None
22223	22224	or	0	None
22224	22225	follicular	0	None
22225	22226	,	0	None
22226	22227	B	0	None
22227	22228	-	0	None
22228	22229	cell	0	None
22229	22230	NHL	0	None
22230	22231	.	0	None

22232	22233	Several	0	None
22233	22234	other	0	None
22234	22236	monoclonal antibodies	1	GENE-Y
22236	22237	in	0	None
22237	22238	conjugated	0	None
22238	22239	and	0	None
22239	22240	unconjugated	0	None
22240	22241	forms	0	None
22241	22242	have	0	None
22242	22243	been	0	None
22243	22244	evaluated	0	None
22244	22245	in	0	None
22245	22246	the	0	None
22246	22247	treatment	0	None
22247	22248	of	0	None
22248	22249	NHL	0	None
22249	22250	.	0	None

22251	22252	Ibritumomab	0	None
22252	22253	,	0	None
22253	22254	the	0	None
22254	22255	murine	0	None
22255	22256	counterpart	0	None
22256	22257	to	0	None
22257	22258	Rituximab	0	None
22258	22259	,	0	None
22259	22260	radiolabeled	0	None
22260	22261	with	0	None
22261	22262	90Y	3	CHEMICAL
22262	22263	(	0	None
22263	22264	Zevalin	0	None
22264	22265	)	0	None
22265	22266	,	0	None
22266	22267	is	0	None
22267	22268	presently	0	None
22268	22269	being	0	None
22269	22270	evaluated	0	None
22270	22271	in	0	None
22271	22272	clinical	0	None
22272	22273	trials	0	None
22273	22274	.	0	None

22275	22276	The	0	None
22276	22277	success	0	None
22277	22278	of	0	None
22278	22279	radioimmunotherapy	0	None
22279	22280	is	0	None
22280	22281	dependent	0	None
22281	22282	upon	0	None
22282	22283	the	0	None
22283	22284	appropriate	0	None
22284	22285	choice	0	None
22285	22286	of	0	None
22286	22287	antibody	0	None
22287	22288	,	0	None
22288	22289	isotope	0	None
22289	22290	,	0	None
22290	22291	and	0	None
22291	22292	chelator	0	None
22292	22293	-	0	None
22293	22294	linker	0	None
22294	22295	.	0	None

22296	22297	The	0	None
22297	22298	Ibritumomab	0	None
22298	22299	antibody	0	None
22299	22300	targets	0	None
22300	22301	the	0	None
22301	22302	CD20	0	None
22302	22303	antigen	0	None
22303	22304	.	0	None

22305	22306	The	0	None
22306	22307	antibody	0	None
22307	22308	is	0	None
22308	22309	covalently	0	None
22309	22310	bound	0	None
22310	22311	to	0	None
22311	22312	the	0	None
22312	22313	chelator	0	None
22313	22314	-	0	None
22314	22315	linker	0	None
22315	22316	tiuxetan	3	CHEMICAL
22316	22317	(	0	None
22317	22318	MX	0	None
22318	22319	-	0	None
22319	22320	DTPA	0	None
22320	22321	)	0	None
22321	22322	,	0	None
22322	22323	which	0	None
22323	22324	tightly	0	None
22324	22325	chelates	0	None
22325	22326	the	0	None
22326	22327	isotope	0	None
22327	22328	90Y	3	CHEMICAL
22328	22329	.	0	None

22330	22331	To	0	None
22331	22332	date	0	None
22332	22333	,	0	None
22333	22334	two	0	None
22334	22335	Phase	0	None
22335	22336	I	0	None
22336	22337	/	0	None
22337	22338	II	0	None
22338	22339	Zevalin	0	None
22339	22340	clinical	0	None
22340	22341	trials	0	None
22341	22342	have	0	None
22342	22343	been	0	None
22343	22344	completed	0	None
22344	22345	in	0	None
22345	22346	patients	0	None
22346	22347	with	0	None
22347	22348	low	0	None
22348	22349	-	0	None
22349	22350	grade	0	None
22350	22351	,	0	None
22351	22352	intermediate	0	None
22352	22353	-	0	None
22353	22354	grade	0	None
22354	22355	,	0	None
22355	22356	and	0	None
22356	22357	mantle	0	None
22357	22358	cell	0	None
22358	22359	NHL	0	None
22359	22360	.	0	None

22361	22362	The	0	None
22362	22363	overall	0	None
22363	22364	response	0	None
22364	22365	rate	0	None
22365	22366	was	0	None
22366	22367	64	0	None
22367	22368	%	0	None
22368	22369	in	0	None
22369	22370	the	0	None
22370	22371	first	0	None
22371	22372	trial	0	None
22372	22373	and	0	None
22373	22374	67	0	None
22374	22375	%	0	None
22375	22376	in	0	None
22376	22377	the	0	None
22377	22378	later	0	None
22378	22379	trial	0	None
22379	22380	.	0	None

22381	22382	Phase	0	None
22382	22383	II	0	None
22383	22384	and	0	None
22384	22385	III	0	None
22385	22386	trials	0	None
22386	22387	are	0	None
22387	22388	ongoing	0	None
22388	22389	.	0	None

22390	22391	Reduction	0	None
22391	22392	of	0	None
22392	22393	oral	0	None
22393	22394	ethanol	3	CHEMICAL
22394	22395	self	0	None
22395	22396	-	0	None
22396	22397	administration	0	None
22397	22398	in	0	None
22398	22399	rats	0	None
22399	22400	by	0	None
22400	22402	monoamine oxidase	2	GENE-N
22402	22403	inhibitors	0	None
22403	22404	.	0	None

22405	22406	Evidence	0	None
22406	22407	for	0	None
22407	22408	a	0	None
22408	22409	role	0	None
22409	22410	of	0	None
22410	22411	dopamine	3	CHEMICAL
22411	22412	and	0	None
22412	22413	serotonin	3	CHEMICAL
22413	22414	in	0	None
22414	22415	the	0	None
22415	22416	control	0	None
22416	22417	of	0	None
22417	22418	ethanol	3	CHEMICAL
22418	22419	intake	0	None
22419	22420	in	0	None
22420	22421	animals	0	None
22421	22422	suggests	0	None
22422	22423	that	0	None
22423	22425	monoamine oxidase	2	GENE-N
22425	22426	(	0	None
22426	22427	MAO	2	GENE-N
22427	22428	)	0	None
22428	22429	inhibitors	0	None
22429	22430	,	0	None
22430	22431	which	0	None
22431	22432	increase	0	None
22432	22433	the	0	None
22433	22434	synaptic	0	None
22434	22435	availability	0	None
22435	22436	of	0	None
22436	22437	serotonin	3	CHEMICAL
22437	22438	and	0	None
22438	22439	dopamine	3	CHEMICAL
22439	22440	by	0	None
22440	22441	blocking	0	None
22441	22442	their	0	None
22442	22443	metabolism	0	None
22443	22444	,	0	None
22444	22445	might	0	None
22445	22446	have	0	None
22446	22447	efficacy	0	None
22447	22448	in	0	None
22448	22449	the	0	None
22449	22450	treatment	0	None
22450	22451	of	0	None
22451	22452	alcohol	3	CHEMICAL
22452	22453	dependence	0	None
22453	22454	.	0	None

22455	22456	The	0	None
22456	22457	aim	0	None
22457	22458	of	0	None
22458	22459	the	0	None
22459	22460	present	0	None
22460	22461	study	0	None
22461	22462	was	0	None
22462	22463	,	0	None
22463	22464	therefore	0	None
22464	22465	,	0	None
22465	22466	to	0	None
22466	22467	evaluate	0	None
22467	22468	several	0	None
22468	22469	MAO	2	GENE-N
22469	22470	inhibitors	0	None
22470	22471	for	0	None
22471	22472	their	0	None
22472	22473	capacity	0	None
22473	22474	to	0	None
22474	22475	affect	0	None
22475	22476	ethanol	3	CHEMICAL
22476	22477	self	0	None
22477	22478	-	0	None
22478	22479	administration	0	None
22479	22480	in	0	None
22480	22481	rats	0	None
22481	22482	trained	0	None
22482	22483	to	0	None
22483	22484	self	0	None
22484	22485	-	0	None
22485	22486	administer	0	None
22486	22487	ethanol	3	CHEMICAL
22487	22488	(	0	None
22488	22489	10	0	None
22489	22490	%	0	None
22490	22491	v	0	None
22491	22492	/	0	None
22492	22493	v	0	None
22493	22494	)	0	None
22494	22495	orally	0	None
22495	22496	in	0	None
22496	22497	a	0	None
22497	22498	free	0	None
22498	22499	-	0	None
22499	22500	choice	0	None
22500	22501	two	0	None
22501	22502	-	0	None
22502	22503	lever	0	None
22503	22504	operant	0	None
22504	22505	task	0	None
22505	22506	.	0	None

22507	22508	The	0	None
22508	22509	nonselective	0	None
22509	22510	and	0	None
22510	22511	irreversible	0	None
22511	22512	MAO	2	GENE-N
22512	22513	inhibitors	0	None
22513	22514	,	0	None
22514	22515	phenelzine	3	CHEMICAL
22515	22516	(	0	None
22516	22517	3	0	None
22517	22518	-	0	None
22518	22519	10	0	None
22519	22520	mg	0	None
22520	22521	/	0	None
22521	22522	kg	0	None
22522	22523	)	0	None
22523	22524	,	0	None
22524	22525	tranylcypromine	3	CHEMICAL
22525	22526	(	0	None
22526	22527	1	0	None
22527	22528	-	0	None
22528	22529	3	0	None
22529	22530	mg	0	None
22530	22531	/	0	None
22531	22532	kg	0	None
22532	22533	)	0	None
22533	22534	,	0	None
22534	22535	and	0	None
22535	22536	nialamide	3	CHEMICAL
22536	22537	(	0	None
22537	22538	30	0	None
22538	22539	mg	0	None
22539	22540	/	0	None
22540	22541	kg	0	None
22541	22542	)	0	None
22542	22543	,	0	None
22543	22544	decreased	0	None
22544	22545	rates	0	None
22545	22546	of	0	None
22546	22547	responding	0	None
22547	22548	maintained	0	None
22548	22549	by	0	None
22549	22550	ethanol	3	CHEMICAL
22550	22551	reinforcement	0	None
22551	22552	.	0	None

22553	22554	The	0	None
22554	22555	reversible	0	None
22555	22556	MAO	2	GENE-N
22556	22557	-	0	None
22557	22558	A	0	None
22558	22559	inhibitor	0	None
22559	22560	,	0	None
22560	22561	befloxatone	0	None
22561	22562	(	0	None
22562	22563	0	0	None
22563	22564	.	0	None
22564	22565	3	0	None
22565	22566	-	0	None
22566	22567	3	0	None
22567	22568	mg	0	None
22568	22569	/	0	None
22569	22570	kg	0	None
22570	22571	)	0	None
22571	22572	,	0	None
22572	22573	and	0	None
22573	22574	the	0	None
22574	22575	irreversible	0	None
22575	22576	MAO	2	GENE-N
22576	22577	-	0	None
22577	22578	A	0	None
22578	22579	inhibitor	0	None
22579	22580	,	0	None
22580	22581	clorgyline	3	CHEMICAL
22581	22582	(	0	None
22582	22583	10	0	None
22583	22584	-	0	None
22584	22585	30	0	None
22585	22586	mg	0	None
22586	22587	/	0	None
22587	22588	kg	0	None
22588	22589	)	0	None
22589	22590	,	0	None
22590	22591	also	0	None
22591	22592	reduced	0	None
22592	22593	ethanol	3	CHEMICAL
22593	22594	self	0	None
22594	22595	-	0	None
22595	22596	administration	0	None
22596	22597	.	0	None

22598	22599	However	0	None
22599	22600	,	0	None
22600	22601	befloxatone	0	None
22601	22602	-	0	None
22602	22603	induced	0	None
22603	22604	effects	0	None
22604	22605	leveled	0	None
22605	22606	off	0	None
22606	22607	at	0	None
22607	22608	a	0	None
22608	22609	50	0	None
22609	22610	%	0	None
22610	22611	decrease	0	None
22611	22612	.	0	None

22613	22614	The	0	None
22614	22615	irreversible	0	None
22615	22616	MAO	2	GENE-N
22616	22617	-	0	None
22617	22618	B	0	None
22618	22619	inhibitors	0	None
22619	22620	,	0	None
22620	22621	pargyline	3	CHEMICAL
22621	22622	(	0	None
22622	22623	30	0	None
22623	22624	mg	0	None
22624	22625	/	0	None
22625	22626	kg	0	None
22626	22627	)	0	None
22627	22628	and	0	None
22628	22629	l	0	None
22629	22630	-	0	None
22630	22631	deprenyl	0	None
22631	22632	(	0	None
22632	22633	3	0	None
22633	22634	-	0	None
22634	22635	10	0	None
22635	22636	mg	0	None
22636	22637	/	0	None
22637	22638	kg	0	None
22638	22639	)	0	None
22639	22640	also	0	None
22640	22641	decreased	0	None
22641	22642	responding	0	None
22642	22643	maintained	0	None
22643	22644	by	0	None
22644	22645	ethanol	3	CHEMICAL
22645	22646	reinforcement	0	None
22646	22647	;	0	None
22647	22648	these	0	None
22648	22649	results	0	None
22649	22650	are	0	None
22650	22651	consistent	0	None
22651	22652	with	0	None
22652	22653	previous	0	None
22653	22654	findings	0	None
22654	22655	that	0	None
22655	22656	both	0	None
22656	22657	drugs	0	None
22657	22658	decreased	0	None
22658	22659	ethanol	3	CHEMICAL
22659	22660	intake	0	None
22660	22661	in	0	None
22661	22662	mice	0	None
22662	22663	.	0	None

22664	22665	In	0	None
22665	22666	conclusion	0	None
22666	22667	,	0	None
22667	22668	the	0	None
22668	22669	present	0	None
22669	22670	results	0	None
22670	22671	showing	0	None
22671	22672	that	0	None
22672	22673	several	0	None
22673	22674	MAO	2	GENE-N
22674	22675	inhibitors	0	None
22675	22676	decreased	0	None
22676	22677	ethanol	3	CHEMICAL
22677	22678	self	0	None
22678	22679	-	0	None
22679	22680	administration	0	None
22680	22681	in	0	None
22681	22682	rats	0	None
22682	22683	are	0	None
22683	22684	consistent	0	None
22684	22685	with	0	None
22685	22686	previous	0	None
22686	22687	findings	0	None
22687	22688	that	0	None
22688	22689	synaptic	0	None
22689	22690	levels	0	None
22690	22691	of	0	None
22691	22692	serotonin	3	CHEMICAL
22692	22693	and	0	None
22693	22694	dopamine	3	CHEMICAL
22694	22695	play	0	None
22695	22696	a	0	None
22696	22697	critical	0	None
22697	22698	role	0	None
22698	22699	in	0	None
22699	22700	the	0	None
22700	22701	control	0	None
22701	22702	of	0	None
22702	22703	ethanol	3	CHEMICAL
22703	22704	self	0	None
22704	22705	-	0	None
22705	22706	administration	0	None
22706	22707	.	0	None

22708	22709	Regulation	0	None
22709	22710	of	0	None
22710	22711	gene	0	None
22711	22712	expression	0	None
22712	22713	by	0	None
22713	22714	activation	0	None
22714	22715	of	0	None
22715	22716	the	0	None
22716	22717	peroxisome	0	None
22717	22718	proliferator	0	None
22718	22719	-	0	None
22719	22720	activated	0	None
22720	22721	receptor	0	None
22721	22722	gamma	0	None
22722	22723	with	0	None
22723	22724	rosiglitazone	3	CHEMICAL
22724	22725	(	0	None
22725	22727	BRL 49653	3	CHEMICAL
22727	22728	)	0	None
22728	22729	in	0	None
22729	22730	human	0	None
22730	22731	adipocytes	0	None
22731	22732	.	0	None

22733	22734	To	0	None
22734	22735	better	0	None
22735	22736	define	0	None
22736	22737	the	0	None
22737	22738	mechanism	0	None
22738	22739	of	0	None
22739	22740	action	0	None
22740	22741	of	0	None
22741	22742	the	0	None
22742	22743	thiazolidinediones	3	CHEMICAL
22743	22744	,	0	None
22744	22745	we	0	None
22745	22746	incubated	0	None
22746	22747	freshly	0	None
22747	22748	isolated	0	None
22748	22749	human	0	None
22749	22750	adipocytes	0	None
22750	22751	with	0	None
22751	22752	rosiglitazone	3	CHEMICAL
22752	22753	and	0	None
22753	22754	investigated	0	None
22754	22755	the	0	None
22755	22756	changes	0	None
22756	22757	in	0	None
22757	22758	mRNA	0	None
22758	22759	expression	0	None
22759	22760	of	0	None
22760	22761	genes	0	None
22761	22762	encoding	0	None
22762	22763	key	0	None
22763	22764	proteins	0	None
22764	22765	of	0	None
22765	22766	adipose	0	None
22766	22767	tissue	0	None
22767	22768	functions	0	None
22768	22769	.	0	None

22770	22771	Rosiglitazone	0	None
22771	22772	(	0	None
22772	22773	10	0	None
22773	22774	(	0	None
22774	22775	-	0	None
22775	22776	6	0	None
22776	22777	)	0	None
22777	22778	M	0	None
22778	22779	,	0	None
22779	22780	4	0	None
22780	22781	h	0	None
22781	22782	)	0	None
22782	22783	increased	0	None
22783	22784	p85alphaphosphatidylinositol	0	None
22784	22785	3	0	None
22785	22786	-	0	None
22786	22787	kinase	2	GENE-N
22787	22788	(	0	None
22788	22789	p85alphaPI	0	None
22789	22790	-	0	None
22790	22791	3K	0	None
22791	22792	)	0	None
22792	22793	and	0	None
22793	22794	uncoupling	0	None
22794	22795	protein	0	None
22795	22796	-	0	None
22796	22797	2	0	None
22797	22798	mRNA	0	None
22798	22799	levels	0	None
22799	22800	and	0	None
22800	22801	decreased	0	None
22801	22802	leptin	1	GENE-Y
22802	22803	expression	0	None
22803	22804	.	0	None

22805	22806	The	0	None
22806	22807	mRNA	0	None
22807	22808	levels	0	None
22808	22809	of	0	None
22809	22811	insulin receptor	2	GENE-N
22811	22812	,	0	None
22812	22813	IRS	2	GENE-N
22813	22814	-	0	None
22814	22815	1	0	None
22815	22816	,	0	None
22816	22817	Glut	0	None
22817	22818	4	0	None
22818	22819	,	0	None
22819	22821	lipoprotein lipase	2	GENE-N
22821	22822	,	0	None
22822	22823	hormone	0	None
22823	22824	-	0	None
22824	22825	sensitive	0	None
22825	22826	lipase	2	GENE-N
22826	22827	,	0	None
22827	22828	acylation	0	None
22828	22829	-	0	None
22829	22831	stimulating protein	2	GENE-N
22831	22832	,	0	None
22832	22834	fatty acid	3	CHEMICAL
22834	22835	transport	0	None
22835	22836	protein	0	None
22836	22837	-	0	None
22837	22838	1	0	None
22838	22839	,	0	None
22839	22840	angiotensinogen	0	None
22840	22841	,	0	None
22841	22844	plasminogen activator inhibitor	2	GENE-N
22844	22845	-	0	None
22845	22846	1	0	None
22846	22847	,	0	None
22847	22848	and	0	None
22848	22849	PPARgamma1	0	None
22849	22850	and	0	None
22850	22851	gamma2	0	None
22851	22852	were	0	None
22852	22853	not	0	None
22853	22854	modified	0	None
22854	22855	by	0	None
22855	22856	rosiglitazone	3	CHEMICAL
22856	22857	treatment	0	None
22857	22858	.	0	None

22859	22860	Activation	0	None
22860	22861	of	0	None
22861	22862	RXR	2	GENE-N
22862	22863	,	0	None
22863	22864	the	0	None
22864	22865	partner	0	None
22865	22866	of	0	None
22866	22867	PPARgamma	1	GENE-Y
22867	22868	,	0	None
22868	22869	in	0	None
22869	22870	the	0	None
22870	22871	presence	0	None
22871	22872	of	0	None
22872	22873	rosiglitazone	3	CHEMICAL
22873	22874	,	0	None
22874	22875	increased	0	None
22875	22876	further	0	None
22876	22877	p85alphaPI	0	None
22877	22878	-	0	None
22878	22879	3K	0	None
22879	22880	and	0	None
22880	22881	UCP2	0	None
22881	22882	mRNA	0	None
22882	22883	levels	0	None
22883	22884	and	0	None
22884	22885	produced	0	None
22885	22886	a	0	None
22886	22887	significant	0	None
22887	22888	augmentation	0	None
22888	22889	of	0	None
22889	22890	Glut	0	None
22890	22891	4	0	None
22891	22892	expression	0	None
22892	22893	.	0	None

22894	22895	Because	0	None
22895	22896	p85alphaPI	0	None
22896	22897	-	0	None
22897	22898	3K	0	None
22898	22899	is	0	None
22899	22900	a	0	None
22900	22901	major	0	None
22901	22902	component	0	None
22902	22903	of	0	None
22903	22904	insulin	0	None
22904	22905	action	0	None
22905	22906	,	0	None
22906	22907	the	0	None
22907	22908	induction	0	None
22908	22909	of	0	None
22909	22910	its	0	None
22910	22911	expression	0	None
22911	22912	might	0	None
22912	22913	explain	0	None
22913	22914	,	0	None
22914	22915	at	0	None
22915	22916	least	0	None
22916	22917	in	0	None
22917	22918	part	0	None
22918	22919	,	0	None
22919	22920	the	0	None
22920	22921	insulin	0	None
22921	22922	-	0	None
22922	22923	sensitizing	0	None
22923	22924	effect	0	None
22924	22925	of	0	None
22925	22926	the	0	None
22926	22927	thiazolidinediones	3	CHEMICAL
22927	22928	.	0	None

22929	22930	Effect	0	None
22930	22931	of	0	None
22931	22932	specific	0	None
22932	22933	COX	2	GENE-N
22933	22934	-	0	None
22934	22935	2	0	None
22935	22936	inhibition	0	None
22936	22937	in	0	None
22937	22938	osteoarthritis	0	None
22938	22939	of	0	None
22939	22940	the	0	None
22940	22941	knee	0	None
22941	22942	:	0	None
22942	22943	a	0	None
22943	22944	6	0	None
22944	22945	week	0	None
22945	22946	double	0	None
22946	22947	blind	0	None
22947	22948	,	0	None
22948	22949	placebo	0	None
22949	22950	controlled	0	None
22950	22951	pilot	0	None
22951	22952	study	0	None
22952	22953	of	0	None
22953	22954	rofecoxib	3	CHEMICAL
22954	22955	.	0	None

22956	22957	Rofecoxib	0	None
22957	22958	Osteoarthritis	0	None
22958	22959	Pilot	0	None
22959	22960	Study	0	None
22960	22961	Group	0	None
22961	22962	.	0	None

22963	22964	OBJECTIVE	0	None
22964	22965	:	0	None
22965	22966	To	0	None
22966	22967	determine	0	None
22967	22968	the	0	None
22968	22969	efficacy	0	None
22969	22970	and	0	None
22970	22971	safety	0	None
22971	22972	of	0	None
22972	22973	the	0	None
22973	22975	cyclooxygenase 2	1	GENE-Y
22975	22976	(	0	None
22976	22977	COX	2	GENE-N
22977	22978	-	0	None
22978	22979	2	0	None
22979	22980	)	0	None
22980	22981	specific	0	None
22981	22982	inhibitor	0	None
22982	22983	,	0	None
22983	22984	rofecoxib	3	CHEMICAL
22984	22985	in	0	None
22985	22986	patients	0	None
22986	22987	with	0	None
22987	22988	osteoarthritis	0	None
22988	22989	(	0	None
22989	22990	OA	3	CHEMICAL
22990	22991	)	0	None
22991	22992	of	0	None
22992	22993	the	0	None
22993	22994	knee	0	None
22994	22995	.	0	None

22996	22997	METHODS	0	None
22997	22998	:	0	None
22998	22999	Rofecoxib	0	None
22999	23000	,	0	None
23000	23001	25	0	None
23001	23002	mg	0	None
23002	23003	or	0	None
23003	23004	125	0	None
23004	23005	mg	0	None
23005	23006	once	0	None
23006	23007	daily	0	None
23007	23008	,	0	None
23008	23009	was	0	None
23009	23010	compared	0	None
23010	23011	with	0	None
23011	23012	placebo	0	None
23012	23013	in	0	None
23013	23014	a	0	None
23014	23015	6	0	None
23015	23016	week	0	None
23016	23017	,	0	None
23017	23018	double	0	None
23018	23019	blind	0	None
23019	23020	,	0	None
23020	23021	parallel	0	None
23021	23022	group	0	None
23022	23023	,	0	None
23023	23024	randomized	0	None
23024	23025	,	0	None
23025	23026	multicenter	0	None
23026	23027	study	0	None
23027	23028	of	0	None
23028	23029	219	0	None
23029	23030	patients	0	None
23030	23031	with	0	None
23031	23032	knee	0	None
23032	23033	OA	3	CHEMICAL
23033	23034	.	0	None

23035	23036	RESULTS	0	None
23036	23037	:	0	None
23037	23038	Both	0	None
23038	23039	doses	0	None
23039	23040	of	0	None
23040	23041	rofecoxib	3	CHEMICAL
23041	23042	produced	0	None
23042	23043	clinically	0	None
23043	23044	significant	0	None
23044	23045	improvement	0	None
23045	23046	as	0	None
23046	23047	assessed	0	None
23047	23048	by	0	None
23048	23049	primary	0	None
23049	23050	(	0	None
23050	23051	e	0	None
23051	23052	.	0	None
23052	23053	g	0	None
23053	23054	.	0	None
23054	23055	,	0	None
23055	23056	WOMAC	0	None
23056	23057	Pain	0	None
23057	23058	Subscale	0	None
23058	23059	0	0	None
23059	23060	-	0	None
23060	23061	100	0	None
23061	23062	mm	0	None
23062	23063	,	0	None
23063	23064	decrease	0	None
23064	23065	from	0	None
23065	23066	baseline	0	None
23066	23067	:	0	None
23067	23068	placebo	0	None
23068	23069	:	0	None
23069	23070	7	0	None
23070	23071	.	0	None
23071	23072	1	0	None
23072	23073	mm	0	None
23073	23074	;	0	None
23074	23075	rofecoxib	3	CHEMICAL
23075	23076	25	0	None
23076	23077	mg	0	None
23077	23078	:	0	None
23078	23079	28	0	None
23079	23080	.	0	None
23080	23081	1	0	None
23081	23082	mm	0	None
23082	23083	,	0	None
23083	23084	rofecoxib	3	CHEMICAL
23084	23085	125	0	None
23085	23086	mg	0	None
23086	23087	:	0	None
23087	23088	28	0	None
23088	23089	.	0	None
23089	23090	0	0	None
23090	23091	mm	0	None
23091	23092	;	0	None
23092	23093	p	0	None
23093	23094	<	0	None
23094	23095	0	0	None
23095	23096	.	0	None
23096	23097	001	0	None
23097	23098	rofecoxib	3	CHEMICAL
23098	23099	vs	0	None
23099	23100	placebo	0	None
23100	23101	)	0	None
23101	23102	and	0	None
23102	23103	secondary	2	GENE-N
23103	23104	efficacy	0	None
23104	23105	(	0	None
23105	23106	p	0	None
23106	23107	<	0	None
23107	23108	0	0	None
23108	23109	.	0	None
23109	23110	05	0	None
23110	23111	)	0	None
23111	23112	criteria	0	None
23112	23113	compared	0	None
23113	23114	with	0	None
23114	23115	placebo	0	None
23115	23116	.	0	None

23117	23118	Clinical	0	None
23118	23119	improvement	0	None
23119	23120	with	0	None
23120	23121	the	0	None
23121	23122	25	0	None
23122	23123	mg	0	None
23123	23124	dose	0	None
23124	23125	was	0	None
23125	23126	similar	0	None
23126	23127	to	0	None
23127	23128	that	0	None
23128	23129	with	0	None
23129	23130	the	0	None
23130	23131	125	0	None
23131	23132	mg	0	None
23132	23133	dose	0	None
23133	23134	.	0	None

23135	23136	Both	0	None
23136	23137	rofecoxib	3	CHEMICAL
23137	23138	doses	0	None
23138	23139	were	0	None
23139	23140	generally	0	None
23140	23141	well	0	None
23141	23142	tolerated	0	None
23142	23143	.	0	None

23144	23145	CONCLUSION	0	None
23145	23146	:	0	None
23146	23147	Specific	0	None
23147	23148	inhibition	0	None
23148	23149	of	0	None
23149	23150	COX	2	GENE-N
23150	23151	-	0	None
23151	23152	2	0	None
23152	23153	by	0	None
23153	23154	25	0	None
23154	23155	and	0	None
23155	23156	125	0	None
23156	23157	mg	0	None
23157	23158	rofecoxib	3	CHEMICAL
23158	23159	,	0	None
23159	23160	administered	0	None
23160	23161	once	0	None
23161	23162	daily	0	None
23162	23163	,	0	None
23163	23164	resulted	0	None
23164	23165	in	0	None
23165	23166	clinically	0	None
23166	23167	meaningful	0	None
23167	23168	improvements	0	None
23168	23169	in	0	None
23169	23170	patients	0	None
23170	23171	with	0	None
23171	23172	OA	3	CHEMICAL
23172	23173	.	0	None

23174	23175	This	0	None
23175	23176	study	0	None
23176	23177	confirms	0	None
23177	23178	that	0	None
23178	23179	COX	2	GENE-N
23179	23180	-	0	None
23180	23181	2	0	None
23181	23182	derived	0	None
23182	23183	prostanoids	3	CHEMICAL
23183	23184	are	0	None
23184	23185	important	0	None
23185	23186	clinical	0	None
23186	23187	mediators	0	None
23187	23188	of	0	None
23188	23189	pain	0	None
23189	23190	and	0	None
23190	23191	other	0	None
23191	23192	symptoms	0	None
23192	23193	of	0	None
23193	23194	knee	0	None
23194	23195	OA	3	CHEMICAL
23195	23196	and	0	None
23196	23197	that	0	None
23197	23198	inhibition	0	None
23198	23199	of	0	None
23199	23200	COX	2	GENE-N
23200	23201	-	0	None
23201	23202	1	0	None
23202	23203	is	0	None
23203	23204	not	0	None
23204	23205	required	0	None
23205	23206	to	0	None
23206	23207	provide	0	None
23207	23208	clinical	0	None
23208	23209	benefit	0	None
23209	23210	.	0	None

23211	23212	Decreased	0	None
23212	23213	intracellular	0	None
23213	23214	proteolysis	0	None
23214	23215	correlates	0	None
23215	23216	with	0	None
23216	23217	the	0	None
23217	23218	maintenance	0	None
23218	23219	of	0	None
23219	23220	a	0	None
23220	23221	specific	0	None
23221	23222	isoenzyme	0	None
23222	23223	of	0	None
23223	23225	cytochrome P	1	GENE-Y
23225	23226	-	0	None
23226	23227	450	0	None
23227	23228	.	0	None

23229	23230	The	0	None
23230	23231	rates	0	None
23231	23232	of	0	None
23232	23233	intracellular	0	None
23233	23234	protein	0	None
23234	23235	degradation	0	None
23235	23236	,	0	None
23236	23237	of	0	None
23237	23238	identically	0	None
23238	23239	labelled	0	None
23239	23240	populations	0	None
23240	23241	of	0	None
23241	23242	proteins	0	None
23242	23243	,	0	None
23243	23244	were	0	None
23244	23245	compared	0	None
23245	23246	in	0	None
23246	23247	hepatocytes	0	None
23247	23248	cultured	0	None
23248	23249	at	0	None
23249	23250	37	0	None
23250	23251	degrees	0	None
23251	23252	(	0	None
23252	23253	on	0	None
23253	23254	an	0	None
23254	23255	adsorbed	0	None
23255	23256	collagen	0	None
23256	23257	layer	0	None
23257	23258	)	0	None
23258	23259	and	0	None
23259	23260	in	0	None
23260	23261	cells	0	None
23261	23262	preserved	0	None
23262	23263	on	0	None
23263	23264	gelatin	0	None
23264	23265	gels	0	None
23265	23266	at	0	None
23266	23267	10	0	None
23267	23268	degrees	0	None
23268	23269	C	0	None
23269	23270	.	0	None

23271	23272	The	0	None
23272	23273	half	0	None
23273	23274	-	0	None
23274	23275	lives	0	None
23275	23276	of	0	None
23276	23277	the	0	None
23277	23278	long	0	None
23278	23279	-	0	None
23279	23280	lived	0	None
23280	23281	proteins	0	None
23281	23282	were	0	None
23282	23283	35	0	None
23283	23284	.	0	None
23284	23285	4	0	None
23285	23286	+	0	None
23286	23287	/	0	None
23287	23288	-	0	None
23288	23289	8	0	None
23289	23290	.	0	None
23290	23291	6	0	None
23291	23292	h	0	None
23292	23293	(	0	None
23293	23294	N	0	None
23294	23295	=	0	None
23295	23296	4	0	None
23296	23297	)	0	None
23297	23298	and	0	None
23298	23299	692	0	None
23299	23300	.	0	None
23300	23301	9	0	None
23301	23302	+	0	None
23302	23303	/	0	None
23303	23304	-	0	None
23304	23305	216	0	None
23305	23306	.	0	None
23306	23307	9	0	None
23307	23308	h	0	None
23308	23309	(	0	None
23309	23310	N	0	None
23310	23311	=	0	None
23311	23312	4	0	None
23312	23313	)	0	None
23313	23314	respectively	0	None
23314	23315	.	0	None

23316	23317	Proteolysis	0	None
23317	23318	was	0	None
23318	23319	substantially	0	None
23319	23320	decreased	0	None
23320	23321	at	0	None
23321	23322	10	0	None
23322	23323	degrees	0	None
23323	23324	C	0	None
23324	23325	but	0	None
23325	23326	the	0	None
23326	23327	rate	0	None
23327	23328	of	0	None
23328	23329	decrease	0	None
23329	23330	remained	0	None
23330	23331	constant	0	None
23331	23332	.	0	None

23333	23334	Hepatocytes	0	None
23334	23335	rapidly	0	None
23335	23336	removed	0	None
23336	23337	resorufin	0	None
23337	23338	from	0	None
23338	23339	the	0	None
23339	23340	culture	0	None
23340	23341	medium	0	None
23341	23342	.	0	None

23343	23344	The	0	None
23344	23345	resorufin	0	None
23345	23346	was	0	None
23346	23347	not	0	None
23347	23348	being	0	None
23348	23349	conjugated	0	None
23349	23350	or	0	None
23350	23351	accumulated	0	None
23351	23352	within	0	None
23352	23353	the	0	None
23353	23354	cells	0	None
23354	23355	.	0	None

23356	23357	Dicumarol	3	CHEMICAL
23357	23358	,	0	None
23358	23359	a	0	None
23359	23360	potent	0	None
23360	23361	inhibitor	0	None
23361	23362	of	0	None
23362	23364	quinone oxidoreductase	2	GENE-N
23364	23365	,	0	None
23365	23366	at	0	None
23366	23367	high	0	None
23367	23368	concentration	0	None
23368	23369	(	0	None
23369	23370	500	0	None
23370	23371	microm	0	None
23371	23372	)	0	None
23372	23373	caused	0	None
23373	23374	only	0	None
23374	23375	a	0	None
23375	23376	72	0	None
23376	23377	%	0	None
23377	23378	decrease	0	None
23378	23379	in	0	None
23379	23380	the	0	None
23380	23381	utilization	0	None
23381	23382	of	0	None
23382	23383	resorufin	0	None
23383	23384	.	0	None

23385	23386	The	0	None
23386	23388	microsomal detoxifying	2	GENE-N
23388	23389	enzyme	0	None
23389	23390	,	0	None
23390	23391	cytochrome	2	GENE-N
23391	23392	P	0	None
23392	23393	-	0	None
23393	23394	450	0	None
23394	23395	1A1	0	None
23395	23396	remained	0	None
23396	23397	at	0	None
23397	23398	a	0	None
23398	23399	constant	0	None
23399	23400	level	0	None
23400	23401	in	0	None
23401	23402	the	0	None
23402	23403	preserved	0	None
23403	23404	hepatocyte	0	None
23404	23405	monolayers	0	None
23405	23406	.	0	None

23407	23408	The	0	None
23408	23409	results	0	None
23409	23410	of	0	None
23410	23411	this	0	None
23411	23412	study	0	None
23412	23413	strongly	0	None
23413	23414	favour	0	None
23414	23415	storing	0	None
23415	23416	hepatocytes	0	None
23416	23417	at	0	None
23417	23418	10	0	None
23418	23419	degrees	0	None
23419	23420	C	0	None
23420	23421	rather	0	None
23421	23422	than	0	None
23422	23423	at	0	None
23423	23424	4	0	None
23424	23425	degrees	0	None
23425	23426	or	0	None
23426	23427	37	0	None
23427	23428	degrees	0	None
23428	23429	C	0	None
23429	23430	.	0	None

23431	23432	Comparison	0	None
23432	23433	of	0	None
23433	23434	rofecoxib	3	CHEMICAL
23434	23435	and	0	None
23435	23436	celecoxib	3	CHEMICAL
23436	23437	,	0	None
23437	23438	two	0	None
23438	23439	cyclooxygenase	2	GENE-N
23439	23440	-	0	None
23440	23441	2	0	None
23441	23442	inhibitors	0	None
23442	23443	,	0	None
23443	23444	in	0	None
23444	23445	postoperative	0	None
23445	23446	dental	0	None
23446	23447	pain	0	None
23447	23448	:	0	None
23448	23449	a	0	None
23449	23450	randomized	0	None
23450	23451	,	0	None
23451	23452	placebo	0	None
23452	23453	-	0	None
23453	23454	and	0	None
23454	23455	active	0	None
23455	23456	-	0	None
23456	23457	comparator	0	None
23457	23458	-	0	None
23458	23459	controlled	0	None
23459	23460	clinical	0	None
23460	23461	trial	0	None
23461	23462	.	0	None

23463	23464	Pain	0	None
23464	23465	is	0	None
23465	23466	a	0	None
23466	23467	common	0	None
23467	23468	complaint	0	None
23468	23469	,	0	None
23469	23470	often	0	None
23470	23471	occurring	0	None
23471	23472	in	0	None
23472	23473	conjunction	0	None
23473	23474	with	0	None
23474	23475	inflammation	0	None
23475	23476	.	0	None

23477	23478	Nonsteroidal	0	None
23478	23479	anti	0	None
23479	23480	-	0	None
23480	23481	inflammatory	0	None
23481	23482	drugs	0	None
23482	23483	(	0	None
23483	23484	NSAIDs	0	None
23484	23485	)	0	None
23485	23486	are	0	None
23486	23487	the	0	None
23487	23488	most	0	None
23488	23489	commonly	0	None
23489	23490	used	0	None
23490	23491	analgesic	0	None
23491	23492	agents	0	None
23492	23493	in	0	None
23493	23494	ambulatory	0	None
23494	23495	patients	0	None
23495	23496	.	0	None

23497	23498	In	0	None
23498	23499	recent	0	None
23499	23500	studies	0	None
23500	23501	,	0	None
23501	23502	the	0	None
23502	23503	cyclooxygenase	2	GENE-N
23503	23504	-	0	None
23504	23505	2	0	None
23505	23506	(	0	None
23506	23507	COX	2	GENE-N
23507	23508	-	0	None
23508	23509	2	0	None
23509	23510	)	0	None
23510	23511	inhibitor	0	None
23511	23512	rofecoxib	3	CHEMICAL
23512	23513	demonstrated	0	None
23513	23514	analgesic	0	None
23514	23515	effects	0	None
23515	23516	similar	0	None
23516	23517	to	0	None
23517	23518	those	0	None
23518	23519	of	0	None
23519	23520	NSAIDs	0	None
23520	23521	in	0	None
23521	23522	the	0	None
23522	23523	treatment	0	None
23523	23524	of	0	None
23524	23525	acute	0	None
23525	23526	pain	0	None
23526	23527	and	0	None
23527	23528	primary	0	None
23528	23529	dysmenorrhea	0	None
23529	23530	.	0	None

23531	23532	The	0	None
23532	23533	present	0	None
23533	23534	randomized	0	None
23534	23535	,	0	None
23535	23536	single	0	None
23536	23537	-	0	None
23537	23538	dose	0	None
23538	23539	,	0	None
23539	23540	double	0	None
23540	23541	-	0	None
23541	23542	blind	0	None
23542	23543	,	0	None
23543	23544	double	0	None
23544	23545	-	0	None
23545	23546	dummy	0	None
23546	23547	,	0	None
23547	23548	placebo	0	None
23548	23549	-	0	None
23549	23550	and	0	None
23550	23551	active	0	None
23551	23552	-	0	None
23552	23553	comparator	0	None
23553	23554	-	0	None
23554	23555	controlled	0	None
23555	23556	,	0	None
23556	23557	parallel	0	None
23557	23558	-	0	None
23558	23559	group	0	None
23559	23560	study	0	None
23560	23561	was	0	None
23561	23562	undertaken	0	None
23562	23563	to	0	None
23563	23564	compare	0	None
23564	23565	the	0	None
23565	23566	analgesic	0	None
23566	23567	efficacy	0	None
23567	23568	of	0	None
23568	23569	the	0	None
23569	23570	COX	2	GENE-N
23570	23571	-	0	None
23571	23572	2	0	None
23572	23573	inhibitors	0	None
23573	23574	rofecoxib	3	CHEMICAL
23574	23575	50	0	None
23575	23576	mg	0	None
23576	23577	and	0	None
23577	23578	celecoxib	3	CHEMICAL
23578	23579	200	0	None
23579	23580	mg	0	None
23580	23581	with	0	None
23581	23582	that	0	None
23582	23583	of	0	None
23583	23584	ibuprofen	3	CHEMICAL
23584	23585	400	0	None
23585	23586	mg	0	None
23586	23587	and	0	None
23587	23588	placebo	0	None
23588	23589	in	0	None
23589	23590	patients	0	None
23590	23591	with	0	None
23591	23592	postoperative	0	None
23592	23593	dental	0	None
23593	23594	pain	0	None
23594	23595	.	0	None

23596	23597	Two	0	None
23597	23598	hundred	0	None
23598	23599	and	0	None
23599	23600	seventy	0	None
23600	23601	-	0	None
23601	23602	two	0	None
23602	23603	patients	0	None
23603	23604	experiencing	0	None
23604	23605	pain	0	None
23605	23606	after	0	None
23606	23607	the	0	None
23607	23608	removal	0	None
23608	23609	of	0	None
23609	23610	>	0	None
23610	23611	or	0	None
23611	23612	=	0	None
23612	23613	2	0	None
23613	23614	third	0	None
23614	23615	molars	0	None
23615	23616	were	0	None
23616	23617	randomized	0	None
23617	23618	according	0	None
23618	23619	to	0	None
23619	23620	pain	0	None
23620	23621	severity	0	None
23621	23622	(	0	None
23622	23623	moderate	0	None
23623	23624	vs	0	None
23624	23625	severe	0	None
23625	23626	)	0	None
23626	23627	to	0	None
23627	23628	receive	0	None
23628	23629	a	0	None
23629	23630	single	0	None
23630	23631	dose	0	None
23631	23632	of	0	None
23632	23633	placebo	0	None
23633	23634	(	0	None
23634	23635	n	0	None
23635	23636	=	0	None
23636	23637	45	0	None
23637	23638	)	0	None
23638	23639	,	0	None
23639	23640	rofecoxib	3	CHEMICAL
23640	23641	50	0	None
23641	23642	mg	0	None
23642	23643	(	0	None
23643	23644	n	0	None
23644	23645	=	0	None
23645	23646	90	0	None
23646	23647	)	0	None
23647	23648	,	0	None
23648	23649	celecoxib	3	CHEMICAL
23649	23650	200	0	None
23650	23651	mg	0	None
23651	23652	(	0	None
23652	23653	n	0	None
23653	23654	=	0	None
23654	23655	91	0	None
23655	23656	)	0	None
23656	23657	,	0	None
23657	23658	or	0	None
23658	23659	ibuprofen	3	CHEMICAL
23659	23660	400	0	None
23660	23661	mg	0	None
23661	23662	(	0	None
23662	23663	n	0	None
23663	23664	=	0	None
23664	23665	46	0	None
23665	23666	)	0	None
23666	23667	.	0	None

23668	23669	Using	0	None
23669	23670	a	0	None
23670	23671	patient	0	None
23671	23672	diary	0	None
23672	23673	,	0	None
23673	23674	patients	0	None
23674	23675	recorded	0	None
23675	23676	pain	0	None
23676	23677	intensity	0	None
23677	23678	,	0	None
23678	23679	pain	0	None
23679	23680	relief	0	None
23680	23681	,	0	None
23681	23682	and	0	None
23682	23683	global	0	None
23683	23684	evaluations	0	None
23684	23685	throughout	0	None
23685	23686	the	0	None
23686	23687	24	0	None
23687	23688	-	0	None
23688	23689	hour	0	None
23689	23690	period	0	None
23690	23691	after	0	None
23691	23692	dosing	0	None
23692	23693	.	0	None

23694	23695	The	0	None
23695	23696	overall	0	None
23696	23697	analgesic	0	None
23697	23698	effect	0	None
23698	23699	,	0	None
23699	23700	onset	0	None
23700	23701	of	0	None
23701	23702	action	0	None
23702	23703	,	0	None
23703	23704	peak	0	None
23704	23705	effect	0	None
23705	23706	,	0	None
23706	23707	and	0	None
23707	23708	duration	0	None
23708	23709	of	0	None
23709	23710	effect	0	None
23710	23711	were	0	None
23711	23712	evaluated	0	None
23712	23713	,	0	None
23713	23714	with	0	None
23714	23715	the	0	None
23715	23716	primary	0	None
23716	23717	end	0	None
23717	23718	point	0	None
23718	23719	being	0	None
23719	23720	total	0	None
23720	23721	pain	0	None
23721	23722	relief	0	None
23722	23723	over	0	None
23723	23724	8	0	None
23724	23725	hours	0	None
23725	23726	(	0	None
23726	23727	TOPAR8	0	None
23727	23728	)	0	None
23728	23729	.	0	None

23730	23731	The	0	None
23731	23732	safety	0	None
23732	23733	profile	0	None
23733	23734	was	0	None
23734	23735	assessed	0	None
23735	23736	on	0	None
23736	23737	the	0	None
23737	23738	basis	0	None
23738	23739	of	0	None
23739	23740	physical	0	None
23740	23741	findings	0	None
23741	23742	,	0	None
23742	23743	laboratory	0	None
23743	23744	results	0	None
23744	23745	,	0	None
23745	23746	and	0	None
23746	23747	spontaneous	0	None
23747	23748	reports	0	None
23748	23749	of	0	None
23749	23750	adverse	0	None
23750	23751	experiences	0	None
23751	23752	.	0	None

23753	23754	The	0	None
23754	23755	results	0	None
23755	23756	showed	0	None
23756	23757	that	0	None
23757	23758	compared	0	None
23758	23759	with	0	None
23759	23760	celecoxib	3	CHEMICAL
23760	23761	,	0	None
23761	23762	rofecoxib	3	CHEMICAL
23762	23763	had	0	None
23763	23764	superior	0	None
23764	23765	analgesic	0	None
23765	23766	effects	0	None
23766	23767	on	0	None
23767	23768	all	0	None
23768	23769	measures	0	None
23769	23770	of	0	None
23770	23771	analgesic	0	None
23771	23772	efficacy	0	None
23772	23773	,	0	None
23773	23774	including	0	None
23774	23775	overall	0	None
23775	23776	analgesic	0	None
23776	23777	effect	0	None
23777	23778	(	0	None
23778	23779	TOPAR8	0	None
23779	23780	,	0	None
23780	23781	18	0	None
23781	23782	.	0	None
23782	23783	3	0	None
23783	23784	vs	0	None
23784	23785	.	0	None
23785	23786	12	0	None
23786	23787	.	0	None
23787	23788	5	0	None
23788	23789	;	0	None
23789	23790	P	0	None
23790	23791	<	0	None
23791	23792	0	0	None
23792	23793	.	0	None
23793	23794	001	0	None
23794	23795	)	0	None
23795	23796	,	0	None
23796	23797	time	0	None
23797	23798	to	0	None
23798	23799	onset	0	None
23799	23800	of	0	None
23800	23801	effect	0	None
23801	23802	(	0	None
23802	23803	30	0	None
23803	23804	vs	0	None
23804	23805	.	0	None
23805	23806	60	0	None
23806	23807	minutes	0	None
23807	23808	;	0	None
23808	23809	P	0	None
23809	23810	=	0	None
23810	23811	0	0	None
23811	23812	.	0	None
23812	23813	003	0	None
23813	23814	)	0	None
23814	23815	,	0	None
23815	23816	peak	0	None
23816	23817	pain	0	None
23817	23818	relief	0	None
23818	23819	(	0	None
23819	23820	score	0	None
23820	23821	,	0	None
23821	23822	2	0	None
23822	23823	.	0	None
23823	23824	8	0	None
23824	23825	vs	0	None
23825	23826	2	0	None
23826	23827	.	0	None
23827	23828	3	0	None
23828	23829	;	0	None
23829	23830	P	0	None
23830	23831	<	0	None
23831	23832	0	0	None
23832	23833	.	0	None
23833	23834	05	0	None
23834	23835	)	0	None
23835	23836	,	0	None
23836	23837	and	0	None
23837	23838	duration	0	None
23838	23839	of	0	None
23839	23840	effect	0	None
23840	23841	(	0	None
23841	23842	>	0	None
23842	23843	24	0	None
23843	23844	vs	0	None
23844	23845	.	0	None
23845	23846	5	0	None
23846	23847	.	0	None
23847	23848	1	0	None
23848	23849	hours	0	None
23849	23850	;	0	None
23850	23851	P	0	None
23851	23852	<	0	None
23852	23853	0	0	None
23853	23854	.	0	None
23854	23855	001	0	None
23855	23856	)	0	None
23856	23857	.	0	None

23858	23859	In	0	None
23859	23860	addition	0	None
23860	23861	,	0	None
23861	23862	rofecoxib	3	CHEMICAL
23862	23863	'	0	None
23863	23864	s	0	None
23864	23865	analgesic	0	None
23865	23866	efficacy	0	None
23866	23867	was	0	None
23867	23868	similar	0	None
23868	23869	to	0	None
23869	23870	that	0	None
23870	23871	of	0	None
23871	23872	ibuprofen	3	CHEMICAL
23872	23873	(	0	None
23873	23874	TOPAR8	0	None
23874	23875	,	0	None
23875	23876	18	0	None
23876	23877	.	0	None
23877	23878	3	0	None
23878	23879	vs	0	None
23879	23880	.	0	None
23880	23881	17	0	None
23881	23882	.	0	None
23882	23883	0	0	None
23883	23884	;	0	None
23884	23885	P	0	None
23885	23886	=	0	None
23886	23887	0	0	None
23887	23888	.	0	None
23888	23889	460	0	None
23889	23890	)	0	None
23890	23891	,	0	None
23891	23892	but	0	None
23892	23893	the	0	None
23893	23894	duration	0	None
23894	23895	was	0	None
23895	23896	longer	0	None
23896	23897	(	0	None
23897	23898	P	0	None
23898	23899	<	0	None
23899	23900	0	0	None
23900	23901	.	0	None
23901	23902	05	0	None
23902	23903	)	0	None
23903	23904	;	0	None
23904	23905	with	0	None
23905	23906	ibuprofen	3	CHEMICAL
23906	23907	,	0	None
23907	23908	the	0	None
23908	23909	time	0	None
23909	23910	to	0	None
23910	23911	on	0	None
23911	23912	set	0	None
23912	23913	was	0	None
23913	23914	24	0	None
23914	23915	minutes	0	None
23915	23916	,	0	None
23916	23917	peak	0	None
23917	23918	pain	0	None
23918	23919	relief	0	None
23919	23920	score	0	None
23920	23921	was	0	None
23921	23922	2	0	None
23922	23923	.	0	None
23923	23924	9	0	None
23924	23925	,	0	None
23925	23926	and	0	None
23926	23927	duration	0	None
23927	23928	of	0	None
23928	23929	analgesic	0	None
23929	23930	effect	0	None
23930	23931	was	0	None
23931	23932	8	0	None
23932	23933	.	0	None
23933	23934	9	0	None
23934	23935	hours	0	None
23935	23936	.	0	None

23937	23938	The	0	None
23938	23939	safety	0	None
23939	23940	profile	0	None
23940	23941	was	0	None
23941	23942	similar	0	None
23942	23943	across	0	None
23943	23944	all	0	None
23944	23945	treatment	0	None
23945	23946	groups	0	None
23946	23947	.	0	None

23948	23949	Thus	0	None
23949	23950	rofecoxib	3	CHEMICAL
23950	23951	provided	0	None
23951	23952	analgesic	0	None
23952	23953	efficacy	0	None
23953	23954	superior	0	None
23954	23955	to	0	None
23955	23956	that	0	None
23956	23957	of	0	None
23957	23958	celecoxib	3	CHEMICAL
23958	23959	and	0	None
23959	23960	comparable	0	None
23960	23961	to	0	None
23961	23962	that	0	None
23962	23963	of	0	None
23963	23964	ibuprofen	3	CHEMICAL
23964	23965	in	0	None
23965	23966	the	0	None
23966	23967	treatment	0	None
23967	23968	of	0	None
23968	23969	patients	0	None
23969	23970	with	0	None
23970	23971	acute	0	None
23971	23972	postoperative	0	None
23972	23973	dental	0	None
23973	23974	pain	0	None
23974	23975	.	0	None

23976	23977	Natriuretic	0	None
23977	23978	response	0	None
23978	23979	to	0	None
23979	23980	increased	0	None
23980	23981	pressure	0	None
23981	23982	is	0	None
23982	23983	preserved	0	None
23983	23984	with	0	None
23984	23985	COX	2	GENE-N
23985	23986	-	0	None
23986	23987	2	0	None
23987	23988	inhibitors	0	None
23988	23989	.	0	None

23990	23991	Elevation	0	None
23991	23992	of	0	None
23992	23993	renal	0	None
23993	23994	interstitial	0	None
23994	23995	hydrostatic	0	None
23995	23996	pressure	0	None
23996	23997	(	0	None
23997	23998	RIHP	0	None
23998	23999	)	0	None
23999	24000	by	0	None
24000	24001	direct	0	None
24001	24002	renal	0	None
24002	24003	interstitial	0	None
24003	24004	volume	0	None
24004	24005	expansion	0	None
24005	24006	increases	0	None
24006	24007	sodium	3	CHEMICAL
24007	24008	excretion	0	None
24008	24009	.	0	None

24010	24011	This	0	None
24011	24012	natriuretic	2	GENE-N
24012	24013	response	0	None
24013	24014	is	0	None
24014	24015	blunted	0	None
24015	24016	by	0	None
24016	24017	the	0	None
24017	24018	nonspecific	0	None
24018	24019	inhibition	0	None
24019	24020	of	0	None
24020	24021	the	0	None
24021	24022	cyclooxygenase	2	GENE-N
24022	24023	(	0	None
24023	24024	COX	2	GENE-N
24024	24025	)	0	None
24025	24026	enzymes	0	None
24026	24027	.	0	None

24028	24029	The	0	None
24029	24030	present	0	None
24030	24031	study	0	None
24031	24032	tested	0	None
24032	24033	the	0	None
24033	24034	hypothesis	0	None
24034	24035	that	0	None
24035	24036	the	0	None
24036	24037	natriuretic	2	GENE-N
24037	24038	response	0	None
24038	24039	to	0	None
24039	24040	increased	0	None
24040	24041	RIHP	0	None
24041	24042	during	0	None
24042	24043	direct	0	None
24043	24044	renal	0	None
24044	24045	interstitial	0	None
24045	24046	volume	0	None
24046	24047	expansion	0	None
24047	24048	is	0	None
24048	24049	dependent	0	None
24049	24050	on	0	None
24050	24051	COX	2	GENE-N
24051	24052	-	0	None
24052	24053	1	0	None
24053	24054	but	0	None
24054	24055	not	0	None
24055	24056	COX	2	GENE-N
24056	24057	-	0	None
24057	24058	2	0	None
24058	24059	.	0	None

24060	24061	RIHP	0	None
24061	24062	and	0	None
24062	24063	fractional	0	None
24063	24064	excretion	0	None
24064	24065	of	0	None
24065	24066	sodium	3	CHEMICAL
24066	24067	(	0	None
24067	24068	FE	3	CHEMICAL
24068	24069	(	0	None
24069	24070	Na	0	None
24070	24071	)	0	None
24071	24072	)	0	None
24072	24073	were	0	None
24073	24074	measured	0	None
24074	24075	before	0	None
24075	24076	and	0	None
24076	24077	after	0	None
24077	24078	direct	0	None
24078	24079	renal	0	None
24079	24080	interstitial	0	None
24080	24081	volume	0	None
24081	24082	expansion	0	None
24082	24083	in	0	None
24083	24084	control	0	None
24084	24085	rats	0	None
24085	24086	(	0	None
24086	24087	n	0	None
24087	24088	=	0	None
24088	24089	7	0	None
24089	24090	)	0	None
24090	24091	,	0	None
24091	24092	rats	0	None
24092	24093	infused	0	None
24093	24094	with	0	None
24094	24095	the	0	None
24095	24096	COX	2	GENE-N
24096	24097	-	0	None
24097	24098	1	0	None
24098	24099	inhibitor	0	None
24099	24100	piroxicam	3	CHEMICAL
24100	24101	(	0	None
24101	24102	n	0	None
24102	24103	=	0	None
24103	24104	6	0	None
24104	24105	,	0	None
24105	24106	1	0	None
24106	24107	.	0	None
24107	24108	5	0	None
24108	24109	mg	0	None
24109	24110	/	0	None
24110	24111	kg	0	None
24111	24112	)	0	None
24112	24113	,	0	None
24113	24114	and	0	None
24114	24115	rats	0	None
24115	24116	infused	0	None
24116	24117	with	0	None
24117	24118	the	0	None
24118	24119	COX	2	GENE-N
24119	24120	-	0	None
24120	24121	2	0	None
24121	24122	inhibitors	0	None
24122	24123	NS	0	None
24123	24124	-	0	None
24124	24125	398	0	None
24125	24126	(	0	None
24126	24127	n	0	None
24127	24128	=	0	None
24128	24129	5	0	None
24129	24130	,	0	None
24130	24131	1	0	None
24131	24132	.	0	None
24132	24133	5	0	None
24133	24134	mg	0	None
24134	24135	/	0	None
24135	24136	kg	0	None
24136	24137	)	0	None
24137	24138	and	0	None
24138	24139	meloxicam	3	CHEMICAL
24139	24140	(	0	None
24140	24141	n	0	None
24141	24142	=	0	None
24142	24143	6	0	None
24143	24144	,	0	None
24144	24145	0	0	None
24145	24146	.	0	None
24146	24147	3	0	None
24147	24148	mg	0	None
24148	24149	/	0	None
24149	24150	kg	0	None
24150	24151	)	0	None
24151	24152	.	0	None

24153	24154	In	0	None
24154	24155	control	0	None
24155	24156	animals	0	None
24156	24157	,	0	None
24157	24158	direct	0	None
24158	24159	renal	0	None
24159	24160	interstitial	0	None
24160	24161	volume	0	None
24161	24162	expansion	0	None
24162	24163	significantly	0	None
24163	24164	increased	0	None
24164	24165	RIHP	0	None
24165	24166	(	0	None
24166	24167	Delta2	1	GENE-Y
24167	24168	.	0	None
24168	24169	3	0	None
24169	24170	+	0	None
24170	24171	/	0	None
24171	24172	-	0	None
24172	24173	0	0	None
24173	24174	.	0	None
24174	24175	5	0	None
24175	24176	mm	0	None
24176	24177	Hg	3	CHEMICAL
24177	24178	,	0	None
24178	24179	P	0	None
24179	24180	<	0	None
24180	24181	0	0	None
24181	24182	.	0	None
24182	24183	05	0	None
24183	24184	)	0	None
24184	24185	and	0	None
24185	24186	FE	3	CHEMICAL
24186	24187	(	0	None
24187	24188	Na	0	None
24188	24189	)	0	None
24189	24190	(	0	None
24190	24191	Delta1	0	None
24191	24192	.	0	None
24192	24193	1	0	None
24193	24194	+	0	None
24194	24195	/	0	None
24195	24196	-	0	None
24196	24197	0	0	None
24197	24198	.	0	None
24198	24199	3	0	None
24199	24200	%	0	None
24200	24201	,	0	None
24201	24202	P	0	None
24202	24203	<	0	None
24203	24204	0	0	None
24204	24205	.	0	None
24205	24206	05	0	None
24206	24207	)	0	None
24207	24208	.	0	None

24209	24210	Likewise	0	None
24210	24211	,	0	None
24211	24212	in	0	None
24212	24213	animals	0	None
24213	24214	infused	0	None
24214	24215	with	0	None
24215	24216	NS	0	None
24216	24217	-	0	None
24217	24218	398	0	None
24218	24219	or	0	None
24219	24220	meloxicam	3	CHEMICAL
24220	24221	,	0	None
24221	24222	direct	0	None
24222	24223	renal	0	None
24223	24224	interstitial	0	None
24224	24225	volume	0	None
24225	24226	expansion	0	None
24226	24227	significantly	0	None
24227	24228	increased	0	None
24228	24229	RIHP	0	None
24229	24230	(	0	None
24230	24231	Delta1	0	None
24231	24232	.	0	None
24232	24233	8	0	None
24233	24234	+	0	None
24234	24235	/	0	None
24235	24236	-	0	None
24236	24237	0	0	None
24237	24238	.	0	None
24238	24239	6	0	None
24239	24240	mm	0	None
24240	24241	Hg	3	CHEMICAL
24241	24242	,	0	None
24242	24243	P	0	None
24243	24244	<	0	None
24244	24245	0	0	None
24245	24246	.	0	None
24246	24247	05	0	None
24247	24248	,	0	None
24248	24249	and	0	None
24249	24250	Delta1	0	None
24250	24251	.	0	None
24251	24252	7	0	None
24252	24253	+	0	None
24253	24254	/	0	None
24254	24255	-	0	None
24255	24256	0	0	None
24256	24257	.	0	None
24257	24258	3	0	None
24258	24259	mm	0	None
24259	24260	Hg	3	CHEMICAL
24260	24261	,	0	None
24261	24262	P	0	None
24262	24263	<	0	None
24263	24264	0	0	None
24264	24265	.	0	None
24265	24266	05	0	None
24266	24267	)	0	None
24267	24268	and	0	None
24268	24269	FE	3	CHEMICAL
24269	24270	(	0	None
24270	24271	Na	0	None
24271	24272	)	0	None
24272	24273	(	0	None
24273	24274	Delta1	0	None
24274	24275	.	0	None
24275	24276	5	0	None
24276	24277	+	0	None
24277	24278	/	0	None
24278	24279	-	0	None
24279	24280	0	0	None
24280	24281	.	0	None
24281	24282	4	0	None
24282	24283	%	0	None
24283	24284	,	0	None
24284	24285	P	0	None
24285	24286	<	0	None
24286	24287	0	0	None
24287	24288	.	0	None
24288	24289	05	0	None
24289	24290	,	0	None
24290	24291	and	0	None
24291	24292	Delta1	0	None
24292	24293	.	0	None
24293	24294	1	0	None
24294	24295	+	0	None
24295	24296	/	0	None
24296	24297	-	0	None
24297	24298	0	0	None
24298	24299	.	0	None
24299	24300	3	0	None
24300	24301	%	0	None
24301	24302	,	0	None
24302	24303	P	0	None
24303	24304	<	0	None
24304	24305	0	0	None
24305	24306	.	0	None
24306	24307	05	0	None
24307	24308	)	0	None
24308	24309	,	0	None
24309	24310	respectively	0	None
24310	24311	.	0	None

24312	24313	In	0	None
24313	24314	contrast	0	None
24314	24315	,	0	None
24315	24316	infusion	0	None
24316	24317	of	0	None
24317	24318	piroxicam	3	CHEMICAL
24318	24319	significantly	0	None
24319	24320	blunted	0	None
24320	24321	the	0	None
24321	24322	natriuretic	2	GENE-N
24322	24323	response	0	None
24323	24324	to	0	None
24324	24325	direct	0	None
24325	24326	renal	0	None
24326	24327	interstitial	0	None
24327	24328	volume	0	None
24328	24329	expansion	0	None
24329	24330	(	0	None
24330	24331	DeltaFE	0	None
24331	24332	(	0	None
24332	24333	Na	0	None
24333	24334	)	0	None
24334	24335	0	0	None
24335	24336	.	0	None
24336	24337	3	0	None
24337	24338	+	0	None
24338	24339	/	0	None
24339	24340	-	0	None
24340	24341	0	0	None
24341	24342	.	0	None
24342	24343	2	0	None
24343	24344	%	0	None
24344	24345	)	0	None
24345	24346	,	0	None
24346	24347	even	0	None
24347	24348	though	0	None
24348	24349	RIHP	0	None
24349	24350	was	0	None
24350	24351	increased	0	None
24351	24352	(	0	None
24352	24353	Delta1	0	None
24353	24354	.	0	None
24354	24355	9	0	None
24355	24356	+	0	None
24356	24357	/	0	None
24357	24358	-	0	None
24358	24359	0	0	None
24359	24360	.	0	None
24360	24361	6	0	None
24361	24362	mm	0	None
24362	24363	Hg	3	CHEMICAL
24363	24364	,	0	None
24364	24365	P	0	None
24365	24366	<	0	None
24366	24367	0	0	None
24367	24368	.	0	None
24368	24369	05	0	None
24369	24370	)	0	None
24370	24371	.	0	None

24372	24373	Infusion	0	None
24373	24374	of	0	None
24374	24375	piroxicam	3	CHEMICAL
24375	24376	but	0	None
24376	24377	not	0	None
24377	24378	NS	0	None
24378	24379	-	0	None
24379	24380	398	0	None
24380	24381	or	0	None
24381	24382	meloxicam	3	CHEMICAL
24382	24383	blunted	0	None
24383	24384	the	0	None
24384	24385	natriuretic	2	GENE-N
24385	24386	response	0	None
24386	24387	to	0	None
24387	24388	increased	0	None
24388	24389	renal	0	None
24389	24390	interstitial	0	None
24390	24391	hydrostatic	0	None
24391	24392	pressure	0	None
24392	24393	,	0	None
24393	24394	suggesting	0	None
24394	24395	that	0	None
24395	24396	the	0	None
24396	24398	natriuretic response	0	None
24398	24399	to	0	None
24399	24400	increased	0	None
24400	24401	blood	0	None
24401	24402	pressure	0	None
24402	24403	may	0	None
24403	24404	be	0	None
24404	24405	preserved	0	None
24405	24406	during	0	None
24406	24407	inhibition	0	None
24407	24408	of	0	None
24408	24409	COX	2	GENE-N
24409	24410	-	0	None
24410	24411	2	0	None
24411	24412	.	0	None

24413	24414	Functional	0	None
24414	24415	significance	0	None
24415	24416	of	0	None
24416	24417	globotriaosyl	0	None
24417	24418	ceramide	3	CHEMICAL
24418	24419	in	0	None
24419	24420	interferon	1	GENE-Y
24420	24421	-	0	None
24421	24422	alpha	0	None
24422	24423	(	0	None
24423	24424	2	0	None
24424	24425	)	0	None
24425	24426	/	0	None
24426	24427	type	0	None
24427	24428	1	0	None
24428	24430	interferon receptor	2	GENE-N
24430	24431	-	0	None
24431	24432	mediated	0	None
24432	24433	antiviral	0	None
24433	24434	activity	0	None
24434	24435	.	0	None

24436	24437	The	0	None
24437	24438	N	0	None
24438	24439	-	0	None
24439	24440	terminus	0	None
24440	24441	of	0	None
24441	24442	the	0	None
24442	24447	type 1 interferon receptor subunit	1	GENE-Y
24447	24448	,	0	None
24448	24449	IFNAR1	1	GENE-Y
24449	24450	,	0	None
24450	24451	has	0	None
24451	24452	high	0	None
24452	24454	amino acid	3	CHEMICAL
24454	24455	sequence	0	None
24455	24456	similarity	0	None
24456	24457	to	0	None
24457	24458	the	0	None
24458	24459	receptor	0	None
24459	24460	binding	0	None
24460	24461	B	0	None
24461	24462	subunit	0	None
24462	24463	of	0	None
24463	24464	the	0	None
24464	24465	Escherichia	0	None
24465	24466	coli	0	None
24466	24467	-	0	None
24467	24468	derived	0	None
24468	24469	verotoxin	0	None
24469	24470	1	0	None
24470	24471	,	0	None
24471	24472	VT1	0	None
24472	24473	.	0	None

24474	24475	The	0	None
24475	24476	glycolipid	0	None
24476	24477	,	0	None
24477	24478	globotriaosyl	0	None
24478	24479	ceramide	3	CHEMICAL
24479	24480	(	0	None
24480	24481	Gb	0	None
24481	24482	(	0	None
24482	24483	3	0	None
24483	24484	)	0	None
24484	24485	:	0	None
24485	24486	Gal	0	None
24486	24487	alpha	0	None
24487	24488	(	0	None
24488	24489	1	0	None
24489	24490	)	0	None
24490	24491	-	0	None
24491	24492	-	0	None
24492	24493	>	0	None
24493	24494	4	0	None
24494	24495	Gal	0	None
24495	24497	beta 1	1	GENE-Y
24497	24498	-	0	None
24498	24499	-	0	None
24499	24500	>	0	None
24500	24501	4	0	None
24501	24502	Glu	3	CHEMICAL
24502	24504	beta 1	0	None
24504	24505	-	0	None
24505	24506	-	0	None
24506	24507	>	0	None
24507	24508	1	0	None
24508	24509	Cer	0	None
24509	24510	)	0	None
24510	24511	is	0	None
24511	24512	the	0	None
24512	24513	specific	0	None
24513	24514	cell	0	None
24514	24515	receptor	0	None
24515	24516	for	0	None
24516	24517	VT1	0	None
24517	24518	.	0	None

24519	24520	Gb	0	None
24520	24521	(	0	None
24521	24522	3	0	None
24522	24523	)	0	None
24523	24524	-	0	None
24524	24525	deficient	0	None
24525	24526	variant	0	None
24526	24527	cells	0	None
24527	24528	selected	0	None
24528	24529	for	0	None
24529	24530	VT	0	None
24530	24531	resistance	0	None
24531	24532	are	0	None
24532	24533	cross	0	None
24533	24534	-	0	None
24534	24535	resistant	0	None
24535	24536	to	0	None
24536	24537	interferon	2	GENE-N
24537	24538	-	0	None
24538	24539	alpha	0	None
24539	24540	(	0	None
24540	24541	IFN	2	GENE-N
24541	24542	-	0	None
24542	24543	alpha	0	None
24543	24544	)	0	None
24544	24545	-	0	None
24545	24546	mediated	0	None
24546	24547	antiproliferative	0	None
24547	24548	activity	0	None
24548	24549	.	0	None

24550	24551	The	0	None
24551	24552	association	0	None
24552	24553	of	0	None
24553	24554	eIFNAR1	0	None
24554	24555	with	0	None
24555	24558	Gal alpha 1	1	GENE-Y
24558	24559	-	0	None
24559	24560	-	0	None
24560	24561	>	0	None
24561	24562	4	0	None
24562	24563	Gal	0	None
24563	24564	containing	0	None
24564	24565	glycolipids	0	None
24565	24566	has	0	None
24566	24567	been	0	None
24567	24568	previously	0	None
24568	24569	shown	0	None
24569	24570	to	0	None
24570	24571	be	0	None
24571	24572	important	0	None
24572	24573	for	0	None
24573	24574	the	0	None
24574	24575	receptor	0	None
24575	24576	-	0	None
24576	24577	mediated	0	None
24577	24578	IFN	2	GENE-N
24578	24579	-	0	None
24579	24580	alpha	0	None
24580	24581	signal	0	None
24581	24582	transduction	0	None
24582	24583	for	0	None
24583	24584	growth	0	None
24584	24585	inhibition	0	None
24585	24586	.	0	None

24587	24588	The	0	None
24588	24589	crucial	0	None
24589	24590	role	0	None
24590	24591	of	0	None
24591	24592	Gb	0	None
24592	24593	(	0	None
24593	24594	3	0	None
24594	24595	)	0	None
24595	24596	for	0	None
24596	24597	the	0	None
24597	24598	signal	0	None
24598	24599	transduction	0	None
24599	24600	of	0	None
24600	24601	IFN	2	GENE-N
24601	24602	-	0	None
24602	24603	alpha	0	None
24603	24604	-	0	None
24604	24605	mediated	0	None
24605	24606	antiviral	0	None
24606	24607	activity	0	None
24607	24608	is	0	None
24608	24609	now	0	None
24609	24610	reported	0	None
24610	24611	.	0	None

24612	24613	IFN	2	GENE-N
24613	24614	-	0	None
24614	24615	alpha	0	None
24615	24616	-	0	None
24616	24617	mediated	0	None
24617	24618	antiviral	0	None
24618	24619	activity	0	None
24619	24620	,	0	None
24620	24621	nuclear	0	None
24621	24622	translocation	0	None
24622	24623	of	0	None
24623	24624	activated	0	None
24624	24625	Stat1	0	None
24625	24626	,	0	None
24626	24627	and	0	None
24627	24628	increased	0	None
24628	24629	expression	0	None
24629	24630	of	0	None
24630	24631	PKR	0	None
24631	24632	were	0	None
24632	24633	defective	0	None
24633	24634	in	0	None
24634	24635	Gb	0	None
24635	24636	(	0	None
24636	24637	3	0	None
24637	24638	)	0	None
24638	24639	-	0	None
24639	24640	deficient	0	None
24640	24641	vero	0	None
24641	24642	mutant	0	None
24642	24643	cells	0	None
24643	24644	,	0	None
24644	24645	although	0	None
24645	24646	the	0	None
24646	24647	surface	0	None
24647	24648	expression	0	None
24648	24649	of	0	None
24649	24650	IFNAR1	1	GENE-Y
24650	24651	was	0	None
24651	24652	unaltered	0	None
24652	24653	.	0	None

24654	24655	The	0	None
24655	24656	VT1B	0	None
24656	24657	subunit	0	None
24657	24658	was	0	None
24658	24659	found	0	None
24659	24660	to	0	None
24660	24661	inhibit	0	None
24661	24662	IFN	2	GENE-N
24662	24663	-	0	None
24663	24664	alpha	0	None
24664	24665	-	0	None
24665	24666	mediated	0	None
24666	24667	antiviral	0	None
24667	24668	activity	0	None
24668	24669	,	0	None
24669	24670	Stat1	0	None
24670	24671	nuclear	0	None
24671	24672	translocation	0	None
24672	24673	and	0	None
24673	24674	PKR	0	None
24674	24675	upregulation	0	None
24675	24676	.	0	None

24677	24678	Unlike	0	None
24678	24679	VT1	0	None
24679	24680	cytotoxicity	0	None
24680	24681	,	0	None
24681	24682	IFN	2	GENE-N
24682	24683	-	0	None
24683	24684	alpha	0	None
24684	24685	-	0	None
24685	24686	induced	0	None
24686	24687	Stat1	0	None
24687	24688	nuclear	0	None
24688	24689	translocation	0	None
24689	24690	was	0	None
24690	24691	not	0	None
24691	24692	inhibited	0	None
24692	24693	when	0	None
24693	24694	RME	0	None
24694	24695	was	0	None
24695	24696	prevented	0	None
24696	24697	,	0	None
24697	24698	suggesting	0	None
24698	24699	that	0	None
24699	24700	the	0	None
24700	24701	accessory	0	None
24701	24702	function	0	None
24702	24703	of	0	None
24703	24704	Gb	0	None
24704	24705	(	0	None
24705	24706	3	0	None
24706	24707	)	0	None
24707	24708	occurs	0	None
24708	24709	at	0	None
24709	24710	the	0	None
24710	24711	plasma	0	None
24711	24712	membrane	0	None
24712	24713	.	0	None

24714	24715	IFN	2	GENE-N
24715	24716	-	0	None
24716	24717	alpha	0	None
24717	24718	antiviral	0	None
24718	24719	activity	0	None
24719	24720	was	0	None
24720	24721	also	0	None
24721	24722	studied	0	None
24722	24723	in	0	None
24723	24724	Gb	0	None
24724	24725	(	0	None
24725	24726	3	0	None
24726	24727	)	0	None
24727	24728	-	0	None
24728	24729	positive	0	None
24729	24730	MRC	0	None
24730	24731	-	0	None
24731	24732	5	0	None
24732	24733	cells	0	None
24733	24734	,	0	None
24734	24735	which	0	None
24735	24736	are	0	None
24736	24737	resistant	0	None
24737	24738	to	0	None
24738	24739	IFN	2	GENE-N
24739	24740	-	0	None
24740	24741	alpha	0	None
24741	24742	growth	0	None
24742	24743	inhibition	0	None
24743	24744	,	0	None
24744	24745	partially	0	None
24745	24746	resistant	0	None
24746	24747	to	0	None
24747	24748	VT1	0	None
24748	24749	but	0	None
24749	24750	still	0	None
24750	24751	remain	0	None
24751	24752	fully	0	None
24752	24753	sensitive	0	None
24753	24754	to	0	None
24754	24755	IFN	2	GENE-N
24755	24756	-	0	None
24756	24757	alpha	0	None
24757	24758	antiviral	0	None
24758	24759	activity	0	None
24759	24760	,	0	None
24760	24761	and	0	None
24761	24762	two	0	None
24762	24763	astrocytoma	0	None
24763	24764	cell	0	None
24764	24765	lines	0	None
24765	24766	expressing	0	None
24766	24767	different	0	None
24767	24768	Gb	0	None
24768	24769	(	0	None
24769	24770	3	0	None
24770	24771	)	0	None
24771	24773	fatty acid	3	CHEMICAL
24773	24774	isoforms	0	None
24774	24775	.	0	None

24776	24777	In	0	None
24777	24778	both	0	None
24778	24779	systems	0	None
24779	24780	,	0	None
24780	24781	long	0	None
24781	24784	chain fatty acid	3	CHEMICAL
24784	24785	-	0	None
24785	24786	containing	0	None
24786	24787	Gb	0	None
24787	24788	(	0	None
24788	24789	3	0	None
24789	24790	)	0	None
24790	24791	isoforms	0	None
24791	24792	,	0	None
24792	24793	which	0	None
24793	24794	are	0	None
24794	24795	less	0	None
24795	24796	effective	0	None
24796	24797	to	0	None
24797	24798	mediate	0	None
24798	24799	VT1	0	None
24799	24800	cytotoxicity	0	None
24800	24801	,	0	None
24801	24802	were	0	None
24802	24803	found	0	None
24803	24804	to	0	None
24804	24805	correlate	0	None
24805	24806	with	0	None
24806	24807	higher	0	None
24807	24808	IFN	2	GENE-N
24808	24809	-	0	None
24809	24810	alpha	0	None
24810	24811	-	0	None
24811	24812	mediated	0	None
24812	24813	antiviral	0	None
24813	24814	activity	0	None
24814	24815	.	0	None

24816	24817	Inhibition	0	None
24817	24818	of	0	None
24818	24819	Gb	0	None
24819	24820	(	0	None
24820	24821	3	0	None
24821	24822	)	0	None
24822	24823	synthesis	0	None
24823	24824	in	0	None
24824	24825	toto	0	None
24825	24826	prevented	0	None
24826	24827	IFN	2	GENE-N
24827	24828	-	0	None
24828	24829	alpha	0	None
24829	24830	antiviral	0	None
24830	24831	activity	0	None
24831	24832	in	0	None
24832	24833	all	0	None
24833	24834	cells	0	None
24834	24835	.	0	None

24836	24837	We	0	None
24837	24838	propose	0	None
24838	24839	that	0	None
24839	24840	the	0	None
24840	24841	long	0	None
24841	24842	chain	0	None
24842	24843	Gb	0	None
24843	24844	(	0	None
24844	24845	3	0	None
24845	24846	)	0	None
24846	24847	fatty	0	None
24847	24848	isoforms	0	None
24848	24849	preferentially	0	None
24849	24850	remain	0	None
24850	24851	in	0	None
24851	24852	the	0	None
24852	24853	plasma	0	None
24853	24854	membrane	0	None
24854	24855	,	0	None
24855	24856	and	0	None
24856	24857	by	0	None
24857	24858	associating	0	None
24858	24859	with	0	None
24859	24860	IFNAR1	1	GENE-Y
24860	24861	,	0	None
24861	24862	mediate	0	None
24862	24863	IFN	2	GENE-N
24863	24864	-	0	None
24864	24865	alpha	0	None
24865	24866	antiviral	0	None
24866	24867	signaling	0	None
24867	24868	,	0	None
24868	24869	whereas	0	None
24869	24870	short	0	None
24870	24871	chain	0	None
24871	24872	Gb	0	None
24872	24873	(	0	None
24873	24874	3	0	None
24874	24875	)	0	None
24875	24877	fatty acid	3	CHEMICAL
24877	24878	isoforms	0	None
24878	24879	are	0	None
24879	24880	preferentially	0	None
24880	24881	internalized	0	None
24881	24882	to	0	None
24882	24883	mediate	0	None
24883	24884	VT1	0	None
24884	24885	cytotoxicity	0	None
24885	24886	and	0	None
24886	24887	IFNAR1	1	GENE-Y
24887	24888	-	0	None
24888	24889	dependent	0	None
24889	24890	IFN	2	GENE-N
24890	24891	-	0	None
24891	24892	alpha	0	None
24892	24893	growth	0	None
24893	24894	inhibition	0	None
24894	24895	.	0	None

24896	24897	Overexpression	0	None
24897	24898	of	0	None
24898	24899	the	0	None
24899	24900	Na	0	None
24900	24901	(	0	None
24901	24902	+	0	None
24902	24903	)	0	None
24903	24904	/	0	None
24904	24905	K	0	None
24905	24906	(	0	None
24906	24907	+	0	None
24907	24908	)	0	None
24908	24909	/	0	None
24909	24910	Cl	0	None
24910	24911	(	0	None
24911	24912	-	0	None
24912	24913	)	0	None
24913	24914	cotransporter	0	None
24914	24915	gene	0	None
24915	24916	induces	0	None
24916	24917	cell	0	None
24917	24918	proliferation	0	None
24918	24919	and	0	None
24919	24920	phenotypic	0	None
24920	24921	transformation	0	None
24921	24922	in	0	None
24922	24923	mouse	0	None
24923	24924	fibroblasts	0	None
24924	24925	.	0	None

24926	24927	Na	0	None
24927	24928	(	0	None
24928	24929	+	0	None
24929	24930	)	0	None
24930	24931	/	0	None
24931	24932	K	0	None
24932	24933	(	0	None
24933	24934	+	0	None
24934	24935	)	0	None
24935	24936	/	0	None
24936	24937	Cl	0	None
24937	24938	(	0	None
24938	24939	-	0	None
24939	24940	)	0	None
24940	24941	cotransporter	0	None
24941	24942	activity	0	None
24942	24943	is	0	None
24943	24944	stimulated	0	None
24944	24945	in	0	None
24945	24946	early	0	None
24946	24947	G	0	None
24947	24948	(	0	None
24948	24949	1	0	None
24949	24950	)	0	None
24950	24951	phase	0	None
24951	24952	of	0	None
24952	24953	the	0	None
24953	24954	cell	0	None
24954	24955	cycle	0	None
24955	24956	and	0	None
24956	24957	this	0	None
24957	24958	stimulation	0	None
24958	24959	was	0	None
24959	24960	shown	0	None
24960	24961	to	0	None
24961	24962	be	0	None
24962	24963	an	0	None
24963	24964	essential	0	None
24964	24965	event	0	None
24965	24966	in	0	None
24966	24967	fibroblast	0	None
24967	24968	cell	0	None
24968	24969	proliferation	0	None
24969	24970	.	0	None

24971	24972	In	0	None
24972	24973	order	0	None
24973	24974	to	0	None
24974	24975	elucidate	0	None
24975	24976	further	0	None
24976	24977	the	0	None
24977	24978	role	0	None
24978	24979	of	0	None
24979	24980	the	0	None
24980	24981	Na	0	None
24981	24982	(	0	None
24982	24983	+	0	None
24983	24984	)	0	None
24984	24985	/	0	None
24985	24986	K	0	None
24986	24987	(	0	None
24987	24988	+	0	None
24988	24989	)	0	None
24989	24990	/	0	None
24990	24991	Cl	0	None
24991	24992	(	0	None
24992	24993	-	0	None
24993	24994	)	0	None
24994	24995	cotransporter	0	None
24995	24996	in	0	None
24996	24997	cell	0	None
24997	24998	proliferation	0	None
24998	24999	,	0	None
24999	25000	we	0	None
25000	25001	overexpressed	0	None
25001	25002	the	0	None
25002	25003	gene	0	None
25003	25004	encoding	0	None
25004	25005	the	0	None
25005	25006	Na	0	None
25006	25007	(	0	None
25007	25008	+	0	None
25008	25009	)	0	None
25009	25010	/	0	None
25010	25011	K	0	None
25011	25012	(	0	None
25012	25013	+	0	None
25013	25014	)	0	None
25014	25015	/	0	None
25015	25016	Cl	0	None
25016	25017	(	0	None
25017	25018	-	0	None
25018	25019	)	0	None
25019	25020	cotransporter	0	None
25020	25021	in	0	None
25021	25022	mouse	0	None
25022	25023	fibroblasts	0	None
25023	25024	,	0	None
25024	25025	and	0	None
25025	25026	analyzed	0	None
25026	25027	cellular	0	None
25027	25028	phenotypic	0	None
25028	25029	changes	0	None
25029	25030	.	0	None

25031	25032	Mouse	0	None
25032	25033	Balb	0	None
25033	25034	/	0	None
25034	25035	c	0	None
25035	25036	3T3	0	None
25036	25037	cells	0	None
25037	25038	were	0	None
25038	25039	stably	0	None
25039	25040	transfected	0	None
25040	25041	with	0	None
25041	25042	the	0	None
25042	25043	cDNA	0	None
25043	25044	of	0	None
25044	25045	the	0	None
25045	25046	shark	0	None
25046	25047	rectal	0	None
25047	25048	gland	0	None
25048	25049	Na	0	None
25049	25050	(	0	None
25050	25051	+	0	None
25051	25052	)	0	None
25052	25053	/	0	None
25053	25054	K	0	None
25054	25055	(	0	None
25055	25056	+	0	None
25056	25057	)	0	None
25057	25058	/	0	None
25058	25059	Cl	0	None
25059	25060	(	0	None
25060	25061	-	0	None
25061	25062	)	0	None
25062	25063	cotransporter	0	None
25063	25064	gene	0	None
25064	25065	(	0	None
25065	25066	NKCC1	1	GENE-Y
25066	25067	)	0	None
25067	25068	,	0	None
25068	25069	and	0	None
25069	25070	expressed	0	None
25070	25071	in	0	None
25071	25072	a	0	None
25072	25073	mammalian	0	None
25073	25074	vector	0	None
25074	25075	under	0	None
25075	25076	the	0	None
25076	25077	cytomegalovirus	0	None
25077	25078	promoter	2	GENE-N
25078	25079	(	0	None
25079	25080	Balb	0	None
25080	25081	/	0	None
25081	25082	c	0	None
25082	25083	-	0	None
25083	25084	NKCC1	1	GENE-Y
25084	25085	cells	0	None
25085	25086	)	0	None
25086	25087	.	0	None

25088	25089	The	0	None
25089	25090	transfected	0	None
25090	25091	cells	0	None
25091	25092	exhibited	0	None
25092	25093	up	0	None
25093	25094	to	0	None
25094	25095	10	0	None
25095	25096	-	0	None
25096	25097	fold	0	None
25097	25098	greater	0	None
25098	25099	bumetanide	3	CHEMICAL
25099	25100	-	0	None
25100	25101	sensitive	0	None
25101	25102	Rb	0	None
25102	25103	(	0	None
25103	25104	+	0	None
25104	25105	)	0	None
25105	25106	influx	0	None
25106	25107	compared	0	None
25107	25108	to	0	None
25108	25109	the	0	None
25109	25110	control	0	None
25110	25111	cells	0	None
25111	25112	.	0	None

25113	25114	The	0	None
25114	25115	Balb	0	None
25115	25116	/	0	None
25116	25117	c	0	None
25117	25118	-	0	None
25118	25119	NKCC1	1	GENE-Y
25119	25120	cells	0	None
25120	25121	have	0	None
25121	25122	acquired	0	None
25122	25123	a	0	None
25123	25124	typical	0	None
25124	25125	transformation	0	None
25125	25126	phenotype	0	None
25126	25127	indicated	0	None
25127	25128	by	0	None
25128	25129	:	0	None
25129	25130	(	0	None
25130	25131	1	0	None
25131	25132	)	0	None
25132	25133	Loss	0	None
25133	25134	of	0	None
25134	25135	contact	0	None
25135	25136	inhibition	0	None
25136	25137	exhibited	0	None
25137	25138	by	0	None
25138	25139	growth	0	None
25139	25140	to	0	None
25140	25141	a	0	None
25141	25142	higher	0	None
25142	25143	cell	0	None
25143	25144	density	0	None
25144	25145	in	0	None
25145	25146	confluent	0	None
25146	25147	cultures	0	None
25147	25148	,	0	None
25148	25149	and	0	None
25149	25150	formation	0	None
25150	25151	of	0	None
25151	25152	cell	0	None
25152	25153	foci	0	None
25153	25154	;	0	None
25154	25155	(	0	None
25155	25156	2	0	None
25156	25157	)	0	None
25157	25158	proliferation	0	None
25158	25159	in	0	None
25159	25160	low	0	None
25160	25161	serum	0	None
25161	25162	concentrations	0	None
25162	25163	;	0	None
25163	25164	and	0	None
25164	25165	(	0	None
25165	25166	3	0	None
25166	25167	)	0	None
25167	25168	formation	0	None
25168	25169	of	0	None
25169	25170	cell	0	None
25170	25171	colonies	0	None
25171	25172	in	0	None
25172	25173	soft	0	None
25173	25174	agar	0	None
25174	25175	.	0	None

25176	25177	The	0	None
25177	25178	control	0	None
25178	25179	cells	0	None
25179	25180	transfected	0	None
25180	25181	with	0	None
25181	25182	the	0	None
25182	25183	NKCC1	1	GENE-Y
25183	25184	gene	0	None
25184	25185	inserted	0	None
25185	25186	in	0	None
25186	25187	the	0	None
25187	25188	opposite	0	None
25188	25189	orientation	0	None
25189	25190	in	0	None
25190	25191	the	0	None
25191	25192	vector	0	None
25192	25193	retained	0	None
25193	25194	their	0	None
25194	25195	normal	0	None
25195	25196	phenotype	0	None
25196	25197	.	0	None

25198	25199	Furthermore	0	None
25199	25200	,	0	None
25200	25201	the	0	None
25201	25202	two	0	None
25202	25203	specific	0	None
25203	25204	inhibitors	0	None
25204	25205	of	0	None
25205	25206	the	0	None
25206	25207	Na	0	None
25207	25208	(	0	None
25208	25209	+	0	None
25209	25210	)	0	None
25210	25211	/	0	None
25211	25212	K	0	None
25212	25213	(	0	None
25213	25214	+	0	None
25214	25215	)	0	None
25215	25216	/	0	None
25216	25217	Cl	0	None
25217	25218	(	0	None
25218	25219	-	0	None
25219	25220	)	0	None
25220	25221	cotransporter	0	None
25221	25222	activity	0	None
25222	25223	;	0	None
25223	25224	bumetanide	3	CHEMICAL
25224	25225	and	0	None
25225	25226	furosemide	3	CHEMICAL
25226	25227	inhibited	0	None
25227	25228	the	0	None
25228	25229	clonogenic	0	None
25229	25230	efficiency	0	None
25230	25231	in	0	None
25231	25232	the	0	None
25232	25233	NKCC1	1	GENE-Y
25233	25234	transfected	0	None
25234	25235	cells	0	None
25235	25236	.	0	None

25237	25238	These	0	None
25238	25239	control	0	None
25239	25240	experiments	0	None
25240	25241	indicate	0	None
25241	25242	that	0	None
25242	25243	the	0	None
25243	25244	apparent	0	None
25244	25245	transformation	0	None
25245	25246	phenotype	0	None
25246	25247	acquired	0	None
25247	25248	by	0	None
25248	25249	the	0	None
25249	25250	Balb	0	None
25250	25251	/	0	None
25251	25252	c	0	None
25252	25253	-	0	None
25253	25254	NKCC1	1	GENE-Y
25254	25255	cells	0	None
25255	25256	was	0	None
25256	25257	not	0	None
25257	25258	merely	0	None
25258	25259	associated	0	None
25259	25260	with	0	None
25260	25261	the	0	None
25261	25262	process	0	None
25262	25263	of	0	None
25263	25264	transfection	0	None
25264	25265	and	0	None
25265	25266	selecting	0	None
25266	25267	for	0	None
25267	25268	the	0	None
25268	25269	neomycin	0	None
25269	25270	-	0	None
25270	25271	resistant	0	None
25271	25272	clones	0	None
25272	25273	,	0	None
25273	25274	but	0	None
25274	25275	rather	0	None
25275	25276	with	0	None
25276	25277	the	0	None
25277	25278	overexpression	0	None
25278	25279	of	0	None
25279	25280	the	0	None
25280	25281	Na	0	None
25281	25282	(	0	None
25282	25283	+	0	None
25283	25284	)	0	None
25284	25285	/	0	None
25285	25286	K	0	None
25286	25287	(	0	None
25287	25288	+	0	None
25288	25289	)	0	None
25289	25290	/	0	None
25290	25291	Cl	0	None
25291	25292	(	0	None
25292	25293	-	0	None
25293	25294	)	0	None
25294	25295	cotransporter	0	None
25295	25296	gene	0	None
25296	25297	.	0	None

25298	25299	In	0	None
25299	25300	order	0	None
25300	25301	to	0	None
25301	25302	ascertain	0	None
25302	25303	that	0	None
25303	25304	the	0	None
25304	25305	regulated	0	None
25305	25306	and	0	None
25306	25307	normal	0	None
25307	25308	expression	0	None
25308	25309	of	0	None
25309	25310	the	0	None
25310	25311	Na	0	None
25311	25312	(	0	None
25312	25313	+	0	None
25313	25314	)	0	None
25314	25315	/	0	None
25315	25316	K	0	None
25316	25317	(	0	None
25317	25318	+	0	None
25318	25319	)	0	None
25319	25320	/	0	None
25320	25321	Cl	0	None
25321	25322	(	0	None
25322	25323	-	0	None
25323	25324	)	0	None
25324	25325	cotransporter	0	None
25325	25326	control	0	None
25326	25327	cell	0	None
25327	25328	proliferation	0	None
25328	25329	,	0	None
25329	25330	the	0	None
25330	25331	effect	0	None
25331	25332	of	0	None
25332	25333	bumetanide	3	CHEMICAL
25333	25334	a	0	None
25334	25335	specific	0	None
25335	25336	inhibitor	0	None
25336	25337	of	0	None
25337	25338	the	0	None
25338	25339	cotransporter	0	None
25339	25340	,	0	None
25340	25341	was	0	None
25341	25342	tested	0	None
25342	25343	on	0	None
25343	25344	Balb	0	None
25344	25345	/	0	None
25345	25346	c	0	None
25346	25347	3T3	0	None
25347	25348	cell	0	None
25348	25349	proliferation	0	None
25349	25350	,	0	None
25350	25351	induced	0	None
25351	25352	by	0	None
25352	25353	fibroblasts	0	None
25353	25355	growth factor	0	None
25355	25356	(	0	None
25356	25357	FGF	2	GENE-N
25357	25358	)	0	None
25358	25359	and	0	None
25359	25360	fetal	0	None
25360	25361	calf	0	None
25361	25362	serum	0	None
25362	25363	(	0	None
25363	25364	FCS	0	None
25364	25365	)	0	None
25365	25366	.	0	None

25367	25368	Bumetanide	0	None
25368	25369	inhibited	0	None
25369	25370	synchronized	0	None
25370	25371	Balb	0	None
25371	25372	/	0	None
25372	25373	c	0	None
25373	25374	3T3	0	None
25374	25375	cell	0	None
25375	25376	exit	0	None
25376	25377	from	0	None
25377	25378	the	0	None
25378	25379	G	0	None
25379	25380	(	0	None
25380	25381	0	0	None
25381	25382	)	0	None
25382	25383	/	0	None
25383	25384	G	0	None
25384	25385	(	0	None
25385	25386	1	0	None
25386	25387	)	0	None
25387	25388	arrest	0	None
25388	25389	and	0	None
25389	25390	entering	0	None
25390	25391	S	0	None
25391	25392	-	0	None
25392	25393	phase	0	None
25393	25394	.	0	None

25395	25396	The	0	None
25396	25397	inhibition	0	None
25397	25398	was	0	None
25398	25399	reversible	0	None
25399	25400	,	0	None
25400	25401	as	0	None
25401	25402	removal	0	None
25402	25403	of	0	None
25403	25404	bumetanide	3	CHEMICAL
25404	25405	completely	0	None
25405	25406	released	0	None
25406	25407	cell	0	None
25407	25408	proliferation	0	None
25408	25409	.	0	None

25410	25411	Taken	0	None
25411	25412	together	0	None
25412	25413	,	0	None
25413	25414	these	0	None
25414	25415	results	0	None
25415	25416	propose	0	None
25416	25417	that	0	None
25417	25418	the	0	None
25418	25419	NKCC1	1	GENE-Y
25419	25420	gene	0	None
25420	25421	is	0	None
25421	25422	involved	0	None
25422	25423	in	0	None
25423	25424	the	0	None
25424	25425	control	0	None
25425	25426	of	0	None
25426	25427	normal	0	None
25427	25428	cell	0	None
25428	25429	proliferation	0	None
25429	25430	,	0	None
25430	25431	while	0	None
25431	25432	its	0	None
25432	25433	overexpression	0	None
25433	25434	results	0	None
25434	25435	in	0	None
25435	25436	apparent	0	None
25436	25437	cell	0	None
25437	25438	transformation	0	None
25438	25439	,	0	None
25439	25440	in	0	None
25440	25441	a	0	None
25441	25442	manner	0	None
25442	25443	similar	0	None
25443	25444	to	0	None
25444	25445	some	0	None
25445	25446	protooncogenes	0	None
25446	25447	.	0	None

25448	25449	Effects	0	None
25449	25450	of	0	None
25450	25451	chronic	0	None
25451	25452	antidepressant	0	None
25452	25453	treatments	0	None
25453	25454	on	0	None
25454	25456	serotonin transporter	1	GENE-Y
25456	25457	function	0	None
25457	25458	,	0	None
25458	25459	density	0	None
25459	25460	,	0	None
25460	25461	and	0	None
25461	25462	mRNA	0	None
25462	25463	level	0	None
25463	25464	.	0	None

25465	25466	To	0	None
25466	25467	investigate	0	None
25467	25468	functional	0	None
25468	25469	changes	0	None
25469	25470	in	0	None
25470	25471	the	0	None
25471	25472	brain	0	None
25472	25474	serotonin transporter	1	GENE-Y
25474	25475	(	0	None
25475	25476	SERT	1	GENE-Y
25476	25477	)	0	None
25477	25478	after	0	None
25478	25479	chronic	0	None
25479	25480	antidepressant	0	None
25480	25481	treatment	0	None
25481	25482	,	0	None
25482	25483	several	0	None
25483	25484	techniques	0	None
25484	25485	were	0	None
25485	25486	used	0	None
25486	25487	to	0	None
25487	25488	assess	0	None
25488	25489	SERT	1	GENE-Y
25489	25490	activity	0	None
25490	25491	,	0	None
25491	25492	density	0	None
25492	25493	,	0	None
25493	25494	or	0	None
25494	25495	its	0	None
25495	25496	mRNA	0	None
25496	25497	content	0	None
25497	25498	.	0	None

25499	25500	Rats	0	None
25500	25501	were	0	None
25501	25502	treated	0	None
25502	25503	by	0	None
25503	25504	osmotic	0	None
25504	25505	minipump	0	None
25505	25506	for	0	None
25506	25507	21	0	None
25507	25508	d	0	None
25508	25509	with	0	None
25509	25510	the	0	None
25510	25511	selective	0	None
25511	25512	serotonin	3	CHEMICAL
25512	25513	reuptake	0	None
25513	25514	inhibitors	0	None
25514	25515	(	0	None
25515	25516	SSRIs	0	None
25516	25517	)	0	None
25517	25518	paroxetine	3	CHEMICAL
25518	25519	or	0	None
25519	25520	sertraline	3	CHEMICAL
25520	25521	,	0	None
25521	25522	the	0	None
25522	25523	selective	0	None
25523	25524	norepinephrine	3	CHEMICAL
25524	25525	reuptake	0	None
25525	25526	inhibitor	0	None
25526	25527	desipramine	3	CHEMICAL
25527	25528	(	0	None
25528	25529	DMI	3	CHEMICAL
25529	25530	)	0	None
25530	25531	,	0	None
25531	25532	or	0	None
25532	25533	the	0	None
25533	25535	monoamine oxidase	2	GENE-N
25535	25536	inhibitor	0	None
25536	25537	phenelzine	3	CHEMICAL
25537	25538	.	0	None

25539	25540	High	0	None
25540	25541	-	0	None
25541	25542	speed	0	None
25542	25543	in	0	None
25543	25544	vivo	0	None
25544	25545	electrochemical	0	None
25545	25546	recordings	0	None
25546	25547	were	0	None
25547	25548	used	0	None
25548	25549	to	0	None
25549	25550	assess	0	None
25550	25551	the	0	None
25551	25552	ability	0	None
25552	25553	of	0	None
25553	25554	the	0	None
25554	25555	SSRI	0	None
25555	25556	fluvoxamine	0	None
25556	25557	to	0	None
25557	25558	modulate	0	None
25558	25559	the	0	None
25559	25560	clearance	0	None
25560	25561	of	0	None
25561	25562	locally	0	None
25562	25563	applied	0	None
25563	25564	serotonin	3	CHEMICAL
25564	25565	in	0	None
25565	25566	the	0	None
25566	25567	CA3	0	None
25567	25568	region	0	None
25568	25569	of	0	None
25569	25570	hippocampus	0	None
25570	25571	in	0	None
25571	25572	drug	0	None
25572	25573	-	0	None
25573	25574	or	0	None
25574	25575	vehicle	0	None
25575	25576	-	0	None
25576	25577	treated	0	None
25577	25578	rats	0	None
25578	25579	.	0	None

25580	25581	Fluvoxamine	0	None
25581	25582	decreased	0	None
25582	25583	the	0	None
25583	25584	clearance	0	None
25584	25585	of	0	None
25585	25586	serotonin	3	CHEMICAL
25586	25587	in	0	None
25587	25588	rats	0	None
25588	25589	treated	0	None
25589	25590	with	0	None
25590	25591	vehicle	0	None
25591	25592	,	0	None
25592	25593	DMI	3	CHEMICAL
25593	25594	,	0	None
25594	25595	or	0	None
25595	25596	phenelzine	3	CHEMICAL
25596	25597	but	0	None
25597	25598	had	0	None
25598	25599	no	0	None
25599	25600	effect	0	None
25600	25601	on	0	None
25601	25602	the	0	None
25602	25603	clearance	0	None
25603	25604	of	0	None
25604	25605	serotonin	3	CHEMICAL
25605	25606	in	0	None
25606	25607	SSRI	0	None
25607	25608	-	0	None
25608	25609	treated	0	None
25609	25610	rats	0	None
25610	25611	.	0	None

25612	25613	SERT	1	GENE-Y
25613	25614	density	0	None
25614	25615	in	0	None
25615	25616	the	0	None
25616	25617	CA3	0	None
25617	25618	region	0	None
25618	25619	of	0	None
25619	25620	the	0	None
25620	25621	hippocampus	0	None
25621	25622	of	0	None
25622	25623	the	0	None
25623	25624	same	0	None
25624	25625	rats	0	None
25625	25626	,	0	None
25626	25627	assessed	0	None
25627	25628	by	0	None
25628	25629	quantitative	0	None
25629	25630	autoradiography	0	None
25630	25631	with	0	None
25631	25632	tritiated	0	None
25632	25633	cyanoimipramine	3	CHEMICAL
25633	25634	(	0	None
25634	25635	[	0	None
25635	25636	(	0	None
25636	25637	3	0	None
25637	25638	)	0	None
25638	25639	H	0	None
25639	25640	]	0	None
25640	25641	CN	3	CHEMICAL
25641	25642	-	0	None
25642	25643	IMI	0	None
25643	25644	)	0	None
25644	25645	,	0	None
25645	25646	was	0	None
25646	25647	decreased	0	None
25647	25648	by	0	None
25648	25649	80	0	None
25649	25650	-	0	None
25650	25651	90	0	None
25651	25652	%	0	None
25652	25653	in	0	None
25653	25654	SSRI	0	None
25654	25655	-	0	None
25655	25656	treated	0	None
25656	25657	rats	0	None
25657	25658	but	0	None
25658	25659	not	0	None
25659	25660	in	0	None
25660	25661	those	0	None
25661	25662	treated	0	None
25662	25663	with	0	None
25663	25664	phenelzine	3	CHEMICAL
25664	25665	or	0	None
25665	25666	DMI	3	CHEMICAL
25666	25667	.	0	None

25668	25669	The	0	None
25669	25670	serotonin	3	CHEMICAL
25670	25671	content	0	None
25671	25672	of	0	None
25672	25673	the	0	None
25673	25674	hippocampus	0	None
25674	25675	was	0	None
25675	25676	unaffected	0	None
25676	25677	by	0	None
25677	25678	paroxetine	3	CHEMICAL
25678	25679	or	0	None
25679	25680	sertraline	3	CHEMICAL
25680	25681	treatment	0	None
25681	25682	,	0	None
25682	25683	ruling	0	None
25683	25684	out	0	None
25684	25685	neurotoxicity	0	None
25685	25686	as	0	None
25686	25687	a	0	None
25687	25688	possible	0	None
25688	25689	explanation	0	None
25689	25690	for	0	None
25690	25691	the	0	None
25691	25692	SSRI	0	None
25692	25693	-	0	None
25693	25694	induced	0	None
25694	25695	decrease	0	None
25695	25696	in	0	None
25696	25697	SERT	1	GENE-Y
25697	25698	binding	0	None
25698	25699	and	0	None
25699	25700	alteration	0	None
25700	25701	in	0	None
25701	25702	5	0	None
25702	25703	-	0	None
25703	25704	HT	3	CHEMICAL
25704	25705	clearance	0	None
25705	25706	.	0	None

25707	25708	Levels	0	None
25708	25709	of	0	None
25709	25710	mRNA	0	None
25710	25711	for	0	None
25711	25712	the	0	None
25712	25713	SERT	1	GENE-Y
25713	25714	in	0	None
25714	25715	the	0	None
25715	25716	raphe	0	None
25716	25717	nucleus	0	None
25717	25718	were	0	None
25718	25719	also	0	None
25719	25720	unaltered	0	None
25720	25721	by	0	None
25721	25722	chronic	0	None
25722	25723	paroxetine	3	CHEMICAL
25723	25724	treatment	0	None
25724	25725	.	0	None

25726	25727	Based	0	None
25727	25728	on	0	None
25728	25729	these	0	None
25729	25730	results	0	None
25730	25731	,	0	None
25731	25732	it	0	None
25732	25733	appears	0	None
25733	25734	that	0	None
25734	25735	the	0	None
25735	25736	SERT	1	GENE-Y
25736	25737	is	0	None
25737	25738	downregulated	0	None
25738	25739	by	0	None
25739	25740	chronic	0	None
25740	25741	administration	0	None
25741	25742	of	0	None
25742	25743	SSRIs	0	None
25743	25744	but	0	None
25744	25745	not	0	None
25745	25746	other	0	None
25746	25747	types	0	None
25747	25748	of	0	None
25748	25749	antidepressants	0	None
25749	25750	;	0	None
25750	25751	furthermore	0	None
25751	25752	,	0	None
25752	25753	the	0	None
25753	25754	downregulation	0	None
25754	25755	is	0	None
25755	25756	not	0	None
25756	25757	caused	0	None
25757	25758	by	0	None
25758	25759	decreases	0	None
25759	25760	in	0	None
25760	25761	SERT	1	GENE-Y
25761	25762	gene	0	None
25762	25763	expression	0	None
25763	25764	.	0	None

25765	25766	A	0	None
25766	25767	novel	0	None
25767	25768	mutation	0	None
25768	25769	of	0	None
25769	25770	the	0	None
25770	25771	erythroid	0	None
25771	25772	-	0	None
25772	25773	specific	0	None
25773	25774	gamma	0	None
25774	25775	-	0	None
25775	25776	Aminolevulinate	0	None
25776	25777	synthase	0	None
25777	25778	gene	0	None
25778	25779	in	0	None
25779	25780	a	0	None
25780	25781	patient	0	None
25781	25782	with	0	None
25782	25783	non	0	None
25783	25784	-	0	None
25784	25785	inherited	0	None
25785	25786	pyridoxine	0	None
25786	25787	-	0	None
25787	25788	responsive	0	None
25788	25789	sideroblastic	0	None
25789	25790	anemia	0	None
25790	25791	.	0	None

25792	25793	A	0	None
25793	25794	novel	0	None
25794	25795	missense	0	None
25795	25796	mutation	0	None
25796	25797	,	0	None
25797	25798	G663A	0	None
25798	25799	,	0	None
25799	25800	in	0	None
25800	25801	exon	0	None
25801	25802	5	0	None
25802	25803	of	0	None
25803	25804	the	0	None
25804	25805	erythroid	0	None
25805	25806	-	0	None
25806	25807	specific	0	None
25807	25808	delta	0	None
25808	25809	-	0	None
25809	25810	aminolevulinate	0	None
25810	25811	synthase	0	None
25811	25812	gene	0	None
25812	25813	(	0	None
25813	25814	ALAS2	0	None
25814	25815	)	0	None
25815	25816	was	0	None
25816	25817	identified	0	None
25817	25818	in	0	None
25818	25819	a	0	None
25819	25820	Japanese	0	None
25820	25821	male	0	None
25821	25822	with	0	None
25822	25823	pyridoxine	0	None
25823	25824	-	0	None
25824	25825	responsive	0	None
25825	25826	sideroblastic	0	None
25826	25827	anemia	0	None
25827	25828	.	0	None

25829	25830	Activity	0	None
25830	25831	of	0	None
25831	25832	the	0	None
25832	25833	mutant	0	None
25833	25834	delta	0	None
25834	25835	-	0	None
25835	25836	aminolevulinate	0	None
25836	25837	synthase	0	None
25837	25838	protein	0	None
25838	25839	expressed	0	None
25839	25840	in	0	None
25840	25841	vitro	0	None
25841	25842	was	0	None
25842	25843	15	0	None
25843	25844	.	0	None
25844	25845	1	0	None
25845	25846	%	0	None
25846	25847	compared	0	None
25847	25848	with	0	None
25848	25849	the	0	None
25849	25850	normal	0	None
25850	25851	control	0	None
25851	25852	,	0	None
25852	25853	but	0	None
25853	25854	was	0	None
25854	25855	increased	0	None
25855	25856	up	0	None
25856	25857	to	0	None
25857	25858	34	0	None
25858	25859	.	0	None
25859	25860	5	0	None
25860	25861	%	0	None
25861	25862	by	0	None
25862	25863	the	0	None
25863	25864	addition	0	None
25864	25865	of	0	None
25865	25866	pyridoxal	0	None
25866	25867	5	0	None
25867	25868	'	0	None
25868	25869	-	0	None
25869	25870	phosphate	3	CHEMICAL
25870	25871	,	0	None
25871	25872	consistent	0	None
25872	25873	with	0	None
25873	25874	the	0	None
25874	25875	clinical	0	None
25875	25876	response	0	None
25876	25877	of	0	None
25877	25878	the	0	None
25878	25879	patient	0	None
25879	25880	to	0	None
25880	25881	pyridoxine	0	None
25881	25882	treatment	0	None
25882	25883	.	0	None

25884	25885	The	0	None
25885	25886	same	0	None
25886	25887	mutation	0	None
25887	25888	was	0	None
25888	25889	also	0	None
25889	25890	detected	0	None
25890	25891	in	0	None
25891	25892	genomic	0	None
25892	25893	DNa	0	None
25893	25894	from	0	None
25894	25895	the	0	None
25895	25896	oral	0	None
25896	25897	mucosal	0	None
25897	25898	membrane	0	None
25898	25899	of	0	None
25899	25900	the	0	None
25900	25901	patiet	0	None
25901	25902	;	0	None
25902	25903	however	0	None
25903	25904	,	0	None
25904	25905	it	0	None
25905	25906	was	0	None
25906	25907	not	0	None
25907	25908	detected	0	None
25908	25909	in	0	None
25909	25910	other	0	None
25910	25911	family	0	None
25911	25912	member	0	None
25912	25913	.	0	None

25914	25915	These	0	None
25915	25916	findings	0	None
25916	25917	suggest	0	None
25917	25918	that	0	None
25918	25919	this	0	None
25919	25920	G663A	0	None
25920	25921	mutation	0	None
25921	25922	is	0	None
25922	25923	responsible	0	None
25923	25924	for	0	None
25924	25925	sideroblastic	0	None
25925	25926	anemia	0	None
25926	25927	in	0	None
25927	25928	the	0	None
25928	25929	proband	0	None
25929	25930	,	0	None
25930	25931	and	0	None
25931	25932	may	0	None
25932	25933	be	0	None
25933	25934	an	0	None
25934	25935	index	0	None
25935	25936	mutation	0	None
25936	25937	in	0	None
25937	25938	this	0	None
25938	25939	pedigree	0	None
25939	25940	.	0	None

25941	25942	Adverse	0	None
25942	25943	upper	0	None
25943	25944	gastrointestinal	0	None
25944	25945	effects	0	None
25945	25946	of	0	None
25946	25947	rofecoxib	3	CHEMICAL
25947	25948	compared	0	None
25948	25949	with	0	None
25949	25950	NSAIDs	0	None
25950	25951	.	0	None

25952	25953	CONTEXT	0	None
25953	25954	:	0	None
25954	25955	Nonsteroidal	0	None
25955	25956	anti	0	None
25956	25957	-	0	None
25957	25958	inflammatory	0	None
25958	25959	drug	0	None
25959	25960	(	0	None
25960	25961	NSAID	0	None
25961	25962	)	0	None
25962	25963	-	0	None
25963	25964	induced	0	None
25964	25965	gastrointestinal	0	None
25965	25966	(	0	None
25966	25967	GI	0	None
25967	25968	)	0	None
25968	25969	toxic	0	None
25969	25970	effects	0	None
25970	25971	,	0	None
25971	25972	such	0	None
25972	25973	as	0	None
25973	25974	upper	0	None
25974	25975	GI	0	None
25975	25976	tract	0	None
25976	25977	perforations	0	None
25977	25978	,	0	None
25978	25979	symptomatic	0	None
25979	25980	gastroduodenal	0	None
25980	25981	ulcers	0	None
25981	25982	,	0	None
25982	25983	and	0	None
25983	25984	upper	0	None
25984	25985	GI	0	None
25985	25986	tract	0	None
25986	25987	bleeding	0	None
25987	25988	(	0	None
25988	25989	PUBs	0	None
25989	25990	)	0	None
25990	25991	,	0	None
25991	25992	are	0	None
25992	25993	thought	0	None
25993	25994	to	0	None
25994	25995	be	0	None
25995	25996	attributable	0	None
25996	25997	to	0	None
25997	25999	cyclooxygenase 1	2	GENE-N
25999	26000	(	0	None
26000	26001	COX	2	GENE-N
26001	26002	-	0	None
26002	26003	1	0	None
26003	26004	)	0	None
26004	26005	inhibition	0	None
26005	26006	.	0	None

26007	26008	Rofecoxib	0	None
26008	26009	specifically	0	None
26009	26010	inhibits	0	None
26010	26011	COX	2	GENE-N
26011	26012	-	0	None
26012	26013	2	0	None
26013	26014	and	0	None
26014	26015	has	0	None
26015	26016	demonstrated	0	None
26016	26017	a	0	None
26017	26018	low	0	None
26018	26019	potential	0	None
26019	26020	for	0	None
26020	26021	causing	0	None
26021	26022	upper	0	None
26022	26023	GI	0	None
26023	26024	injury	0	None
26024	26025	.	0	None

26026	26027	OBJECTIVE	0	None
26027	26028	:	0	None
26028	26029	To	0	None
26029	26030	compare	0	None
26030	26031	the	0	None
26031	26032	incidence	0	None
26032	26033	of	0	None
26033	26034	PUBs	0	None
26034	26035	in	0	None
26035	26036	patients	0	None
26036	26037	with	0	None
26037	26038	osteoarthritis	0	None
26038	26039	treated	0	None
26039	26040	with	0	None
26040	26041	rofecoxib	3	CHEMICAL
26041	26042	vs	0	None
26042	26043	NSAIDs	0	None
26043	26044	.	0	None

26045	26046	DESIGN	0	None
26046	26047	:	0	None
26047	26048	Prespecified	0	None
26048	26049	analysis	0	None
26049	26050	of	0	None
26050	26051	all	0	None
26051	26052	8	0	None
26052	26053	double	0	None
26053	26054	-	0	None
26054	26055	blind	0	None
26055	26056	,	0	None
26056	26057	randomized	0	None
26057	26058	phase	0	None
26058	26059	2b	0	None
26059	26060	/	0	None
26060	26061	3	0	None
26061	26062	rofecoxib	3	CHEMICAL
26062	26063	osteoarthritis	0	None
26063	26064	trials	0	None
26064	26065	conducted	0	None
26065	26066	from	0	None
26066	26067	December	0	None
26067	26068	1996	0	None
26068	26069	through	0	None
26069	26070	March	0	None
26070	26071	1998	0	None
26071	26072	,	0	None
26072	26073	including	0	None
26073	26074	one	0	None
26074	26075	6	0	None
26075	26076	-	0	None
26076	26077	week	0	None
26077	26078	dose	0	None
26078	26079	-	0	None
26079	26080	ranging	0	None
26080	26081	study	0	None
26081	26082	,	0	None
26082	26083	two	0	None
26083	26084	6	0	None
26084	26085	-	0	None
26085	26086	week	0	None
26086	26087	efficacy	0	None
26087	26088	studies	0	None
26088	26089	vs	0	None
26089	26090	ibuprofen	3	CHEMICAL
26090	26091	and	0	None
26091	26092	placebo	0	None
26092	26093	,	0	None
26093	26094	two	0	None
26094	26095	1	0	None
26095	26096	-	0	None
26096	26097	year	0	None
26097	26098	efficacy	0	None
26098	26099	studies	0	None
26099	26100	vs	0	None
26100	26101	diclofenac	3	CHEMICAL
26101	26102	,	0	None
26102	26103	two	0	None
26103	26104	6	0	None
26104	26105	-	0	None
26105	26106	month	0	None
26106	26107	endoscopy	0	None
26107	26108	studies	0	None
26108	26109	vs	0	None
26109	26110	ibuprofen	3	CHEMICAL
26110	26111	and	0	None
26111	26112	placebo	0	None
26112	26113	,	0	None
26113	26114	and	0	None
26114	26115	one	0	None
26115	26116	6	0	None
26116	26117	-	0	None
26117	26118	week	0	None
26118	26119	efficacy	0	None
26119	26120	study	0	None
26120	26121	vs	0	None
26121	26122	nabumetone	3	CHEMICAL
26122	26123	and	0	None
26123	26124	placebo	0	None
26124	26125	.	0	None

26126	26127	SETTING	0	None
26127	26128	:	0	None
26128	26129	Multinational	0	None
26129	26130	sites	0	None
26130	26131	.	0	None

26132	26133	Participants	0	None
26133	26134	Osteoarthritis	0	None
26134	26135	patients	0	None
26135	26136	(	0	None
26136	26137	N	0	None
26137	26138	=	0	None
26138	26139	5435	0	None
26139	26140	;	0	None
26140	26141	mean	0	None
26141	26142	age	1	GENE-Y
26142	26143	,	0	None
26143	26144	63	0	None
26144	26145	years	0	None
26145	26146	[	0	None
26146	26147	range	0	None
26147	26148	,	0	None
26148	26149	38	0	None
26149	26150	-	0	None
26150	26151	94	0	None
26151	26152	years	0	None
26152	26153	]	0	None
26153	26154	;	0	None
26154	26155	72	0	None
26155	26156	.	0	None
26156	26157	9	0	None
26157	26158	%	0	None
26158	26159	women	0	None
26159	26160	)	0	None
26160	26161	.	0	None

26162	26163	INTERVENTIONS	0	None
26163	26164	:	0	None
26164	26165	Rofecoxib	0	None
26165	26166	,	0	None
26166	26167	12	0	None
26167	26168	.	0	None
26168	26169	5	0	None
26169	26170	,	0	None
26170	26171	25	0	None
26171	26172	,	0	None
26172	26173	or	0	None
26173	26174	50	0	None
26174	26175	mg	0	None
26175	26176	/	0	None
26176	26177	d	0	None
26177	26178	(	0	None
26178	26179	n	0	None
26179	26180	=	0	None
26180	26181	1209	0	None
26181	26182	,	0	None
26182	26183	1603	0	None
26183	26184	,	0	None
26184	26185	and	0	None
26185	26186	545	0	None
26186	26187	,	0	None
26187	26188	respectively	0	None
26188	26189	,	0	None
26189	26190	combined	0	None
26190	26191	)	0	None
26191	26192	vs	0	None
26192	26193	ibuprofen	3	CHEMICAL
26193	26194	,	0	None
26194	26195	800	0	None
26195	26196	mg	0	None
26196	26197	3	0	None
26197	26198	times	0	None
26198	26199	per	0	None
26199	26200	day	0	None
26200	26201	(	0	None
26201	26202	n	0	None
26202	26203	=	0	None
26203	26204	847	0	None
26204	26205	)	0	None
26205	26206	,	0	None
26206	26207	diclofenac	3	CHEMICAL
26207	26208	,	0	None
26208	26209	50	0	None
26209	26210	mg	0	None
26210	26211	3	0	None
26211	26212	times	0	None
26212	26213	per	0	None
26213	26214	day	0	None
26214	26215	(	0	None
26215	26216	n	0	None
26216	26217	=	0	None
26217	26218	590	0	None
26218	26219	)	0	None
26219	26220	;	0	None
26220	26221	or	0	None
26221	26222	nabumetone	3	CHEMICAL
26222	26223	,	0	None
26223	26224	1500	0	None
26224	26225	mg	0	None
26225	26226	/	0	None
26226	26227	d	0	None
26227	26228	(	0	None
26228	26229	n	0	None
26229	26230	=	0	None
26230	26231	127	0	None
26231	26232	)	0	None
26232	26233	(	0	None
26233	26234	combined	0	None
26234	26235	)	0	None
26235	26236	.	0	None

26237	26238	MAIN	0	None
26238	26239	OUTCOME	0	None
26239	26240	MEASURE	0	None
26240	26241	:	0	None
26241	26242	Cumulative	0	None
26242	26243	incidence	0	None
26243	26244	of	0	None
26244	26245	PUBs	0	None
26245	26246	for	0	None
26246	26247	rofecoxib	3	CHEMICAL
26247	26248	vs	0	None
26248	26249	NSAIDs	0	None
26249	26250	,	0	None
26250	26251	based	0	None
26251	26252	on	0	None
26252	26253	survival	0	None
26253	26254	analysis	0	None
26254	26255	of	0	None
26255	26256	time	0	None
26256	26257	to	0	None
26257	26258	first	0	None
26258	26259	PUB	0	None
26259	26260	diagnosis	0	None
26260	26261	,	0	None
26261	26262	using	0	None
26262	26263	PUBs	0	None
26263	26264	that	0	None
26264	26265	met	3	CHEMICAL
26265	26266	pre	0	None
26266	26267	-	0	None
26267	26268	specified	0	None
26268	26269	criteria	0	None
26269	26270	judged	0	None
26270	26271	by	0	None
26271	26272	a	0	None
26272	26273	blinded	0	None
26273	26274	,	0	None
26274	26275	external	0	None
26275	26276	adjudication	0	None
26276	26277	committee	0	None
26277	26278	.	0	None

26279	26280	RESULTS	0	None
26280	26281	:	0	None
26281	26282	The	0	None
26282	26283	incidence	0	None
26283	26284	of	0	None
26284	26285	PUBs	0	None
26285	26286	over	0	None
26286	26287	12	0	None
26287	26288	months	0	None
26288	26289	was	0	None
26289	26290	significantly	0	None
26290	26291	lower	0	None
26291	26292	with	0	None
26292	26293	rofecoxib	3	CHEMICAL
26293	26294	vs	0	None
26294	26295	NSAIDs	0	None
26295	26296	(	0	None
26296	26297	12	0	None
26297	26298	-	0	None
26298	26299	month	0	None
26299	26300	cumulative	0	None
26300	26301	incidence	0	None
26301	26302	,	0	None
26302	26303	1	0	None
26303	26304	.	0	None
26304	26305	3	0	None
26305	26306	%	0	None
26306	26307	vs	0	None
26307	26308	1	0	None
26308	26309	.	0	None
26309	26310	8	0	None
26310	26311	%	0	None
26311	26312	;	0	None
26312	26313	P	0	None
26313	26314	=	0	None
26314	26315	.	0	None
26315	26316	046	0	None
26316	26317	;	0	None
26317	26318	rate	0	None
26318	26319	per	0	None
26319	26320	100	0	None
26320	26321	patient	0	None
26321	26322	-	0	None
26322	26323	years	0	None
26323	26324	,	0	None
26324	26325	1	0	None
26325	26326	.	0	None
26326	26327	33	0	None
26327	26328	vs	0	None
26328	26329	2	0	None
26329	26330	.	0	None
26330	26331	60	0	None
26331	26332	;	0	None
26332	26333	relative	0	None
26333	26334	risk	0	None
26334	26335	,	0	None
26335	26336	0	0	None
26336	26337	.	0	None
26337	26338	51	0	None
26338	26339	;	0	None
26339	26340	95	0	None
26340	26341	%	0	None
26341	26342	confidence	0	None
26342	26343	interval	0	None
26343	26344	,	0	None
26344	26345	0	0	None
26345	26346	.	0	None
26346	26347	26	0	None
26347	26348	-	0	None
26348	26349	1	0	None
26349	26350	.	0	None
26350	26351	00	0	None
26351	26352	)	0	None
26352	26353	.	0	None

26354	26355	The	0	None
26355	26356	cumulative	0	None
26356	26357	incidence	0	None
26357	26358	of	0	None
26358	26359	dyspeptic	0	None
26359	26360	GI	0	None
26360	26361	adverse	0	None
26361	26362	experiences	0	None
26362	26363	was	0	None
26363	26364	also	0	None
26364	26365	lower	0	None
26365	26366	with	0	None
26366	26367	rofecoxib	3	CHEMICAL
26367	26368	vs	0	None
26368	26369	NSAIDS	0	None
26369	26370	over	0	None
26370	26371	6	0	None
26371	26372	months	0	None
26372	26373	(	0	None
26373	26374	23	0	None
26374	26375	.	0	None
26375	26376	5	0	None
26376	26377	%	0	None
26377	26378	vs	0	None
26378	26379	25	0	None
26379	26380	.	0	None
26380	26381	5	0	None
26381	26382	%	0	None
26382	26383	;	0	None
26383	26384	P	0	None
26384	26385	=	0	None
26385	26386	.	0	None
26386	26387	02	0	None
26387	26388	)	0	None
26388	26389	,	0	None
26389	26390	after	0	None
26390	26391	which	0	None
26391	26392	the	0	None
26392	26393	incidence	0	None
26393	26394	rates	0	None
26394	26395	converged	0	None
26395	26396	.	0	None

26397	26398	CONCLUSION	0	None
26398	26399	:	0	None
26399	26400	In	0	None
26400	26401	a	0	None
26401	26402	combined	0	None
26402	26403	analysis	0	None
26403	26404	of	0	None
26404	26405	8	0	None
26405	26406	trials	0	None
26406	26407	of	0	None
26407	26408	patients	0	None
26408	26409	with	0	None
26409	26410	osteoarthritis	0	None
26410	26411	,	0	None
26411	26412	treatment	0	None
26412	26413	with	0	None
26413	26414	rofecoxib	3	CHEMICAL
26414	26415	was	0	None
26415	26416	associated	0	None
26416	26417	with	0	None
26417	26418	a	0	None
26418	26419	significantly	0	None
26419	26420	lower	0	None
26420	26421	incidence	0	None
26421	26422	of	0	None
26422	26423	PUBs	0	None
26423	26424	than	0	None
26424	26425	treatment	0	None
26425	26426	with	0	None
26426	26427	NSAIDs	0	None
26427	26428	.	0	None

26429	26430	Preferential	0	None
26430	26431	cerebrospinal	0	None
26431	26432	fluid	0	None
26432	26433	acetylcholinesterase	1	GENE-Y
26433	26434	inhibition	0	None
26434	26435	by	0	None
26435	26436	rivastigmine	3	CHEMICAL
26436	26437	in	0	None
26437	26438	humans	0	None
26438	26439	.	0	None

26440	26441	This	0	None
26441	26442	study	0	None
26442	26443	sought	0	None
26443	26444	to	0	None
26444	26445	examine	0	None
26445	26446	the	0	None
26446	26447	feasibility	0	None
26447	26448	of	0	None
26448	26449	prolonged	0	None
26449	26450	assessment	0	None
26450	26451	of	0	None
26451	26452	acetylcholinesterase	1	GENE-Y
26452	26453	(	0	None
26453	26454	AChE	1	GENE-Y
26454	26455	)	0	None
26455	26456	activity	0	None
26456	26457	in	0	None
26457	26458	the	0	None
26458	26459	cerebrospinal	0	None
26459	26460	fluid	0	None
26460	26461	(	0	None
26461	26462	CSF	0	None
26462	26463	)	0	None
26463	26464	of	0	None
26464	26465	volunteers	0	None
26465	26466	and	0	None
26466	26467	to	0	None
26467	26468	test	3	CHEMICAL
26468	26469	the	0	None
26469	26470	hypothesis	0	None
26470	26471	that	0	None
26471	26472	rivastigmine	3	CHEMICAL
26472	26473	(	0	None
26473	26474	ENA	3	CHEMICAL
26474	26475	-	0	None
26475	26476	713	0	None
26476	26477	;	0	None
26477	26478	Exelon	0	None
26478	26479	,	0	None
26479	26480	Novartis	0	None
26480	26481	Pharma	0	None
26481	26482	AG	3	CHEMICAL
26482	26483	,	0	None
26483	26484	Basel	0	None
26484	26485	,	0	None
26485	26486	Switzerland	0	None
26486	26487	)	0	None
26487	26488	selectively	0	None
26488	26489	inhibits	0	None
26489	26490	AChE	1	GENE-Y
26490	26491	in	0	None
26491	26492	CSF	0	None
26492	26493	in	0	None
26493	26494	humans	0	None
26494	26495	at	0	None
26495	26496	a	0	None
26496	26497	dose	0	None
26497	26498	producing	0	None
26498	26499	minimal	0	None
26499	26500	inhibition	0	None
26500	26501	of	0	None
26501	26502	the	0	None
26502	26503	peripheral	0	None
26503	26504	enzyme	0	None
26504	26505	.	0	None

26506	26507	Lumbar	0	None
26507	26508	CSF	0	None
26508	26509	samples	0	None
26509	26510	were	0	None
26510	26511	collected	0	None
26511	26512	continuously	0	None
26512	26513	(	0	None
26513	26514	0	0	None
26514	26515	.	0	None
26515	26516	1	0	None
26516	26517	mL	0	None
26517	26518	x	0	None
26518	26519	min	0	None
26519	26520	(	0	None
26520	26521	-	0	None
26521	26522	1	0	None
26522	26523	)	0	None
26523	26524	)	0	None
26524	26525	for	0	None
26525	26526	49	0	None
26526	26527	hours	0	None
26527	26528	from	0	None
26528	26529	eight	0	None
26529	26530	healthy	0	None
26530	26531	volunteers	0	None
26531	26532	who	0	None
26532	26533	took	0	None
26533	26534	either	0	None
26534	26535	placebo	0	None
26535	26536	or	0	None
26536	26537	a	0	None
26537	26538	single	0	None
26538	26539	oral	0	None
26539	26540	dose	0	None
26540	26541	of	0	None
26541	26542	rivastigmine	3	CHEMICAL
26542	26543	(	0	None
26543	26544	3	0	None
26544	26545	mg	0	None
26545	26546	)	0	None
26546	26547	.	0	None

26548	26549	CSF	0	None
26549	26550	specimens	0	None
26550	26551	and	0	None
26551	26552	samples	0	None
26552	26553	of	0	None
26553	26554	blood	0	None
26554	26555	cells	0	None
26555	26556	and	0	None
26556	26557	blood	0	None
26557	26558	plasma	0	None
26558	26559	were	0	None
26559	26560	analyzed	0	None
26560	26561	at	0	None
26561	26562	intervals	0	None
26562	26563	for	0	None
26563	26564	rivastigmine	3	CHEMICAL
26564	26565	and	0	None
26565	26566	its	0	None
26566	26567	metabolite	0	None
26567	26568	NAP	3	CHEMICAL
26568	26569	226	0	None
26569	26570	-	0	None
26570	26571	90	0	None
26571	26572	(	0	None
26572	26573	[	0	None
26573	26574	-	0	None
26574	26575	]	0	None
26575	26576	[	0	None
26576	26577	3	0	None
26577	26578	-	0	None
26578	26579	(	0	None
26579	26580	[	0	None
26580	26581	1	0	None
26581	26582	-	0	None
26582	26583	dimethylaminolethyl	0	None
26583	26584	)	0	None
26584	26585	-	0	None
26585	26586	phenol	3	CHEMICAL
26586	26587	]	0	None
26587	26588	)	0	None
26588	26589	,	0	None
26589	26590	erythrocyte	0	None
26590	26591	AChE	1	GENE-Y
26591	26592	activity	0	None
26592	26593	,	0	None
26593	26594	CSF	0	None
26594	26595	AChE	1	GENE-Y
26595	26596	activity	0	None
26596	26597	,	0	None
26597	26598	and	0	None
26598	26599	plasma	0	None
26599	26600	and	0	None
26600	26601	CSF	0	None
26601	26602	butyrylcholinesterase	1	GENE-Y
26602	26603	(	0	None
26603	26604	BuChE	1	GENE-Y
26604	26605	)	0	None
26605	26606	activity	0	None
26606	26607	.	0	None

26608	26609	Safety	0	None
26609	26610	evaluations	0	None
26610	26611	were	0	None
26611	26612	performed	0	None
26612	26613	23	0	None
26613	26614	hours	0	None
26614	26615	after	0	None
26615	26616	drug	0	None
26616	26617	dosing	0	None
26617	26618	and	0	None
26618	26619	at	0	None
26619	26620	the	0	None
26620	26621	end	0	None
26621	26622	of	0	None
26622	26623	the	0	None
26623	26624	study	0	None
26624	26625	.	0	None

26626	26627	Evaluable	0	None
26627	26628	data	0	None
26628	26629	were	0	None
26629	26630	obtained	0	None
26630	26631	from	0	None
26631	26632	six	0	None
26632	26633	subjects	0	None
26633	26634	.	0	None

26635	26636	The	0	None
26636	26637	mean	0	None
26637	26638	time	0	None
26638	26639	to	0	None
26639	26640	maximal	0	None
26640	26641	rivastigmine	3	CHEMICAL
26641	26642	plasma	0	None
26642	26643	concentration	0	None
26643	26644	(	0	None
26644	26645	tmax	0	None
26645	26646	)	0	None
26646	26647	was	0	None
26647	26648	0	0	None
26648	26649	.	0	None
26649	26650	83	0	None
26650	26651	+	0	None
26651	26652	/	0	None
26652	26653	-	0	None
26653	26654	0	0	None
26654	26655	.	0	None
26655	26656	26	0	None
26656	26657	hours	0	None
26657	26658	,	0	None
26658	26659	the	0	None
26659	26660	mean	0	None
26660	26661	maximal	0	None
26661	26662	plasma	0	None
26662	26663	concentration	0	None
26663	26664	(	0	None
26664	26665	Cmax	0	None
26665	26666	)	0	None
26666	26667	was	0	None
26667	26668	4	0	None
26668	26669	.	0	None
26669	26670	88	0	None
26670	26671	+	0	None
26671	26672	/	0	None
26672	26673	-	0	None
26673	26674	3	0	None
26674	26675	.	0	None
26675	26676	82	0	None
26676	26677	ng	0	None
26677	26678	x	0	None
26678	26679	mL	0	None
26679	26680	(	0	None
26680	26681	-	0	None
26681	26682	1	0	None
26682	26683	)	0	None
26683	26684	,	0	None
26684	26685	the	0	None
26685	26686	mean	0	None
26686	26687	plasma	0	None
26687	26688	area	0	None
26688	26689	under	0	None
26689	26690	the	0	None
26690	26691	concentration	0	None
26691	26692	versus	0	None
26692	26693	time	0	None
26693	26694	curve	0	None
26694	26695	(	0	None
26695	26696	AUC0	0	None
26696	26697	-	0	None
26697	26698	infinity	0	None
26698	26699	)	0	None
26699	26700	was	0	None
26700	26701	7	0	None
26701	26702	.	0	None
26702	26703	43	0	None
26703	26704	+	0	None
26704	26705	/	0	None
26705	26706	-	0	None
26706	26707	4	0	None
26707	26708	.	0	None
26708	26709	74	0	None
26709	26710	ng	0	None
26710	26711	x	0	None
26711	26712	hr	2	GENE-N
26712	26713	x	0	None
26713	26714	mL	0	None
26714	26715	(	0	None
26715	26716	-	0	None
26716	26717	1	0	None
26717	26718	)	0	None
26718	26719	,	0	None
26719	26720	and	0	None
26720	26721	the	0	None
26721	26722	mean	0	None
26722	26723	plasma	0	None
26723	26724	t1	0	None
26724	26725	/	0	None
26725	26726	2	0	None
26726	26727	was	0	None
26727	26728	0	0	None
26728	26729	.	0	None
26729	26730	85	0	None
26730	26731	+	0	None
26731	26732	/	0	None
26732	26733	-	0	None
26733	26734	0	0	None
26734	26735	.	0	None
26735	26736	115	0	None
26736	26737	hours	0	None
26737	26738	.	0	None

26739	26740	The	0	None
26740	26741	concentration	0	None
26741	26742	of	0	None
26742	26743	rivastigmine	3	CHEMICAL
26743	26744	in	0	None
26744	26745	CSF	0	None
26745	26746	was	0	None
26746	26747	lower	0	None
26747	26748	than	0	None
26748	26749	the	0	None
26749	26750	quantification	0	None
26750	26751	limit	0	None
26751	26752	for	0	None
26752	26753	assay	0	None
26753	26754	(	0	None
26754	26755	0	0	None
26755	26756	.	0	None
26756	26757	65	0	None
26757	26758	ng	0	None
26758	26759	x	0	None
26759	26760	mL	0	None
26760	26761	(	0	None
26761	26762	-	0	None
26762	26763	1	0	None
26763	26764	)	0	None
26764	26765	)	0	None
26765	26766	,	0	None
26766	26767	but	0	None
26767	26768	NAP	3	CHEMICAL
26768	26769	226	0	None
26769	26770	-	0	None
26770	26771	90	0	None
26771	26772	reached	0	None
26772	26773	a	0	None
26773	26774	mean	0	None
26774	26775	Cmax	0	None
26775	26776	of	0	None
26776	26777	3	0	None
26777	26778	.	0	None
26778	26779	14	0	None
26779	26780	+	0	None
26780	26781	/	0	None
26781	26782	-	0	None
26782	26783	0	0	None
26783	26784	.	0	None
26784	26785	57	0	None
26785	26786	ng	0	None
26786	26787	x	0	None
26787	26788	mL	0	None
26788	26789	(	0	None
26789	26790	-	0	None
26790	26791	1	0	None
26791	26792	)	0	None
26792	26793	.	0	None

26794	26795	Only	0	None
26795	26796	minimal	0	None
26796	26797	inhibition	0	None
26797	26798	of	0	None
26798	26799	erythrocyte	0	None
26799	26800	AChE	1	GENE-Y
26800	26801	activity	0	None
26801	26802	(	0	None
26802	26803	approximately	0	None
26803	26804	3	0	None
26804	26805	%	0	None
26805	26806	)	0	None
26806	26807	was	0	None
26807	26808	observed	0	None
26808	26809	.	0	None

26810	26811	Inhibition	0	None
26811	26812	of	0	None
26812	26813	AChE	1	GENE-Y
26813	26814	in	0	None
26814	26815	the	0	None
26815	26816	CSF	0	None
26816	26817	after	0	None
26817	26818	rivastigmine	3	CHEMICAL
26818	26819	administration	0	None
26819	26820	was	0	None
26820	26821	significantly	0	None
26821	26822	greater	0	None
26822	26823	than	0	None
26823	26824	after	0	None
26824	26825	placebo	0	None
26825	26826	for	0	None
26826	26827	up	0	None
26827	26828	to	0	None
26828	26829	8	0	None
26829	26830	.	0	None
26830	26831	4	0	None
26831	26832	hours	0	None
26832	26833	after	0	None
26833	26834	the	0	None
26834	26835	dose	0	None
26835	26836	and	0	None
26836	26837	was	0	None
26837	26838	maximal	0	None
26838	26839	(	0	None
26839	26840	40	0	None
26840	26841	%	0	None
26841	26842	)	0	None
26842	26843	at	0	None
26843	26844	2	0	None
26844	26845	.	0	None
26845	26846	4	0	None
26846	26847	hours	0	None
26847	26848	.	0	None

26849	26850	Plasma	0	None
26850	26851	BuChE	1	GENE-Y
26851	26852	activity	0	None
26852	26853	was	0	None
26853	26854	significantly	0	None
26854	26855	lower	0	None
26855	26856	after	0	None
26856	26857	rivastigmine	3	CHEMICAL
26857	26858	than	0	None
26858	26859	after	0	None
26859	26860	placebo	0	None
26860	26861	,	0	None
26861	26862	but	0	None
26862	26863	this	0	None
26863	26864	was	0	None
26864	26865	not	0	None
26865	26866	clinically	0	None
26866	26867	relevant	0	None
26867	26868	.	0	None

26869	26870	BuChE	1	GENE-Y
26870	26871	activity	0	None
26871	26872	in	0	None
26872	26873	CSF	0	None
26873	26874	was	0	None
26874	26875	significantly	0	None
26875	26876	lower	0	None
26876	26877	after	0	None
26877	26878	rivastigmine	3	CHEMICAL
26878	26879	than	0	None
26879	26880	after	0	None
26880	26881	placebo	0	None
26881	26882	for	0	None
26882	26883	up	0	None
26883	26884	to	0	None
26884	26885	3	0	None
26885	26886	.	0	None
26886	26887	6	0	None
26887	26888	hours	0	None
26888	26889	after	0	None
26889	26890	dosing	0	None
26890	26891	,	0	None
26891	26892	but	0	None
26892	26893	this	0	None
26893	26894	difference	0	None
26894	26895	was	0	None
26895	26896	not	0	None
26896	26897	sustained	0	None
26897	26898	.	0	None

26899	26900	This	0	None
26900	26901	study	0	None
26901	26902	confirms	0	None
26902	26903	the	0	None
26903	26904	feasibility	0	None
26904	26905	of	0	None
26905	26906	using	0	None
26906	26907	continuous	0	None
26907	26908	measurement	0	None
26908	26909	of	0	None
26909	26910	AChE	1	GENE-Y
26910	26911	activity	0	None
26911	26912	in	0	None
26912	26913	CSF	0	None
26913	26914	over	0	None
26914	26915	prolonged	0	None
26915	26916	periods	0	None
26916	26917	,	0	None
26917	26918	that	0	None
26918	26919	rivastigmine	3	CHEMICAL
26919	26920	markedly	0	None
26920	26921	inhibits	0	None
26921	26922	CSF	0	None
26922	26923	AChE	1	GENE-Y
26923	26924	after	0	None
26924	26925	a	0	None
26925	26926	single	0	None
26926	26927	oral	0	None
26927	26928	dose	0	None
26928	26929	of	0	None
26929	26930	3	0	None
26930	26931	mg	0	None
26931	26932	,	0	None
26932	26933	and	0	None
26933	26934	that	0	None
26934	26935	the	0	None
26935	26936	inhibition	0	None
26936	26937	of	0	None
26937	26938	central	0	None
26938	26939	AChE	1	GENE-Y
26939	26940	is	0	None
26940	26941	substantially	0	None
26941	26942	greater	0	None
26942	26943	than	0	None
26943	26944	that	0	None
26944	26945	of	0	None
26945	26947	peripheral AChE	1	GENE-Y
26947	26948	or	0	None
26948	26949	BuChE	1	GENE-Y
26949	26950	.	0	None

26951	26952	Identification	0	None
26952	26953	of	0	None
26953	26955	amino acids	3	CHEMICAL
26955	26956	in	0	None
26956	26957	the	0	None
26957	26959	factor XI	1	GENE-Y
26959	26960	apple	0	None
26960	26961	3	0	None
26961	26962	domain	0	None
26962	26963	required	0	None
26963	26964	for	0	None
26964	26965	activation	0	None
26965	26966	of	0	None
26966	26967	factor	0	None
26967	26968	IX	0	None
26968	26969	.	0	None

26970	26974	Activated coagulation factor XI	1	GENE-Y
26974	26975	(	0	None
26975	26977	factor XIa	1	GENE-Y
26977	26978	)	0	None
26978	26979	proteolytically	0	None
26979	26980	cleaves	0	None
26980	26981	its	0	None
26981	26982	substrate	0	None
26982	26983	,	0	None
26983	26984	factor	0	None
26984	26985	IX	0	None
26985	26986	,	0	None
26986	26987	in	0	None
26987	26988	an	0	None
26988	26989	interaction	0	None
26989	26990	requiring	0	None
26990	26991	the	0	None
26991	26995	factor XI A3 domain	2	GENE-N
26995	26996	(	0	None
26996	26997	Sun	0	None
26997	26998	,	0	None
26998	26999	Y	0	None
26999	27000	.	0	None
27000	27001	,	0	None
27001	27002	and	0	None
27002	27003	Gailani	0	None
27003	27004	,	0	None
27004	27005	D	0	None
27005	27006	.	0	None
27006	27007	(	0	None
27007	27008	1996	0	None
27008	27009	)	0	None
27009	27010	J	0	None
27010	27011	.	0	None
27011	27012	Biol	0	None
27012	27013	.	0	None
27013	27014	Chem	0	None
27014	27015	.	0	None
27015	27016	271	0	None
27016	27017	,	0	None
27017	27018	29023	0	None
27018	27019	-	0	None
27019	27020	29028	0	None
27020	27021	)	0	None
27021	27022	.	0	None

27023	27024	To	0	None
27024	27025	identify	0	None
27025	27026	key	0	None
27026	27028	amino acids	3	CHEMICAL
27028	27029	involved	0	None
27029	27030	in	0	None
27030	27031	factor	0	None
27031	27032	IX	0	None
27032	27033	activation	0	None
27033	27034	,	0	None
27034	27037	recombinant factor XIa	1	GENE-Y
27037	27038	proteins	0	None
27038	27039	containing	0	None
27039	27040	alanine	3	CHEMICAL
27040	27041	substitutions	0	None
27041	27042	for	0	None
27042	27043	wild	0	None
27043	27044	-	0	None
27044	27045	type	0	None
27045	27046	sequence	0	None
27046	27047	were	0	None
27047	27048	expressed	0	None
27048	27049	in	0	None
27049	27050	293	0	None
27050	27051	fibroblasts	0	None
27051	27052	and	0	None
27052	27053	tested	0	None
27053	27054	in	0	None
27054	27055	a	0	None
27055	27056	plasma	0	None
27056	27057	clotting	0	None
27057	27058	assay	0	None
27058	27059	.	0	None

27060	27061	Substitutions	0	None
27061	27062	for	0	None
27062	27063	Ile	0	None
27063	27064	(	0	None
27064	27065	183	0	None
27065	27066	)	0	None
27066	27067	-	0	None
27067	27068	Val	3	CHEMICAL
27068	27069	(	0	None
27069	27070	191	0	None
27070	27071	)	0	None
27071	27072	and	0	None
27072	27073	Ser	0	None
27073	27074	(	0	None
27074	27075	195	0	None
27075	27076	)	0	None
27076	27077	-	0	None
27077	27078	Ile	0	None
27078	27079	(	0	None
27079	27080	197	0	None
27080	27081	)	0	None
27081	27082	at	0	None
27082	27083	the	0	None
27083	27084	N	0	None
27084	27085	terminus	0	None
27085	27086	and	0	None
27086	27087	for	0	None
27087	27088	Ser	0	None
27088	27089	(	0	None
27089	27090	258	0	None
27090	27091	)	0	None
27091	27092	-	0	None
27092	27093	Ser	0	None
27093	27094	(	0	None
27094	27095	264	0	None
27095	27096	)	0	None
27096	27097	at	0	None
27097	27098	the	0	None
27098	27099	C	0	None
27099	27100	terminus	0	None
27100	27101	of	0	None
27101	27102	the	0	None
27102	27104	A3 domain	2	GENE-N
27104	27105	markedly	0	None
27105	27106	decreased	0	None
27106	27108	factor XI	1	GENE-Y
27108	27109	coagulant	0	None
27109	27110	activity	0	None
27110	27111	.	0	None

27112	27113	The	0	None
27113	27114	plasma	0	None
27114	27115	protease	2	GENE-N
27115	27116	prekallikrein	0	None
27116	27117	is	0	None
27117	27118	structurally	0	None
27118	27119	homologous	0	None
27119	27120	to	0	None
27120	27122	factor XI	1	GENE-Y
27122	27123	,	0	None
27123	27124	but	0	None
27124	27125	activated	0	None
27125	27126	factor	0	None
27126	27127	IX	0	None
27127	27128	poorly	0	None
27128	27129	.	0	None

27130	27131	A	0	None
27131	27132	chimeric	0	None
27132	27134	factor XIa	1	GENE-Y
27134	27135	molecule	0	None
27135	27136	with	0	None
27136	27137	the	0	None
27137	27139	A3 domain	2	GENE-N
27139	27140	replaced	0	None
27140	27141	with	0	None
27141	27142	A3	0	None
27142	27143	from	0	None
27143	27144	prekallikrein	0	None
27144	27145	(	0	None
27145	27146	FXI	0	None
27146	27147	/	0	None
27147	27148	PKA3	2	GENE-N
27148	27149	)	0	None
27149	27150	activated	0	None
27150	27151	factor	0	None
27151	27152	IX	0	None
27152	27153	with	0	None
27153	27154	a	0	None
27154	27155	K	0	None
27155	27156	(	0	None
27156	27157	m	0	None
27157	27158	)	0	None
27158	27159	35	0	None
27159	27160	-	0	None
27160	27161	fold	0	None
27161	27162	greater	0	None
27162	27163	than	0	None
27163	27164	that	0	None
27164	27165	of	0	None
27165	27166	wild	0	None
27166	27167	-	0	None
27167	27168	type	0	None
27168	27170	factor XI	1	GENE-Y
27170	27171	.	0	None

27172	27173	FXI	1	GENE-Y
27173	27174	/	0	None
27174	27175	PKA3	2	GENE-N
27175	27176	was	0	None
27176	27177	used	0	None
27177	27178	as	0	None
27178	27179	a	0	None
27179	27180	template	0	None
27180	27181	for	0	None
27181	27182	a	0	None
27182	27183	series	0	None
27183	27184	of	0	None
27184	27185	proteins	0	None
27185	27186	in	0	None
27186	27187	which	0	None
27187	27188	prekallikrein	0	None
27188	27189	A3	0	None
27189	27190	sequence	0	None
27190	27191	was	0	None
27191	27192	replaced	0	None
27192	27193	with	0	None
27193	27195	factor XI	1	GENE-Y
27195	27196	sequence	0	None
27196	27197	to	0	None
27197	27198	restore	0	None
27198	27199	factor	0	None
27199	27200	IX	0	None
27200	27201	activation	0	None
27201	27202	.	0	None

27203	27204	Clotting	0	None
27204	27205	and	0	None
27205	27206	kinetics	0	None
27206	27207	studies	0	None
27207	27208	using	0	None
27208	27209	these	0	None
27209	27210	chimeras	0	None
27210	27211	confirmed	0	None
27211	27212	the	0	None
27212	27213	results	0	None
27213	27214	obtained	0	None
27214	27215	with	0	None
27215	27216	alanine	3	CHEMICAL
27216	27217	mutants	0	None
27217	27218	.	0	None

27219	27220	Amino	0	None
27220	27221	acids	0	None
27221	27222	between	0	None
27222	27223	Ile	0	None
27223	27224	(	0	None
27224	27225	183	0	None
27225	27226	)	0	None
27226	27227	and	0	None
27227	27228	Val	3	CHEMICAL
27228	27229	(	0	None
27229	27230	191	0	None
27230	27231	)	0	None
27231	27232	are	0	None
27232	27233	necessary	0	None
27233	27234	for	0	None
27234	27235	proper	0	None
27235	27236	factor	0	None
27236	27237	IX	0	None
27237	27238	activation	0	None
27238	27239	,	0	None
27239	27240	but	0	None
27240	27241	additional	0	None
27241	27242	sequence	0	None
27242	27243	between	0	None
27243	27244	Ser	0	None
27244	27245	(	0	None
27245	27246	195	0	None
27246	27247	)	0	None
27247	27248	and	0	None
27248	27249	Ile	0	None
27249	27250	(	0	None
27250	27251	197	0	None
27251	27252	)	0	None
27252	27253	or	0	None
27253	27254	between	0	None
27254	27255	Phe	0	None
27255	27256	(	0	None
27256	27257	260	0	None
27257	27258	)	0	None
27258	27259	and	0	None
27259	27260	Ser	0	None
27260	27261	(	0	None
27261	27262	265	0	None
27262	27263	)	0	None
27263	27264	is	0	None
27264	27265	required	0	None
27265	27266	for	0	None
27266	27267	complete	0	None
27267	27268	restoration	0	None
27268	27269	of	0	None
27269	27270	activation	0	None
27270	27271	.	0	None

27272	27273	Pharmacological	0	None
27273	27274	profile	0	None
27274	27275	of	0	None
27275	27276	LF	0	None
27276	27277	16	0	None
27277	27278	-	0	None
27278	27279	0687	0	None
27279	27280	,	0	None
27280	27281	a	0	None
27281	27282	new	0	None
27282	27283	potent	0	None
27283	27284	non	0	None
27284	27285	-	0	None
27285	27286	peptide	0	None
27286	27289	bradykinin B2 receptor	2	GENE-N
27289	27290	antagonist	0	None
27290	27291	.	0	None

27292	27293	LF	0	None
27293	27294	16	0	None
27294	27295	-	0	None
27295	27296	0687	0	None
27296	27297	(	0	None
27297	27298	1	0	None
27298	27299	-	0	None
27299	27300	[	0	None
27300	27301	[	0	None
27301	27302	2	0	None
27302	27303	,	0	None
27303	27304	4	0	None
27304	27305	-	0	None
27305	27306	dichloro	0	None
27306	27307	-	0	None
27307	27308	3	0	None
27308	27309	-	0	None
27309	27310	[	0	None
27310	27311	[	0	None
27311	27312	(	0	None
27312	27313	2	0	None
27313	27314	,	0	None
27314	27315	4	0	None
27315	27316	-	0	None
27316	27317	dimethylquinolin	0	None
27317	27318	-	0	None
27318	27319	8	0	None
27319	27320	-	0	None
27320	27321	yl	0	None
27321	27322	)	0	None
27322	27323	oxy	0	None
27323	27324	]	0	None
27324	27325	methyl	3	CHEMICAL
27325	27326	]	0	None
27326	27327	phenyl	3	CHEMICAL
27327	27328	]	0	None
27328	27329	sulfonyl	3	CHEMICAL
27329	27330	]	0	None
27330	27331	-	0	None
27331	27332	N	0	None
27332	27333	-	0	None
27333	27334	[	0	None
27334	27335	3	0	None
27335	27336	-	0	None
27336	27337	[	0	None
27337	27338	[	0	None
27338	27339	4	0	None
27339	27340	-	0	None
27340	27341	(	0	None
27341	27342	aminoimethyl	0	None
27342	27343	)	0	None
27343	27344	phenyl	3	CHEMICAL
27344	27345	]	0	None
27345	27346	carbonylamino	0	None
27346	27347	]	0	None
27347	27348	propyl	0	None
27348	27349	]	0	None
27349	27350	-	0	None
27350	27351	2	0	None
27351	27352	(	0	None
27352	27353	S	0	None
27353	27354	)	0	None
27354	27355	-	0	None
27355	27356	pyrrolidinecarboxamide	0	None
27356	27357	)	0	None
27357	27358	has	0	None
27358	27359	been	0	None
27359	27360	selected	0	None
27360	27361	from	0	None
27361	27362	a	0	None
27362	27363	large	0	None
27363	27364	-	0	None
27364	27365	scale	0	None
27365	27366	medicinal	0	None
27366	27367	chemistry	0	None
27367	27368	program	0	None
27368	27369	for	0	None
27369	27370	further	0	None
27370	27371	development	0	None
27371	27372	.	0	None

27373	27374	In	0	None
27374	27375	competition	0	None
27375	27376	binding	0	None
27376	27377	studies	0	None
27377	27378	using	0	None
27378	27379	[	0	None
27379	27380	3H	0	None
27380	27381	]	0	None
27381	27382	bradykinin	0	None
27382	27383	(	0	None
27383	27384	BK	0	None
27384	27385	)	0	None
27385	27386	,	0	None
27386	27387	LF	0	None
27387	27388	16	0	None
27388	27389	-	0	None
27389	27390	0687	0	None
27390	27391	bound	0	None
27391	27392	to	0	None
27392	27393	the	0	None
27393	27394	human	0	None
27394	27395	,	0	None
27395	27396	rat	0	None
27396	27397	and	0	None
27397	27398	guinea	0	None
27398	27399	-	0	None
27399	27400	pig	0	None
27400	27403	recombinant B2 receptor	1	GENE-Y
27403	27404	expressed	0	None
27404	27405	in	0	None
27405	27406	CHO	3	CHEMICAL
27406	27407	cells	0	None
27407	27408	giving	0	None
27408	27409	K	0	None
27409	27410	(	0	None
27410	27411	i	0	None
27411	27412	)	0	None
27412	27413	values	0	None
27413	27414	of	0	None
27414	27415	0	0	None
27415	27416	.	0	None
27416	27417	67	0	None
27417	27418	nM	0	None
27418	27419	,	0	None
27419	27420	1	0	None
27420	27421	.	0	None
27421	27422	74	0	None
27422	27423	nM	0	None
27423	27424	and	0	None
27424	27425	1	0	None
27425	27426	.	0	None
27426	27427	37	0	None
27427	27428	nM	0	None
27428	27429	,	0	None
27429	27430	respectively	0	None
27430	27431	.	0	None

27432	27433	It	0	None
27433	27434	also	0	None
27434	27435	bound	0	None
27435	27436	to	0	None
27436	27437	the	0	None
27437	27438	native	0	None
27438	27439	BK	0	None
27439	27441	B2 receptor	2	GENE-N
27441	27442	from	0	None
27442	27443	human	0	None
27443	27444	umbilical	0	None
27444	27445	vein	0	None
27445	27446	(	0	None
27446	27447	HUV	0	None
27447	27448	)	0	None
27448	27449	,	0	None
27449	27450	rat	0	None
27450	27451	uterus	0	None
27451	27452	(	0	None
27452	27453	RU	0	None
27453	27454	)	0	None
27454	27455	and	0	None
27455	27456	guinea	0	None
27456	27457	-	0	None
27457	27458	pig	0	None
27458	27459	ileum	0	None
27459	27460	(	0	None
27460	27461	GPI	3	CHEMICAL
27461	27462	)	0	None
27462	27463	giving	0	None
27463	27464	K	0	None
27464	27465	(	0	None
27465	27466	i	0	None
27466	27467	)	0	None
27467	27468	values	0	None
27468	27469	of	0	None
27469	27470	0	0	None
27470	27471	.	0	None
27471	27472	89	0	None
27472	27473	nM	0	None
27473	27474	,	0	None
27474	27475	0	0	None
27475	27476	.	0	None
27476	27477	28	0	None
27477	27478	nM	0	None
27478	27479	and	0	None
27479	27480	0	0	None
27480	27481	.	0	None
27481	27482	98	0	None
27482	27483	nM	0	None
27483	27484	,	0	None
27484	27485	respectively	0	None
27485	27486	.	0	None

27487	27488	It	0	None
27488	27489	inhibited	0	None
27489	27490	BK	0	None
27490	27491	-	0	None
27491	27492	induced	0	None
27492	27493	IP1	0	None
27493	27494	,	0	None
27494	27495	IP2	0	None
27495	27496	and	0	None
27496	27497	IP3	3	CHEMICAL
27497	27498	formation	0	None
27498	27499	in	0	None
27499	27500	INT407	0	None
27500	27501	cells	0	None
27501	27502	yielding	0	None
27502	27503	pK	0	None
27503	27504	(	0	None
27504	27505	B	0	None
27505	27506	)	0	None
27506	27507	values	0	None
27507	27508	of	0	None
27508	27509	8	0	None
27509	27510	.	0	None
27510	27511	5	0	None
27511	27512	,	0	None
27512	27513	8	0	None
27513	27514	.	0	None
27514	27515	6	0	None
27515	27516	and	0	None
27516	27517	8	0	None
27517	27518	.	0	None
27518	27519	7	0	None
27519	27520	,	0	None
27520	27521	respectively	0	None
27521	27522	.	0	None

27523	27524	In	0	None
27524	27525	isolated	0	None
27525	27526	organs	0	None
27526	27527	experiments	0	None
27527	27528	,	0	None
27528	27529	LF	0	None
27529	27530	16	0	None
27530	27531	-	0	None
27531	27532	0687	0	None
27532	27533	behaved	0	None
27533	27534	as	0	None
27534	27535	a	0	None
27535	27536	competitive	0	None
27536	27537	antagonist	0	None
27537	27538	of	0	None
27538	27539	BK	0	None
27539	27540	-	0	None
27540	27541	mediated	0	None
27541	27542	contractions	0	None
27542	27543	giving	0	None
27543	27544	pA2	0	None
27544	27545	values	0	None
27545	27546	of	0	None
27546	27547	9	0	None
27547	27548	.	0	None
27548	27549	1	0	None
27549	27550	in	0	None
27550	27551	HUV	0	None
27551	27552	,	0	None
27552	27553	7	0	None
27553	27554	.	0	None
27554	27555	7	0	None
27555	27556	in	0	None
27556	27557	RU	0	None
27557	27558	and	0	None
27558	27559	9	0	None
27559	27560	.	0	None
27560	27561	1	0	None
27561	27562	in	0	None
27562	27563	GPI	3	CHEMICAL
27563	27564	.	0	None

27565	27566	Binding	0	None
27566	27567	and	0	None
27567	27568	functional	0	None
27568	27569	studies	0	None
27569	27570	performed	0	None
27570	27571	over	0	None
27571	27572	40	0	None
27572	27573	different	0	None
27573	27574	receptors	0	None
27574	27575	revealed	0	None
27575	27576	that	0	None
27576	27577	LF	0	None
27577	27578	16	0	None
27578	27579	-	0	None
27579	27580	0687	0	None
27580	27581	was	0	None
27581	27582	selective	0	None
27582	27583	for	0	None
27583	27584	the	0	None
27584	27585	BK	0	None
27585	27587	B2 receptor	1	GENE-Y
27587	27588	.	0	None

27589	27590	A	0	None
27590	27591	continuous	0	None
27591	27592	intravenous	0	None
27592	27593	infusion	0	None
27593	27594	of	0	None
27594	27595	LF	0	None
27595	27596	16	0	None
27596	27597	-	0	None
27597	27598	0687	0	None
27598	27599	antagonized	0	None
27599	27600	in	0	None
27600	27601	a	0	None
27601	27602	dose	0	None
27602	27603	-	0	None
27603	27604	dependent	0	None
27604	27605	manner	0	None
27605	27606	and	0	None
27606	27607	with	0	None
27607	27608	a	0	None
27608	27609	rapid	0	None
27609	27610	onset	0	None
27610	27611	of	0	None
27611	27612	action	0	None
27612	27613	BK	0	None
27613	27614	-	0	None
27614	27615	induced	0	None
27615	27616	hypotensive	0	None
27616	27617	response	0	None
27617	27618	.	0	None

27619	27620	Subcutaneous	0	None
27620	27621	administration	0	None
27621	27622	of	0	None
27622	27623	LF	0	None
27623	27624	16	0	None
27624	27625	-	0	None
27625	27626	0687	0	None
27626	27627	at	0	None
27627	27628	1	0	None
27628	27629	.	0	None
27629	27630	1	0	None
27630	27631	micromol	0	None
27631	27632	/	0	None
27632	27633	kg	0	None
27633	27634	to	0	None
27634	27635	rats	0	None
27635	27636	markedly	0	None
27636	27637	reduced	0	None
27637	27638	BK	0	None
27638	27639	-	0	None
27639	27640	induced	0	None
27640	27641	edema	0	None
27641	27642	of	0	None
27642	27643	the	0	None
27643	27644	stomach	0	None
27644	27645	(	0	None
27645	27646	-	0	None
27646	27647	69	0	None
27647	27648	%	0	None
27648	27649	)	0	None
27649	27650	,	0	None
27650	27651	duodenum	0	None
27651	27652	(	0	None
27652	27653	-	0	None
27653	27654	65	0	None
27654	27655	%	0	None
27655	27656	)	0	None
27656	27657	and	0	None
27657	27658	pancreas	0	None
27658	27659	(	0	None
27659	27660	-	0	None
27660	27661	56	0	None
27661	27662	%	0	None
27662	27663	)	0	None
27663	27664	.	0	None

27665	27666	Vasopeptidase	2	GENE-N
27666	27667	inhibition	0	None
27667	27668	with	0	None
27668	27669	omapatrilat	3	CHEMICAL
27669	27670	improves	0	None
27670	27671	cardiac	0	None
27671	27672	geometry	0	None
27672	27673	and	0	None
27673	27674	survival	0	None
27674	27675	in	0	None
27675	27676	cardiomyopathic	0	None
27676	27677	hamsters	0	None
27677	27678	more	0	None
27678	27679	than	0	None
27679	27680	does	0	None
27680	27681	ACE	1	GENE-Y
27681	27682	inhibition	0	None
27682	27683	with	0	None
27683	27684	captopril	3	CHEMICAL
27684	27685	.	0	None

27686	27687	Vasopeptidase	2	GENE-N
27687	27688	inhibitors	0	None
27688	27689	are	0	None
27689	27690	single	0	None
27690	27691	molecules	0	None
27691	27692	that	0	None
27692	27693	inhibit	0	None
27693	27694	neutral	0	None
27694	27695	endopeptidase	0	None
27695	27696	(	0	None
27696	27697	NEP	0	None
27697	27698	)	0	None
27698	27699	and	0	None
27699	27700	angiotensin	3	CHEMICAL
27700	27701	-	0	None
27701	27703	converting enzyme	1	GENE-Y
27703	27704	(	0	None
27704	27705	ACE	1	GENE-Y
27705	27706	)	0	None
27706	27707	simultaneously	0	None
27707	27708	.	0	None

27709	27710	Omapatrilat	0	None
27710	27711	,	0	None
27711	27712	the	0	None
27712	27713	first	0	None
27713	27714	in	0	None
27714	27715	this	0	None
27715	27716	new	0	None
27716	27717	class	0	None
27717	27718	of	0	None
27718	27719	cardiovascular	0	None
27719	27720	agents	0	None
27720	27721	,	0	None
27721	27722	potentiates	0	None
27722	27723	vasodilatory	0	None
27723	27724	and	0	None
27724	27725	cardioprotective	0	None
27725	27726	peptides	0	None
27726	27727	and	0	None
27727	27728	represses	0	None
27728	27730	angiotensin II	1	GENE-Y
27730	27731	.	0	None

27732	27733	This	0	None
27733	27734	study	0	None
27734	27735	compared	0	None
27735	27736	the	0	None
27736	27737	effects	0	None
27737	27738	of	0	None
27738	27739	omapatrilat	3	CHEMICAL
27739	27740	with	0	None
27740	27741	those	0	None
27741	27742	of	0	None
27742	27743	a	0	None
27743	27744	pure	0	None
27744	27745	ACE	1	GENE-Y
27745	27746	inhibitor	0	None
27746	27747	on	0	None
27747	27748	cardiac	0	None
27748	27749	geometry	0	None
27749	27750	and	0	None
27750	27751	survival	0	None
27751	27752	in	0	None
27752	27753	animals	0	None
27753	27754	with	0	None
27754	27755	heart	0	None
27755	27756	failure	0	None
27756	27757	.	0	None

27758	27759	BIO	0	None
27759	27760	TO	0	None
27760	27761	-	0	None
27761	27762	2	0	None
27762	27763	cardiomyopathic	0	None
27763	27764	hamsters	0	None
27764	27765	(	0	None
27765	27766	CMHs	0	None
27766	27767	)	0	None
27767	27768	in	0	None
27768	27769	the	0	None
27769	27770	early	0	None
27770	27771	stages	0	None
27771	27772	of	0	None
27772	27773	dilated	0	None
27773	27774	heart	0	None
27774	27775	failure	0	None
27775	27776	were	0	None
27776	27777	treated	0	None
27777	27778	with	0	None
27778	27779	vehicle	0	None
27779	27780	or	0	None
27780	27781	maximal	0	None
27781	27782	ACE	1	GENE-Y
27782	27783	inhibitory	0	None
27783	27784	doses	0	None
27784	27785	of	0	None
27785	27786	captopril	3	CHEMICAL
27786	27787	(	0	None
27787	27788	750	0	None
27788	27789	micromol	0	None
27789	27790	/	0	None
27790	27791	kg	0	None
27791	27792	/	0	None
27792	27793	day	0	None
27793	27794	)	0	None
27794	27795	or	0	None
27795	27796	omapatrilat	3	CHEMICAL
27796	27797	(	0	None
27797	27798	200	0	None
27798	27799	micromol	0	None
27799	27800	/	0	None
27800	27801	kg	0	None
27801	27802	/	0	None
27802	27803	day	0	None
27803	27804	)	0	None
27804	27805	.	0	None

27806	27807	Prolonged	0	None
27807	27808	vasopeptidase	2	GENE-N
27808	27809	inhibition	0	None
27809	27810	increased	0	None
27810	27811	median	0	None
27811	27812	survival	0	None
27812	27813	time	0	None
27813	27814	after	0	None
27814	27815	the	0	None
27815	27816	start	0	None
27816	27817	of	0	None
27817	27818	treatment	0	None
27818	27819	by	0	None
27819	27820	99	0	None
27820	27821	and	0	None
27821	27822	31	0	None
27822	27823	%	0	None
27823	27824	compared	0	None
27824	27825	with	0	None
27825	27826	vehicle	0	None
27826	27827	and	0	None
27827	27828	captopril	3	CHEMICAL
27828	27829	,	0	None
27829	27830	respectively	0	None
27830	27831	(	0	None
27831	27832	median	0	None
27832	27833	survival	0	None
27833	27834	times	0	None
27834	27835	:	0	None
27835	27836	146	0	None
27836	27837	,	0	None
27837	27838	221	0	None
27838	27839	,	0	None
27839	27840	and	0	None
27840	27841	290	0	None
27841	27842	days	0	None
27842	27843	with	0	None
27843	27844	vehicle	0	None
27844	27845	,	0	None
27845	27846	captopril	3	CHEMICAL
27846	27847	,	0	None
27847	27848	and	0	None
27848	27849	omapatrilat	3	CHEMICAL
27849	27850	,	0	None
27850	27851	respectively	0	None
27851	27852	;	0	None
27852	27853	p	0	None
27853	27854	<	0	None
27854	27855	0	0	None
27855	27856	.	0	None
27856	27857	001	0	None
27857	27858	for	0	None
27858	27859	all	0	None
27859	27860	comparisons	0	None
27860	27861	)	0	None
27861	27862	.	0	None

27863	27864	In	0	None
27864	27865	similar	0	None
27865	27866	CMHs	0	None
27866	27867	,	0	None
27867	27868	captopril	3	CHEMICAL
27868	27869	or	0	None
27869	27870	omapatrilat	3	CHEMICAL
27870	27871	administered	0	None
27871	27872	for	0	None
27872	27873	2	0	None
27873	27874	months	0	None
27874	27875	significantly	0	None
27875	27876	(	0	None
27876	27877	p	0	None
27877	27878	<	0	None
27878	27879	0	0	None
27879	27880	.	0	None
27880	27881	05	0	None
27881	27882	)	0	None
27882	27883	decreased	0	None
27883	27884	heart	0	None
27884	27885	weight	0	None
27885	27886	,	0	None
27886	27887	pulmonary	0	None
27887	27888	congestion	0	None
27888	27889	(	0	None
27889	27890	lung	0	None
27890	27891	weight	0	None
27891	27892	)	0	None
27892	27893	,	0	None
27893	27894	and	0	None
27894	27895	left	0	None
27895	27896	ventricular	0	None
27896	27897	(	0	None
27897	27898	LV	3	CHEMICAL
27898	27899	)	0	None
27899	27900	chamber	0	None
27900	27901	volume	0	None
27901	27902	compared	0	None
27902	27903	with	0	None
27903	27904	vehicle	0	None
27904	27905	.	0	None

27906	27907	Omapatrilat	0	None
27907	27908	significantly	0	None
27908	27909	increased	0	None
27909	27910	LV	3	CHEMICAL
27910	27911	mass	0	None
27911	27912	-	0	None
27912	27913	to	0	None
27913	27914	-	0	None
27914	27915	volume	0	None
27915	27916	ratio	0	None
27916	27917	compared	0	None
27917	27918	with	0	None
27918	27919	vehicle	0	None
27919	27920	and	0	None
27920	27921	captopril	3	CHEMICAL
27921	27922	.	0	None

27923	27924	Omapatrilat	0	None
27924	27925	,	0	None
27925	27926	but	0	None
27926	27927	not	0	None
27927	27928	captopril	3	CHEMICAL
27928	27929	,	0	None
27929	27930	significantly	0	None
27930	27931	increased	0	None
27931	27935	urinary atrial natriuretic peptide	1	GENE-Y
27935	27936	excretion	0	None
27936	27937	,	0	None
27937	27938	indicating	0	None
27938	27939	NEP	0	None
27939	27940	inhibition	0	None
27940	27941	.	0	None

27942	27943	Thus	0	None
27943	27944	vasopeptidase	2	GENE-N
27944	27945	inhibition	0	None
27945	27946	with	0	None
27946	27947	omapatrilat	3	CHEMICAL
27947	27948	was	0	None
27948	27949	more	0	None
27949	27950	effective	0	None
27950	27951	than	0	None
27951	27952	ACE	1	GENE-Y
27952	27953	inhibition	0	None
27953	27954	with	0	None
27954	27955	captopril	3	CHEMICAL
27955	27956	in	0	None
27956	27957	preventing	0	None
27957	27958	changes	0	None
27958	27959	in	0	None
27959	27960	LV	3	CHEMICAL
27960	27961	geometry	0	None
27961	27962	and	0	None
27962	27963	premature	0	None
27963	27964	mortality	0	None
27964	27965	in	0	None
27965	27966	hamsters	0	None
27966	27967	with	0	None
27967	27968	dilated	0	None
27968	27969	heart	0	None
27969	27970	failure	0	None
27970	27971	.	0	None

27972	27973	The	0	None
27973	27974	effect	0	None
27974	27975	of	0	None
27975	27976	etonogestrel	0	None
27976	27977	on	0	None
27977	27978	VEGF	1	GENE-Y
27978	27979	,	0	None
27979	27980	oestrogen	3	CHEMICAL
27980	27981	and	0	None
27981	27983	progesterone receptor	1	GENE-Y
27983	27984	immunoreactivity	0	None
27984	27985	and	0	None
27985	27986	endothelial	0	None
27986	27987	cell	0	None
27987	27988	number	0	None
27988	27989	in	0	None
27989	27990	human	0	None
27990	27991	endometrium	0	None
27991	27992	.	0	None

27993	27994	Contraceptive	0	None
27994	27995	use	0	None
27995	27996	often	0	None
27996	27997	leads	0	None
27997	27998	to	0	None
27998	27999	disrupted	0	None
27999	28000	endometrial	0	None
28000	28001	bleeding	0	None
28001	28002	patterns	0	None
28002	28003	in	0	None
28003	28004	women	0	None
28004	28005	.	0	None

28006	28007	In	0	None
28007	28008	this	0	None
28008	28009	study	0	None
28009	28010	,	0	None
28010	28011	two	0	None
28011	28012	different	0	None
28012	28013	contraceptive	0	None
28013	28014	regimes	0	None
28014	28015	(	0	None
28015	28016	Mircette	3	CHEMICAL
28016	28017	,	0	None
28017	28018	a	0	None
28018	28019	monophasic	0	None
28019	28020	oral	0	None
28020	28021	contraceptive	0	None
28021	28022	and	0	None
28022	28023	Implanon	3	CHEMICAL
28023	28024	,	0	None
28024	28025	a	0	None
28025	28026	long	0	None
28026	28027	-	0	None
28027	28028	acting	0	None
28028	28029	gestagen	3	CHEMICAL
28029	28030	)	0	None
28030	28031	were	0	None
28031	28032	used	0	None
28032	28033	and	0	None
28033	28034	their	0	None
28034	28035	effects	0	None
28035	28036	on	0	None
28036	28037	the	0	None
28037	28038	immunoreactivity	0	None
28038	28039	of	0	None
28039	28043	vascular endothelial growth factor	1	GENE-Y
28043	28044	(	0	None
28044	28045	VEGF	1	GENE-Y
28045	28046	)	0	None
28046	28047	,	0	None
28047	28049	oestrogen receptor	1	GENE-Y
28049	28050	(	0	None
28050	28051	ER	1	GENE-Y
28051	28052	)	0	None
28052	28053	,	0	None
28053	28055	progesterone receptor	2	GENE-N
28055	28056	(	0	None
28056	28057	PR	2	GENE-N
28057	28058	)	0	None
28058	28059	and	0	None
28059	28060	endothelial	0	None
28060	28061	cell	0	None
28061	28062	number	0	None
28062	28063	were	0	None
28063	28064	determined	0	None
28064	28065	.	0	None

28066	28067	During	0	None
28067	28068	the	0	None
28068	28069	untreated	0	None
28069	28070	normal	0	None
28070	28071	cycle	0	None
28071	28072	,	0	None
28072	28073	there	0	None
28073	28074	was	0	None
28074	28075	a	0	None
28075	28076	significant	0	None
28076	28077	increase	0	None
28077	28078	(	0	None
28078	28079	P	0	None
28079	28080	=	0	None
28080	28081	0	0	None
28081	28082	.	0	None
28082	28083	005	0	None
28083	28084	)	0	None
28084	28085	in	0	None
28085	28086	glandular	0	None
28086	28087	VEGF	1	GENE-Y
28087	28088	immunoreactivity	0	None
28088	28089	and	0	None
28089	28090	a	0	None
28090	28091	significant	0	None
28091	28092	decrease	0	None
28092	28093	(	0	None
28093	28094	P	0	None
28094	28095	<	0	None
28095	28096	0	0	None
28096	28097	.	0	None
28097	28098	05	0	None
28098	28099	)	0	None
28099	28100	in	0	None
28100	28101	PR	2	GENE-N
28101	28102	immunoreactivity	0	None
28102	28103	in	0	None
28103	28104	the	0	None
28104	28105	mid	0	None
28105	28106	-	0	None
28106	28107	and	0	None
28107	28108	late	0	None
28108	28109	secretory	0	None
28109	28110	phases	0	None
28110	28111	compared	0	None
28111	28112	with	0	None
28112	28113	the	0	None
28113	28114	proliferative	0	None
28114	28115	phase	0	None
28115	28116	.	0	None

28117	28118	There	0	None
28118	28119	was	0	None
28119	28120	a	0	None
28120	28121	significant	0	None
28121	28122	positive	0	None
28122	28123	correlation	0	None
28123	28124	(	0	None
28124	28125	gamma	0	None
28125	28126	=	0	None
28126	28127	0	0	None
28127	28128	.	0	None
28128	28129	38	0	None
28129	28130	,	0	None
28130	28131	P	0	None
28131	28132	=	0	None
28132	28133	0	0	None
28133	28134	.	0	None
28134	28135	046	0	None
28135	28136	)	0	None
28136	28137	between	0	None
28137	28138	stromal	0	None
28138	28139	VEGF	1	GENE-Y
28139	28140	immunoreactivity	0	None
28140	28141	and	0	None
28141	28142	endothelial	0	None
28142	28143	cell	0	None
28143	28144	number	0	None
28144	28145	.	0	None

28146	28147	This	0	None
28147	28148	correlation	0	None
28148	28149	was	0	None
28149	28150	also	0	None
28150	28151	apparent	0	None
28151	28152	during	0	None
28152	28153	treatment	0	None
28153	28154	with	0	None
28154	28155	Implanon	3	CHEMICAL
28155	28156	,	0	None
28156	28157	but	0	None
28157	28158	not	0	None
28158	28159	with	0	None
28159	28160	Mircette	3	CHEMICAL
28160	28161	.	0	None

28162	28163	Disrupted	0	None
28163	28164	bleeding	0	None
28164	28165	patterns	0	None
28165	28166	were	0	None
28166	28167	associated	0	None
28167	28168	with	0	None
28168	28169	Implanon	3	CHEMICAL
28169	28170	and	0	None
28170	28171	,	0	None
28171	28172	to	0	None
28172	28173	a	0	None
28173	28174	lesser	0	None
28174	28175	extent	0	None
28175	28176	,	0	None
28176	28177	with	0	None
28177	28178	Mircette	3	CHEMICAL
28178	28179	.	0	None

28180	28181	Both	0	None
28181	28182	contraceptives	0	None
28182	28183	significantly	0	None
28183	28184	reduced	0	None
28184	28185	glandular	0	None
28185	28186	VEGF	1	GENE-Y
28186	28187	immunoreactivity	0	None
28187	28188	.	0	None

28189	28190	Implanon	3	CHEMICAL
28190	28191	significantly	0	None
28191	28192	increased	0	None
28192	28193	(	0	None
28193	28194	P	0	None
28194	28195	=	0	None
28195	28196	0	0	None
28196	28197	.	0	None
28197	28198	016	0	None
28198	28199	)	0	None
28199	28200	glandular	0	None
28200	28201	PR	2	GENE-N
28201	28202	staining	0	None
28202	28203	,	0	None
28203	28204	but	0	None
28204	28205	Mircette	3	CHEMICAL
28205	28206	significantly	0	None
28206	28207	reduced	0	None
28207	28208	(	0	None
28208	28209	P	0	None
28209	28210	=	0	None
28210	28211	0	0	None
28211	28212	.	0	None
28212	28213	027	0	None
28213	28214	)	0	None
28214	28215	stromal	0	None
28215	28216	PR	2	GENE-N
28216	28217	staining	0	None
28217	28218	when	0	None
28218	28219	compared	0	None
28219	28220	with	0	None
28220	28221	secretory	0	None
28221	28222	before	0	None
28222	28223	-	0	None
28223	28224	treatment	0	None
28224	28225	biopsies	0	None
28225	28226	.	0	None

28227	28228	There	0	None
28228	28229	were	0	None
28229	28230	no	0	None
28230	28231	changes	0	None
28231	28232	in	0	None
28232	28233	endothelial	0	None
28233	28234	cell	0	None
28234	28235	number	0	None
28235	28236	or	0	None
28236	28237	glandular	0	None
28237	28238	or	0	None
28238	28239	stromal	0	None
28239	28240	ER	1	GENE-Y
28240	28241	during	0	None
28241	28242	the	0	None
28242	28243	normal	0	None
28243	28244	cycle	0	None
28244	28245	,	0	None
28245	28246	or	0	None
28246	28247	with	0	None
28247	28248	use	0	None
28248	28249	of	0	None
28249	28250	either	0	None
28250	28251	contraceptive	0	None
28251	28252	.	0	None

28253	28254	There	0	None
28254	28255	was	0	None
28255	28256	no	0	None
28256	28257	association	0	None
28257	28258	between	0	None
28258	28259	the	0	None
28259	28260	parameters	0	None
28260	28261	measured	0	None
28261	28262	with	0	None
28262	28263	bleeding	0	None
28263	28264	patterns	0	None
28264	28265	and	0	None
28265	28266	histological	0	None
28266	28267	category	0	None
28267	28268	.	0	None

28269	28270	Agonist	0	None
28270	28271	and	0	None
28271	28272	antagonist	0	None
28272	28273	actions	0	None
28273	28274	of	0	None
28274	28275	yohimbine	3	CHEMICAL
28275	28276	as	0	None
28276	28277	compared	0	None
28277	28278	to	0	None
28278	28279	fluparoxan	3	CHEMICAL
28279	28280	at	0	None
28280	28281	alpha	0	None
28281	28282	(	0	None
28282	28283	2	0	None
28283	28284	)	0	None
28284	28285	-	0	None
28285	28287	adrenergic receptors	2	GENE-N
28287	28288	(	0	None
28288	28289	AR	1	GENE-Y
28289	28290	)	0	None
28290	28291	s	0	None
28291	28292	,	0	None
28292	28293	serotonin	3	CHEMICAL
28293	28294	(	0	None
28294	28295	5	0	None
28295	28296	-	0	None
28296	28297	HT	3	CHEMICAL
28297	28298	)	0	None
28298	28299	(	0	None
28299	28300	1A	0	None
28300	28301	)	0	None
28301	28302	,	0	None
28302	28303	5	0	None
28303	28304	-	0	None
28304	28305	HT	3	CHEMICAL
28305	28306	(	0	None
28306	28307	1B	0	None
28307	28308	)	0	None
28308	28309	,	0	None
28309	28310	5	0	None
28310	28311	-	0	None
28311	28312	HT	3	CHEMICAL
28312	28313	(	0	None
28313	28314	1D	0	None
28314	28315	)	0	None
28315	28316	and	0	None
28316	28317	dopamine	3	CHEMICAL
28317	28318	D	0	None
28318	28319	(	0	None
28319	28320	2	0	None
28320	28321	)	0	None
28321	28322	and	0	None
28322	28323	D	0	None
28323	28324	(	0	None
28324	28325	3	0	None
28325	28326	)	0	None
28326	28327	receptors	0	None
28327	28328	.	0	None

28329	28330	Significance	0	None
28330	28331	for	0	None
28331	28332	the	0	None
28332	28333	modulation	0	None
28333	28334	of	0	None
28334	28335	frontocortical	0	None
28335	28336	monoaminergic	0	None
28336	28337	transmission	0	None
28337	28338	and	0	None
28338	28339	depressive	0	None
28339	28340	states	0	None
28340	28341	.	0	None

28342	28343	Herein	0	None
28343	28344	,	0	None
28344	28345	we	0	None
28345	28346	evaluate	0	None
28346	28347	the	0	None
28347	28348	interaction	0	None
28348	28349	of	0	None
28349	28350	the	0	None
28350	28351	alpha	0	None
28351	28352	(	0	None
28352	28353	2	0	None
28353	28354	)	0	None
28354	28355	-	0	None
28355	28356	AR	1	GENE-Y
28356	28357	antagonist	0	None
28357	28358	,	0	None
28358	28359	yohimbine	3	CHEMICAL
28359	28360	,	0	None
28360	28361	as	0	None
28361	28362	compared	0	None
28362	28363	to	0	None
28363	28364	fluparoxan	3	CHEMICAL
28364	28365	,	0	None
28365	28366	at	0	None
28366	28367	multiple	0	None
28367	28369	monoaminergic receptors	2	GENE-N
28369	28370	and	0	None
28370	28371	examine	0	None
28371	28372	their	0	None
28372	28373	roles	0	None
28373	28374	in	0	None
28374	28375	the	0	None
28375	28376	modulation	0	None
28376	28377	of	0	None
28377	28378	adrenergic	0	None
28378	28379	,	0	None
28379	28380	dopaminergic	0	None
28380	28381	and	0	None
28381	28382	serotonergic	0	None
28382	28383	transmission	0	None
28383	28384	in	0	None
28384	28385	freely	0	None
28385	28386	-	0	None
28386	28387	moving	0	None
28387	28388	rats	0	None
28388	28389	.	0	None

28390	28391	Yohimbine	0	None
28391	28392	displays	0	None
28392	28393	marked	0	None
28393	28394	affinity	0	None
28394	28395	at	0	None
28395	28396	human	0	None
28396	28397	(	0	None
28397	28398	h	0	None
28398	28399	)	0	None
28399	28400	alpha	0	None
28400	28401	(	0	None
28401	28402	2A	0	None
28402	28403	)	0	None
28403	28404	-	0	None
28404	28405	,	0	None
28405	28406	halpha	0	None
28406	28407	(	0	None
28407	28408	2B	0	None
28408	28409	)	0	None
28409	28410	-	0	None
28410	28411	and	0	None
28411	28412	halpha	0	None
28412	28413	(	0	None
28413	28414	2C	0	None
28414	28415	)	0	None
28415	28416	-	0	None
28416	28417	ARs	0	None
28417	28418	,	0	None
28418	28419	significant	0	None
28419	28420	affinity	0	None
28420	28421	for	0	None
28421	28422	h5	0	None
28422	28423	-	0	None
28423	28424	HT	3	CHEMICAL
28424	28425	(	0	None
28425	28426	1A	0	None
28426	28427	)	0	None
28427	28428	,	0	None
28428	28429	h5	0	None
28429	28430	-	0	None
28430	28431	HT	3	CHEMICAL
28431	28432	(	0	None
28432	28433	1B	0	None
28433	28434	)	0	None
28434	28435	,	0	None
28435	28436	h5	0	None
28436	28437	-	0	None
28437	28438	HT	3	CHEMICAL
28438	28439	(	0	None
28439	28440	1D	0	None
28440	28441	)	0	None
28441	28442	,	0	None
28442	28443	and	0	None
28443	28444	hD	0	None
28444	28445	(	0	None
28445	28446	2	0	None
28446	28447	)	0	None
28447	28448	receptors	0	None
28448	28449	and	0	None
28449	28450	weak	0	None
28450	28451	affinity	0	None
28451	28452	for	0	None
28452	28453	hD	0	None
28453	28454	(	0	None
28454	28455	3	0	None
28455	28456	)	0	None
28456	28457	receptors	0	None
28457	28458	.	0	None

28459	28460	In	0	None
28460	28461	[	0	None
28461	28462	(	0	None
28462	28463	35	0	None
28463	28464	)	0	None
28464	28465	S	0	None
28465	28466	]	0	None
28466	28467	GTPgammaS	0	None
28467	28468	binding	0	None
28468	28469	protocols	0	None
28469	28470	,	0	None
28470	28471	yohimbine	3	CHEMICAL
28471	28472	exerts	0	None
28472	28473	antagonist	0	None
28473	28474	actions	0	None
28474	28475	at	0	None
28475	28476	halpha	0	None
28476	28477	(	0	None
28477	28478	2A	0	None
28478	28479	)	0	None
28479	28480	-	0	None
28480	28481	AR	1	GENE-Y
28481	28482	,	0	None
28482	28483	h5	0	None
28483	28484	-	0	None
28484	28485	HT	3	CHEMICAL
28485	28486	(	0	None
28486	28487	1B	0	None
28487	28488	)	0	None
28488	28489	,	0	None
28489	28490	h5	0	None
28490	28491	-	0	None
28491	28492	HT	3	CHEMICAL
28492	28493	(	0	None
28493	28494	1D	0	None
28494	28495	)	0	None
28495	28496	,	0	None
28496	28497	and	0	None
28497	28498	hD	0	None
28498	28499	(	0	None
28499	28500	2	0	None
28500	28501	)	0	None
28501	28502	sites	0	None
28502	28503	,	0	None
28503	28504	yet	0	None
28504	28505	partial	0	None
28505	28506	agonist	0	None
28506	28507	actions	0	None
28507	28508	at	0	None
28508	28509	h5	0	None
28509	28510	-	0	None
28510	28511	HT	3	CHEMICAL
28511	28512	(	0	None
28512	28513	1A	0	None
28513	28514	)	0	None
28514	28515	sites	0	None
28515	28516	.	0	None

28517	28518	In	0	None
28518	28519	vivo	0	None
28519	28520	,	0	None
28520	28521	agonist	0	None
28521	28522	actions	0	None
28522	28523	of	0	None
28523	28524	yohimbine	3	CHEMICAL
28524	28525	at	0	None
28525	28526	5	0	None
28526	28527	-	0	None
28527	28528	HT	3	CHEMICAL
28528	28529	(	0	None
28529	28530	1A	0	None
28530	28531	)	0	None
28531	28532	sites	0	None
28532	28533	are	0	None
28533	28534	revealed	0	None
28534	28535	by	0	None
28535	28536	WAY100	0	None
28536	28537	,	0	None
28537	28538	635	0	None
28538	28539	-	0	None
28539	28540	reversible	0	None
28540	28541	induction	0	None
28541	28542	of	0	None
28542	28543	hypothermia	0	None
28543	28544	in	0	None
28544	28545	the	0	None
28545	28546	rat	0	None
28546	28547	.	0	None

28548	28549	In	0	None
28549	28550	guinea	0	None
28550	28551	pigs	0	None
28551	28552	,	0	None
28552	28553	antagonist	0	None
28553	28554	actions	0	None
28554	28555	of	0	None
28555	28556	yohimbine	3	CHEMICAL
28556	28557	at	0	None
28557	28558	5	0	None
28558	28559	-	0	None
28559	28560	HT	3	CHEMICAL
28560	28561	(	0	None
28561	28562	1B	0	None
28562	28563	)	0	None
28563	28564	receptors	0	None
28564	28565	are	0	None
28565	28566	revealed	0	None
28566	28567	by	0	None
28567	28568	blockade	0	None
28568	28569	of	0	None
28569	28570	hypothermia	0	None
28570	28571	evoked	0	None
28571	28572	by	0	None
28572	28573	the	0	None
28573	28574	5	0	None
28574	28575	-	0	None
28575	28576	HT	3	CHEMICAL
28576	28577	(	0	None
28577	28578	1B	0	None
28578	28579	)	0	None
28579	28580	agonist	0	None
28580	28581	,	0	None
28581	28582	GR46	0	None
28582	28583	,	0	None
28583	28584	611	0	None
28584	28585	.	0	None

28586	28587	In	0	None
28587	28588	distinction	0	None
28588	28589	to	0	None
28589	28590	yohimbine	3	CHEMICAL
28590	28591	,	0	None
28591	28592	fluparoxan	3	CHEMICAL
28592	28593	shows	0	None
28593	28594	only	0	None
28594	28595	modest	0	None
28595	28596	partial	0	None
28596	28597	agonist	0	None
28597	28598	actions	0	None
28598	28599	at	0	None
28599	28600	h5	0	None
28600	28601	-	0	None
28601	28602	HT	3	CHEMICAL
28602	28603	(	0	None
28603	28604	1A	0	None
28604	28605	)	0	None
28605	28606	sites	0	None
28606	28607	versus	0	None
28607	28608	marked	0	None
28608	28609	antagonist	0	None
28609	28610	actions	0	None
28610	28611	at	0	None
28611	28612	halpha	0	None
28612	28613	(	0	None
28613	28614	2	0	None
28614	28615	)	0	None
28615	28616	-	0	None
28616	28617	ARs	0	None
28617	28618	.	0	None

28619	28620	While	0	None
28620	28621	fluparoxan	3	CHEMICAL
28621	28622	selectively	0	None
28622	28623	enhances	0	None
28623	28624	hippocampal	0	None
28624	28625	noradrenaline	3	CHEMICAL
28625	28626	(	0	None
28626	28627	NAD	3	CHEMICAL
28627	28628	)	0	None
28628	28629	turnover	0	None
28629	28630	,	0	None
28630	28631	yohimbine	3	CHEMICAL
28631	28632	also	0	None
28632	28633	enhances	0	None
28633	28634	striatal	0	None
28634	28635	dopamine	3	CHEMICAL
28635	28636	(	0	None
28636	28637	DA	3	CHEMICAL
28637	28638	)	0	None
28638	28639	turnover	0	None
28639	28640	and	0	None
28640	28641	suppresses	0	None
28641	28642	striatal	0	None
28642	28643	turnover	0	None
28643	28644	of	0	None
28644	28645	5	0	None
28645	28646	-	0	None
28646	28647	HT	3	CHEMICAL
28647	28648	.	0	None

28649	28650	Further	0	None
28650	28651	,	0	None
28651	28652	yohimbine	3	CHEMICAL
28652	28653	decreases	0	None
28653	28654	firing	0	None
28654	28655	of	0	None
28655	28656	serotonergic	0	None
28656	28657	neurones	0	None
28657	28658	in	0	None
28658	28659	raphe	0	None
28659	28660	nuclei	0	None
28660	28661	,	0	None
28661	28662	an	0	None
28662	28663	action	0	None
28663	28664	reversed	0	None
28664	28665	by	0	None
28665	28666	WAY100	0	None
28666	28667	,	0	None
28667	28668	635	0	None
28668	28669	.	0	None

28670	28671	Fluparoxan	3	CHEMICAL
28671	28672	increases	0	None
28672	28673	extracellular	3	CHEMICAL
28673	28674	levels	0	None
28674	28675	of	0	None
28675	28676	DA	3	CHEMICAL
28676	28677	and	0	None
28677	28678	NAD	3	CHEMICAL
28678	28679	,	0	None
28679	28680	but	0	None
28680	28681	not	0	None
28681	28682	5	0	None
28682	28683	-	0	None
28683	28684	HT	3	CHEMICAL
28684	28685	,	0	None
28685	28686	in	0	None
28686	28687	frontal	0	None
28687	28688	cortex	0	None
28688	28689	.	0	None

28690	28691	In	0	None
28691	28692	analogy	0	None
28692	28693	,	0	None
28693	28694	yohimbine	3	CHEMICAL
28694	28695	enhances	0	None
28695	28696	FCX	0	None
28696	28697	levels	0	None
28697	28698	of	0	None
28698	28699	DA	3	CHEMICAL
28699	28700	and	0	None
28700	28701	NAD	3	CHEMICAL
28701	28702	,	0	None
28702	28703	yet	0	None
28703	28704	suppresses	0	None
28704	28705	those	0	None
28705	28706	of	0	None
28706	28707	5	0	None
28707	28708	-	0	None
28708	28709	HT	3	CHEMICAL
28709	28710	,	0	None
28710	28711	the	0	None
28711	28712	latter	0	None
28712	28713	effect	0	None
28713	28714	being	0	None
28714	28715	antagonized	0	None
28715	28716	by	0	None
28716	28717	WAY100	0	None
28717	28718	,	0	None
28718	28719	635	0	None
28719	28720	.	0	None

28721	28722	The	0	None
28722	28723	induction	0	None
28723	28724	by	0	None
28724	28725	fluoxetine	3	CHEMICAL
28725	28726	of	0	None
28726	28727	FCX	0	None
28727	28728	levels	0	None
28728	28729	of	0	None
28729	28730	5	0	None
28730	28731	-	0	None
28731	28732	HT	3	CHEMICAL
28732	28733	,	0	None
28733	28734	DA	3	CHEMICAL
28734	28735	,	0	None
28735	28736	and	0	None
28736	28737	NAD	3	CHEMICAL
28737	28738	is	0	None
28738	28739	potentiated	0	None
28739	28740	by	0	None
28740	28741	fluparoxan	3	CHEMICAL
28741	28742	.	0	None

28743	28744	Yohimbine	0	None
28744	28745	likewise	0	None
28745	28746	facilitates	0	None
28746	28747	the	0	None
28747	28748	influence	0	None
28748	28749	of	0	None
28749	28750	fluoxetine	3	CHEMICAL
28750	28751	upon	0	None
28751	28752	DA	3	CHEMICAL
28752	28753	and	0	None
28753	28754	NAD	3	CHEMICAL
28754	28755	levels	0	None
28755	28756	,	0	None
28756	28757	but	0	None
28757	28758	not	0	None
28758	28759	those	0	None
28759	28760	of	0	None
28760	28761	5	0	None
28761	28762	-	0	None
28762	28763	HT	3	CHEMICAL
28763	28764	.	0	None

28765	28766	In	0	None
28766	28767	conclusion	0	None
28767	28768	,	0	None
28768	28769	the	0	None
28769	28770	alpha	0	None
28770	28771	(	0	None
28771	28772	2	0	None
28772	28773	)	0	None
28773	28774	-	0	None
28774	28775	AR	1	GENE-Y
28775	28776	antagonist	0	None
28776	28777	properties	0	None
28777	28778	of	0	None
28778	28779	yohimbine	3	CHEMICAL
28779	28780	increase	0	None
28780	28781	DA	3	CHEMICAL
28781	28782	and	0	None
28782	28783	NAD	3	CHEMICAL
28783	28784	levels	0	None
28784	28785	both	0	None
28785	28786	alone	0	None
28786	28787	and	0	None
28787	28788	in	0	None
28788	28789	association	0	None
28789	28790	with	0	None
28790	28791	fluoxetine	3	CHEMICAL
28791	28792	.	0	None

28793	28794	However	0	None
28794	28795	,	0	None
28795	28796	in	0	None
28796	28797	contrast	0	None
28797	28798	to	0	None
28798	28799	the	0	None
28799	28800	selective	0	None
28800	28801	alpha	0	None
28801	28802	(	0	None
28802	28803	2	0	None
28803	28804	)	0	None
28804	28805	-	0	None
28805	28806	AR	1	GENE-Y
28806	28807	antagonist	0	None
28807	28808	,	0	None
28808	28809	fluparoxan	3	CHEMICAL
28809	28810	,	0	None
28810	28811	the	0	None
28811	28812	5	0	None
28812	28813	-	0	None
28813	28814	HT	3	CHEMICAL
28814	28815	(	0	None
28815	28816	1A	0	None
28816	28817	)	0	None
28817	28818	agonist	0	None
28818	28819	actions	0	None
28819	28820	of	0	None
28820	28821	yohimbine	3	CHEMICAL
28821	28822	suppress	0	None
28822	28823	5	0	None
28823	28824	-	0	None
28824	28825	HT	3	CHEMICAL
28825	28826	levels	0	None
28826	28827	alone	0	None
28827	28828	and	0	None
28828	28829	underlie	0	None
28829	28830	its	0	None
28830	28831	inability	0	None
28831	28832	to	0	None
28832	28833	augment	0	None
28833	28834	the	0	None
28834	28835	influence	0	None
28835	28836	of	0	None
28836	28837	fluoxetine	3	CHEMICAL
28837	28838	upon	0	None
28838	28839	5	0	None
28839	28840	-	0	None
28840	28841	HT	3	CHEMICAL
28841	28842	levels	0	None
28842	28843	.	0	None

28844	28845	Pharmacological	0	None
28845	28846	and	0	None
28846	28847	ocular	0	None
28847	28848	hypotensive	0	None
28848	28849	properties	0	None
28849	28850	of	0	None
28850	28853	topical carbonic anhydrase	2	GENE-N
28853	28854	inhibitors	0	None
28854	28855	.	0	None

28856	28857	There	0	None
28857	28858	was	0	None
28858	28859	a	0	None
28859	28860	time	0	None
28860	28861	gap	0	None
28861	28862	of	0	None
28862	28863	over	0	None
28863	28864	40	0	None
28864	28865	years	0	None
28865	28866	between	0	None
28866	28867	the	0	None
28867	28868	demonstrated	0	None
28868	28869	oral	0	None
28869	28870	effectiveness	0	None
28870	28871	of	0	None
28871	28872	acetazolamide	3	CHEMICAL
28872	28873	in	0	None
28873	28874	lowering	0	None
28874	28875	the	0	None
28875	28876	intraocular	0	None
28876	28877	pressure	0	None
28877	28878	(	0	None
28878	28879	IOP	0	None
28879	28880	)	0	None
28880	28881	of	0	None
28881	28882	glaucoma	0	None
28882	28883	patients	0	None
28883	28884	and	0	None
28884	28885	the	0	None
28885	28886	introduction	0	None
28886	28887	of	0	None
28887	28888	a	0	None
28888	28891	topical carbonic anhydrase	2	GENE-N
28891	28892	(	0	None
28892	28893	CA	2	GENE-N
28893	28894	)	0	None
28894	28895	inhibitor	0	None
28895	28896	.	0	None

28897	28898	This	0	None
28898	28899	is	0	None
28899	28900	due	0	None
28900	28901	to	0	None
28901	28902	the	0	None
28902	28903	fact	0	None
28903	28904	that	0	None
28904	28905	CA	2	GENE-N
28905	28906	-	0	None
28906	28907	II	0	None
28907	28908	,	0	None
28908	28909	the	0	None
28909	28910	isoenzyme	0	None
28910	28911	which	0	None
28911	28912	most	0	None
28912	28913	likely	0	None
28913	28914	plays	0	None
28914	28915	an	0	None
28915	28916	important	0	None
28916	28917	role	0	None
28917	28918	in	0	None
28918	28919	the	0	None
28919	28920	production	0	None
28920	28921	of	0	None
28921	28922	aqueous	0	None
28922	28923	humor	0	None
28923	28924	in	0	None
28924	28925	humans	0	None
28925	28926	,	0	None
28926	28927	must	0	None
28927	28928	be	0	None
28928	28929	essentially	0	None
28929	28930	inhibited	0	None
28930	28931	by	0	None
28931	28932	100	0	None
28932	28933	%	0	None
28933	28934	to	0	None
28934	28935	elicit	0	None
28935	28936	a	0	None
28936	28937	pharmacological	0	None
28937	28938	response	0	None
28938	28939	.	0	None

28940	28941	The	0	None
28941	28942	lack	0	None
28942	28943	of	0	None
28943	28944	success	0	None
28944	28945	with	0	None
28945	28946	earlier	0	None
28946	28947	attempts	0	None
28947	28948	to	0	None
28948	28949	obtain	0	None
28949	28950	a	0	None
28950	28951	topical	0	None
28951	28952	agent	0	None
28952	28953	stems	0	None
28953	28954	from	0	None
28954	28955	an	0	None
28955	28956	inability	0	None
28956	28957	to	0	None
28957	28958	attain	0	None
28958	28959	and	0	None
28959	28960	maintain	0	None
28960	28961	a	0	None
28961	28962	sufficiently	0	None
28962	28963	high	0	None
28963	28964	intraocular	0	None
28964	28965	concentration	0	None
28965	28966	of	0	None
28966	28967	drug	0	None
28967	28968	to	0	None
28968	28969	achieve	0	None
28969	28970	the	0	None
28970	28971	required	0	None
28971	28972	inhibition	0	None
28972	28973	of	0	None
28973	28974	CA	2	GENE-N
28974	28975	.	0	None

28976	28977	Dorzolamide	0	None
28977	28978	and	0	None
28978	28979	brinzolamide	3	CHEMICAL
28979	28980	are	0	None
28980	28981	two	0	None
28981	28982	topical	0	None
28982	28983	CA	2	GENE-N
28983	28984	inhibitors	0	None
28984	28985	which	0	None
28985	28986	are	0	None
28986	28987	currently	0	None
28987	28988	available	0	None
28988	28989	to	0	None
28989	28990	treat	0	None
28990	28991	ocular	0	None
28991	28992	hypertension	0	None
28992	28993	and	0	None
28993	28994	/	0	None
28994	28995	or	0	None
28995	28996	glaucoma	0	None
28996	28997	.	0	None

28998	28999	Dorzolamide	0	None
28999	29000	is	0	None
29000	29001	a	0	None
29001	29002	very	0	None
29002	29003	potent	0	None
29003	29004	inhibitor	0	None
29004	29005	of	0	None
29005	29006	CA	2	GENE-N
29006	29007	-	0	None
29007	29008	II	0	None
29008	29009	and	0	None
29009	29010	its	0	None
29010	29011	site	0	None
29011	29012	of	0	None
29012	29013	action	0	None
29013	29014	is	0	None
29014	29015	local	0	None
29015	29016	within	0	None
29016	29017	the	0	None
29017	29018	eye	0	None
29018	29019	.	0	None

29020	29021	Like	0	None
29021	29022	oral	0	None
29022	29023	CA	2	GENE-N
29023	29024	inhibitors	0	None
29024	29025	,	0	None
29025	29026	topically	0	None
29026	29027	applied	0	None
29027	29028	dorzolamide	0	None
29028	29029	lowers	0	None
29029	29030	IOP	0	None
29030	29031	by	0	None
29031	29032	decreasing	0	None
29032	29033	the	0	None
29033	29034	production	0	None
29034	29035	of	0	None
29035	29036	aqueous	0	None
29036	29037	humor	0	None
29037	29038	.	0	None

29039	29040	The	0	None
29040	29041	drug	0	None
29041	29042	is	0	None
29042	29043	used	0	None
29043	29044	in	0	None
29044	29045	monotherapy	0	None
29045	29046	as	0	None
29046	29047	a	0	None
29047	29048	2	0	None
29048	29049	%	0	None
29049	29050	solution	0	None
29050	29051	administered	0	None
29051	29052	three	0	None
29052	29053	times	0	None
29053	29054	daily	0	None
29054	29055	.	0	None

29056	29057	Its	0	None
29057	29058	ocular	0	None
29058	29059	hypotensive	0	None
29059	29060	effect	0	None
29060	29061	is	0	None
29061	29062	comparable	0	None
29062	29063	to	0	None
29063	29064	that	0	None
29064	29065	of	0	None
29065	29066	timolol	3	CHEMICAL
29066	29067	at	0	None
29067	29068	peak	0	None
29068	29069	but	0	None
29069	29070	is	0	None
29070	29071	somewhat	0	None
29071	29072	less	0	None
29072	29073	at	0	None
29073	29074	trough	0	None
29074	29075	.	0	None

29076	29077	The	0	None
29077	29078	IOP	0	None
29078	29079	lowering	0	None
29079	29080	effect	0	None
29080	29081	of	0	None
29081	29082	timolol	3	CHEMICAL
29082	29083	is	0	None
29083	29084	enhanced	0	None
29084	29085	by	0	None
29085	29086	the	0	None
29086	29087	twice	0	None
29087	29088	daily	0	None
29088	29089	administration	0	None
29089	29090	of	0	None
29090	29091	2	0	None
29091	29092	%	0	None
29092	29093	dorzolamide	0	None
29093	29094	either	0	None
29094	29095	concomitantly	0	None
29095	29096	or	0	None
29096	29097	in	0	None
29097	29098	combination	0	None
29098	29099	.	0	None

29100	29101	Topically	0	None
29101	29102	applied	0	None
29102	29103	dorzolamide	0	None
29103	29104	is	0	None
29104	29105	generally	0	None
29105	29106	well	0	None
29106	29107	tolerated	0	None
29107	29108	and	0	None
29108	29109	had	0	None
29109	29110	a	0	None
29110	29111	low	0	None
29111	29112	drop	0	None
29112	29113	-	0	None
29113	29114	out	0	None
29114	29115	rate	0	None
29115	29116	in	0	None
29116	29117	clinical	0	None
29117	29118	studies	0	None
29118	29119	.	0	None

29120	29121	The	0	None
29121	29122	most	0	None
29122	29123	frequent	0	None
29123	29124	ocular	0	None
29124	29125	adverse	0	None
29125	29126	experience	0	None
29126	29127	is	0	None
29127	29128	burning	0	None
29128	29129	and	0	None
29129	29130	/	0	None
29130	29131	or	0	None
29131	29132	stinging	0	None
29132	29133	.	0	None

29134	29135	Corneal	0	None
29135	29136	and	0	None
29136	29137	lenticular	0	None
29137	29138	problems	0	None
29138	29139	have	0	None
29139	29140	generally	0	None
29140	29141	not	0	None
29141	29142	been	0	None
29142	29143	encountered	0	None
29143	29144	with	0	None
29144	29145	long	0	None
29145	29146	-	0	None
29146	29147	term	0	None
29147	29148	therapy	0	None
29148	29149	with	0	None
29149	29150	dorzolamide	0	None
29150	29151	.	0	None

29152	29153	Topically	0	None
29153	29154	applied	0	None
29154	29155	dorzolamide	0	None
29155	29156	penetrates	0	None
29156	29157	directly	0	None
29157	29158	to	0	None
29158	29159	the	0	None
29159	29160	posterior	0	None
29160	29161	segment	0	None
29161	29162	of	0	None
29162	29163	the	0	None
29163	29164	eye	0	None
29164	29165	and	0	None
29165	29166	its	0	None
29166	29167	presence	0	None
29167	29168	is	0	None
29168	29169	consistent	0	None
29169	29170	with	0	None
29170	29171	the	0	None
29171	29172	initial	0	None
29172	29173	report	0	None
29173	29174	that	0	None
29174	29175	dorzolamide	0	None
29175	29176	increases	0	None
29176	29177	retinal	3	CHEMICAL
29177	29178	blood	0	None
29178	29179	flow	0	None
29179	29180	velocity	0	None
29180	29181	in	0	None
29181	29182	patients	0	None
29182	29183	with	0	None
29183	29184	normal	0	None
29184	29185	tension	0	None
29185	29186	glaucoma	0	None
29186	29187	.	0	None

29188	29189	The	0	None
29189	29190	most	0	None
29190	29191	frequent	0	None
29191	29192	systemic	0	None
29192	29193	adverse	0	None
29193	29194	experience	0	None
29194	29195	is	0	None
29195	29196	a	0	None
29196	29197	transient	0	None
29197	29198	bitter	0	None
29198	29199	taste	0	None
29199	29200	.	0	None

29201	29202	Biochemical	0	None
29202	29203	changes	0	None
29203	29204	indicative	0	None
29204	29205	of	0	None
29205	29206	the	0	None
29206	29207	systemic	0	None
29207	29208	inhibition	0	None
29208	29209	of	0	None
29209	29210	CA	2	GENE-N
29210	29211	have	0	None
29211	29212	not	0	None
29212	29213	been	0	None
29213	29214	observed	0	None
29214	29215	in	0	None
29215	29216	monotherapy	0	None
29216	29217	studies	0	None
29217	29218	lasting	0	None
29218	29219	up	0	None
29219	29220	to	0	None
29220	29221	2	0	None
29221	29222	years	0	None
29222	29223	.	0	None

29224	29225	This	0	None
29225	29226	is	0	None
29226	29227	in	0	None
29227	29228	harmony	0	None
29228	29229	with	0	None
29229	29230	the	0	None
29230	29231	inability	0	None
29231	29232	of	0	None
29232	29233	dorzolamide	0	None
29233	29234	at	0	None
29234	29235	steady	0	None
29235	29236	-	0	None
29236	29237	state	0	None
29237	29238	to	0	None
29238	29239	saturate	0	None
29239	29240	CA	2	GENE-N
29240	29241	in	0	None
29241	29242	the	0	None
29242	29243	red	0	None
29243	29244	blood	0	None
29244	29245	cell	0	None
29245	29246	and	0	None
29246	29247	the	0	None
29247	29248	failure	0	None
29248	29249	to	0	None
29249	29250	detect	0	None
29250	29251	its	0	None
29251	29252	presence	0	None
29252	29253	in	0	None
29253	29254	plasma	0	None
29254	29255	.	0	None

29256	29257	A	0	None
29257	29258	1	0	None
29258	29259	%	0	None
29259	29260	suspension	0	None
29260	29261	of	0	None
29261	29262	brinzolamide	3	CHEMICAL
29262	29263	is	0	None
29263	29264	comparable	0	None
29264	29265	to	0	None
29265	29266	2	0	None
29266	29267	%	0	None
29267	29268	dorzolamide	0	None
29268	29269	in	0	None
29269	29270	lowering	0	None
29270	29271	IOP	0	None
29271	29272	,	0	None
29272	29273	both	0	None
29273	29274	drugs	0	None
29274	29275	being	0	None
29275	29276	administered	0	None
29276	29277	three	0	None
29277	29278	times	0	None
29278	29279	daily	0	None
29279	29280	.	0	None

29281	29282	Although	0	None
29282	29283	brinzolamide	3	CHEMICAL
29283	29284	has	0	None
29284	29285	a	0	None
29285	29286	lower	0	None
29286	29287	incidence	0	None
29287	29288	of	0	None
29288	29289	burning	0	None
29289	29290	/	0	None
29290	29291	stinging	0	None
29291	29292	,	0	None
29292	29293	it	0	None
29293	29294	elicits	0	None
29294	29295	more	0	None
29295	29296	blurred	0	None
29296	29297	vision	0	None
29297	29298	.	0	None

29299	29300	Microvessel	0	None
29300	29301	density	0	None
29301	29302	and	0	None
29302	29303	endothelial	0	None
29303	29304	cell	0	None
29304	29305	proliferation	0	None
29305	29306	after	0	None
29306	29307	amifostine	3	CHEMICAL
29307	29308	(	0	None
29308	29309	Ethyol	3	CHEMICAL
29309	29310	)	0	None
29310	29311	administration	0	None
29311	29312	in	0	None
29312	29313	vivo	0	None
29313	29314	.	0	None

29315	29316	BACKGROUND	0	None
29316	29317	:	0	None
29317	29318	As	0	None
29318	29319	amifostine	3	CHEMICAL
29319	29320	is	0	None
29320	29321	rapidly	0	None
29321	29322	metabolised	0	None
29322	29323	by	0	None
29323	29324	the	0	None
29324	29325	membrane	0	None
29325	29326	-	0	None
29326	29327	bound	0	None
29327	29328	and	0	None
29328	29329	capillary	0	None
29329	29331	alkaline phosphatase	2	GENE-N
29331	29332	to	0	None
29332	29333	the	0	None
29333	29334	active	0	None
29334	29335	metabolite	0	None
29335	29336	WR	0	None
29336	29337	-	0	None
29337	29338	1065	0	None
29338	29339	,	0	None
29339	29340	microvessel	0	None
29340	29341	density	0	None
29341	29342	in	0	None
29342	29343	normal	0	None
29343	29344	and	0	None
29344	29345	cancer	0	None
29345	29346	tissue	0	None
29346	29347	may	0	None
29347	29348	influence	0	None
29348	29349	the	0	None
29349	29350	therapeutic	0	None
29350	29351	potential	0	None
29351	29352	of	0	None
29352	29353	the	0	None
29353	29354	pro	0	None
29354	29355	-	0	None
29355	29356	drug	0	None
29356	29357	WR	0	None
29357	29358	-	0	None
29358	29359	2721	0	None
29359	29360	.	0	None

29361	29362	Thus	0	None
29362	29363	,	0	None
29363	29364	it	0	None
29364	29365	is	0	None
29365	29366	of	0	None
29366	29367	interest	0	None
29367	29368	how	0	None
29368	29369	the	0	None
29369	29370	administration	0	None
29370	29371	of	0	None
29371	29372	amifostine	3	CHEMICAL
29372	29373	itself	0	None
29373	29374	alters	0	None
29374	29375	vascular	0	None
29375	29376	density	0	None
29376	29377	.	0	None

29378	29379	MATERIALS	0	None
29379	29380	AND	0	None
29380	29381	METHOD	0	None
29381	29382	:	0	None
29382	29383	For	0	None
29383	29384	this	0	None
29384	29385	study	0	None
29385	29386	fertilized	0	None
29386	29387	eggs	0	None
29387	29388	were	0	None
29388	29389	used	0	None
29389	29390	and	0	None
29390	29391	0	0	None
29391	29392	.	0	None
29392	29393	05	0	None
29393	29394	ml	0	None
29394	29395	amifostine	3	CHEMICAL
29395	29396	(	0	None
29396	29397	25	0	None
29397	29398	.	0	None
29398	29399	7	0	None
29399	29400	micrograms	0	None
29400	29401	)	0	None
29401	29402	was	0	None
29402	29403	injected	0	None
29403	29404	into	0	None
29404	29405	the	0	None
29405	29406	area	0	None
29406	29407	vasculosa	0	None
29407	29408	.	0	None

29409	29410	As	0	None
29410	29411	controls	0	None
29411	29412	untreated	0	None
29412	29413	area	0	None
29413	29414	vasculosa	0	None
29414	29415	were	0	None
29415	29416	examined	0	None
29416	29417	as	0	None
29417	29418	well	0	None
29418	29419	as	0	None
29419	29420	eggs	0	None
29420	29421	treated	0	None
29421	29422	with	0	None
29422	29423	0	0	None
29423	29424	.	0	None
29424	29425	05	0	None
29425	29426	ml	0	None
29426	29427	NaCl	3	CHEMICAL
29427	29428	0	0	None
29428	29429	.	0	None
29429	29430	9	0	None
29430	29431	%	0	None
29431	29432	,	0	None
29432	29433	48	0	None
29433	29434	hr	2	GENE-N
29434	29435	after	0	None
29435	29436	injection	0	None
29436	29437	the	0	None
29437	29438	vascular	0	None
29438	29439	density	0	None
29439	29440	was	0	None
29440	29441	determined	0	None
29441	29442	by	0	None
29442	29443	histometrical	0	None
29443	29444	methods	0	None
29444	29445	.	0	None

29446	29447	Applying	0	None
29447	29448	the	0	None
29448	29449	LAB	0	None
29449	29450	method	0	None
29450	29451	we	0	None
29451	29452	performed	0	None
29452	29453	immunohistochemical	0	None
29453	29454	analysis	0	None
29454	29455	of	0	None
29455	29456	the	0	None
29456	29460	proliferating cell nuclear antigen	1	GENE-Y
29460	29461	of	0	None
29461	29462	endothelial	0	None
29462	29463	cells	0	None
29463	29464	.	0	None

29465	29466	RESULTS	0	None
29466	29467	:	0	None
29467	29468	There	0	None
29468	29469	was	0	None
29469	29470	a	0	None
29470	29471	significant	0	None
29471	29472	(	0	None
29472	29473	p	0	None
29473	29474	<	0	None
29474	29475	0	0	None
29475	29476	.	0	None
29476	29477	001	0	None
29477	29478	)	0	None
29478	29479	difference	0	None
29479	29480	in	0	None
29480	29481	vascular	0	None
29481	29482	density	0	None
29482	29483	with	0	None
29483	29484	a	0	None
29484	29485	mean	0	None
29485	29486	microvessel	0	None
29486	29487	count	0	None
29487	29488	of	0	None
29488	29489	25	0	None
29489	29490	.	0	None
29490	29491	08	0	None
29491	29492	(	0	None
29492	29493	+	0	None
29493	29494	/	0	None
29494	29495	-	0	None
29495	29496	8	0	None
29496	29497	.	0	None
29497	29498	45	0	None
29498	29499	SD	0	None
29499	29500	)	0	None
29500	29501	vascular	0	None
29501	29502	intersections	0	None
29502	29503	/	0	None
29503	29504	mm2	0	None
29504	29505	in	0	None
29505	29506	the	0	None
29506	29507	untreated	0	None
29507	29508	control	0	None
29508	29509	,	0	None
29509	29510	30	0	None
29510	29511	.	0	None
29511	29512	40	0	None
29512	29513	(	0	None
29513	29514	+	0	None
29514	29515	/	0	None
29515	29516	-	0	None
29516	29517	12	0	None
29517	29518	.	0	None
29518	29519	84	0	None
29519	29520	SD	0	None
29520	29521	)	0	None
29521	29522	in	0	None
29522	29523	the	0	None
29523	29524	NaCl	3	CHEMICAL
29524	29525	control	0	None
29525	29526	and	0	None
29526	29527	53	0	None
29527	29528	.	0	None
29528	29529	69	0	None
29529	29530	(	0	None
29530	29531	+	0	None
29531	29532	/	0	None
29532	29533	-	0	None
29533	29534	24	0	None
29534	29535	.	0	None
29535	29536	56	0	None
29536	29537	SD	0	None
29537	29538	)	0	None
29538	29539	in	0	None
29539	29540	the	0	None
29540	29541	amifostine	3	CHEMICAL
29541	29542	treated	0	None
29542	29543	area	0	None
29543	29544	.	0	None

29545	29546	There	0	None
29546	29547	was	0	None
29547	29548	also	0	None
29548	29549	a	0	None
29549	29550	significant	0	None
29550	29551	(	0	None
29551	29552	p	0	None
29552	29553	<	0	None
29553	29554	0	0	None
29554	29555	.	0	None
29555	29556	001	0	None
29556	29557	)	0	None
29557	29558	difference	0	None
29558	29559	in	0	None
29559	29560	endothelial	0	None
29560	29561	cell	0	None
29561	29562	proliferation	0	None
29562	29563	(	0	None
29563	29564	PCNA	1	GENE-Y
29564	29565	)	0	None
29565	29566	between	0	None
29566	29567	untreated	0	None
29567	29568	controls	0	None
29568	29569	with	0	None
29569	29570	a	0	None
29570	29571	mean	0	None
29571	29572	PCNA	1	GENE-Y
29572	29573	positivity	0	None
29573	29574	of	0	None
29574	29575	14	0	None
29575	29576	.	0	None
29576	29577	05	0	None
29577	29578	(	0	None
29578	29579	+	0	None
29579	29580	/	0	None
29580	29581	-	0	None
29581	29582	5	0	None
29582	29583	.	0	None
29583	29584	28	0	None
29584	29585	SD	0	None
29585	29586	)	0	None
29586	29587	and	0	None
29587	29588	amifostine	3	CHEMICAL
29588	29589	treated	0	None
29589	29590	area	0	None
29590	29591	vasculosa	0	None
29591	29592	with	0	None
29592	29593	a	0	None
29593	29594	mean	0	None
29594	29595	PCNA	1	GENE-Y
29595	29596	positivity	0	None
29596	29597	of	0	None
29597	29598	32	0	None
29598	29599	.	0	None
29599	29600	22	0	None
29600	29601	(	0	None
29601	29602	+	0	None
29602	29603	/	0	None
29603	29604	-	0	None
29604	29605	18	0	None
29605	29606	.	0	None
29606	29607	14	0	None
29607	29608	SD	0	None
29608	29609	)	0	None
29609	29610	.	0	None

29611	29612	CONCLUSION	0	None
29612	29613	:	0	None
29613	29614	A	0	None
29614	29615	single	0	None
29615	29616	dose	0	None
29616	29617	administration	0	None
29617	29618	of	0	None
29618	29619	25	0	None
29619	29620	.	0	None
29620	29621	7	0	None
29621	29622	micrograms	0	None
29622	29623	amifostine	3	CHEMICAL
29623	29624	induces	0	None
29624	29625	endothelial	0	None
29625	29626	cell	0	None
29626	29627	proliferation	0	None
29627	29628	and	0	None
29628	29629	subsequent	0	None
29629	29630	neovascularisation	0	None
29630	29631	in	0	None
29631	29632	the	0	None
29632	29633	area	0	None
29633	29634	vasculosa	0	None
29634	29635	of	0	None
29635	29636	the	0	None
29636	29637	fertilised	0	None
29637	29638	egg	0	None
29638	29639	.	0	None

29640	29641	Biochemically	0	None
29641	29642	based	0	None
29642	29643	design	0	None
29643	29644	of	0	None
29644	29645	cyclooxygenase	2	GENE-N
29645	29646	-	0	None
29646	29647	2	0	None
29647	29648	(	0	None
29648	29649	COX	2	GENE-N
29649	29650	-	0	None
29650	29651	2	0	None
29651	29652	)	0	None
29652	29653	inhibitors	0	None
29653	29654	:	0	None
29654	29655	facile	0	None
29655	29656	conversion	0	None
29656	29657	of	0	None
29657	29658	nonsteroidal	0	None
29658	29659	antiinflammatory	0	None
29659	29660	drugs	0	None
29660	29661	to	0	None
29661	29662	potent	0	None
29662	29663	and	0	None
29663	29664	highly	0	None
29664	29665	selective	0	None
29665	29666	COX	2	GENE-N
29666	29667	-	0	None
29667	29668	2	0	None
29668	29669	inhibitors	0	None
29669	29670	.	0	None

29671	29672	All	0	None
29672	29673	nonsteroidal	0	None
29673	29674	antiinflammatory	0	None
29674	29675	drugs	0	None
29675	29676	(	0	None
29676	29677	NSAIDs	0	None
29677	29678	)	0	None
29678	29679	inhibit	0	None
29679	29680	the	0	None
29680	29681	cyclooxygenase	2	GENE-N
29681	29682	(	0	None
29682	29683	COX	2	GENE-N
29683	29684	)	0	None
29684	29685	isozymes	0	None
29685	29686	to	0	None
29686	29687	different	0	None
29687	29688	extents	0	None
29688	29689	,	0	None
29689	29690	which	0	None
29690	29691	accounts	0	None
29691	29692	for	0	None
29692	29693	their	0	None
29693	29694	anti	0	None
29694	29695	-	0	None
29695	29696	inflammatory	0	None
29696	29697	and	0	None
29697	29698	analgesic	0	None
29698	29699	activities	0	None
29699	29700	and	0	None
29700	29701	their	0	None
29701	29702	gastrointestinal	0	None
29702	29703	side	0	None
29703	29704	effects	0	None
29704	29705	.	0	None

29706	29707	We	0	None
29707	29708	have	0	None
29708	29709	exploited	0	None
29709	29710	biochemical	0	None
29710	29711	differences	0	None
29711	29712	between	0	None
29712	29713	the	0	None
29713	29714	two	0	None
29714	29715	COX	2	GENE-N
29715	29716	enzymes	0	None
29716	29717	to	0	None
29717	29718	identify	0	None
29718	29719	a	0	None
29719	29720	strategy	0	None
29720	29721	for	0	None
29721	29722	converting	0	None
29722	29723	carboxylate	0	None
29723	29724	-	0	None
29724	29725	containing	0	None
29725	29726	NSAIDs	0	None
29726	29727	into	0	None
29727	29728	selective	0	None
29728	29729	COX	2	GENE-N
29729	29730	-	0	None
29730	29731	2	0	None
29731	29732	inhibitors	0	None
29732	29733	.	0	None

29734	29735	Derivatization	0	None
29735	29736	of	0	None
29736	29737	the	0	None
29737	29738	carboxylate	0	None
29738	29739	moiety	0	None
29739	29740	in	0	None
29740	29741	moderately	0	None
29741	29742	selective	0	None
29742	29743	COX	2	GENE-N
29743	29744	-	0	None
29744	29745	1	0	None
29745	29746	inhibitors	0	None
29746	29747	,	0	None
29747	29748	such	0	None
29748	29749	as	0	None
29749	29750	5	0	None
29750	29751	,	0	None
29751	29752	8	0	None
29752	29753	,	0	None
29753	29754	11	0	None
29754	29755	,	0	None
29755	29756	14	0	None
29756	29757	-	0	None
29757	29758	eicosatetraynoic	0	None
29758	29759	acid	0	None
29759	29760	(	0	None
29760	29761	ETYA	3	CHEMICAL
29761	29762	)	0	None
29762	29763	and	0	None
29763	29764	arylacetic	3	CHEMICAL
29764	29765	and	0	None
29765	29767	fenamic acid	3	CHEMICAL
29767	29768	NSAIDs	0	None
29768	29769	,	0	None
29769	29770	exemplified	0	None
29770	29771	by	0	None
29771	29772	indomethacin	3	CHEMICAL
29772	29773	and	0	None
29773	29775	meclofenamic acid	3	CHEMICAL
29775	29776	,	0	None
29776	29777	respectively	0	None
29777	29778	,	0	None
29778	29779	generated	0	None
29779	29780	potent	0	None
29780	29781	and	0	None
29781	29782	selective	0	None
29782	29783	COX	2	GENE-N
29783	29784	-	0	None
29784	29785	2	0	None
29785	29786	inhibitors	0	None
29786	29787	.	0	None

29788	29789	In	0	None
29789	29790	the	0	None
29790	29791	indomethacin	3	CHEMICAL
29791	29792	series	0	None
29792	29793	,	0	None
29793	29794	esters	3	CHEMICAL
29794	29795	and	0	None
29795	29799	primary and secondary amides	3	CHEMICAL
29799	29800	are	0	None
29800	29801	superior	0	None
29801	29802	to	0	None
29802	29804	tertiary amides	3	CHEMICAL
29804	29805	as	0	None
29805	29806	selective	0	None
29806	29807	inhibitors	0	None
29807	29808	.	0	None

29809	29810	Only	0	None
29810	29811	the	0	None
29811	29812	amide	3	CHEMICAL
29812	29813	derivatives	0	None
29813	29814	of	0	None
29814	29815	ETYA	3	CHEMICAL
29815	29816	and	0	None
29816	29818	meclofenamic acid	3	CHEMICAL
29818	29819	inhibit	0	None
29819	29820	COX	2	GENE-N
29820	29821	-	0	None
29821	29822	2	0	None
29822	29823	;	0	None
29823	29824	the	0	None
29824	29825	esters	3	CHEMICAL
29825	29826	are	0	None
29826	29827	either	0	None
29827	29828	inactive	0	None
29828	29829	or	0	None
29829	29830	nonselective	0	None
29830	29831	.	0	None

29832	29833	Inhibition	0	None
29833	29834	kinetics	0	None
29834	29835	reveal	0	None
29835	29836	that	0	None
29836	29838	indomethacin amides	3	CHEMICAL
29838	29839	behave	0	None
29839	29840	as	0	None
29840	29841	slow	0	None
29841	29842	,	0	None
29842	29843	tight	0	None
29843	29844	-	0	None
29844	29845	binding	0	None
29845	29846	inhibitors	0	None
29846	29847	of	0	None
29847	29848	COX	2	GENE-N
29848	29849	-	0	None
29849	29850	2	0	None
29850	29851	and	0	None
29851	29852	that	0	None
29852	29853	selectivity	0	None
29853	29854	is	0	None
29854	29855	a	0	None
29855	29856	function	0	None
29856	29857	of	0	None
29857	29858	the	0	None
29858	29859	time	0	None
29859	29860	-	0	None
29860	29861	dependent	0	None
29861	29862	step	0	None
29862	29863	.	0	None

29864	29865	Site	0	None
29865	29866	-	0	None
29866	29867	directed	0	None
29867	29868	mutagenesis	0	None
29868	29869	of	0	None
29869	29870	murine	0	None
29870	29871	COX	2	GENE-N
29871	29872	-	0	None
29872	29873	2	0	None
29873	29874	indicates	0	None
29874	29875	that	0	None
29875	29876	the	0	None
29876	29877	molecular	0	None
29877	29878	basis	0	None
29878	29879	for	0	None
29879	29880	selectivity	0	None
29880	29881	differs	0	None
29881	29882	from	0	None
29882	29883	the	0	None
29883	29884	parent	0	None
29884	29885	NSAIDs	0	None
29885	29886	and	0	None
29886	29887	from	0	None
29887	29888	diarylheterocycles	0	None
29888	29889	.	0	None

29890	29891	Selectivity	0	None
29891	29892	arises	0	None
29892	29893	from	0	None
29893	29894	novel	0	None
29894	29895	interactions	0	None
29895	29896	at	0	None
29896	29897	the	0	None
29897	29898	opening	0	None
29898	29899	and	0	None
29899	29900	at	0	None
29900	29901	the	0	None
29901	29902	apex	0	None
29902	29903	of	0	None
29903	29904	the	0	None
29904	29905	substrate	0	None
29905	29906	-	0	None
29906	29907	binding	0	None
29907	29908	site	0	None
29908	29909	.	0	None

29910	29911	Lead	0	None
29911	29912	compounds	0	None
29912	29913	in	0	None
29913	29914	the	0	None
29914	29915	present	0	None
29915	29916	study	0	None
29916	29917	are	0	None
29917	29918	potent	0	None
29918	29919	inhibitors	0	None
29919	29920	of	0	None
29920	29921	COX	2	GENE-N
29921	29922	-	0	None
29922	29923	2	0	None
29923	29924	activity	0	None
29924	29925	in	0	None
29925	29926	cultured	0	None
29926	29927	inflammatory	0	None
29927	29928	cells	0	None
29928	29929	.	0	None

29930	29931	Furthermore	0	None
29931	29932	,	0	None
29932	29934	indomethacin amides	3	CHEMICAL
29934	29935	are	0	None
29935	29936	orally	0	None
29936	29937	active	0	None
29937	29938	,	0	None
29938	29939	nonulcerogenic	0	None
29939	29940	,	0	None
29940	29941	anti	0	None
29941	29942	-	0	None
29942	29943	inflammatory	0	None
29943	29944	agents	0	None
29944	29945	in	0	None
29945	29946	an	0	None
29946	29947	in	0	None
29947	29948	vivo	0	None
29948	29949	model	0	None
29949	29950	of	0	None
29950	29951	acute	0	None
29951	29952	inflammation	0	None
29952	29953	.	0	None

29954	29955	Expansion	0	None
29955	29956	of	0	None
29956	29957	this	0	None
29957	29958	approach	0	None
29958	29959	can	0	None
29959	29960	be	0	None
29960	29961	envisioned	0	None
29961	29962	for	0	None
29962	29963	the	0	None
29963	29964	modification	0	None
29964	29965	of	0	None
29965	29966	all	0	None
29966	29968	carboxylic acid	3	CHEMICAL
29968	29969	-	0	None
29969	29970	containing	0	None
29970	29971	NSAIDs	0	None
29971	29972	into	0	None
29972	29973	selective	0	None
29973	29974	COX	2	GENE-N
29974	29975	-	0	None
29975	29976	2	0	None
29976	29977	inhibitors	0	None
29977	29978	.	0	None

29979	29980	The	0	None
29980	29981	antitussive	0	None
29981	29982	activity	0	None
29982	29983	of	0	None
29983	29984	delta	0	None
29984	29985	-	0	None
29985	29987	opioid receptor	2	GENE-N
29987	29988	stimulation	0	None
29988	29989	in	0	None
29989	29990	guinea	0	None
29990	29991	pigs	0	None
29991	29992	.	0	None

29993	29994	In	0	None
29994	29995	this	0	None
29995	29996	study	0	None
29996	29997	,	0	None
29997	29998	the	0	None
29998	29999	activity	0	None
29999	30000	of	0	None
30000	30001	the	0	None
30001	30002	delta	0	None
30002	30003	-	0	None
30003	30005	opioid receptor	2	GENE-N
30005	30006	subtype	0	None
30006	30007	-	0	None
30007	30008	selective	0	None
30008	30009	agonist	0	None
30009	30010	,	0	None
30010	30012	SB 227122	3	CHEMICAL
30012	30013	,	0	None
30013	30014	was	0	None
30014	30015	investigated	0	None
30015	30016	in	0	None
30016	30017	a	0	None
30017	30018	guinea	0	None
30018	30019	pig	0	None
30019	30020	model	0	None
30020	30021	of	0	None
30021	30023	citric acid	3	CHEMICAL
30023	30024	-	0	None
30024	30025	induced	0	None
30025	30026	cough	0	None
30026	30027	.	0	None

30028	30029	Parenteral	0	None
30029	30030	administration	0	None
30030	30031	of	0	None
30031	30032	selective	0	None
30032	30033	agonists	0	None
30033	30034	of	0	None
30034	30035	the	0	None
30035	30036	delta	0	None
30036	30037	-	0	None
30037	30039	opioid receptor	2	GENE-N
30039	30040	(	0	None
30040	30042	SB 227122	3	CHEMICAL
30042	30043	)	0	None
30043	30044	,	0	None
30044	30045	mu	2	GENE-N
30045	30046	-	0	None
30046	30048	opioid receptor	2	GENE-N
30048	30049	(	0	None
30049	30050	codeine	0	None
30050	30051	and	0	None
30051	30052	hydrocodone	3	CHEMICAL
30052	30053	)	0	None
30053	30054	,	0	None
30054	30055	and	0	None
30055	30056	kappa	0	None
30056	30057	-	0	None
30057	30059	opioid receptor	2	GENE-N
30059	30060	(	0	None
30060	30062	BRL 52974	3	CHEMICAL
30062	30063	)	0	None
30063	30064	produced	0	None
30064	30065	dose	0	None
30065	30066	-	0	None
30066	30067	related	0	None
30067	30068	inhibition	0	None
30068	30069	of	0	None
30069	30071	citric acid	3	CHEMICAL
30071	30072	-	0	None
30072	30073	induced	0	None
30073	30074	cough	0	None
30074	30075	with	0	None
30075	30076	ED	0	None
30076	30077	(	0	None
30077	30078	50	0	None
30078	30079	)	0	None
30079	30080	values	0	None
30080	30081	of	0	None
30081	30082	7	0	None
30082	30083	.	0	None
30083	30084	3	0	None
30084	30085	,	0	None
30085	30086	5	0	None
30086	30087	.	0	None
30087	30088	2	0	None
30088	30089	,	0	None
30089	30090	5	0	None
30090	30091	.	0	None
30091	30092	1	0	None
30092	30093	,	0	None
30093	30094	and	0	None
30094	30095	5	0	None
30095	30096	.	0	None
30096	30097	3	0	None
30097	30098	mg	0	None
30098	30099	/	0	None
30099	30100	kg	0	None
30100	30101	,	0	None
30101	30102	respectively	0	None
30102	30103	.	0	None

30104	30105	The	0	None
30105	30106	nonselective	0	None
30106	30108	opioid receptor	2	GENE-N
30108	30109	antagonist	0	None
30109	30110	,	0	None
30110	30111	naloxone	3	CHEMICAL
30111	30112	(	0	None
30112	30113	3	0	None
30113	30114	mg	0	None
30114	30115	/	0	None
30115	30116	kg	0	None
30116	30117	,	0	None
30117	30118	i	0	None
30118	30119	.	0	None
30119	30120	m	0	None
30120	30121	.	0	None
30121	30122	)	0	None
30122	30123	,	0	None
30123	30124	attenuated	0	None
30124	30125	the	0	None
30125	30126	antitussive	0	None
30126	30127	effects	0	None
30127	30128	of	0	None
30128	30129	codeine	0	None
30129	30130	or	0	None
30130	30132	SB 227122	3	CHEMICAL
30132	30133	,	0	None
30133	30134	indicating	0	None
30134	30135	that	0	None
30135	30136	the	0	None
30136	30137	antitussive	0	None
30137	30138	activity	0	None
30138	30139	of	0	None
30139	30140	both	0	None
30140	30141	compounds	0	None
30141	30142	is	0	None
30142	30144	opioid receptor	2	GENE-N
30144	30145	-	0	None
30145	30146	mediated	0	None
30146	30147	.	0	None

30148	30149	The	0	None
30149	30150	delta	0	None
30150	30151	-	0	None
30151	30152	receptor	0	None
30152	30153	antagonist	0	None
30153	30154	,	0	None
30154	30155	SB	0	None
30155	30156	244525	0	None
30156	30157	(	0	None
30157	30158	10	0	None
30158	30159	mg	0	None
30159	30160	/	0	None
30160	30161	kg	0	None
30161	30162	,	0	None
30162	30163	i	0	None
30163	30164	.	0	None
30164	30165	p	0	None
30165	30166	.	0	None
30166	30167	)	0	None
30167	30168	,	0	None
30168	30169	inhibited	0	None
30169	30170	the	0	None
30170	30171	antitussive	0	None
30171	30172	effect	0	None
30172	30173	of	0	None
30173	30175	SB 227122	3	CHEMICAL
30175	30176	(	0	None
30176	30177	20	0	None
30177	30178	mg	0	None
30178	30179	/	0	None
30179	30180	kg	0	None
30180	30181	,	0	None
30181	30182	i	0	None
30182	30183	.	0	None
30183	30184	p	0	None
30184	30185	.	0	None
30185	30186	)	0	None
30186	30187	.	0	None

30188	30189	In	0	None
30189	30190	contrast	0	None
30190	30191	,	0	None
30191	30192	combined	0	None
30192	30193	pretreatment	0	None
30193	30194	with	0	None
30194	30195	beta	0	None
30195	30196	-	0	None
30196	30197	funaltrexamine	0	None
30197	30198	(	0	None
30198	30199	mu	1	GENE-Y
30199	30200	-	0	None
30200	30201	receptor	0	None
30201	30202	antagonist	0	None
30202	30203	;	0	None
30203	30204	20	0	None
30204	30205	mg	0	None
30205	30206	/	0	None
30206	30207	kg	0	None
30207	30208	,	0	None
30208	30209	s	0	None
30209	30210	.	0	None
30210	30211	c	0	None
30211	30212	.	0	None
30212	30213	)	0	None
30213	30214	and	0	None
30214	30215	norbinaltorphimine	3	CHEMICAL
30215	30216	(	0	None
30216	30217	kappa	0	None
30217	30218	-	0	None
30218	30219	receptor	0	None
30219	30220	antagonist	0	None
30220	30221	;	0	None
30221	30222	20	0	None
30222	30223	mg	0	None
30223	30224	/	0	None
30224	30225	kg	0	None
30225	30226	,	0	None
30226	30227	s	0	None
30227	30228	.	0	None
30228	30229	c	0	None
30229	30230	.	0	None
30230	30231	)	0	None
30231	30232	,	0	None
30232	30233	at	0	None
30233	30234	doses	0	None
30234	30235	that	0	None
30235	30236	inhibited	0	None
30236	30237	the	0	None
30237	30238	antitussive	0	None
30238	30239	activity	0	None
30239	30240	of	0	None
30240	30241	mu	1	GENE-Y
30241	30242	-	0	None
30242	30243	and	0	None
30243	30244	kappa	0	None
30244	30245	-	0	None
30245	30246	receptor	0	None
30246	30247	agonists	0	None
30247	30248	,	0	None
30248	30249	respectively	0	None
30249	30250	,	0	None
30250	30251	was	0	None
30251	30252	without	0	None
30252	30253	effect	0	None
30253	30254	on	0	None
30254	30255	the	0	None
30255	30256	antitussive	0	None
30256	30257	response	0	None
30257	30258	of	0	None
30258	30260	SB 227122	3	CHEMICAL
30260	30261	(	0	None
30261	30262	20	0	None
30262	30263	mg	0	None
30263	30264	/	0	None
30264	30265	kg	0	None
30265	30266	,	0	None
30266	30267	i	0	None
30267	30268	.	0	None
30268	30269	p	0	None
30269	30270	.	0	None
30270	30271	)	0	None
30271	30272	.	0	None

30273	30274	The	0	None
30274	30275	sigma	1	GENE-Y
30275	30276	-	0	None
30276	30277	receptor	0	None
30277	30278	antagonist	0	None
30278	30279	rimcazole	3	CHEMICAL
30279	30280	(	0	None
30280	30281	3	0	None
30281	30282	mg	0	None
30282	30283	/	0	None
30283	30284	kg	0	None
30284	30285	,	0	None
30285	30286	i	0	None
30286	30287	.	0	None
30287	30288	p	0	None
30288	30289	.	0	None
30289	30290	)	0	None
30290	30291	inhibited	0	None
30291	30292	the	0	None
30292	30293	antitussive	0	None
30293	30294	effect	0	None
30294	30295	of	0	None
30295	30296	dextromethorphan	3	CHEMICAL
30296	30297	(	0	None
30297	30298	30	0	None
30298	30299	mg	0	None
30299	30300	/	0	None
30300	30301	kg	0	None
30301	30302	,	0	None
30302	30303	i	0	None
30303	30304	.	0	None
30304	30305	p	0	None
30305	30306	.	0	None
30306	30307	)	0	None
30307	30308	,	0	None
30308	30309	a	0	None
30309	30310	sigma	1	GENE-Y
30310	30311	-	0	None
30311	30312	receptor	0	None
30312	30313	agonist	0	None
30313	30314	,	0	None
30314	30315	but	0	None
30315	30316	not	0	None
30316	30317	that	0	None
30317	30318	of	0	None
30318	30320	SB 227122	3	CHEMICAL
30320	30321	.	0	None

30322	30323	These	0	None
30323	30324	studies	0	None
30324	30325	provide	0	None
30325	30326	compelling	0	None
30326	30327	evidence	0	None
30327	30328	that	0	None
30328	30329	the	0	None
30329	30330	antitussive	0	None
30330	30331	effects	0	None
30331	30332	of	0	None
30332	30334	SB 227122	3	CHEMICAL
30334	30335	in	0	None
30335	30336	this	0	None
30336	30337	guinea	0	None
30337	30338	pig	0	None
30338	30339	cough	0	None
30339	30340	model	0	None
30340	30341	are	0	None
30341	30342	mediated	0	None
30342	30343	by	0	None
30343	30344	agonist	0	None
30344	30345	activity	0	None
30345	30346	at	0	None
30346	30347	the	0	None
30347	30348	delta	0	None
30348	30349	-	0	None
30349	30351	opioid receptor	2	GENE-N
30351	30352	.	0	None

30353	30354	COX	2	GENE-N
30354	30355	-	0	None
30355	30356	2	0	None
30356	30357	-	0	None
30357	30358	specific	0	None
30358	30359	inhibition	0	None
30359	30360	:	0	None
30360	30361	implications	0	None
30361	30362	for	0	None
30362	30363	clinical	0	None
30363	30364	practice	0	None
30364	30365	.	0	None

30366	30367	Although	0	None
30367	30368	conventional	0	None
30368	30369	nonsteroidal	0	None
30369	30370	anti	0	None
30370	30371	-	0	None
30371	30372	inflammatory	0	None
30372	30373	drugs	0	None
30373	30374	(	0	None
30374	30375	NSAIDs	0	None
30375	30376	)	0	None
30376	30377	have	0	None
30377	30378	long	0	None
30378	30379	been	0	None
30379	30380	a	0	None
30380	30381	major	0	None
30381	30382	therapeutic	0	None
30382	30383	choice	0	None
30383	30384	for	0	None
30384	30385	the	0	None
30385	30386	management	0	None
30386	30387	of	0	None
30387	30388	arthritic	0	None
30388	30389	conditions	0	None
30389	30390	,	0	None
30390	30391	the	0	None
30391	30392	potential	0	None
30392	30393	adverse	0	None
30393	30394	effects	0	None
30394	30395	of	0	None
30395	30396	these	0	None
30396	30397	agents	0	None
30397	30398	sometimes	0	None
30398	30399	compromise	0	None
30399	30400	their	0	None
30400	30401	clinical	0	None
30401	30402	utility	0	None
30402	30403	.	0	None

30404	30405	New	0	None
30405	30406	modes	0	None
30406	30407	of	0	None
30407	30408	therapy	0	None
30408	30409	have	0	None
30409	30410	recently	0	None
30410	30411	been	0	None
30411	30412	introduced	0	None
30412	30413	,	0	None
30413	30414	and	0	None
30414	30415	data	0	None
30415	30416	on	0	None
30416	30417	the	0	None
30417	30418	cyclooxygenase	2	GENE-N
30418	30419	-	0	None
30419	30420	2	0	None
30420	30421	(	0	None
30421	30422	COX	2	GENE-N
30422	30423	-	0	None
30423	30424	2	0	None
30424	30425	)	0	None
30425	30426	-	0	None
30426	30427	specific	0	None
30427	30428	inhibitors	0	None
30428	30429	celecoxib	3	CHEMICAL
30429	30430	and	0	None
30430	30431	rofecoxib	3	CHEMICAL
30431	30432	suggest	0	None
30432	30433	that	0	None
30433	30434	these	0	None
30434	30435	agents	0	None
30435	30436	will	0	None
30436	30437	meet	0	None
30437	30438	the	0	None
30438	30439	need	0	None
30439	30440	for	0	None
30440	30441	safe	0	None
30441	30442	and	0	None
30442	30443	effective	0	None
30443	30444	therapeutic	0	None
30444	30445	alternatives	0	None
30445	30446	to	0	None
30446	30447	conventional	0	None
30447	30448	NSAIDs	0	None
30448	30449	.	0	None

30450	30451	A	0	None
30451	30452	review	0	None
30452	30453	of	0	None
30453	30454	recent	0	None
30454	30455	advances	0	None
30455	30456	on	0	None
30456	30457	the	0	None
30457	30458	regulation	0	None
30458	30459	of	0	None
30459	30460	pigmentation	0	None
30460	30461	in	0	None
30461	30462	the	0	None
30462	30463	human	0	None
30463	30464	epidermis	0	None
30464	30465	.	0	None

30466	30467	It	0	None
30467	30468	has	0	None
30468	30469	been	0	None
30469	30470	recognised	0	None
30470	30471	that	0	None
30471	30472	the	0	None
30472	30473	active	0	None
30473	30474	transport	0	None
30474	30475	of	0	None
30475	30476	L	0	None
30476	30477	-	0	None
30477	30478	phenylalanine	3	CHEMICAL
30478	30479	and	0	None
30479	30480	its	0	None
30480	30481	autocrine	0	None
30481	30482	turnover	0	None
30482	30483	to	0	None
30483	30484	L	0	None
30484	30485	-	0	None
30485	30486	tyrosine	3	CHEMICAL
30486	30487	via	0	None
30487	30489	phenylalanine hydroxylase	1	GENE-Y
30489	30490	in	0	None
30490	30491	the	0	None
30491	30492	cytosol	0	None
30492	30493	of	0	None
30493	30494	epidermal	0	None
30494	30495	melanocytes	0	None
30495	30496	provides	0	None
30496	30497	the	0	None
30497	30498	majority	0	None
30498	30499	of	0	None
30499	30500	the	0	None
30500	30501	L	0	None
30501	30502	-	0	None
30502	30503	tyrosine	3	CHEMICAL
30503	30504	pool	0	None
30504	30505	for	0	None
30505	30506	melanogenesis	0	None
30506	30507	.	0	None

30508	30509	In	0	None
30509	30510	this	0	None
30510	30511	context	0	None
30511	30512	,	0	None
30512	30513	it	0	None
30513	30514	has	0	None
30514	30515	been	0	None
30515	30516	shown	0	None
30516	30517	that	0	None
30517	30518	the	0	None
30518	30519	cofactor	0	None
30519	30520	6	0	None
30520	30521	(	0	None
30521	30522	R	0	None
30522	30523	)	0	None
30523	30524	-	0	None
30524	30525	L	0	None
30525	30526	-	0	None
30526	30527	erythro	0	None
30527	30528	5	0	None
30528	30529	,	0	None
30529	30530	6	0	None
30530	30531	,	0	None
30531	30532	7	0	None
30532	30533	,	0	None
30533	30534	8	0	None
30534	30535	tetrahydrobiopterin	3	CHEMICAL
30535	30536	(	0	None
30536	30537	6BH4	0	None
30537	30538	)	0	None
30538	30539	is	0	None
30539	30540	produced	0	None
30540	30541	de	0	None
30541	30542	novo	0	None
30542	30543	,	0	None
30543	30544	recycled	0	None
30544	30545	and	0	None
30545	30546	regulated	0	None
30546	30547	in	0	None
30547	30548	both	0	None
30548	30549	epidermal	0	None
30549	30550	melanocytes	0	None
30550	30551	and	0	None
30551	30552	keratinocytes	0	None
30552	30553	to	0	None
30553	30554	control	0	None
30554	30556	tyrosine hydroxylase	1	GENE-Y
30556	30557	,	0	None
30557	30559	phenylalanine hydroxylase	1	GENE-Y
30559	30560	and	0	None
30560	30561	tyrosinase	1	GENE-Y
30561	30562	activity	0	None
30562	30563	.	0	None

30564	30565	Inhibition	0	None
30565	30566	of	0	None
30566	30567	the	0	None
30567	30568	enzymes	0	None
30568	30569	by	0	None
30569	30570	excessive	0	None
30570	30571	6BH4	0	None
30571	30572	levels	0	None
30572	30573	is	0	None
30573	30574	reversible	0	None
30574	30575	with	0	None
30575	30576	alpha	0	None
30576	30577	-	0	None
30577	30578	MSH	1	GENE-Y
30578	30579	by	0	None
30579	30580	specific	0	None
30580	30581	complex	0	None
30581	30582	formation	0	None
30582	30583	between	0	None
30583	30584	6BH4	0	None
30584	30585	and	0	None
30585	30586	the	0	None
30586	30587	hormone	0	None
30587	30588	.	0	None

30589	30590	This	0	None
30590	30591	direct	0	None
30591	30592	mechanism	0	None
30592	30593	of	0	None
30593	30594	alpha	0	None
30594	30595	-	0	None
30595	30596	MSH	1	GENE-Y
30596	30597	is	0	None
30597	30598	supported	0	None
30598	30599	by	0	None
30599	30600	the	0	None
30600	30601	presence	0	None
30601	30602	of	0	None
30602	30603	the	0	None
30603	30604	entire	0	None
30604	30605	POMC	1	GENE-Y
30605	30606	processing	0	None
30606	30607	system	0	None
30607	30608	in	0	None
30608	30609	the	0	None
30609	30610	melanosome	0	None
30610	30611	indicating	0	None
30611	30612	a	0	None
30612	30613	receptor	0	None
30613	30614	independent	0	None
30614	30615	control	0	None
30615	30616	of	0	None
30616	30617	eumelanogenesis	0	None
30617	30618	.	0	None

30619	30620	Finally	0	None
30620	30621	,	0	None
30621	30622	the	0	None
30622	30623	role	0	None
30623	30624	of	0	None
30624	30625	tyrosinase	1	GENE-Y
30625	30626	,	0	None
30626	30627	TRP	0	None
30627	30628	-	0	None
30628	30629	1	0	None
30629	30630	and	0	None
30630	30631	TRP2	1	GENE-Y
30631	30632	is	0	None
30632	30633	discussed	0	None
30633	30634	in	0	None
30634	30635	association	0	None
30635	30636	with	0	None
30636	30637	oxidative	0	None
30637	30638	stress	0	None
30638	30639	specifically	0	None
30639	30640	related	0	None
30640	30641	to	0	None
30641	30643	hydrogen peroxide	3	CHEMICAL
30643	30644	.	0	None

30645	30646	These	0	None
30646	30647	recent	0	None
30647	30648	findings	0	None
30648	30649	are	0	None
30649	30650	based	0	None
30650	30651	on	0	None
30651	30652	detailed	0	None
30652	30653	investigations	0	None
30653	30654	of	0	None
30654	30655	the	0	None
30655	30656	depigmentation	0	None
30656	30657	disorder	0	None
30657	30658	vitiligo	0	None
30658	30659	and	0	None
30659	30660	Hermansky	0	None
30660	30661	-	0	None
30661	30662	Pudlak	0	None
30662	30663	syndrome	0	None
30663	30664	.	0	None

30665	30666	24R	0	None
30666	30667	,	0	None
30667	30668	25	0	None
30668	30669	-	0	None
30669	30670	(	0	None
30670	30671	OH	0	None
30671	30672	)	0	None
30672	30673	(	0	None
30673	30674	2	0	None
30674	30675	)	0	None
30675	30676	D	0	None
30676	30677	(	0	None
30677	30678	3	0	None
30678	30679	)	0	None
30679	30680	mediates	0	None
30680	30681	its	0	None
30681	30682	membrane	0	None
30682	30683	receptor	0	None
30683	30684	-	0	None
30684	30685	dependent	0	None
30685	30686	effects	0	None
30686	30687	on	0	None
30687	30690	protein kinase C	1	GENE-Y
30690	30691	and	0	None
30691	30693	alkaline phosphatase	2	GENE-N
30693	30694	via	0	None
30694	30696	phospholipase A	0	None
30696	30697	(	0	None
30697	30698	2	0	None
30698	30699	)	0	None
30699	30700	and	0	None
30700	30701	cyclooxygenase	2	GENE-N
30701	30702	-	0	None
30702	30703	1	0	None
30703	30704	but	0	None
30704	30705	not	0	None
30705	30706	cyclooxygenase	2	GENE-N
30706	30707	-	0	None
30707	30708	2	0	None
30708	30709	in	0	None
30709	30710	growth	0	None
30710	30711	plate	0	None
30711	30712	chondrocytes	0	None
30712	30713	.	0	None

30714	30715	Recent	0	None
30715	30716	studies	0	None
30716	30717	have	0	None
30717	30718	shown	0	None
30718	30719	that	0	None
30719	30720	24R	0	None
30720	30721	,	0	None
30721	30722	25	0	None
30722	30723	-	0	None
30723	30724	(	0	None
30724	30725	OH	0	None
30725	30726	)	0	None
30726	30727	(	0	None
30727	30728	2	0	None
30728	30729	)	0	None
30729	30730	D	0	None
30730	30731	(	0	None
30731	30732	3	0	None
30732	30733	)	0	None
30733	30734	mediates	0	None
30734	30735	its	0	None
30735	30736	effects	0	None
30736	30737	on	0	None
30737	30738	growth	0	None
30738	30739	plate	0	None
30739	30740	chondrocytes	0	None
30740	30741	via	0	None
30741	30742	membrane	0	None
30742	30743	receptors	0	None
30743	30744	.	0	None

30745	30746	This	0	None
30746	30747	study	0	None
30747	30748	examined	0	None
30748	30749	the	0	None
30749	30750	roles	0	None
30750	30751	of	0	None
30751	30753	phospholipase A	2	GENE-N
30753	30754	(	0	None
30754	30755	2	0	None
30755	30756	)	0	None
30756	30757	(	0	None
30757	30758	PLA	3	CHEMICAL
30758	30759	(	0	None
30759	30760	2	0	None
30760	30761	)	0	None
30761	30762	)	0	None
30762	30763	and	0	None
30763	30764	cyclooxygenase	2	GENE-N
30764	30765	(	0	None
30765	30766	Cox	0	None
30766	30767	)	0	None
30767	30768	in	0	None
30768	30769	the	0	None
30769	30770	mechanism	0	None
30770	30771	of	0	None
30771	30772	action	0	None
30772	30773	of	0	None
30773	30774	24R	0	None
30774	30775	,	0	None
30775	30776	25	0	None
30776	30777	-	0	None
30777	30778	(	0	None
30778	30779	OH	0	None
30779	30780	)	0	None
30780	30781	(	0	None
30781	30782	2	0	None
30782	30783	)	0	None
30783	30784	D	0	None
30784	30785	(	0	None
30785	30786	3	0	None
30786	30787	)	0	None
30787	30788	in	0	None
30788	30789	resting	0	None
30789	30790	zone	0	None
30790	30791	chondrocytes	0	None
30791	30792	in	0	None
30792	30793	order	0	None
30793	30794	to	0	None
30794	30795	determine	0	None
30795	30796	whether	0	None
30796	30797	the	0	None
30797	30798	activity	0	None
30798	30799	of	0	None
30799	30800	one	0	None
30800	30801	or	0	None
30801	30802	both	0	None
30802	30803	enzymes	0	None
30803	30804	provides	0	None
30804	30805	a	0	None
30805	30806	regulatory	0	None
30806	30807	checkpoint	1	GENE-Y
30807	30808	in	0	None
30808	30809	the	0	None
30809	30810	signaling	0	None
30810	30811	pathway	0	None
30811	30812	resulting	0	None
30812	30813	in	0	None
30813	30814	increased	0	None
30814	30817	protein kinase C	1	GENE-Y
30817	30818	(	0	None
30818	30819	PKC	2	GENE-N
30819	30820	)	0	None
30820	30821	activity	0	None
30821	30822	.	0	None

30823	30824	We	0	None
30824	30825	also	0	None
30825	30826	determined	0	None
30826	30827	whether	0	None
30827	30828	constitutive	0	None
30828	30829	or	0	None
30829	30830	inducible	0	None
30830	30831	Cox	0	None
30831	30832	is	0	None
30832	30833	involved	0	None
30833	30834	.	0	None

30835	30836	Cultures	0	None
30836	30837	were	0	None
30837	30838	incubated	0	None
30838	30839	with	0	None
30839	30840	24R	0	None
30840	30841	,	0	None
30841	30842	25	0	None
30842	30843	-	0	None
30843	30844	(	0	None
30844	30845	OH	0	None
30845	30846	)	0	None
30846	30847	(	0	None
30847	30848	2	0	None
30848	30849	)	0	None
30849	30850	D	0	None
30850	30851	(	0	None
30851	30852	3	0	None
30852	30853	)	0	None
30853	30854	for	0	None
30854	30855	90	0	None
30855	30856	min	0	None
30856	30857	to	0	None
30857	30858	measure	0	None
30858	30859	PKC	2	GENE-N
30859	30860	or	0	None
30860	30861	for	0	None
30861	30862	24	0	None
30862	30863	h	0	None
30863	30864	to	0	None
30864	30865	measure	0	None
30865	30866	physiological	0	None
30866	30867	responses	0	None
30867	30868	(	0	None
30868	30869	[	0	None
30869	30870	(	0	None
30870	30871	3	0	None
30871	30872	)	0	None
30872	30873	H	0	None
30873	30874	]	0	None
30874	30875	-	0	None
30875	30876	thymidine	3	CHEMICAL
30876	30877	incorporation	0	None
30877	30878	,	0	None
30878	30880	alkaline phosphatase	2	GENE-N
30880	30881	-	0	None
30881	30882	specific	0	None
30882	30883	activity	0	None
30883	30884	,	0	None
30884	30885	[	0	None
30885	30886	(	0	None
30886	30887	35	0	None
30887	30888	)	0	None
30888	30889	S	0	None
30889	30890	]	0	None
30890	30891	-	0	None
30891	30892	sulfate	3	CHEMICAL
30892	30893	incorporation	0	None
30893	30894	)	0	None
30894	30895	.	0	None

30896	30897	Based	0	None
30897	30898	on	0	None
30898	30899	RT	0	None
30899	30900	-	0	None
30900	30901	PCR	0	None
30901	30902	and	0	None
30902	30903	Northern	0	None
30903	30904	blot	0	None
30904	30905	analysis	0	None
30905	30906	,	0	None
30906	30907	resting	0	None
30907	30908	zone	0	None
30908	30909	chondrocytes	0	None
30909	30910	express	0	None
30910	30911	mRNAs	0	None
30911	30912	for	0	None
30912	30913	both	0	None
30913	30914	Cox	0	None
30914	30915	-	0	None
30915	30916	1	0	None
30916	30917	and	0	None
30917	30918	Cox	0	None
30918	30919	-	0	None
30919	30920	2	0	None
30920	30921	.	0	None

30922	30923	Levels	0	None
30923	30924	of	0	None
30924	30925	mRNA	0	None
30925	30926	for	0	None
30926	30927	both	0	None
30927	30928	proteins	0	None
30928	30929	were	0	None
30929	30930	unchanged	0	None
30930	30931	from	0	None
30931	30932	control	0	None
30932	30933	levels	0	None
30933	30934	after	0	None
30934	30935	a	0	None
30935	30936	24	0	None
30936	30937	-	0	None
30937	30938	h	0	None
30938	30939	incubation	0	None
30939	30940	with	0	None
30940	30941	24R	0	None
30941	30942	,	0	None
30942	30943	25	0	None
30943	30944	-	0	None
30944	30945	(	0	None
30945	30946	OH	0	None
30946	30947	)	0	None
30947	30948	(	0	None
30948	30949	2	0	None
30949	30950	)	0	None
30950	30951	D	0	None
30951	30952	(	0	None
30952	30953	3	0	None
30953	30954	)	0	None
30954	30955	.	0	None

30956	30957	To	0	None
30957	30958	examine	0	None
30958	30959	the	0	None
30959	30960	role	0	None
30960	30961	of	0	None
30961	30962	Cox	0	None
30962	30963	,	0	None
30963	30964	the	0	None
30964	30965	cultures	0	None
30965	30966	were	0	None
30966	30967	also	0	None
30967	30968	treated	0	None
30968	30969	with	0	None
30969	30970	resveratrol	3	CHEMICAL
30970	30971	(	0	None
30971	30972	a	0	None
30972	30973	specific	0	None
30973	30974	inhibitor	0	None
30974	30975	of	0	None
30975	30976	Cox	0	None
30976	30977	-	0	None
30977	30978	1	0	None
30978	30979	)	0	None
30979	30980	,	0	None
30980	30981	NS	0	None
30981	30982	-	0	None
30982	30983	398	0	None
30983	30984	(	0	None
30984	30985	a	0	None
30985	30986	specific	0	None
30986	30987	inhibitor	0	None
30987	30988	of	0	None
30988	30989	Cox	0	None
30989	30990	-	0	None
30990	30991	2	0	None
30991	30992	)	0	None
30992	30993	,	0	None
30993	30994	or	0	None
30994	30995	indomethacin	3	CHEMICAL
30995	30996	(	0	None
30996	30997	a	0	None
30997	30998	general	0	None
30998	30999	Cox	0	None
30999	31000	inhibitor	0	None
31000	31001	)	0	None
31001	31002	.	0	None

31003	31004	Cox	0	None
31004	31005	-	0	None
31005	31006	1	0	None
31006	31007	inhibition	0	None
31007	31008	resulted	0	None
31008	31009	in	0	None
31009	31010	effects	0	None
31010	31011	on	0	None
31011	31012	proliferation	0	None
31012	31013	,	0	None
31013	31014	differentiation	0	None
31014	31015	,	0	None
31015	31016	and	0	None
31016	31017	matrix	0	None
31017	31018	production	0	None
31018	31019	typical	0	None
31019	31020	of	0	None
31020	31021	24R	0	None
31021	31022	,	0	None
31022	31023	25	0	None
31023	31024	-	0	None
31024	31025	(	0	None
31025	31026	OH	0	None
31026	31027	)	0	None
31027	31028	(	0	None
31028	31029	2	0	None
31029	31030	)	0	None
31030	31031	D	0	None
31031	31032	(	0	None
31032	31033	3	0	None
31033	31034	)	0	None
31034	31035	.	0	None

31036	31037	In	0	None
31037	31038	contrast	0	None
31038	31039	,	0	None
31039	31040	inhibition	0	None
31040	31041	of	0	None
31041	31042	Cox	0	None
31042	31043	-	0	None
31043	31044	2	0	None
31044	31045	had	0	None
31045	31046	no	0	None
31046	31047	effect	0	None
31047	31048	,	0	None
31048	31049	indicating	0	None
31049	31050	that	0	None
31050	31051	24R	0	None
31051	31052	,	0	None
31052	31053	25	0	None
31053	31054	-	0	None
31054	31055	(	0	None
31055	31056	OH	0	None
31056	31057	)	0	None
31057	31058	(	0	None
31058	31059	2	0	None
31059	31060	)	0	None
31060	31061	D	0	None
31061	31062	(	0	None
31062	31063	3	0	None
31063	31064	)	0	None
31064	31065	exerts	0	None
31065	31066	its	0	None
31066	31067	effects	0	None
31067	31068	via	0	None
31068	31069	Cox	0	None
31069	31070	-	0	None
31070	31071	1	0	None
31071	31072	.	0	None

31073	31074	Inhibition	0	None
31074	31075	of	0	None
31075	31076	Cox	0	None
31076	31077	-	0	None
31077	31078	1	0	None
31078	31079	also	0	None
31079	31080	blocked	0	None
31080	31081	24R	0	None
31081	31082	,	0	None
31082	31083	25	0	None
31083	31084	-	0	None
31084	31085	(	0	None
31085	31086	OH	0	None
31086	31087	)	0	None
31087	31088	(	0	None
31088	31089	2	0	None
31089	31090	)	0	None
31090	31091	D	0	None
31091	31092	(	0	None
31092	31093	3	0	None
31093	31094	)	0	None
31094	31095	-	0	None
31095	31096	dependent	0	None
31096	31097	increases	0	None
31097	31098	in	0	None
31098	31099	PKC	2	GENE-N
31099	31100	.	0	None

31101	31102	Activation	0	None
31102	31103	of	0	None
31103	31104	PLA	3	CHEMICAL
31104	31105	(	0	None
31105	31106	2	0	None
31106	31107	)	0	None
31107	31108	with	0	None
31108	31109	melittin	0	None
31109	31110	inhibited	0	None
31110	31111	24R	0	None
31111	31112	,	0	None
31112	31113	25	0	None
31113	31114	-	0	None
31114	31115	(	0	None
31115	31116	OH	0	None
31116	31117	)	0	None
31117	31118	(	0	None
31118	31119	2	0	None
31119	31120	)	0	None
31120	31121	D	0	None
31121	31122	(	0	None
31122	31123	3	0	None
31123	31124	)	0	None
31124	31125	-	0	None
31125	31126	dependent	0	None
31126	31127	stimulation	0	None
31127	31128	of	0	None
31128	31129	PKC	2	GENE-N
31129	31130	,	0	None
31130	31131	and	0	None
31131	31132	inhibition	0	None
31132	31133	of	0	None
31133	31134	PLA	3	CHEMICAL
31134	31135	(	0	None
31135	31136	2	0	None
31136	31137	)	0	None
31137	31138	with	0	None
31138	31139	quinacrine	3	CHEMICAL
31139	31140	stimulated	0	None
31140	31141	PKC	2	GENE-N
31141	31142	in	0	None
31142	31143	response	0	None
31143	31144	to	0	None
31144	31145	24R	0	None
31145	31146	,	0	None
31146	31147	25	0	None
31147	31148	-	0	None
31148	31149	(	0	None
31149	31150	OH	0	None
31150	31151	)	0	None
31151	31152	(	0	None
31152	31153	2	0	None
31153	31154	)	0	None
31154	31155	D	0	None
31155	31156	(	0	None
31156	31157	3	0	None
31157	31158	)	0	None
31158	31159	.	0	None

31160	31161	Inclusion	0	None
31161	31162	of	0	None
31162	31163	resveratrol	3	CHEMICAL
31163	31164	reduced	0	None
31164	31165	the	0	None
31165	31166	melittin	0	None
31166	31167	-	0	None
31167	31168	dependent	0	None
31168	31169	inhibition	0	None
31169	31170	of	0	None
31170	31171	PLA	3	CHEMICAL
31171	31172	(	0	None
31172	31173	2	0	None
31173	31174	)	0	None
31174	31175	and	0	None
31175	31176	caused	0	None
31176	31177	an	0	None
31177	31178	increase	0	None
31178	31179	in	0	None
31179	31180	quinacrine	3	CHEMICAL
31180	31181	-	0	None
31181	31182	stimulated	0	None
31182	31183	PLA	3	CHEMICAL
31183	31184	(	0	None
31184	31185	2	0	None
31185	31186	)	0	None
31186	31187	activity	0	None
31187	31188	.	0	None

31189	31190	Metabolism	0	None
31190	31191	of	0	None
31191	31193	arachidonic acid	3	CHEMICAL
31193	31194	to	0	None
31194	31195	leukotrienes	3	CHEMICAL
31195	31196	is	0	None
31196	31197	not	0	None
31197	31198	involved	0	None
31198	31199	in	0	None
31199	31200	the	0	None
31200	31201	response	0	None
31201	31202	to	0	None
31202	31203	24R	0	None
31203	31204	,	0	None
31204	31205	25	0	None
31205	31206	-	0	None
31206	31207	(	0	None
31207	31208	OH	0	None
31208	31209	)	0	None
31209	31210	(	0	None
31210	31211	2	0	None
31211	31212	)	0	None
31212	31213	D	0	None
31213	31214	(	0	None
31214	31215	3	0	None
31215	31216	)	0	None
31216	31217	because	0	None
31217	31218	inhibition	0	None
31218	31219	of	0	None
31219	31220	lipoxygenase	3	CHEMICAL
31220	31221	had	0	None
31221	31222	no	0	None
31222	31223	effect	0	None
31223	31224	.	0	None

31225	31226	The	0	None
31226	31227	effect	0	None
31227	31228	of	0	None
31228	31229	24R	0	None
31229	31230	,	0	None
31230	31231	25	0	None
31231	31232	-	0	None
31232	31233	(	0	None
31233	31234	OH	0	None
31234	31235	)	0	None
31235	31236	(	0	None
31236	31237	2	0	None
31237	31238	)	0	None
31238	31239	D	0	None
31239	31240	(	0	None
31240	31241	3	0	None
31241	31242	)	0	None
31242	31243	was	0	None
31243	31244	specific	0	None
31244	31245	because	0	None
31245	31246	24S	0	None
31246	31247	,	0	None
31247	31248	25	0	None
31248	31249	-	0	None
31249	31250	(	0	None
31250	31251	OH	0	None
31251	31252	)	0	None
31252	31253	(	0	None
31253	31254	2	0	None
31254	31255	)	0	None
31255	31256	D	0	None
31256	31257	(	0	None
31257	31258	3	0	None
31258	31259	)	0	None
31259	31260	,	0	None
31260	31261	the	0	None
31261	31262	biologically	0	None
31262	31263	inactive	0	None
31263	31264	stereoisomer	0	None
31264	31265	,	0	None
31265	31266	failed	0	None
31266	31267	to	0	None
31267	31268	elicit	0	None
31268	31269	a	0	None
31269	31270	response	0	None
31270	31271	from	0	None
31271	31272	the	0	None
31272	31273	cells	0	None
31273	31274	.	0	None

31275	31276	These	0	None
31276	31277	results	0	None
31277	31278	support	0	None
31278	31279	the	0	None
31279	31280	hypothesis	0	None
31280	31281	that	0	None
31281	31282	24R	0	None
31282	31283	,	0	None
31283	31284	25	0	None
31284	31285	-	0	None
31285	31286	(	0	None
31286	31287	OH	0	None
31287	31288	)	0	None
31288	31289	(	0	None
31289	31290	2	0	None
31290	31291	)	0	None
31291	31292	D	0	None
31292	31293	(	0	None
31293	31294	3	0	None
31294	31295	)	0	None
31295	31296	exerts	0	None
31296	31297	its	0	None
31297	31298	effects	0	None
31298	31299	via	0	None
31299	31300	more	0	None
31300	31301	than	0	None
31301	31302	one	0	None
31302	31303	signaling	0	None
31303	31304	pathway	0	None
31304	31305	and	0	None
31305	31306	that	0	None
31306	31307	these	0	None
31307	31308	pathways	0	None
31308	31309	are	0	None
31309	31310	interrelated	0	None
31310	31311	via	0	None
31311	31312	the	0	None
31312	31313	modulation	0	None
31313	31314	of	0	None
31314	31315	PLA	3	CHEMICAL
31315	31316	(	0	None
31316	31317	2	0	None
31317	31318	)	0	None
31318	31319	.	0	None

31320	31321	PKC	2	GENE-N
31321	31322	regulation	0	None
31322	31323	may	0	None
31323	31324	occur	0	None
31324	31325	at	0	None
31325	31326	multiple	0	None
31326	31327	stages	0	None
31327	31328	in	0	None
31328	31329	the	0	None
31329	31330	signal	0	None
31330	31331	transduction	0	None
31331	31332	cascade	0	None
31332	31333	.	0	None

31334	31335	Local	0	None
31335	31336	tolerance	0	None
31336	31337	,	0	None
31337	31338	pharmacokinetics	0	None
31338	31339	,	0	None
31339	31340	and	0	None
31340	31341	dynamics	0	None
31341	31342	of	0	None
31342	31343	ganirelix	0	None
31343	31344	(	0	None
31344	31345	Orgalutran	0	None
31345	31346	)	0	None
31346	31347	administration	0	None
31347	31348	by	0	None
31348	31349	Medi	0	None
31349	31350	-	0	None
31350	31351	Jector	0	None
31351	31352	compared	0	None
31352	31353	to	0	None
31353	31354	conventional	0	None
31354	31355	needle	0	None
31355	31356	injections	0	None
31356	31357	.	0	None

31358	31359	The	0	None
31359	31360	feasibility	0	None
31360	31361	of	0	None
31361	31362	administering	0	None
31362	31363	a	0	None
31363	31364	relatively	0	None
31364	31365	high	0	None
31365	31366	dose	0	None
31366	31367	of	0	None
31367	31368	the	0	None
31368	31369	gonadotrophin	2	GENE-N
31369	31370	-	0	None
31370	31371	releasing	0	None
31371	31372	hormone	0	None
31372	31373	(	0	None
31373	31374	GnRH	0	None
31374	31375	)	0	None
31375	31376	antagonist	0	None
31376	31377	ganirelix	0	None
31377	31378	by	0	None
31378	31379	means	0	None
31379	31380	of	0	None
31380	31381	a	0	None
31381	31382	needle	0	None
31382	31383	-	0	None
31383	31384	free	0	None
31384	31385	injection	0	None
31385	31386	device	0	None
31386	31387	,	0	None
31387	31388	which	0	None
31388	31389	could	0	None
31389	31390	be	0	None
31390	31391	useful	0	None
31391	31392	in	0	None
31392	31393	the	0	None
31393	31394	long	0	None
31394	31395	-	0	None
31395	31396	term	0	None
31396	31397	treatment	0	None
31397	31398	of	0	None
31398	31399	sex	1	GENE-Y
31399	31400	-	0	None
31400	31401	steroid	3	CHEMICAL
31401	31402	-	0	None
31402	31403	dependent	0	None
31403	31404	disorders	0	None
31404	31405	,	0	None
31405	31406	was	0	None
31406	31407	evaluated	0	None
31407	31408	in	0	None
31408	31409	a	0	None
31409	31410	randomized	0	None
31410	31411	,	0	None
31411	31412	crossover	0	None
31412	31413	study	0	None
31413	31414	in	0	None
31414	31415	16	0	None
31415	31416	healthy	0	None
31416	31417	females	0	None
31417	31418	.	0	None

31419	31420	Local	0	None
31420	31421	tolerance	0	None
31421	31422	and	0	None
31422	31423	pharmacokinetics	0	None
31423	31424	of	0	None
31424	31425	ganirelix	0	None
31425	31426	administered	0	None
31426	31427	by	0	None
31427	31428	MediJector	0	None
31428	31429	versus	0	None
31429	31430	conventional	0	None
31430	31431	needle	0	None
31431	31432	injections	0	None
31432	31433	were	0	None
31433	31434	compared	0	None
31434	31435	.	0	None

31436	31437	Additionally	0	None
31437	31438	,	0	None
31438	31439	the	0	None
31439	31440	pharmacodynamic	0	None
31440	31441	effect	0	None
31441	31442	was	0	None
31442	31443	evaluated	0	None
31443	31444	.	0	None

31445	31446	Two	0	None
31446	31447	milligrams	0	None
31447	31448	of	0	None
31448	31449	ganirelix	0	None
31449	31450	was	0	None
31450	31451	administered	0	None
31451	31452	s	0	None
31452	31453	.	0	None
31453	31454	c	0	None
31454	31455	.	0	None
31455	31456	once	0	None
31456	31457	daily	0	None
31457	31458	for	0	None
31458	31459	7	0	None
31459	31460	days	0	None
31460	31461	by	0	None
31461	31462	Medi	0	None
31462	31463	-	0	None
31463	31464	Jector	0	None
31464	31465	or	0	None
31465	31466	conventional	0	None
31466	31467	needle	0	None
31467	31468	in	0	None
31468	31469	a	0	None
31469	31470	randomized	0	None
31470	31471	sequence	0	None
31471	31472	,	0	None
31472	31473	without	0	None
31473	31474	a	0	None
31474	31475	washout	0	None
31475	31476	period	0	None
31476	31477	.	0	None

31478	31479	No	0	None
31479	31480	apparent	0	None
31480	31481	differences	0	None
31481	31482	in	0	None
31482	31483	local	0	None
31483	31484	tolerance	0	None
31484	31485	were	0	None
31485	31486	observed	0	None
31486	31487	.	0	None

31488	31489	Most	0	None
31489	31490	injections	0	None
31490	31491	(	0	None
31491	31492	87	0	None
31492	31493	.	0	None
31493	31494	5	0	None
31494	31495	%	0	None
31495	31496	)	0	None
31496	31497	gave	0	None
31497	31498	either	0	None
31498	31499	no	0	None
31499	31500	or	0	None
31500	31501	only	0	None
31501	31502	a	0	None
31502	31503	mild	0	None
31503	31504	reaction	0	None
31504	31505	.	0	None

31506	31507	Of	0	None
31507	31508	the	0	None
31508	31509	moderate	0	None
31509	31510	reactions	0	None
31510	31511	,	0	None
31511	31512	swelling	0	None
31512	31513	and	0	None
31513	31514	redness	0	None
31514	31515	were	0	None
31515	31516	reported	0	None
31516	31517	most	0	None
31517	31518	frequently	0	None
31518	31519	(	0	None
31519	31520	overall	0	None
31520	31521	4	0	None
31521	31522	.	0	None
31522	31523	9	0	None
31523	31524	and	0	None
31524	31525	8	0	None
31525	31526	.	0	None
31526	31527	5	0	None
31527	31528	%	0	None
31528	31529	per	0	None
31529	31530	injection	0	None
31530	31531	,	0	None
31531	31532	respectively	0	None
31532	31533	)	0	None
31533	31534	.	0	None

31535	31536	Administration	0	None
31536	31537	by	0	None
31537	31538	Medi	0	None
31538	31539	-	0	None
31539	31540	Jector	0	None
31540	31541	was	0	None
31541	31542	bioequivalent	0	None
31542	31543	to	0	None
31543	31544	conventional	0	None
31544	31545	needle	0	None
31545	31546	injection	0	None
31546	31547	with	0	None
31547	31548	respect	0	None
31548	31549	to	0	None
31549	31550	the	0	None
31550	31551	peak	0	None
31551	31552	concentration	0	None
31552	31553	and	0	None
31553	31554	area	0	None
31554	31555	under	0	None
31555	31556	the	0	None
31556	31557	curve	0	None
31557	31558	.	0	None

31559	31560	A	0	None
31560	31561	profound	0	None
31561	31562	suppression	0	None
31562	31563	of	0	None
31563	31565	luteinizing hormone	2	GENE-N
31565	31566	and	0	None
31566	31569	follicle stimulating hormone	2	GENE-N
31569	31570	was	0	None
31570	31571	observed	0	None
31571	31572	.	0	None

31573	31574	Serum	0	None
31574	31575	oestradiol	3	CHEMICAL
31575	31576	and	0	None
31576	31577	progesterone	3	CHEMICAL
31577	31578	concentrations	0	None
31578	31579	were	0	None
31579	31580	relatively	0	None
31580	31581	low	0	None
31581	31582	prior	0	None
31582	31583	to	0	None
31583	31584	treatment	0	None
31584	31585	and	0	None
31585	31586	remained	0	None
31586	31587	low	0	None
31587	31588	during	0	None
31588	31589	the	0	None
31589	31590	entire	0	None
31590	31591	study	0	None
31591	31592	period	0	None
31592	31593	.	0	None

31594	31595	In	0	None
31595	31596	conclusion	0	None
31596	31597	,	0	None
31597	31598	administration	0	None
31598	31599	of	0	None
31599	31600	a	0	None
31600	31601	relatively	0	None
31601	31602	high	0	None
31602	31603	dose	0	None
31603	31604	of	0	None
31604	31605	ganirelix	0	None
31605	31606	by	0	None
31606	31607	Medi	0	None
31607	31608	-	0	None
31608	31609	Jector	0	None
31609	31610	might	0	None
31610	31611	be	0	None
31611	31612	useful	0	None
31612	31613	for	0	None
31613	31614	long	0	None
31614	31615	-	0	None
31615	31616	term	0	None
31616	31617	treatment	0	None
31617	31618	of	0	None
31618	31619	sex	1	GENE-Y
31619	31620	-	0	None
31620	31621	steroid	3	CHEMICAL
31621	31622	dependent	0	None
31622	31623	disorders	0	None
31623	31624	.	0	None

31625	31626	Kinetics	0	None
31626	31627	of	0	None
31627	31628	inhibition	0	None
31628	31629	of	0	None
31629	31630	human	0	None
31630	31631	and	0	None
31631	31632	rat	0	None
31632	31634	dihydroorotate dehydrogenase	0	None
31634	31635	by	0	None
31635	31636	atovaquone	0	None
31636	31637	,	0	None
31637	31638	lawsone	3	CHEMICAL
31638	31639	derivatives	0	None
31639	31640	,	0	None
31640	31642	brequinar sodium	3	CHEMICAL
31642	31643	and	0	None
31643	31645	polyporic acid	3	CHEMICAL
31645	31646	.	0	None

31647	31648	Mitochondrially	0	None
31648	31649	-	0	None
31649	31650	bound	0	None
31650	31651	dihydroorotate	0	None
31651	31652	dehydrogenase	0	None
31652	31653	(	0	None
31653	31654	EC	0	None
31654	31655	1	0	None
31655	31656	.	0	None
31656	31657	3	0	None
31657	31658	.	0	None
31658	31659	99	0	None
31659	31660	.	0	None
31660	31661	11	0	None
31661	31662	)	0	None
31662	31663	catalyzes	0	None
31663	31664	the	0	None
31664	31665	fourth	0	None
31665	31666	sequential	0	None
31666	31667	step	0	None
31667	31668	in	0	None
31668	31669	the	0	None
31669	31670	de	0	None
31670	31671	novo	0	None
31671	31672	synthesis	0	None
31672	31673	of	0	None
31673	31675	uridine monophosphate	3	CHEMICAL
31675	31676	.	0	None

31677	31678	The	0	None
31678	31679	enzyme	0	None
31679	31680	has	0	None
31680	31681	been	0	None
31681	31682	identified	0	None
31682	31683	as	0	None
31683	31684	or	0	None
31684	31685	surmised	0	None
31685	31686	to	0	None
31686	31687	be	0	None
31687	31688	the	0	None
31688	31689	pharmacological	0	None
31689	31690	target	0	None
31690	31691	for	0	None
31691	31692	isoxazol	3	CHEMICAL
31692	31693	,	0	None
31693	31694	triazine	3	CHEMICAL
31694	31695	,	0	None
31695	31696	cinchoninic	0	None
31696	31697	acid	0	None
31697	31698	and	0	None
31698	31699	(	0	None
31699	31700	naphtho	0	None
31700	31701	)	0	None
31701	31702	quinone	3	CHEMICAL
31702	31703	derivatives	0	None
31703	31704	,	0	None
31704	31705	which	0	None
31705	31706	exerted	0	None
31706	31707	antiproliferative	0	None
31707	31708	,	0	None
31708	31709	immunosuppressive	0	None
31709	31710	,	0	None
31710	31711	and	0	None
31711	31712	antiparasitic	0	None
31712	31713	effects	0	None
31713	31714	.	0	None

31715	31716	Despite	0	None
31716	31717	this	0	None
31717	31718	broad	0	None
31718	31719	spectrum	0	None
31719	31720	of	0	None
31720	31721	biological	0	None
31721	31722	and	0	None
31722	31723	clinical	0	None
31723	31724	relevance	0	None
31724	31725	,	0	None
31725	31726	there	0	None
31726	31727	have	0	None
31727	31728	been	0	None
31728	31729	no	0	None
31729	31730	comparative	0	None
31730	31731	studies	0	None
31731	31732	on	0	None
31732	31733	drug	0	None
31733	31734	-	0	None
31734	31735	dihydroorotate	0	None
31735	31736	dehydrogenase	0	None
31736	31737	interactions	0	None
31737	31738	.	0	None

31739	31740	Here	0	None
31740	31741	,	0	None
31741	31742	we	0	None
31742	31743	describe	0	None
31743	31744	a	0	None
31744	31745	study	0	None
31745	31746	of	0	None
31746	31747	the	0	None
31747	31748	inhibition	0	None
31748	31749	of	0	None
31749	31750	the	0	None
31750	31751	purified	0	None
31751	31757	recombinant human and rat dihydroorotate dehydrogenase	1	GENE-Y
31757	31758	by	0	None
31758	31759	ten	0	None
31759	31760	compounds	0	None
31760	31761	.	0	None

31762	31763	1	0	None
31763	31764	,	0	None
31764	31765	4	0	None
31765	31766	-	0	None
31766	31767	Naphthoquinone	0	None
31767	31768	,	0	None
31768	31769	5	0	None
31769	31770	,	0	None
31770	31771	8	0	None
31771	31772	-	0	None
31772	31773	hydroxy	3	CHEMICAL
31773	31774	-	0	None
31774	31775	naphthoquinone	3	CHEMICAL
31775	31776	and	0	None
31776	31777	the	0	None
31777	31778	natural	0	None
31778	31779	compounds	0	None
31779	31780	juglon	0	None
31780	31781	,	0	None
31781	31782	plumbagin	3	CHEMICAL
31782	31783	and	0	None
31783	31785	polyporic acid	3	CHEMICAL
31785	31786	(	0	None
31786	31787	quinone	3	CHEMICAL
31787	31788	derivative	0	None
31788	31789	)	0	None
31789	31790	were	0	None
31790	31791	found	0	None
31791	31792	to	0	None
31792	31793	function	0	None
31793	31794	as	0	None
31794	31795	alternative	0	None
31795	31796	electron	0	None
31796	31797	acceptors	0	None
31797	31798	with	0	None
31798	31799	10	0	None
31799	31800	-	0	None
31800	31801	30	0	None
31801	31802	%	0	None
31802	31803	of	0	None
31803	31804	control	0	None
31804	31805	enzyme	0	None
31805	31806	activity	0	None
31806	31807	.	0	None

31808	31809	The	0	None
31809	31810	human	0	None
31810	31811	and	0	None
31811	31812	rat	0	None
31812	31813	enzyme	0	None
31813	31814	activity	0	None
31814	31815	was	0	None
31815	31816	decreased	0	None
31816	31817	by	0	None
31817	31818	50	0	None
31818	31819	%	0	None
31819	31820	by	0	None
31820	31821	the	0	None
31821	31822	natural	0	None
31822	31824	compound lawsone	3	CHEMICAL
31824	31825	(	0	None
31825	31826	>	0	None
31826	31827	500	0	None
31827	31828	and	0	None
31828	31829	49	0	None
31829	31830	microM	0	None
31830	31831	,	0	None
31831	31832	respectively	0	None
31832	31833	)	0	None
31833	31834	and	0	None
31834	31835	by	0	None
31835	31836	the	0	None
31836	31837	derivatives	0	None
31837	31838	dichloroally	0	None
31838	31839	-	0	None
31839	31840	lawsone	3	CHEMICAL
31840	31841	(	0	None
31841	31842	67	0	None
31842	31843	and	0	None
31843	31844	10	0	None
31844	31845	nM	0	None
31845	31846	)	0	None
31846	31847	,	0	None
31847	31848	lapachol	3	CHEMICAL
31848	31849	(	0	None
31849	31850	618	0	None
31850	31851	and	0	None
31851	31852	61	0	None
31852	31853	nM	0	None
31853	31854	)	0	None
31854	31855	and	0	None
31855	31856	atovaquone	0	None
31856	31857	(	0	None
31857	31858	15	0	None
31858	31859	microM	0	None
31859	31860	and	0	None
31860	31861	698	0	None
31861	31862	nM	0	None
31862	31863	)	0	None
31863	31864	.	0	None

31865	31866	With	0	None
31866	31867	respect	0	None
31867	31868	to	0	None
31868	31869	the	0	None
31869	31870	quinone	3	CHEMICAL
31870	31871	co	0	None
31871	31872	-	0	None
31872	31873	substrate	0	None
31873	31874	of	0	None
31874	31875	the	0	None
31875	31876	dihydroorotate	0	None
31876	31877	dehydrogenase	0	None
31877	31878	,	0	None
31878	31879	atovaquone	0	None
31879	31880	(	0	None
31880	31881	Kic	0	None
31881	31882	=	0	None
31882	31883	2	0	None
31883	31884	.	0	None
31884	31885	7	0	None
31885	31886	microM	0	None
31886	31887	)	0	None
31887	31888	and	0	None
31888	31889	dichloroally	0	None
31889	31890	-	0	None
31890	31891	lawsone	3	CHEMICAL
31891	31892	(	0	None
31892	31893	Kic	0	None
31893	31894	=	0	None
31894	31895	9	0	None
31895	31896	.	0	None
31896	31897	8	0	None
31897	31898	nM	0	None
31898	31899	)	0	None
31899	31900	were	0	None
31900	31901	shown	0	None
31901	31902	to	0	None
31902	31903	be	0	None
31903	31904	competitive	0	None
31904	31905	inhibitors	0	None
31905	31906	of	0	None
31906	31907	human	0	None
31907	31909	dihydroorotate dehydrogenase	0	None
31909	31910	.	0	None

31911	31912	Atovaquone	0	None
31912	31913	(	0	None
31913	31914	Kic	0	None
31914	31915	=	0	None
31915	31916	60	0	None
31916	31917	nM	0	None
31917	31918	)	0	None
31918	31919	was	0	None
31919	31920	also	0	None
31920	31921	acompetitive	0	None
31921	31922	inhibitor	0	None
31922	31923	of	0	None
31923	31924	the	0	None
31924	31925	rat	0	None
31925	31926	enzyme	0	None
31926	31927	.	0	None

31928	31929	Dichloroally	0	None
31929	31930	]	0	None
31930	31931	-	0	None
31931	31932	lawsone	3	CHEMICAL
31932	31933	was	0	None
31933	31934	found	0	None
31934	31935	to	0	None
31935	31936	be	0	None
31936	31937	a	0	None
31937	31938	time	0	None
31938	31939	-	0	None
31939	31940	dependent	0	None
31940	31941	inhibitor	0	None
31941	31942	of	0	None
31942	31943	the	0	None
31943	31944	rat	0	None
31944	31945	enzyme	0	None
31945	31946	,	0	None
31946	31947	with	0	None
31947	31948	the	0	None
31948	31949	lowest	0	None
31949	31950	inhibition	0	None
31950	31951	constant	0	None
31951	31952	(	0	None
31952	31953	Ki	0	None
31953	31954	*	0	None
31954	31955	=	0	None
31955	31956	0	0	None
31956	31957	.	0	None
31957	31958	77	0	None
31958	31959	nM	0	None
31959	31960	)	0	None
31960	31961	determined	0	None
31961	31962	so	0	None
31962	31963	far	0	None
31963	31964	for	0	None
31964	31967	mammalian dihydroorotate dehydrogenases	2	GENE-N
31967	31968	.	0	None

31969	31970	Another	0	None
31970	31971	inhibitor	0	None
31971	31972	,	0	None
31972	31973	brequinar	3	CHEMICAL
31973	31974	was	0	None
31974	31975	previously	0	None
31975	31976	reported	0	None
31976	31977	to	0	None
31977	31978	be	0	None
31978	31979	a	0	None
31979	31980	slow	0	None
31980	31981	-	0	None
31981	31982	binding	0	None
31982	31983	inhibitor	0	None
31983	31984	of	0	None
31984	31985	the	0	None
31985	31986	human	0	None
31986	31988	dihydroorotate dehydrogenase	0	None
31988	31989	[	0	None
31989	31990	W	0	None
31990	31991	.	0	None
31991	31992	Knecht	0	None
31992	31993	,	0	None
31993	31994	M	0	None
31994	31995	.	0	None
31995	31996	Loffler	0	None
31996	31997	,	0	None
31997	31998	Species	0	None
31998	31999	-	0	None
31999	32000	related	0	None
32000	32001	inhibition	0	None
32001	32002	of	0	None
32002	32003	human	0	None
32003	32004	and	0	None
32004	32006	rat dihyroorotate	0	None
32006	32007	dehydrogenase	0	None
32007	32008	by	0	None
32008	32009	immunosuppressive	0	None
32009	32010	isoxazol	3	CHEMICAL
32010	32011	and	0	None
32011	32012	cinchoninic	0	None
32012	32013	acid	0	None
32013	32014	derivatives	0	None
32014	32015	,	0	None
32015	32016	Biochem	0	None
32016	32017	.	0	None
32017	32018	Pharmacol	0	None
32018	32019	.	0	None
32019	32020	56	0	None
32020	32021	(	0	None
32021	32022	1998	0	None
32022	32023	)	0	None
32023	32024	1259	0	None
32024	32025	-	0	None
32025	32026	1264	0	None
32026	32027	]	0	None
32027	32028	.	0	None

32029	32030	The	0	None
32030	32031	slow	0	None
32031	32032	binding	0	None
32032	32033	features	0	None
32033	32034	of	0	None
32034	32035	this	0	None
32035	32036	potent	0	None
32036	32037	inhibitor	0	None
32037	32038	(	0	None
32038	32039	Ki	0	None
32039	32040	*	0	None
32040	32041	=	0	None
32041	32042	1	0	None
32042	32043	.	0	None
32043	32044	8	0	None
32044	32045	nM	0	None
32045	32046	)	0	None
32046	32047	with	0	None
32047	32048	the	0	None
32048	32049	human	0	None
32049	32050	enzyme	0	None
32050	32051	,	0	None
32051	32052	were	0	None
32052	32053	verified	0	None
32053	32054	and	0	None
32054	32055	seen	0	None
32055	32056	to	0	None
32056	32057	be	0	None
32057	32058	one	0	None
32058	32059	of	0	None
32059	32060	the	0	None
32060	32061	reasons	0	None
32061	32062	for	0	None
32062	32063	the	0	None
32063	32064	narrow	0	None
32064	32065	therapeutic	0	None
32065	32066	window	0	None
32066	32067	(	0	None
32067	32068	efficacy	0	None
32068	32069	versus	0	None
32069	32070	toxicity	0	None
32070	32071	)	0	None
32071	32072	reported	0	None
32072	32073	from	0	None
32073	32074	clinical	0	None
32074	32075	trials	0	None
32075	32076	on	0	None
32076	32077	its	0	None
32077	32078	antiproliferative	0	None
32078	32079	and	0	None
32079	32080	immunosuppressive	0	None
32080	32081	action	0	None
32081	32082	.	0	None

32083	32084	With	0	None
32084	32085	respect	0	None
32085	32086	to	0	None
32086	32087	the	0	None
32087	32088	substrate	0	None
32088	32089	dihydroorotate	0	None
32089	32090	,	0	None
32090	32091	atovaquone	0	None
32091	32092	was	0	None
32092	32093	an	0	None
32093	32094	uncompetitive	0	None
32094	32095	inhibitor	0	None
32095	32096	of	0	None
32096	32097	human	0	None
32097	32099	dihydroorotate dehydrogenase	0	None
32099	32100	(	0	None
32100	32101	Kiu	0	None
32101	32102	=	0	None
32102	32103	11	0	None
32103	32104	.	0	None
32104	32105	6	0	None
32105	32106	microM	0	None
32106	32107	)	0	None
32107	32108	and	0	None
32108	32109	a	0	None
32109	32110	non	0	None
32110	32111	-	0	None
32111	32112	competitive	0	None
32112	32113	inhibitor	0	None
32113	32114	of	0	None
32114	32115	the	0	None
32115	32116	rat	0	None
32116	32117	enzyme	0	None
32117	32118	(	0	None
32118	32119	Kiu	0	None
32119	32120	=	0	None
32120	32121	905	0	None
32121	32122	/	0	None
32122	32123	Kic	0	None
32123	32124	=	0	None
32124	32125	1	0	None
32125	32126	,	0	None
32126	32127	012	0	None
32127	32128	nM	0	None
32128	32129	)	0	None
32129	32130	.	0	None

32131	32132	1	0	None
32132	32133	.	0	None
32133	32134	5	0	None
32134	32135	mM	0	None
32135	32137	polyporic acid	3	CHEMICAL
32137	32138	,	0	None
32138	32139	a	0	None
32139	32140	natural	0	None
32140	32141	quinone	3	CHEMICAL
32141	32142	from	0	None
32142	32143	fungi	0	None
32143	32144	,	0	None
32144	32145	influenced	0	None
32145	32146	the	0	None
32146	32147	activity	0	None
32147	32148	of	0	None
32148	32149	the	0	None
32149	32150	human	0	None
32150	32151	enzyme	0	None
32151	32152	only	0	None
32152	32153	slightly	0	None
32153	32154	;	0	None
32154	32155	the	0	None
32155	32156	activity	0	None
32156	32157	of	0	None
32157	32158	the	0	None
32158	32159	rat	0	None
32159	32160	enzyme	0	None
32160	32161	was	0	None
32161	32162	decreased	0	None
32162	32163	by	0	None
32163	32164	30	0	None
32164	32165	%	0	None
32165	32166	.	0	None

32167	32168	[	0	None
32168	32169	New	0	None
32169	32170	prospects	0	None
32170	32171	in	0	None
32171	32172	the	0	None
32172	32173	treatment	0	None
32173	32174	of	0	None
32174	32175	migraine	0	None
32175	32176	]	0	None
32176	32177	.	0	None

32178	32179	The	0	None
32179	32180	options	0	None
32180	32181	for	0	None
32181	32182	migraine	0	None
32182	32183	treatment	0	None
32183	32184	have	0	None
32184	32185	increased	0	None
32185	32186	in	0	None
32186	32187	the	0	None
32187	32188	recent	0	None
32188	32189	years	0	None
32189	32190	and	0	None
32190	32191	will	0	None
32191	32192	expand	0	None
32192	32193	in	0	None
32193	32194	the	0	None
32194	32195	near	0	None
32195	32196	future	0	None
32196	32197	.	0	None

32198	32199	In	0	None
32199	32200	this	0	None
32200	32201	work	0	None
32201	32202	both	0	None
32202	32203	recent	0	None
32203	32204	and	0	None
32204	32205	future	0	None
32205	32206	options	0	None
32206	32207	for	0	None
32207	32208	migraine	0	None
32208	32209	treatment	0	None
32209	32210	are	0	None
32210	32211	critically	0	None
32211	32212	reviewed	0	None
32212	32213	.	0	None

32214	32215	Firstly	0	None
32215	32216	the	0	None
32216	32217	late	0	None
32217	32218	advances	0	None
32218	32219	in	0	None
32219	32220	the	0	None
32220	32221	symptomatic	0	None
32221	32222	treatment	0	None
32222	32223	of	0	None
32223	32224	migraine	0	None
32224	32225	,	0	None
32225	32226	including	0	None
32226	32227	the	0	None
32227	32228	new	0	None
32228	32229	5	0	None
32229	32230	-	0	None
32230	32231	HT1B	0	None
32231	32232	/	0	None
32232	32233	D	0	None
32233	32234	agonists	0	None
32234	32235	"	0	None
32235	32236	triptans	3	CHEMICAL
32236	32237	"	0	None
32237	32238	appeared	0	None
32238	32239	after	0	None
32239	32240	sumatriptan	3	CHEMICAL
32240	32241	,	0	None
32241	32242	are	0	None
32242	32243	reviewed	0	None
32243	32244	.	0	None

32245	32246	Possible	0	None
32246	32247	alternative	0	None
32247	32248	,	0	None
32248	32249	such	0	None
32249	32250	as	0	None
32250	32251	selective	0	None
32251	32252	5	0	None
32252	32253	-	0	None
32253	32254	HT1D	0	None
32254	32255	and	0	None
32255	32256	5	0	None
32256	32257	-	0	None
32257	32258	HT1F	0	None
32258	32259	agonists	0	None
32259	32260	,	0	None
32260	32261	are	0	None
32261	32262	also	0	None
32262	32263	discussed	0	None
32263	32264	.	0	None

32265	32266	In	0	None
32266	32267	the	0	None
32267	32268	second	0	None
32268	32269	part	0	None
32269	32270	of	0	None
32270	32271	this	0	None
32271	32272	manuscript	0	None
32272	32273	the	0	None
32273	32274	new	0	None
32274	32275	,	0	None
32275	32276	possible	0	None
32276	32277	options	0	None
32277	32278	for	0	None
32278	32279	the	0	None
32279	32280	preventive	0	None
32280	32281	treatment	0	None
32281	32282	of	0	None
32282	32283	migraine	0	None
32283	32284	comprising	0	None
32284	32285	"	0	None
32285	32286	antiepileptics	0	None
32286	32287	"	0	None
32287	32288	,	0	None
32288	32289	such	0	None
32289	32290	as	0	None
32290	32292	valproic acid	3	CHEMICAL
32292	32293	,	0	None
32293	32294	gabapentin	3	CHEMICAL
32294	32295	and	0	None
32295	32296	topiramate	3	CHEMICAL
32296	32297	,	0	None
32297	32298	calcium	0	None
32298	32299	-	0	None
32299	32300	antagonists	0	None
32300	32301	,	0	None
32301	32302	such	0	None
32302	32303	as	0	None
32303	32304	cyclandelate	3	CHEMICAL
32304	32305	and	0	None
32305	32306	dotarizin	0	None
32306	32307	,	0	None
32307	32308	and	0	None
32308	32309	a	0	None
32309	32310	miscellany	0	None
32310	32311	,	0	None
32311	32312	including	0	None
32312	32313	riboflavin	3	CHEMICAL
32313	32314	,	0	None
32314	32315	are	0	None
32315	32316	analysed	0	None
32316	32317	.	0	None

32318	32319	Finally	0	None
32319	32320	,	0	None
32320	32321	possible	0	None
32321	32322	compounds	0	None
32322	32323	for	0	None
32323	32324	the	0	None
32324	32325	future	0	None
32325	32326	,	0	None
32326	32327	such	0	None
32327	32328	as	0	None
32328	32329	the	0	None
32329	32330	selective	0	None
32330	32331	inhibitors	0	None
32331	32332	of	0	None
32332	32334	neurokinin receptors	2	GENE-N
32334	32335	or	0	None
32335	32336	drugs	0	None
32336	32337	acting	0	None
32337	32338	upon	0	None
32338	32341	neuronal calcium channels	2	GENE-N
32341	32342	,	0	None
32342	32343	are	0	None
32343	32344	commented	0	None
32344	32345	.	0	None

32346	32347	From	0	None
32347	32348	this	0	None
32348	32349	review	0	None
32349	32350	we	0	None
32350	32351	conclude	0	None
32351	32352	that	0	None
32352	32353	while	0	None
32353	32354	there	0	None
32354	32355	have	0	None
32355	32356	been	0	None
32356	32357	relevant	0	None
32357	32358	advances	0	None
32358	32359	in	0	None
32359	32360	the	0	None
32360	32361	symptomatic	0	None
32361	32362	treatment	0	None
32362	32363	of	0	None
32363	32364	migraine	0	None
32364	32365	,	0	None
32365	32366	there	0	None
32366	32367	is	0	None
32367	32368	a	0	None
32368	32369	need	0	None
32369	32370	for	0	None
32370	32371	the	0	None
32371	32372	development	0	None
32372	32373	of	0	None
32373	32374	better	0	None
32374	32375	preventive	0	None
32375	32376	compounds	0	None
32376	32377	.	0	None

32378	32379	Sodium	0	None
32379	32380	channel	0	None
32380	32381	blockers	0	None
32381	32382	identify	0	None
32382	32383	risk	0	None
32383	32384	for	0	None
32384	32385	sudden	0	None
32385	32386	death	0	None
32386	32387	in	0	None
32387	32388	patients	0	None
32388	32389	with	0	None
32389	32390	ST	3	CHEMICAL
32390	32391	-	0	None
32391	32392	segment	0	None
32392	32393	elevation	0	None
32393	32394	and	0	None
32394	32395	right	0	None
32395	32396	bundle	0	None
32396	32397	branch	0	None
32397	32398	block	0	None
32398	32399	but	0	None
32399	32400	structurally	0	None
32400	32401	normal	0	None
32401	32402	hearts	0	None
32402	32403	.	0	None

32404	32405	BACKGROUND	0	None
32405	32406	:	0	None
32406	32407	A	0	None
32407	32408	mutation	0	None
32408	32409	in	0	None
32409	32410	the	0	None
32410	32413	cardiac sodium channel	2	GENE-N
32413	32414	gene	0	None
32414	32415	(	0	None
32415	32416	SCN5A	1	GENE-Y
32416	32417	)	0	None
32417	32418	has	0	None
32418	32419	been	0	None
32419	32420	described	0	None
32420	32421	in	0	None
32421	32422	patients	0	None
32422	32423	with	0	None
32423	32424	the	0	None
32424	32425	syndrome	0	None
32425	32426	of	0	None
32426	32427	right	0	None
32427	32428	bundle	0	None
32428	32429	branch	0	None
32429	32430	block	0	None
32430	32431	,	0	None
32431	32432	ST	3	CHEMICAL
32432	32433	-	0	None
32433	32434	segment	0	None
32434	32435	elevation	0	None
32435	32436	in	0	None
32436	32437	leads	0	None
32437	32438	V1	0	None
32438	32439	to	0	None
32439	32440	V3	2	GENE-N
32440	32441	,	0	None
32441	32442	and	0	None
32442	32443	sudden	0	None
32443	32444	death	0	None
32444	32445	(	0	None
32445	32446	Brugada	0	None
32446	32447	syndrome	0	None
32447	32448	)	0	None
32448	32449	.	0	None

32450	32451	These	0	None
32451	32452	electrocardiographic	0	None
32452	32453	manifestations	0	None
32453	32454	are	0	None
32454	32455	transient	0	None
32455	32456	in	0	None
32456	32457	many	0	None
32457	32458	patients	0	None
32458	32459	with	0	None
32459	32460	the	0	None
32460	32461	syndrome	0	None
32461	32462	.	0	None

32463	32464	The	0	None
32464	32465	present	0	None
32465	32466	study	0	None
32466	32467	examined	0	None
32467	32468	arrhythmic	0	None
32468	32469	risk	0	None
32469	32470	in	0	None
32470	32471	patients	0	None
32471	32472	with	0	None
32472	32473	overt	0	None
32473	32474	and	0	None
32474	32475	concealed	0	None
32475	32476	forms	0	None
32476	32477	of	0	None
32477	32478	the	0	None
32478	32479	disease	0	None
32479	32480	and	0	None
32480	32481	the	0	None
32481	32482	effectiveness	0	None
32482	32483	of	0	None
32483	32485	sodium channel	2	GENE-N
32485	32486	blockers	0	None
32486	32487	to	0	None
32487	32488	unmask	0	None
32488	32489	the	0	None
32489	32490	syndrome	0	None
32490	32491	and	0	None
32491	32492	,	0	None
32492	32493	thus	0	None
32493	32494	,	0	None
32494	32495	identify	0	None
32495	32496	patients	0	None
32496	32497	at	0	None
32497	32498	risk	0	None
32498	32499	.	0	None

32500	32501	METHODS	0	None
32501	32502	AND	0	None
32502	32503	RESULTS	0	None
32503	32504	:	0	None
32504	32505	The	0	None
32505	32506	effect	0	None
32506	32507	of	0	None
32507	32508	intravenous	0	None
32508	32509	ajmaline	3	CHEMICAL
32509	32510	(	0	None
32510	32511	1	0	None
32511	32512	mg	0	None
32512	32513	/	0	None
32513	32514	kg	0	None
32514	32515	)	0	None
32515	32516	,	0	None
32516	32517	procainamide	3	CHEMICAL
32517	32518	(	0	None
32518	32519	10	0	None
32519	32520	mg	0	None
32520	32521	/	0	None
32521	32522	kg	0	None
32522	32523	)	0	None
32523	32524	,	0	None
32524	32525	or	0	None
32525	32526	flecainide	3	CHEMICAL
32526	32527	(	0	None
32527	32528	2	0	None
32528	32529	mg	0	None
32529	32530	/	0	None
32530	32531	kg	0	None
32531	32532	)	0	None
32532	32533	on	0	None
32533	32534	the	0	None
32534	32535	ECG	2	GENE-N
32535	32536	was	0	None
32536	32537	studied	0	None
32537	32538	in	0	None
32538	32539	34	0	None
32539	32540	patients	0	None
32540	32541	with	0	None
32541	32542	the	0	None
32542	32543	syndrome	0	None
32543	32544	and	0	None
32544	32545	transient	0	None
32545	32546	normalization	0	None
32546	32547	of	0	None
32547	32548	the	0	None
32548	32549	ECG	2	GENE-N
32549	32550	(	0	None
32550	32551	group	0	None
32551	32552	A	0	None
32552	32553	)	0	None
32553	32554	,	0	None
32554	32555	11	0	None
32555	32556	members	0	None
32556	32557	of	0	None
32557	32558	3	0	None
32558	32559	families	0	None
32559	32560	in	0	None
32560	32561	whom	0	None
32561	32562	a	0	None
32562	32563	SCN5A	1	GENE-Y
32563	32564	mutation	0	None
32564	32565	was	0	None
32565	32566	associated	0	None
32566	32567	with	0	None
32567	32568	the	0	None
32568	32569	syndrome	0	None
32569	32570	and	0	None
32570	32571	8	0	None
32571	32572	members	0	None
32572	32573	in	0	None
32573	32574	whom	0	None
32574	32575	it	0	None
32575	32576	was	0	None
32576	32577	not	0	None
32577	32578	(	0	None
32578	32579	group	0	None
32579	32580	B	0	None
32580	32581	)	0	None
32581	32582	,	0	None
32582	32583	and	0	None
32583	32584	53	0	None
32584	32585	control	0	None
32585	32586	subjects	0	None
32586	32587	(	0	None
32587	32588	group	0	None
32588	32589	C	0	None
32589	32590	)	0	None
32590	32591	.	0	None

32592	32593	Ajmaline	0	None
32593	32594	,	0	None
32594	32595	procainamide	3	CHEMICAL
32595	32596	,	0	None
32596	32597	or	0	None
32597	32598	flecainide	3	CHEMICAL
32598	32599	administration	0	None
32599	32600	resulted	0	None
32600	32601	in	0	None
32601	32602	ST	3	CHEMICAL
32602	32603	-	0	None
32603	32604	segment	0	None
32604	32605	elevation	0	None
32605	32606	and	0	None
32606	32607	right	0	None
32607	32608	bundle	0	None
32608	32609	branch	0	None
32609	32610	block	0	None
32610	32611	in	0	None
32611	32612	all	0	None
32612	32613	patients	0	None
32613	32614	in	0	None
32614	32615	group	0	None
32615	32616	A	0	None
32616	32617	and	0	None
32617	32618	in	0	None
32618	32619	all	0	None
32619	32620	11	0	None
32620	32621	patients	0	None
32621	32622	with	0	None
32622	32623	the	0	None
32623	32624	mutation	0	None
32624	32625	in	0	None
32625	32626	group	0	None
32626	32627	B	0	None
32627	32628	.	0	None

32629	32630	A	0	None
32630	32631	similar	0	None
32631	32632	pattern	0	None
32632	32633	could	0	None
32633	32634	not	0	None
32634	32635	be	0	None
32635	32636	elicited	0	None
32636	32637	in	0	None
32637	32638	the	0	None
32638	32639	8	0	None
32639	32640	patients	0	None
32640	32641	in	0	None
32641	32642	group	0	None
32642	32643	B	0	None
32643	32644	who	0	None
32644	32645	lacked	0	None
32645	32646	the	0	None
32646	32647	mutation	0	None
32647	32648	or	0	None
32648	32649	in	0	None
32649	32650	any	0	None
32650	32651	person	0	None
32651	32652	in	0	None
32652	32653	group	0	None
32653	32654	C	0	None
32654	32655	.	0	None

32656	32657	The	0	None
32657	32658	follow	0	None
32658	32659	-	0	None
32659	32660	up	0	None
32660	32661	period	0	None
32661	32662	(	0	None
32662	32663	37	0	None
32663	32664	+	0	None
32664	32665	/	0	None
32665	32666	-	0	None
32666	32667	33	0	None
32667	32668	months	0	None
32668	32669	)	0	None
32669	32670	revealed	0	None
32670	32671	no	0	None
32671	32672	differences	0	None
32672	32673	in	0	None
32673	32674	the	0	None
32674	32675	incidence	0	None
32675	32676	of	0	None
32676	32677	arrhythmia	0	None
32677	32678	between	0	None
32678	32679	the	0	None
32679	32680	34	0	None
32680	32681	patients	0	None
32681	32682	in	0	None
32682	32683	whom	0	None
32683	32684	the	0	None
32684	32685	phenotypic	0	None
32685	32686	manifestation	0	None
32686	32687	of	0	None
32687	32688	the	0	None
32688	32689	syndrome	0	None
32689	32690	was	0	None
32690	32691	transient	0	None
32691	32692	and	0	None
32692	32693	the	0	None
32693	32694	24	0	None
32694	32695	patients	0	None
32695	32696	in	0	None
32696	32697	whom	0	None
32697	32698	it	0	None
32698	32699	was	0	None
32699	32700	persistent	0	None
32700	32701	(	0	None
32701	32702	log	0	None
32702	32703	-	0	None
32703	32704	rank	1	GENE-Y
32704	32705	,	0	None
32705	32706	0	0	None
32706	32707	.	0	None
32707	32708	639	0	None
32708	32709	)	0	None
32709	32710	.	0	None

32711	32712	CONCLUSIONS	0	None
32712	32713	:	0	None
32713	32714	The	0	None
32714	32715	data	0	None
32715	32716	demonstrated	0	None
32716	32717	a	0	None
32717	32718	similar	0	None
32718	32719	incidence	0	None
32719	32720	of	0	None
32720	32721	potentially	0	None
32721	32722	lethal	0	None
32722	32723	arrhythmias	0	None
32723	32724	in	0	None
32724	32725	patients	0	None
32725	32726	displaying	0	None
32726	32727	transient	0	None
32727	32728	versus	0	None
32728	32729	persistent	0	None
32729	32730	ST	3	CHEMICAL
32730	32731	-	0	None
32731	32732	segment	0	None
32732	32733	elevation	0	None
32733	32734	and	0	None
32734	32735	right	0	None
32735	32736	bundle	0	None
32736	32737	branch	0	None
32737	32738	block	0	None
32738	32739	,	0	None
32739	32740	as	0	None
32740	32741	well	0	None
32741	32742	as	0	None
32742	32743	the	0	None
32743	32744	effectiveness	0	None
32744	32745	of	0	None
32745	32747	sodium channel	2	GENE-N
32747	32748	blockers	0	None
32748	32749	to	0	None
32749	32750	unmask	0	None
32750	32751	the	0	None
32751	32752	syndrome	0	None
32752	32753	and	0	None
32753	32754	,	0	None
32754	32755	thus	0	None
32755	32756	,	0	None
32756	32757	identify	0	None
32757	32758	patients	0	None
32758	32759	at	0	None
32759	32760	risk	0	None
32760	32761	.	0	None

32762	32763	Determinants	0	None
32763	32764	of	0	None
32764	32765	voltage	0	None
32765	32766	-	0	None
32766	32767	dependent	0	None
32767	32768	inactivation	0	None
32768	32769	affect	0	None
32769	32770	Mibefradil	0	None
32770	32771	block	0	None
32771	32772	of	0	None
32772	32774	calcium channels	2	GENE-N
32774	32775	.	0	None

32776	32777	The	0	None
32777	32781	voltage gated calcium channel	2	GENE-N
32781	32782	family	0	None
32782	32783	is	0	None
32783	32784	a	0	None
32784	32785	major	0	None
32785	32786	target	0	None
32786	32787	for	0	None
32787	32788	a	0	None
32788	32789	range	0	None
32789	32790	of	0	None
32790	32791	therapeutic	0	None
32791	32792	drugs	0	None
32792	32793	.	0	None

32794	32795	Mibefradil	0	None
32795	32796	(	0	None
32796	32797	Ro	0	None
32797	32798	40	0	None
32798	32799	-	0	None
32799	32800	5967	0	None
32800	32801	)	0	None
32801	32802	belongs	0	None
32802	32803	to	0	None
32803	32804	a	0	None
32804	32805	new	0	None
32805	32806	chemical	0	None
32806	32807	class	0	None
32807	32808	of	0	None
32808	32809	these	0	None
32809	32810	molecules	0	None
32810	32811	which	0	None
32811	32812	differs	0	None
32812	32813	from	0	None
32813	32814	other	0	None
32814	32815	Ca2	0	None
32815	32816	+	0	None
32816	32817	antagonists	0	None
32817	32818	by	0	None
32818	32819	its	0	None
32819	32820	ability	0	None
32820	32821	to	0	None
32821	32822	potently	0	None
32822	32823	block	0	None
32823	32824	T	0	None
32824	32825	-	0	None
32825	32826	type	0	None
32826	32827	Ca2	0	None
32827	32828	+	0	None
32828	32829	channels	0	None
32829	32830	.	0	None

32831	32832	However	0	None
32832	32833	,	0	None
32833	32834	this	0	None
32834	32835	molecule	0	None
32835	32836	has	0	None
32836	32837	also	0	None
32837	32838	been	0	None
32838	32839	shown	0	None
32839	32840	to	0	None
32840	32841	inhibit	0	None
32841	32842	other	0	None
32842	32843	Ca2	0	None
32843	32844	+	0	None
32844	32845	channel	0	None
32845	32846	subtypes	0	None
32846	32847	.	0	None

32848	32849	To	0	None
32849	32850	further	0	None
32850	32851	analyze	0	None
32851	32852	the	0	None
32852	32853	mechanism	0	None
32853	32854	governing	0	None
32854	32855	the	0	None
32855	32856	Ca2	0	None
32856	32857	+	0	None
32857	32858	channel	0	None
32858	32859	-	0	None
32859	32860	Mibefradil	0	None
32860	32861	interaction	0	None
32861	32862	,	0	None
32862	32863	we	0	None
32863	32864	examined	0	None
32864	32865	the	0	None
32865	32866	effect	0	None
32866	32867	of	0	None
32867	32868	Mibefradil	0	None
32868	32869	on	0	None
32869	32870	various	0	None
32870	32872	recombinant Ca2	1	GENE-Y
32872	32873	+	0	None
32873	32874	channels	0	None
32874	32875	expressed	0	None
32875	32876	in	0	None
32876	32877	mammalian	0	None
32877	32878	cells	0	None
32878	32879	from	0	None
32879	32880	their	0	None
32880	32881	cloned	0	None
32881	32882	cDNAs	0	None
32882	32883	,	0	None
32883	32884	using	0	None
32884	32885	Ca2	0	None
32885	32886	+	0	None
32886	32887	as	0	None
32887	32888	the	0	None
32888	32889	permeant	0	None
32889	32890	ion	3	CHEMICAL
32890	32891	at	0	None
32891	32892	physiological	0	None
32892	32893	concentration	0	None
32893	32894	.	0	None

32895	32896	Expression	0	None
32896	32897	of	0	None
32897	32898	alpha1A	0	None
32898	32899	,	0	None
32899	32900	alpha1C	0	None
32900	32901	,	0	None
32901	32902	and	0	None
32902	32903	alpha1E	0	None
32903	32904	in	0	None
32904	32905	tsA	0	None
32905	32906	201	0	None
32906	32907	cells	0	None
32907	32908	resulted	0	None
32908	32909	in	0	None
32909	32910	Ca2	0	None
32910	32911	+	0	None
32911	32912	currents	0	None
32912	32913	with	0	None
32913	32914	functional	0	None
32914	32915	characteristics	0	None
32915	32916	closely	0	None
32916	32917	related	0	None
32917	32918	to	0	None
32918	32919	those	0	None
32919	32920	of	0	None
32920	32921	their	0	None
32921	32922	native	0	None
32922	32923	counterparts	0	None
32923	32924	.	0	None

32925	32926	Mibefradil	0	None
32926	32927	blocked	0	None
32927	32928	alpha1A	0	None
32928	32929	and	0	None
32929	32930	alpha1E	0	None
32930	32931	with	0	None
32931	32932	a	0	None
32932	32933	Kd	0	None
32933	32934	comparable	0	None
32934	32935	to	0	None
32935	32936	that	0	None
32936	32937	reported	0	None
32937	32938	for	0	None
32938	32939	T	0	None
32939	32940	-	0	None
32940	32941	type	0	None
32941	32942	channels	0	None
32942	32943	,	0	None
32943	32944	but	0	None
32944	32945	had	0	None
32945	32946	a	0	None
32946	32947	lower	0	None
32947	32948	affinity	0	None
32948	32949	(	0	None
32949	32950	approximately	0	None
32950	32951	30	0	None
32951	32952	-	0	None
32952	32953	fold	0	None
32953	32954	)	0	None
32954	32955	for	0	None
32955	32956	alpha1C	0	None
32956	32957	.	0	None

32958	32959	For	0	None
32959	32960	each	0	None
32960	32961	channel	0	None
32961	32962	,	0	None
32962	32963	inhibition	0	None
32963	32964	by	0	None
32964	32965	Mibefradil	0	None
32965	32966	was	0	None
32966	32967	consistent	0	None
32967	32968	with	0	None
32968	32969	high	0	None
32969	32970	-	0	None
32970	32971	affinity	0	None
32971	32972	binding	0	None
32972	32973	to	0	None
32973	32974	the	0	None
32974	32975	inactivated	0	None
32975	32976	state	0	None
32976	32977	.	0	None

32978	32979	Modulation	0	None
32979	32980	of	0	None
32980	32981	the	0	None
32981	32982	voltage	0	None
32982	32983	-	0	None
32983	32984	dependent	0	None
32984	32985	inactivation	0	None
32985	32986	properties	0	None
32986	32987	by	0	None
32987	32988	the	0	None
32988	32989	nature	0	None
32989	32990	of	0	None
32990	32991	the	0	None
32991	32992	coexpressed	0	None
32992	32993	beta	0	None
32993	32994	subunit	0	None
32994	32995	or	0	None
32995	32996	the	0	None
32996	32997	alpha1	2	GENE-N
32997	32998	splice	0	None
32998	32999	variant	0	None
32999	33000	altered	0	None
33000	33001	block	0	None
33001	33002	at	0	None
33002	33003	the	0	None
33003	33004	Mibefradil	0	None
33004	33005	receptor	0	None
33005	33006	site	0	None
33006	33007	.	0	None

33008	33009	Therefore	0	None
33009	33010	,	0	None
33010	33011	we	0	None
33011	33012	conclude	0	None
33012	33013	that	0	None
33013	33014	the	0	None
33014	33015	tissue	0	None
33015	33016	and	0	None
33016	33017	sub	0	None
33017	33018	-	0	None
33018	33019	cellular	0	None
33019	33020	localization	0	None
33020	33021	of	0	None
33021	33023	calcium channel	2	GENE-N
33023	33024	subunits	0	None
33024	33025	as	0	None
33025	33026	well	0	None
33026	33027	as	0	None
33027	33028	their	0	None
33028	33029	specific	0	None
33029	33030	associations	0	None
33030	33031	are	0	None
33031	33032	essential	0	None
33032	33033	parameters	0	None
33033	33034	to	0	None
33034	33035	understand	0	None
33035	33036	the	0	None
33036	33037	in	0	None
33037	33038	vivo	0	None
33038	33039	effects	0	None
33039	33040	of	0	None
33040	33041	Mibefradil	0	None
33041	33042	.	0	None

33043	33044	Streptokinase	0	None
33044	33045	-	0	None
33045	33046	induced	0	None
33046	33047	platelet	0	None
33047	33048	activation	0	None
33048	33049	involves	0	None
33049	33050	antistreptokinase	0	None
33050	33051	antibodies	0	None
33051	33052	and	0	None
33052	33053	cleavage	0	None
33053	33054	of	0	None
33054	33055	protease	2	GENE-N
33055	33056	-	0	None
33056	33057	activated	0	None
33057	33058	receptor	0	None
33058	33059	-	0	None
33059	33060	1	0	None
33060	33061	.	0	None

33062	33063	Streptokinase	0	None
33063	33064	activates	0	None
33064	33065	platelets	0	None
33065	33066	,	0	None
33066	33067	limiting	0	None
33067	33068	its	0	None
33068	33069	effectiveness	0	None
33069	33070	as	0	None
33070	33071	a	0	None
33071	33072	thrombolytic	0	None
33072	33073	agent	0	None
33073	33074	.	0	None

33075	33076	The	0	None
33076	33077	role	0	None
33077	33078	of	0	None
33078	33079	antistreptokinase	0	None
33079	33080	antibodies	0	None
33080	33081	and	0	None
33081	33082	proteases	2	GENE-N
33082	33083	in	0	None
33083	33084	streptokinase	2	GENE-N
33084	33085	-	0	None
33085	33086	induced	0	None
33086	33087	platelet	0	None
33087	33088	activation	0	None
33088	33089	was	0	None
33089	33090	investigated	0	None
33090	33091	.	0	None

33092	33093	Streptokinase	0	None
33093	33094	induced	0	None
33094	33095	localization	0	None
33095	33096	of	0	None
33096	33098	human IgG	2	GENE-N
33098	33099	to	0	None
33099	33100	the	0	None
33100	33101	platelet	0	None
33101	33102	surface	0	None
33102	33103	,	0	None
33103	33104	platelet	0	None
33104	33105	aggregation	0	None
33105	33106	,	0	None
33106	33107	and	0	None
33107	33109	thromboxane A	3	CHEMICAL
33109	33110	(	0	None
33110	33111	2	0	None
33111	33112	)	0	None
33112	33113	production	0	None
33113	33114	.	0	None

33115	33116	These	0	None
33116	33117	effects	0	None
33117	33118	were	0	None
33118	33119	inhibited	0	None
33119	33120	by	0	None
33120	33121	a	0	None
33121	33123	monoclonal antibody	2	GENE-N
33123	33124	to	0	None
33124	33125	the	0	None
33125	33128	platelet Fc receptor	1	GENE-Y
33128	33129	,	0	None
33129	33130	IV	0	None
33130	33131	.	0	None
33131	33132	3	0	None
33132	33133	.	0	None

33134	33135	The	0	None
33135	33136	platelet	0	None
33136	33137	response	0	None
33137	33138	to	0	None
33138	33139	streptokinase	2	GENE-N
33139	33140	was	0	None
33140	33141	also	0	None
33141	33142	blocked	0	None
33142	33143	by	0	None
33143	33144	an	0	None
33144	33145	antibody	0	None
33145	33146	directed	0	None
33146	33147	against	0	None
33147	33148	the	0	None
33148	33149	cleavage	0	None
33149	33150	site	0	None
33150	33151	of	0	None
33151	33152	the	0	None
33152	33155	platelet thrombin receptor	2	GENE-N
33155	33156	,	0	None
33156	33157	protease	2	GENE-N
33157	33158	-	0	None
33158	33159	activated	0	None
33159	33160	receptor	0	None
33160	33161	-	0	None
33161	33162	1	0	None
33162	33163	(	0	None
33163	33164	PAR	2	GENE-N
33164	33165	-	0	None
33165	33166	1	0	None
33166	33167	)	0	None
33167	33168	,	0	None
33168	33169	but	0	None
33169	33170	not	0	None
33170	33171	by	0	None
33171	33172	hirudin	0	None
33172	33173	or	0	None
33173	33174	an	0	None
33174	33175	active	0	None
33175	33176	site	0	None
33176	33177	thrombin	2	GENE-N
33177	33178	inhibitor	0	None
33178	33179	,	0	None
33179	33180	Ro46	0	None
33180	33181	-	0	None
33181	33182	6240	0	None
33182	33183	.	0	None

33184	33185	In	0	None
33185	33186	plasma	0	None
33186	33187	depleted	0	None
33187	33188	of	0	None
33188	33189	plasminogen	1	GENE-Y
33189	33190	,	0	None
33190	33191	exogenous	0	None
33191	33192	wild	0	None
33192	33193	-	0	None
33193	33194	type	0	None
33194	33195	plasminogen	1	GENE-Y
33195	33196	,	0	None
33196	33197	but	0	None
33197	33198	not	0	None
33198	33199	an	0	None
33199	33200	inactive	0	None
33200	33201	mutant	0	None
33201	33202	protein	0	None
33202	33203	,	0	None
33203	33204	S	0	None
33204	33205	(	0	None
33205	33206	741	0	None
33206	33207	)	0	None
33207	33208	A	0	None
33208	33209	plasminogen	1	GENE-Y
33209	33210	,	0	None
33210	33211	supported	0	None
33211	33212	platelet	0	None
33212	33213	aggregation	0	None
33213	33214	,	0	None
33214	33215	suggesting	0	None
33215	33216	that	0	None
33216	33217	the	0	None
33217	33218	protease	2	GENE-N
33218	33219	cleaving	0	None
33219	33220	PAR	2	GENE-N
33220	33221	-	0	None
33221	33222	1	0	None
33222	33223	was	0	None
33223	33224	streptokinase	2	GENE-N
33224	33225	-	0	None
33225	33226	plasminogen	1	GENE-Y
33226	33227	.	0	None

33228	33229	Streptokinase	0	None
33229	33230	-	0	None
33230	33231	plasminogen	1	GENE-Y
33231	33232	cleaved	0	None
33232	33233	a	0	None
33233	33234	synthetic	0	None
33234	33235	peptide	0	None
33235	33236	corresponding	0	None
33236	33237	to	0	None
33237	33238	PAR	2	GENE-N
33238	33239	-	0	None
33239	33240	1	0	None
33240	33241	,	0	None
33241	33242	resulting	0	None
33242	33243	in	0	None
33243	33244	generation	0	None
33244	33245	of	0	None
33245	33246	PAR	2	GENE-N
33246	33247	-	0	None
33247	33248	1	0	None
33248	33249	tethered	0	None
33249	33250	ligand	0	None
33250	33251	sequence	0	None
33251	33252	and	0	None
33252	33253	selectively	0	None
33253	33254	reduced	0	None
33254	33255	binding	0	None
33255	33256	of	0	None
33256	33257	a	0	None
33257	33258	cleavage	0	None
33258	33259	-	0	None
33259	33260	sensitive	0	None
33260	33261	PAR	2	GENE-N
33261	33262	-	0	None
33262	33263	1	0	None
33263	33264	antibody	0	None
33264	33265	in	0	None
33265	33266	intact	0	None
33266	33267	cells	0	None
33267	33268	.	0	None

33269	33270	A	0	None
33270	33271	combination	0	None
33271	33272	of	0	None
33272	33273	streptokinase	2	GENE-N
33273	33274	,	0	None
33274	33275	plasminogen	1	GENE-Y
33275	33276	,	0	None
33276	33277	and	0	None
33277	33278	antistreptokinase	0	None
33278	33279	antibodies	0	None
33279	33280	activated	0	None
33280	33281	human	0	None
33281	33282	erythroleukemic	0	None
33282	33283	cells	0	None
33283	33284	and	0	None
33284	33285	was	0	None
33285	33286	inhibited	0	None
33286	33287	by	0	None
33287	33288	pretreatment	0	None
33288	33289	with	0	None
33289	33290	IV	0	None
33290	33291	.	0	None
33291	33292	3	0	None
33292	33293	or	0	None
33293	33294	pretreating	0	None
33294	33295	the	0	None
33295	33296	cells	0	None
33296	33297	with	0	None
33297	33298	the	0	None
33298	33299	PAR	2	GENE-N
33299	33300	-	0	None
33300	33301	1	0	None
33301	33302	agonist	0	None
33302	33303	SFLLRN	0	None
33303	33304	,	0	None
33304	33305	suggesting	0	None
33305	33306	Fc	0	None
33306	33307	receptor	0	None
33307	33308	and	0	None
33308	33309	PAR	2	GENE-N
33309	33310	-	0	None
33310	33311	1	0	None
33311	33312	interactions	0	None
33312	33313	are	0	None
33313	33314	necessary	0	None
33314	33315	for	0	None
33315	33316	cell	0	None
33316	33317	activation	0	None
33317	33318	in	0	None
33318	33319	this	0	None
33319	33320	system	0	None
33320	33321	also	0	None
33321	33322	.	0	None

33323	33324	Streptokinase	0	None
33324	33325	-	0	None
33325	33326	induced	0	None
33326	33327	platelet	0	None
33327	33328	activation	0	None
33328	33329	is	0	None
33329	33330	dependent	0	None
33330	33331	on	0	None
33331	33332	both	0	None
33332	33333	antistreptokinase	0	None
33333	33334	-	0	None
33334	33335	Fc	0	None
33335	33336	receptor	0	None
33336	33337	interactions	0	None
33337	33338	and	0	None
33338	33339	cleavage	0	None
33339	33340	of	0	None
33340	33341	PAR	2	GENE-N
33341	33342	-	0	None
33342	33343	1	0	None
33343	33344	.	0	None

33345	33346	(	0	None
33346	33347	Blood	0	None
33347	33348	.	0	None
33348	33349	2000	0	None
33349	33350	;	0	None
33350	33351	95	0	None
33351	33352	:	0	None
33352	33353	1301	0	None
33353	33354	-	0	None
33354	33355	1308	0	None
33355	33356	)	0	None

33357	33358	Polysulfated	0	None
33358	33359	heparinoids	0	None
33359	33360	selectively	0	None
33360	33361	inactivate	0	None
33361	33362	heparin	0	None
33362	33363	-	0	None
33363	33364	binding	0	None
33364	33365	angiogenesis	0	None
33365	33366	factors	0	None
33366	33367	.	0	None

33368	33369	Angiogenesis	0	None
33369	33370	is	0	None
33370	33371	a	0	None
33371	33372	prerequisite	0	None
33372	33373	for	0	None
33373	33374	tumor	0	None
33374	33375	expansion	0	None
33375	33376	and	0	None
33376	33377	metastasis	0	None
33377	33378	.	0	None

33379	33380	The	0	None
33380	33381	angiogenic	0	None
33381	33382	potential	0	None
33382	33383	of	0	None
33383	33384	the	0	None
33384	33385	heparin	0	None
33385	33386	-	0	None
33386	33387	binding	0	None
33387	33393	growth factors acidic fibroblast growth factor	1	GENE-Y
33393	33394	(	0	None
33394	33395	FGF	2	GENE-N
33395	33396	)	0	None
33396	33397	and	0	None
33397	33399	basic FGF	2	GENE-N
33399	33400	has	0	None
33400	33401	been	0	None
33401	33402	demonstrated	0	None
33402	33403	in	0	None
33403	33404	various	0	None
33404	33405	publications	0	None
33405	33406	.	0	None

33407	33408	We	0	None
33408	33409	studied	0	None
33409	33410	the	0	None
33410	33411	inhibitory	0	None
33411	33412	effects	0	None
33412	33413	of	0	None
33413	33414	suramin	3	CHEMICAL
33414	33415	and	0	None
33415	33416	the	0	None
33416	33417	polysulfated	0	None
33417	33418	heparinoids	0	None
33418	33419	pentosan	0	None
33419	33420	polysulfate	0	None
33420	33421	,	0	None
33421	33422	dextran	0	None
33422	33423	sulfate	3	CHEMICAL
33423	33424	,	0	None
33424	33425	and	0	None
33425	33426	fucoidan	0	None
33426	33427	on	0	None
33427	33428	the	0	None
33428	33429	action	0	None
33429	33430	of	0	None
33430	33431	FGF	2	GENE-N
33431	33432	.	0	None

33433	33434	As	0	None
33434	33435	an	0	None
33435	33436	experimental	0	None
33436	33437	model	0	None
33437	33438	,	0	None
33438	33439	we	0	None
33439	33440	used	0	None
33440	33441	the	0	None
33441	33442	adrenal	0	None
33442	33443	cancer	0	None
33443	33444	cell	0	None
33444	33445	line	0	None
33445	33446	SW	0	None
33446	33447	13	0	None
33447	33448	,	0	None
33448	33449	whose	0	None
33449	33450	anchorage	0	None
33450	33451	-	0	None
33451	33452	independent	0	None
33452	33453	growth	0	None
33453	33454	depends	0	None
33454	33455	on	0	None
33455	33456	the	0	None
33456	33457	presence	0	None
33457	33458	of	0	None
33458	33459	FGF	2	GENE-N
33459	33460	.	0	None

33461	33462	The	0	None
33462	33463	polysulfated	0	None
33463	33464	heparinoids	0	None
33464	33465	inhibited	0	None
33465	33466	FGF	2	GENE-N
33466	33467	-	0	None
33467	33468	induced	0	None
33468	33469	growth	0	None
33469	33470	and	0	None
33470	33471	binding	0	None
33471	33472	to	0	None
33472	33473	the	0	None
33473	33474	receptor	0	None
33474	33475	at	0	None
33475	33476	an	0	None
33476	33477	IC50	0	None
33477	33478	of	0	None
33478	33479	0	0	None
33479	33480	.	0	None
33480	33481	5	0	None
33481	33482	-	0	None
33482	33483	3	0	None
33483	33484	micrograms	0	None
33484	33485	/	0	None
33485	33486	ml	0	None
33486	33487	.	0	None

33488	33489	Suramin	0	None
33489	33490	inhibited	0	None
33490	33491	FGF	2	GENE-N
33491	33492	at	0	None
33492	33493	an	0	None
33493	33494	IC50	0	None
33494	33495	of	0	None
33495	33496	100	0	None
33496	33497	micrograms	0	None
33497	33498	/	0	None
33498	33499	ml	0	None
33499	33500	.	0	None

33501	33502	The	0	None
33502	33503	polysulfated	0	None
33503	33504	heparinoids	0	None
33504	33505	exerted	0	None
33505	33506	no	0	None
33506	33507	effect	0	None
33507	33508	on	0	None
33508	33509	IGF	1	GENE-Y
33509	33510	-	0	None
33510	33511	1	0	None
33511	33512	or	0	None
33512	33513	TGF	0	None
33513	33514	alpha	0	None
33514	33515	-	0	None
33515	33516	related	0	None
33516	33517	growth	0	None
33517	33518	.	0	None

33519	33520	Suramin	0	None
33520	33521	inhibited	0	None
33521	33522	the	0	None
33522	33523	anchorage	0	None
33523	33524	-	0	None
33524	33525	independent	0	None
33525	33526	growth	0	None
33526	33527	induced	0	None
33527	33528	by	0	None
33528	33529	IGF	1	GENE-Y
33529	33530	-	0	None
33530	33531	1	0	None
33531	33532	or	0	None
33532	33533	TGF	0	None
33533	33534	alpha	0	None
33534	33535	only	0	None
33535	33536	at	0	None
33536	33537	an	0	None
33537	33538	IC50	0	None
33538	33539	of	0	None
33539	33540	100	0	None
33540	33541	micrograms	0	None
33541	33542	/	0	None
33542	33543	ml	0	None
33543	33544	.	0	None

33545	33546	Our	0	None
33546	33547	results	0	None
33547	33548	indicate	0	None
33548	33549	that	0	None
33549	33550	suramin	3	CHEMICAL
33550	33551	inhibits	0	None
33551	33552	growth	0	None
33552	33553	factors	0	None
33553	33554	in	0	None
33554	33555	a	0	None
33555	33556	nonselective	0	None
33556	33557	way	0	None
33557	33558	.	0	None

33559	33560	By	0	None
33560	33561	contrast	0	None
33561	33562	,	0	None
33562	33563	polysulfated	0	None
33563	33564	heparinoids	0	None
33564	33565	exert	0	None
33565	33566	a	0	None
33566	33567	selective	0	None
33567	33568	inhibitory	0	None
33568	33569	effect	0	None
33569	33570	on	0	None
33570	33571	heparin	0	None
33571	33572	binding	0	None
33572	33573	angiogenesis	0	None
33573	33574	factors	0	None
33574	33575	at	0	None
33575	33576	an	0	None
33576	33577	IC50	0	None
33577	33578	,	0	None
33578	33579	which	0	None
33579	33580	is	0	None
33580	33581	100	0	None
33581	33582	times	0	None
33582	33583	below	0	None
33583	33584	the	0	None
33584	33585	IC50	0	None
33585	33586	of	0	None
33586	33587	suramin	3	CHEMICAL
33587	33588	.	0	None

33589	33590	Therefore	0	None
33590	33591	,	0	None
33591	33592	the	0	None
33592	33593	administration	0	None
33593	33594	of	0	None
33594	33595	polysulfated	0	None
33595	33596	heparinoids	0	None
33596	33597	might	0	None
33597	33598	become	0	None
33598	33599	a	0	None
33599	33600	novel	0	None
33600	33601	approach	0	None
33601	33602	to	0	None
33602	33603	tumor	0	None
33603	33604	therapy	0	None
33604	33605	based	0	None
33605	33606	on	0	None
33606	33607	blocking	0	None
33607	33608	angiogenesis	0	None
33608	33609	.	0	None

33610	33611	Use	0	None
33611	33612	of	0	None
33612	33614	tranexamic acid	3	CHEMICAL
33614	33615	for	0	None
33615	33616	an	0	None
33616	33617	effective	0	None
33617	33618	blood	0	None
33618	33619	conservation	0	None
33619	33620	strategy	0	None
33620	33621	after	0	None
33621	33622	total	0	None
33622	33623	knee	0	None
33623	33624	arthroplasty	0	None
33624	33625	.	0	None

33626	33627	We	0	None
33627	33628	have	0	None
33628	33629	investigated	0	None
33629	33630	the	0	None
33630	33631	effect	0	None
33631	33632	of	0	None
33632	33633	treatment	0	None
33633	33634	with	0	None
33634	33636	tranexamic acid	3	CHEMICAL
33636	33637	,	0	None
33637	33638	an	0	None
33638	33639	inhibitor	0	None
33639	33640	of	0	None
33640	33641	fibrinolysis	0	None
33641	33642	,	0	None
33642	33643	on	0	None
33643	33644	blood	0	None
33644	33645	loss	0	None
33645	33646	,	0	None
33646	33647	blood	0	None
33647	33648	transfusion	0	None
33648	33649	requirements	0	None
33649	33650	and	0	None
33650	33651	blood	0	None
33651	33652	coagulation	0	None
33652	33653	in	0	None
33653	33654	a	0	None
33654	33655	randomized	0	None
33655	33656	,	0	None
33656	33657	double	0	None
33657	33658	-	0	None
33658	33659	blind	0	None
33659	33660	,	0	None
33660	33661	placebo	0	None
33661	33662	-	0	None
33662	33663	controlled	0	None
33663	33664	study	0	None
33664	33665	of	0	None
33665	33666	42	0	None
33666	33667	patients	0	None
33667	33668	after	0	None
33668	33669	total	0	None
33669	33670	knee	0	None
33670	33671	arthroplasty	0	None
33671	33672	.	0	None

33673	33674	Tranexamic	0	None
33674	33675	acid	0	None
33675	33676	15	0	None
33676	33677	mg	0	None
33677	33678	kg	0	None
33678	33679	-	0	None
33679	33680	1	0	None
33680	33681	(	0	None
33681	33682	n	0	None
33682	33683	=	0	None
33683	33684	21	0	None
33684	33685	)	0	None
33685	33686	or	0	None
33686	33687	an	0	None
33687	33688	equivalent	0	None
33688	33689	volume	0	None
33689	33690	of	0	None
33690	33691	normal	0	None
33691	33692	saline	0	None
33692	33693	(	0	None
33693	33694	n	0	None
33694	33695	=	0	None
33695	33696	21	0	None
33696	33697	)	0	None
33697	33698	was	0	None
33698	33699	given	0	None
33699	33700	30	0	None
33700	33701	min	0	None
33701	33702	before	0	None
33702	33703	surgery	0	None
33703	33704	and	0	None
33704	33705	subsequently	0	None
33705	33706	every	0	None
33706	33707	8	0	None
33707	33708	h	0	None
33708	33709	for	0	None
33709	33710	3	0	None
33710	33711	days	0	None
33711	33712	.	0	None

33713	33714	Coagulation	0	None
33714	33715	and	0	None
33715	33716	fibrinolysis	0	None
33716	33717	values	0	None
33717	33718	,	0	None
33718	33719	blood	0	None
33719	33720	loss	0	None
33720	33721	and	0	None
33721	33722	blood	0	None
33722	33723	units	0	None
33723	33724	administered	0	None
33724	33725	were	0	None
33725	33726	measured	0	None
33726	33727	before	0	None
33727	33728	administration	0	None
33728	33729	of	0	None
33729	33731	tranexamic acid	3	CHEMICAL
33731	33732	,	0	None
33732	33733	8	0	None
33733	33734	h	0	None
33734	33735	after	0	None
33735	33736	the	0	None
33736	33737	end	0	None
33737	33738	of	0	None
33738	33739	surgery	0	None
33739	33740	and	0	None
33740	33741	at	0	None
33741	33742	24	0	None
33742	33743	and	0	None
33743	33744	72	0	None
33744	33745	h	0	None
33745	33746	after	0	None
33746	33747	operation	0	None
33747	33748	.	0	None

33749	33750	Coagulation	0	None
33750	33751	profile	0	None
33751	33752	was	0	None
33752	33753	examined	0	None
33753	33754	(	0	None
33754	33755	bleeding	0	None
33755	33756	time	0	None
33756	33757	,	0	None
33757	33758	platelet	0	None
33758	33759	count	0	None
33759	33760	,	0	None
33760	33761	prothrombin	1	GENE-Y
33761	33762	time	0	None
33762	33763	(	0	None
33763	33764	PT	0	None
33764	33765	)	0	None
33765	33766	,	0	None
33766	33767	activated	0	None
33767	33769	partial thromboplastin	1	GENE-Y
33769	33770	time	0	None
33770	33771	(	0	None
33771	33772	aPTT	0	None
33772	33773	)	0	None
33773	33774	,	0	None
33774	33775	plasminogen	1	GENE-Y
33775	33776	,	0	None
33776	33777	beta	0	None
33777	33778	-	0	None
33778	33779	thromboglobulin	0	None
33779	33780	and	0	None
33780	33781	fibrinogen	1	GENE-Y
33781	33782	)	0	None
33782	33783	.	0	None

33784	33785	Fibrinolysis	0	None
33785	33786	was	0	None
33786	33787	evaluated	0	None
33787	33788	by	0	None
33788	33789	measurement	0	None
33789	33790	of	0	None
33790	33791	concentrations	0	None
33791	33792	of	0	None
33792	33793	D	0	None
33793	33794	-	0	None
33794	33795	dimer	0	None
33795	33796	and	0	None
33796	33799	fibrinogen degradation products	1	GENE-Y
33799	33800	(	0	None
33800	33801	FDP	0	None
33801	33802	)	0	None
33802	33803	.	0	None

33804	33805	Total	0	None
33805	33806	blood	0	None
33806	33807	loss	0	None
33807	33808	in	0	None
33808	33809	the	0	None
33809	33811	tranexamic acid	3	CHEMICAL
33811	33812	group	0	None
33812	33813	was	0	None
33813	33814	678	0	None
33814	33815	(	0	None
33815	33816	SD	0	None
33816	33817	352	0	None
33817	33818	)	0	None
33818	33819	ml	0	None
33819	33820	compared	0	None
33820	33821	with	0	None
33821	33822	1419	0	None
33822	33823	(	0	None
33823	33824	607	0	None
33824	33825	)	0	None
33825	33826	ml	0	None
33826	33827	in	0	None
33827	33828	the	0	None
33828	33829	control	0	None
33829	33830	group	0	None
33830	33831	(	0	None
33831	33832	P	0	None
33832	33833	<	0	None
33833	33834	0	0	None
33834	33835	.	0	None
33835	33836	001	0	None
33836	33837	)	0	None
33837	33838	,	0	None
33838	33839	and	0	None
33839	33840	occurred	0	None
33840	33841	primarily	0	None
33841	33842	during	0	None
33842	33843	the	0	None
33843	33844	first	0	None
33844	33845	24	0	None
33845	33846	h	0	None
33846	33847	after	0	None
33847	33848	surgery	0	None
33848	33849	.	0	None

33850	33851	Thirteen	0	None
33851	33852	patients	0	None
33852	33853	received	0	None
33853	33854	1	0	None
33854	33855	-	0	None
33855	33856	5	0	None
33856	33857	u	0	None
33857	33858	.	0	None
33858	33859	of	0	None
33859	33860	packed	0	None
33860	33861	red	0	None
33861	33862	blood	0	None
33862	33863	cells	0	None
33863	33864	in	0	None
33864	33865	the	0	None
33865	33866	control	0	None
33866	33867	group	0	None
33867	33868	compared	0	None
33868	33869	with	0	None
33869	33870	two	0	None
33870	33871	patients	0	None
33871	33872	in	0	None
33872	33873	the	0	None
33873	33875	tranexamic acid	3	CHEMICAL
33875	33876	group	0	None
33876	33877	,	0	None
33877	33878	who	0	None
33878	33879	received	0	None
33879	33880	3	0	None
33880	33881	u	0	None
33881	33882	.	0	None

33883	33884	(	0	None
33884	33885	P	0	None
33885	33886	<	0	None
33886	33887	0	0	None
33887	33888	.	0	None
33888	33889	001	0	None
33889	33890	)	0	None
33890	33891	.	0	None

33892	33893	Postoperative	0	None
33893	33894	packed	0	None
33894	33895	cell	0	None
33895	33896	volume	0	None
33896	33897	values	0	None
33897	33898	were	0	None
33898	33899	higher	0	None
33899	33900	in	0	None
33900	33901	the	0	None
33901	33903	tranexamic acid	3	CHEMICAL
33903	33904	group	0	None
33904	33905	despite	0	None
33905	33906	fewer	0	None
33906	33907	blood	0	None
33907	33908	transfusions	0	None
33908	33909	.	0	None

33910	33911	Postoperative	0	None
33911	33912	concentrations	0	None
33912	33913	of	0	None
33913	33914	plasminogen	1	GENE-Y
33914	33915	were	0	None
33915	33916	decreased	0	None
33916	33917	significantly	0	None
33917	33918	in	0	None
33918	33919	the	0	None
33919	33921	tranexamic acid	3	CHEMICAL
33921	33922	group	0	None
33922	33923	(	0	None
33923	33924	P	0	None
33924	33925	<	0	None
33925	33926	0	0	None
33926	33927	.	0	None
33927	33928	001	0	None
33928	33929	)	0	None
33929	33930	.	0	None

33931	33932	Platelet	0	None
33932	33933	count	0	None
33933	33934	,	0	None
33934	33935	PT	0	None
33935	33936	,	0	None
33936	33937	aPTT	0	None
33937	33938	,	0	None
33938	33939	bleeding	0	None
33939	33940	time	0	None
33940	33941	,	0	None
33941	33942	beta	0	None
33942	33943	-	0	None
33943	33944	thromboglobulin	0	None
33944	33945	,	0	None
33945	33946	fibrinogen	1	GENE-Y
33946	33947	and	0	None
33947	33948	FDP	0	None
33948	33949	concentrations	0	None
33949	33950	did	0	None
33950	33951	not	0	None
33951	33952	differ	0	None
33952	33953	between	0	None
33953	33954	groups	0	None
33954	33955	,	0	None
33955	33956	but	0	None
33956	33957	D	0	None
33957	33958	-	0	None
33958	33959	dimer	0	None
33959	33960	concentrations	0	None
33960	33961	were	0	None
33961	33962	increased	0	None
33962	33963	in	0	None
33963	33964	the	0	None
33964	33965	control	0	None
33965	33966	group	0	None
33966	33967	.	0	None

33968	33969	Thromboembolic	0	None
33969	33970	complications	0	None
33970	33971	occurred	0	None
33971	33972	in	0	None
33972	33973	two	0	None
33973	33974	patients	0	None
33974	33975	in	0	None
33975	33976	the	0	None
33976	33977	control	0	None
33977	33978	group	0	None
33978	33979	compared	0	None
33979	33980	with	0	None
33980	33981	none	0	None
33981	33982	in	0	None
33982	33983	the	0	None
33983	33985	tranexamic acid	3	CHEMICAL
33985	33986	group	0	None
33986	33987	.	0	None

33988	33989	Nitric	0	None
33989	33990	oxide	0	None
33990	33991	synthase	0	None
33991	33992	expression	0	None
33992	33993	in	0	None
33993	33994	the	0	None
33994	33995	opossum	0	None
33995	33996	superior	0	None
33996	33997	colliculus	0	None
33997	33998	:	0	None
33998	33999	a	0	None
33999	34000	histochemical	0	None
34000	34001	,	0	None
34001	34002	immunohistochemical	0	None
34002	34003	and	0	None
34003	34004	biochemical	0	None
34004	34005	study	0	None
34005	34006	.	0	None

34007	34008	The	0	None
34008	34009	expression	0	None
34009	34010	of	0	None
34010	34014	neuronal nitric oxide synthase	1	GENE-Y
34014	34015	(	0	None
34015	34016	nNOS	0	None
34016	34017	)	0	None
34017	34018	in	0	None
34018	34019	the	0	None
34019	34020	superior	0	None
34020	34021	colliculus	0	None
34021	34022	(	0	None
34022	34023	SC	0	None
34023	34024	)	0	None
34024	34025	of	0	None
34025	34026	the	0	None
34026	34027	opossum	0	None
34027	34028	Didelphis	0	None
34028	34029	marsupialis	0	None
34029	34030	was	0	None
34030	34031	studied	0	None
34031	34032	by	0	None
34032	34034	NADPH diaphorase	2	GENE-N
34034	34035	(	0	None
34035	34036	NADPH	3	CHEMICAL
34036	34037	-	0	None
34037	34038	d	0	None
34038	34039	)	0	None
34039	34040	histochemistry	0	None
34040	34041	and	0	None
34041	34042	nNOS	0	None
34042	34043	immunohistochemistry	0	None
34043	34044	.	0	None

34045	34046	In	0	None
34046	34047	addition	0	None
34047	34048	,	0	None
34048	34049	the	0	None
34049	34050	activity	0	None
34050	34051	of	0	None
34051	34052	nNOS	0	None
34052	34053	was	0	None
34053	34054	quantified	0	None
34054	34055	by	0	None
34055	34056	measurement	0	None
34056	34057	of	0	None
34057	34058	[	0	None
34058	34059	(	0	None
34059	34060	3	0	None
34060	34061	)	0	None
34061	34062	H	0	None
34062	34063	]	0	None
34063	34064	-	0	None
34064	34065	L	0	None
34065	34066	-	0	None
34066	34067	arginine	3	CHEMICAL
34067	34068	conversion	0	None
34068	34069	to	0	None
34069	34070	[	0	None
34070	34071	(	0	None
34071	34072	3	0	None
34072	34073	)	0	None
34073	34074	H	0	None
34074	34075	]	0	None
34075	34076	-	0	None
34076	34077	L	0	None
34077	34078	-	0	None
34078	34079	citrulline	0	None
34079	34080	in	0	None
34080	34081	tissue	0	None
34081	34082	extracts	0	None
34082	34083	from	0	None
34083	34084	SC	0	None
34084	34085	superficial	0	None
34085	34086	layers	0	None
34086	34087	in	0	None
34087	34088	opossums	0	None
34088	34089	and	0	None
34089	34090	rats	0	None
34090	34091	.	0	None

34092	34093	Our	0	None
34093	34094	results	0	None
34094	34095	show	0	None
34095	34096	that	0	None
34096	34097	the	0	None
34097	34098	number	0	None
34098	34099	of	0	None
34099	34100	NADPH	3	CHEMICAL
34100	34101	-	0	None
34101	34102	d	0	None
34102	34103	stained	0	None
34103	34104	cells	0	None
34104	34105	was	0	None
34105	34106	small	0	None
34106	34107	and	0	None
34107	34108	virtually	0	None
34108	34109	identical	0	None
34109	34110	in	0	None
34110	34111	stratum	0	None
34111	34112	opticum	0	None
34112	34113	(	0	None
34113	34114	SO	0	None
34114	34115	)	0	None
34115	34116	and	0	None
34116	34117	stratum	0	None
34117	34118	griseum	0	None
34118	34119	superficiale	0	None
34119	34120	(	0	None
34120	34121	SGS	0	None
34121	34122	)	0	None
34122	34123	and	0	None
34123	34124	their	0	None
34124	34125	staining	0	None
34125	34126	was	0	None
34126	34127	very	0	None
34127	34128	light	0	None
34128	34129	,	0	None
34129	34130	particularly	0	None
34130	34131	in	0	None
34131	34132	SGS	0	None
34132	34133	.	0	None

34134	34135	Neuropil	0	None
34135	34136	staining	0	None
34136	34137	was	0	None
34137	34138	heavier	0	None
34138	34139	in	0	None
34139	34140	the	0	None
34140	34141	stratum	0	None
34141	34142	zonale	0	None
34142	34143	(	0	None
34143	34144	SZ	0	None
34144	34145	)	0	None
34145	34146	than	0	None
34146	34147	in	0	None
34147	34148	SGS	0	None
34148	34149	or	0	None
34149	34150	SO	0	None
34150	34151	.	0	None

34152	34153	The	0	None
34153	34154	intermediate	0	None
34154	34155	and	0	None
34155	34156	deep	0	None
34156	34157	layers	0	None
34157	34158	contained	0	None
34158	34159	heavily	0	None
34159	34160	stained	0	None
34160	34161	cells	0	None
34161	34162	and	0	None
34162	34163	moderate	0	None
34163	34164	neuropil	0	None
34164	34165	staining	0	None
34165	34166	.	0	None

34167	34168	Surprisingly	0	None
34168	34169	,	0	None
34169	34170	nNOS	0	None
34170	34171	-	0	None
34171	34172	immunoreactive	0	None
34172	34173	cells	0	None
34173	34174	were	0	None
34174	34175	far	0	None
34175	34176	more	0	None
34176	34177	numerous	0	None
34177	34178	than	0	None
34178	34179	NADPH	3	CHEMICAL
34179	34180	-	0	None
34180	34181	d	0	None
34181	34182	+	0	None
34182	34183	cells	0	None
34183	34184	in	0	None
34184	34185	every	0	None
34185	34186	layer	0	None
34186	34187	.	0	None

34188	34189	The	0	None
34189	34190	production	0	None
34190	34191	of	0	None
34191	34192	[	0	None
34192	34193	(	0	None
34193	34194	3	0	None
34194	34195	)	0	None
34195	34196	H	0	None
34196	34197	]	0	None
34197	34198	-	0	None
34198	34199	L	0	None
34199	34200	-	0	None
34200	34201	citrulline	0	None
34201	34202	from	0	None
34202	34203	[	0	None
34203	34204	(	0	None
34204	34205	3	0	None
34205	34206	)	0	None
34206	34207	H	0	None
34207	34208	]	0	None
34208	34209	-	0	None
34209	34210	L	0	None
34210	34211	-	0	None
34211	34212	arginine	3	CHEMICAL
34212	34213	in	0	None
34213	34214	tissue	0	None
34214	34215	extracts	0	None
34215	34216	enriched	0	None
34216	34217	in	0	None
34217	34218	superficial	0	None
34218	34219	layers	0	None
34219	34220	indicated	0	None
34220	34221	that	0	None
34221	34222	nNOS	0	None
34222	34223	specific	0	None
34223	34224	activity	0	None
34224	34225	is	0	None
34225	34226	as	0	None
34226	34227	high	0	None
34227	34228	in	0	None
34228	34229	the	0	None
34229	34230	opossum	0	None
34230	34231	as	0	None
34231	34232	in	0	None
34232	34233	the	0	None
34233	34234	rat	0	None
34234	34235	.	0	None

34236	34237	Our	0	None
34237	34238	results	0	None
34238	34239	suggest	0	None
34239	34240	that	0	None
34240	34241	the	0	None
34241	34242	location	0	None
34242	34243	of	0	None
34243	34244	nNOS	0	None
34244	34245	-	0	None
34245	34246	expressing	0	None
34246	34247	neurons	0	None
34247	34248	in	0	None
34248	34249	retino	0	None
34249	34250	-	0	None
34250	34251	receptive	0	None
34251	34252	layers	0	None
34252	34253	may	0	None
34253	34254	be	0	None
34254	34255	related	0	None
34255	34256	to	0	None
34256	34257	inter	0	None
34257	34258	-	0	None
34258	34259	specific	0	None
34259	34260	differences	0	None
34260	34261	in	0	None
34261	34262	the	0	None
34262	34263	processing	0	None
34263	34264	of	0	None
34264	34265	visual	0	None
34265	34266	information	0	None
34266	34267	.	0	None

34268	34269	Correlations	0	None
34269	34270	between	0	None
34270	34271	serotonin	3	CHEMICAL
34271	34272	level	0	None
34272	34273	and	0	None
34273	34274	single	0	None
34274	34275	-	0	None
34275	34276	cell	0	None
34276	34277	firing	0	None
34277	34278	in	0	None
34278	34279	the	0	None
34279	34280	rat	0	None
34280	34281	'	0	None
34281	34282	s	0	None
34282	34283	nucleus	0	None
34283	34284	raphe	0	None
34284	34285	magnus	0	None
34285	34286	.	0	None

34287	34288	The	0	None
34288	34289	relation	0	None
34289	34290	between	0	None
34290	34291	serotonin	3	CHEMICAL
34291	34292	release	0	None
34292	34293	and	0	None
34293	34294	electrical	0	None
34294	34295	activity	0	None
34295	34296	was	0	None
34296	34297	examined	0	None
34297	34298	in	0	None
34298	34299	the	0	None
34299	34300	nucleus	0	None
34300	34301	raphe	0	None
34301	34302	magnus	0	None
34302	34303	of	0	None
34303	34304	rats	0	None
34304	34305	anesthetized	0	None
34305	34306	with	0	None
34306	34307	pentobarbital	3	CHEMICAL
34307	34308	.	0	None

34309	34310	Serotonin	0	None
34310	34311	levels	0	None
34311	34312	were	0	None
34312	34313	monitored	0	None
34313	34314	through	0	None
34314	34315	a	0	None
34315	34316	carbon	3	CHEMICAL
34316	34317	-	0	None
34317	34318	fiber	0	None
34318	34319	microelectrode	0	None
34319	34320	by	0	None
34320	34321	fast	0	None
34321	34322	cyclic	3	CHEMICAL
34322	34323	voltammetry	0	None
34323	34324	(	0	None
34324	34325	usually	0	None
34325	34326	at	0	None
34326	34327	1	0	None
34327	34328	Hz	0	None
34328	34329	)	0	None
34329	34330	.	0	None

34331	34332	Single	0	None
34332	34333	-	0	None
34333	34334	cell	0	None
34334	34335	firing	0	None
34335	34336	was	0	None
34336	34337	recorded	0	None
34337	34338	through	0	None
34338	34339	the	0	None
34339	34340	same	0	None
34340	34341	microelectrode	0	None
34341	34342	,	0	None
34342	34343	except	0	None
34343	34344	during	0	None
34344	34345	the	0	None
34345	34346	voltammetry	0	None
34346	34347	waveform	0	None
34347	34348	and	0	None
34348	34349	associated	0	None
34349	34350	electrical	0	None
34350	34351	artifact	0	None
34351	34352	(	0	None
34352	34353	totaling	0	None
34353	34354	about	0	None
34354	34355	30	0	None
34355	34356	ms	0	None
34356	34357	)	0	None
34357	34358	.	0	None

34359	34360	Multi	0	None
34360	34361	-	0	None
34361	34362	barrel	0	None
34362	34363	micropipettes	0	None
34363	34364	incorporating	0	None
34364	34365	the	0	None
34365	34366	voltammetry	0	None
34366	34367	electrode	0	None
34367	34368	were	0	None
34368	34369	used	0	None
34369	34370	for	0	None
34370	34371	iontophoresis	0	None
34371	34372	of	0	None
34372	34373	drugs	0	None
34373	34374	.	0	None

34375	34376	Cells	0	None
34376	34377	were	0	None
34377	34378	inhibited	0	None
34378	34379	,	0	None
34379	34380	excited	0	None
34380	34381	or	0	None
34381	34382	unaffected	0	None
34382	34383	by	0	None
34383	34384	noxious	0	None
34384	34385	mechanical	0	None
34385	34386	skin	0	None
34386	34387	stimulation	0	None
34387	34388	.	0	None

34389	34390	These	0	None
34390	34391	were	0	None
34391	34392	respectively	0	None
34392	34393	designated	0	None
34393	34394	as	0	None
34394	34395	off	0	None
34395	34396	(	0	None
34396	34397	M	0	None
34397	34398	)	0	None
34398	34399	cells	0	None
34399	34400	,	0	None
34400	34401	on	0	None
34401	34402	(	0	None
34402	34403	M	0	None
34403	34404	)	0	None
34404	34405	cells	0	None
34405	34406	and	0	None
34406	34407	neutral	0	None
34407	34408	(	0	None
34408	34409	M	0	None
34409	34410	)	0	None
34410	34411	cells	0	None
34411	34412	,	0	None
34412	34413	M	0	None
34413	34414	denoting	0	None
34414	34415	mechanical	0	None
34415	34416	.	0	None

34417	34418	During	0	None
34418	34419	3	0	None
34419	34420	min	0	None
34420	34421	of	0	None
34421	34422	pinching	0	None
34422	34423	,	0	None
34423	34424	serotonin	3	CHEMICAL
34424	34425	slowly	0	None
34425	34426	rose	0	None
34426	34427	near	0	None
34427	34428	seven	0	None
34428	34429	of	0	None
34429	34430	14	0	None
34430	34431	on	0	None
34431	34432	(	0	None
34432	34433	M	0	None
34433	34434	)	0	None
34434	34435	cells	0	None
34435	34436	and	0	None
34436	34437	26	0	None
34437	34438	of	0	None
34438	34439	46	0	None
34439	34440	off	0	None
34440	34441	(	0	None
34441	34442	M	0	None
34442	34443	)	0	None
34443	34444	cells	0	None
34444	34445	;	0	None
34445	34446	it	0	None
34446	34447	fell	0	None
34447	34448	near	0	None
34448	34449	two	0	None
34449	34450	off	0	None
34450	34451	(	0	None
34451	34452	M	0	None
34452	34453	)	0	None
34453	34454	cells	0	None
34454	34455	;	0	None
34455	34456	it	0	None
34456	34457	was	0	None
34457	34458	unchanged	0	None
34458	34459	near	0	None
34459	34460	all	0	None
34460	34461	other	0	None
34461	34462	cells	0	None
34462	34463	,	0	None
34463	34464	including	0	None
34464	34465	six	0	None
34465	34466	neutral	0	None
34466	34467	(	0	None
34467	34468	M	0	None
34468	34469	)	0	None
34469	34470	cells	0	None
34470	34471	.	0	None

34472	34473	On	0	None
34473	34474	a	0	None
34474	34475	finer	0	None
34475	34476	spatiotemporal	0	None
34476	34477	scale	0	None
34477	34478	,	0	None
34478	34479	near	0	None
34479	34480	four	0	None
34480	34481	of	0	None
34481	34482	seven	0	None
34482	34483	on	0	None
34483	34484	(	0	None
34484	34485	M	0	None
34485	34486	)	0	None
34486	34487	cells	0	None
34487	34488	,	0	None
34488	34489	10	0	None
34489	34490	of	0	None
34490	34491	14	0	None
34491	34492	off	0	None
34492	34493	(	0	None
34493	34494	M	0	None
34494	34495	)	0	None
34495	34496	cells	0	None
34496	34497	and	0	None
34497	34498	0	0	None
34498	34499	of	0	None
34499	34500	four	0	None
34500	34501	neutral	0	None
34501	34502	(	0	None
34502	34503	M	0	None
34503	34504	)	0	None
34504	34505	cells	0	None
34505	34506	,	0	None
34506	34507	average	0	None
34507	34508	serotonin	3	CHEMICAL
34508	34509	levels	0	None
34509	34510	fell	0	None
34510	34511	significantly	0	None
34511	34512	within	0	None
34512	34513	+	0	None
34513	34514	/	0	None
34514	34515	-	0	None
34515	34516	100	0	None
34516	34517	ms	0	None
34517	34518	of	0	None
34518	34519	spontaneous	0	None
34519	34520	spikes	0	None
34520	34521	.	0	None

34522	34523	Lower	0	None
34523	34524	serotonin	3	CHEMICAL
34524	34525	may	0	None
34525	34526	have	0	None
34526	34527	caused	0	None
34527	34528	the	0	None
34528	34529	higher	0	None
34529	34530	spike	0	None
34530	34531	probability	0	None
34531	34532	;	0	None
34532	34533	the	0	None
34533	34534	converse	0	None
34534	34535	is	0	None
34535	34536	theoretically	0	None
34536	34537	unlikely	0	None
34537	34538	,	0	None
34538	34539	since	0	None
34539	34540	delays	0	None
34540	34541	between	0	None
34541	34542	release	0	None
34542	34543	and	0	None
34543	34544	detection	0	None
34544	34545	are	0	None
34545	34546	estimated	0	None
34546	34547	to	0	None
34547	34548	exceed	0	None
34548	34549	100	0	None
34549	34550	ms	0	None
34550	34551	.	0	None

34552	34553	Increased	0	None
34553	34554	serotonin	3	CHEMICAL
34554	34555	and	0	None
34555	34556	decreased	0	None
34556	34557	firing	0	None
34557	34558	were	0	None
34558	34559	always	0	None
34559	34560	seen	0	None
34560	34561	following	0	None
34561	34562	iontophoresis	0	None
34562	34563	or	0	None
34563	34564	intravenous	0	None
34564	34565	injection	0	None
34565	34566	(	0	None
34566	34567	1	0	None
34567	34568	mg	0	None
34568	34569	/	0	None
34569	34570	kg	0	None
34570	34571	)	0	None
34571	34572	of	0	None
34572	34573	the	0	None
34573	34574	serotonin	3	CHEMICAL
34574	34575	re	0	None
34575	34576	-	0	None
34576	34577	uptake	0	None
34577	34578	inhibitor	0	None
34578	34579	clomipramine	3	CHEMICAL
34579	34580	(	0	None
34580	34581	n	0	None
34581	34582	=	0	None
34582	34583	7	0	None
34583	34584	)	0	None
34584	34585	.	0	None

34586	34587	Iontophoresis	0	None
34587	34588	of	0	None
34588	34589	+	0	None
34589	34590	/	0	None
34590	34591	-	0	None
34591	34592	propranolol	3	CHEMICAL
34592	34593	,	0	None
34593	34594	whose	0	None
34594	34595	serotonergic	0	None
34595	34596	actions	0	None
34596	34597	include	0	None
34597	34598	antagonism	0	None
34598	34599	and	0	None
34599	34600	partial	0	None
34600	34601	agonism	0	None
34601	34602	at	0	None
34602	34603	5	0	None
34603	34604	-	0	None
34604	34605	HT1	0	None
34605	34606	receptors	0	None
34606	34607	,	0	None
34607	34608	also	0	None
34608	34609	increased	0	None
34609	34610	serotonin	3	CHEMICAL
34610	34611	and	0	None
34611	34612	decreased	0	None
34612	34613	firing	0	None
34613	34614	(	0	None
34614	34615	n	0	None
34615	34616	=	0	None
34616	34617	4	0	None
34617	34618	)	0	None
34618	34619	.	0	None

34620	34621	Methiothepin	0	None
34621	34622	(	0	None
34622	34623	intravenous	0	None
34623	34624	,	0	None
34624	34625	1	0	None
34625	34626	mg	0	None
34626	34627	/	0	None
34627	34628	kg	0	None
34628	34629	)	0	None
34629	34630	,	0	None
34630	34631	whose	0	None
34631	34632	serotonergic	0	None
34632	34633	actions	0	None
34633	34634	include	0	None
34634	34635	5	0	None
34635	34636	-	0	None
34636	34637	HT1	0	None
34637	34638	and	0	None
34638	34639	5	0	None
34639	34640	-	0	None
34640	34641	HT2	0	None
34641	34642	antagonism	0	None
34642	34643	,	0	None
34643	34644	typically	0	None
34644	34645	raised	0	None
34645	34646	serotonin	3	CHEMICAL
34646	34647	levels	0	None
34647	34648	(	0	None
34648	34649	four	0	None
34649	34650	of	0	None
34650	34651	five	0	None
34651	34652	cells	0	None
34652	34653	)	0	None
34653	34654	and	0	None
34654	34655	always	0	None
34655	34656	blocked	0	None
34656	34657	inhibition	0	None
34657	34658	by	0	None
34658	34659	clomipramine	3	CHEMICAL
34659	34660	(	0	None
34660	34661	n	0	None
34661	34662	=	0	None
34662	34663	3	0	None
34663	34664	)	0	None
34664	34665	.	0	None

34666	34667	Iontophoresis	0	None
34667	34668	of	0	None
34668	34669	glutamate	3	CHEMICAL
34669	34670	always	0	None
34670	34671	lowered	0	None
34671	34672	serotonin	3	CHEMICAL
34672	34673	and	0	None
34673	34674	increased	0	None
34674	34675	firing	0	None
34675	34676	(	0	None
34676	34677	n	0	None
34677	34678	=	0	None
34678	34679	4	0	None
34679	34680	)	0	None
34680	34681	.	0	None

34682	34683	Since	0	None
34683	34684	serotonin	3	CHEMICAL
34684	34685	levels	0	None
34685	34686	and	0	None
34686	34687	firing	0	None
34687	34688	were	0	None
34688	34689	usually	0	None
34689	34690	inversely	0	None
34690	34691	correlated	0	None
34691	34692	,	0	None
34692	34693	except	0	None
34693	34694	near	0	None
34694	34695	on	0	None
34695	34696	(	0	None
34696	34697	M	0	None
34697	34698	)	0	None
34698	34699	cells	0	None
34699	34700	during	0	None
34700	34701	pinch	0	None
34701	34702	,	0	None
34702	34703	we	0	None
34703	34704	propose	0	None
34704	34705	that	0	None
34705	34706	serotonin	3	CHEMICAL
34706	34707	is	0	None
34707	34708	released	0	None
34708	34709	from	0	None
34709	34710	terminals	0	None
34710	34711	of	0	None
34711	34712	incoming	0	None
34712	34713	nociceptive	0	None
34713	34714	afferents	0	None
34714	34715	.	0	None

34716	34717	Prior	0	None
34717	34718	neuroanatomical	0	None
34718	34719	knowledge	0	None
34719	34720	favors	0	None
34720	34721	a	0	None
34721	34722	midbrain	0	None
34722	34723	origin	0	None
34723	34724	for	0	None
34724	34725	these	0	None
34725	34726	afferents	0	None
34726	34727	,	0	None
34727	34728	while	0	None
34728	34729	some	0	None
34729	34730	of	0	None
34730	34731	the	0	None
34731	34732	drug	0	None
34732	34733	findings	0	None
34733	34734	suggest	0	None
34734	34735	that	0	None
34735	34736	their	0	None
34736	34737	terminals	0	None
34737	34738	possess	0	None
34738	34739	inhibitory	0	None
34739	34740	serotonergic	0	None
34740	34741	autoreceptors	0	None
34741	34742	,	0	None
34742	34743	possibly	0	None
34743	34744	of	0	None
34744	34745	5	0	None
34745	34746	-	0	None
34746	34747	HT1b	0	None
34747	34748	subtype	0	None
34748	34749	.	0	None

34750	34751	The	0	None
34751	34752	released	0	None
34752	34753	serotonin	3	CHEMICAL
34753	34754	could	0	None
34754	34755	contribute	0	None
34755	34756	to	0	None
34756	34757	the	0	None
34757	34758	inhibition	0	None
34758	34759	of	0	None
34759	34760	off	0	None
34760	34761	(	0	None
34761	34762	M	0	None
34762	34763	)	0	None
34763	34764	cells	0	None
34764	34765	and	0	None
34765	34766	excitation	0	None
34766	34767	of	0	None
34767	34768	on	0	None
34768	34769	(	0	None
34769	34770	M	0	None
34770	34771	)	0	None
34771	34772	cells	0	None
34772	34773	by	0	None
34773	34774	noxious	0	None
34774	34775	stimulation	0	None
34775	34776	,	0	None
34776	34777	since	0	None
34777	34778	inhibitory	0	None
34778	34779	5	0	None
34779	34780	-	0	None
34780	34781	HT1a	0	None
34781	34782	receptors	0	None
34782	34783	and	0	None
34783	34784	excitatory	0	None
34784	34785	5	0	None
34785	34786	-	0	None
34786	34787	HT2	0	None
34787	34788	receptors	0	None
34788	34789	,	0	None
34789	34790	respectively	0	None
34790	34791	,	0	None
34791	34792	have	0	None
34792	34793	previously	0	None
34793	34794	been	0	None
34794	34795	shown	0	None
34795	34796	to	0	None
34796	34797	dominate	0	None
34797	34798	their	0	None
34798	34799	serotonergic	0	None
34799	34800	responses	0	None
34800	34801	.	0	None

34802	34803	Abnormal	0	None
34803	34805	fatty acid	3	CHEMICAL
34805	34806	pattern	0	None
34806	34807	in	0	None
34807	34808	rheumatoid	0	None
34808	34809	arthritis	0	None
34809	34810	.	0	None

34811	34812	A	0	None
34812	34813	rationale	0	None
34813	34814	for	0	None
34814	34815	treatment	0	None
34815	34816	with	0	None
34816	34817	marine	0	None
34817	34818	and	0	None
34818	34819	botanical	0	None
34819	34820	lipids	0	None
34820	34821	.	0	None

34822	34823	OBJECTIVE	0	None
34823	34824	:	0	None
34824	34825	To	0	None
34825	34826	assess	0	None
34826	34827	the	0	None
34827	34829	fatty acid	3	CHEMICAL
34829	34830	pattern	0	None
34830	34831	in	0	None
34831	34832	plasma	0	None
34832	34833	and	0	None
34833	34834	synovial	0	None
34834	34835	fluid	0	None
34835	34836	(	0	None
34836	34837	SF	0	None
34837	34838	)	0	None
34838	34839	in	0	None
34839	34840	rheumatoid	0	None
34840	34841	arthritis	0	None
34841	34842	(	0	None
34842	34843	RA	0	None
34843	34844	)	0	None
34844	34845	and	0	None
34845	34846	to	0	None
34846	34847	determine	0	None
34847	34848	clinical	0	None
34848	34849	factors	0	None
34849	34850	related	0	None
34850	34851	to	0	None
34851	34852	possible	0	None
34852	34853	abnormalities	0	None
34853	34854	.	0	None

34855	34856	METHODS	0	None
34856	34857	:	0	None
34857	34858	Thirty	0	None
34858	34859	-	0	None
34859	34860	nine	0	None
34860	34861	patients	0	None
34861	34862	with	0	None
34862	34863	RA	0	None
34863	34864	were	0	None
34864	34865	included	0	None
34865	34866	.	0	None

34867	34868	SF	0	None
34868	34869	samples	0	None
34869	34870	were	0	None
34870	34871	obtained	0	None
34871	34872	from	0	None
34872	34873	9	0	None
34873	34874	patients	0	None
34874	34875	.	0	None

34876	34877	Disease	0	None
34877	34878	activity	0	None
34878	34879	was	0	None
34879	34880	assessed	0	None
34880	34881	using	0	None
34881	34882	the	0	None
34882	34883	Ritchie	0	None
34883	34884	Articular	0	None
34884	34885	Index	0	None
34885	34886	and	0	None
34886	34887	erythrocyte	0	None
34887	34888	sedimentation	0	None
34888	34889	rate	0	None
34889	34890	.	0	None

34891	34892	Fatty	0	None
34892	34893	acids	0	None
34893	34894	were	0	None
34894	34895	assayed	0	None
34895	34896	with	0	None
34896	34897	gas	0	None
34897	34898	liquid	0	None
34898	34899	chromatography	0	None
34899	34900	.	0	None

34901	34902	RESULT	0	None
34902	34903	:	0	None
34903	34904	Decreased	0	None
34904	34905	levels	0	None
34905	34906	of	0	None
34906	34908	eicosapentaenoic acid	3	CHEMICAL
34908	34909	(	0	None
34909	34910	p	0	None
34910	34911	<	0	None
34911	34912	0	0	None
34912	34913	.	0	None
34913	34914	0001	0	None
34914	34915	)	0	None
34915	34916	and	0	None
34916	34917	total	0	None
34917	34921	n3 polyunsaturated fatty acids	3	CHEMICAL
34921	34922	(	0	None
34922	34923	p	0	None
34923	34924	<	0	None
34924	34925	0	0	None
34925	34926	.	0	None
34926	34927	05	0	None
34927	34928	)	0	None
34928	34929	were	0	None
34929	34930	observed	0	None
34930	34931	in	0	None
34931	34932	plasma	0	None
34932	34933	and	0	None
34933	34934	in	0	None
34934	34935	joint	0	None
34935	34936	fluid	0	None
34936	34937	,	0	None
34937	34938	respectively	0	None
34938	34939	.	0	None

34940	34941	An	0	None
34941	34942	increase	0	None
34942	34943	of	0	None
34943	34944	the	0	None
34944	34945	substrates	0	None
34945	34946	of	0	None
34946	34947	delta	0	None
34947	34948	-	0	None
34948	34949	5	0	None
34949	34950	-	0	None
34950	34951	desaturase	0	None
34951	34952	(	0	None
34952	34953	C20	0	None
34953	34954	:	0	None
34954	34955	3n6	0	None
34955	34956	and	0	None
34956	34957	C20	0	None
34957	34958	:	0	None
34958	34959	2n6	0	None
34959	34960	)	0	None
34960	34961	and	0	None
34961	34962	decrease	0	None
34962	34963	of	0	None
34963	34964	their	0	None
34964	34965	products	0	None
34965	34966	(	0	None
34966	34967	C20	0	None
34967	34968	:	0	None
34968	34969	4n6	0	None
34969	34970	and	0	None
34970	34971	C22	0	None
34971	34972	:	0	None
34972	34973	4n6	0	None
34973	34974	)	0	None
34974	34975	was	0	None
34975	34976	observed	0	None
34976	34977	in	0	None
34977	34978	plasma	0	None
34978	34979	total	0	None
34979	34980	lipids	0	None
34980	34981	and	0	None
34981	34982	phospholipids	0	None
34982	34983	.	0	None

34984	34985	The	0	None
34985	34986	long	0	None
34986	34987	chain	0	None
34987	34988	mono	0	None
34988	34989	-	0	None
34989	34992	unsaturated fatty acids	3	CHEMICAL
34992	34993	(	0	None
34993	34994	C20	0	None
34994	34995	:	0	None
34995	34996	1n9	0	None
34996	34997	,	0	None
34997	34998	C22	0	None
34998	34999	:	0	None
34999	35000	1n9	0	None
35000	35001	,	0	None
35001	35002	C24	0	None
35002	35003	:	0	None
35003	35004	ln9	0	None
35004	35005	)	0	None
35005	35006	were	0	None
35006	35007	increased	0	None
35007	35008	in	0	None
35008	35009	the	0	None
35009	35010	joint	0	None
35010	35011	fluid	0	None
35011	35012	and	0	None
35012	35013	in	0	None
35013	35014	plasma	0	None
35014	35015	phospholipids	0	None
35015	35016	.	0	None

35017	35018	Patients	0	None
35018	35019	with	0	None
35019	35020	active	0	None
35020	35021	disease	0	None
35021	35022	showed	0	None
35022	35023	a	0	None
35023	35024	mild	0	None
35024	35025	decrease	0	None
35025	35026	of	0	None
35026	35027	several	0	None
35027	35028	saturated	0	None
35028	35030	fatty acids	3	CHEMICAL
35030	35031	,	0	None
35031	35032	n3	3	CHEMICAL
35032	35033	,	0	None
35033	35034	and	0	None
35034	35038	n6 polyunsaturated fatty acids	3	CHEMICAL
35038	35039	.	0	None

35040	35041	Minor	0	None
35041	35042	abnormalities	0	None
35042	35043	or	0	None
35043	35044	no	0	None
35044	35045	changes	0	None
35045	35046	in	0	None
35046	35048	fatty acid	3	CHEMICAL
35048	35049	profile	0	None
35049	35050	were	0	None
35050	35051	found	0	None
35051	35052	related	0	None
35052	35053	to	0	None
35053	35054	use	0	None
35054	35055	of	0	None
35055	35056	steroids	3	CHEMICAL
35056	35057	,	0	None
35057	35058	nonsteroidal	0	None
35058	35059	antiinflammatory	0	None
35059	35060	drugs	0	None
35060	35061	,	0	None
35061	35062	and	0	None
35062	35063	gold	0	None
35063	35064	salts	0	None
35064	35065	,	0	None
35065	35066	or	0	None
35066	35067	malnutrition	0	None
35067	35068	.	0	None

35069	35070	CONCLUSION	0	None
35070	35071	:	0	None
35071	35072	The	0	None
35072	35074	fatty acid	3	CHEMICAL
35074	35075	pattern	0	None
35075	35076	found	0	None
35076	35077	in	0	None
35077	35078	RA	0	None
35078	35079	(	0	None
35079	35080	decreased	0	None
35080	35081	levels	0	None
35081	35082	of	0	None
35082	35086	n3 polyunsaturated fatty acids	3	CHEMICAL
35086	35087	)	0	None
35087	35088	may	0	None
35088	35089	explain	0	None
35089	35090	the	0	None
35090	35091	beneficial	0	None
35091	35092	effect	0	None
35092	35093	of	0	None
35093	35094	fish	0	None
35094	35095	oil	0	None
35095	35096	.	0	None

35097	35098	Changes	0	None
35098	35099	in	0	None
35099	35103	n6 polyunsaturated fatty acids	3	CHEMICAL
35103	35104	suggest	0	None
35104	35105	that	0	None
35105	35106	delta	0	None
35106	35107	-	0	None
35107	35108	5	0	None
35108	35109	desaturation	0	None
35109	35110	is	0	None
35110	35111	decreased	0	None
35111	35112	and	0	None
35112	35113	this	0	None
35113	35114	might	0	None
35114	35115	facilitate	0	None
35115	35116	the	0	None
35116	35117	antiinflammatory	0	None
35117	35118	effect	0	None
35118	35119	of	0	None
35119	35120	botanical	0	None
35120	35121	lipids	0	None
35121	35122	in	0	None
35122	35123	RA	0	None
35123	35124	.	0	None

35125	35126	Selective	0	None
35126	35127	inhibition	0	None
35127	35128	of	0	None
35128	35131	monoamine neurotransmitter transporters	2	GENE-N
35131	35132	by	0	None
35132	35133	synthetic	0	None
35133	35134	local	0	None
35134	35135	anesthetics	0	None
35135	35136	.	0	None

35137	35138	Synthetic	0	None
35138	35139	local	0	None
35139	35140	anesthetics	0	None
35140	35141	(	0	None
35141	35142	LAs	0	None
35142	35143	)	0	None
35143	35144	have	0	None
35144	35145	been	0	None
35145	35146	found	0	None
35146	35147	to	0	None
35147	35148	have	0	None
35148	35149	cocaine	0	None
35149	35150	-	0	None
35150	35151	like	0	None
35151	35152	characteristics	0	None
35152	35153	with	0	None
35153	35154	some	0	None
35154	35155	psychotomimetic	0	None
35155	35156	action	0	None
35156	35157	,	0	None
35157	35158	possibly	0	None
35158	35159	through	0	None
35159	35160	monoaminergic	0	None
35160	35161	neurotransmission	0	None
35161	35162	.	0	None

35163	35164	To	0	None
35164	35165	gain	0	None
35165	35166	insight	0	None
35166	35167	into	0	None
35167	35168	the	0	None
35168	35169	relation	0	None
35169	35170	between	0	None
35170	35171	LA	0	None
35171	35172	action	0	None
35172	35173	and	0	None
35173	35175	monoamine transporters	2	GENE-N
35175	35176	,	0	None
35176	35177	we	0	None
35177	35178	investigated	0	None
35178	35179	the	0	None
35179	35180	effect	0	None
35180	35181	of	0	None
35181	35182	synthetic	0	None
35182	35183	LAs	0	None
35183	35184	on	0	None
35184	35186	neurotransmitter transporters	2	GENE-N
35186	35187	,	0	None
35187	35188	including	0	None
35188	35190	monoamine transporters	2	GENE-N
35190	35191	.	0	None

35192	35193	We	0	None
35193	35194	used	0	None
35194	35195	cloned	0	None
35195	35196	transporter	0	None
35196	35197	cDNAs	0	None
35197	35198	and	0	None
35198	35199	examined	0	None
35199	35200	transient	0	None
35200	35201	functional	0	None
35201	35202	expression	0	None
35202	35203	in	0	None
35203	35204	COS	0	None
35204	35205	cells	0	None
35205	35206	and	0	None
35206	35207	stable	0	None
35207	35208	expression	0	None
35208	35209	in	0	None
35209	35210	HeLa	0	None
35210	35211	cells	0	None
35211	35212	.	0	None

35213	35214	Among	0	None
35214	35215	the	0	None
35215	35216	LAs	0	None
35216	35217	tested	0	None
35217	35218	,	0	None
35218	35219	procaine	3	CHEMICAL
35219	35220	and	0	None
35220	35221	other	0	None
35221	35222	ester	3	CHEMICAL
35222	35223	-	0	None
35223	35224	type	0	None
35224	35225	LAs	0	None
35225	35226	inhibited	0	None
35226	35227	[	0	None
35227	35228	3H	0	None
35228	35229	]	0	None
35229	35230	DA	3	CHEMICAL
35230	35231	uptake	0	None
35231	35232	and	0	None
35232	35233	binding	0	None
35233	35234	of	0	None
35234	35235	[	0	None
35235	35236	3H	0	None
35236	35237	]	0	None
35237	35238	2	0	None
35238	35239	-	0	None
35239	35240	beta	0	None
35240	35241	-	0	None
35241	35242	carbomethoxy	0	None
35242	35243	-	0	None
35243	35244	3	0	None
35244	35245	-	0	None
35245	35246	beta	0	None
35246	35247	-	0	None
35247	35248	(	0	None
35248	35249	4	0	None
35249	35250	-	0	None
35250	35251	fluorophenyl	0	None
35251	35252	)	0	None
35252	35253	tropane	0	None
35253	35254	(	0	None
35254	35255	CFT	0	None
35255	35256	)	0	None
35256	35257	,	0	None
35257	35258	a	0	None
35258	35259	cocaine	0	None
35259	35260	analogue	0	None
35260	35261	,	0	None
35261	35262	in	0	None
35262	35263	COS	0	None
35263	35264	cells	0	None
35264	35265	expressing	0	None
35265	35268	rat dopamine transporter	1	GENE-Y
35268	35269	(	0	None
35269	35270	DAT	1	GENE-Y
35270	35271	)	0	None
35271	35272	.	0	None

35273	35274	The	0	None
35274	35275	inhibition	0	None
35275	35276	was	0	None
35276	35277	concentration	0	None
35277	35278	-	0	None
35278	35279	dependent	0	None
35279	35280	.	0	None

35281	35282	The	0	None
35282	35283	inhibitory	0	None
35283	35284	effect	0	None
35284	35285	on	0	None
35285	35286	[	0	None
35286	35287	3H	0	None
35287	35288	]	0	None
35288	35289	DA	3	CHEMICAL
35289	35290	uptake	0	None
35290	35291	was	0	None
35291	35292	reversible	0	None
35292	35293	and	0	None
35293	35294	not	0	None
35294	35295	dependent	0	None
35295	35296	on	0	None
35296	35297	pH	0	None
35297	35298	,	0	None
35298	35299	as	0	None
35299	35300	observed	0	None
35300	35301	in	0	None
35301	35302	HeLa	0	None
35302	35303	cells	0	None
35303	35304	stably	0	None
35304	35305	expressing	0	None
35305	35306	DAT	1	GENE-Y
35306	35307	.	0	None

35308	35309	Procaine	0	None
35309	35310	also	0	None
35310	35311	inhibited	0	None
35311	35312	uptake	0	None
35312	35313	of	0	None
35313	35314	norepinephrine	3	CHEMICAL
35314	35315	(	0	None
35315	35316	NE	3	CHEMICAL
35316	35317	)	0	None
35317	35318	and	0	None
35318	35319	serotonin	3	CHEMICAL
35319	35320	(	0	None
35320	35321	5	0	None
35321	35322	-	0	None
35322	35323	HT	3	CHEMICAL
35323	35324	)	0	None
35324	35325	by	0	None
35325	35326	the	0	None
35326	35328	norepinephrine transporter	1	GENE-Y
35328	35329	(	0	None
35329	35330	NET	1	GENE-Y
35330	35331	)	0	None
35331	35332	or	0	None
35332	35334	serotonin transporter	1	GENE-Y
35334	35335	(	0	None
35335	35336	SERT	1	GENE-Y
35336	35337	)	0	None
35337	35338	expressed	0	None
35338	35339	in	0	None
35339	35340	COS	0	None
35340	35341	cells	0	None
35341	35342	.	0	None

35343	35344	On	0	None
35344	35345	the	0	None
35345	35346	other	0	None
35346	35347	hand	0	None
35347	35348	,	0	None
35348	35349	procaine	3	CHEMICAL
35349	35350	and	0	None
35350	35351	other	0	None
35351	35352	LAs	0	None
35352	35353	had	0	None
35353	35354	little	0	None
35354	35355	or	0	None
35355	35356	no	0	None
35356	35357	effect	0	None
35357	35358	on	0	None
35358	35359	[	0	None
35359	35360	3H	0	None
35360	35361	]	0	None
35361	35362	GABA	3	CHEMICAL
35362	35363	and	0	None
35363	35364	[	0	None
35364	35365	3H	0	None
35365	35366	]	0	None
35366	35367	glutamate	3	CHEMICAL
35367	35368	uptake	0	None
35368	35369	in	0	None
35369	35370	COS	0	None
35370	35371	cells	0	None
35371	35372	expressing	0	None
35372	35373	mouse	0	None
35373	35374	GABA	3	CHEMICAL
35374	35375	or	0	None
35375	35377	rat glutamate	3	CHEMICAL
35377	35378	/	0	None
35378	35379	aspartate	3	CHEMICAL
35379	35380	transporter	0	None
35380	35381	.	0	None

35382	35383	IC50	0	None
35383	35384	values	0	None
35384	35385	for	0	None
35385	35386	[	0	None
35386	35387	3H	0	None
35387	35388	]	0	None
35388	35389	DA	3	CHEMICAL
35389	35390	uptake	0	None
35390	35391	inhibition	0	None
35391	35392	correlated	0	None
35392	35393	well	0	None
35393	35394	with	0	None
35394	35395	those	0	None
35395	35396	for	0	None
35396	35397	[	0	None
35397	35398	3H	0	None
35398	35399	]	0	None
35399	35400	CFT	0	None
35400	35401	binding	0	None
35401	35402	inhibition	0	None
35402	35403	,	0	None
35403	35404	but	0	None
35404	35405	not	0	None
35405	35406	with	0	None
35406	35407	intrinsic	0	None
35407	35408	anesthetic	0	None
35408	35409	potency	0	None
35409	35410	.	0	None

35411	35412	Kinetic	0	None
35412	35413	analysis	0	None
35413	35414	of	0	None
35414	35415	monoamine	3	CHEMICAL
35415	35416	uptake	0	None
35416	35417	inhibition	0	None
35417	35418	by	0	None
35418	35419	procaine	3	CHEMICAL
35419	35420	in	0	None
35420	35421	COS	0	None
35421	35422	cells	0	None
35422	35423	expressing	0	None
35423	35425	rat DAT	1	GENE-Y
35425	35426	,	0	None
35426	35427	NET	1	GENE-Y
35427	35428	or	0	None
35428	35429	SERT	1	GENE-Y
35429	35430	revealed	0	None
35430	35431	a	0	None
35431	35432	competitive	0	None
35432	35433	action	0	None
35433	35434	similar	0	None
35434	35435	to	0	None
35435	35436	that	0	None
35436	35437	of	0	None
35437	35438	cocaine	0	None
35438	35439	.	0	None

35440	35441	These	0	None
35441	35442	results	0	None
35442	35443	demonstrate	0	None
35443	35444	that	0	None
35444	35445	certain	0	None
35445	35446	LAs	0	None
35446	35447	selectively	0	None
35447	35448	inhibit	0	None
35448	35450	monoamine transporters	2	GENE-N
35450	35451	.	0	None

35452	35453	This	0	None
35453	35454	might	0	None
35454	35455	contribute	0	None
35455	35456	to	0	None
35456	35457	the	0	None
35457	35458	cocaine	0	None
35458	35459	-	0	None
35459	35460	like	0	None
35460	35461	psychotomimetic	0	None
35461	35462	action	0	None
35462	35463	of	0	None
35463	35464	certain	0	None
35464	35465	LAs	0	None
35465	35466	.	0	None

35467	35468	Estrogen	0	None
35468	35469	receptor	0	None
35469	35470	-	0	None
35470	35471	alpha	0	None
35471	35472	gene	0	None
35472	35473	transfer	0	None
35473	35474	into	0	None
35474	35475	bovine	0	None
35475	35476	aortic	0	None
35476	35477	endothelial	0	None
35477	35478	cells	0	None
35478	35479	induces	0	None
35479	35480	eNOS	1	GENE-Y
35480	35481	gene	0	None
35481	35482	expression	0	None
35482	35483	and	0	None
35483	35484	inhibits	0	None
35484	35485	cell	0	None
35485	35486	migration	0	None
35486	35487	.	0	None

35488	35489	OBJECTIVES	0	None
35489	35490	:	0	None
35490	35491	It	0	None
35491	35492	has	0	None
35492	35493	been	0	None
35493	35494	suggested	0	None
35494	35495	that	0	None
35495	35496	estrogen	3	CHEMICAL
35496	35497	may	0	None
35497	35498	improve	0	None
35498	35499	endothelial	0	None
35499	35500	cell	0	None
35500	35501	function	0	None
35501	35502	to	0	None
35502	35503	delay	0	None
35503	35504	the	0	None
35504	35505	onset	0	None
35505	35506	of	0	None
35506	35507	atherosclerosis	0	None
35507	35508	in	0	None
35508	35509	pre	0	None
35509	35510	-	0	None
35510	35511	menopausal	0	None
35511	35512	females	0	None
35512	35513	,	0	None
35513	35514	though	0	None
35514	35515	its	0	None
35515	35516	mechanism	0	None
35516	35517	of	0	None
35517	35518	action	0	None
35518	35519	is	0	None
35519	35520	not	0	None
35520	35521	fully	0	None
35521	35522	understood	0	None
35522	35523	.	0	None

35524	35525	We	0	None
35525	35526	examined	0	None
35526	35527	the	0	None
35527	35528	hypothesis	0	None
35528	35529	that	0	None
35529	35530	human	0	None
35530	35532	estrogen receptor	1	GENE-Y
35532	35533	-	0	None
35533	35534	alpha	0	None
35534	35535	(	0	None
35535	35536	ER	1	GENE-Y
35536	35537	alpha	0	None
35537	35538	)	0	None
35538	35539	gene	0	None
35539	35540	transfection	0	None
35540	35541	improves	0	None
35541	35542	the	0	None
35542	35543	endothelial	0	None
35543	35544	cell	0	None
35544	35545	function	0	None
35545	35546	.	0	None

35547	35548	METHODS	0	None
35548	35549	:	0	None
35549	35550	A	0	None
35550	35551	replication	0	None
35551	35552	deficient	0	None
35552	35553	adenoviral	0	None
35553	35554	vector	0	None
35554	35555	was	0	None
35555	35556	used	0	None
35556	35557	to	0	None
35557	35558	transfect	0	None
35558	35559	the	0	None
35559	35560	ER	1	GENE-Y
35560	35561	alpha	0	None
35561	35562	gene	0	None
35562	35563	into	0	None
35563	35564	bovine	0	None
35564	35565	aortic	0	None
35565	35566	endothelial	0	None
35566	35567	cells	0	None
35567	35568	(	0	None
35568	35569	BAEC	0	None
35569	35570	)	0	None
35570	35571	and	0	None
35571	35572	a	0	None
35572	35573	GFP	1	GENE-Y
35573	35574	gene	0	None
35574	35575	containing	0	None
35575	35576	vector	0	None
35576	35577	was	0	None
35577	35578	used	0	None
35578	35579	as	0	None
35579	35580	control	0	None
35580	35581	.	0	None

35582	35583	Expression	0	None
35583	35584	of	0	None
35584	35585	the	0	None
35585	35586	eNOS	1	GENE-Y
35586	35587	gene	0	None
35587	35588	was	0	None
35588	35589	determined	0	None
35589	35590	by	0	None
35590	35591	Northern	0	None
35591	35592	blot	0	None
35592	35593	analysis	0	None
35593	35594	and	0	None
35594	35595	enzyme	0	None
35595	35596	activity	0	None
35596	35597	assay	0	None
35597	35598	;	0	None
35598	35599	cell	0	None
35599	35600	migration	0	None
35600	35601	was	0	None
35601	35602	assayed	0	None
35602	35603	using	0	None
35603	35604	a	0	None
35604	35605	Transwell	0	None
35605	35606	apparatus	0	None
35606	35607	;	0	None
35607	35608	and	0	None
35608	35609	tyrosine	3	CHEMICAL
35609	35610	phosphorylation	0	None
35610	35611	of	0	None
35611	35612	FAK	0	None
35612	35613	was	0	None
35613	35614	estimated	0	None
35614	35615	by	0	None
35615	35616	Western	0	None
35616	35617	blot	0	None
35617	35618	analysis	0	None
35618	35619	.	0	None

35620	35621	RESULTS	0	None
35621	35622	:	0	None
35622	35623	ER	1	GENE-Y
35623	35624	alpha	0	None
35624	35625	gene	0	None
35625	35626	transfection	0	None
35626	35627	of	0	None
35627	35628	endothelial	0	None
35628	35629	cells	0	None
35629	35630	produced	0	None
35630	35631	a	0	None
35631	35632	2	0	None
35632	35633	-	0	None
35633	35634	3	0	None
35634	35635	-	0	None
35635	35636	fold	0	None
35636	35637	increase	0	None
35637	35638	in	0	None
35638	35639	eNOS	1	GENE-Y
35639	35640	mRNA	0	None
35640	35641	and	0	None
35641	35642	protein	0	None
35642	35643	levels	0	None
35643	35644	as	0	None
35644	35645	well	0	None
35645	35646	as	0	None
35646	35647	a	0	None
35647	35648	significant	0	None
35648	35649	increase	0	None
35649	35650	(	0	None
35650	35651	P	0	None
35651	35652	<	0	None
35652	35653	0	0	None
35653	35654	.	0	None
35654	35655	05	0	None
35655	35656	)	0	None
35656	35657	in	0	None
35657	35658	NOS	0	None
35658	35659	activity	0	None
35659	35660	as	0	None
35660	35661	measured	0	None
35661	35662	by	0	None
35662	35663	citrulline	0	None
35663	35664	assay	0	None
35664	35665	and	0	None
35665	35666	nitrite	3	CHEMICAL
35666	35667	accumulation	0	None
35667	35668	in	0	None
35668	35669	the	0	None
35669	35670	media	0	None
35670	35671	in	0	None
35671	35672	response	0	None
35672	35673	to	0	None
35673	35674	bradykinin	0	None
35674	35675	stimulation	0	None
35675	35676	.	0	None

35677	35678	Treatment	0	None
35678	35679	of	0	None
35679	35680	cells	0	None
35680	35681	with	0	None
35681	35682	estrogen	3	CHEMICAL
35682	35683	blocking	0	None
35683	35684	agent	0	None
35684	35685	ICI	3	CHEMICAL
35685	35686	182780	3	CHEMICAL
35686	35687	inhibited	0	None
35687	35688	eNOS	1	GENE-Y
35688	35689	induction	0	None
35689	35690	in	0	None
35690	35691	response	0	None
35691	35692	to	0	None
35692	35693	ER	1	GENE-Y
35693	35694	alpha	0	None
35694	35695	transfection	0	None
35695	35696	.	0	None

35697	35698	ER	1	GENE-Y
35698	35699	alpha	0	None
35699	35700	gene	0	None
35700	35701	transfection	0	None
35701	35702	significantly	0	None
35702	35703	inhibited	0	None
35703	35704	(	0	None
35704	35705	P	0	None
35705	35706	<	0	None
35706	35707	0	0	None
35707	35708	.	0	None
35708	35709	05	0	None
35709	35710	)	0	None
35710	35711	bFGF	0	None
35711	35712	-	0	None
35712	35713	induced	0	None
35713	35714	chemotactic	0	None
35714	35715	migration	0	None
35715	35716	of	0	None
35716	35717	endothelial	0	None
35717	35718	cells	0	None
35718	35719	but	0	None
35719	35720	increased	0	None
35720	35721	cell	0	None
35721	35722	attachment	0	None
35722	35723	to	0	None
35723	35724	fibronectin	0	None
35724	35725	,	0	None
35725	35726	laminin	2	GENE-N
35726	35727	,	0	None
35727	35728	and	0	None
35728	35729	type	0	None
35729	35730	I	0	None
35730	35731	and	0	None
35731	35732	IV	0	None
35732	35733	collagens	2	GENE-N
35733	35734	.	0	None

35735	35736	ER	1	GENE-Y
35736	35737	alpha	0	None
35737	35738	gene	0	None
35738	35739	transfer	0	None
35739	35740	also	0	None
35740	35741	inhibited	0	None
35741	35742	bFGF	0	None
35742	35743	-	0	None
35743	35744	stimulated	0	None
35744	35745	tyrosine	3	CHEMICAL
35745	35746	phosphorylation	0	None
35746	35747	of	0	None
35747	35748	FAK	0	None
35748	35749	.	0	None

35750	35751	CONCLUSION	0	None
35751	35752	:	0	None
35752	35753	Our	0	None
35753	35754	results	0	None
35754	35755	suggest	0	None
35755	35756	that	0	None
35756	35757	the	0	None
35757	35758	atheroprotective	0	None
35758	35759	effects	0	None
35759	35760	of	0	None
35760	35761	estrogen	3	CHEMICAL
35761	35762	may	0	None
35762	35763	in	0	None
35763	35764	part	0	None
35764	35765	be	0	None
35765	35766	mediated	0	None
35766	35767	by	0	None
35767	35768	ER	1	GENE-Y
35768	35769	alpha	0	None
35769	35770	-	0	None
35770	35771	induced	0	None
35771	35772	upregulation	0	None
35772	35773	of	0	None
35773	35774	eNOS	1	GENE-Y
35774	35775	gene	0	None
35775	35776	expression	0	None
35776	35777	and	0	None
35777	35778	maintenance	0	None
35778	35779	of	0	None
35779	35780	endothelial	0	None
35780	35781	cell	0	None
35781	35782	function	0	None
35782	35783	and	0	None
35783	35784	integrity	0	None
35784	35785	.	0	None

35786	35787	The	0	None
35787	35788	Hsp90	2	GENE-N
35788	35789	-	0	None
35789	35790	specific	0	None
35790	35791	inhibitor	0	None
35791	35792	geldanamycin	3	CHEMICAL
35792	35793	selectively	0	None
35793	35794	disrupts	0	None
35794	35795	kinase	2	GENE-N
35795	35796	-	0	None
35796	35797	mediated	0	None
35797	35798	signaling	0	None
35798	35799	events	0	None
35799	35800	of	0	None
35800	35801	T	0	None
35801	35802	-	0	None
35802	35803	lymphocyte	0	None
35803	35804	activation	0	None
35804	35805	.	0	None

35806	35807	The	0	None
35807	35808	90	0	None
35808	35809	-	0	None
35809	35810	kDa	0	None
35810	35813	heat shock protein	2	GENE-N
35813	35814	(	0	None
35814	35815	Hsp90	2	GENE-N
35815	35816	)	0	None
35816	35817	is	0	None
35817	35818	the	0	None
35818	35819	most	0	None
35819	35820	abundant	0	None
35820	35822	molecular chaperone	2	GENE-N
35822	35823	of	0	None
35823	35824	eukaryotic	0	None
35824	35825	cells	0	None
35825	35826	.	0	None

35827	35828	Its	0	None
35828	35829	chaperone	2	GENE-N
35829	35830	function	0	None
35830	35831	in	0	None
35831	35832	folding	0	None
35832	35833	nascent	0	None
35833	35834	proteins	0	None
35834	35835	seems	0	None
35835	35836	to	0	None
35836	35837	be	0	None
35837	35838	restricted	0	None
35838	35839	to	0	None
35839	35840	a	0	None
35840	35841	subset	0	None
35841	35842	of	0	None
35842	35843	proteins	0	None
35843	35844	including	0	None
35844	35845	major	0	None
35845	35846	components	0	None
35846	35847	of	0	None
35847	35848	signal	0	None
35848	35849	transduction	0	None
35849	35850	pathways	0	None
35850	35851	(	0	None
35851	35852	eg	0	None
35852	35853	,	0	None
35853	35856	nuclear hormone receptors	2	GENE-N
35856	35857	,	0	None
35857	35858	transcription	0	None
35858	35859	factors	0	None
35859	35860	,	0	None
35860	35861	and	0	None
35861	35863	protein kinases	2	GENE-N
35863	35864	)	0	None
35864	35865	.	0	None

35866	35867	Improper	0	None
35867	35868	function	0	None
35868	35869	of	0	None
35869	35870	these	0	None
35870	35871	proteins	0	None
35871	35872	can	0	None
35872	35873	be	0	None
35873	35874	induced	0	None
35874	35875	by	0	None
35875	35876	selective	0	None
35876	35877	disruption	0	None
35877	35878	of	0	None
35878	35879	their	0	None
35879	35880	complexes	0	None
35880	35881	with	0	None
35881	35882	Hsp90	2	GENE-N
35882	35883	using	0	None
35883	35884	the	0	None
35884	35886	benzoquinonoid ansamycin	3	CHEMICAL
35886	35887	geldanamycin	3	CHEMICAL
35887	35888	.	0	None

35889	35890	In	0	None
35890	35891	this	0	None
35891	35892	study	0	None
35892	35893	,	0	None
35893	35894	we	0	None
35894	35895	demonstrate	0	None
35895	35896	that	0	None
35896	35897	geldanamycin	3	CHEMICAL
35897	35898	treatment	0	None
35898	35899	blocks	0	None
35899	35900	interleukin	1	GENE-Y
35900	35901	(	0	None
35901	35902	IL	0	None
35902	35903	)	0	None
35903	35904	-	0	None
35904	35905	2	0	None
35905	35906	secretion	0	None
35906	35907	,	0	None
35907	35908	IL	0	None
35908	35909	-	0	None
35909	35910	2	0	None
35910	35911	receptor	0	None
35911	35912	expression	0	None
35912	35913	,	0	None
35913	35914	and	0	None
35914	35915	proliferation	0	None
35915	35916	of	0	None
35916	35917	stimulated	0	None
35917	35918	T	0	None
35918	35919	-	0	None
35919	35920	lymphocytes	0	None
35920	35921	.	0	None

35922	35923	Moreover	0	None
35923	35924	,	0	None
35924	35925	geldanamycin	3	CHEMICAL
35925	35926	decreases	0	None
35926	35927	the	0	None
35927	35928	amount	0	None
35928	35929	and	0	None
35929	35930	phosphorylation	0	None
35930	35931	of	0	None
35931	35932	Lck	1	GENE-Y
35932	35933	and	0	None
35933	35934	Raf	2	GENE-N
35934	35935	-	0	None
35935	35936	1	0	None
35936	35937	kinases	2	GENE-N
35937	35938	and	0	None
35938	35939	prevents	0	None
35939	35940	activation	0	None
35940	35941	of	0	None
35941	35942	the	0	None
35942	35946	extracellular signal regulated kinase	2	GENE-N
35946	35947	(	0	None
35947	35948	ERK	1	GENE-Y
35948	35949	)	0	None
35949	35950	-	0	None
35950	35951	2	0	None
35951	35952	kinase	2	GENE-N
35952	35953	.	0	None

35954	35955	Geldanamycin	0	None
35955	35956	also	0	None
35956	35957	disrupts	0	None
35957	35958	the	0	None
35958	35959	T	0	None
35959	35960	-	0	None
35960	35961	cell	0	None
35961	35962	receptor	0	None
35962	35963	-	0	None
35963	35964	mediated	0	None
35964	35965	activation	0	None
35965	35966	of	0	None
35966	35968	nuclear factor	1	GENE-Y
35968	35969	of	0	None
35969	35970	activated	0	None
35970	35971	T	0	None
35971	35972	-	0	None
35972	35973	cells	0	None
35973	35974	(	0	None
35974	35975	NF	2	GENE-N
35975	35976	-	0	None
35976	35977	AT	0	None
35977	35978	)	0	None
35978	35979	.	0	None

35980	35981	Treatment	0	None
35981	35982	with	0	None
35982	35983	geldanamycin	3	CHEMICAL
35983	35984	,	0	None
35984	35985	however	0	None
35985	35986	,	0	None
35986	35987	does	0	None
35987	35988	not	0	None
35988	35989	affect	0	None
35989	35990	the	0	None
35990	35991	activation	0	None
35991	35992	of	0	None
35992	35993	lysophosphatide	0	None
35993	35994	acyltransferase	0	None
35994	35995	,	0	None
35995	35996	which	0	None
35996	35997	is	0	None
35997	35998	a	0	None
35998	35999	plasma	0	None
35999	36000	membrane	0	None
36000	36001	enzyme	0	None
36001	36002	coupled	0	None
36002	36003	to	0	None
36003	36004	the	0	None
36004	36005	T	0	None
36005	36006	-	0	None
36006	36007	cell	0	None
36007	36008	receptor	0	None
36008	36009	after	0	None
36009	36010	T	0	None
36010	36011	-	0	None
36011	36012	cell	0	None
36012	36013	stimulation	0	None
36013	36014	.	0	None

36015	36016	Through	0	None
36016	36017	demonstrating	0	None
36017	36018	the	0	None
36018	36019	selective	0	None
36019	36020	inhibition	0	None
36020	36021	of	0	None
36021	36022	kinase	2	GENE-N
36022	36023	-	0	None
36023	36024	related	0	None
36024	36025	T	0	None
36025	36026	-	0	None
36026	36027	lymphocyte	0	None
36027	36028	responses	0	None
36028	36029	by	0	None
36029	36030	geldanamycin	3	CHEMICAL
36030	36031	,	0	None
36031	36032	our	0	None
36032	36033	results	0	None
36033	36034	emphasize	0	None
36034	36035	the	0	None
36035	36036	substantial	0	None
36036	36037	role	0	None
36037	36038	of	0	None
36038	36039	Hsp90	2	GENE-N
36039	36040	-	0	None
36040	36041	kinase	2	GENE-N
36041	36042	complexes	0	None
36042	36043	in	0	None
36043	36044	T	0	None
36044	36045	-	0	None
36045	36046	cell	0	None
36046	36047	activation	0	None
36047	36048	.	0	None

36049	36050	Prevention	0	None
36050	36051	of	0	None
36051	36052	acute	0	None
36052	36053	allograft	0	None
36053	36054	rejection	0	None
36054	36055	in	0	None
36055	36056	nonhuman	0	None
36056	36057	primate	0	None
36057	36058	lung	0	None
36058	36059	transplant	0	None
36059	36060	recipients	0	None
36060	36061	:	0	None
36061	36062	induction	0	None
36062	36063	with	0	None
36063	36064	chimeric	0	None
36064	36065	anti	0	None
36065	36066	-	0	None
36066	36067	interleukin	1	GENE-Y
36067	36068	-	0	None
36068	36069	2	0	None
36069	36070	receptor	0	None
36070	36072	monoclonal antibody	2	GENE-N
36072	36073	improves	0	None
36073	36074	the	0	None
36074	36075	tolerability	0	None
36075	36076	and	0	None
36076	36077	potentiates	0	None
36077	36078	the	0	None
36078	36079	immunosuppressive	0	None
36079	36080	activity	0	None
36080	36081	of	0	None
36081	36082	a	0	None
36082	36083	regimen	0	None
36083	36084	using	0	None
36084	36085	low	0	None
36085	36086	doses	0	None
36086	36087	of	0	None
36087	36088	both	0	None
36088	36089	microemulsion	0	None
36089	36090	cyclosporine	0	None
36090	36091	and	0	None
36091	36092	40	0	None
36092	36093	-	0	None
36093	36094	O	0	None
36094	36095	-	0	None
36095	36096	(	0	None
36096	36097	2	0	None
36097	36098	-	0	None
36098	36099	hydroxyethyl	0	None
36099	36100	)	0	None
36100	36101	-	0	None
36101	36102	rapamycin	1	GENE-Y
36102	36103	.	0	None

36104	36105	BACKGROUND	0	None
36105	36106	:	0	None
36106	36107	In	0	None
36107	36108	previous	0	None
36108	36109	studies	0	None
36109	36110	of	0	None
36110	36111	cynomolgus	0	None
36111	36112	monkey	0	None
36112	36113	lung	0	None
36113	36114	allograft	0	None
36114	36115	recipients	0	None
36115	36116	,	0	None
36116	36117	we	0	None
36117	36118	demonstrated	0	None
36118	36119	significant	0	None
36119	36120	immunosuppressive	0	None
36120	36121	efficacy	0	None
36121	36122	but	0	None
36122	36123	reduced	0	None
36123	36124	tolerability	0	None
36124	36125	after	0	None
36125	36126	combined	0	None
36126	36127	treatment	0	None
36127	36128	with	0	None
36128	36129	high	0	None
36129	36130	doses	0	None
36130	36131	of	0	None
36131	36132	microemulsion	0	None
36132	36133	cyclosporine	0	None
36133	36134	(	0	None
36134	36135	CsA	0	None
36135	36136	)	0	None
36136	36137	and	0	None
36137	36138	SDZ	0	None
36138	36139	RAD	0	None
36139	36140	(	0	None
36140	36141	40	0	None
36141	36142	-	0	None
36142	36143	O	0	None
36143	36144	-	0	None
36144	36145	(	0	None
36145	36146	2	0	None
36146	36147	-	0	None
36147	36148	hydroxyethyl	0	None
36148	36149	)	0	None
36149	36150	-	0	None
36150	36151	rapamycin	1	GENE-Y
36151	36152	)	0	None
36152	36153	.	0	None

36154	36155	The	0	None
36155	36156	current	0	None
36156	36157	study	0	None
36157	36158	was	0	None
36158	36159	designed	0	None
36159	36160	to	0	None
36160	36161	compare	0	None
36161	36162	efficacy	0	None
36162	36163	and	0	None
36163	36164	tolerability	0	None
36164	36165	of	0	None
36165	36166	a	0	None
36166	36167	combination	0	None
36167	36168	of	0	None
36168	36169	low	0	None
36169	36170	-	0	None
36170	36171	dose	0	None
36171	36172	CsA	0	None
36172	36173	and	0	None
36173	36174	high	0	None
36174	36175	-	0	None
36175	36176	dose	0	None
36176	36177	SDZ	0	None
36177	36178	RAD	0	None
36178	36179	(	0	None
36179	36180	CTL	0	None
36180	36181	group	0	None
36181	36182	)	0	None
36182	36183	to	0	None
36183	36184	triple	0	None
36184	36185	therapy	0	None
36185	36186	using	0	None
36186	36187	the	0	None
36187	36188	chimeric	0	None
36188	36189	anti	0	None
36189	36190	-	0	None
36190	36191	interleukin	1	GENE-Y
36191	36192	-	0	None
36192	36193	2	0	None
36193	36194	(	0	None
36194	36195	IL	0	None
36195	36196	-	0	None
36196	36197	2	0	None
36197	36198	)	0	None
36198	36199	receptor	0	None
36199	36200	(	0	None
36200	36201	CD25	1	GENE-Y
36201	36202	)	0	None
36202	36204	monoclonal antibody	2	GENE-N
36204	36205	(	0	None
36205	36206	mAb	0	None
36206	36207	)	0	None
36207	36208	basiliximab	0	None
36208	36209	(	0	None
36209	36210	anti	0	None
36210	36211	-	0	None
36211	36212	IL	0	None
36212	36213	-	0	None
36213	36214	2	0	None
36214	36215	receptor	0	None
36215	36216	mAb	0	None
36216	36217	)	0	None
36217	36218	for	0	None
36218	36219	induction	0	None
36219	36220	therapy	0	None
36220	36221	(	0	None
36221	36222	basiliximab	0	None
36222	36223	:	0	None
36223	36224	5	0	None
36224	36225	mg	0	None
36225	36226	intravenously	0	None
36226	36227	on	0	None
36227	36228	days	0	None
36228	36229	0	0	None
36229	36230	and	0	None
36230	36231	4	0	None
36231	36232	)	0	None
36232	36233	plus	0	None
36233	36234	low	0	None
36234	36235	-	0	None
36235	36236	dose	0	None
36236	36237	CsA	0	None
36237	36238	and	0	None
36238	36239	low	0	None
36239	36240	-	0	None
36240	36241	dose	0	None
36241	36242	SDZ	0	None
36242	36243	RAD	0	None
36243	36244	for	0	None
36244	36245	maintenance	0	None
36245	36246	immunosuppression	0	None
36246	36247	(	0	None
36247	36248	CD25	1	GENE-Y
36248	36249	group	0	None
36249	36250	)	0	None
36250	36251	.	0	None

36252	36253	CsA	0	None
36253	36254	and	0	None
36254	36255	anti	0	None
36255	36256	-	0	None
36256	36257	IL	0	None
36257	36258	-	0	None
36258	36259	2	0	None
36259	36260	receptor	0	None
36260	36261	mAb	0	None
36261	36262	are	0	None
36262	36263	drugs	0	None
36263	36264	that	0	None
36264	36265	reduce	0	None
36265	36266	cytokine	2	GENE-N
36266	36267	synthesis	0	None
36267	36268	and	0	None
36268	36269	block	0	None
36269	36270	IL	0	None
36270	36271	-	0	None
36271	36272	2	0	None
36272	36273	-	0	None
36273	36274	mediated	0	None
36274	36275	lymphocyte	0	None
36275	36276	stimulation	0	None
36276	36277	,	0	None
36277	36278	respectively	0	None
36278	36279	.	0	None

36280	36281	SDZ	0	None
36281	36282	RAD	0	None
36282	36283	blocks	0	None
36283	36284	lymphocyte	0	None
36284	36285	stimulation	0	None
36285	36286	by	0	None
36286	36287	other	0	None
36287	36288	cytokines	0	None
36288	36289	(	0	None
36289	36290	e	0	None
36290	36291	.	0	None
36291	36292	g	0	None
36292	36293	.	0	None
36293	36294	,	0	None
36294	36295	IL	0	None
36295	36296	-	0	None
36296	36297	15	0	None
36297	36298	)	0	None
36298	36299	that	0	None
36299	36300	are	0	None
36300	36301	not	0	None
36301	36302	inhibited	0	None
36302	36303	by	0	None
36303	36304	anti	0	None
36304	36305	-	0	None
36305	36306	IL	0	None
36306	36307	-	0	None
36307	36308	2	0	None
36308	36309	receptor	0	None
36309	36310	mAb	0	None
36310	36311	.	0	None

36312	36313	METHODS	0	None
36313	36314	:	0	None
36314	36315	Twelve	0	None
36315	36316	unilateral	0	None
36316	36317	lung	0	None
36317	36318	transplants	0	None
36318	36319	were	0	None
36319	36320	performed	0	None
36320	36321	.	0	None

36322	36323	Recipients	0	None
36323	36324	were	0	None
36324	36325	observed	0	None
36325	36326	for	0	None
36326	36327	49	0	None
36327	36328	days	0	None
36328	36329	by	0	None
36329	36330	daily	0	None
36330	36331	weight	0	None
36331	36332	assessment	0	None
36332	36333	,	0	None
36333	36334	hemograms	0	None
36334	36335	,	0	None
36335	36336	blood	0	None
36336	36337	chemistries	0	None
36337	36338	,	0	None
36338	36339	radiographs	0	None
36339	36340	,	0	None
36340	36341	and	0	None
36341	36342	lung	0	None
36342	36343	biopsies	0	None
36343	36344	.	0	None

36345	36346	Monkeys	0	None
36346	36347	were	0	None
36347	36348	euthanized	0	None
36348	36349	before	0	None
36349	36350	day	0	None
36350	36351	49	0	None
36351	36352	in	0	None
36352	36353	the	0	None
36353	36354	event	0	None
36354	36355	of	0	None
36355	36356	excessive	0	None
36356	36357	weight	0	None
36357	36358	loss	0	None
36358	36359	(	0	None
36359	36360	>	0	None
36360	36361	25	0	None
36361	36362	%	0	None
36362	36363	)	0	None
36363	36364	or	0	None
36364	36365	organ	0	None
36365	36366	failure	0	None
36366	36367	.	0	None

36368	36369	Target	0	None
36369	36370	CsA	0	None
36370	36371	trough	0	None
36371	36372	levels	0	None
36372	36373	were	0	None
36373	36374	100	0	None
36374	36375	-	0	None
36375	36376	200	0	None
36376	36377	ng	0	None
36377	36378	/	0	None
36378	36379	ml	0	None
36379	36380	.	0	None

36381	36382	Target	0	None
36382	36383	SDZ	0	None
36383	36384	RAD	0	None
36384	36385	trough	0	None
36385	36386	levels	0	None
36386	36387	in	0	None
36387	36388	the	0	None
36388	36389	CTL	0	None
36389	36390	group	0	None
36390	36391	(	0	None
36391	36392	no	0	None
36392	36393	mAb	0	None
36393	36394	)	0	None
36394	36395	were	0	None
36395	36396	20	0	None
36396	36397	-	0	None
36397	36398	40	0	None
36398	36399	ng	0	None
36399	36400	/	0	None
36400	36401	ml	0	None
36401	36402	,	0	None
36402	36403	and	0	None
36403	36404	10	0	None
36404	36405	-	0	None
36405	36406	20	0	None
36406	36407	ng	0	None
36407	36408	/	0	None
36408	36409	ml	0	None
36409	36410	in	0	None
36410	36411	the	0	None
36411	36412	CD25	1	GENE-Y
36412	36413	group	0	None
36413	36414	.	0	None

36415	36416	RESULTS	0	None
36416	36417	:	0	None
36417	36418	None	0	None
36418	36419	of	0	None
36419	36420	the	0	None
36420	36421	monkeys	0	None
36421	36422	in	0	None
36422	36423	the	0	None
36423	36424	CD25	1	GENE-Y
36424	36425	group	0	None
36425	36426	needed	0	None
36426	36427	to	0	None
36427	36428	be	0	None
36428	36429	euthanized	0	None
36429	36430	early	0	None
36430	36431	due	0	None
36431	36432	to	0	None
36432	36433	signs	0	None
36433	36434	of	0	None
36434	36435	drug	0	None
36435	36436	toxicity	0	None
36436	36437	.	0	None

36438	36439	In	0	None
36439	36440	contrast	0	None
36440	36441	,	0	None
36441	36442	four	0	None
36442	36443	monkeys	0	None
36443	36444	in	0	None
36444	36445	the	0	None
36445	36446	CTL	0	None
36446	36447	group	0	None
36447	36448	were	0	None
36448	36449	sacrificed	0	None
36449	36450	on	0	None
36450	36451	days	0	None
36451	36452	28	0	None
36452	36453	-	0	None
36453	36454	35	0	None
36454	36455	as	0	None
36455	36456	a	0	None
36456	36457	result	0	None
36457	36458	of	0	None
36458	36459	excessive	0	None
36459	36460	weight	0	None
36460	36461	loss	0	None
36461	36462	(	0	None
36462	36463	n	0	None
36463	36464	=	0	None
36464	36465	3	0	None
36465	36466	)	0	None
36466	36467	and	0	None
36467	36468	renal	0	None
36468	36469	functional	0	None
36469	36470	impairment	0	None
36470	36471	(	0	None
36471	36472	n	0	None
36472	36473	=	0	None
36473	36474	1	0	None
36474	36475	)	0	None
36475	36476	.	0	None

36477	36478	Three	0	None
36478	36479	recipients	0	None
36479	36480	in	0	None
36480	36481	the	0	None
36481	36482	CD25	1	GENE-Y
36482	36483	group	0	None
36483	36484	were	0	None
36484	36485	euthanized	0	None
36485	36486	on	0	None
36486	36487	days	0	None
36487	36488	36	0	None
36488	36489	,	0	None
36489	36490	38	0	None
36490	36491	,	0	None
36491	36492	and	0	None
36492	36493	46	0	None
36493	36494	as	0	None
36494	36495	a	0	None
36495	36496	result	0	None
36496	36497	of	0	None
36497	36498	persistent	0	None
36498	36499	high	0	None
36499	36500	fever	0	None
36500	36501	associated	0	None
36501	36502	with	0	None
36502	36503	severe	0	None
36503	36504	rejection	0	None
36504	36505	.	0	None

36506	36507	The	0	None
36507	36508	median	0	None
36508	36509	animal	0	None
36509	36510	survival	0	None
36510	36511	in	0	None
36511	36512	the	0	None
36512	36513	CTL	0	None
36513	36514	group	0	None
36514	36515	was	0	None
36515	36516	32	0	None
36516	36517	vs	0	None
36517	36518	.	0	None
36518	36519	46	0	None
36519	36520	days	0	None
36520	36521	in	0	None
36521	36522	the	0	None
36522	36523	CD25	1	GENE-Y
36523	36524	group	0	None
36524	36525	(	0	None
36525	36526	P	0	None
36526	36527	<	0	None
36527	36528	0	0	None
36528	36529	.	0	None
36529	36530	04	0	None
36530	36531	)	0	None
36531	36532	.	0	None

36533	36534	The	0	None
36534	36535	only	0	None
36535	36536	two	0	None
36536	36537	long	0	None
36537	36538	-	0	None
36538	36539	term	0	None
36539	36540	survivors	0	None
36540	36541	in	0	None
36541	36542	the	0	None
36542	36543	CTL	0	None
36543	36544	group	0	None
36544	36545	showed	0	None
36545	36546	moderate	0	None
36546	36547	rejection	0	None
36547	36548	at	0	None
36548	36549	day	0	None
36549	36550	49	0	None
36550	36551	.	0	None

36552	36553	The	0	None
36553	36554	median	0	None
36554	36555	rejection	0	None
36555	36556	scores	0	None
36556	36557	at	0	None
36557	36558	day	0	None
36558	36559	14	0	None
36559	36560	(	0	None
36560	36561	A0	0	None
36561	36562	)	0	None
36562	36563	and	0	None
36563	36564	day	0	None
36564	36565	28	0	None
36565	36566	(	0	None
36566	36567	A2	0	None
36567	36568	)	0	None
36568	36569	were	0	None
36569	36570	identical	0	None
36570	36571	in	0	None
36571	36572	the	0	None
36572	36573	two	0	None
36573	36574	groups	0	None
36574	36575	,	0	None
36575	36576	despite	0	None
36576	36577	the	0	None
36577	36578	fact	0	None
36578	36579	that	0	None
36579	36580	the	0	None
36580	36581	mean	0	None
36581	36582	SDZ	0	None
36582	36583	RAD	0	None
36583	36584	trough	0	None
36584	36585	level	0	None
36585	36586	was	0	None
36586	36587	significantly	0	None
36587	36588	lower	0	None
36588	36589	in	0	None
36589	36590	the	0	None
36590	36591	CD25	1	GENE-Y
36591	36592	group	0	None
36592	36593	(	0	None
36593	36594	CTL	0	None
36594	36595	:	0	None
36595	36596	38	0	None
36596	36597	+	0	None
36597	36598	/	0	None
36598	36599	-	0	None
36599	36600	3	0	None
36600	36601	ng	0	None
36601	36602	/	0	None
36602	36603	ml	0	None
36603	36604	,	0	None
36604	36605	CD25	1	GENE-Y
36605	36606	:	0	None
36606	36607	18	0	None
36607	36608	+	0	None
36608	36609	/	0	None
36609	36610	-	0	None
36610	36611	2	0	None
36611	36612	ng	0	None
36612	36613	/	0	None
36613	36614	ml	0	None
36614	36615	,	0	None
36615	36616	P	0	None
36616	36617	<	0	None
36617	36618	0	0	None
36618	36619	.	0	None
36619	36620	0001	0	None
36620	36621	)	0	None
36621	36622	.	0	None

36623	36624	After	0	None
36624	36625	basiliximab	0	None
36625	36626	levels	0	None
36626	36627	fell	0	None
36627	36628	below	0	None
36628	36629	the	0	None
36629	36630	minimum	0	None
36630	36631	therapeutic	0	None
36631	36632	level	0	None
36632	36633	(	0	None
36633	36634	1	0	None
36634	36635	mg	0	None
36635	36636	/	0	None
36636	36637	ml	0	None
36637	36638	)	0	None
36638	36639	on	0	None
36639	36640	day	0	None
36640	36641	28	0	None
36641	36642	,	0	None
36642	36643	the	0	None
36643	36644	median	0	None
36644	36645	rejection	0	None
36645	36646	score	0	None
36646	36647	at	0	None
36647	36648	day	0	None
36648	36649	49	0	None
36649	36650	increased	0	None
36650	36651	to	0	None
36651	36652	A4	0	None
36652	36653	in	0	None
36653	36654	the	0	None
36654	36655	CD25	1	GENE-Y
36655	36656	group	0	None
36656	36657	.	0	None

36658	36659	CONCLUSION	0	None
36659	36660	:	0	None
36660	36661	This	0	None
36661	36662	is	0	None
36662	36663	the	0	None
36663	36664	first	0	None
36664	36665	study	0	None
36665	36666	to	0	None
36666	36667	combine	0	None
36667	36668	an	0	None
36668	36669	anti	0	None
36669	36670	-	0	None
36670	36671	IL	0	None
36671	36672	-	0	None
36672	36673	2	0	None
36673	36674	receptor	0	None
36674	36675	mAb	0	None
36675	36676	with	0	None
36676	36677	a	0	None
36677	36678	drug	0	None
36678	36679	from	0	None
36679	36680	the	0	None
36680	36681	rapamycin	1	GENE-Y
36681	36682	class	0	None
36682	36683	plus	0	None
36683	36684	CsA	0	None
36684	36685	.	0	None

36686	36687	Our	0	None
36687	36688	study	0	None
36688	36689	shows	0	None
36689	36690	that	0	None
36690	36691	induction	0	None
36691	36692	therapy	0	None
36692	36693	with	0	None
36693	36694	basiliximab	0	None
36694	36695	enabled	0	None
36695	36696	SDZ	0	None
36696	36697	RAD	0	None
36697	36698	blood	0	None
36698	36699	levels	0	None
36699	36700	to	0	None
36700	36701	be	0	None
36701	36702	significantly	0	None
36702	36703	reduced	0	None
36703	36704	,	0	None
36704	36705	which	0	None
36705	36706	led	0	None
36706	36707	to	0	None
36707	36708	improved	0	None
36708	36709	tolerability	0	None
36709	36710	without	0	None
36710	36711	the	0	None
36711	36712	penalty	0	None
36712	36713	of	0	None
36713	36714	increased	0	None
36714	36715	rejection	0	None
36715	36716	.	0	None

36717	36718	Carnitine	3	CHEMICAL
36718	36719	biosynthesis	0	None
36719	36720	.	0	None

36721	36722	Purification	0	None
36722	36723	of	0	None
36723	36724	gamma	0	None
36724	36725	-	0	None
36725	36726	butyrobetaine	0	None
36726	36727	hydroxylase	0	None
36727	36728	from	0	None
36728	36729	rat	0	None
36729	36730	liver	0	None
36730	36731	.	0	None

36732	36733	gamma	0	None
36733	36734	-	0	None
36734	36735	Butyrobetaine	0	None
36735	36736	hydroxylase	0	None
36736	36737	catalyse	0	None
36737	36738	the	0	None
36738	36739	last	0	None
36739	36740	step	0	None
36740	36741	in	0	None
36741	36742	carnitine	3	CHEMICAL
36742	36743	biosynthesis	0	None
36743	36744	,	0	None
36744	36745	the	0	None
36745	36746	formation	0	None
36746	36747	of	0	None
36747	36748	L	0	None
36748	36749	-	0	None
36749	36750	carnitine	3	CHEMICAL
36750	36751	from	0	None
36751	36752	gamma	0	None
36752	36753	-	0	None
36753	36754	butyrobetaine	0	None
36754	36755	,	0	None
36755	36756	a	0	None
36756	36757	reaction	0	None
36757	36758	dependent	0	None
36758	36759	on	0	None
36759	36760	Fe2	0	None
36760	36761	+	0	None
36761	36762	,	0	None
36762	36763	alpha	0	None
36763	36764	-	0	None
36764	36765	ketoglutarate	0	None
36765	36766	,	0	None
36766	36767	ascorbate	3	CHEMICAL
36767	36768	and	0	None
36768	36769	oxygen	0	None
36769	36770	.	0	None

36771	36772	Initial	0	None
36772	36773	attempts	0	None
36773	36774	to	0	None
36774	36775	purify	0	None
36775	36776	the	0	None
36776	36777	protein	0	None
36777	36778	from	0	None
36778	36779	rat	0	None
36779	36780	liver	0	None
36780	36781	showed	0	None
36781	36782	that	0	None
36782	36783	gamma	0	None
36783	36784	-	0	None
36784	36785	butyrobetaine	0	None
36785	36786	hydroxylase	0	None
36786	36787	is	0	None
36787	36788	unstable	0	None
36788	36789	.	0	None

36790	36791	We	0	None
36791	36792	,	0	None
36792	36793	therefore	0	None
36793	36794	,	0	None
36794	36795	determined	0	None
36795	36796	the	0	None
36796	36797	influence	0	None
36797	36798	of	0	None
36798	36799	various	0	None
36799	36800	compounds	0	None
36800	36801	on	0	None
36801	36802	the	0	None
36802	36803	stability	0	None
36803	36804	of	0	None
36804	36805	gamma	0	None
36805	36806	-	0	None
36806	36807	butyrobetaine	0	None
36807	36808	hydroxylase	0	None
36808	36809	at	0	None
36809	36810	different	0	None
36810	36811	storage	0	None
36811	36812	temperatures	0	None
36812	36813	.	0	None

36814	36815	The	0	None
36815	36816	enzyme	0	None
36816	36817	activity	0	None
36817	36818	was	0	None
36818	36819	best	0	None
36819	36820	conserved	0	None
36820	36821	by	0	None
36821	36822	storing	0	None
36822	36823	the	0	None
36823	36824	protein	0	None
36824	36825	at	0	None
36825	36826	4	0	None
36826	36827	degrees	0	None
36827	36828	C	0	None
36828	36829	in	0	None
36829	36830	the	0	None
36830	36831	presence	0	None
36831	36832	of	0	None
36832	36833	200	0	None
36833	36834	g	0	None
36834	36835	/	0	None
36835	36836	l	0	None
36836	36837	glycerol	0	None
36837	36838	and	0	None
36838	36839	10	0	None
36839	36840	mM	0	None
36840	36841	DTT	0	None
36841	36842	.	0	None

36843	36844	We	0	None
36844	36845	subsequently	0	None
36845	36846	purified	0	None
36846	36847	the	0	None
36847	36848	enzyme	0	None
36848	36849	from	0	None
36849	36850	rat	0	None
36850	36851	liver	0	None
36851	36852	to	0	None
36852	36853	apparent	0	None
36853	36854	homogeneity	0	None
36854	36855	by	0	None
36855	36856	liquid	0	None
36856	36857	chromatography	0	None
36857	36858	.	0	None

36859	36860	Pharmacological	0	None
36860	36861	activation	0	None
36861	36862	of	0	None
36862	36863	cloned	0	None
36863	36864	intermediate	0	None
36864	36865	-	0	None
36865	36866	and	0	None
36866	36867	small	0	None
36867	36868	-	0	None
36868	36869	conductance	0	None
36869	36870	Ca	0	None
36870	36871	(	0	None
36871	36872	2	0	None
36872	36873	+	0	None
36873	36874	)	0	None
36874	36875	-	0	None
36875	36876	activated	0	None
36876	36877	K	0	None
36877	36878	(	0	None
36878	36879	+	0	None
36879	36880	)	0	None
36880	36881	channels	0	None
36881	36882	.	0	None

36883	36884	We	0	None
36884	36885	previously	0	None
36885	36886	characterized	0	None
36886	36887	1	0	None
36887	36888	-	0	None
36888	36889	ethyl	3	CHEMICAL
36889	36890	-	0	None
36890	36891	2	0	None
36891	36892	-	0	None
36892	36893	benzimidazolinone	0	None
36893	36894	(	0	None
36894	36895	1	0	None
36895	36896	-	0	None
36896	36897	EBIO	0	None
36897	36898	)	0	None
36898	36899	,	0	None
36899	36900	as	0	None
36900	36901	well	0	None
36901	36902	as	0	None
36902	36903	the	0	None
36903	36904	clinically	0	None
36904	36905	useful	0	None
36905	36906	benzoxazoles	0	None
36906	36907	,	0	None
36907	36908	chlorzoxazone	3	CHEMICAL
36908	36909	(	0	None
36909	36910	CZ	3	CHEMICAL
36910	36911	)	0	None
36911	36912	,	0	None
36912	36913	and	0	None
36913	36914	zoxazolamine	3	CHEMICAL
36914	36915	(	0	None
36915	36916	ZOX	0	None
36916	36917	)	0	None
36917	36918	,	0	None
36918	36919	as	0	None
36919	36920	pharmacological	0	None
36920	36921	activators	0	None
36921	36922	of	0	None
36922	36923	the	0	None
36923	36924	intermediate	0	None
36924	36925	-	0	None
36925	36926	conductance	0	None
36926	36927	Ca	0	None
36927	36928	(	0	None
36928	36929	2	0	None
36929	36930	+	0	None
36930	36931	)	0	None
36931	36932	-	0	None
36932	36933	activated	0	None
36933	36934	K	0	None
36934	36935	(	0	None
36935	36936	+	0	None
36936	36937	)	0	None
36937	36938	channel	0	None
36938	36939	,	0	None
36939	36940	hIK1	1	GENE-Y
36940	36941	.	0	None

36942	36943	The	0	None
36943	36944	mechanism	0	None
36944	36945	of	0	None
36945	36946	activation	0	None
36946	36947	of	0	None
36947	36948	hIK1	1	GENE-Y
36948	36949	,	0	None
36949	36950	as	0	None
36950	36951	well	0	None
36951	36952	as	0	None
36952	36953	the	0	None
36953	36954	highly	0	None
36954	36955	homologous	0	None
36955	36956	small	0	None
36956	36957	-	0	None
36957	36958	conductance	0	None
36958	36959	,	0	None
36959	36960	Ca	0	None
36960	36961	(	0	None
36961	36962	2	0	None
36962	36963	+	0	None
36963	36964	)	0	None
36964	36965	-	0	None
36965	36966	dependent	0	None
36966	36967	K	0	None
36967	36968	(	0	None
36968	36969	+	0	None
36969	36970	)	0	None
36970	36971	channel	0	None
36971	36972	,	0	None
36972	36973	rSK2	1	GENE-Y
36973	36974	,	0	None
36974	36975	was	0	None
36975	36976	determined	0	None
36976	36977	following	0	None
36977	36978	heterologous	0	None
36978	36979	expression	0	None
36979	36980	in	0	None
36980	36981	Xenopus	0	None
36981	36982	oocytes	0	None
36982	36983	using	0	None
36983	36984	two	0	None
36984	36985	-	0	None
36985	36986	electrode	0	None
36986	36987	voltage	0	None
36987	36988	clamp	0	None
36988	36989	(	0	None
36989	36990	TEVC	0	None
36990	36991	)	0	None
36991	36992	and	0	None
36992	36993	excised	0	None
36993	36994	,	0	None
36994	36995	inside	0	None
36995	36996	-	0	None
36996	36997	out	0	None
36997	36998	patch	0	None
36998	36999	-	0	None
36999	37000	clamp	0	None
37000	37001	techniques	0	None
37001	37002	.	0	None

37003	37004	1	0	None
37004	37005	-	0	None
37005	37006	EBIO	0	None
37006	37007	,	0	None
37007	37008	CZ	3	CHEMICAL
37008	37009	,	0	None
37009	37010	and	0	None
37010	37011	ZOX	0	None
37011	37012	activated	0	None
37012	37013	both	0	None
37013	37014	hIK1	1	GENE-Y
37014	37015	and	0	None
37015	37016	rSK2	1	GENE-Y
37016	37017	in	0	None
37017	37018	TEVC	0	None
37018	37019	and	0	None
37019	37020	excised	0	None
37020	37021	inside	0	None
37021	37022	-	0	None
37022	37023	out	0	None
37023	37024	patch	0	None
37024	37025	-	0	None
37025	37026	clamp	0	None
37026	37027	experiments	0	None
37027	37028	.	0	None

37029	37030	In	0	None
37030	37031	excised	0	None
37031	37032	,	0	None
37032	37033	inside	0	None
37033	37034	-	0	None
37034	37035	out	0	None
37035	37036	patches	0	None
37036	37037	,	0	None
37037	37038	1	0	None
37038	37039	-	0	None
37039	37040	EBIO	0	None
37040	37041	and	0	None
37041	37042	CZ	3	CHEMICAL
37042	37043	induced	0	None
37043	37044	a	0	None
37044	37045	concentration	0	None
37045	37046	-	0	None
37046	37047	dependent	0	None
37047	37048	activation	0	None
37048	37049	of	0	None
37049	37050	hIK1	1	GENE-Y
37050	37051	,	0	None
37051	37052	with	0	None
37052	37053	half	0	None
37053	37054	-	0	None
37054	37055	maximal	0	None
37055	37056	(	0	None
37056	37057	K	0	None
37057	37058	(	0	None
37058	37059	1	0	None
37059	37060	/	0	None
37060	37061	2	0	None
37061	37062	)	0	None
37062	37063	)	0	None
37063	37064	values	0	None
37064	37065	of	0	None
37065	37066	84	0	None
37066	37067	microM	0	None
37067	37068	and	0	None
37068	37069	98	0	None
37069	37070	microM	0	None
37070	37071	,	0	None
37071	37072	respectively	0	None
37072	37073	.	0	None

37074	37075	Similarly	0	None
37075	37076	,	0	None
37076	37077	CZ	3	CHEMICAL
37077	37078	activated	0	None
37078	37079	rSK2	1	GENE-Y
37079	37080	with	0	None
37080	37081	a	0	None
37081	37082	K	0	None
37082	37083	(	0	None
37083	37084	1	0	None
37084	37085	/	0	None
37085	37086	2	0	None
37086	37087	)	0	None
37087	37088	of	0	None
37088	37089	87	0	None
37089	37090	microM	0	None
37090	37091	.	0	None

37092	37093	In	0	None
37093	37094	the	0	None
37094	37095	absence	0	None
37095	37096	of	0	None
37096	37097	CZ	3	CHEMICAL
37097	37098	,	0	None
37098	37099	the	0	None
37099	37100	Ca	0	None
37100	37101	(	0	None
37101	37102	2	0	None
37102	37103	+	0	None
37103	37104	)	0	None
37104	37105	-	0	None
37105	37106	dependent	0	None
37106	37107	activation	0	None
37107	37108	of	0	None
37108	37109	hIK1	1	GENE-Y
37109	37110	was	0	None
37110	37111	best	0	None
37111	37112	fit	0	None
37112	37113	with	0	None
37113	37114	a	0	None
37114	37115	K	0	None
37115	37116	(	0	None
37116	37117	1	0	None
37117	37118	/	0	None
37118	37119	2	0	None
37119	37120	)	0	None
37120	37121	of	0	None
37121	37122	700	0	None
37122	37123	nM	0	None
37123	37124	and	0	None
37124	37125	a	0	None
37125	37126	Hill	0	None
37126	37127	coefficient	0	None
37127	37128	(	0	None
37128	37129	n	0	None
37129	37130	)	0	None
37130	37131	of	0	None
37131	37132	2	0	None
37132	37133	.	0	None
37133	37134	0	0	None
37134	37135	.	0	None

37136	37137	rSK2	1	GENE-Y
37137	37138	was	0	None
37138	37139	activated	0	None
37139	37140	by	0	None
37140	37141	Ca	0	None
37141	37142	(	0	None
37142	37143	2	0	None
37143	37144	+	0	None
37144	37145	)	0	None
37145	37146	with	0	None
37146	37147	a	0	None
37147	37148	K	0	None
37148	37149	(	0	None
37149	37150	1	0	None
37150	37151	/	0	None
37151	37152	2	0	None
37152	37153	)	0	None
37153	37154	of	0	None
37154	37155	700	0	None
37155	37156	nM	0	None
37156	37157	and	0	None
37157	37158	an	0	None
37158	37159	n	0	None
37159	37160	of	0	None
37160	37161	2	0	None
37161	37162	.	0	None
37162	37163	5	0	None
37163	37164	.	0	None

37165	37166	Addition	0	None
37166	37167	of	0	None
37167	37168	CZ	3	CHEMICAL
37168	37169	had	0	None
37169	37170	no	0	None
37170	37171	effect	0	None
37171	37172	on	0	None
37172	37173	either	0	None
37173	37174	the	0	None
37174	37175	K	0	None
37175	37176	(	0	None
37176	37177	1	0	None
37177	37178	/	0	None
37178	37179	2	0	None
37179	37180	)	0	None
37180	37181	or	0	None
37181	37182	n	0	None
37182	37183	for	0	None
37183	37184	Ca	0	None
37184	37185	(	0	None
37185	37186	2	0	None
37186	37187	+	0	None
37187	37188	)	0	None
37188	37189	-	0	None
37189	37190	dependent	0	None
37190	37191	activation	0	None
37191	37192	of	0	None
37192	37193	either	0	None
37193	37194	hIK1	1	GENE-Y
37194	37195	or	0	None
37195	37196	rSK2	1	GENE-Y
37196	37197	.	0	None

37198	37199	Rather	0	None
37199	37200	,	0	None
37200	37201	CZ	3	CHEMICAL
37201	37202	increased	0	None
37202	37203	channel	0	None
37203	37204	activity	0	None
37204	37205	at	0	None
37205	37206	all	0	None
37206	37207	Ca	0	None
37207	37208	(	0	None
37208	37209	2	0	None
37209	37210	+	0	None
37210	37211	)	0	None
37211	37212	concentrations	0	None
37212	37213	(	0	None
37213	37214	V	0	None
37214	37215	(	0	None
37215	37216	max	1	GENE-Y
37216	37217	)	0	None
37217	37218	)	0	None
37218	37219	.	0	None

37220	37221	Event	0	None
37221	37222	-	0	None
37222	37223	duration	0	None
37223	37224	analysis	0	None
37224	37225	revealed	0	None
37225	37226	hIK1	1	GENE-Y
37226	37227	was	0	None
37227	37228	minimally	0	None
37228	37229	described	0	None
37229	37230	by	0	None
37230	37231	two	0	None
37231	37232	open	0	None
37232	37233	and	0	None
37233	37234	three	0	None
37234	37235	closed	0	None
37235	37236	times	0	None
37236	37237	.	0	None

37238	37239	Activation	0	None
37239	37240	by	0	None
37240	37241	1	0	None
37241	37242	-	0	None
37242	37243	EBIO	0	None
37243	37244	had	0	None
37244	37245	no	0	None
37245	37246	effect	0	None
37246	37247	on	0	None
37247	37248	tau	1	GENE-Y
37248	37249	(	0	None
37249	37250	o1	0	None
37250	37251	)	0	None
37251	37252	,	0	None
37252	37253	tau	1	GENE-Y
37253	37254	(	0	None
37254	37255	o2	0	None
37255	37256	)	0	None
37256	37257	,	0	None
37257	37258	or	0	None
37258	37259	tau	1	GENE-Y
37259	37260	(	0	None
37260	37261	c1	0	None
37261	37262	)	0	None
37262	37263	,	0	None
37263	37264	whereas	0	None
37264	37265	tau	1	GENE-Y
37265	37266	(	0	None
37266	37267	c2	1	GENE-Y
37267	37268	)	0	None
37268	37269	and	0	None
37269	37270	tau	1	GENE-Y
37270	37271	(	0	None
37271	37272	c3	0	None
37272	37273	)	0	None
37273	37274	were	0	None
37274	37275	reduced	0	None
37275	37276	from	0	None
37276	37277	9	0	None
37277	37278	.	0	None
37278	37279	0	0	None
37279	37280	and	0	None
37280	37281	92	0	None
37281	37282	.	0	None
37282	37283	6	0	None
37283	37284	ms	0	None
37284	37285	to	0	None
37285	37286	5	0	None
37286	37287	.	0	None
37287	37288	0	0	None
37288	37289	and	0	None
37289	37290	44	0	None
37290	37291	.	0	None
37291	37292	1	0	None
37292	37293	ms	0	None
37293	37294	,	0	None
37294	37295	respectively	0	None
37295	37296	.	0	None

37297	37298	In	0	None
37298	37299	conclusion	0	None
37299	37300	,	0	None
37300	37301	we	0	None
37301	37302	define	0	None
37302	37303	1	0	None
37303	37304	-	0	None
37304	37305	EBIO	0	None
37305	37306	,	0	None
37306	37307	CZ	3	CHEMICAL
37307	37308	,	0	None
37308	37309	and	0	None
37309	37310	ZOX	0	None
37310	37311	as	0	None
37311	37312	the	0	None
37312	37313	first	0	None
37313	37314	known	0	None
37314	37315	activators	0	None
37315	37316	of	0	None
37316	37317	hIK1	1	GENE-Y
37317	37318	and	0	None
37318	37319	rSK2	1	GENE-Y
37319	37320	.	0	None

37321	37322	Openers	0	None
37322	37323	of	0	None
37323	37324	IK	2	GENE-N
37324	37325	and	0	None
37325	37326	SK	2	GENE-N
37326	37327	channels	0	None
37327	37328	may	0	None
37328	37329	be	0	None
37329	37330	therapeutically	0	None
37330	37331	beneficial	0	None
37331	37332	in	0	None
37332	37333	cystic	0	None
37333	37334	fibrosis	0	None
37334	37335	and	0	None
37335	37336	vascular	0	None
37336	37337	diseases	0	None
37337	37338	.	0	None

37339	37340	[	0	None
37340	37341	Plasminogen	0	None
37341	37342	binding	0	None
37342	37343	with	0	None
37343	37344	decapeptide	0	None
37344	37345	and	0	None
37345	37346	polypeptide	0	None
37346	37347	fragments	0	None
37347	37348	of	0	None
37348	37349	streptokinase	2	GENE-N
37349	37350	]	0	None
37350	37351	.	0	None

37352	37353	The	0	None
37353	37354	plasminogen	1	GENE-Y
37354	37355	binding	0	None
37355	37356	with	0	None
37356	37357	streptokinase	2	GENE-N
37357	37358	decapeptides	0	None
37358	37359	,	0	None
37359	37360	modeling	0	None
37360	37361	the	0	None
37361	37362	primary	0	None
37362	37363	structure	0	None
37363	37364	of	0	None
37364	37365	molecule	0	None
37365	37366	,	0	None
37366	37367	and	0	None
37367	37368	chymotryptic	0	None
37368	37369	fragments	0	None
37369	37370	of	0	None
37370	37371	streptokinase	2	GENE-N
37371	37372	have	0	None
37372	37373	been	0	None
37373	37374	investigated	0	None
37374	37375	.	0	None

37376	37377	The	0	None
37377	37378	immunoenzymatic	0	None
37378	37379	assay	0	None
37379	37380	has	0	None
37380	37381	shown	0	None
37381	37382	that	0	None
37382	37383	plasminogen	1	GENE-Y
37383	37384	binds	0	None
37384	37385	to	0	None
37385	37386	all	0	None
37386	37387	streptokinase	2	GENE-N
37387	37388	fragments	0	None
37388	37389	with	0	None
37389	37390	the	0	None
37390	37391	decreasing	0	None
37391	37392	affinity	0	None
37392	37393	in	0	None
37393	37394	the	0	None
37394	37395	set	0	None
37395	37396	of	0	None
37396	37397	fragments	0	None
37397	37398	:	0	None
37398	37399	36	0	None
37399	37400	>	0	None
37400	37401	30	0	None
37401	37402	>	0	None
37402	37403	17	0	None
37403	37404	>	0	None
37404	37405	7	0	None
37405	37406	>	0	None
37406	37407	11	0	None
37407	37408	kDa	0	None
37408	37409	.	0	None

37410	37411	Location	0	None
37411	37412	of	0	None
37412	37413	the	0	None
37413	37414	binding	0	None
37414	37415	sites	0	None
37415	37416	in	0	None
37416	37417	streptokinase	2	GENE-N
37417	37418	primary	0	None
37418	37419	structure	0	None
37419	37420	was	0	None
37420	37421	performed	0	None
37421	37422	using	0	None
37422	37423	the	0	None
37423	37424	immobilized	0	None
37424	37425	decapeptides	0	None
37425	37426	on	0	None
37426	37427	plastic	0	None
37427	37428	pins	0	None
37428	37429	adopted	0	None
37429	37430	to	0	None
37430	37431	IEA	0	None
37431	37432	.	0	None

37433	37434	In	0	None
37434	37435	the	0	None
37435	37436	presence	0	None
37436	37437	of	0	None
37437	37438	10	0	None
37438	37439	mM	0	None
37439	37440	6	0	None
37440	37441	-	0	None
37441	37442	aminohexanoic	0	None
37442	37443	acid	0	None
37443	37444	11	0	None
37444	37445	sites	0	None
37445	37446	for	0	None
37446	37448	human Glu	3	CHEMICAL
37448	37449	-	0	None
37449	37450	and	0	None
37450	37451	mini	0	None
37451	37452	-	0	None
37452	37453	plasminogens	0	None
37453	37454	,	0	None
37454	37458	pig and bovine plasminogens	2	GENE-N
37458	37459	binding	0	None
37459	37460	have	0	None
37460	37461	been	0	None
37461	37462	found	0	None
37462	37463	.	0	None

37464	37465	They	0	None
37465	37466	were	0	None
37466	37467	of	0	None
37467	37468	the	0	None
37468	37469	same	0	None
37469	37470	location	0	None
37470	37471	for	0	None
37471	37472	human	0	None
37472	37473	,	0	None
37473	37477	bovine and pig plasminogens	2	GENE-N
37477	37478	.	0	None

37479	37480	3	0	None
37480	37481	sites	0	None
37481	37482	were	0	None
37482	37483	located	0	None
37483	37484	in	0	None
37484	37485	plasminogen	1	GENE-Y
37485	37486	alpha	0	None
37486	37487	-	0	None
37487	37488	domain	0	None
37488	37489	-	0	None
37489	37490	-	0	None
37490	37491	T43	0	None
37491	37492	-	0	None
37492	37493	A72	0	None
37493	37494	,	0	None
37494	37495	N113	0	None
37495	37496	-	0	None
37496	37497	T126	0	None
37497	37498	,	0	None
37498	37499	Q133	0	None
37499	37500	-	0	None
37500	37501	V158	0	None
37501	37502	,	0	None
37502	37503	5	0	None
37503	37504	sites	0	None
37504	37505	in	0	None
37505	37506	beta	0	None
37506	37507	-	0	None
37507	37508	domain	0	None
37508	37509	-	0	None
37509	37510	-	0	None
37510	37511	T163	0	None
37511	37512	-	0	None
37512	37513	L188	0	None
37513	37514	,	0	None
37514	37515	A203	0	None
37515	37516	-	0	None
37516	37517	S222	0	None
37517	37518	,	0	None
37518	37519	Q239	0	None
37519	37520	-	0	None
37520	37521	I264	0	None
37521	37522	,	0	None
37522	37523	Y275	0	None
37523	37524	-	0	None
37524	37525	L294	0	None
37525	37526	,	0	None
37526	37527	T315	0	None
37527	37528	-	0	None
37528	37529	L340	0	None
37529	37530	,	0	None
37530	37531	and	0	None
37531	37532	3	0	None
37532	37533	sites	0	None
37533	37534	in	0	None
37534	37535	gamma	0	None
37535	37536	-	0	None
37536	37537	domain	0	None
37537	37538	-	0	None
37538	37539	-	0	None
37539	37540	T361	0	None
37540	37541	-	0	None
37541	37542	R362	0	None
37542	37543	,	0	None
37543	37544	N377	0	None
37544	37545	-	0	None
37545	37546	E392	0	None
37546	37547	,	0	None
37547	37548	T397	0	None
37548	37549	-	0	None
37549	37550	N410	0	None
37550	37551	.	0	None

37552	37553	Participation	0	None
37553	37554	of	0	None
37554	37555	linear	0	None
37555	37556	part	0	None
37556	37557	of	0	None
37557	37558	streptokinase	2	GENE-N
37558	37559	polypeptide	0	None
37559	37560	chain	0	None
37560	37561	in	0	None
37561	37562	plasminogen	1	GENE-Y
37562	37563	-	0	None
37563	37564	-	0	None
37564	37565	streptokinase	2	GENE-N
37565	37566	complex	0	None
37566	37567	formation	0	None
37567	37568	is	0	None
37568	37569	suggested	0	None
37569	37570	.	0	None

37571	37572	Interactions	0	None
37572	37573	of	0	None
37573	37574	the	0	None
37574	37578	human multidrug resistance proteins	2	GENE-N
37578	37579	MRP1	1	GENE-Y
37579	37580	and	0	None
37580	37581	MRP2	0	None
37581	37582	with	0	None
37582	37583	organic	3	CHEMICAL
37583	37584	anions	0	None
37584	37585	.	0	None

37586	37587	The	0	None
37587	37591	human multidrug resistance protein	2	GENE-N
37591	37592	MRP1	1	GENE-Y
37592	37593	and	0	None
37593	37594	its	0	None
37594	37595	homolog	0	None
37595	37596	,	0	None
37596	37597	MRP2	0	None
37597	37598	,	0	None
37598	37599	are	0	None
37599	37600	both	0	None
37600	37601	suggested	0	None
37601	37602	as	0	None
37602	37603	being	0	None
37603	37604	involved	0	None
37604	37605	in	0	None
37605	37606	cancer	0	None
37606	37607	drug	0	None
37607	37608	resistance	0	None
37608	37609	and	0	None
37609	37610	the	0	None
37610	37611	transport	0	None
37611	37612	of	0	None
37612	37613	organic	3	CHEMICAL
37613	37614	anions	0	None
37614	37615	.	0	None

37616	37617	We	0	None
37617	37618	expressed	0	None
37618	37619	MRP1	1	GENE-Y
37619	37620	and	0	None
37620	37621	MRP2	0	None
37621	37622	in	0	None
37622	37623	Spodoptera	0	None
37623	37624	frugiperda	0	None
37624	37625	ovarian	0	None
37625	37626	cells	0	None
37626	37627	and	0	None
37627	37628	compared	0	None
37628	37629	their	0	None
37629	37630	ATP	3	CHEMICAL
37630	37631	-	0	None
37631	37632	dependent	0	None
37632	37633	transport	0	None
37633	37634	properties	0	None
37634	37635	and	0	None
37635	37636	vanadate	3	CHEMICAL
37636	37637	-	0	None
37637	37638	sensitive	0	None
37638	37639	ATPase	0	None
37639	37640	activities	0	None
37640	37641	in	0	None
37641	37642	isolated	0	None
37642	37643	membrane	0	None
37643	37644	vesicles	0	None
37644	37645	.	0	None

37646	37647	Both	0	None
37647	37648	MRP1	1	GENE-Y
37648	37649	and	0	None
37649	37650	MRP2	0	None
37650	37651	actively	0	None
37651	37652	transported	0	None
37652	37654	leukotriene C	3	CHEMICAL
37654	37655	(	0	None
37655	37656	4	0	None
37656	37657	)	0	None
37657	37658	and	0	None
37658	37659	N	0	None
37659	37660	-	0	None
37660	37661	ethylmaleimide	0	None
37661	37662	glutathione	3	CHEMICAL
37662	37663	(	0	None
37663	37664	NEM	0	None
37664	37665	-	0	None
37665	37666	GS	0	None
37666	37667	)	0	None
37667	37668	,	0	None
37668	37669	although	0	None
37669	37670	the	0	None
37670	37671	relative	0	None
37671	37672	affinity	0	None
37672	37673	of	0	None
37673	37674	MRP2	0	None
37674	37675	for	0	None
37675	37676	these	0	None
37676	37677	substrates	0	None
37677	37678	was	0	None
37678	37679	found	0	None
37679	37680	to	0	None
37680	37681	be	0	None
37681	37682	significantly	0	None
37682	37683	lower	0	None
37683	37684	than	0	None
37684	37685	that	0	None
37685	37686	of	0	None
37686	37687	MRP1	1	GENE-Y
37687	37688	.	0	None

37689	37690	Methotrexate	0	None
37690	37691	was	0	None
37691	37692	actively	0	None
37692	37693	transported	0	None
37693	37694	by	0	None
37694	37695	both	0	None
37695	37696	proteins	0	None
37696	37697	,	0	None
37697	37698	although	0	None
37698	37699	more	0	None
37699	37700	efficiently	0	None
37700	37701	by	0	None
37701	37702	MRP2	0	None
37702	37703	.	0	None

37704	37705	ATP	3	CHEMICAL
37705	37706	-	0	None
37706	37707	dependent	0	None
37707	37708	NEM	0	None
37708	37709	-	0	None
37709	37710	GS	0	None
37710	37711	transport	0	None
37711	37712	by	0	None
37712	37713	MRP1	1	GENE-Y
37713	37714	and	0	None
37714	37715	MRP2	0	None
37715	37716	was	0	None
37716	37717	variably	0	None
37717	37718	modulated	0	None
37718	37719	by	0	None
37719	37720	organic	3	CHEMICAL
37720	37721	anions	0	None
37721	37722	.	0	None

37723	37724	Probenecid	3	CHEMICAL
37724	37725	and	0	None
37725	37726	furosemide	3	CHEMICAL
37726	37727	inhibited	0	None
37727	37728	,	0	None
37728	37729	whereas	0	None
37729	37730	under	0	None
37730	37731	certain	0	None
37731	37732	conditions	0	None
37732	37733	sulfinpyrazone	0	None
37733	37734	,	0	None
37734	37736	penicillin G	3	CHEMICAL
37736	37737	,	0	None
37737	37738	and	0	None
37738	37739	indomethacin	3	CHEMICAL
37739	37740	greatly	0	None
37740	37741	stimulated	0	None
37741	37742	,	0	None
37742	37743	MRP2	0	None
37743	37744	-	0	None
37744	37745	mediated	0	None
37745	37746	NEM	0	None
37746	37747	-	0	None
37747	37748	GS	0	None
37748	37749	uptake	0	None
37749	37750	.	0	None

37751	37752	Vanadate	0	None
37752	37753	-	0	None
37753	37754	sensitive	0	None
37754	37755	ATPase	0	None
37755	37756	activity	0	None
37756	37757	in	0	None
37757	37758	isolated	0	None
37758	37759	membranes	0	None
37759	37760	containing	0	None
37760	37761	MRP1	1	GENE-Y
37761	37762	or	0	None
37762	37763	MRP2	0	None
37763	37764	was	0	None
37764	37765	significantly	0	None
37765	37766	stimulated	0	None
37766	37767	by	0	None
37767	37768	NEM	0	None
37768	37769	-	0	None
37769	37770	GS	0	None
37770	37771	and	0	None
37771	37772	reduced	0	None
37772	37773	GS	0	None
37773	37774	,	0	None
37774	37775	although	0	None
37775	37776	these	0	None
37776	37777	compounds	0	None
37777	37778	acted	0	None
37778	37779	only	0	None
37779	37780	at	0	None
37780	37781	higher	0	None
37781	37782	concentrations	0	None
37782	37783	in	0	None
37783	37784	MRP2	0	None
37784	37785	.	0	None

37786	37787	ATP	3	CHEMICAL
37787	37788	hydrolysis	0	None
37788	37789	by	0	None
37789	37790	MRP2	0	None
37790	37791	was	0	None
37791	37792	also	0	None
37792	37793	effectively	0	None
37793	37794	stimulated	0	None
37794	37795	by	0	None
37795	37796	methotrexate	3	CHEMICAL
37796	37797	.	0	None

37798	37799	Probenecid	3	CHEMICAL
37799	37800	,	0	None
37800	37801	sulfinpyrazone	0	None
37801	37802	,	0	None
37802	37803	indomethacin	3	CHEMICAL
37803	37804	,	0	None
37804	37805	furosemide	3	CHEMICAL
37805	37806	,	0	None
37806	37807	and	0	None
37807	37809	penicillin G	3	CHEMICAL
37809	37810	all	0	None
37810	37811	significantly	0	None
37811	37812	increased	0	None
37812	37813	MRP2	0	None
37813	37814	-	0	None
37814	37815	ATPase	0	None
37815	37816	activity	0	None
37816	37817	,	0	None
37817	37818	whereas	0	None
37818	37819	these	0	None
37819	37820	compounds	0	None
37820	37821	acted	0	None
37821	37822	more	0	None
37822	37823	as	0	None
37823	37824	ATPase	0	None
37824	37825	inhibitors	0	None
37825	37826	on	0	None
37826	37827	MRP1	1	GENE-Y
37827	37828	.	0	None

37829	37830	These	0	None
37830	37831	results	0	None
37831	37832	indicate	0	None
37832	37833	that	0	None
37833	37834	MRP1	1	GENE-Y
37834	37835	is	0	None
37835	37836	a	0	None
37836	37837	more	0	None
37837	37838	efficient	0	None
37838	37839	transporter	0	None
37839	37840	of	0	None
37840	37841	glutathione	3	CHEMICAL
37841	37842	conjugates	0	None
37842	37843	and	0	None
37843	37844	free	0	None
37844	37845	glutathione	3	CHEMICAL
37845	37846	than	0	None
37846	37847	MRP2	0	None
37847	37848	,	0	None
37848	37849	whereas	0	None
37849	37850	several	0	None
37850	37851	anions	0	None
37851	37852	are	0	None
37852	37853	preferred	0	None
37853	37854	substrates	0	None
37854	37855	for	0	None
37855	37856	MRP2	0	None
37856	37857	.	0	None

37858	37859	Our	0	None
37859	37860	data	0	None
37860	37861	suggest	0	None
37861	37862	that	0	None
37862	37863	MRP2	0	None
37863	37864	may	0	None
37864	37865	be	0	None
37865	37866	responsible	0	None
37866	37867	for	0	None
37867	37868	the	0	None
37868	37869	active	0	None
37869	37870	secretion	0	None
37870	37871	of	0	None
37871	37872	pharmacologically	0	None
37872	37873	relevant	0	None
37873	37874	organic	3	CHEMICAL
37874	37875	anions	0	None
37875	37876	,	0	None
37876	37877	such	0	None
37877	37878	as	0	None
37878	37879	diuretics	0	None
37879	37880	and	0	None
37880	37881	antibiotics	0	None
37881	37882	,	0	None
37882	37883	and	0	None
37883	37884	indicate	0	None
37884	37885	different	0	None
37885	37886	modulation	0	None
37886	37887	possibilities	0	None
37887	37888	for	0	None
37888	37889	MRP1	1	GENE-Y
37889	37890	or	0	None
37890	37891	MRP2	0	None
37891	37892	in	0	None
37892	37893	drug	0	None
37893	37894	-	0	None
37894	37895	resistant	0	None
37895	37896	tumor	0	None
37896	37897	cells	0	None
37897	37898	.	0	None

37899	37900	Aspirin	0	None
37900	37901	and	0	None
37901	37903	sodium salicylate	3	CHEMICAL
37903	37904	inhibit	0	None
37904	37905	endothelin	2	GENE-N
37905	37906	ETA	0	None
37906	37907	receptors	0	None
37907	37908	by	0	None
37908	37909	an	0	None
37909	37910	allosteric	0	None
37910	37911	type	0	None
37911	37912	of	0	None
37912	37913	mechanism	0	None
37913	37914	.	0	None

37915	37916	Aspirin	0	None
37916	37917	is	0	None
37917	37918	a	0	None
37918	37919	commonly	0	None
37919	37920	used	0	None
37920	37921	drug	0	None
37921	37922	with	0	None
37922	37923	a	0	None
37923	37924	wide	0	None
37924	37925	pharmacological	0	None
37925	37926	spectrum	0	None
37926	37927	including	0	None
37927	37928	antiplatelet	0	None
37928	37929	,	0	None
37929	37930	anti	0	None
37930	37931	-	0	None
37931	37932	inflammatory	0	None
37932	37933	,	0	None
37933	37934	and	0	None
37934	37935	neuroprotective	0	None
37935	37936	actions	0	None
37936	37937	.	0	None

37938	37939	This	0	None
37939	37940	study	0	None
37940	37941	shows	0	None
37941	37942	that	0	None
37942	37943	aspirin	0	None
37943	37944	and	0	None
37944	37946	sodium salicylate	3	CHEMICAL
37946	37947	,	0	None
37947	37948	its	0	None
37948	37949	major	0	None
37949	37950	blood	0	None
37950	37951	metabolite	0	None
37951	37952	,	0	None
37952	37953	reverse	0	None
37953	37954	contractile	0	None
37954	37955	actions	0	None
37955	37956	of	0	None
37956	37957	endothelin	2	GENE-N
37957	37958	-	0	None
37958	37959	1	0	None
37959	37960	(	0	None
37960	37961	ET	0	None
37961	37962	-	0	None
37962	37963	1	0	None
37963	37964	)	0	None
37964	37965	in	0	None
37965	37966	isolated	0	None
37966	37967	rat	0	None
37967	37968	aorta	0	None
37968	37969	and	0	None
37969	37970	human	0	None
37970	37971	mammary	0	None
37971	37972	arteries	0	None
37972	37973	.	0	None

37974	37975	They	0	None
37975	37976	also	0	None
37976	37977	prevent	0	None
37977	37978	the	0	None
37978	37979	intracellular	0	None
37979	37980	Ca	0	None
37980	37981	(	0	None
37981	37982	2	0	None
37982	37983	+	0	None
37983	37984	)	0	None
37984	37985	mobilizing	0	None
37985	37986	action	0	None
37986	37987	of	0	None
37987	37988	ET	0	None
37988	37989	-	0	None
37989	37990	1	0	None
37990	37991	in	0	None
37991	37992	cultured	0	None
37992	37993	endothelial	0	None
37993	37994	cells	0	None
37994	37995	but	0	None
37995	37996	not	0	None
37996	37997	those	0	None
37997	37998	of	0	None
37998	37999	neuromedin	0	None
37999	38000	B	0	None
38000	38001	or	0	None
38001	38002	UTP	3	CHEMICAL
38002	38003	.	0	None

38004	38005	Inhibition	0	None
38005	38006	of	0	None
38006	38007	the	0	None
38007	38008	actions	0	None
38008	38009	of	0	None
38009	38010	ET	0	None
38010	38011	-	0	None
38011	38012	1	0	None
38012	38013	by	0	None
38013	38014	salicylates	3	CHEMICAL
38014	38015	is	0	None
38015	38016	apparently	0	None
38016	38017	competitive	0	None
38017	38018	.	0	None

38019	38020	Salicylates	3	CHEMICAL
38020	38021	inhibit	0	None
38021	38022	(	0	None
38022	38023	125	0	None
38023	38024	)	0	None
38024	38025	I	0	None
38025	38026	-	0	None
38026	38027	ET	0	None
38027	38028	-	0	None
38028	38029	1	0	None
38029	38030	binding	0	None
38030	38031	to	0	None
38031	38035	recombinant rat ETA receptors	1	GENE-Y
38035	38036	.	0	None

38037	38039	Salicylic acid	3	CHEMICAL
38039	38040	promotes	0	None
38040	38041	dissociation	0	None
38041	38042	of	0	None
38042	38043	(	0	None
38043	38044	125	0	None
38044	38045	)	0	None
38045	38046	I	0	None
38046	38047	-	0	None
38047	38048	ET	0	None
38048	38049	-	0	None
38049	38050	1	0	None
38050	38051	ETA	0	None
38051	38052	receptor	0	None
38052	38053	complexes	0	None
38053	38054	both	0	None
38054	38055	in	0	None
38055	38056	the	0	None
38056	38057	absence	0	None
38057	38058	and	0	None
38058	38059	the	0	None
38059	38060	presence	0	None
38060	38061	of	0	None
38061	38062	unlabeled	0	None
38062	38063	ET	0	None
38063	38064	-	0	None
38064	38065	1	0	None
38065	38066	.	0	None

38067	38068	It	0	None
38068	38069	has	0	None
38069	38070	no	0	None
38070	38071	influence	0	None
38071	38072	on	0	None
38072	38073	the	0	None
38073	38074	rate	0	None
38074	38075	of	0	None
38075	38076	association	0	None
38076	38077	of	0	None
38077	38078	(	0	None
38078	38079	125	0	None
38079	38080	)	0	None
38080	38081	I	0	None
38081	38082	-	0	None
38082	38083	ET	0	None
38083	38084	-	0	None
38084	38085	1	0	None
38085	38086	to	0	None
38086	38087	ETA	0	None
38087	38088	receptors	0	None
38088	38089	.	0	None

38090	38091	Salicylates	3	CHEMICAL
38091	38092	do	0	None
38092	38093	not	0	None
38093	38094	promote	0	None
38094	38095	dissociation	0	None
38095	38096	of	0	None
38096	38097	(	0	None
38097	38098	125	0	None
38098	38099	)	0	None
38099	38100	I	0	None
38100	38101	-	0	None
38101	38102	ET	0	None
38102	38103	-	0	None
38103	38104	1	0	None
38104	38105	ETB	1	GENE-Y
38105	38106	receptor	0	None
38106	38107	complexes	0	None
38107	38108	.	0	None

38109	38110	Salicylates	3	CHEMICAL
38110	38111	potentiate	0	None
38111	38112	relaxing	0	None
38112	38113	actions	0	None
38113	38114	of	0	None
38114	38115	receptor	0	None
38115	38116	antagonists	0	None
38116	38117	such	0	None
38117	38118	as	0	None
38118	38119	bosentan	3	CHEMICAL
38119	38120	.	0	None

38121	38122	It	0	None
38122	38123	is	0	None
38123	38124	concluded	0	None
38124	38125	that	0	None
38125	38126	salicylates	3	CHEMICAL
38126	38127	are	0	None
38127	38128	allosteric	0	None
38128	38129	inhibitors	0	None
38129	38130	of	0	None
38130	38132	ETA receptors	1	GENE-Y
38132	38133	.	0	None

38134	38135	The	0	None
38135	38136	results	0	None
38136	38137	also	0	None
38137	38138	suggest	0	None
38138	38139	that	0	None
38139	38140	:	0	None
38140	38141	1	0	None
38141	38142	)	0	None
38142	38143	irreversible	0	None
38143	38144	ET	0	None
38144	38145	-	0	None
38145	38146	1	0	None
38146	38147	binding	0	None
38147	38148	probably	0	None
38148	38149	limits	0	None
38149	38150	actions	0	None
38150	38151	of	0	None
38151	38152	receptor	0	None
38152	38153	antagonists	0	None
38153	38154	in	0	None
38154	38155	vivo	0	None
38155	38156	,	0	None
38156	38157	and	0	None
38157	38158	2	0	None
38158	38159	)	0	None
38159	38160	an	0	None
38160	38161	association	0	None
38161	38162	of	0	None
38162	38163	salicylates	3	CHEMICAL
38163	38164	and	0	None
38164	38165	ETA	0	None
38165	38166	receptor	0	None
38166	38167	antagonists	0	None
38167	38168	should	0	None
38168	38169	be	0	None
38169	38170	used	0	None
38170	38171	to	0	None
38171	38172	evaluate	0	None
38172	38173	the	0	None
38173	38174	physiopathological	0	None
38174	38175	role	0	None
38175	38176	of	0	None
38176	38177	ET	0	None
38177	38178	-	0	None
38178	38179	1	0	None
38179	38180	and	0	None
38180	38181	may	0	None
38181	38182	be	0	None
38182	38183	of	0	None
38183	38184	therapeutic	0	None
38184	38185	interest	0	None
38185	38186	in	0	None
38186	38187	the	0	None
38187	38188	treatment	0	None
38188	38189	of	0	None
38189	38190	ischemic	0	None
38190	38191	heart	0	None
38191	38192	disease	0	None
38192	38193	.	0	None

38194	38195	Nitric	0	None
38195	38196	oxide	0	None
38196	38197	,	0	None
38197	38198	but	0	None
38198	38199	not	0	None
38199	38202	vasopressin V2 receptor	1	GENE-Y
38202	38203	-	0	None
38203	38204	mediated	0	None
38204	38205	vasodilation	0	None
38205	38206	,	0	None
38206	38207	modulates	0	None
38207	38208	vasopressin	3	CHEMICAL
38208	38209	-	0	None
38209	38210	induced	0	None
38210	38211	renal	0	None
38211	38212	vasoconstriction	0	None
38212	38213	in	0	None
38213	38214	rats	0	None
38214	38215	.	0	None

38216	38217	The	0	None
38217	38221	renal vascular response to	0	None
38221	38222	vasopressin	3	CHEMICAL
38222	38223	and	0	None
38223	38224	its	0	None
38224	38225	modulation	0	None
38225	38226	were	0	None
38226	38227	evaluated	0	None
38227	38228	in	0	None
38228	38229	vivo	0	None
38229	38230	by	0	None
38230	38231	infusing	0	None
38231	38232	the	0	None
38232	38233	peptide	0	None
38233	38234	directly	0	None
38234	38235	into	0	None
38235	38236	the	0	None
38236	38237	renal	0	None
38237	38238	artery	0	None
38238	38239	of	0	None
38239	38240	anaesthetized	0	None
38240	38241	rats	0	None
38241	38242	.	0	None

38243	38244	The	0	None
38244	38245	intra	0	None
38245	38246	-	0	None
38246	38247	renal	0	None
38247	38248	artery	0	None
38248	38249	(	0	None
38249	38250	i	0	None
38250	38251	.	0	None
38251	38252	r	0	None
38252	38253	.	0	None
38253	38254	a	0	None
38254	38255	)	0	None
38255	38256	infusion	0	None
38256	38257	of	0	None
38257	38258	vasopressin	3	CHEMICAL
38258	38259	induced	0	None
38259	38260	a	0	None
38260	38261	dose	0	None
38261	38262	-	0	None
38262	38263	dependent	0	None
38263	38264	decrease	0	None
38264	38265	in	0	None
38265	38266	renal	0	None
38266	38267	blood	0	None
38267	38268	flow	0	None
38268	38269	.	0	None

38270	38271	Vasoconstriction	0	None
38271	38272	was	0	None
38272	38273	obvious	0	None
38273	38274	at	0	None
38274	38275	a	0	None
38275	38276	dose	0	None
38276	38277	of	0	None
38277	38278	3	0	None
38278	38279	ng	0	None
38279	38280	/	0	None
38280	38281	kg	0	None
38281	38282	per	0	None
38282	38283	min	0	None
38283	38284	and	0	None
38284	38285	reached	0	None
38285	38286	a	0	None
38286	38287	maximum	0	None
38287	38288	at	0	None
38288	38289	100	0	None
38289	38290	ng	0	None
38290	38291	/	0	None
38291	38292	kg	0	None
38292	38293	per	0	None
38293	38294	min	0	None
38294	38295	.	0	None

38296	38297	The	0	None
38297	38298	dose	0	None
38298	38299	required	0	None
38299	38300	for	0	None
38300	38301	a	0	None
38301	38302	half	0	None
38302	38303	-	0	None
38303	38304	maximal	0	None
38304	38305	response	0	None
38305	38306	(	0	None
38306	38307	ED50	0	None
38307	38308	)	0	None
38308	38309	was	0	None
38309	38310	24	0	None
38310	38311	+	0	None
38311	38312	/	0	None
38312	38313	-	0	None
38313	38314	4	0	None
38314	38315	ng	0	None
38315	38316	/	0	None
38316	38317	kg	0	None
38317	38318	per	0	None
38318	38319	min	0	None
38319	38320	(	0	None
38320	38321	mean	0	None
38321	38322	+	0	None
38322	38323	/	0	None
38323	38324	-	0	None
38324	38325	SEM	0	None
38325	38326	,	0	None
38326	38327	n	0	None
38327	38328	=	0	None
38328	38329	8	0	None
38329	38330	)	0	None
38330	38331	,	0	None
38331	38332	corresponding	0	None
38332	38333	to	0	None
38333	38334	an	0	None
38334	38335	estimated	0	None
38335	38336	concentration	0	None
38336	38337	in	0	None
38337	38338	renal	0	None
38338	38339	arterial	0	None
38339	38340	blood	0	None
38340	38341	required	0	None
38341	38342	for	0	None
38342	38343	a	0	None
38343	38344	half	0	None
38344	38345	-	0	None
38345	38346	maximal	0	None
38346	38347	response	0	None
38347	38348	(	0	None
38348	38349	EC50	0	None
38349	38350	)	0	None
38350	38351	of	0	None
38351	38352	1	0	None
38352	38353	.	0	None
38353	38354	9	0	None
38354	38355	+	0	None
38355	38356	/	0	None
38356	38357	-	0	None
38357	38358	0	0	None
38358	38359	.	0	None
38359	38360	6	0	None
38360	38361	nM	0	None
38361	38362	.	0	None

38363	38364	Thiobutabarbitone	0	None
38364	38365	anaesthesia	0	None
38365	38366	markedly	0	None
38366	38367	increased	0	None
38367	38368	plasma	0	None
38368	38369	vasopressin	3	CHEMICAL
38369	38370	concentration	0	None
38370	38371	.	0	None

38372	38373	This	0	None
38373	38374	increase	0	None
38374	38375	was	0	None
38375	38376	prevented	0	None
38376	38377	partially	0	None
38377	38378	by	0	None
38378	38379	hypotonic	0	None
38379	38380	hydration	0	None
38380	38381	of	0	None
38381	38382	the	0	None
38382	38383	rats	0	None
38383	38384	without	0	None
38384	38385	any	0	None
38385	38386	change	0	None
38386	38387	in	0	None
38387	38388	the	0	None
38388	38389	renal	0	None
38389	38390	vascular	0	None
38390	38391	response	0	None
38391	38392	to	0	None
38392	38393	exogenous	0	None
38393	38394	vasopressin	3	CHEMICAL
38394	38395	.	0	None

38396	38397	Vasopressin	0	None
38397	38398	-	0	None
38398	38399	induced	0	None
38399	38400	vasoconstriction	0	None
38400	38401	dose	0	None
38401	38402	/	0	None
38402	38403	response	0	None
38403	38404	curves	0	None
38404	38405	were	0	None
38405	38406	similar	0	None
38406	38407	in	0	None
38407	38408	homozygous	0	None
38408	38409	and	0	None
38409	38410	heterozygous	0	None
38410	38411	Brattleboro	0	None
38411	38412	rats	0	None
38412	38413	.	0	None

38414	38415	Infusion	0	None
38415	38416	of	0	None
38416	38417	desmopressin	3	CHEMICAL
38417	38418	(	0	None
38418	38419	1	0	None
38419	38420	-	0	None
38420	38421	1000	0	None
38421	38422	ng	0	None
38422	38423	/	0	None
38423	38424	kg	0	None
38424	38425	per	0	None
38425	38426	min	0	None
38426	38427	,	0	None
38427	38428	i	0	None
38428	38429	.	0	None
38429	38430	r	0	None
38430	38431	.	0	None
38431	38432	a	0	None
38432	38433	.	0	None
38433	38434	)	0	None
38434	38435	,	0	None
38435	38436	a	0	None
38436	38439	vasopressin V2 receptor	1	GENE-Y
38439	38440	-	0	None
38440	38441	selective	0	None
38441	38442	agonist	0	None
38442	38443	,	0	None
38443	38444	failed	0	None
38444	38445	to	0	None
38445	38446	induce	0	None
38446	38447	renal	0	None
38447	38448	vasodilation	0	None
38448	38449	or	0	None
38449	38450	vasoconstriction	0	None
38450	38451	.	0	None

38452	38453	In	0	None
38453	38454	the	0	None
38454	38455	presence	0	None
38455	38456	of	0	None
38456	38458	SR 49059	3	CHEMICAL
38458	38459	(	0	None
38459	38460	1	0	None
38460	38461	mg	0	None
38461	38462	/	0	None
38462	38463	kg	0	None
38463	38464	i	0	None
38464	38465	.	0	None
38465	38466	v	0	None
38466	38467	.	0	None
38467	38468	)	0	None
38468	38469	,	0	None
38469	38470	a	0	None
38470	38472	vasopressin V1A	1	GENE-Y
38472	38473	receptor	0	None
38473	38474	antagonist	0	None
38474	38475	that	0	None
38475	38476	completely	0	None
38476	38477	abolished	0	None
38477	38478	the	0	None
38478	38479	vasopressin	3	CHEMICAL
38479	38480	-	0	None
38480	38481	induced	0	None
38481	38482	renal	0	None
38482	38483	vasoconstriction	0	None
38483	38484	,	0	None
38484	38485	desmopressin	3	CHEMICAL
38485	38486	again	0	None
38486	38487	failed	0	None
38487	38488	to	0	None
38488	38489	induce	0	None
38489	38490	vasodilation	0	None
38490	38491	.	0	None

38492	38493	Inhibition	0	None
38493	38494	of	0	None
38494	38497	nitric oxide synthase	1	GENE-Y
38497	38498	by	0	None
38498	38499	N	0	None
38499	38500	(	0	None
38500	38501	omega	0	None
38501	38502	)	0	None
38502	38503	-	0	None
38503	38504	nitro	3	CHEMICAL
38504	38505	-	0	None
38505	38506	L	0	None
38506	38507	-	0	None
38507	38508	arginine	3	CHEMICAL
38508	38509	(	0	None
38509	38510	L	0	None
38510	38511	-	0	None
38511	38512	NNA	0	None
38512	38513	,	0	None
38513	38514	100	0	None
38514	38515	microg	0	None
38515	38516	/	0	None
38516	38517	kg	0	None
38517	38518	for	0	None
38518	38519	10	0	None
38519	38520	min	0	None
38520	38521	and	0	None
38521	38522	7	0	None
38522	38523	.	0	None
38523	38524	5	0	None
38524	38525	microg	0	None
38525	38526	/	0	None
38526	38527	kg	0	None
38527	38528	per	0	None
38528	38529	min	0	None
38529	38530	,	0	None
38530	38531	i	0	None
38531	38532	.	0	None
38532	38533	r	0	None
38533	38534	.	0	None
38534	38535	a	0	None
38535	38536	.	0	None
38536	38537	)	0	None
38537	38538	enhanced	0	None
38538	38539	vasopressin	3	CHEMICAL
38539	38540	-	0	None
38540	38541	induced	0	None
38541	38542	renal	0	None
38542	38543	vasoconstriction	0	None
38543	38544	(	0	None
38544	38545	EC50	0	None
38545	38546	0	0	None
38546	38547	.	0	None
38547	38548	6	0	None
38548	38549	+	0	None
38549	38550	/	0	None
38550	38551	-	0	None
38551	38552	0	0	None
38552	38553	.	0	None
38553	38554	1	0	None
38554	38555	nM	0	None
38555	38556	,	0	None
38556	38557	P	0	None
38557	38558	<	0	None
38558	38559	0	0	None
38559	38560	.	0	None
38560	38561	05	0	None
38561	38562	)	0	None
38562	38563	.	0	None

38564	38565	In	0	None
38565	38566	contrast	0	None
38566	38567	,	0	None
38567	38568	cyclooxygenase	2	GENE-N
38568	38569	blockade	0	None
38569	38570	by	0	None
38570	38571	indomethacin	3	CHEMICAL
38571	38572	(	0	None
38572	38573	5	0	None
38573	38574	mg	0	None
38574	38575	/	0	None
38575	38576	kg	0	None
38576	38577	,	0	None
38577	38578	i	0	None
38578	38579	.	0	None
38579	38580	v	0	None
38580	38581	.	0	None
38581	38582	)	0	None
38582	38583	neither	0	None
38583	38584	modified	0	None
38584	38585	the	0	None
38585	38586	vasopressin	3	CHEMICAL
38586	38587	-	0	None
38587	38588	induced	0	None
38588	38589	decrease	0	None
38589	38590	in	0	None
38590	38591	renal	0	None
38591	38592	blood	0	None
38592	38593	flow	0	None
38593	38594	nor	0	None
38594	38595	altered	0	None
38595	38596	the	0	None
38596	38597	potentiation	0	None
38597	38598	of	0	None
38598	38599	vasoconstriction	0	None
38599	38600	by	0	None
38600	38601	L	0	None
38601	38602	-	0	None
38602	38603	NNA	0	None
38603	38604	.	0	None

38605	38606	These	0	None
38606	38607	results	0	None
38607	38608	show	0	None
38608	38609	that	0	None
38609	38610	the	0	None
38610	38611	constrictor	0	None
38611	38612	response	0	None
38612	38613	of	0	None
38613	38614	the	0	None
38614	38615	rat	0	None
38615	38616	renal	0	None
38616	38617	vascular	0	None
38617	38618	bed	0	None
38618	38619	in	0	None
38619	38620	vivo	0	None
38620	38621	is	0	None
38621	38622	observed	0	None
38622	38623	only	0	None
38623	38624	with	0	None
38624	38625	high	0	None
38625	38626	local	0	None
38626	38627	concentrations	0	None
38627	38628	of	0	None
38628	38629	vasopressin	3	CHEMICAL
38629	38630	.	0	None

38631	38632	This	0	None
38632	38633	hyporeactivity	0	None
38633	38634	in	0	None
38634	38635	vivo	0	None
38635	38636	was	0	None
38636	38637	not	0	None
38637	38638	explained	0	None
38638	38639	by	0	None
38639	38640	an	0	None
38640	38641	anaesthesia	0	None
38641	38642	-	0	None
38642	38643	elicited	0	None
38643	38644	increase	0	None
38644	38645	in	0	None
38645	38646	endogenous	0	None
38646	38647	vasopressin	3	CHEMICAL
38647	38648	,	0	None
38648	38649	nor	0	None
38649	38650	by	0	None
38650	38651	a	0	None
38651	38652	modulatory	0	None
38652	38653	effect	0	None
38653	38654	linked	0	None
38654	38655	to	0	None
38655	38657	V2 receptor	2	GENE-N
38657	38658	activation	0	None
38658	38659	or	0	None
38659	38660	prostanoid	3	CHEMICAL
38660	38661	release	0	None
38661	38662	.	0	None

38663	38664	In	0	None
38664	38665	contrast	0	None
38665	38666	,	0	None
38666	38667	NO	0	None
38667	38668	release	0	None
38668	38669	contributed	0	None
38669	38670	to	0	None
38670	38671	the	0	None
38671	38672	attenuation	0	None
38672	38673	of	0	None
38673	38674	vasopressin	3	CHEMICAL
38674	38675	-	0	None
38675	38676	induced	0	None
38676	38677	renal	0	None
38677	38678	vasoconstriction	0	None
38678	38679	.	0	None

38680	38681	N	0	None
38681	38682	-	0	None
38682	38683	methyl	3	CHEMICAL
38683	38684	-	0	None
38684	38685	D	0	None
38685	38686	-	0	None
38686	38687	aspartate	3	CHEMICAL
38687	38688	receptor	0	None
38688	38689	channel	0	None
38689	38690	block	0	None
38690	38691	by	0	None
38691	38692	meperidine	3	CHEMICAL
38692	38693	is	0	None
38693	38694	dependent	0	None
38694	38695	on	0	None
38695	38697	extracellular pH	0	None
38697	38698	.	0	None

38699	38700	UNLABELLED	0	None
38700	38701	:	0	None
38701	38702	Large	0	None
38702	38703	concentrations	0	None
38703	38704	of	0	None
38704	38705	meperidine	3	CHEMICAL
38705	38706	inhibit	0	None
38706	38707	N	0	None
38707	38708	-	0	None
38708	38709	methyl	3	CHEMICAL
38709	38710	-	0	None
38710	38711	D	0	None
38711	38712	-	0	None
38712	38713	aspartate	3	CHEMICAL
38713	38714	-	0	None
38714	38715	(	0	None
38715	38716	NMDA	3	CHEMICAL
38716	38717	)	0	None
38717	38718	receptor	0	None
38718	38719	channels	0	None
38719	38720	by	0	None
38720	38721	channel	0	None
38721	38722	block	0	None
38722	38723	mechanisms	0	None
38723	38724	.	0	None

38725	38726	Extracellular	0	None
38726	38727	pH	0	None
38727	38728	regulates	0	None
38728	38729	the	0	None
38729	38730	activity	0	None
38730	38731	and	0	None
38731	38732	drug	0	None
38732	38733	sensitivity	0	None
38733	38734	of	0	None
38734	38735	NMDA	3	CHEMICAL
38735	38736	-	0	None
38736	38737	receptor	0	None
38737	38738	channels	0	None
38738	38739	.	0	None

38740	38741	We	0	None
38741	38742	examined	0	None
38742	38743	the	0	None
38743	38744	influence	0	None
38744	38745	of	0	None
38745	38746	extracellular	3	CHEMICAL
38746	38747	pH	0	None
38747	38748	on	0	None
38748	38749	sensitivity	0	None
38749	38750	to	0	None
38750	38751	meperidine	3	CHEMICAL
38751	38752	of	0	None
38752	38753	epsilon	2	GENE-N
38753	38754	/	0	None
38754	38755	zeta	0	None
38755	38756	heteromeric	0	None
38756	38757	NMDA	3	CHEMICAL
38757	38758	-	0	None
38758	38759	receptor	0	None
38759	38760	channels	0	None
38760	38761	expressed	0	None
38761	38762	in	0	None
38762	38763	Xenopus	0	None
38763	38764	oocytes	0	None
38764	38765	.	0	None

38766	38767	Inhibition	0	None
38767	38768	of	0	None
38768	38769	epsilon1	0	None
38769	38770	/	0	None
38770	38771	zeta1	0	None
38771	38772	,	0	None
38772	38773	epsilon2	0	None
38773	38774	/	0	None
38774	38775	zeta1	0	None
38775	38776	,	0	None
38776	38777	epsilon3	0	None
38777	38778	/	0	None
38778	38779	zeta1	0	None
38779	38780	,	0	None
38780	38781	and	0	None
38781	38782	epsilon4	0	None
38782	38783	/	0	None
38783	38784	zeta1	0	None
38784	38785	channels	0	None
38785	38786	by	0	None
38786	38787	meperidine	3	CHEMICAL
38787	38788	was	0	None
38788	38789	dependent	0	None
38789	38790	on	0	None
38790	38791	pH	0	None
38791	38792	,	0	None
38792	38793	with	0	None
38793	38794	more	0	None
38794	38795	inhibition	0	None
38795	38796	at	0	None
38796	38797	acidic	0	None
38797	38798	pH	0	None
38798	38799	and	0	None
38799	38800	less	0	None
38800	38801	inhibition	0	None
38801	38802	at	0	None
38802	38803	alkaline	0	None
38803	38804	pH	0	None
38804	38805	.	0	None

38806	38807	The	0	None
38807	38808	degree	0	None
38808	38809	of	0	None
38809	38810	voltage	0	None
38810	38811	-	0	None
38811	38812	dependence	0	None
38812	38813	of	0	None
38813	38814	meperidine	3	CHEMICAL
38814	38815	block	0	None
38815	38816	was	0	None
38816	38817	only	0	None
38817	38818	slightly	0	None
38818	38819	affected	0	None
38819	38820	by	0	None
38820	38821	changes	0	None
38821	38822	in	0	None
38822	38823	pH	0	None
38823	38824	,	0	None
38824	38825	whereas	0	None
38825	38826	affinity	0	None
38826	38827	for	0	None
38827	38828	meperidine	3	CHEMICAL
38828	38829	was	0	None
38829	38830	greatly	0	None
38830	38831	reduced	0	None
38831	38832	at	0	None
38832	38833	alkaline	0	None
38833	38834	pH	0	None
38834	38835	.	0	None

38836	38837	Furthermore	0	None
38837	38838	,	0	None
38838	38839	interaction	0	None
38839	38840	of	0	None
38840	38841	meperidine	3	CHEMICAL
38841	38842	with	0	None
38842	38843	Mg	0	None
38843	38844	(	0	None
38844	38845	2	0	None
38845	38846	+	0	None
38846	38847	)	0	None
38847	38848	block	0	None
38848	38849	was	0	None
38849	38850	reduced	0	None
38850	38851	at	0	None
38851	38852	alkaline	0	None
38852	38853	pH	0	None
38853	38854	.	0	None

38855	38856	Because	0	None
38856	38857	the	0	None
38857	38858	percentage	0	None
38858	38859	of	0	None
38859	38860	the	0	None
38860	38861	protonated	0	None
38861	38862	form	0	None
38862	38863	of	0	None
38863	38864	meperidine	3	CHEMICAL
38864	38865	is	0	None
38865	38866	only	0	None
38866	38867	slightly	0	None
38867	38868	affected	0	None
38868	38869	by	0	None
38869	38870	pH	0	None
38870	38871	,	0	None
38871	38872	changes	0	None
38872	38873	in	0	None
38873	38874	properties	0	None
38874	38875	of	0	None
38875	38876	the	0	None
38876	38877	meperidine	3	CHEMICAL
38877	38878	binding	0	None
38878	38879	site	0	None
38879	38880	may	0	None
38880	38881	be	0	None
38881	38882	involved	0	None
38882	38883	in	0	None
38883	38884	mechanisms	0	None
38884	38885	of	0	None
38885	38886	alteration	0	None
38886	38887	of	0	None
38887	38888	meperidine	3	CHEMICAL
38888	38889	potency	0	None
38889	38890	by	0	None
38890	38891	pH	0	None
38891	38892	.	0	None

38893	38894	IMPLICATIONS	0	None
38894	38895	:	0	None
38895	38896	At	0	None
38896	38897	acidic	0	None
38897	38898	pH	0	None
38898	38899	the	0	None
38899	38900	potency	0	None
38900	38901	of	0	None
38901	38902	meperidine	3	CHEMICAL
38902	38903	for	0	None
38903	38904	N	0	None
38904	38905	-	0	None
38905	38906	methyl	3	CHEMICAL
38906	38907	-	0	None
38907	38908	D	0	None
38908	38909	-	0	None
38909	38910	aspartate	3	CHEMICAL
38910	38911	-	0	None
38911	38912	receptor	0	None
38912	38913	channels	0	None
38913	38914	was	0	None
38914	38915	increased	0	None
38915	38916	.	0	None

38917	38918	Any	0	None
38918	38919	antinociceptive	0	None
38919	38920	and	0	None
38920	38921	neuroprotective	0	None
38921	38922	benefit	0	None
38922	38923	from	0	None
38923	38924	the	0	None
38924	38925	N	0	None
38925	38926	-	0	None
38926	38927	methyl	3	CHEMICAL
38927	38928	-	0	None
38928	38929	D	0	None
38929	38930	-	0	None
38930	38931	aspartate	3	CHEMICAL
38931	38932	-	0	None
38932	38933	receptor	0	None
38933	38934	antagonist	0	None
38934	38935	property	0	None
38935	38936	of	0	None
38936	38937	meperidine	3	CHEMICAL
38937	38938	may	0	None
38938	38939	be	0	None
38939	38940	pH	0	None
38940	38941	dependent	0	None
38941	38942	.	0	None

38943	38944	Statins	0	None
38944	38945	:	0	None
38945	38946	effective	0	None
38946	38947	antiatherosclerotic	0	None
38947	38948	therapy	0	None
38948	38949	.	0	None

38950	38951	BACKGROUND	0	None
38951	38952	:	0	None
38952	38953	Statins	0	None
38953	38954	are	0	None
38954	38955	the	0	None
38955	38956	most	0	None
38956	38957	effective	0	None
38957	38958	agents	0	None
38958	38959	currently	0	None
38959	38960	available	0	None
38960	38961	for	0	None
38961	38962	lowering	0	None
38962	38963	plasma	0	None
38963	38964	levels	0	None
38964	38965	of	0	None
38965	38966	low	0	None
38966	38967	-	0	None
38967	38968	density	0	None
38968	38970	lipoprotein cholesterol	3	CHEMICAL
38970	38971	(	0	None
38971	38972	LDL	3	CHEMICAL
38972	38973	-	0	None
38973	38974	C	0	None
38974	38975	)	0	None
38975	38976	and	0	None
38976	38977	are	0	None
38977	38978	the	0	None
38978	38979	mainstay	0	None
38979	38980	of	0	None
38980	38981	therapy	0	None
38981	38982	for	0	None
38982	38983	hyperlipidemia	0	None
38983	38984	.	0	None

38985	38986	The	0	None
38986	38987	statins	0	None
38987	38988	are	0	None
38988	38989	highly	0	None
38989	38990	liver	0	None
38990	38991	-	0	None
38991	38992	selective	0	None
38992	38993	,	0	None
38993	38994	inhibiting	0	None
38994	38995	3	0	None
38995	38996	-	0	None
38996	38997	hydroxy	3	CHEMICAL
38997	38998	-	0	None
38998	38999	3	0	None
38999	39000	-	0	None
39000	39001	methylglutaryl	0	None
39001	39002	-	0	None
39002	39003	coenzyme	0	None
39003	39004	A	0	None
39004	39005	(	0	None
39005	39006	HMG	0	None
39006	39007	-	0	None
39007	39008	CoA	3	CHEMICAL
39008	39009	)	0	None
39009	39010	reductase	2	GENE-N
39010	39011	,	0	None
39011	39012	a	0	None
39012	39013	key	0	None
39013	39014	enzyme	0	None
39014	39015	in	0	None
39015	39016	the	0	None
39016	39017	synthesis	0	None
39017	39018	of	0	None
39018	39019	cholesterol	0	None
39019	39020	.	0	None

39021	39022	Several	0	None
39022	39023	large	0	None
39023	39024	,	0	None
39024	39025	controlled	0	None
39025	39026	clinical	0	None
39026	39027	trials	0	None
39027	39028	have	0	None
39028	39029	confirmed	0	None
39029	39030	significant	0	None
39030	39031	reductions	0	None
39031	39032	in	0	None
39032	39033	rates	0	None
39033	39034	of	0	None
39034	39035	coronary	0	None
39035	39036	heart	0	None
39036	39037	disease	0	None
39037	39038	morbidity	0	None
39038	39039	and	0	None
39039	39040	death	0	None
39040	39041	with	0	None
39041	39042	long	0	None
39042	39043	-	0	None
39043	39044	term	0	None
39044	39045	statin	0	None
39045	39046	therapy	0	None
39046	39047	in	0	None
39047	39048	patients	0	None
39048	39049	with	0	None
39049	39050	mild	0	None
39050	39051	to	0	None
39051	39052	severe	0	None
39052	39053	hypercholesterolemia	0	None
39053	39054	.	0	None

39055	39056	METHODS	0	None
39056	39057	AND	0	None
39057	39058	RESULTS	0	None
39058	39059	:	0	None
39059	39060	This	0	None
39060	39061	review	0	None
39061	39062	article	0	None
39062	39063	is	0	None
39063	39064	based	0	None
39064	39065	on	0	None
39065	39066	a	0	None
39066	39067	literature	0	None
39067	39068	search	0	None
39068	39069	of	0	None
39069	39070	more	0	None
39070	39071	than	0	None
39071	39072	60	0	None
39072	39073	relevant	0	None
39073	39074	articles	0	None
39074	39075	from	0	None
39075	39076	peer	0	None
39076	39077	-	0	None
39077	39078	reviewed	0	None
39078	39079	journals	0	None
39079	39080	.	0	None

39081	39082	Search	0	None
39082	39083	engines	0	None
39083	39084	included	0	None
39084	39085	Medline	0	None
39085	39086	and	0	None
39086	39087	Embase	0	None
39087	39088	.	0	None

39089	39090	In	0	None
39090	39091	surveying	0	None
39091	39092	clinical	0	None
39092	39093	and	0	None
39093	39094	angiographic	0	None
39094	39095	evidence	0	None
39095	39096	,	0	None
39096	39097	we	0	None
39097	39098	found	0	None
39098	39099	that	0	None
39099	39100	statins	0	None
39100	39101	appear	0	None
39101	39102	to	0	None
39102	39103	reduce	0	None
39103	39104	the	0	None
39104	39105	incidence	0	None
39105	39106	of	0	None
39106	39107	coronary	0	None
39107	39108	events	0	None
39108	39109	by	0	None
39109	39110	slowing	0	None
39110	39111	the	0	None
39111	39112	progression	0	None
39112	39113	of	0	None
39113	39114	atherosclerosis	0	None
39114	39115	and	0	None
39115	39116	preventing	0	None
39116	39117	atheromatous	0	None
39117	39118	lesion	0	None
39118	39119	formation	0	None
39119	39120	.	0	None

39121	39122	We	0	None
39122	39123	found	0	None
39123	39124	that	0	None
39124	39125	the	0	None
39125	39126	6	0	None
39126	39127	statins	0	None
39127	39128	currently	0	None
39128	39129	marketed	0	None
39129	39130	-	0	None
39130	39131	atorvastatin	3	CHEMICAL
39131	39132	,	0	None
39132	39133	cerivastatin	3	CHEMICAL
39133	39134	,	0	None
39134	39135	fluvastatin	3	CHEMICAL
39135	39136	,	0	None
39136	39137	lovastatin	3	CHEMICAL
39137	39138	,	0	None
39138	39139	pravastatin	0	None
39139	39140	,	0	None
39140	39141	and	0	None
39141	39142	simvastatin	3	CHEMICAL
39142	39143	-	0	None
39143	39144	differ	0	None
39144	39145	in	0	None
39145	39146	their	0	None
39146	39147	inhibitory	0	None
39147	39148	action	0	None
39148	39149	on	0	None
39149	39150	the	0	None
39150	39151	HMG	0	None
39151	39152	-	0	None
39152	39153	CoA	3	CHEMICAL
39153	39154	reductase	2	GENE-N
39154	39155	enzyme	0	None
39155	39156	.	0	None

39157	39158	CONCLUSIONS	0	None
39158	39159	:	0	None
39159	39160	The	0	None
39160	39161	use	0	None
39161	39162	of	0	None
39162	39163	more	0	None
39163	39164	potent	0	None
39164	39165	statins	0	None
39165	39166	such	0	None
39166	39167	as	0	None
39167	39168	atorvastatin	3	CHEMICAL
39168	39169	and	0	None
39169	39170	simvastatin	3	CHEMICAL
39170	39171	affords	0	None
39171	39172	greater	0	None
39172	39173	lowering	0	None
39173	39174	of	0	None
39174	39175	LDL	3	CHEMICAL
39175	39176	-	0	None
39176	39177	C	0	None
39177	39178	and	0	None
39178	39179	triglyceride	3	CHEMICAL
39179	39180	levels	0	None
39180	39181	,	0	None
39181	39182	allowing	0	None
39182	39183	more	0	None
39183	39184	patients	0	None
39184	39185	to	0	None
39185	39186	achieve	0	None
39186	39187	target	0	None
39187	39188	goals	0	None
39188	39189	.	0	None

39190	39191	The	0	None
39191	39192	question	0	None
39192	39193	of	0	None
39193	39194	how	0	None
39194	39195	low	0	None
39195	39196	LDL	3	CHEMICAL
39196	39197	-	0	None
39197	39198	C	0	None
39198	39199	levels	0	None
39199	39200	should	0	None
39200	39201	be	0	None
39201	39202	lowered	0	None
39202	39203	will	0	None
39203	39204	be	0	None
39204	39205	answered	0	None
39205	39206	by	0	None
39206	39207	ongoing	0	None
39207	39208	clinical	0	None
39208	39209	trials	0	None
39209	39210	.	0	None

39211	39212	A	0	None
39212	39213	unique	0	None
39213	39214	cytosolic	0	None
39214	39215	activity	0	None
39215	39216	related	0	None
39216	39217	but	0	None
39217	39218	distinct	0	None
39218	39219	from	0	None
39219	39220	NQO1	0	None
39220	39221	catalyses	0	None
39221	39222	metabolic	0	None
39222	39223	activation	0	None
39223	39224	of	0	None
39224	39225	mitomycin	0	None
39225	39226	C	0	None
39226	39227	.	0	None

39228	39229	Mitomycin	0	None
39229	39230	C	0	None
39230	39231	(	0	None
39231	39232	MMC	3	CHEMICAL
39232	39233	)	0	None
39233	39234	is	0	None
39234	39235	a	0	None
39235	39236	prototype	0	None
39236	39237	bioreductive	0	None
39237	39238	drug	0	None
39238	39239	employed	0	None
39239	39240	to	0	None
39240	39241	treat	0	None
39241	39242	a	0	None
39242	39243	variety	0	None
39243	39244	of	0	None
39244	39245	cancers	0	None
39245	39246	including	0	None
39246	39247	head	0	None
39247	39248	and	0	None
39248	39249	neck	0	None
39249	39250	cancer	0	None
39250	39251	.	0	None

39252	39253	Among	0	None
39253	39254	the	0	None
39254	39255	various	0	None
39255	39256	enzymes	0	None
39256	39257	,	0	None
39257	39258	dicoumarol	0	None
39258	39259	inhibitable	0	None
39259	39260	cytosolic	0	None
39260	39261	NAD	3	CHEMICAL
39261	39262	(	0	None
39262	39263	P	0	None
39263	39264	)	0	None
39264	39265	H	0	None
39265	39266	:	0	None
39266	39267	quinone	3	CHEMICAL
39267	39268	oxidoreductase1	0	None
39268	39269	(	0	None
39269	39270	NQO1	0	None
39270	39271	)	0	None
39271	39272	was	0	None
39272	39273	shown	0	None
39273	39274	to	0	None
39274	39275	catalyse	0	None
39275	39276	bioreductive	0	None
39276	39277	activation	0	None
39277	39278	of	0	None
39278	39279	MMC	3	CHEMICAL
39279	39280	leading	0	None
39280	39281	to	0	None
39281	39282	cross	0	None
39282	39283	-	0	None
39283	39284	linking	0	None
39284	39285	of	0	None
39285	39286	the	0	None
39286	39287	DNA	3	CHEMICAL
39287	39288	and	0	None
39288	39289	cytotoxicity	0	None
39289	39290	.	0	None

39291	39292	However	0	None
39292	39293	,	0	None
39293	39294	the	0	None
39294	39295	role	0	None
39295	39296	of	0	None
39296	39297	NQO1	0	None
39297	39298	in	0	None
39298	39299	metabolic	0	None
39299	39300	activation	0	None
39300	39301	of	0	None
39301	39302	MMC	3	CHEMICAL
39302	39303	has	0	None
39303	39304	been	0	None
39304	39305	disputed	0	None
39305	39306	.	0	None

39307	39308	In	0	None
39308	39309	this	0	None
39309	39310	report	0	None
39310	39311	,	0	None
39311	39312	we	0	None
39312	39313	present	0	None
39313	39314	cellular	0	None
39314	39315	and	0	None
39315	39316	animal	0	None
39316	39317	models	0	None
39317	39318	to	0	None
39318	39319	demonstrate	0	None
39319	39320	that	0	None
39320	39321	NQO1	0	None
39321	39322	may	0	None
39322	39323	play	0	None
39323	39324	only	0	None
39324	39325	a	0	None
39325	39326	minor	0	None
39326	39327	role	0	None
39327	39328	in	0	None
39328	39329	metabolic	0	None
39329	39330	activation	0	None
39330	39331	of	0	None
39331	39332	MMC	3	CHEMICAL
39332	39333	.	0	None

39334	39335	We	0	None
39335	39336	further	0	None
39336	39337	demonstrate	0	None
39337	39338	that	0	None
39338	39339	bioreductive	0	None
39339	39340	activation	0	None
39340	39341	of	0	None
39341	39342	MMC	3	CHEMICAL
39342	39343	is	0	None
39343	39344	catalysed	0	None
39344	39345	by	0	None
39345	39346	a	0	None
39346	39347	unique	0	None
39347	39348	cytosolic	0	None
39348	39349	activity	0	None
39349	39350	which	0	None
39350	39351	is	0	None
39351	39352	related	0	None
39352	39353	but	0	None
39353	39354	distinct	0	None
39354	39355	from	0	None
39355	39356	NQO1	0	None
39356	39357	.	0	None

39358	39359	Chinese	0	None
39359	39360	hamster	0	None
39360	39361	ovary	0	None
39361	39362	(	0	None
39362	39363	CHO	3	CHEMICAL
39363	39364	)	0	None
39364	39365	cells	0	None
39365	39366	were	0	None
39366	39367	developed	0	None
39367	39368	that	0	None
39368	39369	permanently	0	None
39369	39370	express	0	None
39370	39371	higher	0	None
39371	39372	levels	0	None
39372	39373	of	0	None
39373	39374	cDNA	0	None
39374	39375	-	0	None
39375	39376	derived	0	None
39376	39377	NQO1	0	None
39377	39378	.	0	None

39379	39380	These	0	None
39380	39381	cells	0	None
39381	39382	showed	0	None
39382	39383	significantly	0	None
39383	39384	increased	0	None
39384	39385	protection	0	None
39385	39386	against	0	None
39386	39387	menadione	0	None
39387	39388	toxicity	0	None
39388	39389	.	0	None

39390	39391	However	0	None
39391	39392	,	0	None
39392	39393	they	0	None
39393	39394	failed	0	None
39394	39395	to	0	None
39395	39396	demonstrate	0	None
39396	39397	higher	0	None
39397	39398	cytotoxicity	0	None
39398	39399	due	0	None
39399	39400	to	0	None
39400	39401	exposure	0	None
39401	39402	to	0	None
39402	39403	MMC	3	CHEMICAL
39403	39404	under	0	None
39404	39405	oxygen	0	None
39405	39406	(	0	None
39406	39407	normal	0	None
39407	39408	air	0	None
39408	39409	)	0	None
39409	39410	or	0	None
39410	39411	hypoxia	0	None
39411	39412	,	0	None
39412	39413	as	0	None
39413	39414	compared	0	None
39414	39415	to	0	None
39415	39416	the	0	None
39416	39417	wild	0	None
39417	39418	-	0	None
39418	39419	type	0	None
39419	39420	control	0	None
39420	39421	CHO	3	CHEMICAL
39421	39422	cells	0	None
39422	39423	.	0	None

39424	39425	Disruption	0	None
39425	39426	of	0	None
39426	39427	the	0	None
39427	39428	NQO1	0	None
39428	39429	gene	0	None
39429	39430	by	0	None
39430	39431	homologous	0	None
39431	39432	recombination	0	None
39432	39433	generated	0	None
39433	39434	NQO1	0	None
39434	39435	-	0	None
39435	39436	/	0	None
39436	39437	-	0	None
39437	39438	mice	0	None
39438	39439	that	0	None
39439	39440	do	0	None
39440	39441	not	0	None
39441	39442	express	0	None
39442	39443	the	0	None
39443	39444	NQO1	0	None
39444	39445	gene	0	None
39445	39446	resulting	0	None
39446	39447	in	0	None
39447	39448	the	0	None
39448	39449	loss	0	None
39449	39450	of	0	None
39450	39451	NQO1	0	None
39451	39452	protein	0	None
39452	39453	and	0	None
39453	39454	activity	0	None
39454	39455	.	0	None

39456	39457	The	0	None
39457	39458	cytosolic	0	None
39458	39459	fractions	0	None
39459	39460	from	0	None
39460	39461	liver	0	None
39461	39462	and	0	None
39462	39463	colon	0	None
39463	39464	tissues	0	None
39464	39465	of	0	None
39465	39466	NQO1	0	None
39466	39467	-	0	None
39467	39468	/	0	None
39468	39469	-	0	None
39469	39470	mice	0	None
39470	39471	showed	0	None
39471	39472	similar	0	None
39472	39473	amounts	0	None
39473	39474	of	0	None
39474	39475	DNA	3	CHEMICAL
39475	39476	cross	0	None
39476	39477	-	0	None
39477	39478	linking	0	None
39478	39479	upon	0	None
39479	39480	exposure	0	None
39480	39481	to	0	None
39481	39482	MMC	3	CHEMICAL
39482	39483	,	0	None
39483	39484	as	0	None
39484	39485	observed	0	None
39485	39486	in	0	None
39486	39487	NQO1	0	None
39487	39488	+	0	None
39488	39489	/	0	None
39489	39490	+	0	None
39490	39491	mice	0	None
39491	39492	.	0	None

39493	39494	The	0	None
39494	39495	unique	0	None
39495	39496	cytosolic	0	None
39496	39497	activity	0	None
39497	39498	that	0	None
39498	39499	activated	0	None
39499	39500	MMC	3	CHEMICAL
39500	39501	in	0	None
39501	39502	cytosolic	0	None
39502	39503	fractions	0	None
39503	39504	of	0	None
39504	39505	liver	0	None
39505	39506	and	0	None
39506	39507	colon	0	None
39507	39508	tissues	0	None
39508	39509	of	0	None
39509	39510	NQO1	0	None
39510	39511	-	0	None
39511	39512	/	0	None
39512	39513	-	0	None
39513	39514	mice	0	None
39514	39515	was	0	None
39515	39516	designated	0	None
39516	39517	as	0	None
39517	39518	cytosolic	0	None
39518	39520	MMC reductase	2	GENE-N
39520	39521	.	0	None

39522	39523	This	0	None
39523	39524	activity	0	None
39524	39525	,	0	None
39525	39526	like	0	None
39526	39527	NQO1	0	None
39527	39528	,	0	None
39528	39529	was	0	None
39529	39530	inhibited	0	None
39530	39531	by	0	None
39531	39532	dicoumarol	0	None
39532	39533	and	0	None
39533	39534	immunologically	0	None
39534	39535	related	0	None
39535	39536	to	0	None
39536	39537	NQO1	0	None
39537	39538	.	0	None

39539	39540	High	0	None
39540	39541	affinity	0	None
39541	39542	blockade	0	None
39542	39543	of	0	None
39543	39544	the	0	None
39544	39545	HERG	0	None
39545	39546	cardiac	0	None
39546	39547	K	0	None
39547	39548	(	0	None
39548	39549	+	0	None
39549	39550	)	0	None
39550	39551	channel	0	None
39551	39552	by	0	None
39552	39553	the	0	None
39553	39554	neuroleptic	0	None
39554	39555	pimozide	3	CHEMICAL
39555	39556	.	0	None

39557	39558	Pimozide	3	CHEMICAL
39558	39559	is	0	None
39559	39560	an	0	None
39560	39561	antipsychotic	0	None
39561	39562	agent	0	None
39562	39563	also	0	None
39563	39564	used	0	None
39564	39565	to	0	None
39565	39566	treat	0	None
39566	39567	facial	0	None
39567	39568	tics	0	None
39568	39569	.	0	None

39570	39571	Pimozide	3	CHEMICAL
39571	39572	can	0	None
39572	39573	cause	0	None
39573	39574	acquired	0	None
39574	39575	long	0	None
39575	39576	QT	0	None
39576	39577	syndrome	0	None
39577	39578	and	0	None
39578	39579	ventricular	0	None
39579	39580	arrhythmias	0	None
39580	39581	.	0	None

39582	39583	To	0	None
39583	39584	elucidate	0	None
39584	39585	the	0	None
39585	39586	mechanism	0	None
39586	39587	behind	0	None
39587	39588	these	0	None
39588	39589	clinical	0	None
39589	39590	findings	0	None
39590	39591	,	0	None
39591	39592	we	0	None
39592	39593	examined	0	None
39593	39594	the	0	None
39594	39595	effects	0	None
39595	39596	of	0	None
39596	39597	pimozide	3	CHEMICAL
39597	39598	on	0	None
39598	39599	the	0	None
39599	39600	cloned	0	None
39600	39601	human	0	None
39601	39602	cardiac	0	None
39602	39603	K	0	None
39603	39604	(	0	None
39604	39605	+	0	None
39605	39606	)	0	None
39606	39607	channels	0	None
39607	39608	HERG	0	None
39608	39609	(	0	None
39609	39611	human ether	3	CHEMICAL
39611	39612	-	0	None
39612	39613	a	0	None
39613	39614	-	0	None
39614	39615	go	0	None
39615	39616	-	0	None
39616	39617	go	0	None
39617	39618	-	0	None
39618	39619	related	0	None
39619	39620	gene	0	None
39620	39621	;	0	None
39621	39622	rapid	0	None
39622	39623	component	0	None
39623	39624	of	0	None
39624	39625	delayed	0	None
39625	39626	rectifier	0	None
39626	39627	)	0	None
39627	39628	,	0	None
39628	39629	Kv1	0	None
39629	39630	.	0	None
39630	39631	5	0	None
39631	39632	(	0	None
39632	39633	ultra	0	None
39633	39634	-	0	None
39634	39635	rapid	0	None
39635	39636	delayed	0	None
39636	39637	rectifier	0	None
39637	39638	)	0	None
39638	39639	and	0	None
39639	39640	KvLQT1	0	None
39640	39641	/	0	None
39641	39642	minK	0	None
39642	39643	(	0	None
39643	39644	slow	0	None
39644	39645	component	0	None
39645	39646	of	0	None
39646	39647	delayed	0	None
39647	39648	rectifier	0	None
39648	39649	)	0	None
39649	39650	.	0	None

39651	39652	Using	0	None
39652	39653	patch	0	None
39653	39654	clamp	0	None
39654	39655	electrophysiology	0	None
39655	39656	,	0	None
39656	39657	we	0	None
39657	39658	found	0	None
39658	39659	that	0	None
39659	39660	pimozide	3	CHEMICAL
39660	39661	was	0	None
39661	39662	a	0	None
39662	39663	potent	0	None
39663	39664	inhibitor	0	None
39664	39665	of	0	None
39665	39666	HERG	1	GENE-Y
39666	39667	displaying	0	None
39667	39668	an	0	None
39668	39669	IC	0	None
39669	39670	(	0	None
39670	39671	50	0	None
39671	39672	)	0	None
39672	39673	value	0	None
39673	39674	of	0	None
39674	39675	18	0	None
39675	39676	nM	0	None
39676	39677	.	0	None

39678	39679	In	0	None
39679	39680	contrast	0	None
39680	39681	,	0	None
39681	39682	pimozide	3	CHEMICAL
39682	39683	(	0	None
39683	39684	10	0	None
39684	39685	microM	0	None
39685	39686	)	0	None
39686	39687	was	0	None
39687	39688	a	0	None
39688	39689	weak	0	None
39689	39690	inhibitor	0	None
39690	39691	of	0	None
39691	39692	KvLQT1	0	None
39692	39693	/	0	None
39693	39694	minK	0	None
39694	39695	and	0	None
39695	39696	Kv1	0	None
39696	39697	.	0	None
39697	39698	5	0	None
39698	39699	.	0	None

39700	39701	We	0	None
39701	39702	conclude	0	None
39702	39703	that	0	None
39703	39704	pimozide	3	CHEMICAL
39704	39705	is	0	None
39705	39706	a	0	None
39706	39707	specific	0	None
39707	39708	,	0	None
39708	39709	high	0	None
39709	39710	affinity	0	None
39710	39711	antagonist	0	None
39711	39712	of	0	None
39712	39713	HERG	1	GENE-Y
39713	39714	,	0	None
39714	39715	and	0	None
39715	39716	that	0	None
39716	39717	this	0	None
39717	39718	interaction	0	None
39718	39719	leads	0	None
39719	39720	to	0	None
39720	39721	prolongation	0	None
39721	39722	of	0	None
39722	39723	cardiac	0	None
39723	39724	repolarization	0	None
39724	39725	.	0	None

39726	39727	Effect	0	None
39727	39728	of	0	None
39728	39729	L	0	None
39729	39730	-	0	None
39730	39731	arginine	3	CHEMICAL
39731	39732	-	0	None
39732	39733	nitric	0	None
39733	39734	oxide	0	None
39734	39735	system	0	None
39735	39736	on	0	None
39736	39737	the	0	None
39737	39738	metabolism	0	None
39738	39739	of	0	None
39739	39740	essential	0	None
39740	39742	fatty acids	3	CHEMICAL
39742	39743	in	0	None
39743	39744	chemical	0	None
39744	39745	-	0	None
39745	39746	induced	0	None
39746	39747	diabetes	0	None
39747	39748	mellitus	0	None
39748	39749	.	0	None

39750	39751	Several	0	None
39751	39752	studies	0	None
39752	39753	have	0	None
39753	39754	shown	0	None
39754	39755	that	0	None
39755	39756	the	0	None
39756	39757	activities	0	None
39757	39758	of	0	None
39758	39759	delta	0	None
39759	39760	-	0	None
39760	39761	6	0	None
39761	39762	-	0	None
39762	39763	desaturase	0	None
39763	39764	and	0	None
39764	39765	delta	0	None
39765	39766	-	0	None
39766	39767	5	0	None
39767	39768	-	0	None
39768	39769	desaturase	0	None
39769	39770	are	0	None
39770	39771	depressed	0	None
39771	39772	in	0	None
39772	39773	experimental	0	None
39773	39774	diabetes	0	None
39774	39775	and	0	None
39775	39776	in	0	None
39776	39777	humans	0	None
39777	39778	with	0	None
39778	39779	insulin	0	None
39779	39780	-	0	None
39780	39781	and	0	None
39781	39782	non	0	None
39782	39783	-	0	None
39783	39784	insulin	0	None
39784	39785	-	0	None
39785	39786	dependent	0	None
39786	39787	diabetes	0	None
39787	39788	mellitus	0	None
39788	39789	(	0	None
39789	39790	type	0	None
39790	39791	I	0	None
39791	39792	and	0	None
39792	39793	type	0	None
39793	39794	II	0	None
39794	39795	diabetes	0	None
39795	39796	mellitus	0	None
39796	39797	respectively	0	None
39797	39798	)	0	None
39798	39799	.	0	None

39800	39801	Furthermore	0	None
39801	39802	,	0	None
39802	39803	treatment	0	None
39803	39804	with	0	None
39804	39805	insulin	0	None
39805	39806	is	0	None
39806	39807	known	0	None
39807	39808	to	0	None
39808	39809	correct	0	None
39809	39810	the	0	None
39810	39811	defects	0	None
39811	39812	in	0	None
39812	39813	desaturases	2	GENE-N
39813	39814	in	0	None
39814	39815	rats	0	None
39815	39816	and	0	None
39816	39817	humans	0	None
39817	39818	with	0	None
39818	39819	diabetes	0	None
39819	39820	,	0	None
39820	39821	especially	0	None
39821	39822	in	0	None
39822	39823	type	0	None
39823	39824	I	0	None
39824	39825	.	0	None

39826	39827	In	0	None
39827	39828	a	0	None
39828	39829	recent	0	None
39829	39830	study	0	None
39830	39831	,	0	None
39831	39832	we	0	None
39832	39833	demonstrated	0	None
39833	39834	that	0	None
39834	39835	L	0	None
39835	39836	-	0	None
39836	39837	arginine	3	CHEMICAL
39837	39838	and	0	None
39838	39840	nitric oxide	3	CHEMICAL
39840	39841	can	0	None
39841	39842	prevent	0	None
39842	39843	alloxan	3	CHEMICAL
39843	39844	-	0	None
39844	39845	induced	0	None
39845	39846	beta	0	None
39846	39847	cell	0	None
39847	39848	damage	0	None
39848	39849	,	0	None
39849	39850	and	0	None
39850	39851	the	0	None
39851	39852	severity	0	None
39852	39853	of	0	None
39853	39854	diabetes	0	None
39854	39855	,	0	None
39855	39856	and	0	None
39856	39857	restore	0	None
39857	39858	the	0	None
39858	39859	antioxidant	0	None
39859	39860	status	0	None
39860	39861	to	0	None
39861	39862	near	0	None
39862	39863	normal	0	None
39863	39864	levels	0	None
39864	39865	.	0	None

39866	39867	But	0	None
39867	39868	,	0	None
39868	39869	no	0	None
39869	39870	information	0	None
39870	39871	is	0	None
39871	39872	available	0	None
39872	39873	as	0	None
39873	39874	to	0	None
39874	39875	the	0	None
39875	39876	relationship	0	None
39876	39877	between	0	None
39877	39878	L	0	None
39878	39879	-	0	None
39879	39880	arginine	3	CHEMICAL
39880	39881	-	0	None
39881	39882	nitric	0	None
39882	39883	oxide	0	None
39883	39884	system	0	None
39884	39885	and	0	None
39885	39886	the	0	None
39886	39887	metabolism	0	None
39887	39888	of	0	None
39888	39889	essential	0	None
39889	39891	fatty acids	3	CHEMICAL
39891	39892	in	0	None
39892	39893	diabetes	0	None
39893	39894	mellitus	0	None
39894	39895	.	0	None

39896	39897	In	0	None
39897	39898	the	0	None
39898	39899	present	0	None
39899	39900	study	0	None
39900	39901	,	0	None
39901	39902	it	0	None
39902	39903	was	0	None
39903	39904	noted	0	None
39904	39905	that	0	None
39905	39906	the	0	None
39906	39907	plasma	0	None
39907	39908	levels	0	None
39908	39909	of	0	None
39909	39910	saturated	0	None
39910	39912	fatty acids	3	CHEMICAL
39912	39913	:	0	None
39913	39914	stearic	0	None
39914	39915	and	0	None
39915	39916	palmitic	0	None
39916	39917	were	0	None
39917	39918	increased	0	None
39918	39919	where	0	None
39919	39920	as	0	None
39920	39923	unsaturated fatty acids	3	CHEMICAL
39923	39924	such	0	None
39924	39925	as	0	None
39925	39926	oleic	3	CHEMICAL
39926	39927	,	0	None
39927	39928	linoleic	0	None
39928	39929	,	0	None
39929	39930	gamma	0	None
39930	39931	-	0	None
39931	39932	linolenic	0	None
39932	39933	and	0	None
39933	39935	eicosapentaenoic acids	3	CHEMICAL
39935	39936	(	0	None
39936	39937	OA	3	CHEMICAL
39937	39938	,	0	None
39938	39939	LA	0	None
39939	39940	,	0	None
39940	39941	GLA	3	CHEMICAL
39941	39942	and	0	None
39942	39943	EPA	3	CHEMICAL
39943	39944	respectively	0	None
39944	39945	)	0	None
39945	39946	were	0	None
39946	39947	decreased	0	None
39947	39948	in	0	None
39948	39949	alloxan	3	CHEMICAL
39949	39950	-	0	None
39950	39951	induced	0	None
39951	39952	diabetic	0	None
39952	39953	rats	0	None
39953	39954	.	0	None

39955	39956	In	0	None
39956	39957	the	0	None
39957	39958	liver	0	None
39958	39959	phospholipid	3	CHEMICAL
39959	39960	(	0	None
39960	39961	PL	0	None
39961	39962	)	0	None
39962	39963	fraction	0	None
39963	39964	,	0	None
39964	39965	GLA	3	CHEMICAL
39965	39966	,	0	None
39966	39967	DGLA	3	CHEMICAL
39967	39968	(	0	None
39968	39969	dihomo	0	None
39969	39970	-	0	None
39970	39971	GLA	3	CHEMICAL
39971	39972	)	0	None
39972	39973	and	0	None
39973	39974	alpha	0	None
39974	39975	-	0	None
39975	39977	linolenic acid	3	CHEMICAL
39977	39978	(	0	None
39978	39979	ALA	0	None
39979	39980	)	0	None
39980	39981	were	0	None
39981	39982	decreased	0	None
39982	39983	in	0	None
39983	39984	the	0	None
39984	39985	alloxan	3	CHEMICAL
39985	39986	-	0	None
39986	39987	treated	0	None
39987	39988	group	0	None
39988	39989	;	0	None
39989	39990	in	0	None
39990	39991	the	0	None
39991	39992	muscle	0	None
39992	39993	PL	0	None
39993	39994	fraction	0	None
39994	39995	,	0	None
39995	39996	LA	0	None
39996	39997	,	0	None
39997	39998	GLA	3	CHEMICAL
39998	39999	and	0	None
39999	40000	DGLA	3	CHEMICAL
40000	40001	were	0	None
40001	40002	low	0	None
40002	40003	,	0	None
40003	40004	whereas	0	None
40004	40005	an	0	None
40005	40006	increase	0	None
40006	40007	in	0	None
40007	40008	the	0	None
40008	40009	saturated	0	None
40009	40011	fatty acid	3	CHEMICAL
40011	40012	content	0	None
40012	40013	was	0	None
40013	40014	noted	0	None
40014	40015	.	0	None

40016	40017	L	0	None
40017	40018	-	0	None
40018	40019	arginine	3	CHEMICAL
40019	40020	(	0	None
40020	40021	the	0	None
40021	40022	precursor	0	None
40022	40023	of	0	None
40023	40025	nitric oxide	3	CHEMICAL
40025	40026	)	0	None
40026	40027	and	0	None
40027	40029	sodium nitroprusside	3	CHEMICAL
40029	40030	(	0	None
40030	40031	a	0	None
40031	40033	nitric oxide	0	None
40033	40034	donor	0	None
40034	40035	)	0	None
40035	40036	treatment	0	None
40036	40037	of	0	None
40037	40038	alloxan	3	CHEMICAL
40038	40039	-	0	None
40039	40040	induced	0	None
40040	40041	diabetic	0	None
40041	40042	rats	0	None
40042	40043	enhanced	0	None
40043	40044	the	0	None
40044	40045	levels	0	None
40045	40046	of	0	None
40046	40047	LA	0	None
40047	40048	,	0	None
40048	40049	GLA	3	CHEMICAL
40049	40050	and	0	None
40050	40051	DGLA	3	CHEMICAL
40051	40052	.	0	None

40053	40054	Further	0	None
40054	40055	,	0	None
40055	40058	nitric oxide synthase	1	GENE-Y
40058	40059	inhibitor	0	None
40059	40060	,	0	None
40060	40061	L	0	None
40061	40062	-	0	None
40062	40063	NMMA	0	None
40063	40064	,	0	None
40064	40065	prevented	0	None
40065	40066	this	0	None
40066	40067	beneficial	0	None
40067	40068	action	0	None
40068	40069	of	0	None
40069	40070	L	0	None
40070	40071	-	0	None
40071	40072	arginine	3	CHEMICAL
40072	40073	-	0	None
40073	40074	nitric	0	None
40074	40075	oxide	0	None
40075	40076	system	0	None
40076	40077	on	0	None
40077	40078	essential	0	None
40078	40080	fatty acid	3	CHEMICAL
40080	40081	metabolism	0	None
40081	40082	.	0	None

40083	40084	The	0	None
40084	40085	abnormalities	0	None
40085	40086	in	0	None
40086	40087	the	0	None
40087	40088	essential	0	None
40088	40090	fatty acid	3	CHEMICAL
40090	40091	metabolism	0	None
40091	40092	observed	0	None
40092	40093	also	0	None
40093	40094	reverted	0	None
40094	40095	to	0	None
40095	40096	normalcy	0	None
40096	40097	following	0	None
40097	40098	control	0	None
40098	40099	of	0	None
40099	40100	diabetes	0	None
40100	40101	with	0	None
40101	40102	insulin	0	None
40102	40103	.	0	None

40104	40105	These	0	None
40105	40106	results	0	None
40106	40107	indicate	0	None
40107	40108	that	0	None
40108	40110	nitric oxide	3	CHEMICAL
40110	40111	can	0	None
40111	40112	enhance	0	None
40112	40113	the	0	None
40113	40114	activities	0	None
40114	40115	of	0	None
40115	40116	delta	0	None
40116	40117	-	0	None
40117	40118	6	0	None
40118	40119	-	0	None
40119	40120	and	0	None
40120	40121	delta	0	None
40121	40122	-	0	None
40122	40123	5	0	None
40123	40124	desaturases	2	GENE-N
40124	40125	,	0	None
40125	40126	which	0	None
40126	40127	are	0	None
40127	40128	depressed	0	None
40128	40129	in	0	None
40129	40130	diabetes	0	None
40130	40131	,	0	None
40131	40132	and	0	None
40132	40133	suggests	0	None
40133	40134	that	0	None
40134	40135	there	0	None
40135	40136	is	0	None
40136	40137	a	0	None
40137	40138	close	0	None
40138	40139	interaction	0	None
40139	40140	between	0	None
40140	40141	L	0	None
40141	40142	-	0	None
40142	40143	arginine	3	CHEMICAL
40143	40144	-	0	None
40144	40145	nitric	0	None
40145	40146	oxide	0	None
40146	40147	system	0	None
40147	40148	and	0	None
40148	40149	the	0	None
40149	40150	metabolism	0	None
40150	40151	of	0	None
40151	40152	essential	0	None
40152	40154	fatty acids	3	CHEMICAL
40154	40155	.	0	None

40156	40157	Troglitazone	0	None
40157	40158	reduces	0	None
40158	40161	plasminogen activator inhibitor	2	GENE-N
40161	40162	-	0	None
40162	40163	1	0	None
40163	40164	expression	0	None
40164	40165	and	0	None
40165	40166	secretion	0	None
40166	40167	in	0	None
40167	40168	cultured	0	None
40168	40169	human	0	None
40169	40170	adipocytes	0	None
40170	40171	.	0	None

40172	40173	AIMS	0	None
40173	40174	/	0	None
40174	40175	HYPOTHESIS	0	None
40175	40176	:	0	None
40176	40177	Increased	0	None
40177	40178	plasma	0	None
40178	40181	plasminogen activator inhibitor	2	GENE-N
40181	40182	-	0	None
40182	40183	1	0	None
40183	40184	(	0	None
40184	40185	PAI	2	GENE-N
40185	40186	-	0	None
40186	40187	1	0	None
40187	40188	)	0	None
40188	40189	concentrations	0	None
40189	40190	are	0	None
40190	40191	characteristic	0	None
40191	40192	for	0	None
40192	40193	subjects	0	None
40193	40194	with	0	None
40194	40195	insulin	0	None
40195	40196	resistance	0	None
40196	40197	and	0	None
40197	40198	could	0	None
40198	40199	contribute	0	None
40199	40200	to	0	None
40200	40201	the	0	None
40201	40202	increased	0	None
40202	40203	cardiovascular	0	None
40203	40204	risk	0	None
40204	40205	in	0	None
40205	40206	this	0	None
40206	40207	state	0	None
40207	40208	.	0	None

40209	40210	In	0	None
40210	40211	this	0	None
40211	40212	study	0	None
40212	40213	,	0	None
40213	40214	we	0	None
40214	40215	investigated	0	None
40215	40216	the	0	None
40216	40217	effect	0	None
40217	40218	of	0	None
40218	40219	troglitazone	3	CHEMICAL
40219	40220	,	0	None
40220	40221	a	0	None
40221	40222	ligand	0	None
40222	40223	of	0	None
40223	40224	the	0	None
40224	40226	nuclear receptor	2	GENE-N
40226	40227	peroxisome	0	None
40227	40228	proliferator	0	None
40228	40229	activated	0	None
40229	40230	receptor	0	None
40230	40231	-	0	None
40231	40232	gamma	0	None
40232	40233	,	0	None
40233	40234	on	0	None
40234	40235	PAI	2	GENE-N
40235	40236	-	0	None
40236	40237	1	0	None
40237	40238	expression	0	None
40238	40239	and	0	None
40239	40240	secretion	0	None
40240	40241	in	0	None
40241	40242	human	0	None
40242	40243	adipocytes	0	None
40243	40244	.	0	None

40245	40246	METHODS	0	None
40246	40247	:	0	None
40247	40248	We	0	None
40248	40249	used	0	None
40249	40250	two	0	None
40250	40251	models	0	None
40251	40252	:	0	None
40252	40253	in	0	None
40253	40254	vitro	0	None
40254	40255	differentiated	0	None
40255	40256	subcutaneous	0	None
40256	40257	and	0	None
40257	40258	omental	0	None
40258	40259	adipocytes	0	None
40259	40260	cultured	0	None
40260	40261	under	0	None
40261	40262	serum	0	None
40262	40263	-	0	None
40263	40264	free	0	None
40264	40265	conditions	0	None
40265	40266	and	0	None
40266	40267	isolated	0	None
40267	40268	subcutaneous	0	None
40268	40269	and	0	None
40269	40270	omental	0	None
40270	40271	fat	0	None
40271	40272	cells	0	None
40272	40273	kept	0	None
40273	40274	in	0	None
40274	40275	suspension	0	None
40275	40276	culture	0	None
40276	40277	.	0	None

40278	40279	Plasminogen	0	None
40279	40280	activator	0	None
40280	40281	inhibitor	0	None
40281	40282	-	0	None
40282	40283	1	0	None
40283	40284	protein	0	None
40284	40285	was	0	None
40285	40286	measured	0	None
40286	40287	by	0	None
40287	40288	ELISA	0	None
40288	40289	,	0	None
40289	40290	PAI	2	GENE-N
40290	40291	-	0	None
40291	40292	1	0	None
40292	40293	mRNA	0	None
40293	40294	by	0	None
40294	40295	a	0	None
40295	40296	semiquantitative	0	None
40296	40297	RT	0	None
40297	40298	-	0	None
40298	40299	PCR	0	None
40299	40300	technique	0	None
40300	40301	.	0	None

40302	40303	RESULTS	0	None
40303	40304	:	0	None
40304	40305	Exposure	0	None
40305	40306	of	0	None
40306	40307	in	0	None
40307	40308	vitro	0	None
40308	40309	differentiated	0	None
40309	40310	subcutaneous	0	None
40310	40311	adipocytes	0	None
40311	40312	from	0	None
40312	40313	young	0	None
40313	40314	normal	0	None
40314	40315	-	0	None
40315	40316	weight	0	None
40316	40317	females	0	None
40317	40318	to	0	None
40318	40319	1	0	None
40319	40320	microgram	0	None
40320	40321	/	0	None
40321	40322	ml	0	None
40322	40323	troglitazone	3	CHEMICAL
40323	40324	for	0	None
40324	40325	72	0	None
40325	40326	h	0	None
40326	40327	caused	0	None
40327	40328	a	0	None
40328	40329	reduction	0	None
40329	40330	of	0	None
40330	40331	both	0	None
40331	40332	PAI	2	GENE-N
40332	40333	-	0	None
40333	40334	1	0	None
40334	40335	secretion	0	None
40335	40336	(	0	None
40336	40337	by	0	None
40337	40338	29	0	None
40338	40339	+	0	None
40339	40340	/	0	None
40340	40341	-	0	None
40341	40342	5	0	None
40342	40343	%	0	None
40343	40344	;	0	None
40344	40345	p	0	None
40345	40346	<	0	None
40346	40347	0	0	None
40347	40348	.	0	None
40348	40349	01	0	None
40349	40350	)	0	None
40350	40351	and	0	None
40351	40352	PAI	2	GENE-N
40352	40353	-	0	None
40353	40354	1	0	None
40354	40355	mRNA	0	None
40355	40356	expression	0	None
40356	40357	(	0	None
40357	40358	by	0	None
40358	40359	26	0	None
40359	40360	+	0	None
40360	40361	/	0	None
40361	40362	-	0	None
40362	40363	3	0	None
40363	40364	%	0	None
40364	40365	;	0	None
40365	40366	p	0	None
40366	40367	<	0	None
40367	40368	0	0	None
40368	40369	.	0	None
40369	40370	05	0	None
40370	40371	)	0	None
40371	40372	.	0	None

40373	40374	In	0	None
40374	40375	cultures	0	None
40375	40376	from	0	None
40376	40377	severely	0	None
40377	40378	obese	0	None
40378	40379	subjects	0	None
40379	40380	,	0	None
40380	40381	troglitazone	3	CHEMICAL
40381	40382	induced	0	None
40382	40383	a	0	None
40383	40384	decrease	0	None
40384	40385	of	0	None
40385	40386	PAI	2	GENE-N
40386	40387	-	0	None
40387	40388	1	0	None
40388	40389	antigen	0	None
40389	40390	secretion	0	None
40390	40391	from	0	None
40391	40392	newly	0	None
40392	40393	differentiated	0	None
40393	40394	omental	0	None
40394	40395	adipocytes	0	None
40395	40396	by	0	None
40396	40397	49	0	None
40397	40398	+	0	None
40398	40399	/	0	None
40399	40400	-	0	None
40400	40401	8	0	None
40401	40402	%	0	None
40402	40403	(	0	None
40403	40404	p	0	None
40404	40405	<	0	None
40405	40406	0	0	None
40406	40407	.	0	None
40407	40408	01	0	None
40408	40409	)	0	None
40409	40410	and	0	None
40410	40411	from	0	None
40411	40412	subcutaneous	0	None
40412	40413	adipocytes	0	None
40413	40414	by	0	None
40414	40415	30	0	None
40415	40416	+	0	None
40416	40417	/	0	None
40417	40418	-	0	None
40418	40419	7	0	None
40419	40420	%	0	None
40420	40421	(	0	None
40421	40422	p	0	None
40422	40423	<	0	None
40423	40424	0	0	None
40424	40425	.	0	None
40425	40426	05	0	None
40426	40427	)	0	None
40427	40428	.	0	None

40429	40430	Exposure	0	None
40430	40431	of	0	None
40431	40432	freshly	0	None
40432	40433	isolated	0	None
40433	40434	subcutaneous	0	None
40434	40435	and	0	None
40435	40436	omental	0	None
40436	40437	adipocytes	0	None
40437	40438	in	0	None
40438	40439	suspension	0	None
40439	40440	culture	0	None
40440	40441	to	0	None
40441	40442	troglitazone	3	CHEMICAL
40442	40443	induced	0	None
40443	40444	a	0	None
40444	40445	similar	0	None
40445	40446	reduction	0	None
40446	40447	of	0	None
40447	40448	PAI	2	GENE-N
40448	40449	-	0	None
40449	40450	1	0	None
40450	40451	concentration	0	None
40451	40452	in	0	None
40452	40453	the	0	None
40453	40454	culture	0	None
40454	40455	medium	0	None
40455	40456	(	0	None
40456	40457	by	0	None
40457	40458	35	0	None
40458	40459	+	0	None
40459	40460	/	0	None
40460	40461	-	0	None
40461	40462	11	0	None
40462	40463	%	0	None
40463	40464	,	0	None
40464	40465	p	0	None
40465	40466	<	0	None
40466	40467	0	0	None
40467	40468	.	0	None
40468	40469	05	0	None
40469	40470	,	0	None
40470	40471	and	0	None
40471	40472	33	0	None
40472	40473	+	0	None
40473	40474	/	0	None
40474	40475	-	0	None
40475	40476	8	0	None
40476	40477	%	0	None
40477	40478	,	0	None
40478	40479	p	0	None
40479	40480	<	0	None
40480	40481	0	0	None
40481	40482	.	0	None
40482	40483	05	0	None
40483	40484	compared	0	None
40484	40485	with	0	None
40485	40486	control	0	None
40486	40487	,	0	None
40487	40488	respectively	0	None
40488	40489	)	0	None
40489	40490	.	0	None

40491	40492	CONCLUSION	0	None
40492	40493	/	0	None
40493	40494	INTERPRETATION	0	None
40494	40495	:	0	None
40495	40496	This	0	None
40496	40497	study	0	None
40497	40498	provides	0	None
40498	40499	evidence	0	None
40499	40500	that	0	None
40500	40501	troglitazone	3	CHEMICAL
40501	40502	reduces	0	None
40502	40503	PAI	2	GENE-N
40503	40504	-	0	None
40504	40505	1	0	None
40505	40506	production	0	None
40506	40507	in	0	None
40507	40508	human	0	None
40508	40509	adipocytes	0	None
40509	40510	,	0	None
40510	40511	probably	0	None
40511	40512	at	0	None
40512	40513	the	0	None
40513	40514	transcriptional	0	None
40514	40515	level	0	None
40515	40516	.	0	None

40517	40518	This	0	None
40518	40519	observation	0	None
40519	40520	could	0	None
40520	40521	point	0	None
40521	40522	to	0	None
40522	40523	a	0	None
40523	40524	new	0	None
40524	40525	beneficial	0	None
40525	40526	effect	0	None
40526	40527	of	0	None
40527	40528	troglitazone	3	CHEMICAL
40528	40529	,	0	None
40529	40530	particularly	0	None
40530	40531	in	0	None
40531	40532	obese	0	None
40532	40533	subjects	0	None
40533	40534	,	0	None
40534	40535	which	0	None
40535	40536	could	0	None
40536	40537	be	0	None
40537	40538	associated	0	None
40538	40539	with	0	None
40539	40540	a	0	None
40540	40541	reduced	0	None
40541	40542	cardiovascular	0	None
40542	40543	risk	0	None
40543	40544	.	0	None

40545	40546	Topiramate	0	None
40546	40547	as	0	None
40547	40548	an	0	None
40548	40549	inhibitor	0	None
40549	40550	of	0	None
40550	40552	carbonic anhydrase	2	GENE-N
40552	40553	isoenzymes	0	None
40553	40554	.	0	None

40555	40556	PURPOSE	0	None
40556	40557	:	0	None
40557	40558	This	0	None
40558	40559	study	0	None
40559	40560	investigated	0	None
40560	40561	the	0	None
40561	40562	effectiveness	0	None
40562	40563	of	0	None
40563	40564	topiramate	3	CHEMICAL
40564	40565	(	0	None
40565	40566	TPM	3	CHEMICAL
40566	40567	)	0	None
40567	40568	as	0	None
40568	40569	an	0	None
40569	40570	inhibitor	0	None
40570	40571	of	0	None
40571	40572	six	0	None
40572	40573	isozymes	0	None
40573	40574	of	0	None
40574	40576	carbonic anhydrase	2	GENE-N
40576	40577	(	0	None
40577	40578	CA	2	GENE-N
40578	40579	)	0	None
40579	40580	.	0	None

40581	40582	METHODS	0	None
40582	40583	:	0	None
40583	40584	The	0	None
40584	40585	inhibition	0	None
40585	40586	constants	0	None
40586	40587	(	0	None
40587	40588	Ki	0	None
40588	40589	)	0	None
40589	40590	of	0	None
40590	40591	TPM	3	CHEMICAL
40591	40592	and	0	None
40592	40593	acetazolamide	3	CHEMICAL
40593	40594	(	0	None
40594	40595	AZM	0	None
40595	40596	)	0	None
40596	40597	for	0	None
40597	40599	CA I	2	GENE-N
40599	40600	,	0	None
40600	40602	CA II	1	GENE-Y
40602	40603	,	0	None
40603	40605	CA III	2	GENE-N
40605	40606	,	0	None
40606	40608	CA IV	1	GENE-Y
40608	40609	,	0	None
40609	40611	CA V	2	GENE-N
40611	40612	,	0	None
40612	40613	and	0	None
40613	40615	CA VI	1	GENE-Y
40615	40616	were	0	None
40616	40617	determined	0	None
40617	40618	for	0	None
40618	40619	human	0	None
40619	40620	(	0	None
40620	40621	HCA	2	GENE-N
40621	40622	)	0	None
40622	40623	,	0	None
40623	40624	rat	0	None
40624	40625	(	0	None
40625	40626	RCA	2	GENE-N
40626	40627	)	0	None
40627	40628	,	0	None
40628	40629	or	0	None
40629	40630	mouse	0	None
40630	40631	(	0	None
40631	40632	MCA	2	GENE-N
40632	40633	)	0	None
40633	40634	.	0	None

40635	40636	The	0	None
40636	40637	activity	0	None
40637	40638	of	0	None
40638	40639	CA	2	GENE-N
40639	40640	was	0	None
40640	40641	studied	0	None
40641	40642	by	0	None
40642	40643	using	0	None
40643	40644	purified	0	None
40644	40645	isozymes	0	None
40645	40646	,	0	None
40646	40647	erythrocytes	0	None
40647	40648	,	0	None
40648	40649	subcellular	0	None
40649	40650	fractions	0	None
40650	40651	of	0	None
40651	40652	kidney	0	None
40652	40653	or	0	None
40653	40654	brain	0	None
40654	40655	,	0	None
40655	40656	and	0	None
40656	40657	saliva	0	None
40657	40658	,	0	None
40658	40659	and	0	None
40659	40660	was	0	None
40660	40661	assayed	0	None
40661	40662	at	0	None
40662	40663	37	0	None
40663	40664	degrees	0	None
40664	40665	C	0	None
40665	40666	or	0	None
40666	40667	25	0	None
40667	40668	degrees	0	None
40668	40669	C	0	None
40669	40670	by	0	None
40670	40671	18O	0	None
40671	40672	mass	0	None
40672	40673	spectrometry	0	None
40673	40674	and	0	None
40674	40675	/	0	None
40675	40676	or	0	None
40676	40677	by	0	None
40677	40678	measuring	0	None
40678	40679	the	0	None
40679	40680	pH	0	None
40680	40681	shift	0	None
40681	40682	at	0	None
40682	40683	0	0	None
40683	40684	degrees	0	None
40684	40685	C	0	None
40685	40686	.	0	None

40687	40688	RESULTS	0	None
40688	40689	:	0	None
40689	40690	Topiramate	0	None
40690	40691	Ki	0	None
40691	40692	values	0	None
40692	40693	for	0	None
40693	40695	HCA I	2	GENE-N
40695	40696	,	0	None
40696	40698	HCA II	1	GENE-Y
40698	40699	,	0	None
40699	40701	HCA IV	1	GENE-Y
40701	40702	,	0	None
40702	40703	and	0	None
40703	40705	HCA VI	1	GENE-Y
40705	40706	were	0	None
40706	40707	approximately	0	None
40707	40708	100	0	None
40708	40709	,	0	None
40709	40710	7	0	None
40710	40711	,	0	None
40711	40712	10	0	None
40712	40713	,	0	None
40713	40714	and	0	None
40714	40715	>	0	None
40715	40716	100	0	None
40716	40717	microM	0	None
40717	40718	,	0	None
40718	40719	respectively	0	None
40719	40720	.	0	None

40721	40722	TPM	3	CHEMICAL
40722	40723	Ki	0	None
40723	40724	values	0	None
40724	40725	for	0	None
40725	40727	RCA I	2	GENE-N
40727	40728	,	0	None
40728	40730	RCA II	1	GENE-Y
40730	40731	,	0	None
40731	40733	RCA III	1	GENE-Y
40733	40734	,	0	None
40734	40736	RCA IV	1	GENE-Y
40736	40737	,	0	None
40737	40738	and	0	None
40738	40739	RCA	2	GENE-N
40739	40740	V	0	None
40740	40741	were	0	None
40741	40742	approximately	0	None
40742	40743	180	0	None
40743	40744	,	0	None
40744	40745	0	0	None
40745	40746	.	0	None
40746	40747	1	0	None
40747	40748	to	0	None
40748	40749	1	0	None
40749	40750	,	0	None
40750	40751	>	0	None
40751	40752	100	0	None
40752	40753	,	0	None
40753	40754	0	0	None
40754	40755	.	0	None
40755	40756	2	0	None
40756	40757	to	0	None
40757	40758	10	0	None
40758	40759	and	0	None
40759	40760	18	0	None
40760	40761	microM	0	None
40761	40762	,	0	None
40762	40763	respectively	0	None
40763	40764	.	0	None

40765	40766	For	0	None
40766	40768	RCA II	1	GENE-Y
40768	40769	and	0	None
40769	40771	RCA IV	1	GENE-Y
40771	40772	,	0	None
40772	40773	the	0	None
40773	40774	Ki	0	None
40774	40775	values	0	None
40775	40776	were	0	None
40776	40777	temperature	0	None
40777	40778	dependent	0	None
40778	40779	.	0	None

40780	40781	TPM	3	CHEMICAL
40781	40782	Ki	0	None
40782	40783	values	0	None
40783	40784	for	0	None
40784	40786	MCA II	1	GENE-Y
40786	40787	and	0	None
40787	40788	MCA	2	GENE-N
40788	40789	IV	0	None
40789	40790	ranged	0	None
40790	40791	between	0	None
40791	40792	1	0	None
40792	40793	and	0	None
40793	40794	20	0	None
40794	40795	microM	0	None
40795	40796	.	0	None

40797	40798	CONCLUSIONS	0	None
40798	40799	:	0	None
40799	40800	These	0	None
40800	40801	results	0	None
40801	40802	indicate	0	None
40802	40803	that	0	None
40803	40804	TPM	3	CHEMICAL
40804	40805	is	0	None
40805	40806	more	0	None
40806	40807	potent	0	None
40807	40808	as	0	None
40808	40809	an	0	None
40809	40810	inhibitor	0	None
40810	40811	of	0	None
40811	40813	CA II	1	GENE-Y
40813	40814	and	0	None
40814	40816	CA IV	1	GENE-Y
40816	40817	than	0	None
40817	40818	of	0	None
40818	40820	CA I	2	GENE-N
40820	40821	,	0	None
40821	40823	CA III	2	GENE-N
40823	40824	,	0	None
40824	40825	and	0	None
40825	40827	CA VI	1	GENE-Y
40827	40828	.	0	None

40829	40830	In	0	None
40830	40831	all	0	None
40831	40832	three	0	None
40832	40833	species	0	None
40833	40834	,	0	None
40834	40835	AZM	0	None
40835	40836	was	0	None
40836	40837	usually	0	None
40837	40838	10	0	None
40838	40839	to	0	None
40839	40840	100	0	None
40840	40841	times	0	None
40841	40842	more	0	None
40842	40843	potent	0	None
40843	40844	than	0	None
40844	40845	TPM	3	CHEMICAL
40845	40846	as	0	None
40846	40847	an	0	None
40847	40848	inhibitor	0	None
40848	40849	of	0	None
40849	40850	CA	2	GENE-N
40850	40851	isozymes	0	None
40851	40852	.	0	None

40853	40854	Effect	0	None
40854	40855	of	0	None
40855	40856	JTH	0	None
40856	40857	-	0	None
40857	40858	601	0	None
40858	40859	,	0	None
40859	40860	a	0	None
40860	40861	novel	0	None
40861	40862	alpha	0	None
40862	40863	(	0	None
40863	40864	1	0	None
40864	40865	)	0	None
40865	40866	-	0	None
40866	40867	adrenoceptor	0	None
40867	40868	antagonist	0	None
40868	40869	,	0	None
40869	40870	on	0	None
40870	40871	prostate	0	None
40871	40872	function	0	None
40872	40873	in	0	None
40873	40874	dogs	0	None
40874	40875	.	0	None

40876	40877	We	0	None
40877	40878	examined	0	None
40878	40879	the	0	None
40879	40880	effect	0	None
40880	40881	of	0	None
40881	40882	JTH	0	None
40882	40883	-	0	None
40883	40884	601	0	None
40884	40885	(	0	None
40885	40886	3	0	None
40886	40887	-	0	None
40887	40888	inverted	0	None
40888	40889	question	0	None
40889	40890	markN	0	None
40890	40891	-	0	None
40891	40892	[	0	None
40892	40893	2	0	None
40893	40894	-	0	None
40894	40895	(	0	None
40895	40896	4	0	None
40896	40897	-	0	None
40897	40898	hydroxy	3	CHEMICAL
40898	40899	-	0	None
40899	40900	2	0	None
40900	40901	-	0	None
40901	40902	isopropyl	0	None
40902	40903	-	0	None
40903	40904	5	0	None
40904	40905	-	0	None
40905	40906	methylphenoxy	0	None
40906	40907	)	0	None
40907	40908	ethyl	3	CHEMICAL
40908	40909	]	0	None
40909	40910	-	0	None
40910	40911	N	0	None
40911	40912	-	0	None
40912	40913	methylaminom	0	None
40913	40914	ethyl	3	CHEMICAL
40914	40915	inverted	0	None
40915	40916	question	0	None
40916	40917	mark	0	None
40917	40918	-	0	None
40918	40919	4	0	None
40919	40920	-	0	None
40920	40921	methoxy	3	CHEMICAL
40921	40922	-	0	None
40922	40923	2	0	None
40923	40924	,	0	None
40924	40925	5	0	None
40925	40926	,	0	None
40926	40927	6	0	None
40927	40928	-	0	None
40928	40929	trimethylphenol	0	None
40929	40930	hemifumarate	0	None
40930	40931	)	0	None
40931	40932	,	0	None
40932	40933	a	0	None
40933	40934	new	0	None
40934	40935	alpha	0	None
40935	40936	(	0	None
40936	40937	1L	0	None
40937	40938	)	0	None
40938	40939	-	0	None
40939	40940	adrenoceptor	0	None
40940	40941	antagonist	0	None
40941	40942	,	0	None
40942	40943	on	0	None
40943	40944	prostatic	0	None
40944	40945	function	0	None
40945	40946	in	0	None
40946	40947	isolated	0	None
40947	40948	canine	0	None
40948	40949	prostate	0	None
40949	40950	and	0	None
40950	40951	in	0	None
40951	40952	anesthetized	0	None
40952	40953	dogs	0	None
40953	40954	.	0	None

40955	40956	In	0	None
40956	40957	the	0	None
40957	40958	contraction	0	None
40958	40959	study	0	None
40959	40960	,	0	None
40960	40961	phenylephrine	3	CHEMICAL
40961	40962	and	0	None
40962	40963	noradrenaline	3	CHEMICAL
40963	40964	produced	0	None
40964	40965	concentration	0	None
40965	40966	-	0	None
40966	40967	dependent	0	None
40967	40968	contractions	0	None
40968	40969	in	0	None
40969	40970	canine	0	None
40970	40971	prostate	0	None
40971	40972	and	0	None
40972	40973	carotid	0	None
40973	40974	artery	0	None
40974	40975	,	0	None
40975	40976	respectively	0	None
40976	40977	.	0	None

40978	40979	In	0	None
40979	40980	these	0	None
40980	40981	tissues	0	None
40981	40982	,	0	None
40982	40983	JTH	0	None
40983	40984	-	0	None
40984	40985	601	0	None
40985	40986	,	0	None
40986	40987	prazosin	3	CHEMICAL
40987	40988	(	0	None
40988	40989	a	0	None
40989	40990	non	0	None
40990	40991	-	0	None
40991	40992	selective	0	None
40992	40993	alpha	0	None
40993	40994	(	0	None
40994	40995	1	0	None
40995	40996	)	0	None
40996	40997	-	0	None
40997	40998	adrenoceptor	0	None
40998	40999	antagonist	0	None
40999	41000	)	0	None
41000	41001	,	0	None
41001	41002	and	0	None
41002	41003	tamsulosin	3	CHEMICAL
41003	41004	(	0	None
41004	41005	an	0	None
41005	41006	alpha	0	None
41006	41007	(	0	None
41007	41008	1A	0	None
41008	41009	)	0	None
41009	41010	-	0	None
41010	41011	adrenoceptor	0	None
41011	41012	antagonist	0	None
41012	41013	)	0	None
41013	41014	competitively	0	None
41014	41015	antagonized	0	None
41015	41016	contraction	0	None
41016	41017	in	0	None
41017	41018	a	0	None
41018	41019	concentration	0	None
41019	41020	-	0	None
41020	41021	dependent	0	None
41021	41022	manner	0	None
41022	41023	.	0	None

41024	41025	The	0	None
41025	41026	pA	0	None
41026	41027	(	0	None
41027	41028	2	0	None
41028	41029	)	0	None
41029	41030	(	0	None
41030	41031	pK	0	None
41031	41032	(	0	None
41032	41033	B	0	None
41033	41034	)	0	None
41034	41035	)	0	None
41035	41036	values	0	None
41036	41037	with	0	None
41037	41038	prostate	0	None
41038	41039	were	0	None
41039	41040	8	0	None
41040	41041	.	0	None
41041	41042	49	0	None
41042	41043	+	0	None
41043	41044	/	0	None
41044	41045	-	0	None
41045	41046	0	0	None
41046	41047	.	0	None
41047	41048	07	0	None
41048	41049	for	0	None
41049	41050	JTH	0	None
41050	41051	-	0	None
41051	41052	601	0	None
41052	41053	,	0	None
41053	41054	7	0	None
41054	41055	.	0	None
41055	41056	94	0	None
41056	41057	+	0	None
41057	41058	/	0	None
41058	41059	-	0	None
41059	41060	0	0	None
41060	41061	.	0	None
41061	41062	04	0	None
41062	41063	for	0	None
41063	41064	prazosin	3	CHEMICAL
41064	41065	and	0	None
41065	41066	9	0	None
41066	41067	.	0	None
41067	41068	42	0	None
41068	41069	+	0	None
41069	41070	/	0	None
41070	41071	-	0	None
41071	41072	0	0	None
41072	41073	.	0	None
41073	41074	22	0	None
41074	41075	for	0	None
41075	41076	tamsulosin	3	CHEMICAL
41076	41077	.	0	None

41078	41079	The	0	None
41079	41080	ratio	0	None
41080	41081	of	0	None
41081	41082	pA	0	None
41082	41083	(	0	None
41083	41084	2	0	None
41084	41085	)	0	None
41085	41086	(	0	None
41086	41087	carotid	0	None
41087	41088	artery	0	None
41088	41089	/	0	None
41089	41090	prostate	0	None
41090	41091	)	0	None
41091	41092	,	0	None
41092	41093	i	0	None
41093	41094	.	0	None
41094	41095	e	0	None
41095	41096	.	0	None
41096	41097	prostatic	0	None
41097	41098	selectivity	0	None
41098	41099	,	0	None
41099	41100	was	0	None
41100	41101	10	0	None
41101	41102	.	0	None
41102	41103	471	0	None
41103	41104	for	0	None
41104	41105	JTH	0	None
41105	41106	-	0	None
41106	41107	601	0	None
41107	41108	,	0	None
41108	41109	0	0	None
41109	41110	.	0	None
41110	41111	008	0	None
41111	41112	for	0	None
41112	41113	prazosin	3	CHEMICAL
41113	41114	and	0	None
41114	41115	0	0	None
41115	41116	.	0	None
41116	41117	371	0	None
41117	41118	for	0	None
41118	41119	tamsulosin	3	CHEMICAL
41119	41120	,	0	None
41120	41121	respectively	0	None
41121	41122	.	0	None

41123	41124	In	0	None
41124	41125	anesthetized	0	None
41125	41126	dogs	0	None
41126	41127	,	0	None
41127	41128	JTH	0	None
41128	41129	-	0	None
41129	41130	601	0	None
41130	41131	(	0	None
41131	41132	1	0	None
41132	41133	mg	0	None
41133	41134	/	0	None
41134	41135	kg	0	None
41135	41136	,	0	None
41136	41137	i	0	None
41137	41138	.	0	None
41138	41139	d	0	None
41139	41140	.	0	None
41140	41141	)	0	None
41141	41142	significantly	0	None
41142	41143	decreased	0	None
41143	41144	urethral	0	None
41144	41145	pressure	0	None
41145	41146	by	0	None
41146	41147	15	0	None
41147	41148	%	0	None
41148	41149	without	0	None
41149	41150	affecting	0	None
41150	41151	blood	0	None
41151	41152	pressure	0	None
41152	41153	or	0	None
41153	41154	heart	0	None
41154	41155	rate	0	None
41155	41156	.	0	None

41157	41158	Tamsulosin	0	None
41158	41159	(	0	None
41159	41160	0	0	None
41160	41161	.	0	None
41161	41162	1	0	None
41162	41163	mg	0	None
41163	41164	/	0	None
41164	41165	kg	0	None
41165	41166	,	0	None
41166	41167	i	0	None
41167	41168	.	0	None
41168	41169	d	0	None
41169	41170	.	0	None
41170	41171	)	0	None
41171	41172	decreased	0	None
41172	41173	urethral	0	None
41173	41174	pressure	0	None
41174	41175	to	0	None
41175	41176	the	0	None
41176	41177	same	0	None
41177	41178	extent	0	None
41178	41179	as	0	None
41179	41180	did	0	None
41180	41181	JTH	0	None
41181	41182	-	0	None
41182	41183	601	0	None
41183	41184	,	0	None
41184	41185	but	0	None
41185	41186	with	0	None
41186	41187	a	0	None
41187	41188	significant	0	None
41188	41189	effect	0	None
41189	41190	on	0	None
41190	41191	blood	0	None
41191	41192	pressure	0	None
41192	41193	and	0	None
41193	41194	heart	0	None
41194	41195	rate	0	None
41195	41196	.	0	None

41197	41198	JTH	0	None
41198	41199	-	0	None
41199	41200	601	0	None
41200	41201	showed	0	None
41201	41202	higher	0	None
41202	41203	selectivity	0	None
41203	41204	for	0	None
41204	41205	canine	0	None
41205	41206	prostate	0	None
41206	41207	both	0	None
41207	41208	in	0	None
41208	41209	vitro	0	None
41209	41210	and	0	None
41210	41211	in	0	None
41211	41212	vivo	0	None
41212	41213	.	0	None

41214	41215	In	0	None
41215	41216	prostate	0	None
41216	41217	,	0	None
41217	41218	an	0	None
41218	41219	important	0	None
41219	41220	role	0	None
41220	41221	of	0	None
41221	41222	the	0	None
41222	41223	alpha	0	None
41223	41224	(	0	None
41224	41225	1L	0	None
41225	41226	)	0	None
41226	41227	-	0	None
41227	41228	adrenoceptor	0	None
41228	41229	is	0	None
41229	41230	suggested	0	None
41230	41231	in	0	None
41231	41232	the	0	None
41232	41233	smooth	0	None
41233	41234	muscle	0	None
41234	41235	contraction	0	None
41235	41236	mediated	0	None
41236	41237	by	0	None
41237	41238	alpha	0	None
41238	41239	(	0	None
41239	41240	1	0	None
41240	41241	)	0	None
41241	41242	-	0	None
41242	41243	adrenoceptors	2	GENE-N
41243	41244	.	0	None

41245	41246	JTH	0	None
41246	41247	-	0	None
41247	41248	601	0	None
41248	41249	is	0	None
41249	41250	expected	0	None
41250	41251	to	0	None
41251	41252	be	0	None
41252	41253	an	0	None
41253	41254	effective	0	None
41254	41255	alpha	0	None
41255	41256	(	0	None
41256	41257	1	0	None
41257	41258	)	0	None
41258	41259	-	0	None
41259	41260	adrenoceptor	0	None
41260	41261	antagonist	0	None
41261	41262	for	0	None
41262	41263	the	0	None
41263	41264	treatment	0	None
41264	41265	of	0	None
41265	41266	urinary	0	None
41266	41267	outlet	0	None
41267	41268	obstruction	0	None
41268	41269	by	0	None
41269	41270	benign	0	None
41270	41271	prostatic	0	None
41271	41272	hypertrophy	0	None
41272	41273	with	0	None
41273	41274	a	0	None
41274	41275	minimum	0	None
41275	41276	effect	0	None
41276	41277	on	0	None
41277	41278	the	0	None
41278	41279	cardiovascular	0	None
41279	41280	system	0	None
41280	41281	.	0	None

41282	41283	Cyclooxygenase	0	None
41283	41284	-	0	None
41284	41285	2	0	None
41285	41286	contributes	0	None
41286	41287	to	0	None
41287	41288	N	0	None
41288	41289	-	0	None
41289	41290	methyl	3	CHEMICAL
41290	41291	-	0	None
41291	41292	D	0	None
41292	41293	-	0	None
41293	41294	aspartate	3	CHEMICAL
41294	41295	-	0	None
41295	41296	mediated	0	None
41296	41297	neuronal	0	None
41297	41298	cell	0	None
41298	41299	death	0	None
41299	41300	in	0	None
41300	41301	primary	0	None
41301	41302	cortical	0	None
41302	41303	cell	0	None
41303	41304	culture	0	None
41304	41305	.	0	None

41306	41307	Cyclooxygenase	0	None
41307	41308	isozymes	0	None
41308	41309	(	0	None
41309	41310	COX	2	GENE-N
41310	41311	-	0	None
41311	41312	1	0	None
41312	41313	and	0	None
41313	41314	COX	2	GENE-N
41314	41315	-	0	None
41315	41316	2	0	None
41316	41317	)	0	None
41317	41318	are	0	None
41318	41319	found	0	None
41319	41320	to	0	None
41320	41321	be	0	None
41321	41322	constitutively	0	None
41322	41323	expressed	0	None
41323	41324	in	0	None
41324	41325	brain	0	None
41325	41326	,	0	None
41326	41327	with	0	None
41327	41328	neuronal	0	None
41328	41329	expression	0	None
41329	41330	of	0	None
41330	41331	COX	2	GENE-N
41331	41332	-	0	None
41332	41333	2	0	None
41333	41334	being	0	None
41334	41335	rapidly	0	None
41335	41336	induced	0	None
41336	41337	after	0	None
41337	41338	numerous	0	None
41338	41339	insults	0	None
41339	41340	,	0	None
41340	41341	including	0	None
41341	41342	cerebral	0	None
41342	41343	ischemia	0	None
41343	41344	.	0	None

41345	41346	Because	0	None
41346	41347	overactivation	0	None
41347	41348	of	0	None
41348	41349	N	0	None
41349	41350	-	0	None
41350	41351	methyl	3	CHEMICAL
41351	41352	-	0	None
41352	41353	D	0	None
41353	41354	-	0	None
41354	41355	aspartate	3	CHEMICAL
41355	41356	(	0	None
41356	41357	NMDA	3	CHEMICAL
41357	41358	)	0	None
41358	41359	receptors	0	None
41359	41360	has	0	None
41360	41361	been	0	None
41361	41362	implicated	0	None
41362	41363	in	0	None
41363	41364	the	0	None
41364	41365	cell	0	None
41365	41366	loss	0	None
41366	41367	associated	0	None
41367	41368	with	0	None
41368	41369	ischemia	0	None
41369	41370	,	0	None
41370	41371	we	0	None
41371	41372	characterized	0	None
41372	41373	the	0	None
41373	41374	expression	0	None
41374	41375	of	0	None
41375	41376	the	0	None
41376	41377	COX	2	GENE-N
41377	41378	isozymes	0	None
41378	41379	in	0	None
41379	41380	murine	0	None
41380	41381	mixed	0	None
41381	41382	cortical	0	None
41382	41383	cell	0	None
41383	41384	cultures	0	None
41384	41385	and	0	None
41385	41386	used	0	None
41386	41387	isozyme	0	None
41387	41388	-	0	None
41388	41389	selective	0	None
41389	41390	inhibitors	0	None
41390	41391	to	0	None
41391	41392	determine	0	None
41392	41393	their	0	None
41393	41394	relative	0	None
41394	41395	contribution	0	None
41395	41396	to	0	None
41396	41398	NMDA receptor	2	GENE-N
41398	41399	-	0	None
41399	41400	stimulated	0	None
41400	41401	prostaglandin	3	CHEMICAL
41401	41402	(	0	None
41402	41403	PG	3	CHEMICAL
41403	41404	)	0	None
41404	41405	production	0	None
41405	41406	and	0	None
41406	41407	excitotoxic	0	None
41407	41408	neuronal	0	None
41408	41409	cell	0	None
41409	41410	death	0	None
41410	41411	.	0	None

41412	41413	Immunocytochemical	0	None
41413	41414	analysis	0	None
41414	41415	of	0	None
41415	41416	mixed	0	None
41416	41417	cortical	0	None
41417	41418	cell	0	None
41418	41419	cultures	0	None
41419	41420	revealed	0	None
41420	41421	that	0	None
41421	41422	COX	2	GENE-N
41422	41423	-	0	None
41423	41424	2	0	None
41424	41425	expression	0	None
41425	41426	was	0	None
41426	41427	restricted	0	None
41427	41428	to	0	None
41428	41429	neurons	0	None
41429	41430	,	0	None
41430	41431	whereas	0	None
41431	41432	COX	2	GENE-N
41432	41433	-	0	None
41433	41434	1	0	None
41434	41435	was	0	None
41435	41436	expressed	0	None
41436	41437	in	0	None
41437	41438	both	0	None
41438	41439	neurons	0	None
41439	41440	and	0	None
41440	41441	astrocytes	0	None
41441	41442	.	0	None

41443	41444	Brief	0	None
41444	41445	exposure	0	None
41445	41446	to	0	None
41446	41447	NMDA	3	CHEMICAL
41447	41448	(	0	None
41448	41449	5	0	None
41449	41450	min	0	None
41450	41451	;	0	None
41451	41452	100	0	None
41452	41453	microM	0	None
41453	41454	)	0	None
41454	41455	elicited	0	None
41455	41456	a	0	None
41456	41457	time	0	None
41457	41458	-	0	None
41458	41459	dependent	0	None
41459	41460	accumulation	0	None
41460	41461	of	0	None
41461	41462	PGs	0	None
41462	41463	in	0	None
41463	41464	the	0	None
41464	41465	culture	0	None
41465	41466	medium	0	None
41466	41467	that	0	None
41467	41468	preceded	0	None
41468	41469	neuronal	0	None
41469	41470	cell	0	None
41470	41471	death	0	None
41471	41472	and	0	None
41472	41473	correlated	0	None
41473	41474	with	0	None
41474	41475	the	0	None
41475	41476	induction	0	None
41476	41477	of	0	None
41477	41478	COX	2	GENE-N
41478	41479	-	0	None
41479	41480	2	0	None
41480	41481	mRNA	0	None
41481	41482	.	0	None

41483	41484	COX	2	GENE-N
41484	41485	-	0	None
41485	41486	1	0	None
41486	41487	expression	0	None
41487	41488	remained	0	None
41488	41489	unchanged	0	None
41489	41490	.	0	None

41491	41492	Flurbiprofen	0	None
41492	41493	,	0	None
41493	41494	a	0	None
41494	41495	nonselective	0	None
41495	41496	COX	2	GENE-N
41496	41497	-	0	None
41497	41498	1	0	None
41498	41499	/	0	None
41499	41500	COX	2	GENE-N
41500	41501	-	0	None
41501	41502	2	0	None
41502	41503	inhibitor	0	None
41503	41504	,	0	None
41504	41505	blocked	0	None
41505	41506	NMDA	3	CHEMICAL
41506	41507	-	0	None
41507	41508	stimulated	0	None
41508	41509	PG	3	CHEMICAL
41509	41510	production	0	None
41510	41511	and	0	None
41511	41512	attenuated	0	None
41512	41513	neuronal	0	None
41513	41514	death	0	None
41514	41515	in	0	None
41515	41516	a	0	None
41516	41517	concentration	0	None
41517	41518	-	0	None
41518	41519	dependent	0	None
41519	41520	manner	0	None
41520	41521	.	0	None

41522	41523	Similar	0	None
41523	41524	results	0	None
41524	41525	were	0	None
41525	41526	obtained	0	None
41526	41527	with	0	None
41527	41528	the	0	None
41528	41529	specific	0	None
41529	41530	COX	2	GENE-N
41530	41531	-	0	None
41531	41532	2	0	None
41532	41533	inhibitor	0	None
41533	41534	NS	0	None
41534	41535	-	0	None
41535	41536	398	0	None
41536	41537	(	0	None
41537	41538	10	0	None
41538	41539	-	0	None
41539	41540	30	0	None
41540	41541	microM	0	None
41541	41542	)	0	None
41542	41543	but	0	None
41543	41544	not	0	None
41544	41545	with	0	None
41545	41546	the	0	None
41546	41547	selective	0	None
41547	41548	COX	2	GENE-N
41548	41549	-	0	None
41549	41550	1	0	None
41550	41551	inhibitor	0	None
41551	41553	valeryl salicylate	3	CHEMICAL
41553	41554	(	0	None
41554	41555	10	0	None
41555	41556	-	0	None
41556	41557	300	0	None
41557	41558	microM	0	None
41558	41559	)	0	None
41559	41560	.	0	None

41561	41562	Inhibition	0	None
41562	41563	of	0	None
41563	41564	total	0	None
41564	41565	constitutive	0	None
41565	41566	COX	2	GENE-N
41566	41567	activity	0	None
41567	41568	with	0	None
41568	41569	aspirin	0	None
41569	41570	(	0	None
41570	41571	100	0	None
41571	41572	microM	0	None
41572	41573	,	0	None
41573	41574	1	0	None
41574	41575	.	0	None
41575	41576	5	0	None
41576	41577	h	0	None
41577	41578	)	0	None
41578	41579	before	0	None
41579	41580	NMDA	3	CHEMICAL
41580	41581	exposure	0	None
41581	41582	did	0	None
41582	41583	not	0	None
41583	41584	prevent	0	None
41584	41585	subsequent	0	None
41585	41586	NMDA	3	CHEMICAL
41586	41587	-	0	None
41587	41588	mediated	0	None
41588	41589	neuronal	0	None
41589	41590	cell	0	None
41590	41591	death	0	None
41591	41592	.	0	None

41593	41594	However	0	None
41594	41595	,	0	None
41595	41596	neuronal	0	None
41596	41597	injury	0	None
41597	41598	in	0	None
41598	41599	aspirin	0	None
41599	41600	-	0	None
41600	41601	pretreated	0	None
41601	41602	cultures	0	None
41602	41603	was	0	None
41603	41604	attenuated	0	None
41604	41605	by	0	None
41605	41606	flurbiprofen	3	CHEMICAL
41606	41607	administration	0	None
41607	41608	after	0	None
41608	41609	NMDA	3	CHEMICAL
41609	41610	exposure	0	None
41610	41611	.	0	None

41612	41613	Finally	0	None
41613	41614	,	0	None
41614	41615	the	0	None
41615	41616	protection	0	None
41616	41617	afforded	0	None
41617	41618	by	0	None
41618	41619	COX	2	GENE-N
41619	41620	-	0	None
41620	41621	2	0	None
41621	41622	inhibition	0	None
41622	41623	was	0	None
41623	41624	specific	0	None
41624	41625	for	0	None
41625	41626	NMDA	3	CHEMICAL
41626	41627	because	0	None
41627	41628	neither	0	None
41628	41629	flurbiprofen	3	CHEMICAL
41629	41630	nor	0	None
41630	41631	NS	0	None
41631	41632	-	0	None
41632	41633	398	0	None
41633	41634	protected	0	None
41634	41635	neurons	0	None
41635	41636	against	0	None
41636	41637	kainate	3	CHEMICAL
41637	41638	-	0	None
41638	41639	mediated	0	None
41639	41640	neurotoxicity	0	None
41640	41641	.	0	None

41642	41643	Together	0	None
41643	41644	,	0	None
41644	41645	these	0	None
41645	41646	results	0	None
41646	41647	support	0	None
41647	41648	the	0	None
41648	41649	conclusion	0	None
41649	41650	that	0	None
41650	41651	newly	0	None
41651	41652	synthesized	0	None
41652	41653	COX	2	GENE-N
41653	41654	-	0	None
41654	41655	2	0	None
41655	41656	protein	0	None
41656	41657	contributes	0	None
41657	41658	to	0	None
41658	41659	NMDA	3	CHEMICAL
41659	41660	-	0	None
41660	41661	induced	0	None
41661	41662	neuronal	0	None
41662	41663	injury	0	None
41663	41664	.	0	None

41665	41666	Inhibition	0	None
41666	41667	of	0	None
41667	41668	the	0	None
41668	41669	human	0	None
41669	41670	intermediate	0	None
41670	41671	conductance	0	None
41671	41672	Ca	0	None
41672	41673	(	0	None
41673	41674	2	0	None
41674	41675	+	0	None
41675	41676	)	0	None
41676	41677	-	0	None
41677	41678	activated	0	None
41678	41679	K	0	None
41679	41680	(	0	None
41680	41681	+	0	None
41681	41682	)	0	None
41682	41683	channel	0	None
41683	41684	,	0	None
41684	41685	hIK1	1	GENE-Y
41685	41686	,	0	None
41686	41687	by	0	None
41687	41688	volatile	0	None
41688	41689	anesthetics	0	None
41689	41690	.	0	None

41691	41692	Ca	0	None
41692	41693	(	0	None
41693	41694	2	0	None
41694	41695	+	0	None
41695	41696	)	0	None
41696	41697	-	0	None
41697	41698	activated	0	None
41698	41699	K	0	None
41699	41700	(	0	None
41700	41701	+	0	None
41701	41702	)	0	None
41702	41703	channels	0	None
41703	41704	(	0	None
41704	41705	K	0	None
41705	41706	(	0	None
41706	41707	Ca	0	None
41707	41708	)	0	None
41708	41709	)	0	None
41709	41710	regulate	0	None
41710	41711	a	0	None
41711	41712	wide	0	None
41712	41713	variety	0	None
41713	41714	of	0	None
41714	41715	cellular	0	None
41715	41716	functions	0	None
41716	41717	by	0	None
41717	41718	coupling	0	None
41718	41719	intracellular	0	None
41719	41720	Ca	0	None
41720	41721	(	0	None
41721	41722	2	0	None
41722	41723	+	0	None
41723	41724	)	0	None
41724	41725	concentration	0	None
41725	41726	to	0	None
41726	41727	membrane	0	None
41727	41728	potential	0	None
41728	41729	.	0	None

41730	41731	There	0	None
41731	41732	are	0	None
41732	41733	three	0	None
41733	41734	major	0	None
41734	41735	groups	0	None
41735	41736	of	0	None
41736	41737	K	0	None
41737	41738	(	0	None
41738	41739	Ca	0	None
41739	41740	)	0	None
41740	41741	classified	0	None
41741	41742	by	0	None
41742	41743	their	0	None
41743	41744	unit	0	None
41744	41745	conductances	0	None
41745	41746	:	0	None
41746	41747	large	0	None
41747	41748	(	0	None
41748	41749	BK	0	None
41749	41750	)	0	None
41750	41751	,	0	None
41751	41752	intermediate	0	None
41752	41753	(	0	None
41753	41754	IK	2	GENE-N
41754	41755	)	0	None
41755	41756	,	0	None
41756	41757	and	0	None
41757	41758	small	0	None
41758	41759	(	0	None
41759	41760	SK	2	GENE-N
41760	41761	)	0	None
41761	41762	conductance	0	None
41762	41763	of	0	None
41763	41764	channels	0	None
41764	41765	.	0	None

41766	41767	BK	0	None
41767	41768	channel	0	None
41768	41769	is	0	None
41769	41770	gated	0	None
41770	41771	by	0	None
41771	41772	combined	0	None
41772	41773	influences	0	None
41773	41774	of	0	None
41774	41775	Ca	0	None
41775	41776	(	0	None
41776	41777	2	0	None
41777	41778	+	0	None
41778	41779	)	0	None
41779	41780	and	0	None
41780	41781	voltage	0	None
41781	41782	,	0	None
41782	41783	while	0	None
41783	41784	IK	2	GENE-N
41784	41785	and	0	None
41785	41786	SK	2	GENE-N
41786	41787	channels	0	None
41787	41788	are	0	None
41788	41789	gated	0	None
41789	41790	solely	0	None
41790	41791	by	0	None
41791	41792	Ca	0	None
41792	41793	(	0	None
41793	41794	2	0	None
41794	41795	+	0	None
41795	41796	)	0	None
41796	41797	.	0	None

41798	41799	Volatile	0	None
41799	41800	anesthetics	0	None
41800	41801	inhibit	0	None
41801	41802	BK	0	None
41802	41803	channel	0	None
41803	41804	activity	0	None
41804	41805	by	0	None
41805	41806	interfering	0	None
41806	41807	with	0	None
41807	41808	the	0	None
41808	41809	Ca	0	None
41809	41810	(	0	None
41810	41811	2	0	None
41811	41812	+	0	None
41812	41813	)	0	None
41813	41814	gating	0	None
41814	41815	mechanism	0	None
41815	41816	.	0	None

41817	41818	However	0	None
41818	41819	,	0	None
41819	41820	the	0	None
41820	41821	effects	0	None
41821	41822	of	0	None
41822	41823	anesthetics	0	None
41823	41824	on	0	None
41824	41825	IK	2	GENE-N
41825	41826	and	0	None
41826	41827	SK	2	GENE-N
41827	41828	channels	0	None
41828	41829	are	0	None
41829	41830	unknown	0	None
41830	41831	.	0	None

41832	41833	Using	0	None
41833	41834	cloned	0	None
41834	41835	IK	2	GENE-N
41835	41836	and	0	None
41836	41837	SK	2	GENE-N
41837	41838	channels	0	None
41838	41839	,	0	None
41839	41840	hIK1	1	GENE-Y
41840	41841	and	0	None
41841	41842	hSK1	0	None
41842	41843	-	0	None
41843	41844	3	0	None
41844	41845	,	0	None
41845	41846	respectively	0	None
41846	41847	,	0	None
41847	41848	we	0	None
41848	41849	found	0	None
41849	41850	that	0	None
41850	41851	the	0	None
41851	41852	currents	0	None
41852	41853	of	0	None
41853	41854	hIK1	1	GENE-Y
41854	41855	were	0	None
41855	41856	inhibited	0	None
41856	41857	rapidly	0	None
41857	41858	and	0	None
41858	41859	reversibly	0	None
41859	41860	by	0	None
41860	41861	volatile	0	None
41861	41862	anesthetics	0	None
41862	41863	,	0	None
41863	41864	whereas	0	None
41864	41865	those	0	None
41865	41866	of	0	None
41866	41867	SK	2	GENE-N
41867	41868	channels	0	None
41868	41869	were	0	None
41869	41870	not	0	None
41870	41871	affected	0	None
41871	41872	.	0	None

41873	41874	The	0	None
41874	41875	IC	0	None
41875	41876	(	0	None
41876	41877	50	0	None
41877	41878	)	0	None
41878	41879	values	0	None
41879	41880	of	0	None
41880	41881	the	0	None
41881	41882	volatile	0	None
41882	41883	anesthetics	0	None
41883	41884	,	0	None
41884	41885	halothane	3	CHEMICAL
41885	41886	,	0	None
41886	41887	sevoflurane	3	CHEMICAL
41887	41888	,	0	None
41888	41889	enflurane	3	CHEMICAL
41889	41890	,	0	None
41890	41891	and	0	None
41891	41892	isoflurane	3	CHEMICAL
41892	41893	for	0	None
41893	41894	hIK1	1	GENE-Y
41894	41895	inhibition	0	None
41895	41896	were	0	None
41896	41897	0	0	None
41897	41898	.	0	None
41898	41899	69	0	None
41899	41900	,	0	None
41900	41901	0	0	None
41901	41902	.	0	None
41902	41903	42	0	None
41903	41904	,	0	None
41904	41905	1	0	None
41905	41906	.	0	None
41906	41907	01	0	None
41907	41908	and	0	None
41908	41909	1	0	None
41909	41910	.	0	None
41910	41911	03	0	None
41911	41912	mM	0	None
41912	41913	,	0	None
41913	41914	respectively	0	None
41914	41915	,	0	None
41915	41916	and	0	None
41916	41917	were	0	None
41917	41918	in	0	None
41918	41919	the	0	None
41919	41920	clinically	0	None
41920	41921	used	0	None
41921	41922	concentration	0	None
41922	41923	range	0	None
41923	41924	.	0	None

41925	41926	In	0	None
41926	41927	contrast	0	None
41927	41928	to	0	None
41928	41929	BK	0	None
41929	41930	channel	0	None
41930	41931	,	0	None
41931	41932	halothane	3	CHEMICAL
41932	41933	inhibition	0	None
41933	41934	of	0	None
41934	41935	hIK1	1	GENE-Y
41935	41936	currents	0	None
41936	41937	was	0	None
41937	41938	independent	0	None
41938	41939	of	0	None
41939	41940	Ca	0	None
41940	41941	(	0	None
41941	41942	2	0	None
41942	41943	+	0	None
41943	41944	)	0	None
41944	41945	concentration	0	None
41945	41946	,	0	None
41946	41947	suggesting	0	None
41947	41948	that	0	None
41948	41949	Ca	0	None
41949	41950	(	0	None
41950	41951	2	0	None
41951	41952	+	0	None
41952	41953	)	0	None
41953	41954	gating	0	None
41954	41955	mechanism	0	None
41955	41956	is	0	None
41956	41957	not	0	None
41957	41958	involved	0	None
41958	41959	.	0	None

41960	41961	These	0	None
41961	41962	results	0	None
41962	41963	demonstrate	0	None
41963	41964	that	0	None
41964	41965	volatile	0	None
41965	41966	anesthetics	0	None
41966	41967	,	0	None
41967	41968	such	0	None
41968	41969	as	0	None
41969	41970	halothane	3	CHEMICAL
41970	41971	,	0	None
41971	41972	enflurane	3	CHEMICAL
41972	41973	,	0	None
41973	41974	isoflurane	3	CHEMICAL
41974	41975	,	0	None
41975	41976	and	0	None
41976	41977	sevoflurane	3	CHEMICAL
41977	41978	,	0	None
41978	41979	affect	0	None
41979	41980	BK	0	None
41980	41981	,	0	None
41981	41982	IK	2	GENE-N
41982	41983	,	0	None
41983	41984	and	0	None
41984	41985	SK	2	GENE-N
41985	41986	channels	0	None
41986	41987	in	0	None
41987	41988	distinct	0	None
41988	41989	ways	0	None
41989	41990	.	0	None

41991	41992	Characterization	0	None
41992	41993	of	0	None
41993	41994	phentermine	3	CHEMICAL
41994	41995	and	0	None
41995	41996	related	0	None
41996	41997	compounds	0	None
41997	41998	as	0	None
41998	42000	monoamine oxidase	2	GENE-N
42000	42001	(	0	None
42001	42002	MAO	2	GENE-N
42002	42003	)	0	None
42003	42004	inhibitors	0	None
42004	42005	.	0	None

42006	42007	Phentermine	0	None
42007	42008	was	0	None
42008	42009	shown	0	None
42009	42010	in	0	None
42010	42011	the	0	None
42011	42012	1970s	0	None
42012	42013	to	0	None
42013	42014	inhibit	0	None
42014	42015	the	0	None
42015	42016	metabolism	0	None
42016	42017	of	0	None
42017	42018	serotonin	3	CHEMICAL
42018	42019	by	0	None
42019	42021	monoamine oxidase	2	GENE-N
42021	42022	(	0	None
42022	42023	MAO	2	GENE-N
42023	42024	)	0	None
42024	42025	,	0	None
42025	42026	but	0	None
42026	42027	never	0	None
42027	42028	was	0	None
42028	42029	labeled	0	None
42029	42030	as	0	None
42030	42031	an	0	None
42031	42032	MAO	2	GENE-N
42032	42033	inhibitor	0	None
42033	42034	;	0	None
42034	42035	hence	0	None
42035	42036	,	0	None
42036	42037	it	0	None
42037	42038	was	0	None
42038	42039	widely	0	None
42039	42040	used	0	None
42040	42041	in	0	None
42041	42042	combination	0	None
42042	42043	with	0	None
42043	42044	fenfluramine	3	CHEMICAL
42044	42045	,	0	None
42045	42046	and	0	None
42046	42047	continues	0	None
42047	42048	to	0	None
42048	42049	be	0	None
42049	42050	used	0	None
42050	42051	,	0	None
42051	42052	in	0	None
42052	42053	violation	0	None
42053	42054	of	0	None
42054	42055	their	0	None
42055	42056	labels	0	None
42056	42057	,	0	None
42057	42058	with	0	None
42058	42059	other	0	None
42059	42060	serotonin	3	CHEMICAL
42060	42061	uptake	0	None
42061	42062	blockers	0	None
42062	42063	.	0	None

42064	42065	We	0	None
42065	42066	examined	0	None
42066	42067	the	0	None
42067	42068	effects	0	None
42068	42069	of	0	None
42069	42070	phentermine	3	CHEMICAL
42070	42071	and	0	None
42071	42072	several	0	None
42072	42073	other	0	None
42073	42074	unlabeled	0	None
42074	42075	MAO	2	GENE-N
42075	42076	inhibitors	0	None
42076	42077	on	0	None
42077	42078	MAO	2	GENE-N
42078	42079	activities	0	None
42079	42080	in	0	None
42080	42081	rat	0	None
42081	42082	lung	0	None
42082	42083	,	0	None
42083	42084	brain	0	None
42084	42085	,	0	None
42085	42086	and	0	None
42086	42087	liver	0	None
42087	42088	,	0	None
42088	42089	and	0	None
42089	42090	also	0	None
42090	42091	the	0	None
42091	42092	interactions	0	None
42092	42093	of	0	None
42093	42094	such	0	None
42094	42095	drugs	0	None
42095	42096	when	0	None
42096	42097	administered	0	None
42097	42098	together	0	None
42098	42099	.	0	None

42100	42101	Rat	0	None
42101	42102	tissues	0	None
42102	42103	were	0	None
42103	42104	assayed	0	None
42104	42105	for	0	None
42105	42106	MAO	2	GENE-N
42106	42107	-	0	None
42107	42108	A	0	None
42108	42109	and	0	None
42109	42110	-	0	None
42110	42111	B	0	None
42111	42112	,	0	None
42112	42113	using	0	None
42113	42114	serotonin	3	CHEMICAL
42114	42115	and	0	None
42115	42116	beta	0	None
42116	42117	-	0	None
42117	42118	phenylethylamine	3	CHEMICAL
42118	42119	as	0	None
42119	42120	substrates	0	None
42120	42121	.	0	None

42122	42123	Phentermine	0	None
42123	42124	inhibited	0	None
42124	42125	serotonin	3	CHEMICAL
42125	42126	-	0	None
42126	42127	metabolizing	0	None
42127	42128	(	0	None
42128	42129	MAO	2	GENE-N
42129	42130	-	0	None
42130	42131	A	0	None
42131	42132	)	0	None
42132	42133	activity	0	None
42133	42134	in	0	None
42134	42135	all	0	None
42135	42136	three	0	None
42136	42137	tissues	0	None
42137	42138	with	0	None
42138	42139	K	0	None
42139	42140	(	0	None
42140	42141	i	0	None
42141	42142	)	0	None
42142	42143	values	0	None
42143	42144	of	0	None
42144	42145	85	0	None
42145	42146	-	0	None
42146	42147	88	0	None
42147	42148	microM	0	None
42148	42149	.	0	None

42150	42151	These	0	None
42151	42152	potencies	0	None
42152	42153	were	0	None
42153	42154	similar	0	None
42154	42155	to	0	None
42155	42156	those	0	None
42156	42157	of	0	None
42157	42158	the	0	None
42158	42159	antidepressant	0	None
42159	42160	MAO	2	GENE-N
42160	42161	inhibitors	0	None
42161	42162	iproniazid	3	CHEMICAL
42162	42163	and	0	None
42163	42164	moclobemide	3	CHEMICAL
42164	42165	.	0	None

42166	42167	When	0	None
42167	42168	phentermine	3	CHEMICAL
42168	42169	was	0	None
42169	42170	mixed	0	None
42170	42171	with	0	None
42171	42172	other	0	None
42172	42173	unlabeled	0	None
42173	42174	reversible	0	None
42174	42175	MAO	2	GENE-N
42175	42176	inhibitors	0	None
42176	42177	(	0	None
42177	42178	e	0	None
42178	42179	.	0	None
42179	42180	g	0	None
42180	42181	.	0	None
42181	42182	pseudoephedrine	0	None
42182	42183	,	0	None
42183	42184	ephedrine	3	CHEMICAL
42184	42185	,	0	None
42185	42186	norephedrine	3	CHEMICAL
42186	42187	;	0	None
42187	42188	estradiol	3	CHEMICAL
42188	42189	benzoate	0	None
42189	42190	)	0	None
42190	42191	,	0	None
42191	42192	the	0	None
42192	42193	degree	0	None
42193	42194	of	0	None
42194	42195	MAO	2	GENE-N
42195	42196	inhibition	0	None
42196	42197	was	0	None
42197	42198	additive	0	None
42198	42199	.	0	None

42200	42201	The	0	None
42201	42202	cardiac	0	None
42202	42203	valvular	0	None
42203	42204	lesions	0	None
42204	42205	and	0	None
42205	42206	primary	0	None
42206	42207	pulmonary	0	None
42207	42208	hypertension	0	None
42208	42209	that	0	None
42209	42210	have	0	None
42210	42211	been	0	None
42211	42212	reported	0	None
42212	42213	to	0	None
42213	42214	be	0	None
42214	42215	associated	0	None
42215	42216	with	0	None
42216	42217	fenfluramine	3	CHEMICAL
42217	42218	-	0	None
42218	42219	phentermine	3	CHEMICAL
42219	42220	use	0	None
42220	42221	may	0	None
42221	42222	have	0	None
42222	42223	resulted	0	None
42223	42224	from	0	None
42224	42225	the	0	None
42225	42226	intermittent	0	None
42226	42227	concurrent	0	None
42227	42228	blockage	0	None
42228	42229	of	0	None
42229	42230	both	0	None
42230	42231	serotonin	3	CHEMICAL
42231	42232	uptake	0	None
42232	42233	and	0	None
42233	42234	metabolism	0	None
42234	42235	.	0	None

42236	42237	Comparison	0	None
42237	42238	of	0	None
42238	42239	the	0	None
42239	42240	AT1	1	GENE-Y
42240	42241	-	0	None
42241	42242	receptor	0	None
42242	42243	blocker	0	None
42243	42244	,	0	None
42244	42246	candesartan cilexetil	3	CHEMICAL
42246	42247	,	0	None
42247	42248	and	0	None
42248	42249	the	0	None
42249	42250	ACE	1	GENE-Y
42250	42251	inhibitor	0	None
42251	42252	,	0	None
42252	42253	lisinopril	3	CHEMICAL
42253	42254	,	0	None
42254	42255	in	0	None
42255	42256	fixed	0	None
42256	42257	combination	0	None
42257	42258	with	0	None
42258	42259	low	0	None
42259	42260	dose	0	None
42260	42261	hydrochlorothiazide	3	CHEMICAL
42261	42262	in	0	None
42262	42263	hypertensive	0	None
42263	42264	patients	0	None
42264	42265	.	0	None

42266	42267	AIM	0	None
42267	42268	:	0	None
42268	42269	To	0	None
42269	42270	compare	0	None
42270	42272	candesartan cilexetil	3	CHEMICAL
42272	42273	and	0	None
42273	42274	lisinopril	3	CHEMICAL
42274	42275	in	0	None
42275	42276	fixed	0	None
42276	42277	combination	0	None
42277	42278	with	0	None
42278	42279	hydrochlorothiazide	3	CHEMICAL
42279	42280	with	0	None
42280	42281	respect	0	None
42281	42282	to	0	None
42282	42283	antihypertensive	0	None
42283	42284	efficacy	0	None
42284	42285	and	0	None
42285	42286	tolerability	0	None
42286	42287	.	0	None

42288	42289	METHODS	0	None
42289	42290	:	0	None
42290	42291	This	0	None
42291	42292	was	0	None
42292	42293	a	0	None
42293	42294	double	0	None
42294	42295	-	0	None
42295	42296	blind	0	None
42296	42297	(	0	None
42297	42298	double	0	None
42298	42299	-	0	None
42299	42300	dummy	0	None
42300	42301	)	0	None
42301	42302	,	0	None
42302	42303	randomised	0	None
42303	42304	,	0	None
42304	42305	parallel	0	None
42305	42306	group	0	None
42306	42307	comparison	0	None
42307	42308	in	0	None
42308	42309	patients	0	None
42309	42310	with	0	None
42310	42311	a	0	None
42311	42312	mean	0	None
42312	42313	sitting	0	None
42313	42314	diastolic	0	None
42314	42315	blood	0	None
42315	42316	pressure	0	None
42316	42317	95	0	None
42317	42318	-	0	None
42318	42319	115	0	None
42319	42320	mm	0	None
42320	42321	Hg	3	CHEMICAL
42321	42322	on	0	None
42322	42323	prior	0	None
42323	42324	antihypertensive	0	None
42324	42325	monotherapy	0	None
42325	42326	.	0	None

42327	42328	Treatments	0	None
42328	42329	were	0	None
42329	42331	candesartan cilexetil	3	CHEMICAL
42331	42332	/	0	None
42332	42333	hydrochlorothiazide	3	CHEMICAL
42333	42334	8	0	None
42334	42335	/	0	None
42335	42336	12	0	None
42336	42337	.	0	None
42337	42338	5	0	None
42338	42339	mg	0	None
42339	42340	once	0	None
42340	42341	daily	0	None
42341	42342	(	0	None
42342	42343	n	0	None
42343	42344	=	0	None
42344	42345	237	0	None
42345	42346	)	0	None
42346	42347	and	0	None
42347	42348	lisinopril	3	CHEMICAL
42348	42349	/	0	None
42349	42350	hydrochlorothiazide	3	CHEMICAL
42350	42351	10	0	None
42351	42352	/	0	None
42352	42353	12	0	None
42353	42354	.	0	None
42354	42355	5	0	None
42355	42356	mg	0	None
42356	42357	once	0	None
42357	42358	daily	0	None
42358	42359	(	0	None
42359	42360	n	0	None
42360	42361	=	0	None
42361	42362	116	0	None
42362	42363	)	0	None
42363	42364	for	0	None
42364	42365	26	0	None
42365	42366	weeks	0	None
42366	42367	.	0	None

42368	42369	The	0	None
42369	42370	primary	0	None
42370	42371	efficacy	0	None
42371	42372	variable	0	None
42372	42373	was	0	None
42373	42374	change	0	None
42374	42375	in	0	None
42375	42376	trough	0	None
42376	42377	sitting	0	None
42377	42378	diastolic	0	None
42378	42379	blood	0	None
42379	42380	pressure	0	None
42380	42381	.	0	None

42382	42383	RESULTS	0	None
42383	42384	:	0	None
42384	42385	Changes	0	None
42385	42386	in	0	None
42386	42387	mean	0	None
42387	42388	sitting	0	None
42388	42389	diastolic	0	None
42389	42390	blood	0	None
42390	42391	pressure	0	None
42391	42392	did	0	None
42392	42393	not	0	None
42393	42394	differ	0	None
42394	42395	significantly	0	None
42395	42396	between	0	None
42396	42397	the	0	None
42397	42398	groups	0	None
42398	42399	(	0	None
42399	42400	mean	0	None
42400	42401	difference	0	None
42401	42402	0	0	None
42402	42403	.	0	None
42403	42404	5	0	None
42404	42405	mm	0	None
42405	42406	Hg	3	CHEMICAL
42406	42407	;	0	None
42407	42408	95	0	None
42408	42409	%	0	None
42409	42410	confidence	0	None
42410	42411	interval	0	None
42411	42412	-	0	None
42412	42413	1	0	None
42413	42414	.	0	None
42414	42415	6	0	None
42415	42416	,	0	None
42416	42417	2	0	None
42417	42418	.	0	None
42418	42419	7	0	None
42419	42420	,	0	None
42420	42421	P	0	None
42421	42422	=	0	None
42422	42423	0	0	None
42423	42424	.	0	None
42424	42425	20	0	None
42425	42426	)	0	None
42426	42427	.	0	None

42428	42429	No	0	None
42429	42430	significant	0	None
42430	42431	differences	0	None
42431	42432	between	0	None
42432	42433	the	0	None
42433	42434	groups	0	None
42434	42435	was	0	None
42435	42436	found	0	None
42436	42437	for	0	None
42437	42438	other	0	None
42438	42439	haemodynamic	0	None
42439	42440	variables	0	None
42440	42441	(	0	None
42441	42442	sitting	0	None
42442	42443	systolic	0	None
42443	42444	blood	0	None
42444	42445	pressure	0	None
42445	42446	,	0	None
42446	42447	standing	0	None
42447	42448	blood	0	None
42448	42449	pressure	0	None
42449	42450	,	0	None
42450	42451	sitting	0	None
42451	42452	/	0	None
42452	42453	erect	0	None
42453	42454	heart	0	None
42454	42455	rate	0	None
42455	42456	,	0	None
42456	42457	and	0	None
42457	42458	proportion	0	None
42458	42459	of	0	None
42459	42460	responders	0	None
42460	42461	and	0	None
42461	42462	controlled	0	None
42462	42463	patients	0	None
42463	42464	)	0	None
42464	42465	.	0	None

42466	42467	Both	0	None
42467	42468	drugs	0	None
42468	42469	were	0	None
42469	42470	well	0	None
42470	42471	tolerated	0	None
42471	42472	but	0	None
42472	42473	the	0	None
42473	42474	proportion	0	None
42474	42475	of	0	None
42475	42476	patients	0	None
42476	42477	with	0	None
42477	42478	at	0	None
42478	42479	least	0	None
42479	42480	one	0	None
42480	42481	adverse	0	None
42481	42482	event	0	None
42482	42483	was	0	None
42483	42484	significantly	0	None
42484	42485	greater	0	None
42485	42486	in	0	None
42486	42487	the	0	None
42487	42488	lisinopril	3	CHEMICAL
42488	42489	group	0	None
42489	42490	(	0	None
42490	42491	80	0	None
42491	42492	%	0	None
42492	42493	vs	0	None
42493	42494	69	0	None
42494	42495	%	0	None
42495	42496	,	0	None
42496	42497	P	0	None
42497	42498	=	0	None
42498	42499	0	0	None
42499	42500	.	0	None
42500	42501	020	0	None
42501	42502	)	0	None
42502	42503	.	0	None

42504	42505	The	0	None
42505	42506	proportion	0	None
42506	42507	of	0	None
42507	42508	patients	0	None
42508	42509	spontaneously	0	None
42509	42510	reporting	0	None
42510	42511	cough	0	None
42511	42512	(	0	None
42512	42513	23	0	None
42513	42514	.	0	None
42514	42515	1	0	None
42515	42516	%	0	None
42516	42517	vs	0	None
42517	42518	4	0	None
42518	42519	.	0	None
42519	42520	6	0	None
42520	42521	%	0	None
42521	42522	)	0	None
42522	42523	and	0	None
42523	42524	discontinuing	0	None
42524	42525	therapy	0	None
42525	42526	due	0	None
42526	42527	to	0	None
42527	42528	adverse	0	None
42528	42529	events	0	None
42529	42530	(	0	None
42530	42531	12	0	None
42531	42532	.	0	None
42532	42533	0	0	None
42533	42534	%	0	None
42534	42535	vs	0	None
42535	42536	5	0	None
42536	42537	.	0	None
42537	42538	9	0	None
42538	42539	%	0	None
42539	42540	)	0	None
42540	42541	was	0	None
42541	42542	also	0	None
42542	42543	higher	0	None
42543	42544	in	0	None
42544	42545	the	0	None
42545	42546	lisinopril	3	CHEMICAL
42546	42547	group	0	None
42547	42548	compared	0	None
42548	42549	with	0	None
42549	42550	the	0	None
42550	42552	candesartan cilexetil	3	CHEMICAL
42552	42553	group	0	None
42553	42554	.	0	None

42555	42556	CONCLUSIONS	0	None
42556	42557	:	0	None
42557	42558	The	0	None
42558	42559	fixed	0	None
42559	42560	combinations	0	None
42560	42561	of	0	None
42561	42563	candesartan cilexetil	3	CHEMICAL
42563	42564	and	0	None
42564	42565	hydrochlorothiazide	3	CHEMICAL
42565	42566	8	0	None
42566	42567	/	0	None
42567	42568	12	0	None
42568	42569	.	0	None
42569	42570	5	0	None
42570	42571	mg	0	None
42571	42572	and	0	None
42572	42573	lisinopril	3	CHEMICAL
42573	42574	and	0	None
42574	42575	hydrochlorothiazide	3	CHEMICAL
42575	42576	10	0	None
42576	42577	/	0	None
42577	42578	12	0	None
42578	42579	.	0	None
42579	42580	5	0	None
42580	42581	mg	0	None
42581	42582	once	0	None
42582	42583	daily	0	None
42583	42584	are	0	None
42584	42585	equally	0	None
42585	42586	effective	0	None
42586	42587	as	0	None
42587	42588	antihypertensive	0	None
42588	42589	agents	0	None
42589	42590	.	0	None

42591	42592	The	0	None
42592	42593	fixed	0	None
42593	42594	combination	0	None
42594	42595	containing	0	None
42595	42597	candesartan cilexetil	3	CHEMICAL
42597	42598	is	0	None
42598	42599	better	0	None
42599	42600	tolerated	0	None
42600	42601	than	0	None
42601	42602	that	0	None
42602	42603	containing	0	None
42603	42604	lisinopril	3	CHEMICAL
42604	42605	.	0	None

42606	42607	NADH	3	CHEMICAL
42607	42608	-	0	None
42608	42609	ferric	3	CHEMICAL
42609	42610	reductase	2	GENE-N
42610	42611	activity	0	None
42611	42612	associated	0	None
42612	42613	with	0	None
42613	42614	dihydropteridine	0	None
42614	42615	reductase	2	GENE-N
42615	42616	.	0	None

42617	42618	In	0	None
42618	42619	mammals	0	None
42619	42622	dietary ferric iron	3	CHEMICAL
42622	42623	is	0	None
42623	42624	reduced	0	None
42624	42625	to	0	None
42625	42627	ferrous iron	3	CHEMICAL
42627	42628	for	0	None
42628	42629	more	0	None
42629	42630	efficient	0	None
42630	42631	absorption	0	None
42631	42632	by	0	None
42632	42633	the	0	None
42633	42634	intestine	0	None
42634	42635	.	0	None

42636	42637	Analysis	0	None
42637	42638	of	0	None
42638	42639	a	0	None
42639	42640	pig	0	None
42640	42641	duodenal	0	None
42641	42642	membrane	0	None
42642	42643	fraction	0	None
42643	42644	revealed	0	None
42644	42645	two	0	None
42645	42646	NADH	3	CHEMICAL
42646	42647	-	0	None
42647	42648	dependent	0	None
42648	42650	ferric reductase	2	GENE-N
42650	42651	activities	0	None
42651	42652	,	0	None
42652	42653	one	0	None
42653	42654	associated	0	None
42654	42655	with	0	None
42655	42656	a	0	None
42656	42657	b	0	None
42657	42658	-	0	None
42658	42659	type	0	None
42659	42660	cytochrome	2	GENE-N
42660	42661	and	0	None
42661	42662	the	0	None
42662	42663	other	0	None
42663	42664	not	0	None
42664	42665	.	0	None

42666	42667	Purification	0	None
42667	42668	and	0	None
42668	42669	characterization	0	None
42669	42670	of	0	None
42670	42671	the	0	None
42671	42672	non	0	None
42672	42673	-	0	None
42673	42676	cytochrome ferric reductase	2	GENE-N
42676	42677	identified	0	None
42677	42678	a	0	None
42678	42679	31	0	None
42679	42680	kDa	0	None
42680	42681	protein	0	None
42681	42682	.	0	None

42683	42684	MALDI	0	None
42684	42685	-	0	None
42685	42686	MS	0	None
42686	42687	analysis	0	None
42687	42688	and	0	None
42688	42690	amino acid	3	CHEMICAL
42690	42691	sequencing	0	None
42691	42692	identified	0	None
42692	42693	the	0	None
42693	42695	ferric reductase	2	GENE-N
42695	42696	as	0	None
42696	42697	being	0	None
42697	42698	related	0	None
42698	42699	to	0	None
42699	42700	the	0	None
42700	42701	26	0	None
42701	42702	kDa	0	None
42702	42703	liver	0	None
42703	42704	NADH	3	CHEMICAL
42704	42705	-	0	None
42705	42706	dependent	0	None
42706	42709	quinoid dihydropteridine reductase	2	GENE-N
42709	42710	(	0	None
42710	42711	DHPR	0	None
42711	42712	)	0	None
42712	42713	.	0	None

42714	42715	The	0	None
42715	42716	NADH	3	CHEMICAL
42716	42717	-	0	None
42717	42718	dependent	0	None
42718	42719	DHPR	0	None
42719	42721	ferric reductase	2	GENE-N
42721	42722	activity	0	None
42722	42723	was	0	None
42723	42724	found	0	None
42724	42725	to	0	None
42725	42726	be	0	None
42726	42727	pteridine	3	CHEMICAL
42727	42728	-	0	None
42728	42729	independent	0	None
42729	42730	since	0	None
42730	42731	exhaustive	0	None
42731	42732	dialysis	0	None
42732	42733	did	0	None
42733	42734	not	0	None
42734	42735	reduce	0	None
42735	42736	activity	0	None
42736	42737	and	0	None
42737	42738	heat	1	GENE-Y
42738	42739	-	0	None
42739	42740	inactivation	0	None
42740	42741	destroyed	0	None
42741	42742	activity	0	None
42742	42743	.	0	None

42744	42745	In	0	None
42745	42746	intestinal	0	None
42746	42747	Caco	0	None
42747	42748	-	0	None
42748	42749	2	0	None
42749	42750	cells	0	None
42750	42751	,	0	None
42751	42752	DHPR	0	None
42752	42753	mRNA	0	None
42753	42754	levels	0	None
42754	42755	were	0	None
42755	42756	found	0	None
42756	42757	to	0	None
42757	42758	be	0	None
42758	42759	regulated	0	None
42759	42760	by	0	None
42760	42761	iron	3	CHEMICAL
42761	42762	.	0	None

42763	42764	Thus	0	None
42764	42765	,	0	None
42765	42766	DHPR	0	None
42766	42767	appears	0	None
42767	42768	to	0	None
42768	42769	be	0	None
42769	42770	a	0	None
42770	42771	dual	0	None
42771	42772	function	0	None
42772	42773	enzyme	0	None
42773	42774	,	0	None
42774	42775	a	0	None
42775	42776	NADH	3	CHEMICAL
42776	42777	-	0	None
42777	42778	dependent	0	None
42778	42780	dihydopteridine reductase	2	GENE-N
42780	42781	and	0	None
42781	42782	an	0	None
42782	42783	iron	3	CHEMICAL
42783	42784	-	0	None
42784	42785	regulated	0	None
42785	42786	,	0	None
42786	42787	NADH	3	CHEMICAL
42787	42788	-	0	None
42788	42789	dependent	0	None
42789	42790	,	0	None
42790	42791	pteridine	3	CHEMICAL
42791	42792	-	0	None
42792	42793	independent	0	None
42793	42795	ferric reductase	2	GENE-N
42795	42796	.	0	None

42797	42798	Functional	0	None
42798	42799	evidence	0	None
42799	42800	that	0	None
42800	42801	gastroprotection	0	None
42801	42802	can	0	None
42802	42803	be	0	None
42803	42804	induced	0	None
42804	42805	by	0	None
42805	42806	activation	0	None
42806	42807	of	0	None
42807	42808	central	0	None
42808	42809	alpha	0	None
42809	42810	(	0	None
42810	42811	2B	0	None
42811	42812	)	0	None
42812	42813	-	0	None
42813	42814	adrenoceptor	0	None
42814	42815	subtypes	0	None
42815	42816	in	0	None
42816	42817	the	0	None
42817	42818	rat	0	None
42818	42819	.	0	None

42820	42821	Clonidine	0	None
42821	42822	injected	0	None
42822	42823	intracerebroventricularly	0	None
42823	42824	(	0	None
42824	42825	i	0	None
42825	42826	.	0	None
42826	42827	c	0	None
42827	42828	.	0	None
42828	42829	v	0	None
42829	42830	.	0	None
42830	42831	)	0	None
42831	42832	(	0	None
42832	42833	0	0	None
42833	42834	.	0	None
42834	42835	47	0	None
42835	42836	nmol	0	None
42836	42837	/	0	None
42837	42838	rat	0	None
42838	42839	)	0	None
42839	42840	exerted	0	None
42840	42841	gastric	0	None
42841	42842	mucosal	0	None
42842	42843	protective	0	None
42843	42844	effect	0	None
42844	42845	against	0	None
42845	42846	acidified	0	None
42846	42847	ethanol	0	None
42847	42848	.	0	None

42849	42850	Evidence	0	None
42850	42851	was	0	None
42851	42852	obtained	0	None
42852	42853	that	0	None
42853	42854	the	0	None
42854	42855	gastroprotective	0	None
42855	42856	effect	0	None
42856	42857	of	0	None
42857	42858	clonidine	3	CHEMICAL
42858	42859	was	0	None
42859	42860	blocked	0	None
42860	42861	by	0	None
42861	42862	i	0	None
42862	42863	.	0	None
42863	42864	c	0	None
42864	42865	.	0	None
42865	42866	v	0	None
42866	42867	.	0	None
42867	42868	injected	0	None
42868	42869	alpha	0	None
42869	42870	(	0	None
42870	42871	2	0	None
42871	42872	)	0	None
42872	42873	-	0	None
42873	42874	adrenoceptor	0	None
42874	42875	antagonists	0	None
42875	42876	yohimbine	3	CHEMICAL
42876	42877	(	0	None
42877	42878	non	0	None
42878	42879	-	0	None
42879	42880	subtype	0	None
42880	42881	selective	0	None
42881	42882	antagonist	0	None
42882	42883	)	0	None
42883	42884	,	0	None
42884	42885	prazosin	3	CHEMICAL
42885	42886	and	0	None
42886	42887	2	0	None
42887	42888	-	0	None
42888	42889	[	0	None
42889	42890	2	0	None
42890	42891	-	0	None
42891	42892	(	0	None
42892	42893	4	0	None
42893	42894	-	0	None
42894	42895	(	0	None
42895	42896	O	0	None
42896	42897	-	0	None
42897	42898	methoxyphenyl	3	CHEMICAL
42898	42899	)	0	None
42899	42900	piperazin	0	None
42900	42901	-	0	None
42901	42902	1	0	None
42902	42903	-	0	None
42903	42904	yl	0	None
42904	42905	)	0	None
42905	42906	ethyl	3	CHEMICAL
42906	42907	]	0	None
42907	42908	-	0	None
42908	42909	4	0	None
42909	42910	,	0	None
42910	42911	4	0	None
42911	42912	-	0	None
42912	42913	dimethyl	0	None
42913	42914	-	0	None
42914	42915	1	0	None
42915	42916	,	0	None
42916	42917	3	0	None
42917	42918	-	0	None
42918	42919	(	0	None
42919	42920	2	0	None
42920	42921	H	0	None
42921	42922	,	0	None
42922	42923	4H	0	None
42923	42924	)	0	None
42924	42925	-	0	None
42925	42926	isoquinolindione	0	None
42926	42927	(	0	None
42927	42928	ARC	0	None
42928	42929	-	0	None
42929	42930	239	0	None
42930	42931	)	0	None
42931	42932	(	0	None
42932	42933	representative	0	None
42933	42934	alpha	0	None
42934	42935	(	0	None
42935	42936	2B	0	None
42936	42937	/	0	None
42937	42938	2C	0	None
42938	42939	)	0	None
42939	42940	-	0	None
42940	42941	adrenoceptor	0	None
42941	42942	blocking	0	None
42942	42943	agents	0	None
42943	42944	)	0	None
42944	42945	and	0	None
42945	42947	opioid receptor	2	GENE-N
42947	42948	antagonists	0	None
42948	42949	naloxone	3	CHEMICAL
42949	42950	(	0	None
42950	42951	a	0	None
42951	42952	non	0	None
42952	42953	-	0	None
42953	42954	selective	0	None
42954	42955	,	0	None
42955	42956	moderately	0	None
42956	42957	mu	1	GENE-Y
42957	42958	-	0	None
42958	42960	opioid receptor	2	GENE-N
42960	42961	preferring	0	None
42961	42962	antagonist	0	None
42962	42963	)	0	None
42963	42964	,	0	None
42964	42965	naltrindole	0	None
42965	42966	and	0	None
42966	42967	naltriben	3	CHEMICAL
42967	42968	delta	2	GENE-N
42968	42969	-	0	None
42969	42971	opioid receptor	2	GENE-N
42971	42972	antagonists	0	None
42972	42973	)	0	None
42973	42974	.	0	None

42975	42976	The	0	None
42976	42977	centrally	0	None
42977	42978	injected	0	None
42978	42979	naltrindole	0	None
42979	42980	(	0	None
42980	42981	0	0	None
42981	42982	.	0	None
42982	42983	5	0	None
42983	42984	nmol	0	None
42984	42985	/	0	None
42985	42986	rat	0	None
42986	42987	)	0	None
42987	42988	antagonised	0	None
42988	42989	also	0	None
42989	42990	the	0	None
42990	42991	gastroprotective	0	None
42991	42992	effect	0	None
42992	42993	of	0	None
42993	42994	clonidine	3	CHEMICAL
42994	42995	-	0	None
42995	42996	-	0	None
42996	42997	but	0	None
42997	42998	not	0	None
42998	42999	that	0	None
42999	43000	of	0	None
43000	43001	the	0	None
43001	43002	delta	0	None
43002	43003	-	0	None
43003	43004	agonist	0	None
43004	43005	[	0	None
43005	43006	D	0	None
43006	43007	-	0	None
43007	43008	Ala	0	None
43008	43009	(	0	None
43009	43010	2	0	None
43010	43011	)	0	None
43011	43012	,	0	None
43012	43013	D	0	None
43013	43014	-	0	None
43014	43015	Leu	3	CHEMICAL
43015	43016	(	0	None
43016	43017	5	0	None
43017	43018	)	0	None
43018	43019	]	0	None
43019	43020	enkephalin	2	GENE-N
43020	43021	-	0	None
43021	43022	-	0	None
43022	43023	administered	0	None
43023	43024	peripherally	0	None
43024	43025	.	0	None

43026	43027	The	0	None
43027	43028	results	0	None
43028	43029	suggest	0	None
43029	43030	that	0	None
43030	43031	central	0	None
43031	43032	alpha	0	None
43032	43033	(	0	None
43033	43034	2B	0	None
43034	43035	/	0	None
43035	43036	2C	0	None
43036	43037	)	0	None
43037	43038	-	0	None
43038	43039	adrenoceptor	0	None
43039	43040	subtypes	0	None
43040	43041	and	0	None
43041	43042	opioid	0	None
43042	43043	-	0	None
43043	43044	-	0	None
43044	43045	particularly	0	None
43045	43046	delta	0	None
43046	43047	-	0	None
43047	43048	-	0	None
43048	43049	receptors	0	None
43049	43050	are	0	None
43050	43051	likely	0	None
43051	43052	to	0	None
43052	43053	be	0	None
43053	43054	involved	0	None
43054	43055	in	0	None
43055	43056	the	0	None
43056	43057	gastric	0	None
43057	43058	mucosal	0	None
43058	43059	protective	0	None
43059	43060	effect	0	None
43060	43061	of	0	None
43061	43062	clonidine	3	CHEMICAL
43062	43063	.	0	None

43064	43065	Irbesartan	0	None
43065	43066	:	0	None
43066	43067	review	0	None
43067	43068	of	0	None
43068	43069	pharmacology	0	None
43069	43070	and	0	None
43070	43071	comparative	0	None
43071	43072	properties	0	None
43072	43073	.	0	None

43074	43075	The	0	None
43075	43076	recently	0	None
43076	43077	developed	0	None
43077	43078	and	0	None
43078	43079	marketed	0	None
43079	43083	angiotensin II type 1	1	GENE-Y
43083	43084	(	0	None
43084	43085	AT1	1	GENE-Y
43085	43086	)	0	None
43086	43087	receptor	0	None
43087	43088	blockers	0	None
43088	43089	(	0	None
43089	43090	ARBs	0	None
43090	43091	)	0	None
43091	43092	have	0	None
43092	43093	demonstrated	0	None
43093	43094	efficacy	0	None
43094	43095	equivalent	0	None
43095	43096	to	0	None
43096	43097	that	0	None
43097	43098	of	0	None
43098	43099	other	0	None
43099	43100	leading	0	None
43100	43101	classes	0	None
43101	43102	of	0	None
43102	43103	antihypertensive	0	None
43103	43104	agents	0	None
43104	43105	,	0	None
43105	43106	with	0	None
43106	43107	superior	0	None
43107	43108	tolerability	0	None
43108	43109	profiles	0	None
43109	43110	.	0	None

43111	43112	The	0	None
43112	43113	specific	0	None
43113	43114	targeting	0	None
43114	43115	of	0	None
43115	43116	the	0	None
43116	43118	AT1 receptor	1	GENE-Y
43118	43119	afforded	0	None
43119	43120	by	0	None
43120	43121	these	0	None
43121	43122	agents	0	None
43122	43123	has	0	None
43123	43124	demonstrated	0	None
43124	43125	more	0	None
43125	43126	complete	0	None
43126	43127	blockade	0	None
43127	43128	of	0	None
43128	43129	the	0	None
43129	43130	renin	1	GENE-Y
43130	43131	-	0	None
43131	43132	angiotensin	3	CHEMICAL
43132	43133	system	0	None
43133	43134	than	0	None
43134	43135	that	0	None
43135	43136	offered	0	None
43136	43137	by	0	None
43137	43138	angiotensin	3	CHEMICAL
43138	43139	-	0	None
43139	43141	converting enzyme	1	GENE-Y
43141	43142	inhibitors	0	None
43142	43143	.	0	None

43144	43145	These	0	None
43145	43146	data	0	None
43146	43147	notwithstanding	0	None
43147	43148	,	0	None
43148	43149	differentiation	0	None
43149	43150	within	0	None
43150	43151	the	0	None
43151	43152	class	0	None
43152	43153	of	0	None
43153	43154	ARBs	0	None
43154	43155	has	0	None
43155	43156	been	0	None
43156	43157	limited	0	None
43157	43158	.	0	None

43159	43160	With	0	None
43160	43161	the	0	None
43161	43162	accumulation	0	None
43162	43163	of	0	None
43163	43164	additional	0	None
43164	43165	data	0	None
43165	43166	with	0	None
43166	43167	ARBs	0	None
43167	43168	,	0	None
43168	43169	it	0	None
43169	43170	has	0	None
43170	43171	recently	0	None
43171	43172	become	0	None
43172	43173	possible	0	None
43173	43174	to	0	None
43174	43175	make	0	None
43175	43176	within	0	None
43176	43177	-	0	None
43177	43178	class	0	None
43178	43179	distinctions	0	None
43179	43180	,	0	None
43180	43181	based	0	None
43181	43182	in	0	None
43182	43183	large	0	None
43183	43184	part	0	None
43184	43185	on	0	None
43185	43186	the	0	None
43186	43187	individual	0	None
43187	43188	pharmacological	0	None
43188	43189	profiles	0	None
43189	43190	of	0	None
43190	43191	the	0	None
43191	43192	ARBs	0	None
43192	43193	.	0	None

43194	43195	To	0	None
43195	43196	this	0	None
43196	43197	end	0	None
43197	43198	,	0	None
43198	43199	absorption	0	None
43199	43200	,	0	None
43200	43201	distribution	0	None
43201	43202	,	0	None
43202	43203	half	0	None
43203	43204	-	0	None
43204	43205	life	0	None
43205	43206	,	0	None
43206	43207	dose	0	None
43207	43208	response	0	None
43208	43209	and	0	None
43209	43210	level	0	None
43210	43211	of	0	None
43211	43213	angiotensin II	1	GENE-Y
43213	43214	antagonism	0	None
43214	43215	are	0	None
43215	43216	of	0	None
43216	43217	special	0	None
43217	43218	note	0	None
43218	43219	.	0	None

43220	43221	When	0	None
43221	43222	these	0	None
43222	43223	properties	0	None
43223	43224	are	0	None
43224	43225	viewed	0	None
43225	43226	as	0	None
43226	43227	a	0	None
43227	43228	group	0	None
43228	43229	,	0	None
43229	43230	the	0	None
43230	43231	ARB	0	None
43231	43232	irbesartan	3	CHEMICAL
43232	43233	appears	0	None
43233	43234	to	0	None
43234	43235	offer	0	None
43235	43236	advantages	0	None
43236	43237	beyond	0	None
43237	43238	those	0	None
43238	43239	attained	0	None
43239	43240	with	0	None
43240	43241	other	0	None
43241	43242	ARBs	0	None
43242	43243	.	0	None

43244	43245	Irbesartan	0	None
43245	43246	is	0	None
43246	43247	well	0	None
43247	43248	absorbed	0	None
43248	43249	,	0	None
43249	43250	does	0	None
43250	43251	not	0	None
43251	43252	require	0	None
43252	43253	biotransformation	0	None
43253	43254	to	0	None
43254	43255	an	0	None
43255	43256	active	0	None
43256	43257	metabolite	0	None
43257	43258	to	0	None
43258	43259	exert	0	None
43259	43260	its	0	None
43260	43261	antihypertensive	0	None
43261	43262	activity	0	None
43262	43263	,	0	None
43263	43264	offers	0	None
43264	43265	a	0	None
43265	43266	large	0	None
43266	43267	volume	0	None
43267	43268	of	0	None
43268	43269	distribution	0	None
43269	43270	,	0	None
43270	43271	has	0	None
43271	43272	a	0	None
43272	43273	half	0	None
43273	43274	-	0	None
43274	43275	life	0	None
43275	43276	that	0	None
43276	43277	is	0	None
43277	43278	sufficient	0	None
43278	43279	to	0	None
43279	43280	allow	0	None
43280	43281	once	0	None
43281	43282	-	0	None
43282	43283	daily	0	None
43283	43284	dosing	0	None
43284	43285	,	0	None
43285	43286	is	0	None
43286	43287	associated	0	None
43287	43288	with	0	None
43288	43289	a	0	None
43289	43290	strong	0	None
43290	43291	and	0	None
43291	43292	consistent	0	None
43292	43293	dose	0	None
43293	43294	-	0	None
43294	43295	response	0	None
43295	43296	and	0	None
43296	43297	has	0	None
43297	43298	been	0	None
43298	43299	demonstrated	0	None
43299	43300	to	0	None
43300	43301	provide	0	None
43301	43302	a	0	None
43302	43303	level	0	None
43303	43304	of	0	None
43304	43306	angiotensin II	1	GENE-Y
43306	43307	antagonism	0	None
43307	43308	that	0	None
43308	43309	is	0	None
43309	43310	statistically	0	None
43310	43311	superior	0	None
43311	43312	to	0	None
43312	43313	that	0	None
43313	43314	offered	0	None
43314	43315	by	0	None
43315	43316	some	0	None
43316	43317	other	0	None
43317	43318	ARBs	0	None
43318	43319	.	0	None

43320	43321	These	0	None
43321	43322	pharmacological	0	None
43322	43323	differences	0	None
43323	43324	may	0	None
43324	43325	explain	0	None
43325	43326	the	0	None
43326	43327	clinical	0	None
43327	43328	superiority	0	None
43328	43329	of	0	None
43329	43330	irbesartan	3	CHEMICAL
43330	43331	compared	0	None
43331	43332	with	0	None
43332	43333	losartan	3	CHEMICAL
43333	43334	,	0	None
43334	43335	the	0	None
43335	43336	first	0	None
43336	43337	member	0	None
43337	43338	of	0	None
43338	43339	the	0	None
43339	43340	ARB	0	None
43340	43341	class	0	None
43341	43342	.	0	None

43343	43344	As	0	None
43344	43345	even	0	None
43345	43346	more	0	None
43346	43347	data	0	None
43347	43348	on	0	None
43348	43349	the	0	None
43349	43350	ARBs	0	None
43350	43351	become	0	None
43351	43352	available	0	None
43352	43353	,	0	None
43353	43354	the	0	None
43354	43355	ability	0	None
43355	43356	to	0	None
43356	43357	determine	0	None
43357	43358	the	0	None
43358	43359	advantages	0	None
43359	43360	of	0	None
43360	43361	specific	0	None
43361	43362	members	0	None
43362	43363	of	0	None
43363	43364	this	0	None
43364	43365	class	0	None
43365	43366	will	0	None
43366	43367	be	0	None
43367	43368	enhanced	0	None
43368	43369	,	0	None
43369	43370	distinctions	0	None
43370	43371	that	0	None
43371	43372	already	0	None
43372	43373	have	0	None
43373	43374	begun	0	None
43374	43375	to	0	None
43375	43376	come	0	None
43376	43377	to	0	None
43377	43378	light	0	None
43378	43379	.	0	None

43380	43381	Amphetamine	0	None
43381	43382	-	0	None
43382	43383	induced	0	None
43383	43384	loss	0	None
43384	43385	of	0	None
43385	43388	human dopamine transporter	1	GENE-Y
43388	43389	activity	0	None
43389	43390	:	0	None
43390	43391	an	0	None
43391	43392	internalization	0	None
43392	43393	-	0	None
43393	43394	dependent	0	None
43394	43395	and	0	None
43395	43396	cocaine	0	None
43396	43397	-	0	None
43397	43398	sensitive	0	None
43398	43399	mechanism	0	None
43399	43400	.	0	None

43401	43402	The	0	None
43402	43404	dopamine transporter	1	GENE-Y
43404	43405	(	0	None
43405	43406	DAT	1	GENE-Y
43406	43407	)	0	None
43407	43408	is	0	None
43408	43409	a	0	None
43409	43410	target	0	None
43410	43411	of	0	None
43411	43412	amphetamine	3	CHEMICAL
43412	43413	(	0	None
43413	43414	AMPH	3	CHEMICAL
43414	43415	)	0	None
43415	43416	and	0	None
43416	43417	cocaine	0	None
43417	43418	.	0	None

43419	43420	These	0	None
43420	43421	psychostimulants	0	None
43421	43422	attenuate	0	None
43422	43423	DAT	1	GENE-Y
43423	43424	clearance	0	None
43424	43425	efficiency	0	None
43425	43426	,	0	None
43426	43427	thereby	0	None
43427	43428	increasing	0	None
43428	43429	synaptic	0	None
43429	43430	dopamine	3	CHEMICAL
43430	43431	(	0	None
43431	43432	DA	3	CHEMICAL
43432	43433	)	0	None
43433	43434	levels	0	None
43434	43435	.	0	None

43436	43437	Re	0	None
43437	43438	-	0	None
43438	43439	uptake	0	None
43439	43440	rate	0	None
43440	43441	is	0	None
43441	43442	determined	0	None
43442	43443	by	0	None
43443	43444	the	0	None
43444	43445	number	0	None
43445	43446	of	0	None
43446	43447	functional	0	None
43447	43448	transporters	0	None
43448	43449	at	0	None
43449	43450	the	0	None
43450	43451	cell	0	None
43451	43452	surface	0	None
43452	43453	as	0	None
43453	43454	well	0	None
43454	43455	as	0	None
43455	43456	by	0	None
43456	43457	their	0	None
43457	43458	turnover	0	None
43458	43459	rate	0	None
43459	43460	.	0	None

43461	43462	Here	0	None
43462	43463	,	0	None
43463	43464	we	0	None
43464	43465	present	0	None
43465	43466	evidence	0	None
43466	43467	that	0	None
43467	43468	DAT	1	GENE-Y
43468	43469	substrates	0	None
43469	43470	,	0	None
43470	43471	including	0	None
43471	43472	AMPH	3	CHEMICAL
43472	43473	and	0	None
43473	43474	DA	3	CHEMICAL
43474	43475	,	0	None
43475	43476	cause	0	None
43476	43477	internalization	0	None
43477	43478	of	0	None
43478	43479	human	0	None
43479	43480	DAT	1	GENE-Y
43480	43481	,	0	None
43481	43482	thereby	0	None
43482	43483	reducing	0	None
43483	43484	transport	0	None
43484	43485	capacity	0	None
43485	43486	.	0	None

43487	43488	Acute	0	None
43488	43489	treatment	0	None
43489	43490	with	0	None
43490	43491	AMPH	3	CHEMICAL
43491	43492	reduced	0	None
43492	43493	the	0	None
43493	43494	maximal	0	None
43494	43495	rate	0	None
43495	43496	of	0	None
43496	43497	[	0	None
43497	43498	(	0	None
43498	43499	3	0	None
43499	43500	)	0	None
43500	43501	H	0	None
43501	43502	]	0	None
43502	43503	DA	3	CHEMICAL
43503	43504	uptake	0	None
43504	43505	,	0	None
43505	43506	decreased	0	None
43506	43507	AMPH	3	CHEMICAL
43507	43508	-	0	None
43508	43509	induced	0	None
43509	43510	currents	0	None
43510	43511	,	0	None
43511	43512	and	0	None
43512	43513	significantly	0	None
43513	43514	redistributed	0	None
43514	43515	the	0	None
43515	43516	immunofluorescence	0	None
43516	43517	of	0	None
43517	43518	an	0	None
43518	43519	epitope	0	None
43519	43520	-	0	None
43520	43521	tagged	0	None
43521	43522	DAT	1	GENE-Y
43522	43523	from	0	None
43523	43524	the	0	None
43524	43525	plasma	0	None
43525	43526	membrane	0	None
43526	43527	to	0	None
43527	43528	the	0	None
43528	43529	cytosol	0	None
43529	43530	in	0	None
43530	43531	human	0	None
43531	43532	embryonic	0	None
43532	43533	kidney	0	None
43533	43534	293	0	None
43534	43535	cells	0	None
43535	43536	.	0	None

43537	43538	Conversely	0	None
43538	43539	,	0	None
43539	43540	DAT	1	GENE-Y
43540	43541	inhibitors	0	None
43541	43542	,	0	None
43542	43543	such	0	None
43543	43544	as	0	None
43544	43545	cocaine	0	None
43545	43546	,	0	None
43546	43547	mazindol	3	CHEMICAL
43547	43548	,	0	None
43548	43549	and	0	None
43549	43550	nomifensine	3	CHEMICAL
43550	43551	,	0	None
43551	43552	when	0	None
43552	43553	administered	0	None
43553	43554	with	0	None
43554	43555	AMPH	3	CHEMICAL
43555	43556	,	0	None
43556	43557	blocked	0	None
43557	43558	the	0	None
43558	43559	reduction	0	None
43559	43560	in	0	None
43560	43561	[	0	None
43561	43562	(	0	None
43562	43563	3	0	None
43563	43564	)	0	None
43564	43565	H	0	None
43565	43566	]	0	None
43566	43567	DA	3	CHEMICAL
43567	43568	uptake	0	None
43568	43569	and	0	None
43569	43570	the	0	None
43570	43571	redistribution	0	None
43571	43572	of	0	None
43572	43573	DAT	1	GENE-Y
43573	43574	immunofluorescence	0	None
43574	43575	to	0	None
43575	43576	the	0	None
43576	43577	cytosol	0	None
43577	43578	.	0	None

43579	43580	The	0	None
43580	43581	reductions	0	None
43581	43582	of	0	None
43582	43583	[	0	None
43583	43584	(	0	None
43584	43585	3	0	None
43585	43586	)	0	None
43586	43587	H	0	None
43587	43588	]	0	None
43588	43589	DA	3	CHEMICAL
43589	43590	uptake	0	None
43590	43591	and	0	None
43591	43592	AMPH	3	CHEMICAL
43592	43593	-	0	None
43593	43594	induced	0	None
43594	43595	DAT	1	GENE-Y
43595	43596	internalization	0	None
43596	43597	also	0	None
43597	43598	were	0	None
43598	43599	inhibited	0	None
43599	43600	by	0	None
43600	43601	coexpression	0	None
43601	43602	of	0	None
43602	43603	a	0	None
43603	43604	dominant	0	None
43604	43605	negative	0	None
43605	43606	mutant	0	None
43606	43607	of	0	None
43607	43608	dynamin	2	GENE-N
43608	43609	I	0	None
43609	43610	(	0	None
43610	43611	K44A	1	GENE-Y
43611	43612	)	0	None
43612	43613	,	0	None
43613	43614	indicating	0	None
43614	43615	that	0	None
43615	43616	endocytosis	0	None
43616	43617	modulates	0	None
43617	43618	transport	0	None
43618	43619	capacity	0	None
43619	43620	,	0	None
43620	43621	likely	0	None
43621	43622	through	0	None
43622	43623	a	0	None
43623	43624	clathrin	2	GENE-N
43624	43625	-	0	None
43625	43626	mediated	0	None
43626	43627	pathway	0	None
43627	43628	.	0	None

43629	43630	With	0	None
43630	43631	this	0	None
43631	43632	mechanism	0	None
43632	43633	of	0	None
43633	43634	regulation	0	None
43634	43635	,	0	None
43635	43636	acute	0	None
43636	43637	application	0	None
43637	43638	of	0	None
43638	43639	AMPH	3	CHEMICAL
43639	43640	would	0	None
43640	43641	reduce	0	None
43641	43642	DA	3	CHEMICAL
43642	43643	uptake	0	None
43643	43644	not	0	None
43644	43645	only	0	None
43645	43646	by	0	None
43646	43647	direct	0	None
43647	43648	competition	0	None
43648	43649	for	0	None
43649	43650	uptake	0	None
43650	43651	,	0	None
43651	43652	but	0	None
43652	43653	also	0	None
43653	43654	by	0	None
43654	43655	reducing	0	None
43655	43656	the	0	None
43656	43657	available	0	None
43657	43658	cell	0	None
43658	43659	-	0	None
43659	43660	surface	0	None
43660	43661	DAT	1	GENE-Y
43661	43662	.	0	None

43663	43664	Moreover	0	None
43664	43665	,	0	None
43665	43666	AMPH	3	CHEMICAL
43666	43667	-	0	None
43667	43668	induced	0	None
43668	43669	internalization	0	None
43669	43670	might	0	None
43670	43671	diminish	0	None
43671	43672	the	0	None
43672	43673	amount	0	None
43673	43674	of	0	None
43674	43675	DAT	1	GENE-Y
43675	43676	available	0	None
43676	43677	for	0	None
43677	43678	DA	3	CHEMICAL
43678	43679	efflux	0	None
43679	43680	,	0	None
43680	43681	thereby	0	None
43681	43682	modulating	0	None
43682	43683	the	0	None
43683	43684	cytotoxic	0	None
43684	43685	effects	0	None
43685	43686	of	0	None
43686	43687	elevated	0	None
43687	43689	extracellular DA	3	CHEMICAL
43689	43690	.	0	None

43691	43692	Peroxisome	0	None
43692	43693	proliferator	0	None
43693	43694	-	0	None
43694	43695	activated	0	None
43695	43696	receptor	0	None
43696	43697	alpha	0	None
43697	43698	activators	0	None
43698	43699	improve	0	None
43699	43700	insulin	0	None
43700	43701	sensitivity	0	None
43701	43702	and	0	None
43702	43703	reduce	0	None
43703	43704	adiposity	0	None
43704	43705	.	0	None

43706	43707	Fibrates	0	None
43707	43708	and	0	None
43708	43709	glitazones	3	CHEMICAL
43709	43710	are	0	None
43710	43711	two	0	None
43711	43712	classes	0	None
43712	43713	of	0	None
43713	43714	drugs	0	None
43714	43715	currently	0	None
43715	43716	used	0	None
43716	43717	in	0	None
43717	43718	the	0	None
43718	43719	treatment	0	None
43719	43720	of	0	None
43720	43721	dyslipidemia	0	None
43721	43722	and	0	None
43722	43723	insulin	0	None
43723	43724	resistance	0	None
43724	43725	(	0	None
43725	43726	IR	1	GENE-Y
43726	43727	)	0	None
43727	43728	,	0	None
43728	43729	respectively	0	None
43729	43730	.	0	None

43731	43732	Whereas	0	None
43732	43733	glitazones	3	CHEMICAL
43733	43734	are	0	None
43734	43735	insulin	0	None
43735	43736	sensitizers	0	None
43736	43737	acting	0	None
43737	43738	via	0	None
43738	43739	activation	0	None
43739	43740	of	0	None
43740	43741	the	0	None
43741	43742	peroxisome	0	None
43742	43743	proliferator	0	None
43743	43744	-	0	None
43744	43745	activated	0	None
43745	43746	receptor	0	None
43746	43747	(	0	None
43747	43748	PPAR	1	GENE-Y
43748	43749	)	0	None
43749	43750	gamma	0	None
43750	43751	subtype	0	None
43751	43752	,	0	None
43752	43753	fibrates	3	CHEMICAL
43753	43754	exert	0	None
43754	43755	their	0	None
43755	43756	lipid	0	None
43756	43757	-	0	None
43757	43758	lowering	0	None
43758	43759	activity	0	None
43759	43760	via	0	None
43760	43761	PPARalpha	1	GENE-Y
43761	43762	.	0	None

43763	43764	To	0	None
43764	43765	determine	0	None
43765	43766	whether	0	None
43766	43767	PPARalpha	1	GENE-Y
43767	43768	activators	0	None
43768	43769	also	0	None
43769	43770	improve	0	None
43770	43771	insulin	0	None
43771	43772	sensitivity	0	None
43772	43773	,	0	None
43773	43774	we	0	None
43774	43775	measured	0	None
43775	43776	the	0	None
43776	43777	capacity	0	None
43777	43778	of	0	None
43778	43779	three	0	None
43779	43780	PPARalpha	1	GENE-Y
43780	43781	-	0	None
43781	43782	selective	0	None
43782	43783	agonists	0	None
43783	43784	,	0	None
43784	43785	fenofibrate	3	CHEMICAL
43785	43786	,	0	None
43786	43787	ciprofibrate	3	CHEMICAL
43787	43788	,	0	None
43788	43789	and	0	None
43789	43790	the	0	None
43790	43791	new	0	None
43791	43793	compound GW9578	3	CHEMICAL
43793	43794	,	0	None
43794	43795	in	0	None
43795	43796	two	0	None
43796	43797	rodent	0	None
43797	43798	models	0	None
43798	43799	of	0	None
43799	43800	high	0	None
43800	43801	fat	0	None
43801	43802	diet	0	None
43802	43803	-	0	None
43803	43804	induced	0	None
43804	43805	(	0	None
43805	43806	C57BL	0	None
43806	43807	/	0	None
43807	43808	6	0	None
43808	43809	mice	0	None
43809	43810	)	0	None
43810	43811	or	0	None
43811	43812	genetic	0	None
43812	43813	(	0	None
43813	43814	obese	0	None
43814	43815	Zucker	0	None
43815	43816	rats	0	None
43816	43817	)	0	None
43817	43818	IR	1	GENE-Y
43818	43819	.	0	None

43820	43821	At	0	None
43821	43822	doses	0	None
43822	43823	yielding	0	None
43823	43824	serum	0	None
43824	43825	concentrations	0	None
43825	43826	shown	0	None
43826	43827	to	0	None
43827	43828	activate	0	None
43828	43829	selectively	0	None
43829	43830	PPARalpha	1	GENE-Y
43830	43831	,	0	None
43831	43832	these	0	None
43832	43833	compounds	0	None
43833	43834	markedly	0	None
43834	43835	lowered	0	None
43835	43836	hyperinsulinemia	0	None
43836	43837	and	0	None
43837	43838	,	0	None
43838	43839	when	0	None
43839	43840	present	0	None
43840	43841	,	0	None
43841	43842	hyperglycemia	0	None
43842	43843	in	0	None
43843	43844	both	0	None
43844	43845	animal	0	None
43845	43846	models	0	None
43846	43847	.	0	None

43848	43849	This	0	None
43849	43850	effect	0	None
43850	43851	relied	0	None
43851	43852	on	0	None
43852	43853	the	0	None
43853	43854	improvement	0	None
43854	43855	of	0	None
43855	43856	insulin	0	None
43856	43857	action	0	None
43857	43858	on	0	None
43858	43859	glucose	3	CHEMICAL
43859	43860	utilization	0	None
43860	43861	,	0	None
43861	43862	as	0	None
43862	43863	indicated	0	None
43863	43864	by	0	None
43864	43865	a	0	None
43865	43866	lower	0	None
43866	43867	insulin	0	None
43867	43868	peak	0	None
43868	43869	in	0	None
43869	43870	response	0	None
43870	43871	to	0	None
43871	43872	intraperitoneal	0	None
43872	43873	glucose	3	CHEMICAL
43873	43874	in	0	None
43874	43875	ciprofibrate	3	CHEMICAL
43875	43876	-	0	None
43876	43877	treated	0	None
43877	43878	IR	1	GENE-Y
43878	43879	obese	0	None
43879	43880	Zucker	0	None
43880	43881	rats	0	None
43881	43882	.	0	None

43883	43884	In	0	None
43884	43885	addition	0	None
43885	43886	,	0	None
43886	43887	fenofibrate	3	CHEMICAL
43887	43888	treatment	0	None
43888	43889	prevented	0	None
43889	43890	high	0	None
43890	43891	fat	0	None
43891	43892	diet	0	None
43892	43893	-	0	None
43893	43894	induced	0	None
43894	43895	increase	0	None
43895	43896	of	0	None
43896	43897	body	0	None
43897	43898	weight	0	None
43898	43899	and	0	None
43899	43900	adipose	0	None
43900	43901	tissue	0	None
43901	43902	mass	0	None
43902	43903	without	0	None
43903	43904	influencing	0	None
43904	43905	caloric	0	None
43905	43906	intake	0	None
43906	43907	.	0	None

43908	43909	The	0	None
43909	43910	specificity	0	None
43910	43911	for	0	None
43911	43912	PPARalpha	1	GENE-Y
43912	43913	activation	0	None
43913	43914	in	0	None
43914	43915	vivo	0	None
43915	43916	was	0	None
43916	43917	demonstrated	0	None
43917	43918	by	0	None
43918	43919	marked	0	None
43919	43920	alterations	0	None
43920	43921	in	0	None
43921	43922	the	0	None
43922	43923	expression	0	None
43923	43924	of	0	None
43924	43925	PPARalpha	1	GENE-Y
43925	43926	target	0	None
43926	43927	genes	0	None
43927	43928	,	0	None
43928	43929	whereas	0	None
43929	43930	PPARgamma	1	GENE-Y
43930	43931	target	0	None
43931	43932	gene	0	None
43932	43933	mRNA	0	None
43933	43934	levels	0	None
43934	43935	did	0	None
43935	43936	not	0	None
43936	43937	change	0	None
43937	43938	in	0	None
43938	43939	treated	0	None
43939	43940	animals	0	None
43940	43941	.	0	None

43942	43943	These	0	None
43943	43944	results	0	None
43944	43945	indicate	0	None
43945	43946	that	0	None
43946	43947	compounds	0	None
43947	43948	with	0	None
43948	43949	a	0	None
43949	43950	selective	0	None
43950	43951	PPARalpha	1	GENE-Y
43951	43952	activation	0	None
43952	43953	profile	0	None
43953	43954	reduce	0	None
43954	43955	insulin	0	None
43955	43956	resistance	0	None
43956	43957	without	0	None
43957	43958	having	0	None
43958	43959	adverse	0	None
43959	43960	effects	0	None
43960	43961	on	0	None
43961	43962	body	0	None
43962	43963	weight	0	None
43963	43964	and	0	None
43964	43965	adipose	0	None
43965	43966	tissue	0	None
43966	43967	mass	0	None
43967	43968	in	0	None
43968	43969	animal	0	None
43969	43970	models	0	None
43970	43971	of	0	None
43971	43972	IR	1	GENE-Y
43972	43973	.	0	None

43974	43975	Recent	0	None
43975	43976	developments	0	None
43976	43977	in	0	None
43977	43978	receptor	0	None
43978	43979	-	0	None
43979	43980	selective	0	None
43980	43981	retinoids	3	CHEMICAL
43981	43982	.	0	None

43983	43984	Natural	0	None
43984	43985	(	0	None
43985	43986	all	0	None
43986	43987	trans	0	None
43987	43988	-	0	None
43988	43990	retinoic acid	3	CHEMICAL
43990	43991	,	0	None
43991	43992	RA	0	None
43992	43993	)	0	None
43993	43994	and	0	None
43994	43995	synthetic	0	None
43995	43996	retinoids	3	CHEMICAL
43996	43997	exhibit	0	None
43997	43998	potent	0	None
43998	43999	anti	0	None
43999	44000	-	0	None
44000	44001	proliferative	0	None
44001	44002	,	0	None
44002	44003	normalization	0	None
44003	44004	of	0	None
44004	44005	differentiation	0	None
44005	44006	and	0	None
44006	44007	anti	0	None
44007	44008	-	0	None
44008	44009	inflammatory	0	None
44009	44010	activities	0	None
44010	44011	which	0	None
44011	44012	appear	0	None
44012	44013	to	0	None
44013	44014	account	0	None
44014	44015	for	0	None
44015	44016	their	0	None
44016	44017	therapeutic	0	None
44017	44018	effects	0	None
44018	44019	in	0	None
44019	44020	acne	0	None
44020	44021	,	0	None
44021	44022	psoriasis	0	None
44022	44023	,	0	None
44023	44024	photoaging	0	None
44024	44025	,	0	None
44025	44026	precancerous	0	None
44026	44027	lesions	0	None
44027	44028	and	0	None
44028	44029	established	0	None
44029	44030	cancers	0	None
44030	44031	.	0	None

44032	44033	Although	0	None
44033	44034	RA	0	None
44034	44035	has	0	None
44035	44036	shown	0	None
44036	44037	considerable	0	None
44037	44038	promise	0	None
44038	44039	in	0	None
44039	44040	dermatologic	0	None
44040	44041	indications	0	None
44041	44042	,	0	None
44042	44043	certain	0	None
44043	44044	side	0	None
44044	44045	effects	0	None
44045	44046	have	0	None
44046	44047	restricted	0	None
44047	44048	its	0	None
44048	44049	use	0	None
44049	44050	as	0	None
44050	44051	a	0	None
44051	44052	choice	0	None
44052	44053	of	0	None
44053	44054	agent	0	None
44054	44055	for	0	None
44055	44056	chronic	0	None
44056	44057	administration	0	None
44057	44058	.	0	None

44059	44060	Systematic	0	None
44060	44061	synthesis	0	None
44061	44062	of	0	None
44062	44063	receptor	0	None
44063	44064	-	0	None
44064	44065	selective	0	None
44065	44066	retinoids	3	CHEMICAL
44066	44067	has	0	None
44067	44068	resulted	0	None
44068	44069	in	0	None
44069	44070	two	0	None
44070	44071	topical	0	None
44071	44072	drugs	0	None
44072	44073	,	0	None
44073	44074	Tazorac	0	None
44074	44075	/	0	None
44075	44076	Zorac	3	CHEMICAL
44076	44077	(	0	None
44077	44078	tazarotene	3	CHEMICAL
44078	44079	)	0	None
44079	44080	and	0	None
44080	44081	Differin	3	CHEMICAL
44081	44082	(	0	None
44082	44083	adapalene	3	CHEMICAL
44083	44084	)	0	None
44084	44085	.	0	None

44086	44087	Tazorac	0	None
44087	44088	is	0	None
44088	44089	indicated	0	None
44089	44090	for	0	None
44090	44091	psoriasis	0	None
44091	44092	and	0	None
44092	44093	acne	0	None
44093	44094	and	0	None
44094	44095	Differin	3	CHEMICAL
44095	44096	gel	0	None
44096	44097	for	0	None
44097	44098	the	0	None
44098	44099	treatment	0	None
44099	44100	of	0	None
44100	44101	acne	0	None
44101	44102	.	0	None

44103	44104	These	0	None
44104	44105	drugs	0	None
44105	44106	bind	0	None
44106	44107	to	0	None
44107	44108	the	0	None
44108	44111	retinoic acid receptor	2	GENE-N
44111	44112	(	0	None
44112	44113	RAR	1	GENE-Y
44113	44114	)	0	None
44114	44115	family	0	None
44115	44116	members	0	None
44116	44117	.	0	None

44118	44119	Various	0	None
44119	44120	RAR	1	GENE-Y
44120	44121	subtype	0	None
44121	44122	-	0	None
44122	44123	specific	0	None
44123	44124	and	0	None
44124	44125	function	0	None
44125	44126	-	0	None
44126	44127	selective	0	None
44127	44128	retinoids	3	CHEMICAL
44128	44129	have	0	None
44129	44130	been	0	None
44130	44131	synthesized	0	None
44131	44132	.	0	None

44133	44134	These	0	None
44134	44135	retinoids	3	CHEMICAL
44135	44136	,	0	None
44136	44137	which	0	None
44137	44138	are	0	None
44138	44139	in	0	None
44139	44140	various	0	None
44140	44141	stages	0	None
44141	44142	of	0	None
44142	44143	pre	0	None
44143	44144	-	0	None
44144	44145	clinical	0	None
44145	44146	development	0	None
44146	44147	for	0	None
44147	44148	the	0	None
44148	44149	treatment	0	None
44149	44150	of	0	None
44150	44151	cancers	0	None
44151	44152	,	0	None
44152	44153	psoriasis	0	None
44153	44154	and	0	None
44154	44155	as	0	None
44155	44156	an	0	None
44156	44157	antidote	0	None
44157	44158	to	0	None
44158	44159	Accutane	3	CHEMICAL
44159	44160	-	0	None
44160	44161	mediated	0	None
44161	44162	mucocutaneous	0	None
44162	44163	toxicity	0	None
44163	44164	,	0	None
44164	44165	will	0	None
44165	44166	also	0	None
44166	44167	be	0	None
44167	44168	discussed	0	None
44168	44169	in	0	None
44169	44170	this	0	None
44170	44171	review	0	None
44171	44172	.	0	None

44173	44174	Discovery	0	None
44174	44175	of	0	None
44175	44176	another	0	None
44176	44178	retinoid receptor	2	GENE-N
44178	44179	,	0	None
44179	44180	retinoid	0	None
44180	44181	X	0	None
44181	44182	receptor	0	None
44182	44183	(	0	None
44183	44184	RXR	2	GENE-N
44184	44185	)	0	None
44185	44186	,	0	None
44186	44187	revealed	0	None
44187	44188	that	0	None
44188	44189	RXR	2	GENE-N
44189	44190	-	0	None
44190	44191	specific	0	None
44191	44192	retinoids	3	CHEMICAL
44192	44193	already	0	None
44193	44194	existed	0	None
44194	44195	in	0	None
44195	44196	retinoid	3	CHEMICAL
44196	44197	chemical	0	None
44197	44198	libraries	0	None
44198	44199	.	0	None

44200	44201	Structure	0	None
44201	44202	activity	0	None
44202	44203	relationship	0	None
44203	44204	studies	0	None
44204	44205	based	0	None
44205	44206	upon	0	None
44206	44207	binding	0	None
44207	44208	and	0	None
44208	44209	transactivation	0	None
44209	44210	assays	0	None
44210	44211	led	0	None
44211	44212	to	0	None
44212	44213	the	0	None
44213	44214	synthesis	0	None
44214	44215	of	0	None
44215	44216	RXR	2	GENE-N
44216	44217	-	0	None
44217	44218	specific	0	None
44218	44219	ligands	0	None
44219	44220	with	0	None
44220	44221	high	0	None
44221	44222	affinities	0	None
44222	44223	for	0	None
44223	44224	RXR	2	GENE-N
44224	44225	subtypes	0	None
44225	44226	.	0	None

44227	44228	These	0	None
44228	44229	compounds	0	None
44229	44230	were	0	None
44230	44231	found	0	None
44231	44232	to	0	None
44232	44233	be	0	None
44233	44234	effective	0	None
44234	44235	in	0	None
44235	44236	the	0	None
44236	44237	treatment	0	None
44237	44238	of	0	None
44238	44239	hyperglycemia	0	None
44239	44240	in	0	None
44240	44241	animal	0	None
44241	44242	models	0	None
44242	44243	of	0	None
44243	44244	type	0	None
44244	44245	II	0	None
44245	44246	diabetes	0	None
44246	44247	.	0	None

44248	44249	The	0	None
44249	44250	discovery	0	None
44250	44251	of	0	None
44251	44252	novel	0	None
44252	44253	retinoids	3	CHEMICAL
44253	44254	along	0	None
44254	44255	with	0	None
44255	44256	an	0	None
44256	44257	increased	0	None
44257	44258	understanding	0	None
44258	44259	of	0	None
44259	44260	the	0	None
44260	44261	biological	0	None
44261	44262	functions	0	None
44262	44263	and	0	None
44263	44264	mechanisms	0	None
44264	44265	of	0	None
44265	44266	action	0	None
44266	44267	of	0	None
44267	44269	retinoid receptors	2	GENE-N
44269	44270	are	0	None
44270	44271	likely	0	None
44271	44272	to	0	None
44272	44273	result	0	None
44273	44274	in	0	None
44274	44275	improved	0	None
44275	44276	treatments	0	None
44276	44277	for	0	None
44277	44278	existing	0	None
44278	44279	responsive	0	None
44279	44280	indications	0	None
44280	44281	and	0	None
44281	44282	identification	0	None
44282	44283	of	0	None
44283	44284	new	0	None
44284	44285	retinoid	3	CHEMICAL
44285	44286	therapeutic	0	None
44286	44287	targets	0	None
44287	44288	.	0	None

44289	44290	Severe	0	None
44290	44291	impairment	0	None
44291	44292	of	0	None
44292	44293	salivation	0	None
44293	44294	in	0	None
44294	44295	Na	0	None
44295	44296	+	0	None
44296	44297	/	0	None
44297	44298	K	0	None
44298	44299	+	0	None
44299	44300	/	0	None
44300	44301	2Cl	0	None
44301	44302	-	0	None
44302	44303	cotransporter	0	None
44303	44304	(	0	None
44304	44305	NKCC1	1	GENE-Y
44305	44306	)	0	None
44306	44307	-	0	None
44307	44308	deficient	0	None
44308	44309	mice	0	None
44309	44310	.	0	None

44311	44312	The	0	None
44312	44313	salivary	0	None
44313	44314	fluid	0	None
44314	44315	secretory	0	None
44315	44316	mechanism	0	None
44316	44317	is	0	None
44317	44318	thought	0	None
44318	44319	to	0	None
44319	44320	require	0	None
44320	44321	Na	0	None
44321	44322	(	0	None
44322	44323	+	0	None
44323	44324	)	0	None
44324	44325	/	0	None
44325	44326	K	0	None
44326	44327	(	0	None
44327	44328	+	0	None
44328	44329	)	0	None
44329	44330	/	0	None
44330	44331	2Cl	0	None
44331	44332	(	0	None
44332	44333	-	0	None
44333	44334	)	0	None
44334	44335	cotransporter	0	None
44335	44336	-	0	None
44336	44337	mediated	0	None
44337	44338	Cl	0	None
44338	44339	(	0	None
44339	44340	-	0	None
44340	44341	)	0	None
44341	44342	uptake	0	None
44342	44343	.	0	None

44344	44345	To	0	None
44345	44346	directly	0	None
44346	44347	test	3	CHEMICAL
44347	44348	this	0	None
44348	44349	possibility	0	None
44349	44350	we	0	None
44350	44351	studied	0	None
44351	44352	the	0	None
44352	44353	in	0	None
44353	44354	vivo	0	None
44354	44355	and	0	None
44355	44356	in	0	None
44356	44357	vitro	0	None
44357	44358	functioning	0	None
44358	44359	of	0	None
44359	44360	acinar	0	None
44360	44361	cells	0	None
44361	44362	from	0	None
44362	44363	the	0	None
44363	44364	parotid	0	None
44364	44365	glands	0	None
44365	44366	of	0	None
44366	44367	mice	0	None
44367	44368	with	0	None
44368	44369	targeted	0	None
44369	44370	disruption	0	None
44370	44371	of	0	None
44371	44372	Na	0	None
44372	44373	(	0	None
44373	44374	+	0	None
44374	44375	)	0	None
44375	44376	/	0	None
44376	44377	K	0	None
44377	44378	(	0	None
44378	44379	+	0	None
44379	44380	)	0	None
44380	44381	/	0	None
44381	44382	2Cl	0	None
44382	44383	(	0	None
44383	44384	-	0	None
44384	44385	)	0	None
44385	44386	cotransporter	0	None
44386	44387	isoform	0	None
44387	44388	1	0	None
44388	44389	(	0	None
44389	44390	Nkcc1	0	None
44390	44391	)	0	None
44391	44392	,	0	None
44392	44393	the	0	None
44393	44394	gene	0	None
44394	44395	encoding	0	None
44395	44396	the	0	None
44396	44397	salivary	0	None
44397	44398	Na	0	None
44398	44399	(	0	None
44399	44400	+	0	None
44400	44401	)	0	None
44401	44402	/	0	None
44402	44403	K	0	None
44403	44404	(	0	None
44404	44405	+	0	None
44405	44406	)	0	None
44406	44407	/	0	None
44407	44408	2Cl	0	None
44408	44409	(	0	None
44409	44410	-	0	None
44410	44411	)	0	None
44411	44412	cotransporter	0	None
44412	44413	.	0	None

44414	44415	In	0	None
44415	44416	wild	0	None
44416	44417	-	0	None
44417	44418	type	0	None
44418	44419	mice	0	None
44419	44420	NKCC1	1	GENE-Y
44420	44421	was	0	None
44421	44422	localized	0	None
44422	44423	to	0	None
44423	44424	the	0	None
44424	44425	basolateral	0	None
44425	44426	membranes	0	None
44426	44427	of	0	None
44427	44428	parotid	0	None
44428	44429	acinar	0	None
44429	44430	cells	0	None
44430	44431	,	0	None
44431	44432	whereas	0	None
44432	44433	expression	0	None
44433	44434	was	0	None
44434	44435	not	0	None
44435	44436	detected	0	None
44436	44437	in	0	None
44437	44438	duct	0	None
44438	44439	cells	0	None
44439	44440	.	0	None

44441	44442	The	0	None
44442	44443	lack	0	None
44443	44444	of	0	None
44444	44445	functional	0	None
44445	44446	NKCC1	1	GENE-Y
44446	44447	resulted	0	None
44447	44448	in	0	None
44448	44449	a	0	None
44449	44450	dramatic	0	None
44450	44451	reduction	0	None
44451	44452	(	0	None
44452	44453	>	0	None
44453	44454	60	0	None
44454	44455	%	0	None
44455	44456	)	0	None
44456	44457	in	0	None
44457	44458	the	0	None
44458	44459	volume	0	None
44459	44460	of	0	None
44460	44461	saliva	0	None
44461	44462	secreted	0	None
44462	44463	in	0	None
44463	44464	response	0	None
44464	44465	to	0	None
44465	44466	a	0	None
44466	44467	muscarinic	0	None
44467	44468	agonist	0	None
44468	44469	,	0	None
44469	44470	the	0	None
44470	44471	primary	0	None
44471	44472	in	0	None
44472	44473	situ	0	None
44473	44474	salivation	0	None
44474	44475	signal	0	None
44475	44476	.	0	None

44477	44478	Consistent	0	None
44478	44479	with	0	None
44479	44480	defective	0	None
44480	44481	Cl	0	None
44481	44482	(	0	None
44482	44483	-	0	None
44483	44484	)	0	None
44484	44485	uptake	0	None
44485	44486	,	0	None
44486	44487	a	0	None
44487	44488	loss	0	None
44488	44489	of	0	None
44489	44490	bumetanide	3	CHEMICAL
44490	44491	-	0	None
44491	44492	sensitive	0	None
44492	44493	Cl	0	None
44493	44494	(	0	None
44494	44495	-	0	None
44495	44496	)	0	None
44496	44497	influx	0	None
44497	44498	was	0	None
44498	44499	observed	0	None
44499	44500	in	0	None
44500	44501	parotid	0	None
44501	44502	acinar	0	None
44502	44503	cells	0	None
44503	44504	from	0	None
44504	44505	mice	0	None
44505	44506	lacking	0	None
44506	44507	NKCC1	1	GENE-Y
44507	44508	.	0	None

44509	44510	Cl	0	None
44510	44511	(	0	None
44511	44512	-	0	None
44512	44513	)	0	None
44513	44514	/	0	None
44514	44515	HCO	3	CHEMICAL
44515	44516	(	0	None
44516	44517	3	0	None
44517	44518	)	0	None
44518	44519	(	0	None
44519	44520	-	0	None
44520	44521	)	0	None
44521	44522	exchanger	0	None
44522	44523	activity	0	None
44523	44524	was	0	None
44524	44525	increased	0	None
44525	44526	in	0	None
44526	44527	parotid	0	None
44527	44528	acinar	0	None
44528	44529	cells	0	None
44529	44530	isolated	0	None
44530	44531	from	0	None
44531	44532	knockout	0	None
44532	44533	mice	0	None
44533	44534	suggesting	0	None
44534	44535	that	0	None
44535	44536	the	0	None
44536	44537	residual	0	None
44537	44538	saliva	0	None
44538	44539	secreted	0	None
44539	44540	by	0	None
44540	44541	mice	0	None
44541	44542	lacking	0	None
44542	44543	NKCC1	1	GENE-Y
44543	44544	is	0	None
44544	44545	associated	0	None
44545	44546	with	0	None
44546	44547	anion	0	None
44547	44548	exchanger	0	None
44548	44549	-	0	None
44549	44550	dependent	0	None
44550	44551	Cl	0	None
44551	44552	(	0	None
44552	44553	-	0	None
44553	44554	)	0	None
44554	44555	uptake	0	None
44555	44556	.	0	None

44557	44558	Indeed	0	None
44558	44559	,	0	None
44559	44560	expression	0	None
44560	44561	of	0	None
44561	44562	the	0	None
44562	44563	Cl	0	None
44563	44564	(	0	None
44564	44565	-	0	None
44565	44566	)	0	None
44566	44567	/	0	None
44567	44568	HCO	3	CHEMICAL
44568	44569	(	0	None
44569	44570	3	0	None
44570	44571	)	0	None
44571	44572	(	0	None
44572	44573	-	0	None
44573	44574	)	0	None
44574	44575	exchanger	0	None
44575	44576	AE2	0	None
44576	44577	was	0	None
44577	44578	enhanced	0	None
44578	44579	suggesting	0	None
44579	44580	that	0	None
44580	44581	this	0	None
44581	44582	transporter	0	None
44582	44583	compensates	0	None
44583	44584	for	0	None
44584	44585	the	0	None
44585	44586	loss	0	None
44586	44587	of	0	None
44587	44588	functional	0	None
44588	44589	Na	0	None
44589	44590	(	0	None
44590	44591	+	0	None
44591	44592	)	0	None
44592	44593	/	0	None
44593	44594	K	0	None
44594	44595	(	0	None
44595	44596	+	0	None
44596	44597	)	0	None
44597	44598	/	0	None
44598	44599	2Cl	0	None
44599	44600	(	0	None
44600	44601	-	0	None
44601	44602	)	0	None
44602	44603	cotransporter	0	None
44603	44604	.	0	None

44605	44606	Furthermore	0	None
44606	44607	,	0	None
44607	44608	the	0	None
44608	44609	ability	0	None
44609	44610	of	0	None
44610	44611	the	0	None
44611	44612	parotid	0	None
44612	44613	gland	0	None
44613	44614	to	0	None
44614	44615	conserve	0	None
44615	44616	NaCl	3	CHEMICAL
44616	44617	was	0	None
44617	44618	abolished	0	None
44618	44619	in	0	None
44619	44620	NKCC1	1	GENE-Y
44620	44621	-	0	None
44621	44622	deficient	0	None
44622	44623	mice	0	None
44623	44624	.	0	None

44625	44626	This	0	None
44626	44627	deficit	0	None
44627	44628	was	0	None
44628	44629	not	0	None
44629	44630	associated	0	None
44630	44631	with	0	None
44631	44632	changes	0	None
44632	44633	in	0	None
44633	44634	the	0	None
44634	44635	morphology	0	None
44635	44636	of	0	None
44636	44637	the	0	None
44637	44638	ducts	0	None
44638	44639	,	0	None
44639	44640	but	0	None
44640	44641	transcript	0	None
44641	44642	levels	0	None
44642	44643	for	0	None
44643	44644	the	0	None
44644	44645	alpha	0	None
44645	44646	-	0	None
44646	44647	,	0	None
44647	44648	beta	0	None
44648	44649	-	0	None
44649	44650	,	0	None
44650	44651	and	0	None
44651	44652	gamma	0	None
44652	44653	-	0	None
44653	44654	subunits	0	None
44654	44655	of	0	None
44655	44656	the	0	None
44656	44657	epithelial	0	None
44657	44658	Na	0	None
44658	44659	(	0	None
44659	44660	+	0	None
44660	44661	)	0	None
44661	44662	channel	0	None
44662	44663	were	0	None
44663	44664	reduced	0	None
44664	44665	.	0	None

44666	44667	These	0	None
44667	44668	data	0	None
44668	44669	directly	0	None
44669	44670	demonstrate	0	None
44670	44671	that	0	None
44671	44672	NKCC1	1	GENE-Y
44672	44673	is	0	None
44673	44674	the	0	None
44674	44675	major	0	None
44675	44676	Cl	0	None
44676	44677	(	0	None
44677	44678	-	0	None
44678	44679	)	0	None
44679	44680	uptake	0	None
44680	44681	mechanism	0	None
44681	44682	across	0	None
44682	44683	the	0	None
44683	44684	basolateral	0	None
44684	44685	membrane	0	None
44685	44686	of	0	None
44686	44687	acinar	0	None
44687	44688	cells	0	None
44688	44689	and	0	None
44689	44690	is	0	None
44690	44691	critical	0	None
44691	44692	for	0	None
44692	44693	driving	0	None
44693	44694	saliva	0	None
44694	44695	secretion	0	None
44695	44696	in	0	None
44696	44697	vivo	0	None
44697	44698	.	0	None

44699	44700	Induction	0	None
44700	44701	of	0	None
44701	44703	estrogen receptor	1	GENE-Y
44703	44704	-	0	None
44704	44705	alpha	0	None
44705	44706	and	0	None
44706	44707	-	0	None
44707	44708	beta	0	None
44708	44709	activities	0	None
44709	44710	by	0	None
44710	44711	synthetic	0	None
44711	44712	progestins	3	CHEMICAL
44712	44713	.	0	None

44714	44715	The	0	None
44715	44716	cellular	0	None
44716	44717	action	0	None
44717	44718	of	0	None
44718	44720	steroid hormones	3	CHEMICAL
44720	44721	is	0	None
44721	44722	mediated	0	None
44722	44723	by	0	None
44723	44724	specific	0	None
44724	44725	receptors	0	None
44725	44726	.	0	None

44727	44728	Recently	0	None
44728	44729	,	0	None
44729	44730	two	0	None
44730	44731	different	0	None
44731	44733	estrogen receptors	2	GENE-N
44733	44734	(	0	None
44734	44735	ER	1	GENE-Y
44735	44736	)	0	None
44736	44737	,	0	None
44737	44738	alpha	0	None
44738	44739	and	0	None
44739	44740	beta	0	None
44740	44741	,	0	None
44741	44742	have	0	None
44742	44743	been	0	None
44743	44744	cloned	0	None
44744	44745	with	0	None
44745	44746	a	0	None
44746	44747	specific	0	None
44747	44748	tissue	0	None
44748	44749	distribution	0	None
44749	44750	.	0	None

44751	44752	Active	0	None
44752	44753	estrogen	3	CHEMICAL
44753	44754	as	0	None
44754	44755	well	0	None
44755	44756	as	0	None
44756	44757	active	0	None
44757	44758	progestin	3	CHEMICAL
44758	44759	are	0	None
44759	44760	compounds	0	None
44760	44761	of	0	None
44761	44762	oral	0	None
44762	44763	hormonal	0	None
44763	44764	contraceptives	0	None
44764	44765	and	0	None
44765	44766	hormone	0	None
44766	44767	replacement	0	None
44767	44768	therapy	0	None
44768	44769	.	0	None

44770	44771	To	0	None
44771	44772	examine	0	None
44772	44773	the	0	None
44773	44774	regulation	0	None
44774	44775	of	0	None
44775	44776	ER	1	GENE-Y
44776	44777	-	0	None
44777	44778	alpha	0	None
44778	44779	and	0	None
44779	44780	-	0	None
44780	44781	beta	0	None
44781	44782	activities	0	None
44782	44783	after	0	None
44783	44784	treatment	0	None
44784	44785	with	0	None
44785	44786	synthetic	0	None
44786	44787	progestins	3	CHEMICAL
44787	44788	and	0	None
44788	44789	synthetic	0	None
44789	44790	and	0	None
44790	44791	natural	0	None
44791	44792	estrogens	3	CHEMICAL
44792	44793	,	0	None
44793	44794	COS	0	None
44794	44795	7	0	None
44795	44796	cells	0	None
44796	44797	were	0	None
44797	44798	transfected	0	None
44798	44799	with	0	None
44799	44800	the	0	None
44800	44801	vector	0	None
44801	44802	expressing	0	None
44802	44803	ER	1	GENE-Y
44803	44804	-	0	None
44804	44805	alpha	0	None
44805	44806	and	0	None
44806	44807	-	0	None
44807	44808	beta	0	None
44808	44809	in	0	None
44809	44810	combination	0	None
44810	44811	with	0	None
44811	44812	a	0	None
44812	44813	luciferase	0	None
44813	44814	reporter	0	None
44814	44815	vector	0	None
44815	44816	.	0	None

44817	44818	ER	1	GENE-Y
44818	44819	-	0	None
44819	44820	alpha	0	None
44820	44821	activity	0	None
44821	44822	was	0	None
44822	44823	upregulated	0	None
44823	44824	in	0	None
44824	44825	the	0	None
44825	44826	presence	0	None
44826	44827	of	0	None
44827	44828	synthetic	0	None
44828	44829	progestins	3	CHEMICAL
44829	44830	in	0	None
44830	44831	a	0	None
44831	44832	dose	0	None
44832	44833	-	0	None
44833	44834	dependent	0	None
44834	44835	manner	0	None
44835	44836	.	0	None

44837	44838	Norethisterone	0	None
44838	44839	,	0	None
44839	44840	norethynodrel	3	CHEMICAL
44840	44841	and	0	None
44841	44842	desogestrel	0	None
44842	44843	proved	0	None
44843	44844	to	0	None
44844	44845	be	0	None
44845	44846	the	0	None
44846	44847	most	0	None
44847	44848	potent	0	None
44848	44849	stimulatory	0	None
44849	44850	agents	0	None
44850	44851	of	0	None
44851	44852	ER	1	GENE-Y
44852	44853	-	0	None
44853	44854	alpha	0	None
44854	44855	expression	0	None
44855	44856	.	0	None

44857	44858	On	0	None
44858	44859	the	0	None
44859	44860	other	0	None
44860	44861	hand	0	None
44861	44862	,	0	None
44862	44863	not	0	None
44863	44864	all	0	None
44864	44865	progestins	3	CHEMICAL
44865	44866	exhibited	0	None
44866	44867	a	0	None
44867	44868	stimulatory	0	None
44868	44869	action	0	None
44869	44870	on	0	None
44870	44871	ER	1	GENE-Y
44871	44872	-	0	None
44872	44873	beta	0	None
44873	44874	activity	0	None
44874	44875	.	0	None

44876	44877	Only	0	None
44877	44878	norgestrel	0	None
44878	44879	,	0	None
44879	44880	levonorgestrel	3	CHEMICAL
44880	44881	,	0	None
44881	44882	norethynodrel	3	CHEMICAL
44882	44883	and	0	None
44883	44884	norethisterone	0	None
44884	44885	induced	0	None
44885	44886	ER	1	GENE-Y
44886	44887	-	0	None
44887	44888	beta	0	None
44888	44889	-	0	None
44889	44890	activating	0	None
44890	44891	functions	0	None
44891	44892	in	0	None
44892	44893	a	0	None
44893	44894	dose	0	None
44894	44895	-	0	None
44895	44896	dependent	0	None
44896	44897	manner	0	None
44897	44898	.	0	None

44899	44900	Luciferase	0	None
44900	44901	activity	0	None
44901	44902	due	0	None
44902	44903	to	0	None
44903	44904	estrogen	3	CHEMICAL
44904	44905	stimulation	0	None
44905	44906	served	0	None
44906	44907	as	0	None
44907	44908	a	0	None
44908	44909	positive	0	None
44909	44910	control	0	None
44910	44911	.	0	None

44912	44913	Our	0	None
44913	44914	results	0	None
44914	44915	indicate	0	None
44915	44916	that	0	None
44916	44917	progestins	3	CHEMICAL
44917	44918	have	0	None
44918	44919	different	0	None
44919	44920	effects	0	None
44920	44921	on	0	None
44921	44922	the	0	None
44922	44923	activities	0	None
44923	44924	of	0	None
44924	44925	ER	1	GENE-Y
44925	44926	-	0	None
44926	44927	alpha	0	None
44927	44928	and	0	None
44928	44929	-	0	None
44929	44930	beta	0	None
44930	44931	.	0	None

44932	44933	Na	0	None
44933	44934	(	0	None
44934	44935	+	0	None
44935	44936	)	0	None
44936	44937	-	0	None
44937	44938	dependent	0	None
44938	44939	transporters	0	None
44939	44940	mediate	0	None
44940	44941	HCO	3	CHEMICAL
44941	44942	(	0	None
44942	44943	3	0	None
44943	44944	)	0	None
44944	44945	(	0	None
44945	44946	-	0	None
44946	44947	)	0	None
44947	44948	salvage	0	None
44948	44949	across	0	None
44949	44950	the	0	None
44950	44951	luminal	0	None
44951	44952	membrane	0	None
44952	44953	of	0	None
44953	44954	the	0	None
44954	44955	main	0	None
44955	44956	pancreatic	0	None
44956	44957	duct	0	None
44957	44958	.	0	None

44959	44960	To	0	None
44960	44961	study	0	None
44961	44962	the	0	None
44962	44963	roles	0	None
44963	44964	of	0	None
44964	44965	Na	0	None
44965	44966	(	0	None
44966	44967	+	0	None
44967	44968	)	0	None
44968	44969	-	0	None
44969	44970	dependent	0	None
44970	44971	H	0	None
44971	44972	(	0	None
44972	44973	+	0	None
44973	44974	)	0	None
44974	44975	transporters	0	None
44975	44976	,	0	None
44976	44977	we	0	None
44977	44978	characterized	0	None
44978	44979	H	0	None
44979	44980	(	0	None
44980	44981	+	0	None
44981	44982	)	0	None
44982	44983	efflux	0	None
44983	44984	mechanisms	0	None
44984	44985	in	0	None
44985	44986	the	0	None
44986	44987	pancreatic	0	None
44987	44988	duct	0	None
44988	44989	in	0	None
44989	44990	wild	0	None
44990	44991	-	0	None
44991	44992	type	0	None
44992	44993	,	0	None
44993	44994	NHE2	1	GENE-Y
44994	44995	(	0	None
44995	44996	-	0	None
44996	44997	/	0	None
44997	44998	-	0	None
44998	44999	)	0	None
44999	45000	,	0	None
45000	45001	and	0	None
45001	45002	NHE3	1	GENE-Y
45002	45003	(	0	None
45003	45004	-	0	None
45004	45005	/	0	None
45005	45006	-	0	None
45006	45007	)	0	None
45007	45008	mice	0	None
45008	45009	.	0	None

45010	45011	The	0	None
45011	45012	pancreatic	0	None
45012	45013	duct	0	None
45013	45014	expresses	0	None
45014	45015	NHE1	1	GENE-Y
45015	45016	in	0	None
45016	45017	the	0	None
45017	45018	basolateral	0	None
45018	45019	membrane	0	None
45019	45020	,	0	None
45020	45021	and	0	None
45021	45022	NHE2	1	GENE-Y
45022	45023	and	0	None
45023	45024	NHE3	1	GENE-Y
45024	45025	in	0	None
45025	45026	the	0	None
45026	45027	luminal	0	None
45027	45028	membrane	0	None
45028	45029	,	0	None
45029	45030	but	0	None
45030	45031	does	0	None
45031	45032	not	0	None
45032	45033	contain	0	None
45033	45034	NHE4	1	GENE-Y
45034	45035	or	0	None
45035	45036	NHE5	1	GENE-Y
45036	45037	.	0	None

45038	45039	Basolateral	0	None
45039	45040	Na	0	None
45040	45041	(	0	None
45041	45042	+	0	None
45042	45043	)	0	None
45043	45044	-	0	None
45044	45045	dependent	0	None
45045	45046	H	0	None
45046	45047	(	0	None
45047	45048	+	0	None
45048	45049	)	0	None
45049	45050	efflux	0	None
45050	45051	in	0	None
45051	45052	the	0	None
45052	45053	microperfused	0	None
45053	45054	duct	0	None
45054	45055	was	0	None
45055	45056	inhibited	0	None
45056	45057	by	0	None
45057	45058	1	0	None
45058	45059	.	0	None
45059	45060	5	0	None
45060	45061	microM	0	None
45061	45062	of	0	None
45062	45063	the	0	None
45063	45064	amiloride	3	CHEMICAL
45064	45065	analogue	0	None
45065	45067	HOE 694	3	CHEMICAL
45067	45068	,	0	None
45068	45069	consistent	0	None
45069	45070	with	0	None
45070	45071	expression	0	None
45071	45072	of	0	None
45072	45073	NHE1	1	GENE-Y
45073	45074	,	0	None
45074	45075	whereas	0	None
45075	45076	the	0	None
45076	45077	luminal	0	None
45077	45078	activity	0	None
45078	45079	required	0	None
45079	45080	50	0	None
45080	45081	microM	0	None
45081	45083	HOE 694	3	CHEMICAL
45083	45084	for	0	None
45084	45085	effective	0	None
45085	45086	inhibition	0	None
45086	45087	,	0	None
45087	45088	suggesting	0	None
45088	45089	that	0	None
45089	45090	the	0	None
45090	45091	efflux	0	None
45091	45092	might	0	None
45092	45093	be	0	None
45093	45094	mediated	0	None
45094	45095	by	0	None
45095	45096	NHE2	1	GENE-Y
45096	45097	.	0	None

45098	45099	However	0	None
45099	45100	,	0	None
45100	45101	disruption	0	None
45101	45102	of	0	None
45102	45103	NHE2	1	GENE-Y
45103	45104	had	0	None
45104	45105	no	0	None
45105	45106	effect	0	None
45106	45107	on	0	None
45107	45108	luminal	0	None
45108	45109	transport	0	None
45109	45110	,	0	None
45110	45111	while	0	None
45111	45112	disruption	0	None
45112	45113	of	0	None
45113	45114	the	0	None
45114	45115	NHE3	1	GENE-Y
45115	45116	gene	0	None
45116	45117	reduced	0	None
45117	45118	luminal	0	None
45118	45119	Na	0	None
45119	45120	(	0	None
45120	45121	+	0	None
45121	45122	)	0	None
45122	45123	-	0	None
45123	45124	dependent	0	None
45124	45125	H	0	None
45125	45126	(	0	None
45126	45127	+	0	None
45127	45128	)	0	None
45128	45129	efflux	0	None
45129	45130	by	0	None
45130	45131	approximately	0	None
45131	45132	45	0	None
45132	45133	%	0	None
45133	45134	.	0	None

45135	45136	Notably	0	None
45136	45137	,	0	None
45137	45138	the	0	None
45138	45139	remaining	0	None
45139	45140	luminal	0	None
45140	45141	Na	0	None
45141	45142	(	0	None
45142	45143	+	0	None
45143	45144	)	0	None
45144	45145	-	0	None
45145	45146	dependent	0	None
45146	45147	H	0	None
45147	45148	(	0	None
45148	45149	+	0	None
45149	45150	)	0	None
45150	45151	efflux	0	None
45151	45152	in	0	None
45152	45153	ducts	0	None
45153	45154	from	0	None
45154	45155	NHE3	1	GENE-Y
45155	45156	(	0	None
45156	45157	-	0	None
45157	45158	/	0	None
45158	45159	-	0	None
45159	45160	)	0	None
45160	45161	mice	0	None
45161	45162	was	0	None
45162	45163	inhibited	0	None
45163	45164	by	0	None
45164	45165	50	0	None
45165	45166	microM	0	None
45166	45168	HOE 694	3	CHEMICAL
45168	45169	.	0	None

45170	45171	Hence	0	None
45171	45172	,	0	None
45172	45173	approximately	0	None
45173	45174	55	0	None
45174	45175	%	0	None
45175	45176	of	0	None
45176	45177	luminal	0	None
45177	45178	H	0	None
45178	45179	(	0	None
45179	45180	+	0	None
45180	45181	)	0	None
45181	45182	efflux	0	None
45182	45183	(	0	None
45183	45184	or	0	None
45184	45185	HCO	3	CHEMICAL
45185	45186	(	0	None
45186	45187	3	0	None
45187	45188	)	0	None
45188	45189	(	0	None
45189	45190	-	0	None
45190	45191	)	0	None
45191	45192	influx	0	None
45192	45193	)	0	None
45193	45194	in	0	None
45194	45195	the	0	None
45195	45196	pancreatic	0	None
45196	45197	duct	0	None
45197	45198	is	0	None
45198	45199	mediated	0	None
45199	45200	by	0	None
45200	45201	a	0	None
45201	45202	novel	0	None
45202	45203	,	0	None
45203	45205	HOE 694	3	CHEMICAL
45205	45206	-	0	None
45206	45207	sensitive	0	None
45207	45208	,	0	None
45208	45209	Na	0	None
45209	45210	(	0	None
45210	45211	+	0	None
45211	45212	)	0	None
45212	45213	-	0	None
45213	45214	dependent	0	None
45214	45215	mechanism	0	None
45215	45216	.	0	None

45217	45218	H	0	None
45218	45219	(	0	None
45219	45220	+	0	None
45220	45221	)	0	None
45221	45222	transport	0	None
45222	45223	by	0	None
45223	45224	NHE3	1	GENE-Y
45224	45225	and	0	None
45225	45226	the	0	None
45226	45227	novel	0	None
45227	45228	transporter	0	None
45228	45229	is	0	None
45229	45230	inhibited	0	None
45230	45231	by	0	None
45231	45232	cAMP	0	None
45232	45233	,	0	None
45233	45234	albeit	0	None
45234	45235	to	0	None
45235	45236	different	0	None
45236	45237	extents	0	None
45237	45238	.	0	None

45239	45240	We	0	None
45240	45241	propose	0	None
45241	45242	that	0	None
45242	45243	multiple	0	None
45243	45244	Na	0	None
45244	45245	(	0	None
45245	45246	+	0	None
45246	45247	)	0	None
45247	45248	-	0	None
45248	45249	dependent	0	None
45249	45250	mechanisms	0	None
45250	45251	in	0	None
45251	45252	the	0	None
45252	45253	luminal	0	None
45253	45254	membrane	0	None
45254	45255	of	0	None
45255	45256	the	0	None
45256	45257	pancreatic	0	None
45257	45258	duct	0	None
45258	45259	absorb	0	None
45259	45260	Na	0	None
45260	45261	(	0	None
45261	45262	+	0	None
45262	45263	)	0	None
45263	45264	and	0	None
45264	45265	HCO	3	CHEMICAL
45265	45266	(	0	None
45266	45267	3	0	None
45267	45268	)	0	None
45268	45269	(	0	None
45269	45270	-	0	None
45270	45271	)	0	None
45271	45272	to	0	None
45272	45273	produce	0	None
45273	45274	a	0	None
45274	45275	pancreatic	0	None
45275	45276	juice	0	None
45276	45277	that	0	None
45277	45278	is	0	None
45278	45279	poor	0	None
45279	45280	in	0	None
45280	45281	HCO	3	CHEMICAL
45281	45282	(	0	None
45282	45283	3	0	None
45283	45284	)	0	None
45284	45285	(	0	None
45285	45286	-	0	None
45286	45287	)	0	None
45287	45288	and	0	None
45288	45289	rich	0	None
45289	45290	in	0	None
45290	45291	Cl	0	None
45291	45292	(	0	None
45292	45293	-	0	None
45293	45294	)	0	None
45294	45295	during	0	None
45295	45296	basal	0	None
45296	45297	secretion	0	None
45297	45298	.	0	None

45299	45300	Inhibition	0	None
45300	45301	of	0	None
45301	45302	the	0	None
45302	45303	transporters	0	None
45303	45304	during	0	None
45304	45305	stimulated	0	None
45305	45306	secretion	0	None
45306	45307	aids	0	None
45307	45308	in	0	None
45308	45309	producing	0	None
45309	45310	the	0	None
45310	45311	HCO	3	CHEMICAL
45311	45312	(	0	None
45312	45313	3	0	None
45313	45314	)	0	None
45314	45315	(	0	None
45315	45316	-	0	None
45316	45317	)	0	None
45317	45318	-	0	None
45318	45319	rich	0	None
45319	45320	pancreatic	0	None
45320	45321	juice	0	None
45321	45322	.	0	None

45323	45324	Improvement	0	None
45324	45325	of	0	None
45325	45326	cardiac	0	None
45326	45327	output	0	None
45327	45328	in	0	None
45328	45329	patients	0	None
45329	45330	with	0	None
45330	45331	severe	0	None
45331	45332	heart	0	None
45332	45333	failure	0	None
45333	45334	by	0	None
45334	45335	use	0	None
45335	45336	of	0	None
45336	45337	ACE	1	GENE-Y
45337	45338	-	0	None
45338	45339	inhibitors	0	None
45339	45340	combined	0	None
45340	45341	with	0	None
45341	45342	the	0	None
45342	45343	AT1	1	GENE-Y
45343	45344	-	0	None
45344	45345	antagonist	0	None
45345	45346	eprosartan	3	CHEMICAL
45346	45347	.	0	None

45348	45349	BACKGROUND	0	None
45349	45350	:	0	None
45350	45351	The	0	None
45351	45352	efficacy	0	None
45352	45353	of	0	None
45353	45354	ACE	1	GENE-Y
45354	45355	-	0	None
45355	45356	inhibitor	0	None
45356	45357	therapy	0	None
45357	45358	is	0	None
45358	45359	well	0	None
45359	45360	documented	0	None
45360	45361	in	0	None
45361	45362	the	0	None
45362	45363	treatment	0	None
45363	45364	of	0	None
45364	45365	chronic	0	None
45365	45366	heart	0	None
45366	45367	failure	0	None
45367	45368	.	0	None

45369	45370	As	0	None
45370	45371	pharmacological	0	None
45371	45372	mechanisms	0	None
45372	45373	of	0	None
45373	45374	ACE	1	GENE-Y
45374	45375	-	0	None
45375	45376	inhibition	0	None
45376	45377	and	0	None
45377	45380	angiotensin II AT1	1	GENE-Y
45380	45381	-	0	None
45381	45382	receptor	0	None
45382	45383	-	0	None
45383	45384	antagonists	0	None
45384	45385	differ	0	None
45385	45386	,	0	None
45386	45387	an	0	None
45387	45388	additional	0	None
45388	45389	positive	0	None
45389	45390	effect	0	None
45390	45391	concerning	0	None
45391	45392	left	0	None
45392	45393	ventricular	0	None
45393	45394	function	0	None
45394	45395	can	0	None
45395	45396	be	0	None
45396	45397	expected	0	None
45397	45398	in	0	None
45398	45399	combining	0	None
45399	45400	both	0	None
45400	45401	classes	0	None
45401	45402	of	0	None
45402	45403	drugs	0	None
45403	45404	.	0	None

45405	45406	METHODS	0	None
45406	45407	:	0	None
45407	45408	Twenty	0	None
45408	45409	patients	0	None
45409	45410	(	0	None
45410	45411	64	0	None
45411	45412	.	0	None
45412	45413	9	0	None
45413	45414	+	0	None
45414	45415	/	0	None
45415	45416	-	0	None
45416	45417	8	0	None
45417	45418	.	0	None
45418	45419	5	0	None
45419	45420	years	0	None
45420	45421	)	0	None
45421	45422	with	0	None
45422	45423	advanced	0	None
45423	45424	chronic	0	None
45424	45425	heart	0	None
45425	45426	failure	0	None
45426	45427	(	0	None
45427	45428	NYHA	0	None
45428	45429	class	0	None
45429	45430	III	0	None
45430	45431	)	0	None
45431	45432	receiving	0	None
45432	45433	long	0	None
45433	45434	-	0	None
45434	45435	term	0	None
45435	45436	medication	0	None
45436	45437	with	0	None
45437	45438	digitalis	0	None
45438	45439	,	0	None
45439	45440	diuretics	0	None
45440	45441	and	0	None
45441	45442	ACE	1	GENE-Y
45442	45443	-	0	None
45443	45444	inhibitors	0	None
45444	45445	were	0	None
45445	45446	randomized	0	None
45446	45447	to	0	None
45447	45448	either	0	None
45448	45449	eprosartan	3	CHEMICAL
45449	45450	(	0	None
45450	45451	540	0	None
45451	45452	+	0	None
45452	45453	/	0	None
45453	45454	-	0	None
45454	45455	96	0	None
45455	45456	mg	0	None
45456	45457	/	0	None
45457	45458	day	0	None
45458	45459	)	0	None
45459	45460	or	0	None
45460	45461	placebo	0	None
45461	45462	,	0	None
45462	45463	according	0	None
45463	45464	to	0	None
45464	45465	a	0	None
45465	45466	blinded	0	None
45466	45467	protocol	0	None
45467	45468	.	0	None

45469	45470	Hemodynamic	0	None
45470	45471	measurements	0	None
45471	45472	by	0	None
45472	45473	impedance	0	None
45473	45474	cardiography	0	None
45474	45475	were	0	None
45475	45476	performed	0	None
45476	45477	at	0	None
45477	45478	baseline	0	None
45478	45479	and	0	None
45479	45480	after	0	None
45480	45481	8	0	None
45481	45482	.	0	None
45482	45483	85	0	None
45483	45484	+	0	None
45484	45485	/	0	None
45485	45486	-	0	None
45486	45487	1	0	None
45487	45488	.	0	None

45489	45490	5	0	None
45490	45491	days	0	None
45491	45492	of	0	None
45492	45493	study	0	None
45493	45494	medication	0	None
45494	45495	treatment	0	None
45495	45496	.	0	None

45497	45498	RESULTS	0	None
45498	45499	:	0	None
45499	45500	Additional	0	None
45500	45501	treatment	0	None
45501	45502	with	0	None
45502	45503	eprosartan	3	CHEMICAL
45503	45504	resulted	0	None
45504	45505	in	0	None
45505	45506	a	0	None
45506	45507	higher	0	None
45507	45508	cardiac	0	None
45508	45509	output	0	None
45509	45510	than	0	None
45510	45511	in	0	None
45511	45512	the	0	None
45512	45513	control	0	None
45513	45514	group	0	None
45514	45515	(	0	None
45515	45516	P	0	None
45516	45517	<	0	None
45517	45518	0	0	None
45518	45519	.	0	None
45519	45520	05	0	None
45520	45521	)	0	None
45521	45522	.	0	None

45523	45524	While	0	None
45524	45525	in	0	None
45525	45526	the	0	None
45526	45527	active	0	None
45527	45528	treatment	0	None
45528	45529	group	0	None
45529	45530	cardiac	0	None
45530	45531	output	0	None
45531	45532	increased	0	None
45532	45533	significantly	0	None
45533	45534	from	0	None
45534	45535	baseline	0	None
45535	45536	(	0	None
45536	45537	2	0	None
45537	45538	.	0	None
45538	45539	27	0	None
45539	45540	-	0	None
45540	45541	3	0	None
45541	45542	.	0	None
45542	45543	24	0	None
45543	45544	l	0	None
45544	45545	/	0	None
45545	45546	min	0	None
45546	45547	,	0	None
45547	45548	P	0	None
45548	45549	=	0	None
45549	45550	0	0	None
45550	45551	.	0	None
45551	45552	039	0	None
45552	45553	)	0	None
45553	45554	,	0	None
45554	45555	there	0	None
45555	45556	was	0	None
45556	45557	no	0	None
45557	45558	change	0	None
45558	45559	in	0	None
45559	45560	the	0	None
45560	45561	control	0	None
45561	45562	group	0	None
45562	45563	.	0	None

45564	45565	CONCLUSIONS	0	None
45565	45566	:	0	None
45566	45567	The	0	None
45567	45568	additional	0	None
45568	45569	treatment	0	None
45569	45570	with	0	None
45570	45571	the	0	None
45571	45572	AT1	1	GENE-Y
45572	45573	-	0	None
45573	45574	receptor	0	None
45574	45575	antagonist	0	None
45575	45576	eprosartan	3	CHEMICAL
45576	45577	,	0	None
45577	45578	given	0	None
45578	45579	to	0	None
45579	45580	severe	0	None
45580	45581	heart	0	None
45581	45582	failure	0	None
45582	45583	patients	0	None
45583	45584	,	0	None
45584	45585	who	0	None
45585	45586	received	0	None
45586	45587	digitalis	0	None
45587	45588	,	0	None
45588	45589	diuretics	0	None
45589	45590	and	0	None
45590	45591	ACE	1	GENE-Y
45591	45592	-	0	None
45592	45593	inhibitors	0	None
45593	45594	,	0	None
45594	45595	resulted	0	None
45595	45596	in	0	None
45596	45597	a	0	None
45597	45598	beneficial	0	None
45598	45599	effect	0	None
45599	45600	by	0	None
45600	45601	increasing	0	None
45601	45602	cardiac	0	None
45602	45603	output	0	None
45603	45604	.	0	None

45605	45606	This	0	None
45606	45607	effect	0	None
45607	45608	may	0	None
45608	45609	be	0	None
45609	45610	due	0	None
45610	45611	to	0	None
45611	45612	eprosartan	3	CHEMICAL
45612	45613	'	0	None
45613	45614	s	0	None
45614	45615	additional	0	None
45615	45616	property	0	None
45616	45617	of	0	None
45617	45618	blocking	0	None
45618	45619	the	0	None
45619	45620	autocrine	0	None
45620	45621	interaction	0	None
45621	45622	of	0	None
45622	45623	locally	0	None
45623	45624	and	0	None
45624	45625	not	0	None
45625	45626	ACE	1	GENE-Y
45626	45627	-	0	None
45627	45628	generated	0	None
45628	45630	angiotensin II	1	GENE-Y
45630	45631	with	0	None
45631	45632	their	0	None
45632	45633	respective	0	None
45633	45634	vascular	0	None
45634	45635	and	0	None
45635	45636	myocardial	0	None
45636	45637	AT1	1	GENE-Y
45637	45638	-	0	None
45638	45639	receptors	0	None
45639	45640	as	0	None
45640	45641	well	0	None
45641	45642	as	0	None
45642	45643	the	0	None
45643	45644	influence	0	None
45644	45645	on	0	None
45645	45646	prejunctional	0	None
45646	45647	AT1	1	GENE-Y
45647	45648	-	0	None
45648	45649	receptors	0	None
45649	45650	located	0	None
45650	45651	on	0	None
45651	45652	sympathetic	0	None
45652	45653	nerve	0	None
45653	45654	terminals	0	None
45654	45655	.	0	None

45656	45657	Gene	0	None
45657	45658	expression	0	None
45658	45659	of	0	None
45659	45660	the	0	None
45660	45661	phosphodiesterases	2	GENE-N
45661	45662	3A	0	None
45662	45663	and	0	None
45663	45664	5A	0	None
45664	45665	in	0	None
45665	45666	human	0	None
45666	45667	corpus	0	None
45667	45668	cavernosum	0	None
45668	45669	penis	0	None
45669	45670	.	0	None

45671	45672	OBJECTIVE	0	None
45672	45673	:	0	None
45673	45674	The	0	None
45674	45675	following	0	None
45675	45676	study	0	None
45676	45677	was	0	None
45677	45678	performed	0	None
45678	45679	to	0	None
45679	45680	evaluate	0	None
45680	45681	the	0	None
45681	45682	importance	0	None
45682	45683	of	0	None
45683	45684	phosphodiesterases	2	GENE-N
45684	45685	3A	0	None
45685	45686	(	0	None
45686	45687	PDE3A	0	None
45687	45688	)	0	None
45688	45689	and	0	None
45689	45690	5A	0	None
45690	45691	(	0	None
45691	45692	PDE5A	1	GENE-Y
45692	45693	)	0	None
45693	45694	for	0	None
45694	45695	the	0	None
45695	45696	regulation	0	None
45696	45697	of	0	None
45697	45698	penile	0	None
45698	45699	smooth	0	None
45699	45700	muscle	0	None
45700	45701	tone	0	None
45701	45702	.	0	None

45703	45704	Furthermore	0	None
45704	45705	,	0	None
45705	45706	indications	0	None
45706	45707	of	0	None
45707	45708	side	0	None
45708	45709	effects	0	None
45709	45710	of	0	None
45710	45711	specific	0	None
45711	45712	inhibitors	0	None
45712	45713	in	0	None
45713	45714	certain	0	None
45714	45715	tissues	0	None
45715	45716	as	0	None
45716	45717	well	0	None
45717	45718	as	0	None
45718	45719	of	0	None
45719	45720	a	0	None
45720	45721	possible	0	None
45721	45722	relation	0	None
45722	45723	between	0	None
45723	45724	the	0	None
45724	45725	level	0	None
45725	45726	of	0	None
45726	45727	PDE3A	0	None
45727	45728	and	0	None
45728	45729	PDE5A	1	GENE-Y
45729	45730	gene	0	None
45730	45731	expression	0	None
45731	45732	and	0	None
45732	45733	erectile	0	None
45733	45734	dysfunction	0	None
45734	45735	should	0	None
45735	45736	have	0	None
45736	45737	been	0	None
45737	45738	deduced	0	None
45738	45739	from	0	None
45739	45740	the	0	None
45740	45741	results	0	None
45741	45742	obtained	0	None
45742	45743	.	0	None

45744	45745	METHODS	0	None
45745	45746	:	0	None
45746	45747	Total	0	None
45747	45748	ribonucleic	0	None
45748	45749	acid	0	None
45749	45750	was	0	None
45750	45751	isolated	0	None
45751	45752	from	0	None
45752	45753	different	0	None
45753	45754	human	0	None
45754	45755	tissues	0	None
45755	45756	(	0	None
45756	45757	urogenital	0	None
45757	45758	tract	0	None
45758	45759	,	0	None
45759	45760	gastrointestinal	0	None
45760	45761	tract	0	None
45761	45762	,	0	None
45762	45763	cardiovascular	0	None
45763	45764	system	0	None
45764	45765	and	0	None
45765	45766	central	0	None
45766	45767	nervous	0	None
45767	45768	system	0	None
45768	45769	)	0	None
45769	45770	and	0	None
45770	45771	subjected	0	None
45771	45772	to	0	None
45772	45773	RTPCR	0	None
45773	45774	analysis	0	None
45774	45775	and	0	None
45775	45776	Northern	0	None
45776	45777	blotting	0	None
45777	45778	using	0	None
45778	45779	primers	0	None
45779	45780	and	0	None
45780	45781	probes	0	None
45781	45782	specific	0	None
45782	45783	for	0	None
45783	45784	PDE3A	0	None
45784	45785	and	0	None
45785	45786	PDE5A	1	GENE-Y
45786	45787	.	0	None

45788	45789	RESULTS	0	None
45789	45790	:	0	None
45790	45791	As	0	None
45791	45792	shown	0	None
45792	45793	by	0	None
45793	45794	RT	0	None
45794	45795	-	0	None
45795	45796	PCR	0	None
45796	45797	and	0	None
45797	45798	Northern	0	None
45798	45799	blotting	0	None
45799	45800	,	0	None
45800	45801	PDE3A	0	None
45801	45802	and	0	None
45802	45803	PDE5A	1	GENE-Y
45803	45804	mRNAs	0	None
45804	45805	exhibit	0	None
45805	45806	a	0	None
45806	45807	distinct	0	None
45807	45808	distribution	0	None
45808	45809	throughout	0	None
45809	45810	the	0	None
45810	45811	tissues	0	None
45811	45812	examined	0	None
45812	45813	but	0	None
45813	45814	were	0	None
45814	45815	2	0	None
45815	45816	-	0	None
45816	45817	fold	0	None
45817	45818	higher	0	None
45818	45819	in	0	None
45819	45820	cavernous	0	None
45820	45821	tissue	0	None
45821	45822	than	0	None
45822	45823	in	0	None
45823	45824	all	0	None
45824	45825	other	0	None
45825	45826	tissues	0	None
45826	45827	investigated	0	None
45827	45828	.	0	None

45829	45830	However	0	None
45830	45831	,	0	None
45831	45832	there	0	None
45832	45833	were	0	None
45833	45834	no	0	None
45834	45835	significant	0	None
45835	45836	differences	0	None
45836	45837	in	0	None
45837	45838	the	0	None
45838	45839	levels	0	None
45839	45840	of	0	None
45840	45841	gene	0	None
45841	45842	expression	0	None
45842	45843	between	0	None
45843	45844	the	0	None
45844	45845	two	0	None
45845	45846	subgroups	0	None
45846	45847	of	0	None
45847	45848	patients	0	None
45848	45849	.	0	None

45850	45851	CONCLUSIONS	0	None
45851	45852	:	0	None
45852	45853	Very	0	None
45853	45854	high	0	None
45854	45855	expression	0	None
45855	45856	levels	0	None
45856	45857	of	0	None
45857	45858	PDE3A	0	None
45858	45859	and	0	None
45859	45860	PDE5A	1	GENE-Y
45860	45861	in	0	None
45861	45862	human	0	None
45862	45863	cavernous	0	None
45863	45864	tissue	0	None
45864	45865	underscore	0	None
45865	45866	the	0	None
45866	45867	physiological	0	None
45867	45868	importance	0	None
45868	45869	of	0	None
45869	45870	these	0	None
45870	45871	enzymes	0	None
45871	45872	for	0	None
45872	45873	the	0	None
45873	45874	regulation	0	None
45874	45875	of	0	None
45875	45876	penile	0	None
45876	45877	erection	0	None
45877	45878	,	0	None
45878	45879	emphasizing	0	None
45879	45880	their	0	None
45880	45881	therapeutical	0	None
45881	45882	and	0	None
45882	45883	pharmacological	0	None
45883	45884	relevance	0	None
45884	45885	.	0	None

45886	45887	The	0	None
45887	45888	distribution	0	None
45888	45889	pattern	0	None
45889	45890	of	0	None
45890	45891	the	0	None
45891	45892	mRNA	0	None
45892	45893	for	0	None
45893	45894	the	0	None
45894	45895	isoenzymes	0	None
45895	45896	PDE3A	0	None
45896	45897	and	0	None
45897	45898	PDE5A	1	GENE-Y
45898	45899	may	0	None
45899	45900	explain	0	None
45900	45901	the	0	None
45901	45902	pharmacological	0	None
45902	45903	effects	0	None
45903	45904	as	0	None
45904	45905	well	0	None
45905	45906	as	0	None
45906	45907	the	0	None
45907	45908	side	0	None
45908	45909	effects	0	None
45909	45910	of	0	None
45910	45911	milrinone	0	None
45911	45912	and	0	None
45912	45913	sidenafil	3	CHEMICAL
45913	45914	.	0	None

45915	45916	Effects	0	None
45916	45917	of	0	None
45917	45918	troglitazone	3	CHEMICAL
45918	45919	on	0	None
45919	45920	blood	0	None
45920	45921	concentrations	0	None
45921	45922	of	0	None
45922	45926	plasminogen activator inhibitor 1	2	GENE-N
45926	45927	in	0	None
45927	45928	patients	0	None
45928	45929	with	0	None
45929	45930	type	0	None
45930	45931	2	0	None
45931	45932	diabetes	0	None
45932	45933	and	0	None
45933	45934	in	0	None
45934	45935	lean	0	None
45935	45936	and	0	None
45936	45937	obese	0	None
45937	45938	normal	0	None
45938	45939	subjects	0	None
45939	45940	.	0	None

45941	45942	Low	0	None
45942	45943	plasma	0	None
45943	45944	fibrinolytic	0	None
45944	45945	activity	0	None
45945	45946	in	0	None
45946	45947	association	0	None
45947	45948	with	0	None
45948	45949	increased	0	None
45949	45950	plasma	0	None
45950	45954	plasminogen activator inhibitor 1	2	GENE-N
45954	45955	(	0	None
45955	45956	PAI	2	GENE-N
45956	45957	-	0	None
45957	45958	1	0	None
45958	45959	)	0	None
45959	45960	levels	0	None
45960	45961	has	0	None
45961	45962	been	0	None
45962	45963	linked	0	None
45963	45964	to	0	None
45964	45965	an	0	None
45965	45966	increased	0	None
45966	45967	risk	0	None
45967	45968	of	0	None
45968	45969	atherosclerosis	0	None
45969	45970	in	0	None
45970	45971	obesity	0	None
45971	45972	and	0	None
45972	45973	type	0	None
45973	45974	2	0	None
45974	45975	diabetes	0	None
45975	45976	.	0	None

45977	45978	We	0	None
45978	45979	tested	0	None
45979	45980	the	0	None
45980	45981	hypothesis	0	None
45981	45982	that	0	None
45982	45983	troglitazone	3	CHEMICAL
45983	45984	,	0	None
45984	45985	which	0	None
45985	45986	improves	0	None
45986	45987	insulin	0	None
45987	45988	sensitivity	0	None
45988	45989	and	0	None
45989	45990	lowers	0	None
45990	45991	plasma	0	None
45991	45992	insulin	0	None
45992	45993	levels	0	None
45993	45994	in	0	None
45994	45995	insulin	0	None
45995	45996	-	0	None
45996	45997	resistant	0	None
45997	45998	obese	0	None
45998	45999	subjects	0	None
45999	46000	and	0	None
46000	46001	patients	0	None
46001	46002	with	0	None
46002	46003	type	0	None
46003	46004	2	0	None
46004	46005	diabetes	0	None
46005	46006	,	0	None
46006	46007	would	0	None
46007	46008	also	0	None
46008	46009	lower	0	None
46009	46010	circulating	0	None
46010	46011	PAI	2	GENE-N
46011	46012	-	0	None
46012	46013	1	0	None
46013	46014	antigen	0	None
46014	46015	concentrations	0	None
46015	46016	and	0	None
46016	46017	activity	0	None
46017	46018	.	0	None

46019	46020	We	0	None
46020	46021	assessed	0	None
46021	46022	insulin	0	None
46022	46023	sensitivity	0	None
46023	46024	(	0	None
46024	46025	5	0	None
46025	46026	-	0	None
46026	46027	h	0	None
46027	46028	,	0	None
46028	46029	80	0	None
46029	46030	mU	0	None
46030	46031	x	0	None
46031	46032	m	0	None
46032	46033	(	0	None
46033	46034	-	0	None
46034	46035	2	0	None
46035	46036	)	0	None
46036	46037	x	0	None
46037	46038	min	0	None
46038	46039	(	0	None
46039	46040	-	0	None
46040	46041	1	0	None
46041	46042	)	0	None
46042	46043	hyperinsulinemic	0	None
46043	46044	-	0	None
46044	46045	euglycemic	0	None
46045	46046	clamp	0	None
46046	46047	)	0	None
46047	46048	and	0	None
46048	46049	measured	0	None
46049	46050	plasma	0	None
46050	46051	PAI	2	GENE-N
46051	46052	-	0	None
46052	46053	1	0	None
46053	46054	antigen	0	None
46054	46055	and	0	None
46055	46056	activities	0	None
46056	46057	and	0	None
46057	46060	tissue plasminogen activator	1	GENE-Y
46060	46061	(	0	None
46061	46062	tPA	1	GENE-Y
46062	46063	)	0	None
46063	46064	in	0	None
46064	46065	14	0	None
46065	46066	patients	0	None
46066	46067	with	0	None
46067	46068	type	0	None
46068	46069	2	0	None
46069	46070	diabetes	0	None
46070	46071	and	0	None
46071	46072	20	0	None
46072	46073	normal	0	None
46073	46074	control	0	None
46074	46075	subjects	0	None
46075	46076	(	0	None
46076	46077	10	0	None
46077	46078	lean	0	None
46078	46079	,	0	None
46079	46080	10	0	None
46080	46081	obese	0	None
46081	46082	)	0	None
46082	46083	before	0	None
46083	46084	and	0	None
46084	46085	after	0	None
46085	46086	3	0	None
46086	46087	months	0	None
46087	46088	of	0	None
46088	46089	treatment	0	None
46089	46090	with	0	None
46090	46091	troglitazone	3	CHEMICAL
46091	46092	(	0	None
46092	46093	600	0	None
46093	46094	mg	0	None
46094	46095	/	0	None
46095	46096	day	0	None
46096	46097	)	0	None
46097	46098	.	0	None

46099	46100	At	0	None
46100	46101	baseline	0	None
46101	46102	,	0	None
46102	46103	plasma	0	None
46103	46104	PAI	2	GENE-N
46104	46105	-	0	None
46105	46106	1	0	None
46106	46107	antigen	0	None
46107	46108	levels	0	None
46108	46109	after	0	None
46109	46110	an	0	None
46110	46111	overnight	0	None
46111	46112	fast	0	None
46112	46113	were	0	None
46113	46114	significantly	0	None
46114	46115	higher	0	None
46115	46116	in	0	None
46116	46117	the	0	None
46117	46118	obese	0	None
46118	46119	(	0	None
46119	46120	33	0	None
46120	46121	.	0	None
46121	46122	5	0	None
46122	46123	+	0	None
46123	46124	/	0	None
46124	46125	-	0	None
46125	46126	4	0	None
46126	46127	.	0	None
46127	46128	7	0	None
46128	46129	microg	0	None
46129	46130	/	0	None
46130	46131	l	0	None
46131	46132	)	0	None
46132	46133	and	0	None
46133	46134	type	0	None
46134	46135	2	0	None
46135	46136	diabetic	0	None
46136	46137	subjects	0	None
46137	46138	(	0	None
46138	46139	54	0	None
46139	46140	.	0	None
46140	46141	9	0	None
46141	46142	+	0	None
46142	46143	/	0	None
46143	46144	-	0	None
46144	46145	6	0	None
46145	46146	.	0	None
46146	46147	3	0	None
46147	46148	microg	0	None
46148	46149	/	0	None
46149	46150	l	0	None
46150	46151	)	0	None
46151	46152	than	0	None
46152	46153	in	0	None
46153	46154	the	0	None
46154	46155	lean	0	None
46155	46156	control	0	None
46156	46157	subjects	0	None
46157	46158	(	0	None
46158	46159	16	0	None
46159	46160	.	0	None
46160	46161	3	0	None
46161	46162	+	0	None
46162	46163	/	0	None
46163	46164	-	0	None
46164	46165	3	0	None
46165	46166	.	0	None
46166	46167	2	0	None
46167	46168	microg	0	None
46168	46169	/	0	None
46169	46170	l	0	None
46170	46171	;	0	None
46171	46172	P	0	None
46172	46173	<	0	None
46173	46174	0	0	None
46174	46175	.	0	None
46175	46176	01	0	None
46176	46177	and	0	None
46177	46178	P	0	None
46178	46179	<	0	None
46179	46180	0	0	None
46180	46181	.	0	None
46181	46182	001	0	None
46182	46183	,	0	None
46183	46184	respectively	0	None
46184	46185	)	0	None
46185	46186	.	0	None

46187	46188	Troglitazone	0	None
46188	46189	decreased	0	None
46189	46190	plasma	0	None
46190	46191	PAI	2	GENE-N
46191	46192	-	0	None
46192	46193	1	0	None
46193	46194	antigen	0	None
46194	46195	concentrations	0	None
46195	46196	in	0	None
46196	46197	the	0	None
46197	46198	diabetic	0	None
46198	46199	patients	0	None
46199	46200	(	0	None
46200	46201	36	0	None
46201	46202	.	0	None
46202	46203	8	0	None
46203	46204	+	0	None
46204	46205	/	0	None
46205	46206	-	0	None
46206	46207	5	0	None
46207	46208	.	0	None
46208	46209	0	0	None
46209	46210	microg	0	None
46210	46211	/	0	None
46211	46212	l	0	None
46212	46213	;	0	None
46213	46214	P	0	None
46214	46215	<	0	None
46215	46216	0	0	None
46216	46217	.	0	None
46217	46218	001	0	None
46218	46219	vs	0	None
46219	46220	.	0	None
46220	46221	baseline	0	None
46221	46222	)	0	None
46222	46223	,	0	None
46223	46224	but	0	None
46224	46225	the	0	None
46225	46226	reduction	0	None
46226	46227	in	0	None
46227	46228	the	0	None
46228	46229	obese	0	None
46229	46230	subjects	0	None
46230	46231	did	0	None
46231	46232	not	0	None
46232	46233	reach	0	None
46233	46234	statistical	0	None
46234	46235	significance	0	None
46235	46236	(	0	None
46236	46237	baseline	0	None
46237	46238	,	0	None
46238	46239	33	0	None
46239	46240	.	0	None
46240	46241	5	0	None
46241	46242	+	0	None
46242	46243	/	0	None
46243	46244	-	0	None
46244	46245	4	0	None
46245	46246	.	0	None
46246	46247	7	0	None
46247	46248	;	0	None
46248	46249	after	0	None
46249	46250	troglitazone	3	CHEMICAL
46250	46251	,	0	None
46251	46252	25	0	None
46252	46253	.	0	None
46253	46254	6	0	None
46254	46255	+	0	None
46255	46256	/	0	None
46256	46257	-	0	None
46257	46258	5	0	None
46258	46259	.	0	None
46259	46260	2	0	None
46260	46261	microg	0	None
46261	46262	/	0	None
46262	46263	l	0	None
46263	46264	)	0	None
46264	46265	.	0	None

46266	46267	Changes	0	None
46267	46268	in	0	None
46268	46269	plasma	0	None
46269	46270	PAI	2	GENE-N
46270	46271	-	0	None
46271	46272	1	0	None
46272	46273	activity	0	None
46273	46274	paralleled	0	None
46274	46275	those	0	None
46275	46276	of	0	None
46276	46277	PAI	2	GENE-N
46277	46278	-	0	None
46278	46279	1	0	None
46279	46280	antigen	0	None
46280	46281	.	0	None

46282	46283	The	0	None
46283	46284	extent	0	None
46284	46285	of	0	None
46285	46286	the	0	None
46286	46287	reduction	0	None
46287	46288	in	0	None
46288	46289	plasma	0	None
46289	46290	PAI	2	GENE-N
46290	46291	-	0	None
46291	46292	1	0	None
46292	46293	antigen	0	None
46293	46294	concentrations	0	None
46294	46295	in	0	None
46295	46296	the	0	None
46296	46297	diabetic	0	None
46297	46298	patients	0	None
46298	46299	after	0	None
46299	46300	troglitazone	3	CHEMICAL
46300	46301	correlated	0	None
46301	46302	with	0	None
46302	46303	the	0	None
46303	46304	reductions	0	None
46304	46305	in	0	None
46305	46306	fasting	0	None
46306	46307	plasma	0	None
46307	46308	insulin	0	None
46308	46309	(	0	None
46309	46310	r	0	None
46310	46311	=	0	None
46311	46312	0	0	None
46312	46313	.	0	None
46313	46314	60	0	None
46314	46315	,	0	None
46315	46316	P	0	None
46316	46317	<	0	None
46317	46318	0	0	None
46318	46319	.	0	None
46319	46320	05	0	None
46320	46321	)	0	None
46321	46322	,	0	None
46322	46325	nonesterified fatty acid	3	CHEMICAL
46325	46326	(	0	None
46326	46327	r	0	None
46327	46328	=	0	None
46328	46329	0	0	None
46329	46330	.	0	None
46330	46331	63	0	None
46331	46332	,	0	None
46332	46333	P	0	None
46333	46334	<	0	None
46334	46335	0	0	None
46335	46336	.	0	None
46336	46337	02	0	None
46337	46338	)	0	None
46338	46339	,	0	None
46339	46340	and	0	None
46340	46341	glucose	3	CHEMICAL
46341	46342	concentrations	0	None
46342	46343	(	0	None
46343	46344	r	0	None
46344	46345	=	0	None
46345	46346	0	0	None
46346	46347	.	0	None
46347	46348	64	0	None
46348	46349	,	0	None
46349	46350	P	0	None
46350	46351	<	0	None
46351	46352	0	0	None
46352	46353	.	0	None
46353	46354	02	0	None
46354	46355	)	0	None
46355	46356	but	0	None
46356	46357	not	0	None
46357	46358	with	0	None
46358	46359	the	0	None
46359	46360	improvement	0	None
46360	46361	in	0	None
46361	46362	glucose	3	CHEMICAL
46362	46363	disposal	0	None
46363	46364	rates	0	None
46364	46365	during	0	None
46365	46366	the	0	None
46366	46367	glucose	3	CHEMICAL
46367	46368	clamps	0	None
46368	46369	.	0	None

46370	46371	Three	0	None
46371	46372	nonresponders	0	None
46372	46373	to	0	None
46373	46374	troglitazone	3	CHEMICAL
46374	46375	with	0	None
46375	46376	respect	0	None
46376	46377	to	0	None
46377	46378	effects	0	None
46378	46379	on	0	None
46379	46380	insulin	0	None
46380	46381	sensitivity	0	None
46381	46382	and	0	None
46382	46383	fasting	0	None
46383	46384	glucose	3	CHEMICAL
46384	46385	and	0	None
46385	46386	insulin	0	None
46386	46387	levels	0	None
46387	46388	also	0	None
46388	46389	had	0	None
46389	46390	no	0	None
46390	46391	reduction	0	None
46391	46392	in	0	None
46392	46393	circulating	0	None
46393	46394	PAI	2	GENE-N
46394	46395	-	0	None
46395	46396	1	0	None
46396	46397	.	0	None

46398	46399	In	0	None
46399	46400	conclusion	0	None
46400	46401	,	0	None
46401	46402	troglitazone	3	CHEMICAL
46402	46403	enhances	0	None
46403	46404	fibrinolytic	0	None
46404	46405	system	0	None
46405	46406	activity	0	None
46406	46407	in	0	None
46407	46408	insulin	0	None
46408	46409	-	0	None
46409	46410	resistant	0	None
46410	46411	type	0	None
46411	46412	2	0	None
46412	46413	diabetic	0	None
46413	46414	patients	0	None
46414	46415	.	0	None

46416	46417	This	0	None
46417	46418	effect	0	None
46418	46419	appears	0	None
46419	46420	to	0	None
46420	46421	be	0	None
46421	46422	intimately	0	None
46422	46423	linked	0	None
46423	46424	to	0	None
46424	46425	its	0	None
46425	46426	potential	0	None
46426	46427	to	0	None
46427	46428	lower	0	None
46428	46429	plasma	0	None
46429	46430	insulin	0	None
46430	46431	levels	0	None
46431	46432	and	0	None
46432	46433	improve	0	None
46433	46434	glycemic	0	None
46434	46435	control	0	None
46435	46436	through	0	None
46436	46437	its	0	None
46437	46438	peripheral	0	None
46438	46439	tissue	0	None
46439	46440	insulin	0	None
46440	46441	-	0	None
46441	46442	sensitizing	0	None
46442	46443	effects	0	None
46443	46444	.	0	None

46445	46446	Tetrahydropterin	0	None
46446	46447	-	0	None
46447	46448	dependent	0	None
46448	46451	amino acid hydroxylases	2	GENE-N
46451	46452	.	0	None

46453	46454	Phenylalanine	0	None
46454	46455	hydroxylase	0	None
46455	46456	,	0	None
46456	46458	tyrosine hydroxylase	1	GENE-Y
46458	46459	,	0	None
46459	46460	and	0	None
46460	46462	tryptophan hydroxylase	1	GENE-Y
46462	46463	constitute	0	None
46463	46464	a	0	None
46464	46465	small	0	None
46465	46466	family	0	None
46466	46467	of	0	None
46467	46468	monooxygenases	2	GENE-N
46468	46469	that	0	None
46469	46470	utilize	0	None
46470	46471	tetrahydropterins	3	CHEMICAL
46471	46472	as	0	None
46472	46473	substrates	0	None
46473	46474	.	0	None

46475	46476	When	0	None
46476	46477	from	0	None
46477	46478	eukaryotic	0	None
46478	46479	sources	0	None
46479	46480	,	0	None
46480	46481	these	0	None
46481	46482	enzymes	0	None
46482	46483	are	0	None
46483	46484	composed	0	None
46484	46485	of	0	None
46485	46486	a	0	None
46486	46487	homologous	0	None
46487	46488	catalytic	0	None
46488	46489	domain	0	None
46489	46490	to	0	None
46490	46491	which	0	None
46491	46492	are	0	None
46492	46493	attached	0	None
46493	46494	discrete	0	None
46494	46495	N	0	None
46495	46496	-	0	None
46496	46497	terminal	0	None
46497	46498	regulatory	0	None
46498	46499	domains	0	None
46499	46500	and	0	None
46500	46501	short	0	None
46501	46502	C	0	None
46502	46503	-	0	None
46503	46504	terminal	0	None
46504	46505	tetramerization	0	None
46505	46506	domains	0	None
46506	46507	,	0	None
46507	46508	whereas	0	None
46508	46509	the	0	None
46509	46510	bacterial	0	None
46510	46511	enzymes	0	None
46511	46512	lack	0	None
46512	46513	the	0	None
46513	46514	N	0	None
46514	46515	-	0	None
46515	46516	terminal	0	None
46516	46517	and	0	None
46517	46518	C	0	None
46518	46519	-	0	None
46519	46520	terminal	0	None
46520	46521	domains	0	None
46521	46522	.	0	None

46523	46524	Each	0	None
46524	46525	enzyme	0	None
46525	46526	contains	0	None
46526	46527	a	0	None
46527	46528	single	0	None
46528	46530	ferrous iron	3	CHEMICAL
46530	46531	atom	0	None
46531	46532	bound	0	None
46532	46533	to	0	None
46533	46534	two	0	None
46534	46535	histidines	0	None
46535	46536	and	0	None
46536	46537	a	0	None
46537	46538	glutamate	3	CHEMICAL
46538	46539	.	0	None

46540	46541	Recent	0	None
46541	46542	mechanistic	0	None
46542	46543	studies	0	None
46543	46544	have	0	None
46544	46545	begun	0	None
46545	46546	to	0	None
46546	46547	provide	0	None
46547	46548	insights	0	None
46548	46549	into	0	None
46549	46550	the	0	None
46550	46551	mechanisms	0	None
46551	46552	of	0	None
46552	46553	oxygen	0	None
46553	46554	activation	0	None
46554	46555	and	0	None
46555	46556	hydroxylation	0	None
46556	46557	.	0	None

46558	46559	Although	0	None
46559	46560	the	0	None
46560	46561	hydroxylating	0	None
46561	46562	intermediate	0	None
46562	46563	in	0	None
46563	46564	these	0	None
46564	46565	enzymes	0	None
46565	46566	has	0	None
46566	46567	not	0	None
46567	46568	been	0	None
46568	46569	identified	0	None
46569	46570	,	0	None
46570	46571	the	0	None
46571	46572	iron	3	CHEMICAL
46572	46573	is	0	None
46573	46574	likely	0	None
46574	46575	to	0	None
46575	46576	be	0	None
46576	46577	involved	0	None
46577	46578	.	0	None

46579	46580	Reversible	0	None
46580	46581	phosphorylation	0	None
46581	46582	of	0	None
46582	46583	serine	3	CHEMICAL
46583	46584	residues	0	None
46584	46585	in	0	None
46585	46586	the	0	None
46586	46587	regulatory	0	None
46587	46588	domains	0	None
46588	46589	affects	0	None
46589	46590	the	0	None
46590	46591	activities	0	None
46591	46592	of	0	None
46592	46593	all	0	None
46593	46594	three	0	None
46594	46595	enzymes	0	None
46595	46596	.	0	None

46597	46598	In	0	None
46598	46599	addition	0	None
46599	46600	,	0	None
46600	46602	phenylalanine hydroxylase	1	GENE-Y
46602	46603	is	0	None
46603	46604	allosterically	0	None
46604	46605	regulated	0	None
46605	46606	by	0	None
46606	46607	its	0	None
46607	46608	substrates	0	None
46608	46609	,	0	None
46609	46610	phenylalanine	3	CHEMICAL
46610	46611	and	0	None
46611	46612	tetrahydrobiopterin	3	CHEMICAL
46612	46613	.	0	None

46614	46615	Protective	0	None
46615	46616	action	0	None
46616	46617	of	0	None
46617	46618	cardiac	0	None
46618	46619	DT	3	CHEMICAL
46619	46620	-	0	None
46620	46621	diaphorase	2	GENE-N
46621	46622	against	0	None
46622	46623	menadione	0	None
46623	46624	toxicity	0	None
46624	46625	in	0	None
46625	46626	guinea	0	None
46626	46627	pig	0	None
46627	46628	isolated	0	None
46628	46629	atria	0	None
46629	46630	.	0	None

46631	46632	In	0	None
46632	46633	myocardial	0	None
46633	46634	preparations	0	None
46634	46635	isolated	0	None
46635	46636	from	0	None
46636	46637	guinea	0	None
46637	46638	pigs	0	None
46638	46639	,	0	None
46639	46640	2	0	None
46640	46641	-	0	None
46641	46642	methyl	3	CHEMICAL
46642	46643	-	0	None
46643	46644	1	0	None
46644	46645	,	0	None
46645	46646	4	0	None
46646	46647	-	0	None
46647	46648	naphthoquinone	3	CHEMICAL
46648	46649	(	0	None
46649	46650	menadione	0	None
46650	46651	)	0	None
46651	46652	causes	0	None
46652	46653	an	0	None
46653	46654	increase	0	None
46654	46655	in	0	None
46655	46656	contractility	0	None
46656	46657	that	0	None
46657	46658	is	0	None
46658	46659	strictly	0	None
46659	46660	related	0	None
46660	46661	to	0	None
46661	46662	the	0	None
46662	46663	generation	0	None
46663	46664	of	0	None
46664	46665	reactive	0	None
46665	46666	oxygen	0	None
46666	46667	species	0	None
46667	46668	(	0	None
46668	46669	ROS	1	GENE-Y
46669	46670	)	0	None
46670	46671	as	0	None
46671	46672	a	0	None
46672	46673	consequence	0	None
46673	46674	of	0	None
46674	46675	quinone	3	CHEMICAL
46675	46676	metabolism	0	None
46676	46677	.	0	None

46678	46679	In	0	None
46679	46680	heart	0	None
46680	46681	,	0	None
46681	46682	menadione	0	None
46682	46683	undergoes	0	None
46683	46684	one	0	None
46684	46685	-	0	None
46685	46686	electron	0	None
46686	46687	reduction	0	None
46687	46688	to	0	None
46688	46689	semiquinone	0	None
46689	46690	,	0	None
46690	46691	a	0	None
46691	46692	reaction	0	None
46692	46693	mainly	0	None
46693	46694	catalysed	0	None
46694	46695	by	0	None
46695	46696	mitochondrial	0	None
46696	46697	NADH	3	CHEMICAL
46697	46698	:	0	None
46698	46699	ubiquinone	3	CHEMICAL
46699	46700	oxidoreductase	0	None
46700	46701	.	0	None

46702	46703	It	0	None
46703	46704	is	0	None
46704	46705	also	0	None
46705	46706	converted	0	None
46706	46707	to	0	None
46707	46708	hydroquinone	3	CHEMICAL
46708	46709	by	0	None
46709	46710	the	0	None
46710	46711	soluble	0	None
46711	46712	two	0	None
46712	46713	-	0	None
46713	46714	electron	0	None
46714	46715	reductase	2	GENE-N
46715	46716	,	0	None
46716	46717	DT	3	CHEMICAL
46717	46718	-	0	None
46718	46719	diaphorase	2	GENE-N
46719	46720	,	0	None
46720	46721	and	0	None
46721	46722	is	0	None
46722	46723	conjugated	0	None
46723	46724	with	0	None
46724	46725	GSH	3	CHEMICAL
46725	46726	by	0	None
46726	46727	glutathione	3	CHEMICAL
46727	46728	S	0	None
46728	46729	-	0	None
46729	46730	transferase	0	None
46730	46731	.	0	None

46732	46733	In	0	None
46733	46734	order	0	None
46734	46735	to	0	None
46735	46736	assess	0	None
46736	46737	the	0	None
46737	46738	role	0	None
46738	46739	of	0	None
46739	46740	DT	3	CHEMICAL
46740	46741	-	0	None
46741	46742	diaphorase	2	GENE-N
46742	46743	in	0	None
46743	46744	cardiac	0	None
46744	46745	responses	0	None
46745	46746	to	0	None
46746	46747	menadione	0	None
46747	46748	,	0	None
46748	46749	we	0	None
46749	46750	examined	0	None
46750	46751	the	0	None
46751	46752	effects	0	None
46752	46753	of	0	None
46753	46754	both	0	None
46754	46755	a	0	None
46755	46756	specific	0	None
46756	46757	inhibitor	0	None
46757	46758	(	0	None
46758	46759	dicoumarol	0	None
46759	46760	)	0	None
46760	46761	and	0	None
46761	46762	an	0	None
46762	46763	inducer	0	None
46763	46764	(	0	None
46764	46765	beta	0	None
46765	46766	-	0	None
46766	46767	naphthoflavone	0	None
46767	46768	)	0	None
46768	46769	of	0	None
46769	46770	the	0	None
46770	46771	enzyme	0	None
46771	46772	on	0	None
46772	46773	the	0	None
46773	46774	inotropic	0	None
46774	46775	action	0	None
46775	46776	of	0	None
46776	46777	the	0	None
46777	46778	quinone	3	CHEMICAL
46778	46779	.	0	None

46780	46781	In	0	None
46781	46782	electrically	0	None
46782	46783	driven	0	None
46783	46784	left	0	None
46784	46785	atria	0	None
46785	46786	of	0	None
46786	46787	guinea	0	None
46787	46788	pig	0	None
46788	46789	,	0	None
46789	46790	4	0	None
46790	46791	microM	0	None
46791	46792	dicoumarol	0	None
46792	46793	significantly	0	None
46793	46794	enhanced	0	None
46794	46795	the	0	None
46795	46796	positive	0	None
46796	46797	inotropic	0	None
46797	46798	effect	0	None
46798	46799	of	0	None
46799	46800	menadione	0	None
46800	46801	,	0	None
46801	46802	especially	0	None
46802	46803	at	0	None
46803	46804	the	0	None
46804	46805	lower	0	None
46805	46806	concentrations	0	None
46806	46807	of	0	None
46807	46808	the	0	None
46808	46809	quinone	3	CHEMICAL
46809	46810	.	0	None

46811	46812	In	0	None
46812	46813	myocardial	0	None
46813	46814	preparations	0	None
46814	46815	isolated	0	None
46815	46816	from	0	None
46816	46817	guinea	0	None
46817	46818	pigs	0	None
46818	46819	treated	0	None
46819	46820	with	0	None
46820	46821	beta	0	None
46821	46822	-	0	None
46822	46823	naphthoflavone	0	None
46823	46824	(	0	None
46824	46825	80	0	None
46825	46826	mg	0	None
46826	46827	/	0	None
46827	46828	kg	0	None
46828	46829	i	0	None
46829	46830	.	0	None
46830	46831	p	0	None
46831	46832	.	0	None
46832	46833	for	0	None
46833	46834	2	0	None
46834	46835	days	0	None
46835	46836	)	0	None
46836	46837	,	0	None
46837	46838	DT	3	CHEMICAL
46838	46839	-	0	None
46839	46840	diaphorase	2	GENE-N
46840	46841	activity	0	None
46841	46842	was	0	None
46842	46843	enhanced	0	None
46843	46844	(	0	None
46844	46845	+	0	None
46845	46846	36	0	None
46846	46847	%	0	None
46847	46848	with	0	None
46848	46849	respect	0	None
46849	46850	to	0	None
46850	46851	control	0	None
46851	46852	animals	0	None
46852	46853	,	0	None
46853	46854	P	0	None
46854	46855	<	0	None
46855	46856	0	0	None
46856	46857	.	0	None
46857	46858	01	0	None
46858	46859	)	0	None
46859	46860	,	0	None
46860	46861	whereas	0	None
46861	46862	the	0	None
46862	46863	activities	0	None
46863	46864	of	0	None
46864	46865	the	0	None
46865	46866	other	0	None
46866	46867	enzymes	0	None
46867	46868	involved	0	None
46868	46869	in	0	None
46869	46870	menadione	0	None
46870	46871	metabolism	0	None
46871	46872	were	0	None
46872	46873	not	0	None
46873	46874	modified	0	None
46874	46875	.	0	None

46876	46877	In	0	None
46877	46878	these	0	None
46878	46879	preparations	0	None
46879	46880	,	0	None
46880	46881	menadione	0	None
46881	46882	caused	0	None
46882	46883	a	0	None
46883	46884	significantly	0	None
46884	46885	lower	0	None
46885	46886	increase	0	None
46886	46887	in	0	None
46887	46888	the	0	None
46888	46889	force	0	None
46889	46890	of	0	None
46890	46891	contraction	0	None
46891	46892	than	0	None
46892	46893	in	0	None
46893	46894	atria	0	None
46894	46895	from	0	None
46895	46896	untreated	0	None
46896	46897	animals	0	None
46897	46898	;	0	None
46898	46899	moreover	0	None
46899	46900	,	0	None
46900	46901	pretreatment	0	None
46901	46902	with	0	None
46902	46903	beta	0	None
46903	46904	-	0	None
46904	46905	naphthoflavone	0	None
46905	46906	caused	0	None
46906	46907	a	0	None
46907	46908	significant	0	None
46908	46909	decrease	0	None
46909	46910	in	0	None
46910	46911	the	0	None
46911	46912	menadione	0	None
46912	46913	-	0	None
46913	46914	induced	0	None
46914	46915	oxidative	0	None
46915	46916	stress	0	None
46916	46917	,	0	None
46917	46918	as	0	None
46918	46919	evaluated	0	None
46919	46920	from	0	None
46920	46921	the	0	None
46921	46922	GSH	3	CHEMICAL
46922	46923	redox	0	None
46923	46924	index	0	None
46924	46925	.	0	None

46926	46927	Taken	0	None
46927	46928	together	0	None
46928	46929	,	0	None
46929	46930	these	0	None
46930	46931	results	0	None
46931	46932	demonstrate	0	None
46932	46933	that	0	None
46933	46934	cardiac	0	None
46934	46935	DT	3	CHEMICAL
46935	46936	-	0	None
46936	46937	diaphorase	2	GENE-N
46937	46938	does	0	None
46938	46939	not	0	None
46939	46940	contribute	0	None
46940	46941	to	0	None
46941	46942	ROS	1	GENE-Y
46942	46943	generation	0	None
46943	46944	,	0	None
46944	46945	but	0	None
46945	46946	represents	0	None
46946	46947	a	0	None
46947	46948	detoxification	0	None
46948	46949	system	0	None
46949	46950	.	0	None

46951	46952	The	0	None
46952	46953	use	0	None
46953	46954	of	0	None
46954	46955	leflunomide	0	None
46955	46956	in	0	None
46956	46957	the	0	None
46957	46958	treatment	0	None
46958	46959	of	0	None
46959	46960	rheumatoid	0	None
46960	46961	arthritis	0	None
46961	46962	:	0	None
46962	46963	an	0	None
46963	46964	experimental	0	None
46964	46965	and	0	None
46965	46966	clinical	0	None
46966	46967	review	0	None
46967	46968	.	0	None

46969	46970	Leflunomide	0	None
46970	46971	,	0	None
46971	46972	the	0	None
46972	46973	newest	0	None
46973	46974	disease	0	None
46974	46975	-	0	None
46975	46976	modifying	0	None
46976	46977	antirheumatic	0	None
46977	46978	drug	0	None
46978	46979	(	0	None
46979	46980	DMARD	0	None
46980	46981	)	0	None
46981	46982	for	0	None
46982	46983	the	0	None
46983	46984	treatment	0	None
46984	46985	of	0	None
46985	46986	rheumatoid	0	None
46986	46987	arthritis	0	None
46987	46988	(	0	None
46988	46989	RA	0	None
46989	46990	)	0	None
46990	46991	,	0	None
46991	46992	acts	0	None
46992	46993	by	0	None
46993	46994	inhibiting	0	None
46994	46995	dihydroorotate	0	None
46995	46996	dehydrogenase	0	None
46996	46997	,	0	None
46997	46998	the	0	None
46998	46999	rate	0	None
46999	47000	-	0	None
47000	47001	limiting	0	None
47001	47002	enzyme	0	None
47002	47003	in	0	None
47003	47004	the	0	None
47004	47005	pathway	0	None
47005	47006	for	0	None
47006	47007	pyrimidine	3	CHEMICAL
47007	47008	production	0	None
47008	47009	.	0	None

47010	47011	The	0	None
47011	47012	drug	0	None
47012	47013	thus	0	None
47013	47014	limits	0	None
47014	47015	T	0	None
47015	47016	-	0	None
47016	47017	cell	0	None
47017	47018	proliferation	0	None
47018	47019	,	0	None
47019	47020	a	0	None
47020	47021	process	0	None
47021	47022	thought	0	None
47022	47023	to	0	None
47023	47024	be	0	None
47024	47025	a	0	None
47025	47026	key	0	None
47026	47027	step	0	None
47027	47028	in	0	None
47028	47029	the	0	None
47029	47030	pathogenesis	0	None
47030	47031	of	0	None
47031	47032	RA	0	None
47032	47033	.	0	None

47034	47035	In	0	None
47035	47036	placebo	0	None
47036	47037	-	0	None
47037	47038	controlled	0	None
47038	47039	trials	0	None
47039	47040	,	0	None
47040	47041	leflunomide	0	None
47041	47042	was	0	None
47042	47043	superior	0	None
47043	47044	to	0	None
47044	47045	placebo	0	None
47045	47046	and	0	None
47046	47047	comparable	0	None
47047	47048	to	0	None
47048	47049	sulfasalazine	3	CHEMICAL
47049	47050	and	0	None
47050	47051	methotrexate	3	CHEMICAL
47051	47052	for	0	None
47052	47053	improving	0	None
47053	47054	the	0	None
47054	47055	signs	0	None
47055	47056	and	0	None
47056	47057	symptoms	0	None
47057	47058	of	0	None
47058	47059	RA	0	None
47059	47060	;	0	None
47060	47061	and	0	None
47061	47062	superior	0	None
47062	47063	to	0	None
47063	47064	placebo	0	None
47064	47065	,	0	None
47065	47066	sulfasalazine	3	CHEMICAL
47066	47067	,	0	None
47067	47068	and	0	None
47068	47069	methotrexate	3	CHEMICAL
47069	47070	for	0	None
47070	47071	improving	0	None
47071	47072	health	0	None
47072	47073	-	0	None
47073	47074	related	0	None
47074	47075	quality	0	None
47075	47076	of	0	None
47076	47077	life	0	None
47077	47078	.	0	None

47079	47080	In	0	None
47080	47081	the	0	None
47081	47082	same	0	None
47082	47083	trials	0	None
47083	47084	,	0	None
47084	47085	leflunomide	0	None
47085	47086	was	0	None
47086	47087	also	0	None
47087	47088	superior	0	None
47088	47089	to	0	None
47089	47090	methotrexate	3	CHEMICAL
47090	47091	and	0	None
47091	47092	comparable	0	None
47092	47093	to	0	None
47093	47094	sulfasalazine	3	CHEMICAL
47094	47095	for	0	None
47095	47096	slowing	0	None
47096	47097	radiographically	0	None
47097	47098	assessed	0	None
47098	47099	progression	0	None
47099	47100	of	0	None
47100	47101	RA	0	None
47101	47102	.	0	None

47103	47104	When	0	None
47104	47105	used	0	None
47105	47106	in	0	None
47106	47107	combination	0	None
47107	47108	therapy	0	None
47108	47109	in	0	None
47109	47110	an	0	None
47110	47111	open	0	None
47111	47112	-	0	None
47112	47113	label	0	None
47113	47114	trial	0	None
47114	47115	,	0	None
47115	47116	leflunomide	0	None
47116	47117	resulted	0	None
47117	47118	in	0	None
47118	47119	improvement	0	None
47119	47120	for	0	None
47120	47121	over	0	None
47121	47122	half	0	None
47122	47123	of	0	None
47123	47124	a	0	None
47124	47125	group	0	None
47125	47126	of	0	None
47126	47127	RA	0	None
47127	47128	patients	0	None
47128	47129	who	0	None
47129	47130	had	0	None
47130	47131	failed	0	None
47131	47132	to	0	None
47132	47133	respond	0	None
47133	47134	to	0	None
47134	47135	methotrexate	3	CHEMICAL
47135	47136	alone	0	None
47136	47137	.	0	None

47138	47139	The	0	None
47139	47140	most	0	None
47140	47141	common	0	None
47141	47142	adverse	0	None
47142	47143	events	0	None
47143	47144	associated	0	None
47144	47145	with	0	None
47145	47146	leflunomide	0	None
47146	47147	treatment	0	None
47147	47148	were	0	None
47148	47149	gastrointestinal	0	None
47149	47150	symptoms	0	None
47150	47151	,	0	None
47151	47152	allergic	0	None
47152	47153	reactions	0	None
47153	47154	,	0	None
47154	47155	alopecia	0	None
47155	47156	,	0	None
47156	47157	and	0	None
47157	47158	elevated	0	None
47158	47159	liver	0	None
47159	47160	enzyme	0	None
47160	47161	levels	0	None
47161	47162	.	0	None

47163	47164	Adverse	0	None
47164	47165	events	0	None
47165	47166	were	0	None
47166	47167	generally	0	None
47167	47168	mild	0	None
47168	47169	to	0	None
47169	47170	moderate	0	None
47170	47171	in	0	None
47171	47172	severity	0	None
47172	47173	and	0	None
47173	47174	resolved	0	None
47174	47175	without	0	None
47175	47176	sequelae	0	None
47176	47177	.	0	None

47178	47179	Clinical	0	None
47179	47180	trial	0	None
47180	47181	results	0	None
47181	47182	indicate	0	None
47182	47183	that	0	None
47183	47184	leflunomide	0	None
47184	47185	is	0	None
47185	47186	an	0	None
47186	47187	efficacious	0	None
47187	47188	and	0	None
47188	47189	safe	0	None
47189	47190	addition	0	None
47190	47191	to	0	None
47191	47192	the	0	None
47192	47193	roster	0	None
47193	47194	of	0	None
47194	47195	therapeutic	0	None
47195	47196	agents	0	None
47196	47197	used	0	None
47197	47198	to	0	None
47198	47199	treat	0	None
47199	47200	RA	0	None
47200	47201	.	0	None

47202	47203	Mechanisms	0	None
47203	47204	of	0	None
47204	47205	reduced	0	None
47205	47206	body	0	None
47206	47207	growth	0	None
47207	47208	in	0	None
47208	47209	the	0	None
47209	47210	pubertal	0	None
47210	47211	feminized	0	None
47211	47212	male	0	None
47212	47213	rat	0	None
47213	47214	:	0	None
47214	47215	unbalanced	0	None
47215	47216	estrogen	3	CHEMICAL
47216	47217	and	0	None
47217	47218	androgen	3	CHEMICAL
47218	47219	action	0	None
47219	47220	on	0	None
47220	47221	the	0	None
47221	47222	somatotropic	0	None
47222	47223	axis	0	None
47223	47224	.	0	None

47225	47226	It	0	None
47226	47227	is	0	None
47227	47228	well	0	None
47228	47229	known	0	None
47229	47230	that	0	None
47230	47231	the	0	None
47231	47232	sex	1	GENE-Y
47232	47233	difference	0	None
47233	47234	in	0	None
47234	47235	body	0	None
47235	47236	growth	0	None
47236	47237	at	0	None
47237	47238	puberty	0	None
47238	47239	is	0	None
47239	47240	modulated	0	None
47240	47241	by	0	None
47241	47242	a	0	None
47242	47243	complex	0	None
47243	47244	interplay	0	None
47244	47245	between	0	None
47245	47246	sex	0	None
47246	47247	steroids	3	CHEMICAL
47247	47248	and	0	None
47248	47249	somatotropic	0	None
47249	47250	axis	0	None
47250	47251	;	0	None
47251	47252	however	0	None
47252	47253	,	0	None
47253	47254	the	0	None
47254	47255	exact	0	None
47255	47256	role	0	None
47256	47257	played	0	None
47257	47258	by	0	None
47258	47259	sex	0	None
47259	47260	steroids	3	CHEMICAL
47260	47261	remains	0	None
47261	47262	a	0	None
47262	47263	matter	0	None
47263	47264	of	0	None
47264	47265	controversy	0	None
47265	47266	.	0	None

47267	47268	The	0	None
47268	47269	aim	0	None
47269	47270	of	0	None
47270	47271	this	0	None
47271	47272	study	0	None
47272	47273	was	0	None
47273	47274	to	0	None
47274	47275	assess	0	None
47275	47276	the	0	None
47276	47277	mechanisms	0	None
47277	47278	by	0	None
47278	47279	which	0	None
47279	47280	sex	0	None
47280	47281	steroids	3	CHEMICAL
47281	47282	regulate	0	None
47282	47283	body	0	None
47283	47284	growth	0	None
47284	47285	during	0	None
47285	47286	pubertal	0	None
47286	47287	development	0	None
47287	47288	.	0	None

47289	47290	Flutamide	0	None
47290	47291	,	0	None
47291	47292	a	0	None
47292	47293	non	0	None
47293	47294	-	0	None
47294	47295	steroid	3	CHEMICAL
47295	47296	-	0	None
47296	47297	blocking	0	None
47297	47298	androgen	3	CHEMICAL
47298	47299	receptor	0	None
47299	47300	,	0	None
47300	47301	was	0	None
47301	47302	subcutaneously	0	None
47302	47303	administered	0	None
47303	47304	to	0	None
47304	47305	30	0	None
47305	47306	-	0	None
47306	47307	d	0	None
47307	47308	-	0	None
47308	47309	old	0	None
47309	47310	male	0	None
47310	47311	Wistar	0	None
47311	47312	rats	0	None
47312	47313	for	0	None
47313	47314	4	0	None
47314	47315	wk	0	None
47315	47316	.	0	None

47317	47318	The	0	None
47318	47319	blockade	0	None
47319	47320	of	0	None
47320	47321	the	0	None
47321	47323	androgen receptor	1	GENE-Y
47323	47324	led	0	None
47324	47325	to	0	None
47325	47326	a	0	None
47326	47327	marked	0	None
47327	47328	elevation	0	None
47328	47329	in	0	None
47329	47330	serum	0	None
47330	47331	testosterone	3	CHEMICAL
47331	47332	and	0	None
47332	47333	an	0	None
47333	47334	increment	0	None
47334	47335	in	0	None
47335	47336	serum	0	None
47336	47337	estradiol	3	CHEMICAL
47337	47338	.	0	None

47339	47340	Flutamide	0	None
47340	47341	administration	0	None
47341	47342	decreased	0	None
47342	47343	body	0	None
47343	47344	weight	0	None
47344	47345	gain	0	None
47345	47346	,	0	None
47346	47347	serum	0	None
47347	47348	IGF	1	GENE-Y
47348	47349	-	0	None
47349	47350	I	0	None
47350	47351	levels	0	None
47351	47352	,	0	None
47352	47353	hepatic	0	None
47353	47354	IGF	1	GENE-Y
47354	47355	-	0	None
47355	47356	I	0	None
47356	47357	mRNA	0	None
47357	47358	,	0	None
47358	47359	and	0	None
47359	47361	GH receptor	1	GENE-Y
47361	47362	mRNA	0	None
47362	47363	content	0	None
47363	47364	.	0	None

47365	47366	There	0	None
47366	47367	were	0	None
47367	47368	no	0	None
47368	47369	significant	0	None
47369	47370	changes	0	None
47370	47371	in	0	None
47371	47372	serum	0	None
47372	47373	GH	1	GENE-Y
47373	47374	concentration	0	None
47374	47375	,	0	None
47375	47377	pituitary GH	1	GENE-Y
47377	47378	reserve	0	None
47378	47379	,	0	None
47379	47380	and	0	None
47380	47382	pituitary GH	1	GENE-Y
47382	47383	mRNA	0	None
47383	47384	content	0	None
47384	47385	.	0	None

47386	47387	Flutamide	0	None
47387	47388	lowered	0	None
47388	47389	hypothalamic	0	None
47389	47390	somatostatin	3	CHEMICAL
47390	47391	mRNA	0	None
47391	47392	content	0	None
47392	47393	and	0	None
47393	47394	augmented	0	None
47394	47395	hypothalamic	0	None
47395	47396	immunoreactive	0	None
47396	47397	somatostatin	3	CHEMICAL
47397	47398	stores	0	None
47398	47399	,	0	None
47399	47400	but	0	None
47400	47401	did	0	None
47401	47402	not	0	None
47402	47403	alter	0	None
47403	47404	hypothalamic	0	None
47404	47405	immunoreactive	0	None
47405	47406	GH	1	GENE-Y
47406	47407	-	0	None
47407	47408	releasing	0	None
47408	47409	factor	0	None
47409	47410	stores	0	None
47410	47411	.	0	None

47412	47413	Our	0	None
47413	47414	findings	0	None
47414	47415	indicate	0	None
47415	47416	that	0	None
47416	47417	during	0	None
47417	47418	pubertal	0	None
47418	47419	development	0	None
47419	47420	of	0	None
47420	47421	the	0	None
47421	47422	male	0	None
47422	47423	rat	0	None
47423	47424	,	0	None
47424	47425	the	0	None
47425	47426	imbalance	0	None
47426	47427	between	0	None
47427	47428	androgen	3	CHEMICAL
47428	47429	and	0	None
47429	47430	estrogen	3	CHEMICAL
47430	47431	actions	0	None
47431	47432	determines	0	None
47432	47433	an	0	None
47433	47434	abnormal	0	None
47434	47435	somatic	0	None
47435	47436	growth	0	None
47436	47437	,	0	None
47437	47438	which	0	None
47438	47439	is	0	None
47439	47440	at	0	None
47440	47441	least	0	None
47441	47442	partly	0	None
47442	47443	exerted	0	None
47443	47444	through	0	None
47444	47445	the	0	None
47445	47446	peripheral	0	None
47446	47447	or	0	None
47447	47448	hepatic	0	None
47448	47449	modification	0	None
47449	47450	of	0	None
47450	47451	the	0	None
47451	47452	somatotropic	0	None
47452	47453	axis	0	None
47453	47454	that	0	None
47454	47455	occurs	0	None
47455	47456	under	0	None
47456	47457	the	0	None
47457	47458	high	0	None
47458	47459	or	0	None
47459	47460	exclusive	0	None
47460	47461	action	0	None
47461	47462	of	0	None
47462	47463	estrogens	3	CHEMICAL
47463	47464	.	0	None

47465	47466	Potential	0	None
47466	47467	implication	0	None
47467	47468	of	0	None
47468	47469	coincident	0	None
47469	47470	sex	1	GENE-Y
47470	47471	-	0	None
47471	47472	specific	0	None
47472	47473	regulated	0	None
47473	47474	mode	0	None
47474	47475	of	0	None
47475	47476	pulsatile	0	None
47476	47477	GH	1	GENE-Y
47477	47478	secretion	0	None
47478	47479	cannot	0	None
47479	47480	be	0	None
47480	47481	excluded	0	None
47481	47482	from	0	None
47482	47483	this	0	None
47483	47484	random	0	None
47484	47485	serum	0	None
47485	47486	GH	1	GENE-Y
47486	47487	sample	0	None
47487	47488	study	0	None
47488	47489	.	0	None

47490	47491	Clinical	0	None
47491	47492	pharmacology	0	None
47492	47493	,	0	None
47493	47494	therapeutic	0	None
47494	47495	use	0	None
47495	47496	and	0	None
47496	47497	potential	0	None
47497	47498	of	0	None
47498	47499	COMT	1	GENE-Y
47499	47500	inhibitors	0	None
47500	47501	in	0	None
47501	47502	Parkinson	0	None
47502	47503	'	0	None
47503	47504	s	0	None
47504	47505	disease	0	None
47505	47506	.	0	None

47507	47508	When	0	None
47508	47509	peripheral	0	None
47509	47510	decarboxylation	0	None
47510	47511	is	0	None
47511	47512	blocked	0	None
47512	47513	by	0	None
47513	47514	carbidopa	3	CHEMICAL
47514	47515	or	0	None
47515	47516	benserazide	0	None
47516	47517	,	0	None
47517	47518	the	0	None
47518	47519	main	0	None
47519	47520	metabolic	0	None
47520	47521	pathway	0	None
47521	47522	of	0	None
47522	47523	levodopa	3	CHEMICAL
47523	47524	is	0	None
47524	47525	O	0	None
47525	47526	-	0	None
47526	47527	methylation	0	None
47527	47528	by	0	None
47528	47529	catechol	3	CHEMICAL
47529	47530	-	0	None
47530	47531	O	0	None
47531	47532	-	0	None
47532	47533	methyltransferase	0	None
47533	47534	(	0	None
47534	47535	COMT	1	GENE-Y
47535	47536	)	0	None
47536	47537	.	0	None

47538	47539	Entacapone	3	CHEMICAL
47539	47540	and	0	None
47540	47541	tolcapone	3	CHEMICAL
47541	47542	are	0	None
47542	47543	new	0	None
47543	47544	potent	0	None
47544	47545	,	0	None
47545	47546	selective	0	None
47546	47547	and	0	None
47547	47548	reversible	0	None
47548	47549	nitrocatechol	0	None
47549	47550	-	0	None
47550	47551	type	0	None
47551	47552	COMT	1	GENE-Y
47552	47553	inhibitors	0	None
47553	47554	.	0	None

47555	47556	Animal	0	None
47556	47557	studies	0	None
47557	47558	have	0	None
47558	47559	demonstrated	0	None
47559	47560	that	0	None
47560	47561	entacapone	3	CHEMICAL
47561	47562	mainly	0	None
47562	47563	has	0	None
47563	47564	a	0	None
47564	47565	peripheral	0	None
47565	47566	effect	0	None
47566	47567	whereas	0	None
47567	47568	tolcapone	3	CHEMICAL
47568	47569	also	0	None
47569	47570	inhibits	0	None
47570	47571	O	0	None
47571	47572	-	0	None
47572	47573	methylation	0	None
47573	47574	in	0	None
47574	47575	the	0	None
47575	47576	brain	0	None
47576	47577	.	0	None

47578	47579	In	0	None
47579	47580	human	0	None
47580	47581	volunteers	0	None
47581	47582	,	0	None
47582	47583	both	0	None
47583	47584	entacapone	3	CHEMICAL
47584	47585	and	0	None
47585	47586	tolcapone	3	CHEMICAL
47586	47587	dose	0	None
47587	47588	-	0	None
47588	47589	dependently	0	None
47589	47590	inhibit	0	None
47590	47591	the	0	None
47591	47592	COMT	1	GENE-Y
47592	47593	activity	0	None
47593	47594	in	0	None
47594	47595	erythrocytes	0	None
47595	47596	,	0	None
47596	47597	improve	0	None
47597	47598	the	0	None
47598	47599	bioavailability	0	None
47599	47600	and	0	None
47600	47601	decrease	0	None
47601	47602	the	0	None
47602	47603	elimination	0	None
47603	47604	of	0	None
47604	47605	levodopa	3	CHEMICAL
47605	47606	,	0	None
47606	47607	and	0	None
47607	47608	inhibit	0	None
47608	47609	the	0	None
47609	47610	formation	0	None
47610	47611	of	0	None
47611	47612	3	0	None
47612	47613	-	0	None
47613	47614	O	0	None
47614	47615	-	0	None
47615	47616	methyldopa	0	None
47616	47617	(	0	None
47617	47618	3	0	None
47618	47619	-	0	None
47619	47620	OMD	0	None
47620	47621	)	0	None
47621	47622	.	0	None

47623	47624	Entacapone	3	CHEMICAL
47624	47625	is	0	None
47625	47626	administered	0	None
47626	47627	with	0	None
47627	47628	every	0	None
47628	47629	scheduled	0	None
47629	47630	dose	0	None
47630	47631	of	0	None
47631	47632	levodopa	3	CHEMICAL
47632	47633	whereas	0	None
47633	47634	tolcapone	3	CHEMICAL
47634	47635	is	0	None
47635	47636	administered	0	None
47636	47637	3	0	None
47637	47638	times	0	None
47638	47639	daily	0	None
47639	47640	.	0	None

47641	47642	The	0	None
47642	47643	different	0	None
47643	47644	administration	0	None
47644	47645	regimens	0	None
47645	47646	for	0	None
47646	47647	these	0	None
47647	47648	agents	0	None
47648	47649	are	0	None
47649	47650	based	0	None
47650	47651	on	0	None
47651	47652	their	0	None
47652	47653	different	0	None
47653	47654	pharmacokinetic	0	None
47654	47655	and	0	None
47655	47656	pharmacodynamic	0	None
47656	47657	profiles	0	None
47657	47658	.	0	None

47659	47660	Both	0	None
47660	47661	entacapone	3	CHEMICAL
47661	47662	and	0	None
47662	47663	tolcapone	3	CHEMICAL
47663	47664	enhance	0	None
47664	47665	and	0	None
47665	47666	extend	0	None
47666	47667	the	0	None
47667	47668	therapeutic	0	None
47668	47669	effect	0	None
47669	47670	of	0	None
47670	47671	levodopa	3	CHEMICAL
47671	47672	in	0	None
47672	47673	patients	0	None
47673	47674	with	0	None
47674	47675	advanced	0	None
47675	47676	and	0	None
47676	47677	fluctuating	0	None
47677	47678	Parkinson	0	None
47678	47679	'	0	None
47679	47680	s	0	None
47680	47681	disease	0	None
47681	47682	.	0	None

47683	47684	They	0	None
47684	47685	prolong	0	None
47685	47686	the	0	None
47686	47687	duration	0	None
47687	47688	of	0	None
47688	47689	levodopa	3	CHEMICAL
47689	47690	effect	0	None
47690	47691	.	0	None

47692	47693	Clinical	0	None
47693	47694	studies	0	None
47694	47695	show	0	None
47695	47696	that	0	None
47696	47697	they	0	None
47697	47698	increase	0	None
47698	47699	the	0	None
47699	47700	daily	0	None
47700	47701	ON	0	None
47701	47702	time	0	None
47702	47703	by	0	None
47703	47704	an	0	None
47704	47705	average	0	None
47705	47706	1	0	None
47706	47707	to	0	None
47707	47708	3	0	None
47708	47709	hours	0	None
47709	47710	,	0	None
47710	47711	improve	0	None
47711	47712	the	0	None
47712	47713	activities	0	None
47713	47714	of	0	None
47714	47715	daily	0	None
47715	47716	living	0	None
47716	47717	and	0	None
47717	47718	allow	0	None
47718	47719	daily	0	None
47719	47720	levodopa	3	CHEMICAL
47720	47721	dosage	0	None
47721	47722	to	0	None
47722	47723	be	0	None
47723	47724	decreased	0	None
47724	47725	.	0	None

47726	47727	Correspondingly	0	None
47727	47728	,	0	None
47728	47729	they	0	None
47729	47730	significantly	0	None
47730	47731	reduce	0	None
47731	47732	the	0	None
47732	47733	daily	0	None
47733	47734	OFF	0	None
47734	47735	time	0	None
47735	47736	.	0	None

47737	47738	No	0	None
47738	47739	comparative	0	None
47739	47740	studies	0	None
47740	47741	between	0	None
47741	47742	entacapone	3	CHEMICAL
47742	47743	and	0	None
47743	47744	tolcapone	3	CHEMICAL
47744	47745	have	0	None
47745	47746	been	0	None
47746	47747	performed	0	None
47747	47748	.	0	None

47749	47750	Tolcapone	0	None
47750	47751	also	0	None
47751	47752	appears	0	None
47752	47753	to	0	None
47753	47754	have	0	None
47754	47755	a	0	None
47755	47756	beneficial	0	None
47756	47757	effect	0	None
47757	47758	in	0	None
47758	47759	patients	0	None
47759	47760	with	0	None
47760	47761	nonfluctuating	0	None
47761	47762	Parkinson	0	None
47762	47763	'	0	None
47763	47764	s	0	None
47764	47765	disease	0	None
47765	47766	.	0	None

47767	47768	The	0	None
47768	47769	main	0	None
47769	47770	adverse	0	None
47770	47771	effects	0	None
47771	47772	of	0	None
47772	47773	the	0	None
47773	47774	COMT	1	GENE-Y
47774	47775	inhibitors	0	None
47775	47776	are	0	None
47776	47777	related	0	None
47777	47778	to	0	None
47778	47779	their	0	None
47779	47780	dopaminergic	0	None
47780	47781	and	0	None
47781	47782	gastrointestinal	0	None
47782	47783	effects	0	None
47783	47784	.	0	None

47785	47786	Enhancement	0	None
47786	47787	of	0	None
47787	47788	dopaminergic	0	None
47788	47789	activity	0	None
47789	47790	may	0	None
47790	47791	cause	0	None
47791	47792	an	0	None
47792	47793	initial	0	None
47793	47794	worsening	0	None
47794	47795	of	0	None
47795	47796	levodopa	3	CHEMICAL
47796	47797	-	0	None
47797	47798	induced	0	None
47798	47799	adverse	0	None
47799	47800	effects	0	None
47800	47801	,	0	None
47801	47802	such	0	None
47802	47803	as	0	None
47803	47804	dyskinesia	0	None
47804	47805	,	0	None
47805	47806	nausea	0	None
47806	47807	,	0	None
47807	47808	vomiting	0	None
47808	47809	,	0	None
47809	47810	orthostatic	0	None
47810	47811	hypotension	0	None
47811	47812	,	0	None
47812	47813	sleep	0	None
47813	47814	disorders	0	None
47814	47815	and	0	None
47815	47816	hallucinations	0	None
47816	47817	.	0	None

47818	47819	Levodopa	0	None
47819	47820	dose	0	None
47820	47821	adjustment	0	None
47821	47822	is	0	None
47822	47823	recommended	0	None
47823	47824	to	0	None
47824	47825	avoid	0	None
47825	47826	these	0	None
47826	47827	events	0	None
47827	47828	.	0	None

47829	47830	Tolcapone	0	None
47830	47831	is	0	None
47831	47832	associated	0	None
47832	47833	with	0	None
47833	47834	diarrhoea	0	None
47834	47835	in	0	None
47835	47836	about	0	None
47836	47837	16	0	None
47837	47838	to	0	None
47838	47839	18	0	None
47839	47840	%	0	None
47840	47841	of	0	None
47841	47842	patients	0	None
47842	47843	and	0	None
47843	47844	entacapone	3	CHEMICAL
47844	47845	in	0	None
47845	47846	less	0	None
47846	47847	than	0	None
47847	47848	10	0	None
47848	47849	%	0	None
47849	47850	of	0	None
47850	47851	patients	0	None
47851	47852	.	0	None

47853	47854	Diarrhoea	0	None
47854	47855	has	0	None
47855	47856	led	0	None
47856	47857	to	0	None
47857	47858	discontinuation	0	None
47858	47859	in	0	None
47859	47860	5	0	None
47860	47861	to	0	None
47861	47862	6	0	None
47862	47863	%	0	None
47863	47864	of	0	None
47864	47865	patients	0	None
47865	47866	treated	0	None
47866	47867	with	0	None
47867	47868	tolcapone	3	CHEMICAL
47868	47869	and	0	None
47869	47870	in	0	None
47870	47871	2	0	None
47871	47872	.	0	None
47872	47873	5	0	None
47873	47874	%	0	None
47874	47875	of	0	None
47875	47876	those	0	None
47876	47877	treated	0	None
47877	47878	with	0	None
47878	47879	entacapone	3	CHEMICAL
47879	47880	.	0	None

47881	47882	Urine	0	None
47882	47883	discoloration	0	None
47883	47884	to	0	None
47884	47885	dark	0	None
47885	47886	yellow	0	None
47886	47887	or	0	None
47887	47888	orange	0	None
47888	47889	is	0	None
47889	47890	related	0	None
47890	47891	to	0	None
47891	47892	the	0	None
47892	47893	colour	0	None
47893	47894	of	0	None
47894	47895	COMT	1	GENE-Y
47895	47896	inhibitors	0	None
47896	47897	and	0	None
47897	47898	their	0	None
47898	47899	metabolites	0	None
47899	47900	.	0	None

47901	47902	Elevated	0	None
47902	47904	liver transaminase	2	GENE-N
47904	47905	levels	0	None
47905	47906	are	0	None
47906	47907	reported	0	None
47907	47908	in	0	None
47908	47909	1	0	None
47909	47910	to	0	None
47910	47911	3	0	None
47911	47912	%	0	None
47912	47913	of	0	None
47913	47914	patients	0	None
47914	47915	treated	0	None
47915	47916	with	0	None
47916	47917	tolcapone	3	CHEMICAL
47917	47918	but	0	None
47918	47919	very	0	None
47919	47920	rarely	0	None
47920	47921	,	0	None
47921	47922	if	0	None
47922	47923	at	0	None
47923	47924	all	0	None
47924	47925	,	0	None
47925	47926	in	0	None
47926	47927	patients	0	None
47927	47928	treated	0	None
47928	47929	with	0	None
47929	47930	entacapone	3	CHEMICAL
47930	47931	.	0	None

47932	47933	The	0	None
47933	47934	descriptions	0	None
47934	47935	of	0	None
47935	47936	acute	0	None
47936	47937	,	0	None
47937	47938	fatal	0	None
47938	47939	fulminant	0	None
47939	47940	hepatitis	0	None
47940	47941	and	0	None
47941	47942	potentially	0	None
47942	47943	fatal	0	None
47943	47944	neurological	0	None
47944	47945	reactions	0	None
47945	47946	,	0	None
47946	47947	such	0	None
47947	47948	as	0	None
47948	47949	neuroleptic	0	None
47949	47950	malignant	0	None
47950	47951	syndrome	0	None
47951	47952	and	0	None
47952	47953	rhabdomyolysis	0	None
47953	47954	,	0	None
47954	47955	in	0	None
47955	47956	association	0	None
47956	47957	with	0	None
47957	47958	tolcapone	3	CHEMICAL
47958	47959	led	0	None
47959	47960	to	0	None
47960	47961	the	0	None
47961	47962	suspension	0	None
47962	47963	of	0	None
47963	47964	its	0	None
47964	47965	marketing	0	None
47965	47966	authorisation	0	None
47966	47967	in	0	None
47967	47968	the	0	None
47968	47969	European	0	None
47969	47970	Community	0	None
47970	47971	and	0	None
47971	47972	Canada	0	None
47972	47973	.	0	None

47974	47975	In	0	None
47975	47976	many	0	None
47976	47977	other	0	None
47977	47978	countries	0	None
47978	47979	,	0	None
47979	47980	the	0	None
47980	47981	use	0	None
47981	47982	of	0	None
47982	47983	tolcapone	3	CHEMICAL
47983	47984	is	0	None
47984	47985	restricted	0	None
47985	47986	to	0	None
47986	47987	patients	0	None
47987	47988	who	0	None
47988	47989	are	0	None
47989	47990	not	0	None
47990	47991	responding	0	None
47991	47992	satisfactorily	0	None
47992	47993	to	0	None
47993	47994	other	0	None
47994	47995	therapies	0	None
47995	47996	.	0	None

47997	47998	Regular	0	None
47998	47999	monitoring	0	None
47999	48000	of	0	None
48000	48001	liver	0	None
48001	48002	enzymes	0	None
48002	48003	is	0	None
48003	48004	required	0	None
48004	48005	if	0	None
48005	48006	tolcapone	3	CHEMICAL
48006	48007	is	0	None
48007	48008	used	0	None
48008	48009	.	0	None

48010	48011	No	0	None
48011	48012	such	0	None
48012	48013	adverse	0	None
48013	48014	reactions	0	None
48014	48015	have	0	None
48015	48016	so	0	None
48016	48017	far	0	None
48017	48018	been	0	None
48018	48019	described	0	None
48019	48020	for	0	None
48020	48021	entacapone	3	CHEMICAL
48021	48022	and	0	None
48022	48023	no	0	None
48023	48024	laboratory	0	None
48024	48025	monitoring	0	None
48025	48026	has	0	None
48026	48027	been	0	None
48027	48028	proposed	0	None
48028	48029	.	0	None

48030	48031	COMT	1	GENE-Y
48031	48032	inhibitors	0	None
48032	48033	added	0	None
48033	48034	to	0	None
48034	48035	levodopa	3	CHEMICAL
48035	48036	therapy	0	None
48036	48037	are	0	None
48037	48038	beneficial	0	None
48038	48039	,	0	None
48039	48040	particularly	0	None
48040	48041	in	0	None
48041	48042	patients	0	None
48042	48043	with	0	None
48043	48044	fluctuating	0	None
48044	48045	disease	0	None
48045	48046	.	0	None

48047	48048	They	0	None
48048	48049	may	0	None
48049	48050	be	0	None
48050	48051	combined	0	None
48051	48052	with	0	None
48052	48053	other	0	None
48053	48054	antiparkinsonian	0	None
48054	48055	drugs	0	None
48055	48056	,	0	None
48056	48057	such	0	None
48057	48058	as	0	None
48058	48059	dopamine	3	CHEMICAL
48059	48060	agonists	0	None
48060	48061	,	0	None
48061	48062	selegiline	0	None
48062	48063	and	0	None
48063	48064	anticholinergics	0	None
48064	48065	without	0	None
48065	48066	adverse	0	None
48066	48067	interactions	0	None
48067	48068	.	0	None

48069	48070	They	0	None
48070	48071	provide	0	None
48071	48072	a	0	None
48072	48073	new	0	None
48073	48074	treatment	0	None
48074	48075	possibility	0	None
48075	48076	in	0	None
48076	48077	patients	0	None
48077	48078	with	0	None
48078	48079	Parkinson	0	None
48079	48080	'	0	None
48080	48081	s	0	None
48081	48082	disease	0	None
48082	48083	who	0	None
48083	48084	have	0	None
48084	48085	problems	0	None
48085	48086	with	0	None
48086	48087	their	0	None
48087	48088	present	0	None
48088	48089	levodopa	3	CHEMICAL
48089	48090	therapy	0	None
48090	48091	.	0	None

48092	48093	The	0	None
48093	48094	inhibition	0	None
48094	48095	of	0	None
48095	48096	cholera	0	None
48096	48097	toxin	0	None
48097	48098	-	0	None
48098	48099	induced	0	None
48099	48100	5	0	None
48100	48101	-	0	None
48101	48102	HT	3	CHEMICAL
48102	48103	release	0	None
48103	48104	by	0	None
48104	48105	the	0	None
48105	48106	5	0	None
48106	48107	-	0	None
48107	48108	HT	3	CHEMICAL
48108	48109	(	0	None
48109	48110	3	0	None
48110	48111	)	0	None
48111	48112	receptor	0	None
48112	48113	antagonist	0	None
48113	48114	,	0	None
48114	48115	granisetron	3	CHEMICAL
48115	48116	,	0	None
48116	48117	in	0	None
48117	48118	the	0	None
48118	48119	rat	0	None
48119	48120	.	0	None

48121	48122	1	0	None
48122	48123	.	0	None

48124	48125	The	0	None
48125	48126	secretagogue	0	None
48126	48127	5	0	None
48127	48128	-	0	None
48128	48129	hydroxytryptamine	0	None
48129	48130	(	0	None
48130	48131	5	0	None
48131	48132	-	0	None
48132	48133	HT	3	CHEMICAL
48133	48134	)	0	None
48134	48135	is	0	None
48135	48136	implicated	0	None
48136	48137	in	0	None
48137	48138	the	0	None
48138	48139	pathophysiology	0	None
48139	48140	of	0	None
48140	48141	cholera	0	None
48141	48142	.	0	None

48143	48144	5	0	None
48144	48145	-	0	None
48145	48146	HT	3	CHEMICAL
48146	48147	released	0	None
48147	48148	from	0	None
48148	48149	enterochromaffin	0	None
48149	48150	cells	0	None
48150	48151	after	0	None
48151	48152	cholera	0	None
48152	48153	toxin	0	None
48153	48154	exposure	0	None
48154	48155	is	0	None
48155	48156	thought	0	None
48156	48157	to	0	None
48157	48158	activate	0	None
48158	48159	non	0	None
48159	48160	-	0	None
48160	48161	neuronally	0	None
48161	48162	(	0	None
48162	48163	5	0	None
48163	48164	-	0	None
48164	48165	HT	3	CHEMICAL
48165	48166	(	0	None
48166	48167	2	0	None
48167	48168	)	0	None
48168	48169	dependent	0	None
48169	48170	)	0	None
48170	48171	and	0	None
48171	48172	neuronally	0	None
48172	48173	(	0	None
48173	48174	5	0	None
48174	48175	-	0	None
48175	48176	HT	3	CHEMICAL
48176	48177	(	0	None
48177	48178	3	0	None
48178	48179	)	0	None
48179	48180	dependent	0	None
48180	48181	)	0	None
48181	48182	mediated	0	None
48182	48183	water	0	None
48183	48184	and	0	None
48184	48185	electrolyte	0	None
48185	48186	secretion	0	None
48186	48187	.	0	None

48188	48189	CT	3	CHEMICAL
48189	48190	-	0	None
48190	48191	secretion	0	None
48191	48192	can	0	None
48192	48193	be	0	None
48193	48194	reduced	0	None
48194	48195	by	0	None
48195	48196	preventing	0	None
48196	48197	the	0	None
48197	48198	release	0	None
48198	48199	of	0	None
48199	48200	5	0	None
48200	48201	-	0	None
48201	48202	HT	3	CHEMICAL
48202	48203	.	0	None

48204	48205	Enterochromaffin	0	None
48205	48206	cells	0	None
48206	48207	possess	0	None
48207	48208	numerous	0	None
48208	48209	receptors	0	None
48209	48210	that	0	None
48210	48211	,	0	None
48211	48212	under	0	None
48212	48213	basal	0	None
48213	48214	conditions	0	None
48214	48215	,	0	None
48215	48216	modulate	0	None
48216	48217	5	0	None
48217	48218	-	0	None
48218	48219	HT	3	CHEMICAL
48219	48220	release	0	None
48220	48221	.	0	None

48222	48223	2	0	None
48223	48224	.	0	None

48225	48226	These	0	None
48226	48227	include	0	None
48227	48228	basolateral	0	None
48228	48229	5	0	None
48229	48230	-	0	None
48230	48231	HT	3	CHEMICAL
48231	48232	(	0	None
48232	48233	3	0	None
48233	48234	)	0	None
48234	48235	receptors	0	None
48235	48236	,	0	None
48236	48237	the	0	None
48237	48238	activation	0	None
48238	48239	of	0	None
48239	48240	which	0	None
48240	48241	is	0	None
48241	48242	known	0	None
48242	48243	to	0	None
48243	48244	enhance	0	None
48244	48245	5	0	None
48245	48246	-	0	None
48246	48247	HT	3	CHEMICAL
48247	48248	release	0	None
48248	48249	.	0	None

48250	48251	3	0	None
48251	48252	.	0	None

48253	48254	Until	0	None
48254	48255	now	0	None
48255	48256	,	0	None
48256	48257	5	0	None
48257	48258	-	0	None
48258	48259	HT	3	CHEMICAL
48259	48260	(	0	None
48260	48261	3	0	None
48261	48262	)	0	None
48262	48263	receptor	0	None
48263	48264	antagonists	0	None
48264	48265	(	0	None
48265	48266	e	0	None
48266	48267	.	0	None
48267	48268	g	0	None
48268	48269	.	0	None
48269	48270	granisetron	3	CHEMICAL
48270	48271	)	0	None
48271	48272	have	0	None
48272	48273	been	0	None
48273	48274	thought	0	None
48274	48275	to	0	None
48275	48276	inhibit	0	None
48276	48277	cholera	0	None
48277	48278	toxin	0	None
48278	48279	-	0	None
48279	48280	induced	0	None
48280	48281	fluid	0	None
48281	48282	secretion	0	None
48282	48283	by	0	None
48283	48284	blockading	0	None
48284	48285	5	0	None
48285	48286	-	0	None
48286	48287	HT	3	CHEMICAL
48287	48288	(	0	None
48288	48289	3	0	None
48289	48290	)	0	None
48290	48291	receptors	0	None
48291	48292	on	0	None
48292	48293	secretory	0	None
48293	48294	enteric	0	None
48294	48295	neurones	0	None
48295	48296	.	0	None

48297	48298	Instead	0	None
48298	48299	we	0	None
48299	48300	postulated	0	None
48300	48301	that	0	None
48301	48302	they	0	None
48302	48303	act	0	None
48303	48304	by	0	None
48304	48305	inhibiting	0	None
48305	48306	cholera	0	None
48306	48307	toxin	0	None
48307	48308	-	0	None
48308	48309	induced	0	None
48309	48310	enterochromaffin	0	None
48310	48311	cell	0	None
48311	48312	degranulation	0	None
48312	48313	.	0	None

48314	48315	4	0	None
48315	48316	.	0	None

48317	48318	Isolated	0	None
48318	48319	intestinal	0	None
48319	48320	segments	0	None
48320	48321	in	0	None
48321	48322	anaesthetized	0	None
48322	48323	male	0	None
48323	48324	Wistar	0	None
48324	48325	rats	0	None
48325	48326	,	0	None
48326	48327	pre	0	None
48327	48328	-	0	None
48328	48329	treated	0	None
48329	48330	with	0	None
48330	48331	granisetron	3	CHEMICAL
48331	48332	75	0	None
48332	48333	microg	0	None
48333	48334	kg	0	None
48334	48335	(	0	None
48335	48336	-	0	None
48336	48337	1	0	None
48337	48338	)	0	None
48338	48339	,	0	None
48339	48340	lidoocaine	0	None
48340	48341	6	0	None
48341	48342	mg	0	None
48342	48343	kg	0	None
48343	48344	(	0	None
48344	48345	-	0	None
48345	48346	1	0	None
48346	48347	)	0	None
48347	48348	or	0	None
48348	48349	saline	0	None
48349	48350	,	0	None
48350	48351	were	0	None
48351	48352	instilled	0	None
48352	48353	with	0	None
48353	48354	a	0	None
48354	48355	supramaximal	0	None
48355	48356	dose	0	None
48356	48357	of	0	None
48357	48358	cholera	0	None
48358	48359	toxin	0	None
48359	48360	or	0	None
48360	48361	saline	0	None
48361	48362	.	0	None

48363	48364	Net	0	None
48364	48365	fluid	0	None
48365	48366	movement	0	None
48366	48367	was	0	None
48367	48368	determined	0	None
48368	48369	by	0	None
48369	48370	small	0	None
48370	48371	intestinal	0	None
48371	48372	perfusion	0	None
48372	48373	or	0	None
48373	48374	gravimetry	0	None
48374	48375	and	0	None
48375	48376	small	0	None
48376	48377	intestinal	0	None
48377	48378	and	0	None
48378	48379	luminal	0	None
48379	48380	fluid	0	None
48380	48381	5	0	None
48381	48382	-	0	None
48382	48383	HT	3	CHEMICAL
48383	48384	levels	0	None
48384	48385	were	0	None
48385	48386	determined	0	None
48386	48387	by	0	None
48387	48388	HPLC	0	None
48388	48389	with	0	None
48389	48390	fluorimetric	0	None
48390	48391	detection	0	None
48391	48392	.	0	None

48393	48394	5	0	None
48394	48395	.	0	None

48396	48397	Intraluminal	0	None
48397	48398	5	0	None
48398	48399	-	0	None
48399	48400	HT	3	CHEMICAL
48400	48401	release	0	None
48401	48402	was	0	None
48402	48403	proportional	0	None
48403	48404	to	0	None
48404	48405	the	0	None
48405	48406	reduction	0	None
48406	48407	in	0	None
48407	48408	tissue	0	None
48408	48409	5	0	None
48409	48410	-	0	None
48410	48411	HT	3	CHEMICAL
48411	48412	levels	0	None
48412	48413	and	0	None
48413	48414	to	0	None
48414	48415	the	0	None
48415	48416	onset	0	None
48416	48417	of	0	None
48417	48418	water	0	None
48418	48419	and	0	None
48419	48420	electrolyte	0	None
48420	48421	secretion	0	None
48421	48422	,	0	None
48422	48423	suggesting	0	None
48423	48424	that	0	None
48424	48425	luminal	0	None
48425	48426	5	0	None
48426	48427	-	0	None
48427	48428	HT	3	CHEMICAL
48428	48429	levels	0	None
48429	48430	reflect	0	None
48430	48431	enterochromaffin	0	None
48431	48432	cell	0	None
48432	48433	activity	0	None
48433	48434	.	0	None

48435	48436	6	0	None
48436	48437	.	0	None

48438	48439	Both	0	None
48439	48440	lidocaine	0	None
48440	48441	and	0	None
48441	48442	granisetron	3	CHEMICAL
48442	48443	inhibited	0	None
48443	48444	fluid	0	None
48444	48445	secretion	0	None
48445	48446	.	0	None

48447	48448	However	0	None
48448	48449	,	0	None
48449	48450	granisetron	3	CHEMICAL
48450	48451	alone	0	None
48451	48452	,	0	None
48452	48453	and	0	None
48453	48454	proportionately	0	None
48454	48455	,	0	None
48455	48456	reduced	0	None
48456	48457	5	0	None
48457	48458	-	0	None
48458	48459	HT	3	CHEMICAL
48459	48460	release	0	None
48460	48461	.	0	None

48462	48463	7	0	None
48463	48464	.	0	None

48465	48466	The	0	None
48466	48467	simultaneous	0	None
48467	48468	inhibition	0	None
48468	48469	of	0	None
48469	48470	5	0	None
48470	48471	-	0	None
48471	48472	HT	3	CHEMICAL
48472	48473	release	0	None
48473	48474	and	0	None
48474	48475	fluid	0	None
48475	48476	secretion	0	None
48476	48477	by	0	None
48477	48478	granisetron	3	CHEMICAL
48478	48479	suggests	0	None
48479	48480	that	0	None
48480	48481	5	0	None
48481	48482	-	0	None
48482	48483	HT	3	CHEMICAL
48483	48484	release	0	None
48484	48485	from	0	None
48485	48486	enterochromaffin	0	None
48486	48487	cells	0	None
48487	48488	is	0	None
48488	48489	potentiated	0	None
48489	48490	by	0	None
48490	48491	endogenous	0	None
48491	48492	5	0	None
48492	48493	-	0	None
48493	48494	HT	3	CHEMICAL
48494	48495	(	0	None
48495	48496	3	0	None
48496	48497	)	0	None
48497	48498	receptors	0	None
48498	48499	.	0	None

48500	48501	The	0	None
48501	48502	accentuated	0	None
48502	48503	5	0	None
48503	48504	-	0	None
48504	48505	HT	3	CHEMICAL
48505	48506	release	0	None
48506	48507	promotes	0	None
48507	48508	cholera	0	None
48508	48509	toxin	0	None
48509	48510	-	0	None
48510	48511	induced	0	None
48511	48512	fluid	0	None
48512	48513	secretion	0	None
48513	48514	.	0	None

48515	48516	Effects	0	None
48516	48517	of	0	None
48517	48518	sustained	0	None
48518	48519	administration	0	None
48519	48520	of	0	None
48520	48521	the	0	None
48521	48522	serotonin	3	CHEMICAL
48522	48523	and	0	None
48523	48524	norepinephrine	3	CHEMICAL
48524	48525	reuptake	0	None
48525	48526	inhibitor	0	None
48526	48527	venlafaxine	3	CHEMICAL
48527	48528	:	0	None
48528	48529	I	0	None
48529	48530	.	0	None
48530	48531	in	0	None
48531	48532	vivo	0	None
48532	48533	electrophysiological	0	None
48533	48534	studies	0	None
48534	48535	in	0	None
48535	48536	the	0	None
48536	48537	rat	0	None
48537	48538	.	0	None

48539	48540	The	0	None
48540	48541	effect	0	None
48541	48542	of	0	None
48542	48543	a	0	None
48543	48544	21	0	None
48544	48545	-	0	None
48545	48546	day	0	None
48546	48547	treatment	0	None
48547	48548	with	0	None
48548	48549	the	0	None
48549	48550	dual	0	None
48550	48551	5	0	None
48551	48552	-	0	None
48552	48553	HT	3	CHEMICAL
48553	48554	and	0	None
48554	48555	NE	3	CHEMICAL
48555	48556	reuptake	0	None
48556	48557	blocker	0	None
48557	48558	venlafaxine	3	CHEMICAL
48558	48559	(	0	None
48559	48560	delivered	0	None
48560	48561	s	0	None
48561	48562	.	0	None
48562	48563	c	0	None
48563	48564	.	0	None
48564	48565	by	0	None
48565	48566	osmotic	0	None
48566	48567	minipumps	0	None
48567	48568	)	0	None
48568	48569	was	0	None
48569	48570	assessed	0	None
48570	48571	on	0	None
48571	48572	the	0	None
48572	48573	time	0	None
48573	48574	required	0	None
48574	48575	for	0	None
48575	48576	a	0	None
48576	48577	50	0	None
48577	48578	%	0	None
48578	48579	recovery	0	None
48579	48580	(	0	None
48580	48581	RT	0	None
48581	48582	(	0	None
48582	48583	50	0	None
48583	48584	)	0	None
48584	48585	)	0	None
48585	48586	of	0	None
48586	48587	the	0	None
48587	48588	firing	0	None
48588	48589	activity	0	None
48589	48590	of	0	None
48590	48591	dorsal	0	None
48591	48592	hippocampus	0	None
48592	48593	CA	2	GENE-N
48593	48594	(	0	None
48594	48595	3	0	None
48595	48596	)	0	None
48596	48597	pyramidal	0	None
48597	48598	neurons	0	None
48598	48599	from	0	None
48599	48600	the	0	None
48600	48601	suppression	0	None
48601	48602	induced	0	None
48602	48603	by	0	None
48603	48604	microiontophoretic	0	None
48604	48605	applications	0	None
48605	48606	of	0	None
48606	48607	5	0	None
48607	48608	-	0	None
48608	48609	HT	3	CHEMICAL
48609	48610	and	0	None
48610	48611	NE	3	CHEMICAL
48611	48612	.	0	None

48613	48614	The	0	None
48614	48615	RT	0	None
48615	48616	(	0	None
48616	48617	50	0	None
48617	48618	)	0	None
48618	48619	values	0	None
48619	48620	for	0	None
48620	48621	5	0	None
48621	48622	-	0	None
48622	48623	HT	3	CHEMICAL
48623	48624	were	0	None
48624	48625	increased	0	None
48625	48626	by	0	None
48626	48627	both	0	None
48627	48628	10	0	None
48628	48629	and	0	None
48629	48630	40	0	None
48630	48631	mg	0	None
48631	48632	/	0	None
48632	48633	kg	0	None
48633	48634	/	0	None
48634	48635	day	0	None
48635	48636	regimens	0	None
48636	48637	of	0	None
48637	48638	venlafaxine	3	CHEMICAL
48638	48639	,	0	None
48639	48640	whereas	0	None
48640	48641	those	0	None
48641	48642	for	0	None
48642	48643	NE	3	CHEMICAL
48643	48644	were	0	None
48644	48645	increased	0	None
48645	48646	only	0	None
48646	48647	by	0	None
48647	48648	the	0	None
48648	48649	40	0	None
48649	48650	mg	0	None
48650	48651	/	0	None
48651	48652	kg	0	None
48652	48653	/	0	None
48653	48654	day	0	None
48654	48655	regimen	0	None
48655	48656	,	0	None
48656	48657	indicative	0	None
48657	48658	of	0	None
48658	48659	a	0	None
48659	48660	greater	0	None
48660	48661	potency	0	None
48661	48662	of	0	None
48662	48663	venlafaxine	3	CHEMICAL
48663	48664	in	0	None
48664	48665	blocking	0	None
48665	48666	5	0	None
48666	48667	-	0	None
48667	48668	HT	3	CHEMICAL
48668	48669	reuptake	0	None
48669	48670	.	0	None

48671	48672	The	0	None
48672	48673	sensitivity	0	None
48673	48674	of	0	None
48674	48675	the	0	None
48675	48676	postsynaptic	0	None
48676	48677	5	0	None
48677	48678	-	0	None
48678	48679	HT	3	CHEMICAL
48679	48680	(	0	None
48680	48681	1A	0	None
48681	48682	)	0	None
48682	48683	and	0	None
48683	48684	alpha	0	None
48684	48685	(	0	None
48685	48686	2	0	None
48686	48687	)	0	None
48687	48688	-	0	None
48688	48690	adrenergic receptors	2	GENE-N
48690	48691	was	0	None
48691	48692	altered	0	None
48692	48693	by	0	None
48693	48694	neither	0	None
48694	48695	regimen	0	None
48695	48696	of	0	None
48696	48697	venlafaxine	3	CHEMICAL
48697	48698	.	0	None

48699	48700	Using	0	None
48700	48701	a	0	None
48701	48702	paradigm	0	None
48702	48703	by	0	None
48703	48704	which	0	None
48704	48705	the	0	None
48705	48706	5	0	None
48706	48707	-	0	None
48707	48708	HT	3	CHEMICAL
48708	48709	(	0	None
48709	48710	1A	0	None
48710	48711	)	0	None
48711	48712	antagonist	0	None
48712	48714	WAY 100635	3	CHEMICAL
48714	48715	can	0	None
48715	48716	induce	0	None
48716	48717	a	0	None
48717	48718	disinhibition	0	None
48718	48719	of	0	None
48719	48720	firing	0	None
48720	48721	activity	0	None
48721	48722	of	0	None
48722	48723	CA	2	GENE-N
48723	48724	(	0	None
48724	48725	3	0	None
48725	48726	)	0	None
48726	48727	pyramidal	0	None
48727	48728	neurons	0	None
48728	48729	,	0	None
48729	48730	it	0	None
48730	48731	was	0	None
48731	48732	demonstrated	0	None
48732	48733	that	0	None
48733	48734	the	0	None
48734	48735	high	0	None
48735	48736	,	0	None
48736	48737	but	0	None
48737	48738	not	0	None
48738	48739	the	0	None
48739	48740	low	0	None
48740	48741	,	0	None
48741	48742	dose	0	None
48742	48743	of	0	None
48743	48744	venlafaxine	3	CHEMICAL
48744	48745	led	0	None
48745	48746	to	0	None
48746	48747	an	0	None
48747	48748	enhanced	0	None
48748	48749	tonic	0	None
48749	48750	activation	0	None
48750	48751	of	0	None
48751	48752	postsynaptic	0	None
48752	48753	5	0	None
48753	48754	-	0	None
48754	48755	HT	3	CHEMICAL
48755	48756	(	0	None
48756	48757	1A	0	None
48757	48758	)	0	None
48758	48759	receptors	0	None
48759	48760	in	0	None
48760	48761	the	0	None
48761	48762	dorsal	0	None
48762	48763	hippocampus	0	None
48763	48764	.	0	None

48765	48766	The	0	None
48766	48767	duration	0	None
48767	48768	of	0	None
48768	48769	the	0	None
48769	48770	suppressant	0	None
48770	48771	effect	0	None
48771	48772	of	0	None
48772	48773	the	0	None
48773	48774	firing	0	None
48774	48775	activity	0	None
48775	48776	of	0	None
48776	48777	CA	2	GENE-N
48777	48778	(	0	None
48778	48779	3	0	None
48779	48780	)	0	None
48780	48781	hippocampus	0	None
48781	48782	pyramidal	0	None
48782	48783	neurons	0	None
48783	48784	produced	0	None
48784	48785	by	0	None
48785	48786	the	0	None
48786	48787	electrical	0	None
48787	48788	stimulation	0	None
48788	48789	of	0	None
48789	48790	the	0	None
48790	48791	ascending	0	None
48791	48792	5	0	None
48792	48793	-	0	None
48793	48794	HT	3	CHEMICAL
48794	48795	pathway	0	None
48795	48796	was	0	None
48796	48797	significantly	0	None
48797	48798	reduced	0	None
48798	48799	when	0	None
48799	48800	the	0	None
48800	48801	frequency	0	None
48801	48802	of	0	None
48802	48803	the	0	None
48803	48804	stimulation	0	None
48804	48805	was	0	None
48805	48806	enhanced	0	None
48806	48807	from	0	None
48807	48808	1	0	None
48808	48809	Hz	0	None
48809	48810	to	0	None
48810	48811	5	0	None
48811	48812	Hz	0	None
48812	48813	in	0	None
48813	48814	control	0	None
48814	48815	rats	0	None
48815	48816	and	0	None
48816	48817	in	0	None
48817	48818	rats	0	None
48818	48819	treated	0	None
48819	48820	with	0	None
48820	48821	10	0	None
48821	48822	mg	0	None
48822	48823	/	0	None
48823	48824	kg	0	None
48824	48825	/	0	None
48825	48826	day	0	None
48826	48827	,	0	None
48827	48828	but	0	None
48828	48829	not	0	None
48829	48830	with	0	None
48830	48831	40	0	None
48831	48832	mg	0	None
48832	48833	/	0	None
48833	48834	kg	0	None
48834	48835	/	0	None
48835	48836	day	0	None
48836	48837	of	0	None
48837	48838	venlafaxine	3	CHEMICAL
48838	48839	.	0	None

48840	48841	Hence	0	None
48841	48842	,	0	None
48842	48843	venlafaxine	3	CHEMICAL
48843	48844	induced	0	None
48844	48845	a	0	None
48845	48846	desensitization	0	None
48846	48847	of	0	None
48847	48848	the	0	None
48848	48849	terminal	0	None
48849	48850	5	0	None
48850	48851	-	0	None
48851	48852	HT	3	CHEMICAL
48852	48853	(	0	None
48853	48854	1B	0	None
48854	48855	)	0	None
48855	48856	autoreceptor	0	None
48856	48857	only	0	None
48857	48858	at	0	None
48858	48859	the	0	None
48859	48860	high	0	None
48860	48861	dose	0	None
48861	48862	.	0	None

48863	48864	A	0	None
48864	48865	2	0	None
48865	48866	-	0	None
48866	48867	day	0	None
48867	48868	treatment	0	None
48868	48869	with	0	None
48869	48870	10	0	None
48870	48871	mg	0	None
48871	48872	/	0	None
48872	48873	kg	0	None
48873	48874	/	0	None
48874	48875	day	0	None
48875	48876	of	0	None
48876	48877	venlafaxine	3	CHEMICAL
48877	48878	induced	0	None
48878	48879	a	0	None
48879	48880	suppression	0	None
48880	48881	of	0	None
48881	48882	the	0	None
48882	48883	firing	0	None
48883	48884	activity	0	None
48884	48885	of	0	None
48885	48886	5	0	None
48886	48887	-	0	None
48887	48888	HT	3	CHEMICAL
48888	48889	neurons	0	None
48889	48890	of	0	None
48890	48891	the	0	None
48891	48892	dorsal	0	None
48892	48893	raphe	0	None
48893	48894	.	0	None

48895	48896	The	0	None
48896	48897	firing	0	None
48897	48898	activity	0	None
48898	48899	of	0	None
48899	48900	these	0	None
48900	48901	neurons	0	None
48901	48902	was	0	None
48902	48903	back	0	None
48903	48904	to	0	None
48904	48905	control	0	None
48905	48906	level	0	None
48906	48907	in	0	None
48907	48908	rats	0	None
48908	48909	that	0	None
48909	48910	had	0	None
48910	48911	been	0	None
48911	48912	treated	0	None
48912	48913	for	0	None
48913	48914	21	0	None
48914	48915	days	0	None
48915	48916	with	0	None
48916	48917	the	0	None
48917	48918	same	0	None
48918	48919	dose	0	None
48919	48920	of	0	None
48920	48921	venlafaxine	3	CHEMICAL
48921	48922	.	0	None

48923	48924	The	0	None
48924	48925	suppressant	0	None
48925	48926	effect	0	None
48926	48927	of	0	None
48927	48928	the	0	None
48928	48929	i	0	None
48929	48930	.	0	None
48930	48931	v	0	None
48931	48932	.	0	None
48932	48933	administration	0	None
48933	48934	of	0	None
48934	48935	the	0	None
48935	48936	5	0	None
48936	48937	-	0	None
48937	48938	HT	3	CHEMICAL
48938	48939	autoreceptor	0	None
48939	48940	agonist	0	None
48940	48941	LSD	0	None
48941	48942	on	0	None
48942	48943	the	0	None
48943	48944	firing	0	None
48944	48945	activity	0	None
48945	48946	of	0	None
48946	48947	dorsal	0	None
48947	48948	raphe	0	None
48948	48949	5	0	None
48949	48950	-	0	None
48950	48951	HT	3	CHEMICAL
48951	48952	neurons	0	None
48952	48953	was	0	None
48953	48954	reduced	0	None
48954	48955	in	0	None
48955	48956	rats	0	None
48956	48957	that	0	None
48957	48958	had	0	None
48958	48959	been	0	None
48959	48960	treated	0	None
48960	48961	for	0	None
48961	48962	21	0	None
48962	48963	days	0	None
48963	48964	with	0	None
48964	48965	10	0	None
48965	48966	mg	0	None
48966	48967	/	0	None
48967	48968	kg	0	None
48968	48969	/	0	None
48969	48970	day	0	None
48970	48971	of	0	None
48971	48972	venlafaxine	3	CHEMICAL
48972	48973	.	0	None

48974	48975	A	0	None
48975	48976	2	0	None
48976	48977	-	0	None
48977	48978	day	0	None
48978	48979	treatment	0	None
48979	48980	with	0	None
48980	48981	40	0	None
48981	48982	mg	0	None
48982	48983	/	0	None
48983	48984	kg	0	None
48984	48985	/	0	None
48985	48986	day	0	None
48986	48987	of	0	None
48987	48988	venlafaxine	3	CHEMICAL
48988	48989	,	0	None
48989	48990	unlike	0	None
48990	48991	the	0	None
48991	48992	10	0	None
48992	48993	mg	0	None
48993	48994	/	0	None
48994	48995	kg	0	None
48995	48996	/	0	None
48996	48997	day	0	None
48997	48998	regimen	0	None
48998	48999	,	0	None
48999	49000	induced	0	None
49000	49001	a	0	None
49001	49002	marked	0	None
49002	49003	suppression	0	None
49003	49004	of	0	None
49004	49005	the	0	None
49005	49006	firing	0	None
49006	49007	activity	0	None
49007	49008	of	0	None
49008	49009	locus	0	None
49009	49010	coeruleus	0	None
49010	49011	NE	3	CHEMICAL
49011	49012	neurons	0	None
49012	49013	.	0	None

49014	49015	However	0	None
49015	49016	,	0	None
49016	49017	in	0	None
49017	49018	contrast	0	None
49018	49019	to	0	None
49019	49020	5	0	None
49020	49021	-	0	None
49021	49022	HT	3	CHEMICAL
49022	49023	neurons	0	None
49023	49024	,	0	None
49024	49025	NE	3	CHEMICAL
49025	49026	neurons	0	None
49026	49027	did	0	None
49027	49028	not	0	None
49028	49029	recover	0	None
49029	49030	their	0	None
49030	49031	firing	0	None
49031	49032	activity	0	None
49032	49033	after	0	None
49033	49034	a	0	None
49034	49035	21	0	None
49035	49036	-	0	None
49036	49037	day	0	None
49037	49038	treatment	0	None
49038	49039	.	0	None

49040	49041	Taken	0	None
49041	49042	together	0	None
49042	49043	,	0	None
49043	49044	the	0	None
49044	49045	results	0	None
49045	49046	from	0	None
49046	49047	this	0	None
49047	49048	study	0	None
49048	49049	indicate	0	None
49049	49050	that	0	None
49050	49051	the	0	None
49051	49052	low	0	None
49052	49053	dose	0	None
49053	49054	of	0	None
49054	49055	venlafaxine	3	CHEMICAL
49055	49056	blocked	0	None
49056	49057	selectively	0	None
49057	49058	the	0	None
49058	49059	reuptake	0	None
49059	49060	of	0	None
49060	49061	5	0	None
49061	49062	-	0	None
49062	49063	HT	3	CHEMICAL
49063	49064	,	0	None
49064	49065	whereas	0	None
49065	49066	the	0	None
49066	49067	high	0	None
49067	49068	dose	0	None
49068	49069	blocked	0	None
49069	49070	the	0	None
49070	49071	reuptake	0	None
49071	49072	of	0	None
49072	49073	both	0	None
49073	49074	5	0	None
49074	49075	-	0	None
49075	49076	HT	3	CHEMICAL
49076	49077	and	0	None
49077	49078	NE	3	CHEMICAL
49078	49079	.	0	None

49080	49081	Moreover	0	None
49081	49082	,	0	None
49082	49083	an	0	None
49083	49084	enhancement	0	None
49084	49085	of	0	None
49085	49086	serotonergic	0	None
49086	49087	neurotransmission	0	None
49087	49088	by	0	None
49088	49089	venlafaxine	3	CHEMICAL
49089	49090	was	0	None
49090	49091	only	0	None
49091	49092	achieved	0	None
49092	49093	under	0	None
49093	49094	conditions	0	None
49094	49095	whereby	0	None
49095	49096	the	0	None
49096	49097	desensitization	0	None
49097	49098	of	0	None
49098	49099	the	0	None
49099	49100	terminal	0	None
49100	49101	5	0	None
49101	49102	-	0	None
49102	49103	HT	3	CHEMICAL
49103	49104	(	0	None
49104	49105	1B	0	None
49105	49106	)	0	None
49106	49107	autoreceptor	0	None
49107	49108	is	0	None
49108	49109	appended	0	None
49109	49110	to	0	None
49110	49111	that	0	None
49111	49112	of	0	None
49112	49113	the	0	None
49113	49114	somatodendritic	0	None
49114	49115	5	0	None
49115	49116	-	0	None
49116	49117	HT	3	CHEMICAL
49117	49118	(	0	None
49118	49119	1A	0	None
49119	49120	)	0	None
49120	49121	receptor	0	None
49121	49122	.	0	None

49123	49124	Phosphoacetylcholinesterase	0	None
49124	49125	:	0	None
49125	49126	toxicity	0	None
49126	49127	of	0	None
49127	49128	phosphorus	3	CHEMICAL
49128	49129	oxychloride	0	None
49129	49130	to	0	None
49130	49131	mammals	0	None
49131	49132	and	0	None
49132	49133	insects	0	None
49133	49134	that	0	None
49134	49135	can	0	None
49135	49136	be	0	None
49136	49137	attributed	0	None
49137	49138	to	0	None
49138	49139	selective	0	None
49139	49140	phosphorylation	0	None
49140	49141	of	0	None
49141	49142	acetylcholinesterase	1	GENE-Y
49142	49143	by	0	None
49143	49145	phosphorodichloridic acid	3	CHEMICAL
49145	49146	.	0	None

49147	49148	Phosphorus	0	None
49148	49149	oxychloride	0	None
49149	49150	(	0	None
49150	49151	POCl	0	None
49151	49152	(	0	None
49152	49153	3	0	None
49153	49154	)	0	None
49154	49155	)	0	None
49155	49156	is	0	None
49156	49157	an	0	None
49157	49158	intermediate	0	None
49158	49159	in	0	None
49159	49160	the	0	None
49160	49161	synthesis	0	None
49161	49162	of	0	None
49162	49163	many	0	None
49163	49164	organophosphorus	3	CHEMICAL
49164	49165	insecticides	0	None
49165	49166	and	0	None
49166	49167	chemical	0	None
49167	49168	warfare	0	None
49168	49169	nerve	0	None
49169	49170	gases	0	None
49170	49171	that	0	None
49171	49172	are	0	None
49172	49173	toxic	0	None
49173	49174	to	0	None
49174	49175	insects	0	None
49175	49176	and	0	None
49176	49177	mammals	0	None
49177	49178	by	0	None
49178	49179	inhibition	0	None
49179	49180	of	0	None
49180	49181	acetylcholinesterase	1	GENE-Y
49181	49182	(	0	None
49182	49183	AChE	1	GENE-Y
49183	49184	)	0	None
49184	49185	activity	0	None
49185	49186	.	0	None

49187	49188	It	0	None
49188	49189	was	0	None
49189	49190	therefore	0	None
49190	49191	surprising	0	None
49191	49192	to	0	None
49192	49193	observe	0	None
49193	49194	that	0	None
49194	49195	POCl	0	None
49195	49196	(	0	None
49196	49197	3	0	None
49197	49198	)	0	None
49198	49199	,	0	None
49199	49200	which	0	None
49200	49201	is	0	None
49201	49202	hydrolytically	0	None
49202	49203	unstable	0	None
49203	49204	,	0	None
49204	49205	also	0	None
49205	49206	itself	0	None
49206	49207	gives	0	None
49207	49208	poisoning	0	None
49208	49209	signs	0	None
49209	49210	in	0	None
49210	49211	ip	0	None
49211	49212	-	0	None
49212	49213	treated	0	None
49213	49214	mice	0	None
49214	49215	and	0	None
49215	49216	fumigant	0	None
49216	49217	-	0	None
49217	49218	exposed	0	None
49218	49219	houseflies	0	None
49219	49220	similar	0	None
49220	49221	to	0	None
49221	49222	those	0	None
49222	49223	produced	0	None
49223	49224	by	0	None
49224	49225	the	0	None
49225	49227	organophosphorus ester	3	CHEMICAL
49227	49228	insecticides	0	None
49228	49229	and	0	None
49229	49230	chemical	0	None
49230	49231	warfare	0	None
49231	49232	agents	0	None
49232	49233	.	0	None

49234	49235	In	0	None
49235	49236	mice	0	None
49236	49237	,	0	None
49237	49238	POCl	0	None
49238	49239	(	0	None
49239	49240	3	0	None
49240	49241	)	0	None
49241	49242	inhibits	0	None
49242	49243	serum	0	None
49243	49244	butyrylcholinesterase	1	GENE-Y
49244	49245	(	0	None
49245	49246	BuChE	1	GENE-Y
49246	49247	)	0	None
49247	49248	at	0	None
49248	49249	a	0	None
49249	49250	sublethal	0	None
49250	49251	dose	0	None
49251	49252	and	0	None
49252	49253	muscle	0	None
49253	49254	but	0	None
49254	49255	not	0	None
49255	49256	brain	0	None
49256	49257	AChE	1	GENE-Y
49257	49258	at	0	None
49258	49259	a	0	None
49259	49260	lethal	0	None
49260	49261	dose	0	None
49261	49262	.	0	None

49263	49264	In	0	None
49264	49265	houseflies	0	None
49265	49266	,	0	None
49266	49267	POCl	0	None
49267	49268	(	0	None
49268	49269	3	0	None
49269	49270	)	0	None
49270	49271	-	0	None
49271	49272	induced	0	None
49272	49273	brain	0	None
49273	49274	AChE	1	GENE-Y
49274	49275	inhibition	0	None
49275	49276	is	0	None
49276	49277	correlated	0	None
49277	49278	with	0	None
49278	49279	poisoning	0	None
49279	49280	and	0	None
49280	49281	the	0	None
49281	49282	probable	0	None
49282	49283	cause	0	None
49283	49284	thereof	0	None
49284	49285	.	0	None

49286	49287	POCl	0	None
49287	49288	(	0	None
49288	49289	3	0	None
49289	49290	)	0	None
49290	49291	in	0	None
49291	49292	vitro	0	None
49292	49293	is	0	None
49293	49294	selective	0	None
49294	49295	for	0	None
49295	49296	AChE	1	GENE-Y
49296	49297	(	0	None
49297	49298	IC	0	None
49298	49299	(	0	None
49299	49300	50	0	None
49300	49301	)	0	None
49301	49302	=	0	None
49302	49303	12	0	None
49303	49304	-	0	None
49304	49305	36	0	None
49305	49306	microM	0	None
49306	49307	)	0	None
49307	49308	compared	0	None
49308	49309	with	0	None
49309	49310	several	0	None
49310	49311	other	0	None
49311	49313	serine hydrolases	2	GENE-N
49313	49314	(	0	None
49314	49315	BuChE	1	GENE-Y
49315	49316	,	0	None
49316	49317	carboxylesterase	0	None
49317	49318	,	0	None
49318	49319	elastase	2	GENE-N
49319	49320	,	0	None
49320	49321	alpha	0	None
49321	49322	-	0	None
49322	49323	chymotrypsin	2	GENE-N
49323	49324	,	0	None
49324	49325	and	0	None
49325	49326	thrombin	2	GENE-N
49326	49327	)	0	None
49327	49328	(	0	None
49328	49329	IC	0	None
49329	49330	(	0	None
49330	49331	50	0	None
49331	49332	)	0	None
49332	49333	=	0	None
49333	49334	88	0	None
49334	49335	-	0	None
49335	49336	2000	0	None
49336	49337	microM	0	None
49337	49338	)	0	None
49338	49339	.	0	None

49340	49341	With	0	None
49341	49344	electric eel AChE	1	GENE-Y
49344	49345	,	0	None
49345	49346	methylcarbamoylation	0	None
49346	49347	of	0	None
49347	49348	the	0	None
49348	49349	active	0	None
49349	49350	site	0	None
49350	49351	with	0	None
49351	49352	eserine	0	None
49352	49353	reversibly	0	None
49353	49354	protects	0	None
49354	49355	against	0	None
49355	49356	subsequent	0	None
49356	49357	irreversible	0	None
49357	49358	inhibition	0	None
49358	49359	by	0	None
49359	49360	POCl	0	None
49360	49361	(	0	None
49361	49362	3	0	None
49362	49363	)	0	None
49363	49364	.	0	None

49365	49366	Most	0	None
49366	49367	importantly	0	None
49367	49368	,	0	None
49368	49369	POCl	0	None
49369	49370	(	0	None
49370	49371	3	0	None
49371	49372	)	0	None
49372	49373	-	0	None
49373	49374	induced	0	None
49374	49377	electric eel AChE	1	GENE-Y
49377	49378	inhibition	0	None
49378	49379	prevents	0	None
49379	49380	postlabeling	0	None
49380	49381	with	0	None
49381	49382	[	0	None
49382	49383	(	0	None
49383	49384	3	0	None
49384	49385	)	0	None
49385	49386	H	0	None
49386	49387	]	0	None
49387	49389	diisopropyl phosphorofluoridate	3	CHEMICAL
49389	49390	;	0	None
49390	49391	i	0	None
49391	49392	.	0	None
49392	49393	e	0	None
49393	49394	.	0	None
49394	49395	,	0	None
49395	49396	both	0	None
49396	49397	compounds	0	None
49397	49398	phosphorylate	0	None
49398	49399	at	0	None
49399	49400	Ser	0	None
49400	49401	-	0	None
49401	49402	200	0	None
49402	49403	in	0	None
49403	49404	the	0	None
49404	49405	catalytic	0	None
49405	49406	triad	0	None
49406	49407	.	0	None

49408	49409	Pyridine	0	None
49409	49410	-	0	None
49410	49411	2	0	None
49411	49412	-	0	None
49412	49413	aldoxime	0	None
49413	49414	methiodide	0	None
49414	49415	does	0	None
49415	49416	not	0	None
49416	49417	reactivate	0	None
49417	49418	POCl	0	None
49418	49419	(	0	None
49419	49420	3	0	None
49420	49421	)	0	None
49421	49422	-	0	None
49422	49423	inhibited	0	None
49423	49424	AChE	1	GENE-Y
49424	49425	,	0	None
49425	49426	consistent	0	None
49426	49427	with	0	None
49427	49428	an	0	None
49428	49429	anionic	0	None
49429	49430	phosphoserine	3	CHEMICAL
49430	49431	residue	0	None
49431	49432	at	0	None
49432	49433	the	0	None
49433	49434	esteratic	0	None
49434	49435	site	0	None
49435	49436	.	0	None

49437	49438	The	0	None
49438	49439	actual	0	None
49439	49440	phosphorylating	0	None
49440	49441	agent	0	None
49441	49442	is	0	None
49442	49443	formed	0	None
49443	49444	within	0	None
49444	49445	seconds	0	None
49445	49446	from	0	None
49446	49447	POCl	0	None
49447	49448	(	0	None
49448	49449	3	0	None
49449	49450	)	0	None
49450	49451	in	0	None
49451	49452	water	0	None
49452	49453	,	0	None
49453	49454	has	0	None
49454	49455	a	0	None
49455	49456	half	0	None
49456	49457	-	0	None
49457	49458	life	0	None
49458	49459	of	0	None
49459	49460	approximately	0	None
49460	49461	2	0	None
49461	49462	min	0	None
49462	49463	,	0	None
49463	49464	and	0	None
49464	49465	is	0	None
49465	49466	identified	0	None
49466	49467	as	0	None
49467	49469	phosphorodichloridic acid	3	CHEMICAL
49469	49470	[	0	None
49470	49471	HOP	0	None
49471	49472	(	0	None
49472	49473	O	0	None
49473	49474	)	0	None
49474	49475	Cl	0	None
49475	49476	(	0	None
49476	49477	2	0	None
49477	49478	)	0	None
49478	49479	]	0	None
49479	49480	by	0	None
49480	49481	(	0	None
49481	49482	31	0	None
49482	49483	)	0	None
49483	49484	P	0	None
49484	49485	NMR	0	None
49485	49486	and	0	None
49486	49487	derivatization	0	None
49487	49488	with	0	None
49488	49489	dimethylamine	3	CHEMICAL
49489	49490	to	0	None
49490	49491	HOP	0	None
49491	49492	(	0	None
49492	49493	O	0	None
49493	49494	)	0	None
49494	49495	(	0	None
49495	49496	NMe	0	None
49496	49497	(	0	None
49497	49498	2	0	None
49498	49499	)	0	None
49499	49500	)	0	None
49500	49501	(	0	None
49501	49502	2	0	None
49502	49503	)	0	None
49503	49504	.	0	None

49505	49506	POCl	0	None
49506	49507	(	0	None
49507	49508	3	0	None
49508	49509	)	0	None
49509	49510	on	0	None
49510	49511	reaction	0	None
49511	49512	with	0	None
49512	49513	water	0	None
49513	49514	and	0	None
49514	49515	HOP	0	None
49515	49516	(	0	None
49516	49517	O	0	None
49517	49518	)	0	None
49518	49519	Cl	0	None
49519	49520	(	0	None
49520	49521	2	0	None
49521	49522	)	0	None
49522	49523	have	0	None
49523	49524	the	0	None
49524	49525	same	0	None
49525	49526	potency	0	None
49526	49527	for	0	None
49527	49528	inhibition	0	None
49528	49529	of	0	None
49529	49530	AChE	1	GENE-Y
49530	49531	from	0	None
49531	49532	either	0	None
49532	49533	electric	0	None
49533	49534	eel	0	None
49534	49535	or	0	None
49535	49536	housefly	0	None
49536	49537	head	0	None
49537	49538	as	0	None
49538	49539	well	0	None
49539	49540	as	0	None
49540	49541	the	0	None
49541	49542	same	0	None
49542	49543	toxicity	0	None
49543	49544	for	0	None
49544	49545	mice	0	None
49545	49546	.	0	None

49547	49548	In	0	None
49548	49549	summary	0	None
49549	49550	,	0	None
49550	49551	the	0	None
49551	49552	acute	0	None
49552	49553	toxicity	0	None
49553	49554	of	0	None
49554	49555	POCl	0	None
49555	49556	(	0	None
49556	49557	3	0	None
49557	49558	)	0	None
49558	49559	is	0	None
49559	49560	attributable	0	None
49560	49561	to	0	None
49561	49562	hydrolytic	0	None
49562	49563	activation	0	None
49563	49564	to	0	None
49564	49565	HOP	0	None
49565	49566	(	0	None
49566	49567	O	0	None
49567	49568	)	0	None
49568	49569	Cl	0	None
49569	49570	(	0	None
49570	49571	2	0	None
49571	49572	)	0	None
49572	49573	that	0	None
49573	49574	phosphorylates	0	None
49574	49575	AChE	1	GENE-Y
49575	49576	at	0	None
49576	49577	the	0	None
49577	49578	active	0	None
49578	49579	site	0	None
49579	49580	to	0	None
49580	49581	form	0	None
49581	49582	enzymatically	0	None
49582	49583	inactive	0	None
49583	49584	[	0	None
49584	49585	O	0	None
49585	49586	-	0	None
49586	49587	phosphoserine	3	CHEMICAL
49587	49588	]	0	None
49588	49589	AChE	1	GENE-Y
49589	49590	.	0	None

49591	49592	Effects	0	None
49592	49593	of	0	None
49593	49594	2	0	None
49594	49595	,	0	None
49595	49596	3	0	None
49596	49597	,	0	None
49597	49598	7	0	None
49598	49599	,	0	None
49599	49600	8	0	None
49600	49601	-	0	None
49601	49602	tetrachlorodibenzo	0	None
49602	49603	-	0	None
49603	49604	p	0	None
49604	49605	-	0	None
49605	49606	dioxin	3	CHEMICAL
49606	49607	or	0	None
49607	49608	2	0	None
49608	49609	,	0	None
49609	49610	2	0	None
49610	49611	'	0	None
49611	49612	,	0	None
49612	49613	4	0	None
49613	49614	,	0	None
49614	49615	4	0	None
49615	49616	'	0	None
49616	49617	,	0	None
49617	49618	5	0	None
49618	49619	,	0	None
49619	49620	5	0	None
49620	49621	'	0	None
49621	49622	-	0	None
49622	49623	hexachlorobiphenyl	0	None
49623	49624	on	0	None
49624	49626	vitamin K	3	CHEMICAL
49626	49627	-	0	None
49627	49628	dependent	0	None
49628	49629	blood	0	None
49629	49630	coagulation	0	None
49630	49631	in	0	None
49631	49632	male	0	None
49632	49633	and	0	None
49633	49634	female	0	None
49634	49635	WAG	0	None
49635	49636	/	0	None
49636	49637	Rij	0	None
49637	49638	-	0	None
49638	49639	rats	0	None
49639	49640	.	0	None

49641	49642	Newborns	0	None
49642	49643	are	0	None
49643	49644	susceptible	0	None
49644	49645	to	0	None
49645	49646	hemorrhages	0	None
49646	49647	(	0	None
49647	49648	hemorrhagic	0	None
49648	49649	disease	0	None
49649	49650	of	0	None
49650	49651	the	0	None
49651	49652	newborn	0	None
49652	49653	or	0	None
49653	49654	HDN	0	None
49654	49655	)	0	None
49655	49656	due	0	None
49656	49657	to	0	None
49657	49659	vitamin K	3	CHEMICAL
49659	49660	deficiency	0	None
49660	49661	.	0	None

49662	49663	Induction	0	None
49663	49664	of	0	None
49664	49666	cytochrome P450	2	GENE-N
49666	49667	in	0	None
49667	49668	the	0	None
49668	49669	fetal	0	None
49669	49670	liver	0	None
49670	49671	by	0	None
49671	49672	maternal	0	None
49672	49673	anticonvulsant	0	None
49673	49674	therapy	0	None
49674	49675	such	0	None
49675	49676	as	0	None
49676	49677	phenobarbital	0	None
49677	49678	or	0	None
49678	49679	phenytoin	3	CHEMICAL
49679	49680	is	0	None
49680	49681	considered	0	None
49681	49682	to	0	None
49682	49683	be	0	None
49683	49684	a	0	None
49684	49685	major	0	None
49685	49686	cause	0	None
49686	49687	.	0	None

49688	49689	An	0	None
49689	49690	observed	0	None
49690	49691	increase	0	None
49691	49692	in	0	None
49692	49693	late	0	None
49693	49694	hemorrhagic	0	None
49694	49695	disease	0	None
49695	49696	(	0	None
49696	49697	LHD	0	None
49697	49698	)	0	None
49698	49699	in	0	None
49699	49700	breast	0	None
49700	49701	fed	0	None
49701	49702	neonates	0	None
49702	49703	gave	0	None
49703	49704	rise	0	None
49704	49705	to	0	None
49705	49706	the	0	None
49706	49707	hypothesis	0	None
49707	49708	that	0	None
49708	49709	PCBs	3	CHEMICAL
49709	49710	and	0	None
49710	49711	dioxins	3	CHEMICAL
49711	49712	,	0	None
49712	49713	P450	2	GENE-N
49713	49714	-	0	None
49714	49715	inducing	0	None
49715	49716	contaminants	0	None
49716	49717	present	0	None
49717	49718	in	0	None
49718	49719	human	0	None
49719	49720	milk	0	None
49720	49721	,	0	None
49721	49722	might	0	None
49722	49723	effect	0	None
49723	49725	vitamin K	3	CHEMICAL
49725	49726	-	0	None
49726	49727	dependent	0	None
49727	49728	blood	0	None
49728	49729	coagulation	0	None
49729	49730	.	0	None

49731	49732	This	0	None
49732	49733	hypothesis	0	None
49733	49734	was	0	None
49734	49735	studied	0	None
49735	49736	in	0	None
49736	49737	rats	0	None
49737	49738	.	0	None

49739	49740	Administration	0	None
49740	49741	of	0	None
49741	49742	a	0	None
49742	49743	single	0	None
49743	49744	oral	0	None
49744	49745	dose	0	None
49745	49746	of	0	None
49746	49747	0	0	None
49747	49748	.	0	None
49748	49749	003	0	None
49749	49750	,	0	None
49750	49751	0	0	None
49751	49752	.	0	None
49752	49753	03	0	None
49753	49754	,	0	None
49754	49755	0	0	None
49755	49756	.	0	None
49756	49757	3	0	None
49757	49758	,	0	None
49758	49759	3	0	None
49759	49760	or	0	None
49760	49761	30	0	None
49761	49762	nmol	0	None
49762	49763	2	0	None
49763	49764	,	0	None
49764	49765	3	0	None
49765	49766	,	0	None
49766	49767	7	0	None
49767	49768	,	0	None
49768	49769	8	0	None
49769	49770	-	0	None
49770	49771	tetrachlorodibenzo	0	None
49771	49772	-	0	None
49772	49773	p	0	None
49773	49774	-	0	None
49774	49775	dioxin	3	CHEMICAL
49775	49776	(	0	None
49776	49777	TCDD	3	CHEMICAL
49777	49778	)	0	None
49778	49779	per	0	None
49779	49780	kg	0	None
49780	49781	bodyweight	0	None
49781	49782	or	0	None
49782	49783	0	0	None
49783	49784	.	0	None
49784	49785	75	0	None
49785	49786	,	0	None
49786	49787	4	0	None
49787	49788	,	0	None
49788	49789	20	0	None
49789	49790	,	0	None
49790	49791	100	0	None
49791	49792	or	0	None
49792	49793	500	0	None
49793	49794	micromol	0	None
49794	49795	2	0	None
49795	49796	,	0	None
49796	49797	2	0	None
49797	49798	'	0	None
49798	49799	,	0	None
49799	49800	4	0	None
49800	49801	,	0	None
49801	49802	4	0	None
49802	49803	'	0	None
49803	49804	,	0	None
49804	49805	5	0	None
49805	49806	,	0	None
49806	49807	5	0	None
49807	49808	'	0	None
49808	49809	-	0	None
49809	49810	hexachlorobiphenyl	0	None
49810	49811	/	0	None
49811	49812	kg	0	None
49812	49813	bw	0	None
49813	49814	(	0	None
49814	49815	HxCB	3	CHEMICAL
49815	49816	)	0	None
49816	49817	to	0	None
49817	49818	female	0	None
49818	49819	and	0	None
49819	49820	male	0	None
49820	49821	rats	0	None
49821	49822	resulted	0	None
49822	49823	in	0	None
49823	49824	dose	0	None
49824	49825	-	0	None
49825	49826	related	0	None
49826	49827	reductions	0	None
49827	49828	of	0	None
49828	49829	the	0	None
49829	49831	vitamin K	3	CHEMICAL
49831	49832	-	0	None
49832	49833	dependent	0	None
49833	49836	coagulation factor VII	1	GENE-Y
49836	49837	.	0	None

49838	49839	The	0	None
49839	49840	highest	0	None
49840	49841	factor	0	None
49841	49842	VII	0	None
49842	49843	reduction	0	None
49843	49844	in	0	None
49844	49845	female	0	None
49845	49846	rats	0	None
49846	49847	was	0	None
49847	49848	44	0	None
49848	49849	%	0	None
49849	49850	,	0	None
49850	49851	observed	0	None
49851	49852	after	0	None
49852	49853	TCDD	3	CHEMICAL
49853	49854	exposure	0	None
49854	49855	.	0	None

49856	49857	The	0	None
49857	49858	Lowest	0	None
49858	49859	Observed	0	None
49859	49860	Adverse	0	None
49860	49861	Effect	0	None
49861	49862	Level	0	None
49862	49863	(	0	None
49863	49864	LOAEL	0	None
49864	49865	)	0	None
49865	49866	of	0	None
49866	49867	TCDD	3	CHEMICAL
49867	49868	on	0	None
49868	49869	female	0	None
49869	49870	factor	0	None
49870	49871	VII	0	None
49871	49872	levels	0	None
49872	49873	was	0	None
49873	49874	0	0	None
49874	49875	.	0	None
49875	49876	3	0	None
49876	49877	nmol	0	None
49877	49878	/	0	None
49878	49879	kg	0	None
49879	49880	bw	0	None
49880	49881	(	0	None
49881	49882	96	0	None
49882	49883	ng	0	None
49883	49884	/	0	None
49884	49885	kg	0	None
49885	49886	)	0	None
49886	49887	.	0	None

49888	49889	There	0	None
49889	49890	was	0	None
49890	49891	a	0	None
49891	49892	significant	0	None
49892	49893	inverse	0	None
49893	49894	correlation	0	None
49894	49895	between	0	None
49895	49896	Factor	0	None
49896	49897	VII	0	None
49897	49898	levels	0	None
49898	49899	and	0	None
49899	49900	induction	0	None
49900	49901	of	0	None
49901	49902	hepatic	0	None
49902	49903	ethoxyresorufin	3	CHEMICAL
49903	49904	O	0	None
49904	49905	-	0	None
49905	49906	deethylating	0	None
49906	49907	(	0	None
49907	49908	EROD	0	None
49908	49909	)	0	None
49909	49910	activity	0	None
49910	49911	,	0	None
49911	49912	reflecting	0	None
49912	49913	CYP1A1	0	None
49913	49914	,	0	None
49914	49915	and	0	None
49915	49916	total	0	None
49916	49917	P450	2	GENE-N
49917	49918	content	0	None
49918	49919	.	0	None

49920	49921	HxCB	3	CHEMICAL
49921	49922	had	0	None
49922	49923	no	0	None
49923	49924	effect	0	None
49924	49925	on	0	None
49925	49926	female	0	None
49926	49927	coagulation	0	None
49927	49928	factors	0	None
49928	49929	.	0	None

49930	49931	In	0	None
49931	49932	contrast	0	None
49932	49933	,	0	None
49933	49934	in	0	None
49934	49935	male	0	None
49935	49936	rats	0	None
49936	49937	only	0	None
49937	49938	exposure	0	None
49938	49939	to	0	None
49939	49940	HxCB	3	CHEMICAL
49940	49941	,	0	None
49941	49942	which	0	None
49942	49943	induces	0	None
49943	49944	mainly	0	None
49944	49945	CYP2B1	0	None
49945	49946	and	0	None
49946	49947	2B2	0	None
49947	49948	,	0	None
49948	49949	decreased	0	None
49949	49950	both	0	None
49950	49951	coagulation	0	None
49951	49952	factors	0	None
49952	49953	dramatically	0	None
49953	49954	up	0	None
49954	49955	to	0	None
49955	49956	88	0	None
49956	49957	%	0	None
49957	49958	.	0	None

49959	49960	The	0	None
49960	49961	LOAEL	0	None
49961	49962	of	0	None
49962	49963	HxCB	3	CHEMICAL
49963	49964	on	0	None
49964	49965	factor	0	None
49965	49966	VII	0	None
49966	49967	in	0	None
49967	49968	male	0	None
49968	49969	rats	0	None
49969	49970	was	0	None
49970	49971	100	0	None
49971	49972	micromol	0	None
49972	49973	/	0	None
49973	49974	kg	0	None
49974	49975	bw	0	None
49975	49976	(	0	None
49976	49977	36	0	None
49977	49978	mg	0	None
49978	49979	/	0	None
49979	49980	kg	0	None
49980	49981	)	0	None
49981	49982	.	0	None

49983	49984	In	0	None
49984	49985	general	0	None
49985	49986	,	0	None
49986	49987	effects	0	None
49987	49988	on	0	None
49988	49989	coagulation	0	None
49989	49990	factors	0	None
49990	49991	in	0	None
49991	49992	male	0	None
49992	49993	rats	0	None
49993	49994	exceeded	0	None
49994	49995	those	0	None
49995	49996	in	0	None
49996	49997	females	0	None
49997	49998	.	0	None

49999	50000	In	0	None
50000	50001	addition	0	None
50001	50002	,	0	None
50002	50003	sex	1	GENE-Y
50003	50004	-	0	None
50004	50005	dependent	0	None
50005	50006	differences	0	None
50006	50007	of	0	None
50007	50008	TCDD	3	CHEMICAL
50008	50009	and	0	None
50009	50010	HxCB	3	CHEMICAL
50010	50011	were	0	None
50011	50012	observed	0	None
50012	50013	on	0	None
50013	50014	the	0	None
50014	50015	hepatic	0	None
50015	50017	vitamin K	3	CHEMICAL
50017	50018	cycle	0	None
50018	50019	enzyme	0	None
50019	50020	activities	0	None
50020	50021	in	0	None
50021	50022	female	0	None
50022	50023	and	0	None
50023	50024	male	0	None
50024	50025	rats	0	None
50025	50026	.	0	None

50027	50028	Vitamin	0	None
50028	50029	K	0	None
50029	50030	-	0	None
50030	50031	dependent	0	None
50031	50032	(	0	None
50032	50033	gamma	0	None
50033	50034	-	0	None
50034	50035	glutamyl	3	CHEMICAL
50035	50036	carboxylase	2	GENE-N
50036	50037	activity	0	None
50037	50038	was	0	None
50038	50039	mainly	0	None
50039	50040	induced	0	None
50040	50041	in	0	None
50041	50042	female	0	None
50042	50043	rats	0	None
50043	50044	;	0	None
50044	50045	2	0	None
50045	50046	.	0	None
50046	50047	3	0	None
50047	50048	-	0	None
50048	50049	fold	0	None
50049	50050	in	0	None
50050	50051	the	0	None
50051	50052	highest	0	None
50052	50053	dose	0	None
50053	50054	group	0	None
50054	50055	of	0	None
50055	50056	TCDD	3	CHEMICAL
50056	50057	.	0	None

50058	50059	In	0	None
50059	50060	male	0	None
50060	50061	rats	0	None
50061	50062	only	0	None
50062	50064	vitamin K	3	CHEMICAL
50064	50065	2	0	None
50065	50066	,	0	None
50066	50067	3	0	None
50067	50068	-	0	None
50068	50069	epoxide	3	CHEMICAL
50069	50070	reductase	2	GENE-N
50070	50071	(	0	None
50071	50072	KO	0	None
50072	50073	-	0	None
50073	50074	reductase	2	GENE-N
50074	50075	)	0	None
50075	50076	activity	0	None
50076	50077	was	0	None
50077	50078	induced	0	None
50078	50079	1	0	None
50079	50080	.	0	None
50080	50081	7	0	None
50081	50082	-	0	None
50082	50083	fold	0	None
50083	50084	by	0	None
50084	50085	the	0	None
50085	50086	highest	0	None
50086	50087	dose	0	None
50087	50088	of	0	None
50088	50089	HxCB	3	CHEMICAL
50089	50090	.	0	None

50091	50092	KO	0	None
50092	50093	-	0	None
50093	50094	reductase	2	GENE-N
50094	50095	activity	0	None
50095	50096	in	0	None
50096	50097	female	0	None
50097	50098	rats	0	None
50098	50099	was	0	None
50099	50100	also	0	None
50100	50101	increased	0	None
50101	50102	by	0	None
50102	50103	TCDD	3	CHEMICAL
50103	50104	,	0	None
50104	50105	however	0	None
50105	50106	,	0	None
50106	50107	less	0	None
50107	50108	pronounced	0	None
50108	50109	than	0	None
50109	50110	the	0	None
50110	50111	carboxylase	2	GENE-N
50111	50112	activity	0	None
50112	50113	.	0	None

50114	50115	Concluding	0	None
50115	50116	,	0	None
50116	50117	the	0	None
50117	50118	hepatic	0	None
50118	50120	vitamin K	3	CHEMICAL
50120	50121	cycle	0	None
50121	50122	still	0	None
50122	50123	functions	0	None
50123	50124	and	0	None
50124	50125	is	0	None
50125	50126	not	0	None
50126	50127	blocked	0	None
50127	50128	by	0	None
50128	50129	TCDD	3	CHEMICAL
50129	50130	or	0	None
50130	50131	HxCB	3	CHEMICAL
50131	50132	,	0	None
50132	50133	thus	0	None
50133	50134	explaining	0	None
50134	50135	the	0	None
50135	50136	observed	0	None
50136	50137	reduction	0	None
50137	50138	in	0	None
50138	50139	factor	0	None
50139	50140	VII	0	None
50140	50141	.	0	None

50142	50143	Finally	0	None
50143	50144	,	0	None
50144	50145	the	0	None
50145	50146	possible	0	None
50146	50147	role	0	None
50147	50148	of	0	None
50148	50149	P450	2	GENE-N
50149	50150	in	0	None
50150	50152	vitamin K	3	CHEMICAL
50152	50153	deficiency	0	None
50153	50154	is	0	None
50154	50155	discussed	0	None
50155	50156	.	0	None

50157	50158	Based	0	None
50158	50159	on	0	None
50159	50160	these	0	None
50160	50161	results	0	None
50161	50162	it	0	None
50162	50163	is	0	None
50163	50164	suggested	0	None
50164	50165	to	0	None
50165	50166	investigate	0	None
50166	50167	the	0	None
50167	50168	possible	0	None
50168	50169	role	0	None
50169	50170	of	0	None
50170	50171	PCBs	3	CHEMICAL
50171	50172	and	0	None
50172	50173	dioxin	3	CHEMICAL
50173	50174	-	0	None
50174	50175	like	0	None
50175	50176	compounds	0	None
50176	50177	in	0	None
50177	50178	LHD	0	None
50178	50179	in	0	None
50179	50180	more	0	None
50180	50181	detail	0	None
50181	50182	.	0	None

50183	50184	Low	0	None
50184	50185	grade	0	None
50185	50186	inflammation	0	None
50186	50187	and	0	None
50187	50188	coronary	0	None
50188	50189	heart	0	None
50189	50190	disease	0	None
50190	50191	:	0	None
50191	50192	prospective	0	None
50192	50193	study	0	None
50193	50194	and	0	None
50194	50195	updated	0	None
50195	50196	meta	0	None
50196	50197	-	0	None
50197	50198	analyses	0	None
50198	50199	.	0	None

50200	50201	OBJECTIVE	0	None
50201	50202	:	0	None
50202	50203	To	0	None
50203	50204	assess	0	None
50204	50205	associations	0	None
50205	50206	between	0	None
50206	50207	baseline	0	None
50207	50208	values	0	None
50208	50209	of	0	None
50209	50210	four	0	None
50210	50211	different	0	None
50211	50212	circulating	0	None
50212	50213	markers	0	None
50213	50214	of	0	None
50214	50215	inflammation	0	None
50215	50216	and	0	None
50216	50217	future	0	None
50217	50218	risk	0	None
50218	50219	of	0	None
50219	50220	coronary	0	None
50220	50221	heart	0	None
50221	50222	disease	0	None
50222	50223	,	0	None
50223	50224	potential	0	None
50224	50225	triggers	0	None
50225	50226	of	0	None
50226	50227	systemic	0	None
50227	50228	inflammation	0	None
50228	50229	(	0	None
50229	50230	such	0	None
50230	50231	as	0	None
50231	50232	persistent	0	None
50232	50233	infection	0	None
50233	50234	)	0	None
50234	50235	,	0	None
50235	50236	and	0	None
50236	50237	other	0	None
50237	50238	markers	0	None
50238	50239	of	0	None
50239	50240	inflammation	0	None
50240	50241	.	0	None

50242	50243	DESIGN	0	None
50243	50244	:	0	None
50244	50245	Nested	0	None
50245	50246	case	0	None
50246	50247	-	0	None
50247	50248	control	0	None
50248	50249	comparisons	0	None
50249	50250	in	0	None
50250	50251	a	0	None
50251	50252	prospective	0	None
50252	50253	,	0	None
50253	50254	population	0	None
50254	50255	based	0	None
50255	50256	cohort	0	None
50256	50257	.	0	None

50258	50259	SETTING	0	None
50259	50260	:	0	None
50260	50261	General	0	None
50261	50262	practices	0	None
50262	50263	in	0	None
50263	50264	18	0	None
50264	50265	towns	0	None
50265	50266	in	0	None
50266	50267	Britain	0	None
50267	50268	.	0	None

50269	50270	PARTICIPANTS	0	None
50270	50271	:	0	None
50271	50272	506	0	None
50272	50273	men	0	None
50273	50274	who	0	None
50274	50275	died	0	None
50275	50276	from	0	None
50276	50277	coronary	0	None
50277	50278	heart	0	None
50278	50279	disease	0	None
50279	50280	or	0	None
50280	50281	had	0	None
50281	50282	a	0	None
50282	50283	non	0	None
50283	50284	-	0	None
50284	50285	fatal	0	None
50285	50286	myocardial	0	None
50286	50287	infarction	0	None
50287	50288	and	0	None
50288	50289	1025	0	None
50289	50290	men	0	None
50290	50291	who	0	None
50291	50292	remained	0	None
50292	50293	free	0	None
50293	50294	of	0	None
50294	50295	such	0	None
50295	50296	disease	0	None
50296	50297	until	0	None
50297	50298	1996	0	None
50298	50299	selected	0	None
50299	50300	from	0	None
50300	50301	5661	0	None
50301	50302	men	0	None
50302	50303	aged	0	None
50303	50304	40	0	None
50304	50305	-	0	None
50305	50306	59	0	None
50306	50307	years	0	None
50307	50308	who	0	None
50308	50309	provided	0	None
50309	50310	blood	0	None
50310	50311	samples	0	None
50311	50312	in	0	None
50312	50313	1978	0	None
50313	50314	-	0	None
50314	50315	1980	0	None
50315	50316	.	0	None

50317	50318	MAIN	0	None
50318	50319	OUTCOME	0	None
50319	50320	MEASURES	0	None
50320	50321	:	0	None
50321	50322	Plasma	0	None
50322	50323	concentrations	0	None
50323	50324	of	0	None
50324	50325	C	0	None
50325	50327	reactive protein	1	GENE-Y
50327	50328	,	0	None
50328	50332	serum amyloid A protein	1	GENE-Y
50332	50333	,	0	None
50333	50334	and	0	None
50334	50336	serum albumin	1	GENE-Y
50336	50337	and	0	None
50337	50338	leucocyte	0	None
50338	50339	count	0	None
50339	50340	.	0	None

50341	50342	Information	0	None
50342	50343	on	0	None
50343	50344	fatal	0	None
50344	50345	and	0	None
50345	50346	non	0	None
50346	50347	-	0	None
50347	50348	fatal	0	None
50348	50349	coronary	0	None
50349	50350	heart	0	None
50350	50351	disease	0	None
50351	50352	was	0	None
50352	50353	obtained	0	None
50353	50354	from	0	None
50354	50355	medical	0	None
50355	50356	records	0	None
50356	50357	and	0	None
50357	50358	death	0	None
50358	50359	certificates	0	None
50359	50360	.	0	None

50361	50362	RESULTS	0	None
50362	50363	:	0	None
50363	50364	Compared	0	None
50364	50365	with	0	None
50365	50366	men	0	None
50366	50367	in	0	None
50367	50368	the	0	None
50368	50369	bottom	0	None
50369	50370	third	0	None
50370	50371	of	0	None
50371	50372	baseline	0	None
50372	50373	measurements	0	None
50373	50374	of	0	None
50374	50375	C	0	None
50375	50376	reactive	0	None
50376	50377	protein	0	None
50377	50378	,	0	None
50378	50379	men	0	None
50379	50380	in	0	None
50380	50381	the	0	None
50381	50382	top	0	None
50382	50383	third	0	None
50383	50384	had	0	None
50384	50385	an	0	None
50385	50386	odds	0	None
50386	50387	ratio	0	None
50387	50388	for	0	None
50388	50389	coronary	0	None
50389	50390	heart	0	None
50390	50391	disease	0	None
50391	50392	of	0	None
50392	50393	2	0	None
50393	50394	.	0	None
50394	50395	13	0	None
50395	50396	(	0	None
50396	50397	95	0	None
50397	50398	%	0	None
50398	50399	confidence	0	None
50399	50400	interval	0	None
50400	50401	1	0	None
50401	50402	.	0	None
50402	50403	38	0	None
50403	50404	to	0	None
50404	50405	3	0	None
50405	50406	.	0	None
50406	50407	28	0	None
50407	50408	)	0	None
50408	50409	after	0	None
50409	50410	age	1	GENE-Y
50410	50411	,	0	None
50411	50412	town	0	None
50412	50413	,	0	None
50413	50414	smoking	0	None
50414	50415	,	0	None
50415	50416	vascular	0	None
50416	50417	risk	0	None
50417	50418	factors	0	None
50418	50419	,	0	None
50419	50420	and	0	None
50420	50421	indicators	0	None
50421	50422	of	0	None
50422	50423	socioeconomic	0	None
50423	50424	status	0	None
50424	50425	were	0	None
50425	50426	adjusted	0	None
50426	50427	for	0	None
50427	50428	.	0	None

50429	50430	Similar	0	None
50430	50431	adjusted	0	None
50431	50432	odds	0	None
50432	50433	ratios	0	None
50433	50434	were	0	None
50434	50435	1	0	None
50435	50436	.	0	None
50436	50437	65	0	None
50437	50438	(	0	None
50438	50439	1	0	None
50439	50440	.	0	None
50440	50441	07	0	None
50441	50442	to	0	None
50442	50443	2	0	None
50443	50444	.	0	None
50444	50445	55	0	None
50445	50446	)	0	None
50446	50447	for	0	None
50447	50451	serum amyloid A protein	1	GENE-Y
50451	50452	;	0	None
50452	50453	1	0	None
50453	50454	.	0	None
50454	50455	12	0	None
50455	50456	(	0	None
50456	50457	0	0	None
50457	50458	.	0	None
50458	50459	71	0	None
50459	50460	to	0	None
50460	50461	1	0	None
50461	50462	.	0	None
50462	50463	77	0	None
50463	50464	)	0	None
50464	50465	for	0	None
50465	50466	leucocyte	0	None
50466	50467	count	0	None
50467	50468	;	0	None
50468	50469	and	0	None
50469	50470	0	0	None
50470	50471	.	0	None
50471	50472	67	0	None
50472	50473	(	0	None
50473	50474	0	0	None
50474	50475	.	0	None
50475	50476	43	0	None
50476	50477	to	0	None
50477	50478	1	0	None
50478	50479	.	0	None
50479	50480	04	0	None
50480	50481	)	0	None
50481	50482	for	0	None
50482	50483	albumin	1	GENE-Y
50483	50484	.	0	None

50485	50486	No	0	None
50486	50487	strong	0	None
50487	50488	associations	0	None
50488	50489	were	0	None
50489	50490	observed	0	None
50490	50491	of	0	None
50491	50492	these	0	None
50492	50493	factors	0	None
50493	50494	with	0	None
50494	50495	Helicobacter	0	None
50495	50496	pylori	0	None
50496	50497	seropositivity	0	None
50497	50498	,	0	None
50498	50499	Chlamydia	0	None
50499	50500	pneumoniae	0	None
50500	50501	IgG	2	GENE-N
50501	50502	titres	0	None
50502	50503	,	0	None
50503	50504	or	0	None
50504	50505	plasma	0	None
50505	50506	total	0	None
50506	50507	homocysteine	0	None
50507	50508	concentrations	0	None
50508	50509	.	0	None

50510	50511	Baseline	0	None
50511	50512	values	0	None
50512	50513	of	0	None
50513	50514	the	0	None
50514	50515	acute	0	None
50515	50516	phase	0	None
50516	50517	reactants	0	None
50517	50518	were	0	None
50518	50519	significantly	0	None
50519	50520	associated	0	None
50520	50521	with	0	None
50521	50522	one	0	None
50522	50523	another	0	None
50523	50524	(	0	None
50524	50525	P	0	None
50525	50526	<	0	None
50526	50527	0	0	None
50527	50528	.	0	None
50528	50529	0001	0	None
50529	50530	)	0	None
50530	50531	,	0	None
50531	50532	although	0	None
50532	50533	the	0	None
50533	50534	association	0	None
50534	50535	between	0	None
50535	50536	low	0	None
50536	50538	serum albumin	1	GENE-Y
50538	50539	concentration	0	None
50539	50540	and	0	None
50540	50541	leucocyte	0	None
50541	50542	count	0	None
50542	50543	was	0	None
50543	50544	weaker	0	None
50544	50545	(	0	None
50545	50546	P	0	None
50546	50547	=	0	None
50547	50548	0	0	None
50548	50549	.	0	None
50549	50550	08	0	None
50550	50551	)	0	None
50551	50552	.	0	None

50553	50554	CONCLUSION	0	None
50554	50555	:	0	None
50555	50556	In	0	None
50556	50557	the	0	None
50557	50558	context	0	None
50558	50559	of	0	None
50559	50560	results	0	None
50560	50561	from	0	None
50561	50562	other	0	None
50562	50563	relevant	0	None
50563	50564	studies	0	None
50564	50565	these	0	None
50565	50566	findings	0	None
50566	50567	suggest	0	None
50567	50568	that	0	None
50568	50569	some	0	None
50569	50570	inflammatory	0	None
50570	50571	processes	0	None
50571	50572	,	0	None
50572	50573	unrelated	0	None
50573	50574	to	0	None
50574	50575	the	0	None
50575	50576	chronic	0	None
50576	50577	infections	0	None
50577	50578	studied	0	None
50578	50579	here	0	None
50579	50580	,	0	None
50580	50581	are	0	None
50581	50582	likely	0	None
50582	50583	to	0	None
50583	50584	be	0	None
50584	50585	involved	0	None
50585	50586	in	0	None
50586	50587	coronary	0	None
50587	50588	heart	0	None
50588	50589	disease	0	None
50589	50590	.	0	None

50591	50592	Identification	0	None
50592	50593	of	0	None
50593	50594	mu	2	GENE-N
50594	50595	-	0	None
50595	50596	class	0	None
50596	50598	glutathione transferases	2	GENE-N
50598	50599	M2	2	GENE-N
50599	50600	-	0	None
50600	50601	2	0	None
50601	50602	and	0	None
50602	50603	M3	0	None
50603	50604	-	0	None
50604	50605	3	0	None
50605	50606	as	0	None
50606	50607	cytosolic	0	None
50607	50609	prostaglandin E	3	CHEMICAL
50609	50610	synthases	0	None
50610	50611	in	0	None
50611	50612	the	0	None
50612	50613	human	0	None
50613	50614	brain	0	None
50614	50615	.	0	None

50616	50617	Cytosolic	0	None
50617	50618	prostaglandin	3	CHEMICAL
50618	50619	(	0	None
50619	50620	PG	3	CHEMICAL
50620	50621	)	0	None
50621	50622	E	0	None
50622	50623	synthase	0	None
50623	50624	was	0	None
50624	50625	purified	0	None
50625	50626	from	0	None
50626	50627	human	0	None
50627	50628	brain	0	None
50628	50629	cortex	0	None
50629	50630	.	0	None

50631	50632	The	0	None
50632	50633	N	0	None
50633	50634	-	0	None
50634	50635	terminal	0	None
50635	50637	amino acid	3	CHEMICAL
50637	50638	sequence	0	None
50638	50639	,	0	None
50639	50640	PMTLGYXNIRGL	0	None
50640	50641	,	0	None
50641	50642	was	0	None
50642	50643	identical	0	None
50643	50644	to	0	None
50644	50645	that	0	None
50645	50646	of	0	None
50646	50647	the	0	None
50647	50648	human	0	None
50648	50649	mu	1	GENE-Y
50649	50650	-	0	None
50650	50651	class	0	None
50651	50653	glutathione transferase	2	GENE-N
50653	50654	(	0	None
50654	50655	GST	0	None
50655	50656	)	0	None
50656	50657	M2	1	GENE-Y
50657	50658	subunit	0	None
50658	50659	.	0	None

50660	50661	Complementary	0	None
50661	50662	DNAs	0	None
50662	50663	for	0	None
50663	50665	human GSTM2	1	GENE-Y
50665	50666	,	0	None
50666	50667	GSTM3	1	GENE-Y
50667	50668	,	0	None
50668	50669	and	0	None
50669	50670	GSTM4	1	GENE-Y
50670	50671	subunits	0	None
50671	50672	were	0	None
50672	50673	cloned	0	None
50673	50674	,	0	None
50674	50675	and	0	None
50675	50677	recombinant proteins	2	GENE-N
50677	50678	were	0	None
50678	50679	expressed	0	None
50679	50680	as	0	None
50680	50681	homodimers	0	None
50681	50682	in	0	None
50682	50683	Escherichia	0	None
50683	50684	coli	0	None
50684	50685	.	0	None

50686	50687	The	0	None
50687	50689	recombinant GSTM2	1	GENE-Y
50689	50690	-	0	None
50690	50691	2	0	None
50691	50692	and	0	None
50692	50693	3	0	None
50693	50694	-	0	None
50694	50695	3	0	None
50695	50696	catalyzed	0	None
50696	50697	the	0	None
50697	50698	conversion	0	None
50698	50699	of	0	None
50699	50700	PGH2	0	None
50700	50701	to	0	None
50701	50702	PGE2	3	CHEMICAL
50702	50703	at	0	None
50703	50704	the	0	None
50704	50705	rates	0	None
50705	50706	of	0	None
50706	50707	282	0	None
50707	50708	and	0	None
50708	50709	923	0	None
50709	50710	nmol	0	None
50710	50711	/	0	None
50711	50712	min	0	None
50712	50713	/	0	None
50713	50714	mg	0	None
50714	50715	of	0	None
50715	50716	protein	0	None
50716	50717	,	0	None
50717	50718	respectively	0	None
50718	50719	,	0	None
50719	50720	at	0	None
50720	50721	the	0	None
50721	50722	optimal	0	None
50722	50723	pH	0	None
50723	50724	of	0	None
50724	50725	8	0	None
50725	50726	,	0	None
50726	50727	whereas	0	None
50727	50728	GSTM4	1	GENE-Y
50728	50729	-	0	None
50729	50730	4	0	None
50730	50731	was	0	None
50731	50732	inactive	0	None
50732	50733	;	0	None
50733	50734	although	0	None
50734	50735	all	0	None
50735	50736	three	0	None
50736	50737	enzymes	0	None
50737	50738	showed	0	None
50738	50739	GST	0	None
50739	50740	activity	0	None
50740	50741	.	0	None

50742	50743	The	0	None
50743	50745	PGE synthase	1	GENE-Y
50745	50746	activity	0	None
50746	50747	depended	0	None
50747	50748	on	0	None
50748	50749	thiols	0	None
50749	50750	,	0	None
50750	50751	such	0	None
50751	50752	as	0	None
50752	50753	glutathione	3	CHEMICAL
50753	50754	,	0	None
50754	50755	dithiothreitol	3	CHEMICAL
50755	50756	,	0	None
50756	50757	2	0	None
50757	50758	-	0	None
50758	50759	mercaptoethanol	0	None
50759	50760	,	0	None
50760	50761	or	0	None
50761	50762	L	0	None
50762	50763	-	0	None
50763	50764	cysteine	3	CHEMICAL
50764	50765	.	0	None

50766	50767	Michaelis	0	None
50767	50768	-	0	None
50768	50769	Menten	0	None
50769	50770	constants	0	None
50770	50771	and	0	None
50771	50772	turnover	0	None
50772	50773	numbers	0	None
50773	50774	for	0	None
50774	50775	PGH2	0	None
50775	50776	were	0	None
50776	50777	141	0	None
50777	50778	microM	0	None
50778	50779	and	0	None
50779	50780	10	0	None
50780	50781	.	0	None
50781	50782	8	0	None
50782	50783	min	0	None
50783	50784	(	0	None
50784	50785	-	0	None
50785	50786	1	0	None
50786	50787	)	0	None
50787	50788	for	0	None
50788	50789	GSTM2	0	None
50789	50790	-	0	None
50790	50791	2	0	None
50791	50792	and	0	None
50792	50793	1	0	None
50793	50794	.	0	None
50794	50795	5	0	None
50795	50796	mM	0	None
50796	50797	and	0	None
50797	50798	130	0	None
50798	50799	min	0	None
50799	50800	(	0	None
50800	50801	-	0	None
50801	50802	1	0	None
50802	50803	)	0	None
50803	50804	for	0	None
50804	50805	GSTM3	1	GENE-Y
50805	50806	-	0	None
50806	50807	3	0	None
50807	50808	,	0	None
50808	50809	respectively	0	None
50809	50810	.	0	None

50811	50812	GSTM2	0	None
50812	50813	-	0	None
50813	50814	2	0	None
50814	50815	and	0	None
50815	50816	3	0	None
50816	50817	-	0	None
50817	50818	3	0	None
50818	50819	may	0	None
50819	50820	play	0	None
50820	50821	crucial	0	None
50821	50822	roles	0	None
50822	50823	in	0	None
50823	50824	temperature	0	None
50824	50825	regulation	0	None
50825	50826	,	0	None
50826	50827	nociception	0	None
50827	50828	,	0	None
50828	50829	and	0	None
50829	50830	sleep	0	None
50830	50831	-	0	None
50831	50832	wake	0	None
50832	50833	regulation	0	None
50833	50834	by	0	None
50834	50835	producing	0	None
50835	50836	PGE2	3	CHEMICAL
50836	50837	in	0	None
50837	50838	the	0	None
50838	50839	brain	0	None
50839	50840	.	0	None

50841	50842	Evaluation	0	None
50842	50843	of	0	None
50843	50844	in	0	None
50844	50845	vivo	0	None
50845	50846	binding	0	None
50846	50847	properties	0	None
50847	50848	of	0	None
50848	50849	3H	0	None
50849	50850	-	0	None
50850	50851	NMPB	3	CHEMICAL
50851	50852	and	0	None
50852	50853	3H	0	None
50853	50854	-	0	None
50854	50855	QNB	0	None
50855	50856	in	0	None
50856	50857	mouse	0	None
50857	50858	brain	0	None
50858	50859	.	0	None

50860	50861	UNLABELLED	0	None
50861	50862	:	0	None
50862	50863	Apparent	0	None
50863	50865	muscarinic acetylcholine	3	CHEMICAL
50865	50866	(	0	None
50866	50867	mAch	0	None
50867	50868	)	0	None
50868	50869	receptor	0	None
50869	50870	occupancy	0	None
50870	50871	in	0	None
50871	50872	mouse	0	None
50872	50873	cerebral	0	None
50873	50874	cortex	0	None
50874	50875	,	0	None
50875	50876	hippocampus	0	None
50876	50877	,	0	None
50877	50878	and	0	None
50878	50879	striatum	0	None
50879	50880	by	0	None
50880	50881	scopolamine	0	None
50881	50882	,	0	None
50882	50883	an	0	None
50883	50884	antagonist	0	None
50884	50885	,	0	None
50885	50886	and	0	None
50886	50887	biperiden	0	None
50887	50888	,	0	None
50888	50889	a	0	None
50889	50890	relatively	0	None
50890	50891	selective	0	None
50891	50892	M1	1	GENE-Y
50892	50893	antagonist	0	None
50893	50894	,	0	None
50894	50895	was	0	None
50895	50896	estimated	0	None
50896	50897	with	0	None
50897	50898	competitive	0	None
50898	50899	binding	0	None
50899	50900	studies	0	None
50900	50901	using	0	None
50901	50902	two	0	None
50902	50903	different	0	None
50903	50904	radioligands	0	None
50904	50905	:	0	None
50905	50906	3H	0	None
50906	50907	-	0	None
50907	50908	N	0	None
50908	50909	-	0	None
50909	50910	methyl	3	CHEMICAL
50910	50911	piperidyl	0	None
50911	50912	benzilate	0	None
50912	50913	(	0	None
50913	50914	3H	0	None
50914	50915	-	0	None
50915	50916	NMPB	3	CHEMICAL
50916	50917	)	0	None
50917	50918	and	0	None
50918	50919	3H	0	None
50919	50920	-	0	None
50920	50921	quinuclidinyl	0	None
50921	50922	benzilate	0	None
50922	50923	(	0	None
50923	50924	3H	0	None
50924	50925	-	0	None
50925	50926	QNB	0	None
50926	50927	)	0	None
50927	50928	.	0	None

50929	50930	Both	0	None
50930	50931	radioligands	0	None
50931	50932	labeled	0	None
50932	50934	mAch receptors	2	GENE-N
50934	50935	in	0	None
50935	50936	these	0	None
50936	50937	brain	0	None
50937	50938	regions	0	None
50938	50939	,	0	None
50939	50940	and	0	None
50940	50941	the	0	None
50941	50942	relative	0	None
50942	50943	regional	0	None
50943	50944	distributions	0	None
50944	50945	of	0	None
50945	50946	the	0	None
50946	50947	specific	0	None
50947	50948	binding	0	None
50948	50949	of	0	None
50949	50950	3H	0	None
50950	50951	-	0	None
50951	50952	NMPB	3	CHEMICAL
50952	50953	in	0	None
50953	50954	vivo	0	None
50954	50955	paralleled	0	None
50955	50956	the	0	None
50956	50957	distribution	0	None
50957	50958	of	0	None
50958	50960	mAch receptors	2	GENE-N
50960	50961	.	0	None

50962	50963	3H	0	None
50963	50964	-	0	None
50964	50965	NMPB	3	CHEMICAL
50965	50966	binding	0	None
50966	50967	in	0	None
50967	50968	vivo	0	None
50968	50969	was	0	None
50969	50970	much	0	None
50970	50971	more	0	None
50971	50972	sensitive	0	None
50972	50973	to	0	None
50973	50974	direct	0	None
50974	50975	competitive	0	None
50975	50976	inhibition	0	None
50976	50977	by	0	None
50977	50978	scopolamine	0	None
50978	50979	than	0	None
50979	50980	was	0	None
50980	50981	3H	0	None
50981	50982	-	0	None
50982	50983	QNB	0	None
50983	50984	.	0	None

50985	50986	A	0	None
50986	50987	similar	0	None
50987	50988	discrepancy	0	None
50988	50989	in	0	None
50989	50990	sensitivity	0	None
50990	50991	to	0	None
50991	50992	competitors	0	None
50992	50993	between	0	None
50993	50994	3H	0	None
50994	50995	-	0	None
50995	50996	NMPB	3	CHEMICAL
50996	50997	and	0	None
50997	50998	3H	0	None
50998	50999	-	0	None
50999	51000	QNB	0	None
51000	51001	was	0	None
51001	51002	also	0	None
51002	51003	observed	0	None
51003	51004	when	0	None
51004	51005	biperiden	0	None
51005	51006	was	0	None
51006	51007	used	0	None
51007	51008	as	0	None
51008	51009	a	0	None
51009	51010	competitor	0	None
51010	51011	,	0	None
51011	51012	indicating	0	None
51012	51013	that	0	None
51013	51014	binding	0	None
51014	51015	to	0	None
51015	51016	different	0	None
51016	51017	subtypes	0	None
51017	51018	of	0	None
51018	51019	the	0	None
51019	51021	mAch receptor	2	GENE-N
51021	51022	could	0	None
51022	51023	not	0	None
51023	51024	account	0	None
51024	51025	for	0	None
51025	51026	the	0	None
51026	51027	observed	0	None
51027	51028	differences	0	None
51028	51029	in	0	None
51029	51030	sensitivity	0	None
51030	51031	to	0	None
51031	51032	competition	0	None
51032	51033	.	0	None

51034	51035	An	0	None
51035	51036	in	0	None
51036	51037	vivo	0	None
51037	51038	saturation	0	None
51038	51039	study	0	None
51039	51040	suggested	0	None
51040	51041	that	0	None
51041	51042	the	0	None
51042	51043	apparent	0	None
51043	51044	association	0	None
51044	51045	rate	0	None
51045	51046	constant	0	None
51046	51047	(	0	None
51047	51048	k	0	None
51048	51049	on	0	None
51049	51050	)	0	None
51050	51051	of	0	None
51051	51052	3H	0	None
51052	51053	-	0	None
51053	51054	QNB	0	None
51054	51055	binding	0	None
51055	51056	might	0	None
51056	51057	be	0	None
51057	51058	changed	0	None
51058	51059	by	0	None
51059	51060	ligand	0	None
51060	51061	concentration	0	None
51061	51062	.	0	None

51063	51064	The	0	None
51064	51065	heterogeneity	0	None
51065	51066	of	0	None
51066	51067	the	0	None
51067	51068	free	0	None
51068	51069	ligand	0	None
51069	51070	concentration	0	None
51070	51071	in	0	None
51071	51072	intact	0	None
51072	51073	brain	0	None
51073	51074	was	0	None
51074	51075	assessed	0	None
51075	51076	in	0	None
51076	51077	relation	0	None
51077	51078	to	0	None
51078	51079	the	0	None
51079	51080	ligand	0	None
51080	51081	concentration	0	None
51081	51082	dependency	0	None
51082	51083	of	0	None
51083	51084	the	0	None
51084	51085	apparent	0	None
51085	51086	association	0	None
51086	51087	rate	0	None
51087	51088	constant	0	None
51088	51089	(	0	None
51089	51090	k	0	None
51090	51091	on	0	None
51091	51092	)	0	None
51092	51093	of	0	None
51093	51094	3H	0	None
51094	51095	-	0	None
51095	51096	QNB	0	None
51096	51097	binding	0	None
51097	51098	.	0	None

51099	51100	This	0	None
51100	51101	finding	0	None
51101	51102	,	0	None
51102	51103	together	0	None
51103	51104	with	0	None
51104	51105	the	0	None
51105	51106	more	0	None
51106	51107	favorable	0	None
51107	51108	accumulation	0	None
51108	51109	of	0	None
51109	51110	3H	0	None
51110	51111	-	0	None
51111	51112	NMPB	3	CHEMICAL
51112	51113	in	0	None
51113	51114	cerebral	0	None
51114	51115	cortex	0	None
51115	51116	,	0	None
51116	51117	hippocampus	0	None
51117	51118	,	0	None
51118	51119	and	0	None
51119	51120	striatum	0	None
51120	51121	,	0	None
51121	51122	leads	0	None
51122	51123	us	0	None
51123	51124	to	0	None
51124	51125	conclude	0	None
51125	51126	that	0	None
51126	51127	3H	0	None
51127	51128	-	0	None
51128	51129	NMPB	3	CHEMICAL
51129	51130	,	0	None
51130	51131	or	0	None
51131	51132	its	0	None
51132	51133	positron	0	None
51133	51134	emitting	0	None
51134	51135	counterpart	0	None
51135	51136	,	0	None
51136	51137	should	0	None
51137	51138	be	0	None
51138	51139	the	0	None
51139	51140	more	0	None
51140	51141	favorable	0	None
51141	51142	radiotracer	0	None
51142	51143	for	0	None
51143	51144	the	0	None
51144	51145	estimation	0	None
51145	51146	of	0	None
51146	51148	mAch receptor	2	GENE-N
51148	51149	occupancy	0	None
51149	51150	by	0	None
51150	51151	cholinergic	0	None
51151	51152	drugs	0	None
51152	51153	in	0	None
51153	51154	the	0	None
51154	51155	brain	0	None
51155	51156	.	0	None

51157	51158	KEYWORDS	0	None
51158	51159	:	0	None
51159	51161	mAch receptor	2	GENE-N
51161	51162	,	0	None
51162	51163	QNB	0	None
51163	51164	,	0	None
51164	51165	NMPB	3	CHEMICAL
51165	51166	,	0	None
51166	51167	in	0	None
51167	51168	vivo	0	None
51168	51169	,	0	None
51169	51170	mouse	0	None
51170	51171	.	0	None

51172	51173	Modulation	0	None
51173	51174	of	0	None
51174	51175	KCNQ2	0	None
51175	51176	/	0	None
51176	51177	3	0	None
51177	51179	potassium channels	2	GENE-N
51179	51180	by	0	None
51180	51181	the	0	None
51181	51182	novel	0	None
51182	51183	anticonvulsant	0	None
51183	51184	retigabine	3	CHEMICAL
51184	51185	.	0	None

51186	51187	Retigabine	0	None
51187	51188	is	0	None
51188	51189	a	0	None
51189	51190	novel	0	None
51190	51191	anticonvulsant	0	None
51191	51192	with	0	None
51192	51193	an	0	None
51193	51194	unknown	0	None
51194	51195	mechanism	0	None
51195	51196	of	0	None
51196	51197	action	0	None
51197	51198	.	0	None

51199	51200	It	0	None
51200	51201	has	0	None
51201	51202	recently	0	None
51202	51203	been	0	None
51203	51204	reported	0	None
51204	51205	that	0	None
51205	51206	retigabine	3	CHEMICAL
51206	51207	modulates	0	None
51207	51208	a	0	None
51208	51210	potassium channel	2	GENE-N
51210	51211	current	0	None
51211	51212	in	0	None
51212	51215	nerve growth factor	1	GENE-Y
51215	51216	-	0	None
51216	51217	differentiated	0	None
51217	51218	PC12	0	None
51218	51219	cells	0	None
51219	51220	(	0	None
51220	51221	)	0	None
51221	51222	,	0	None
51222	51223	however	0	None
51223	51224	,	0	None
51224	51225	to	0	None
51225	51226	date	0	None
51226	51227	the	0	None
51227	51228	molecular	0	None
51228	51229	correlate	0	None
51229	51230	of	0	None
51230	51231	this	0	None
51231	51232	current	0	None
51232	51233	has	0	None
51233	51234	not	0	None
51234	51235	been	0	None
51235	51236	identified	0	None
51236	51237	.	0	None

51238	51239	In	0	None
51239	51240	the	0	None
51240	51241	present	0	None
51241	51242	study	0	None
51242	51243	we	0	None
51243	51244	have	0	None
51244	51245	examined	0	None
51245	51246	the	0	None
51246	51247	effects	0	None
51247	51248	of	0	None
51248	51249	retigabine	3	CHEMICAL
51249	51250	on	0	None
51250	51253	recombinant human KCNQ2	1	GENE-Y
51253	51254	and	0	None
51254	51255	KCNQ3	0	None
51255	51257	potassium channels	2	GENE-N
51257	51258	,	0	None
51258	51259	expressed	0	None
51259	51260	either	0	None
51260	51261	alone	0	None
51261	51262	or	0	None
51262	51263	in	0	None
51263	51264	combination	0	None
51264	51265	in	0	None
51265	51266	Xenopus	0	None
51266	51267	oocytes	0	None
51267	51268	.	0	None

51269	51270	Application	0	None
51270	51271	of	0	None
51271	51272	10	0	None
51272	51273	microM	0	None
51273	51274	retigabine	3	CHEMICAL
51274	51275	to	0	None
51275	51276	oocytes	0	None
51276	51277	expressing	0	None
51277	51278	the	0	None
51278	51279	KCNQ2	0	None
51279	51280	/	0	None
51280	51281	3	0	None
51281	51282	heteromeric	0	None
51282	51283	channel	0	None
51283	51284	shifted	0	None
51284	51285	both	0	None
51285	51286	the	0	None
51286	51287	activation	0	None
51287	51288	threshold	0	None
51288	51289	and	0	None
51289	51290	voltage	0	None
51290	51291	for	0	None
51291	51292	half	0	None
51292	51293	-	0	None
51293	51294	activation	0	None
51294	51295	by	0	None
51295	51296	approximately	0	None
51296	51297	20	0	None
51297	51298	mV	0	None
51298	51299	in	0	None
51299	51300	the	0	None
51300	51301	hyperpolarizing	0	None
51301	51302	direction	0	None
51302	51303	,	0	None
51303	51304	leading	0	None
51304	51305	to	0	None
51305	51306	an	0	None
51306	51307	increase	0	None
51307	51308	in	0	None
51308	51309	current	0	None
51309	51310	amplitude	0	None
51310	51311	at	0	None
51311	51312	test	3	CHEMICAL
51312	51313	potentials	0	None
51313	51314	between	0	None
51314	51315	-	0	None
51315	51316	80	0	None
51316	51317	mV	0	None
51317	51318	and	0	None
51318	51319	+	0	None
51319	51320	20	0	None
51320	51321	mV	0	None
51321	51322	.	0	None

51323	51324	Retigabine	0	None
51324	51325	also	0	None
51325	51326	had	0	None
51326	51327	a	0	None
51327	51328	marked	0	None
51328	51329	effect	0	None
51329	51330	on	0	None
51330	51331	KCNQ	2	GENE-N
51331	51332	current	0	None
51332	51333	kinetics	0	None
51333	51334	,	0	None
51334	51335	increasing	0	None
51335	51336	the	0	None
51336	51337	rate	0	None
51337	51338	of	0	None
51338	51339	channel	0	None
51339	51340	activation	0	None
51340	51341	but	0	None
51341	51342	slowing	0	None
51342	51343	deactivation	0	None
51343	51344	at	0	None
51344	51345	a	0	None
51345	51346	given	0	None
51346	51347	test	3	CHEMICAL
51347	51348	potential	0	None
51348	51349	.	0	None

51350	51351	Similar	0	None
51351	51352	effects	0	None
51352	51353	of	0	None
51353	51354	retigabine	3	CHEMICAL
51354	51355	were	0	None
51355	51356	observed	0	None
51356	51357	in	0	None
51357	51358	oocytes	0	None
51358	51359	expressing	0	None
51359	51360	KCNQ2	0	None
51360	51361	alone	0	None
51361	51362	,	0	None
51362	51363	suggesting	0	None
51363	51364	that	0	None
51364	51365	KCNQ2	0	None
51365	51366	may	0	None
51366	51367	be	0	None
51367	51368	the	0	None
51368	51369	molecular	0	None
51369	51370	target	0	None
51370	51371	of	0	None
51371	51372	retigabine	3	CHEMICAL
51372	51373	.	0	None

51374	51375	Membrane	0	None
51375	51376	potential	0	None
51376	51377	recordings	0	None
51377	51378	in	0	None
51378	51379	oocytes	0	None
51379	51380	expressing	0	None
51380	51381	the	0	None
51381	51382	KCNQ2	0	None
51382	51383	/	0	None
51383	51384	3	0	None
51384	51385	heteromeric	0	None
51385	51386	channel	0	None
51386	51387	showed	0	None
51387	51388	that	0	None
51388	51389	application	0	None
51389	51390	of	0	None
51390	51391	retigabine	3	CHEMICAL
51391	51392	leads	0	None
51392	51393	to	0	None
51393	51394	a	0	None
51394	51395	concentration	0	None
51395	51396	-	0	None
51396	51397	dependent	0	None
51397	51398	hyperpolarization	0	None
51398	51399	of	0	None
51399	51400	the	0	None
51400	51401	oocyte	0	None
51401	51402	,	0	None
51402	51403	from	0	None
51403	51404	a	0	None
51404	51405	resting	0	None
51405	51406	potential	0	None
51406	51407	of	0	None
51407	51408	-	0	None
51408	51409	63	0	None
51409	51410	mV	0	None
51410	51411	under	0	None
51411	51412	control	0	None
51412	51413	conditions	0	None
51413	51414	to	0	None
51414	51415	-	0	None
51415	51416	85	0	None
51416	51417	mV	0	None
51417	51418	in	0	None
51418	51419	the	0	None
51419	51420	presence	0	None
51420	51421	of	0	None
51421	51422	100	0	None
51422	51423	microM	0	None
51423	51424	retigabine	3	CHEMICAL
51424	51425	(	0	None
51425	51426	IC	0	None
51426	51427	(	0	None
51427	51428	50	0	None
51428	51429	)	0	None
51429	51430	=	0	None
51430	51431	5	0	None
51431	51432	.	0	None
51432	51433	2	0	None
51433	51434	microM	0	None
51434	51435	)	0	None
51435	51436	.	0	None

51437	51438	In	0	None
51438	51439	control	0	None
51439	51440	experiments	0	None
51440	51441	retigabine	3	CHEMICAL
51441	51442	had	0	None
51442	51443	no	0	None
51443	51444	effect	0	None
51444	51445	on	0	None
51445	51446	either	0	None
51446	51447	resting	0	None
51447	51448	membrane	0	None
51448	51449	potential	0	None
51449	51450	or	0	None
51450	51451	endogenous	0	None
51451	51452	oocyte	0	None
51452	51453	membrane	0	None
51453	51454	currents	0	None
51454	51455	.	0	None

51456	51457	In	0	None
51457	51458	conclusion	0	None
51458	51459	,	0	None
51459	51460	we	0	None
51460	51461	have	0	None
51461	51462	shown	0	None
51462	51463	that	0	None
51463	51464	retigabine	3	CHEMICAL
51464	51465	acts	0	None
51465	51466	as	0	None
51466	51467	a	0	None
51467	51468	KCNQ	2	GENE-N
51468	51470	potassium channel	2	GENE-N
51470	51471	opener	0	None
51471	51472	.	0	None

51473	51474	Because	0	None
51474	51475	the	0	None
51475	51476	heteromeric	0	None
51476	51477	KCNQ2	0	None
51477	51478	/	0	None
51478	51479	3	0	None
51479	51480	channel	0	None
51480	51481	has	0	None
51481	51482	recently	0	None
51482	51483	been	0	None
51483	51484	reported	0	None
51484	51485	to	0	None
51485	51486	underlie	0	None
51486	51487	the	0	None
51487	51488	M	0	None
51488	51489	-	0	None
51489	51490	current	0	None
51490	51491	,	0	None
51491	51492	it	0	None
51492	51493	is	0	None
51493	51494	likely	0	None
51494	51495	that	0	None
51495	51496	M	0	None
51496	51497	-	0	None
51497	51498	current	0	None
51498	51499	modulation	0	None
51499	51500	can	0	None
51500	51501	explain	0	None
51501	51502	the	0	None
51502	51503	anticonvulsant	0	None
51503	51504	actions	0	None
51504	51505	of	0	None
51505	51506	retigabine	3	CHEMICAL
51506	51507	in	0	None
51507	51508	animal	0	None
51508	51509	models	0	None
51509	51510	of	0	None
51510	51511	epilepsy	0	None
51511	51512	.	0	None

51513	51514	Impaired	0	None
51514	51515	expression	0	None
51515	51516	of	0	None
51516	51517	the	0	None
51517	51518	uncoupling	0	None
51518	51519	protein	0	None
51519	51520	-	0	None
51520	51521	3	0	None
51521	51522	gene	0	None
51522	51523	in	0	None
51523	51524	skeletal	0	None
51524	51525	muscle	0	None
51525	51526	during	0	None
51526	51527	lactation	0	None
51527	51528	:	0	None
51528	51529	fibrates	3	CHEMICAL
51529	51530	and	0	None
51530	51531	troglitazone	3	CHEMICAL
51531	51532	reverse	0	None
51532	51533	lactation	0	None
51533	51534	-	0	None
51534	51535	induced	0	None
51535	51536	downregulation	0	None
51536	51537	of	0	None
51537	51538	the	0	None
51538	51539	uncoupling	0	None
51539	51540	protein	0	None
51540	51541	-	0	None
51541	51542	3	0	None
51542	51543	gene	0	None
51543	51544	.	0	None

51545	51546	The	0	None
51546	51547	expression	0	None
51547	51548	of	0	None
51548	51549	uncoupling	0	None
51549	51550	protein	0	None
51550	51551	(	0	None
51551	51552	UCP	0	None
51552	51553	)	0	None
51553	51554	-	0	None
51554	51555	3	0	None
51555	51556	mRNA	0	None
51556	51557	in	0	None
51557	51558	skeletal	0	None
51558	51559	muscle	0	None
51559	51560	is	0	None
51560	51561	dramatically	0	None
51561	51562	reduced	0	None
51562	51563	during	0	None
51563	51564	lactation	0	None
51564	51565	in	0	None
51565	51566	mice	0	None
51566	51567	.	0	None

51568	51569	The	0	None
51569	51570	reduction	0	None
51570	51571	in	0	None
51571	51572	UCP	0	None
51572	51573	-	0	None
51573	51574	3	0	None
51574	51575	mRNA	0	None
51575	51576	levels	0	None
51576	51577	lowers	0	None
51577	51578	the	0	None
51578	51579	amount	0	None
51579	51580	of	0	None
51580	51581	the	0	None
51581	51582	UCP	0	None
51582	51583	-	0	None
51583	51584	3	0	None
51584	51585	protein	0	None
51585	51586	in	0	None
51586	51587	skeletal	0	None
51587	51588	muscle	0	None
51588	51589	mitochondria	0	None
51589	51590	during	0	None
51590	51591	lactation	0	None
51591	51592	.	0	None

51593	51594	Spontaneous	0	None
51594	51595	or	0	None
51595	51596	abrupt	0	None
51596	51597	weaning	0	None
51597	51598	reverses	0	None
51598	51599	the	0	None
51599	51600	downregulation	0	None
51600	51601	of	0	None
51601	51602	the	0	None
51602	51603	UCP	0	None
51603	51604	-	0	None
51604	51605	3	0	None
51605	51606	mRNA	0	None
51606	51607	but	0	None
51607	51608	not	0	None
51608	51609	the	0	None
51609	51610	reduction	0	None
51610	51611	in	0	None
51611	51612	UCP	0	None
51612	51613	-	0	None
51613	51614	3	0	None
51614	51615	protein	0	None
51615	51616	levels	0	None
51616	51617	.	0	None

51618	51619	In	0	None
51619	51620	lactating	0	None
51620	51621	and	0	None
51621	51622	virgin	0	None
51622	51623	mice	0	None
51623	51624	,	0	None
51624	51625	however	0	None
51625	51626	,	0	None
51626	51627	fasting	0	None
51627	51628	increases	0	None
51628	51629	UCP	0	None
51629	51630	-	0	None
51630	51631	3	0	None
51631	51632	mRNA	0	None
51632	51633	levels	0	None
51633	51634	.	0	None

51635	51636	Changes	0	None
51636	51637	in	0	None
51637	51638	UCP	0	None
51638	51639	-	0	None
51639	51640	3	0	None
51640	51641	mRNA	0	None
51641	51642	occur	0	None
51642	51643	in	0	None
51643	51644	parallel	0	None
51644	51645	with	0	None
51645	51646	modifications	0	None
51646	51647	in	0	None
51647	51648	the	0	None
51648	51649	levels	0	None
51649	51650	of	0	None
51650	51653	free fatty acids	3	CHEMICAL
51653	51654	,	0	None
51654	51655	which	0	None
51655	51656	are	0	None
51656	51657	reduced	0	None
51657	51658	in	0	None
51658	51659	lactation	0	None
51659	51660	and	0	None
51660	51661	are	0	None
51661	51662	upregulated	0	None
51662	51663	due	0	None
51663	51664	to	0	None
51664	51665	weaning	0	None
51665	51666	or	0	None
51666	51667	fasting	0	None
51667	51668	.	0	None

51669	51670	Modifications	0	None
51670	51671	in	0	None
51671	51672	the	0	None
51672	51673	energy	0	None
51673	51674	nutritional	0	None
51674	51675	stress	0	None
51675	51676	of	0	None
51676	51677	lactating	0	None
51677	51678	dams	0	None
51678	51679	achieved	0	None
51679	51680	by	0	None
51680	51681	manipulating	0	None
51681	51682	litter	0	None
51682	51683	sizes	0	None
51683	51684	do	0	None
51684	51685	not	0	None
51685	51686	influence	0	None
51686	51687	UCP	0	None
51687	51688	-	0	None
51688	51689	3	0	None
51689	51690	mRNA	0	None
51690	51691	levels	0	None
51691	51692	in	0	None
51692	51693	skeletal	0	None
51693	51694	muscle	0	None
51694	51695	.	0	None

51696	51697	Conversely	0	None
51697	51698	,	0	None
51698	51699	when	0	None
51699	51700	mice	0	None
51700	51701	are	0	None
51701	51702	fed	0	None
51702	51703	a	0	None
51703	51704	high	0	None
51704	51705	-	0	None
51705	51706	fat	0	None
51706	51707	diet	0	None
51707	51708	after	0	None
51708	51709	parturition	0	None
51709	51710	,	0	None
51710	51711	the	0	None
51711	51712	downregulation	0	None
51712	51713	of	0	None
51713	51714	UCP	0	None
51714	51715	-	0	None
51715	51716	3	0	None
51716	51717	mRNA	0	None
51717	51718	and	0	None
51718	51719	UCP	0	None
51719	51720	-	0	None
51720	51721	3	0	None
51721	51722	protein	0	None
51722	51723	levels	0	None
51723	51724	due	0	None
51724	51725	to	0	None
51725	51726	lactation	0	None
51726	51727	is	0	None
51727	51728	partially	0	None
51728	51729	reversed	0	None
51729	51730	,	0	None
51730	51731	as	0	None
51731	51732	is	0	None
51732	51733	the	0	None
51733	51734	reduction	0	None
51734	51735	in	0	None
51735	51736	serum	0	None
51736	51739	free fatty acid	3	CHEMICAL
51739	51740	levels	0	None
51740	51741	.	0	None

51742	51743	Treatment	0	None
51743	51744	of	0	None
51744	51745	lactating	0	None
51745	51746	mice	0	None
51746	51747	with	0	None
51747	51748	a	0	None
51748	51749	single	0	None
51749	51750	injection	0	None
51750	51751	of	0	None
51751	51752	bezafibrate	0	None
51752	51753	,	0	None
51753	51754	an	0	None
51754	51755	activator	0	None
51755	51756	of	0	None
51756	51757	the	0	None
51757	51758	peroxisome	0	None
51758	51759	proliferator	0	None
51759	51760	-	0	None
51760	51761	activated	0	None
51761	51762	receptor	0	None
51762	51763	(	0	None
51763	51764	PPAR	1	GENE-Y
51764	51765	)	0	None
51765	51766	,	0	None
51766	51767	raises	0	None
51767	51768	UCP	0	None
51768	51769	-	0	None
51769	51770	3	0	None
51770	51771	mRNA	0	None
51771	51772	in	0	None
51772	51773	skeletal	0	None
51773	51774	muscle	0	None
51774	51775	to	0	None
51775	51776	levels	0	None
51776	51777	similar	0	None
51777	51778	to	0	None
51778	51779	those	0	None
51779	51780	in	0	None
51780	51781	virgin	0	None
51781	51782	mice	0	None
51782	51783	.	0	None

51784	51785	4	0	None
51785	51786	-	0	None
51786	51787	chloro	3	CHEMICAL
51787	51788	-	0	None
51788	51789	6	0	None
51789	51790	-	0	None
51790	51791	[	0	None
51791	51792	(	0	None
51792	51793	2	0	None
51793	51794	,	0	None
51794	51795	3	0	None
51795	51796	-	0	None
51796	51797	xylidine	0	None
51797	51798	)	0	None
51798	51799	-	0	None
51799	51800	pirimidinylthio	0	None
51800	51801	]	0	None
51801	51803	acetic acid	3	CHEMICAL
51803	51804	(	0	None
51804	51805	WY	0	None
51805	51806	-	0	None
51806	51807	14	0	None
51807	51808	,	0	None
51808	51809	643	0	None
51809	51810	)	0	None
51810	51811	,	0	None
51811	51812	a	0	None
51812	51813	specific	0	None
51813	51814	ligand	0	None
51814	51815	of	0	None
51815	51816	the	0	None
51816	51817	PPAR	1	GENE-Y
51817	51818	-	0	None
51818	51819	alpha	0	None
51819	51820	subtype	0	None
51820	51821	,	0	None
51821	51822	causes	0	None
51822	51823	the	0	None
51823	51824	most	0	None
51824	51825	dramatic	0	None
51825	51826	increase	0	None
51826	51827	in	0	None
51827	51828	UCP	0	None
51828	51829	-	0	None
51829	51830	3	0	None
51830	51831	mRNA	0	None
51831	51832	,	0	None
51832	51833	whereas	0	None
51833	51834	troglitazone	3	CHEMICAL
51834	51835	,	0	None
51835	51836	a	0	None
51836	51837	specific	0	None
51837	51838	activator	0	None
51838	51839	of	0	None
51839	51840	PPAR	1	GENE-Y
51840	51841	-	0	None
51841	51842	gamma	0	None
51842	51843	,	0	None
51843	51844	also	0	None
51844	51845	significantly	0	None
51845	51846	increases	0	None
51846	51847	UCP	0	None
51847	51848	-	0	None
51848	51849	3	0	None
51849	51850	mRNA	0	None
51850	51851	abundance	0	None
51851	51852	in	0	None
51852	51853	skeletal	0	None
51853	51854	muscle	0	None
51854	51855	of	0	None
51855	51856	lactating	0	None
51856	51857	mice	0	None
51857	51858	.	0	None

51859	51860	However	0	None
51860	51861	,	0	None
51861	51862	in	0	None
51862	51863	virgin	0	None
51863	51864	mice	0	None
51864	51865	,	0	None
51865	51866	bezafibrate	0	None
51866	51867	and	0	None
51867	51868	WY	0	None
51868	51869	-	0	None
51869	51870	14	0	None
51870	51871	,	0	None
51871	51872	643	0	None
51872	51873	do	0	None
51873	51874	not	0	None
51874	51875	significantly	0	None
51875	51876	affect	0	None
51876	51877	UCP	0	None
51877	51878	-	0	None
51878	51879	3	0	None
51879	51880	mRNA	0	None
51880	51881	expression	0	None
51881	51882	,	0	None
51882	51883	whereas	0	None
51883	51884	troglitazone	3	CHEMICAL
51884	51885	is	0	None
51885	51886	at	0	None
51886	51887	least	0	None
51887	51888	as	0	None
51888	51889	effective	0	None
51889	51890	as	0	None
51890	51891	it	0	None
51891	51892	is	0	None
51892	51893	in	0	None
51893	51894	lactating	0	None
51894	51895	dams	0	None
51895	51896	.	0	None

51897	51898	It	0	None
51898	51899	is	0	None
51899	51900	proposed	0	None
51900	51901	that	0	None
51901	51902	the	0	None
51902	51903	UCP	0	None
51903	51904	-	0	None
51904	51905	3	0	None
51905	51906	gene	0	None
51906	51907	is	0	None
51907	51908	regulated	0	None
51908	51909	in	0	None
51909	51910	skeletal	0	None
51910	51911	muscle	0	None
51911	51912	during	0	None
51912	51913	lactation	0	None
51913	51914	in	0	None
51914	51915	response	0	None
51915	51916	to	0	None
51916	51917	changes	0	None
51917	51918	in	0	None
51918	51919	circulating	0	None
51919	51922	free fatty acids	3	CHEMICAL
51922	51923	by	0	None
51923	51924	mechanisms	0	None
51924	51925	involving	0	None
51925	51926	activation	0	None
51926	51927	of	0	None
51927	51928	PPARs	0	None
51928	51929	.	0	None

51930	51931	The	0	None
51931	51932	impaired	0	None
51932	51933	expression	0	None
51933	51934	of	0	None
51934	51935	the	0	None
51935	51936	UCP	0	None
51936	51937	-	0	None
51937	51938	3	0	None
51938	51939	gene	0	None
51939	51940	is	0	None
51940	51941	consistent	0	None
51941	51942	with	0	None
51942	51943	the	0	None
51943	51944	involvement	0	None
51944	51945	of	0	None
51945	51946	UCP	0	None
51946	51947	-	0	None
51947	51948	3	0	None
51948	51949	gene	0	None
51949	51950	regulation	0	None
51950	51951	in	0	None
51951	51952	the	0	None
51952	51953	reduction	0	None
51953	51954	of	0	None
51954	51955	the	0	None
51955	51956	use	0	None
51956	51957	of	0	None
51957	51959	fatty acids	3	CHEMICAL
51959	51960	as	0	None
51960	51961	fuel	0	None
51961	51962	by	0	None
51962	51963	the	0	None
51963	51964	skeletal	0	None
51964	51965	muscle	0	None
51965	51966	and	0	None
51966	51967	in	0	None
51967	51968	impaired	0	None
51968	51969	adaptative	0	None
51969	51970	thermogenesis	0	None
51970	51971	,	0	None
51971	51972	both	0	None
51972	51973	of	0	None
51973	51974	which	0	None
51974	51975	are	0	None
51975	51976	major	0	None
51976	51977	metabolic	0	None
51977	51978	adaptations	0	None
51978	51979	that	0	None
51979	51980	occur	0	None
51980	51981	during	0	None
51981	51982	lactation	0	None
51982	51983	.	0	None

51984	51985	Hypertrophic	0	None
51985	51986	effect	0	None
51986	51987	of	0	None
51987	51988	selective	0	None
51988	51989	beta	0	None
51989	51990	(	0	None
51990	51991	1	0	None
51991	51992	)	0	None
51992	51993	-	0	None
51993	51994	adrenoceptor	0	None
51994	51995	stimulation	0	None
51995	51996	on	0	None
51996	51997	ventricular	0	None
51997	51998	cardiomyocytes	0	None
51998	51999	from	0	None
51999	52000	adult	0	None
52000	52001	rat	0	None
52001	52002	.	0	None

52003	52004	We	0	None
52004	52005	investigated	0	None
52005	52006	whether	0	None
52006	52007	selective	0	None
52007	52008	beta	0	None
52008	52009	(	0	None
52009	52010	1	0	None
52010	52011	)	0	None
52011	52012	-	0	None
52012	52013	adrenoceptor	0	None
52013	52014	stimulation	0	None
52014	52015	causes	0	None
52015	52016	hypertrophic	0	None
52016	52017	growth	0	None
52017	52018	on	0	None
52018	52019	isolated	0	None
52019	52020	ventricular	0	None
52020	52021	cardiomyocytes	0	None
52021	52022	from	0	None
52022	52023	adult	0	None
52023	52024	rat	0	None
52024	52025	.	0	None

52026	52027	As	0	None
52027	52028	parameters	0	None
52028	52029	for	0	None
52029	52030	the	0	None
52030	52031	induction	0	None
52031	52032	of	0	None
52032	52033	hypertrophic	0	None
52033	52034	growth	0	None
52034	52035	,	0	None
52035	52036	the	0	None
52036	52037	increases	0	None
52037	52038	of	0	None
52038	52039	[	0	None
52039	52040	(	0	None
52040	52041	14	0	None
52041	52042	)	0	None
52042	52043	C	0	None
52043	52044	]	0	None
52044	52045	phenylalanine	3	CHEMICAL
52045	52046	incorporation	0	None
52046	52047	,	0	None
52047	52048	protein	0	None
52048	52049	and	0	None
52049	52050	RNA	0	None
52050	52051	mass	0	None
52051	52052	,	0	None
52052	52053	and	0	None
52053	52054	cell	0	None
52054	52055	size	0	None
52055	52056	were	0	None
52056	52057	determined	0	None
52057	52058	.	0	None

52059	52060	Isoproterenol	0	None
52060	52061	(	0	None
52061	52062	Iso	0	None
52062	52063	,	0	None
52063	52064	10	0	None
52064	52065	microM	0	None
52065	52066	)	0	None
52066	52067	alone	0	None
52067	52068	had	0	None
52068	52069	no	0	None
52069	52070	growth	0	None
52070	52071	effect	0	None
52071	52072	.	0	None

52073	52074	In	0	None
52074	52075	the	0	None
52075	52076	presence	0	None
52076	52077	of	0	None
52077	52078	the	0	None
52078	52079	beta	0	None
52079	52080	(	0	None
52080	52081	2	0	None
52081	52082	)	0	None
52082	52083	-	0	None
52083	52084	adrenoceptor	0	None
52084	52085	antagonist	0	None
52085	52086	ICI	3	CHEMICAL
52086	52087	-	0	None
52087	52088	118551	0	None
52088	52089	(	0	None
52089	52090	ICI	3	CHEMICAL
52090	52091	,	0	None
52091	52092	10	0	None
52092	52093	microM	0	None
52093	52094	)	0	None
52094	52095	,	0	None
52095	52096	Iso	0	None
52096	52097	caused	0	None
52097	52098	an	0	None
52098	52099	increase	0	None
52099	52100	in	0	None
52100	52101	[	0	None
52101	52102	(	0	None
52102	52103	14	0	None
52103	52104	)	0	None
52104	52105	C	0	None
52105	52106	]	0	None
52106	52107	phenylalanine	3	CHEMICAL
52107	52108	incorporation	0	None
52108	52109	,	0	None
52109	52110	protein	0	None
52110	52111	and	0	None
52111	52112	RNA	0	None
52112	52113	mass	0	None
52113	52114	,	0	None
52114	52115	cell	0	None
52115	52116	volume	0	None
52116	52117	,	0	None
52117	52118	and	0	None
52118	52119	cross	0	None
52119	52120	-	0	None
52120	52121	sectional	0	None
52121	52122	area	0	None
52122	52123	.	0	None

52124	52125	We	0	None
52125	52126	showed	0	None
52126	52127	for	0	None
52127	52128	phenylalanine	3	CHEMICAL
52128	52129	incorporation	0	None
52129	52130	that	0	None
52130	52131	the	0	None
52131	52132	growth	0	None
52132	52133	effect	0	None
52133	52134	of	0	None
52134	52135	Iso	0	None
52135	52136	+	0	None
52136	52137	ICI	3	CHEMICAL
52137	52138	could	0	None
52138	52139	be	0	None
52139	52140	antagonized	0	None
52140	52141	by	0	None
52141	52142	beta	0	None
52142	52143	(	0	None
52143	52144	1	0	None
52144	52145	)	0	None
52145	52146	-	0	None
52146	52147	adrenoceptor	0	None
52147	52148	blockade	0	None
52148	52149	with	0	None
52149	52150	atenolol	3	CHEMICAL
52150	52151	(	0	None
52151	52152	10	0	None
52152	52153	microM	0	None
52153	52154	)	0	None
52154	52155	or	0	None
52155	52156	metoprolol	3	CHEMICAL
52156	52157	(	0	None
52157	52158	10	0	None
52158	52159	microM	0	None
52159	52160	)	0	None
52160	52161	,	0	None
52161	52162	indicating	0	None
52162	52163	that	0	None
52163	52164	it	0	None
52164	52165	was	0	None
52165	52166	caused	0	None
52166	52167	by	0	None
52167	52168	selective	0	None
52168	52169	beta	0	None
52169	52170	(	0	None
52170	52171	1	0	None
52171	52172	)	0	None
52172	52173	-	0	None
52173	52174	adrenoceptor	0	None
52174	52175	stimulation	0	None
52175	52176	.	0	None

52177	52178	The	0	None
52178	52179	growth	0	None
52179	52180	response	0	None
52180	52181	to	0	None
52181	52182	Iso	0	None
52182	52183	+	0	None
52183	52184	ICI	3	CHEMICAL
52184	52185	was	0	None
52185	52186	accompanied	0	None
52186	52187	by	0	None
52187	52188	an	0	None
52188	52189	increase	0	None
52189	52190	in	0	None
52190	52192	ornithine decarboxylase	1	GENE-Y
52192	52193	(	0	None
52193	52194	ODC	0	None
52194	52195	)	0	None
52195	52196	activity	0	None
52196	52197	and	0	None
52197	52198	expression	0	None
52198	52199	.	0	None

52200	52201	Inhibition	0	None
52201	52202	of	0	None
52202	52203	ODC	0	None
52203	52204	by	0	None
52204	52205	the	0	None
52205	52206	ODC	0	None
52206	52207	antagonist	0	None
52207	52208	difluoromethylornithine	3	CHEMICAL
52208	52209	(	0	None
52209	52210	1	0	None
52210	52211	mM	0	None
52211	52212	)	0	None
52212	52213	attenuated	0	None
52213	52214	this	0	None
52214	52215	hypertrophic	0	None
52215	52216	response	0	None
52216	52217	,	0	None
52217	52218	indicating	0	None
52218	52219	that	0	None
52219	52220	ODC	0	None
52220	52221	induction	0	None
52221	52222	is	0	None
52222	52223	causally	0	None
52223	52224	involved	0	None
52224	52225	.	0	None

52226	52227	The	0	None
52227	52228	growth	0	None
52228	52229	response	0	None
52229	52230	to	0	None
52230	52231	Iso	0	None
52231	52232	+	0	None
52232	52233	ICI	3	CHEMICAL
52233	52234	was	0	None
52234	52235	found	0	None
52235	52236	to	0	None
52236	52237	be	0	None
52237	52238	cAMP	0	None
52238	52239	independent	0	None
52239	52240	but	0	None
52240	52241	was	0	None
52241	52242	sensitive	0	None
52242	52243	to	0	None
52243	52244	genistein	3	CHEMICAL
52244	52245	(	0	None
52245	52246	100	0	None
52246	52247	microM	0	None
52247	52248	)	0	None
52248	52249	or	0	None
52249	52250	rapamycin	1	GENE-Y
52250	52251	(	0	None
52251	52252	0	0	None
52252	52253	.	0	None
52253	52254	1	0	None
52254	52255	microM	0	None
52255	52256	)	0	None
52256	52257	.	0	None

52258	52259	The	0	None
52259	52260	reaction	0	None
52260	52261	was	0	None
52261	52262	enhanced	0	None
52262	52263	in	0	None
52263	52264	the	0	None
52264	52265	presence	0	None
52265	52266	of	0	None
52266	52268	pertussis toxin	2	GENE-N
52268	52269	(	0	None
52269	52270	10	0	None
52270	52271	microM	0	None
52271	52272	)	0	None
52272	52273	.	0	None

52274	52275	We	0	None
52275	52276	conclude	0	None
52276	52277	that	0	None
52277	52278	selective	0	None
52278	52279	beta	0	None
52279	52280	(	0	None
52280	52281	1	0	None
52281	52282	)	0	None
52282	52283	-	0	None
52283	52284	adrenoceptor	0	None
52284	52285	stimulation	0	None
52285	52286	causes	0	None
52286	52287	hypertrophic	0	None
52287	52288	growth	0	None
52288	52289	of	0	None
52289	52290	ventricular	0	None
52290	52291	cardiomyocytes	0	None
52291	52292	by	0	None
52292	52293	a	0	None
52293	52294	mechanism	0	None
52294	52295	that	0	None
52295	52296	is	0	None
52296	52297	independent	0	None
52297	52298	of	0	None
52298	52299	cAMP	0	None
52299	52300	but	0	None
52300	52301	dependent	0	None
52301	52302	on	0	None
52302	52303	a	0	None
52303	52305	tyrosine kinase	2	GENE-N
52305	52306	and	0	None
52306	52307	ODC	0	None
52307	52308	.	0	None

52309	52310	Hyperphenylalaninemia	0	None
52310	52311	and	0	None
52311	52312	7	0	None
52312	52313	-	0	None
52313	52314	pterin	0	None
52314	52315	excretion	0	None
52315	52316	associated	0	None
52316	52317	with	0	None
52317	52318	mutations	0	None
52318	52319	in	0	None
52319	52320	4a	0	None
52320	52321	-	0	None
52321	52322	hydroxy	3	CHEMICAL
52322	52323	-	0	None
52323	52324	tetrahydrobiopterin	3	CHEMICAL
52324	52325	dehydratase	2	GENE-N
52325	52326	/	0	None
52326	52327	DCoH	1	GENE-Y
52327	52328	:	0	None
52328	52329	analysis	0	None
52329	52330	of	0	None
52330	52331	enzyme	0	None
52331	52332	activity	0	None
52332	52333	in	0	None
52333	52334	intestinal	0	None
52334	52335	biopsies	0	None
52335	52336	.	0	None

52337	52338	Hyperphenylalaninemia	0	None
52338	52339	,	0	None
52339	52340	which	0	None
52340	52341	can	0	None
52341	52342	cause	0	None
52342	52343	neurological	0	None
52343	52344	disorders	0	None
52344	52345	and	0	None
52345	52346	mental	0	None
52346	52347	retardation	0	None
52347	52348	,	0	None
52348	52349	results	0	None
52349	52350	from	0	None
52350	52351	a	0	None
52351	52352	mutation	0	None
52352	52353	in	0	None
52353	52355	phenylalanine hydroxylase	1	GENE-Y
52355	52356	or	0	None
52356	52357	an	0	None
52357	52358	enzyme	0	None
52358	52359	required	0	None
52359	52360	for	0	None
52360	52361	biosynthesis	0	None
52361	52362	or	0	None
52362	52363	regeneration	0	None
52363	52364	of	0	None
52364	52365	its	0	None
52365	52366	cofactor	0	None
52366	52367	,	0	None
52367	52368	tetrahydrobiopterin	3	CHEMICAL
52368	52369	.	0	None

52370	52371	The	0	None
52371	52372	hyperphenylalaninemia	0	None
52372	52373	variant	0	None
52373	52374	primapterinuria	0	None
52374	52375	is	0	None
52375	52376	characterized	0	None
52376	52377	by	0	None
52377	52378	the	0	None
52378	52379	excretion	0	None
52379	52380	of	0	None
52380	52381	7	0	None
52381	52382	-	0	None
52382	52383	biopterin	0	None
52383	52384	(	0	None
52384	52385	primapterin	3	CHEMICAL
52385	52386	)	0	None
52386	52387	.	0	None

52388	52389	This	0	None
52389	52390	disorder	0	None
52390	52391	is	0	None
52391	52392	thought	0	None
52392	52393	to	0	None
52393	52394	be	0	None
52394	52395	due	0	None
52395	52396	to	0	None
52396	52397	a	0	None
52397	52398	deficiency	0	None
52398	52399	of	0	None
52399	52400	4a	0	None
52400	52401	-	0	None
52401	52402	hydroxy	3	CHEMICAL
52402	52403	-	0	None
52403	52404	tetrahydrobiopterin	3	CHEMICAL
52404	52405	dehydratase	2	GENE-N
52405	52406	(	0	None
52406	52407	pterin	0	None
52407	52408	-	0	None
52408	52409	4a	0	None
52409	52410	-	0	None
52410	52411	carbinolamine	0	None
52411	52412	dehydratase	2	GENE-N
52412	52413	)	0	None
52413	52414	,	0	None
52414	52415	but	0	None
52415	52416	a	0	None
52416	52417	lack	0	None
52417	52418	of	0	None
52418	52419	tissue	0	None
52419	52420	activity	0	None
52420	52421	has	0	None
52421	52422	not	0	None
52422	52423	been	0	None
52423	52424	directly	0	None
52424	52425	demonstrated	0	None
52425	52426	.	0	None

52427	52428	The	0	None
52428	52429	five	0	None
52429	52430	mutations	0	None
52430	52431	so	0	None
52431	52432	far	0	None
52432	52433	recognized	0	None
52433	52434	in	0	None
52434	52435	patients	0	None
52435	52436	with	0	None
52436	52437	primapterinuria	0	None
52437	52438	are	0	None
52438	52439	associated	0	None
52439	52440	with	0	None
52440	52441	either	0	None
52441	52442	a	0	None
52442	52443	single	0	None
52443	52445	amino acid	3	CHEMICAL
52445	52446	change	0	None
52446	52447	or	0	None
52447	52448	a	0	None
52448	52449	premature	0	None
52449	52450	stop	0	None
52450	52451	codon	3	CHEMICAL
52451	52452	.	0	None

52453	52454	Only	0	None
52454	52455	C81R	2	GENE-N
52455	52456	has	0	None
52456	52457	been	0	None
52457	52458	successfully	0	None
52458	52459	expressed	0	None
52459	52460	in	0	None
52460	52461	soluble	0	None
52461	52462	form	0	None
52462	52463	,	0	None
52463	52464	and	0	None
52464	52465	was	0	None
52465	52466	found	0	None
52466	52467	to	0	None
52467	52468	have	0	None
52468	52469	40	0	None
52469	52470	%	0	None
52470	52471	of	0	None
52471	52472	normal	0	None
52472	52473	activity	0	None
52473	52474	.	0	None

52475	52476	Tissues	0	None
52476	52477	which	0	None
52477	52478	could	0	None
52478	52479	be	0	None
52479	52480	obtained	0	None
52480	52481	by	0	None
52481	52482	minimally	0	None
52482	52483	invasive	0	None
52483	52484	procedures	0	None
52484	52485	were	0	None
52485	52486	analyzed	0	None
52486	52487	for	0	None
52487	52488	dehydratase	2	GENE-N
52488	52489	activity	0	None
52489	52490	.	0	None

52491	52492	None	0	None
52492	52493	was	0	None
52493	52494	detected	0	None
52494	52495	in	0	None
52495	52496	normal	0	None
52496	52497	human	0	None
52497	52498	white	0	None
52498	52499	cells	0	None
52499	52500	or	0	None
52500	52501	fibroblasts	0	None
52501	52502	.	0	None

52503	52504	However	0	None
52504	52505	,	0	None
52505	52506	activity	0	None
52506	52507	was	0	None
52507	52508	found	0	None
52508	52509	in	0	None
52509	52510	intestine	0	None
52510	52511	of	0	None
52511	52512	rat	0	None
52512	52513	,	0	None
52513	52514	dog	0	None
52514	52515	,	0	None
52515	52516	pig	0	None
52516	52517	,	0	None
52517	52518	and	0	None
52518	52519	particularly	0	None
52519	52520	humans	0	None
52520	52521	where	0	None
52521	52522	it	0	None
52522	52523	was	0	None
52523	52524	only	0	None
52524	52525	eight	0	None
52525	52526	times	0	None
52526	52527	lower	0	None
52527	52528	than	0	None
52528	52529	in	0	None
52529	52530	liver	0	None
52530	52531	.	0	None

52532	52533	Distribution	0	None
52533	52534	along	0	None
52534	52535	the	0	None
52535	52536	length	0	None
52536	52537	and	0	None
52537	52538	across	0	None
52538	52539	the	0	None
52539	52540	wall	0	None
52540	52541	of	0	None
52541	52542	small	0	None
52542	52543	intestine	0	None
52543	52544	was	0	None
52544	52545	relatively	0	None
52545	52546	uniform	0	None
52546	52547	.	0	None

52548	52549	Moreover	0	None
52549	52550	,	0	None
52550	52551	the	0	None
52551	52552	dehydratases	0	None
52552	52553	from	0	None
52553	52554	human	0	None
52554	52555	liver	0	None
52555	52556	and	0	None
52556	52557	intestinal	0	None
52557	52558	mucosa	0	None
52558	52559	have	0	None
52559	52560	identical	0	None
52560	52561	kinetic	0	None
52561	52562	properties	0	None
52562	52563	.	0	None

52564	52565	A	0	None
52565	52566	biopsy	0	None
52566	52567	of	0	None
52567	52568	duodenal	0	None
52568	52569	mucosa	0	None
52569	52570	from	0	None
52570	52571	a	0	None
52571	52572	patient	0	None
52572	52573	with	0	None
52573	52574	homozygous	0	None
52574	52575	E96K	2	GENE-N
52575	52576	dehydratase	2	GENE-N
52576	52577	had	0	None
52577	52578	activity	0	None
52578	52579	of	0	None
52579	52580	55	0	None
52580	52581	nmol	0	None
52581	52582	.	0	None

52583	52584	min	0	None
52584	52585	(	0	None
52585	52586	-	0	None
52586	52587	1	0	None
52587	52588	)	0	None
52588	52589	g	0	None
52589	52590	(	0	None
52590	52591	-	0	None
52591	52592	1	0	None
52592	52593	)	0	None
52593	52594	mucosa	0	None
52594	52595	compared	0	None
52595	52596	to	0	None
52596	52597	329	0	None
52597	52598	+	0	None
52598	52599	/	0	None
52599	52600	-	0	None
52600	52601	32	0	None
52601	52602	nmol	0	None
52602	52603	.	0	None

52604	52605	min	0	None
52605	52606	(	0	None
52606	52607	-	0	None
52607	52608	1	0	None
52608	52609	)	0	None
52609	52610	g	0	None
52610	52611	(	0	None
52611	52612	-	0	None
52612	52613	1	0	None
52613	52614	)	0	None
52614	52615	tissue	0	None
52615	52616	in	0	None
52616	52617	controls	0	None
52617	52618	(	0	None
52618	52619	n	0	None
52619	52620	=	0	None
52620	52621	12	0	None
52621	52622	)	0	None
52622	52623	.	0	None

52624	52625	The	0	None
52625	52626	sixfold	0	None
52626	52627	lower	0	None
52627	52628	tissue	0	None
52628	52629	activity	0	None
52629	52630	of	0	None
52630	52631	the	0	None
52631	52632	E96K	2	GENE-N
52632	52633	mutant	0	None
52633	52634	alone	0	None
52634	52635	may	0	None
52635	52636	not	0	None
52636	52637	be	0	None
52637	52638	sufficient	0	None
52638	52639	to	0	None
52639	52640	account	0	None
52640	52641	for	0	None
52641	52642	the	0	None
52642	52643	biochemical	0	None
52643	52644	symptoms	0	None
52644	52645	of	0	None
52645	52646	primapterinuria	0	None
52646	52647	in	0	None
52647	52648	this	0	None
52648	52649	patient	0	None
52649	52650	.	0	None

52651	52652	However	0	None
52652	52653	,	0	None
52653	52654	accumulation	0	None
52654	52655	of	0	None
52655	52656	a	0	None
52656	52657	4a	0	None
52657	52658	-	0	None
52658	52659	hydroxy	3	CHEMICAL
52659	52660	-	0	None
52660	52661	tetrahydrobiopterin	3	CHEMICAL
52661	52662	degradation	0	None
52662	52663	product	0	None
52663	52664	(	0	None
52664	52665	a	0	None
52665	52666	side	0	None
52666	52667	-	0	None
52667	52668	chain	0	None
52668	52669	cyclic	3	CHEMICAL
52669	52670	adduct	0	None
52670	52671	)	0	None
52671	52672	,	0	None
52672	52673	which	0	None
52673	52674	has	0	None
52674	52675	been	0	None
52675	52676	observed	0	None
52676	52677	in	0	None
52677	52678	vitro	0	None
52678	52679	and	0	None
52679	52680	appears	0	None
52680	52681	to	0	None
52681	52682	be	0	None
52682	52683	a	0	None
52683	52684	dehydratase	2	GENE-N
52684	52685	inhibitor	0	None
52685	52686	,	0	None
52686	52687	may	0	None
52687	52688	further	0	None
52688	52689	exacerbate	0	None
52689	52690	the	0	None
52690	52691	problem	0	None
52691	52692	.	0	None

52693	52694	Effects	0	None
52694	52695	of	0	None
52695	52696	the	0	None
52696	52697	inhibition	0	None
52697	52698	of	0	None
52698	52699	cyclo	0	None
52699	52700	-	0	None
52700	52701	oxygenase	0	None
52701	52702	1	0	None
52702	52703	or	0	None
52703	52704	2	0	None
52704	52705	or	0	None
52705	52706	5	0	None
52706	52707	-	0	None
52707	52708	lipoxygenase	0	None
52708	52709	on	0	None
52709	52710	the	0	None
52710	52711	activation	0	None
52711	52712	of	0	None
52712	52713	the	0	None
52713	52714	hypothalamic	0	None
52714	52715	-	0	None
52715	52716	pituitary	0	None
52716	52717	-	0	None
52717	52718	adrenal	0	None
52718	52719	axis	0	None
52719	52720	induced	0	None
52720	52721	by	0	None
52721	52722	interleukin	1	GENE-Y
52722	52723	-	0	None
52723	52724	1beta	0	None
52724	52725	in	0	None
52725	52726	the	0	None
52726	52727	male	0	None
52727	52728	Rat	0	None
52728	52729	.	0	None

52730	52731	The	0	None
52731	52732	limited	0	None
52732	52733	entry	0	None
52733	52734	of	0	None
52734	52735	interleukin	1	GENE-Y
52735	52736	-	0	None
52736	52737	1beta	0	None
52737	52738	(	0	None
52738	52739	IL	0	None
52739	52740	-	0	None
52740	52741	1beta	0	None
52741	52742	)	0	None
52742	52743	into	0	None
52743	52744	the	0	None
52744	52745	central	0	None
52745	52746	nervous	0	None
52746	52747	system	0	None
52747	52748	has	0	None
52748	52749	led	0	None
52749	52750	to	0	None
52750	52751	the	0	None
52751	52752	hypothesis	0	None
52752	52753	that	0	None
52753	52754	IL	0	None
52754	52755	-	0	None
52755	52756	1beta	0	None
52756	52757	acts	0	None
52757	52758	,	0	None
52758	52759	through	0	None
52759	52760	IL	0	None
52760	52761	-	0	None
52761	52762	1beta	0	None
52762	52763	receptors	0	None
52763	52764	located	0	None
52764	52765	notably	0	None
52765	52766	on	0	None
52766	52767	endothelial	0	None
52767	52768	cells	0	None
52768	52769	,	0	None
52769	52770	on	0	None
52770	52771	the	0	None
52771	52772	release	0	None
52772	52773	of	0	None
52773	52774	prostaglandins	3	CHEMICAL
52774	52775	which	0	None
52775	52776	in	0	None
52776	52777	turn	0	None
52777	52778	stimulate	0	None
52778	52779	the	0	None
52779	52780	hypothalamic	0	None
52780	52781	-	0	None
52781	52782	pituitary	0	None
52782	52783	-	0	None
52783	52784	adrenal	0	None
52784	52785	(	0	None
52785	52786	HPA	0	None
52786	52787	)	0	None
52787	52788	axis	0	None
52788	52789	.	0	None

52790	52791	We	0	None
52791	52792	used	0	None
52792	52793	cyclo	0	None
52793	52794	-	0	None
52794	52795	oxygenase	0	None
52795	52796	-	0	None
52796	52797	1	0	None
52797	52798	(	0	None
52798	52799	COX	2	GENE-N
52799	52800	-	0	None
52800	52801	1	0	None
52801	52802	)	0	None
52802	52803	and	0	None
52803	52804	cyclo	0	None
52804	52805	-	0	None
52805	52806	oxygenase	0	None
52806	52807	-	0	None
52807	52808	2	0	None
52808	52809	(	0	None
52809	52810	COX	2	GENE-N
52810	52811	-	0	None
52811	52812	2	0	None
52812	52813	)	0	None
52813	52814	and	0	None
52814	52815	5	0	None
52815	52816	-	0	None
52816	52817	lipoxygenase	0	None
52817	52818	(	0	None
52818	52819	5	0	None
52819	52820	-	0	None
52820	52821	LOX	0	None
52821	52822	)	0	None
52822	52823	inhibitors	0	None
52823	52824	,	0	None
52824	52825	before	0	None
52825	52826	the	0	None
52826	52827	injection	0	None
52827	52828	of	0	None
52828	52829	IL	0	None
52829	52830	-	0	None
52830	52831	1beta	0	None
52831	52832	,	0	None
52832	52833	to	0	None
52833	52834	explore	0	None
52834	52835	the	0	None
52835	52836	role	0	None
52836	52837	of	0	None
52837	52839	arachidonic acid	3	CHEMICAL
52839	52840	metabolic	0	None
52840	52841	pathways	0	None
52841	52842	on	0	None
52842	52843	HPA	0	None
52843	52844	axis	0	None
52844	52845	activation	0	None
52845	52846	.	0	None

52847	52848	Adult	0	None
52848	52849	male	0	None
52849	52850	rats	0	None
52850	52851	were	0	None
52851	52852	i	0	None
52852	52853	.	0	None
52853	52854	m	0	None
52854	52855	injected	0	None
52855	52856	20	0	None
52856	52857	min	0	None
52857	52858	before	0	None
52858	52859	i	0	None
52859	52860	.	0	None
52860	52861	p	0	None
52861	52862	injection	0	None
52862	52863	of	0	None
52863	52864	IL	0	None
52864	52865	-	0	None
52865	52866	1beta	0	None
52866	52867	,	0	None
52867	52868	with	0	None
52868	52869	(	0	None
52869	52870	i	0	None
52870	52871	)	0	None
52871	52872	:	0	None
52872	52873	a	0	None
52873	52874	COX	2	GENE-N
52874	52875	-	0	None
52875	52876	1	0	None
52876	52877	/	0	None
52877	52878	COX	2	GENE-N
52878	52879	-	0	None
52879	52880	2	0	None
52880	52881	inhibitor	0	None
52881	52882	(	0	None
52882	52883	ketoprofen	3	CHEMICAL
52883	52884	)	0	None
52884	52885	;	0	None
52885	52886	(	0	None
52886	52887	ii	0	None
52887	52888	)	0	None
52888	52889	a	0	None
52889	52890	COX	2	GENE-N
52890	52891	-	0	None
52891	52892	2	0	None
52892	52893	selective	0	None
52893	52894	inhibitor	0	None
52894	52895	(	0	None
52895	52896	NS	0	None
52896	52897	398	0	None
52897	52898	)	0	None
52898	52899	;	0	None
52899	52900	or	0	None
52900	52901	(	0	None
52901	52902	iii	0	None
52902	52903	)	0	None
52903	52904	a	0	None
52904	52905	5	0	None
52905	52906	-	0	None
52906	52907	LOX	0	None
52907	52908	inhibitor	0	None
52908	52909	(	0	None
52909	52910	BW	0	None
52910	52911	A4C	0	None
52911	52912	)	0	None
52912	52913	.	0	None

52914	52915	Following	0	None
52915	52916	this	0	None
52916	52917	,	0	None
52917	52918	rats	0	None
52918	52919	were	0	None
52919	52920	killed	0	None
52920	52921	90	0	None
52921	52922	min	0	None
52922	52923	after	0	None
52923	52924	i	0	None
52924	52925	.	0	None
52925	52926	p	0	None
52926	52927	.	0	None

52928	52929	IL	0	None
52929	52930	-	0	None
52930	52931	1beta	0	None
52931	52932	injection	0	None
52932	52933	and	0	None
52933	52934	analysis	0	None
52934	52935	for	0	None
52935	52936	plasma	0	None
52936	52938	adrenocorticotropic hormone	1	GENE-Y
52938	52939	(	0	None
52939	52940	ACTH	1	GENE-Y
52940	52941	)	0	None
52941	52942	and	0	None
52942	52943	corticosterone	0	None
52943	52944	concentrations	0	None
52944	52945	and	0	None
52945	52946	determination	0	None
52946	52947	of	0	None
52947	52948	anterior	0	None
52948	52950	pituitary pro	1	GENE-Y
52950	52951	-	0	None
52951	52952	opio	0	None
52952	52953	melanocortin	0	None
52953	52954	(	0	None
52954	52955	POMC	1	GENE-Y
52955	52956	)	0	None
52956	52957	gene	0	None
52957	52958	transcription	0	None
52958	52959	was	0	None
52959	52960	conducted	0	None
52960	52961	.	0	None

52962	52963	Administration	0	None
52963	52964	of	0	None
52964	52965	the	0	None
52965	52966	COX	2	GENE-N
52966	52967	-	0	None
52967	52968	1	0	None
52968	52969	/	0	None
52969	52970	COX	2	GENE-N
52970	52971	-	0	None
52971	52972	2	0	None
52972	52973	inhibitor	0	None
52973	52974	led	0	None
52974	52975	to	0	None
52975	52976	a	0	None
52976	52977	complete	0	None
52977	52978	blockage	0	None
52978	52979	of	0	None
52979	52980	ACTH	1	GENE-Y
52980	52981	and	0	None
52981	52982	corticosterone	0	None
52982	52983	secretion	0	None
52983	52984	and	0	None
52984	52985	POMC	1	GENE-Y
52985	52986	gene	0	None
52986	52987	transcription	0	None
52987	52988	.	0	None

52989	52990	The	0	None
52990	52991	COX	2	GENE-N
52991	52992	-	0	None
52992	52993	2	0	None
52993	52994	inhibitor	0	None
52994	52995	led	0	None
52995	52996	to	0	None
52996	52997	a	0	None
52997	52998	complete	0	None
52998	52999	blockade	0	None
52999	53000	of	0	None
53000	53001	ACTH	1	GENE-Y
53001	53002	secretion	0	None
53002	53003	and	0	None
53003	53004	POMC	1	GENE-Y
53004	53005	gene	0	None
53005	53006	transcription	0	None
53006	53007	but	0	None
53007	53008	had	0	None
53008	53009	no	0	None
53009	53010	effect	0	None
53010	53011	on	0	None
53011	53012	corticosterone	0	None
53012	53013	secretion	0	None
53013	53014	.	0	None

53015	53016	The	0	None
53016	53017	5	0	None
53017	53018	-	0	None
53018	53019	LOX	0	None
53019	53020	inhibitor	0	None
53020	53021	had	0	None
53021	53022	no	0	None
53022	53023	significant	0	None
53023	53024	effect	0	None
53024	53025	on	0	None
53025	53026	any	0	None
53026	53027	parameter	0	None
53027	53028	.	0	None

53029	53030	These	0	None
53030	53031	results	0	None
53031	53032	demonstrate	0	None
53032	53033	the	0	None
53033	53034	crucial	0	None
53034	53035	role	0	None
53035	53036	of	0	None
53036	53037	eicosanoid	3	CHEMICAL
53037	53038	pathways	0	None
53038	53039	in	0	None
53039	53040	mediating	0	None
53040	53041	the	0	None
53041	53042	stimulation	0	None
53042	53043	of	0	None
53043	53044	the	0	None
53044	53045	HPA	0	None
53045	53046	axis	0	None
53046	53047	induced	0	None
53047	53048	by	0	None
53048	53049	IL	0	None
53049	53050	-	0	None
53050	53051	1beta	0	None
53051	53052	.	0	None

53053	53054	Moreover	0	None
53054	53055	,	0	None
53055	53056	we	0	None
53056	53057	found	0	None
53057	53058	a	0	None
53058	53059	clear	0	None
53059	53060	dissociation	0	None
53060	53061	of	0	None
53061	53062	the	0	None
53062	53063	effect	0	None
53063	53064	of	0	None
53064	53065	the	0	None
53065	53066	blockage	0	None
53066	53067	of	0	None
53067	53068	COXs	2	GENE-N
53068	53069	upon	0	None
53069	53070	ACTH	1	GENE-Y
53070	53071	and	0	None
53071	53072	corticosterone	0	None
53072	53073	secretion	0	None
53073	53074	,	0	None
53074	53075	suggesting	0	None
53075	53076	that	0	None
53076	53077	IL	0	None
53077	53078	-	0	None
53078	53079	1beta	0	None
53079	53080	may	0	None
53080	53081	act	0	None
53081	53082	at	0	None
53082	53083	the	0	None
53083	53084	brain	0	None
53084	53085	as	0	None
53085	53086	well	0	None
53086	53087	as	0	None
53087	53088	at	0	None
53088	53089	the	0	None
53089	53090	adrenal	0	None
53090	53091	cortex	0	None
53091	53092	to	0	None
53092	53093	stimulate	0	None
53093	53094	the	0	None
53094	53095	secretion	0	None
53095	53096	of	0	None
53096	53097	corticosterone	0	None
53097	53098	.	0	None

53099	53100	Drug	0	None
53100	53101	treatment	0	None
53101	53102	of	0	None
53102	53103	obesity	0	None
53103	53104	.	0	None

53105	53106	Drugs	0	None
53106	53107	to	0	None
53107	53108	treat	0	None
53108	53109	obesity	0	None
53109	53110	can	0	None
53110	53111	be	0	None
53111	53112	divided	0	None
53112	53113	into	0	None
53113	53114	three	0	None
53114	53115	groups	0	None
53115	53116	:	0	None
53116	53117	those	0	None
53117	53118	which	0	None
53118	53119	reduce	0	None
53119	53120	food	0	None
53120	53121	intake	0	None
53121	53122	,	0	None
53122	53123	those	0	None
53123	53124	which	0	None
53124	53125	alter	0	None
53125	53126	metabolism	0	None
53126	53127	and	0	None
53127	53128	those	0	None
53128	53129	which	0	None
53129	53130	increase	0	None
53130	53131	thermogenesis	0	None
53131	53132	.	0	None

53133	53134	Monoamines	0	None
53134	53135	acting	0	None
53135	53136	on	0	None
53136	53138	noradrenergic receptors	2	GENE-N
53138	53139	,	0	None
53139	53141	serotonin receptors	2	GENE-N
53141	53142	,	0	None
53142	53144	dopamine receptors	2	GENE-N
53144	53145	and	0	None
53145	53147	histamine receptors	2	GENE-N
53147	53148	can	0	None
53148	53149	reduce	0	None
53149	53150	food	0	None
53150	53151	intake	0	None
53151	53152	.	0	None

53153	53154	A	0	None
53154	53155	number	0	None
53155	53156	of	0	None
53156	53157	peptides	0	None
53157	53158	also	0	None
53158	53159	affect	0	None
53159	53160	food	0	None
53160	53161	intake	0	None
53161	53162	.	0	None

53163	53164	The	0	None
53164	53165	noradrenergic	0	None
53165	53166	drugs	0	None
53166	53167	phentermine	3	CHEMICAL
53167	53168	,	0	None
53168	53169	diethylpropion	3	CHEMICAL
53169	53170	,	0	None
53170	53171	mazindol	3	CHEMICAL
53171	53172	benzphetamine	3	CHEMICAL
53172	53173	and	0	None
53173	53174	phendimetrazine	3	CHEMICAL
53174	53175	are	0	None
53175	53176	approved	0	None
53176	53177	only	0	None
53177	53178	for	0	None
53178	53179	short	0	None
53179	53180	-	0	None
53180	53181	term	0	None
53181	53182	use	0	None
53182	53183	.	0	None

53184	53185	Sibutramine	0	None
53185	53186	,	0	None
53186	53187	a	0	None
53187	53188	norepinephrine	3	CHEMICAL
53188	53189	-	0	None
53189	53190	serotonin	3	CHEMICAL
53190	53191	re	0	None
53191	53192	-	0	None
53192	53193	uptake	0	None
53193	53194	inhibitor	0	None
53194	53195	,	0	None
53195	53196	is	0	None
53196	53197	approved	0	None
53197	53198	for	0	None
53198	53199	long	0	None
53199	53200	-	0	None
53200	53201	term	0	None
53201	53202	use	0	None
53202	53203	.	0	None

53204	53205	Orlistat	3	CHEMICAL
53205	53206	inhibits	0	None
53206	53208	pancreatic lipase	2	GENE-N
53208	53209	and	0	None
53209	53210	can	0	None
53210	53211	block	0	None
53211	53212	30	0	None
53212	53213	%	0	None
53213	53214	of	0	None
53214	53215	triglyceride	3	CHEMICAL
53215	53216	hydrolysis	0	None
53216	53217	in	0	None
53217	53218	subjects	0	None
53218	53219	eating	0	None
53219	53220	a	0	None
53220	53221	30	0	None
53221	53222	%	0	None
53222	53223	fat	0	None
53223	53224	diet	0	None
53224	53225	.	0	None

53226	53227	The	0	None
53227	53228	only	0	None
53228	53229	thermogenic	0	None
53229	53230	drug	0	None
53230	53231	combination	0	None
53231	53232	that	0	None
53232	53233	has	0	None
53233	53234	been	0	None
53234	53235	tested	0	None
53235	53236	is	0	None
53236	53237	ephedrine	3	CHEMICAL
53237	53238	and	0	None
53238	53239	caffeine	3	CHEMICAL
53239	53240	,	0	None
53240	53241	but	0	None
53241	53242	this	0	None
53242	53243	treatment	0	None
53243	53244	has	0	None
53244	53245	not	0	None
53245	53246	been	0	None
53246	53247	approved	0	None
53247	53248	by	0	None
53248	53249	regulating	0	None
53249	53250	agencies	0	None
53250	53251	.	0	None

53252	53253	Leptin	0	None
53253	53254	is	0	None
53254	53255	currently	0	None
53255	53256	in	0	None
53256	53257	clinical	0	None
53257	53258	trials	0	None
53258	53259	and	0	None
53259	53260	other	0	None
53260	53261	drugs	0	None
53261	53262	that	0	None
53262	53263	may	0	None
53263	53264	modulate	0	None
53264	53265	peptide	0	None
53265	53266	-	0	None
53266	53267	feeding	0	None
53267	53268	systems	0	None
53268	53269	are	0	None
53269	53270	being	0	None
53270	53271	developed	0	None
53271	53272	.	0	None

53273	53274	The	0	None
53274	53275	apoptosome	0	None
53275	53276	:	0	None
53276	53277	heart	0	None
53277	53278	and	0	None
53278	53279	soul	0	None
53279	53280	of	0	None
53280	53281	the	0	None
53281	53282	cell	0	None
53282	53283	death	0	None
53283	53284	machine	0	None
53284	53285	.	0	None

53286	53287	Apoptosis	0	None
53287	53288	is	0	None
53288	53289	a	0	None
53289	53290	fundamental	0	None
53290	53291	biologic	0	None
53291	53292	process	0	None
53292	53293	by	0	None
53293	53294	which	0	None
53294	53295	metazoan	0	None
53295	53296	cells	0	None
53296	53297	orchestrate	0	None
53297	53298	their	0	None
53298	53299	own	0	None
53299	53300	self	0	None
53300	53301	-	0	None
53301	53302	demise	0	None
53302	53303	.	0	None

53304	53305	Genetic	0	None
53305	53306	analyses	0	None
53306	53307	of	0	None
53307	53308	the	0	None
53308	53309	nematode	0	None
53309	53310	C	0	None
53310	53311	elegans	0	None
53311	53312	identified	0	None
53312	53313	three	0	None
53313	53314	core	0	None
53314	53315	components	0	None
53315	53316	of	0	None
53316	53317	the	0	None
53317	53318	suicide	0	None
53318	53319	apparatus	0	None
53319	53320	which	0	None
53320	53321	include	0	None
53321	53322	CED	0	None
53322	53323	-	0	None
53323	53324	3	0	None
53324	53325	,	0	None
53325	53326	CED	0	None
53326	53327	-	0	None
53327	53328	4	0	None
53328	53329	,	0	None
53329	53330	and	0	None
53330	53331	CED	0	None
53331	53332	-	0	None
53332	53333	9	0	None
53333	53334	.	0	None

53335	53336	An	0	None
53336	53337	analogous	0	None
53337	53338	set	0	None
53338	53339	of	0	None
53339	53340	core	0	None
53340	53341	constituents	0	None
53341	53342	exists	0	None
53342	53343	in	0	None
53343	53344	mammalian	0	None
53344	53345	cells	0	None
53345	53346	and	0	None
53346	53347	includes	0	None
53347	53348	caspase	0	None
53348	53349	-	0	None
53349	53350	9	0	None
53350	53351	,	0	None
53351	53352	Apaf	0	None
53352	53353	-	0	None
53353	53354	1	0	None
53354	53355	,	0	None
53355	53356	and	0	None
53356	53357	bcl	0	None
53357	53358	-	0	None
53358	53359	2	0	None
53359	53360	/	0	None
53360	53361	xL	0	None
53361	53362	,	0	None
53362	53363	respectively	0	None
53363	53364	.	0	None

53365	53366	CED	0	None
53366	53367	-	0	None
53367	53368	3	0	None
53368	53369	and	0	None
53369	53370	CED	0	None
53370	53371	-	0	None
53371	53372	4	0	None
53372	53373	,	0	None
53373	53374	along	0	None
53374	53375	with	0	None
53375	53376	their	0	None
53376	53377	mammalian	0	None
53377	53378	counterparts	0	None
53378	53379	,	0	None
53379	53380	function	0	None
53380	53381	to	0	None
53381	53382	kill	0	None
53382	53383	cells	0	None
53383	53384	,	0	None
53384	53385	whereas	0	None
53385	53386	CED	0	None
53386	53387	-	0	None
53387	53388	9	0	None
53388	53389	and	0	None
53389	53390	its	0	None
53390	53391	mammalian	0	None
53391	53392	equivalents	0	None
53392	53393	protect	0	None
53393	53394	cells	0	None
53394	53395	from	0	None
53395	53396	death	0	None
53396	53397	.	0	None

53398	53399	These	0	None
53399	53400	central	0	None
53400	53401	components	0	None
53401	53402	biochemically	0	None
53402	53403	intermingle	0	None
53403	53404	in	0	None
53404	53405	a	0	None
53405	53406	ternary	0	None
53406	53407	complex	0	None
53407	53408	recently	0	None
53408	53409	dubbed	0	None
53409	53410	the	0	None
53410	53411	"	0	None
53411	53412	apoptosome	0	None
53412	53413	.	0	None
53413	53414	"	0	None
53414	53415	The	0	None
53415	53416	C	0	None
53416	53417	elegans	0	None
53417	53418	protein	0	None
53418	53419	EGL	0	None
53419	53420	-	0	None
53420	53421	1	0	None
53421	53422	and	0	None
53422	53423	its	0	None
53423	53424	mammalian	0	None
53424	53425	counterparts	0	None
53425	53426	,	0	None
53426	53427	pro	0	None
53427	53428	-	0	None
53428	53429	apoptotic	0	None
53429	53430	members	0	None
53430	53431	of	0	None
53431	53432	the	0	None
53432	53433	bcl	0	None
53433	53434	-	0	None
53434	53435	2	0	None
53435	53436	family	0	None
53436	53437	,	0	None
53437	53438	induce	0	None
53438	53439	cell	0	None
53439	53440	death	0	None
53440	53441	by	0	None
53441	53442	disrupting	0	None
53442	53443	apoptosome	0	None
53443	53444	interactions	0	None
53444	53445	.	0	None

53446	53447	Thus	0	None
53447	53448	,	0	None
53448	53449	EGL	0	None
53449	53450	-	0	None
53450	53451	1	0	None
53451	53452	may	0	None
53452	53453	represent	0	None
53453	53454	a	0	None
53454	53455	primordial	0	None
53455	53456	signal	0	None
53456	53457	integrator	0	None
53457	53458	for	0	None
53458	53459	the	0	None
53459	53460	apoptosome	0	None
53460	53461	.	0	None

53462	53463	Various	0	None
53463	53464	biochemical	0	None
53464	53465	processes	0	None
53465	53466	including	0	None
53466	53467	oligomerization	0	None
53467	53468	,	0	None
53468	53471	adenosine triphosphate ATP	3	CHEMICAL
53471	53472	/	0	None
53472	53473	dATP	3	CHEMICAL
53473	53474	binding	0	None
53474	53475	,	0	None
53475	53476	and	0	None
53476	53478	cytochrome c	1	GENE-Y
53478	53479	interaction	0	None
53479	53480	play	0	None
53480	53481	a	0	None
53481	53482	role	0	None
53482	53483	in	0	None
53483	53484	regulating	0	None
53484	53485	the	0	None
53485	53486	ternary	0	None
53486	53487	death	0	None
53487	53488	complex	0	None
53488	53489	.	0	None

53490	53491	Recent	0	None
53491	53492	studies	0	None
53492	53493	suggest	0	None
53493	53494	that	0	None
53494	53495	cell	0	None
53495	53497	death receptors	2	GENE-N
53497	53498	,	0	None
53498	53499	such	0	None
53499	53500	as	0	None
53500	53501	CD95	1	GENE-Y
53501	53502	,	0	None
53502	53503	may	0	None
53503	53504	amplify	0	None
53504	53505	their	0	None
53505	53506	suicide	0	None
53506	53507	signal	0	None
53507	53508	by	0	None
53508	53509	activating	0	None
53509	53510	the	0	None
53510	53511	apoptosome	0	None
53511	53512	.	0	None

53513	53514	These	0	None
53514	53515	mutual	0	None
53515	53516	associations	0	None
53516	53517	by	0	None
53517	53518	core	0	None
53518	53519	components	0	None
53519	53520	of	0	None
53520	53521	the	0	None
53521	53522	suicide	0	None
53522	53523	apparatus	0	None
53523	53524	provide	0	None
53524	53525	a	0	None
53525	53526	molecular	0	None
53526	53527	framework	0	None
53527	53528	in	0	None
53528	53529	which	0	None
53529	53530	diverse	0	None
53530	53531	death	0	None
53531	53532	signals	0	None
53532	53533	likely	0	None
53533	53534	interface	0	None
53534	53535	.	0	None

53536	53537	Understanding	0	None
53537	53538	the	0	None
53538	53539	apoptosome	0	None
53539	53540	and	0	None
53540	53541	its	0	None
53541	53542	cellular	0	None
53542	53543	connections	0	None
53543	53544	will	0	None
53544	53545	facilitate	0	None
53545	53546	the	0	None
53546	53547	design	0	None
53547	53548	of	0	None
53548	53549	novel	0	None
53549	53550	therapeutic	0	None
53550	53551	strategies	0	None
53551	53552	for	0	None
53552	53553	cancer	0	None
53553	53554	and	0	None
53554	53555	other	0	None
53555	53556	disease	0	None
53556	53557	states	0	None
53557	53558	in	0	None
53558	53559	which	0	None
53559	53560	apoptosis	0	None
53560	53561	plays	0	None
53561	53562	a	0	None
53562	53563	pivotal	0	None
53563	53564	role	0	None
53564	53565	.	0	None

53566	53567	Calicheamicin	3	CHEMICAL
53567	53568	-	0	None
53568	53569	conjugated	0	None
53569	53570	humanized	0	None
53570	53571	anti	0	None
53571	53572	-	0	None
53572	53573	CD33	1	GENE-Y
53573	53575	monoclonal antibody	2	GENE-N
53575	53576	(	0	None
53576	53577	gemtuzumab	0	None
53577	53578	zogamicin	0	None
53578	53579	,	0	None
53579	53580	CMA	0	None
53580	53581	-	0	None
53581	53582	676	0	None
53582	53583	)	0	None
53583	53584	shows	0	None
53584	53585	cytocidal	0	None
53585	53586	effect	0	None
53586	53587	on	0	None
53587	53588	CD33	1	GENE-Y
53588	53589	-	0	None
53589	53590	positive	0	None
53590	53591	leukemia	0	None
53591	53592	cell	0	None
53592	53593	lines	0	None
53593	53594	,	0	None
53594	53595	but	0	None
53595	53596	is	0	None
53596	53597	inactive	0	None
53597	53598	on	0	None
53598	53599	P	0	None
53599	53600	-	0	None
53600	53601	glycoprotein	2	GENE-N
53601	53602	-	0	None
53602	53603	expressing	0	None
53603	53604	sublines	0	None
53604	53605	.	0	None

53606	53607	Calicheamicin	3	CHEMICAL
53607	53608	-	0	None
53608	53609	conjugated	0	None
53609	53610	humanized	0	None
53610	53611	anti	0	None
53611	53612	-	0	None
53612	53613	CD33	1	GENE-Y
53613	53614	mouse	0	None
53614	53616	monoclonal antibody	2	GENE-N
53616	53617	,	0	None
53617	53618	CMA	0	None
53618	53619	-	0	None
53619	53620	676	0	None
53620	53621	,	0	None
53621	53622	has	0	None
53622	53623	recently	0	None
53623	53624	been	0	None
53624	53625	introduced	0	None
53625	53626	to	0	None
53626	53627	clinics	0	None
53627	53628	as	0	None
53628	53629	a	0	None
53629	53630	promising	0	None
53630	53631	drug	0	None
53631	53632	to	0	None
53632	53633	treat	0	None
53633	53634	patients	0	None
53634	53635	with	0	None
53635	53636	acute	0	None
53636	53637	myeloid	0	None
53637	53638	leukemia	0	None
53638	53639	(	0	None
53639	53640	AML	0	None
53640	53641	)	0	None
53641	53642	in	0	None
53642	53643	relapse	0	None
53643	53644	.	0	None

53645	53646	However	0	None
53646	53647	,	0	None
53647	53648	the	0	None
53648	53649	mechanism	0	None
53649	53650	of	0	None
53650	53651	action	0	None
53651	53652	of	0	None
53652	53653	CMA	0	None
53653	53654	-	0	None
53654	53655	676	0	None
53655	53656	has	0	None
53656	53657	not	0	None
53657	53658	been	0	None
53658	53659	well	0	None
53659	53660	elucidated	0	None
53660	53661	.	0	None

53662	53663	The	0	None
53663	53664	cytotoxic	0	None
53664	53665	effect	0	None
53665	53666	of	0	None
53666	53667	CMA	0	None
53667	53668	-	0	None
53668	53669	676	0	None
53669	53670	on	0	None
53670	53671	HL60	0	None
53671	53672	,	0	None
53672	53673	NOMO	0	None
53673	53674	-	0	None
53674	53675	1	0	None
53675	53676	,	0	None
53676	53677	NB4	0	None
53677	53678	,	0	None
53678	53679	NKM	0	None
53679	53680	-	0	None
53680	53681	1	0	None
53681	53682	,	0	None
53682	53683	K562	0	None
53683	53684	,	0	None
53684	53685	Daudi	0	None
53685	53686	,	0	None
53686	53687	and	0	None
53687	53688	the	0	None
53688	53689	multidrug	0	None
53689	53690	-	0	None
53690	53691	resistant	0	None
53691	53692	sublines	0	None
53692	53693	,	0	None
53693	53694	NOMO	0	None
53694	53695	-	0	None
53695	53696	1	0	None
53696	53697	/	0	None
53697	53698	ADR	0	None
53698	53699	and	0	None
53699	53700	NB4	0	None
53700	53701	/	0	None
53701	53702	MDR	0	None
53702	53703	,	0	None
53703	53704	was	0	None
53704	53705	investigated	0	None
53705	53706	by	0	None
53706	53707	cell	0	None
53707	53708	cycle	0	None
53708	53709	distribution	0	None
53709	53710	and	0	None
53710	53711	morphology	0	None
53711	53712	.	0	None

53713	53714	These	0	None
53714	53715	studies	0	None
53715	53716	were	0	None
53716	53717	done	0	None
53717	53718	by	0	None
53718	53719	a	0	None
53719	53720	video	0	None
53720	53721	-	0	None
53721	53722	microscopic	0	None
53722	53723	system	0	None
53723	53724	,	0	None
53724	53725	DNA	3	CHEMICAL
53725	53726	fragmentation	0	None
53726	53727	,	0	None
53727	53728	dye	0	None
53728	53729	exclusion	0	None
53729	53730	and	0	None
53730	53731	3H	0	None
53731	53732	-	0	None
53732	53733	thymidine	3	CHEMICAL
53733	53734	uptake	0	None
53734	53735	after	0	None
53735	53736	analysis	0	None
53736	53737	of	0	None
53737	53738	CD33	1	GENE-Y
53738	53739	,	0	None
53739	53740	CD34	1	GENE-Y
53740	53741	,	0	None
53741	53742	P	0	None
53742	53743	-	0	None
53743	53744	glycoprotein	2	GENE-N
53744	53745	(	0	None
53745	53746	P	0	None
53746	53747	-	0	None
53747	53748	gp	1	GENE-Y
53748	53749	)	0	None
53749	53750	,	0	None
53750	53751	multidrug	0	None
53751	53752	resistance	0	None
53752	53753	(	0	None
53753	53754	MDR	0	None
53754	53755	)	0	None
53755	53756	-	0	None
53756	53757	associated	0	None
53757	53758	protein	0	None
53758	53759	and	0	None
53759	53760	lung	0	None
53760	53761	-	0	None
53761	53762	related	0	None
53762	53763	protein	0	None
53763	53764	on	0	None
53764	53765	these	0	None
53765	53766	cells	0	None
53766	53767	.	0	None

53768	53769	A	0	None
53769	53770	dose	0	None
53770	53771	-	0	None
53771	53772	dependent	0	None
53772	53773	,	0	None
53773	53774	selective	0	None
53774	53775	cytotoxic	0	None
53775	53776	effect	0	None
53776	53777	of	0	None
53777	53778	CMA	0	None
53778	53779	-	0	None
53779	53780	676	0	None
53780	53781	was	0	None
53781	53782	observed	0	None
53782	53783	in	0	None
53783	53784	cell	0	None
53784	53785	lines	0	None
53785	53786	that	0	None
53786	53787	expressed	0	None
53787	53788	CD33	1	GENE-Y
53788	53789	,	0	None
53789	53790	and	0	None
53790	53791	was	0	None
53791	53792	dependent	0	None
53792	53793	on	0	None
53793	53794	the	0	None
53794	53795	amount	0	None
53795	53796	of	0	None
53796	53797	CD33	1	GENE-Y
53797	53798	and	0	None
53798	53799	the	0	None
53799	53800	proliferative	0	None
53800	53801	speed	0	None
53801	53802	of	0	None
53802	53803	the	0	None
53803	53804	cells	0	None
53804	53805	.	0	None

53806	53807	Sensitive	0	None
53807	53808	cells	0	None
53808	53809	were	0	None
53809	53810	temporally	0	None
53810	53811	arrested	0	None
53811	53812	at	0	None
53812	53813	the	0	None
53813	53814	G2	0	None
53814	53815	/	0	None
53815	53816	M	0	None
53816	53817	phase	0	None
53817	53818	before	0	None
53818	53819	undergoing	0	None
53819	53820	morphological	0	None
53820	53821	changes	0	None
53821	53822	.	0	None

53823	53824	CMA	0	None
53824	53825	-	0	None
53825	53826	676	0	None
53826	53827	is	0	None
53827	53828	not	0	None
53828	53829	effective	0	None
53829	53830	on	0	None
53830	53831	P	0	None
53831	53832	-	0	None
53832	53833	gp	1	GENE-Y
53833	53834	-	0	None
53834	53835	expressing	0	None
53835	53836	multidrug	0	None
53836	53837	-	0	None
53837	53838	resistant	0	None
53838	53839	sublines	0	None
53839	53840	compared	0	None
53840	53841	with	0	None
53841	53842	parental	0	None
53842	53843	cell	0	None
53843	53844	lines	0	None
53844	53845	.	0	None

53846	53847	MDR	0	None
53847	53848	modifiers	0	None
53848	53849	,	0	None
53849	53850	MS209	0	None
53850	53851	and	0	None
53851	53852	PSC833	0	None
53852	53853	,	0	None
53853	53854	restored	0	None
53854	53855	the	0	None
53855	53856	cytotoxic	0	None
53856	53857	effect	0	None
53857	53858	of	0	None
53858	53859	CMA	0	None
53859	53860	-	0	None
53860	53861	676	0	None
53861	53862	in	0	None
53862	53863	P	0	None
53863	53864	-	0	None
53864	53865	gp	1	GENE-Y
53865	53866	-	0	None
53866	53867	expressing	0	None
53867	53868	sublines	0	None
53868	53869	.	0	None

53870	53871	CMA	0	None
53871	53872	-	0	None
53872	53873	676	0	None
53873	53874	is	0	None
53874	53875	a	0	None
53875	53876	promising	0	None
53876	53877	agent	0	None
53877	53878	in	0	None
53878	53879	the	0	None
53879	53880	treatment	0	None
53880	53881	of	0	None
53881	53882	patients	0	None
53882	53883	with	0	None
53883	53884	AML	0	None
53884	53885	that	0	None
53885	53886	expresses	0	None
53886	53887	CD33	1	GENE-Y
53887	53888	.	0	None

53889	53890	The	0	None
53890	53891	combined	0	None
53891	53892	use	0	None
53892	53893	of	0	None
53893	53894	CMA	0	None
53894	53895	-	0	None
53895	53896	676	0	None
53896	53897	and	0	None
53897	53898	MDR	0	None
53898	53899	modifiers	0	None
53899	53900	may	0	None
53900	53901	increase	0	None
53901	53902	the	0	None
53902	53903	selective	0	None
53903	53904	cytotoxic	0	None
53904	53905	effect	0	None
53905	53906	in	0	None
53906	53907	multidrug	0	None
53907	53908	-	0	None
53908	53909	resistant	0	None
53909	53910	AML	0	None
53910	53911	.	0	None

53912	53913	Retigabine	0	None
53913	53914	,	0	None
53914	53915	a	0	None
53915	53916	novel	0	None
53916	53917	anti	0	None
53917	53918	-	0	None
53918	53919	convulsant	0	None
53919	53920	,	0	None
53920	53921	enhances	0	None
53921	53922	activation	0	None
53922	53923	of	0	None
53923	53924	KCNQ2	0	None
53924	53925	/	0	None
53925	53926	Q3	0	None
53926	53928	potassium channels	2	GENE-N
53928	53929	.	0	None

53930	53931	Retigabine	0	None
53931	53932	[	0	None
53932	53933	N	0	None
53933	53934	-	0	None
53934	53935	(	0	None
53935	53936	2	0	None
53936	53937	-	0	None
53937	53938	amino	3	CHEMICAL
53938	53939	-	0	None
53939	53940	4	0	None
53940	53941	-	0	None
53941	53942	[	0	None
53942	53943	fluorobenzylamino	0	None
53943	53944	]	0	None
53944	53945	-	0	None
53945	53946	phenyl	3	CHEMICAL
53946	53947	)	0	None
53947	53948	carbamic	0	None
53948	53949	acid	0	None
53949	53950	;	0	None
53950	53951	D	0	None
53951	53952	-	0	None
53952	53953	23129	0	None
53953	53954	]	0	None
53954	53955	is	0	None
53955	53956	a	0	None
53956	53957	novel	0	None
53957	53958	anticonvulsant	0	None
53958	53959	,	0	None
53959	53960	unrelated	0	None
53960	53961	to	0	None
53961	53962	currently	0	None
53962	53963	available	0	None
53963	53964	antiepileptic	0	None
53964	53965	agents	0	None
53965	53966	,	0	None
53966	53967	with	0	None
53967	53968	activity	0	None
53968	53969	in	0	None
53969	53970	a	0	None
53970	53971	broad	0	None
53971	53972	range	0	None
53972	53973	of	0	None
53973	53974	seizure	0	None
53974	53975	models	0	None
53975	53976	.	0	None

53977	53978	In	0	None
53978	53979	the	0	None
53979	53980	present	0	None
53980	53981	study	0	None
53981	53982	,	0	None
53982	53983	we	0	None
53983	53984	sought	0	None
53984	53985	to	0	None
53985	53986	determine	0	None
53986	53987	whether	0	None
53987	53988	retigabine	3	CHEMICAL
53988	53989	could	0	None
53989	53990	enhance	0	None
53990	53991	current	0	None
53991	53992	through	0	None
53992	53993	M	0	None
53993	53994	-	0	None
53994	53995	like	0	None
53995	53996	currents	0	None
53996	53997	in	0	None
53997	53998	PC12	0	None
53998	53999	cells	0	None
53999	54000	and	0	None
54000	54001	KCNQ2	0	None
54001	54002	/	0	None
54002	54003	Q3	0	None
54003	54004	K	0	None
54004	54005	(	0	None
54005	54006	+	0	None
54006	54007	)	0	None
54007	54008	channels	0	None
54008	54009	expressed	0	None
54009	54010	in	0	None
54010	54011	Chinese	0	None
54011	54012	hamster	0	None
54012	54013	ovary	0	None
54013	54014	cells	0	None
54014	54015	(	0	None
54015	54016	CHO	3	CHEMICAL
54016	54017	-	0	None
54017	54018	KCNQ2	0	None
54018	54019	/	0	None
54019	54020	Q3	0	None
54020	54021	)	0	None
54021	54022	.	0	None

54023	54024	In	0	None
54024	54025	differentiated	0	None
54025	54026	PC12	0	None
54026	54027	cells	0	None
54027	54028	,	0	None
54028	54029	retigabine	3	CHEMICAL
54029	54030	enhanced	0	None
54030	54031	a	0	None
54031	54032	linopirdine	3	CHEMICAL
54032	54033	-	0	None
54033	54034	sensitive	0	None
54034	54035	current	0	None
54035	54036	.	0	None

54037	54038	The	0	None
54038	54039	effect	0	None
54039	54040	of	0	None
54040	54041	retigabine	3	CHEMICAL
54041	54042	was	0	None
54042	54043	associated	0	None
54043	54044	with	0	None
54044	54045	a	0	None
54045	54046	slowing	0	None
54046	54047	of	0	None
54047	54048	M	0	None
54048	54049	-	0	None
54049	54050	like	0	None
54050	54051	tail	0	None
54051	54052	current	0	None
54052	54053	deactivation	0	None
54053	54054	in	0	None
54054	54055	these	0	None
54055	54056	cells	0	None
54056	54057	.	0	None

54058	54059	Retigabine	0	None
54059	54060	(	0	None
54060	54061	0	0	None
54061	54062	.	0	None
54062	54063	1	0	None
54063	54064	to	0	None
54064	54065	10	0	None
54065	54066	microM	0	None
54066	54067	)	0	None
54067	54068	induced	0	None
54068	54069	a	0	None
54069	54070	potassium	3	CHEMICAL
54070	54071	current	0	None
54071	54072	and	0	None
54072	54073	hyperpolarized	0	None
54073	54074	CHO	3	CHEMICAL
54074	54075	cells	0	None
54075	54076	expressing	0	None
54076	54077	KCNQ2	0	None
54077	54078	/	0	None
54078	54079	Q3	0	None
54079	54080	cells	0	None
54080	54081	but	0	None
54081	54082	not	0	None
54082	54083	in	0	None
54083	54084	wild	0	None
54084	54085	-	0	None
54085	54086	type	0	None
54086	54087	cells	0	None
54087	54088	.	0	None

54089	54090	Retigabine	0	None
54090	54091	-	0	None
54091	54092	induced	0	None
54092	54093	currents	0	None
54093	54094	in	0	None
54094	54095	CHO	3	CHEMICAL
54095	54096	-	0	None
54096	54097	KCNQ2	0	None
54097	54098	/	0	None
54098	54099	Q3	0	None
54099	54100	cells	0	None
54100	54101	were	0	None
54101	54102	inhibited	0	None
54102	54103	by	0	None
54103	54104	60	0	None
54104	54105	.	0	None
54105	54106	6	0	None
54106	54107	+	0	None
54107	54108	/	0	None
54108	54109	-	0	None
54109	54110	11	0	None
54110	54111	%	0	None
54111	54112	(	0	None
54112	54113	n	0	None
54113	54114	=	0	None
54114	54115	4	0	None
54115	54116	)	0	None
54116	54117	by	0	None
54117	54118	the	0	None
54118	54119	KCNQ2	0	None
54119	54120	/	0	None
54120	54121	Q3	0	None
54121	54122	blocker	0	None
54122	54123	,	0	None
54123	54124	linopirdine	3	CHEMICAL
54124	54125	(	0	None
54125	54126	10	0	None
54126	54127	microM	0	None
54127	54128	)	0	None
54128	54129	,	0	None
54129	54130	and	0	None
54130	54131	82	0	None
54131	54132	.	0	None
54132	54133	7	0	None
54133	54134	+	0	None
54134	54135	/	0	None
54135	54136	-	0	None
54136	54137	5	0	None
54137	54138	.	0	None
54138	54139	4	0	None
54139	54140	%	0	None
54140	54141	(	0	None
54141	54142	n	0	None
54142	54143	=	0	None
54143	54144	4	0	None
54144	54145	)	0	None
54145	54146	by	0	None
54146	54147	BaCl	0	None
54147	54148	(	0	None
54148	54149	2	0	None
54149	54150	)	0	None
54150	54151	(	0	None
54151	54152	10	0	None
54152	54153	mM	0	None
54153	54154	)	0	None
54154	54155	.	0	None

54156	54157	The	0	None
54157	54158	mechanism	0	None
54158	54159	by	0	None
54159	54160	which	0	None
54160	54161	retigabine	3	CHEMICAL
54161	54162	enhanced	0	None
54162	54163	KCNQ2	0	None
54163	54164	/	0	None
54164	54165	Q3	0	None
54165	54166	currents	0	None
54166	54167	involved	0	None
54167	54168	large	0	None
54168	54169	,	0	None
54169	54170	drug	0	None
54170	54171	-	0	None
54171	54172	induced	0	None
54172	54173	,	0	None
54173	54174	leftward	0	None
54174	54175	shifts	0	None
54175	54176	in	0	None
54176	54177	the	0	None
54177	54178	voltage	0	None
54178	54179	dependence	0	None
54179	54180	of	0	None
54180	54181	channel	0	None
54181	54182	activation	0	None
54182	54183	(	0	None
54183	54184	-	0	None
54184	54185	33	0	None
54185	54186	.	0	None
54186	54187	1	0	None
54187	54188	+	0	None
54188	54189	/	0	None
54189	54190	-	0	None
54190	54191	2	0	None
54191	54192	.	0	None
54192	54193	6	0	None
54193	54194	mV	0	None
54194	54195	,	0	None
54195	54196	n	0	None
54196	54197	=	0	None
54197	54198	4	0	None
54198	54199	,	0	None
54199	54200	by	0	None
54200	54201	10	0	None
54201	54202	microM	0	None
54202	54203	retigabine	3	CHEMICAL
54203	54204	)	0	None
54204	54205	.	0	None

54206	54207	Retigabine	0	None
54207	54208	shifted	0	None
54208	54209	the	0	None
54209	54210	voltage	0	None
54210	54211	dependence	0	None
54211	54212	of	0	None
54212	54213	channel	0	None
54213	54214	activation	0	None
54214	54215	with	0	None
54215	54216	an	0	None
54216	54217	EC	0	None
54217	54218	(	0	None
54218	54219	50	0	None
54219	54220	)	0	None
54220	54221	value	0	None
54221	54222	of	0	None
54222	54223	1	0	None
54223	54224	.	0	None
54224	54225	6	0	None
54225	54226	+	0	None
54226	54227	/	0	None
54227	54228	-	0	None
54228	54229	0	0	None
54229	54230	.	0	None
54230	54231	3	0	None
54231	54232	microM	0	None
54232	54233	(	0	None
54233	54234	slope	0	None
54234	54235	factor	0	None
54235	54236	was	0	None
54236	54237	1	0	None
54237	54238	.	0	None
54238	54239	2	0	None
54239	54240	+	0	None
54240	54241	/	0	None
54241	54242	-	0	None
54242	54243	0	0	None
54243	54244	.	0	None
54244	54245	1	0	None
54245	54246	,	0	None
54246	54247	n	0	None
54247	54248	=	0	None
54248	54249	4	0	None
54249	54250	to	0	None
54250	54251	5	0	None
54251	54252	cells	0	None
54252	54253	per	0	None
54253	54254	concentration	0	None
54254	54255	)	0	None
54255	54256	.	0	None

54257	54258	Retigabine	0	None
54258	54259	(	0	None
54259	54260	0	0	None
54260	54261	.	0	None
54261	54262	1	0	None
54262	54263	to	0	None
54263	54264	10	0	None
54264	54265	microM	0	None
54265	54266	)	0	None
54266	54267	also	0	None
54267	54268	slowed	0	None
54268	54269	the	0	None
54269	54270	rate	0	None
54270	54271	of	0	None
54271	54272	channel	0	None
54272	54273	deactivation	0	None
54273	54274	,	0	None
54274	54275	predominantly	0	None
54275	54276	by	0	None
54276	54277	increasing	0	None
54277	54278	the	0	None
54278	54279	contribution	0	None
54279	54280	of	0	None
54280	54281	a	0	None
54281	54282	slowly	0	None
54282	54283	deactivating	0	None
54283	54284	tail	0	None
54284	54285	current	0	None
54285	54286	component	0	None
54286	54287	.	0	None

54288	54289	Our	0	None
54289	54290	findings	0	None
54290	54291	identify	0	None
54291	54292	KCNQ2	0	None
54292	54293	/	0	None
54293	54294	Q3	0	None
54294	54295	channels	0	None
54295	54296	as	0	None
54296	54297	a	0	None
54297	54298	molecular	0	None
54298	54299	target	0	None
54299	54300	for	0	None
54300	54301	retigabine	3	CHEMICAL
54301	54302	and	0	None
54302	54303	suggest	0	None
54303	54304	that	0	None
54304	54305	activation	0	None
54305	54306	of	0	None
54306	54307	KCNQ2	0	None
54307	54308	/	0	None
54308	54309	Q3	0	None
54309	54310	channels	0	None
54310	54311	may	0	None
54311	54312	be	0	None
54312	54313	responsible	0	None
54313	54314	for	0	None
54314	54315	at	0	None
54315	54316	least	0	None
54316	54317	some	0	None
54317	54318	of	0	None
54318	54319	the	0	None
54319	54320	anticonvulsant	0	None
54320	54321	activity	0	None
54321	54322	of	0	None
54322	54323	this	0	None
54323	54324	agent	0	None
54324	54325	.	0	None

54326	54327	Interaction	0	None
54327	54328	of	0	None
54328	54329	flavodoxin	3	CHEMICAL
54329	54330	with	0	None
54330	54331	cobalamin	3	CHEMICAL
54331	54332	-	0	None
54332	54333	dependent	0	None
54333	54335	methionine synthase	1	GENE-Y
54335	54336	.	0	None

54337	54338	Cobalamin	3	CHEMICAL
54338	54339	-	0	None
54339	54340	dependent	0	None
54340	54342	methionine synthase	1	GENE-Y
54342	54343	catalyzes	0	None
54343	54344	the	0	None
54344	54345	transfer	0	None
54345	54346	of	0	None
54346	54347	a	0	None
54347	54348	methyl	3	CHEMICAL
54348	54349	group	0	None
54349	54350	from	0	None
54350	54351	methyltetrahydrofolate	0	None
54351	54352	to	0	None
54352	54353	homocysteine	0	None
54353	54354	,	0	None
54354	54355	forming	0	None
54355	54356	tetrahydrofolate	3	CHEMICAL
54356	54357	and	0	None
54357	54358	methionine	3	CHEMICAL
54358	54359	.	0	None

54360	54361	The	0	None
54361	54362	Escherichia	0	None
54362	54363	coli	0	None
54363	54364	enzyme	0	None
54364	54365	,	0	None
54365	54366	like	0	None
54366	54367	its	0	None
54367	54368	mammalian	0	None
54368	54369	homologue	0	None
54369	54370	,	0	None
54370	54371	is	0	None
54371	54372	occasionally	0	None
54372	54373	inactivated	0	None
54373	54374	by	0	None
54374	54375	oxidation	0	None
54375	54376	of	0	None
54376	54377	the	0	None
54377	54378	cofactor	0	None
54378	54379	to	0	None
54379	54380	cob	1	GENE-Y
54380	54381	(	0	None
54381	54382	II	0	None
54382	54383	)	0	None
54383	54384	alamin	0	None
54384	54385	.	0	None

54386	54387	To	0	None
54387	54388	return	0	None
54388	54389	to	0	None
54389	54390	the	0	None
54390	54391	catalytic	0	None
54391	54392	cycle	0	None
54392	54393	,	0	None
54393	54394	the	0	None
54394	54395	cob	1	GENE-Y
54395	54396	(	0	None
54396	54397	II	0	None
54397	54398	)	0	None
54398	54399	alamin	0	None
54399	54400	forms	0	None
54400	54401	of	0	None
54401	54402	both	0	None
54402	54403	the	0	None
54403	54404	bacterial	0	None
54404	54405	and	0	None
54405	54406	mammalian	0	None
54406	54407	enzymes	0	None
54407	54408	must	0	None
54408	54409	be	0	None
54409	54410	reductively	0	None
54410	54411	remethylated	0	None
54411	54412	.	0	None

54413	54414	Reduced	0	None
54414	54415	flavodoxin	3	CHEMICAL
54415	54416	donates	0	None
54416	54417	an	0	None
54417	54418	electron	0	None
54418	54419	for	0	None
54419	54420	this	0	None
54420	54421	reaction	0	None
54421	54422	in	0	None
54422	54423	E	0	None
54423	54424	.	0	None
54424	54425	coli	0	None
54425	54426	,	0	None
54426	54427	and	0	None
54427	54428	S	0	None
54428	54429	-	0	None
54429	54430	adenosylmethionine	0	None
54430	54431	serves	0	None
54431	54432	as	0	None
54432	54433	the	0	None
54433	54434	methyl	3	CHEMICAL
54434	54435	donor	0	None
54435	54436	.	0	None

54437	54438	In	0	None
54438	54439	humans	0	None
54439	54440	,	0	None
54440	54441	the	0	None
54441	54442	electron	0	None
54442	54443	is	0	None
54443	54444	thought	0	None
54444	54445	to	0	None
54445	54446	be	0	None
54446	54447	provided	0	None
54447	54448	by	0	None
54448	54451	methionine synthase reductase	2	GENE-N
54451	54452	,	0	None
54452	54453	a	0	None
54453	54454	protein	0	None
54454	54455	containing	0	None
54455	54456	a	0	None
54456	54457	domain	0	None
54457	54458	with	0	None
54458	54459	a	0	None
54459	54460	significant	0	None
54460	54461	degree	0	None
54461	54462	of	0	None
54462	54463	homology	0	None
54463	54464	to	0	None
54464	54465	flavodoxin	3	CHEMICAL
54465	54466	.	0	None

54467	54468	Because	0	None
54468	54469	of	0	None
54469	54470	this	0	None
54470	54471	homology	0	None
54471	54472	,	0	None
54472	54473	studies	0	None
54473	54474	of	0	None
54474	54475	the	0	None
54475	54476	interactions	0	None
54476	54477	between	0	None
54477	54478	E	0	None
54478	54479	.	0	None
54479	54480	coli	0	None
54480	54481	flavodoxin	3	CHEMICAL
54481	54482	and	0	None
54482	54484	methionine synthase	1	GENE-Y
54484	54485	provide	0	None
54485	54486	a	0	None
54486	54487	model	0	None
54487	54488	for	0	None
54488	54489	the	0	None
54489	54490	mammalian	0	None
54490	54491	system	0	None
54491	54492	.	0	None

54493	54494	To	0	None
54494	54495	characterize	0	None
54495	54496	the	0	None
54496	54497	binding	0	None
54497	54498	interface	0	None
54498	54499	between	0	None
54499	54500	E	0	None
54500	54501	.	0	None
54501	54502	coli	0	None
54502	54503	flavodoxin	3	CHEMICAL
54503	54504	and	0	None
54504	54506	methionine synthase	1	GENE-Y
54506	54507	,	0	None
54507	54508	we	0	None
54508	54509	have	0	None
54509	54510	employed	0	None
54510	54511	site	0	None
54511	54512	-	0	None
54512	54513	directed	0	None
54513	54514	mutagenesis	0	None
54514	54515	and	0	None
54515	54516	chemical	0	None
54516	54517	cross	0	None
54517	54518	-	0	None
54518	54519	linking	0	None
54519	54520	using	0	None
54520	54521	carbodiimide	0	None
54521	54522	and	0	None
54522	54523	N	0	None
54523	54524	-	0	None
54524	54525	hydroxysuccinimide	0	None
54525	54526	.	0	None

54527	54528	Glutamate	0	None
54528	54529	61	0	None
54529	54530	of	0	None
54530	54531	flavodoxin	3	CHEMICAL
54531	54532	is	0	None
54532	54533	identified	0	None
54533	54534	as	0	None
54534	54535	a	0	None
54535	54536	cross	0	None
54536	54537	-	0	None
54537	54538	linked	0	None
54538	54539	residue	0	None
54539	54540	,	0	None
54540	54541	and	0	None
54541	54542	lysine	3	CHEMICAL
54542	54543	959	0	None
54543	54544	of	0	None
54544	54545	the	0	None
54545	54546	C	0	None
54546	54547	-	0	None
54547	54548	terminal	0	None
54548	54549	activation	0	None
54549	54550	domain	0	None
54550	54551	of	0	None
54551	54553	methionine synthase	1	GENE-Y
54553	54554	is	0	None
54554	54555	assigned	0	None
54555	54556	as	0	None
54556	54557	its	0	None
54557	54558	partner	0	None
54558	54559	.	0	None

54560	54561	The	0	None
54561	54562	mutation	0	None
54562	54563	of	0	None
54563	54567	lysine 959 to threonine	3	CHEMICAL
54567	54568	results	0	None
54568	54569	in	0	None
54569	54570	a	0	None
54570	54571	diminished	0	None
54571	54572	level	0	None
54572	54573	of	0	None
54573	54574	cross	0	None
54574	54575	-	0	None
54575	54576	linking	0	None
54576	54577	,	0	None
54577	54578	but	0	None
54578	54579	has	0	None
54579	54580	only	0	None
54580	54581	a	0	None
54581	54582	small	0	None
54582	54583	effect	0	None
54583	54584	on	0	None
54584	54585	the	0	None
54585	54586	affinity	0	None
54586	54587	of	0	None
54587	54589	methionine synthase	1	GENE-Y
54589	54590	for	0	None
54590	54591	flavodoxin	3	CHEMICAL
54591	54592	.	0	None

54593	54594	Identification	0	None
54594	54595	of	0	None
54595	54596	these	0	None
54596	54597	cross	0	None
54597	54598	-	0	None
54598	54599	linked	0	None
54599	54600	residues	0	None
54600	54601	provides	0	None
54601	54602	evidence	0	None
54602	54603	in	0	None
54603	54604	support	0	None
54604	54605	of	0	None
54605	54606	a	0	None
54606	54607	docking	0	None
54607	54608	model	0	None
54608	54609	that	0	None
54609	54610	will	0	None
54610	54611	be	0	None
54611	54612	useful	0	None
54612	54613	in	0	None
54613	54614	predicting	0	None
54614	54615	the	0	None
54615	54616	effects	0	None
54616	54617	of	0	None
54617	54618	mutations	0	None
54618	54619	observed	0	None
54619	54620	in	0	None
54620	54621	mammalian	0	None
54621	54622	homologues	0	None
54622	54623	of	0	None
54623	54624	E	0	None
54624	54625	.	0	None
54625	54626	coli	0	None
54626	54627	flavodoxin	3	CHEMICAL
54627	54628	and	0	None
54628	54630	methionine synthase	1	GENE-Y
54630	54631	.	0	None

54632	54633	A	0	None
54633	54634	gene	0	None
54634	54635	for	0	None
54635	54636	pyridoxine	0	None
54636	54637	-	0	None
54637	54638	dependent	0	None
54638	54639	epilepsy	0	None
54639	54640	maps	2	GENE-N
54640	54641	to	0	None
54641	54642	chromosome	0	None
54642	54643	5q31	0	None
54643	54644	.	0	None

54645	54646	Pyridoxine	0	None
54646	54647	-	0	None
54647	54648	dependent	0	None
54648	54649	epilepsy	0	None
54649	54650	(	0	None
54650	54651	PDE	2	GENE-N
54651	54652	)	0	None
54652	54653	is	0	None
54653	54654	a	0	None
54654	54655	rare	0	None
54655	54656	autosomal	0	None
54656	54657	recessive	0	None
54657	54658	disorder	0	None
54658	54659	characterized	0	None
54659	54660	by	0	None
54660	54661	generalized	0	None
54661	54662	seizures	0	None
54662	54663	in	0	None
54663	54664	the	0	None
54664	54665	first	0	None
54665	54666	hours	0	None
54666	54667	of	0	None
54667	54668	life	0	None
54668	54669	and	0	None
54669	54670	responding	0	None
54670	54671	only	0	None
54671	54672	to	0	None
54672	54674	pyridoxine hydrochloride	3	CHEMICAL
54674	54675	.	0	None

54676	54677	The	0	None
54677	54678	pathogenesis	0	None
54678	54679	of	0	None
54679	54680	PDE	2	GENE-N
54680	54681	is	0	None
54681	54682	unknown	0	None
54682	54683	,	0	None
54683	54684	but	0	None
54684	54685	an	0	None
54685	54686	alteration	0	None
54686	54687	in	0	None
54687	54688	the	0	None
54688	54689	binding	0	None
54689	54690	of	0	None
54690	54691	pyridoxal	0	None
54691	54692	5	0	None
54692	54693	-	0	None
54693	54694	phosphate	3	CHEMICAL
54694	54695	to	0	None
54695	54698	glutamic acid decarboxylase	2	GENE-N
54698	54699	(	0	None
54699	54700	GAD	1	GENE-Y
54700	54701	)	0	None
54701	54702	has	0	None
54702	54703	been	0	None
54703	54704	postulated	0	None
54704	54705	in	0	None
54705	54706	patients	0	None
54706	54707	with	0	None
54707	54708	PDE	2	GENE-N
54708	54709	.	0	None

54710	54711	Results	0	None
54711	54712	are	0	None
54712	54713	reported	0	None
54713	54714	for	0	None
54714	54715	genetic	0	None
54715	54716	linkage	0	None
54716	54717	analyses	0	None
54717	54718	in	0	None
54718	54719	four	0	None
54719	54720	families	0	None
54720	54721	with	0	None
54721	54722	consanguineous	0	None
54722	54723	parents	0	None
54723	54724	and	0	None
54724	54725	in	0	None
54725	54726	one	0	None
54726	54727	family	0	None
54727	54728	with	0	None
54728	54729	nonconsanguineous	0	None
54729	54730	parents	0	None
54730	54731	.	0	None

54732	54733	The	0	None
54733	54734	GAD1	1	GENE-Y
54734	54735	(	0	None
54735	54736	2q31	0	None
54736	54737	)	0	None
54737	54738	and	0	None
54738	54739	GAD2	1	GENE-Y
54739	54740	genes	0	None
54740	54741	(	0	None
54741	54742	10p23	0	None
54742	54743	)	0	None
54743	54744	were	0	None
54744	54745	tested	0	None
54745	54746	and	0	None
54746	54747	excluded	0	None
54747	54748	.	0	None

54749	54750	A	0	None
54750	54751	genomewide	0	None
54751	54752	search	0	None
54752	54753	was	0	None
54753	54754	subsequently	0	None
54754	54755	performed	0	None
54755	54756	,	0	None
54756	54757	using	0	None
54757	54758	microsatellite	0	None
54758	54759	markers	0	None
54759	54760	at	0	None
54760	54761	an	0	None
54761	54762	average	0	None
54762	54763	distance	0	None
54763	54764	of	0	None
54764	54765	10	0	None
54765	54766	cM	0	None
54766	54767	,	0	None
54767	54768	and	0	None
54768	54769	the	0	None
54769	54770	search	0	None
54770	54771	revealed	0	None
54771	54772	linkage	0	None
54772	54773	of	0	None
54773	54774	the	0	None
54774	54775	disease	0	None
54775	54776	-	0	None
54776	54777	causing	0	None
54777	54778	gene	0	None
54778	54779	to	0	None
54779	54780	markers	0	None
54780	54781	on	0	None
54781	54782	chromosome	0	None
54782	54783	5q31	0	None
54783	54784	.	0	None
54784	54785	2	0	None
54785	54786	-	0	None
54786	54787	q31	0	None
54787	54788	.	0	None
54788	54789	3	0	None
54789	54790	(	0	None
54790	54791	maximum	0	None
54791	54792	LOD	0	None
54792	54793	score	0	None
54793	54794	[	0	None
54794	54795	Z	0	None
54795	54796	(	0	None
54796	54797	max	1	GENE-Y
54797	54798	)	0	None
54798	54799	]	0	None
54799	54800	8	0	None
54800	54801	.	0	None
54801	54802	43	0	None
54802	54803	at	0	None
54803	54804	recombination	0	None
54804	54805	fraction	0	None
54805	54806	[	0	None
54806	54807	theta	0	None
54807	54808	]	0	None
54808	54809	0	0	None
54809	54810	and	0	None
54810	54811	Zmax	0	None
54811	54812	=	0	None
54812	54813	7	0	None
54813	54814	.	0	None
54814	54815	58	0	None
54815	54816	at	0	None
54816	54817	straight	0	None
54817	54818	theta	0	None
54818	54819	=	0	None
54819	54820	0	0	None
54820	54821	at	0	None
54821	54822	loci	0	None
54822	54823	D5S2017	0	None
54823	54824	and	0	None
54824	54825	D5S1972	0	None
54825	54826	,	0	None
54826	54827	respectively	0	None
54827	54828	)	0	None
54828	54829	.	0	None

54830	54831	A	0	None
54831	54832	recombination	0	None
54832	54833	event	0	None
54833	54834	,	0	None
54834	54835	between	0	None
54835	54836	loci	0	None
54836	54837	D5S638	0	None
54837	54838	and	0	None
54838	54839	D5S463	0	None
54839	54840	,	0	None
54840	54841	in	0	None
54841	54842	one	0	None
54842	54843	family	0	None
54843	54844	defined	0	None
54844	54845	the	0	None
54845	54846	distal	0	None
54846	54847	boundary	0	None
54847	54848	,	0	None
54848	54849	and	0	None
54849	54850	a	0	None
54850	54851	second	0	None
54851	54852	recombination	0	None
54852	54853	event	0	None
54853	54854	between	0	None
54854	54855	loci	0	None
54855	54856	D5S2011	0	None
54856	54857	and	0	None
54857	54858	D5S2017	0	None
54858	54859	in	0	None
54859	54860	another	0	None
54860	54861	family	0	None
54861	54862	defined	0	None
54862	54863	the	0	None
54863	54864	proximal	0	None
54864	54865	boundary	0	None
54865	54866	of	0	None
54866	54867	the	0	None
54867	54868	genetic	0	None
54868	54869	interval	0	None
54869	54870	encompassing	0	None
54870	54871	the	0	None
54871	54872	PDE	2	GENE-N
54872	54873	gene	0	None
54873	54874	(	0	None
54874	54875	5	0	None
54875	54876	.	0	None
54876	54877	1	0	None
54877	54878	cM	0	None
54878	54879	)	0	None
54879	54880	.	0	None

54881	54882	Ongoing	0	None
54882	54883	studies	0	None
54883	54884	may	0	None
54884	54885	lead	0	None
54885	54886	to	0	None
54886	54887	the	0	None
54887	54888	identification	0	None
54888	54889	of	0	None
54889	54890	the	0	None
54890	54891	disease	0	None
54891	54892	-	0	None
54892	54893	causing	0	None
54893	54894	gene	0	None
54894	54895	.	0	None

54896	54897	Serotonin	0	None
54897	54898	transporter	0	None
54898	54899	gene	0	None
54899	54900	regulatory	0	None
54900	54901	region	0	None
54901	54902	polymorphism	0	None
54902	54903	(	0	None
54903	54904	5	0	None
54904	54905	-	0	None
54905	54906	HTTLPR	0	None
54906	54907	)	0	None
54907	54908	,	0	None
54908	54909	[	0	None
54909	54910	3H	0	None
54910	54911	]	0	None
54911	54912	paroxetine	3	CHEMICAL
54912	54913	binding	0	None
54913	54914	in	0	None
54914	54915	healthy	0	None
54915	54916	control	0	None
54916	54917	subjects	0	None
54917	54918	and	0	None
54918	54919	alcohol	3	CHEMICAL
54919	54920	-	0	None
54920	54921	dependent	0	None
54921	54922	patients	0	None
54922	54923	and	0	None
54923	54924	their	0	None
54924	54925	relationships	0	None
54925	54926	to	0	None
54926	54927	impulsivity	0	None
54927	54928	.	0	None

54929	54930	The	0	None
54930	54931	aim	0	None
54931	54932	of	0	None
54932	54933	this	0	None
54933	54934	study	0	None
54934	54935	was	0	None
54935	54936	to	0	None
54936	54937	investigate	0	None
54937	54938	[	0	None
54938	54939	3H	0	None
54939	54940	]	0	None
54940	54941	paroxetine	3	CHEMICAL
54941	54942	binding	0	None
54942	54943	and	0	None
54943	54944	impulsivity	0	None
54944	54945	in	0	None
54945	54946	alcohol	3	CHEMICAL
54946	54947	-	0	None
54947	54948	dependent	0	None
54948	54949	and	0	None
54949	54950	age	1	GENE-Y
54950	54951	-	0	None
54951	54952	matched	0	None
54952	54953	control	0	None
54953	54954	subjects	0	None
54954	54955	in	0	None
54955	54956	relation	0	None
54956	54957	to	0	None
54957	54958	a	0	None
54958	54959	5	0	None
54959	54960	'	0	None
54960	54961	-	0	None
54961	54962	promoter	2	GENE-N
54962	54963	region	0	None
54963	54965	serotonin transporter	1	GENE-Y
54965	54966	(	0	None
54966	54967	5	0	None
54967	54968	-	0	None
54968	54969	HTT	0	None
54969	54970	)	0	None
54970	54971	polymorphism	0	None
54971	54972	(	0	None
54972	54973	5	0	None
54973	54974	-	0	None
54974	54975	HTTLPR	0	None
54975	54976	)	0	None
54976	54977	.	0	None

54978	54979	Alcohol	0	None
54979	54980	-	0	None
54980	54981	dependent	0	None
54981	54982	subjects	0	None
54982	54983	were	0	None
54983	54984	hypothesized	0	None
54984	54985	to	0	None
54985	54986	show	0	None
54986	54987	a	0	None
54987	54988	decreased	0	None
54988	54989	number	0	None
54989	54990	of	0	None
54990	54991	bindings	0	None
54991	54992	sites	0	None
54992	54993	and	0	None
54993	54994	a	0	None
54994	54995	lower	0	None
54995	54996	dissociation	0	None
54996	54997	constant	0	None
54997	54998	.	0	None

54999	55000	5	0	None
55000	55001	-	0	None
55001	55002	HTTLPR	0	None
55002	55003	S	0	None
55003	55004	-	0	None
55004	55005	genotype	0	None
55005	55006	carriers	0	None
55006	55007	in	0	None
55007	55008	both	0	None
55008	55009	alcohol	3	CHEMICAL
55009	55010	-	0	None
55010	55011	dependent	0	None
55011	55012	and	0	None
55012	55013	control	0	None
55013	55014	subjects	0	None
55014	55015	were	0	None
55015	55016	expected	0	None
55016	55017	to	0	None
55017	55018	show	0	None
55018	55019	significantly	0	None
55019	55020	fewer	0	None
55020	55021	binding	0	None
55021	55022	sites	0	None
55022	55023	and	0	None
55023	55024	a	0	None
55024	55025	lower	0	None
55025	55026	dissociation	0	None
55026	55027	constant	0	None
55027	55028	.	0	None

55029	55030	Influences	0	None
55030	55031	of	0	None
55031	55032	impulsive	0	None
55032	55033	traits	0	None
55033	55034	,	0	None
55034	55035	chronic	0	None
55035	55036	daily	0	None
55036	55037	alcohol	3	CHEMICAL
55037	55038	intake	0	None
55038	55039	,	0	None
55039	55040	duration	0	None
55040	55041	of	0	None
55041	55042	alcohol	3	CHEMICAL
55042	55043	dependence	0	None
55043	55044	,	0	None
55044	55045	age	1	GENE-Y
55045	55046	of	0	None
55046	55047	onset	0	None
55047	55048	and	0	None
55048	55049	age	1	GENE-Y
55049	55050	on	0	None
55050	55051	[	0	None
55051	55052	3H	0	None
55052	55053	]	0	None
55053	55054	paroxetine	3	CHEMICAL
55054	55055	binding	0	None
55055	55056	were	0	None
55056	55057	also	0	None
55057	55058	investigated	0	None
55058	55059	.	0	None

55060	55061	Inpatients	0	None
55061	55062	meeting	0	None
55062	55063	DSM	0	None
55063	55064	IV	0	None
55064	55065	alcohol	3	CHEMICAL
55065	55066	dependence	0	None
55066	55067	criteria	0	None
55067	55068	and	0	None
55068	55069	of	0	None
55069	55070	German	0	None
55070	55071	descent	0	None
55071	55072	were	0	None
55072	55073	recruited	0	None
55073	55074	to	0	None
55074	55075	avoid	0	None
55075	55076	ethnic	0	None
55076	55077	stratification	0	None
55077	55078	effects	0	None
55078	55079	.	0	None

55080	55081	One	0	None
55081	55082	hundred	0	None
55082	55083	and	0	None
55083	55084	seventeen	0	None
55084	55085	control	0	None
55085	55086	subjects	0	None
55086	55087	of	0	None
55087	55088	similar	0	None
55088	55089	social	0	None
55089	55090	status	0	None
55090	55091	were	0	None
55091	55092	recruited	0	None
55092	55093	from	0	None
55093	55094	a	0	None
55094	55095	town	0	None
55095	55096	community	0	None
55096	55097	.	0	None

55098	55099	Blood	0	None
55099	55100	samples	0	None
55100	55101	were	0	None
55101	55102	taken	0	None
55102	55103	from	0	None
55103	55104	both	0	None
55104	55105	alcohol	3	CHEMICAL
55105	55106	-	0	None
55106	55107	dependent	0	None
55107	55108	and	0	None
55108	55109	control	0	None
55109	55110	subjects	0	None
55110	55111	to	0	None
55111	55112	determine	0	None
55112	55113	5	0	None
55113	55114	-	0	None
55114	55115	HTTLPR	0	None
55115	55116	genotypes	0	None
55116	55117	using	0	None
55117	55118	PCR	0	None
55118	55119	of	0	None
55119	55120	lymphocyte	0	None
55120	55121	DNA	3	CHEMICAL
55121	55122	,	0	None
55122	55123	and	0	None
55123	55124	to	0	None
55124	55125	perform	0	None
55125	55126	platelet	0	None
55126	55127	[	0	None
55127	55128	3H	0	None
55128	55129	]	0	None
55129	55130	paroxetine	3	CHEMICAL
55130	55131	binding	0	None
55131	55132	(	0	None
55132	55133	binding	0	None
55133	55134	capacity	0	None
55134	55135	:	0	None
55135	55136	B	0	None
55136	55137	(	0	None
55137	55138	max	1	GENE-Y
55138	55139	)	0	None
55139	55140	;	0	None
55140	55141	and	0	None
55141	55142	dissociation	0	None
55142	55143	constant	0	None
55143	55144	:	0	None
55144	55145	K	0	None
55145	55146	(	0	None
55146	55147	D	0	None
55147	55148	)	0	None
55148	55149	)	0	None
55149	55150	.	0	None

55151	55152	Impulsivity	0	None
55152	55153	was	0	None
55153	55154	assessed	0	None
55154	55155	using	0	None
55155	55156	the	0	None
55156	55157	Barratt	0	None
55157	55158	impulsiveness	0	None
55158	55159	scale	0	None
55159	55160	version	0	None
55160	55161	5	0	None
55161	55162	(	0	None
55162	55163	BIS	0	None
55163	55164	-	0	None
55164	55165	5	0	None
55165	55166	)	0	None
55166	55167	in	0	None
55167	55168	alcohol	3	CHEMICAL
55168	55169	-	0	None
55169	55170	dependent	0	None
55170	55171	subjects	0	None
55171	55172	only	0	None
55172	55173	.	0	None

55174	55175	Alcohol	0	None
55175	55176	-	0	None
55176	55177	dependent	0	None
55177	55178	subjects	0	None
55178	55179	were	0	None
55179	55180	subdivided	0	None
55180	55181	into	0	None
55181	55182	low	0	None
55182	55183	or	0	None
55183	55184	high	0	None
55184	55185	impulsivity	0	None
55185	55186	groups	0	None
55186	55187	using	0	None
55187	55188	a	0	None
55188	55189	median	0	None
55189	55190	-	0	None
55190	55191	split	0	None
55191	55192	of	0	None
55192	55193	the	0	None
55193	55194	BIS	0	None
55194	55195	-	0	None
55195	55196	5	0	None
55196	55197	scale	0	None
55197	55198	.	0	None

55199	55200	The	0	None
55200	55201	control	0	None
55201	55202	group	0	None
55202	55203	was	0	None
55203	55204	slightly	0	None
55204	55205	older	0	None
55205	55206	than	0	None
55206	55207	the	0	None
55207	55208	alcohol	3	CHEMICAL
55208	55209	-	0	None
55209	55210	dependent	0	None
55210	55211	group	0	None
55211	55212	(	0	None
55212	55213	not	0	None
55213	55214	statistically	0	None
55214	55215	significant	0	None
55215	55216	)	0	None
55216	55217	.	0	None

55218	55219	[	0	None
55219	55220	3H	0	None
55220	55221	]	0	None
55221	55222	paroxetine	3	CHEMICAL
55222	55223	binding	0	None
55223	55224	was	0	None
55224	55225	investigated	0	None
55225	55226	in	0	None
55226	55227	72	0	None
55227	55228	control	0	None
55228	55229	subjects	0	None
55229	55230	and	0	None
55230	55231	72	0	None
55231	55232	patients	0	None
55232	55233	,	0	None
55233	55234	of	0	None
55234	55235	which	0	None
55235	55236	five	0	None
55236	55237	patients	0	None
55237	55238	met	3	CHEMICAL
55238	55239	type	0	None
55239	55240	2	0	None
55240	55241	alcohol	3	CHEMICAL
55241	55242	dependence	0	None
55242	55243	criteria	0	None
55243	55244	.	0	None

55245	55246	Genotyping	0	None
55246	55247	was	0	None
55247	55248	carried	0	None
55248	55249	out	0	None
55249	55250	in	0	None
55250	55251	all	0	None
55251	55252	patients	0	None
55252	55253	and	0	None
55253	55254	control	0	None
55254	55255	subjects	0	None
55255	55256	.	0	None

55257	55258	A	0	None
55258	55259	significant	0	None
55259	55260	influence	0	None
55260	55261	of	0	None
55261	55262	duration	0	None
55262	55263	of	0	None
55263	55264	alcohol	3	CHEMICAL
55264	55265	dependence	0	None
55265	55266	was	0	None
55266	55267	found	0	None
55267	55268	on	0	None
55268	55269	the	0	None
55269	55270	[	0	None
55270	55271	3H	0	None
55271	55272	]	0	None
55272	55273	paroxetine	3	CHEMICAL
55273	55274	binding	0	None
55274	55275	K	0	None
55275	55276	(	0	None
55276	55277	D	0	None
55277	55278	)	0	None
55278	55279	but	0	None
55279	55280	not	0	None
55280	55281	B	0	None
55281	55282	(	0	None
55282	55283	max	1	GENE-Y
55283	55284	.	0	None
55284	55285	)	0	None
55285	55286	Neither	0	None
55286	55287	alcohol	3	CHEMICAL
55287	55288	-	0	None
55288	55289	dependent	0	None
55289	55290	nor	0	None
55290	55291	control	0	None
55291	55292	subjects	0	None
55292	55293	showed	0	None
55293	55294	any	0	None
55294	55295	differences	0	None
55295	55296	in	0	None
55296	55297	B	0	None
55297	55298	(	0	None
55298	55299	max	1	GENE-Y
55299	55300	)	0	None
55300	55301	or	0	None
55301	55302	K	0	None
55302	55303	(	0	None
55303	55304	D	0	None
55304	55305	)	0	None
55305	55306	.	0	None

55307	55308	S	0	None
55308	55309	-	0	None
55309	55310	allele	0	None
55310	55311	carriers	0	None
55311	55312	did	0	None
55312	55313	not	0	None
55313	55314	show	0	None
55314	55315	a	0	None
55315	55316	decreased	0	None
55316	55317	binding	0	None
55317	55318	or	0	None
55318	55319	lower	0	None
55319	55320	dissociation	0	None
55320	55321	constant	0	None
55321	55322	.	0	None

55323	55324	Furthermore	0	None
55324	55325	,	0	None
55325	55326	no	0	None
55326	55327	significant	0	None
55327	55328	interaction	0	None
55328	55329	between	0	None
55329	55330	B	0	None
55330	55331	(	0	None
55331	55332	max	1	GENE-Y
55332	55333	)	0	None
55333	55334	and	0	None
55334	55335	K	0	None
55335	55336	(	0	None
55336	55337	D	0	None
55337	55338	)	0	None
55338	55339	with	0	None
55339	55340	either	0	None
55340	55341	5	0	None
55341	55342	-	0	None
55342	55343	HTTLPR	0	None
55343	55344	genotype	0	None
55344	55345	or	0	None
55345	55346	impulsivity	0	None
55346	55347	was	0	None
55347	55348	revealed	0	None
55348	55349	.	0	None

55350	55351	This	0	None
55351	55352	was	0	None
55352	55353	the	0	None
55353	55354	first	0	None
55354	55355	study	0	None
55355	55356	to	0	None
55356	55357	investigate	0	None
55357	55358	platelet	0	None
55358	55359	[	0	None
55359	55360	3H	0	None
55360	55361	]	0	None
55361	55362	paroxetine	3	CHEMICAL
55362	55363	binding	0	None
55363	55364	in	0	None
55364	55365	alcohol	3	CHEMICAL
55365	55366	-	0	None
55366	55367	dependent	0	None
55367	55368	and	0	None
55368	55369	age	1	GENE-Y
55369	55370	-	0	None
55370	55371	matched	0	None
55371	55372	control	0	None
55372	55373	subjects	0	None
55373	55374	in	0	None
55374	55375	relation	0	None
55375	55376	to	0	None
55376	55377	the	0	None
55377	55378	5	0	None
55378	55379	-	0	None
55379	55380	HTTLPR	0	None
55380	55381	genotype	0	None
55381	55382	.	0	None

55383	55384	No	0	None
55384	55385	differences	0	None
55385	55386	concerning	0	None
55386	55387	5	0	None
55387	55388	-	0	None
55388	55389	HTTLPR	0	None
55389	55390	-	0	None
55390	55391	alleles	0	None
55391	55392	were	0	None
55392	55393	found	0	None
55393	55394	in	0	None
55394	55395	these	0	None
55395	55396	groups	0	None
55396	55397	Furthermore	0	None
55397	55398	,	0	None
55398	55399	no	0	None
55399	55400	significant	0	None
55400	55401	interaction	0	None
55401	55402	between	0	None
55402	55403	these	0	None
55403	55404	parameters	0	None
55404	55405	and	0	None
55405	55406	impulsivity	0	None
55406	55407	was	0	None
55407	55408	shown	0	None
55408	55409	in	0	None
55409	55410	alcohol	3	CHEMICAL
55410	55411	-	0	None
55411	55412	dependent	0	None
55412	55413	subjects	0	None
55413	55414	.	0	None

55415	55416	These	0	None
55416	55417	results	0	None
55417	55418	do	0	None
55418	55419	not	0	None
55419	55420	support	0	None
55420	55421	previous	0	None
55421	55422	results	0	None
55422	55423	of	0	None
55423	55424	altered	0	None
55424	55425	[	0	None
55425	55426	3H	0	None
55426	55427	]	0	None
55427	55428	paroxetine	3	CHEMICAL
55428	55429	binding	0	None
55429	55430	sites	0	None
55430	55431	in	0	None
55431	55432	alcohol	3	CHEMICAL
55432	55433	-	0	None
55433	55434	dependent	0	None
55434	55435	subjects	0	None
55435	55436	or	0	None
55436	55437	5	0	None
55437	55438	-	0	None
55438	55439	HTTLPR	0	None
55439	55440	S	0	None
55440	55441	-	0	None
55441	55442	allele	0	None
55442	55443	carriers	0	None
55443	55444	.	0	None

55445	55446	K	0	None
55446	55447	(	0	None
55447	55448	D	0	None
55448	55449	)	0	None
55449	55450	might	0	None
55450	55451	be	0	None
55451	55452	influenced	0	None
55452	55453	by	0	None
55453	55454	duration	0	None
55454	55455	of	0	None
55455	55456	alcohol	3	CHEMICAL
55456	55457	dependence	0	None
55457	55458	,	0	None
55458	55459	but	0	None
55459	55460	not	0	None
55460	55461	sufficiently	0	None
55461	55462	to	0	None
55462	55463	yield	0	None
55463	55464	differences	0	None
55464	55465	between	0	None
55465	55466	alcohol	3	CHEMICAL
55466	55467	-	0	None
55467	55468	dependent	0	None
55468	55469	and	0	None
55469	55470	control	0	None
55470	55471	subjects	0	None
55471	55472	.	0	None

55473	55474	Entacapone	3	CHEMICAL
55474	55475	.	0	None

55476	55477	OBJECTIVE	0	None
55477	55478	:	0	None
55478	55479	To	0	None
55479	55480	introduce	0	None
55480	55481	entacapone	3	CHEMICAL
55481	55482	,	0	None
55482	55483	a	0	None
55483	55484	new	0	None
55484	55485	catechol	3	CHEMICAL
55485	55486	-	0	None
55486	55487	O	0	None
55487	55488	-	0	None
55488	55489	methyltransferase	0	None
55489	55490	inhibitor	0	None
55490	55491	,	0	None
55491	55492	and	0	None
55492	55493	discuss	0	None
55493	55494	its	0	None
55494	55495	pharmacology	0	None
55495	55496	,	0	None
55496	55497	pharmacodynamics	0	None
55497	55498	,	0	None
55498	55499	pharmacokinetics	0	None
55499	55500	,	0	None
55500	55501	clinical	0	None
55501	55502	efficacy	0	None
55502	55503	,	0	None
55503	55504	drug	0	None
55504	55505	interactions	0	None
55505	55506	,	0	None
55506	55507	adverse	0	None
55507	55508	events	0	None
55508	55509	,	0	None
55509	55510	dosage	0	None
55510	55511	guidelines	0	None
55511	55512	,	0	None
55512	55513	and	0	None
55513	55514	therapeutic	0	None
55514	55515	and	0	None
55515	55516	formulary	0	None
55516	55517	considerations	0	None
55517	55518	.	0	None

55519	55520	DATA	0	None
55520	55521	SOURCE	0	None
55521	55522	:	0	None
55522	55523	A	0	None
55523	55524	MEDLINE	0	None
55524	55525	database	0	None
55525	55526	search	0	None
55526	55527	(	0	None
55527	55528	1966	0	None
55528	55529	-	0	None
55529	55530	December	0	None
55530	55531	1999	0	None
55531	55532	)	0	None
55532	55533	was	0	None
55533	55534	performed	0	None
55534	55535	to	0	None
55535	55536	identify	0	None
55536	55537	relevant	0	None
55537	55538	English	0	None
55538	55539	-	0	None
55539	55540	language	0	None
55540	55541	articles	0	None
55541	55542	including	0	None
55542	55543	recent	0	None
55543	55544	studies	0	None
55544	55545	,	0	None
55545	55546	abstracts	0	None
55546	55547	,	0	None
55547	55548	and	0	None
55548	55549	reviews	0	None
55549	55550	.	0	None

55551	55552	Search	0	None
55552	55553	terms	0	None
55553	55554	included	0	None
55554	55555	entacapone	3	CHEMICAL
55555	55556	,	0	None
55556	55557	OR	0	None
55557	55558	-	0	None
55558	55559	611	0	None
55559	55560	,	0	None
55560	55561	catechol	3	CHEMICAL
55561	55562	-	0	None
55562	55563	O	0	None
55563	55564	-	0	None
55564	55565	methyltransferase	0	None
55565	55566	inhibitor	0	None
55566	55567	,	0	None
55567	55568	and	0	None
55568	55569	Parkinson	0	None
55569	55570	'	0	None
55570	55571	s	0	None
55571	55572	disease	0	None
55572	55573	.	0	None

55574	55575	STUDY	0	None
55575	55576	SELECTION	0	None
55576	55577	:	0	None
55577	55578	Relevant	0	None
55578	55579	published	0	None
55579	55580	human	0	None
55580	55581	studies	0	None
55581	55582	were	0	None
55582	55583	chosen	0	None
55583	55584	to	0	None
55584	55585	summarize	0	None
55585	55586	the	0	None
55586	55587	pharmacokinetics	0	None
55587	55588	,	0	None
55588	55589	clinical	0	None
55589	55590	efficacy	0	None
55590	55591	,	0	None
55591	55592	adverse	0	None
55592	55593	effects	0	None
55593	55594	,	0	None
55594	55595	and	0	None
55595	55596	drug	0	None
55596	55597	interactions	0	None
55597	55598	.	0	None

55599	55600	DATA	0	None
55600	55601	EXTRACTION	0	None
55601	55602	:	0	None
55602	55603	All	0	None
55603	55604	available	0	None
55604	55605	human	0	None
55605	55606	clinical	0	None
55606	55607	trials	0	None
55607	55608	were	0	None
55608	55609	reviewed	0	None
55609	55610	.	0	None

55611	55612	DATA	0	None
55612	55613	SYNTHESIS	0	None
55613	55614	:	0	None
55614	55615	Entacapone	3	CHEMICAL
55615	55616	is	0	None
55616	55617	the	0	None
55617	55618	second	0	None
55618	55619	medication	0	None
55619	55620	of	0	None
55620	55621	a	0	None
55621	55622	new	0	None
55622	55623	class	0	None
55623	55624	of	0	None
55624	55625	drugs	0	None
55625	55626	,	0	None
55626	55627	the	0	None
55627	55628	catechol	3	CHEMICAL
55628	55629	-	0	None
55629	55630	O	0	None
55630	55631	-	0	None
55631	55632	methyltransferase	0	None
55632	55633	inhibitors	0	None
55633	55634	,	0	None
55634	55635	indicated	0	None
55635	55636	for	0	None
55636	55637	clinical	0	None
55637	55638	use	0	None
55638	55639	as	0	None
55639	55640	an	0	None
55640	55641	adjunct	0	None
55641	55642	to	0	None
55642	55643	levodopa	3	CHEMICAL
55643	55644	/	0	None
55644	55645	carbidopa	3	CHEMICAL
55645	55646	to	0	None
55646	55647	treat	0	None
55647	55648	patients	0	None
55648	55649	with	0	None
55649	55650	idiopathic	0	None
55650	55651	Parkinson	0	None
55651	55652	'	0	None
55652	55653	s	0	None
55653	55654	disease	0	None
55654	55655	who	0	None
55655	55656	experience	0	None
55656	55657	the	0	None
55657	55658	signs	0	None
55658	55659	and	0	None
55659	55660	symptoms	0	None
55660	55661	of	0	None
55661	55662	end	0	None
55662	55663	-	0	None
55663	55664	of	0	None
55664	55665	-	0	None
55665	55666	dose	0	None
55666	55667	wearing	0	None
55667	55668	-	0	None
55668	55669	off	0	None
55669	55670	.	0	None

55671	55672	Entacapone	3	CHEMICAL
55672	55673	in	0	None
55673	55674	combination	0	None
55674	55675	with	0	None
55675	55676	levodopa	3	CHEMICAL
55676	55677	/	0	None
55677	55679	dopa decarboxylase	1	GENE-Y
55679	55680	inhibitor	0	None
55680	55681	has	0	None
55681	55682	been	0	None
55682	55683	shown	0	None
55683	55684	to	0	None
55684	55685	increase	0	None
55685	55686	the	0	None
55686	55687	AUC	0	None
55687	55688	of	0	None
55688	55689	levodopa	3	CHEMICAL
55689	55690	,	0	None
55690	55691	which	0	None
55691	55692	leads	0	None
55692	55693	to	0	None
55693	55694	less	0	None
55694	55695	fluctuation	0	None
55695	55696	of	0	None
55696	55697	levodopa	3	CHEMICAL
55697	55698	plasma	0	None
55698	55699	concentrations	0	None
55699	55700	.	0	None

55701	55702	Clinically	0	None
55702	55703	,	0	None
55703	55704	the	0	None
55704	55705	duration	0	None
55705	55706	of	0	None
55706	55707	motor	0	None
55707	55708	response	0	None
55708	55709	to	0	None
55709	55710	levodopa	3	CHEMICAL
55710	55711	was	0	None
55711	55712	prolonged	0	None
55712	55713	as	0	None
55713	55714	reflected	0	None
55714	55715	by	0	None
55715	55716	an	0	None
55716	55717	increase	0	None
55717	55718	in	0	None
55718	55719	the	0	None
55719	55720	mean	0	None
55720	55721	on	0	None
55721	55722	time	0	None
55722	55723	.	0	None

55724	55725	The	0	None
55725	55726	addition	0	None
55726	55727	of	0	None
55727	55728	entacapone	3	CHEMICAL
55728	55729	resulted	0	None
55729	55730	in	0	None
55730	55731	a	0	None
55731	55732	decrease	0	None
55732	55733	in	0	None
55733	55734	the	0	None
55734	55735	mean	0	None
55735	55736	daily	0	None
55736	55737	dosage	0	None
55737	55738	of	0	None
55738	55739	levodopa	3	CHEMICAL
55739	55740	.	0	None

55741	55742	The	0	None
55742	55743	recommended	0	None
55743	55744	dosage	0	None
55744	55745	of	0	None
55745	55746	entacapone	3	CHEMICAL
55746	55747	is	0	None
55747	55748	200	0	None
55748	55749	mg	0	None
55749	55750	administered	0	None
55750	55751	orally	0	None
55751	55752	with	0	None
55752	55753	each	0	None
55753	55754	dose	0	None
55754	55755	of	0	None
55755	55756	levodopa	3	CHEMICAL
55756	55757	/	0	None
55757	55758	carbidopa	3	CHEMICAL
55758	55759	,	0	None
55759	55760	up	0	None
55760	55761	to	0	None
55761	55762	a	0	None
55762	55763	maximum	0	None
55763	55764	of	0	None
55764	55765	eight	0	None
55765	55766	doses	0	None
55766	55767	per	0	None
55767	55768	day	0	None
55768	55769	.	0	None

55770	55771	Common	0	None
55771	55772	adverse	0	None
55772	55773	effects	0	None
55773	55774	include	0	None
55774	55775	dyskinesia	0	None
55775	55776	,	0	None
55776	55777	nausea	0	None
55777	55778	,	0	None
55778	55779	diarrhea	0	None
55779	55780	,	0	None
55780	55781	and	0	None
55781	55782	urine	0	None
55782	55783	discoloration	0	None
55783	55784	.	0	None

55785	55786	CONCLUSIONS	0	None
55786	55787	:	0	None
55787	55788	Entacapone	3	CHEMICAL
55788	55789	should	0	None
55789	55790	be	0	None
55790	55791	considered	0	None
55791	55792	as	0	None
55792	55793	add	0	None
55793	55794	-	0	None
55794	55795	on	0	None
55795	55796	treatment	0	None
55796	55797	to	0	None
55797	55798	levodopa	3	CHEMICAL
55798	55799	/	0	None
55799	55800	carbidopa	3	CHEMICAL
55800	55801	in	0	None
55801	55802	Parkinson	0	None
55802	55803	'	0	None
55803	55804	s	0	None
55804	55805	disease	0	None
55805	55806	patients	0	None
55806	55807	with	0	None
55807	55808	end	0	None
55808	55809	-	0	None
55809	55810	of	0	None
55810	55811	-	0	None
55811	55812	dose	0	None
55812	55813	wearing	0	None
55813	55814	-	0	None
55814	55815	off	0	None
55815	55816	effect	0	None
55816	55817	.	0	None

55818	55819	Bupropion	0	None
55819	55820	is	0	None
55820	55821	a	0	None
55821	55822	nicotinic	3	CHEMICAL
55822	55823	antagonist	0	None
55823	55824	.	0	None

55825	55828	Neuronal nicotinic receptors	2	GENE-N
55828	55829	are	0	None
55829	55830	ligand	0	None
55830	55831	-	0	None
55831	55832	gated	0	None
55832	55833	ion	3	CHEMICAL
55833	55834	channels	0	None
55834	55835	of	0	None
55835	55836	the	0	None
55836	55837	central	0	None
55837	55838	and	0	None
55838	55839	peripheral	0	None
55839	55840	central	0	None
55840	55841	nervous	0	None
55841	55842	system	0	None
55842	55843	that	0	None
55843	55844	regulate	0	None
55844	55845	synaptic	0	None
55845	55846	activity	0	None
55846	55847	from	0	None
55847	55848	both	0	None
55848	55849	pre	0	None
55849	55850	-	0	None
55850	55851	and	0	None
55851	55852	postsynaptic	0	None
55852	55853	sites	0	None
55853	55854	.	0	None

55855	55856	The	0	None
55856	55857	present	0	None
55857	55858	study	0	None
55858	55859	establishes	0	None
55859	55860	the	0	None
55860	55861	acute	0	None
55861	55862	interaction	0	None
55862	55863	of	0	None
55863	55864	bupropion	3	CHEMICAL
55864	55865	,	0	None
55865	55866	an	0	None
55866	55867	antidepressant	0	None
55867	55868	agent	0	None
55868	55869	that	0	None
55869	55870	is	0	None
55870	55871	also	0	None
55871	55872	effective	0	None
55872	55873	in	0	None
55873	55874	nicotine	3	CHEMICAL
55874	55875	dependence	0	None
55875	55876	,	0	None
55876	55877	with	0	None
55877	55878	nicotine	3	CHEMICAL
55878	55879	and	0	None
55879	55881	nicotinic receptors	2	GENE-N
55881	55882	using	0	None
55882	55883	different	0	None
55883	55884	in	0	None
55884	55885	vivo	0	None
55885	55886	and	0	None
55886	55887	in	0	None
55887	55888	vitro	0	None
55888	55889	tests	0	None
55889	55890	.	0	None

55891	55892	Bupropion	0	None
55892	55893	was	0	None
55893	55894	found	0	None
55894	55895	to	0	None
55895	55896	block	0	None
55896	55897	nicotine	3	CHEMICAL
55897	55898	'	0	None
55898	55899	s	0	None
55899	55900	antinociception	0	None
55900	55901	(	0	None
55901	55902	in	0	None
55902	55903	two	0	None
55903	55904	tests	0	None
55904	55905	)	0	None
55905	55906	,	0	None
55906	55907	motor	0	None
55907	55908	effects	0	None
55908	55909	,	0	None
55909	55910	hypothermia	0	None
55910	55911	,	0	None
55911	55912	and	0	None
55912	55913	convulsive	0	None
55913	55914	effects	0	None
55914	55915	with	0	None
55915	55916	different	0	None
55916	55917	potencies	0	None
55917	55918	in	0	None
55918	55919	the	0	None
55919	55920	present	0	None
55920	55921	investigation	0	None
55921	55922	,	0	None
55922	55923	suggesting	0	None
55923	55924	that	0	None
55924	55925	bupropion	3	CHEMICAL
55925	55926	possesses	0	None
55926	55927	some	0	None
55927	55928	selectivity	0	None
55928	55929	for	0	None
55929	55932	neuronal nicotinic receptors	2	GENE-N
55932	55933	underlying	0	None
55933	55934	these	0	None
55934	55935	various	0	None
55935	55936	nicotinic	3	CHEMICAL
55936	55937	effects	0	None
55937	55938	.	0	None

55939	55940	In	0	None
55940	55941	addition	0	None
55941	55942	,	0	None
55942	55943	bupropion	3	CHEMICAL
55943	55944	blocks	0	None
55944	55945	nicotine	3	CHEMICAL
55945	55946	activation	0	None
55946	55947	of	0	None
55947	55948	alpha	0	None
55948	55949	(	0	None
55949	55950	3	0	None
55950	55951	)	0	None
55951	55952	beta	0	None
55952	55953	(	0	None
55953	55954	2	0	None
55954	55955	)	0	None
55955	55956	,	0	None
55956	55957	alpha	0	None
55957	55958	(	0	None
55958	55959	4	0	None
55959	55960	)	0	None
55960	55961	beta	0	None
55961	55962	(	0	None
55962	55963	2	0	None
55963	55964	)	0	None
55964	55965	,	0	None
55965	55966	and	0	None
55966	55967	alpha	0	None
55967	55968	(	0	None
55968	55969	7	0	None
55969	55970	)	0	None
55970	55974	neuronal acetylcholine nicotinic receptors	2	GENE-N
55974	55975	(	0	None
55975	55976	nAChRs	2	GENE-N
55976	55977	)	0	None
55977	55978	with	0	None
55978	55979	some	0	None
55979	55980	degree	0	None
55980	55981	of	0	None
55981	55982	selectivity	0	None
55982	55983	.	0	None

55984	55985	It	0	None
55985	55986	was	0	None
55986	55987	approximately	0	None
55987	55988	50	0	None
55988	55989	and	0	None
55989	55990	12	0	None
55990	55991	times	0	None
55991	55992	more	0	None
55992	55993	effective	0	None
55993	55994	in	0	None
55994	55995	blocking	0	None
55995	55996	alpha	0	None
55996	55997	(	0	None
55997	55998	3	0	None
55998	55999	)	0	None
55999	56000	beta	0	None
56000	56001	(	0	None
56001	56002	2	0	None
56002	56003	)	0	None
56003	56004	and	0	None
56004	56005	alpha	0	None
56005	56006	(	0	None
56006	56007	4	0	None
56007	56008	)	0	None
56008	56009	beta	0	None
56009	56010	(	0	None
56010	56011	2	0	None
56011	56012	)	0	None
56012	56013	than	0	None
56013	56014	alpha	0	None
56014	56015	(	0	None
56015	56016	7	0	None
56016	56017	.	0	None
56017	56018	)	0	None
56018	56019	This	0	None
56019	56020	functional	0	None
56020	56021	blockade	0	None
56021	56022	was	0	None
56022	56023	noncompetitive	0	None
56023	56024	,	0	None
56024	56025	because	0	None
56025	56026	it	0	None
56026	56027	was	0	None
56027	56028	insurmountable	0	None
56028	56029	by	0	None
56029	56030	increasing	0	None
56030	56031	concentration	0	None
56031	56032	of	0	None
56032	56033	ACh	3	CHEMICAL
56033	56034	in	0	None
56034	56035	the	0	None
56035	56036	nAChRs	2	GENE-N
56036	56037	subtypes	0	None
56037	56038	tested	0	None
56038	56039	.	0	None

56040	56041	Furthermore	0	None
56041	56042	,	0	None
56042	56043	bupropion	3	CHEMICAL
56043	56044	at	0	None
56044	56045	high	0	None
56045	56046	concentration	0	None
56046	56047	failed	0	None
56047	56048	to	0	None
56048	56049	displace	0	None
56049	56050	brain	0	None
56050	56051	[	0	None
56051	56052	(	0	None
56052	56053	3	0	None
56053	56054	)	0	None
56054	56055	H	0	None
56055	56056	]	0	None
56056	56057	nicotine	3	CHEMICAL
56057	56058	binding	0	None
56058	56059	sites	0	None
56059	56060	,	0	None
56060	56061	a	0	None
56061	56062	site	0	None
56062	56063	largely	0	None
56063	56064	composed	0	None
56064	56065	of	0	None
56065	56066	alpha	0	None
56066	56067	(	0	None
56067	56068	4	0	None
56068	56069	)	0	None
56069	56070	beta	0	None
56070	56071	(	0	None
56071	56072	2	0	None
56072	56073	)	0	None
56073	56074	subunit	0	None
56074	56075	combination	0	None
56075	56076	.	0	None

56077	56078	Given	0	None
56078	56079	the	0	None
56079	56080	observation	0	None
56080	56081	that	0	None
56081	56082	bupropion	3	CHEMICAL
56082	56083	inhibition	0	None
56083	56084	of	0	None
56084	56085	alpha	0	None
56085	56086	(	0	None
56086	56087	3	0	None
56087	56088	)	0	None
56088	56089	beta	0	None
56089	56090	(	0	None
56090	56091	2	0	None
56091	56092	)	0	None
56092	56093	and	0	None
56093	56094	alpha	0	None
56094	56095	(	0	None
56095	56096	4	0	None
56096	56097	)	0	None
56097	56098	beta	0	None
56098	56099	(	0	None
56099	56100	2	0	None
56100	56101	)	0	None
56101	56102	receptors	0	None
56102	56103	exhibits	0	None
56103	56104	voltage	0	None
56104	56105	-	0	None
56105	56106	independence	0	None
56106	56107	properties	0	None
56107	56108	,	0	None
56108	56109	bupropion	3	CHEMICAL
56109	56110	may	0	None
56110	56111	not	0	None
56111	56112	be	0	None
56112	56113	acting	0	None
56113	56114	as	0	None
56114	56115	an	0	None
56115	56116	open	0	None
56116	56117	channel	0	None
56117	56118	blocker	0	None
56118	56119	.	0	None

56120	56121	These	0	None
56121	56122	effects	0	None
56122	56123	may	0	None
56123	56124	explain	0	None
56124	56125	in	0	None
56125	56126	part	0	None
56126	56127	bupropion	3	CHEMICAL
56127	56128	'	0	None
56128	56129	s	0	None
56129	56130	efficacy	0	None
56130	56131	in	0	None
56131	56132	nicotine	3	CHEMICAL
56132	56133	dependence	0	None
56133	56134	.	0	None

56135	56136	Our	0	None
56136	56137	present	0	None
56137	56138	findings	0	None
56138	56139	suggest	0	None
56139	56140	that	0	None
56140	56141	functional	0	None
56141	56142	blockade	0	None
56142	56143	of	0	None
56143	56145	neuronal nAChRs	2	GENE-N
56145	56146	are	0	None
56146	56147	useful	0	None
56147	56148	in	0	None
56148	56149	nicotine	3	CHEMICAL
56149	56150	dependence	0	None
56150	56151	treatment	0	None
56151	56152	.	0	None

56153	56154	A	0	None
56154	56155	novel	0	None
56155	56156	hepatointestinal	0	None
56156	56159	leukotriene B4 receptor	1	GENE-Y
56159	56160	.	0	None

56161	56162	Cloning	0	None
56162	56163	and	0	None
56163	56164	functional	0	None
56164	56165	characterization	0	None
56165	56166	.	0	None

56167	56168	Leukotriene	0	None
56168	56169	B	0	None
56169	56170	(	0	None
56170	56171	4	0	None
56171	56172	)	0	None
56172	56173	(	0	None
56173	56174	LTB	0	None
56174	56175	(	0	None
56175	56176	4	0	None
56176	56177	)	0	None
56177	56178	)	0	None
56178	56179	is	0	None
56179	56180	a	0	None
56180	56181	product	0	None
56181	56182	of	0	None
56182	56183	eicosanoid	3	CHEMICAL
56183	56184	metabolism	0	None
56184	56185	and	0	None
56185	56186	acts	0	None
56186	56187	as	0	None
56187	56188	an	0	None
56188	56189	extremely	0	None
56189	56190	potent	0	None
56190	56191	chemotactic	0	None
56191	56192	mediator	0	None
56192	56193	for	0	None
56193	56194	inflammation	0	None
56194	56195	.	0	None

56196	56197	LTB	0	None
56197	56198	(	0	None
56198	56199	4	0	None
56199	56200	)	0	None
56200	56201	exerts	0	None
56201	56202	positive	0	None
56202	56203	effects	0	None
56203	56204	on	0	None
56204	56205	the	0	None
56205	56206	immigration	0	None
56206	56207	and	0	None
56207	56208	activation	0	None
56208	56209	of	0	None
56209	56210	leukocytes	0	None
56210	56211	.	0	None

56212	56213	These	0	None
56213	56214	effects	0	None
56214	56215	suggest	0	None
56215	56216	an	0	None
56216	56217	involvement	0	None
56217	56218	of	0	None
56218	56219	LTB	0	None
56219	56220	(	0	None
56220	56221	4	0	None
56221	56222	)	0	None
56222	56223	in	0	None
56223	56224	several	0	None
56224	56225	diseases	0	None
56225	56226	:	0	None
56226	56227	inflammatory	0	None
56227	56228	bowel	0	None
56228	56229	disease	0	None
56229	56230	,	0	None
56230	56231	psoriasis	0	None
56231	56232	,	0	None
56232	56233	arthritis	0	None
56233	56234	,	0	None
56234	56235	and	0	None
56235	56236	asthma	0	None
56236	56237	.	0	None

56238	56239	LTB	0	None
56239	56240	(	0	None
56240	56241	4	0	None
56241	56242	)	0	None
56242	56243	elicits	0	None
56243	56244	actions	0	None
56244	56245	through	0	None
56245	56246	interaction	0	None
56246	56247	with	0	None
56247	56248	one	0	None
56248	56249	or	0	None
56249	56250	more	0	None
56250	56253	cell surface receptors	2	GENE-N
56253	56254	that	0	None
56254	56255	lead	0	None
56255	56256	to	0	None
56256	56257	chemotaxis	0	None
56257	56258	and	0	None
56258	56259	inflammation	0	None
56259	56260	.	0	None

56261	56262	One	0	None
56262	56264	leukotriene B	3	CHEMICAL
56264	56265	(	0	None
56265	56266	4	0	None
56266	56267	)	0	None
56267	56268	receptor	0	None
56268	56269	has	0	None
56269	56270	been	0	None
56270	56271	recently	0	None
56271	56272	identified	0	None
56272	56273	(	0	None
56273	56274	LTB	0	None
56274	56275	(	0	None
56275	56276	4	0	None
56276	56277	)	0	None
56277	56278	-	0	None
56278	56279	R1	0	None
56279	56280	)	0	None
56280	56281	.	0	None

56282	56283	In	0	None
56283	56284	this	0	None
56284	56285	report	0	None
56285	56286	we	0	None
56286	56287	describe	0	None
56287	56288	cloning	0	None
56288	56289	of	0	None
56289	56290	a	0	None
56290	56291	cDNA	0	None
56291	56292	encoding	0	None
56292	56293	a	0	None
56293	56294	novel	0	None
56294	56295	358	0	None
56295	56296	-	0	None
56296	56299	amino acid receptor	2	GENE-N
56299	56300	(	0	None
56300	56301	LTB	0	None
56301	56302	(	0	None
56302	56303	4	0	None
56303	56304	)	0	None
56304	56305	-	0	None
56305	56306	R2	0	None
56306	56307	)	0	None
56307	56308	that	0	None
56308	56309	possesses	0	None
56309	56310	seven	0	None
56310	56311	membrane	0	None
56311	56312	-	0	None
56312	56313	spanning	0	None
56313	56314	domains	0	None
56314	56315	and	0	None
56315	56316	is	0	None
56316	56317	homologous	0	None
56317	56318	(	0	None
56318	56319	42	0	None
56319	56320	%	0	None
56320	56321	)	0	None
56321	56322	and	0	None
56322	56323	genetically	0	None
56323	56324	linked	0	None
56324	56325	to	0	None
56325	56326	LTB	0	None
56326	56327	(	0	None
56327	56328	4	0	None
56328	56329	)	0	None
56329	56330	-	0	None
56330	56331	R1	0	None
56331	56332	.	0	None

56333	56334	Expression	0	None
56334	56335	of	0	None
56335	56336	LTB	0	None
56336	56337	(	0	None
56337	56338	4	0	None
56338	56339	)	0	None
56339	56340	-	0	None
56340	56341	R2	0	None
56341	56342	is	0	None
56342	56343	broad	0	None
56343	56344	but	0	None
56344	56345	highest	0	None
56345	56346	in	0	None
56346	56347	liver	0	None
56347	56348	,	0	None
56348	56349	intestine	0	None
56349	56350	,	0	None
56350	56351	spleen	0	None
56351	56352	,	0	None
56352	56353	and	0	None
56353	56354	kidney	0	None
56354	56355	.	0	None

56356	56357	In	0	None
56357	56358	radioligand	0	None
56358	56359	binding	0	None
56359	56360	assays	0	None
56360	56361	,	0	None
56361	56362	membranes	0	None
56362	56363	prepared	0	None
56363	56364	from	0	None
56364	56365	COS	0	None
56365	56366	-	0	None
56366	56367	7	0	None
56367	56368	cells	0	None
56368	56369	transfected	0	None
56369	56370	with	0	None
56370	56371	LTB	0	None
56371	56372	(	0	None
56372	56373	4	0	None
56373	56374	)	0	None
56374	56375	-	0	None
56375	56376	R2	0	None
56376	56377	cDNA	0	None
56377	56378	displayed	0	None
56378	56379	high	0	None
56379	56380	affinity	0	None
56380	56381	(	0	None
56381	56382	K	0	None
56382	56383	(	0	None
56383	56384	d	0	None
56384	56385	)	0	None
56385	56386	=	0	None
56386	56387	0	0	None
56387	56388	.	0	None
56388	56389	17	0	None
56389	56390	nm	0	None
56390	56391	)	0	None
56391	56392	for	0	None
56392	56393	[	0	None
56393	56394	(	0	None
56394	56395	3	0	None
56395	56396	)	0	None
56396	56397	H	0	None
56397	56398	]	0	None
56398	56399	LTB	0	None
56399	56400	(	0	None
56400	56401	4	0	None
56401	56402	)	0	None
56402	56403	.	0	None

56404	56405	Radioligand	0	None
56405	56406	competition	0	None
56406	56407	assays	0	None
56407	56408	revealed	0	None
56408	56409	high	0	None
56409	56410	affinities	0	None
56410	56411	of	0	None
56411	56412	the	0	None
56412	56413	receptor	0	None
56413	56414	for	0	None
56414	56415	LTB	0	None
56415	56416	(	0	None
56416	56417	4	0	None
56417	56418	)	0	None
56418	56419	and	0	None
56419	56420	LTB	0	None
56420	56421	(	0	None
56421	56422	5	0	None
56422	56423	)	0	None
56423	56424	,	0	None
56424	56425	and	0	None
56425	56426	20	0	None
56426	56427	-	0	None
56427	56428	hydroxy	3	CHEMICAL
56428	56429	-	0	None
56429	56430	LTB	0	None
56430	56431	(	0	None
56431	56432	4	0	None
56432	56433	)	0	None
56433	56434	,	0	None
56434	56435	and	0	None
56435	56436	intermediate	0	None
56436	56437	affinities	0	None
56437	56438	for	0	None
56438	56439	15	0	None
56439	56440	(	0	None
56440	56441	S	0	None
56441	56442	)	0	None
56442	56443	-	0	None
56443	56444	HETE	0	None
56444	56445	and	0	None
56445	56446	12	0	None
56446	56447	-	0	None
56447	56448	oxo	3	CHEMICAL
56448	56449	-	0	None
56449	56450	ETE	0	None
56450	56451	.	0	None

56452	56453	Three	0	None
56453	56454	LTB	0	None
56454	56455	(	0	None
56455	56456	4	0	None
56456	56457	)	0	None
56457	56458	receptor	0	None
56458	56459	antagonists	0	None
56459	56460	,	0	None
56460	56461	14	0	None
56461	56462	,	0	None
56462	56463	15	0	None
56463	56464	-	0	None
56464	56465	dehydro	0	None
56465	56466	-	0	None
56466	56467	LTB	0	None
56467	56468	(	0	None
56468	56469	4	0	None
56469	56470	)	0	None
56470	56471	,	0	None
56471	56472	LTB	0	None
56472	56473	(	0	None
56473	56474	4	0	None
56474	56475	)	0	None
56475	56476	-	0	None
56476	56477	3	0	None
56477	56478	-	0	None
56478	56479	aminopropylamide	0	None
56479	56480	,	0	None
56480	56481	and	0	None
56481	56482	U	0	None
56482	56483	-	0	None
56483	56484	75302	0	None
56484	56485	,	0	None
56485	56486	had	0	None
56486	56487	high	0	None
56487	56488	affinity	0	None
56488	56489	for	0	None
56489	56490	LTB	0	None
56490	56491	(	0	None
56491	56492	4	0	None
56492	56493	)	0	None
56493	56494	-	0	None
56494	56495	R1	0	None
56495	56496	but	0	None
56496	56497	not	0	None
56497	56498	for	0	None
56498	56499	LTB	0	None
56499	56500	(	0	None
56500	56501	4	0	None
56501	56502	)	0	None
56502	56503	-	0	None
56503	56504	R2	0	None
56504	56505	.	0	None

56506	56507	No	0	None
56507	56508	apparent	0	None
56508	56509	affinity	0	None
56509	56510	binding	0	None
56510	56511	for	0	None
56511	56512	the	0	None
56512	56513	receptors	0	None
56513	56514	was	0	None
56514	56515	detected	0	None
56515	56516	for	0	None
56516	56517	the	0	None
56517	56518	CysLT1	1	GENE-Y
56518	56519	-	0	None
56519	56520	selective	0	None
56520	56521	antagonists	0	None
56521	56522	montelukast	3	CHEMICAL
56522	56523	and	0	None
56523	56524	zafirlukast	0	None
56524	56525	.	0	None

56526	56527	LTB	0	None
56527	56528	(	0	None
56528	56529	4	0	None
56529	56530	)	0	None
56530	56531	functionally	0	None
56531	56532	mobilized	0	None
56532	56533	intracellular	0	None
56533	56534	calcium	0	None
56534	56535	and	0	None
56535	56536	inhibited	0	None
56536	56537	forskolin	3	CHEMICAL
56537	56538	-	0	None
56538	56539	stimulated	0	None
56539	56540	cAMP	0	None
56540	56541	production	0	None
56541	56542	in	0	None
56542	56543	293	0	None
56543	56544	cells	0	None
56544	56545	.	0	None

56546	56547	The	0	None
56547	56548	discovery	0	None
56548	56549	of	0	None
56549	56550	this	0	None
56550	56551	new	0	None
56551	56552	receptor	0	None
56552	56553	should	0	None
56553	56554	aid	1	GENE-Y
56554	56555	in	0	None
56555	56556	further	0	None
56556	56557	understanding	0	None
56557	56558	the	0	None
56558	56559	roles	0	None
56559	56560	of	0	None
56560	56561	LTB	0	None
56561	56562	(	0	None
56562	56563	4	0	None
56563	56564	)	0	None
56564	56565	in	0	None
56565	56566	pathologies	0	None
56566	56567	in	0	None
56567	56568	these	0	None
56568	56569	tissues	0	None
56569	56570	and	0	None
56570	56571	may	0	None
56571	56572	provide	0	None
56572	56573	a	0	None
56573	56574	tool	0	None
56574	56575	in	0	None
56575	56576	identification	0	None
56576	56577	of	0	None
56577	56578	specific	0	None
56578	56579	antagonists	0	None
56579	56580	/	0	None
56580	56581	agonists	0	None
56581	56582	for	0	None
56582	56583	potential	0	None
56583	56584	therapeutic	0	None
56584	56585	treatments	0	None
56585	56586	.	0	None

56587	56588	Arachidonic	0	None
56588	56589	acid	0	None
56589	56590	and	0	None
56590	56591	nonsteroidal	0	None
56591	56592	anti	0	None
56592	56593	-	0	None
56593	56594	inflammatory	0	None
56594	56595	drugs	0	None
56595	56596	induce	0	None
56596	56597	conformational	0	None
56597	56598	changes	0	None
56598	56599	in	0	None
56599	56600	the	0	None
56600	56601	human	0	None
56601	56602	prostaglandin	3	CHEMICAL
56602	56603	endoperoxide	0	None
56603	56604	H2	0	None
56604	56605	synthase	0	None
56605	56606	-	0	None
56606	56607	2	0	None
56607	56608	(	0	None
56608	56609	cyclooxygenase	2	GENE-N
56609	56610	-	0	None
56610	56611	2	0	None
56611	56612	)	0	None
56612	56613	.	0	None

56614	56615	By	0	None
56615	56616	using	0	None
56616	56617	the	0	None
56617	56618	technique	0	None
56618	56619	of	0	None
56619	56620	site	0	None
56620	56621	-	0	None
56621	56622	directed	0	None
56622	56623	spin	0	None
56623	56624	labeling	0	None
56624	56625	combined	0	None
56625	56626	with	0	None
56626	56627	EPR	0	None
56627	56628	spectroscopy	0	None
56628	56629	,	0	None
56629	56630	we	0	None
56630	56631	have	0	None
56631	56632	observed	0	None
56632	56633	that	0	None
56633	56634	binding	0	None
56634	56635	of	0	None
56635	56637	arachidonic acid	3	CHEMICAL
56637	56638	and	0	None
56638	56639	nonsteroidal	0	None
56639	56640	anti	0	None
56640	56641	-	0	None
56641	56642	inflammatory	0	None
56642	56643	drugs	0	None
56643	56644	induces	0	None
56644	56645	conformational	0	None
56645	56646	changes	0	None
56646	56647	in	0	None
56647	56648	the	0	None
56648	56649	human	0	None
56649	56650	prostaglandin	3	CHEMICAL
56650	56651	endoperoxide	0	None
56651	56652	H	0	None
56652	56653	(	0	None
56653	56654	2	0	None
56654	56655	)	0	None
56655	56656	synthase	0	None
56656	56657	enzyme	0	None
56657	56658	(	0	None
56658	56659	PGHS	0	None
56659	56660	-	0	None
56660	56661	2	0	None
56661	56662	)	0	None
56662	56663	.	0	None

56664	56665	Line	0	None
56665	56666	shape	0	None
56666	56667	broadening	0	None
56667	56668	resulting	0	None
56668	56669	from	0	None
56669	56670	spin	0	None
56670	56671	-	0	None
56671	56672	spin	0	None
56672	56673	coupling	0	None
56673	56674	of	0	None
56674	56675	nitroxide	0	None
56675	56676	pairs	0	None
56676	56677	introduced	0	None
56677	56678	into	0	None
56678	56679	the	0	None
56679	56680	membrane	0	None
56680	56681	-	0	None
56681	56682	binding	0	None
56682	56683	helices	0	None
56683	56684	of	0	None
56684	56685	PGHS	0	None
56685	56686	-	0	None
56686	56687	2	0	None
56687	56688	was	0	None
56688	56689	used	0	None
56689	56690	to	0	None
56690	56691	calculate	0	None
56691	56692	the	0	None
56692	56693	inter	0	None
56693	56694	-	0	None
56694	56695	helical	0	None
56695	56696	distances	0	None
56696	56697	and	0	None
56697	56698	changes	0	None
56698	56699	in	0	None
56699	56700	these	0	None
56700	56701	distances	0	None
56701	56702	that	0	None
56702	56703	occur	0	None
56703	56704	in	0	None
56704	56705	response	0	None
56705	56706	to	0	None
56706	56707	binding	0	None
56707	56708	various	0	None
56708	56709	ligands	0	None
56709	56710	.	0	None

56711	56712	The	0	None
56712	56713	inter	0	None
56713	56714	-	0	None
56714	56715	residue	0	None
56715	56716	distances	0	None
56716	56717	determined	0	None
56717	56718	for	0	None
56718	56719	the	0	None
56719	56720	PGHS	0	None
56720	56721	-	0	None
56721	56722	2	0	None
56722	56723	holoenzyme	0	None
56723	56724	using	0	None
56724	56725	EPR	0	None
56725	56726	were	0	None
56726	56727	1	0	None
56727	56728	-	0	None
56728	56729	7	0	None
56729	56730	.	0	None
56730	56731	9	0	None
56731	56732	A	0	None
56732	56733	shorter	0	None
56733	56734	than	0	None
56734	56735	those	0	None
56735	56736	of	0	None
56736	56737	the	0	None
56737	56738	crystal	0	None
56738	56739	structure	0	None
56739	56740	of	0	None
56740	56741	the	0	None
56741	56742	PGHS	0	None
56742	56743	-	0	None
56743	56744	2	0	None
56744	56745	holoenzyme	0	None
56745	56746	.	0	None

56747	56748	However	0	None
56748	56749	,	0	None
56749	56750	inter	0	None
56750	56751	-	0	None
56751	56752	helical	0	None
56752	56753	distances	0	None
56753	56754	calculated	0	None
56754	56755	and	0	None
56755	56756	determined	0	None
56756	56757	by	0	None
56757	56758	EPR	0	None
56758	56759	for	0	None
56759	56760	PGHS	0	None
56760	56761	-	0	None
56761	56762	2	0	None
56762	56763	complexed	0	None
56763	56764	with	0	None
56764	56766	arachidonic acid	3	CHEMICAL
56766	56767	,	0	None
56767	56768	flurbiprofen	3	CHEMICAL
56768	56769	,	0	None
56769	56770	and	0	None
56770	56771	SC	0	None
56771	56772	-	0	None
56772	56773	58125	0	None
56773	56774	were	0	None
56774	56775	in	0	None
56775	56776	close	0	None
56776	56777	agreement	0	None
56777	56778	with	0	None
56778	56779	those	0	None
56779	56780	obtained	0	None
56780	56781	from	0	None
56781	56782	the	0	None
56782	56783	cognate	0	None
56783	56784	crystal	0	None
56784	56785	structures	0	None
56785	56786	.	0	None

56787	56788	These	0	None
56788	56789	results	0	None
56789	56790	indicate	0	None
56790	56791	that	0	None
56791	56792	the	0	None
56792	56793	structure	0	None
56793	56794	of	0	None
56794	56795	the	0	None
56795	56796	solubilized	0	None
56796	56797	PGHS	0	None
56797	56798	-	0	None
56798	56799	2	0	None
56799	56800	holoenzyme	0	None
56800	56801	measured	0	None
56801	56802	in	0	None
56802	56803	solution	0	None
56803	56804	differs	0	None
56804	56805	from	0	None
56805	56806	the	0	None
56806	56807	crystal	0	None
56807	56808	structure	0	None
56808	56809	of	0	None
56809	56810	PGHS	0	None
56810	56811	-	0	None
56811	56812	2	0	None
56812	56813	holoenzyme	0	None
56813	56814	obtained	0	None
56814	56815	by	0	None
56815	56816	x	0	None
56816	56817	-	0	None
56817	56818	ray	0	None
56818	56819	analysis	0	None
56819	56820	.	0	None

56821	56822	Furthermore	0	None
56822	56823	,	0	None
56823	56824	binding	0	None
56824	56825	of	0	None
56825	56826	ligands	0	None
56826	56827	induces	0	None
56827	56828	a	0	None
56828	56829	conformational	0	None
56829	56830	change	0	None
56830	56831	in	0	None
56831	56832	the	0	None
56832	56833	holo	0	None
56833	56834	-	0	None
56834	56835	PGHS	0	None
56835	56836	-	0	None
56836	56837	2	0	None
56837	56838	,	0	None
56838	56839	converting	0	None
56839	56840	it	0	None
56840	56841	to	0	None
56841	56842	a	0	None
56842	56843	structure	0	None
56843	56844	similar	0	None
56844	56845	to	0	None
56845	56846	those	0	None
56846	56847	obtained	0	None
56847	56848	by	0	None
56848	56849	x	0	None
56849	56850	-	0	None
56850	56851	ray	0	None
56851	56852	analysis	0	None
56852	56853	.	0	None

56854	56855	Proteolysis	0	None
56855	56856	protection	0	None
56856	56857	assays	0	None
56857	56858	had	0	None
56858	56859	previously	0	None
56859	56860	provided	0	None
56860	56861	circumstantial	0	None
56861	56862	evidence	0	None
56862	56863	that	0	None
56863	56864	binding	0	None
56864	56865	of	0	None
56865	56866	heme	3	CHEMICAL
56866	56867	and	0	None
56867	56868	non	0	None
56868	56869	-	0	None
56869	56870	steroidal	0	None
56870	56871	anti	0	None
56871	56872	-	0	None
56872	56873	inflammatory	0	None
56873	56874	drugs	0	None
56874	56875	alters	0	None
56875	56876	the	0	None
56876	56877	conformation	0	None
56877	56878	of	0	None
56878	56879	PGHS	0	None
56879	56880	,	0	None
56880	56881	but	0	None
56881	56882	the	0	None
56882	56883	present	0	None
56883	56884	experiments	0	None
56884	56885	are	0	None
56885	56886	the	0	None
56886	56887	first	0	None
56887	56888	to	0	None
56888	56889	directly	0	None
56889	56890	measure	0	None
56890	56891	such	0	None
56891	56892	changes	0	None
56892	56893	.	0	None

56894	56895	The	0	None
56895	56896	finding	0	None
56896	56897	that	0	None
56897	56898	arachidonate	0	None
56898	56899	can	0	None
56899	56900	also	0	None
56900	56901	induce	0	None
56901	56902	a	0	None
56902	56903	conformational	0	None
56903	56904	change	0	None
56904	56905	in	0	None
56905	56906	PGHS	0	None
56906	56907	-	0	None
56907	56908	2	0	None
56908	56909	was	0	None
56909	56910	unexpected	0	None
56910	56911	,	0	None
56911	56912	and	0	None
56912	56913	the	0	None
56913	56914	magnitude	0	None
56914	56915	of	0	None
56915	56916	changes	0	None
56916	56917	suggests	0	None
56917	56918	this	0	None
56918	56919	structural	0	None
56919	56920	flexibility	0	None
56920	56921	may	0	None
56921	56922	be	0	None
56922	56923	integral	0	None
56923	56924	to	0	None
56924	56925	the	0	None
56925	56926	cyclooxygenase	2	GENE-N
56926	56927	catalytic	0	None
56927	56928	mechanism	0	None
56928	56929	.	0	None

56930	56931	A	0	None
56931	56932	comparison	0	None
56932	56933	of	0	None
56933	56934	the	0	None
56934	56935	effects	0	None
56935	56936	of	0	None
56936	56937	etodolac	3	CHEMICAL
56937	56938	and	0	None
56938	56939	ibuprofen	3	CHEMICAL
56939	56940	on	0	None
56940	56941	renal	0	None
56941	56942	haemodynamics	0	None
56942	56943	,	0	None
56943	56944	tubular	0	None
56944	56945	function	0	None
56945	56946	,	0	None
56946	56947	renin	1	GENE-Y
56947	56948	,	0	None
56948	56949	vasopressin	3	CHEMICAL
56949	56950	and	0	None
56950	56951	urinary	0	None
56951	56952	excretion	0	None
56952	56953	of	0	None
56953	56954	albumin	1	GENE-Y
56954	56955	and	0	None
56955	56956	alpha	0	None
56956	56957	-	0	None
56957	56958	glutathione	3	CHEMICAL
56958	56959	-	0	None
56959	56960	S	0	None
56960	56961	-	0	None
56961	56962	transferase	0	None
56962	56963	in	0	None
56963	56964	healthy	0	None
56964	56965	subjects	0	None
56965	56966	:	0	None
56966	56967	a	0	None
56967	56968	placebo	0	None
56968	56969	-	0	None
56969	56970	controlled	0	None
56970	56971	cross	0	None
56971	56972	-	0	None
56972	56973	over	0	None
56973	56974	study	0	None
56974	56975	.	0	None

56976	56977	BACKGROUND	0	None
56977	56978	:	0	None
56978	56979	Non	0	None
56979	56980	-	0	None
56980	56981	steroidal	0	None
56981	56982	anti	0	None
56982	56983	-	0	None
56983	56984	inflammatory	0	None
56984	56985	drugs	0	None
56985	56986	(	0	None
56986	56987	NSAIDs	0	None
56987	56988	)	0	None
56988	56989	are	0	None
56989	56990	known	0	None
56990	56991	to	0	None
56991	56992	be	0	None
56992	56993	potentially	0	None
56993	56994	nephrotoxic	0	None
56994	56995	agents	0	None
56995	56996	.	0	None

56997	56998	NSAIDs	0	None
56998	56999	inhibit	0	None
56999	57000	the	0	None
57000	57001	enzyme	0	None
57001	57002	cyclo	0	None
57002	57003	-	0	None
57003	57004	oxygenase	0	None
57004	57005	and	0	None
57005	57006	thereby	0	None
57006	57007	block	0	None
57007	57008	the	0	None
57008	57009	prostaglandin	3	CHEMICAL
57009	57010	synthesis	0	None
57010	57011	in	0	None
57011	57012	the	0	None
57012	57013	kidneys	0	None
57013	57014	.	0	None

57015	57016	Cyclo	0	None
57016	57017	-	0	None
57017	57018	oxygenase	0	None
57018	57019	exists	0	None
57019	57020	in	0	None
57020	57021	two	0	None
57021	57022	isoforms	0	None
57022	57023	(	0	None
57023	57024	COX	2	GENE-N
57024	57025	-	0	None
57025	57026	1	0	None
57026	57027	and	0	None
57027	57028	COX	2	GENE-N
57028	57029	-	0	None
57029	57030	2	0	None
57030	57031	)	0	None
57031	57032	.	0	None

57033	57034	It	0	None
57034	57035	has	0	None
57035	57036	been	0	None
57036	57037	proposed	0	None
57037	57038	that	0	None
57038	57039	NSAIDs	0	None
57039	57040	with	0	None
57040	57041	preferential	0	None
57041	57042	COX	2	GENE-N
57042	57043	-	0	None
57043	57044	2	0	None
57044	57045	selectivity	0	None
57045	57046	have	0	None
57046	57047	fewer	0	None
57047	57048	renal	0	None
57048	57049	side	0	None
57049	57050	effects	0	None
57050	57051	than	0	None
57051	57052	drugs	0	None
57052	57053	with	0	None
57053	57054	preferential	0	None
57054	57055	COX	2	GENE-N
57055	57056	-	0	None
57056	57057	1	0	None
57057	57058	selectivity	0	None
57058	57059	.	0	None

57060	57061	Etodolac	0	None
57061	57062	is	0	None
57062	57063	a	0	None
57063	57064	relative	0	None
57064	57065	selective	0	None
57065	57066	inhibitor	0	None
57066	57067	of	0	None
57067	57068	COX	2	GENE-N
57068	57069	-	0	None
57069	57070	2	0	None
57070	57071	,	0	None
57071	57072	while	0	None
57072	57073	ibuprofen	3	CHEMICAL
57073	57074	has	0	None
57074	57075	a	0	None
57075	57076	higher	0	None
57076	57077	potency	0	None
57077	57078	against	0	None
57078	57079	COX	2	GENE-N
57079	57080	-	0	None
57080	57081	1	0	None
57081	57082	than	0	None
57082	57083	COX	2	GENE-N
57083	57084	-	0	None
57084	57085	2	0	None
57085	57086	.	0	None

57087	57088	OBJECTIVE	0	None
57088	57089	:	0	None
57089	57090	In	0	None
57090	57091	this	0	None
57091	57092	study	0	None
57092	57093	,	0	None
57093	57094	we	0	None
57094	57095	compared	0	None
57095	57096	the	0	None
57096	57097	effects	0	None
57097	57098	of	0	None
57098	57099	etodolac	3	CHEMICAL
57099	57100	and	0	None
57100	57101	ibuprofen	3	CHEMICAL
57101	57102	on	0	None
57102	57103	renal	0	None
57103	57104	function	0	None
57104	57105	,	0	None
57105	57106	plasma	0	None
57106	57107	renin	1	GENE-Y
57107	57108	,	0	None
57108	57109	plasma	0	None
57109	57111	arginine vasopressin	3	CHEMICAL
57111	57112	and	0	None
57112	57113	the	0	None
57113	57114	urinary	0	None
57114	57115	excretion	0	None
57115	57116	of	0	None
57116	57117	albumin	1	GENE-Y
57117	57118	and	0	None
57118	57119	alpha	0	None
57119	57120	-	0	None
57120	57121	glutathione	3	CHEMICAL
57121	57122	-	0	None
57122	57123	S	0	None
57123	57124	-	0	None
57124	57125	transferase	0	None
57125	57126	(	0	None
57126	57127	alpha	0	None
57127	57128	-	0	None
57128	57129	GST	0	None
57129	57130	)	0	None
57130	57131	.	0	None

57132	57133	METHODS	0	None
57133	57134	:	0	None
57134	57135	In	0	None
57135	57136	a	0	None
57136	57137	randomised	0	None
57137	57138	,	0	None
57138	57139	double	0	None
57139	57140	-	0	None
57140	57141	blind	0	None
57141	57142	,	0	None
57142	57143	three	0	None
57143	57144	-	0	None
57144	57145	way	0	None
57145	57146	crossover	0	None
57146	57147	study	0	None
57147	57148	with	0	None
57148	57149	placebo	0	None
57149	57150	,	0	None
57150	57151	we	0	None
57151	57152	compared	0	None
57152	57153	the	0	None
57153	57154	effects	0	None
57154	57155	of	0	None
57155	57156	2	0	None
57156	57157	weeks	0	None
57157	57158	of	0	None
57158	57159	treatment	0	None
57159	57160	with	0	None
57160	57161	ibuprofen	3	CHEMICAL
57161	57162	and	0	None
57162	57163	etodolac	3	CHEMICAL
57163	57164	on	0	None
57164	57165	renal	0	None
57165	57166	haemodynamics	0	None
57166	57167	[	0	None
57167	57168	glomerular	0	None
57168	57169	filtration	0	None
57169	57170	rate	0	None
57170	57171	(	0	None
57171	57172	GFR	0	None
57172	57173	)	0	None
57173	57174	,	0	None
57174	57175	renal	0	None
57175	57176	plasma	0	None
57176	57177	flow	0	None
57177	57178	(	0	None
57178	57179	RPF	0	None
57179	57180	)	0	None
57180	57181	and	0	None
57181	57182	filtration	0	None
57182	57183	fraction	0	None
57183	57184	(	0	None
57184	57185	FF	0	None
57185	57186	)	0	None
57186	57187	]	0	None
57187	57188	,	0	None
57188	57189	tubular	0	None
57189	57190	function	0	None
57190	57191	and	0	None
57191	57192	plasma	0	None
57192	57193	concentrations	0	None
57193	57194	of	0	None
57194	57195	the	0	None
57195	57196	hormones	3	CHEMICAL
57196	57197	renin	1	GENE-Y
57197	57198	(	0	None
57198	57199	PRC	0	None
57199	57200	)	0	None
57200	57201	and	0	None
57201	57203	arginine vasopressin	3	CHEMICAL
57203	57204	(	0	None
57204	57205	AVP	3	CHEMICAL
57205	57206	)	0	None
57206	57207	in	0	None
57207	57208	18	0	None
57208	57209	healthy	0	None
57209	57210	subjects	0	None
57210	57211	.	0	None

57212	57213	In	0	None
57213	57214	addition	0	None
57214	57215	,	0	None
57215	57216	we	0	None
57216	57217	examined	0	None
57217	57218	the	0	None
57218	57219	effects	0	None
57219	57220	on	0	None
57220	57221	the	0	None
57221	57222	urinary	0	None
57222	57223	excretion	0	None
57223	57224	of	0	None
57224	57225	albumin	1	GENE-Y
57225	57226	and	0	None
57226	57227	alpha	0	None
57227	57228	-	0	None
57228	57229	GST	0	None
57229	57230	as	0	None
57230	57231	markers	0	None
57231	57232	of	0	None
57232	57233	renal	0	None
57233	57234	injury	0	None
57234	57235	.	0	None

57236	57237	RESULTS	0	None
57237	57238	:	0	None
57238	57239	No	0	None
57239	57240	differences	0	None
57240	57241	were	0	None
57241	57242	found	0	None
57242	57243	between	0	None
57243	57244	the	0	None
57244	57245	three	0	None
57245	57246	treatments	0	None
57246	57247	,	0	None
57247	57248	placebo	0	None
57248	57249	,	0	None
57249	57250	ibuprofen	3	CHEMICAL
57250	57251	and	0	None
57251	57252	etodolac	3	CHEMICAL
57252	57253	,	0	None
57253	57254	in	0	None
57254	57255	the	0	None
57255	57256	effects	0	None
57256	57257	on	0	None
57257	57258	GFR	0	None
57258	57259	,	0	None
57259	57260	RPF	0	None
57260	57261	,	0	None
57261	57262	FF	0	None
57262	57263	,	0	None
57263	57264	free	0	None
57264	57265	water	0	None
57265	57266	clearance	0	None
57266	57267	,	0	None
57267	57268	urinary	0	None
57268	57269	output	0	None
57269	57270	or	0	None
57270	57271	fractional	0	None
57271	57272	excretion	0	None
57272	57273	of	0	None
57273	57274	potassium	3	CHEMICAL
57274	57275	and	0	None
57275	57276	sodium	3	CHEMICAL
57276	57277	.	0	None

57278	57279	However	0	None
57279	57280	,	0	None
57280	57281	ibuprofen	3	CHEMICAL
57281	57282	,	0	None
57282	57283	in	0	None
57283	57284	contrast	0	None
57284	57285	to	0	None
57285	57286	etodolac	3	CHEMICAL
57286	57287	,	0	None
57287	57288	caused	0	None
57288	57289	a	0	None
57289	57290	significant	0	None
57290	57291	decrease	0	None
57291	57292	in	0	None
57292	57293	both	0	None
57293	57294	lithium	3	CHEMICAL
57294	57295	clearance	0	None
57295	57296	(	0	None
57296	57297	-	0	None
57297	57298	16	0	None
57298	57299	%	0	None
57299	57300	versus	0	None
57300	57301	placebo	0	None
57301	57302	)	0	None
57302	57303	and	0	None
57303	57304	the	0	None
57304	57305	fractional	0	None
57305	57306	excretion	0	None
57306	57307	of	0	None
57307	57308	lithium	3	CHEMICAL
57308	57309	(	0	None
57309	57310	-	0	None
57310	57311	17	0	None
57311	57312	%	0	None
57312	57313	versus	0	None
57313	57314	placebo	0	None
57314	57315	)	0	None
57315	57316	,	0	None
57316	57317	suggesting	0	None
57317	57318	an	0	None
57318	57319	increase	0	None
57319	57320	in	0	None
57320	57321	the	0	None
57321	57322	reabsorption	0	None
57322	57323	in	0	None
57323	57324	the	0	None
57324	57325	proximal	0	None
57325	57326	tubuli	0	None
57326	57327	.	0	None

57328	57329	PRC	0	None
57329	57330	was	0	None
57330	57331	reduced	0	None
57331	57332	significantly	0	None
57332	57333	by	0	None
57333	57334	ibuprofen	3	CHEMICAL
57334	57335	(	0	None
57335	57336	-	0	None
57336	57337	32	0	None
57337	57338	%	0	None
57338	57339	versus	0	None
57339	57340	placebo	0	None
57340	57341	)	0	None
57341	57342	but	0	None
57342	57343	not	0	None
57343	57344	etodolac	3	CHEMICAL
57344	57345	.	0	None

57346	57347	None	0	None
57347	57348	of	0	None
57348	57349	the	0	None
57349	57350	drugs	0	None
57350	57351	changed	0	None
57351	57352	AVP	3	CHEMICAL
57352	57353	.	0	None

57354	57355	Fourteen	0	None
57355	57356	days	0	None
57356	57357	of	0	None
57357	57358	treatment	0	None
57358	57359	with	0	None
57359	57360	ibuprofen	3	CHEMICAL
57360	57361	caused	0	None
57361	57362	a	0	None
57362	57363	significant	0	None
57363	57364	decrease	0	None
57364	57365	(	0	None
57365	57366	-	0	None
57366	57367	47	0	None
57367	57368	%	0	None
57368	57369	versus	0	None
57369	57370	placebo	0	None
57370	57371	)	0	None
57371	57372	in	0	None
57372	57373	the	0	None
57373	57374	urinary	0	None
57374	57375	excretion	0	None
57375	57376	of	0	None
57376	57377	alpha	0	None
57377	57378	-	0	None
57378	57379	GST	0	None
57379	57380	,	0	None
57380	57381	while	0	None
57381	57382	no	0	None
57382	57383	changes	0	None
57383	57384	were	0	None
57384	57385	seen	0	None
57385	57386	after	0	None
57386	57387	etodolac	3	CHEMICAL
57387	57388	.	0	None

57389	57390	None	0	None
57390	57391	of	0	None
57391	57392	the	0	None
57392	57393	drugs	0	None
57393	57394	changed	0	None
57394	57395	the	0	None
57395	57396	urinary	0	None
57396	57397	excretion	0	None
57397	57398	of	0	None
57398	57399	albumin	1	GENE-Y
57399	57400	.	0	None

57401	57402	CONCLUSION	0	None
57402	57403	:	0	None
57403	57404	In	0	None
57404	57405	conclusion	0	None
57405	57406	,	0	None
57406	57407	a	0	None
57407	57408	14	0	None
57408	57409	-	0	None
57409	57410	day	0	None
57410	57411	administration	0	None
57411	57412	of	0	None
57412	57413	etodolac	3	CHEMICAL
57413	57414	or	0	None
57414	57415	ibuprofen	3	CHEMICAL
57415	57416	in	0	None
57416	57417	therapeutic	0	None
57417	57418	doses	0	None
57418	57419	did	0	None
57419	57420	not	0	None
57420	57421	affect	0	None
57421	57422	the	0	None
57422	57423	renal	0	None
57423	57424	haemodynamics	0	None
57424	57425	,	0	None
57425	57426	the	0	None
57426	57427	net	1	GENE-Y
57427	57428	excretion	0	None
57428	57429	of	0	None
57429	57430	electrolytes	0	None
57430	57431	or	0	None
57431	57432	the	0	None
57432	57433	urinary	0	None
57433	57434	excretion	0	None
57434	57435	of	0	None
57435	57436	albumin	1	GENE-Y
57436	57437	in	0	None
57437	57438	healthy	0	None
57438	57439	subjects	0	None
57439	57440	.	0	None

57441	57442	However	0	None
57442	57443	,	0	None
57443	57444	ibuprofen	3	CHEMICAL
57444	57445	,	0	None
57445	57446	in	0	None
57446	57447	contrast	0	None
57447	57448	to	0	None
57448	57449	etodolac	3	CHEMICAL
57449	57450	,	0	None
57450	57451	caused	0	None
57451	57452	a	0	None
57452	57453	reduction	0	None
57453	57454	in	0	None
57454	57455	PRC	0	None
57455	57456	,	0	None
57456	57457	suggesting	0	None
57457	57458	that	0	None
57458	57459	COX	2	GENE-N
57459	57460	-	0	None
57460	57461	1	0	None
57461	57462	is	0	None
57462	57463	involved	0	None
57463	57464	in	0	None
57464	57465	basal	0	None
57465	57466	renin	1	GENE-Y
57466	57467	release	0	None
57467	57468	in	0	None
57468	57469	humans	0	None
57469	57470	.	0	None

57471	57472	Furthermore	0	None
57472	57473	,	0	None
57473	57474	ibuprofen	3	CHEMICAL
57474	57475	decreased	0	None
57475	57476	lithium	3	CHEMICAL
57476	57477	excretion	0	None
57477	57478	suggesting	0	None
57478	57479	that	0	None
57479	57480	COX	2	GENE-N
57480	57481	-	0	None
57481	57482	1	0	None
57482	57483	is	0	None
57483	57484	involved	0	None
57484	57485	in	0	None
57485	57486	the	0	None
57486	57487	re	0	None
57487	57488	-	0	None
57488	57489	absorption	0	None
57489	57490	of	0	None
57490	57491	sodium	3	CHEMICAL
57491	57492	and	0	None
57492	57493	/	0	None
57493	57494	or	0	None
57494	57495	water	0	None
57495	57496	in	0	None
57496	57497	the	0	None
57497	57498	proximal	0	None
57498	57499	tubuli	0	None
57499	57500	.	0	None

57501	57502	The	0	None
57502	57503	reduction	0	None
57503	57504	in	0	None
57504	57505	the	0	None
57505	57506	urinary	0	None
57506	57507	excretion	0	None
57507	57508	of	0	None
57508	57509	alpha	0	None
57509	57510	-	0	None
57510	57511	GST	0	None
57511	57512	by	0	None
57512	57513	ibuprofen	3	CHEMICAL
57513	57514	may	0	None
57514	57515	be	0	None
57515	57516	caused	0	None
57516	57517	by	0	None
57517	57518	an	0	None
57518	57519	inhibition	0	None
57519	57520	of	0	None
57520	57521	the	0	None
57521	57522	detoxification	0	None
57522	57523	enzyme	0	None
57523	57524	by	0	None
57524	57525	ibuprofen	3	CHEMICAL
57525	57526	.	0	None

57527	57528	Overall	0	None
57528	57529	the	0	None
57529	57530	study	0	None
57530	57531	indicates	0	None
57531	57532	that	0	None
57532	57533	only	0	None
57533	57534	small	0	None
57534	57535	differences	0	None
57535	57536	in	0	None
57536	57537	the	0	None
57537	57538	effects	0	None
57538	57539	of	0	None
57539	57540	the	0	None
57540	57541	two	0	None
57541	57542	drugs	0	None
57542	57543	on	0	None
57543	57544	renal	0	None
57544	57545	function	0	None
57545	57546	in	0	None
57546	57547	healthy	0	None
57547	57548	subjects	0	None
57548	57549	exist	0	None
57549	57550	during	0	None
57550	57551	a	0	None
57551	57552	treatment	0	None
57552	57553	period	0	None
57553	57554	of	0	None
57554	57555	2	0	None
57555	57556	weeks	0	None
57556	57557	.	0	None

57558	57559	The	0	None
57559	57560	active	0	None
57560	57561	-	0	None
57561	57562	site	0	None
57562	57563	residue	0	None
57563	57564	tyr	3	CHEMICAL
57564	57565	-	0	None
57565	57566	175	0	None
57566	57567	in	0	None
57567	57568	human	0	None
57568	57569	glyoxalase	0	None
57569	57570	II	0	None
57570	57571	contributes	0	None
57571	57572	to	0	None
57572	57573	binding	0	None
57573	57574	of	0	None
57574	57575	glutathione	3	CHEMICAL
57575	57576	derivatives	0	None
57576	57577	.	0	None

57578	57579	Tyrosine	0	None
57579	57580	-	0	None
57580	57581	175	0	None
57581	57582	located	0	None
57582	57583	in	0	None
57583	57584	the	0	None
57584	57585	active	0	None
57585	57586	site	0	None
57586	57587	of	0	None
57587	57588	human	0	None
57588	57589	glyoxalase	0	None
57589	57590	II	0	None
57590	57591	was	0	None
57591	57592	replaced	0	None
57592	57593	by	0	None
57593	57594	phenylalanine	3	CHEMICAL
57594	57595	in	0	None
57595	57596	order	0	None
57596	57597	to	0	None
57597	57598	study	0	None
57598	57599	the	0	None
57599	57600	contribution	0	None
57600	57601	of	0	None
57601	57602	this	0	None
57602	57603	residue	0	None
57603	57604	to	0	None
57604	57605	catalysis	0	None
57605	57606	.	0	None

57607	57608	The	0	None
57608	57609	mutation	0	None
57609	57610	had	0	None
57610	57611	a	0	None
57611	57612	marginal	0	None
57612	57613	effect	0	None
57613	57614	on	0	None
57614	57615	the	0	None
57615	57616	k	0	None
57616	57617	(	0	None
57617	57618	cat	0	None
57618	57619	)	0	None
57619	57620	value	0	None
57620	57621	determined	0	None
57621	57622	using	0	None
57622	57623	S	0	None
57623	57624	-	0	None
57624	57625	D	0	None
57625	57626	-	0	None
57626	57627	lactoylglutathione	0	None
57627	57628	as	0	None
57628	57629	substrate	0	None
57629	57630	.	0	None

57631	57632	However	0	None
57632	57633	,	0	None
57633	57634	the	0	None
57634	57635	Y175F	0	None
57635	57636	mutant	0	None
57636	57637	had	0	None
57637	57638	an	0	None
57638	57639	8	0	None
57639	57640	-	0	None
57640	57641	fold	0	None
57641	57642	higher	0	None
57642	57643	K	0	None
57643	57644	(	0	None
57644	57645	m	0	None
57645	57646	)	0	None
57646	57647	value	0	None
57647	57648	than	0	None
57648	57649	the	0	None
57649	57650	wild	0	None
57650	57651	-	0	None
57651	57652	type	0	None
57652	57653	enzyme	0	None
57653	57654	.	0	None

57655	57656	The	0	None
57656	57657	competitive	0	None
57657	57658	inhibitor	0	None
57658	57659	S	0	None
57659	57660	-	0	None
57660	57661	(	0	None
57661	57662	N	0	None
57662	57663	-	0	None
57663	57664	hydroxy	3	CHEMICAL
57664	57665	-	0	None
57665	57666	N	0	None
57666	57667	-	0	None
57667	57668	bromophenylcarbamoyl	0	None
57668	57669	)	0	None
57669	57670	glutathione	3	CHEMICAL
57670	57671	had	0	None
57671	57672	a	0	None
57672	57673	30	0	None
57673	57674	-	0	None
57674	57675	fold	0	None
57675	57676	higher	0	None
57676	57677	K	0	None
57677	57678	(	0	None
57678	57679	i	0	None
57679	57680	)	0	None
57680	57681	value	0	None
57681	57682	towards	0	None
57682	57683	the	0	None
57683	57684	mutant	0	None
57684	57685	,	0	None
57685	57686	than	0	None
57686	57687	that	0	None
57687	57688	of	0	None
57688	57689	the	0	None
57689	57690	wild	0	None
57690	57691	-	0	None
57691	57692	type	0	None
57692	57693	.	0	None

57694	57695	Pre	0	None
57695	57696	-	0	None
57696	57697	equilibrium	0	None
57697	57698	fluorescence	0	None
57698	57699	studies	0	None
57699	57700	with	0	None
57700	57701	the	0	None
57701	57702	inhibitor	0	None
57702	57703	showed	0	None
57703	57704	that	0	None
57704	57705	this	0	None
57705	57706	was	0	None
57706	57707	due	0	None
57707	57708	to	0	None
57708	57709	a	0	None
57709	57710	significantly	0	None
57710	57711	increased	0	None
57711	57712	off	0	None
57712	57713	-	0	None
57713	57714	rate	0	None
57714	57715	for	0	None
57715	57716	the	0	None
57716	57717	mutant	0	None
57717	57718	enzyme	0	None
57718	57719	.	0	None

57720	57721	The	0	None
57721	57722	phenolic	3	CHEMICAL
57722	57723	hydroxyl	3	CHEMICAL
57723	57724	group	0	None
57724	57725	of	0	None
57725	57726	tyrosine	3	CHEMICAL
57726	57727	-	0	None
57727	57728	175	0	None
57728	57729	is	0	None
57729	57730	within	0	None
57730	57731	hydrogen	3	CHEMICAL
57731	57732	bonding	0	None
57732	57733	distance	0	None
57733	57734	of	0	None
57734	57735	the	0	None
57735	57737	amide nitrogen	3	CHEMICAL
57737	57738	of	0	None
57738	57739	the	0	None
57739	57740	glycine	3	CHEMICAL
57740	57741	in	0	None
57741	57742	the	0	None
57742	57743	glutathione	3	CHEMICAL
57743	57744	moiety	0	None
57744	57745	and	0	None
57745	57746	the	0	None
57746	57747	present	0	None
57747	57748	study	0	None
57748	57749	shows	0	None
57749	57750	that	0	None
57750	57751	this	0	None
57751	57752	interaction	0	None
57752	57753	makes	0	None
57753	57754	a	0	None
57754	57755	significant	0	None
57755	57756	contribution	0	None
57756	57757	to	0	None
57757	57758	the	0	None
57758	57759	binding	0	None
57759	57760	of	0	None
57760	57761	the	0	None
57761	57762	active	0	None
57762	57763	-	0	None
57763	57764	site	0	None
57764	57765	ligand	0	None
57765	57766	.	0	None

57767	57768	Beneficial	0	None
57768	57769	renal	0	None
57769	57770	and	0	None
57770	57771	hemodynamic	0	None
57771	57772	effects	0	None
57772	57773	of	0	None
57773	57774	omapatrilat	3	CHEMICAL
57774	57775	in	0	None
57775	57776	mild	0	None
57776	57777	and	0	None
57777	57778	severe	0	None
57778	57779	heart	0	None
57779	57780	failure	0	None
57780	57781	.	0	None

57782	57783	Omapatrilat	0	None
57783	57784	is	0	None
57784	57785	a	0	None
57785	57786	member	0	None
57786	57787	of	0	None
57787	57788	the	0	None
57788	57789	new	0	None
57789	57790	drug	0	None
57790	57791	class	0	None
57791	57792	of	0	None
57792	57793	vasopeptidase	2	GENE-N
57793	57794	inhibitors	0	None
57794	57795	that	0	None
57795	57796	may	0	None
57796	57797	offer	0	None
57797	57798	benefit	0	None
57798	57799	in	0	None
57799	57800	the	0	None
57800	57801	treatment	0	None
57801	57802	of	0	None
57802	57803	heart	0	None
57803	57804	failure	0	None
57804	57805	(	0	None
57805	57806	HF	0	None
57806	57807	)	0	None
57807	57808	through	0	None
57808	57809	simultaneous	0	None
57809	57810	inhibition	0	None
57810	57811	of	0	None
57811	57812	angiotensin	3	CHEMICAL
57812	57813	-	0	None
57813	57815	converting enzyme	1	GENE-Y
57815	57816	and	0	None
57816	57817	neutral	0	None
57817	57818	endopeptidase	0	None
57818	57819	.	0	None

57820	57821	We	0	None
57821	57822	examined	0	None
57822	57823	the	0	None
57823	57824	effects	0	None
57824	57825	of	0	None
57825	57826	omapatrilat	3	CHEMICAL
57826	57827	in	0	None
57827	57828	a	0	None
57828	57829	placebo	0	None
57829	57830	-	0	None
57830	57831	controlled	0	None
57831	57832	crossover	0	None
57832	57833	study	0	None
57833	57834	using	0	None
57834	57835	a	0	None
57835	57836	pacing	0	None
57836	57837	model	0	None
57837	57838	of	0	None
57838	57839	HF	0	None
57839	57840	.	0	None

57841	57842	Seven	0	None
57842	57843	sheep	0	None
57843	57844	were	0	None
57844	57845	paced	0	None
57845	57846	sequentially	0	None
57846	57847	at	0	None
57847	57848	180	0	None
57848	57849	bpm	0	None
57849	57850	(	0	None
57850	57851	mild	0	None
57851	57852	HF	0	None
57852	57853	)	0	None
57853	57854	and	0	None
57854	57855	then	0	None
57855	57856	225	0	None
57856	57857	bpm	0	None
57857	57858	(	0	None
57858	57859	severe	0	None
57859	57860	HF	0	None
57860	57861	)	0	None
57861	57862	for	0	None
57862	57863	7	0	None
57863	57864	days	0	None
57864	57865	each	0	None
57865	57866	.	0	None

57867	57868	Omapatrilat	0	None
57868	57869	(	0	None
57869	57870	0	0	None
57870	57871	.	0	None
57871	57872	005	0	None
57872	57873	mg	0	None
57873	57874	/	0	None
57874	57875	kg	0	None
57875	57876	)	0	None
57876	57877	or	0	None
57877	57878	vehicle	0	None
57878	57879	was	0	None
57879	57880	administered	0	None
57880	57881	by	0	None
57881	57882	intravenous	0	None
57882	57883	bolus	0	None
57883	57884	on	0	None
57884	57885	days	0	None
57885	57886	4	0	None
57886	57887	to	0	None
57887	57888	7	0	None
57888	57889	of	0	None
57889	57890	each	0	None
57890	57891	paced	0	None
57891	57892	period	0	None
57892	57893	.	0	None

57894	57895	Omapatrilat	0	None
57895	57896	lowered	0	None
57896	57897	mean	0	None
57897	57898	arterial	0	None
57898	57899	and	0	None
57899	57900	left	0	None
57900	57901	atrial	0	None
57901	57902	pressure	0	None
57902	57903	and	0	None
57903	57904	increased	0	None
57904	57905	cardiac	0	None
57905	57906	output	0	None
57906	57907	acutely	0	None
57907	57908	and	0	None
57908	57909	chronically	0	None
57909	57910	in	0	None
57910	57911	both	0	None
57911	57912	mild	0	None
57912	57913	and	0	None
57913	57914	severe	0	None
57914	57915	HF	0	None
57915	57916	(	0	None
57916	57917	P	0	None
57917	57918	<	0	None
57918	57919	0	0	None
57919	57920	.	0	None
57920	57921	01	0	None
57921	57922	for	0	None
57922	57923	all	0	None
57923	57924	)	0	None
57924	57925	.	0	None

57926	57927	Plasma	0	None
57927	57928	atrial	0	None
57928	57929	and	0	None
57929	57932	brain natriuretic peptide	1	GENE-Y
57932	57933	and	0	None
57933	57934	cGMP	3	CHEMICAL
57934	57935	levels	0	None
57935	57936	were	0	None
57936	57937	stable	0	None
57937	57938	acutely	0	None
57938	57939	(	0	None
57939	57940	P	0	None
57940	57941	=	0	None
57941	57942	NS	0	None
57942	57943	)	0	None
57943	57944	,	0	None
57944	57945	while	0	None
57945	57948	brain natriuretic peptide	1	GENE-Y
57948	57949	increased	0	None
57949	57950	after	0	None
57950	57951	repeated	0	None
57951	57952	dosing	0	None
57952	57953	in	0	None
57953	57954	severe	0	None
57954	57955	HF	0	None
57955	57956	(	0	None
57956	57957	P	0	None
57957	57958	<	0	None
57958	57959	0	0	None
57959	57960	.	0	None
57960	57961	05	0	None
57961	57962	)	0	None
57962	57963	.	0	None

57964	57965	Plasma	0	None
57965	57966	renin	1	GENE-Y
57966	57967	activity	0	None
57967	57968	rose	0	None
57968	57969	,	0	None
57969	57970	whereas	0	None
57970	57972	angiotensin II	1	GENE-Y
57972	57973	and	0	None
57973	57974	aldosterone	3	CHEMICAL
57974	57975	levels	0	None
57975	57976	fell	0	None
57976	57977	after	0	None
57977	57978	acute	0	None
57978	57979	and	0	None
57979	57980	repeated	0	None
57980	57981	dosing	0	None
57981	57982	in	0	None
57982	57983	both	0	None
57983	57984	states	0	None
57984	57985	(	0	None
57985	57986	P	0	None
57986	57987	<	0	None
57987	57988	0	0	None
57988	57989	.	0	None
57989	57990	01	0	None
57990	57991	for	0	None
57991	57992	all	0	None
57992	57993	)	0	None
57993	57994	.	0	None

57995	57996	Omapatrilat	0	None
57996	57997	increased	0	None
57997	57998	urinary	0	None
57998	57999	sodium	3	CHEMICAL
57999	58000	excretion	0	None
58000	58001	by	0	None
58001	58002	day	0	None
58002	58003	7	0	None
58003	58004	in	0	None
58004	58005	both	0	None
58005	58006	mild	0	None
58006	58007	and	0	None
58007	58008	severe	0	None
58008	58009	HF	0	None
58009	58010	(	0	None
58010	58011	P	0	None
58011	58012	<	0	None
58012	58013	0	0	None
58013	58014	.	0	None
58014	58015	05	0	None
58015	58016	)	0	None
58016	58017	.	0	None

58018	58019	Effective	0	None
58019	58020	renal	0	None
58020	58021	plasma	0	None
58021	58022	flow	0	None
58022	58023	and	0	None
58023	58024	glomerular	0	None
58024	58025	filtration	0	None
58025	58026	rate	0	None
58026	58027	increased	0	None
58027	58028	or	0	None
58028	58029	were	0	None
58029	58030	stable	0	None
58030	58031	after	0	None
58031	58032	omapatrilat	3	CHEMICAL
58032	58033	in	0	None
58033	58034	mild	0	None
58034	58035	and	0	None
58035	58036	severe	0	None
58036	58037	HF	0	None
58037	58038	after	0	None
58038	58039	both	0	None
58039	58040	acute	0	None
58040	58041	and	0	None
58041	58042	repeated	0	None
58042	58043	dosing	0	None
58043	58044	.	0	None

58045	58046	Omapatrilat	0	None
58046	58047	exhibited	0	None
58047	58048	pronounced	0	None
58048	58049	acute	0	None
58049	58050	and	0	None
58050	58051	sustained	0	None
58051	58052	beneficial	0	None
58052	58053	hemodynamic	0	None
58053	58054	and	0	None
58054	58055	renal	0	None
58055	58056	effects	0	None
58056	58057	in	0	None
58057	58058	both	0	None
58058	58059	mild	0	None
58059	58060	and	0	None
58060	58061	severe	0	None
58061	58062	heart	0	None
58062	58063	failure	0	None
58063	58064	.	0	None

58065	58066	Pharmacological	0	None
58066	58067	analysis	0	None
58067	58068	of	0	None
58068	58069	contractile	0	None
58069	58070	effects	0	None
58070	58071	of	0	None
58071	58072	eletriptan	3	CHEMICAL
58072	58073	and	0	None
58073	58074	sumatriptan	3	CHEMICAL
58074	58075	on	0	None
58075	58076	human	0	None
58076	58077	isolated	0	None
58077	58078	blood	0	None
58078	58079	vessels	0	None
58079	58080	.	0	None

58081	58082	Eletriptan	0	None
58082	58083	,	0	None
58083	58084	a	0	None
58084	58085	second	0	None
58085	58086	-	0	None
58086	58087	generation	0	None
58087	58088	triptan	0	None
58088	58089	with	0	None
58089	58090	high	0	None
58090	58091	affinity	0	None
58091	58092	for	0	None
58092	58093	5	0	None
58093	58094	-	0	None
58094	58095	HT	3	CHEMICAL
58095	58096	(	0	None
58096	58097	1B	0	None
58097	58098	/	0	None
58098	58099	1D	0	None
58099	58100	)	0	None
58100	58101	receptors	0	None
58101	58102	,	0	None
58102	58103	is	0	None
58103	58104	highly	0	None
58104	58105	effective	0	None
58105	58106	in	0	None
58106	58107	migraine	0	None
58107	58108	,	0	None
58108	58109	with	0	None
58109	58110	or	0	None
58110	58111	without	0	None
58111	58112	aura	0	None
58112	58113	.	0	None

58114	58115	We	0	None
58115	58116	compared	0	None
58116	58117	the	0	None
58117	58118	effects	0	None
58118	58119	of	0	None
58119	58120	eletriptan	3	CHEMICAL
58120	58121	and	0	None
58121	58122	sumatriptan	3	CHEMICAL
58122	58123	on	0	None
58123	58124	the	0	None
58124	58125	human	0	None
58125	58126	isolated	0	None
58126	58127	middle	0	None
58127	58128	meningeal	0	None
58128	58129	and	0	None
58129	58130	coronary	0	None
58130	58131	arteries	0	None
58131	58132	and	0	None
58132	58133	saphenous	0	None
58133	58134	vein	0	None
58134	58135	,	0	None
58135	58136	used	0	None
58136	58137	as	0	None
58137	58138	models	0	None
58138	58139	for	0	None
58139	58140	therapeutic	0	None
58140	58141	efficacy	0	None
58141	58142	and	0	None
58142	58143	potential	0	None
58143	58144	side	0	None
58144	58145	effects	0	None
58145	58146	,	0	None
58146	58147	and	0	None
58147	58148	have	0	None
58148	58149	investigated	0	None
58149	58150	the	0	None
58150	58151	role	0	None
58151	58152	of	0	None
58152	58153	5	0	None
58153	58154	-	0	None
58154	58155	HT	3	CHEMICAL
58155	58156	(	0	None
58156	58157	1B	0	None
58157	58158	/	0	None
58158	58159	1D	0	None
58159	58160	)	0	None
58160	58161	receptors	0	None
58161	58162	in	0	None
58162	58163	contractions	0	None
58163	58164	induced	0	None
58164	58165	by	0	None
58165	58166	these	0	None
58166	58167	triptans	3	CHEMICAL
58167	58168	.	0	None

58169	58170	Concentration	0	None
58170	58171	-	0	None
58171	58172	response	0	None
58172	58173	curves	0	None
58173	58174	to	0	None
58174	58175	eletriptan	3	CHEMICAL
58175	58176	and	0	None
58176	58177	sumatriptan	3	CHEMICAL
58177	58178	were	0	None
58178	58179	constructed	0	None
58179	58180	in	0	None
58180	58181	the	0	None
58181	58182	absence	0	None
58182	58183	or	0	None
58183	58184	presence	0	None
58184	58185	of	0	None
58185	58186	a	0	None
58186	58187	selective	0	None
58187	58188	5	0	None
58188	58189	-	0	None
58189	58190	HT	3	CHEMICAL
58190	58191	(	0	None
58191	58192	1B	0	None
58192	58193	/	0	None
58193	58194	1D	0	None
58194	58195	)	0	None
58195	58196	receptor	0	None
58196	58197	antagonist	0	None
58197	58198	,	0	None
58198	58199	N	0	None
58199	58200	-	0	None
58200	58201	[	0	None
58201	58202	4	0	None
58202	58203	-	0	None
58203	58204	methoxy	3	CHEMICAL
58204	58205	-	0	None
58205	58206	3	0	None
58206	58207	-	0	None
58207	58208	(	0	None
58208	58209	4	0	None
58209	58210	-	0	None
58210	58211	methylpiperazin	0	None
58211	58212	-	0	None
58212	58213	1	0	None
58213	58214	-	0	None
58214	58215	yl	0	None
58215	58216	)	0	None
58216	58217	phenyl	3	CHEMICAL
58217	58218	]	0	None
58218	58219	-	0	None
58219	58220	3	0	None
58220	58221	-	0	None
58221	58222	methyl	3	CHEMICAL
58222	58223	-	0	None
58223	58224	4	0	None
58224	58225	-	0	None
58225	58226	(	0	None
58226	58227	4	0	None
58227	58228	-	0	None
58228	58229	py	0	None
58229	58230	rid	0	None
58230	58231	yl	0	None
58231	58232	)	0	None
58232	58233	benzamide	3	CHEMICAL
58233	58234	(	0	None
58234	58235	GR125743	3	CHEMICAL
58235	58236	)	0	None
58236	58237	.	0	None

58238	58239	All	0	None
58239	58240	three	0	None
58240	58241	blood	0	None
58241	58242	vessels	0	None
58242	58243	constricted	0	None
58243	58244	in	0	None
58244	58245	response	0	None
58245	58246	to	0	None
58246	58247	eletriptan	3	CHEMICAL
58247	58248	and	0	None
58248	58249	sumatriptan	3	CHEMICAL
58249	58250	,	0	None
58250	58251	but	0	None
58251	58252	the	0	None
58252	58253	middle	0	None
58253	58254	meningeal	0	None
58254	58255	artery	0	None
58255	58256	relaxed	0	None
58256	58257	following	0	None
58257	58258	the	0	None
58258	58259	highest	0	None
58259	58260	concentration	0	None
58260	58261	(	0	None
58261	58262	100	0	None
58262	58263	microM	0	None
58263	58264	)	0	None
58264	58265	of	0	None
58265	58266	eletriptan	3	CHEMICAL
58266	58267	.	0	None

58268	58269	In	0	None
58269	58270	the	0	None
58270	58271	middle	0	None
58271	58272	meningeal	0	None
58272	58273	artery	0	None
58273	58274	,	0	None
58274	58275	GR125743	3	CHEMICAL
58275	58276	antagonised	0	None
58276	58277	the	0	None
58277	58278	contractions	0	None
58278	58279	induced	0	None
58279	58280	by	0	None
58280	58281	both	0	None
58281	58282	eletriptan	3	CHEMICAL
58282	58283	(	0	None
58283	58284	pEC	0	None
58284	58285	(	0	None
58285	58286	50	0	None
58286	58287	)	0	None
58287	58288	:	0	None
58288	58289	7	0	None
58289	58290	.	0	None
58290	58291	34	0	None
58291	58292	+	0	None
58292	58293	/	0	None
58293	58294	-	0	None
58294	58295	0	0	None
58295	58296	.	0	None
58296	58297	13	0	None
58297	58298	)	0	None
58298	58299	and	0	None
58299	58300	sumatriptan	3	CHEMICAL
58300	58301	(	0	None
58301	58302	pEC	0	None
58302	58303	(	0	None
58303	58304	50	0	None
58304	58305	)	0	None
58305	58306	:	0	None
58306	58307	6	0	None
58307	58308	.	0	None
58308	58309	91	0	None
58309	58310	+	0	None
58310	58311	/	0	None
58311	58312	-	0	None
58312	58313	0	0	None
58313	58314	.	0	None
58314	58315	17	0	None
58315	58316	)	0	None
58316	58317	to	0	None
58317	58318	a	0	None
58318	58319	similar	0	None
58319	58320	degree	0	None
58320	58321	(	0	None
58321	58322	pA	0	None
58322	58323	(	0	None
58323	58324	2	0	None
58324	58325	)	0	None
58325	58326	:	0	None
58326	58327	8	0	None
58327	58328	.	0	None
58328	58329	81	0	None
58329	58330	+	0	None
58330	58331	/	0	None
58331	58332	-	0	None
58332	58333	0	0	None
58333	58334	.	0	None
58334	58335	17	0	None
58335	58336	and	0	None
58336	58337	8	0	None
58337	58338	.	0	None
58338	58339	64	0	None
58339	58340	+	0	None
58340	58341	/	0	None
58341	58342	-	0	None
58342	58343	0	0	None
58343	58344	.	0	None
58344	58345	21	0	None
58345	58346	,	0	None
58346	58347	respectively	0	None
58347	58348	)	0	None
58348	58349	.	0	None

58350	58351	In	0	None
58351	58352	the	0	None
58352	58353	human	0	None
58353	58354	coronary	0	None
58354	58355	artery	0	None
58355	58356	and	0	None
58356	58357	saphenous	0	None
58357	58358	vein	0	None
58358	58359	,	0	None
58359	58360	sumatriptan	3	CHEMICAL
58360	58361	-	0	None
58361	58362	induced	0	None
58362	58363	contractions	0	None
58363	58364	(	0	None
58364	58365	pEC	0	None
58365	58366	(	0	None
58366	58367	50	0	None
58367	58368	)	0	None
58368	58369	:	0	None
58369	58370	6	0	None
58370	58371	.	0	None
58371	58372	24	0	None
58372	58373	+	0	None
58373	58374	/	0	None
58374	58375	-	0	None
58375	58376	0	0	None
58376	58377	.	0	None
58377	58378	14	0	None
58378	58379	and	0	None
58379	58380	6	0	None
58380	58381	.	0	None
58381	58382	19	0	None
58382	58383	+	0	None
58383	58384	/	0	None
58384	58385	-	0	None
58385	58386	0	0	None
58386	58387	.	0	None
58387	58388	12	0	None
58388	58389	,	0	None
58389	58390	respectively	0	None
58390	58391	)	0	None
58391	58392	were	0	None
58392	58393	also	0	None
58393	58394	potently	0	None
58394	58395	antagonised	0	None
58395	58396	by	0	None
58396	58397	GR125743	3	CHEMICAL
58397	58398	(	0	None
58398	58399	pA	0	None
58399	58400	(	0	None
58400	58401	2	0	None
58401	58402	)	0	None
58402	58403	:	0	None
58403	58404	8	0	None
58404	58405	.	0	None
58405	58406	18	0	None
58406	58407	+	0	None
58407	58408	/	0	None
58408	58409	-	0	None
58409	58410	0	0	None
58410	58411	.	0	None
58411	58412	27	0	None
58412	58413	and	0	None
58413	58414	8	0	None
58414	58415	.	0	None
58415	58416	34	0	None
58416	58417	+	0	None
58417	58418	/	0	None
58418	58419	-	0	None
58419	58420	0	0	None
58420	58421	.	0	None
58421	58422	12	0	None
58422	58423	,	0	None
58423	58424	respectively	0	None
58424	58425	)	0	None
58425	58426	.	0	None

58427	58428	The	0	None
58428	58429	eletriptan	3	CHEMICAL
58429	58430	-	0	None
58430	58431	induced	0	None
58431	58432	contractions	0	None
58432	58433	of	0	None
58433	58434	the	0	None
58434	58435	human	0	None
58435	58436	saphenous	0	None
58436	58437	vein	0	None
58437	58438	(	0	None
58438	58439	pEC	0	None
58439	58440	(	0	None
58440	58441	50	0	None
58441	58442	)	0	None
58442	58443	:	0	None
58443	58444	6	0	None
58444	58445	.	0	None
58445	58446	09	0	None
58446	58447	+	0	None
58447	58448	/	0	None
58448	58449	-	0	None
58449	58450	0	0	None
58450	58451	.	0	None
58451	58452	13	0	None
58452	58453	)	0	None
58453	58454	were	0	None
58454	58455	antagonised	0	None
58455	58456	less	0	None
58456	58457	effectively	0	None
58457	58458	by	0	None
58458	58459	GR125743	3	CHEMICAL
58459	58460	(	0	None
58460	58461	pK	0	None
58461	58462	(	0	None
58462	58463	B	0	None
58463	58464	)	0	None
58464	58465	:	0	None
58465	58466	7	0	None
58466	58467	.	0	None
58467	58468	73	0	None
58468	58469	+	0	None
58469	58470	/	0	None
58470	58471	-	0	None
58471	58472	0	0	None
58472	58473	.	0	None
58473	58474	18	0	None
58474	58475	)	0	None
58475	58476	,	0	None
58476	58477	and	0	None
58477	58478	those	0	None
58478	58479	of	0	None
58479	58480	the	0	None
58480	58481	human	0	None
58481	58482	coronary	0	None
58482	58483	artery	0	None
58483	58484	(	0	None
58484	58485	pEC	0	None
58485	58486	(	0	None
58486	58487	50	0	None
58487	58488	)	0	None
58488	58489	:	0	None
58489	58490	5	0	None
58490	58491	.	0	None
58491	58492	54	0	None
58492	58493	+	0	None
58493	58494	/	0	None
58494	58495	-	0	None
58495	58496	0	0	None
58496	58497	.	0	None
58497	58498	22	0	None
58498	58499	)	0	None
58499	58500	remained	0	None
58500	58501	unaffected	0	None
58501	58502	by	0	None
58502	58503	GR125743	3	CHEMICAL
58503	58504	up	0	None
58504	58505	to	0	None
58505	58506	a	0	None
58506	58507	concentration	0	None
58507	58508	of	0	None
58508	58509	100	0	None
58509	58510	nM	0	None
58510	58511	.	0	None

58512	58513	These	0	None
58513	58514	results	0	None
58514	58515	suggest	0	None
58515	58516	that	0	None
58516	58517	(	0	None
58517	58518	i	0	None
58518	58519	)	0	None
58519	58520	based	0	None
58520	58521	on	0	None
58521	58522	the	0	None
58522	58523	differences	0	None
58523	58524	in	0	None
58524	58525	pEC	0	None
58525	58526	(	0	None
58526	58527	50	0	None
58527	58528	)	0	None
58528	58529	values	0	None
58529	58530	,	0	None
58530	58531	the	0	None
58531	58532	cranioselectivity	0	None
58532	58533	of	0	None
58533	58534	eletriptan	3	CHEMICAL
58534	58535	(	0	None
58535	58536	63	0	None
58536	58537	-	0	None
58537	58538	fold	0	None
58538	58539	)	0	None
58539	58540	is	0	None
58540	58541	higher	0	None
58541	58542	than	0	None
58542	58543	that	0	None
58543	58544	of	0	None
58544	58545	sumatriptan	3	CHEMICAL
58545	58546	(	0	None
58546	58547	5	0	None
58547	58548	-	0	None
58548	58549	fold	0	None
58549	58550	)	0	None
58550	58551	in	0	None
58551	58552	coronary	0	None
58552	58553	artery	0	None
58553	58554	,	0	None
58554	58555	(	0	None
58555	58556	ii	0	None
58556	58557	)	0	None
58557	58558	the	0	None
58558	58559	contractile	0	None
58559	58560	effects	0	None
58560	58561	of	0	None
58561	58562	sumatriptan	3	CHEMICAL
58562	58563	and	0	None
58563	58564	eletriptan	3	CHEMICAL
58564	58565	(	0	None
58565	58566	lower	0	None
58566	58567	concentrations	0	None
58567	58568	)	0	None
58568	58569	in	0	None
58569	58570	the	0	None
58570	58571	three	0	None
58571	58572	blood	0	None
58572	58573	vessels	0	None
58573	58574	are	0	None
58574	58575	mediated	0	None
58575	58576	via	0	None
58576	58577	the	0	None
58577	58578	5	0	None
58578	58579	-	0	None
58579	58580	HT	3	CHEMICAL
58580	58581	(	0	None
58581	58582	1B	0	None
58582	58583	)	0	None
58583	58584	receptor	0	None
58584	58585	,	0	None
58585	58586	and	0	None
58586	58587	(	0	None
58587	58588	iii	0	None
58588	58589	)	0	None
58589	58590	additional	0	None
58590	58591	mechanisms	0	None
58591	58592	seem	0	None
58592	58593	to	0	None
58593	58594	be	0	None
58594	58595	involved	0	None
58595	58596	in	0	None
58596	58597	coronary	0	None
58597	58598	artery	0	None
58598	58599	and	0	None
58599	58600	saphenous	0	None
58600	58601	vein	0	None
58601	58602	contractions	0	None
58602	58603	and	0	None
58603	58604	middle	0	None
58604	58605	meningeal	0	None
58605	58606	artery	0	None
58606	58607	relaxation	0	None
58607	58608	following	0	None
58608	58609	high	0	None
58609	58610	concentrations	0	None
58610	58611	of	0	None
58611	58612	eletriptan	3	CHEMICAL
58612	58613	.	0	None

58614	58615	A	0	None
58615	58616	comparison	0	None
58616	58617	of	0	None
58617	58618	agonist	0	None
58618	58619	-	0	None
58619	58620	specific	0	None
58620	58621	coupling	0	None
58621	58622	of	0	None
58622	58623	cloned	0	None
58623	58624	human	0	None
58624	58625	alpha	0	None
58625	58626	(	0	None
58626	58627	2	0	None
58627	58628	)	0	None
58628	58629	-	0	None
58629	58630	adrenoceptor	0	None
58630	58631	subtypes	0	None
58631	58632	.	0	None

58633	58634	The	0	None
58634	58635	agonist	0	None
58635	58636	-	0	None
58636	58637	specific	0	None
58637	58638	coupling	0	None
58638	58639	properties	0	None
58639	58640	of	0	None
58640	58641	the	0	None
58641	58642	three	0	None
58642	58643	cloned	0	None
58643	58644	human	0	None
58644	58645	alpha	0	None
58645	58646	(	0	None
58646	58647	2	0	None
58647	58648	)	0	None
58648	58649	-	0	None
58649	58650	adrenoceptor	0	None
58650	58651	subtypes	0	None
58651	58652	have	0	None
58652	58653	been	0	None
58653	58654	compared	0	None
58654	58655	,	0	None
58655	58656	when	0	None
58656	58657	expressed	0	None
58657	58658	at	0	None
58658	58659	similar	0	None
58659	58660	levels	0	None
58660	58661	in	0	None
58661	58662	Chinese	0	None
58662	58663	hamster	0	None
58663	58664	ovary	0	None
58664	58665	(	0	None
58665	58666	CHO	3	CHEMICAL
58666	58667	)	0	None
58667	58668	cell	0	None
58668	58669	lines	0	None
58669	58670	,	0	None
58670	58671	using	0	None
58671	58672	noradrenaline	3	CHEMICAL
58672	58673	and	0	None
58673	58674	(	0	None
58674	58675	+	0	None
58675	58676	/	0	None
58676	58677	-	0	None
58677	58678	)	0	None
58678	58679	-	0	None
58679	58680	meta	0	None
58680	58681	-	0	None
58681	58682	octopamine	0	None
58682	58683	as	0	None
58683	58684	agonists	0	None
58684	58685	.	0	None

58686	58687	Noradrenaline	0	None
58687	58688	can	0	None
58688	58689	couple	0	None
58689	58690	the	0	None
58690	58691	receptor	0	None
58691	58692	to	0	None
58692	58693	both	0	None
58693	58694	the	0	None
58694	58695	inhibition	0	None
58695	58696	and	0	None
58696	58697	stimulation	0	None
58697	58698	of	0	None
58698	58699	forskolin	3	CHEMICAL
58699	58700	-	0	None
58700	58701	stimulated	0	None
58701	58703	cyclic AMP	3	CHEMICAL
58703	58704	production	0	None
58704	58705	in	0	None
58705	58706	all	0	None
58706	58707	three	0	None
58707	58708	receptor	0	None
58708	58709	subtypes	0	None
58709	58710	,	0	None
58710	58711	with	0	None
58711	58712	the	0	None
58712	58713	relative	0	None
58713	58714	strength	0	None
58714	58715	of	0	None
58715	58716	the	0	None
58716	58717	coupling	0	None
58717	58718	to	0	None
58718	58719	the	0	None
58719	58720	pathways	0	None
58720	58721	varying	0	None
58721	58722	for	0	None
58722	58723	each	0	None
58723	58724	of	0	None
58724	58725	the	0	None
58725	58726	receptor	0	None
58726	58727	subtypes	0	None
58727	58728	.	0	None

58729	58730	meta	0	None
58730	58731	-	0	None
58731	58732	Octopamine	0	None
58732	58733	selectively	0	None
58733	58734	couples	0	None
58734	58735	the	0	None
58735	58736	alpha	0	None
58736	58737	(	0	None
58737	58738	2A	0	None
58738	58739	)	0	None
58739	58740	-	0	None
58740	58741	adrenoceptor	0	None
58741	58742	only	0	None
58742	58743	to	0	None
58743	58744	the	0	None
58744	58745	inhibition	0	None
58745	58746	of	0	None
58746	58747	forskolin	3	CHEMICAL
58747	58748	-	0	None
58748	58749	stimulated	0	None
58749	58751	cyclic AMP	3	CHEMICAL
58751	58752	production	0	None
58752	58753	.	0	None

58754	58755	However	0	None
58755	58756	,	0	None
58756	58757	meta	0	None
58757	58758	-	0	None
58758	58759	octopamine	0	None
58759	58760	couples	0	None
58760	58761	the	0	None
58761	58762	alpha	0	None
58762	58763	(	0	None
58763	58764	2B	0	None
58764	58765	)	0	None
58765	58766	-	0	None
58766	58767	and	0	None
58767	58768	alpha	0	None
58768	58769	(	0	None
58769	58770	2C	0	None
58770	58771	)	0	None
58771	58772	-	0	None
58772	58773	adrenoceptors	2	GENE-N
58773	58774	to	0	None
58774	58775	both	0	None
58775	58776	the	0	None
58776	58777	inhibition	0	None
58777	58778	and	0	None
58778	58779	stimulation	0	None
58779	58780	of	0	None
58780	58781	forskolin	3	CHEMICAL
58781	58782	-	0	None
58782	58783	stimulated	0	None
58783	58785	cyclic AMP	3	CHEMICAL
58785	58786	production	0	None
58786	58787	.	0	None

58788	58789	The	0	None
58789	58790	relative	0	None
58790	58791	potency	0	None
58791	58792	of	0	None
58792	58793	meta	0	None
58793	58794	-	0	None
58794	58795	octopamine	0	None
58795	58796	to	0	None
58796	58797	noradrenaline	3	CHEMICAL
58797	58798	varies	0	None
58798	58799	between	0	None
58799	58800	the	0	None
58800	58801	different	0	None
58801	58802	alpha	0	None
58802	58803	(	0	None
58803	58804	2	0	None
58804	58805	)	0	None
58805	58806	-	0	None
58806	58807	adrenoceptor	0	None
58807	58808	subtypes	0	None
58808	58809	.	0	None

58810	58811	The	0	None
58811	58812	effects	0	None
58812	58813	of	0	None
58813	58814	meta	0	None
58814	58815	-	0	None
58815	58816	octopamine	0	None
58816	58817	are	0	None
58817	58818	around	0	None
58818	58819	two	0	None
58819	58820	orders	0	None
58820	58821	of	0	None
58821	58822	magnitude	0	None
58822	58823	less	0	None
58823	58824	potent	0	None
58824	58825	than	0	None
58825	58826	those	0	None
58826	58827	of	0	None
58827	58828	noradrenaline	3	CHEMICAL
58828	58829	on	0	None
58829	58830	both	0	None
58830	58831	the	0	None
58831	58832	alpha	0	None
58832	58833	(	0	None
58833	58834	2A	0	None
58834	58835	)	0	None
58835	58836	-	0	None
58836	58837	and	0	None
58837	58838	alpha	0	None
58838	58839	(	0	None
58839	58840	2B	0	None
58840	58841	)	0	None
58841	58842	-	0	None
58842	58843	adrenoceptor	0	None
58843	58844	subtypes	0	None
58844	58845	.	0	None

58846	58847	In	0	None
58847	58848	contrast	0	None
58848	58849	,	0	None
58849	58850	in	0	None
58850	58851	the	0	None
58851	58852	case	0	None
58852	58853	of	0	None
58853	58854	the	0	None
58854	58855	alpha	0	None
58855	58856	(	0	None
58856	58857	2C	0	None
58857	58858	)	0	None
58858	58859	-	0	None
58859	58860	adrenoceptor	0	None
58860	58861	,	0	None
58861	58862	meta	0	None
58862	58863	-	0	None
58863	58864	octopamine	0	None
58864	58865	is	0	None
58865	58866	only	0	None
58866	58867	one	0	None
58867	58868	order	0	None
58868	58869	of	0	None
58869	58870	magnitude	0	None
58870	58871	less	0	None
58871	58872	potent	0	None
58872	58873	than	0	None
58873	58874	noradrenaline	3	CHEMICAL
58874	58875	in	0	None
58875	58876	the	0	None
58876	58877	stimulation	0	None
58877	58878	of	0	None
58878	58879	forskolin	3	CHEMICAL
58879	58880	-	0	None
58880	58881	stimulated	0	None
58881	58883	cyclic AMP	3	CHEMICAL
58883	58884	production	0	None
58884	58885	and	0	None
58885	58886	,	0	None
58886	58887	in	0	None
58887	58888	addition	0	None
58888	58889	,	0	None
58889	58890	is	0	None
58890	58891	equipotent	0	None
58891	58892	with	0	None
58892	58893	noradrenaline	3	CHEMICAL
58893	58894	in	0	None
58894	58895	the	0	None
58895	58896	inhibition	0	None
58896	58897	of	0	None
58897	58898	forskolin	3	CHEMICAL
58898	58899	-	0	None
58899	58900	stimulated	0	None
58900	58902	cyclic AMP	3	CHEMICAL
58902	58903	production	0	None
58903	58904	and	0	None
58904	58905	has	0	None
58905	58906	an	0	None
58906	58907	increased	0	None
58907	58908	maximal	0	None
58908	58909	response	0	None
58909	58910	.	0	None

58911	58912	This	0	None
58912	58913	raises	0	None
58913	58914	the	0	None
58914	58915	possibility	0	None
58915	58916	that	0	None
58916	58917	meta	0	None
58917	58918	-	0	None
58918	58919	octopamine	0	None
58919	58920	may	0	None
58920	58921	have	0	None
58921	58922	physiologically	0	None
58922	58923	important	0	None
58923	58924	actions	0	None
58924	58925	via	0	None
58925	58926	alpha	0	None
58926	58927	(	0	None
58927	58928	2C	0	None
58928	58929	)	0	None
58929	58930	-	0	None
58930	58931	adrenoceptors	2	GENE-N
58931	58932	in	0	None
58932	58933	vivo	0	None
58933	58934	.	0	None

58935	58936	The	0	None
58936	58937	results	0	None
58937	58938	show	0	None
58938	58939	that	0	None
58939	58940	the	0	None
58940	58941	modulation	0	None
58941	58942	of	0	None
58942	58944	cyclic AMP	3	CHEMICAL
58944	58945	production	0	None
58945	58946	occurs	0	None
58946	58947	in	0	None
58947	58948	both	0	None
58948	58949	a	0	None
58949	58950	subtype	0	None
58950	58951	-	0	None
58951	58952	and	0	None
58952	58953	agonist	0	None
58953	58954	-	0	None
58954	58955	specific	0	None
58955	58956	manner	0	None
58956	58957	for	0	None
58957	58958	alpha	0	None
58958	58959	(	0	None
58959	58960	2A	0	None
58960	58961	)	0	None
58961	58962	-	0	None
58962	58963	adrenoceptors	2	GENE-N
58963	58964	and	0	None
58964	58965	in	0	None
58965	58966	a	0	None
58966	58967	subtype	0	None
58967	58968	specific	0	None
58968	58969	manner	0	None
58969	58970	for	0	None
58970	58971	alpha	0	None
58971	58972	(	0	None
58972	58973	2B	0	None
58973	58974	)	0	None
58974	58975	-	0	None
58975	58976	and	0	None
58976	58977	alpha	0	None
58977	58978	(	0	None
58978	58979	2C	0	None
58979	58980	)	0	None
58980	58981	-	0	None
58981	58982	adrenoceptors	2	GENE-N
58982	58983	.	0	None

58984	58985	Suppression	0	None
58985	58986	of	0	None
58986	58987	NF	2	GENE-N
58987	58988	-	0	None
58988	58989	kappaB	0	None
58989	58990	activity	0	None
58990	58991	by	0	None
58991	58992	sulfasalazine	3	CHEMICAL
58992	58993	is	0	None
58993	58994	mediated	0	None
58994	58995	by	0	None
58995	58996	direct	0	None
58996	58997	inhibition	0	None
58997	58998	of	0	None
58998	59003	IkappaB kinases alpha and beta	1	GENE-Y
59003	59004	.	0	None

59005	59006	BACKGROUND	0	None
59006	59007	&	0	None
59007	59008	AIMS	0	None
59008	59009	:	0	None
59009	59010	Activation	0	None
59010	59011	of	0	None
59011	59012	NF	2	GENE-N
59012	59013	-	0	None
59013	59014	kappaB	0	None
59014	59015	/	0	None
59015	59016	Rel	1	GENE-Y
59016	59017	has	0	None
59017	59018	been	0	None
59018	59019	implicated	0	None
59019	59020	in	0	None
59020	59021	the	0	None
59021	59022	pathogenesis	0	None
59022	59023	of	0	None
59023	59024	inflammatory	0	None
59024	59025	bowel	0	None
59025	59026	disease	0	None
59026	59027	(	0	None
59027	59028	IBD	0	None
59028	59029	)	0	None
59029	59030	.	0	None

59031	59032	Various	0	None
59032	59033	drugs	0	None
59033	59034	used	0	None
59034	59035	in	0	None
59035	59036	the	0	None
59036	59037	treatment	0	None
59037	59038	of	0	None
59038	59039	IBD	0	None
59039	59040	,	0	None
59040	59041	such	0	None
59041	59042	as	0	None
59042	59043	glucocorticoids	3	CHEMICAL
59043	59044	,	0	None
59044	59045	5	0	None
59045	59046	-	0	None
59046	59048	aminosalicylic acid	3	CHEMICAL
59048	59049	,	0	None
59049	59050	and	0	None
59050	59051	sulfasalazine	3	CHEMICAL
59051	59052	,	0	None
59052	59053	interfere	0	None
59053	59054	with	0	None
59054	59055	NF	2	GENE-N
59055	59056	-	0	None
59056	59057	kappaB	0	None
59057	59058	/	0	None
59058	59059	Rel	2	GENE-N
59059	59060	signaling	0	None
59060	59061	.	0	None

59062	59063	The	0	None
59063	59064	aim	0	None
59064	59065	of	0	None
59065	59066	this	0	None
59066	59067	study	0	None
59067	59068	was	0	None
59068	59069	to	0	None
59069	59070	define	0	None
59070	59071	the	0	None
59071	59072	molecular	0	None
59072	59073	mechanism	0	None
59073	59074	by	0	None
59074	59075	which	0	None
59075	59076	sulfasalazine	3	CHEMICAL
59076	59077	inhibits	0	None
59077	59078	NF	2	GENE-N
59078	59079	-	0	None
59079	59080	kappaB	0	None
59080	59081	activation	0	None
59081	59082	.	0	None

59083	59084	METHODS	0	None
59084	59085	:	0	None
59085	59086	The	0	None
59086	59087	effects	0	None
59087	59088	of	0	None
59088	59089	sulfasalazine	3	CHEMICAL
59089	59090	and	0	None
59090	59091	its	0	None
59091	59092	moieties	0	None
59092	59093	on	0	None
59093	59094	NF	2	GENE-N
59094	59095	-	0	None
59095	59096	kappaB	0	None
59096	59097	signaling	0	None
59097	59098	were	0	None
59098	59099	evaluated	0	None
59099	59100	using	0	None
59100	59101	electromobility	0	None
59101	59102	shift	0	None
59102	59103	,	0	None
59103	59104	transfection	0	None
59104	59105	,	0	None
59105	59106	and	0	None
59106	59109	immune complex kinase	2	GENE-N
59109	59110	assays	0	None
59110	59111	.	0	None

59112	59113	The	0	None
59113	59114	direct	0	None
59114	59115	effect	0	None
59115	59116	of	0	None
59116	59117	sulfasalazine	3	CHEMICAL
59117	59118	on	0	None
59118	59119	IkappaB	0	None
59119	59120	kinase	2	GENE-N
59120	59121	(	0	None
59121	59122	IKK	2	GENE-N
59122	59123	)	0	None
59123	59124	activity	0	None
59124	59125	was	0	None
59125	59126	investigated	0	None
59126	59127	using	0	None
59127	59128	purified	0	None
59128	59130	recombinant IKK	2	GENE-N
59130	59131	-	0	None
59131	59132	alpha	0	None
59132	59133	and	0	None
59133	59134	-	0	None
59134	59135	beta	0	None
59135	59136	proteins	0	None
59136	59137	.	0	None

59138	59139	RESULTS	0	None
59139	59140	:	0	None
59140	59141	NF	2	GENE-N
59141	59142	-	0	None
59142	59143	kappaB	0	None
59143	59144	/	0	None
59144	59145	Rel	2	GENE-N
59145	59146	activity	0	None
59146	59147	induced	0	None
59147	59148	by	0	None
59148	59152	tumor necrosis factor alpha	1	GENE-Y
59152	59153	,	0	None
59153	59154	12	0	None
59154	59155	-	0	None
59155	59156	O	0	None
59156	59157	-	0	None
59157	59158	tetradecanoylphorbol	0	None
59158	59159	-	0	None
59159	59160	13	0	None
59160	59161	-	0	None
59161	59162	acetate	0	None
59162	59163	,	0	None
59163	59164	or	0	None
59164	59165	overexpression	0	None
59165	59166	of	0	None
59166	59167	NF	2	GENE-N
59167	59168	-	0	None
59168	59169	kappaB	0	None
59169	59170	-	0	None
59170	59171	inducing	0	None
59171	59172	kinase	2	GENE-N
59172	59173	,	0	None
59173	59174	IKK	2	GENE-N
59174	59175	-	0	None
59175	59176	alpha	0	None
59176	59177	,	0	None
59177	59178	IKK	2	GENE-N
59178	59179	-	0	None
59179	59180	beta	0	None
59180	59181	,	0	None
59181	59182	or	0	None
59182	59183	constitutively	0	None
59183	59184	active	0	None
59184	59185	IKK	2	GENE-N
59185	59186	-	0	None
59186	59187	alpha	0	None
59187	59188	and	0	None
59188	59189	IKK	2	GENE-N
59189	59190	-	0	None
59190	59191	beta	0	None
59191	59192	mutants	0	None
59192	59193	was	0	None
59193	59194	inhibited	0	None
59194	59195	dose	0	None
59195	59196	dependently	0	None
59196	59197	by	0	None
59197	59198	sulfasalazine	3	CHEMICAL
59198	59199	.	0	None

59200	59201	Sulfasalazine	0	None
59201	59202	inhibited	0	None
59202	59206	tumor necrosis factor alpha	1	GENE-Y
59206	59207	-	0	None
59207	59208	induced	0	None
59208	59209	activation	0	None
59209	59210	of	0	None
59210	59211	endogenous	0	None
59211	59212	IKK	2	GENE-N
59212	59213	in	0	None
59213	59214	Jurkat	0	None
59214	59215	T	0	None
59215	59216	cells	0	None
59216	59217	and	0	None
59217	59218	SW620	0	None
59218	59219	colon	0	None
59219	59220	cells	0	None
59220	59221	,	0	None
59221	59222	as	0	None
59222	59223	well	0	None
59223	59224	as	0	None
59224	59225	the	0	None
59225	59226	catalytic	0	None
59226	59227	activity	0	None
59227	59228	of	0	None
59228	59229	purified	0	None
59229	59230	IKK	2	GENE-N
59230	59231	-	0	None
59231	59232	alpha	0	None
59232	59233	and	0	None
59233	59234	IKK	2	GENE-N
59234	59235	-	0	None
59235	59236	beta	0	None
59236	59237	in	0	None
59237	59238	vitro	0	None
59238	59239	.	0	None

59240	59241	In	0	None
59241	59242	contrast	0	None
59242	59243	,	0	None
59243	59244	the	0	None
59244	59245	moieties	0	None
59245	59246	of	0	None
59246	59247	sulfasalazine	3	CHEMICAL
59247	59248	,	0	None
59248	59249	5	0	None
59249	59250	-	0	None
59250	59252	aminosalicylic acid	3	CHEMICAL
59252	59253	,	0	None
59253	59254	and	0	None
59254	59255	sulfapyridine	0	None
59255	59256	or	0	None
59256	59257	4	0	None
59257	59258	-	0	None
59258	59260	aminosalicylic acid	3	CHEMICAL
59260	59261	had	0	None
59261	59262	no	0	None
59262	59263	effect	0	None
59263	59264	.	0	None

59265	59266	Activation	0	None
59266	59267	of	0	None
59267	59269	extracellular signal	3	CHEMICAL
59269	59270	-	0	None
59270	59271	related	0	None
59271	59272	kinase	2	GENE-N
59272	59273	(	0	None
59273	59274	ERK	1	GENE-Y
59274	59275	)	0	None
59275	59276	1	0	None
59276	59277	and	0	None
59277	59278	2	0	None
59278	59279	,	0	None
59279	59280	c	0	None
59280	59281	-	0	None
59281	59282	Jun	0	None
59282	59283	-	0	None
59283	59284	N	0	None
59284	59285	-	0	None
59285	59286	terminal	0	None
59286	59287	kinase	2	GENE-N
59287	59288	(	0	None
59288	59289	JNK	2	GENE-N
59289	59290	)	0	None
59290	59291	1	0	None
59291	59292	,	0	None
59292	59293	and	0	None
59293	59294	p38	2	GENE-N
59294	59295	was	0	None
59295	59296	unaffected	0	None
59296	59297	by	0	None
59297	59298	sulfasalazine	3	CHEMICAL
59298	59299	.	0	None

59300	59301	The	0	None
59301	59302	decrease	0	None
59302	59303	in	0	None
59303	59304	substrate	0	None
59304	59305	phosphorylation	0	None
59305	59306	by	0	None
59306	59307	IKK	2	GENE-N
59307	59308	-	0	None
59308	59309	alpha	0	None
59309	59310	and	0	None
59310	59311	-	0	None
59311	59312	beta	0	None
59312	59313	is	0	None
59313	59314	associated	0	None
59314	59315	with	0	None
59315	59316	a	0	None
59316	59317	decrease	0	None
59317	59318	in	0	None
59318	59319	autophosphorylation	0	None
59319	59320	of	0	None
59320	59321	IKKs	2	GENE-N
59321	59322	and	0	None
59322	59323	can	0	None
59323	59324	be	0	None
59324	59325	antagonized	0	None
59325	59326	by	0	None
59326	59327	excess	0	None
59327	59329	adenosine triphosphate	3	CHEMICAL
59329	59330	.	0	None

59331	59332	CONCLUSIONS	0	None
59332	59333	:	0	None
59333	59334	These	0	None
59334	59335	data	0	None
59335	59336	identify	0	None
59336	59337	sulfasalazine	3	CHEMICAL
59337	59338	as	0	None
59338	59339	a	0	None
59339	59340	direct	0	None
59340	59341	inhibitor	0	None
59341	59342	of	0	None
59342	59343	IKK	2	GENE-N
59343	59344	-	0	None
59344	59345	alpha	0	None
59345	59346	and	0	None
59346	59347	-	0	None
59347	59348	beta	0	None
59348	59349	by	0	None
59349	59350	antagonizing	0	None
59350	59352	adenosine triphosphate	3	CHEMICAL
59352	59353	binding	0	None
59353	59354	.	0	None

59355	59356	The	0	None
59356	59357	suppression	0	None
59357	59358	of	0	None
59358	59359	NF	2	GENE-N
59359	59360	-	0	None
59360	59361	kappaB	0	None
59361	59362	activation	0	None
59362	59363	by	0	None
59363	59364	inhibition	0	None
59364	59365	of	0	None
59365	59366	the	0	None
59366	59367	IKKs	2	GENE-N
59367	59368	contributes	0	None
59368	59369	to	0	None
59369	59370	the	0	None
59370	59371	well	0	None
59371	59372	-	0	None
59372	59373	known	0	None
59373	59374	anti	0	None
59374	59375	-	0	None
59375	59376	inflammatory	0	None
59376	59377	and	0	None
59377	59378	immunosuppressive	0	None
59378	59379	effects	0	None
59379	59380	of	0	None
59380	59381	sulfasalazine	3	CHEMICAL
59381	59382	.	0	None

59383	59384	The	0	None
59384	59385	reactive	0	None
59385	59386	oxygen	0	None
59386	59387	species	0	None
59387	59388	-	0	None
59388	59389	-	0	None
59389	59390	and	0	None
59390	59391	Michael	0	None
59391	59392	acceptor	0	None
59392	59393	-	0	None
59393	59394	inducible	0	None
59394	59396	human aldo	3	CHEMICAL
59396	59397	-	0	None
59397	59398	keto	3	CHEMICAL
59398	59399	reductase	2	GENE-N
59399	59400	AKR1C1	1	GENE-Y
59400	59401	reduces	0	None
59401	59402	the	0	None
59402	59403	alpha	0	None
59403	59404	,	0	None
59404	59405	beta	0	None
59405	59406	-	0	None
59406	59407	unsaturated	0	None
59407	59408	aldehyde	3	CHEMICAL
59408	59409	4	0	None
59409	59410	-	0	None
59410	59411	hydroxy	3	CHEMICAL
59411	59412	-	0	None
59412	59413	2	0	None
59413	59414	-	0	None
59414	59415	nonenal	0	None
59415	59416	to	0	None
59416	59417	1	0	None
59417	59418	,	0	None
59418	59419	4	0	None
59419	59420	-	0	None
59420	59421	dihydroxy	3	CHEMICAL
59421	59422	-	0	None
59422	59423	2	0	None
59423	59424	-	0	None
59424	59425	nonene	0	None
59425	59426	.	0	None

59427	59428	The	0	None
59428	59429	human	0	None
59429	59430	aldo	3	CHEMICAL
59430	59431	-	0	None
59431	59432	keto	3	CHEMICAL
59432	59433	reductase	2	GENE-N
59433	59434	AKR1C1	1	GENE-Y
59434	59435	(	0	None
59435	59436	20alpha	0	None
59436	59437	(	0	None
59437	59438	3alpha	0	None
59438	59439	)	0	None
59439	59440	-	0	None
59440	59442	hydroxysteroid dehydrogenase	1	GENE-Y
59442	59443	)	0	None
59443	59444	is	0	None
59444	59445	induced	0	None
59445	59446	by	0	None
59446	59447	electrophilic	0	None
59447	59448	Michael	0	None
59448	59449	acceptors	0	None
59449	59450	and	0	None
59450	59451	reactive	0	None
59451	59452	oxygen	0	None
59452	59453	species	0	None
59453	59454	(	0	None
59454	59455	ROS	1	GENE-Y
59455	59456	)	0	None
59456	59457	via	0	None
59457	59458	a	0	None
59458	59459	presumptive	0	None
59459	59460	antioxidant	0	None
59460	59461	response	0	None
59461	59462	element	0	None
59462	59463	(	0	None
59463	59464	Burczynski	0	None
59464	59465	,	0	None
59465	59466	M	0	None
59466	59467	.	0	None
59467	59468	E	0	None
59468	59469	.	0	None
59469	59470	,	0	None
59470	59471	Lin	0	None
59471	59472	,	0	None
59472	59473	H	0	None
59473	59474	.	0	None
59474	59475	K	0	None
59475	59476	.	0	None
59476	59477	,	0	None
59477	59478	and	0	None
59478	59479	Penning	0	None
59479	59480	,	0	None
59480	59481	T	0	None
59481	59482	.	0	None
59482	59483	M	0	None
59483	59484	.	0	None
59484	59485	(	0	None
59485	59486	1999	0	None
59486	59487	)	0	None
59487	59488	Cancer	0	None
59488	59489	Res	0	None
59489	59490	.	0	None
59490	59491	59	0	None
59491	59492	,	0	None
59492	59493	607	0	None
59493	59494	-	0	None
59494	59495	614	0	None
59495	59496	)	0	None
59496	59497	.	0	None

59498	59499	Physiologically	0	None
59499	59500	,	0	None
59500	59501	AKR1C1	1	GENE-Y
59501	59502	regulates	0	None
59502	59503	progesterone	3	CHEMICAL
59503	59504	action	0	None
59504	59505	by	0	None
59505	59506	converting	0	None
59506	59507	the	0	None
59507	59508	hormone	0	None
59508	59509	into	0	None
59509	59510	its	0	None
59510	59511	inactive	0	None
59511	59512	metabolite	0	None
59512	59513	20alpha	0	None
59513	59514	-	0	None
59514	59515	hydroxyprogesterone	0	None
59515	59516	,	0	None
59516	59517	and	0	None
59517	59518	toxicologically	0	None
59518	59519	this	0	None
59519	59520	enzyme	0	None
59520	59521	activates	0	None
59521	59524	polycyclic aromatic hydrocarbon	3	CHEMICAL
59524	59525	trans	0	None
59525	59526	-	0	None
59526	59527	dihydrodiols	0	None
59527	59528	to	0	None
59528	59529	redox	0	None
59529	59530	-	0	None
59530	59531	cycling	0	None
59531	59532	o	0	None
59532	59533	-	0	None
59533	59534	quinones	0	None
59534	59535	.	0	None

59536	59537	However	0	None
59537	59538	,	0	None
59538	59539	the	0	None
59539	59540	significance	0	None
59540	59541	of	0	None
59541	59542	its	0	None
59542	59543	potent	0	None
59543	59544	induction	0	None
59544	59545	by	0	None
59545	59546	Michael	0	None
59546	59547	acceptors	0	None
59547	59548	and	0	None
59548	59549	oxidative	0	None
59549	59550	stress	0	None
59550	59551	is	0	None
59551	59552	unknown	0	None
59552	59553	.	0	None

59554	59555	4	0	None
59555	59556	-	0	None
59556	59557	Hydroxy	0	None
59557	59558	-	0	None
59558	59559	2	0	None
59559	59560	-	0	None
59560	59561	nonenal	0	None
59561	59562	(	0	None
59562	59563	HNE	3	CHEMICAL
59563	59564	)	0	None
59564	59565	and	0	None
59565	59566	other	0	None
59566	59567	alpha	0	None
59567	59568	,	0	None
59568	59569	beta	0	None
59569	59570	-	0	None
59570	59571	unsaturated	0	None
59571	59572	aldehydes	0	None
59572	59573	produced	0	None
59573	59574	during	0	None
59574	59575	lipid	0	None
59575	59576	peroxidation	0	None
59576	59577	were	0	None
59577	59578	reduced	0	None
59578	59579	by	0	None
59579	59580	AKR1C1	1	GENE-Y
59580	59581	with	0	None
59581	59582	high	0	None
59582	59583	catalytic	0	None
59583	59584	efficiency	0	None
59584	59585	.	0	None

59586	59587	Kinetic	0	None
59587	59588	studies	0	None
59588	59589	revealed	0	None
59589	59590	that	0	None
59590	59591	AKR1C1	1	GENE-Y
59591	59592	reduced	0	None
59592	59593	HNE	3	CHEMICAL
59593	59594	(	0	None
59594	59595	K	0	None
59595	59596	(	0	None
59596	59597	m	0	None
59597	59598	)	0	None
59598	59599	=	0	None
59599	59600	34	0	None
59600	59601	microm	0	None
59601	59602	,	0	None
59602	59603	k	0	None
59603	59604	(	0	None
59604	59605	cat	0	None
59605	59606	)	0	None
59606	59607	=	0	None
59607	59608	8	0	None
59608	59609	.	0	None
59609	59610	8	0	None
59610	59611	min	0	None
59611	59612	(	0	None
59612	59613	-	0	None
59613	59614	1	0	None
59614	59615	)	0	None
59615	59616	)	0	None
59616	59617	with	0	None
59617	59618	a	0	None
59618	59619	k	0	None
59619	59620	(	0	None
59620	59621	cat	0	None
59621	59622	)	0	None
59622	59623	/	0	None
59623	59624	K	0	None
59624	59625	(	0	None
59625	59626	m	0	None
59626	59627	)	0	None
59627	59628	similar	0	None
59628	59629	to	0	None
59629	59630	that	0	None
59630	59631	for	0	None
59631	59632	20alpha	0	None
59632	59633	-	0	None
59633	59634	hydroxysteroids	3	CHEMICAL
59634	59635	.	0	None

59636	59637	Six	0	None
59637	59638	other	0	None
59638	59639	homogeneous	0	None
59639	59641	recombinant AKRs	2	GENE-N
59641	59642	were	0	None
59642	59643	examined	0	None
59643	59644	for	0	None
59644	59645	their	0	None
59645	59646	ability	0	None
59646	59647	to	0	None
59647	59648	reduce	0	None
59648	59649	HNE	3	CHEMICAL
59649	59650	.	0	None

59651	59652	Of	0	None
59652	59653	these	0	None
59653	59654	,	0	None
59654	59655	AKR1C1	1	GENE-Y
59655	59656	possessed	0	None
59656	59657	one	0	None
59657	59658	of	0	None
59658	59659	the	0	None
59659	59660	highest	0	None
59660	59661	specific	0	None
59661	59662	activities	0	None
59662	59663	and	0	None
59663	59664	was	0	None
59664	59665	the	0	None
59665	59666	only	0	None
59666	59667	isoform	0	None
59667	59668	induced	0	None
59668	59669	by	0	None
59669	59670	oxidative	0	None
59670	59671	stress	0	None
59671	59672	and	0	None
59672	59673	by	0	None
59673	59674	agents	0	None
59674	59675	that	0	None
59675	59676	deplete	0	None
59676	59677	glutathione	3	CHEMICAL
59677	59678	(	0	None
59678	59680	ethacrynic acid	3	CHEMICAL
59680	59681	)	0	None
59681	59682	.	0	None

59683	59684	Several	0	None
59684	59686	hydroxysteroid dehydrogenases	2	GENE-N
59686	59687	of	0	None
59687	59688	the	0	None
59688	59689	AKR1C	0	None
59689	59690	subfamily	0	None
59690	59691	catalyzed	0	None
59691	59692	the	0	None
59692	59693	reduction	0	None
59693	59694	of	0	None
59694	59695	HNE	3	CHEMICAL
59695	59696	with	0	None
59696	59697	higher	0	None
59697	59698	activity	0	None
59698	59699	than	0	None
59699	59701	aldehyde reductase	2	GENE-N
59701	59702	(	0	None
59702	59703	AKR1A1	1	GENE-Y
59703	59704	)	0	None
59704	59705	.	0	None

59706	59707	NMR	0	None
59707	59708	spectroscopy	0	None
59708	59709	identified	0	None
59709	59710	the	0	None
59710	59711	product	0	None
59711	59712	of	0	None
59712	59713	the	0	None
59713	59714	NADPH	3	CHEMICAL
59714	59715	-	0	None
59715	59716	dependent	0	None
59716	59717	reduction	0	None
59717	59718	of	0	None
59718	59719	HNE	3	CHEMICAL
59719	59720	as	0	None
59720	59721	1	0	None
59721	59722	,	0	None
59722	59723	4	0	None
59723	59724	-	0	None
59724	59725	dihydroxy	3	CHEMICAL
59725	59726	-	0	None
59726	59727	2	0	None
59727	59728	-	0	None
59728	59729	nonene	0	None
59729	59730	.	0	None

59731	59732	The	0	None
59732	59733	K	0	None
59733	59734	(	0	None
59734	59735	m	0	None
59735	59736	)	0	None
59736	59737	of	0	None
59737	59739	recombinant AKR1C1	1	GENE-Y
59739	59740	for	0	None
59740	59741	nicotinamide	3	CHEMICAL
59741	59742	cofactors	0	None
59742	59743	(	0	None
59743	59744	K	0	None
59744	59745	(	0	None
59745	59746	m	0	None
59746	59747	)	0	None
59747	59748	NADPH	3	CHEMICAL
59748	59749	approximately	0	None
59749	59750	6	0	None
59750	59751	microm	0	None
59751	59752	,	0	None
59752	59753	K	0	None
59753	59754	(	0	None
59754	59755	m	0	None
59755	59756	)	0	None
59756	59757	(	0	None
59757	59758	app	1	GENE-Y
59758	59759	)	0	None
59759	59760	NADH	3	CHEMICAL
59760	59761	>	0	None
59761	59762	6	0	None
59762	59763	mm	0	None
59763	59764	)	0	None
59764	59765	suggested	0	None
59765	59766	that	0	None
59766	59767	it	0	None
59767	59768	is	0	None
59768	59769	primed	0	None
59769	59770	for	0	None
59770	59771	reductive	0	None
59771	59772	metabolism	0	None
59772	59773	of	0	None
59773	59774	HNE	3	CHEMICAL
59774	59775	.	0	None

59776	59777	Isoform	0	None
59777	59778	-	0	None
59778	59779	specific	0	None
59779	59781	reverse transcription	1	GENE-Y
59781	59782	-	0	None
59782	59783	polymerase	2	GENE-N
59783	59784	chain	0	None
59784	59785	reaction	0	None
59785	59786	showed	0	None
59786	59787	that	0	None
59787	59788	exposure	0	None
59788	59789	of	0	None
59789	59790	HepG2	0	None
59790	59791	cells	0	None
59791	59792	to	0	None
59792	59793	HNE	3	CHEMICAL
59793	59794	resulted	0	None
59794	59795	in	0	None
59795	59796	elevated	0	None
59796	59797	levels	0	None
59797	59798	of	0	None
59798	59799	AKR1C1	1	GENE-Y
59799	59800	mRNA	0	None
59800	59801	.	0	None

59802	59803	Thus	0	None
59803	59804	,	0	None
59804	59805	HNE	3	CHEMICAL
59805	59806	induces	0	None
59806	59807	its	0	None
59807	59808	own	0	None
59808	59809	metabolism	0	None
59809	59810	via	0	None
59810	59811	AKR1C1	1	GENE-Y
59811	59812	,	0	None
59812	59813	and	0	None
59813	59814	this	0	None
59814	59815	enzyme	0	None
59815	59816	may	0	None
59816	59817	play	0	None
59817	59818	a	0	None
59818	59819	hitherto	0	None
59819	59820	unrecognized	0	None
59820	59821	role	0	None
59821	59822	in	0	None
59822	59823	a	0	None
59823	59824	response	0	None
59824	59825	mounted	0	None
59825	59826	to	0	None
59826	59827	counter	0	None
59827	59828	oxidative	0	None
59828	59829	stress	0	None
59829	59830	.	0	None

59831	59832	AKRs	2	GENE-N
59832	59833	represent	0	None
59833	59834	alternative	0	None
59834	59835	GSH	3	CHEMICAL
59835	59836	-	0	None
59836	59837	independent	0	None
59837	59838	/	0	None
59838	59839	NADPH	3	CHEMICAL
59839	59840	-	0	None
59840	59841	dependent	0	None
59841	59842	routes	0	None
59842	59843	for	0	None
59843	59844	the	0	None
59844	59845	reductive	0	None
59845	59846	elimination	0	None
59846	59847	of	0	None
59847	59848	HNE	3	CHEMICAL
59848	59849	.	0	None

59850	59851	Of	0	None
59851	59852	these	0	None
59852	59853	,	0	None
59853	59854	AKR1C1	1	GENE-Y
59854	59855	provides	0	None
59855	59856	an	0	None
59856	59857	inducible	0	None
59857	59858	cytosolic	0	None
59858	59859	barrier	0	None
59859	59860	to	0	None
59860	59861	HNE	3	CHEMICAL
59861	59862	following	0	None
59862	59863	ROS	1	GENE-Y
59863	59864	exposure	0	None
59864	59865	.	0	None

59866	59867	Stable	0	None
59867	59868	expression	0	None
59868	59869	of	0	None
59869	59870	varied	0	None
59870	59871	levels	0	None
59871	59872	of	0	None
59872	59876	inducible nitric oxide synthase	1	GENE-Y
59876	59877	in	0	None
59877	59878	primary	0	None
59878	59879	cultures	0	None
59879	59880	of	0	None
59880	59881	endothelial	0	None
59881	59882	cells	0	None
59882	59883	.	0	None

59884	59885	Nitric	0	None
59885	59886	oxide	0	None
59886	59887	(	0	None
59887	59888	NO	0	None
59888	59889	*	0	None
59889	59890	)	0	None
59890	59891	,	0	None
59891	59892	generated	0	None
59892	59893	by	0	None
59893	59896	nitric oxide synthase	1	GENE-Y
59896	59897	(	0	None
59897	59898	NOS	0	None
59898	59899	II	0	None
59899	59900	)	0	None
59900	59901	from	0	None
59901	59902	immunostimulated	0	None
59902	59903	cells	0	None
59903	59904	during	0	None
59904	59905	infection	0	None
59905	59906	,	0	None
59906	59907	plays	0	None
59907	59908	an	0	None
59908	59909	important	0	None
59909	59910	role	0	None
59910	59911	in	0	None
59911	59912	host	0	None
59912	59913	immune	0	None
59913	59914	defense	0	None
59914	59915	against	0	None
59915	59916	microbial	0	None
59916	59917	invasion	0	None
59917	59918	.	0	None

59919	59920	The	0	None
59920	59921	impact	0	None
59921	59922	of	0	None
59922	59923	different	0	None
59923	59924	rates	0	None
59924	59925	of	0	None
59925	59926	NO	0	None
59926	59927	*	0	None
59927	59928	production	0	None
59928	59929	on	0	None
59929	59930	host	0	None
59930	59931	cell	0	None
59931	59932	function	0	None
59932	59933	has	0	None
59933	59934	not	0	None
59934	59935	been	0	None
59935	59936	defined	0	None
59936	59937	.	0	None

59938	59939	Herein	0	None
59939	59940	,	0	None
59940	59941	we	0	None
59941	59942	describe	0	None
59942	59943	the	0	None
59943	59944	development	0	None
59944	59945	of	0	None
59945	59946	a	0	None
59946	59947	method	0	None
59947	59948	to	0	None
59948	59949	express	0	None
59949	59950	varied	0	None
59950	59951	levels	0	None
59951	59952	of	0	None
59952	59955	murine NOS II	1	GENE-Y
59955	59956	in	0	None
59956	59957	bovine	0	None
59957	59958	pulmonary	0	None
59958	59959	artery	0	None
59959	59960	endothelial	0	None
59960	59961	cells	0	None
59961	59962	.	0	None

59963	59964	A	0	None
59964	59965	retroviral	0	None
59965	59966	vector	0	None
59966	59967	(	0	None
59967	59968	pMFGSNOS	0	None
59968	59969	)	0	None
59969	59970	encoding	0	None
59970	59971	NOS	0	None
59971	59972	II	0	None
59972	59973	was	0	None
59973	59974	used	0	None
59974	59975	to	0	None
59975	59976	transduce	0	None
59976	59977	primary	0	None
59977	59978	cultures	0	None
59978	59979	of	0	None
59979	59980	endothelial	0	None
59980	59981	cells	0	None
59981	59982	.	0	None

59983	59984	Bovine	0	None
59984	59985	endothelial	0	None
59985	59986	cells	0	None
59986	59987	were	0	None
59987	59988	susceptible	0	None
59988	59989	to	0	None
59989	59990	this	0	None
59990	59991	transduction	0	None
59991	59992	and	0	None
59992	59993	up	0	None
59993	59994	to	0	None
59994	59995	18	0	None
59995	59996	%	0	None
59996	59997	of	0	None
59997	59998	the	0	None
59998	59999	cells	0	None
59999	60000	expressed	0	None
60000	60001	immunodetectable	0	None
60001	60004	murine NOS II	1	GENE-Y
60004	60005	.	0	None

60006	60007	The	0	None
60007	60008	NOS	0	None
60008	60009	II	0	None
60009	60010	-	0	None
60010	60011	transduced	0	None
60011	60012	endothelial	0	None
60012	60013	cells	0	None
60013	60014	were	0	None
60014	60015	cultured	0	None
60015	60016	on	0	None
60016	60017	the	0	None
60017	60018	three	0	None
60018	60019	-	0	None
60019	60020	dimensional	0	None
60020	60021	matrix	0	None
60021	60022	,	0	None
60022	60023	Gelfoam	0	None
60023	60024	,	0	None
60024	60025	for	0	None
60025	60026	8	0	None
60026	60027	-	0	None
60027	60028	10	0	None
60028	60029	days	0	None
60029	60030	.	0	None

60031	60032	Stable	0	None
60032	60033	expression	0	None
60033	60034	of	0	None
60034	60035	NOS	0	None
60035	60036	II	0	None
60036	60037	was	0	None
60037	60038	assessed	0	None
60038	60039	by	0	None
60039	60040	measuring	0	None
60040	60041	nitrite	3	CHEMICAL
60041	60042	accumulation	0	None
60042	60043	in	0	None
60043	60044	media	0	None
60044	60045	every	0	None
60045	60046	2	0	None
60046	60047	days	0	None
60047	60048	.	0	None

60049	60050	By	0	None
60050	60051	day	0	None
60051	60052	10	0	None
60052	60053	,	0	None
60053	60054	endothelial	0	None
60054	60055	cells	0	None
60055	60056	on	0	None
60056	60057	Gelfoam	0	None
60057	60058	were	0	None
60058	60059	found	0	None
60059	60060	to	0	None
60060	60061	secrete	0	None
60061	60062	NO	0	None
60062	60063	*	0	None
60063	60064	at	0	None
60064	60065	a	0	None
60065	60066	rate	0	None
60066	60067	exceeding	0	None
60067	60068	1	0	None
60068	60069	.	0	None
60069	60070	0	0	None
60070	60071	microM	0	None
60071	60072	/	0	None
60072	60073	h	0	None
60073	60074	/	0	None
60074	60075	10	0	None
60075	60076	(	0	None
60076	60077	6	0	None
60077	60078	)	0	None
60078	60079	cells	0	None
60079	60080	,	0	None
60080	60081	concomitant	0	None
60081	60082	with	0	None
60082	60083	an	0	None
60083	60084	enhanced	0	None
60084	60085	level	0	None
60085	60086	of	0	None
60086	60087	NOS	0	None
60087	60088	II	0	None
60088	60089	activity	0	None
60089	60090	.	0	None

60091	60092	Argininosuccinate	0	None
60092	60093	synthetase	2	GENE-N
60093	60094	,	0	None
60094	60095	a	0	None
60095	60096	key	0	None
60096	60097	enzyme	0	None
60097	60098	in	0	None
60098	60099	the	0	None
60099	60100	metabolism	0	None
60100	60101	of	0	None
60101	60102	l	0	None
60102	60103	-	0	None
60103	60104	citrulline	0	None
60104	60105	to	0	None
60105	60106	l	0	None
60106	60107	-	0	None
60107	60108	arginine	3	CHEMICAL
60108	60109	,	0	None
60109	60110	increased	0	None
60110	60111	as	0	None
60111	60112	well	0	None
60112	60113	,	0	None
60113	60114	perhaps	0	None
60114	60115	in	0	None
60115	60116	response	0	None
60116	60117	to	0	None
60117	60118	dimunition	0	None
60118	60119	of	0	None
60119	60120	the	0	None
60120	60121	intracellular	0	None
60121	60122	arginine	3	CHEMICAL
60122	60123	pool	0	None
60123	60124	corresponding	0	None
60124	60125	to	0	None
60125	60126	the	0	None
60126	60127	observed	0	None
60127	60128	high	0	None
60128	60129	output	0	None
60129	60130	of	0	None
60130	60131	NO	0	None
60131	60132	*	0	None
60132	60133	.	0	None

60134	60135	In	0	None
60135	60136	spite	0	None
60136	60137	of	0	None
60137	60138	the	0	None
60138	60139	continuous	0	None
60139	60140	flux	0	None
60140	60141	of	0	None
60141	60142	NO	0	None
60142	60143	*	0	None
60143	60144	,	0	None
60144	60145	endothelial	0	None
60145	60146	cell	0	None
60146	60147	viability	0	None
60147	60148	was	0	None
60148	60149	not	0	None
60149	60150	effected	0	None
60150	60151	.	0	None

60152	60153	This	0	None
60153	60154	system	0	None
60154	60155	provides	0	None
60155	60156	the	0	None
60156	60157	opportunity	0	None
60157	60158	to	0	None
60158	60159	assess	0	None
60159	60160	the	0	None
60160	60161	impact	0	None
60161	60162	of	0	None
60162	60163	different	0	None
60163	60164	levels	0	None
60164	60165	of	0	None
60165	60166	sustained	0	None
60166	60167	NO	0	None
60167	60168	*	0	None
60168	60169	production	0	None
60169	60170	on	0	None
60170	60171	endothelial	0	None
60171	60172	cell	0	None
60172	60173	physiology	0	None
60173	60174	.	0	None

60175	60176	Effects	0	None
60176	60177	of	0	None
60177	60178	eletriptan	3	CHEMICAL
60178	60179	on	0	None
60179	60180	the	0	None
60180	60181	peptidergic	0	None
60181	60182	innervation	0	None
60182	60183	of	0	None
60183	60184	the	0	None
60184	60185	cerebral	0	None
60185	60186	dura	0	None
60186	60187	mater	0	None
60187	60188	and	0	None
60188	60189	trigeminal	0	None
60189	60190	ganglion	0	None
60190	60191	,	0	None
60191	60192	and	0	None
60192	60193	on	0	None
60193	60194	the	0	None
60194	60195	expression	0	None
60195	60196	of	0	None
60196	60197	c	0	None
60197	60198	-	0	None
60198	60199	fos	1	GENE-Y
60199	60200	and	0	None
60200	60201	c	0	None
60201	60202	-	0	None
60202	60203	jun	0	None
60203	60204	in	0	None
60204	60205	the	0	None
60205	60206	trigeminal	0	None
60206	60207	complex	0	None
60207	60208	of	0	None
60208	60209	the	0	None
60209	60210	rat	0	None
60210	60211	in	0	None
60211	60212	an	0	None
60212	60213	experimental	0	None
60213	60214	migraine	0	None
60214	60215	model	0	None
60215	60216	.	0	None

60217	60218	Nociceptive	0	None
60218	60219	axons	0	None
60219	60220	and	0	None
60220	60221	terminals	0	None
60221	60222	in	0	None
60222	60223	the	0	None
60223	60224	supratentorial	0	None
60224	60225	cerebral	0	None
60225	60226	dura	0	None
60226	60227	mater	0	None
60227	60228	display	0	None
60228	60229	an	0	None
60229	60230	intense	0	None
60230	60231	calcitonin	1	GENE-Y
60231	60232	gene	0	None
60232	60233	-	0	None
60233	60234	related	0	None
60234	60235	peptide	0	None
60235	60236	(	0	None
60236	60237	CGRP	2	GENE-N
60237	60238	)	0	None
60238	60239	immunoreactivity	0	None
60239	60240	.	0	None

60241	60242	In	0	None
60242	60243	an	0	None
60243	60244	experimental	0	None
60244	60245	migraine	0	None
60245	60246	model	0	None
60246	60247	,	0	None
60247	60248	it	0	None
60248	60249	has	0	None
60249	60250	been	0	None
60250	60251	shown	0	None
60251	60252	that	0	None
60252	60253	electrical	0	None
60253	60254	stimulation	0	None
60254	60255	of	0	None
60255	60256	the	0	None
60256	60257	rat	0	None
60257	60258	trigeminal	0	None
60258	60259	ganglion	0	None
60259	60260	induced	0	None
60260	60261	an	0	None
60261	60262	increase	0	None
60262	60263	in	0	None
60263	60264	the	0	None
60264	60265	lengths	0	None
60265	60266	of	0	None
60266	60267	CGRP	2	GENE-N
60267	60268	-	0	None
60268	60269	immunoreactive	0	None
60269	60270	axons	0	None
60270	60271	,	0	None
60271	60272	increased	0	None
60272	60273	size	0	None
60273	60274	and	0	None
60274	60275	number	0	None
60275	60276	of	0	None
60276	60277	pleomorphic	0	None
60277	60278	axonal	0	None
60278	60279	varicosities	0	None
60279	60280	in	0	None
60280	60281	the	0	None
60281	60282	dura	0	None
60282	60283	mater	0	None
60283	60284	,	0	None
60284	60285	and	0	None
60285	60286	an	0	None
60286	60287	increased	0	None
60287	60288	number	0	None
60288	60289	of	0	None
60289	60290	c	0	None
60290	60291	-	0	None
60291	60292	jun	0	None
60292	60293	and	0	None
60293	60294	c	0	None
60294	60295	-	0	None
60295	60296	fos	1	GENE-Y
60296	60297	protein	0	None
60297	60298	-	0	None
60298	60299	expressing	0	None
60299	60300	nerve	1	GENE-Y
60300	60301	cells	0	None
60301	60302	in	0	None
60302	60303	the	0	None
60303	60304	trigeminal	0	None
60304	60305	complex	0	None
60305	60306	.	0	None

60307	60308	We	0	None
60308	60309	demonstrate	0	None
60309	60310	the	0	None
60310	60311	effect	0	None
60311	60312	of	0	None
60312	60313	the	0	None
60313	60314	highly	0	None
60314	60315	specific	0	None
60315	60316	and	0	None
60316	60317	moderately	0	None
60317	60318	lipophilic	0	None
60318	60319	serotonin	3	CHEMICAL
60319	60320	agonist	0	None
60320	60321	eletriptan	3	CHEMICAL
60321	60322	(	0	None
60322	60323	Pfizer	3	CHEMICAL
60323	60324	)	0	None
60324	60325	which	0	None
60325	60326	prevents	0	None
60326	60327	the	0	None
60327	60328	effects	0	None
60328	60329	of	0	None
60329	60330	electrical	0	None
60330	60331	stimulation	0	None
60331	60332	in	0	None
60332	60333	the	0	None
60333	60334	dura	0	None
60334	60335	mater	0	None
60335	60336	.	0	None

60337	60338	Eletriptan	0	None
60338	60339	also	0	None
60339	60340	affected	0	None
60340	60341	the	0	None
60341	60342	caudal	0	None
60342	60343	trigeminal	0	None
60343	60344	complex	0	None
60344	60345	;	0	None
60345	60346	it	0	None
60346	60347	markedly	0	None
60347	60348	reduced	0	None
60348	60349	the	0	None
60349	60350	numbers	0	None
60350	60351	of	0	None
60351	60352	the	0	None
60352	60353	oncoprotein	0	None
60353	60354	-	0	None
60354	60355	expressing	0	None
60355	60356	cells	0	None
60356	60357	,	0	None
60357	60358	mainly	0	None
60358	60359	after	0	None
60359	60360	stimulation	0	None
60360	60361	and	0	None
60361	60362	to	0	None
60362	60363	some	0	None
60363	60364	extent	0	None
60364	60365	also	0	None
60365	60366	in	0	None
60366	60367	nonstimulated	0	None
60367	60368	animals	0	None
60368	60369	.	0	None

60370	60371	Eletriptan	0	None
60371	60372	also	0	None
60372	60373	affected	0	None
60373	60374	expression	0	None
60374	60375	of	0	None
60375	60376	CGRP	2	GENE-N
60376	60377	in	0	None
60377	60378	perikarya	0	None
60378	60379	of	0	None
60379	60380	trigeminal	0	None
60380	60381	ganglion	0	None
60381	60382	cells	0	None
60382	60383	,	0	None
60383	60384	insofar	0	None
60384	60385	as	0	None
60385	60386	the	0	None
60386	60387	number	0	None
60387	60388	of	0	None
60388	60389	small	0	None
60389	60390	nerve	1	GENE-Y
60390	60391	cells	0	None
60391	60392	exhibiting	0	None
60392	60393	a	0	None
60393	60394	compact	0	None
60394	60395	CGRP	2	GENE-N
60395	60396	immunoreaction	0	None
60396	60397	was	0	None
60397	60398	decreased	0	None
60398	60399	to	0	None
60399	60400	one	0	None
60400	60401	quarter	0	None
60401	60402	of	0	None
60402	60403	the	0	None
60403	60404	original	0	None
60404	60405	value	0	None
60405	60406	.	0	None

60407	60408	In	0	None
60408	60409	all	0	None
60409	60410	these	0	None
60410	60411	respects	0	None
60411	60412	,	0	None
60412	60413	eletriptan	3	CHEMICAL
60413	60414	acted	0	None
60414	60415	in	0	None
60415	60416	a	0	None
60416	60417	similar	0	None
60417	60418	way	0	None
60418	60419	to	0	None
60419	60420	sumatriptan	3	CHEMICAL
60420	60421	,	0	None
60421	60422	with	0	None
60422	60423	the	0	None
60423	60424	notable	0	None
60424	60425	exception	0	None
60425	60426	that	0	None
60426	60427	eletriptan	3	CHEMICAL
60427	60428	also	0	None
60428	60429	blocked	0	None
60429	60430	the	0	None
60430	60431	stimulation	0	None
60431	60432	-	0	None
60432	60433	induced	0	None
60433	60434	effects	0	None
60434	60435	in	0	None
60435	60436	the	0	None
60436	60437	nucleus	0	None
60437	60438	caudalis	0	None
60438	60439	trigemini	0	None
60439	60440	and	0	None
60440	60441	the	0	None
60441	60442	upper	0	None
60442	60443	cervical	0	None
60443	60444	spinal	0	None
60444	60445	cord	0	None
60445	60446	(	0	None
60446	60447	trigeminal	0	None
60447	60448	complex	0	None
60448	60449	)	0	None
60449	60450	,	0	None
60450	60451	whereas	0	None
60451	60452	sumatriptan	3	CHEMICAL
60452	60453	did	0	None
60453	60454	not	0	None
60454	60455	.	0	None

60456	60457	It	0	None
60457	60458	is	0	None
60458	60459	concluded	0	None
60459	60460	that	0	None
60460	60461	eletriptan	3	CHEMICAL
60461	60462	,	0	None
60462	60463	acting	0	None
60463	60464	on	0	None
60464	60465	perikarya	0	None
60465	60466	and	0	None
60466	60467	both	0	None
60467	60468	the	0	None
60468	60469	peripheral	0	None
60469	60470	and	0	None
60470	60471	the	0	None
60471	60472	central	0	None
60472	60473	axon	0	None
60473	60474	terminals	0	None
60474	60475	of	0	None
60475	60476	primary	0	None
60476	60477	sensory	0	None
60477	60478	neurons	0	None
60478	60479	,	0	None
60479	60480	exerts	0	None
60480	60481	its	0	None
60481	60482	antimigraine	3	CHEMICAL
60482	60483	effect	0	None
60483	60484	by	0	None
60484	60485	an	0	None
60485	60486	agonist	0	None
60486	60487	action	0	None
60487	60488	on	0	None
60488	60489	5	0	None
60489	60490	-	0	None
60490	60491	HT1B	0	None
60491	60492	/	0	None
60492	60493	1D	0	None
60493	60494	receptors	0	None
60494	60495	throughout	0	None
60495	60496	the	0	None
60496	60497	entire	0	None
60497	60498	trigeminal	0	None
60498	60499	system	0	None
60499	60500	,	0	None
60500	60501	probably	0	None
60501	60502	by	0	None
60502	60503	passing	0	None
60503	60504	the	0	None
60504	60505	blood	0	None
60505	60506	-	0	None
60506	60507	brain	0	None
60507	60508	-	0	None
60508	60509	barrier	0	None
60509	60510	because	0	None
60510	60511	of	0	None
60511	60512	its	0	None
60512	60513	lipophilic	0	None
60513	60514	character	0	None
60514	60515	.	0	None

60516	60517	Human	0	None
60517	60521	peptidylarginine deiminase type III	1	GENE-Y
60521	60522	:	0	None
60522	60523	molecular	0	None
60523	60524	cloning	0	None
60524	60525	and	0	None
60525	60526	nucleotide	0	None
60526	60527	sequence	0	None
60527	60528	of	0	None
60528	60529	the	0	None
60529	60530	cDNA	0	None
60530	60531	,	0	None
60531	60532	properties	0	None
60532	60533	of	0	None
60533	60534	the	0	None
60534	60536	recombinant enzyme	1	GENE-Y
60536	60537	,	0	None
60537	60538	and	0	None
60538	60539	immunohistochemical	0	None
60539	60540	localization	0	None
60540	60541	in	0	None
60541	60542	human	0	None
60542	60543	skin	0	None
60543	60544	.	0	None

60545	60547	Peptidylarginine deiminase	2	GENE-N
60547	60548	catalyzes	0	None
60548	60549	the	0	None
60549	60550	post	0	None
60550	60551	-	0	None
60551	60552	translational	0	None
60552	60553	modification	0	None
60553	60554	of	0	None
60554	60555	proteins	0	None
60555	60556	through	0	None
60556	60557	the	0	None
60557	60558	conversion	0	None
60558	60559	of	0	None
60559	60560	arginine	3	CHEMICAL
60560	60561	to	0	None
60561	60562	citrulline	0	None
60562	60563	in	0	None
60563	60564	the	0	None
60564	60565	presence	0	None
60565	60566	of	0	None
60566	60567	calcium	0	None
60567	60568	ions	0	None
60568	60569	.	0	None

60570	60571	In	0	None
60571	60572	rodents	0	None
60572	60573	,	0	None
60573	60575	peptidylarginine deiminase	2	GENE-N
60575	60576	has	0	None
60576	60577	been	0	None
60577	60578	classified	0	None
60578	60579	into	0	None
60579	60580	four	0	None
60580	60581	isoforms	0	None
60581	60582	,	0	None
60582	60583	types	0	None
60583	60584	I	0	None
60584	60585	,	0	None
60585	60586	II	0	None
60586	60587	,	0	None
60587	60588	III	1	GENE-Y
60588	60589	,	0	None
60589	60590	and	0	None
60590	60591	IV	0	None
60591	60592	,	0	None
60592	60593	which	0	None
60593	60594	are	0	None
60594	60595	distinct	0	None
60595	60596	in	0	None
60596	60597	their	0	None
60597	60598	molecular	0	None
60598	60599	weights	0	None
60599	60600	,	0	None
60600	60601	substrate	0	None
60601	60602	specificities	0	None
60602	60603	,	0	None
60603	60604	and	0	None
60604	60605	tissue	0	None
60605	60606	localization	0	None
60606	60607	.	0	None

60608	60609	Of	0	None
60609	60610	these	0	None
60610	60611	isoforms	0	None
60611	60612	,	0	None
60612	60613	only	0	None
60613	60614	type	0	None
60614	60615	III	1	GENE-Y
60615	60616	was	0	None
60616	60617	detected	0	None
60617	60618	in	0	None
60618	60619	epidermis	0	None
60619	60620	and	0	None
60620	60621	hair	0	None
60621	60622	follicles	0	None
60622	60623	.	0	None

60624	60625	Although	0	None
60625	60626	the	0	None
60626	60627	role	0	None
60627	60628	of	0	None
60628	60629	this	0	None
60629	60630	enzyme	0	None
60630	60631	in	0	None
60631	60632	these	0	None
60632	60633	tissues	0	None
60633	60634	is	0	None
60634	60635	not	0	None
60635	60636	yet	0	None
60636	60637	clear	0	None
60637	60638	,	0	None
60638	60639	indirect	0	None
60639	60640	data	0	None
60640	60641	have	0	None
60641	60642	shown	0	None
60642	60643	that	0	None
60643	60644	several	0	None
60644	60645	structural	0	None
60645	60646	proteins	0	None
60646	60647	such	0	None
60647	60648	as	0	None
60648	60649	filaggrin	0	None
60649	60650	,	0	None
60650	60651	trichohyalin	1	GENE-Y
60651	60652	,	0	None
60652	60653	and	0	None
60653	60654	keratin	0	None
60654	60655	are	0	None
60655	60656	substrates	0	None
60656	60657	for	0	None
60657	60659	peptidylarginine deiminase	2	GENE-N
60659	60660	.	0	None

60661	60662	In	0	None
60662	60663	this	0	None
60663	60664	study	0	None
60664	60665	,	0	None
60665	60666	we	0	None
60666	60667	cloned	0	None
60667	60668	the	0	None
60668	60669	full	0	None
60669	60670	-	0	None
60670	60671	length	0	None
60671	60672	cDNA	0	None
60672	60673	of	0	None
60673	60678	human peptidylarginine deiminase type III	1	GENE-Y
60678	60679	(	0	None
60679	60680	3142	0	None
60680	60681	bp	3	CHEMICAL
60681	60682	)	0	None
60682	60683	from	0	None
60683	60684	cultured	0	None
60684	60685	human	0	None
60685	60686	keratinocytes	0	None
60686	60687	by	0	None
60687	60689	reverse transcription	0	None
60689	60690	-	0	None
60690	60691	polymerase	2	GENE-N
60691	60692	chain	0	None
60692	60693	reaction	0	None
60693	60694	and	0	None
60694	60695	by	0	None
60695	60696	rapid	0	None
60696	60697	amplification	0	None
60697	60698	of	0	None
60698	60699	cDNA	0	None
60699	60700	ends	0	None
60700	60701	methods	0	None
60701	60702	.	0	None

60703	60704	This	0	None
60704	60705	cDNA	0	None
60705	60706	contained	0	None
60706	60707	a	0	None
60707	60708	1995	0	None
60708	60712	bp open reading frame	2	GENE-N
60712	60713	encoding	0	None
60713	60714	664	0	None
60714	60716	amino acids	3	CHEMICAL
60716	60717	(	0	None
60717	60718	Mr	0	None
60718	60719	=	0	None
60719	60720	74	0	None
60720	60721	770	0	None
60721	60722	)	0	None
60722	60723	.	0	None

60724	60725	To	0	None
60725	60726	explore	0	None
60726	60727	the	0	None
60727	60728	physicochemical	0	None
60728	60729	and	0	None
60729	60730	enzymatic	0	None
60730	60731	properties	0	None
60731	60732	of	0	None
60732	60737	human peptidylarginine deiminase type III	1	GENE-Y
60737	60738	,	0	None
60738	60739	we	0	None
60739	60740	constructed	0	None
60740	60741	a	0	None
60741	60742	plasmid	0	None
60742	60743	for	0	None
60743	60744	producing	0	None
60744	60745	a	0	None
60745	60751	recombinant human peptidylarginine deiminase type III	1	GENE-Y
60751	60752	in	0	None
60752	60753	bacteria	0	None
60753	60754	.	0	None

60755	60756	The	0	None
60756	60757	enzymatic	0	None
60757	60758	characteristics	0	None
60758	60759	of	0	None
60759	60760	the	0	None
60760	60762	recombinant enzyme	1	GENE-Y
60762	60763	were	0	None
60763	60764	very	0	None
60764	60765	similar	0	None
60765	60766	to	0	None
60766	60767	those	0	None
60767	60768	of	0	None
60768	60769	the	0	None
60769	60770	rodent	0	None
60770	60774	peptidylarginine deiminase type III	1	GENE-Y
60774	60775	.	0	None

60776	60777	The	0	None
60777	60778	recombinant	0	None
60778	60779	enzyme	0	None
60779	60780	showed	0	None
60780	60781	the	0	None
60781	60782	catalytic	0	None
60782	60783	activities	0	None
60783	60784	toward	0	None
60784	60785	structural	0	None
60785	60786	proteins	0	None
60786	60787	of	0	None
60787	60788	epidermis	0	None
60788	60789	and	0	None
60789	60790	hair	0	None
60790	60791	follicle	0	None
60791	60792	,	0	None
60792	60793	filaggrin	0	None
60793	60794	and	0	None
60794	60795	trichohyalin	1	GENE-Y
60795	60796	,	0	None
60796	60797	in	0	None
60797	60798	which	0	None
60798	60799	the	0	None
60799	60800	deiminations	0	None
60800	60801	maxima	0	None
60801	60802	of	0	None
60802	60803	about	0	None
60803	60804	60	0	None
60804	60805	%	0	None
60805	60806	and	0	None
60806	60807	13	0	None
60807	60808	%	0	None
60808	60809	arginine	3	CHEMICAL
60809	60810	residues	0	None
60810	60811	were	0	None
60811	60812	observed	0	None
60812	60813	in	0	None
60813	60814	filaggrin	0	None
60814	60815	and	0	None
60815	60816	trichohyalin	1	GENE-Y
60816	60817	,	0	None
60817	60818	respectively	0	None
60818	60819	.	0	None

60820	60821	An	0	None
60821	60822	immunohistochemical	0	None
60822	60823	study	0	None
60823	60824	of	0	None
60824	60825	human	0	None
60825	60826	scalp	0	None
60826	60827	skin	0	None
60827	60828	with	0	None
60828	60829	a	0	None
60829	60830	monospecific	0	None
60830	60831	anti	0	None
60831	60832	-	0	None
60832	60833	peptidyl	0	None
60833	60834	-	0	None
60834	60835	arginine	3	CHEMICAL
60835	60836	deiminase	0	None
60836	60837	type	0	None
60837	60838	III	0	None
60838	60839	antibody	0	None
60839	60840	revealed	0	None
60840	60841	that	0	None
60841	60842	the	0	None
60842	60843	type	0	None
60843	60844	III	1	GENE-Y
60844	60845	enzyme	0	None
60845	60846	was	0	None
60846	60847	localized	0	None
60847	60848	to	0	None
60848	60849	the	0	None
60849	60850	inner	0	None
60850	60851	root	0	None
60851	60852	sheath	0	None
60852	60853	and	0	None
60853	60854	outer	0	None
60854	60855	root	0	None
60855	60856	sheath	0	None
60856	60857	of	0	None
60857	60858	hair	0	None
60858	60859	follicles	0	None
60859	60860	.	0	None

60861	60865	Peptidylarginine deiminase type III	1	GENE-Y
60865	60866	in	0	None
60866	60867	the	0	None
60867	60868	inner	0	None
60868	60869	root	0	None
60869	60870	sheath	0	None
60870	60871	was	0	None
60871	60872	notable	0	None
60872	60873	between	0	None
60873	60874	supramatrix	0	None
60874	60875	and	0	None
60875	60876	keratogenous	0	None
60876	60877	zone	0	None
60877	60878	and	0	None
60878	60879	was	0	None
60879	60880	scarcely	0	None
60880	60881	detected	0	None
60881	60882	in	0	None
60882	60883	cornified	0	None
60883	60884	hair	0	None
60884	60885	zone	0	None
60885	60886	.	0	None

60887	60888	The	0	None
60888	60889	enzyme	0	None
60889	60890	was	0	None
60890	60891	also	0	None
60891	60892	expressed	0	None
60892	60893	in	0	None
60893	60894	the	0	None
60894	60895	cuticle	0	None
60895	60896	layer	0	None
60896	60897	of	0	None
60897	60898	hair	0	None
60898	60899	.	0	None

60900	60901	On	0	None
60901	60902	the	0	None
60902	60903	other	0	None
60903	60904	hand	0	None
60904	60905	,	0	None
60905	60906	expression	0	None
60906	60907	of	0	None
60907	60908	the	0	None
60908	60909	enzyme	0	None
60909	60910	in	0	None
60910	60911	the	0	None
60911	60912	epidermis	0	None
60912	60913	was	0	None
60913	60914	very	0	None
60914	60915	low	0	None
60915	60916	.	0	None

60917	60918	These	0	None
60918	60919	data	0	None
60919	60920	imply	0	None
60920	60921	that	0	None
60921	60926	human peptidylarginine deiminase type III	1	GENE-Y
60926	60927	is	0	None
60927	60928	the	0	None
60928	60929	predominant	0	None
60929	60930	isoform	0	None
60930	60931	in	0	None
60931	60932	hair	0	None
60932	60933	follicles	0	None
60933	60934	and	0	None
60934	60935	may	0	None
60935	60936	function	0	None
60936	60937	as	0	None
60937	60938	a	0	None
60938	60939	modulator	0	None
60939	60940	of	0	None
60940	60941	hair	0	None
60941	60942	structural	0	None
60942	60943	proteins	0	None
60943	60944	,	0	None
60944	60945	including	0	None
60945	60946	trichohyalin	1	GENE-Y
60946	60947	during	0	None
60947	60948	hair	0	None
60948	60949	and	0	None
60949	60950	hair	0	None
60950	60951	follicle	0	None
60951	60952	formation	0	None
60952	60953	.	0	None

60954	60955	Coinduction	0	None
60955	60956	of	0	None
60956	60960	inducible nitric oxide synthase	1	GENE-Y
60960	60961	and	0	None
60961	60962	arginine	3	CHEMICAL
60962	60963	recycling	0	None
60963	60964	enzymes	0	None
60964	60965	in	0	None
60965	60966	cytokine	2	GENE-N
60966	60967	-	0	None
60967	60968	stimulated	0	None
60968	60969	PC12	0	None
60969	60970	cells	0	None
60970	60971	and	0	None
60971	60972	high	0	None
60972	60973	output	0	None
60973	60974	production	0	None
60974	60975	of	0	None
60975	60977	nitric oxide	0	None
60977	60978	.	0	None

60979	60980	Nitric	0	None
60980	60981	oxide	0	None
60981	60982	(	0	None
60982	60983	NO	0	None
60983	60984	)	0	None
60984	60985	is	0	None
60985	60986	involved	0	None
60986	60987	in	0	None
60987	60988	many	0	None
60988	60989	physiological	0	None
60989	60990	and	0	None
60990	60991	pathological	0	None
60991	60992	processes	0	None
60992	60993	in	0	None
60993	60994	the	0	None
60994	60995	brain	0	None
60995	60996	.	0	None

60997	60998	NO	0	None
60998	60999	is	0	None
60999	61000	synthesized	0	None
61000	61001	from	0	None
61001	61002	arginine	3	CHEMICAL
61002	61003	by	0	None
61003	61006	nitric oxide synthase	1	GENE-Y
61006	61007	(	0	None
61007	61008	NOS	0	None
61008	61009	)	0	None
61009	61010	,	0	None
61010	61011	and	0	None
61011	61012	the	0	None
61012	61013	citrulline	0	None
61013	61014	generated	0	None
61014	61015	as	0	None
61015	61016	a	0	None
61016	61017	by	0	None
61017	61018	-	0	None
61018	61019	product	0	None
61019	61020	can	0	None
61020	61021	be	0	None
61021	61022	recycled	0	None
61022	61023	to	0	None
61023	61024	arginine	3	CHEMICAL
61024	61025	by	0	None
61025	61027	argininosuccinate synthetase	1	GENE-Y
61027	61028	(	0	None
61028	61029	AS	0	None
61029	61030	)	0	None
61030	61031	and	0	None
61031	61032	argininosuccinate	0	None
61032	61033	lyase	0	None
61033	61034	(	0	None
61034	61035	AL	1	GENE-Y
61035	61036	)	0	None
61036	61037	via	0	None
61037	61038	the	0	None
61038	61039	citrulline	0	None
61039	61040	-	0	None
61040	61041	NO	0	None
61041	61042	cycle	0	None
61042	61043	.	0	None

61044	61045	When	0	None
61045	61046	neuronal	0	None
61046	61047	PC12	0	None
61047	61048	cells	0	None
61048	61049	differentiated	0	None
61049	61050	with	0	None
61050	61053	nerve growth factor	1	GENE-Y
61053	61054	were	0	None
61054	61055	treated	0	None
61055	61056	with	0	None
61056	61057	interferon	2	GENE-N
61057	61058	-	0	None
61058	61059	gamma	0	None
61059	61060	(	0	None
61060	61061	IFNgamma	0	None
61061	61062	)	0	None
61062	61063	and	0	None
61063	61066	tumor necrosis factor	1	GENE-Y
61066	61067	-	0	None
61067	61068	alpha	0	None
61068	61069	(	0	None
61069	61070	TNFalpha	1	GENE-Y
61070	61071	)	0	None
61071	61072	,	0	None
61072	61073	iNOS	0	None
61073	61074	and	0	None
61074	61075	AS	0	None
61075	61076	mRNAs	0	None
61076	61077	and	0	None
61077	61078	proteins	0	None
61078	61079	were	0	None
61079	61080	markedly	0	None
61080	61081	induced	0	None
61081	61082	,	0	None
61082	61083	with	0	None
61083	61084	AL	1	GENE-Y
61084	61085	mRNA	0	None
61085	61086	and	0	None
61086	61087	protein	0	None
61087	61088	being	0	None
61088	61089	weakly	0	None
61089	61090	induced	0	None
61090	61091	.	0	None

61092	61093	Cationic	0	None
61093	61096	amino acid transporter	2	GENE-N
61096	61097	-	0	None
61097	61098	1	0	None
61098	61099	and	0	None
61099	61100	-	0	None
61100	61101	2	0	None
61101	61102	were	0	None
61102	61103	not	0	None
61103	61104	induced	0	None
61104	61105	.	0	None

61106	61107	IFNgamma	0	None
61107	61108	or	0	None
61108	61109	TNFalpha	1	GENE-Y
61109	61110	alone	0	None
61110	61111	was	0	None
61111	61112	ineffective	0	None
61112	61113	.	0	None

61114	61115	A	0	None
61115	61116	large	0	None
61116	61117	amount	0	None
61117	61118	of	0	None
61118	61119	NO	0	None
61119	61120	(	0	None
61120	61121	190	0	None
61121	61122	microM	0	None
61122	61123	NO	0	None
61123	61124	(	0	None
61124	61125	2	0	None
61125	61126	)	0	None
61126	61127	(	0	None
61127	61128	-	0	None
61128	61129	)	0	None
61129	61130	plus	0	None
61130	61131	NO	0	None
61131	61132	(	0	None
61132	61133	3	0	None
61133	61134	)	0	None
61134	61135	(	0	None
61135	61136	-	0	None
61136	61137	)	0	None
61137	61138	in	0	None
61138	61139	culture	0	None
61139	61140	medium	0	None
61140	61141	in	0	None
61141	61142	24	0	None
61142	61143	h	0	None
61143	61144	)	0	None
61144	61145	was	0	None
61145	61146	produced	0	None
61146	61147	from	0	None
61147	61148	arginine	3	CHEMICAL
61148	61149	by	0	None
61149	61150	cytokine	2	GENE-N
61150	61151	-	0	None
61151	61152	stimulated	0	None
61152	61153	cells	0	None
61153	61154	,	0	None
61154	61155	and	0	None
61155	61156	arginine	3	CHEMICAL
61156	61157	could	0	None
61157	61158	be	0	None
61158	61159	replaced	0	None
61159	61160	by	0	None
61160	61161	citrulline	0	None
61161	61162	.	0	None

61163	61164	iNOS	0	None
61164	61165	induction	0	None
61165	61166	and	0	None
61166	61167	NO	0	None
61167	61168	production	0	None
61168	61169	were	0	None
61169	61170	attenuated	0	None
61170	61171	by	0	None
61171	61172	dexamethasone	3	CHEMICAL
61172	61173	and	0	None
61173	61174	dibutyryl	0	None
61174	61175	cAMP	0	None
61175	61176	and	0	None
61176	61177	even	0	None
61177	61178	more	0	None
61178	61179	strongly	0	None
61179	61180	so	0	None
61180	61181	when	0	None
61181	61182	combined	0	None
61182	61183	.	0	None

61184	61185	Therefore	0	None
61185	61186	,	0	None
61186	61187	a	0	None
61187	61188	large	0	None
61188	61189	amount	0	None
61189	61190	of	0	None
61190	61191	NO	0	None
61191	61192	is	0	None
61192	61193	produced	0	None
61193	61194	in	0	None
61194	61195	cytokine	2	GENE-N
61195	61196	-	0	None
61196	61197	stimulated	0	None
61197	61198	PC12	0	None
61198	61199	cells	0	None
61199	61200	following	0	None
61200	61201	to	0	None
61201	61202	induction	0	None
61202	61203	of	0	None
61203	61204	iNOS	0	None
61204	61205	and	0	None
61205	61206	citrulline	0	None
61206	61207	-	0	None
61207	61208	arginine	3	CHEMICAL
61208	61209	recycling	0	None
61209	61210	is	0	None
61210	61211	important	0	None
61211	61212	for	0	None
61212	61213	NO	0	None
61213	61214	production	0	None
61214	61215	.	0	None

61216	61217	The	0	None
61217	61218	new	0	None
61218	61219	cholinesterase	1	GENE-Y
61219	61220	inhibitors	0	None
61220	61221	for	0	None
61221	61222	Alzheimer	0	None
61222	61223	'	0	None
61223	61224	s	0	None
61224	61225	disease	0	None
61225	61226	,	0	None
61226	61227	Part	0	None
61227	61228	1	0	None
61228	61229	:	0	None
61229	61230	their	0	None
61230	61231	similarities	0	None
61231	61232	are	0	None
61232	61233	different	0	None
61233	61234	.	0	None

61235	61236	Three	0	None
61236	61237	new	0	None
61237	61238	cholinesterase	1	GENE-Y
61238	61239	inhibitors	0	None
61239	61240	,	0	None
61240	61241	donepezil	3	CHEMICAL
61241	61242	,	0	None
61242	61243	rivastigmine	3	CHEMICAL
61243	61244	,	0	None
61244	61245	and	0	None
61245	61246	galantamine	3	CHEMICAL
61246	61247	,	0	None
61247	61248	all	0	None
61248	61249	inhibit	0	None
61249	61250	the	0	None
61250	61251	enzyme	0	None
61251	61252	AChE	1	GENE-Y
61252	61253	.	0	None

61254	61255	Rivastigmine	3	CHEMICAL
61255	61256	also	0	None
61256	61257	inhibits	0	None
61257	61258	BuChE	1	GENE-Y
61258	61259	,	0	None
61259	61260	which	0	None
61260	61261	could	0	None
61261	61262	lead	0	None
61262	61263	to	0	None
61263	61264	additional	0	None
61264	61265	benefits	0	None
61265	61266	in	0	None
61266	61267	late	0	None
61267	61268	-	0	None
61268	61269	stage	0	None
61269	61270	Alzheimer	0	None
61270	61271	'	0	None
61271	61272	s	0	None
61272	61273	disease	0	None
61273	61274	,	0	None
61274	61275	but	0	None
61275	61276	also	0	None
61276	61277	cause	0	None
61277	61278	more	0	None
61278	61279	GI	0	None
61279	61280	side	0	None
61280	61281	effects	0	None
61281	61282	at	0	None
61282	61283	initiation	0	None
61283	61284	of	0	None
61284	61285	therapy	0	None
61285	61286	.	0	None

61287	61288	Galantamine	0	None
61288	61289	is	0	None
61289	61290	also	0	None
61290	61291	an	0	None
61291	61292	allosteric	0	None
61292	61293	modulator	0	None
61293	61294	of	0	None
61294	61296	nicotinic receptors	2	GENE-N
61296	61297	,	0	None
61297	61298	which	0	None
61298	61299	could	0	None
61299	61300	lead	0	None
61300	61301	to	0	None
61301	61302	additional	0	None
61302	61303	efficacy	0	None
61303	61304	for	0	None
61304	61305	attention	0	None
61305	61306	and	0	None
61306	61307	for	0	None
61307	61308	behaviors	0	None
61308	61309	mediated	0	None
61309	61310	by	0	None
61310	61311	neurotransmitters	0	None
61311	61312	other	0	None
61312	61313	than	0	None
61313	61314	ACh	3	CHEMICAL
61314	61315	.	0	None

61316	61317	We	0	None
61317	61318	are	0	None
61318	61319	now	0	None
61319	61320	entering	0	None
61320	61321	an	0	None
61321	61322	exciting	0	None
61322	61323	era	0	None
61323	61324	where	0	None
61324	61325	the	0	None
61325	61326	options	0	None
61326	61327	for	0	None
61327	61328	treating	0	None
61328	61329	the	0	None
61329	61330	devastating	0	None
61330	61331	illness	0	None
61331	61332	Alzheimer	0	None
61332	61333	'	0	None
61333	61334	s	0	None
61334	61335	disease	0	None
61335	61336	are	0	None
61336	61337	multiplying	0	None
61337	61338	and	0	None
61338	61339	creating	0	None
61339	61340	a	0	None
61340	61341	foundation	0	None
61341	61342	upon	0	None
61342	61343	which	0	None
61343	61344	new	0	None
61344	61345	therapies	0	None
61345	61346	with	0	None
61346	61347	new	0	None
61347	61348	mechanisms	0	None
61348	61349	of	0	None
61349	61350	action	0	None
61350	61351	can	0	None
61351	61352	be	0	None
61352	61353	built	0	None
61353	61354	.	0	None

61355	61356	Biochemistry	0	None
61356	61357	of	0	None
61357	61358	cyclooxygenase	2	GENE-N
61358	61359	(	0	None
61359	61360	COX	2	GENE-N
61360	61361	)	0	None
61361	61362	-	0	None
61362	61363	2	0	None
61363	61364	inhibitors	0	None
61364	61365	and	0	None
61365	61366	molecular	0	None
61366	61367	pathology	0	None
61367	61368	of	0	None
61368	61369	COX	2	GENE-N
61369	61370	-	0	None
61370	61371	2	0	None
61371	61372	in	0	None
61372	61373	neoplasia	0	None
61373	61374	.	0	None

61375	61376	Several	0	None
61376	61377	types	0	None
61377	61378	of	0	None
61378	61379	human	0	None
61379	61380	tumors	0	None
61380	61381	overexpress	0	None
61381	61382	cyclooxygenase	2	GENE-N
61382	61383	(	0	None
61383	61384	COX	2	GENE-N
61384	61385	)	0	None
61385	61386	-	0	None
61386	61387	2	0	None
61387	61388	but	0	None
61388	61389	not	0	None
61389	61390	COX	2	GENE-N
61390	61391	-	0	None
61391	61392	1	0	None
61392	61393	,	0	None
61393	61394	and	0	None
61394	61395	gene	0	None
61395	61396	knockout	0	None
61396	61397	transfection	0	None
61397	61398	experiments	0	None
61398	61399	demonstrate	0	None
61399	61400	a	0	None
61400	61401	central	0	None
61401	61402	role	0	None
61402	61403	of	0	None
61403	61404	COX	2	GENE-N
61404	61405	-	0	None
61405	61406	2	0	None
61406	61407	in	0	None
61407	61408	experimental	0	None
61408	61409	tumorigenesis	0	None
61409	61410	.	0	None

61411	61412	COX	2	GENE-N
61412	61413	-	0	None
61413	61414	2	0	None
61414	61415	produces	0	None
61415	61416	prostaglandins	3	CHEMICAL
61416	61417	that	0	None
61417	61418	inhibit	0	None
61418	61419	apoptosis	0	None
61419	61420	and	0	None
61420	61421	stimulate	0	None
61421	61422	angiogenesis	0	None
61422	61423	and	0	None
61423	61424	invasiveness	0	None
61424	61425	.	0	None

61426	61427	Selective	0	None
61427	61428	COX	2	GENE-N
61428	61429	-	0	None
61429	61430	2	0	None
61430	61431	inhibitors	0	None
61431	61432	reduce	0	None
61432	61433	prostaglandin	3	CHEMICAL
61433	61434	synthesis	0	None
61434	61435	,	0	None
61435	61436	restore	0	None
61436	61437	apoptosis	0	None
61437	61438	,	0	None
61438	61439	and	0	None
61439	61440	inhibit	0	None
61440	61441	cancer	0	None
61441	61442	cell	0	None
61442	61443	proliferation	0	None
61443	61444	.	0	None

61445	61446	In	0	None
61446	61447	animal	0	None
61447	61448	studies	0	None
61448	61449	they	0	None
61449	61450	limit	0	None
61450	61451	carcinogen	0	None
61451	61452	-	0	None
61452	61453	induced	0	None
61453	61454	tumorigenesis	0	None
61454	61455	.	0	None

61456	61457	In	0	None
61457	61458	contrast	0	None
61458	61459	,	0	None
61459	61460	aspirin	0	None
61460	61461	-	0	None
61461	61462	like	0	None
61462	61463	nonselective	0	None
61463	61464	NSAIDs	0	None
61464	61465	such	0	None
61465	61466	as	0	None
61466	61467	sulindac	3	CHEMICAL
61467	61468	and	0	None
61468	61469	indomethacin	3	CHEMICAL
61469	61470	inhibit	0	None
61470	61471	not	0	None
61471	61472	only	0	None
61472	61473	the	0	None
61473	61474	enzymatic	0	None
61474	61475	action	0	None
61475	61476	of	0	None
61476	61477	the	0	None
61477	61478	highly	0	None
61478	61479	inducible	0	None
61479	61480	,	0	None
61480	61481	proinflammatory	0	None
61481	61482	COX	2	GENE-N
61482	61483	-	0	None
61483	61484	2	0	None
61484	61485	but	0	None
61485	61486	the	0	None
61486	61487	constitutively	0	None
61487	61488	expressed	0	None
61488	61489	,	0	None
61489	61490	cytoprotective	0	None
61490	61491	COX	2	GENE-N
61491	61492	-	0	None
61492	61493	1	0	None
61493	61494	as	0	None
61494	61495	well	0	None
61495	61496	.	0	None

61497	61498	Consequently	0	None
61498	61499	,	0	None
61499	61500	nonselective	0	None
61500	61501	NSAIDs	0	None
61501	61502	can	0	None
61502	61503	cause	0	None
61503	61504	platelet	0	None
61504	61505	dysfunction	0	None
61505	61506	,	0	None
61506	61507	gastrointestinal	0	None
61507	61508	ulceration	0	None
61508	61509	,	0	None
61509	61510	and	0	None
61510	61511	kidney	0	None
61511	61512	damage	0	None
61512	61513	.	0	None

61514	61515	For	0	None
61515	61516	that	0	None
61516	61517	reason	0	None
61517	61518	,	0	None
61518	61519	selective	0	None
61519	61520	inhibition	0	None
61520	61521	of	0	None
61521	61522	COX	2	GENE-N
61522	61523	-	0	None
61523	61524	2	0	None
61524	61525	to	0	None
61525	61526	treat	0	None
61526	61527	neoplastic	0	None
61527	61528	proliferation	0	None
61528	61529	is	0	None
61529	61530	preferable	0	None
61530	61531	to	0	None
61531	61532	nonselective	0	None
61532	61533	inhibition	0	None
61533	61534	.	0	None

61535	61536	Selective	0	None
61536	61537	COX	2	GENE-N
61537	61538	-	0	None
61538	61539	2	0	None
61539	61540	inhibitors	0	None
61540	61541	,	0	None
61541	61542	such	0	None
61542	61543	as	0	None
61543	61544	meloxicam	3	CHEMICAL
61544	61545	,	0	None
61545	61546	celecoxib	3	CHEMICAL
61546	61547	(	0	None
61547	61548	SC	0	None
61548	61549	-	0	None
61549	61550	58635	0	None
61550	61551	)	0	None
61551	61552	,	0	None
61552	61553	and	0	None
61553	61554	rofecoxib	3	CHEMICAL
61554	61555	(	0	None
61555	61556	MK	1	GENE-Y
61556	61557	-	0	None
61557	61558	0966	0	None
61558	61559	)	0	None
61559	61560	,	0	None
61560	61561	are	0	None
61561	61562	NSAIDs	0	None
61562	61563	that	0	None
61563	61564	have	0	None
61564	61565	been	0	None
61565	61566	modified	0	None
61566	61567	chemically	0	None
61567	61568	to	0	None
61568	61569	preferentially	0	None
61569	61570	inhibit	0	None
61570	61571	COX	2	GENE-N
61571	61572	-	0	None
61572	61573	2	0	None
61573	61574	but	0	None
61574	61575	not	0	None
61575	61576	COX	2	GENE-N
61576	61577	-	0	None
61577	61578	1	0	None
61578	61579	.	0	None

61580	61581	For	0	None
61581	61582	instance	0	None
61582	61583	,	0	None
61583	61584	meloxicam	3	CHEMICAL
61584	61585	inhibits	0	None
61585	61586	the	0	None
61586	61587	growth	0	None
61587	61588	of	0	None
61588	61589	cultured	0	None
61589	61590	colon	0	None
61590	61591	cancer	0	None
61591	61592	cells	0	None
61592	61593	(	0	None
61593	61594	HCA	2	GENE-N
61594	61595	-	0	None
61595	61596	7	0	None
61596	61597	and	0	None
61597	61598	Moser	0	None
61598	61599	-	0	None
61599	61600	S	0	None
61600	61601	)	0	None
61601	61602	that	0	None
61602	61603	express	0	None
61603	61604	COX	2	GENE-N
61604	61605	-	0	None
61605	61606	2	0	None
61606	61607	but	0	None
61607	61608	has	0	None
61608	61609	no	0	None
61609	61610	effect	0	None
61610	61611	on	0	None
61611	61612	HCT	0	None
61612	61613	-	0	None
61613	61614	116	0	None
61614	61615	tumor	0	None
61615	61616	cells	0	None
61616	61617	that	0	None
61617	61618	do	0	None
61618	61619	not	0	None
61619	61620	express	0	None
61620	61621	COX	2	GENE-N
61621	61622	-	0	None
61622	61623	2	0	None
61623	61624	.	0	None

61625	61626	NS	0	None
61626	61627	-	0	None
61627	61628	398	0	None
61628	61629	induces	0	None
61629	61630	apoptosis	0	None
61630	61631	in	0	None
61631	61632	COX	2	GENE-N
61632	61633	-	0	None
61633	61634	2	0	None
61634	61635	expressing	0	None
61635	61636	LNCaP	0	None
61636	61637	prostate	0	None
61637	61638	cancer	0	None
61638	61639	cells	0	None
61639	61640	and	0	None
61640	61641	,	0	None
61641	61642	surprisingly	0	None
61642	61643	,	0	None
61643	61644	in	0	None
61644	61645	colon	0	None
61645	61646	cancer	0	None
61646	61647	S	0	None
61647	61648	/	0	None
61648	61649	KS	0	None
61649	61650	cells	0	None
61650	61651	that	0	None
61651	61652	does	0	None
61652	61653	not	0	None
61653	61654	express	0	None
61654	61655	COX	2	GENE-N
61655	61656	-	0	None
61656	61657	2	0	None
61657	61658	.	0	None

61659	61660	This	0	None
61660	61661	effect	0	None
61661	61662	may	0	None
61662	61663	due	0	None
61663	61664	to	0	None
61664	61665	induction	0	None
61665	61666	of	0	None
61666	61667	apoptosis	0	None
61667	61668	through	0	None
61668	61669	uncoupling	0	None
61669	61670	of	0	None
61670	61671	oxidative	0	None
61671	61672	phosphorylation	0	None
61672	61673	and	0	None
61673	61674	down	0	None
61674	61675	-	0	None
61675	61676	regulation	0	None
61676	61677	of	0	None
61677	61678	Bcl	0	None
61678	61679	-	0	None
61679	61680	2	0	None
61680	61681	,	0	None
61681	61682	as	0	None
61682	61683	has	0	None
61683	61684	been	0	None
61684	61685	demonstrated	0	None
61685	61686	for	0	None
61686	61687	some	0	None
61687	61688	nonselective	0	None
61688	61689	NSAIDs	0	None
61689	61690	,	0	None
61690	61691	for	0	None
61691	61692	instance	0	None
61692	61693	,	0	None
61693	61694	flurbiprofen	3	CHEMICAL
61694	61695	.	0	None

61696	61697	COX	2	GENE-N
61697	61698	-	0	None
61698	61699	2	0	None
61699	61700	mRNA	0	None
61700	61701	and	0	None
61701	61702	COX	2	GENE-N
61702	61703	-	0	None
61703	61704	2	0	None
61704	61705	protein	0	None
61705	61706	is	0	None
61706	61707	constitutively	0	None
61707	61708	expressed	0	None
61708	61709	in	0	None
61709	61710	the	0	None
61710	61711	kidney	0	None
61711	61712	,	0	None
61712	61713	brain	0	None
61713	61714	,	0	None
61714	61715	spinal	0	None
61715	61716	cord	0	None
61716	61717	,	0	None
61717	61718	and	0	None
61718	61719	ductus	0	None
61719	61720	deferens	0	None
61720	61721	,	0	None
61721	61722	and	0	None
61722	61723	in	0	None
61723	61724	the	0	None
61724	61725	uterus	0	None
61725	61726	during	0	None
61726	61727	implantation	0	None
61727	61728	.	0	None

61729	61730	In	0	None
61730	61731	addition	0	None
61731	61732	,	0	None
61732	61733	COX	2	GENE-N
61733	61734	-	0	None
61734	61735	2	0	None
61735	61736	is	0	None
61736	61737	constitutively	0	None
61737	61738	and	0	None
61738	61739	dominantly	0	None
61739	61740	expressed	0	None
61740	61741	in	0	None
61741	61742	the	0	None
61742	61743	pancreatic	0	None
61743	61744	islet	0	None
61744	61745	cells	0	None
61745	61746	.	0	None

61747	61748	These	0	None
61748	61749	findings	0	None
61749	61750	might	0	None
61750	61751	somewhat	0	None
61751	61752	limit	0	None
61752	61753	the	0	None
61753	61754	use	0	None
61754	61755	of	0	None
61755	61756	presently	0	None
61756	61757	available	0	None
61757	61758	selective	0	None
61758	61759	COX	2	GENE-N
61759	61760	-	0	None
61760	61761	2	0	None
61761	61762	inhibitors	0	None
61762	61763	in	0	None
61763	61764	cancer	0	None
61764	61765	prevention	0	None
61765	61766	but	0	None
61766	61767	will	0	None
61767	61768	probably	0	None
61768	61769	not	0	None
61769	61770	deter	0	None
61770	61771	their	0	None
61771	61772	successful	0	None
61772	61773	application	0	None
61773	61774	for	0	None
61774	61775	the	0	None
61775	61776	treatment	0	None
61776	61777	of	0	None
61777	61778	human	0	None
61778	61779	cancers	0	None
61779	61780	.	0	None

61781	61782	Sulfonylurea	0	None
61782	61783	sensitivity	0	None
61783	61784	of	0	None
61784	61786	adenosine triphosphate	3	CHEMICAL
61786	61787	-	0	None
61787	61788	sensitive	0	None
61788	61790	potassium channels	2	GENE-N
61790	61791	from	0	None
61791	61792	beta	0	None
61792	61793	cells	0	None
61793	61794	and	0	None
61794	61795	extrapancreatic	0	None
61795	61796	tissues	0	None
61796	61797	.	0	None

61798	61799	Sulfonylureas	0	None
61799	61800	are	0	None
61800	61801	widely	0	None
61801	61802	used	0	None
61802	61803	to	0	None
61803	61804	stimulate	0	None
61804	61805	insulin	0	None
61805	61806	secretion	0	None
61806	61807	in	0	None
61807	61808	type	0	None
61808	61809	2	0	None
61809	61810	diabetic	0	None
61810	61811	patients	0	None
61811	61812	because	0	None
61812	61813	they	0	None
61813	61814	close	0	None
61814	61816	adenosine triphosphate	3	CHEMICAL
61816	61817	-	0	None
61817	61818	sensitive	0	None
61818	61819	potassium	3	CHEMICAL
61819	61820	(	0	None
61820	61821	K	0	None
61821	61822	(	0	None
61822	61823	ATP	3	CHEMICAL
61823	61824	)	0	None
61824	61825	)	0	None
61825	61826	channels	0	None
61826	61827	in	0	None
61827	61828	the	0	None
61828	61829	pancreatic	0	None
61829	61830	beta	0	None
61830	61831	-	0	None
61831	61832	cell	0	None
61832	61833	membrane	0	None
61833	61834	.	0	None

61835	61836	This	0	None
61836	61837	action	0	None
61837	61838	is	0	None
61838	61839	mediated	0	None
61839	61840	by	0	None
61840	61841	binding	0	None
61841	61842	of	0	None
61842	61843	the	0	None
61843	61844	drug	0	None
61844	61845	to	0	None
61845	61846	the	0	None
61846	61848	sulfonylurea receptor	2	GENE-N
61848	61849	(	0	None
61849	61850	SUR1	1	GENE-Y
61850	61851	)	0	None
61851	61852	subunit	0	None
61852	61853	of	0	None
61853	61854	the	0	None
61854	61855	channel	0	None
61855	61856	.	0	None

61857	61858	K	0	None
61858	61859	(	0	None
61859	61860	ATP	3	CHEMICAL
61860	61861	)	0	None
61861	61862	channels	0	None
61862	61863	are	0	None
61863	61864	also	0	None
61864	61865	present	0	None
61865	61866	in	0	None
61866	61867	a	0	None
61867	61868	range	0	None
61868	61869	of	0	None
61869	61870	extrapancreatic	0	None
61870	61871	tissues	0	None
61871	61872	,	0	None
61872	61873	but	0	None
61873	61874	many	0	None
61874	61875	of	0	None
61875	61876	these	0	None
61876	61877	contain	0	None
61877	61878	an	0	None
61878	61879	alternative	0	None
61879	61880	type	0	None
61880	61881	of	0	None
61881	61882	SUR	0	None
61882	61883	subunit	0	None
61883	61884	(	0	None
61884	61885	SUR2A	0	None
61885	61886	in	0	None
61886	61887	heart	0	None
61887	61888	and	0	None
61888	61889	SUR2B	0	None
61889	61890	in	0	None
61890	61891	smooth	0	None
61891	61892	muscle	0	None
61892	61893	)	0	None
61893	61894	.	0	None

61895	61896	The	0	None
61896	61897	sulfonylurea	3	CHEMICAL
61897	61898	-	0	None
61898	61899	sensitivity	0	None
61899	61900	of	0	None
61900	61901	K	0	None
61901	61902	(	0	None
61902	61903	ATP	3	CHEMICAL
61903	61904	)	0	None
61904	61905	channels	0	None
61905	61906	containing	0	None
61906	61907	the	0	None
61907	61908	different	0	None
61908	61909	types	0	None
61909	61910	of	0	None
61910	61911	SUR	0	None
61911	61912	is	0	None
61912	61913	variable	0	None
61913	61914	:	0	None
61914	61915	gliclazide	3	CHEMICAL
61915	61916	and	0	None
61916	61917	tolbutamide	0	None
61917	61918	block	0	None
61918	61919	the	0	None
61919	61920	beta	0	None
61920	61921	cell	0	None
61921	61922	,	0	None
61922	61923	but	0	None
61923	61924	not	0	None
61924	61925	the	0	None
61925	61926	cardiac	0	None
61926	61927	or	0	None
61927	61928	smooth	0	None
61928	61929	muscle	0	None
61929	61930	types	0	None
61930	61931	of	0	None
61931	61932	K	0	None
61932	61933	(	0	None
61933	61934	ATP	3	CHEMICAL
61934	61935	)	0	None
61935	61936	channels	0	None
61936	61937	with	0	None
61937	61938	high	0	None
61938	61939	affinity	0	None
61939	61940	.	0	None

61941	61942	Glibenclamide	0	None
61942	61943	and	0	None
61943	61944	glimepiride	3	CHEMICAL
61944	61945	,	0	None
61945	61946	on	0	None
61946	61947	the	0	None
61947	61948	other	0	None
61948	61949	hand	0	None
61949	61950	,	0	None
61950	61951	block	0	None
61951	61952	channels	0	None
61952	61953	containing	0	None
61953	61954	SUR1	1	GENE-Y
61954	61955	and	0	None
61955	61956	SUR2	1	GENE-Y
61956	61957	with	0	None
61957	61958	similar	0	None
61958	61959	affinity	0	None
61959	61960	.	0	None

61961	61962	The	0	None
61962	61963	reversibility	0	None
61963	61964	of	0	None
61964	61965	the	0	None
61965	61966	different	0	None
61966	61967	sulfonylureas	3	CHEMICAL
61967	61968	also	0	None
61968	61969	varies	0	None
61969	61970	.	0	None

61971	61972	Tolbutamide	0	None
61972	61973	and	0	None
61973	61974	gliclazide	3	CHEMICAL
61974	61975	produce	0	None
61975	61976	a	0	None
61976	61977	reversible	0	None
61977	61978	inhibition	0	None
61978	61979	of	0	None
61979	61980	Kir6	0	None
61980	61981	.	0	None
61981	61982	2	0	None
61982	61983	/	0	None
61983	61984	SUR1	1	GENE-Y
61984	61985	and	0	None
61985	61986	Kir6	0	None
61986	61987	.	0	None
61987	61988	2	0	None
61988	61989	/	0	None
61989	61990	SUR2	1	GENE-Y
61990	61991	channels	0	None
61991	61992	,	0	None
61992	61993	whereas	0	None
61993	61994	glibenclamide	3	CHEMICAL
61994	61995	has	0	None
61995	61996	a	0	None
61996	61997	reversible	0	None
61997	61998	effect	0	None
61998	61999	on	0	None
61999	62000	cardiac	0	None
62000	62001	,	0	None
62001	62002	but	0	None
62002	62003	not	0	None
62003	62004	beta	0	None
62004	62005	-	0	None
62005	62006	cell	0	None
62006	62007	,	0	None
62007	62008	K	0	None
62008	62009	(	0	None
62009	62010	ATP	3	CHEMICAL
62010	62011	)	0	None
62011	62012	channels	0	None
62012	62013	.	0	None

62014	62015	In	0	None
62015	62016	this	0	None
62016	62017	article	0	None
62017	62018	,	0	None
62018	62019	we	0	None
62019	62020	summarize	0	None
62020	62021	current	0	None
62021	62022	knowledge	0	None
62022	62023	of	0	None
62023	62024	how	0	None
62024	62025	sulfonylureas	3	CHEMICAL
62025	62026	act	0	None
62026	62027	on	0	None
62027	62028	K	0	None
62028	62029	(	0	None
62029	62030	ATP	3	CHEMICAL
62030	62031	)	0	None
62031	62032	channels	0	None
62032	62033	containing	0	None
62033	62034	the	0	None
62034	62035	different	0	None
62035	62036	types	0	None
62036	62037	of	0	None
62037	62039	sulfonylurea receptor	2	GENE-N
62039	62040	,	0	None
62040	62041	and	0	None
62041	62042	discuss	0	None
62042	62043	the	0	None
62043	62044	implications	0	None
62044	62045	of	0	None
62045	62046	these	0	None
62046	62047	findings	0	None
62047	62048	for	0	None
62048	62049	the	0	None
62049	62050	use	0	None
62050	62051	of	0	None
62051	62052	sulfonylureas	3	CHEMICAL
62052	62053	in	0	None
62053	62054	the	0	None
62054	62055	treatment	0	None
62055	62056	of	0	None
62056	62057	diabetes	0	None
62057	62058	mellitus	0	None
62058	62059	.	0	None

62060	62061	Determination	0	None
62061	62062	of	0	None
62062	62063	residues	0	None
62063	62064	in	0	None
62064	62065	the	0	None
62065	62067	norepinephrine transporter	1	GENE-Y
62067	62068	that	0	None
62068	62069	are	0	None
62069	62070	critical	0	None
62070	62071	for	0	None
62071	62072	tricyclic	0	None
62072	62073	antidepressant	0	None
62073	62074	affinity	0	None
62074	62075	.	0	None

62076	62077	The	0	None
62077	62078	norepinephrine	3	CHEMICAL
62078	62079	(	0	None
62079	62080	NET	1	GENE-Y
62080	62081	)	0	None
62081	62082	and	0	None
62082	62083	dopamine	3	CHEMICAL
62083	62084	(	0	None
62084	62085	DAT	1	GENE-Y
62085	62086	)	0	None
62086	62087	transporters	0	None
62087	62088	are	0	None
62088	62089	highly	0	None
62089	62090	homologous	0	None
62090	62091	proteins	0	None
62091	62092	,	0	None
62092	62093	displaying	0	None
62093	62094	many	0	None
62094	62095	pharmacological	0	None
62095	62096	similarities	0	None
62096	62097	.	0	None

62098	62099	Both	0	None
62099	62100	transport	0	None
62100	62101	dopamine	3	CHEMICAL
62101	62102	with	0	None
62102	62103	higher	0	None
62103	62104	affinity	0	None
62104	62105	than	0	None
62105	62106	norepinephrine	3	CHEMICAL
62106	62107	and	0	None
62107	62108	are	0	None
62108	62109	targets	0	None
62109	62110	for	0	None
62110	62111	the	0	None
62111	62112	psychostimulants	0	None
62112	62113	cocaine	0	None
62113	62114	and	0	None
62114	62115	amphetamine	3	CHEMICAL
62115	62116	.	0	None

62117	62118	However	0	None
62118	62119	,	0	None
62119	62120	they	0	None
62120	62121	strikingly	0	None
62121	62122	contrast	0	None
62122	62123	in	0	None
62123	62124	their	0	None
62124	62125	affinities	0	None
62125	62126	for	0	None
62126	62127	tricyclic	3	CHEMICAL
62127	62128	antidepressants	0	None
62128	62129	(	0	None
62129	62130	TCA	3	CHEMICAL
62130	62131	)	0	None
62131	62132	.	0	None

62133	62134	Previous	0	None
62134	62135	studies	0	None
62135	62136	,	0	None
62136	62137	based	0	None
62137	62138	on	0	None
62138	62139	chimeric	0	None
62139	62140	proteins	0	None
62140	62141	between	0	None
62141	62142	DAT	1	GENE-Y
62142	62143	and	0	None
62143	62144	NET	1	GENE-Y
62144	62145	suggest	0	None
62145	62146	that	0	None
62146	62147	domains	0	None
62147	62148	ranging	0	None
62148	62149	from	0	None
62149	62150	putative	0	None
62150	62151	transmembrane	0	None
62151	62152	domain	0	None
62152	62153	(	0	None
62153	62154	TMD	0	None
62154	62155	)	0	None
62155	62156	5	0	None
62156	62157	to	0	None
62157	62158	8	0	None
62158	62159	are	0	None
62159	62160	involved	0	None
62160	62161	in	0	None
62161	62162	the	0	None
62162	62163	high	0	None
62163	62164	affinity	0	None
62164	62165	binding	0	None
62165	62166	of	0	None
62166	62167	TCA	3	CHEMICAL
62167	62168	to	0	None
62168	62169	NET	1	GENE-Y
62169	62170	.	0	None

62171	62172	We	0	None
62172	62173	substituted	0	None
62173	62174	24	0	None
62174	62176	amino acids	3	CHEMICAL
62176	62177	within	0	None
62177	62178	this	0	None
62178	62179	region	0	None
62179	62180	in	0	None
62180	62181	the	0	None
62181	62182	human	0	None
62182	62183	NET	1	GENE-Y
62183	62184	with	0	None
62184	62185	their	0	None
62185	62186	counterparts	0	None
62186	62187	in	0	None
62187	62188	the	0	None
62188	62190	human DAT	1	GENE-Y
62190	62191	,	0	None
62191	62192	resulting	0	None
62192	62193	in	0	None
62193	62194	22	0	None
62194	62195	different	0	None
62195	62196	mutants	0	None
62196	62197	.	0	None

62198	62199	Mutations	0	None
62199	62200	of	0	None
62200	62201	residues	0	None
62201	62202	located	0	None
62202	62203	in	0	None
62203	62204	extra	0	None
62204	62205	-	0	None
62205	62206	or	0	None
62206	62207	intracytoplasmic	0	None
62207	62208	loops	0	None
62208	62209	have	0	None
62209	62210	no	0	None
62210	62211	effect	0	None
62211	62212	on	0	None
62212	62213	binding	0	None
62213	62214	affinity	0	None
62214	62215	of	0	None
62215	62216	neither	0	None
62216	62217	TCA	3	CHEMICAL
62217	62218	nor	0	None
62218	62219	cocaine	0	None
62219	62220	.	0	None

62221	62222	Three	0	None
62222	62223	point	0	None
62223	62224	mutations	0	None
62224	62225	in	0	None
62225	62226	TMD6	0	None
62226	62227	(	0	None
62227	62228	F316C	0	None
62228	62229	)	0	None
62229	62230	,	0	None
62230	62231	-	0	None
62231	62232	7	0	None
62232	62233	(	0	None
62233	62234	V356S	0	None
62234	62235	)	0	None
62235	62236	,	0	None
62236	62237	and	0	None
62237	62238	-	0	None
62238	62239	8	0	None
62239	62240	(	0	None
62240	62241	G400L	0	None
62241	62242	)	0	None
62242	62243	induced	0	None
62243	62244	a	0	None
62244	62245	loss	0	None
62245	62246	of	0	None
62246	62247	TCA	3	CHEMICAL
62247	62248	binding	0	None
62248	62249	affinity	0	None
62249	62250	of	0	None
62250	62251	8	0	None
62251	62252	-	0	None
62252	62253	,	0	None
62253	62254	5	0	None
62254	62255	-	0	None
62255	62256	,	0	None
62256	62257	and	0	None
62257	62258	4	0	None
62258	62259	-	0	None
62259	62260	fold	0	None
62260	62261	,	0	None
62261	62262	respectively	0	None
62262	62263	,	0	None
62263	62264	without	0	None
62264	62265	affecting	0	None
62265	62266	the	0	None
62266	62267	affinity	0	None
62267	62268	of	0	None
62268	62269	cocaine	0	None
62269	62270	.	0	None

62271	62272	The	0	None
62272	62273	triple	0	None
62273	62274	mutation	0	None
62274	62275	F316C	0	None
62275	62276	/	0	None
62276	62277	V356S	0	None
62277	62278	/	0	None
62278	62279	G400L	0	None
62279	62280	produced	0	None
62280	62281	a	0	None
62281	62282	40	0	None
62282	62283	-	0	None
62283	62284	fold	0	None
62284	62285	shift	0	None
62285	62286	in	0	None
62286	62287	desipramine	3	CHEMICAL
62287	62288	affinity	0	None
62288	62289	.	0	None

62290	62291	These	0	None
62291	62292	three	0	None
62292	62293	residues	0	None
62293	62294	are	0	None
62294	62295	strongly	0	None
62295	62296	conserved	0	None
62296	62297	in	0	None
62297	62298	all	0	None
62298	62299	TCA	3	CHEMICAL
62299	62300	-	0	None
62300	62301	sensitive	0	None
62301	62302	transporters	0	None
62302	62303	cloned	0	None
62303	62304	in	0	None
62304	62305	mammalian	0	None
62305	62306	and	0	None
62306	62307	nonmammalian	0	None
62307	62308	species	0	None
62308	62309	.	0	None

62310	62311	A	0	None
62311	62312	strong	0	None
62312	62313	shift	0	None
62313	62314	in	0	None
62314	62315	TCA	3	CHEMICAL
62315	62316	affinity	0	None
62316	62317	(	0	None
62317	62318	IC	0	None
62318	62319	(	0	None
62319	62320	50	0	None
62320	62321	)	0	None
62321	62322	)	0	None
62322	62323	was	0	None
62323	62324	also	0	None
62324	62325	observed	0	None
62325	62326	for	0	None
62326	62327	double	0	None
62327	62328	mutants	0	None
62328	62329	F316C	0	None
62329	62330	/	0	None
62330	62331	D336T	0	None
62331	62332	(	0	None
62332	62333	35	0	None
62333	62334	-	0	None
62334	62335	fold	0	None
62335	62336	)	0	None
62336	62337	and	0	None
62337	62338	S399P	0	None
62338	62339	/	0	None
62339	62340	G400L	0	None
62340	62341	(	0	None
62341	62342	80	0	None
62342	62343	-	0	None
62343	62344	fold	0	None
62344	62345	for	0	None
62345	62346	nortriptyline	0	None
62346	62347	and	0	None
62347	62348	1000	0	None
62348	62349	-	0	None
62349	62350	fold	0	None
62350	62351	for	0	None
62351	62352	desipramine	3	CHEMICAL
62352	62353	)	0	None
62353	62354	.	0	None

62355	62356	Reverse	0	None
62356	62357	mutations	0	None
62357	62358	P401S	0	None
62358	62359	/	0	None
62359	62360	L402G	0	None
62360	62361	in	0	None
62361	62362	hDAT	1	GENE-Y
62362	62363	did	0	None
62363	62364	not	0	None
62364	62365	elicit	0	None
62365	62366	any	0	None
62366	62367	gain	0	None
62367	62368	in	0	None
62368	62369	TCA	3	CHEMICAL
62369	62370	affinities	0	None
62370	62371	,	0	None
62371	62372	whereas	0	None
62372	62373	C318F	0	None
62373	62374	and	0	None
62374	62375	S358V	0	None
62375	62376	resulted	0	None
62376	62377	in	0	None
62377	62378	a	0	None
62378	62379	3	0	None
62379	62380	-	0	None
62380	62381	and	0	None
62381	62382	10	0	None
62382	62383	-	0	None
62383	62384	fold	0	None
62384	62385	increase	0	None
62385	62386	in	0	None
62386	62387	affinity	0	None
62387	62388	,	0	None
62388	62389	respectively	0	None
62389	62390	.	0	None

62391	62392	Our	0	None
62392	62393	results	0	None
62393	62394	clearly	0	None
62394	62395	indicate	0	None
62395	62396	that	0	None
62396	62397	two	0	None
62397	62398	residues	0	None
62398	62399	located	0	None
62399	62400	in	0	None
62400	62401	TMD6	0	None
62401	62402	and	0	None
62402	62403	-	0	None
62403	62404	7	0	None
62404	62405	of	0	None
62405	62406	hNET	1	GENE-Y
62406	62407	may	0	None
62407	62408	play	0	None
62408	62409	an	0	None
62409	62410	important	0	None
62410	62411	role	0	None
62411	62412	in	0	None
62412	62413	TCA	3	CHEMICAL
62413	62414	interaction	0	None
62414	62415	and	0	None
62415	62416	that	0	None
62416	62417	a	0	None
62417	62418	critical	0	None
62418	62419	region	0	None
62419	62420	in	0	None
62420	62421	TMD8	0	None
62421	62422	is	0	None
62422	62423	likely	0	None
62423	62424	to	0	None
62424	62425	be	0	None
62425	62426	involved	0	None
62426	62427	in	0	None
62427	62428	the	0	None
62428	62429	tertiary	0	None
62429	62430	structure	0	None
62430	62431	allowing	0	None
62431	62432	the	0	None
62432	62433	high	0	None
62433	62434	affinity	0	None
62434	62435	binding	0	None
62435	62436	of	0	None
62436	62437	TCA	3	CHEMICAL
62437	62438	.	0	None

62439	62440	Lyprinol	0	None
62440	62441	:	0	None
62441	62442	anti	0	None
62442	62443	-	0	None
62443	62444	inflammatory	0	None
62444	62445	and	0	None
62445	62446	uterine	0	None
62446	62447	-	0	None
62447	62448	relaxant	0	None
62448	62449	activities	0	None
62449	62450	in	0	None
62450	62451	rats	0	None
62451	62452	,	0	None
62452	62453	with	0	None
62453	62454	special	0	None
62454	62455	reference	0	None
62455	62456	to	0	None
62456	62457	a	0	None
62457	62458	model	0	None
62458	62459	for	0	None
62459	62460	dysmenorrhoea	0	None
62460	62461	.	0	None

62462	62463	Lyprinol	0	None
62463	62464	exhibits	0	None
62464	62465	anti	0	None
62465	62466	-	0	None
62466	62467	inflammatory	0	None
62467	62468	activity	0	None
62468	62469	distinct	0	None
62469	62470	from	0	None
62470	62471	that	0	None
62471	62472	of	0	None
62472	62473	most	0	None
62473	62474	NSAIDs	0	None
62474	62475	,	0	None
62475	62476	controlling	0	None
62476	62477	chronic	0	None
62477	62478	but	0	None
62478	62479	not	0	None
62479	62480	acute	0	None
62480	62481	inflammation	0	None
62481	62482	.	0	None

62483	62484	Unlike	0	None
62484	62485	Cox	0	None
62485	62486	-	0	None
62486	62487	1	0	None
62487	62488	inhibitors	0	None
62488	62489	(	0	None
62489	62490	aspirin	0	None
62490	62491	,	0	None
62491	62493	meclofenamic acid	3	CHEMICAL
62493	62494	)	0	None
62494	62495	it	0	None
62495	62496	is	0	None
62496	62497	not	0	None
62497	62498	gastro	0	None
62498	62499	-	0	None
62499	62500	toxic	0	None
62500	62501	.	0	None

62502	62503	Predosing	0	None
62503	62504	rats	0	None
62504	62505	with	0	None
62505	62506	Lyprinol	0	None
62506	62507	can	0	None
62507	62508	modify	0	None
62508	62509	both	0	None
62509	62510	(	0	None
62510	62511	i	0	None
62511	62512	)	0	None
62512	62513	the	0	None
62513	62514	spontaneous	0	None
62514	62515	and	0	None
62515	62516	(	0	None
62516	62517	ii	0	None
62517	62518	)	0	None
62518	62519	the	0	None
62519	62520	oxytocin	3	CHEMICAL
62520	62521	-	0	None
62521	62522	induced	0	None
62522	62523	contractions	0	None
62523	62524	of	0	None
62524	62525	the	0	None
62525	62526	uterus	0	None
62526	62527	.	0	None

62528	62529	In	0	None
62529	62530	humans	0	None
62530	62531	there	0	None
62531	62532	is	0	None
62532	62533	anecdotal	0	None
62533	62534	evidence	0	None
62534	62535	that	0	None
62535	62536	Lyprinol	0	None
62536	62537	can	0	None
62537	62538	relieve	0	None
62538	62539	dysmenorrhea	0	None
62539	62540	.	0	None

62541	62542	This	0	None
62542	62543	report	0	None
62543	62544	explores	0	None
62544	62545	the	0	None
62545	62546	concept	0	None
62546	62547	that	0	None
62547	62548	the	0	None
62548	62549	uterotrophic	0	None
62549	62550	actions	0	None
62550	62551	of	0	None
62551	62552	Lyprinol	0	None
62552	62553	are	0	None
62553	62554	conditioned	0	None
62554	62555	by	0	None
62555	62556	:	0	None
62556	62557	the	0	None
62557	62558	intrinsic	0	None
62558	62559	profile	0	None
62559	62560	of	0	None
62560	62561	estrogenic	0	None
62561	62562	hormones	3	CHEMICAL
62562	62563	and	0	None
62563	62564	progestagens	3	CHEMICAL
62564	62565	and	0	None
62565	62566	,	0	None
62566	62567	certain	0	None
62567	62568	extrinsic	0	None
62568	62569	stimuli	0	None
62569	62570	.	0	None

62571	62572	Evidence	0	None
62572	62573	from	0	None
62573	62574	in	0	None
62574	62575	vitro	0	None
62575	62576	studies	0	None
62576	62577	indicates	0	None
62577	62578	that	0	None
62578	62579	Lyprinol	0	None
62579	62580	is	0	None
62580	62581	not	0	None
62581	62582	a	0	None
62582	62583	smooth	0	None
62583	62584	muscle	0	None
62584	62585	relaxant	0	None
62585	62586	and	0	None
62586	62587	that	0	None
62587	62588	its	0	None
62588	62589	uterotrophic	0	None
62589	62590	mechanism	0	None
62590	62591	is	0	None
62591	62592	not	0	None
62592	62593	that	0	None
62593	62594	of	0	None
62594	62595	a	0	None
62595	62596	cyclo	0	None
62596	62597	-	0	None
62597	62598	oxygenase	0	None
62598	62599	inhibitor	0	None
62599	62600	,	0	None
62600	62601	but	0	None
62601	62602	may	0	None
62602	62603	mimic	0	None
62603	62604	that	0	None
62604	62605	of	0	None
62605	62606	a	0	None
62606	62608	leukotriene receptor	2	GENE-N
62608	62609	antagonist	0	None
62609	62610	.	0	None

62611	62612	NMDA	3	CHEMICAL
62612	62613	and	0	None
62613	62614	glutamate	3	CHEMICAL
62614	62615	evoke	0	None
62615	62616	excitotoxicity	0	None
62616	62617	at	0	None
62617	62618	distinct	0	None
62618	62619	cellular	0	None
62619	62620	locations	0	None
62620	62621	in	0	None
62621	62622	rat	0	None
62622	62623	cortical	0	None
62623	62624	neurons	0	None
62624	62625	in	0	None
62625	62626	vitro	0	None
62626	62627	.	0	None

62628	62629	The	0	None
62629	62630	development	0	None
62630	62631	of	0	None
62631	62632	cortical	0	None
62632	62633	neurons	0	None
62633	62634	in	0	None
62634	62635	vivo	0	None
62635	62636	and	0	None
62636	62637	in	0	None
62637	62638	vitro	0	None
62638	62639	is	0	None
62639	62640	accompanied	0	None
62640	62641	by	0	None
62641	62642	alterations	0	None
62642	62643	in	0	None
62643	62645	NMDA receptor	2	GENE-N
62645	62646	subunit	0	None
62646	62647	expression	0	None
62647	62648	and	0	None
62648	62649	concomitant	0	None
62649	62650	modifications	0	None
62650	62651	in	0	None
62651	62652	the	0	None
62652	62653	pharmacological	0	None
62653	62654	profile	0	None
62654	62655	of	0	None
62655	62656	NMDA	3	CHEMICAL
62656	62657	-	0	None
62657	62658	activated	0	None
62658	62659	ionic	0	None
62659	62660	currents	0	None
62660	62661	.	0	None

62662	62663	For	0	None
62663	62664	example	0	None
62664	62665	,	0	None
62665	62666	we	0	None
62666	62667	observed	0	None
62667	62668	that	0	None
62668	62669	with	0	None
62669	62670	decreasing	0	None
62670	62671	NR2B	1	GENE-Y
62671	62672	/	0	None
62672	62673	NR2A	1	GENE-Y
62673	62674	subunit	0	None
62674	62675	expression	0	None
62675	62676	ratio	0	None
62676	62677	,	0	None
62677	62678	the	0	None
62678	62679	block	0	None
62679	62680	of	0	None
62680	62682	NMDA receptor	2	GENE-N
62682	62683	-	0	None
62683	62684	mediated	0	None
62684	62685	whole	0	None
62685	62686	-	0	None
62686	62687	cell	0	None
62687	62688	responses	0	None
62688	62689	by	0	None
62689	62690	the	0	None
62690	62691	NR2B	1	GENE-Y
62691	62692	-	0	None
62692	62693	selective	0	None
62693	62694	antagonist	0	None
62694	62695	haloperidol	3	CHEMICAL
62695	62696	was	0	None
62696	62697	also	0	None
62697	62698	decreased	0	None
62698	62699	.	0	None

62700	62701	In	0	None
62701	62702	mature	0	None
62702	62703	cultures	0	None
62703	62704	(	0	None
62704	62705	>	0	None
62705	62706	22	0	None
62706	62707	d	0	None
62707	62708	in	0	None
62708	62709	vitro	0	None
62709	62710	)	0	None
62710	62711	,	0	None
62711	62712	however	0	None
62712	62713	,	0	None
62713	62714	NMDA	3	CHEMICAL
62714	62715	responses	0	None
62715	62716	obtained	0	None
62716	62717	from	0	None
62717	62718	excised	0	None
62718	62719	nucleated	0	None
62719	62720	macropatches	0	None
62720	62721	,	0	None
62721	62722	which	0	None
62722	62723	comprised	0	None
62723	62724	a	0	None
62724	62725	large	0	None
62725	62726	portion	0	None
62726	62727	of	0	None
62727	62728	the	0	None
62728	62729	soma	0	None
62729	62730	,	0	None
62730	62731	remained	0	None
62731	62732	strongly	0	None
62732	62733	antagonized	0	None
62733	62734	by	0	None
62734	62735	haloperidol	3	CHEMICAL
62735	62736	.	0	None

62737	62738	These	0	None
62738	62739	results	0	None
62739	62740	suggest	0	None
62740	62741	that	0	None
62741	62742	in	0	None
62742	62743	more	0	None
62743	62744	mature	0	None
62744	62745	neurons	0	None
62745	62746	NR1	1	GENE-Y
62746	62747	/	0	None
62747	62748	NR2B	1	GENE-Y
62748	62749	receptors	0	None
62749	62750	appear	0	None
62750	62751	to	0	None
62751	62752	be	0	None
62752	62753	preferentially	0	None
62753	62754	expressed	0	None
62754	62755	in	0	None
62755	62756	the	0	None
62756	62757	cell	0	None
62757	62758	body	0	None
62758	62759	.	0	None

62760	62761	As	0	None
62761	62762	predicted	0	None
62762	62763	from	0	None
62763	62764	the	0	None
62764	62765	whole	0	None
62765	62766	-	0	None
62766	62767	cell	0	None
62767	62768	recording	0	None
62768	62769	pharmacological	0	None
62769	62770	profile	0	None
62770	62771	,	0	None
62771	62772	NMDA	3	CHEMICAL
62772	62773	-	0	None
62773	62774	induced	0	None
62774	62775	toxicity	0	None
62775	62776	was	0	None
62776	62777	largely	0	None
62777	62778	unaffected	0	None
62778	62779	by	0	None
62779	62780	haloperidol	3	CHEMICAL
62780	62781	in	0	None
62781	62782	mature	0	None
62782	62783	cultures	0	None
62783	62784	.	0	None

62785	62786	However	0	None
62786	62787	,	0	None
62787	62788	haloperidol	3	CHEMICAL
62788	62789	effectively	0	None
62789	62790	blocked	0	None
62790	62791	glutamate	3	CHEMICAL
62791	62792	toxicity	0	None
62792	62793	in	0	None
62793	62794	the	0	None
62794	62795	same	0	None
62795	62796	cultures	0	None
62796	62797	,	0	None
62797	62798	suggesting	0	None
62798	62799	that	0	None
62799	62800	the	0	None
62800	62801	neurotoxic	0	None
62801	62802	actions	0	None
62802	62803	of	0	None
62803	62804	this	0	None
62804	62806	amino acid	3	CHEMICAL
62806	62807	were	0	None
62807	62808	mostly	0	None
62808	62809	due	0	None
62809	62810	to	0	None
62810	62811	the	0	None
62811	62812	activation	0	None
62812	62813	of	0	None
62813	62814	somatic	0	None
62814	62816	NMDA receptors	2	GENE-N
62816	62817	.	0	None

62818	62819	In	0	None
62819	62820	experiments	0	None
62820	62821	in	0	None
62821	62822	which	0	None
62822	62823	the	0	None
62823	62824	potency	0	None
62824	62825	of	0	None
62825	62826	glutamate	3	CHEMICAL
62826	62827	toxicity	0	None
62827	62828	was	0	None
62828	62829	increased	0	None
62829	62830	by	0	None
62830	62831	the	0	None
62831	62832	transport	0	None
62832	62833	inhibitor	0	None
62833	62834	l	0	None
62834	62835	-	0	None
62835	62836	trans	0	None
62836	62837	-	0	None
62837	62838	pyrrolidine	0	None
62838	62839	-	0	None
62839	62840	2	0	None
62840	62841	,	0	None
62841	62842	4	0	None
62842	62843	-	0	None
62843	62844	dicarboxylic	0	None
62844	62845	acid	0	None
62845	62846	,	0	None
62846	62847	the	0	None
62847	62848	neuroprotective	0	None
62848	62849	effects	0	None
62849	62850	of	0	None
62850	62851	haloperidol	3	CHEMICAL
62851	62852	were	0	None
62852	62853	significantly	0	None
62853	62854	diminished	0	None
62854	62855	.	0	None

62856	62857	This	0	None
62857	62858	was	0	None
62858	62859	likely	0	None
62859	62860	because	0	None
62860	62861	of	0	None
62861	62862	the	0	None
62862	62863	fact	0	None
62863	62864	that	0	None
62864	62865	glutamate	3	CHEMICAL
62865	62866	,	0	None
62866	62867	now	0	None
62867	62868	toxic	0	None
62868	62869	at	0	None
62869	62870	much	0	None
62870	62871	lower	0	None
62871	62872	concentrations	0	None
62872	62873	,	0	None
62873	62874	was	0	None
62874	62875	able	0	None
62875	62876	to	0	None
62876	62877	reach	0	None
62877	62878	and	0	None
62878	62879	activate	0	None
62879	62880	dendritic	0	None
62880	62881	receptors	0	None
62881	62882	under	0	None
62882	62883	these	0	None
62883	62884	conditions	0	None
62884	62885	.	0	None

62886	62887	These	0	None
62887	62888	results	0	None
62888	62889	strongly	0	None
62889	62890	argue	0	None
62890	62891	that	0	None
62891	62892	exogenous	0	None
62892	62893	glutamate	3	CHEMICAL
62893	62894	and	0	None
62894	62895	NMDA	3	CHEMICAL
62895	62896	normally	0	None
62896	62897	induce	0	None
62897	62898	excitotoxicity	0	None
62898	62899	at	0	None
62899	62900	distinct	0	None
62900	62901	cellular	0	None
62901	62902	locations	0	None
62902	62903	in	0	None
62903	62904	mature	0	None
62904	62905	mixed	0	None
62905	62906	neuronal	0	None
62906	62907	cultures	0	None
62907	62908	and	0	None
62908	62909	that	0	None
62909	62910	NR1	1	GENE-Y
62910	62911	/	0	None
62911	62912	NR2B	1	GENE-Y
62912	62913	receptors	0	None
62913	62914	remain	0	None
62914	62915	an	0	None
62915	62916	important	0	None
62916	62917	component	0	None
62917	62918	in	0	None
62918	62919	the	0	None
62919	62920	expression	0	None
62920	62921	of	0	None
62921	62922	glutamate	3	CHEMICAL
62922	62923	,	0	None
62923	62924	but	0	None
62924	62925	not	0	None
62925	62926	NMDA	3	CHEMICAL
62926	62927	-	0	None
62927	62928	induced	0	None
62928	62929	excitotoxicity	0	None
62929	62930	.	0	None

62931	62932	In	0	None
62932	62933	-	0	None
62933	62934	vivo	0	None
62934	62935	assessment	0	None
62935	62936	of	0	None
62936	62937	5	0	None
62937	62938	-	0	None
62938	62939	HT2A	0	None
62939	62940	and	0	None
62940	62941	5	0	None
62941	62942	-	0	None
62942	62943	HT2C	0	None
62943	62944	antagonistic	0	None
62944	62945	properties	0	None
62945	62946	of	0	None
62946	62947	newer	0	None
62947	62948	antipsychotics	0	None
62948	62949	.	0	None

62950	62951	The	0	None
62951	62952	effects	0	None
62952	62953	of	0	None
62953	62954	serotonin	3	CHEMICAL
62954	62955	(	0	None
62955	62956	5	0	None
62956	62957	-	0	None
62957	62958	HT	3	CHEMICAL
62958	62959	)	0	None
62959	62960	receptor	0	None
62960	62961	ligands	0	None
62961	62962	on	0	None
62962	62963	the	0	None
62963	62964	MK	1	GENE-Y
62964	62965	212	0	None
62965	62966	(	0	None
62966	62967	6	0	None
62967	62968	-	0	None
62968	62969	chloro	3	CHEMICAL
62969	62970	-	0	None
62970	62971	2	0	None
62971	62972	[	0	None
62972	62973	1	0	None
62973	62974	-	0	None
62974	62975	piperazinyl	0	None
62975	62976	]	0	None
62976	62977	pyrazine	0	None
62977	62978	)	0	None
62978	62979	discriminative	0	None
62979	62980	stimulus	0	None
62980	62981	and	0	None
62981	62982	quipazine	3	CHEMICAL
62982	62983	-	0	None
62983	62984	induced	0	None
62984	62985	head	0	None
62985	62986	twitches	0	None
62986	62987	were	0	None
62987	62988	studied	0	None
62988	62989	in	0	None
62989	62990	rats	0	None
62990	62991	.	0	None

62992	62993	5	0	None
62993	62994	-	0	None
62994	62995	HT1A	0	None
62995	62996	(	0	None
62996	62997	8	0	None
62997	62998	-	0	None
62998	62999	OH	0	None
62999	63000	-	0	None
63000	63001	DPAT	0	None
63001	63002	)	0	None
63002	63003	and	0	None
63003	63004	preferential	0	None
63004	63005	5	0	None
63005	63006	-	0	None
63006	63007	HT2A	0	None
63007	63008	(	0	None
63008	63009	DOI	0	None
63009	63010	)	0	None
63010	63011	receptor	0	None
63011	63012	agonists	0	None
63012	63013	did	0	None
63013	63014	not	0	None
63014	63015	generalize	0	None
63015	63016	to	0	None
63016	63017	the	0	None
63017	63018	discriminative	0	None
63018	63019	stimulus	0	None
63019	63020	.	0	None

63021	63022	The	0	None
63022	63023	5	0	None
63023	63024	-	0	None
63024	63025	HT2B	0	None
63025	63026	/	0	None
63026	63027	2C	0	None
63027	63028	-	0	None
63028	63029	receptor	0	None
63029	63030	antagonist	0	None
63030	63031	,	0	None
63031	63032	SB	0	None
63032	63033	206553	0	None
63033	63034	(	0	None
63034	63035	5	0	None
63035	63036	-	0	None
63036	63037	methyl	3	CHEMICAL
63037	63038	-	0	None
63038	63039	1	0	None
63039	63040	-	0	None
63040	63041	(	0	None
63041	63042	3	0	None
63042	63043	-	0	None
63043	63044	pyridylcarbamoyl	0	None
63044	63045	)	0	None
63045	63046	-	0	None
63046	63047	1	0	None
63047	63048	,	0	None
63048	63049	2	0	None
63049	63050	,	0	None
63050	63051	3	0	None
63051	63052	,	0	None
63052	63053	5	0	None
63053	63054	-	0	None
63054	63055	tetrahydropyrrolo	0	None
63055	63056	[	0	None
63056	63057	2	0	None
63057	63058	,	0	None
63058	63059	3	0	None
63059	63060	-	0	None
63060	63061	f	0	None
63061	63062	]	0	None
63062	63063	indole	0	None
63063	63064	)	0	None
63064	63065	,	0	None
63065	63066	and	0	None
63066	63067	the	0	None
63067	63068	5	0	None
63068	63069	-	0	None
63069	63070	HT2A	0	None
63070	63071	/	0	None
63071	63072	2C	0	None
63072	63073	-	0	None
63073	63074	receptor	0	None
63074	63075	antagonist	0	None
63075	63076	,	0	None
63076	63077	ritanserin	0	None
63077	63078	,	0	None
63078	63079	acted	0	None
63079	63080	as	0	None
63080	63081	potent	0	None
63081	63082	antagonists	0	None
63082	63083	,	0	None
63083	63084	whereas	0	None
63084	63085	the	0	None
63085	63086	5	0	None
63086	63087	-	0	None
63087	63088	HT2A	0	None
63088	63089	-	0	None
63089	63090	receptor	0	None
63090	63091	antagonist	0	None
63091	63092	,	0	None
63092	63093	MDL	0	None
63093	63094	100	0	None
63094	63095	.	0	None
63095	63096	151	0	None
63096	63097	(	0	None
63097	63098	[	0	None
63098	63099	(	0	None
63099	63100	+	0	None
63100	63101	/	0	None
63101	63102	-	0	None
63102	63103	)	0	None
63103	63104	-	0	None
63104	63105	alpha	0	None
63105	63106	-	0	None
63106	63107	(	0	None
63107	63108	2	0	None
63108	63109	,	0	None
63109	63110	3	0	None
63110	63111	-	0	None
63111	63112	dimethoxyphenyl	0	None
63112	63113	)	0	None
63113	63114	-	0	None
63114	63115	1	0	None
63115	63116	-	0	None
63116	63117	[	0	None
63117	63118	2	0	None
63118	63119	-	0	None
63119	63120	(	0	None
63120	63121	4	0	None
63121	63122	-	0	None
63122	63123	fluorophenylethyl	0	None
63123	63124	)	0	None
63124	63125	]	0	None
63125	63126	-	0	None
63126	63127	4	0	None
63127	63128	-	0	None
63128	63129	piperidine	3	CHEMICAL
63129	63130	-	0	None
63130	63131	methanol	0	None
63131	63132	)	0	None
63132	63133	,	0	None
63133	63134	produced	0	None
63134	63135	minor	0	None
63135	63136	and	0	None
63136	63137	inconsistent	0	None
63137	63138	inhibition	0	None
63138	63139	.	0	None

63140	63141	SB	0	None
63141	63142	206553	0	None
63142	63143	was	0	None
63143	63144	a	0	None
63144	63145	weak	0	None
63145	63146	antagonist	0	None
63146	63147	against	0	None
63147	63148	quipazine	3	CHEMICAL
63148	63149	-	0	None
63149	63150	induced	0	None
63150	63151	head	0	None
63151	63152	twitches	0	None
63152	63153	,	0	None
63153	63154	whereas	0	None
63154	63155	MDL	0	None
63155	63156	100	0	None
63156	63157	.	0	None
63157	63158	151	0	None
63158	63159	and	0	None
63159	63160	ritanserin	0	None
63160	63161	were	0	None
63161	63162	potent	0	None
63162	63163	antagonists	0	None
63163	63164	.	0	None

63165	63166	This	0	None
63166	63167	suggests	0	None
63167	63168	that	0	None
63168	63169	the	0	None
63169	63170	MK	1	GENE-Y
63170	63171	212	0	None
63171	63172	discriminative	0	None
63172	63173	stimulus	0	None
63173	63174	is	0	None
63174	63175	mediated	0	None
63175	63176	by	0	None
63176	63177	5	0	None
63177	63178	-	0	None
63178	63179	HT2C	0	None
63179	63180	receptors	0	None
63180	63181	,	0	None
63181	63182	while	0	None
63182	63183	quipazine	3	CHEMICAL
63183	63184	-	0	None
63184	63185	induced	0	None
63185	63186	head	0	None
63186	63187	twitches	0	None
63187	63188	are	0	None
63188	63189	mediated	0	None
63189	63190	primarily	0	None
63190	63191	by	0	None
63191	63192	5	0	None
63192	63193	-	0	None
63193	63194	HT2A	0	None
63194	63195	receptors	0	None
63195	63196	.	0	None

63197	63198	The	0	None
63198	63199	effects	0	None
63199	63200	on	0	None
63200	63201	quipazine	3	CHEMICAL
63201	63202	-	0	None
63202	63203	induced	0	None
63203	63204	head	0	None
63204	63205	twitches	0	None
63205	63206	were	0	None
63206	63207	comparable	0	None
63207	63208	to	0	None
63208	63209	previously	0	None
63209	63210	published	0	None
63210	63211	effects	0	None
63211	63212	on	0	None
63212	63213	the	0	None
63213	63214	DOI	0	None
63214	63215	discriminative	0	None
63215	63216	stimulus	0	None
63216	63217	.	0	None

63218	63219	5	0	None
63219	63220	-	0	None
63220	63221	HT2A	0	None
63221	63222	-	0	None
63222	63223	and	0	None
63223	63224	5	0	None
63224	63225	-	0	None
63225	63226	HT2C	0	None
63226	63227	-	0	None
63227	63228	receptor	0	None
63228	63229	antagonistic	0	None
63229	63230	potencies	0	None
63230	63231	of	0	None
63231	63232	clozapine	3	CHEMICAL
63232	63233	,	0	None
63233	63234	olanzapine	3	CHEMICAL
63234	63235	,	0	None
63235	63236	risperidone	3	CHEMICAL
63236	63237	,	0	None
63237	63238	sertindole	3	CHEMICAL
63238	63239	and	0	None
63239	63240	ziprasidone	3	CHEMICAL
63240	63241	were	0	None
63241	63242	compared	0	None
63242	63243	in	0	None
63243	63244	the	0	None
63244	63245	same	0	None
63245	63246	models	0	None
63246	63247	.	0	None

63248	63249	Clozapine	0	None
63249	63250	showed	0	None
63250	63251	similar	0	None
63251	63252	potencies	0	None
63252	63253	in	0	None
63253	63254	both	0	None
63254	63255	models	0	None
63255	63256	,	0	None
63256	63257	while	0	None
63257	63258	sertindole	3	CHEMICAL
63258	63259	,	0	None
63259	63260	olanzapine	3	CHEMICAL
63260	63261	and	0	None
63261	63262	risperidone	3	CHEMICAL
63262	63263	inhibited	0	None
63263	63264	quipazine	3	CHEMICAL
63264	63265	-	0	None
63265	63266	induced	0	None
63266	63267	effects	0	None
63267	63268	more	0	None
63268	63269	potently	0	None
63269	63270	than	0	None
63270	63271	the	0	None
63271	63272	MK	1	GENE-Y
63272	63273	212	0	None
63273	63274	discriminative	0	None
63274	63275	stimulus	0	None
63275	63276	.	0	None

63277	63278	Ziprasidone	0	None
63278	63279	exerted	0	None
63279	63280	a	0	None
63280	63281	minor	0	None
63281	63282	preference	0	None
63282	63283	for	0	None
63283	63284	5	0	None
63284	63285	-	0	None
63285	63286	HT2A	0	None
63286	63287	-	0	None
63287	63288	compared	0	None
63288	63289	to	0	None
63289	63290	5	0	None
63290	63291	-	0	None
63291	63292	HT2C	0	None
63292	63293	-	0	None
63293	63294	receptor	0	None
63294	63295	-	0	None
63295	63296	mediated	0	None
63296	63297	effects	0	None
63297	63298	.	0	None

63299	63300	The	0	None
63300	63301	ratio	0	None
63301	63302	between	0	None
63302	63303	in	0	None
63303	63304	vivo	0	None
63304	63305	inhibitory	0	None
63305	63306	potencies	0	None
63306	63307	at	0	None
63307	63308	5	0	None
63308	63309	-	0	None
63309	63310	HT2A	0	None
63310	63311	and	0	None
63311	63312	5	0	None
63312	63313	-	0	None
63313	63314	HT2C	0	None
63314	63315	receptors	0	None
63315	63316	did	0	None
63316	63317	not	0	None
63317	63318	correlate	0	None
63318	63319	with	0	None
63319	63320	corresponding	0	None
63320	63321	ratios	0	None
63321	63322	from	0	None
63322	63323	in	0	None
63323	63324	-	0	None
63324	63325	vitro	0	None
63325	63326	affinity	0	None
63326	63327	and	0	None
63327	63328	ex	0	None
63328	63329	-	0	None
63329	63330	vivo	0	None
63330	63331	occupancy	0	None
63331	63332	studies	0	None
63332	63333	in	0	None
63333	63334	the	0	None
63334	63335	literature	0	None
63335	63336	.	0	None

63337	63338	The	0	None
63338	63339	aromatic	3	CHEMICAL
63339	63340	-	0	None
63340	63341	L	0	None
63341	63342	-	0	None
63342	63345	amino acid decarboxylase	2	GENE-N
63345	63346	inhibitor	0	None
63346	63347	carbidopa	3	CHEMICAL
63347	63348	is	0	None
63348	63349	selectively	0	None
63349	63350	cytotoxic	0	None
63350	63351	to	0	None
63351	63352	human	0	None
63352	63353	pulmonary	0	None
63353	63354	carcinoid	0	None
63354	63355	and	0	None
63355	63356	small	0	None
63356	63357	cell	0	None
63357	63358	lung	0	None
63358	63359	carcinoma	0	None
63359	63360	cells	0	None
63360	63361	.	0	None

63362	63363	The	0	None
63363	63364	carcinoid	0	None
63364	63365	tumor	0	None
63365	63366	is	0	None
63366	63367	an	0	None
63367	63368	uncommon	0	None
63368	63369	neuroendocrine	0	None
63369	63370	neoplasm	0	None
63370	63371	the	0	None
63371	63372	hallmark	0	None
63372	63373	of	0	None
63373	63374	which	0	None
63374	63375	is	0	None
63375	63376	excessive	0	None
63376	63377	serotonin	3	CHEMICAL
63377	63378	production	0	None
63378	63379	.	0	None

63380	63381	In	0	None
63381	63382	studying	0	None
63382	63383	kinetics	0	None
63383	63384	of	0	None
63384	63386	tryptophan hydroxylase	1	GENE-Y
63386	63387	and	0	None
63387	63388	aromatic	3	CHEMICAL
63388	63389	-	0	None
63389	63390	L	0	None
63390	63391	-	0	None
63391	63394	amino acid decarboxylase	2	GENE-N
63394	63395	(	0	None
63395	63396	AAAD	0	None
63396	63397	)	0	None
63397	63398	in	0	None
63398	63399	human	0	None
63399	63400	carcinoid	0	None
63400	63401	hepatic	0	None
63401	63402	metastases	0	None
63402	63403	and	0	None
63403	63404	adjacent	0	None
63404	63405	normal	0	None
63405	63406	liver	0	None
63406	63407	(	0	None
63407	63408	J	0	None
63408	63409	.	0	None
63409	63410	A	0	None
63410	63411	.	0	None
63411	63412	Gilbert	0	None
63412	63413	et	0	None
63413	63414	al	0	None
63414	63415	,	0	None
63415	63416	Biochem	0	None
63416	63417	.	0	None
63417	63418	Pharmacol	0	None
63418	63419	.	0	None
63419	63420	,	0	None
63420	63421	50	0	None
63421	63422	:	0	None
63422	63423	845	0	None
63423	63424	-	0	None
63424	63425	850	0	None
63425	63426	,	0	None
63426	63427	1995	0	None
63427	63428	)	0	None
63428	63429	,	0	None
63429	63430	we	0	None
63430	63431	identified	0	None
63431	63432	one	0	None
63432	63433	significant	0	None
63433	63434	difference	0	None
63434	63435	:	0	None
63435	63436	the	0	None
63436	63437	Vmax	0	None
63437	63438	of	0	None
63438	63439	carcinoid	0	None
63439	63440	AAAD	0	None
63440	63441	was	0	None
63441	63442	50	0	None
63442	63443	-	0	None
63443	63444	fold	0	None
63444	63445	higher	0	None
63445	63446	than	0	None
63446	63447	that	0	None
63447	63448	in	0	None
63448	63449	normal	0	None
63449	63450	liver	0	None
63450	63451	.	0	None

63452	63453	Here	0	None
63453	63454	,	0	None
63454	63455	we	0	None
63455	63456	report	0	None
63456	63457	Western	0	None
63457	63458	and	0	None
63458	63459	Northern	0	None
63459	63460	analyses	0	None
63460	63461	detecting	0	None
63461	63462	large	0	None
63462	63463	quantities	0	None
63463	63464	of	0	None
63464	63465	AAAD	0	None
63465	63466	polypeptide	0	None
63466	63467	and	0	None
63467	63468	mRNA	0	None
63468	63469	in	0	None
63469	63470	human	0	None
63470	63471	carcinoid	0	None
63471	63472	primary	0	None
63472	63473	as	0	None
63473	63474	well	0	None
63474	63475	as	0	None
63475	63476	metastatic	0	None
63476	63477	tumors	0	None
63477	63478	compared	0	None
63478	63479	with	0	None
63479	63480	normal	0	None
63480	63481	surrounding	0	None
63481	63482	tissues	0	None
63482	63483	.	0	None

63484	63485	To	0	None
63485	63486	assess	0	None
63486	63487	the	0	None
63487	63488	feasibility	0	None
63488	63489	of	0	None
63489	63490	targeting	0	None
63490	63491	these	0	None
63491	63492	high	0	None
63492	63493	AAAD	0	None
63493	63494	levels	0	None
63494	63495	for	0	None
63495	63496	chemotherapy	0	None
63496	63497	,	0	None
63497	63498	AAAD	0	None
63498	63499	inhibitors	0	None
63499	63500	carbidopa	3	CHEMICAL
63500	63501	(	0	None
63501	63502	alpha	0	None
63502	63503	-	0	None
63503	63504	methyl	3	CHEMICAL
63504	63505	-	0	None
63505	63506	dopahydrazine	0	None
63506	63507	)	0	None
63507	63508	,	0	None
63508	63509	alpha	0	None
63509	63510	-	0	None
63510	63511	monofluoromethyldopa	0	None
63511	63512	(	0	None
63512	63513	MFMD	0	None
63513	63514	)	0	None
63514	63515	,	0	None
63515	63516	and	0	None
63516	63517	3	0	None
63517	63518	-	0	None
63518	63519	hydroxybenzylhydrazine	0	None
63519	63520	(	0	None
63520	63521	NSD	0	None
63521	63522	-	0	None
63522	63523	1015	0	None
63523	63524	)	0	None
63524	63525	were	0	None
63525	63526	incubated	0	None
63526	63527	(	0	None
63527	63528	72	0	None
63528	63529	h	0	None
63529	63530	)	0	None
63530	63531	with	0	None
63531	63532	NCI	0	None
63532	63533	-	0	None
63533	63534	H727	0	None
63534	63535	human	0	None
63535	63536	lung	0	None
63536	63537	carcinoid	0	None
63537	63538	cells	0	None
63538	63539	.	0	None

63540	63541	Carbidopa	0	None
63541	63542	and	0	None
63542	63543	MFMD	0	None
63543	63544	were	0	None
63544	63545	lethal	0	None
63545	63546	(	0	None
63546	63547	IC50	0	None
63547	63548	=	0	None
63548	63549	29	0	None
63549	63550	+	0	None
63550	63551	/	0	None
63551	63552	-	0	None
63552	63553	2	0	None
63553	63554	microM	0	None
63554	63555	and	0	None
63555	63556	56	0	None
63556	63557	+	0	None
63557	63558	/	0	None
63558	63559	-	0	None
63559	63560	6	0	None
63560	63561	microM	0	None
63561	63562	,	0	None
63562	63563	respectively	0	None
63563	63564	)	0	None
63564	63565	;	0	None
63565	63566	NSD	0	None
63566	63567	-	0	None
63567	63568	1015	0	None
63568	63569	had	0	None
63569	63570	no	0	None
63570	63571	effect	0	None
63571	63572	on	0	None
63572	63573	proliferation	0	None
63573	63574	.	0	None

63575	63576	On	0	None
63576	63577	exposure	0	None
63577	63578	to	0	None
63578	63579	other	0	None
63579	63580	human	0	None
63580	63581	tumor	0	None
63581	63582	lines	0	None
63582	63583	,	0	None
63583	63584	carbidopa	3	CHEMICAL
63584	63585	was	0	None
63585	63586	lethal	0	None
63586	63587	only	0	None
63587	63588	to	0	None
63588	63589	NCI	0	None
63589	63590	-	0	None
63590	63591	H146	0	None
63591	63592	and	0	None
63592	63593	NCI	0	None
63593	63594	-	0	None
63594	63595	H209	0	None
63595	63596	small	0	None
63596	63597	cell	0	None
63597	63598	lung	0	None
63598	63599	carcinoma	0	None
63599	63600	(	0	None
63600	63601	SCLC	0	None
63601	63602	)	0	None
63602	63603	lines	0	None
63603	63604	(	0	None
63604	63605	IC50	0	None
63605	63606	=	0	None
63606	63607	12	0	None
63607	63608	+	0	None
63608	63609	/	0	None
63609	63610	-	0	None
63610	63611	1	0	None
63611	63612	microM	0	None
63612	63613	and	0	None
63613	63614	22	0	None
63614	63615	+	0	None
63615	63616	/	0	None
63616	63617	-	0	None
63617	63618	5	0	None
63618	63619	microM	0	None
63619	63620	,	0	None
63620	63621	respectively	0	None
63621	63622	)	0	None
63622	63623	.	0	None

63624	63625	Carbidopa	0	None
63625	63626	(	0	None
63626	63627	100	0	None
63627	63628	microM	0	None
63628	63629	)	0	None
63629	63630	decreased	0	None
63630	63631	growth	0	None
63631	63632	of	0	None
63632	63633	(	0	None
63633	63634	but	0	None
63634	63635	did	0	None
63635	63636	not	0	None
63636	63637	kill	0	None
63637	63638	)	0	None
63638	63639	SK	2	GENE-N
63639	63640	-	0	None
63640	63641	N	0	None
63641	63642	-	0	None
63642	63643	SH	3	CHEMICAL
63643	63644	neuroblastoma	0	None
63644	63645	and	0	None
63645	63646	A204	0	None
63646	63647	rhabdomyosarcoma	0	None
63647	63648	cells	0	None
63648	63649	and	0	None
63649	63650	did	0	None
63650	63651	not	0	None
63651	63652	affect	0	None
63652	63653	proliferation	0	None
63653	63654	of	0	None
63654	63655	DU	0	None
63655	63656	145	0	None
63656	63657	prostate	0	None
63657	63658	,	0	None
63658	63659	MCF7	0	None
63659	63660	breast	0	None
63660	63661	,	0	None
63661	63662	or	0	None
63662	63663	NCI	0	None
63663	63664	-	0	None
63664	63665	H460	0	None
63665	63666	large	0	None
63666	63667	cell	0	None
63667	63668	lung	0	None
63668	63669	carcinoma	0	None
63669	63670	lines	0	None
63670	63671	.	0	None

63672	63673	The	0	None
63673	63674	rank	1	GENE-Y
63674	63675	order	0	None
63675	63676	of	0	None
63676	63677	lines	0	None
63677	63678	by	0	None
63678	63679	AAAD	0	None
63679	63680	activity	0	None
63680	63681	was	0	None
63681	63682	NCI	0	None
63682	63683	-	0	None
63683	63684	H146	0	None
63684	63685	>	0	None
63685	63686	NCI	0	None
63686	63687	-	0	None
63687	63688	H209	0	None
63688	63689	>	0	None
63689	63690	SK	2	GENE-N
63690	63691	-	0	None
63691	63692	N	0	None
63692	63693	-	0	None
63693	63694	SH	3	CHEMICAL
63694	63695	>	0	None
63695	63696	NCI	0	None
63696	63697	-	0	None
63697	63698	H727	0	None
63698	63699	,	0	None
63699	63700	whereas	0	None
63700	63701	A204	0	None
63701	63702	,	0	None
63702	63703	DU	0	None
63703	63704	145	0	None
63704	63705	,	0	None
63705	63706	MCF7	0	None
63706	63707	,	0	None
63707	63708	and	0	None
63708	63709	NCI	0	None
63709	63710	-	0	None
63710	63711	H460	0	None
63711	63712	had	0	None
63712	63713	no	0	None
63713	63714	measurable	0	None
63714	63715	activity	0	None
63715	63716	.	0	None

63717	63718	For	0	None
63718	63719	lung	0	None
63719	63720	tumor	0	None
63720	63721	lines	0	None
63721	63722	(	0	None
63722	63723	carcinoid	0	None
63723	63724	,	0	None
63724	63725	two	0	None
63725	63726	SCLC	0	None
63726	63727	,	0	None
63727	63728	and	0	None
63728	63729	one	0	None
63729	63730	large	0	None
63730	63731	cell	0	None
63731	63732	lung	0	None
63732	63733	carcinoma	0	None
63733	63734	)	0	None
63734	63735	,	0	None
63735	63736	AAAD	0	None
63736	63737	activity	0	None
63737	63738	was	0	None
63738	63739	correlated	0	None
63739	63740	with	0	None
63740	63741	the	0	None
63741	63742	potency	0	None
63742	63743	of	0	None
63743	63744	carbidopa	3	CHEMICAL
63744	63745	-	0	None
63745	63746	induced	0	None
63746	63747	cytotoxicity	0	None
63747	63748	.	0	None

63749	63750	However	0	None
63750	63751	,	0	None
63751	63752	carcinoid	0	None
63752	63753	cell	0	None
63753	63754	death	0	None
63754	63755	was	0	None
63755	63756	not	0	None
63756	63757	solely	0	None
63757	63758	attributable	0	None
63758	63759	to	0	None
63759	63760	complete	0	None
63760	63761	inhibition	0	None
63761	63762	of	0	None
63762	63763	either	0	None
63763	63764	AAAD	0	None
63764	63765	activity	0	None
63765	63766	or	0	None
63766	63767	the	0	None
63767	63768	serotonin	3	CHEMICAL
63768	63769	synthetic	0	None
63769	63770	pathway	0	None
63770	63771	.	0	None

63772	63773	In	0	None
63773	63774	further	0	None
63774	63775	evaluating	0	None
63775	63776	potential	0	None
63776	63777	applications	0	None
63777	63778	of	0	None
63778	63779	these	0	None
63779	63780	findings	0	None
63780	63781	with	0	None
63781	63782	carbidopa	3	CHEMICAL
63782	63783	,	0	None
63783	63784	we	0	None
63784	63785	determined	0	None
63785	63786	that	0	None
63786	63787	sublethal	0	None
63787	63788	doses	0	None
63788	63789	of	0	None
63789	63790	carbidopa	3	CHEMICAL
63790	63791	produced	0	None
63791	63792	additive	0	None
63792	63793	cytotoxic	0	None
63793	63794	effects	0	None
63794	63795	in	0	None
63795	63796	carcinoid	0	None
63796	63797	cells	0	None
63797	63798	in	0	None
63798	63799	combination	0	None
63799	63800	with	0	None
63800	63801	etoposide	3	CHEMICAL
63801	63802	and	0	None
63802	63803	cytotoxic	0	None
63803	63804	synergy	0	None
63804	63805	in	0	None
63805	63806	SCLC	0	None
63806	63807	cells	0	None
63807	63808	when	0	None
63808	63809	coincubated	0	None
63809	63810	with	0	None
63810	63811	topotecan	0	None
63811	63812	.	0	None

63813	63814	Role	0	None
63814	63815	of	0	None
63815	63816	multidrug	0	None
63816	63817	-	0	None
63817	63818	resistance	0	None
63818	63819	protein	0	None
63819	63820	2	0	None
63820	63821	in	0	None
63821	63822	glutathione	3	CHEMICAL
63822	63823	S	0	None
63823	63824	-	0	None
63824	63825	transferase	0	None
63825	63826	P1	2	GENE-N
63826	63827	-	0	None
63827	63828	1	0	None
63828	63829	-	0	None
63829	63830	mediated	0	None
63830	63831	resistance	0	None
63831	63832	to	0	None
63832	63833	4	0	None
63833	63834	-	0	None
63834	63835	nitroquinoline	0	None
63835	63836	1	0	None
63836	63837	-	0	None
63837	63838	oxide	0	None
63838	63839	toxicities	0	None
63839	63840	in	0	None
63840	63841	HepG2	0	None
63841	63842	cells	0	None
63842	63843	.	0	None

63844	63845	Previous	0	None
63845	63846	studies	0	None
63846	63847	in	0	None
63847	63848	our	0	None
63848	63849	laboratory	0	None
63849	63850	have	0	None
63850	63851	shown	0	None
63851	63852	that	0	None
63852	63853	the	0	None
63853	63854	phase	0	None
63854	63855	III	1	GENE-Y
63855	63856	efflux	0	None
63856	63857	transporter	0	None
63857	63858	multidrug	0	None
63858	63859	-	0	None
63859	63860	resistance	0	None
63860	63861	protein	0	None
63861	63862	(	0	None
63862	63863	MRP	0	None
63863	63864	)	0	None
63864	63865	1	0	None
63865	63866	can	0	None
63866	63867	act	0	None
63867	63868	synergistically	0	None
63868	63869	with	0	None
63869	63870	the	0	None
63870	63871	phase	0	None
63871	63872	II	0	None
63872	63873	conjugating	0	None
63873	63875	glutathione S	3	CHEMICAL
63875	63876	-	0	None
63876	63877	transferases	2	GENE-N
63877	63878	(	0	None
63878	63879	GST	0	None
63879	63880	)	0	None
63880	63881	to	0	None
63881	63882	confer	0	None
63882	63883	resistance	0	None
63883	63884	to	0	None
63884	63885	the	0	None
63885	63886	toxicities	0	None
63886	63887	of	0	None
63887	63888	some	0	None
63888	63889	electrophilic	0	None
63889	63890	drugs	0	None
63890	63891	and	0	None
63891	63892	carcinogens	0	None
63892	63893	.	0	None

63894	63895	To	0	None
63895	63896	determine	0	None
63896	63897	whether	0	None
63897	63898	the	0	None
63898	63899	distinct	0	None
63899	63900	efflux	0	None
63900	63901	transporter	0	None
63901	63902	MRP2	0	None
63902	63903	could	0	None
63903	63904	also	0	None
63904	63905	potentiate	0	None
63905	63906	GST	0	None
63906	63907	-	0	None
63907	63908	mediated	0	None
63908	63909	protection	0	None
63909	63910	from	0	None
63910	63911	electrophilic	0	None
63911	63912	toxins	0	None
63912	63913	,	0	None
63913	63914	we	0	None
63914	63915	examined	0	None
63915	63916	the	0	None
63916	63917	effect	0	None
63917	63918	of	0	None
63918	63919	regulatable	0	None
63919	63920	GSTP1	1	GENE-Y
63920	63921	-	0	None
63921	63922	1	0	None
63922	63923	expression	0	None
63923	63924	in	0	None
63924	63925	MRP2	0	None
63925	63926	-	0	None
63926	63927	rich	0	None
63927	63928	HepG2	0	None
63928	63929	cells	0	None
63929	63930	on	0	None
63930	63931	4	0	None
63931	63932	-	0	None
63932	63933	nitroquinoline	0	None
63933	63934	1	0	None
63934	63935	-	0	None
63935	63936	oxide	0	None
63936	63937	(	0	None
63937	63938	4NQO	0	None
63938	63939	)	0	None
63939	63940	-	0	None
63940	63941	induced	0	None
63941	63942	cytotoxicity	0	None
63942	63943	and	0	None
63943	63944	genotoxicity	0	None
63944	63945	(	0	None
63945	63946	nucleic	0	None
63946	63947	-	0	None
63947	63948	acid	0	None
63948	63949	adduct	0	None
63949	63950	formation	0	None
63950	63951	)	0	None
63951	63952	.	0	None

63953	63954	Expression	0	None
63954	63955	of	0	None
63955	63956	GSTP1	1	GENE-Y
63956	63957	-	0	None
63957	63958	1	0	None
63958	63959	was	0	None
63959	63960	associated	0	None
63960	63961	with	0	None
63961	63962	a	0	None
63962	63963	fourfold	0	None
63963	63964	to	0	None
63964	63965	tenfold	0	None
63965	63966	protection	0	None
63966	63967	from	0	None
63967	63968	4NQO	0	None
63968	63969	-	0	None
63969	63970	induced	0	None
63970	63971	cytotoxicity	0	None
63971	63972	.	0	None

63973	63974	Inhibition	0	None
63974	63975	of	0	None
63975	63976	MRP2	0	None
63976	63977	-	0	None
63977	63978	mediated	0	None
63978	63979	efflux	0	None
63979	63980	activity	0	None
63980	63981	by	0	None
63981	63982	sulfinpyrazone	0	None
63982	63983	or	0	None
63983	63984	cyclosporin	0	None
63984	63985	A	0	None
63985	63986	completely	0	None
63986	63987	reversed	0	None
63987	63988	GSTP1	1	GENE-Y
63988	63989	-	0	None
63989	63990	1	0	None
63990	63991	-	0	None
63991	63992	associated	0	None
63992	63993	resistance	0	None
63993	63994	-	0	None
63994	63995	a	0	None
63995	63996	result	0	None
63996	63997	indicating	0	None
63997	63998	that	0	None
63998	63999	GSTP1	1	GENE-Y
63999	64000	-	0	None
64000	64001	1	0	None
64001	64002	-	0	None
64002	64003	mediated	0	None
64003	64004	cytoprotection	0	None
64004	64005	is	0	None
64005	64006	absolutely	0	None
64006	64007	dependent	0	None
64007	64008	on	0	None
64008	64009	MRP2	0	None
64009	64010	efflux	0	None
64010	64011	activity	0	None
64011	64012	.	0	None

